,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
16771,GO:0071944,1.70560321960249e-21,1,140,5014,cell periphery,CC,ITGA3;ITGA5;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;SLC52A3;ACVR1;NMT2;GUCY1B3;ADORA1;CASQ2;PLAU;RAB40B;RAB40A;PRKACB;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;FZD7;TYRO3;LPAR2;LIMS2;CDH2;FGF10;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;SNX18;AXIN1;RHOQ;RHOJ;RHOB;NPR1;SCIN;FGF8;SDC4;SPTB;HBEGF;LGALS4;BMP2;DLL1;RAB20;DRP2;SLC2A14;VAMP1;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;AKT1;PKP3;PKP1;RAB17;CYTIP;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;RAB44;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;KCNG2;LZTS1;CLDN23;SHC4;SLC18B1;DSC3;GPSM1;AMOT;KCND1;TSPAN2;RAB38;RAB3D;MYZAP;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PARVB;EFNB2;PDE4B
2856,GO:0005886,1.02135143355972e-20,1,137,4920,plasma membrane,CC,ITGA3;ITGA5;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;SLC52A3;ACVR1;NMT2;GUCY1B3;ADORA1;CASQ2;PLAU;RAB40B;RAB40A;PRKACB;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;FZD7;TYRO3;LPAR2;LIMS2;CDH2;FGF10;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;SNX18;AXIN1;RHOQ;RHOJ;RHOB;NPR1;FGF8;SDC4;SPTB;HBEGF;LGALS4;BMP2;DLL1;RAB20;DRP2;SLC2A14;VAMP1;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;AKT1;PKP3;PKP1;RAB17;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;BCAR1;GJA3;RAB44;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;KCNG2;LZTS1;CLDN23;SHC4;SLC18B1;DSC3;GPSM1;AMOT;KCND1;TSPAN2;RAB38;RAB3D;MYZAP;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PARVB;EFNB2;PDE4B
4668,GO:0009888,2.08698920060688e-19,1,76,1837,tissue development,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;DSC2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;PRKACB;FZD7;CDH2;FGF10;PDGFB;WNT5B;WNT5A;AXIN1;RHOB;SCIN;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;WNK4;MSN;DDR1;DSG3;CTGF;GJB2;AKT1;PKP3;PKP1;NRTN;WNT2B;KITLG;NPPC;NAB2;JAG2;MYO7A;CLDN1;CLDN3;CLDN5;PIK3CA;GAS6;MYH11;DSC3;VDR;LAMA5;GDNF;DUSP5;HEY1;ACTA2;EFNB2
3663,GO:0007155,2.02886776012397e-18,1,64,1311,cell adhesion,BP,ITGA3;ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;CDH23;ITGB5;ITGB4;ITGB8;DSC2;WNT7B;ACVR1;PLAU;MFGE8;TTYH1;FZD7;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;RHOB;SDC4;LGALS4;BMP7;BMP4;BMP2;CAMSAP3;DLL1;RND3;MSN;DDR1;DSG3;CTGF;AKT1;PKP3;PKP1;CYTIP;KITLG;JAG2;CDH1;BCAR1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;CLDN23;DSC3;LAMA1;LAMA5;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;PARVB;EFNB2
7112,GO:0022610,2.66313490488832e-18,1,64,1318,biological adhesion,BP,ITGA3;ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;CDH23;ITGB5;ITGB4;ITGB8;DSC2;WNT7B;ACVR1;PLAU;MFGE8;TTYH1;FZD7;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;RHOB;SDC4;LGALS4;BMP7;BMP4;BMP2;CAMSAP3;DLL1;RND3;MSN;DDR1;DSG3;CTGF;AKT1;PKP3;PKP1;CYTIP;KITLG;JAG2;CDH1;BCAR1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;CLDN23;DSC3;LAMA1;LAMA5;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;PARVB;EFNB2
13381,GO:0048731,5.05165734849293e-18,1,123,4323,system development,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;CDH23;STRA6;IGSF8;ITGB4;ITGB8;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOJ;RHOB;NPR1;PFKFB3;SCIN;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;DRP2;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;DSC3;GPSM1;VDR;AMOT;LAMA5;UNC119;TSPAN2;GDNF;ACSL4;FZD8;HEY1;ACTA2;CLDN11;CLDN18;EFNB2
11868,GO:0044707,3.59394684519993e-17,1,146,5907,single-multicellular organism process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOJ;RHOB;NPR1;PFKFB3;SCIN;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;PKN3;DRP2;SLC2A14;SFXN1;WNK4;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;TLE1;CLDN1;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;HAPLN3;DTX4;MYH11;LZTS1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;KCND1;TSPAN2;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;EFNB2;PDE4B
3751,GO:0007275,1.29726210427101e-16,1,129,4864,multicellular organism development,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOJ;RHOB;NPR1;PFKFB3;SCIN;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;EFNB2
13379,GO:0048729,1.32624531001154e-16,1,41,607,tissue morphogenesis,BP,ITGA3;ITGA5;ARTN;LIF;WNT3;WNT2;WNT4;NOTCH1;ITGB4;CRB2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;PRKACB;FZD7;FGF10;WNT5A;AXIN1;RHOB;FGF8;SDC4;HBEGF;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;MSN;DDR1;WNT2B;JAG2;VDR;LAMA5;GDNF;HEY1;ACTA2;EFNB2
7211,GO:0030054,2.39472521545746e-16,1,57,1164,cell junction,CC,ITGA3;ITGA5;TMEM163;SYT5;ACTN3;ACTN2;NOTCH1;ITGB5;ITGB4;DSC2;PLAU;SPTBN4;MPZL1;RRAS2;LIMS2;CDH2;PIK3R1;CGN;TJP3;JAM3;RHOB;SCIN;SDC4;CAMSAP3;DLL1;DRP2;VAMP1;WNK4;RND3;MSN;DSG3;GJB1;GJB2;GJB6;AKT1;PKP3;PKP1;CDH1;BCAR1;GJA3;CLDN1;CLDN2;CLDN3;CLDN5;LZTS1;CLDN23;SHC4;DSC3;AMOT;MYZAP;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;PARVB;EFNB2
11863,GO:0044700,3.28289272114356e-16,1,143,5938,single organism signaling,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;DHH;DSC2;WNT6;WNT7A;WNT7B;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;KCNK6;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;DDR1;CTGF;GJB1;GJB2;RRAD;AKT1;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;GJA3;SPSB1;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;ZCCHC12;LZTS1;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
7172,GO:0023052,3.7233662371587e-16,1,143,5945,signaling,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;DHH;DSC2;WNT6;WNT7A;WNT7B;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;KCNK6;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;DDR1;CTGF;GJB1;GJB2;RRAD;AKT1;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;GJA3;SPSB1;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;ZCCHC12;LZTS1;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
4617,GO:0009653,5.88842288263656e-16,1,83,2328,anatomical structure morphogenesis,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;WNT3;WNT2;WNT4;ACTN2;NOTCH1;STRA6;ITGB5;ITGB4;CRB2;CRISPLD2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;CASQ2;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;FZD7;TYRO3;LIMS2;CDH2;FGF10;PIK3R1;FOXO4;HRAS;WNT5A;JAM3;AXIN1;RHOQ;RHOJ;RHOB;NPR1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;DLL1;WNK4;MSN;DDR1;CTGF;GJB6;TPD52;NRTN;WNT2B;SEMA6C;NPPC;NAB2;JAG2;MYO7A;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;MYH11;LZTS1;VDR;AMOT;LAMA5;GDNF;FZD8;DUSP5;HEY1;ACTA2;PARVB;EFNB2
3662,GO:0007154,1.26027720666035e-15,1,142,5959,cell communication,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;DHH;DSC2;WNT6;WNT7A;WNT7B;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;DDR1;CTGF;GJB1;GJB2;GJB6;RRAD;AKT1;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;GJA3;SPSB1;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;ZCCHC12;LZTS1;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
13258,GO:0048513,1.77448984585698e-15,1,96,3169,animal organ development,BP,ITGA3;ARTN;TAGLN;FHOD3;LIF;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;CDH23;STRA6;IGSF8;ITGB4;ITGB8;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOJ;PFKFB3;SCIN;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;NRTN;WNT2B;KITLG;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN5;PIK3CA;GAS6;MYH11;DSC3;VDR;LAMA5;TSPAN2;GDNF;FZD8;HEY1;ACTA2;CLDN18;EFNB2
2446,GO:0005102,1.78697366939333e-15,1,58,1400,receptor binding,MF,ITGA3;ITGA5;ARTN;LIF;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;TF;ITGB4;ITGB8;DHH;WNT6;WNT7A;WNT7B;ADORA1;EDN1;MFGE8;CCL20;FZD7;FGF10;FGF17;PIK3R2;PIK3R1;REEP1;PDGFB;WNT5B;WNT5A;JAM3;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;MSN;CTGF;NRTN;WNT2B;KITLG;NPPC;JAG2;INHBB;PIK3CG;GAS6;SHC4;VDR;LAMA1;LAMA5;GDNF;FZD8;EFNB2
14949,GO:0060429,1.79748274728877e-15,1,54,1200,epithelium development,BP,ITGA5;TAGLN;LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;STRA6;CRB2;DSC2;WNT6;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;FZD7;CDH2;FGF10;PDGFB;WNT5B;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;WNK4;MSN;DDR1;DSG3;AKT1;PKP3;PKP1;WNT2B;JAG2;MYO7A;CLDN1;CLDN3;CLDN5;DSC3;VDR;LAMA5;GDNF;HEY1;ACTA2;EFNB2
5888,GO:0016338,1.83858193250566e-15,1,11,23,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,BMP2;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
13440,GO:0048856,2.19825818640638e-15,1,133,5288,anatomical structure development,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;SCIN;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;PARVB;EFNB2
11898,GO:0044767,5.7513501545261e-15,1,137,5610,single-organism developmental process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;SCIN;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;RAB38;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;PARVB;EFNB2
3673,GO:0007165,6.41400862072923e-15,1,132,5449,signal transduction,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;DHH;WNT6;WNT7A;WNT7B;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;DDR1;CTGF;RRAD;AKT1;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;SPSB1;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;DTX4;ZCCHC12;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
8550,GO:0032501,6.950857016191e-15,1,152,6860,multicellular organismal process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;ACVR1;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOJ;RHOB;NPR1;PFKFB3;SCIN;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;PKN3;DRP2;SLC2A14;ESPN;SFXN1;WNK4;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;TLE1;CLDN1;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;HAPLN3;DTX4;MYH11;LZTS1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;KCND1;TSPAN2;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;EFNB2;PDE4B
7263,GO:0030154,7.3608119565902e-15,1,105,3698,cell differentiation,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;CDH23;ITGB5;ITGB4;CRB2;DHH;DSC2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;CASQ2;EDN1;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOB;SCIN;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;SLC2A14;SFXN1;MSN;DDR1;DSG3;CTGF;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;MYO7A;INHBB;CLDN1;CLDN3;CLDN5;PIK3CA;GAS6;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;UNC119;TSPAN2;RAB38;GDNF;ACSL4;FZD8;HEY1;ACTA2;CLDN18;EFNB2
13450,GO:0048869,7.84016104267907e-15,1,108,3868,cellular developmental process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;CDH23;ITGB5;ITGB4;CRB2;DHH;DSC2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;CASQ2;EDN1;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOQ;RHOJ;RHOB;SCIN;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;SLC2A14;SFXN1;MSN;DDR1;DSG3;CTGF;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;MYO7A;INHBB;CLDN1;CLDN3;CLDN5;PIK3CA;GAS6;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;UNC119;TSPAN2;RAB38;GDNF;ACSL4;FZD8;HEY1;ACTA2;CLDN18;PARVB;EFNB2
7621,GO:0030855,1.24019352032509e-14,1,39,708,epithelial cell differentiation,BP,TAGLN;LIF;WNT4;POU3F1;NOTCH1;DSC2;WNT7A;WNT7B;ACVR1;FZD7;CDH2;FGF10;PDGFB;WNT5B;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;MSN;DSG3;AKT1;PKP3;PKP1;JAG2;MYO7A;CLDN1;CLDN3;CLDN5;DSC3;VDR;LAMA5;GDNF;HEY1;ACTA2
8551,GO:0032502,2.0037410269391e-14,1,137,5693,developmental process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;SCIN;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;RAB38;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;PARVB;EFNB2
3675,GO:0007167,3.65221694303682e-14,1,48,963,enzyme linked receptor protein signaling pathway,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT4;NOTCH1;RASL11B;ITGB5;CRB2;ACVR1;ADORA1;DKK3;MPZL1;MAPK12;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;FOXO4;HRAS;WNT5A;RHOQ;NPR1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;DDR1;CTGF;AKT1;NRTN;NPPC;EPN1;BCAR1;INHBB;CLDN5;PIK3CA;GAS6;ZCCHC12;SHC4;EFNB2
3674,GO:0007166,5.85423778967551e-14,1,82,2540,cell surface receptor signaling pathway,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;TSPAN15;TSPAN17;NOTCH1;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;CRB2;DHH;WNT6;WNT7A;WNT7B;ACVR1;ADORA1;DKK3;EDN1;PRKACB;CCL20;MPZL1;TSPAN13;MAPK12;FZD7;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;AXIN1;RHOQ;NPR1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;DDR1;CTGF;AKT1;NRTN;WNT2B;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;TLE1;CLDN5;PIK3CA;GAS6;DTX4;ZCCHC12;SHC4;LAMA1;LAMA5;TSPAN2;GDNF;FZD8;HEY1;CLDN18;EFNB2;PDE4B
17018,GO:0072358,7.50970798319734e-14,1,37,596,cardiovascular system development,BP,ITGA5;LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;CRB2;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RHOJ;RHOB;NPR1;FGF8;BMP7;BMP4;WT1;DLL1;CTGF;AKT1;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
16787,GO:0072001,9.20025593818897e-14,1,26,278,renal system development,BP,ITGA3;LIF;WNT4;NOTCH1;STRA6;ITGB4;WNT6;WNT7B;FSTL3;FGF10;PDGFB;WNT5A;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2;EFNB2
8796,GO:0032879,1.05272820558141e-13,1,79,2401,regulation of localization,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT4;ACTN2;NOTCH1;RAB27A;TF;PMAIP1;DSC2;WNT7A;ACVR1;ADORA1;CASQ2;EDN1;PLAU;KCNK6;MFGE8;CCL20;SPTBN4;TTYH1;RRAS2;TSPAN13;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;SESN2;RHOQ;RHOB;NPR1;SCIN;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;RAB20;WNK4;CHGA;MSN;AKT1;RAB17;KITLG;JAG2;CDH1;BCAR1;INHBB;PIK3CG;RAB11FIP1;KCNG2;GAS6;AMOT;LAMA1;LAMA5;UNC119;KCND1;RAB3D;GDNF;CLDN18;PDE4B
13236,GO:0048468,1.47204877667289e-13,1,68,1834,cell development,BP,ITGA3;ARTN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CDH23;DHH;WNT7A;WNT7B;ZFPM1;ACVR1;CASQ2;EDN1;SPTBN5;SPTBN4;FZD7;TYRO3;CDH2;PIK3R1;PDGFB;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;MSN;DDR1;AKT1;RAB17;NRTN;KITLG;SEMA6C;NPPC;CDH1;MYO7A;INHBB;CLDN1;CLDN3;CLDN5;PIK3CA;MYH11;LZTS1;LAMA5;TSPAN2;GDNF;ACSL4;ACTA2;CLDN18
2871,GO:0005911,1.87246986930406e-13,1,30,394,cell-cell junction,CC,ITGA5;DSC2;CDH2;PIK3R1;CGN;TJP3;JAM3;CAMSAP3;WNK4;DSG3;GJB1;GJB2;GJB6;AKT1;PKP3;PKP1;CDH1;GJA3;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;DSC3;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
4854,GO:0010562,1.8746897749161e-13,1,47,1022,positive regulation of phosphorus metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CHGA;CTGF;AKT1;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
12436,GO:0045937,1.8746897749161e-13,1,47,1022,positive regulation of phosphate metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CHGA;CTGF;AKT1;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
768,GO:0001944,2.40464094067877e-13,1,36,587,vasculature development,BP,ITGA5;LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RHOJ;RHOB;NPR1;FGF8;BMP7;BMP4;WT1;DLL1;CTGF;AKT1;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
13330,GO:0048646,2.44004476231882e-13,1,46,941,anatomical structure formation involved in morphogenesis,BP,ITGA3;ITGA5;FHOD3;WNT3;WNT2;WNT4;ACTN2;NOTCH1;STRA6;ITGB5;ITGB4;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;CASQ2;EDN1;PRKACB;MFGE8;FZD7;FGF10;FOXO4;WNT5A;JAM3;AXIN1;RHOB;NPR1;FGF8;SDC4;BMP7;BMP4;WT1;DLL1;CTGF;WNT2B;PIK3CA;PIK3CG;MYH11;AMOT;LAMA5;GDNF;FZD8;DUSP5;HEY1;EFNB2
759,GO:0001934,2.53572873053865e-13,1,43,868,positive regulation of protein phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
17019,GO:0072359,2.68218619030404e-13,1,45,901,circulatory system development,BP,ITGA3;ITGA5;FHOD3;LIF;WNT2;WNT4;ACTN2;NOTCH1;STRA6;ITGB8;CRB2;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;MFGE8;FZD7;CDH2;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RHOJ;RHOB;NPR1;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;CTGF;AKT1;CLDN5;PIK3CA;PIK3CG;MYH11;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
3537,GO:0006928,2.91968170641351e-13,1,65,1768,movement of cell or subcellular component,BP,ITGA3;ITGA5;ARTN;WNT3;WNT4;ACTN3;ACTN2;NOTCH1;IGSF8;ITGB4;CRB2;DSC2;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;RRAS2;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;BMP2;B3GNT2;PKN3;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;SEMA6C;JAG2;MYO7A;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
18089,GO:0098609,4.00643199712476e-13,1,41,771,cell-cell adhesion,BP,ITGA5;WNT4;CDH23;ITGB5;DSC2;WNT7B;ACVR1;TTYH1;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;SDC4;BMP7;BMP4;BMP2;CAMSAP3;MSN;DSG3;AKT1;PKP3;PKP1;CDH1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;CLDN23;DSC3;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;EFNB2
1447,GO:0003156,4.16512541436484e-13,1,11,33,regulation of animal organ formation,BP,WNT2;NOTCH1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;WNT2B;GDNF
7159,GO:0023014,4.84057502077092e-13,1,43,880,signal transduction by protein phosphorylation,BP,ARTN;LIF;ADRA2B;ADRA2C;ACTN2;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;CCL20;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;CDH2;FGF10;FGF17;PDGFB;KCNH2;HRAS;WNT5A;AXIN1;FGF8;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CG;GAS6;ARAF;GDNF;FZD8;DUSP5
9759,GO:0035295,5.90795596969905e-13,1,35,566,tube development,BP,ITGA3;LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB4;CRISPLD2;WNT6;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;FSTL3;FGF10;WNT5A;RHOB;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;CDKN1A;DLL1;WNK4;DDR1;CTGF;WNT2B;VDR;LAMA5;GDNF;CLDN18;EFNB2
13922,GO:0051179,6.38485887069247e-13,1,136,5858,localization,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RAB27A;CDH23;STRA6;TF;ITGB4;PMAIP1;CRB2;CRISPLD2;SLC45A4;DSC2;SERPINA5;WNT7A;SLC52A3;ACVR1;RABIF;NMT2;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;SLC25A53;TTYH1;RRAS2;TSPAN13;RAB39B;RAB39A;SYCN;FZD7;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;GPRASP1;SESN2;RHOQ;RHOB;NPR1;SCIN;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;RAB20;SLC2A14;VAMP1;SFXN1;WNK4;CHGA;MSN;DDR1;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;KITLG;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;RAB44;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SLC18B1;VDR;AMOT;LAMA1;LAMA5;SH3BP4;UNC119;KCND1;RAB38;RAB3D;GDNF;ACSL4;CLDN16;CLDN15;CLDN18;EFNB2;PDE4B
5943,GO:0016477,6.98859748186227e-13,1,51,1193,cell migration,BP,ITGA3;ITGA5;ARTN;WNT4;NOTCH1;CRB2;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;HBEGF;BMP4;BMP2;PKN3;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
10583,GO:0040011,7.0721164564945e-13,1,59,1541,locomotion,BP,ITGA3;ITGA5;ARTN;WNT3;WNT4;NOTCH1;ITGB4;CRB2;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;RRAS2;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;BMP2;B3GNT2;PKN3;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;SEMA6C;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
4646,GO:0009790,8.27352153862016e-13,1,45,931,embryo development,BP,ITGA3;ITGA5;LIF;WNT3;WNT2;WNT4;NOTCH1;STRA6;ITGB5;ITGB4;CRB2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;PRKACB;FZD7;FGF10;PDGFB;WNT5A;AXIN1;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;DLL1;GJB6;AKT1;WNT2B;KITLG;JAG2;EPN1;MYO7A;DSC3;AMOT;LAMA1;LAMA5;GDNF;ACSL4;DUSP5;HEY1
10767,GO:0042327,1.05920268950194e-12,1,43,904,positive regulation of phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
3928,GO:0008083,1.17143321849456e-12,1,18,159,growth factor activity,MF,ARTN;LIF;FGF10;FGF17;PDGFB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CTGF;NRTN;KITLG;JAG2;INHBB;GDNF
568,GO:0001655,1.38362727638668e-12,1,26,313,urogenital system development,BP,ITGA3;LIF;WNT4;NOTCH1;STRA6;ITGB4;WNT6;WNT7B;FSTL3;FGF10;PDGFB;WNT5A;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2;EFNB2
678,GO:0001822,1.39664451641009e-12,1,24,263,kidney development,BP,ITGA3;LIF;WNT4;NOTCH1;STRA6;WNT6;WNT7B;FSTL3;FGF10;PDGFB;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2;EFNB2
4667,GO:0009887,1.55085462581908e-12,1,45,966,animal organ morphogenesis,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB4;CRB2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;FZD7;LIMS2;CDH2;FGF10;HRAS;WNT5A;AXIN1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;MSN;DDR1;CTGF;GJB6;WNT2B;NPPC;NAB2;JAG2;MYO7A;TLE1;CLDN5;VDR;LAMA5;GDNF;HEY1;ACTA2;EFNB2
14225,GO:0051716,1.91733725075102e-12,1,143,6569,cellular response to stimulus,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RASL11B;TF;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;DHH;DSC2;WNT6;WNT7A;WNT7B;SLC52A3;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;MSN;DDR1;CTGF;GJB2;GJB6;RRAD;AKT1;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;DTX4;ZCCHC12;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
525,GO:0001568,1.95328560979749e-12,1,34,564,blood vessel development,BP,ITGA5;WNT2;WNT4;NOTCH1;STRA6;ITGB8;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RHOB;NPR1;FGF8;BMP7;BMP4;WT1;DLL1;CTGF;AKT1;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
819,GO:0002009,2.59228173347386e-12,1,32,509,morphogenesis of an epithelium,BP,ITGA5;LIF;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;FZD7;FGF10;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;MSN;DDR1;WNT2B;JAG2;VDR;LAMA5;GDNF;EFNB2
16790,GO:0072006,2.86499646674912e-12,1,18,139,nephron development,BP,ITGA3;LIF;WNT4;NOTCH1;WNT6;WNT7B;PDGFB;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2
579,GO:0001667,3.208455310823e-12,1,25,311,ameboidal-type cell migration,BP,ITGA3;NOTCH1;CRB2;WNT7A;ACVR1;EDN1;PRR5L;FGF10;PDGFB;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP4;PKN3;AKT1;NRTN;KITLG;BCAR1;PIK3CA;AMOT;LAMA5;GDNF;EFNB2
11322,GO:0043296,3.79669097831722e-12,1,17,123,apical junction complex,CC,CGN;TJP3;JAM3;CAMSAP3;WNK4;CDH1;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
9895,GO:0035556,6.11278868352417e-12,1,78,2530,intracellular signal transduction,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;RAB6C;NOTCH1;PMAIP1;GADD45A;WNT7A;WNT7B;RABIF;GUCY1B3;ADORA1;CASQ2;EDN1;RAB40B;RAB40A;CCL20;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;RALB;HRAS;WNT5A;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;PKN3;WNK4;RND3;CTGF;RRAD;AKT1;NRTN;KITLG;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SHC4;AMOT;ARAF;SH3BP4;RAB38;GDNF;MYZAP;FZD8;DUSP5;PIM2
11894,GO:0044763,6.51623316664354e-12,1,191,10179,single-organism cellular process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;TTYH1;MPZL1;RRAS2;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;PLEKHH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;KHK;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;PTGES;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;MYO7A;BCAR1;INHBB;GJA3;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;PIM2;PARVB;EFNB2;PDE4B
13451,GO:0048870,6.79122136644385e-12,1,52,1317,cell motility,BP,ITGA3;ITGA5;ARTN;WNT4;NOTCH1;ITGB4;CRB2;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;HBEGF;BMP4;BMP2;PKN3;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
14205,GO:0051674,6.79122136644385e-12,1,52,1317,localization of cell,BP,ITGA3;ITGA5;ARTN;WNT4;NOTCH1;ITGB4;CRB2;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;HBEGF;BMP4;BMP2;PKN3;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
15343,GO:0061061,6.82314073519187e-12,1,33,563,muscle structure development,BP,TAGLN;FHOD3;LIF;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;STRA6;IGSF8;ZFPM1;ACVR1;CASQ2;EDN1;MAPK12;FZD7;CDH2;FGF10;PDGFB;FOXO4;WNT5A;AXIN1;FGF8;HBEGF;BMP4;BMP2;WT1;DLL1;AKT1;MYH11;LAMA5;HEY1;EFNB2
13306,GO:0048608,6.94515941210067e-12,1,28,412,reproductive structure development,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;WT1;GJB1;GJB2;AKT1;WNT2B;KITLG;INHBB;VDR;HEY1
13395,GO:0048754,7.2266846123293e-12,1,18,148,branching morphogenesis of an epithelial tube,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DDR1;WNT2B;VDR;LAMA5;GDNF
13304,GO:0048598,7.79973587293144e-12,1,33,561,embryonic morphogenesis,BP,ITGA3;ITGA5;WNT3;WNT2;WNT4;NOTCH1;STRA6;ITGB5;ITGB4;CRB2;WNT6;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;FZD7;FGF10;WNT5A;AXIN1;FGF8;SDC4;BMP7;BMP4;DLL1;GJB6;WNT2B;JAG2;MYO7A;AMOT;LAMA5;GDNF;DUSP5
3542,GO:0006935,7.96364893782969e-12,1,31,539,chemotaxis,BP,ARTN;WNT3;NOTCH1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;JAM3;FGF8;SPTB;HBEGF;BMP7;BMP4;B3GNT2;CHGA;NRTN;SEMA6C;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;GDNF;EFNB2;PDE4B
15512,GO:0061458,8.05935617033899e-12,1,28,415,reproductive system development,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;WT1;GJB1;GJB2;AKT1;WNT2B;KITLG;INHBB;VDR;HEY1
82,GO:0000165,8.18467160623684e-12,1,40,846,MAPK cascade,BP,ARTN;LIF;ADRA2B;ADRA2C;ACTN2;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;CCL20;SPTBN5;SPTBN4;MAPK12;FZD7;CDH2;FGF10;FGF17;PDGFB;HRAS;WNT5A;AXIN1;FGF8;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CG;GAS6;ARAF;GDNF;FZD8;DUSP5
10769,GO:0042330,8.24526727318871e-12,1,31,540,taxis,BP,ARTN;WNT3;NOTCH1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;JAM3;FGF8;SPTB;HBEGF;BMP7;BMP4;B3GNT2;CHGA;NRTN;SEMA6C;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;GDNF;EFNB2;PDE4B
3208,GO:0006468,8.34903744870567e-12,1,63,1808,protein phosphorylation,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;MARK4;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;PKN3;WNK4;DDR1;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;GDNF;FZD8;DUSP5;PIM2
1710,GO:0003924,1.381998856827e-11,1,22,266,GTPase activity,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
4597,GO:0009611,2.8537534788605e-11,1,33,626,response to wounding,BP,ITGA5;ADRA2B;ADRA2C;WNT4;NOTCH1;RAB27A;ITGB4;SERPINA5;WNT7A;ZFPM1;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;FGF10;PIK3R1;PDGFB;PRKAR1B;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;HBEGF;DDR1;CTGF;AKT1;PIK3CA;PIK3CG;GAS6
10632,GO:0042060,3.02041738476902e-11,1,30,522,wound healing,BP,ITGA5;ADRA2B;ADRA2C;WNT4;NOTCH1;RAB27A;SERPINA5;WNT7A;ZFPM1;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;FGF10;PIK3R1;PDGFB;PRKAR1B;HRAS;WNT5B;WNT5A;RHOB;SDC4;HBEGF;DDR1;AKT1;PIK3CA;PIK3CG;GAS6
3792,GO:0007399,3.14703960126369e-11,1,70,2141,nervous system development,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;NOTCH1;MARK4;CDH23;IGSF8;CRB2;DHH;WNT6;WNT7A;WNT7B;ADORA1;PRKACB;SPTBN5;SPTBN4;FZD7;TYRO3;CDH2;FGF10;FGF17;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DLL1;DRP2;DDR1;GJB1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;NAB2;JAG2;CDH1;MYO7A;CLDN1;PIK3CA;GAS6;HAPLN3;LZTS1;GPSM1;UNC119;TSPAN2;GDNF;ACSL4;FZD8;CLDN11;EFNB2
12062,GO:0045165,3.33275257967939e-11,1,21,240,cell fate commitment,BP,WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;FZD7;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP4;BMP2;WT1;DLL1;WNT2B;JAG2
16830,GO:0072073,3.40579826685660e-11,1,17,140,kidney epithelium development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;EFNB2
15047,GO:0060562,3.64361285766891e-11,1,24,309,epithelial tube morphogenesis,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;PRKACB;FGF10;WNT5A;RHOB;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;DDR1;WNT2B;VDR;LAMA5;GDNF;EFNB2
7078,GO:0022008,3.85430775893625e-11,1,54,1405,neurogenesis,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;NOTCH1;CDH23;WNT6;WNT7A;WNT7B;SPTBN5;SPTBN4;FZD7;CDH2;FGF10;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DLL1;DDR1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;NAB2;JAG2;CDH1;MYO7A;PIK3CA;GAS6;LZTS1;UNC119;TSPAN2;GDNF;ACSL4;FZD8
722,GO:0001883,5.20699810727037e-11,1,25,363,purine nucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;ADORA1;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
7401,GO:0030334,5.21497754648816e-11,1,34,653,regulation of cell migration,BP,ITGA3;ITGA5;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;PRR5L;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5
2449,GO:0005109,5.53598064976411e-11,1,10,36,frizzled binding,MF,WNT3;WNT2;WNT4;WNT6;WNT7A;WNT7B;FZD7;WNT5B;WNT5A;WNT2B
13961,GO:0051239,6.63495612877888e-11,1,76,2576,regulation of multicellular organismal process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;CRB2;DSC2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;CASQ2;EDN1;PLAU;PRKACB;KCNK6;CCL20;SPTBN4;FZD7;LIMS2;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;KCNH2;FOXO4;HRAS;WNT5A;RHOB;NPR1;SCIN;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;CHGA;CTGF;AKT1;RAB17;WNT2B;KITLG;NPPC;BCAR1;INHBB;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;LZTS1;VDR;AMOT;LAMA1;LAMA5;KCND1;GDNF;HEY1;CLDN18;EFNB2;PDE4B
10584,GO:0040012,6.6684895679371e-11,1,37,770,regulation of locomotion,BP,ITGA3;ITGA5;ARTN;WNT3;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;PRR5L;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5;EFNB2
9722,GO:0035239,6.69244694342816e-11,1,25,346,tube morphogenesis,BP,WNT2;WNT4;NOTCH1;STRA6;WNT6;ACVR1;EDN1;PRKACB;FGF10;WNT5A;RHOB;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;DDR1;WNT2B;VDR;LAMA5;GDNF;EFNB2
2879,GO:0005923,6.78349072699338e-11,1,15,109,bicellular tight junction,CC,CGN;TJP3;JAM3;WNK4;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
15290,GO:0060993,7.55138612753902e-11,1,14,92,kidney morphogenesis,BP,LIF;WNT4;WNT6;WNT7B;FGF10;FGF8;BMP7;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
16837,GO:0072080,7.5520128739215e-11,1,14,92,nephron tubule development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF
13984,GO:0051270,7.63861668188204e-11,1,37,772,regulation of cellular component movement,BP,ITGA3;ITGA5;WNT3;WNT4;NOTCH1;DSC2;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;PRR5L;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5;PDE4B
721,GO:0001882,8.5407923567505e-11,1,25,371,nucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;ADORA1;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
5871,GO:0016310,9.55960929281204e-11,1,67,2145,phosphorylation,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;MARK4;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;RALB;HRAS;WNT5A;KHK;SESN2;AXIN1;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;PKN3;WNK4;DDR1;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;GDNF;FZD8;DUSP5;PIM2
15765,GO:0070160,1.10673252224301e-10,0.999999999991188,15,112,occluding junction,CC,CGN;TJP3;JAM3;WNK4;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
13364,GO:0048699,1.11131241368871e-10,1,51,1311,generation of neurons,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;CDH23;WNT6;WNT7A;WNT7B;SPTBN5;SPTBN4;FZD7;CDH2;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DLL1;DDR1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;JAG2;CDH1;MYO7A;PIK3CA;GAS6;LZTS1;UNC119;TSPAN2;GDNF;ACSL4;FZD8
15455,GO:0061326,1.12103822921999e-10,0.999999999992034,14,94,renal tubule development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF
7286,GO:0030182,1.55293202182114e-10,1,48,1196,neuron differentiation,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;CDH23;WNT6;WNT7A;WNT7B;SPTBN5;SPTBN4;FZD7;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DLL1;DDR1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;JAG2;CDH1;MYO7A;PIK3CA;LZTS1;UNC119;TSPAN2;GDNF;ACSL4;FZD8
12388,GO:0045860,1.59938650415848e-10,1,28,468,positive regulation of protein kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;SDC4;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
13738,GO:0050896,1.77167650897411e-10,1,157,8010,response to stimulus,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RAB27A;CDH23;STRA6;RASL11B;TF;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;MSN;DDR1;CTGF;GJB2;GJB6;RRAD;AKT1;PKP1;RAB17;NRTN;WNT2B;PTGES;KITLG;SEMA6C;NPPC;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;DTX4;ZCCHC12;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN18;PIM2;EFNB2;PDE4B
16520,GO:0071495,2.04774848771255e-10,1,47,1204,cellular response to endogenous stimulus,BP,ITGA3;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;ITGB5;CRB2;WNT7A;ACVR1;CASQ2;DKK3;EDN1;PRKACB;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;PRKAR1B;FOXO4;WNT5A;SESN2;RHOQ;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CTGF;GJB2;AKT1;CDH1;BCAR1;INHBB;CLDN1;CLDN5;PIK3CA;PIK3CG;ZCCHC12;VDR;SH3BP4;HEY1;PDE4B
5725,GO:0016020,2.0548114207962e-10,1,166,8566,membrane,CC,ITGA3;ITGA5;TMEM163;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;RAB27A;CDH23;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;CRB2;RHBDL3;SLC45A4;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;PLAU;RAB40B;RAB40A;PRKACB;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;FZD7;TYRO3;LPAR2;LIMS2;CDH2;HRCT1;FGF10;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;AXIN1;RHOQ;RHOJ;RHOB;NPR1;FGF8;SDC4;SPTB;HBEGF;PGBD5;LGALS4;BMP2;B3GNT2;DLL1;RAB20;DRP2;SLC2A14;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;AKT1;PKP3;PKP1;RAB12;RAB17;PTGES;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;BCAR1;GJA3;TPBGL;HPCAL1;RAB44;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;LZTS1;CLDN23;SHC4;SLC18B1;DSC3;GPSM1;AMOT;LAMA1;SH3BP4;KCND1;TSPAN2;RAB38;RAB3D;ACSL4;MYZAP;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PARVB;EFNB2;PDE4B
7926,GO:0031401,2.07421357859651e-10,1,44,1114,positive regulation of protein modification process,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
2649,GO:0005525,2.0775641072751e-10,1,24,357,GTP binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
7792,GO:0031128,2.22744709945748e-10,0.99999999999369,9,30,developmental induction,BP,WNT3;WNT2;WNT4;FGF10;FGF8;BMP4;BMP2;WNT2B;GDNF
15383,GO:0061138,2.28772761337751e-10,0.999999999975232,18,180,morphogenesis of a branching epithelium,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DDR1;WNT2B;VDR;LAMA5;GDNF
8575,GO:0032550,2.47810444409504e-10,1,24,360,purine ribonucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
12468,GO:0045995,2.56270286468385e-10,0.999999999978318,15,117,regulation of embryonic development,BP,WNT2;WNT4;NOTCH1;CRB2;PRKACB;FZD7;WNT5A;BMP7;BMP4;DLL1;WNT2B;AMOT;LAMA1;LAMA5;GDNF
8574,GO:0032549,3.21362279723533e-10,1,24,364,ribonucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
21025,GO:2000145,3.44324477933303e-10,1,34,704,regulation of cell motility,BP,ITGA3;ITGA5;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;PRR5L;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5
13259,GO:0048514,3.89052772508814e-10,1,28,481,blood vessel morphogenesis,BP,ITGA5;WNT4;NOTCH1;STRA6;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF10;FOXO4;WNT5A;JAM3;RHOB;NPR1;FGF8;BMP4;WT1;DLL1;CTGF;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;EFNB2
4673,GO:0009893,4.10800154870205e-10,1,82,3038,positive regulation of metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;RAB27A;ITGB8;PMAIP1;GADD45A;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;EDN1;PRKACB;CCL20;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;MSN;CTGF;AKT1;PKP3;PKP1;RAB12;KITLG;NPPC;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
1379,GO:0003006,4.34624383822957e-10,1,31,607,developmental process involved in reproduction,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;ACVR1;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;JAM3;FGF8;BMP7;BMP6;BMP4;WT1;GJB1;GJB2;AKT1;WNT2B;KITLG;NPPC;INHBB;VDR;HEY1
8586,GO:0032561,5.78468551671141e-10,1,24,375,guanyl ribonucleotide binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
6456,GO:0019001,6.14917327535836e-10,1,24,376,guanyl nucleotide binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
7402,GO:0030335,6.20483104001168e-10,1,24,379,positive regulation of cell migration,BP,ITGA3;ITGA5;NOTCH1;WNT7A;ACVR1;EDN1;PLAU;CCL20;RRAS2;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
15766,GO:0070161,6.23315989897675e-10,1,28,498,anchoring junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;NOTCH1;ITGB5;DSC2;PLAU;SPTBN4;MPZL1;RRAS2;LIMS2;CDH2;JAM3;RHOB;SDC4;CAMSAP3;DLL1;RND3;MSN;DSG3;PKP3;PKP1;CDH1;BCAR1;DSC3;PARVB;EFNB2
8214,GO:0031982,6.60796329351614e-10,1,97,4076,vesicle,CC,ITGA3;ITGA5;TMEM163;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN3;ACTN2;TSPAN15;NOTCH1;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;RAB39B;RAB39A;SYCN;FZD7;LPAR2;CDH2;FSTL3;PDGFB;FRMPD1;RALB;WNT5B;WNT5A;SNX18;KHK;AXIN1;RHOQ;RHOJ;RHOB;SCIN;SDC4;CLCF1;HBEGF;BMP7;BMP6;B3GNT2;DAAM2;DLL1;RAB20;VAMP1;RND3;CHGA;MSN;DDR1;DSG3;AKT1;PKP1;RAB12;RAB17;CYTIP;NPPC;CDH1;MYO7A;HPCAL1;RAB44;CLDN2;CLDN3;CLDN5;RAB11FIP1;KCNG2;GAS6;MYH11;PM20D2;AMOT;LAMA5;SH3BP4;RAB38;RAB3D;ACSL4;ACTA2;CLDN11;RNF144A;PDE4B
9161,GO:0033674,6.82687895934607e-10,1,28,498,positive regulation of kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;SDC4;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
634,GO:0001763,7.62315102985975e-10,0.999999999911229,18,193,morphogenesis of a branching structure,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DDR1;WNT2B;VDR;LAMA5;GDNF
13962,GO:0051240,7.82185739066406e-10,1,50,1403,positive regulation of multicellular organismal process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;CRB2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;CCL20;SPTBN4;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;RHOB;NPR1;SCIN;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;NPPC;BCAR1;INHBB;GAS6;VDR;AMOT;GDNF;EFNB2;PDE4B
11616,GO:0044057,8.77969484462133e-10,1,27,484,regulation of system process,BP,ADRA2B;ADRA2C;ACTN3;DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;FGF10;PDGFB;KCNH2;NPR1;HBEGF;BMP6;WNK4;CHGA;CTGF;AKT1;NPPC;INHBB;PIK3CG;RAB11FIP1;KCNG2;GAS6;KCND1;PDE4B
11792,GO:0044421,8.98845385365523e-10,1,88,3687,extracellular region part,CC,ITGA3;ARTN;LIF;WNT3;WNT2;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;DKK3;EDN1;PLAU;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;RRAS2;CDH2;FSTL3;FGF10;FGF17;PDGFB;FRMPD1;RALB;WNT5B;WNT5A;JAM3;SNX18;KHK;RHOQ;RHOJ;RHOB;SCIN;SDC4;CLCF1;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;B3GNT2;DAAM2;RND3;CHGA;MSN;DDR1;DSG3;CTGF;PKP1;RAB17;WNT2B;KITLG;NPPC;CDH1;INHBB;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;HAPLN3;MYH11;PM20D2;LAMA1;LAMA5;SH3BP4;UNC119;RAB3D;ACSL4;ACTA2;CLDN11
10589,GO:0040017,8.99504711851818e-10,1,25,421,positive regulation of locomotion,BP,ITGA3;ITGA5;ARTN;NOTCH1;WNT7A;ACVR1;EDN1;PLAU;CCL20;RRAS2;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
16427,GO:0071363,9.24641537078038e-10,1,31,610,cellular response to growth factor stimulus,BP,ITGA3;ITGA5;WNT2;WNT4;NOTCH1;RASL11B;ITGB5;CRB2;WNT7A;ACVR1;DKK3;EDN1;FSTL3;FGF10;FGF17;CGN;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;DLL1;CTGF;AKT1;BCAR1;CLDN1;CLDN5;GAS6;ZCCHC12
16793,GO:0072009,9.75718619350959e-10,0.999999999917758,14,110,nephron epithelium development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF
15508,GO:0061448,1.03221716756287e-09,1,19,230,connective tissue development,BP,NOTCH1;ITGB8;WNT7A;WNT7B;EDN1;PDGFB;WNT5B;WNT5A;SCIN;BMP7;BMP6;BMP4;BMP2;WT1;CTGF;WNT2B;NPPC;PIK3CA;ACTA2
21027,GO:2000147,1.0793676906042e-09,1,24,393,positive regulation of cell motility,BP,ITGA3;ITGA5;NOTCH1;WNT7A;ACVR1;EDN1;PLAU;CCL20;RRAS2;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
4698,GO:0009967,1.22891593802796e-09,1,49,1402,positive regulation of signal transduction,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;CRB2;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;CCL20;FZD7;LIMS2;CDH2;PRR5L;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;FZD8;DUSP5;PIM2
4697,GO:0009966,1.25707639540771e-09,1,75,2670,regulation of signal transduction,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;CRB2;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;EPN1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;GPSM1;AMOT;ARAF;SH3BP4;GDNF;FZD8;DUSP5;HEY1;PIM2
14995,GO:0060485,1.30342357248183e-09,1,19,234,mesenchyme development,BP,WNT2;WNT4;NOTCH1;CRB2;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;NRTN;KITLG;LAMA5;GDNF;HEY1;ACTA2
16807,GO:0072028,1.35252720627989e-09,0.999999999909333,12,77,nephron morphogenesis,BP,LIF;WNT4;WNT6;FGF8;BMP7;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
13862,GO:0051094,1.35270269779483e-09,1,44,1140,positive regulation of developmental process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;CRB2;WNT6;WNT7A;WNT7B;ACVR1;EDN1;SPTBN4;MAPK12;CDH2;FGF10;PDGFB;WNT5B;WNT5A;RHOB;SCIN;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;CTGF;AKT1;WNT2B;KITLG;NPPC;CLDN5;GAS6;VDR;AMOT;GDNF;EFNB2
7194,GO:0030029,1.35700506437653e-09,1,32,646,actin filament-based process,BP,FHOD3;WNT4;ACTN3;ACTN2;ITGB5;DSC2;CASQ2;EDN1;SPTBN5;SPTBN4;FGF10;PIK3R1;KCNH2;PLEKHH2;HRAS;JAM3;RHOQ;RHOJ;NUAK2;SCIN;SDC4;SPTB;DAAM2;ESPN;RND3;CTGF;MYO7A;BCAR1;MYH11;AMOT;PARVB;PDE4B
13398,GO:0048762,1.37450430242229e-09,0.999999999828814,17,180,mesenchymal cell differentiation,BP,WNT2;WNT4;NOTCH1;CRB2;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;NRTN;KITLG;LAMA5;GDNF;HEY1
11391,GO:0043410,1.38857920895153e-09,1,26,463,positive regulation of MAPK cascade,BP,LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;CCL20;FZD7;CDH2;FGF10;PDGFB;HRAS;WNT5A;AXIN1;FGF8;BMP4;BMP2;CTGF;KITLG;PIK3CG;GAS6;ARAF;FZD8;DUSP5
10765,GO:0042325,1.40028113320918e-09,1,48,1349,regulation of phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
13957,GO:0051234,1.40418660016609e-09,1,111,4853,establishment of localization,BP,ITGA3;LIF;ADRA2B;ADRA2C;SYT5;WNT4;RIN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RAB27A;CDH23;STRA6;TF;PMAIP1;CRISPLD2;SLC45A4;SERPINA5;WNT7A;SLC52A3;RABIF;NMT2;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;SLC25A53;TTYH1;TSPAN13;RAB39B;RAB39A;SYCN;FZD7;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;RALB;HRAS;WNT5A;SNX18;GPRASP1;SESN2;RHOQ;RHOB;NPR1;SCIN;PSRC1;SDC4;SPTB;BMP7;BMP6;BMP4;CDKN1A;DLL1;RAB20;SLC2A14;VAMP1;SFXN1;WNK4;CHGA;MSN;DDR1;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;CDH1;EPN1;MYO7A;INHBB;GJA3;RAB44;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SLC18B1;VDR;LAMA5;SH3BP4;UNC119;KCND1;RAB38;RAB3D;GDNF;ACSL4;CLDN16;CLDN15;PDE4B
18139,GO:0098742,1.58795245610891e-09,1,19,222,cell-cell adhesion via plasma-membrane adhesion molecules,BP,ITGA5;CDH23;DSC2;ACVR1;CDH2;BMP2;DSG3;CDH1;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;DSC3;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
20958,GO:2000027,1.60012678379409e-09,1,19,247,regulation of organ morphogenesis,BP,LIF;WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FZD7;LIMS2;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;WNT2B;VDR;GDNF
7103,GO:0022414,1.86976575402589e-09,1,46,1304,reproductive process,BP,ITGA3;LIF;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;STRA6;IGSF8;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;MFGE8;SPTBN4;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;JAM3;FGF8;BMP7;BMP6;BMP4;WT1;SLC2A14;DDR1;GJB1;GJB2;AKT1;WNT2B;KITLG;NPPC;JAG2;EPN1;INHBB;VDR;ACSL4;HEY1;CLDN11;PIM2
2,GO:0000003,1.89975736455914e-09,1,46,1305,reproduction,BP,ITGA3;LIF;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;STRA6;IGSF8;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;MFGE8;SPTBN4;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;JAM3;FGF8;BMP7;BMP6;BMP4;WT1;SLC2A14;DDR1;GJB1;GJB2;AKT1;WNT2B;KITLG;NPPC;JAG2;EPN1;INHBB;VDR;ACSL4;HEY1;CLDN11;PIM2
13382,GO:0048732,1.96194594884732e-09,0.999999999668255,25,415,gland development,BP,WNT3;WNT2;WNT4;NOTCH1;STRA6;SERPINA5;WNT7B;DKK3;LIMS2;FSTL3;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;MSN;DDR1;AKT1;CDH1;CLDN1;PIK3CA;VDR;LAMA5
13986,GO:0051272,2.18959409876304e-09,0.9999999996398,24,403,positive regulation of cellular component movement,BP,ITGA3;ITGA5;NOTCH1;WNT7A;ACVR1;EDN1;PLAU;CCL20;RRAS2;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
16151,GO:0070848,2.31880716401234e-09,1,31,635,response to growth factor,BP,ITGA3;ITGA5;WNT2;WNT4;NOTCH1;RASL11B;ITGB5;CRB2;WNT7A;ACVR1;DKK3;EDN1;FSTL3;FGF10;FGF17;CGN;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;DLL1;CTGF;AKT1;BCAR1;CLDN1;CLDN5;GAS6;ZCCHC12
9748,GO:0035270,2.47439124052325e-09,0.999999999756363,14,124,endocrine system development,BP,WNT4;STRA6;DKK3;FSTL3;FGF10;WNT5A;FGF8;BMP6;BMP4;BMP2;WT1;DLL1;AKT1;CDH1
13664,GO:0050793,2.4967413837765e-09,1,65,2180,regulation of developmental process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;CRB2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;PRKACB;SPTBN4;MAPK12;FZD7;LIMS2;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5B;WNT5A;AXIN1;RHOQ;RHOJ;RHOB;NPR1;SCIN;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;MSN;CTGF;AKT1;RAB17;WNT2B;KITLG;NPPC;NAB2;CLDN5;PIK3CA;GAS6;LZTS1;VDR;AMOT;LAMA1;LAMA5;GDNF;HEY1;CLDN18;PARVB;EFNB2
6538,GO:0019220,2.57344917454995e-09,1,52,1573,regulation of phosphate metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;CDKN1A;CHGA;CTGF;AKT1;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
11862,GO:0044699,2.66697866062613e-09,1,211,12673,single-organism process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;SLC45A4;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;PTGES;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;HAPLN3;DTX4;ZCCHC12;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;PIM2;PARVB;EFNB2;PDE4B
2667,GO:0005576,2.72579918929275e-09,1,97,4413,extracellular region,CC,ITGA3;ARTN;LIF;WNT3;WNT2;WNT4;ACTN3;ACTN2;TSPAN15;NOTCH1;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;DKK3;EDN1;PLAU;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;RRAS2;PRND;CDH2;FSTL3;FGF10;FGF17;PDGFB;FRMPD1;RALB;WNT5B;WNT5A;JAM3;SNX18;KHK;RHOQ;RHOJ;RHOB;SCIN;FGF8;OLFML2B;SDC4;CLCF1;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;B3GNT2;DAAM2;DLL1;RND3;CHGA;MSN;DDR1;DSG3;CTGF;PKP1;RAB17;NRTN;WNT2B;KITLG;NPPC;CST9L;CDH1;INHBB;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;HAPLN3;MYH11;PM20D2;DSC3;LAMA1;LAMA5;SH3BP4;UNC119;RAB3D;GDNF;ACSL4;ACTA2;CLDN11
8371,GO:0032270,2.77935051051548e-09,1,48,1396,positive regulation of cellular protein metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;MAPK12;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;MSN;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5;RNF144A
4876,GO:0010604,2.93463464905559e-09,1,76,2817,positive regulation of macromolecule metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;ITGB8;PMAIP1;GADD45A;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;EDN1;PRKACB;CCL20;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;MSN;CTGF;AKT1;PKP3;PKP1;KITLG;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
11864,GO:0044702,2.98890257169102e-09,1,43,1182,single organism reproductive process,BP,ITGA3;LIF;WNT3;WNT2;WNT4;NOTCH1;STRA6;IGSF8;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;MFGE8;SPTBN4;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;JAM3;FGF8;BMP7;BMP6;BMP4;WT1;SLC2A14;DDR1;GJB2;AKT1;WNT2B;KITLG;NPPC;JAG2;INHBB;VDR;ACSL4;HEY1;CLDN11;PIM2
632,GO:0001759,3.21349176194609e-09,0.999999999938562,7,19,organ induction,BP,WNT2;FGF10;FGF8;BMP4;BMP2;WNT2B;GDNF
13919,GO:0051174,3.50905057177962e-09,1,52,1586,regulation of phosphorus metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;CDKN1A;CHGA;CTGF;AKT1;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
1381,GO:0003008,3.58772877450687e-09,1,55,1906,system process,BP,ITGA3;ITGA5;ADRA2B;ADRA2C;ACTN3;ACTN2;CDH23;STRA6;ITGB5;DSC2;SLC52A3;GUCY1B3;ADORA1;CASQ2;EDN1;PRKACB;KCNK6;SPTBN4;FGF10;PDGFB;KCNH2;PRKAR1B;JAM3;NPR1;HBEGF;BMP6;BMP4;B3GNT2;DLL1;ESPN;WNK4;CHGA;CTGF;GJB2;GJB6;AKT1;NPPC;JAG2;MYO7A;INHBB;GJA3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;MYH11;VDR;UNC119;KCND1;GDNF;ACTA2;CLDN16;PDE4B
13266,GO:0048523,3.70019844889311e-09,1,99,4185,negative regulation of cellular process,BP,ITGA3;ITGA5;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;GADD45A;CRB2;SERPINA5;WNT7A;ZFPM1;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PRKACB;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOB;NPR1;NUAK2;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;ESPN;CHGA;DDR1;CTGF;GJB6;AKT1;PKP3;PKP1;PTGES;KITLG;NPPC;CST9L;NAB2;CDH1;EPN1;INHBB;TLE1;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;LZTS1;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2
7171,GO:0023051,4.23308442425517e-09,1,80,3019,regulation of signaling,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;CRB2;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;NPPC;JAG2;EPN1;INHBB;TLE1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;LZTS1;GPSM1;AMOT;ARAF;SH3BP4;GDNF;FZD8;DUSP5;HEY1;PIM2
5883,GO:0016331,4.62603073978952e-09,0.999999999470081,15,145,morphogenesis of embryonic epithelium,BP,WNT2;WNT4;WNT6;WNT7B;PRKACB;FGF10;WNT5A;FGF8;SDC4;BMP7;BMP4;WNT2B;JAG2;LAMA5;GDNF
757,GO:0001932,4.71310548421748e-09,1,45,1264,regulation of protein phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
15030,GO:0060541,4.76589366702368e-09,0.999999999352504,17,194,respiratory system development,BP,ITGA3;LIF;WNT2;NOTCH1;STRA6;CRISPLD2;WNT7B;FSTL3;FGF10;WNT5A;AXIN1;FGF8;BMP4;WT1;CTGF;WNT2B;LAMA5
3807,GO:0007423,5.64976789325663e-09,0.999999998940278,27,504,sensory organ development,BP,WNT2;NOTCH1;CDH23;STRA6;WNT6;WNT7A;WNT7B;EDN1;FGF10;WNT5B;WNT5A;AXIN1;RHOJ;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;DDR1;GJB2;GJB6;WNT2B;JAG2;MYO7A
13965,GO:0051247,6.76794524283907e-09,1,49,1485,positive regulation of protein metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;EDN1;PRKACB;CCL20;MAPK12;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;MSN;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5;RNF144A
1449,GO:0003158,8.64499401800705e-09,0.999999999158465,13,109,endothelium development,BP,NOTCH1;WNT7A;WNT7B;ACVR1;RHOB;BMP6;BMP4;DLL1;MSN;CLDN1;CLDN5;LAMA5;HEY1
19223,GO:1902578,8.96938545288153e-09,1,79,3072,single-organism localization,BP,ITGA3;LIF;ADRA2B;ADRA2C;SYT5;WNT4;ACTN2;TSPAN15;NOTCH1;RAB27A;STRA6;TF;PMAIP1;CRISPLD2;SLC45A4;SERPINA5;WNT7A;SLC52A3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;KCNK6;MFGE8;FLVCR2;SPTBN4;RAB39A;SYCN;FZD7;TYRO3;CDH2;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;RALB;WNT5A;SESN2;RHOQ;NPR1;SCIN;SDC4;BMP7;BMP6;BMP4;CDKN1A;RAB20;SLC2A14;VAMP1;WNK4;CHGA;DDR1;CTGF;GJB1;TPD52;AKT1;PKP3;PKP1;RAB17;CDH1;MYO7A;INHBB;RAB44;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;VDR;LAMA5;UNC119;KCND1;RAB3D;GDNF;ACSL4
7883,GO:0031325,8.97475360604754e-09,1,75,2825,positive regulation of cellular metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;RAB27A;PMAIP1;GADD45A;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;EDN1;PRKACB;CCL20;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;MSN;CTGF;AKT1;RAB12;KITLG;NPPC;CDH1;INHBB;PIK3CA;PIK3CG;GAS6;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2
17400,GO:0090130,9.51570082478255e-09,0.999999998706627,18,235,tissue migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF10;PDGFB;WNT5A;RHOB;FGF8;HBEGF;BMP4;PKN3;AKT1;BCAR1;PIK3CA;AMOT;ACTA2;EFNB2
2698,GO:0005615,1.01046773773975e-08,1,43,1364,extracellular space,CC,ARTN;LIF;WNT3;WNT2;WNT4;TF;DHH;SERPINA5;WNT6;WNT7A;WNT7B;DKK3;EDN1;PLAU;MFGE8;CCL20;FSTL3;FGF10;FGF17;PDGFB;WNT5B;WNT5A;JAM3;CLCF1;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;CHGA;MSN;DDR1;CTGF;WNT2B;KITLG;NPPC;INHBB;GAS6;HAPLN3;LAMA1;LAMA5;ACTA2
4910,GO:0010646,1.04760298114667e-08,1,78,2967,regulation of cell communication,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;CRB2;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;EPN1;INHBB;TLE1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;LZTS1;GPSM1;AMOT;ARAF;SH3BP4;GDNF;FZD8;DUSP5;HEY1;PIM2
11389,GO:0043408,1.07199850124732e-08,0.999999997787166,30,649,regulation of MAPK cascade,BP,LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;CCL20;FZD7;CDH2;FGF10;PDGFB;HRAS;WNT5A;AXIN1;FGF8;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;KITLG;INHBB;PIK3CG;GAS6;ARAF;FZD8;DUSP5
13262,GO:0048519,1.09635142770326e-08,1,104,4623,negative regulation of biological process,BP,ITGA3;ITGA5;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;ITGB8;GADD45A;CRB2;SERPINA5;WNT7A;ZFPM1;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOB;NPR1;NUAK2;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;ESPN;WNK4;CHGA;DDR1;CTGF;GJB6;AKT1;PKP3;PKP1;PTGES;KITLG;NPPC;CST9L;NAB2;CDH1;EPN1;INHBB;TLE1;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;LZTS1;VDR;AMOT;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
20957,GO:2000026,1.09697666151621e-08,1,53,1660,regulation of multicellular organismal development,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;PRKACB;FZD7;LIMS2;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5A;RHOB;NPR1;SCIN;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;CTGF;AKT1;RAB17;WNT2B;KITLG;CLDN5;GAS6;LZTS1;VDR;AMOT;LAMA1;LAMA5;GDNF;HEY1;CLDN18;EFNB2
19643,GO:1903522,1.10555688766289e-08,0.999999998398843,19,269,regulation of blood circulation,BP,ADRA2B;ADRA2C;DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;NPR1;HBEGF;CHGA;CTGF;AKT1;NPPC;PIK3CG;KCNG2;KCND1;PDE4B
12187,GO:0045446,1.12125300663316e-08,0.999999999020233,12,91,endothelial cell differentiation,BP,NOTCH1;WNT7A;WNT7B;ACVR1;BMP6;BMP4;DLL1;MSN;CLDN1;CLDN5;LAMA5;HEY1
18905,GO:1901700,1.14212111398752e-08,1,48,1464,response to oxygen-containing compound,BP,WNT3;WNT2;ACTN2;NOTCH1;DHH;WNT6;WNT7A;WNT7B;GUCY1B3;EDN1;PRKACB;CCL20;FZD7;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;WNT5B;WNT5A;KHK;SESN2;RHOQ;RHOB;BMP7;BMP6;WT1;CDKN1A;MSN;CTGF;GJB2;GJB6;AKT1;PTGES;NPPC;CDH1;BCAR1;INHBB;CLDN1;CLDN3;PIK3CA;PIK3CG;GAS6;VDR;SH3BP4;CLDN18;PDE4B
16841,GO:0072088,1.25726143939472e-08,0.999999999046617,11,75,nephron epithelium morphogenesis,BP,LIF;WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
10981,GO:0042692,1.38024640388166e-08,0.999999997343643,22,357,muscle cell differentiation,BP,FHOD3;WNT4;ACTN2;NOTCH1;ACVR1;CASQ2;EDN1;MAPK12;FZD7;CDH2;FGF10;PDGFB;FOXO4;AXIN1;BMP4;BMP2;WT1;DLL1;AKT1;MYH11;HEY1;EFNB2
13385,GO:0048738,1.64817823315253e-08,0.999999997701215,16,186,cardiac muscle tissue development,BP,FHOD3;WNT2;ACTN2;NOTCH1;ZFPM1;ACVR1;EDN1;FZD7;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;MYH11;EFNB2
16750,GO:0071900,1.6744209867124e-08,0.999999996356943,25,467,regulation of protein serine/threonine kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;BMP7;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CG;ARAF;FZD8;DUSP5
16174,GO:0070887,1.74069545087351e-08,1,70,2645,cellular response to chemical stimulus,BP,ITGA3;ITGA5;WNT3;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;TF;ITGB5;PMAIP1;CRB2;WNT6;WNT7A;WNT7B;ACVR1;GUCY1B3;CASQ2;DKK3;EDN1;PRKACB;CCL20;FZD7;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;WNT5B;WNT5A;JAM3;SESN2;RHOQ;RHOB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;CHGA;MSN;CTGF;GJB2;GJB6;AKT1;CDH1;BCAR1;INHBB;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;VDR;SH3BP4;HEY1;CLDN18;PDE4B
4623,GO:0009719,1.7434220012848e-08,1,50,1551,response to endogenous stimulus,BP,ITGA3;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;ITGB5;CRB2;WNT7A;WNT7B;ACVR1;CASQ2;DKK3;EDN1;PRKACB;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;PRKAR1B;FOXO4;WNT5A;KHK;SESN2;RHOQ;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;CTGF;GJB2;AKT1;CDH1;BCAR1;INHBB;CLDN1;CLDN5;PIK3CA;PIK3CG;ZCCHC12;VDR;SH3BP4;HEY1;PDE4B
5167,GO:0012501,1.77667697726307e-08,1,56,1885,programmed cell death,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;DSC2;WNT7A;ACVR1;ADORA1;EDN1;PHLDA1;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;RALB;HRAS;WNT5A;AXIN1;RHOB;NUAK2;SCIN;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;DSG3;CTGF;GJB6;AKT1;PKP3;PKP1;KITLG;JAG2;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SHC4;DSC3;VDR;ARAF;GDNF;PIM2
13836,GO:0051049,1.80135761631924e-08,1,54,1748,regulation of transport,BP,LIF;ADRA2B;ADRA2C;SYT5;ACTN2;NOTCH1;RAB27A;TF;PMAIP1;ADORA1;CASQ2;EDN1;KCNK6;MFGE8;SPTBN4;TTYH1;TSPAN13;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;RALB;WNT5A;RHOQ;NPR1;SCIN;SDC4;BMP7;BMP6;BMP4;CDKN1A;DLL1;RAB20;WNK4;CHGA;MSN;AKT1;RAB17;CDH1;INHBB;PIK3CG;RAB11FIP1;KCNG2;GAS6;UNC119;KCND1;RAB3D;GDNF;PDE4B
4593,GO:0009605,1.81412688913235e-08,1,57,2000,response to external stimulus,BP,ARTN;WNT3;WNT4;NOTCH1;STRA6;PMAIP1;GADD45A;DSC2;NMT2;ADORA1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;TYRO3;FGF10;PIK3R1;PDGFB;FOXO4;RALB;HRAS;WNT5A;JAM3;NUAK2;FGF8;SPTB;HBEGF;BMP7;BMP6;BMP4;B3GNT2;CDKN1A;CHGA;GJB2;GJB6;AKT1;NRTN;WNT2B;PTGES;SEMA6C;BCAR1;INHBB;CLDN1;PIK3CA;PIK3CG;GAS6;VDR;AMOT;UNC119;RAB38;GDNF;ACSL4;ACTA2;PIM2;EFNB2;PDE4B
11181,GO:0043085,1.90729616652594e-08,1,50,1554,positive regulation of catalytic activity,BP,ARTN;ADRA2B;ADRA2C;WNT4;RIN3;ACTN2;PMAIP1;GADD45A;WNT7B;RABIF;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;AXIN1;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP4;BMP2;CDKN1A;CTGF;AKT1;NRTN;KITLG;PIK3CA;PIK3CG;GAS6;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5
4911,GO:0010647,1.91314229127842e-08,1,49,1530,positive regulation of cell communication,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;CRB2;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;CCL20;FZD7;LIMS2;CDH2;PRR5L;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;FZD8;DUSP5;PIM2
4017,GO:0008219,1.93066316374818e-08,1,58,1990,cell death,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;DSC2;WNT7A;ACVR1;ADORA1;EDN1;PHLDA1;RRAS2;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;RALB;HRAS;WNT5A;AXIN1;RHOB;NUAK2;SCIN;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;DSG3;CTGF;GJB6;AKT1;PKP3;PKP1;KITLG;JAG2;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SHC4;DSC3;VDR;ARAF;GDNF;PIM2
4052,GO:0008283,1.99792116266097e-08,1,56,1890,cell proliferation,BP,ARTN;LIF;WNT3;WNT2;WNT4;NOTCH1;IGSF8;WNT7A;WNT7B;ADORA1;EDN1;PLAU;FZD7;LIMS2;CDH2;FGF10;FGF17;PDGFB;FOXO4;HRAS;WNT5A;NPR1;SCIN;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;MSN;DDR1;CTGF;GJB6;AKT1;WNT2B;PTGES;KITLG;NPPC;NAB2;JAG2;BCAR1;PIK3CG;GAS6;SHC4;VDR;LAMA5;SH3BP4;GDNF;PIM2;EFNB2
5737,GO:0016043,2.07016150058438e-08,1,122,5728,cellular component organization,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;SYT5;WNT3;WNT4;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;MARK4;RAB27A;CDH23;TF;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRISPLD2;SERPINA5;WNT7A;WNT7B;ZFPM1;RABIF;CASQ2;EDN1;RAB40B;RAB40A;MFGE8;SPTBN5;SPTBN4;TTYH1;RAB39B;RAB39A;PRND;FZD7;TYRO3;LIMS2;CDH2;FGF10;PIK3R1;REEP1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;PSTPIP2;SNX18;SESN2;AXIN1;RHOQ;RHOJ;NPR1;NUAK2;SCIN;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;RAB20;DRP2;ESPN;VAMP1;RND3;CHGA;MSN;DDR1;CTGF;GJB1;GJB2;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;SEMA6C;CDH1;EPN1;MYO7A;BCAR1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;KCNG2;GAS6;SIN3B;MYH11;LZTS1;VDR;AMOT;LAMA1;LAMA5;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;GDNF;ACSL4;PIM2;PARVB
18906,GO:1901701,2.08657854181203e-08,0.999999995053853,37,948,cellular response to oxygen-containing compound,BP,WNT3;WNT2;ACTN2;WNT6;WNT7B;GUCY1B3;EDN1;PRKACB;CCL20;FZD7;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;WNT5B;WNT5A;SESN2;RHOQ;RHOB;BMP7;BMP6;WT1;MSN;GJB2;GJB6;AKT1;CDH1;BCAR1;INHBB;CLDN1;PIK3CA;PIK3CG;GAS6;VDR;SH3BP4;PDE4B
10708,GO:0042221,2.1297944536139e-08,1,90,4006,response to chemical,BP,ITGA3;ITGA5;ARTN;WNT3;WNT2;WNT4;ACTN2;RAB6C;NOTCH1;RASL11B;TF;ITGB5;PMAIP1;CRB2;DHH;WNT6;WNT7A;WNT7B;ACVR1;GUCY1B3;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;SPTBN5;SPTBN4;FZD7;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;KHK;SESN2;RHOQ;RHOB;FGF8;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;CHGA;MSN;CTGF;GJB2;GJB6;AKT1;NRTN;PTGES;SEMA6C;NPPC;CDH1;BCAR1;INHBB;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;VDR;AMOT;SH3BP4;GDNF;ACSL4;HEY1;CLDN18;EFNB2;PDE4B
498,GO:0001525,2.1371395797795e-08,0.999999995612471,23,400,angiogenesis,BP,ITGA5;NOTCH1;WNT7A;ACVR1;EDN1;MFGE8;FGF10;FOXO4;WNT5A;JAM3;RHOB;NPR1;FGF8;BMP4;DLL1;CTGF;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;EFNB2
7173,GO:0023056,2.26067843818189e-08,1,49,1538,positive regulation of signaling,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;CRB2;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;CCL20;FZD7;LIMS2;CDH2;PRR5L;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;FZD8;DUSP5;PIM2
859,GO:0002064,2.63967900552031e-08,0.999999996185105,16,190,epithelial cell development,BP,NOTCH1;WNT7A;WNT7B;PDGFB;WNT5B;WNT5A;BMP6;BMP4;CDKN1A;DLL1;MSN;MYO7A;CLDN1;CLDN3;CLDN5;ACTA2
599,GO:0001704,2.71533303609615e-08,0.99999999704793,13,118,formation of primary germ layer,BP,ITGA3;ITGA5;WNT3;ITGB5;ITGB4;CRB2;ACVR1;FZD7;WNT5A;AXIN1;BMP7;BMP4;DUSP5
860,GO:0002065,2.77768008664816e-08,0.999999997326414,12,101,columnar/cuboidal epithelial cell differentiation,BP,WNT4;NOTCH1;CDH2;WNT5A;FGF8;BMP6;BMP4;BMP2;CDKN1A;DLL1;JAG2;MYO7A
3890,GO:0008015,2.78038297701222e-08,0.999999993790399,25,487,blood circulation,BP,ADRA2B;ADRA2C;DSC2;GUCY1B3;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;PDGFB;KCNH2;NPR1;HBEGF;DLL1;CHGA;CTGF;AKT1;NPPC;PIK3CA;PIK3CG;KCNG2;GAS6;KCND1;ACTA2;PDE4B
14029,GO:0051347,2.78952078901697e-08,0.999999993040382,29,635,positive regulation of transferase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;SDC4;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
15677,GO:0065008,3.04917616987373e-08,1,83,3394,regulation of biological quality,BP,FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT4;ACTN2;RAB27A;CDH23;TF;PMAIP1;DSC2;SERPINA5;WNT7A;WNT7B;ZFPM1;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;KCNK6;SPTBN5;SPTBN4;RAB39A;PRND;TYRO3;LPAR2;CDH2;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;HRAS;WNT5A;JAM3;SESN2;RHOQ;RHOJ;RHOB;NPR1;SCIN;SPTB;BMP6;BMP4;BMP2;CDKN1A;DLL1;RAB20;SFXN1;WNK4;CHGA;MSN;DDR1;CTGF;GJB6;AKT1;RAB17;KITLG;NPPC;INHBB;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;LZTS1;VDR;RAB38;RAB3D;GDNF;ACTA2;CLDN16;CLDN18;PIM2;PARVB;PDE4B
3828,GO:0007517,3.07378199466146e-08,0.999999994066963,21,343,muscle organ development,BP,TAGLN;LIF;WNT2;ACTN3;NOTCH1;STRA6;IGSF8;ZFPM1;EDN1;MAPK12;FZD7;FOXO4;WNT5A;FGF8;HBEGF;BMP4;BMP2;WT1;DLL1;LAMA5;EFNB2
3684,GO:0007178,3.17958027470752e-08,0.999999994132271,20,309,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ITGA3;NOTCH1;RASL11B;ITGB5;CRB2;ACVR1;DKK3;FSTL3;FGF10;CGN;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;INHBB;CLDN5;ZCCHC12
1386,GO:0003013,3.23647830801309e-08,0.999999992715437,25,491,circulatory system process,BP,ADRA2B;ADRA2C;DSC2;GUCY1B3;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;PDGFB;KCNH2;NPR1;HBEGF;DLL1;CHGA;CTGF;AKT1;NPPC;PIK3CA;PIK3CG;KCNG2;GAS6;KCND1;ACTA2;PDE4B
13261,GO:0048518,3.38145921827087e-08,1,111,5094,positive regulation of biological process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;STRA6;TF;ITGB8;PMAIP1;GADD45A;CRB2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;CASQ2;EDN1;PLAU;PRKACB;MFGE8;CCL20;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;RHOB;NPR1;SCIN;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;ESPN;CHGA;MSN;CTGF;AKT1;PKP3;PKP1;RAB12;WNT2B;KITLG;NPPC;JAG2;CDH1;BCAR1;INHBB;TLE1;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;SHC4;VDR;AMOT;ARAF;SH3BP4;UNC119;RAB3D;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2;EFNB2;PDE4B
7392,GO:0030324,3.42217385660966e-08,0.999999995351262,15,169,lung development,BP,ITGA3;LIF;WNT2;NOTCH1;STRA6;CRISPLD2;WNT7B;FSTL3;FGF10;WNT5A;FGF8;BMP4;CTGF;WNT2B;LAMA5
679,GO:0001823,3.47079021767899e-08,0.99999999658694,12,102,mesonephros development,BP,WNT4;WNT6;FGF10;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
576,GO:0001664,3.48242958885847e-08,0.999999995429746,16,245,G-protein coupled receptor binding,MF,ADRA2C;WNT3;WNT2;WNT4;ITGB4;WNT6;WNT7A;WNT7B;ADORA1;EDN1;CCL20;FZD7;REEP1;WNT5B;WNT5A;WNT2B
12884,GO:0046934,3.63056311806636e-08,0.9999999973977,10,66,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
18088,GO:0098602,3.77057714874427e-08,0.999999990466073,29,633,single organism cell adhesion,BP,ITGA5;WNT4;ITGB5;DSC2;WNT7B;ACVR1;TTYH1;FZD7;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;SDC4;BMP7;BMP4;CAMSAP3;MSN;AKT1;PKP3;PKP1;CDH1;PIK3CA;PIK3CG;GAS6;LAMA5;EFNB2
16859,GO:0072109,3.92888433136507e-08,0.999999999279444,6,15,glomerular mesangium development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
11494,GO:0043583,4.13283837943929e-08,0.999999993896382,16,201,ear development,BP,NOTCH1;CDH23;STRA6;EDN1;FGF10;WNT5A;FGF8;SDC4;BMP4;BMP2;DLL1;DDR1;GJB2;GJB6;JAG2;MYO7A
5120,GO:0010941,4.13908735759508e-08,1,47,1470,regulation of cell death,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;WNT7A;ACVR1;ADORA1;EDN1;RRAS2;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;RHOB;NUAK2;SCIN;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;KITLG;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;VDR;ARAF;GDNF;PIM2
17402,GO:0090132,4.15647111959842e-08,0.999999993412598,17,229,epithelium migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF10;PDGFB;WNT5A;RHOB;FGF8;HBEGF;BMP4;PKN3;AKT1;BCAR1;PIK3CA;AMOT;EFNB2
16387,GO:0071310,4.40009425603914e-08,1,61,2192,cellular response to organic substance,BP,ITGA3;ITGA5;WNT3;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;ITGB5;CRB2;WNT6;WNT7A;WNT7B;ACVR1;CASQ2;DKK3;EDN1;PRKACB;CCL20;FZD7;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;PRKAR1B;FOXO4;RALB;WNT5B;WNT5A;SESN2;RHOQ;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;MSN;CTGF;GJB2;GJB6;AKT1;CDH1;BCAR1;INHBB;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;VDR;SH3BP4;HEY1;CLDN18;PDE4B
11175,GO:0043067,4.44183034224631e-08,1,45,1377,regulation of programmed cell death,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;WNT7A;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;RHOB;NUAK2;SCIN;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;VDR;ARAF;GDNF;PIM2
13291,GO:0048568,4.51201823494471e-08,0.999999990083458,23,417,embryonic organ development,BP,LIF;WNT2;NOTCH1;STRA6;CRB2;WNT7B;ZFPM1;ACVR1;EDN1;FGF10;PDGFB;WNT5A;AXIN1;FGF8;BMP7;BMP4;DLL1;GJB6;AKT1;KITLG;EPN1;MYO7A;HEY1
10665,GO:0042127,4.52382662930137e-08,1,47,1489,regulation of cell proliferation,BP,LIF;WNT3;WNT2;NOTCH1;WNT7A;ADORA1;EDN1;PLAU;FZD7;LIMS2;CDH2;FGF10;FGF17;PDGFB;FOXO4;HRAS;WNT5A;NPR1;SCIN;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;DDR1;CTGF;GJB6;AKT1;PTGES;KITLG;NPPC;JAG2;GAS6;SHC4;VDR;LAMA5;SH3BP4;GDNF;PIM2;EFNB2
7391,GO:0030323,4.79740633745494e-08,0.999999993302109,15,173,respiratory tube development,BP,ITGA3;LIF;WNT2;NOTCH1;STRA6;CRISPLD2;WNT7B;FSTL3;FGF10;WNT5A;FGF8;BMP4;CTGF;WNT2B;LAMA5
4703,GO:0009986,4.93580521271984e-08,0.999999987077888,30,682,cell surface,CC,ITGA3;ITGA5;WNT4;TSPAN15;NOTCH1;TF;ITGB5;ITGB4;ITGB8;SERPINA5;WNT6;WNT7A;TMEM206;PLAU;MFGE8;MPZL1;LPAR2;FGF10;PDGFB;KCNH2;WNT5B;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP2;VAMP1;MSN;AMOT
14499,GO:0052813,5.89945755809253e-08,0.999999995523303,10,69,phosphatidylinositol bisphosphate kinase activity,MF,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
3784,GO:0007369,5.90439805664844e-08,0.999999991603139,15,176,gastrulation,BP,ITGA3;ITGA5;WNT3;ITGB5;ITGB4;CRB2;ACVR1;FZD7;WNT5A;AXIN1;FGF8;BMP7;BMP4;AMOT;DUSP5
3461,GO:0006810,5.96114111586364e-08,1,104,4735,transport,BP,LIF;ADRA2B;ADRA2C;SYT5;RIN3;ACTN2;RAB6C;NOTCH1;RAB27A;CDH23;STRA6;TF;PMAIP1;CRISPLD2;SLC45A4;SERPINA5;WNT7A;SLC52A3;RABIF;NMT2;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;SLC25A53;TTYH1;TSPAN13;RAB39B;RAB39A;SYCN;FZD7;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;RALB;HRAS;WNT5A;SNX18;GPRASP1;SESN2;RHOQ;RHOB;NPR1;SCIN;SDC4;SPTB;BMP7;BMP6;BMP4;CDKN1A;DLL1;RAB20;SLC2A14;VAMP1;SFXN1;WNK4;CHGA;MSN;DDR1;CTGF;GJB1;GJB2;TPD52;AKT1;PKP1;RAB12;RAB17;CDH1;EPN1;MYO7A;INHBB;GJA3;RAB44;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SLC18B1;VDR;SH3BP4;UNC119;KCND1;RAB38;RAB3D;GDNF;ACSL4;CLDN16;CLDN15;PDE4B
3454,GO:0006796,6.51174500168535e-08,1,75,2984,phosphate-containing compound metabolic process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;MARK4;GADD45A;WNT7A;WNT7B;ACVR1;GUCY1B3;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MBOAT2;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;RALB;HRAS;WNT5A;KHK;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;CDKN1A;PKN3;WNK4;CHGA;DDR1;CTGF;AKT1;NRTN;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;GDNF;FZD8;DUSP5;PIM2;PDE4B
7200,GO:0030036,7.04758170425167e-08,0.99999998192524,27,562,actin cytoskeleton organization,BP,FHOD3;WNT4;ACTN2;ITGB5;CASQ2;EDN1;SPTBN5;SPTBN4;FGF10;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;RHOJ;NUAK2;SCIN;SDC4;SPTB;DAAM2;ESPN;RND3;CTGF;BCAR1;MYH11;AMOT;PARVB
19200,GO:1902533,7.20348971262734e-08,0.999999979307518,34,885,positive regulation of intracellular signal transduction,BP,LIF;ADRA2B;ADRA2C;NOTCH1;PMAIP1;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP4;BMP2;CTGF;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;FZD8;DUSP5;PIM2
11475,GO:0043549,7.38355889821881e-08,0.999999978632114,32,772,regulation of kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;SDC4;BMP7;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
5887,GO:0016337,8.44224138758114e-08,0.999999978137217,27,582,single organismal cell-cell adhesion,BP,ITGA5;WNT4;ITGB5;DSC2;WNT7B;ACVR1;TTYH1;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;SDC4;BMP7;BMP4;CAMSAP3;MSN;AKT1;PKP3;PKP1;CDH1;PIK3CA;PIK3CG;GAS6;EFNB2
15051,GO:0060572,9.09406932118454e-08,0.99999999797417,6,17,morphogenesis of an epithelial bud,BP,WNT2;FGF10;WNT5A;BMP7;BMP4;WNT2B
3453,GO:0006793,9.40991445372282e-08,1,76,3069,phosphorus metabolic process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;MARK4;GADD45A;WNT7A;WNT7B;ACVR1;GUCY1B3;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MBOAT2;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;RALB;HRAS;WNT5A;KHK;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;CDKN1A;PKN3;WNK4;CHGA;DDR1;CTGF;AKT1;NRTN;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;GDNF;ACSL4;FZD8;DUSP5;PIM2;PDE4B
2640,GO:0005515,9.9753663088844e-08,1,183,10444,protein binding,MF,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;RABIF;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;PHLDA1;RHPN1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;RAB39B;RAB39A;MAPK12;FZD7;TYRO3;LPAR2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;MB21D2;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;DAAM2;WT1;CDKN1A;DLL1;PKN3;ESPN;VAMP1;WNK4;RND3;MSN;DDR1;CTGF;GJB1;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;HPCAL1;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;ZCCHC12;MYH11;LZTS1;CLDN23;SHC4;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;RAB3D;GDNF;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
13724,GO:0050878,1.02247957031333e-07,0.999999975570747,24,495,regulation of body fluid levels,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;ADORA1;EDN1;PLAU;PRKACB;TYRO3;FGF10;PIK3R1;PDGFB;PRKAR1B;RHOB;NPR1;WNK4;DDR1;AKT1;CLDN1;PIK3CA;PIK3CG;GAS6;VDR
11823,GO:0044459,1.02865765341748e-07,1,67,2478,plasma membrane part,CC,ITGA3;ITGA5;ADRA2B;ADRA2C;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;ITGB5;ITGB4;ITGB8;CRB2;SERPINA5;SLC52A3;ACVR1;ADORA1;CASQ2;KCNK6;MFGE8;SPTBN5;TTYH1;MPZL1;TSPAN13;TYRO3;LPAR2;CDH2;PDGFB;KCNH2;PTPN7;SNX18;AXIN1;NPR1;FGF8;SDC4;SPTB;HBEGF;BMP2;DLL1;DRP2;VAMP1;MSN;DDR1;GJB1;GJB2;GJB6;RAB17;JAG2;CDH1;MYO7A;GJA3;CLDN1;CLDN3;CLDN5;KCNG2;LZTS1;SHC4;SLC18B1;AMOT;KCND1;TSPAN2;MYZAP;FZD8;CLDN12;CLDN15;EFNB2;PDE4B
16710,GO:0071840,1.09416856739275e-07,1,122,5922,cellular component organization or biogenesis,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;SYT5;WNT3;WNT4;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;MARK4;RAB27A;CDH23;TF;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRISPLD2;SERPINA5;WNT7A;WNT7B;ZFPM1;RABIF;CASQ2;EDN1;RAB40B;RAB40A;MFGE8;SPTBN5;SPTBN4;TTYH1;RAB39B;RAB39A;PRND;FZD7;TYRO3;LIMS2;CDH2;FGF10;PIK3R1;REEP1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;PSTPIP2;SNX18;SESN2;AXIN1;RHOQ;RHOJ;NPR1;NUAK2;SCIN;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;RAB20;DRP2;ESPN;VAMP1;RND3;CHGA;MSN;DDR1;CTGF;GJB1;GJB2;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;SEMA6C;CDH1;EPN1;MYO7A;BCAR1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;KCNG2;GAS6;SIN3B;MYH11;LZTS1;VDR;AMOT;LAMA1;LAMA5;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;GDNF;ACSL4;PIM2;PARVB
5221,GO:0014065,1.09641297365886e-07,0.999999984964534,14,161,phosphatidylinositol 3-kinase signaling,BP,EDN1;TYRO3;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA;PIK3CG
2872,GO:0005912,1.10483612528168e-07,0.999999973507548,24,479,adherens junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;NOTCH1;ITGB5;DSC2;PLAU;SPTBN4;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;CAMSAP3;DLL1;RND3;MSN;PKP3;CDH1;BCAR1;PARVB;EFNB2
16835,GO:0072078,1.10956193117967e-07,0.999999990933017,10,73,nephron tubule morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
7108,GO:0022603,1.160102966743e-07,0.999999963828191,35,911,regulation of anatomical structure morphogenesis,BP,ITGA5;LIF;WNT3;WNT2;WNT4;NOTCH1;CRB2;WNT6;WNT7A;ACVR1;EDN1;FZD7;LIMS2;FGF10;FOXO4;WNT5A;RHOQ;RHOJ;RHOB;NPR1;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;MSN;WNT2B;LZTS1;VDR;AMOT;GDNF;HEY1;PARVB;EFNB2
13329,GO:0048645,1.20377346104074e-07,0.999999991840897,9,58,animal organ formation,BP,WNT2;FGF10;WNT5A;FGF8;BMP7;BMP4;WT1;WNT2B;GDNF
17327,GO:0090002,1.20423939012775e-07,0.999999984944045,13,136,establishment of protein localization to plasma membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
11111,GO:0042981,1.21163845917304e-07,0.999999967346791,44,1363,regulation of apoptotic process,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;PMAIP1;GADD45A;WNT7A;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;RHOB;NUAK2;SCIN;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;VDR;ARAF;GDNF;PIM2
13296,GO:0048584,1.2122674237246e-07,1,55,1941,positive regulation of response to stimulus,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;CRB2;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;BCAR1;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;FZD8;DUSP5;PIM2;PDE4B
9641,GO:0035004,1.27775754934776e-07,0.999999989383377,10,74,phosphatidylinositol 3-kinase activity,MF,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
14677,GO:0060047,1.30903356265837e-07,0.999999977048292,17,255,heart contraction,BP,DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;NPR1;HBEGF;CHGA;CTGF;NPPC;PIK3CA;PIK3CG;KCNG2;KCND1;PDE4B
3790,GO:0007389,1.33080293646656e-07,0.999999970009978,22,413,pattern specification process,BP,WNT3;WNT2;NOTCH1;CRB2;WNT6;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;FGF10;WNT5A;AXIN1;FGF8;BMP7;BMP4;BMP2;DAAM2;WT1;DLL1;WNT2B;GDNF
3891,GO:0008016,1.36140309361057e-07,0.999999977983245,16,225,regulation of heart contraction,BP,DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;NPR1;HBEGF;CHGA;CTGF;NPPC;PIK3CG;KCNG2;KCND1;PDE4B
7932,GO:0031410,1.42353704317742e-07,1,58,2095,cytoplasmic vesicle,CC,ITGA5;TMEM163;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN2;TSPAN15;NOTCH1;RAB27A;TF;ITGB5;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RAB39A;SYCN;FZD7;LPAR2;FSTL3;PDGFB;WNT5B;WNT5A;SNX18;AXIN1;RHOQ;RHOB;HBEGF;DLL1;RAB20;VAMP1;CHGA;PKP1;RAB12;RAB17;CYTIP;NPPC;CDH1;MYO7A;RAB44;RAB11FIP1;GAS6;MYH11;AMOT;SH3BP4;RAB38;RAB3D;RNF144A;PDE4B
8024,GO:0031589,1.43105601126791e-07,0.999999971736974,19,298,cell-substrate adhesion,BP,ITGA3;ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;ITGB5;ITGB4;PLAU;TTYH1;FZD7;TYRO3;PIK3R1;JAM3;SDC4;DDR1;CTGF;GAS6;LAMA5
3744,GO:0007267,1.4911712409817e-07,1,47,1519,cell-cell signaling,BP,ITGA3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;NOTCH1;DHH;WNT6;WNT7A;WNT7B;ADORA1;CASQ2;DKK3;EDN1;CCL20;MPZL1;FZD7;CDH2;FGF10;FGF17;PDGFB;HRAS;WNT5B;WNT5A;AXIN1;FGF8;BMP6;BMP4;BMP2;DLL1;GJB1;GJB2;AKT1;WNT2B;INHBB;GJA3;TLE1;RAB11FIP1;KCNG2;LZTS1;UNC119;GDNF;FZD8;EFNB2
18023,GO:0097708,1.50297059248618e-07,1,58,2098,intracellular vesicle,CC,ITGA5;TMEM163;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN2;TSPAN15;NOTCH1;RAB27A;TF;ITGB5;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RAB39A;SYCN;FZD7;LPAR2;FSTL3;PDGFB;WNT5B;WNT5A;SNX18;AXIN1;RHOQ;RHOB;HBEGF;DLL1;RAB20;VAMP1;CHGA;PKP1;RAB12;RAB17;CYTIP;NPPC;CDH1;MYO7A;RAB44;RAB11FIP1;GAS6;MYH11;AMOT;SH3BP4;RAB38;RAB3D;RNF144A;PDE4B
1388,GO:0003015,1.5523903935732e-07,0.999999972436084,17,258,heart process,BP,DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;NPR1;HBEGF;CHGA;CTGF;NPPC;PIK3CA;PIK3CG;KCNG2;KCND1;PDE4B
7629,GO:0030864,1.66055319995775e-07,0.999999988364286,9,55,cortical actin cytoskeleton,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;SPTB;CDH1;CLDN5;MYZAP
13072,GO:0048018,1.72784321025167e-07,0.999999995420782,6,21,receptor agonist activity,MF,WNT3;WNT2;WNT4;WNT7A;WNT5A;GAS6
15036,GO:0060548,1.78151521158819e-07,0.999999945310886,33,872,negative regulation of cell death,BP,ITGA5;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;FGF10;PIK3R1;HRAS;WNT5A;NUAK2;FGF8;CLCF1;BMP7;BMP4;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;KITLG;TLE1;PIK3CA;PIK3CG;GAS6;ARAF;GDNF;PIM2
12387,GO:0045859,1.79885615465442e-07,0.999999947962809,30,723,regulation of protein kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;SDC4;BMP7;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
3677,GO:0007169,1.81989124160696e-07,0.999999947983065,29,671,transmembrane receptor protein tyrosine kinase signaling pathway,BP,ITGA5;ADRA2B;ADRA2C;WNT4;ADORA1;MPZL1;MAPK12;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;RHOQ;FGF8;HBEGF;BMP2;DLL1;DDR1;CTGF;AKT1;NRTN;EPN1;BCAR1;PIK3CA;SHC4;EFNB2
571,GO:0001658,1.91658103499734e-07,0.999999986237862,9,59,branching involved in ureteric bud morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
15456,GO:0061333,1.96363817294285e-07,0.999999982838739,10,77,renal tubule morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
7113,GO:0022612,2.05046177369125e-07,0.999999975910514,12,120,gland morphogenesis,BP,WNT4;NOTCH1;LIMS2;FGF10;WNT5A;FGF8;BMP7;BMP4;MSN;DDR1;VDR;LAMA5
9374,GO:0034330,2.07818248804792e-07,0.999999962392882,17,242,cell junction organization,BP,ITGA5;WNT4;ACTN3;ACTN2;ITGB4;LIMS2;CDH2;SDC4;CAMSAP3;GJB1;GJB2;PKP3;CDH1;CLDN1;CLDN3;CLDN5;LAMA5
15027,GO:0060537,2.10462317445081e-07,0.999999955195606,20,345,muscle tissue development,BP,FHOD3;WNT2;ACTN3;ACTN2;NOTCH1;STRA6;IGSF8;ZFPM1;ACVR1;EDN1;FZD7;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;MYH11;EFNB2
570,GO:0001657,2.11763874270137e-07,0.999999978141054,11,97,ureteric bud development,BP,WNT4;WNT6;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
4895,GO:0010631,2.1873340353208e-07,0.999999962728568,16,227,epithelial cell migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF10;PDGFB;WNT5A;RHOB;HBEGF;BMP4;PKN3;AKT1;BCAR1;PIK3CA;AMOT;EFNB2
11174,GO:0043066,2.18875476625665e-07,0.999999933958023,31,795,negative regulation of apoptotic process,BP,ITGA5;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;FGF10;PIK3R1;HRAS;WNT5A;NUAK2;FGF8;CLCF1;BMP7;BMP4;WT1;CDKN1A;DLL1;HMGN5;AKT1;KITLG;TLE1;PIK3CA;PIK3CG;GAS6;ARAF;GDNF;PIM2
11386,GO:0043405,2.24946315625153e-07,0.999999954130557,19,321,regulation of MAP kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;FGF10;PDGFB;HRAS;WNT5A;AXIN1;BMP7;BMP4;BMP2;KITLG;PIK3CG;ARAF;FZD8;DUSP5
16888,GO:0072163,2.38032764433059e-07,0.999999975117168,11,98,mesonephric epithelium development,BP,WNT4;WNT6;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
16889,GO:0072164,2.38032764433059e-07,0.999999975117168,11,98,mesonephric tubule development,BP,WNT4;WNT6;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
1378,GO:0003002,2.50792428122129e-07,0.999999948464642,19,327,regionalization,BP,WNT3;WNT2;NOTCH1;CRB2;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;FGF10;WNT5A;AXIN1;FGF8;BMP4;BMP2;WT1;DLL1;WNT2B;GDNF
14796,GO:0060231,2.54759952385357e-07,0.999999992870599,6,20,mesenchymal to epithelial transition,BP,LIF;WNT4;FZD7;BMP4;WT1;GDNF
862,GO:0002067,2.55675565194138e-07,0.999999984972927,8,45,glandular epithelial cell differentiation,BP,WNT4;NOTCH1;WNT5A;FGF8;BMP6;BMP4;BMP2;DLL1
13740,GO:0050900,2.85715388859692e-07,0.999999937488321,20,391,leukocyte migration,BP,ITGA3;ITGA5;ARTN;ADORA1;EDN1;CCL20;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5A;JAM3;SDC4;CHGA;MSN;KITLG;PIK3CA;PIK3CG;GAS6;PDE4B
4912,GO:0010648,2.86324304514308e-07,0.999999905855538,40,1182,negative regulation of cell communication,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT4;ACTN3;NOTCH1;RASL11B;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PRKACB;TYRO3;CDH2;PRR5L;FSTL3;FGF10;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;BMP7;BMP4;BMP2;AKT1;EPN1;INHBB;TLE1;RAB11FIP1;GAS6;ARAF;SH3BP4;GDNF;DUSP5;HEY1
7254,GO:0030139,2.89520038153729e-07,0.99999994615351,17,270,endocytic vesicle,CC,WNT3;WNT4;TF;ITGB5;WNT6;WNT7A;WNT7B;RAB39A;LPAR2;WNT5B;WNT5A;HBEGF;RAB20;RAB17;RAB11FIP1;AMOT;RAB38
16752,GO:0071902,2.97696979092196e-07,0.999999941250525,18,297,positive regulation of protein serine/threonine kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;EDN1;FGF10;PDGFB;RALB;HRAS;WNT5A;AXIN1;PSRC1;BMP2;AKT1;KITLG;PIK3CG;FZD8;DUSP5
13265,GO:0048522,2.97769858880215e-07,1,100,4576,positive regulation of cellular process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;TF;PMAIP1;GADD45A;CRB2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;CASQ2;EDN1;PLAU;PRKACB;MFGE8;CCL20;RRAS2;MAPK12;FZD7;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;RHOB;NPR1;SCIN;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;ESPN;CHGA;MSN;CTGF;AKT1;RAB12;WNT2B;KITLG;NPPC;JAG2;CDH1;BCAR1;INHBB;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;SHC4;VDR;ARAF;SH3BP4;UNC119;RAB3D;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2;EFNB2
13945,GO:0051216,2.98787284005929e-07,0.999999955246239,14,176,cartilage development,BP,ITGB8;WNT7A;WNT7B;EDN1;WNT5B;WNT5A;SCIN;BMP7;BMP6;BMP4;BMP2;CTGF;WNT2B;NPPC
11177,GO:0043069,3.02725852425011e-07,0.999999907219565,31,806,negative regulation of programmed cell death,BP,ITGA5;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;FGF10;PIK3R1;HRAS;WNT5A;NUAK2;FGF8;CLCF1;BMP7;BMP4;WT1;CDKN1A;DLL1;HMGN5;AKT1;KITLG;TLE1;PIK3CA;PIK3CG;GAS6;ARAF;GDNF;PIM2
7174,GO:0023057,3.13799342080492e-07,0.999999896477164,40,1186,negative regulation of signaling,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT4;ACTN3;NOTCH1;RASL11B;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PRKACB;TYRO3;CDH2;PRR5L;FSTL3;FGF10;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;BMP7;BMP4;BMP2;AKT1;EPN1;INHBB;TLE1;RAB11FIP1;GAS6;ARAF;SH3BP4;GDNF;DUSP5;HEY1
13662,GO:0050790,3.1768172916251e-07,1,61,2320,regulation of catalytic activity,BP,ARTN;ADRA2B;ADRA2C;WNT4;RIN3;ACTN2;NOTCH1;PMAIP1;GADD45A;CRB2;SERPINA5;WNT7B;RABIF;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;SESN2;AXIN1;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;BMP2;CAMSAP3;CDKN1A;CTGF;AKT1;NRTN;KITLG;CST9L;PIK3CA;PIK3CG;GAS6;GPSM1;VDR;AMOT;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5
16872,GO:0072132,3.24370380485714e-07,0.999999980265643,8,46,mesenchyme morphogenesis,BP,NOTCH1;ACVR1;WNT5A;FGF8;BMP7;BMP2;HEY1;ACTA2
4719,GO:0010033,3.46302619883973e-07,1,69,2793,response to organic substance,BP,ITGA3;ITGA5;WNT3;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;ITGB5;PMAIP1;CRB2;DHH;WNT6;WNT7A;WNT7B;ACVR1;CASQ2;DKK3;EDN1;PRKACB;CCL20;FZD7;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;PRKAR1B;FOXO4;RALB;WNT5B;WNT5A;KHK;SESN2;RHOQ;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;MSN;CTGF;GJB2;GJB6;AKT1;PTGES;NPPC;CDH1;BCAR1;INHBB;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;VDR;SH3BP4;ACSL4;HEY1;CLDN18;PDE4B
19198,GO:1902531,3.64665211314307e-07,0.999999894142235,50,1683,regulation of intracellular signal transduction,BP,ITGA3;LIF;ADRA2B;ADRA2C;ACTN3;NOTCH1;PMAIP1;GADD45A;WNT7A;WNT7B;ADORA1;CASQ2;EDN1;CCL20;FZD7;CDH2;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5A;SESN2;AXIN1;RHOQ;RHOJ;RHOB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;KITLG;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;AMOT;ARAF;SH3BP4;FZD8;DUSP5;PIM2
21078,GO:2000242,3.78308654893046e-07,0.999999976235342,8,51,negative regulation of reproductive process,BP,LIF;WNT4;PRKACB;WNT5A;BMP7;BMP4;WT1;NPPC
1563,GO:0003338,3.79530678075114e-07,0.999999982499113,7,33,metanephros morphogenesis,BP,LIF;WNT4;WNT7B;FGF10;BMP4;WT1;GDNF
12231,GO:0045595,3.80676359535233e-07,0.999999892284803,46,1471,regulation of cell differentiation,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;CRB2;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;MAPK12;FZD7;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5B;WNT5A;AXIN1;SCIN;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;CTGF;AKT1;RAB17;KITLG;NPPC;CLDN5;GAS6;LZTS1;VDR;GDNF;HEY1;CLDN18;EFNB2
15110,GO:0060675,3.90188884953188e-07,0.999999969225614,9,64,ureteric bud morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
15048,GO:0060563,4.00015164813383e-07,0.999999974846392,8,48,neuroepithelial cell differentiation,BP,WNT4;NOTCH1;CDH2;FGF8;BMP2;DLL1;JAG2;MYO7A
8869,GO:0032989,4.3040418700048e-07,0.999999855941844,36,973,cellular component morphogenesis,BP,ARTN;FHOD3;WNT3;ACTN2;NOTCH1;WNT7A;WNT7B;ZFPM1;CASQ2;EDN1;SPTBN5;SPTBN4;FZD7;TYRO3;PIK3R1;HRAS;WNT5A;RHOQ;RHOJ;FGF8;SPTB;BMP7;B3GNT2;MSN;DDR1;NRTN;SEMA6C;MYO7A;CLDN3;PIK3CA;MYH11;LZTS1;VDR;LAMA5;GDNF;PARVB
12233,GO:0045597,4.32961319194047e-07,0.99999986241487,32,824,positive regulation of cell differentiation,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;CRB2;WNT7B;ACVR1;EDN1;MAPK12;CDH2;WNT5B;WNT5A;SCIN;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;KITLG;NPPC;CLDN5;GAS6;VDR;GDNF;EFNB2
16896,GO:0072171,4.39635705125346e-07,0.999999964771186,9,65,mesonephric tubule morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
15405,GO:0061180,4.68967721370936e-07,0.999999962074703,9,66,mammary gland epithelium development,BP,WNT3;WNT2;WNT4;WNT7B;FGF10;WNT5A;DDR1;AKT1;VDR
5233,GO:0014706,4.69740992336857e-07,0.999999898840159,19,331,striated muscle tissue development,BP,FHOD3;WNT2;ACTN3;ACTN2;NOTCH1;IGSF8;ZFPM1;ACVR1;EDN1;FZD7;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;MYH11;EFNB2
4898,GO:0010634,5.4577213465104e-07,0.999999937462018,11,109,positive regulation of epithelial cell migration,BP,ITGA3;WNT7A;EDN1;FGF10;PDGFB;WNT5A;RHOB;HBEGF;BMP4;AKT1;BCAR1
2806,GO:0005796,5.46089752791712e-07,0.999999945666114,10,97,Golgi lumen,CC,WNT3;WNT4;WNT6;WNT7A;WNT7B;PDGFB;WNT5B;WNT5A;SDC4;GAS6
13898,GO:0051145,5.72120866098142e-07,0.999999962076134,8,50,smooth muscle cell differentiation,BP,WNT4;NOTCH1;ACVR1;FGF10;PDGFB;FOXO4;BMP4;HEY1
17147,GO:0072659,5.87926343783993e-07,0.99999989904714,15,212,protein localization to plasma membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
14697,GO:0060070,5.88681279016544e-07,0.999999884131547,17,283,canonical Wnt signaling pathway,BP,WNT3;WNT2;WNT4;NOTCH1;WNT7A;WNT7B;DKK3;FZD7;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP2;WNT2B;FZD8
15678,GO:0065009,6.24932715645864e-07,1,70,2865,regulation of molecular function,BP,ARTN;LIF;ADRA2B;ADRA2C;WNT2;WNT4;RIN3;ACTN2;NOTCH1;PMAIP1;GADD45A;CRB2;SERPINA5;WNT7B;ZFPM1;RABIF;ADORA1;CASQ2;EDN1;PLAU;PRKACB;CCL20;SPTBN5;SPTBN4;TSPAN13;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;SESN2;AXIN1;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;BMP2;CAMSAP3;CDKN1A;WNK4;CTGF;AKT1;NRTN;KITLG;CST9L;PIK3CA;PIK3CG;GAS6;GPSM1;VDR;AMOT;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;PDE4B
7488,GO:0030546,6.30792075458329e-07,0.999999968061902,7,37,receptor activator activity,MF,WNT3;WNT2;WNT4;ACTN2;WNT7A;WNT5A;GAS6
569,GO:0001656,6.69855800537935e-07,0.999999932222244,10,88,metanephros development,BP,LIF;WNT4;WNT7B;FGF10;PDGFB;FGF8;BMP7;BMP4;WT1;GDNF
7010,GO:0021871,7.02392297229789e-07,0.99999997574646,6,23,forebrain regionalization,BP,WNT7B;AXIN1;FGF8;BMP4;BMP2;WNT2B
13963,GO:0051241,7.15401024583744e-07,0.999999758748828,34,976,negative regulation of multicellular organismal process,BP,ADRA2C;WNT3;WNT4;NOTCH1;WNT7A;ZFPM1;ADORA1;EDN1;PLAU;PRKACB;SPTBN4;FZD7;LIMS2;FSTL3;PIK3R1;PDGFB;FOXO4;WNT5A;NPR1;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;NPPC;INHBB;PIK3CG;RAB11FIP1;GAS6;AMOT;CLDN18;PDE4B
602,GO:0001707,7.22850704192082e-07,0.999999938218474,9,68,mesoderm formation,BP,ITGA3;WNT3;ITGB4;CRB2;ACVR1;WNT5A;AXIN1;BMP7;BMP4
1468,GO:0003179,7.6376463491597e-07,0.999999960664835,7,34,heart valve morphogenesis,BP,NOTCH1;STRA6;ZFPM1;ACVR1;BMP4;BMP2;HEY1
3532,GO:0006915,7.72288657221661e-07,0.999999771111935,50,1763,apoptotic process,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;PMAIP1;GADD45A;WNT7A;ACVR1;ADORA1;EDN1;PHLDA1;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;RALB;HRAS;WNT5A;AXIN1;RHOB;NUAK2;SCIN;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;GJB6;AKT1;KITLG;JAG2;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SHC4;VDR;ARAF;GDNF;PIM2
2459,GO:0005125,8.38428295257975e-07,0.999999873071644,13,218,cytokine activity,MF,LIF;WNT2;WNT7A;EDN1;CCL20;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;KITLG;INHBB
4893,GO:0010628,8.84756075988338e-07,0.999999672312106,49,1687,positive regulation of gene expression,BP,ITGA3;LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;ITGB8;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;MSN;CTGF;AKT1;PKP3;PKP1;CDH1;TLE1;GAS6;VDR;GDNF;FZD8;HEY1;ACTA2;PIM2
3543,GO:0006936,9.05211310541858e-07,0.999999805538265,18,326,muscle contraction,BP,ADRA2B;ADRA2C;ACTN3;ACTN2;ITGB5;DSC2;ADORA1;CASQ2;EDN1;KCNH2;CHGA;CTGF;PIK3CA;PIK3CG;MYH11;GDNF;ACTA2;PDE4B
11896,GO:0044765,9.05719726113526e-07,0.999999706391643,71,2931,single-organism transport,BP,LIF;ADRA2B;ADRA2C;SYT5;ACTN2;NOTCH1;RAB27A;STRA6;TF;CRISPLD2;SLC45A4;SERPINA5;WNT7A;SLC52A3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;KCNK6;MFGE8;FLVCR2;RAB39A;SYCN;FZD7;TYRO3;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;RALB;WNT5A;SESN2;RHOQ;NPR1;SCIN;SDC4;BMP7;BMP6;BMP4;CDKN1A;RAB20;SLC2A14;VAMP1;WNK4;CHGA;DDR1;CTGF;GJB1;TPD52;AKT1;PKP1;RAB17;CDH1;MYO7A;INHBB;RAB44;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;VDR;UNC119;KCND1;RAB3D;GDNF;ACSL4
8412,GO:0032344,9.12204329061375e-07,0.999999994223535,4,6,regulation of aldosterone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
8415,GO:0032347,9.12204329061375e-07,0.999999994223535,4,6,regulation of aldosterone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
16796,GO:0072012,9.41271163291067e-07,0.999999965490396,6,24,glomerulus vasculature development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
13203,GO:0048332,9.53994910443692e-07,0.999999915445836,9,70,mesoderm morphogenesis,BP,ITGA3;WNT3;ITGB4;CRB2;ACVR1;WNT5A;AXIN1;BMP7;BMP4
5882,GO:0016328,9.756101625918e-07,0.999999930206642,8,52,lateral plasma membrane,CC,AXIN1;GJB1;GJB2;CDH1;CLDN1;CLDN3;CLDN12;CLDN15
3590,GO:0007010,1.01746049000127e-06,0.999999630627666,38,1111,cytoskeleton organization,BP,FHOD3;WNT4;TUBG2;ACTN2;RAB6C;MARK4;ITGB5;GADD45A;CASQ2;EDN1;SPTBN5;SPTBN4;FGF10;PIK3R1;PLEKHH2;HRAS;JAM3;PSTPIP2;AXIN1;RHOQ;RHOJ;NUAK2;SCIN;PSRC1;SDC4;SPTB;CAMSAP3;DAAM2;ESPN;RND3;MSN;CTGF;PKP1;BCAR1;MYH11;AMOT;LAMA5;PARVB
18775,GO:1901342,1.03897339710179e-06,0.99999981215172,15,230,regulation of vasculature development,BP,ITGA5;WNT4;NOTCH1;PDGFB;FOXO4;WNT5A;RHOB;NPR1;BMP7;BMP4;WT1;DLL1;AMOT;HEY1;EFNB2
14020,GO:0051338,1.14744438294874e-06,0.999999609261608,33,933,regulation of transferase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;SDC4;BMP7;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
12094,GO:0045216,1.15550583126624e-06,0.999999789737293,15,214,cell-cell junction organization,BP,WNT4;ACTN3;ACTN2;LIMS2;CDH2;SDC4;CAMSAP3;GJB1;GJB2;PKP3;CDH1;CLDN1;CLDN3;CLDN5;LAMA5
3799,GO:0007411,1.16891220510925e-06,0.999999786965299,15,218,axon guidance,BP,ARTN;WNT3;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;PIK3CA;GDNF
15050,GO:0060571,1.17661662065671e-06,0.999999954785825,6,25,morphogenesis of an epithelial fold,BP,WNT2;FGF10;WNT5A;BMP7;BMP4;WNT2B
15774,GO:0070169,1.2806136062679e-06,0.99999992728757,7,39,positive regulation of biomineral tissue development,BP,WNT4;WNT6;ACVR1;BMP7;BMP6;BMP4;BMP2
8313,GO:0032147,1.28919420557664e-06,0.999999730707055,17,294,activation of protein kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;PRKACB;FGF10;PDGFB;PRKAR1B;WNT5A;AXIN1;BMP4;BMP2;PIK3CA;GAS6;ARAF;DUSP5
17944,GO:0097485,1.32082771352072e-06,0.999999756770911,15,220,neuron projection guidance,BP,ARTN;WNT3;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;PIK3CA;GDNF
17437,GO:0090183,1.36548844601421e-06,0.999999897193851,8,55,regulation of kidney development,BP,LIF;WNT4;PDGFB;BMP7;BMP4;WT1;WNT2B;GDNF
9373,GO:0034329,1.37867576379911e-06,0.999999763716941,14,191,cell junction assembly,BP,ITGA5;WNT4;ACTN3;ACTN2;ITGB4;LIMS2;SDC4;GJB1;GJB2;PKP3;CLDN1;CLDN3;CLDN5;LAMA5
20875,GO:1990778,1.4637153003385e-06,0.999999727818514,15,229,protein localization to cell periphery,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
12836,GO:0046854,1.53209197798224e-06,0.999999828893879,10,96,phosphatidylinositol phosphorylation,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
12293,GO:0045669,1.61405102537086e-06,0.999999875274556,8,57,positive regulation of osteoblast differentiation,BP,WNT4;WNT7B;ACVR1;BMP7;BMP6;BMP4;BMP2;NPPC
15500,GO:0061437,1.63629418870509e-06,0.999999932898898,6,26,renal system vasculature development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
15503,GO:0061440,1.63629418870509e-06,0.999999932898898,6,26,kidney vasculature development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
9664,GO:0035051,1.64802010388314e-06,0.999999786996975,11,120,cardiocyte differentiation,BP,FHOD3;ACTN2;NOTCH1;ACVR1;EDN1;FZD7;BMP4;BMP2;WT1;MYH11;EFNB2
15446,GO:0061311,1.66034635333222e-06,0.999999931738208,6,26,cell surface receptor signaling pathway involved in heart development,BP,NOTCH1;ACVR1;WNT5A;BMP4;BMP2;HEY1
14562,GO:0055007,1.67109138065605e-06,0.999999811408392,10,97,cardiac muscle cell differentiation,BP,FHOD3;ACTN2;ACVR1;EDN1;FZD7;BMP4;BMP2;WT1;MYH11;EFNB2
480,GO:0001501,1.69258951322947e-06,0.999999549872615,22,473,skeletal system development,BP,ITGB8;WNT7A;WNT7B;ZFPM1;EDN1;WNT5B;WNT5A;AXIN1;SCIN;FGF8;BMP7;BMP6;BMP4;BMP2;CTGF;WNT2B;NPPC;NAB2;JAG2;HAPLN3;VDR;CLDN18
7066,GO:0021983,1.6932696109033e-06,0.999999898776198,7,42,pituitary gland development,BP,WNT4;FGF10;WNT5A;FGF8;BMP4;BMP2;CDH1
1461,GO:0003170,1.70149643019035e-06,0.999999899432227,7,38,heart valve development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;BMP4;BMP2;HEY1
1480,GO:0003197,1.70217945709224e-06,0.999999899054326,7,39,endocardial cushion development,BP,NOTCH1;ACVR1;FGF8;BMP7;BMP4;BMP2;HEY1
15302,GO:0061005,1.7475578626604e-06,0.999999863701287,8,56,cell differentiation involved in kidney development,BP,LIF;WNT4;NOTCH1;PDGFB;BMP4;WT1;GDNF;ACTA2
17356,GO:0090066,1.79261280400608e-06,0.999999538519454,21,439,regulation of anatomical structure size,BP,FHOD3;ADRA2B;ADRA2C;WNT3;ACTN2;WNT7A;WNT7B;ADORA1;EDN1;SPTBN5;SPTBN4;PLEKHH2;WNT5A;NPR1;SCIN;SPTB;CHGA;MSN;AKT1;NPPC;ACTA2
8562,GO:0032526,1.85011111154135e-06,0.99999978806622,10,103,response to retinoic acid,BP,WNT3;WNT2;WNT6;WNT7B;FZD7;WNT5B;WNT5A;BMP6;GJB2;PTGES
18776,GO:1901343,1.85253946285911e-06,0.999999820237012,9,79,negative regulation of vasculature development,BP,WNT4;NOTCH1;PDGFB;FOXO4;NPR1;BMP7;BMP4;WT1;AMOT
13427,GO:0048839,1.86595211405063e-06,0.999999697626016,13,175,inner ear development,BP,NOTCH1;CDH23;FGF10;WNT5A;FGF8;SDC4;BMP4;BMP2;DLL1;GJB2;GJB6;JAG2;MYO7A
13069,GO:0048015,1.8775857652748e-06,0.999999668944727,14,201,phosphatidylinositol-mediated signaling,BP,EDN1;TYRO3;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA;PIK3CG
17438,GO:0090184,1.90357138275401e-06,0.999999884804344,7,40,positive regulation of kidney development,BP,LIF;WNT4;PDGFB;BMP4;WT1;WNT2B;GDNF
7465,GO:0030509,1.94300987926829e-06,0.999999713469021,12,146,BMP signaling pathway,BP,ITGA3;NOTCH1;CRB2;ACVR1;FSTL3;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;ZCCHC12
13665,GO:0050794,1.96877416289149e-06,1,170,9810,regulation of cellular process,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;MARK4;RAB27A;RASL11B;TF;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;ESPN;WNK4;RND3;CHGA;MSN;DDR1;CTGF;GJB6;RRAD;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;RAB3D;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
17379,GO:0090092,2.01383841308685e-06,0.999999642447101,14,206,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ITGA3;NOTCH1;RASL11B;CRB2;ACVR1;DKK3;FSTL3;FGF10;WNT5A;BMP7;BMP6;BMP4;BMP2;INHBB
13661,GO:0050789,2.03708396310374e-06,1,177,10394,regulation of biological process,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;MARK4;RAB27A;STRA6;RASL11B;TF;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;TTYH1;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;ESPN;WNK4;RND3;CHGA;MSN;DDR1;CTGF;GJB6;RRAD;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
11468,GO:0043542,2.1909455857062e-06,0.999999672424943,12,153,endothelial cell migration,BP,NOTCH1;WNT7A;EDN1;PDGFB;WNT5A;RHOB;BMP4;AKT1;BCAR1;PIK3CA;AMOT;EFNB2
4648,GO:0009792,2.2156548362487e-06,0.999999360850946,24,555,embryo development ending in birth or egg hatching,BP,LIF;WNT2;NOTCH1;CRB2;WNT7B;ACVR1;EDN1;PRKACB;PDGFB;WNT5A;AXIN1;FGF8;SDC4;BMP7;BMP4;BMP2;DLL1;AKT1;JAG2;EPN1;DSC3;AMOT;ACSL4;HEY1
11630,GO:0044093,2.25785893978106e-06,0.999999064049264,51,1841,positive regulation of molecular function,BP,ARTN;ADRA2B;ADRA2C;WNT2;WNT4;RIN3;ACTN2;PMAIP1;GADD45A;WNT7B;RABIF;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;AXIN1;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP4;BMP2;CDKN1A;CTGF;AKT1;NRTN;KITLG;PIK3CA;PIK3CG;GAS6;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5
13071,GO:0048017,2.26119965461189e-06,0.99999959456279,14,204,inositol lipid-mediated signaling,BP,EDN1;TYRO3;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA;PIK3CG
13579,GO:0050679,2.29068034230201e-06,0.999999655568056,12,158,positive regulation of epithelial cell proliferation,BP,WNT2;NOTCH1;WNT7A;FZD7;FGF10;PDGFB;HRAS;WNT5A;BMP6;BMP4;BMP2;AKT1
10850,GO:0042475,2.32806373883633e-06,0.999999767211333,9,81,odontogenesis of dentin-containing tooth,BP,ITGB4;WNT6;FGF10;FGF8;BMP7;BMP4;BMP2;JAG2;LAMA5
5867,GO:0016303,2.3490166640509e-06,0.999999851963287,7,43,1-phosphatidylinositol-3-kinase activity,MF,FGF10;FGF17;PIK3R2;PIK3R1;FGF8;PIK3CA;PIK3CG
13626,GO:0050731,2.39921850529975e-06,0.999999637164464,12,163,positive regulation of peptidyl-tyrosine phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;FGF10;PDGFB;CLCF1;HBEGF;KITLG;GAS6;UNC119
427,GO:0001101,2.43599525851785e-06,0.999999464818412,17,313,response to acid chemical,BP,WNT3;WNT2;WNT6;WNT7B;EDN1;FZD7;PDGFB;WNT5B;WNT5A;SESN2;BMP6;CTGF;GJB2;AKT1;PTGES;CLDN1;SH3BP4
12346,GO:0045778,2.46274368115121e-06,0.999999751821421,9,82,positive regulation of ossification,BP,WNT4;WNT7B;ACVR1;WNT5A;BMP7;BMP6;BMP4;BMP2;NPPC
14734,GO:0060129,2.47684176154766e-06,1,3,3,thyroid-stimulating hormone-secreting cell differentiation,BP,WNT4;FGF8;BMP2
7214,GO:0030057,2.50978194605756e-06,0.999999889848166,6,25,desmosome,CC,DSC2;JAM3;DSG3;PKP3;PKP1;DSC3
17882,GO:0097367,2.6510440246756e-06,0.999998930806428,58,2130,carbohydrate derivative binding,MF,ITGA3;TUBG2;RAB6C;MARK4;RAB27A;RASL11B;CRISPLD2;SERPINA5;ACVR1;GUCY1B3;ADORA1;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;FGF10;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;HBEGF;LGALS4;BMP7;BMP4;PKN3;RAB20;WNK4;RND3;DDR1;CTGF;RRAD;AKT1;RAB12;RAB17;CDH1;MYO7A;RAB44;PIK3CA;PIK3CG;HAPLN3;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
4054,GO:0008285,2.65379522578061e-06,0.999999203480221,25,623,negative regulation of cell proliferation,BP,LIF;NOTCH1;ADORA1;LIMS2;FGF10;FOXO4;HRAS;WNT5A;NPR1;SCIN;SDC4;BMP7;BMP4;BMP2;WT1;CDKN1A;DLL1;DDR1;GJB6;PTGES;NPPC;VDR;SH3BP4;PIM2;EFNB2
13415,GO:0048806,2.74096132402988e-06,0.999999822678365,7,44,genitalia development,BP,STRA6;TYRO3;FGF10;WNT5A;FGF8;BMP6;WT1
11387,GO:0043406,2.76230936242594e-06,0.999999495151027,14,214,positive regulation of MAP kinase activity,BP,ADRA2B;ADRA2C;WNT7B;EDN1;FGF10;PDGFB;HRAS;WNT5A;AXIN1;BMP2;KITLG;PIK3CG;FZD8;DUSP5
4736,GO:0010092,2.76500278305987e-06,0.999999873376526,6,29,specification of animal organ identity,BP,WNT2;FGF10;FGF8;BMP4;WNT2B;GDNF
13295,GO:0048583,2.8827499100432e-06,0.999998747188636,80,3506,regulation of response to stimulus,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;CRB2;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;EPN1;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;GPSM1;AMOT;ARAF;SH3BP4;GDNF;FZD8;DUSP5;HEY1;PIM2;EFNB2;PDE4B
16559,GO:0071560,3.05982179048145e-06,0.999999435879621,14,212,cellular response to transforming growth factor beta stimulus,BP,ITGA3;WNT2;WNT4;RASL11B;ITGB5;WNT7A;ACVR1;DKK3;EDN1;CGN;PDGFB;WNT5A;CLDN1;CLDN5
7924,GO:0031399,3.14352854045697e-06,0.999998728970242,46,1619,regulation of protein modification process,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
16558,GO:0071559,3.46230983564626e-06,0.999999354482421,14,214,response to transforming growth factor beta,BP,ITGA3;WNT2;WNT4;RASL11B;ITGB5;WNT7A;ACVR1;DKK3;EDN1;CGN;PDGFB;WNT5A;CLDN1;CLDN5
7628,GO:0030863,3.61003071384432e-06,0.999999619364127,9,79,cortical cytoskeleton,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;SPTB;CDH1;CLDN5;MYZAP
7538,GO:0030666,3.66122318826307e-06,0.999999422335487,12,165,endocytic vesicle membrane,CC,WNT3;WNT4;WNT6;WNT7A;WNT7B;RAB39A;WNT5B;WNT5A;HBEGF;RAB20;RAB11FIP1;RAB38
1483,GO:0003203,3.6789093258898e-06,0.999999822828187,6,29,endocardial cushion morphogenesis,BP,NOTCH1;ACVR1;FGF8;BMP7;BMP2;HEY1
4650,GO:0009798,3.73703430240535e-06,0.9999996015944,9,88,axis specification,BP,WNT3;NOTCH1;WNT6;WNT7A;FGF10;WNT5A;BMP4;WT1;DLL1
16673,GO:0071772,3.82679192978272e-06,0.999999394830014,12,156,response to BMP,BP,ITGA3;NOTCH1;CRB2;ACVR1;FSTL3;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;ZCCHC12
16674,GO:0071773,3.82679192978272e-06,0.999999394830014,12,156,cellular response to BMP stimulus,BP,ITGA3;NOTCH1;CRB2;ACVR1;FSTL3;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;ZCCHC12
1387,GO:0003014,3.8303952092899e-06,0.99999952221528,10,107,renal system process,BP,ITGA3;ADORA1;EDN1;PRKACB;PDGFB;PRKAR1B;NPR1;BMP4;WNK4;GAS6
7296,GO:0030198,3.99864993567925e-06,0.999999087982704,17,306,extracellular matrix organization,BP,ITGA3;ITGA5;NOTCH1;ITGB5;ITGB4;ITGB8;CRISPLD2;PDGFB;JAM3;WT1;DDR1;CTGF;CDH1;GAS6;MYH11;LAMA1;LAMA5
5805,GO:0016192,4.06428574193023e-06,0.999998303388061,49,1770,vesicle-mediated transport,BP,SYT5;RIN3;ACTN2;RAB6C;NOTCH1;RAB27A;TF;CRISPLD2;WNT7A;RABIF;ADORA1;PLAU;RAB40B;RAB40A;MFGE8;SPTBN5;SPTBN4;RAB39B;RAB39A;SYCN;TYRO3;PIK3R2;PIK3R1;PDGFB;RALB;HRAS;WNT5A;SNX18;SCIN;SDC4;SPTB;DLL1;RAB20;VAMP1;CHGA;MSN;PKP1;RAB17;EPN1;MYO7A;RAB44;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SH3BP4;UNC119;RAB38;RAB3D
3825,GO:0007507,4.14314445928547e-06,0.999998832216134,22,488,heart development,BP,ITGA3;FHOD3;WNT2;ACTN2;NOTCH1;STRA6;ZFPM1;ACVR1;EDN1;FZD7;PDGFB;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;CLDN5;MYH11;HEY1;EFNB2
11171,GO:0043062,4.19528964812708e-06,0.999999039507005,17,307,extracellular structure organization,BP,ITGA3;ITGA5;NOTCH1;ITGB5;ITGB4;ITGB8;CRISPLD2;PDGFB;JAM3;WT1;DDR1;CTGF;CDH1;GAS6;MYH11;LAMA1;LAMA5
14934,GO:0060411,4.32906791183267e-06,0.99999961424778,8,62,cardiac septum morphogenesis,BP,NOTCH1;ZFPM1;ACVR1;WNT5A;FGF8;BMP7;BMP4;HEY1
8858,GO:0032970,4.65828464877177e-06,0.999998923948646,17,318,regulation of actin filament-based process,BP,FHOD3;WNT4;ACTN2;DSC2;EDN1;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;SCIN;SDC4;SPTB;CTGF;PDE4B
16343,GO:0071229,4.76520463489187e-06,0.99999915470726,13,190,cellular response to acid chemical,BP,WNT3;WNT2;WNT6;WNT7B;EDN1;FZD7;PDGFB;WNT5B;WNT5A;SESN2;AKT1;CLDN1;SH3BP4
12825,GO:0046834,4.90796726968782e-06,0.999999369776898,10,108,lipid phosphorylation,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
16864,GO:0072124,5.00288864063911e-06,0.999999928414625,4,9,regulation of glomerular mesangial cell proliferation,BP,PDGFB;BMP7;BMP4;WT1
10581,GO:0040008,5.11665609400173e-06,0.999998445028051,24,607,regulation of growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;WNT5A;SESN2;NPR1;PSRC1;FGF8;HBEGF;BMP4;WT1;CDKN1A;DLL1;DDR1;CTGF;AKT1;NPPC;BCAR1;PIK3CA;GAS6;SH3BP4
10083,GO:0035850,5.3653919824356e-06,0.99999961320592,7,46,epithelial cell differentiation involved in kidney development,BP,LIF;NOTCH1;PDGFB;BMP4;WT1;GDNF;ACTA2
16091,GO:0070700,5.36563876765984e-06,0.99999992183464,4,9,BMP receptor binding,MF,BMP7;BMP6;BMP4;BMP2
14858,GO:0060317,5.37191398452587e-06,0.999999720651442,6,31,cardiac epithelial to mesenchymal transition,BP,WNT2;NOTCH1;ACVR1;FGF8;BMP2;HEY1
13445,GO:0048863,5.4314056567117e-06,0.99999910918566,12,162,stem cell differentiation,BP,LIF;WNT3;NOTCH1;WNT7A;ACVR1;EDN1;FOXO4;NRTN;KITLG;SHC4;LAMA5;GDNF
3855,GO:0007596,5.45201751741258e-06,0.999998723006631,17,343,blood coagulation,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;EDN1;PLAU;PRKACB;TYRO3;PIK3R1;PDGFB;PRKAR1B;RHOB;AKT1;PIK3CA;PIK3CG;GAS6
14577,GO:0055024,5.45407174906699e-06,0.999999495824152,8,66,regulation of cardiac muscle tissue development,BP,WNT2;NOTCH1;EDN1;FZD7;FGF8;BMP4;BMP2;EFNB2
7393,GO:0030325,5.70771647767701e-06,0.999999809563056,5,20,adrenal gland development,BP,WNT4;STRA6;DKK3;FSTL3;WT1
21077,GO:2000241,6.04148767499254e-06,0.999999200231194,10,124,regulation of reproductive process,BP,LIF;WNT4;NOTCH1;PRKACB;WNT5A;BMP7;BMP4;WT1;NPPC;INHBB
10851,GO:0042476,6.09435893108845e-06,0.999999195146998,10,115,odontogenesis,BP,ITGB4;WNT6;EDN1;FGF10;FGF8;BMP7;BMP4;BMP2;JAG2;LAMA5
11233,GO:0043168,6.12703642865742e-06,0.999997182835481,65,2575,anion binding,MF,SYT5;TUBG2;ACTN2;RAB6C;GLDC;MARK4;RAB27A;RASL11B;CRISPLD2;SERPINA5;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;MFGE8;SPTBN4;RRAS2;RAB39B;RAB39A;MAPK12;FZD7;TYRO3;FGF10;PRKAR1B;RALB;HRAS;SNX18;KHK;SESN2;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;HBEGF;BMP7;BMP4;PKN3;RAB20;WNK4;RND3;DDR1;CTGF;RRAD;AKT1;RAB12;RAB17;PTGES;MYO7A;RAB44;PIK3CA;PIK3CG;GAS6;MYH11;VDR;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
8791,GO:0032874,6.23752837857798e-06,0.999999065650293,11,137,positive regulation of stress-activated MAPK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;FZD8
13682,GO:0050817,6.39540370966643e-06,0.999998482671625,17,347,coagulation,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;EDN1;PLAU;PRKACB;TYRO3;PIK3R1;PDGFB;PRKAR1B;RHOB;AKT1;PIK3CA;PIK3CG;GAS6
14485,GO:0052742,6.52081778996246e-06,0.999999512518958,7,49,phosphatidylinositol kinase activity,MF,FGF10;FGF17;PIK3R2;PIK3R1;FGF8;PIK3CA;PIK3CG
3544,GO:0006937,6.60205121957019e-06,0.999999002440502,11,146,regulation of muscle contraction,BP,ADRA2B;ADRA2C;ACTN3;DSC2;ADORA1;CASQ2;EDN1;CHGA;CTGF;PIK3CG;PDE4B
3858,GO:0007599,6.63341805544776e-06,0.999998421616123,17,348,hemostasis,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;EDN1;PLAU;PRKACB;TYRO3;PIK3R1;PDGFB;PRKAR1B;RHOB;AKT1;PIK3CA;PIK3CG;GAS6
11137,GO:0043009,6.69164383557784e-06,0.999997991220086,23,552,chordate embryonic development,BP,LIF;WNT2;NOTCH1;CRB2;WNT7B;ACVR1;EDN1;PRKACB;PDGFB;WNT5A;AXIN1;FGF8;SDC4;BMP7;BMP4;BMP2;DLL1;AKT1;JAG2;EPN1;DSC3;AMOT;HEY1
15863,GO:0070304,6.7325835940335e-06,0.99999898286341,11,138,positive regulation of stress-activated protein kinase signaling cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;FZD8
4873,GO:0010595,6.95937342586319e-06,0.99999933243289,8,69,positive regulation of endothelial cell migration,BP,WNT7A;EDN1;PDGFB;WNT5A;RHOB;BMP4;AKT1;BCAR1
562,GO:0001649,7.12684135076892e-06,0.999998684929653,13,201,osteoblast differentiation,BP,WNT3;WNT4;NOTCH1;DHH;WNT7B;ACVR1;RRAS2;BMP7;BMP6;BMP4;BMP2;AKT1;NPPC
7487,GO:0030545,7.1695612025994e-06,0.999999452289571,7,53,receptor regulator activity,MF,WNT3;WNT2;WNT4;ACTN2;WNT7A;WNT5A;GAS6
15011,GO:0060513,7.41104098968904e-06,0.999999876233586,4,10,prostatic bud formation,BP,FGF10;WNT5A;BMP7;BMP4
17339,GO:0090030,7.49568910873737e-06,0.999999881025224,4,9,regulation of steroid hormone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
20468,GO:1905332,7.54522158707199e-06,0.999999581430499,6,32,positive regulation of morphogenesis of an epithelium,BP,LIF;WNT2;WNT4;BMP4;WNT2B;GDNF
8410,GO:0032341,7.67085979003349e-06,0.999999877520226,4,9,aldosterone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
8411,GO:0032342,7.67085979003349e-06,0.999999877520226,4,9,aldosterone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
10227,GO:0036092,7.68057736980371e-06,0.999999409928222,7,50,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGF10;FGF17;PIK3R2;PIK3R1;FGF8;PIK3CA;PIK3CG
15709,GO:0070062,7.73972301068463e-06,0.999996470868762,61,2675,extracellular exosome,CC,ITGA3;WNT3;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;CDH2;FRMPD1;RALB;WNT5B;WNT5A;SNX18;KHK;RHOQ;RHOJ;RHOB;SCIN;SDC4;CLCF1;B3GNT2;DAAM2;RND3;MSN;DDR1;DSG3;PKP1;RAB17;CDH1;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;MYH11;PM20D2;LAMA5;SH3BP4;RAB3D;ACSL4;ACTA2;CLDN11
5531,GO:0015629,7.75939169480439e-06,0.999997872737471,20,433,actin cytoskeleton,CC,FHOD3;ACTN3;ACTN2;SPTBN5;SPTBN4;CDH2;CGN;PLEKHH2;RHOQ;SCIN;SPTB;ESPN;CDH1;MYO7A;BCAR1;CLDN5;MYH11;AMOT;MYZAP;ACTA2
5222,GO:0014066,8.02647892167238e-06,0.999998762397051,11,143,regulation of phosphatidylinositol 3-kinase signaling,BP,PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA
3727,GO:0007229,8.0731806572418e-06,0.999999051136224,9,89,integrin-mediated signaling pathway,BP,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8;LIMS2;CTGF;BCAR1;LAMA5
3668,GO:0007160,8.10494233855635e-06,0.999998487311113,13,193,cell-matrix adhesion,BP,ITGA3;WNT4;ACTN3;ACTN2;ITGB5;ITGB4;PLAU;PIK3R1;JAM3;SDC4;DDR1;CTGF;LAMA5
5809,GO:0016202,8.15833923554932e-06,0.999998885446327,10,115,regulation of striated muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;FZD7;FGF8;BMP4;BMP2;DLL1;EFNB2
15772,GO:0070167,8.22384472766595e-06,0.999999189545961,8,73,regulation of biomineral tissue development,BP,WNT4;WNT6;ACVR1;BMP7;BMP6;BMP4;BMP2;GAS6
15676,GO:0065007,8.47181412989537e-06,0.999997053300875,183,10987,biological regulation,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;MARK4;RAB27A;CDH23;STRA6;RASL11B;TF;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39A;PRND;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;SNX18;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;ESPN;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;CTGF;GJB6;RRAD;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN16;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
20389,GO:1905114,8.69137884883244e-06,0.999997346108778,23,565,cell surface receptor signaling pathway involved in cell-cell signaling,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ADORA1;DKK3;FZD7;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP4;BMP2;AKT1;WNT2B;TLE1;FZD8
9701,GO:0035148,8.72752633952323e-06,0.999998642439466,11,142,tube formation,BP,WNT4;NOTCH1;WNT6;PRKACB;FGF10;WNT5A;FGF8;SDC4;BMP7;BMP4;GDNF
12596,GO:0046330,8.73747718862163e-06,0.999998796270278,10,116,positive regulation of JNK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;CTGF;FZD8
16860,GO:0072110,8.74253026581813e-06,0.999999847670221,4,10,glomerular mesangial cell proliferation,BP,PDGFB;BMP7;BMP4;WT1
16861,GO:0072111,8.79735012859178e-06,0.999999678720107,5,20,cell proliferation involved in kidney development,BP,PDGFB;BMP7;BMP4;BMP2;WT1
4896,GO:0010632,8.85382036770673e-06,0.999998470969284,12,173,regulation of epithelial cell migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF10;PDGFB;WNT5A;RHOB;HBEGF;BMP4;AKT1;BCAR1
857,GO:0002062,8.86801216393215e-06,0.999998943924041,9,91,chondrocyte differentiation,BP,WNT7A;WNT5B;SCIN;BMP6;BMP4;BMP2;CTGF;WNT2B;NPPC
15311,GO:0061024,8.99413609299714e-06,0.999996602779164,33,1001,membrane organization,BP,ITGA3;SYT5;WNT4;RIN3;ACTN2;TSPAN15;RAB27A;TF;PMAIP1;SERPINA5;RABIF;RAB40B;RAB40A;MFGE8;SPTBN4;RAB39A;CDH2;PIK3R1;REEP1;WNT5A;SNX18;RHOQ;RAB20;VAMP1;AKT1;PKP3;RAB12;CDH1;EPN1;GAS6;LAMA5;RAB38;GDNF
820,GO:0002011,9.10039141046082e-06,0.999999283440202,7,49,morphogenesis of an epithelial sheet,BP,ITGA5;NOTCH1;WNT7A;WNT5A;HBEGF;BMP7;DDR1
14721,GO:0060113,9.19486679509292e-06,0.999999271001153,7,52,inner ear receptor cell differentiation,BP,NOTCH1;CDH23;SDC4;BMP4;DLL1;JAG2;MYO7A
19669,GO:1903561,9.51376175420485e-06,0.99999563322963,61,2690,extracellular vesicle,CC,ITGA3;WNT3;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;CDH2;FRMPD1;RALB;WNT5B;WNT5A;SNX18;KHK;RHOQ;RHOJ;RHOB;SCIN;SDC4;CLCF1;B3GNT2;DAAM2;RND3;MSN;DDR1;DSG3;PKP1;RAB17;CDH1;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;MYH11;PM20D2;LAMA5;SH3BP4;RAB3D;ACSL4;ACTA2;CLDN11
16865,GO:0072125,9.60723848926459e-06,0.99999996766911,3,4,negative regulation of glomerular mesangial cell proliferation,BP,BMP7;BMP4;WT1
17448,GO:0090194,9.60723848926459e-06,0.99999996766911,3,4,negative regulation of glomerulus development,BP,BMP7;BMP4;WT1
11277,GO:0043230,9.62997900938256e-06,0.999995578164334,61,2691,extracellular organelle,CC,ITGA3;WNT3;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;CDH2;FRMPD1;RALB;WNT5B;WNT5A;SNX18;KHK;RHOQ;RHOJ;RHOB;SCIN;SDC4;CLCF1;B3GNT2;DAAM2;RND3;MSN;DDR1;DSG3;PKP1;RAB17;CDH1;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;MYH11;PM20D2;LAMA5;SH3BP4;RAB3D;ACSL4;ACTA2;CLDN11
18944,GO:1901861,9.67914534023455e-06,0.999998649991078,10,117,regulation of muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;FZD7;FGF8;BMP4;BMP2;DLL1;EFNB2
10629,GO:0042056,9.69131748326422e-06,0.999999621921355,5,26,chemoattractant activity,MF,FGF10;PDGFB;WNT5A;FGF8;BMP4
328,GO:0000902,9.70971079849852e-06,0.99999643419114,31,883,cell morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;ZFPM1;SPTBN5;SPTBN4;FZD7;TYRO3;PIK3R1;HRAS;WNT5A;RHOQ;RHOJ;FGF8;SPTB;BMP7;B3GNT2;MSN;DDR1;NRTN;SEMA6C;MYO7A;CLDN3;PIK3CA;LZTS1;VDR;LAMA5;GDNF;PARVB
567,GO:0001654,1.01561267420317e-05,0.999997503648682,17,333,eye development,BP,WNT2;STRA6;WNT6;WNT7A;WNT7B;FGF10;WNT5B;WNT5A;AXIN1;RHOJ;BMP7;BMP6;BMP4;WT1;DLL1;WNT2B;MYO7A
14946,GO:0060425,1.0231439280701e-05,0.999999175179203,7,52,lung morphogenesis,BP,LIF;WNT2;WNT7B;FGF10;FGF8;BMP4;WNT2B
14669,GO:0060039,1.03186252038364e-05,0.999999610362345,5,20,pericardium development,BP,NOTCH1;WNT5A;BMP7;BMP2;WT1
13319,GO:0048634,1.03777652453513e-05,0.999998539599191,10,119,regulation of muscle organ development,BP,WNT2;ACTN3;NOTCH1;EDN1;FZD7;FGF8;BMP4;BMP2;DLL1;EFNB2
2512,GO:0005198,1.04742398144336e-05,0.999996755113557,23,677,structural molecule activity,MF,TUBG2;ACTN3;ACTN2;SPTBN4;MPZL1;AXIN1;SPTB;MSN;PKP1;CLDN1;CLDN2;CLDN3;CLDN5;HAPLN3;MYH11;CLDN23;LAMA1;LAMA5;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
14107,GO:0051493,1.06792168940657e-05,0.999997117143355,19,413,regulation of cytoskeleton organization,BP,FHOD3;WNT4;ACTN2;RAB6C;EDN1;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;SCIN;PSRC1;SDC4;SPTB;CAMSAP3;ESPN;CTGF
7624,GO:0030858,1.06819707024642e-05,0.999999130304724,7,54,positive regulation of epithelial cell differentiation,BP,LIF;NOTCH1;BMP6;BMP4;CLDN5;VDR;GDNF
2885,GO:0005938,1.1090263748504e-05,0.999997699343946,14,229,cell cortex,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;RALB;SCIN;SPTB;CTGF;CYTIP;CDH1;MYO7A;CLDN5;MYZAP
13899,GO:0051146,1.13262420470807e-05,0.99999764339409,14,238,striated muscle cell differentiation,BP,FHOD3;ACTN2;NOTCH1;ACVR1;CASQ2;EDN1;FZD7;CDH2;BMP4;BMP2;WT1;AKT1;MYH11;EFNB2
5747,GO:0016055,1.18345777908636e-05,0.999996653603714,20,461,Wnt signaling pathway,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;DKK3;FZD7;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP2;WNT2B;TLE1;FZD8
7459,GO:0030501,1.1867889812332e-05,0.999999278128958,6,35,positive regulation of bone mineralization,BP,WNT4;ACVR1;BMP7;BMP6;BMP4;BMP2
7533,GO:0030659,1.18879191366716e-05,0.999995998117712,26,711,cytoplasmic vesicle membrane,CC,TMEM163;SYT5;WNT3;WNT4;RAB27A;TF;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;RAB39A;SYCN;WNT5B;WNT5A;SNX18;HBEGF;RAB20;VAMP1;CHGA;PKP1;RAB44;RAB11FIP1;RAB38;RAB3D;RNF144A
18904,GO:1901699,1.20700219821983e-05,0.999996234944802,23,574,cellular response to nitrogen compound,BP,ACTN2;GUCY1B3;CASQ2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RALB;SESN2;RHOQ;BMP4;WT1;GJB2;AKT1;CDH1;BCAR1;INHBB;PIK3CA;PIK3CG;SH3BP4;PDE4B
7212,GO:0030055,1.21232936932604e-05,0.999996830526531,18,391,cell-substrate junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;ITGB5;ITGB4;PLAU;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;RND3;MSN;BCAR1;PARVB;EFNB2
18426,GO:0198738,1.21691557323333e-05,0.999996552067031,20,462,cell-cell signaling by wnt,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;DKK3;FZD7;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP2;WNT2B;TLE1;FZD8
13374,GO:0048711,1.23227909272898e-05,0.99999975580117,4,11,positive regulation of astrocyte differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
15333,GO:0061047,1.25357036877275e-05,0.999999953842934,3,4,positive regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4;WNT2B
13578,GO:0050678,1.25368890686446e-05,0.999997187106873,15,282,regulation of epithelial cell proliferation,BP,WNT2;NOTCH1;WNT7A;FZD7;LIMS2;FGF10;PDGFB;HRAS;WNT5A;BMP6;BMP4;BMP2;AKT1;VDR;EFNB2
3820,GO:0007498,1.26525402871032e-05,0.999998174398993,10,124,mesoderm development,BP,ITGA3;WNT3;ITGB4;CRB2;ACVR1;WNT5A;AXIN1;FGF8;BMP7;BMP4
17412,GO:0090150,1.27464930567502e-05,0.999996958604278,16,359,establishment of protein localization to membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;PMAIP1;ADORA1;SPTBN4;CDH2;PIK3R1;REEP1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
4699,GO:0009968,1.32361400422534e-05,0.999994820793074,34,1080,negative regulation of signal transduction,BP,ITGA3;LIF;WNT4;ACTN3;NOTCH1;RASL11B;ACVR1;CASQ2;DKK3;PRKACB;TYRO3;CDH2;PRR5L;FSTL3;FGF10;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;BMP7;BMP4;BMP2;AKT1;EPN1;TLE1;GAS6;ARAF;SH3BP4;GDNF;DUSP5;HEY1
15120,GO:0060688,1.33069589301483e-05,0.999998878676776,7,54,regulation of morphogenesis of a branching structure,BP,WNT2;FGF10;WNT5A;BMP7;BMP4;WNT2B;GDNF
1524,GO:0003272,1.39685410475994e-05,0.999999427431848,5,22,endocardial cushion formation,BP,NOTCH1;ACVR1;FGF8;BMP7;HEY1
3680,GO:0007173,1.39844056437512e-05,0.999997960517618,10,121,epidermal growth factor receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;PIK3R1;HRAS;HBEGF;AKT1;EPN1;BCAR1;PIK3CA
11813,GO:0044448,1.41138668762727e-05,0.999997940915388,10,119,cell cortex part,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;RALB;SPTB;CDH1;CLDN5;MYZAP
8846,GO:0032956,1.41649631208152e-05,0.999996789065404,15,278,regulation of actin cytoskeleton organization,BP,FHOD3;WNT4;ACTN2;EDN1;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;SCIN;SDC4;SPTB;CTGF
15118,GO:0060686,1.45513782650995e-05,0.999999943647711,3,4,negative regulation of prostatic bud formation,BP,WNT5A;BMP7;BMP4
1470,GO:0003181,1.46740969507273e-05,0.999999397520159,5,21,atrioventricular valve morphogenesis,BP,NOTCH1;ZFPM1;ACVR1;BMP2;HEY1
692,GO:0001837,1.48351062980195e-05,0.999997819825501,10,123,epithelial to mesenchymal transition,BP,WNT2;WNT4;NOTCH1;CRB2;ACVR1;WNT5A;FGF8;BMP7;BMP2;HEY1
7264,GO:0030155,1.49040308048602e-05,0.999995155250838,24,634,regulation of cell adhesion,BP,ITGA3;ITGA5;WNT4;NOTCH1;PLAU;FZD7;FSTL3;PIK3R1;WNT5A;SDC4;BMP7;BMP4;BMP2;DLL1;DDR1;AKT1;CYTIP;JAG2;CDH1;PIK3CA;PIK3CG;LAMA1;LAMA5;EFNB2
10858,GO:0042490,1.49178283461597e-05,0.999998716486577,7,56,mechanoreceptor differentiation,BP,NOTCH1;CDH23;SDC4;BMP4;DLL1;JAG2;MYO7A
18534,GO:1900180,1.49737266350353e-05,0.999997026865507,13,214,regulation of protein localization to nucleus,BP,LIF;FZD7;PIK3R2;PIK3R1;SESN2;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6;CLDN18
11865,GO:0044703,1.53792227931359e-05,0.999994403562903,29,909,multi-organism reproductive process,BP,ITGA3;LIF;ADRA2C;WNT3;WNT4;NOTCH1;IGSF8;DHH;SERPINA5;ACVR1;EDN1;MFGE8;SPTBN4;TYRO3;FSTL3;JAM3;BMP4;WT1;SLC2A14;DDR1;GJB2;AKT1;NPPC;JAG2;EPN1;INHBB;VDR;ACSL4;CLDN11
1385,GO:0003012,1.5452796320147e-05,0.999995883070173,18,397,muscle system process,BP,ADRA2B;ADRA2C;ACTN3;ACTN2;ITGB5;DSC2;ADORA1;CASQ2;EDN1;KCNH2;CHGA;CTGF;PIK3CA;PIK3CG;MYH11;GDNF;ACTA2;PDE4B
13338,GO:0048666,1.55712789957703e-05,0.999994038181997,32,954,neuron development,BP,ITGA3;ARTN;LIF;WNT3;NOTCH1;CDH23;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;JAM3;FGF8;SDC4;SPTB;BMP7;CAMSAP3;B3GNT2;DDR1;AKT1;RAB17;NRTN;SEMA6C;CDH1;MYO7A;PIK3CA;LZTS1;TSPAN2;GDNF;ACSL4
3589,GO:0007009,1.56220588896277e-05,0.999996429405748,15,275,plasma membrane organization,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
14935,GO:0060412,1.63638269611074e-05,0.999998942274796,6,36,ventricular septum morphogenesis,BP,NOTCH1;ZFPM1;ACVR1;WNT5A;BMP4;HEY1
15363,GO:0061098,1.6547398841588e-05,0.99999892494044,6,37,positive regulation of protein tyrosine kinase activity,BP,ADRA2B;ADRA2C;ADORA1;PDGFB;GAS6;UNC119
1529,GO:0003279,1.68910485101649e-05,0.999997811183489,9,95,cardiac septum development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;WNT5A;FGF8;BMP7;BMP4;HEY1
15550,GO:0061564,1.71472194766925e-05,0.999995023748361,20,450,axon development,BP,ARTN;WNT3;NOTCH1;WNT7A;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;JAM3;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;TSPAN2;GDNF
19802,GO:1903827,1.7305169479738e-05,0.999994629399511,22,553,regulation of cellular protein localization,BP,ITGA3;LIF;ACTN2;PMAIP1;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;RALB;WNT5A;SESN2;RHOQ;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;CDH1;GAS6;CLDN18
5170,GO:0012506,1.78332148891732e-05,0.999993846628469,26,727,vesicle membrane,CC,TMEM163;SYT5;WNT3;WNT4;RAB27A;TF;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;RAB39A;SYCN;WNT5B;WNT5A;SNX18;HBEGF;RAB20;VAMP1;CHGA;PKP1;RAB44;RAB11FIP1;RAB38;RAB3D;RNF144A
16935,GO:0072215,1.8395194635167e-05,0.999999194767468,5,23,regulation of metanephros development,BP,LIF;PDGFB;BMP4;WT1;GDNF
12865,GO:0046903,1.84978734417558e-05,0.999992014466489,41,1489,secretion,BP,LIF;ADRA2B;ADRA2C;SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;WNT7A;ADORA1;EDN1;PLAU;RAB40B;RAB40A;SYCN;TYRO3;FGF10;PDGFB;RALB;WNT5A;NPR1;SCIN;SDC4;BMP6;VAMP1;WNK4;CHGA;DDR1;CTGF;TPD52;PKP1;INHBB;RAB44;PIK3CG;RAB11FIP1;KCNG2;GAS6;VDR;RAB3D;GDNF
13901,GO:0051148,1.85217053007123e-05,0.999998344764005,7,59,negative regulation of muscle cell differentiation,BP,NOTCH1;FZD7;PDGFB;FOXO4;BMP4;BMP2;DLL1
3840,GO:0007548,1.96740844122846e-05,0.999995685610905,14,257,sex differentiation,BP,WNT4;STRA6;DHH;WNT7A;TYRO3;FSTL3;FGF10;WNT5A;FGF8;BMP6;WT1;WNT2B;KITLG;INHBB
8314,GO:0032148,1.98821112023935e-05,0.999999098115838,5,26,activation of protein kinase B activity,BP,ADRA2B;ADRA2C;PDGFB;WNT5A;GAS6
12857,GO:0046888,2.0463645875124e-05,0.999998133691014,7,63,negative regulation of hormone secretion,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;INHBB;RAB11FIP1
16900,GO:0072175,2.04853099028872e-05,0.999996867330608,10,128,epithelial tube formation,BP,WNT4;WNT6;PRKACB;FGF10;WNT5A;FGF8;SDC4;BMP7;BMP4;GDNF
10852,GO:0042481,2.09028254108422e-05,0.999999047318498,5,25,regulation of odontogenesis,BP,WNT6;EDN1;FGF8;BMP4;BMP2
7638,GO:0030879,2.09176533031555e-05,0.999996792280142,10,129,mammary gland development,BP,WNT3;WNT2;WNT4;WNT7B;FGF10;WNT5A;BMP4;DDR1;AKT1;VDR
4858,GO:0010566,2.20291143686039e-05,0.999999476679833,4,12,regulation of ketone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
4053,GO:0008284,2.23522669747709e-05,0.999992007033789,27,816,positive regulation of cell proliferation,BP,LIF;WNT2;NOTCH1;WNT7A;EDN1;FZD7;FGF10;FGF17;PDGFB;HRAS;WNT5A;FGF8;CLCF1;HBEGF;BMP6;BMP4;BMP2;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;GAS6;SHC4;GDNF;EFNB2
3401,GO:0006705,2.31160711997557e-05,0.999999443980622,4,12,mineralocorticoid biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
4010,GO:0008212,2.31160711997557e-05,0.999999443980622,4,12,mineralocorticoid metabolic process,BP,WNT4;DKK3;BMP6;BMP2
3519,GO:0006897,2.36817295357426e-05,0.99999227501919,23,603,endocytosis,BP,SYT5;RIN3;RAB27A;TF;ADORA1;MFGE8;RAB39A;TYRO3;PIK3R2;PIK3R1;HRAS;WNT5A;SNX18;DLL1;RAB20;RAB17;EPN1;MYO7A;PIK3CA;PIK3CG;GAS6;SH3BP4;UNC119
1467,GO:0003177,2.45723488230731e-05,0.999999399542051,4,12,pulmonary valve development,BP,NOTCH1;STRA6;BMP4;HEY1
1472,GO:0003184,2.45723488230731e-05,0.999999399542051,4,12,pulmonary valve morphogenesis,BP,NOTCH1;STRA6;BMP4;HEY1
13900,GO:0051147,2.46189639800206e-05,0.999995689011724,11,163,regulation of muscle cell differentiation,BP,NOTCH1;EDN1;MAPK12;FZD7;CDH2;PDGFB;FOXO4;BMP4;BMP2;DLL1;EFNB2
482,GO:0001503,2.48760683207116e-05,0.999993419444703,17,366,ossification,BP,WNT3;WNT4;NOTCH1;DHH;WNT7B;ACVR1;RRAS2;FSTL3;WNT5A;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;NPPC;NAB2
12291,GO:0045667,2.4961792991898e-05,0.999996578844424,9,107,regulation of osteoblast differentiation,BP,WNT4;NOTCH1;WNT7B;ACVR1;BMP7;BMP6;BMP4;BMP2;NPPC
4221,GO:0008544,2.50340725004023e-05,0.999993353036141,17,440,epidermis development,BP,POU3F1;NOTCH1;DSC2;FGF10;WNT5A;BMP4;DLL1;DSG3;CTGF;PKP3;PKP1;NAB2;JAG2;MYO7A;DSC3;VDR;LAMA5
2438,GO:0005088,2.56934360383421e-05,0.999994229511632,14,249,Ras guanyl-nucleotide exchange factor activity,MF,ARTN;RIN3;ACTN2;SPTBN5;SPTBN4;FGF10;FGF17;PDGFB;FGF8;SPTB;HBEGF;NRTN;KITLG;GDNF
16932,GO:0072210,2.57312117128057e-05,0.9999981752131,6,40,metanephric nephron development,BP,LIF;WNT4;PDGFB;BMP4;WT1;GDNF
17145,GO:0072657,2.76852214696681e-05,0.999991955586035,19,493,protein localization to membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;PMAIP1;ADORA1;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;REEP1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5;RAB38
1462,GO:0003171,2.77092621528034e-05,0.999998668160503,5,24,atrioventricular valve development,BP,NOTCH1;ZFPM1;ACVR1;BMP2;HEY1
12594,GO:0046328,2.79993359336185e-05,0.999995029835004,11,160,regulation of JNK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;CTGF;AKT1;FZD8
7234,GO:0030111,2.80019957749242e-05,0.999993248731945,15,303,regulation of Wnt signaling pathway,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT7A;DKK3;CDH2;FGF10;WNT5B;WNT5A;AXIN1;BMP2;WNT2B;TLE1
16882,GO:0072144,2.84721058448194e-05,0.999999796428338,3,5,glomerular mesangial cell development,BP,NOTCH1;PDGFB;ACTA2
3548,GO:0006942,2.85404813366392e-05,0.999996621335664,8,84,regulation of striated muscle contraction,BP,ACTN3;DSC2;ADORA1;CASQ2;CHGA;CTGF;PIK3CG;PDE4B
15077,GO:0060601,2.86587077386077e-05,0.999999252620871,4,13,lateral sprouting from an epithelium,BP,FGF10;WNT5A;BMP7;BMP4
18176,GO:0098805,2.91587090767159e-05,0.999987027798886,42,1511,whole membrane,CC,TMEM163;SYT5;WNT3;WNT4;TSPAN15;RAB27A;TF;PMAIP1;CRB2;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;RAB39A;SYCN;FZD7;CDH2;WNT5B;WNT5A;SNX18;RHOQ;RHOB;SDC4;HBEGF;DLL1;RAB20;VAMP1;CHGA;PKP1;RAB12;RAB17;CDH1;EPN1;MYO7A;RAB44;RAB11FIP1;SH3BP4;RAB38;RAB3D;ACSL4;RNF144A
18903,GO:1901698,2.94818449571998e-05,0.999988867935549,29,900,response to nitrogen compound,BP,ACTN2;NOTCH1;PMAIP1;GUCY1B3;CASQ2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RALB;KHK;SESN2;RHOQ;BMP7;BMP4;WT1;CDKN1A;CTGF;GJB2;AKT1;CDH1;BCAR1;INHBB;PIK3CA;PIK3CG;SH3BP4;PDE4B
18910,GO:1901722,2.95736689734301e-05,0.999999222460423,4,13,regulation of cell proliferation involved in kidney development,BP,PDGFB;BMP7;BMP4;WT1
4691,GO:0009952,2.97302287440759e-05,0.999994160053128,12,200,anterior/posterior pattern specification,BP,WNT3;WNT2;NOTCH1;CRB2;WNT5A;AXIN1;FGF8;BMP4;BMP2;WT1;DLL1;WNT2B
7195,GO:0030030,2.98397635436969e-05,0.999987218364874,38,1276,cell projection organization,BP,ITGA3;ARTN;WNT3;ACTN2;NOTCH1;MARK4;CDH23;WNT7A;WNT7B;SPTBN5;SPTBN4;TTYH1;PIK3R1;HRAS;WNT5A;JAM3;RHOQ;FGF8;SDC4;SPTB;BMP7;CAMSAP3;B3GNT2;ESPN;DDR1;AKT1;RAB17;NRTN;SEMA6C;CDH1;MYO7A;PIK3CA;LZTS1;LAMA5;TSPAN2;GDNF;ACSL4;PARVB
16087,GO:0070696,2.99873318947978e-05,0.999999208744051,4,13,transmembrane receptor protein serine/threonine kinase binding,MF,BMP7;BMP6;BMP4;BMP2
13446,GO:0048864,3.07951173690266e-05,0.999997007114302,7,62,stem cell development,BP,WNT7A;ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
880,GO:0002088,3.12994626030456e-05,0.999996946940184,7,63,lens development in camera-type eye,BP,WNT2;WNT7A;WNT7B;WNT5B;WNT5A;BMP4;WNT2B
10636,GO:0042074,3.20842407044479e-05,0.999999120434952,4,14,cell migration involved in gastrulation,BP,CRB2;WNT5A;FGF8;AMOT
5190,GO:0014031,3.24528783234013e-05,0.999996819627174,7,62,mesenchymal cell development,BP,NOTCH1;ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
16924,GO:0072202,3.2601706255684e-05,0.999998358287896,5,26,cell differentiation involved in metanephros development,BP,LIF;WNT4;PDGFB;BMP4;GDNF
16967,GO:0072273,3.31167558382215e-05,0.999998326804084,5,26,metanephric nephron morphogenesis,BP,LIF;WNT4;BMP4;WT1;GDNF
6103,GO:0016773,3.33908455610914e-05,0.999987781262766,27,752,phosphotransferase activity, alcohol group as acceptor,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;KHK;NPR1;NUAK2;PFKFB3;FGF8;HBEGF;CDKN1A;PKN3;WNK4;DDR1;AKT1;KITLG;PIK3CA;PIK3CG;ARAF;PIM2
7804,GO:0031175,3.35158737961856e-05,0.999987488732381,28,811,neuron projection development,BP,ITGA3;ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;JAM3;FGF8;SPTB;BMP7;CAMSAP3;B3GNT2;DDR1;AKT1;RAB17;NRTN;SEMA6C;CDH1;PIK3CA;LZTS1;TSPAN2;GDNF;ACSL4
13297,GO:0048585,3.40592058276244e-05,0.999985310643274,38,1339,negative regulation of response to stimulus,BP,ITGA3;LIF;WNT3;WNT4;ACTN3;NOTCH1;RASL11B;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;TYRO3;CDH2;PRR5L;FSTL3;FGF10;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;BMP7;BMP4;BMP2;AKT1;EPN1;TLE1;GAS6;ARAF;SH3BP4;GDNF;DUSP5;HEY1
2881,GO:0005925,3.47447662827311e-05,0.999990547812358,17,384,focal adhesion,CC,ITGA3;ITGA5;ACTN3;ACTN2;ITGB5;PLAU;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;RND3;MSN;BCAR1;PARVB;EFNB2
5226,GO:0014070,3.54133463364021e-05,0.99998648526566,29,908,response to organic cyclic compound,BP,NOTCH1;PMAIP1;DHH;WNT7A;WNT7B;CASQ2;EDN1;PRKACB;FGF10;PDGFB;RALB;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;MSN;CTGF;GJB2;AKT1;PTGES;CDH1;CLDN1;PIK3CG;VDR;HEY1;PDE4B
16463,GO:0071417,3.64823650701069e-05,0.999988801590733,20,491,cellular response to organonitrogen compound,BP,ACTN2;CASQ2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;SESN2;RHOQ;WT1;GJB2;AKT1;CDH1;BCAR1;INHBB;PIK3CA;PIK3CG;SH3BP4;PDE4B
329,GO:0000904,3.69490597458955e-05,0.999987268486975,24,634,cell morphogenesis involved in differentiation,BP,ARTN;WNT3;NOTCH1;WNT7A;ZFPM1;SPTBN5;SPTBN4;FZD7;TYRO3;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;MYO7A;CLDN3;PIK3CA;LZTS1;LAMA5;GDNF
12434,GO:0045935,3.74123933922185e-05,0.999982870622592,44,1645,positive regulation of nucleobase-containing compound metabolic process,BP,LIF;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;CHGA;AKT1;KITLG;NPPC;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
19225,GO:1902580,3.75341377070127e-05,0.999985630002705,29,894,single-organism cellular localization,BP,ITGA3;SYT5;WNT4;ACTN2;TSPAN15;RAB27A;PMAIP1;WNT7A;RAB40B;RAB40A;SPTBN4;FZD7;CDH2;PIK3R2;PIK3R1;RHOQ;BMP7;BMP6;BMP4;CDKN1A;CHGA;AKT1;PKP3;RAB17;CDH1;MYO7A;PIK3CG;GAS6;LAMA5
2880,GO:0005924,3.76159620403407e-05,0.999989698738094,17,387,cell-substrate adherens junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;ITGB5;PLAU;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;RND3;MSN;BCAR1;PARVB;EFNB2
9694,GO:0035116,3.77107640203373e-05,0.99999802148521,5,28,embryonic hindlimb morphogenesis,BP,WNT3;NOTCH1;WNT7A;FGF8;BMP4
12465,GO:0045992,3.78111546900265e-05,0.99999803515434,5,26,negative regulation of embryonic development,BP,PRKACB;FZD7;WNT5A;BMP7;BMP4
18155,GO:0098772,3.83088801047271e-05,0.99998337904804,38,1372,molecular function regulator,MF,ARTN;WNT3;WNT2;WNT4;RIN3;ACTN2;NOTCH1;CRB2;SERPINA5;WNT7A;RABIF;SPTBN5;SPTBN4;TSPAN13;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PRKAR1B;WNT5A;SESN2;AXIN1;FGF8;SPTB;HBEGF;BMP2;CDKN1A;WNK4;AKT1;NRTN;KITLG;CST9L;PIK3CA;GAS6;GPSM1;SH3BP4;GDNF
15162,GO:0060740,4.01874215456471e-05,0.999997884470142,5,26,prostate gland epithelium morphogenesis,BP,NOTCH1;FGF10;WNT5A;BMP7;BMP4
10580,GO:0040007,4.04886695552758e-05,0.999984428371893,29,907,growth,BP,WNT3;WNT2;ACTN3;NOTCH1;STRA6;WNT7A;WNT7B;EDN1;SPTBN4;FZD7;FGF10;WNT5A;SESN2;NPR1;PSRC1;FGF8;HBEGF;BMP4;WT1;CDKN1A;DLL1;DDR1;CTGF;AKT1;NPPC;BCAR1;PIK3CA;GAS6;SH3BP4
8789,GO:0032872,4.08409151630046e-05,0.999991708738316,12,198,regulation of stress-activated MAPK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
729,GO:0001890,4.14319113785102e-05,0.999993079444413,10,143,placenta development,BP,LIF;WNT2;ITGB8;WNT7B;PDGFB;BMP7;GJB2;AKT1;VDR;HEY1
12383,GO:0045844,4.14889712508365e-05,0.99999576733992,7,63,positive regulation of striated muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;BMP4;DLL1;EFNB2
13321,GO:0048636,4.14889712508365e-05,0.99999576733992,7,63,positive regulation of muscle organ development,BP,WNT2;ACTN3;NOTCH1;EDN1;BMP4;DLL1;EFNB2
17914,GO:0097435,4.16286134624762e-05,0.999986675603654,21,534,supramolecular fiber organization,BP,FHOD3;WNT4;TUBG2;ACTN2;ITGB5;CASQ2;EDN1;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;AXIN1;SCIN;PSRC1;SDC4;SPTB;ESPN;CTGF;PKP1;BCAR1;MYH11
17446,GO:0090192,4.24464223403829e-05,0.999998748781972,4,14,regulation of glomerulus development,BP,PDGFB;BMP7;BMP4;WT1
15861,GO:0070302,4.30924505634702e-05,0.999991201068313,12,199,regulation of stress-activated protein kinase signaling cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
14684,GO:0060054,4.32103127922508e-05,0.999999532234982,3,7,positive regulation of epithelial cell proliferation involved in wound healing,BP,WNT7A;FZD7;FGF10
18010,GO:0097651,4.32735320456189e-05,0.999999643331373,3,5,phosphatidylinositol 3-kinase complex, class I,CC,PIK3R1;PIK3CA;PIK3CG
763,GO:0001938,4.43836630669463e-05,0.999995400658527,7,68,positive regulation of endothelial cell proliferation,BP,WNT2;PDGFB;WNT5A;BMP6;BMP4;BMP2;AKT1
16936,GO:0072216,4.54386470628133e-05,0.999998636670209,4,14,positive regulation of metanephros development,BP,LIF;PDGFB;WT1;GDNF
4872,GO:0010594,4.5654274153532e-05,0.999993211119727,9,115,regulation of endothelial cell migration,BP,NOTCH1;WNT7A;EDN1;PDGFB;WNT5A;RHOB;BMP4;AKT1;BCAR1
12734,GO:0046622,4.57573957591392e-05,0.999996366077561,6,44,positive regulation of organ growth,BP,WNT2;NOTCH1;EDN1;FGF8;WT1;AKT1
16382,GO:0071300,4.59893194161574e-05,0.999995216003735,7,66,cellular response to retinoic acid,BP,WNT3;WNT2;WNT6;WNT7B;FZD7;WNT5B;WNT5A
14963,GO:0060443,4.6179035182929e-05,0.999996319238606,6,45,mammary gland morphogenesis,BP,WNT4;FGF10;WNT5A;BMP4;DDR1;VDR
18946,GO:1901863,4.64903924253545e-05,0.999995165059482,7,64,positive regulation of muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;BMP4;DLL1;EFNB2
11404,GO:0043434,4.92842096923807e-05,0.999986195001467,17,396,response to peptide hormone,BP,ACTN2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;KHK;SESN2;RHOQ;BMP7;CTGF;GJB2;AKT1;BCAR1;INHBB;PIK3CA
9134,GO:0033612,5.05322672687548e-05,0.999998414241909,4,15,receptor serine/threonine kinase binding,MF,BMP7;BMP6;BMP4;BMP2
13625,GO:0050730,5.05452752185578e-05,0.9999894813283,12,216,regulation of peptidyl-tyrosine phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;FGF10;PDGFB;CLCF1;HBEGF;KITLG;GAS6;UNC119
1530,GO:0003281,5.10414630632098e-05,0.999994623183801,7,62,ventricular septum development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;WNT5A;BMP4;HEY1
15010,GO:0060512,5.16349457656253e-05,0.999997103796074,5,28,prostate gland morphogenesis,BP,NOTCH1;FGF10;WNT5A;BMP7;BMP4
16883,GO:0072148,5.20568749091648e-05,0.999998353724123,4,15,epithelial cell fate commitment,BP,NOTCH1;ACVR1;DLL1;JAG2
4625,GO:0009725,5.22654013734433e-05,0.999980322814283,27,837,response to hormone,BP,ITGA3;ACTN2;NOTCH1;WNT7B;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;KHK;SESN2;RHOQ;BMP7;BMP6;BMP4;WT1;CDKN1A;CTGF;GJB2;AKT1;BCAR1;INHBB;CLDN1;PIK3CA;VDR;HEY1
597,GO:0001701,5.2920624498241e-05,0.999986491151844,15,307,in utero embryonic development,BP,LIF;WNT2;NOTCH1;WNT7B;ACVR1;EDN1;PDGFB;BMP7;BMP2;AKT1;JAG2;EPN1;DSC3;AMOT;HEY1
13837,GO:0051050,5.30323209728226e-05,0.999979635750025,28,889,positive regulation of transport,BP,ACTN2;RAB27A;TF;PMAIP1;ADORA1;EDN1;MFGE8;CDH2;PRR5L;PIK3R2;PIK3R1;PDGFB;KCNH2;WNT5A;RHOQ;NPR1;SCIN;SDC4;BMP6;BMP4;DLL1;MSN;AKT1;CDH1;INHBB;GAS6;RAB3D;GDNF
16881,GO:0072143,5.34245993188704e-05,0.999999437676082,3,6,mesangial cell development,BP,NOTCH1;PDGFB;ACTA2
13885,GO:0051128,5.41960615871913e-05,0.999973045958704,54,2195,regulation of cellular component organization,BP,ITGA3;FHOD3;LIF;WNT3;WNT4;ACTN2;RAB6C;NOTCH1;RAB27A;TF;PMAIP1;WNT7A;EDN1;MFGE8;SPTBN5;SPTBN4;CDH2;PIK3R1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;SESN2;RHOQ;RHOJ;NPR1;SCIN;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;CAMSAP3;WT1;CDKN1A;DLL1;RAB20;ESPN;MSN;DDR1;CTGF;AKT1;RAB17;BCAR1;CLDN1;GAS6;LZTS1;SH3BP4;UNC119;PARVB
12372,GO:0045833,5.49048472888673e-05,0.999994098300717,7,71,negative regulation of lipid metabolic process,BP,WNT4;ADORA1;DKK3;PDGFB;BMP2;AKT1;PIK3CG
18911,GO:1901723,5.60301848901336e-05,0.999999400621681,3,6,negative regulation of cell proliferation involved in kidney development,BP,BMP7;BMP4;WT1
8369,GO:0032268,5.61562722907268e-05,0.999972025086826,54,2281,regulation of cellular protein metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;CRB2;SERPINA5;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;MSN;CTGF;AKT1;KITLG;CST9L;INHBB;PIK3CA;PIK3CG;GAS6;PM20D2;ARAF;UNC119;FZD8;DUSP5;RNF144A
13271,GO:0048534,5.62047925580469e-05,0.999979604264196,25,752,hematopoietic or lymphoid organ development,BP,ARTN;LIF;WNT4;NOTCH1;ZFPM1;FZD7;TYRO3;FSTL3;FGF10;PIK3R1;WNT5A;JAM3;SCIN;CLCF1;BMP4;DLL1;SFXN1;TPD52;WNT2B;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
13756,GO:0050918,5.63217892452309e-05,0.999995292007868,6,52,positive chemotaxis,BP,ARTN;FGF10;PDGFB;WNT5A;FGF8;BMP4
1485,GO:0003206,5.69936105063116e-05,0.999991268788103,9,117,cardiac chamber morphogenesis,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A;FGF8;BMP7;BMP4;HEY1
21415,GO:2000725,5.71113496940841e-05,0.999996712411832,5,29,regulation of cardiac muscle cell differentiation,BP,EDN1;FZD7;BMP4;BMP2;EFNB2
14865,GO:0060326,5.79035656215178e-05,0.999987738797203,12,245,cell chemotaxis,BP,NOTCH1;EDN1;CCL20;PDGFB;WNT5A;JAM3;HBEGF;CHGA;BCAR1;PIK3CG;GAS6;PDE4B
18874,GO:1901652,5.81494689044665e-05,0.999982786347119,18,442,response to peptide,BP,ACTN2;NOTCH1;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;KHK;SESN2;RHOQ;BMP7;CTGF;GJB2;AKT1;BCAR1;INHBB;PIK3CA
4651,GO:0009799,5.83094019284193e-05,0.999991034305999,9,119,specification of symmetry,BP,NOTCH1;ACVR1;FGF10;WNT5A;AXIN1;FGF8;BMP4;DAAM2;DLL1
15332,GO:0061046,5.88024316267288e-05,0.999999360545349,3,6,regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4;WNT2B
16792,GO:0072008,5.89349437313326e-05,0.999999358613241,3,6,glomerular mesangial cell differentiation,BP,NOTCH1;PDGFB;ACTA2
10498,GO:0038127,6.0736012196841e-05,0.99998937518885,10,143,ERBB signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;PIK3R1;HRAS;HBEGF;AKT1;EPN1;BCAR1;PIK3CA
7606,GO:0030834,6.13839146948289e-05,0.999994837294548,6,46,regulation of actin filament depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
15117,GO:0060685,6.31637970626853e-05,0.99999929618462,3,6,regulation of prostatic bud formation,BP,WNT5A;BMP7;BMP4
4711,GO:0010001,6.35560869707977e-05,0.999987591476292,11,178,glial cell differentiation,BP,LIF;POU3F1;NOTCH1;CDH2;FGF10;CLCF1;BMP2;DLL1;AKT1;NAB2;TSPAN2
13861,GO:0051093,6.41108635222365e-05,0.999976035781897,26,796,negative regulation of developmental process,BP,WNT3;WNT4;NOTCH1;WNT7A;ZFPM1;PRKACB;FZD7;LIMS2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5A;AXIN1;NPR1;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;NPPC;GAS6;AMOT;CLDN18
5054,GO:0010862,6.51759315404666e-05,0.99999443872986,6,48,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
13111,GO:0048146,6.54919791558754e-05,0.99999438072987,6,51,positive regulation of fibroblast proliferation,BP,WNT2;FGF10;PDGFB;WNT5A;CDKN1A;GAS6
9760,GO:0035296,6.5602828840827e-05,0.999989742035696,9,123,regulation of tube diameter,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
18038,GO:0097746,6.5602828840827e-05,0.999989742035696,9,123,regulation of blood vessel diameter,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
10933,GO:0042592,6.58544972496402e-05,0.999969774885888,41,1571,homeostatic process,BP,CDH23;TF;PMAIP1;WNT7B;ZFPM1;ADORA1;CASQ2;EDN1;PRKACB;RAB39A;PRND;TYRO3;LPAR2;CDH2;PIK3R2;PIK3R1;KCNH2;PRKAR1B;JAM3;SESN2;NPR1;BMP6;BMP4;DLL1;RAB20;SFXN1;WNK4;CTGF;GJB6;AKT1;KITLG;CLDN1;PIK3CA;PIK3CG;GAS6;VDR;RAB38;RAB3D;CLDN16;CLDN18;PDE4B
9231,GO:0033993,6.63607080106807e-05,0.999974640175563,27,859,response to lipid,BP,WNT3;WNT2;NOTCH1;DHH;WNT6;WNT7A;WNT7B;EDN1;CCL20;FZD7;FGF10;WNT5B;WNT5A;BMP7;BMP6;BMP4;CDKN1A;MSN;CTGF;GJB2;GJB6;AKT1;PTGES;CLDN1;VDR;HEY1;PDE4B
15220,GO:0060842,6.66187679565462e-05,0.999999244102933,3,6,arterial endothelial cell differentiation,BP,NOTCH1;DLL1;HEY1
2460,GO:0005126,6.66949481254402e-05,0.999985645685341,12,260,cytokine receptor binding,MF,ITGA5;LIF;RASL11B;CCL20;PIK3R1;CLCF1;BMP7;BMP6;BMP4;BMP2;KITLG;INHBB
12561,GO:0046184,6.67880643426168e-05,0.999997746271447,4,15,aldehyde biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
14678,GO:0060048,6.70306881976392e-05,0.999989492264588,9,122,cardiac muscle contraction,BP,DSC2;ADORA1;CASQ2;KCNH2;CHGA;CTGF;PIK3CA;PIK3CG;PDE4B
6353,GO:0018108,6.76297471772916e-05,0.99998141344841,16,360,peptidyl-tyrosine phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;TYRO3;FGF10;FGF17;PDGFB;FGF8;CLCF1;HBEGF;DDR1;KITLG;GAS6;UNC119
13286,GO:0048562,6.88570689245305e-05,0.999982984191166,14,283,embryonic organ morphogenesis,BP,NOTCH1;STRA6;CRB2;ACVR1;EDN1;FGF10;WNT5A;AXIN1;FGF8;BMP7;BMP4;DLL1;GJB6;MYO7A
13322,GO:0048638,6.88824340046698e-05,0.999982981216595,14,280,regulation of developmental growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;WNT5A;FGF8;BMP4;WT1;DLL1;AKT1;NPPC;PIK3CA
13835,GO:0051048,6.89004018703302e-05,0.999986397249665,11,191,negative regulation of secretion,BP,LIF;ADRA2B;ADRA2C;NOTCH1;ADORA1;EDN1;WNK4;CHGA;INHBB;RAB11FIP1;GAS6
17636,GO:0090596,6.92592474555452e-05,0.999983954174671,13,245,sensory organ morphogenesis,BP,WNT2;STRA6;EDN1;FGF10;WNT5A;AXIN1;FGF8;BMP7;BMP4;DLL1;GJB6;WNT2B;MYO7A
13833,GO:0051046,7.04789428503027e-05,0.999975229190596,23,673,regulation of secretion,BP,LIF;ADRA2B;ADRA2C;SYT5;NOTCH1;RAB27A;ADORA1;EDN1;FGF10;RALB;WNT5A;NPR1;SCIN;SDC4;BMP6;WNK4;CHGA;INHBB;RAB11FIP1;KCNG2;GAS6;RAB3D;GDNF
13758,GO:0050920,7.11051002927504e-05,0.999987252729849,10,169,regulation of chemotaxis,BP,ARTN;WNT3;NOTCH1;EDN1;FGF10;PDGFB;WNT5A;JAM3;GAS6;EFNB2
6387,GO:0018212,7.18394902840915e-05,0.999980150715511,16,362,peptidyl-tyrosine modification,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;TYRO3;FGF10;FGF17;PDGFB;FGF8;CLCF1;HBEGF;DDR1;KITLG;GAS6;UNC119
2491,GO:0005160,7.19088816603072e-05,0.999993742799327,6,49,transforming growth factor beta receptor binding,MF,RASL11B;BMP7;BMP6;BMP4;BMP2;INHBB
645,GO:0001775,7.25460357203789e-05,0.99996854872587,35,1279,cell activation,BP,ADRA2B;ADRA2C;WNT4;RAB27A;CRISPLD2;WNT7A;ZFPM1;EDN1;PLAU;FZD7;TYRO3;FGF10;PIK3R1;PDGFB;WNT5A;RHOB;SDC4;CLCF1;BMP4;CDKN1A;DLL1;CHGA;MSN;CTGF;TPD52;AKT1;PKP1;JAG2;RAB44;PIK3CA;PIK3CG;GAS6;RAB3D;FZD8;EFNB2
12239,GO:0045603,7.59127076401875e-05,0.999997312355684,4,16,positive regulation of endothelial cell differentiation,BP,NOTCH1;BMP6;BMP4;CLDN5
4520,GO:0009267,7.68882348028504e-05,0.999987734465163,9,120,cellular response to starvation,BP,WNT4;PMAIP1;DSC2;RALB;NUAK2;CDKN1A;WNT2B;INHBB;GAS6
20984,GO:2000064,7.73972815112186e-05,0.999999075757668,3,6,regulation of cortisol biosynthetic process,BP,WNT4;DKK3;BMP2
20463,GO:1905314,7.80409937165782e-05,0.999997216991975,4,16,semi-lunar valve development,BP,NOTCH1;STRA6;BMP4;HEY1
12764,GO:0046661,7.85361020912844e-05,0.999985786375043,10,155,male sex differentiation,BP,WNT4;DHH;FSTL3;FGF10;WNT5A;FGF8;BMP6;WT1;WNT2B;KITLG
12325,GO:0045740,7.95994372640947e-05,0.999992893152314,6,54,positive regulation of DNA replication,BP,FGF10;PDGFB;HRAS;BMP6;BMP4;KITLG
7485,GO:0030540,8.12011334205073e-05,0.999997037179188,4,17,female genitalia development,BP,STRA6;TYRO3;FGF10;WNT5A
15079,GO:0060603,8.46907702603456e-05,0.999994654080422,5,31,mammary gland duct morphogenesis,BP,WNT4;FGF10;WNT5A;DDR1;VDR
14627,GO:0055117,8.4802750131464e-05,0.999990216098307,7,72,regulation of cardiac muscle contraction,BP,DSC2;ADORA1;CASQ2;CHGA;CTGF;PIK3CG;PDE4B
1488,GO:0003209,8.54444122833598e-05,0.999994616793547,5,30,cardiac atrium morphogenesis,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A
1649,GO:0003779,8.82398341200158e-05,0.999974059511197,17,393,actin binding,MF,TAGLN;FHOD3;ACTN3;ACTN2;SPTBN5;SPTBN4;CGN;PLEKHH2;PSTPIP2;SCIN;SPTB;DAAM2;ESPN;MSN;MYO7A;MYH11;PARVB
18173,GO:0098801,8.98597666927394e-05,0.999994197965291,5,34,regulation of renal system process,BP,ADORA1;EDN1;PDGFB;NPR1;GAS6
11499,GO:0043588,8.98740352555209e-05,0.999975816626201,15,398,skin development,BP,ITGA3;POU3F1;NOTCH1;ITGB4;DSC2;FGF10;WNT5A;DLL1;DSG3;PKP3;PKP1;CLDN1;DSC3;VDR;LAMA5
1481,GO:0003198,8.99499246092755e-05,0.999996629050517,4,17,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,NOTCH1;ACVR1;FGF8;HEY1
7204,GO:0030042,9.12983101255022e-05,0.999991700043511,6,49,actin filament depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
21475,GO:2000811,9.21696893569868e-05,0.999996567083351,4,16,negative regulation of anoikis,BP,ITGA5;NOTCH1;TLE1;PIK3CA
15909,GO:0070374,9.31221284743521e-05,0.999982732013891,10,174,positive regulation of ERK1 and ERK2 cascade,BP,CCL20;FGF10;PDGFB;HRAS;FGF8;BMP4;BMP2;CTGF;GAS6;ARAF
13677,GO:0050810,9.39240727342359e-05,0.999991390783179,6,51,regulation of steroid biosynthetic process,BP,WNT4;DHH;DKK3;BMP6;BMP2;VDR
6834,GO:0021536,9.64833150961561e-05,0.999988599903806,7,76,diencephalon development,BP,WNT4;FGF10;WNT5A;FGF8;BMP4;BMP2;CDH1
16791,GO:0072007,9.69454998218099e-05,0.999998618524139,3,7,mesangial cell differentiation,BP,NOTCH1;PDGFB;ACTA2
8466,GO:0032403,9.6959766031368e-05,0.999964337352836,24,710,protein complex binding,MF,ITGA3;ITGA5;TAGLN;ACTN3;ACTN2;ACVR1;ADORA1;MFGE8;FSTL3;PIK3R1;PDGFB;JAM3;SCIN;SPTB;MB21D2;CDKN1A;ESPN;DDR1;CTGF;PKP1;MYO7A;MYH11;LAMA5;RAB38
13574,GO:0050673,9.79630897431359e-05,0.999973508451432,15,335,epithelial cell proliferation,BP,WNT2;NOTCH1;WNT7A;FZD7;LIMS2;FGF10;PDGFB;HRAS;WNT5A;BMP6;BMP4;BMP2;AKT1;VDR;EFNB2
13726,GO:0050880,9.87046149257764e-05,0.999983670748063,9,131,regulation of blood vessel size,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
3933,GO:0008092,9.9409512146414e-05,0.999961060822983,27,823,cytoskeletal protein binding,MF,TAGLN;FHOD3;ACTN3;ACTN2;MARK4;RAB27A;SPTBN5;SPTBN4;RAB39B;CGN;REEP1;PLEKHH2;PSTPIP2;SCIN;PSRC1;SPTB;CAMSAP3;DAAM2;ESPN;MSN;CDH1;MYO7A;MYH11;LZTS1;RAB3D;PARVB;PDE4B
7712,GO:0031012,0.000100068245100477,0.999967892102947,19,517,extracellular matrix,CC,WNT3;WNT2;WNT4;CRISPLD2;WNT6;WNT7A;WNT7B;MFGE8;FGF10;PDGFB;WNT5B;WNT5A;BMP7;BMP4;CTGF;WNT2B;HAPLN3;LAMA1;LAMA5
7275,GO:0030168,0.000100183370800352,0.99998131214671,10,157,platelet activation,BP,ADRA2B;ADRA2C;TYRO3;PIK3R1;PDGFB;RHOB;AKT1;PIK3CA;PIK3CG;GAS6
9702,GO:0035150,0.000103169494587848,0.999982826717256,9,132,regulation of tube size,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
12400,GO:0045893,0.000103184338099206,0.99995340444867,37,1335,positive regulation of transcription, DNA-templated,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;AKT1;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
19633,GO:1903508,0.000103184338099206,0.99995340444867,37,1335,positive regulation of nucleic acid-templated transcription,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;AKT1;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
11183,GO:0043087,0.000104249765947332,0.999961477535213,24,695,regulation of GTPase activity,BP,ARTN;WNT4;RIN3;ACTN2;RABIF;CCL20;SPTBN5;SPTBN4;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;SPTB;HBEGF;NRTN;KITLG;AMOT;SH3BP4;GDNF
14861,GO:0060322,0.000105868543623251,0.999960836021255,24,699,head development,BP,WNT3;WNT2;WNT4;POU3F1;NOTCH1;STRA6;CRISPLD2;WNT7A;WNT7B;TYRO3;CDH2;FGF10;WNT5A;AXIN1;PFKFB3;FGF8;BMP7;BMP4;BMP2;DLL1;WNT2B;CDH1;CLDN5;TSPAN2
11138,GO:0043010,0.000105882274234269,0.999972722636926,14,288,camera-type eye development,BP,WNT2;STRA6;WNT6;WNT7A;WNT7B;FGF10;WNT5B;WNT5A;RHOJ;BMP7;BMP4;WT1;DLL1;WNT2B
17383,GO:0090100,0.000106173638520955,0.999984690943146,8,99,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,NOTCH1;CRB2;ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
1484,GO:0003205,0.000107499429838173,0.999979789308074,10,153,cardiac chamber development,BP,WNT2;NOTCH1;STRA6;ZFPM1;ACVR1;WNT5A;FGF8;BMP7;BMP4;HEY1
2435,GO:0005085,0.000107998669136081,0.999970557105661,15,320,guanyl-nucleotide exchange factor activity,MF,ARTN;RIN3;ACTN2;RABIF;SPTBN5;SPTBN4;FGF10;FGF17;PDGFB;FGF8;SPTB;HBEGF;NRTN;KITLG;GDNF
19907,GO:1904031,0.000108537125492272,0.999992680901992,5,35,positive regulation of cyclin-dependent protein kinase activity,BP,FGF10;PDGFB;PSRC1;CDKN1A;AKT1
11312,GO:0043276,0.000109376565476681,0.999992680092351,5,32,anoikis,BP,ITGA5;NOTCH1;AKT1;TLE1;PIK3CA
18169,GO:0098797,0.000109980537615954,0.999975096795704,12,230,plasma membrane protein complex,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8;CDH2;GJB1;GJB2;GJB6;CDH1;GJA3;FZD8
13323,GO:0048639,0.000110127683732047,0.999979224881754,10,155,positive regulation of developmental growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;FGF8;WT1;DLL1;AKT1
15210,GO:0060828,0.000111241163067842,0.999974770246818,12,234,regulation of canonical Wnt signaling pathway,BP,WNT2;WNT4;NOTCH1;WNT7A;DKK3;CDH2;FGF10;WNT5B;WNT5A;AXIN1;BMP2;WNT2B
861,GO:0002066,0.000112892880783393,0.999989280412833,6,52,columnar/cuboidal epithelial cell development,BP,WNT5A;BMP6;BMP4;CDKN1A;DLL1;MYO7A
13307,GO:0048609,0.000115690454685446,0.999956908219197,24,755,multicellular organismal reproductive process,BP,ITGA3;LIF;WNT3;WNT4;NOTCH1;DHH;SERPINA5;ACVR1;EDN1;TYRO3;FSTL3;JAM3;BMP4;WT1;SLC2A14;GJB2;AKT1;KITLG;NPPC;JAG2;INHBB;VDR;ACSL4;CLDN11
5866,GO:0016301,0.000116277063856968,0.999954006691639,27,816,kinase activity,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;KHK;NPR1;NUAK2;PFKFB3;FGF8;HBEGF;CDKN1A;PKN3;WNK4;DDR1;AKT1;KITLG;PIK3CA;PIK3CG;ARAF;PIM2
14218,GO:0051704,0.000116616127718459,0.999941176349053,50,2241,multi-organism process,BP,ITGA3;ITGA5;LIF;ADRA2C;WNT3;WNT4;NOTCH1;IGSF8;ITGB5;PMAIP1;DHH;SERPINA5;ACVR1;NMT2;EDN1;RAB40B;MFGE8;CCL20;SPTBN4;TYRO3;FSTL3;FGF10;PIK3R1;HRAS;WNT5A;JAM3;BMP6;BMP4;WT1;SLC2A14;CHGA;DDR1;GJB2;GJB6;AKT1;PTGES;NPPC;JAG2;CDH1;EPN1;INHBB;CLDN1;GAS6;VDR;ACSL4;ACTA2;CLDN11;PIM2;EFNB2;PDE4B
3937,GO:0008104,0.000116653135365295,0.999939031030245,57,2482,protein localization,BP,ITGA3;LIF;ADRA2C;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;PMAIP1;WNT7A;RABIF;ADORA1;RAB40B;RAB40A;SPTBN4;RAB39B;RAB39A;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SNX18;SESN2;RHOQ;RHOB;SCIN;BMP7;BMP6;BMP4;CDKN1A;RAB20;WNK4;MSN;AKT1;PKP3;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;AMOT;LAMA5;SH3BP4;UNC119;RAB38;RAB3D;CLDN18
3547,GO:0006941,0.000117658035293635,0.999977587895963,10,163,striated muscle contraction,BP,ACTN3;DSC2;ADORA1;CASQ2;KCNH2;CHGA;CTGF;PIK3CA;PIK3CG;PDE4B
4680,GO:0009913,0.000117797454771616,0.999971023260157,13,335,epidermal cell differentiation,BP,POU3F1;NOTCH1;DSC2;WNT5A;BMP4;DLL1;DSG3;PKP3;PKP1;JAG2;MYO7A;DSC3;VDR
21092,GO:2000270,0.000119329361084056,0.999998174560743,3,7,negative regulation of fibroblast apoptotic process,BP,PIK3CA;PIK3CG;GAS6
2878,GO:0005922,0.00012011259716544,0.999995002655729,4,20,connexin complex,CC,GJB1;GJB2;GJB6;GJA3
18352,GO:0099568,0.000120282840763264,0.99996863021729,14,287,cytoplasmic region,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;RALB;SCIN;SPTB;CTGF;CYTIP;CDH1;MYO7A;CLDN5;MYZAP
15366,GO:0061101,0.000120881591627093,0.999998016850865,3,8,neuroendocrine cell differentiation,BP,WNT4;FGF8;BMP2
1119,GO:0002520,0.000125099615139925,0.999952144344131,25,789,immune system development,BP,ARTN;LIF;WNT4;NOTCH1;ZFPM1;FZD7;TYRO3;FSTL3;FGF10;PIK3R1;WNT5A;JAM3;SCIN;CLCF1;BMP4;DLL1;SFXN1;TPD52;WNT2B;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
19650,GO:1903531,0.000125524561584426,0.999975872034654,10,169,negative regulation of secretion by cell,BP,LIF;ADRA2B;ADRA2C;NOTCH1;ADORA1;EDN1;CHGA;INHBB;RAB11FIP1;GAS6
11867,GO:0044706,0.000126006868585214,0.999973281786042,11,210,multi-multicellular organism process,BP,ITGA3;LIF;ADRA2C;WNT4;EDN1;DDR1;GJB2;AKT1;EPN1;VDR;ACSL4
1476,GO:0003190,0.000126437686009681,0.999998027185706,3,7,atrioventricular valve formation,BP,NOTCH1;ZFPM1;HEY1
12854,GO:0046885,0.000126885824167034,0.999994796469516,4,17,regulation of hormone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
16831,GO:0072074,0.000129836608325018,0.999994584756409,4,18,kidney mesenchyme development,BP,WNT4;BMP7;BMP4;WT1
13972,GO:0051254,0.000129956291381657,0.999939990507653,38,1403,positive regulation of RNA metabolic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;AKT1;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
10591,GO:0040019,0.000129987485507306,0.999990941307305,5,33,positive regulation of embryonic development,BP,WNT2;WNT4;WNT2B;AMOT;GDNF
3733,GO:0007254,0.000130015780936701,0.999972402569652,11,190,JNK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;CTGF;AKT1;FZD8
15095,GO:0060638,0.000131355447479654,0.999997782979937,3,8,mesenchymal-epithelial cell signaling,BP,FGF10;WNT5A;WNT2B
6534,GO:0019216,0.000131733365340927,0.999967357412808,13,269,regulation of lipid metabolic process,BP,WNT4;DHH;ADORA1;DKK3;PIK3R2;PIK3R1;PDGFB;SESN2;BMP6;BMP2;AKT1;PIK3CG;VDR
628,GO:0001755,0.000132261861115601,0.999990693103433,5,35,neural crest cell migration,BP,ACVR1;NRTN;KITLG;LAMA5;GDNF
10443,GO:0038030,0.000133287266247502,0.999997882449202,3,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,WNT4;FZD7;WNT5A
17809,GO:0097205,0.000134078207647763,0.999994360458277,4,18,renal filtration,BP,ITGA3;ADORA1;PDGFB;GAS6
8195,GO:0031946,0.000136033193497371,0.999997823695244,3,7,regulation of glucocorticoid biosynthetic process,BP,WNT4;DKK3;BMP2
12756,GO:0046649,0.000136033738744024,0.99995245916496,21,613,lymphocyte activation,BP,WNT4;RAB27A;ZFPM1;FZD7;TYRO3;FGF10;PIK3R1;SDC4;CLCF1;BMP4;CDKN1A;DLL1;MSN;TPD52;AKT1;JAG2;PIK3CA;PIK3CG;GAS6;FZD8;EFNB2
8552,GO:0032504,0.000136337478053529,0.99994864054557,24,764,multicellular organism reproduction,BP,ITGA3;LIF;WNT3;WNT4;NOTCH1;DHH;SERPINA5;ACVR1;EDN1;TYRO3;FSTL3;JAM3;BMP4;WT1;SLC2A14;GJB2;AKT1;KITLG;NPPC;JAG2;INHBB;VDR;ACSL4;CLDN11
17488,GO:0090257,0.000136939112380968,0.999970715612411,11,201,regulation of muscle system process,BP,ADRA2B;ADRA2C;ACTN3;DSC2;ADORA1;CASQ2;EDN1;CHGA;CTGF;PIK3CG;PDE4B
19263,GO:1902680,0.000137609326808402,0.999936906881696,37,1357,positive regulation of RNA biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;AKT1;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
2507,GO:0005178,0.000138718437811351,0.999979190187171,8,100,integrin binding,MF,ITGA3;ITGA5;ACTN3;ACTN2;MFGE8;JAM3;CTGF;LAMA5
6458,GO:0019003,0.00014292103701662,0.99998573581604,6,57,GDP binding,MF,RAB27A;RALB;HRAS;RHOB;RAB12;RAB17
2799,GO:0005788,0.000144215921400736,0.999968993974633,11,196,endoplasmic reticulum lumen,CC,WNT3;WNT4;WNT6;WNT7A;WNT7B;CASQ2;EDN1;PDGFB;WNT5B;WNT5A;GAS6
4069,GO:0008305,0.000145096361210294,0.999989679297517,5,32,integrin complex,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8
14733,GO:0060128,0.000145539041606882,1,2,2,corticotropin hormone secreting cell differentiation,BP,FGF8;BMP2
16834,GO:0072077,0.000146597038790714,0.999993627271742,4,19,renal vesicle morphogenesis,BP,LIF;WNT4;BMP4;GDNF
9699,GO:0035137,0.000146834962799485,0.999989403294971,5,36,hindlimb morphogenesis,BP,WNT3;NOTCH1;WNT7A;FGF8;BMP4
13109,GO:0048144,0.000147968868754628,0.99998116275217,7,84,fibroblast proliferation,BP,WNT2;WNT7B;FGF10;PDGFB;WNT5A;CDKN1A;GAS6
16521,GO:0071496,0.000148153404405916,0.999962846640046,13,268,cellular response to external stimulus,BP,WNT4;PMAIP1;GADD45A;DSC2;RALB;NUAK2;BMP6;CDKN1A;AKT1;WNT2B;INHBB;GAS6;VDR
8838,GO:0032940,0.000150452867099167,0.999931381696754,36,1364,secretion by cell,BP,LIF;ADRA2B;ADRA2C;SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;WNT7A;ADORA1;EDN1;PLAU;RAB40B;RAB40A;SYCN;TYRO3;FGF10;PDGFB;RALB;WNT5A;SCIN;SDC4;BMP6;VAMP1;CHGA;CTGF;PKP1;INHBB;RAB44;PIK3CG;RAB11FIP1;KCNG2;GAS6;RAB3D;GDNF
13918,GO:0051173,0.00015064098273102,0.999926188968491,44,1750,positive regulation of nitrogen compound metabolic process,BP,LIF;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;CHGA;AKT1;KITLG;NPPC;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
1552,GO:0003323,0.000151532876696656,0.999993355124242,4,19,type B pancreatic cell development,BP,WNT5A;BMP6;BMP4;DLL1
13838,GO:0051051,0.000152087592946217,0.999953090788243,17,442,negative regulation of transport,BP,LIF;ADRA2B;ADRA2C;ACTN2;NOTCH1;ADORA1;CASQ2;EDN1;KCNH2;BMP7;WNK4;CHGA;AKT1;INHBB;RAB11FIP1;GAS6;UNC119
1503,GO:0003230,0.000159102464922277,0.999988381787204,5,34,cardiac atrium development,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A
19990,GO:1904238,0.000162628914242899,0.999997047161904,3,8,pericyte cell differentiation,BP,NOTCH1;PDGFB;ACTA2
1380,GO:0003007,0.000163039965800487,0.999961480358783,12,228,heart morphogenesis,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A;FGF8;BMP7;BMP4;BMP2;DLL1;CLDN5;HEY1
14737,GO:0060135,0.000163976432388546,0.999983175499564,6,59,maternal process involved in female pregnancy,BP,ITGA3;LIF;WNT4;GJB2;AKT1;VDR
3671,GO:0007163,0.000165089500061819,0.999967215912676,10,161,establishment or maintenance of cell polarity,BP,MARK4;CRB2;WNT7A;WNT7B;FGF10;WNT5A;JAM3;MSN;AMOT;PARVB
4761,GO:0010243,0.000165662760242718,0.999935425930737,25,792,response to organonitrogen compound,BP,ACTN2;NOTCH1;CASQ2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;KHK;SESN2;RHOQ;BMP7;WT1;CDKN1A;CTGF;GJB2;AKT1;CDH1;BCAR1;INHBB;PIK3CA;PIK3CG;SH3BP4;PDE4B
3853,GO:0007589,0.000166326473141449,0.999978381705134,7,87,body fluid secretion,BP,ADORA1;EDN1;FGF10;NPR1;WNK4;DDR1;VDR
3206,GO:0006464,0.000166439826575233,0.999905442760374,78,3744,cellular protein modification process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;MARK4;GADD45A;FBXO41;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;EDN1;RAB40B;RAB40A;PRKACB;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;PKN3;WNK4;DDR1;CTGF;AKT1;NRTN;KITLG;INHBB;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;RNF144A;PIM2
10278,GO:0036211,0.000166439826575233,0.999905442760374,78,3744,protein modification process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;MARK4;GADD45A;FBXO41;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;EDN1;RAB40B;RAB40A;PRKACB;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;PKN3;WNK4;DDR1;CTGF;AKT1;NRTN;KITLG;INHBB;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;RNF144A;PIM2
3842,GO:0007565,0.000166475965541064,0.999966792060305,10,182,female pregnancy,BP,ITGA3;LIF;ADRA2C;WNT4;DDR1;GJB2;AKT1;EPN1;VDR;ACSL4
7223,GO:0030097,0.000169948950808827,0.999936460640855,23,712,hemopoiesis,BP,LIF;WNT4;NOTCH1;ZFPM1;FZD7;TYRO3;FSTL3;PIK3R1;WNT5A;JAM3;SCIN;CLCF1;BMP4;DLL1;SFXN1;TPD52;WNT2B;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
15215,GO:0060837,0.000170548762462283,0.999996852532437,3,8,blood vessel endothelial cell differentiation,BP,NOTCH1;DLL1;HEY1
11803,GO:0044433,0.000170873236758461,0.99992153000784,36,1367,cytoplasmic vesicle part,CC,TMEM163;SYT5;WNT3;WNT4;ACTN2;TSPAN15;RAB27A;TF;CRISPLD2;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;RAB39A;SYCN;FZD7;PDGFB;WNT5B;WNT5A;SNX18;RHOQ;RHOB;HBEGF;RAB20;VAMP1;CHGA;PKP1;RAB12;RAB17;RAB44;RAB11FIP1;GAS6;RAB38;RAB3D;RNF144A
6278,GO:0017111,0.000170906335609635,0.999933260109011,25,772,nucleoside-triphosphatase activity,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
19343,GO:1902903,0.000171959448436114,0.999956196263518,13,272,regulation of supramolecular fiber organization,BP,FHOD3;WNT4;ACTN2;EDN1;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;SCIN;PSRC1;SDC4;SPTB;CTGF
13457,GO:0048878,0.000175767303811821,0.99992613599782,29,1004,chemical homeostasis,BP,CDH23;TF;WNT7B;ADORA1;CASQ2;EDN1;PRKACB;RAB39A;PRND;LPAR2;PIK3R2;PIK3R1;KCNH2;PRKAR1B;SESN2;NPR1;BMP6;RAB20;SFXN1;WNK4;GJB6;AKT1;CLDN1;PIK3CA;PIK3CG;GAS6;VDR;RAB38;CLDN16
17514,GO:0090287,0.000176440253917356,0.99995792794657,12,234,regulation of cellular response to growth factor stimulus,BP,ITGA3;ITGA5;WNT4;NOTCH1;RASL11B;CRB2;DKK3;FSTL3;FGF10;WNT5A;BMP4;DLL1
16840,GO:0072087,0.000176833327897069,0.999991856049599,4,20,renal vesicle development,BP,LIF;WNT4;BMP4;GDNF
14027,GO:0051345,0.000176984400035414,0.999926800819877,28,925,positive regulation of hydrolase activity,BP,ARTN;WNT4;RIN3;ACTN2;PMAIP1;RABIF;CCL20;SPTBN5;SPTBN4;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;SPTB;HBEGF;BMP2;CTGF;AKT1;NRTN;KITLG;GDNF
18041,GO:0097756,0.000177096971498219,0.999976835363637,7,80,negative regulation of blood vessel diameter,BP,ADRA2B;ADRA2C;ADORA1;EDN1;CHGA;AKT1;ACTA2
8952,GO:0033138,0.000181376558637251,0.999976029981466,7,92,positive regulation of peptidyl-serine phosphorylation,BP,LIF;WNT5A;AXIN1;AKT1;PIK3CA;GAS6;ARAF
5191,GO:0014032,0.000188349151678204,0.999980191320909,6,58,neural crest cell development,BP,ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
8071,GO:0031669,0.000191232726012465,0.999961265969834,10,169,cellular response to nutrient levels,BP,WNT4;PMAIP1;DSC2;RALB;NUAK2;CDKN1A;WNT2B;INHBB;GAS6;VDR
12763,GO:0046660,0.000192370343893386,0.999969608368776,8,109,female sex differentiation,BP,WNT4;STRA6;TYRO3;FGF10;WNT5A;WT1;KITLG;INHBB
20466,GO:1905330,0.000194273504335032,0.999960515949466,10,178,regulation of morphogenesis of an epithelium,BP,LIF;WNT2;WNT4;FZD7;FGF10;WNT5A;BMP7;BMP4;WNT2B;GDNF
3783,GO:0007368,0.000199224550560443,0.999968350629769,8,110,determination of left/right symmetry,BP,NOTCH1;ACVR1;FGF10;WNT5A;AXIN1;FGF8;DAAM2;DLL1
13299,GO:0048589,0.000200072494762418,0.999930066448913,20,551,developmental growth,BP,WNT3;WNT2;ACTN3;NOTCH1;STRA6;WNT7A;WNT7B;EDN1;SPTBN4;FZD7;FGF10;WNT5A;FGF8;BMP4;WT1;DLL1;DDR1;AKT1;NPPC;PIK3CA
2451,GO:0005111,0.000201752255615634,0.999999447419228,2,3,type 2 fibroblast growth factor receptor binding,MF,FGF10;FGF17
7721,GO:0031032,0.000202726013546207,0.999958672403628,10,164,actomyosin structure organization,BP,FHOD3;WNT4;ACTN2;ITGB5;CASQ2;EDN1;PIK3R1;SDC4;CTGF;MYH11
1430,GO:0003130,0.000203467324046392,1,2,2,BMP signaling pathway involved in heart induction,BP,BMP4;BMP2
1432,GO:0003133,0.000203467324046392,1,2,2,endodermal-mesodermal cell signaling,BP,BMP4;BMP2
1433,GO:0003134,0.000203467324046392,1,2,2,endodermal-mesodermal cell signaling involved in heart induction,BP,BMP4;BMP2
13964,GO:0051246,0.000206054179543691,0.999890537720887,55,2455,regulation of protein metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;CRB2;SERPINA5;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;MSN;CTGF;AKT1;KITLG;CST9L;INHBB;PIK3CA;PIK3CG;GAS6;PM20D2;ARAF;UNC119;FZD8;DUSP5;RNF144A
16450,GO:0071396,0.000209037544079847,0.999928880176,19,522,cellular response to lipid,BP,WNT3;WNT2;WNT6;WNT7B;EDN1;CCL20;FZD7;WNT5B;WNT5A;BMP7;BMP6;BMP4;MSN;GJB2;AKT1;CLDN1;VDR;HEY1;PDE4B
2887,GO:0005942,0.000210171377955527,0.999989954213533,4,19,phosphatidylinositol 3-kinase complex,CC,PIK3R2;PIK3R1;PIK3CA;PIK3CG
14019,GO:0051336,0.000210284641161258,0.999903378676696,35,1321,regulation of hydrolase activity,BP,ARTN;WNT4;RIN3;ACTN2;PMAIP1;CRB2;SERPINA5;RABIF;CCL20;SPTBN5;SPTBN4;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;SPTB;HBEGF;BMP2;CAMSAP3;CTGF;AKT1;NRTN;KITLG;CST9L;GAS6;AMOT;SH3BP4;GDNF
3798,GO:0007409,0.000212867951348446,0.999932477277802,17,416,axonogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;PIK3CA;GDNF
14083,GO:0051445,0.000214743571098559,0.999983050871336,5,39,regulation of meiotic cell cycle,BP,LIF;WNT4;PRKACB;WNT5A;NPPC
3527,GO:0006909,0.000217019313759936,0.999950989018548,11,209,phagocytosis,BP,RAB27A;ADORA1;MFGE8;RAB39A;TYRO3;PIK3R2;PIK3R1;RAB20;MYO7A;PIK3CA;GAS6
11473,GO:0043547,0.000218160730453376,0.999918969369093,22,640,positive regulation of GTPase activity,BP,ARTN;WNT4;RIN3;ACTN2;RABIF;CCL20;SPTBN5;SPTBN4;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;SPTB;HBEGF;NRTN;KITLG;GDNF
18098,GO:0098636,0.000219523337485692,0.999982760340269,5,35,protein complex involved in cell adhesion,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8
4663,GO:0009880,0.000219862458676036,0.999976104421348,6,62,embryonic pattern specification,BP,WNT7A;FGF10;WNT5A;BMP7;WT1;DLL1
8580,GO:0032555,0.00022092470027423,0.999888138048232,46,1791,purine ribonucleotide binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
8568,GO:0032535,0.000221972509579723,0.999938426160972,14,313,regulation of cellular component size,BP,FHOD3;WNT3;ACTN2;WNT7A;WNT7B;EDN1;SPTBN5;SPTBN4;PLEKHH2;WNT5A;SCIN;SPTB;MSN;AKT1
13432,GO:0048844,0.000223920923904372,0.999975704262403,6,57,artery morphogenesis,BP,NOTCH1;STRA6;FGF8;BMP4;HEY1;EFNB2
7607,GO:0030835,0.00022494768291502,0.999982147778216,5,37,negative regulation of actin filament depolymerization,BP,SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
8949,GO:0033135,0.000225343101165232,0.999963414193577,8,121,regulation of peptidyl-serine phosphorylation,BP,LIF;SPTBN4;WNT5A;AXIN1;AKT1;PIK3CA;GAS6;ARAF
14920,GO:0060393,0.000226542762614867,0.999975288034783,6,60,regulation of pathway-restricted SMAD protein phosphorylation,BP,ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
16078,GO:0070673,0.00023115882986144,0.999995040706302,3,9,response to interleukin-18,BP,PDGFB;AKT1;CLDN1
8192,GO:0031943,0.000232581159088229,0.999994999675552,3,9,regulation of glucocorticoid metabolic process,BP,WNT4;DKK3;BMP2
19230,GO:1902589,0.000232990065102851,0.99988702604105,40,1542,single-organism organelle organization,BP,FHOD3;SYT5;WNT4;TUBG2;ACTN2;NOTCH1;MARK4;ITGB5;PMAIP1;CASQ2;EDN1;SPTBN5;SPTBN4;RAB39A;FGF10;PIK3R1;PLEKHH2;HRAS;JAM3;AXIN1;RHOQ;RHOJ;NUAK2;SCIN;PSRC1;SDC4;SPTB;DAAM2;RAB20;ESPN;VAMP1;RND3;CTGF;PKP1;RAB17;BCAR1;MYH11;AMOT;LAMA5;PARVB
20416,GO:1905207,0.000234543941139311,0.999981171540868,5,38,regulation of cardiocyte differentiation,BP,EDN1;FZD7;BMP4;BMP2;EFNB2
7484,GO:0030539,0.000234765679624744,0.999988182778456,4,22,male genitalia development,BP,FGF10;FGF8;BMP6;WT1
7355,GO:0030278,0.000236165935989307,0.999950803312181,10,179,regulation of ossification,BP,WNT4;NOTCH1;WNT7B;ACVR1;WNT5A;BMP7;BMP6;BMP4;BMP2;NPPC
3932,GO:0008091,0.000236413385256953,0.999995119861381,3,8,spectrin,CC,SPTBN5;SPTBN4;SPTB
4671,GO:0009891,0.000245313744932435,0.999877749104741,43,1746,positive regulation of biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;CCL20;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;CTGF;AKT1;KITLG;NPPC;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
7284,GO:0030177,0.000245776553272521,0.999953815914066,9,151,positive regulation of Wnt signaling pathway,BP,WNT3;WNT2;WNT4;WNT7A;FGF10;WNT5A;AXIN1;BMP2;WNT2B
5880,GO:0016324,0.000249486891321543,0.999933931418509,13,274,apical plasma membrane,CC,NOTCH1;RAB27A;TF;CRB2;SLC52A3;CDH2;DLL1;MSN;GJB6;RAB17;MYO7A;CLDN1;LZTS1
3803,GO:0007417,0.000251459761391774,0.99989540593508,27,886,central nervous system development,BP,LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;WNT7A;WNT7B;SPTBN4;TYRO3;CDH2;FGF10;WNT5A;AXIN1;PFKFB3;FGF8;CLCF1;BMP7;BMP4;BMP2;DLL1;DRP2;AKT1;WNT2B;CDH1;HAPLN3;TSPAN2
13300,GO:0048592,0.00025735581965726,0.999951459049246,9,139,eye morphogenesis,BP,WNT2;STRA6;WNT5A;AXIN1;BMP7;BMP4;DLL1;WNT2B;MYO7A
6260,GO:0017076,0.000258035723814541,0.999868362339814,46,1804,purine nucleotide binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
10853,GO:0042482,0.000261517744636407,0.999993940729987,3,10,positive regulation of odontogenesis,BP,WNT6;EDN1;BMP2
14878,GO:0060341,0.000262416378471152,0.999894450544012,25,811,regulation of cellular localization,BP,ITGA3;LIF;ACTN2;PMAIP1;CASQ2;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SESN2;RHOQ;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;CDH1;GAS6;GDNF;CLDN18
8414,GO:0032346,0.000268375702572783,1,2,2,positive regulation of aldosterone metabolic process,BP,WNT4;BMP6
8417,GO:0032349,0.000268375702572783,1,2,2,positive regulation of aldosterone biosynthetic process,BP,WNT4;BMP6
8578,GO:0032553,0.000272765897065688,0.999860471886631,46,1808,ribonucleotide binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
2669,GO:0005578,0.000273064469868978,0.999918670610914,15,351,proteinaceous extracellular matrix,CC,WNT3;WNT2;WNT4;CRISPLD2;WNT6;WNT7A;WNT7B;WNT5B;WNT5A;BMP4;CTGF;WNT2B;HAPLN3;LAMA1;LAMA5
2888,GO:0005943,0.000273395665116,1,2,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3R1;PIK3CA
3396,GO:0006700,0.000273511342686386,0.999985578337017,4,23,C21-steroid hormone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
19812,GO:1903847,0.000273557737954873,1,2,2,regulation of aorta morphogenesis,BP,NOTCH1;EFNB2
19813,GO:1903849,0.000273557737954873,1,2,2,positive regulation of aorta morphogenesis,BP,NOTCH1;EFNB2
20581,GO:1905651,0.000273557737954873,1,2,2,regulation of artery morphogenesis,BP,NOTCH1;EFNB2
20582,GO:1905653,0.000273557737954873,1,2,2,positive regulation of artery morphogenesis,BP,NOTCH1;EFNB2
1491,GO:0003213,0.000273557737980754,1,2,2,cardiac right atrium morphogenesis,BP,NOTCH1;WNT5A
9744,GO:0035265,0.000276688596457844,0.999947257579085,9,142,organ growth,BP,WNT2;NOTCH1;EDN1;FGF10;FGF8;WT1;DLL1;AKT1;NPPC
14948,GO:0060428,0.000278935560581442,0.999976643797928,5,40,lung epithelium development,BP,WNT2;STRA6;WNT7B;FGF10;BMP4
13371,GO:0048708,0.000279006464639402,0.999968292722443,6,62,astrocyte differentiation,BP,LIF;NOTCH1;CLCF1;BMP2;DLL1;TSPAN2
14347,GO:0051953,0.000281658597694784,0.999985122473956,4,22,negative regulation of amine transport,BP,ADRA2B;ADRA2C;ADORA1;CHGA
15315,GO:0061028,0.000282791368733615,0.999976352568929,5,38,establishment of endothelial barrier,BP,WNT7A;WNT7B;MSN;CLDN1;CLDN5
15322,GO:0061035,0.000287066219441616,0.999967264709399,6,60,regulation of cartilage development,BP,WNT5A;SCIN;BMP6;BMP4;BMP2;CTGF
1120,GO:0002521,0.000295538181142354,0.999903384757604,17,462,leukocyte differentiation,BP,LIF;WNT4;ZFPM1;FZD7;TYRO3;FSTL3;PIK3R1;CLCF1;BMP4;DLL1;TPD52;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
8204,GO:0031960,0.000297126743895134,0.999942615507834,9,159,response to corticosteroid,BP,NOTCH1;WNT7B;EDN1;BMP6;CDKN1A;CTGF;GJB2;CLDN1;HEY1
1569,GO:0003344,0.000298999123123675,0.999992992138651,3,9,pericardium morphogenesis,BP,NOTCH1;WNT5A;BMP7
731,GO:0001892,0.000305824381483101,0.999956023190152,7,88,embryonic placenta development,BP,LIF;WNT2;WNT7B;PDGFB;BMP7;AKT1;HEY1
14916,GO:0060389,0.00030748941623966,0.999964378884587,6,63,pathway-restricted SMAD protein phosphorylation,BP,ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
14965,GO:0060445,0.000308269031906688,0.999983222051049,4,23,branching involved in salivary gland morphogenesis,BP,FGF10;FGF8;BMP7;LAMA5
4849,GO:0010557,0.000309448095882278,0.999847634692331,40,1587,positive regulation of macromolecule biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;CCL20;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;CTGF;AKT1;KITLG;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
14578,GO:0055025,0.000314589554886057,0.999972956112106,5,40,positive regulation of cardiac muscle tissue development,BP,WNT2;NOTCH1;EDN1;BMP4;EFNB2
4239,GO:0008593,0.000315581009727198,0.999963229979803,6,64,regulation of Notch signaling pathway,BP,NOTCH1;FGF10;BMP7;DLL1;JAG2;HEY1
7458,GO:0030500,0.000317582647616285,0.999962921156305,6,65,regulation of bone mineralization,BP,WNT4;ACVR1;BMP7;BMP6;BMP4;BMP2
16433,GO:0071375,0.000319823454648936,0.999912953868238,13,293,cellular response to peptide hormone stimulus,BP,ACTN2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RHOQ;GJB2;AKT1;BCAR1;INHBB;PIK3CA
14059,GO:0051403,0.000320706939097139,0.999918212774638,12,247,stress-activated MAPK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
9537,GO:0034650,0.000321843266272359,0.999992263088016,3,9,cortisol metabolic process,BP,WNT4;DKK3;BMP2
9538,GO:0034651,0.000321843266272359,0.999992263088016,3,9,cortisol biosynthetic process,BP,WNT4;DKK3;BMP2
4662,GO:0009855,0.000322094446038785,0.999944886408141,8,118,determination of bilateral symmetry,BP,NOTCH1;ACVR1;FGF10;WNT5A;AXIN1;FGF8;DAAM2;DLL1
1391,GO:0003018,0.000322604494408204,0.99993706770923,9,152,vascular process in circulatory system,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
13339,GO:0048667,0.000324249791796936,0.999885705285545,19,512,cell morphogenesis involved in neuron differentiation,BP,ARTN;WNT3;NOTCH1;WNT7A;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;MYO7A;PIK3CA;LZTS1;GDNF
7658,GO:0030900,0.000330883737079966,0.999899583539529,15,360,forebrain development,BP,WNT4;POU3F1;NOTCH1;WNT7A;WNT7B;TYRO3;CDH2;FGF10;WNT5A;AXIN1;FGF8;BMP4;BMP2;WNT2B;CDH1
11922,GO:0044802,0.000331205796574378,0.999870093464257,23,717,single-organism membrane organization,BP,ITGA3;SYT5;WNT4;ACTN2;TSPAN15;PMAIP1;SERPINA5;RAB40B;RAB40A;SPTBN4;RAB39A;CDH2;PIK3R1;REEP1;RHOQ;RAB20;VAMP1;AKT1;PKP3;CDH1;GAS6;LAMA5;GDNF
5939,GO:0016462,0.000331452957555022,0.999864524896217,25,810,pyrophosphatase activity,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
3592,GO:0007015,0.000333710694754238,0.999903510362717,14,328,actin filament organization,BP,FHOD3;WNT4;ACTN2;ITGB5;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;SCIN;SDC4;SPTB;ESPN;CTGF;BCAR1
21062,GO:2000209,0.000334606456647828,0.999981387947515,4,23,regulation of anoikis,BP,ITGA5;NOTCH1;TLE1;PIK3CA
14667,GO:0060037,0.000335633116623076,0.999981213923118,4,24,pharyngeal system development,BP,ACVR1;FGF8;BMP7;BMP4
7341,GO:0030258,0.000336486563778115,0.999913677127219,12,254,lipid modification,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;SESN2;FGF8;HBEGF;AKT1;KITLG;PIK3CA;PIK3CG
6135,GO:0016818,0.000337436593296988,0.999861905153986,25,812,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
17160,GO:0072676,0.000337707899627402,0.999959646676464,6,83,lymphocyte migration,BP,ARTN;CCL20;WNT5A;MSN;PIK3CG;GAS6
14964,GO:0060444,0.000337902972658386,0.999981155570901,4,23,branching involved in mammary gland duct morphogenesis,BP,WNT4;WNT5A;DDR1;VDR
14561,GO:0055006,0.000346251971448268,0.999958944697485,6,64,cardiac cell development,BP,FHOD3;ACTN2;NOTCH1;EDN1;BMP4;MYH11
6134,GO:0016817,0.000347755865711882,0.99985738152653,25,814,hydrolase activity, acting on acid anhydrides,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
1545,GO:0003309,0.000349117699763829,0.999980360478147,4,23,type B pancreatic cell differentiation,BP,WNT5A;BMP6;BMP4;DLL1
7622,GO:0030856,0.000350355726129713,0.999939234945497,8,121,regulation of epithelial cell differentiation,BP,LIF;NOTCH1;BMP6;BMP4;DLL1;CLDN5;VDR;GDNF
863,GO:0002068,0.000352184519292497,0.999980141839705,4,23,glandular epithelial cell development,BP,WNT5A;BMP6;BMP4;DLL1
3615,GO:0007044,0.000359304643321396,0.999947007279518,7,85,cell-substrate junction assembly,BP,ITGA5;WNT4;ACTN3;ACTN2;ITGB4;SDC4;LAMA5
1041,GO:0002376,0.000361327474194825,0.99980303644983,55,2604,immune system process,BP,ITGA3;ITGA5;ARTN;LIF;WNT4;NOTCH1;RAB27A;ITGB5;PMAIP1;CRISPLD2;ZFPM1;ADORA1;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5A;JAM3;SCIN;SDC4;CLCF1;BMP6;BMP4;CDKN1A;DLL1;SFXN1;CHGA;MSN;TPD52;AKT1;PKP1;RAB17;WNT2B;KITLG;JAG2;BCAR1;RAB44;CLDN1;PIK3CA;PIK3CG;GAS6;TSPAN2;RAB3D;FZD8;CLDN18;EFNB2;PDE4B
6756,GO:0019898,0.000364335038769795,0.99990569721509,12,254,extrinsic component of membrane,CC,TF;NMT2;MFGE8;CDH2;PIK3R2;PIK3R1;SNX18;MSN;CDH1;PIK3CA;PIK3CG;MYZAP
13418,GO:0048812,0.000366802402234028,0.99986548850945,20,561,neuron projection morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;LZTS1;GDNF
13064,GO:0048010,0.000369300776358793,0.999945119650552,7,91,vascular endothelial growth factor receptor signaling pathway,BP,ITGA5;MAPK12;FGF10;PIK3R2;PIK3R1;BCAR1;PIK3CA
761,GO:0001936,0.000377052129693155,0.999943673679471,7,95,regulation of endothelial cell proliferation,BP,WNT2;PDGFB;WNT5A;BMP6;BMP4;BMP2;AKT1
5192,GO:0014033,0.000379819829995148,0.999954093821489,6,66,neural crest cell differentiation,BP,ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
7717,GO:0031018,0.000384104323519005,0.999965246926643,5,44,endocrine pancreas development,BP,WNT5A;BMP6;BMP4;DLL1;AKT1
8902,GO:0033036,0.000384671938589613,0.99978518120157,60,2775,macromolecule localization,BP,ITGA3;LIF;ADRA2C;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;PMAIP1;SERPINA5;WNT7A;RABIF;ADORA1;EDN1;RAB40B;RAB40A;SPTBN4;RAB39B;RAB39A;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SNX18;SESN2;RHOQ;RHOB;SCIN;BMP7;BMP6;BMP4;CDKN1A;RAB20;WNK4;MSN;AKT1;PKP3;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;AMOT;LAMA5;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;CLDN18
12297,GO:0045682,0.000393898120784965,0.999951952696161,6,69,regulation of epidermis development,BP,NOTCH1;WNT5A;BMP4;DLL1;NAB2;VDR
8797,GO:0032880,0.000395527613833177,0.999830413684231,27,937,regulation of protein localization,BP,ITGA3;LIF;ADRA2C;ACTN2;PMAIP1;WNT7A;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;RALB;WNT5A;SESN2;RHOQ;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6;CLDN18
4692,GO:0009953,0.000396090301347072,0.999940365147236,7,94,dorsal/ventral pattern formation,BP,WNT3;WNT7A;ACVR1;EDN1;PRKACB;FGF8;BMP4
8775,GO:0032835,0.000396168135594994,0.999951856947801,6,63,glomerulus development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
7766,GO:0031098,0.000397227058175578,0.999896189261794,12,253,stress-activated protein kinase signaling cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
1471,GO:0003183,0.000398444279081665,0.999989328557531,3,10,mitral valve morphogenesis,BP,NOTCH1;ZFPM1;ACVR1
700,GO:0001845,0.000398716187653499,0.999989029379085,3,11,phagolysosome assembly,BP,RAB39A;RAB20;MYO7A
15046,GO:0060561,0.00040444107356519,0.999976211477393,4,24,apoptotic process involved in morphogenesis,BP,NOTCH1;BMP7;JAG2;VDR
15362,GO:0061097,0.000408080503350626,0.99995008661145,6,64,regulation of protein tyrosine kinase activity,BP,ADRA2B;ADRA2C;ADORA1;PDGFB;GAS6;UNC119
7815,GO:0031214,0.000408615599839941,0.9999273687585,8,126,biomineral tissue development,BP,WNT4;WNT6;ACVR1;BMP7;BMP6;BMP4;BMP2;GAS6
18951,GO:1901879,0.00041478263434049,0.999949025289882,6,66,regulation of protein depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
502,GO:0001533,0.00042043679977435,0.999960355914892,5,63,cornified envelope,CC,DSC2;DSG3;PKP3;PKP1;DSC3
3545,GO:0006939,0.000424008958380279,0.999935428584095,7,94,smooth muscle contraction,BP,ADRA2B;ADRA2C;ADORA1;EDN1;MYH11;GDNF;ACTA2
15907,GO:0070372,0.000434652418641338,0.999893092632413,11,240,regulation of ERK1 and ERK2 cascade,BP,LIF;CCL20;FGF10;PDGFB;HRAS;FGF8;BMP4;BMP2;CTGF;GAS6;ARAF
7509,GO:0030595,0.000448579653130991,0.99990792679407,9,187,leukocyte chemotaxis,BP,EDN1;CCL20;PDGFB;WNT5A;JAM3;CHGA;PIK3CG;GAS6;PDE4B
693,GO:0001838,0.000449803300785193,0.999919007087504,8,120,embryonic epithelial tube formation,BP,WNT4;WNT6;PRKACB;WNT5A;SDC4;BMP7;BMP4;GDNF
11624,GO:0044087,0.00045151050763348,0.99981502400412,24,771,regulation of cellular component biogenesis,BP,FHOD3;WNT4;NOTCH1;PMAIP1;WNT7A;EDN1;SPTBN5;SPTBN4;PIK3R1;RALB;HRAS;WNT5A;RHOQ;SCIN;PSRC1;SDC4;SPTB;BMP7;ESPN;CHGA;MSN;CTGF;RAB17;CLDN1
4015,GO:0008217,0.000453572291735345,0.99990704452094,9,165,regulation of blood pressure,BP,ADORA1;EDN1;KCNK6;PDGFB;NPR1;DLL1;CHGA;GAS6;ACTA2
13373,GO:0048710,0.000453697660023733,0.999972348101092,4,25,regulation of astrocyte differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
3719,GO:0007219,0.000458361352382146,0.999906018932895,9,159,Notch signaling pathway,BP,NOTCH1;FGF10;BMP7;BMP2;DLL1;JAG2;EPN1;DTX4;HEY1
12441,GO:0045944,0.000465935858588053,0.999791774295228,29,1031,positive regulation of transcription from RNA polymerase II promoter,BP,LIF;WNT2;POU3F1;NOTCH1;WNT7A;ZFPM1;ACVR1;EDN1;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;RHOQ;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;AKT1;VDR;GDNF;FZD8;HEY1
10935,GO:0042594,0.000467124205518429,0.999904020065626,9,156,response to starvation,BP,WNT4;PMAIP1;DSC2;RALB;NUAK2;CDKN1A;WNT2B;INHBB;GAS6
12326,GO:0045741,0.000472335710947053,0.999986221115681,3,11,positive regulation of epidermal growth factor-activated receptor activity,BP,ADRA2B;ADRA2C;ADORA1
9960,GO:0035639,0.000486761631928354,0.999747059623905,44,1749,purine ribonucleoside triphosphate binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2
16348,GO:0071241,0.000489251787160426,0.999898670870023,9,165,cellular response to inorganic substance,BP,TF;GUCY1B3;EDN1;FSTL3;WNT5A;BMP6;AKT1;CDH1;CLDN1
12859,GO:0046890,0.000490025965820831,0.999910397708186,8,129,regulation of lipid biosynthetic process,BP,WNT4;DHH;DKK3;PDGFB;BMP6;BMP2;AKT1;VDR
18536,GO:1900182,0.000496451284049264,0.999909133992929,8,125,positive regulation of protein localization to nucleus,BP,LIF;PIK3R2;PIK3R1;SESN2;BMP6;BMP4;AKT1;CDH1
13442,GO:0048858,0.000498166593449029,0.999812712347543,20,575,cell projection morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;LZTS1;GDNF
1417,GO:0003093,0.000506359834581072,0.999984543155922,3,12,regulation of glomerular filtration,BP,ADORA1;PDGFB;GAS6
15426,GO:0061217,0.000528842513288786,0.999966269733883,4,26,regulation of mesonephros development,BP,BMP4;WT1;WNT2B;GDNF
7616,GO:0030850,0.000532331831025771,0.999948157778386,5,45,prostate gland development,BP,NOTCH1;FGF10;WNT5A;BMP7;BMP4
8418,GO:0032350,0.00053404879298574,0.999965848277356,4,26,regulation of hormone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
13288,GO:0048565,0.000546940818989907,0.9998984041057,8,125,digestive tract development,BP,NOTCH1;STRA6;ITGB4;FGF10;WNT5A;BMP4;CDKN1A;CLDN18
1464,GO:0003174,0.00055035380943382,0.999983073637654,3,11,mitral valve development,BP,NOTCH1;ZFPM1;ACVR1
10107,GO:0035883,0.000555458275880099,0.999964103488897,4,26,enteroendocrine cell differentiation,BP,WNT5A;BMP6;BMP4;DLL1
11734,GO:0044319,0.00055774480135047,0.99996391605145,4,26,wound healing, spreading of cells,BP,ITGA5;WNT7A;HBEGF;DDR1
17610,GO:0090505,0.00055774480135047,0.99996391605145,4,26,epiboly involved in wound healing,BP,ITGA5;WNT7A;HBEGF;DDR1
12067,GO:0045177,0.000560736260638303,0.999829006481367,14,339,apical part of cell,CC,NOTCH1;RAB27A;TF;CRB2;SLC52A3;ACVR1;CDH2;DLL1;MSN;GJB6;RAB17;MYO7A;CLDN1;LZTS1
14184,GO:0051641,0.000561281021506907,0.999689189833711,54,2455,cellular localization,BP,ITGA3;LIF;SYT5;WNT4;ACTN2;RAB6C;TSPAN15;TSPAN17;RAB27A;PMAIP1;WNT7A;NMT2;ADORA1;CASQ2;RAB40B;RAB40A;SPTBN5;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;GPRASP1;SESN2;RHOQ;RHOB;SCIN;PSRC1;SPTB;BMP7;BMP6;BMP4;CDKN1A;CHGA;MSN;AKT1;PKP3;RAB12;RAB17;CDH1;MYO7A;PIK3CG;GAS6;AMOT;LAMA5;SH3BP4;RAB38;GDNF;CLDN18
7464,GO:0030507,0.000567608892308034,0.999963270093906,4,25,spectrin binding,MF,SPTBN5;SPTBN4;CAMSAP3;MYO7A
790,GO:0001968,0.000572174935889346,0.999962728348901,4,26,fibronectin binding,MF,ITGA3;FSTL3;SDC4;CTGF
16929,GO:0072207,0.000576526135703223,0.999962368603878,4,26,metanephric epithelium development,BP,LIF;WNT4;WNT7B;WT1
7067,GO:0021984,0.000576703952088546,0.9999809886438,3,14,adenohypophysis development,BP,WNT4;FGF8;BMP2
7609,GO:0030837,0.000579539174359566,0.999942315929179,5,47,negative regulation of actin filament polymerization,BP,FHOD3;SPTBN5;SPTBN4;SCIN;SPTB
3806,GO:0007422,0.000584266112745064,0.999923181721341,6,69,peripheral nervous system development,BP,ARTN;POU3F1;AKT1;NAB2;CLDN1;GDNF
7715,GO:0031016,0.000586993877875804,0.999922593456331,6,72,pancreas development,BP,FGF10;WNT5A;BMP6;BMP4;DLL1;AKT1
2159,GO:0004672,0.000594612469618884,0.999767309099291,21,624,protein kinase activity,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;FGF10;FGF17;KCNH2;NPR1;NUAK2;FGF8;HBEGF;CDKN1A;PKN3;WNK4;DDR1;AKT1;PIK3CA;PIK3CG;ARAF;PIM2
11809,GO:0044444,0.000602437552939039,0.999623327855744,147,8745,cytoplasmic part,CC,ITGA3;ITGA5;FHOD3;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT4;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;PNMT;TF;ITGB5;PMAIP1;CRISPLD2;FBXO41;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HMGCS2;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;SCIN;PSRC1;SDC4;SPTB;HBEGF;LGALS4;B3GNT2;WT1;CDKN1A;DLL1;PKN3;RAB20;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP1;RAB12;RAB17;CYTIP;PTGES;NPPC;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;RAB44;TLE1;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;DTX4;MYH11;GPSM1;AMOT;ARAF;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;FZD8;ACTA2;RNF144A;PARVB;PDE4B
15140,GO:0060711,0.000606430749303054,0.999939028923241,5,47,labyrinthine layer development,BP,WNT2;WNT7B;BMP7;AKT1;HEY1
12428,GO:0045927,0.000608578034657014,0.999844148989502,11,237,positive regulation of growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;FGF8;HBEGF;WT1;DLL1;AKT1
16878,GO:0072138,0.000609278342417683,0.99999708206126,2,3,mesenchymal cell proliferation involved in ureteric bud development,BP,BMP4;BMP2
14823,GO:0060272,0.000611276417579239,0.999980084375255,3,12,embryonic skeletal joint morphogenesis,BP,AXIN1;BMP7;BMP4
4764,GO:0010256,0.000612865123724636,0.999772010771658,19,553,endomembrane system organization,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB27A;RAB40B;RAB40A;SPTBN5;SPTBN4;CDH2;PIK3R1;REEP1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5;RAB38
8070,GO:0031668,0.000616689749320011,0.999854392497377,10,198,cellular response to extracellular stimulus,BP,WNT4;PMAIP1;DSC2;RALB;NUAK2;CDKN1A;WNT2B;INHBB;GAS6;VDR
18875,GO:1901653,0.000621080237847992,0.999818307125903,13,315,cellular response to peptide,BP,ACTN2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RHOQ;GJB2;AKT1;BCAR1;INHBB;PIK3CA
12244,GO:0045608,0.000621686052813764,0.999996992029511,2,3,negative regulation of auditory receptor cell differentiation,BP,NOTCH1;DLL1
11796,GO:0044425,0.000632135637746619,0.999604412263372,110,6187,membrane part,CC,ITGA3;ITGA5;TMEM163;ADRA2B;ADRA2C;SYT5;TSPAN15;TSPAN17;NOTCH1;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;RHBDL3;SLC45A4;DSC2;SERPINA5;SLC52A3;TMEM206;ACVR1;NMT2;ADORA1;CASQ2;KCNK6;MFGE8;FLVCR2;SPTBN5;MBOAT2;SLC25A53;TTYH1;MPZL1;TSPAN13;PRND;FZD7;TYRO3;LPAR2;CDH2;HRCT1;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;PTPN7;JAM3;SNX18;AXIN1;RHOQ;NPR1;FGF8;SDC4;SPTB;HBEGF;PGBD5;BMP2;B3GNT2;DLL1;DRP2;SLC2A14;VAMP1;SFXN1;MSN;DDR1;DSG3;GJB1;GJB2;GJB6;RAB17;PTGES;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;GJA3;TPBGL;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;KCNG2;LZTS1;CLDN23;SHC4;SLC18B1;DSC3;GPSM1;AMOT;SH3BP4;KCND1;TSPAN2;ACSL4;MYZAP;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;EFNB2;PDE4B
6536,GO:0019218,0.000632527668885926,0.999915226848252,6,75,regulation of steroid metabolic process,BP,WNT4;DHH;DKK3;BMP6;BMP2;VDR
9130,GO:0033604,0.000632893001647685,0.999979130299952,3,12,negative regulation of catecholamine secretion,BP,ADRA2B;ADRA2C;CHGA
8877,GO:0033002,0.000644902506175676,0.999861192798066,9,164,muscle cell proliferation,BP,WNT2;NOTCH1;EDN1;PDGFB;NPR1;HBEGF;BMP4;AKT1;NPPC
20323,GO:1904953,0.000652537519602581,0.99997825330239,3,12,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2;WNT5A
17609,GO:0090504,0.000657122677614247,0.99995539267381,4,27,epiboly,BP,ITGA5;WNT7A;HBEGF;DDR1
8181,GO:0031929,0.000658539915313866,0.99989179498773,7,98,TOR signaling,BP,PRR5L;SESN2;AKT1;PIK3CA;GAS6;ARAF;SH3BP4
7886,GO:0031328,0.000673508728414568,0.999651433268549,41,1717,positive regulation of cellular biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;CCL20;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;AKT1;KITLG;NPPC;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
527,GO:0001570,0.000675774604953808,0.999908510390418,6,71,vasculogenesis,BP,NOTCH1;WNT7A;WNT7B;WT1;AMOT;HEY1
10855,GO:0042487,0.000681398330071561,0.99997654391237,3,13,regulation of odontogenesis of dentin-containing tooth,BP,FGF8;BMP4;BMP2
15866,GO:0070307,0.00069171795640498,0.999976064230458,3,13,lens fiber cell development,BP,WNT7A;WNT7B;WNT5B
1562,GO:0003337,0.000693141209330257,0.999975997876317,3,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF;BMP4;GDNF
8870,GO:0032990,0.000693496255253913,0.999732057311553,20,593,cell part morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;LZTS1;GDNF
2346,GO:0004938,0.000697034480676194,0.999996425822685,2,3,alpha2-adrenergic receptor activity,MF,ADRA2B;ADRA2C
10752,GO:0042306,0.0007027537508548,0.999846852149284,9,166,regulation of protein import into nucleus,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CDH1;GAS6
2877,GO:0005921,0.000705116641119836,0.999950704492523,4,30,gap junction,CC,GJB1;GJB2;GJB6;GJA3
15466,GO:0061351,0.000708416552451238,0.999863016714517,8,127,neural precursor cell proliferation,BP,ARTN;WNT2;NOTCH1;WNT7A;LIMS2;CDH2;WNT5A;FGF8
14944,GO:0060423,0.000716715232952879,0.999996272565714,2,3,foregut regionalization,BP,WNT2;WNT2B
14945,GO:0060424,0.000716715232952879,0.999996272565714,2,3,lung field specification,BP,WNT2;WNT2B
15002,GO:0060492,0.000716715232952879,0.999996272565714,2,3,lung induction,BP,WNT2;WNT2B
11392,GO:0043412,0.000720545966761032,0.999563934080831,79,3985,macromolecule modification,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;MARK4;GADD45A;FBXO41;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;EDN1;RAB40B;RAB40A;PRKACB;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;HMGN5;PKN3;WNK4;DDR1;CTGF;AKT1;NRTN;KITLG;INHBB;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;RNF144A;PIM2
15420,GO:0061205,0.000722458718194826,0.999996227431108,2,3,paramesonephric duct development,BP,WNT4;STRA6
9512,GO:0034613,0.000726450234023166,0.999625309508913,40,1682,cellular protein localization,BP,ITGA3;LIF;WNT4;ACTN2;TSPAN15;TSPAN17;RAB27A;PMAIP1;ADORA1;RAB40B;RAB40A;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SESN2;RHOQ;RHOB;SCIN;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;PKP3;CDH1;MYO7A;GAS6;AMOT;LAMA5;SH3BP4;RAB38;CLDN18
16353,GO:0071248,0.000738968194744216,0.999855700383167,8,142,cellular response to metal ion,BP,TF;EDN1;FSTL3;WNT5A;BMP6;AKT1;CDH1;CLDN1
18077,GO:0098588,0.000739271629589568,0.999607310827929,44,1865,bounding membrane of organelle,CC,TMEM163;SYT5;WNT3;WNT4;TSPAN15;NOTCH1;RAB27A;TF;PMAIP1;SERPINA5;WNT6;WNT7A;WNT7B;CASQ2;PLAU;SPTBN5;TTYH1;RAB39A;SYCN;FZD7;PDGFB;HRAS;WNT5B;WNT5A;SNX18;RHOQ;RHOB;HBEGF;B3GNT2;RAB20;VAMP1;RND3;CHGA;PKP1;RAB12;RAB17;MYO7A;RAB44;RAB11FIP1;GPSM1;RAB38;RAB3D;ACSL4;RNF144A
4805,GO:0010463,0.000744919589959792,0.999921597984766,5,47,mesenchymal cell proliferation,BP,WNT2;WNT5A;BMP7;BMP4;BMP2
17340,GO:0090031,0.000755636781508188,0.999995963132163,2,3,positive regulation of steroid hormone biosynthetic process,BP,WNT4;BMP6
10633,GO:0042063,0.000759974184312787,0.999799997976609,11,239,gliogenesis,BP,LIF;POU3F1;NOTCH1;CDH2;FGF10;CLCF1;BMP2;DLL1;AKT1;NAB2;TSPAN2
14961,GO:0060441,0.000763581793577578,0.999945636916394,4,29,epithelial tube branching involved in lung morphogenesis,BP,WNT2;FGF10;BMP4;WNT2B
15089,GO:0060627,0.000765796666822132,0.999736940073926,16,441,regulation of vesicle-mediated transport,BP,SYT5;ACTN2;NOTCH1;RAB27A;TF;MFGE8;RALB;WNT5A;SDC4;DLL1;RAB20;MSN;RAB17;GAS6;UNC119;RAB3D
14830,GO:0060284,0.000767979183323604,0.999679251190067,23,747,regulation of cell development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;EDN1;CDH2;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;NPPC;CLDN5;LZTS1;CLDN18
9569,GO:0034698,0.000769713362566931,0.999945479135554,4,27,response to gonadotropin,BP,ITGA3;NOTCH1;WT1;GJB2
20141,GO:1904589,0.00077844080588215,0.999827810436736,9,169,regulation of protein import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CDH1;GAS6
15906,GO:0070371,0.00078288302348501,0.999792945660575,11,256,ERK1 and ERK2 cascade,BP,LIF;CCL20;FGF10;PDGFB;HRAS;FGF8;BMP4;BMP2;CTGF;GAS6;ARAF
12072,GO:0045184,0.000785470214981487,0.999576016818683,46,2049,establishment of protein localization,BP,ITGA3;ADRA2C;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;PMAIP1;RABIF;ADORA1;RAB40B;RAB40A;SPTBN4;RAB39B;RAB39A;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;REEP1;WNT5A;SNX18;RHOQ;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;AKT1;PKP3;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;LAMA5;UNC119;RAB38;RAB3D
11702,GO:0044267,0.000786532897115685,0.999514732429417,88,4698,cellular protein metabolic process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;MARK4;PMAIP1;GADD45A;CRB2;FBXO41;SERPINA5;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;EDN1;RAB40B;RAB40A;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;DLL1;PKN3;WNK4;MSN;DDR1;CTGF;AKT1;RAB12;NRTN;KITLG;CST9L;JAG2;INHBB;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;PM20D2;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;RNF144A;PIM2
13279,GO:0048546,0.000787250026182642,0.999915886957011,5,49,digestive tract morphogenesis,BP,NOTCH1;STRA6;FGF10;WNT5A;BMP4
8907,GO:0033043,0.00079342922677764,0.999627901395231,30,1117,regulation of organelle organization,BP,FHOD3;LIF;WNT4;ACTN2;RAB6C;PMAIP1;EDN1;SPTBN5;SPTBN4;CDH2;PIK3R1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;RHOQ;SCIN;PSRC1;FGF8;SDC4;SPTB;BMP7;BMP4;CAMSAP3;ESPN;MSN;CTGF;AKT1
7111,GO:0022607,0.000797668340017076,0.999548825728608,55,2570,cellular component assembly,BP,ITGA5;FHOD3;WNT4;TUBG2;ACTN3;ACTN2;NOTCH1;MARK4;ITGB5;ITGB4;PMAIP1;WNT7A;CASQ2;EDN1;SPTBN5;SPTBN4;TTYH1;RAB39A;PRND;LIMS2;CDH2;PIK3R1;RALB;HRAS;WNT5A;AXIN1;RHOQ;SCIN;PSRC1;SDC4;SPTB;BMP7;RAB20;ESPN;VAMP1;MSN;CTGF;GJB1;GJB2;PKP3;PKP1;RAB17;CDH1;MYO7A;TLE1;CLDN1;CLDN3;CLDN5;KCNG2;GAS6;MYH11;LAMA5;KCND1;RAB38;PARVB
598,GO:0001702,0.000799467240706832,0.999942573841691,4,28,gastrulation with mouth forming second,BP,CRB2;ACVR1;WNT5A;AMOT
2441,GO:0005092,0.000799569119724641,0.999970481211493,3,14,GDP-dissociation inhibitor activity,MF,SESN2;GPSM1;SH3BP4
8545,GO:0032496,0.000800476342914999,0.999772718523699,12,299,response to lipopolysaccharide,BP,NOTCH1;EDN1;CCL20;FGF10;WNT5A;BMP6;GJB2;GJB6;AKT1;PTGES;CLDN1;PDE4B
14255,GO:0051783,0.000801538951067695,0.999821939217376,9,170,regulation of nuclear division,BP,LIF;WNT4;EDN1;PDGFB;WNT5A;PSRC1;FGF8;BMP7;BMP4
1477,GO:0003192,0.000805507329427363,0.999995554615635,2,3,mitral valve formation,BP,NOTCH1;ZFPM1
12133,GO:0045321,0.000805781230587482,0.999626540613089,29,1129,leukocyte activation,BP,WNT4;RAB27A;CRISPLD2;ZFPM1;EDN1;PLAU;FZD7;TYRO3;FGF10;PIK3R1;WNT5A;SDC4;CLCF1;BMP4;CDKN1A;DLL1;CHGA;MSN;TPD52;AKT1;PKP1;JAG2;RAB44;PIK3CA;PIK3CG;GAS6;RAB3D;FZD8;EFNB2
2638,GO:0005509,0.0008072136068257,0.999676051080887,21,676,calcium ion binding,MF,SYT5;ACTN3;ACTN2;NOTCH1;CDH23;CRB2;RHBDL3;DHH;DSC2;CASQ2;TTYH1;CDH2;SCIN;DLL1;DSG3;TPD52;JAG2;CDH1;HPCAL1;GAS6;DSC3
11626,GO:0044089,0.0008151226104709,0.999718325755916,16,441,positive regulation of cellular component biogenesis,BP,WNT4;PMAIP1;WNT7A;EDN1;RALB;HRAS;RHOQ;SCIN;PSRC1;SDC4;BMP7;ESPN;CHGA;MSN;CTGF;CLDN1
16101,GO:0070727,0.000815170613462974,0.999576851971788,40,1692,cellular macromolecule localization,BP,ITGA3;LIF;WNT4;ACTN2;TSPAN15;TSPAN17;RAB27A;PMAIP1;ADORA1;RAB40B;RAB40A;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SESN2;RHOQ;RHOB;SCIN;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;PKP3;CDH1;MYO7A;GAS6;AMOT;LAMA5;SH3BP4;RAB38;CLDN18
1205,GO:0002685,0.000818605046457687,0.999837200827821,8,156,regulation of leukocyte migration,BP,ADORA1;EDN1;CCL20;WNT5A;JAM3;MSN;KITLG;GAS6
2533,GO:0005243,0.000819110253616008,0.999969505027643,3,14,gap junction channel activity,MF,GJB1;GJB2;GJA3
1475,GO:0003188,0.000826835908920923,0.999969559818917,3,13,heart valve formation,BP,NOTCH1;ZFPM1;HEY1
18291,GO:0099068,0.000827118128845294,0.999970069423402,3,12,postsynapse assembly,BP,WNT7A;CDH2;WNT5A
13384,GO:0048736,0.000829067970472284,0.99981510794916,9,164,appendage development,BP,WNT3;NOTCH1;ITGB4;WNT7A;FGF10;WNT5A;FGF8;BMP7;BMP4
14764,GO:0060173,0.000829067970472284,0.99981510794916,9,164,limb development,BP,WNT3;NOTCH1;ITGB4;WNT7A;FGF10;WNT5A;FGF8;BMP7;BMP4
3805,GO:0007420,0.000858010844764996,0.999654023536214,21,666,brain development,BP,WNT3;WNT2;WNT4;POU3F1;NOTCH1;WNT7A;WNT7B;TYRO3;CDH2;FGF10;WNT5A;AXIN1;PFKFB3;FGF8;BMP7;BMP4;BMP2;DLL1;WNT2B;CDH1;TSPAN2
11956,GO:0044877,0.000876325901350481,0.999616017304215,25,880,macromolecular complex binding,MF,ITGA3;ITGA5;TAGLN;ACTN3;ACTN2;ACVR1;ADORA1;MFGE8;FSTL3;PIK3R1;PDGFB;JAM3;SCIN;SPTB;MB21D2;CDKN1A;HMGN5;ESPN;DDR1;CTGF;PKP1;MYO7A;MYH11;LAMA5;RAB38
16814,GO:0072044,0.000876782609659983,0.999967055658371,3,13,collecting duct development,BP,NOTCH1;WNT7B;BMP4
14631,GO:0055123,0.000878749770077617,0.999823964045561,8,136,digestive system development,BP,NOTCH1;STRA6;ITGB4;FGF10;WNT5A;BMP4;CDKN1A;CLDN18
18721,GO:1901213,0.00088424432939802,0.999966677153045,3,13,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,NOTCH1;ACVR1;BMP4
520,GO:0001558,0.000887364305470988,0.999715815516562,14,373,regulation of cell growth,BP,WNT3;EDN1;WNT5A;SESN2;NPR1;PSRC1;HBEGF;WT1;CDKN1A;DDR1;CTGF;AKT1;BCAR1;SH3BP4
7183,GO:0030010,0.000891527337948994,0.999845561307059,7,101,establishment of cell polarity,BP,MARK4;WNT7A;FGF10;WNT5A;JAM3;MSN;AMOT
12322,GO:0045737,0.000892328700170426,0.99993314554186,4,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,FGF10;PDGFB;PSRC1;AKT1
40,GO:0000079,0.000898354397448107,0.999870759449595,6,81,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,GADD45A;FGF10;PDGFB;PSRC1;CDKN1A;AKT1
19287,GO:1902742,0.000904548175531621,0.99993259005116,4,29,apoptotic process involved in development,BP,NOTCH1;BMP7;JAG2;VDR
13328,GO:0048644,0.000905732582794221,0.999869699556701,6,78,muscle organ morphogenesis,BP,LIF;WNT2;NOTCH1;ZFPM1;WNT5A;BMP2
12232,GO:0045596,0.000907627103203445,0.999650545538257,19,603,negative regulation of cell differentiation,BP,WNT3;WNT4;NOTCH1;WNT7A;ZFPM1;FZD7;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5A;AXIN1;BMP7;BMP4;BMP2;DLL1;NPPC;CLDN18
15109,GO:0060674,0.000911085751127918,0.999931970601095,4,29,placenta blood vessel development,BP,WNT2;ITGB8;AKT1;HEY1
732,GO:0001893,0.000912712701587444,0.999931391548525,4,31,maternal placenta development,BP,LIF;GJB2;AKT1;VDR
2628,GO:0005488,0.000917510221099107,0.999504875342494,208,13522,binding,MF,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;RHBDL3;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;RABIF;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;TTYH1;MPZL1;RRAS2;RAB39B;RAB39A;PRND;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;MB21D2;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;CAMSAP3;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;ESPN;VAMP1;WNK4;RND3;MSN;DDR1;DSG3;CTGF;GJB1;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;HPCAL1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;HAPLN3;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;SHC4;DSC3;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
15457,GO:0061337,0.000925827303697623,0.999813024806106,8,136,cardiac conduction,BP,DSC2;CASQ2;KCNK6;SPTBN4;KCNH2;NPR1;NPPC;KCND1
2666,GO:0005575,0.000929630126305622,1,240,16973,cellular_component,CC,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;RHBDL3;FBXO41;SLC45A4;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;HRCT1;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;FGF8;OLFML2B;SDC4;CLCF1;SPTB;HBEGF;PGBD5;LGALS4;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;SEMA6C;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;TPBGL;SPSB1;HPCAL1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;HAPLN3;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;PM20D2;SHC4;SLC18B1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
13110,GO:0048145,0.000931138648397756,0.999864976494594,6,83,regulation of fibroblast proliferation,BP,WNT2;FGF10;PDGFB;WNT5A;CDKN1A;GAS6
17059,GO:0072498,0.000941167238525221,0.999963226326755,3,14,embryonic skeletal joint development,BP,AXIN1;BMP7;BMP4
13301,GO:0048593,0.000942573653832242,0.999835033079316,7,103,camera-type eye morphogenesis,BP,WNT2;STRA6;WNT5A;BMP7;BMP4;DLL1;WNT2B
15323,GO:0061036,0.000958634294667988,0.999927428862429,4,29,positive regulation of cartilage development,BP,WNT5A;BMP6;BMP4;BMP2
20628,GO:1905867,0.000982159686323341,0.999991538943315,2,4,epididymis development,BP,GJB1;GJB2
12299,GO:0045684,0.000983903294722509,0.999924115747539,4,33,positive regulation of epidermis development,BP,NOTCH1;WNT5A;BMP4;VDR
12302,GO:0045687,0.000985139487975045,0.999924191931104,4,32,positive regulation of glial cell differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
10119,GO:0035909,0.000986062924852607,0.999924780404227,4,29,aorta morphogenesis,BP,NOTCH1;FGF8;HEY1;EFNB2
12237,GO:0045601,0.000986463697492744,0.999924499320538,4,30,regulation of endothelial cell differentiation,BP,NOTCH1;BMP6;BMP4;CLDN5
760,GO:0001935,0.000999898358604594,0.999822761872738,7,111,endothelial cell proliferation,BP,WNT2;PDGFB;WNT5A;BMP6;BMP4;BMP2;AKT1
10859,GO:0042491,0.00102349526610857,0.999920643065587,4,31,auditory receptor cell differentiation,BP,NOTCH1;DLL1;JAG2;MYO7A
12262,GO:0045632,0.0010326953477724,0.999990873765478,2,4,negative regulation of mechanoreceptor differentiation,BP,NOTCH1;DLL1
21528,GO:2000981,0.0010326953477724,0.999990873765478,2,4,negative regulation of inner ear receptor cell differentiation,BP,NOTCH1;DLL1
3815,GO:0007492,0.00103526562232746,0.9998472398021,6,77,endoderm development,BP,ITGA5;NOTCH1;ITGB5;FGF8;BMP4;DUSP5
12351,GO:0045787,0.00104342609952609,0.999676613483204,13,334,positive regulation of cell cycle,BP,WNT4;GADD45A;EDN1;FGF10;PDGFB;FOXO4;WNT5A;PSRC1;FGF8;CDKN1A;HMGN5;CTGF;AKT1
12916,GO:0046982,0.00105336885728988,0.999640555302107,15,466,protein heterodimerization activity,MF,ITGA3;ADRA2C;SYT5;NOTCH1;GADD45A;ADORA1;TYRO3;PIK3R2;PIK3R1;PDGFB;JAM3;CLCF1;BMP6;BMP2;TPD52
21181,GO:2000379,0.00105462244910267,0.999843257124715,6,84,positive regulation of reactive oxygen species metabolic process,BP,RAB27A;GADD45A;EDN1;PDGFB;CDKN1A;AKT1
16732,GO:0071880,0.00105734439542189,0.999956976557546,3,14,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,ADRA2B;ADRA2C;CHGA
14257,GO:0051785,0.00106144503516441,0.999877904284675,5,55,positive regulation of nuclear division,BP,WNT4;EDN1;PDGFB;WNT5A;FGF8
98,GO:0000187,0.00106153639408562,0.999780651571966,8,144,activation of MAPK activity,BP,ADRA2B;ADRA2C;WNT7B;FGF10;WNT5A;AXIN1;BMP2;DUSP5
13332,GO:0048660,0.00107554160210435,0.999806885321099,7,112,regulation of smooth muscle cell proliferation,BP,EDN1;PDGFB;NPR1;HBEGF;BMP4;AKT1;NPPC
17493,GO:0090263,0.00107985942984038,0.999805607893315,7,119,positive regulation of canonical Wnt signaling pathway,BP,WNT2;WNT4;WNT7A;FGF10;WNT5A;AXIN1;WNT2B
12332,GO:0045747,0.00108043861271859,0.999914531933952,4,33,positive regulation of Notch signaling pathway,BP,NOTCH1;FGF10;DLL1;JAG2
11289,GO:0043244,0.00108881632160861,0.999837576183751,6,79,regulation of protein complex disassembly,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
19905,GO:1904029,0.00109451055949103,0.999836150450899,6,84,regulation of cyclin-dependent protein kinase activity,BP,GADD45A;FGF10;PDGFB;PSRC1;CDKN1A;AKT1
18952,GO:1901880,0.00110273284312676,0.999872327511949,5,53,negative regulation of protein depolymerization,BP,SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
19649,GO:1903530,0.00110797330976184,0.999565894629609,19,617,regulation of secretion by cell,BP,LIF;ADRA2B;ADRA2C;SYT5;NOTCH1;RAB27A;ADORA1;EDN1;RALB;WNT5A;SDC4;BMP6;CHGA;INHBB;RAB11FIP1;KCNG2;GAS6;RAB3D;GDNF
16858,GO:0072108,0.00110983863052893,0.999989825982813,2,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF;GDNF
8758,GO:0032811,0.00112760773717398,0.999989579212678,2,4,negative regulation of epinephrine secretion,BP,ADRA2B;ADRA2C
3363,GO:0006661,0.00113726855753143,0.999762641546617,8,140,phosphatidylinositol biosynthetic process,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;PIK3CA;PIK3CG
6102,GO:0016772,0.0011384651866811,0.999475193871967,27,955,transferase activity, transferring phosphorus-containing groups,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;KHK;NPR1;NUAK2;PFKFB3;FGF8;HBEGF;CDKN1A;PKN3;WNK4;DDR1;AKT1;KITLG;PIK3CA;PIK3CG;ARAF;PIM2
3741,GO:0007264,0.0011450893933223,0.999576662675687,17,482,small GTPase mediated signal transduction,BP,ITGA3;RAB6C;RABIF;RRAS2;FGF10;PIK3R2;RALB;HRAS;RHOQ;RHOJ;RHOB;CDKN1A;RND3;RRAD;KITLG;AMOT;RAB38
4006,GO:0008207,0.0011482141842555,0.99990743513418,4,34,C21-steroid hormone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
17125,GO:0072593,0.00115440142157937,0.999703111213571,10,228,reactive oxygen species metabolic process,BP,RAB27A;PMAIP1;GADD45A;EDN1;PDGFB;SESN2;BMP7;CDKN1A;CTGF;AKT1
21487,GO:2000826,0.00118193169287429,0.999904445902268,4,32,regulation of heart morphogenesis,BP,NOTCH1;ACVR1;BMP4;BMP2
12327,GO:0045742,0.00119056572527446,0.999903072590973,4,34,positive regulation of epidermal growth factor receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;AKT1
877,GO:0002085,0.00119648998222847,0.99998860384708,2,4,inhibition of neuroepithelial cell differentiation,BP,NOTCH1;DLL1
10982,GO:0042693,0.00120219187917403,0.999947195010516,3,17,muscle cell fate commitment,BP,ACVR1;FGF10;WT1
20324,GO:1904954,0.00121485968451324,0.999988338768841,2,4,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
12668,GO:0046488,0.00121609382162173,0.999685492278925,10,213,phosphatidylinositol metabolic process,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
724,GO:0001885,0.00121723891762041,0.999855895189595,5,53,endothelial cell development,BP,WNT7A;WNT7B;MSN;CLDN1;CLDN5
5009,GO:0010810,0.00122675238679968,0.99971023111,9,174,regulation of cell-substrate adhesion,BP,ITGA3;ITGA5;WNT4;NOTCH1;PLAU;FZD7;PIK3R1;SDC4;DDR1
7193,GO:0030027,0.00123130711035486,0.999709080574385,9,172,lamellipodium,CC,CDH2;PLEKHH2;KITLG;CDH1;BCAR1;PIK3CA;AMOT;ACTA2;PARVB
12732,GO:0046620,0.00126804338177427,0.999804931101533,6,81,regulation of organ growth,BP,WNT2;NOTCH1;EDN1;FGF8;WT1;AKT1
955,GO:0002237,0.00127722069609224,0.999616732604882,12,314,response to molecule of bacterial origin,BP,NOTCH1;EDN1;CCL20;FGF10;WNT5A;BMP6;GJB2;GJB6;AKT1;PTGES;CLDN1;PDE4B
13331,GO:0048659,0.00127740584242832,0.999763509271236,7,115,smooth muscle cell proliferation,BP,EDN1;PDGFB;NPR1;HBEGF;BMP4;AKT1;NPPC
16842,GO:0072089,0.00128496076428897,0.999762498982776,7,106,stem cell proliferation,BP,ARTN;WNT3;NOTCH1;WNT7B;WNT5A;WNT2B;KITLG
3749,GO:0007272,0.00128573322669124,0.999762037104319,7,110,ensheathment of neurons,BP,POU3F1;DHH;JAM3;AKT1;NAB2;TSPAN2;CLDN11
4104,GO:0008366,0.00128573322669124,0.999762037104319,7,110,axon ensheathment,BP,POU3F1;DHH;JAM3;AKT1;NAB2;TSPAN2;CLDN11
15422,GO:0061209,0.00128610343209238,0.999987291338426,2,4,cell proliferation involved in mesonephros development,BP,BMP4;BMP2
8788,GO:0032870,0.00128676799260304,0.999489286767549,19,610,cellular response to hormone stimulus,BP,ACTN2;NOTCH1;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RHOQ;BMP7;BMP4;WT1;GJB2;AKT1;BCAR1;INHBB;PIK3CA;VDR;HEY1
15218,GO:0060840,0.00129705096393524,0.999799899854074,6,78,artery development,BP,NOTCH1;STRA6;FGF8;BMP4;HEY1;EFNB2
9689,GO:0035107,0.00130516306984349,0.999721541206376,8,142,appendage morphogenesis,BP,WNT3;NOTCH1;WNT7A;FGF10;WNT5A;FGF8;BMP7;BMP4
9690,GO:0035108,0.00130516306984349,0.999721541206376,8,142,limb morphogenesis,BP,WNT3;NOTCH1;WNT7A;FGF10;WNT5A;FGF8;BMP7;BMP4
11287,GO:0043242,0.00133821561823822,0.99983764740135,5,56,negative regulation of protein complex disassembly,BP,SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
5280,GO:0014834,0.00134130131168654,0.999986459022277,2,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,WNT7A;FZD7
19739,GO:1903707,0.00134969662275258,0.999746767364873,7,131,negative regulation of hemopoiesis,BP,NOTCH1;ZFPM1;FSTL3;PIK3R1;BMP4;DLL1;CLDN18
7285,GO:0030178,0.00135003013058103,0.999675919757001,9,193,negative regulation of Wnt signaling pathway,BP,WNT4;NOTCH1;DKK3;CDH2;WNT5B;WNT5A;AXIN1;BMP2;TLE1
14108,GO:0051494,0.00135107205906702,0.999747560857079,7,113,negative regulation of cytoskeleton organization,BP,FHOD3;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB;ESPN
19356,GO:1902936,0.00135510561414261,0.999788918900505,6,80,phosphatidylinositol bisphosphate binding,MF,SYT5;ACTN2;FZD7;SNX18;SCIN;AKT1
7466,GO:0030510,0.00135520443867018,0.999788792610242,6,81,regulation of BMP signaling pathway,BP,ITGA3;NOTCH1;CRB2;FSTL3;WNT5A;BMP4
14922,GO:0060395,0.00136052821000482,0.999834321300866,5,56,SMAD protein signal transduction,BP,BMP7;BMP6;BMP4;BMP2;INHBB
5202,GO:0014045,0.00137437524189303,0.999985951777036,2,4,establishment of endothelial blood-brain barrier,BP,WNT7A;WNT7B
7079,GO:0022009,0.00137437524189303,0.999985951777036,2,4,central nervous system vasculogenesis,BP,WNT7A;WNT7B
16832,GO:0072075,0.00140453708308714,0.999936112354664,3,15,metanephric mesenchyme development,BP,WNT4;BMP7;WT1
10701,GO:0042181,0.00140935607123694,0.999879341181849,4,36,ketone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
14085,GO:0051447,0.00140961846357281,0.999934540555562,3,17,negative regulation of meiotic cell cycle,BP,LIF;PRKACB;NPPC
14942,GO:0060421,0.00141280034444496,0.999879787504834,4,33,positive regulation of heart growth,BP,WNT2;NOTCH1;EDN1;WT1
16974,GO:0072283,0.00141399298539633,0.999934856414922,3,16,metanephric renal vesicle morphogenesis,BP,LIF;BMP4;GDNF
8413,GO:0032345,0.00143203547472361,0.999985052428429,2,4,negative regulation of aldosterone metabolic process,BP,DKK3;BMP2
8416,GO:0032348,0.00143203547472361,0.999985052428429,2,4,negative regulation of aldosterone biosynthetic process,BP,DKK3;BMP2
20985,GO:2000065,0.00143203547472361,0.999985052428429,2,4,negative regulation of cortisol biosynthetic process,BP,DKK3;BMP2
9951,GO:0035625,0.00143312421600949,0.999985035265058,2,4,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C
14862,GO:0060323,0.00143440704027425,0.999877442706048,4,33,head morphogenesis,BP,WNT3;STRA6;CRISPLD2;CLDN5
16735,GO:0071883,0.00143480761153418,0.999985008714132,2,4,activation of MAPK activity by adrenergic receptor signaling pathway,BP,ADRA2B;ADRA2C
3810,GO:0007435,0.00143494363518191,0.999877087903308,4,34,salivary gland morphogenesis,BP,FGF10;FGF8;BMP7;LAMA5
21091,GO:2000269,0.00143528179419912,0.999934216602595,3,15,regulation of fibroblast apoptotic process,BP,PIK3CA;PIK3CG;GAS6
17162,GO:0072678,0.00144259418424047,0.999874586974315,4,41,T cell migration,BP,CCL20;WNT5A;MSN;PIK3CG
14211,GO:0051693,0.00144326149088328,0.999876478955916,4,33,actin filament capping,BP,SPTBN5;SPTBN4;SCIN;SPTB
13091,GO:0048048,0.00144807618787975,0.999876273700344,4,32,embryonic eye morphogenesis,BP,STRA6;WNT5A;AXIN1;BMP7
2976,GO:0006081,0.00144896526669205,0.99977026786329,6,90,cellular aldehyde metabolic process,BP,WNT4;GLDC;DKK3;KHK;BMP6;BMP2
18206,GO:0098858,0.00145597158606377,0.999647276398682,9,178,actin-based cell projection,CC,ITGA3;ACTN2;CDH23;TTYH1;ESPN;MSN;KITLG;MYO7A;ACTA2
1424,GO:0003104,0.00146598691281742,0.999984514063574,2,4,positive regulation of glomerular filtration,BP,PDGFB;GAS6
8373,GO:0032272,0.00146743387481183,0.999817876436686,5,58,negative regulation of protein polymerization,BP,FHOD3;SPTBN5;SPTBN4;SCIN;SPTB
7976,GO:0031489,0.00148198538893119,0.999929962568229,3,17,myosin V binding,MF,RAB27A;RAB39B;RAB3D
18706,GO:1901186,0.00150154040412885,0.999869208192823,4,36,positive regulation of ERBB signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;AKT1
5216,GO:0014060,0.00151410948443621,0.999981134630148,2,5,regulation of epinephrine secretion,BP,ADRA2B;ADRA2C
13150,GO:0048242,0.00151410948443621,0.999981134630148,2,5,epinephrine secretion,BP,ADRA2B;ADRA2C
8069,GO:0031667,0.00153235528005682,0.99947946952877,14,403,response to nutrient levels,BP,WNT4;PMAIP1;DSC2;FOXO4;RALB;NUAK2;BMP7;CDKN1A;AKT1;WNT2B;INHBB;GAS6;VDR;ACSL4
799,GO:0001977,0.00153364658529709,0.999926645312051,3,17,renal system process involved in regulation of blood volume,BP,ADORA1;PDGFB;GAS6
7379,GO:0030308,0.00154231357480258,0.999661390863106,8,155,negative regulation of cell growth,BP,WNT3;WNT5A;SESN2;NPR1;PSRC1;WT1;CDKN1A;SH3BP4
13318,GO:0048633,0.00156521061987353,0.999982904011035,2,4,positive regulation of skeletal muscle tissue growth,BP,ACTN3;DLL1
17377,GO:0090090,0.00158028574240703,0.999651395848403,8,161,negative regulation of canonical Wnt signaling pathway,BP,WNT4;NOTCH1;DKK3;CDH2;WNT5B;WNT5A;AXIN1;BMP2
14557,GO:0055001,0.00159803376370923,0.999647529572623,8,149,muscle cell development,BP,FHOD3;ACTN2;NOTCH1;CASQ2;EDN1;AXIN1;BMP4;MYH11
6717,GO:0019827,0.00160320612869976,0.999646268851035,8,148,stem cell population maintenance,BP,LIF;NOTCH1;WNT7A;FZD7;CDH2;FGF10;BMP7;DLL1
4247,GO:0008610,0.00160747656037979,0.999349191445073,19,628,lipid biosynthetic process,BP,WNT4;DHH;HMGCS2;DKK3;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;BMP6;BMP2;AKT1;PTGES;PIK3CA;PIK3CG;VDR
13887,GO:0051130,0.00160823372654924,0.999219098088683,29,1116,positive regulation of cellular component organization,BP,ITGA3;LIF;WNT3;WNT4;ACTN2;RAB27A;TF;PMAIP1;WNT7A;EDN1;MFGE8;PIK3R1;PDGFB;RALB;HRAS;WNT5A;RHOQ;SCIN;PSRC1;FGF8;SDC4;BMP7;DLL1;ESPN;MSN;CTGF;AKT1;CLDN1;GAS6
14568,GO:0055013,0.00165208626087082,0.999789176400184,5,59,cardiac muscle cell development,BP,FHOD3;ACTN2;EDN1;BMP4;MYH11
13906,GO:0051153,0.00165736200984355,0.99973018888573,6,90,regulation of striated muscle cell differentiation,BP,NOTCH1;EDN1;FZD7;BMP4;BMP2;EFNB2
1429,GO:0003129,0.00167195685821907,0.999978087630563,2,5,heart induction,BP,BMP4;BMP2
2661,GO:0005546,0.00167749953086847,0.999785567564939,5,57,phosphatidylinositol-4,5-bisphosphate binding,MF,SYT5;ACTN2;FZD7;SNX18;SCIN
12917,GO:0046983,0.00168169703814208,0.999191037501312,28,1157,protein dimerization activity,MF,ITGA3;ADRA2C;SYT5;ACTN3;ACTN2;NOTCH1;GLDC;GADD45A;ACVR1;ADORA1;CASQ2;TYRO3;PIK3R2;PIK3R1;PDGFB;KCNH2;JAM3;AXIN1;CLCF1;BMP6;BMP2;GJB1;TPD52;NPPC;MYO7A;INHBB;GDNF;HEY1
11623,GO:0044085,0.00169912243887986,0.998995211103867,57,2815,cellular component biogenesis,BP,ITGA5;FHOD3;WNT4;TUBG2;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;ITGB5;ITGB4;PMAIP1;WNT7A;CASQ2;EDN1;SPTBN5;SPTBN4;TTYH1;RAB39A;PRND;LIMS2;CDH2;PIK3R1;RALB;HRAS;WNT5A;AXIN1;RHOQ;SCIN;PSRC1;SDC4;SPTB;BMP7;RAB20;ESPN;VAMP1;CHGA;MSN;CTGF;GJB1;GJB2;PKP3;PKP1;RAB17;CDH1;MYO7A;TLE1;CLDN1;CLDN3;CLDN5;KCNG2;GAS6;MYH11;LAMA5;KCND1;RAB38;PARVB
3400,GO:0006704,0.00170671332807242,0.999915245900851,3,17,glucocorticoid biosynthetic process,BP,WNT4;DKK3;BMP2
7224,GO:0030098,0.00171094636694792,0.999468443522508,12,314,lymphocyte differentiation,BP,WNT4;ZFPM1;FZD7;TYRO3;PIK3R1;CLCF1;BMP4;DLL1;TPD52;JAG2;GAS6;FZD8
18132,GO:0098727,0.00175771630089202,0.99960633063695,8,150,maintenance of cell number,BP,LIF;NOTCH1;WNT7A;FZD7;CDH2;FGF10;BMP7;DLL1
13238,GO:0048471,0.00176046514393892,0.999281555377615,19,621,perinuclear region of cytoplasm,CC,ITGA3;SYT5;TF;RAB40B;PRKACB;PIK3R1;KCNH2;HRAS;AXIN1;CDKN1A;PKN3;CHGA;MSN;CTGF;GJB2;TPD52;PTGES;CDH1;INHBB
7600,GO:0030825,0.00177714958613217,0.999908080359143,3,21,positive regulation of cGMP metabolic process,BP,WNT5A;NPR1;NPPC
7331,GO:0030239,0.00179323667967439,0.999766846380321,5,59,myofibril assembly,BP,FHOD3;ACTN2;CASQ2;EDN1;MYH11
15440,GO:0061302,0.00180619611457792,0.99997537686877,2,5,smooth muscle cell-matrix adhesion,BP,PLAU;DDR1
18789,GO:1901380,0.00181376759204535,0.999907982735837,3,17,negative regulation of potassium ion transmembrane transport,BP,ACTN2;CASQ2;KCNH2
9769,GO:0035313,0.00181814983383732,0.999908507968168,3,16,wound healing, spreading of epidermal cells,BP,ITGA5;WNT7A;HBEGF
16544,GO:0071542,0.00182897890900202,0.99983151479179,4,37,dopaminergic neuron differentiation,BP,WNT3;WNT2;WNT5A;FGF8
11051,GO:0042802,0.0018379829930468,0.999067445630159,32,1331,identical protein binding,MF,ADRA2C;ACTN3;ACTN2;GADD45A;ACVR1;CASQ2;PDGFB;KCNH2;PLEKHH2;FOXO4;JAM3;AXIN1;GJB1;TPD52;AKT1;NPPC;NAB2;MYO7A;INHBB;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;SH3BP4;GDNF;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
1504,GO:0003231,0.00186628103292504,0.999630707246175,7,116,cardiac ventricle development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;WNT5A;BMP4;HEY1
4055,GO:0008286,0.00191829647740482,0.999618184545807,7,120,insulin receptor signaling pathway,BP,PIK3R2;PIK3R1;FOXO4;RHOQ;AKT1;BCAR1;PIK3CA
13790,GO:0050995,0.00192777801189304,0.999897961811723,3,20,negative regulation of lipid catabolic process,BP,ADORA1;AKT1;PIK3CG
19645,GO:1903524,0.00193074642104429,0.999743881880247,5,63,positive regulation of blood circulation,BP,ADRA2C;EDN1;CHGA;CTGF;AKT1
1418,GO:0003094,0.00197663625902413,0.999896638092502,3,17,glomerular filtration,BP,ADORA1;PDGFB;GAS6
13979,GO:0051261,0.001991044984883,0.999664165167647,6,88,protein depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
7796,GO:0031143,0.00199126463987771,0.999895602282616,3,17,pseudopodium,CC,ACTN3;ACTN2;MSN
19804,GO:1903829,0.00199359807028464,0.999334832518201,13,357,positive regulation of cellular protein localization,BP,ITGA3;LIF;PMAIP1;PRR5L;PIK3R2;PIK3R1;SESN2;BMP6;BMP4;MSN;AKT1;CDH1;GAS6
9958,GO:0035637,0.00200530427975209,0.999490204697976,9,190,multicellular organismal signaling,BP,DSC2;CASQ2;KCNK6;SPTBN4;KCNH2;JAM3;NPR1;NPPC;KCND1
21417,GO:2000727,0.00200724019341054,0.999893636119117,3,18,positive regulation of cardiac muscle cell differentiation,BP,EDN1;BMP4;EFNB2
10229,GO:0036094,0.00201758903288837,0.998826198419416,51,2314,small molecule binding,MF,TUBG2;RAB6C;GLDC;MARK4;RAB27A;RASL11B;SERPINA5;ACVR1;GUCY1B3;ADORA1;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;SESN2;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;VDR;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
13179,GO:0048286,0.00203649160753206,0.99980716220837,4,36,lung alveolus development,BP,LIF;STRA6;FGF10;BMP4
7507,GO:0030593,0.00205529657325346,0.999720021608134,5,86,neutrophil chemotaxis,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
14563,GO:0055008,0.00205548921417756,0.999723605115631,5,62,cardiac muscle tissue morphogenesis,BP,WNT2;NOTCH1;ZFPM1;WNT5A;BMP2
9970,GO:0035655,0.00206714429141468,0.999969808307276,2,5,interleukin-18-mediated signaling pathway,BP,PDGFB;AKT1
17575,GO:0090382,0.00207333432590641,0.999800937891316,4,41,phagosome maturation,BP,RAB39A;RAB20;MYO7A;RAB38
12382,GO:0045843,0.00207348995990946,0.999801919693079,4,38,negative regulation of striated muscle tissue development,BP,FZD7;FGF8;BMP4;BMP2
3809,GO:0007431,0.0020861978664763,0.999800370336842,4,38,salivary gland development,BP,FGF10;FGF8;BMP7;LAMA5
8828,GO:0032924,0.00209375249053933,0.999799092312933,4,39,activin receptor signaling pathway,BP,ACVR1;FSTL3;FGF10;INHBB
17439,GO:0090185,0.00209418786506316,0.999887357814644,3,18,negative regulation of kidney development,BP,BMP7;BMP4;WT1
9485,GO:0034504,0.00210345177849697,0.999293942152709,13,354,protein localization to nucleus,BP,LIF;FZD7;PIK3R2;PIK3R1;SESN2;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6;CLDN18
7747,GO:0031076,0.0021117801581916,0.999798450589641,4,35,embryonic camera-type eye development,BP,STRA6;FGF10;WNT5A;BMP7
9376,GO:0034332,0.00212236866898201,0.999570616232603,7,114,adherens junction organization,BP,WNT4;ACTN3;ACTN2;CDH2;SDC4;CDH1;LAMA5
6350,GO:0018105,0.00213834584879287,0.999357878939316,11,272,peptidyl-serine phosphorylation,BP,LIF;SPTBN4;MAPK12;PDGFB;WNT5A;AXIN1;PKN3;AKT1;PIK3CA;GAS6;ARAF
7343,GO:0030260,0.00215115924359602,0.999562668038954,7,124,entry into host cell,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
11785,GO:0044409,0.00215115924359602,0.999562668038954,7,124,entry into host,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
14274,GO:0051806,0.00215115924359602,0.999562668038954,7,124,entry into cell of other organism involved in symbiotic interaction,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
14281,GO:0051828,0.00215115924359602,0.999562668038954,7,124,entry into other organism involved in symbiotic interaction,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
10068,GO:0035812,0.00216516531425343,0.999879953191776,3,21,renal sodium excretion,BP,ADORA1;EDN1;NPR1
10069,GO:0035813,0.00216516531425343,0.999879953191776,3,21,regulation of renal sodium excretion,BP,ADORA1;EDN1;NPR1
14951,GO:0060431,0.00219687046512397,0.999966899134555,2,5,primary lung bud formation,BP,WNT2;WNT2B
9770,GO:0035315,0.00220050997223776,0.999786315265878,4,38,hair cell differentiation,BP,NOTCH1;DLL1;JAG2;MYO7A
13149,GO:0048241,0.00226085662801996,0.999962407332619,2,6,epinephrine transport,BP,ADRA2B;ADRA2C
12366,GO:0045822,0.0022635438980556,0.999873215905771,3,20,negative regulation of heart contraction,BP,ADORA1;SPTBN4;PIK3CG
18704,GO:1901184,0.00226451838423957,0.999607658258507,6,91,regulation of ERBB signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;HBEGF;AKT1;EPN1
20319,GO:1904948,0.00226996425463435,0.999874380728662,3,18,midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2;WNT5A
3787,GO:0007386,0.00227942296012594,0.999965000858245,2,5,compartment pattern specification,BP,NOTCH1;DLL1
15397,GO:0061156,0.00228378766867268,0.999964899490872,2,5,pulmonary artery morphogenesis,BP,STRA6;BMP4
13335,GO:0048663,0.00228620413877781,0.999684081293075,5,66,neuron fate commitment,BP,NOTCH1;AXIN1;BMP4;DLL1;JAG2
7394,GO:0030326,0.00228623856597678,0.999530376919852,7,122,embryonic limb morphogenesis,BP,WNT3;NOTCH1;WNT7A;WNT5A;FGF8;BMP7;BMP4
9692,GO:0035113,0.00228623856597678,0.999530376919852,7,122,embryonic appendage morphogenesis,BP,WNT3;NOTCH1;WNT7A;WNT5A;FGF8;BMP7;BMP4
11814,GO:0044449,0.00229869514393238,0.999402922094801,9,203,contractile fiber part,CC,FHOD3;ACTN2;CASQ2;SDC4;MYH11;MYZAP;ACTA2;PARVB;PDE4B
4679,GO:0009912,0.00230877987285438,0.999961196586837,2,6,auditory receptor cell fate commitment,BP,NOTCH1;JAG2
14726,GO:0060120,0.00230877987285438,0.999961196586837,2,6,inner ear receptor cell fate commitment,BP,NOTCH1;JAG2
656,GO:0001786,0.00232043054169708,0.999771775309232,4,37,phosphatidylserine binding,MF,SYT5;MFGE8;SCIN;GAS6
4950,GO:0010720,0.00232635631024519,0.999139514653646,15,437,positive regulation of cell development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;EDN1;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;CLDN5
13155,GO:0048247,0.00232794020368343,0.999765372786311,4,56,lymphocyte chemotaxis,BP,CCL20;WNT5A;PIK3CG;GAS6
6641,GO:0019538,0.00233019782027594,0.998486249778031,94,5268,protein metabolic process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN15;TSPAN17;MARK4;PMAIP1;GADD45A;CRB2;RHBDL3;FBXO41;DHH;SERPINA5;WNT7A;WNT7B;ZFPM1;ACVR1;NMT2;ADORA1;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;DLL1;PKN3;WNK4;MSN;DDR1;CTGF;AKT1;RAB12;NRTN;KITLG;CST9L;JAG2;INHBB;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;PM20D2;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;RNF144A;PIM2
13452,GO:0048871,0.00233959541975495,0.999244983676825,12,320,multicellular organismal homeostasis,BP,CDH23;TF;ADORA1;PRKACB;PRKAR1B;BMP6;DLL1;CTGF;CLDN1;PIK3CA;RAB3D;CLDN18
10499,GO:0038128,0.00234382344720969,0.999768402540094,4,38,ERBB2 signaling pathway,BP,PIK3R1;HRAS;HBEGF;PIK3CA
17007,GO:0072341,0.00234802821524943,0.999673326321079,5,67,modified amino acid binding,MF,SYT5;MFGE8;SCIN;PTGES;GAS6
3614,GO:0007043,0.00235212719311871,0.999589542084175,6,90,cell-cell junction assembly,BP,GJB1;GJB2;PKP3;CLDN1;CLDN3;CLDN5
7767,GO:0031099,0.00238050313152908,0.999438651580097,8,170,regeneration,BP,NOTCH1;WNT7A;FZD7;FGF10;JAM3;CDKN1A;CLDN1;GAS6
20467,GO:1905331,0.00239504147783838,0.999864922953777,3,18,negative regulation of morphogenesis of an epithelium,BP,WNT5A;BMP7;BMP4
20659,GO:1905940,0.00240413513471645,0.999962065422024,2,5,negative regulation of gonad development,BP,WNT4;WT1
12286,GO:0045662,0.00240552331487245,0.999861578874032,3,21,negative regulation of myoblast differentiation,BP,NOTCH1;BMP4;DLL1
8193,GO:0031944,0.00241739463688302,0.999961748602453,2,5,negative regulation of glucocorticoid metabolic process,BP,DKK3;BMP2
8196,GO:0031947,0.00241739463688302,0.999961748602453,2,5,negative regulation of glucocorticoid biosynthetic process,BP,DKK3;BMP2
8421,GO:0032353,0.00241739463688302,0.999961748602453,2,5,negative regulation of hormone biosynthetic process,BP,DKK3;BMP2
17341,GO:0090032,0.00241739463688302,0.999961748602453,2,5,negative regulation of steroid hormone biosynthetic process,BP,DKK3;BMP2
9950,GO:0035624,0.00241924239814198,0.999961704381073,2,5,receptor transactivation,BP,ADRA2B;ADRA2C
8933,GO:0033093,0.00242458459022361,0.999961576431446,2,5,Weibel-Palade body,CC,RAB27A;EDN1
13320,GO:0048635,0.00245854831811399,0.999752990704782,4,40,negative regulation of muscle organ development,BP,FZD7;FGF8;BMP4;BMP2
13518,GO:0050433,0.00246189830589988,0.999751103651416,4,44,regulation of catecholamine secretion,BP,ADRA2B;ADRA2C;CHGA;GDNF
11758,GO:0044346,0.00246495041179087,0.999859558367508,3,18,fibroblast apoptotic process,BP,PIK3CA;PIK3CG;GAS6
83,GO:0000166,0.00247259821478007,0.998581142809772,46,2024,nucleotide binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
18748,GO:1901265,0.00248495704259234,0.998573653755809,46,2025,nucleoside phosphate binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
18945,GO:1901862,0.00249607448263518,0.999748168109651,4,40,negative regulation of muscle tissue development,BP,FZD7;FGF8;BMP4;BMP2
1466,GO:0003176,0.00249950390533118,0.999956250299048,2,6,aortic valve development,BP,NOTCH1;BMP4
1469,GO:0003180,0.00249950390533118,0.999956250299048,2,6,aortic valve morphogenesis,BP,NOTCH1;BMP4
16941,GO:0072223,0.00250610405125716,0.999959605994955,2,5,metanephric glomerular mesangium development,BP,PDGFB;WT1
18318,GO:0099503,0.00251366842149616,0.998846267035681,23,905,secretory vesicle,CC,TMEM163;SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;SERPINA5;EDN1;PLAU;RAB40B;RAB40A;SYCN;FSTL3;PDGFB;VAMP1;CHGA;PKP1;NPPC;RAB44;GAS6;RAB3D;PDE4B
12782,GO:0046697,0.00251939189103164,0.999853444234671,3,20,decidualization,BP,LIF;GJB2;VDR
14628,GO:0055118,0.00252419558635328,0.99995916415147,2,5,negative regulation of cardiac muscle contraction,BP,ADORA1;PIK3CG
12242,GO:0045606,0.00253452358626338,0.99985225138029,3,20,positive regulation of epidermal cell differentiation,BP,NOTCH1;BMP4;VDR
9755,GO:0035282,0.00253624111171098,0.999549852342471,6,95,segmentation,BP,NOTCH1;CRB2;WNT5A;BMP4;WT1;DLL1
7226,GO:0030100,0.00255126286463473,0.999326929019019,9,204,regulation of endocytosis,BP,RAB27A;TF;MFGE8;WNT5A;DLL1;RAB20;RAB17;GAS6;UNC119
14346,GO:0051952,0.00259013610158333,0.999630504827938,5,71,regulation of amine transport,BP,ADRA2B;ADRA2C;ADORA1;CHGA;GDNF
1440,GO:0003143,0.00259284985671899,0.999631669058195,5,64,embryonic heart tube morphogenesis,BP,NOTCH1;ACVR1;WNT5A;FGF8;DLL1
7358,GO:0030282,0.00259970039377708,0.999536137709941,6,96,bone mineralization,BP,WNT4;ACVR1;BMP7;BMP6;BMP4;BMP2
15167,GO:0060745,0.0026224893443968,0.999956735045432,2,5,mammary gland branching involved in pregnancy,BP,WNT4;VDR
12592,GO:0046326,0.00264593300997547,0.999728706584376,4,40,positive regulation of glucose import,BP,PIK3R2;PIK3R1;RHOQ;AKT1
12431,GO:0045932,0.00265562881086318,0.999842612947364,3,20,negative regulation of muscle contraction,BP,ADRA2C;ADORA1;PIK3CG
16416,GO:0071351,0.00269475460156085,0.999950980825894,2,6,cellular response to interleukin-18,BP,PDGFB;AKT1
7130,GO:0022829,0.00270096351289823,0.999838078055789,3,21,wide pore channel activity,MF,GJB1;GJB2;GJA3
8786,GO:0032868,0.0027063875476577,0.999217639860245,10,244,response to insulin,BP,PIK3R2;PIK3R1;FOXO4;KHK;SESN2;RHOQ;AKT1;BCAR1;INHBB;PIK3CA
7102,GO:0022412,0.00274904715187841,0.999203045609671,10,254,cellular process involved in reproduction in multicellular organism,BP,WNT4;DHH;SERPINA5;ACVR1;JAM3;BMP4;WT1;AKT1;NPPC;INHBB
552,GO:0001618,0.00278194030758835,0.999598321578983,5,64,virus receptor activity,MF,ITGA5;ITGB5;TYRO3;CLDN1;EFNB2
7177,GO:0030001,0.00279283859908051,0.998731350229072,22,797,metal ion transport,BP,ACTN2;CDH23;TF;ADORA1;CASQ2;KCNK6;SPTBN4;TTYH1;TSPAN13;PDGFB;KCNH2;SFXN1;WNK4;CTGF;AKT1;PIK3CG;KCNG2;GAS6;VDR;KCND1;CLDN16;PDE4B
4128,GO:0008406,0.00286405195097508,0.999231052514379,9,207,gonad development,BP,WNT4;DHH;FSTL3;WNT5A;FGF8;WT1;WNT2B;KITLG;INHBB
11440,GO:0043507,0.00287124915187548,0.999582679886182,5,63,positive regulation of JUN kinase activity,BP,WNT7B;EDN1;WNT5A;AXIN1;FZD8
15447,GO:0061312,0.00287669866787083,0.999945889368244,2,6,BMP signaling pathway involved in heart development,BP,ACVR1;BMP4
4706,GO:0009991,0.00290270753110397,0.998941844862779,14,433,response to extracellular stimulus,BP,WNT4;PMAIP1;DSC2;FOXO4;RALB;NUAK2;BMP7;CDKN1A;AKT1;WNT2B;INHBB;GAS6;VDR;ACSL4
4948,GO:0010718,0.00291122686676227,0.999693998135388,4,39,positive regulation of epithelial to mesenchymal transition,BP,NOTCH1;CRB2;ACVR1;BMP2
15078,GO:0060602,0.00291224535764431,0.999821667782922,3,20,branch elongation of an epithelium,BP,FGF10;WNT5A;BMP4
7282,GO:0030175,0.00292815655014505,0.999465663069151,6,92,filopodium,CC,ITGA3;ACTN2;TTYH1;MSN;KITLG;ACTA2
3511,GO:0006887,0.00293755186334712,0.998659487180404,22,833,exocytosis,BP,SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;PLAU;RAB40B;RAB40A;SYCN;PDGFB;RALB;SCIN;SDC4;VAMP1;CHGA;PKP1;RAB44;PIK3CG;RAB11FIP1;GAS6;RAB3D
1202,GO:0002682,0.0029573100865902,0.998482890576873,30,1306,regulation of immune system process,BP,LIF;NOTCH1;ZFPM1;ADORA1;EDN1;PRKACB;CCL20;TYRO3;FSTL3;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;JAM3;SCIN;SDC4;CLCF1;BMP4;CDKN1A;DLL1;MSN;AKT1;KITLG;BCAR1;PIK3CA;GAS6;CLDN18;EFNB2;PDE4B
3863,GO:0007605,0.00296952304015309,0.999359628774222,7,131,sensory perception of sound,BP,CDH23;SLC52A3;SPTBN4;ESPN;GJB2;GJB6;MYO7A
8856,GO:0032967,0.00297427741206853,0.999814583090959,3,22,positive regulation of collagen biosynthetic process,BP,WNT4;BMP4;CTGF
6777,GO:0019953,0.00297625676993236,0.998694949615556,20,747,sexual reproduction,BP,WNT3;WNT4;NOTCH1;IGSF8;DHH;SERPINA5;ACVR1;MFGE8;SPTBN4;TYRO3;FSTL3;JAM3;BMP4;WT1;SLC2A14;AKT1;NPPC;JAG2;INHBB;CLDN11
14947,GO:0060426,0.00298964226220821,0.999942643297511,2,6,lung vasculature development,BP,LIF;STRA6
4234,GO:0008584,0.0030100887748342,0.999349041752863,7,133,male gonad development,BP,WNT4;DHH;FSTL3;WNT5A;WT1;WNT2B;KITLG
12703,GO:0046546,0.0030100887748342,0.999349041752863,7,133,development of primary male sexual characteristics,BP,WNT4;DHH;FSTL3;WNT5A;WT1;WNT2B;KITLG
3753,GO:0007281,0.00302312127829808,0.999181035652561,9,217,germ cell development,BP,WNT4;DHH;ACVR1;JAM3;BMP4;WT1;AKT1;NPPC;INHBB
7463,GO:0030506,0.00308110864538814,0.999808686460455,3,19,ankyrin binding,MF,SPTBN4;SPTB;CDH1
15144,GO:0060716,0.00308564179051486,0.999807129532823,3,20,labyrinthine layer blood vessel development,BP,WNT2;AKT1;HEY1
15325,GO:0061038,0.00309765620905541,0.999939478943419,2,6,uterus morphogenesis,BP,STRA6;WNT7A
4944,GO:0010714,0.00309947681599394,0.999803053839711,3,23,positive regulation of collagen metabolic process,BP,WNT4;BMP4;CTGF
11690,GO:0044253,0.00309947681599394,0.999803053839711,3,23,positive regulation of multicellular organismal metabolic process,BP,WNT4;BMP4;CTGF
8419,GO:0032351,0.00310611506666363,0.99993922868814,2,6,negative regulation of hormone metabolic process,BP,DKK3;BMP2
14232,GO:0051726,0.00311023977352789,0.998499809884478,25,969,regulation of cell cycle,BP,LIF;WNT4;RAB6C;GADD45A;EDN1;PRKACB;MAPK12;FGF10;PDGFB;FOXO4;HRAS;WNT5A;RHOB;PSRC1;FGF8;BMP7;BMP4;BMP2;CDKN1A;HMGN5;CTGF;AKT1;NPPC;GAS6;PIM2
4856,GO:0010564,0.0031203430360814,0.998727779781293,17,568,regulation of cell cycle process,BP,LIF;WNT4;RAB6C;GADD45A;EDN1;FGF10;PDGFB;FOXO4;WNT5A;PSRC1;FGF8;BMP7;BMP4;CDKN1A;HMGN5;CTGF;AKT1
12427,GO:0045926,0.00312370709975739,0.999149552374787,9,218,negative regulation of growth,BP,WNT3;WNT5A;SESN2;NPR1;PSRC1;BMP4;WT1;CDKN1A;SH3BP4
14693,GO:0060065,0.00315401849776677,0.999801313972595,3,20,uterus development,BP,STRA6;WNT7A;WNT5A
4704,GO:0009987,0.0031860669291028,0.998285579782049,216,14598,cellular process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;FBXO41;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;PTGES;KITLG;SEMA6C;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;MYH11;LZTS1;PM20D2;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
12816,GO:0046822,0.00319237391694521,0.999128925970468,9,206,regulation of nucleocytoplasmic transport,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CDH1;GAS6
8919,GO:0033077,0.00321755467935176,0.999518196758877,5,68,T cell differentiation in thymus,BP,WNT4;FZD7;BMP4;JAG2;FZD8
2344,GO:0004936,0.00322554505069993,0.999935657870484,2,6,alpha-adrenergic receptor activity,MF,ADRA2B;ADRA2C
16469,GO:0071425,0.0032290774738075,0.999794877399841,3,20,hematopoietic stem cell proliferation,BP,WNT5A;WNT2B;KITLG
4674,GO:0009894,0.00324115188153956,0.998568327395507,20,723,regulation of catabolic process,BP,ACTN3;ADORA1;PRR5L;PIK3R2;RALB;WNT5A;SESN2;AXIN1;MSN;AKT1;PKP3;PKP1;RAB12;PIK3CA;PIK3CG;LZTS1;ARAF;SH3BP4;RNF144A;PIM2
11282,GO:0043235,0.00324749636296302,0.998909011482046,12,320,receptor complex,CC,ITGA3;ITGA5;NOTCH1;TF;ITGB5;ITGB4;ITGB8;ACVR1;NPR1;BMP2;DDR1;VDR
19897,GO:1904018,0.00324839013624613,0.999287543067097,7,135,positive regulation of vasculature development,BP,ITGA5;NOTCH1;PDGFB;WNT5A;RHOB;DLL1;EFNB2
1571,GO:0003348,0.00326316335407214,0.99993451874538,2,6,cardiac endothelial cell differentiation,BP,NOTCH1;ACVR1
15265,GO:0060956,0.00326316335407214,0.99993451874538,2,6,endocardial cell differentiation,BP,NOTCH1;ACVR1
14047,GO:0051384,0.00326619945874163,0.999281800988422,7,144,response to glucocorticoid,BP,WNT7B;EDN1;BMP6;CDKN1A;GJB2;CLDN1;HEY1
14043,GO:0051379,0.00329441144266913,0.999933567326314,2,6,epinephrine binding,MF,ADRA2B;ADRA2C
6384,GO:0018209,0.0032972078537775,0.998951736421801,11,288,peptidyl-serine modification,BP,LIF;SPTBN4;MAPK12;PDGFB;WNT5A;AXIN1;PKN3;AKT1;PIK3CA;GAS6;ARAF
5083,GO:0010894,0.00330728856039115,0.999786952117671,3,21,negative regulation of steroid biosynthetic process,BP,WNT4;DKK3;BMP2
12266,GO:0045637,0.00331916239903585,0.999172535436608,8,184,regulation of myeloid cell differentiation,BP,LIF;ZFPM1;FSTL3;PIK3R1;SCIN;DLL1;KITLG;CLDN18
3685,GO:0007179,0.00332908278688508,0.999171335698687,8,167,transforming growth factor beta receptor signaling pathway,BP,ITGA3;RASL11B;ITGB5;ACVR1;DKK3;CGN;PDGFB;CLDN5
15352,GO:0061082,0.00333310122526605,0.999783633486817,3,22,myeloid leukocyte cytokine production,BP,WNT5A;CHGA;GAS6
13517,GO:0050432,0.0033453170375317,0.999630398002979,4,47,catecholamine secretion,BP,ADRA2B;ADRA2C;CHGA;GDNF
12049,GO:0045137,0.00335515747641949,0.999077134921893,9,212,development of primary sexual characteristics,BP,WNT4;DHH;FSTL3;WNT5A;FGF8;WT1;WNT2B;KITLG;INHBB
20743,GO:1990266,0.00336155742656141,0.999485780913113,5,93,neutrophil migration,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
17970,GO:0097529,0.00337043973314404,0.999252727156829,7,162,myeloid leukocyte migration,BP,EDN1;CCL20;PDGFB;JAM3;CHGA;PIK3CG;PDE4B
16975,GO:0072284,0.00341285419968955,0.999929918669085,2,6,metanephric S-shaped body morphogenesis,BP,BMP4;WT1
4723,GO:0010038,0.00345498211299848,0.998893727923769,11,308,response to metal ion,BP,TF;CASQ2;EDN1;FSTL3;WNT5A;KHK;BMP6;AKT1;PTGES;CDH1;CLDN1
12243,GO:0045607,0.0034561137207541,0.999924608340584,2,7,regulation of auditory receptor cell differentiation,BP,NOTCH1;DLL1
12261,GO:0045631,0.0034561137207541,0.999924608340584,2,7,regulation of mechanoreceptor differentiation,BP,NOTCH1;DLL1
21527,GO:2000980,0.0034561137207541,0.999924608340584,2,7,regulation of inner ear receptor cell differentiation,BP,NOTCH1;DLL1
11619,GO:0044062,0.00348332094982634,0.999768348810199,3,24,regulation of excretion,BP,ADORA1;EDN1;NPR1
16728,GO:0071875,0.00350331461496523,0.99976965064369,3,21,adrenergic receptor signaling pathway,BP,ADRA2B;ADRA2C;CHGA
14035,GO:0051353,0.00350932365783873,0.999607068124958,4,47,positive regulation of oxidoreductase activity,BP,EDN1;AKT1;VDR;GDNF
15139,GO:0060710,0.0035372137318957,0.999926016434947,2,6,chorio-allantoic fusion,BP,WNT7B;BMP7
13842,GO:0051055,0.00356057448162392,0.999601179416502,4,44,negative regulation of lipid biosynthetic process,BP,WNT4;DKK3;PDGFB;BMP2
13333,GO:0048661,0.00356083960176368,0.999452772099494,5,72,positive regulation of smooth muscle cell proliferation,BP,EDN1;PDGFB;HBEGF;BMP4;AKT1
2452,GO:0005112,0.00356646817238924,0.999765284115947,3,20,Notch binding,MF,NOTCH1;DLL1;JAG2
10444,GO:0038031,0.00358632243545678,0.999924455612026,2,6,non-canonical Wnt signaling pathway via JNK cascade,BP,FZD7;WNT5A
15217,GO:0060839,0.00359385803994888,0.99992421512056,2,6,endothelial cell fate commitment,BP,ACVR1;DLL1
15970,GO:0070482,0.00360393337447899,0.998772073314394,12,349,response to oxygen levels,BP,NOTCH1;PMAIP1;ADORA1;EDN1;PLAU;BMP7;BMP2;CDKN1A;CTGF;AKT1;NPPC;CLDN3
17767,GO:0097150,0.0036355538468011,0.999759094878008,3,20,neuronal stem cell population maintenance,BP,NOTCH1;CDH2;DLL1
14602,GO:0055082,0.00363703278815605,0.998412977611331,19,690,cellular chemical homeostasis,BP,CDH23;TF;CASQ2;EDN1;RAB39A;PRND;LPAR2;PIK3R2;PIK3R1;SESN2;BMP6;RAB20;GJB6;PIK3CA;PIK3CG;GAS6;VDR;RAB38;CLDN16
21043,GO:2000181,0.00365229345572688,0.999435382700775,5,72,negative regulation of blood vessel morphogenesis,BP,WNT4;NOTCH1;FOXO4;NPR1;AMOT
11319,GO:0043292,0.00367512382833734,0.99897460632263,9,218,contractile fiber,CC,FHOD3;ACTN2;CASQ2;SDC4;MYH11;MYZAP;ACTA2;PARVB;PDE4B
1446,GO:0003151,0.00367701220659671,0.999431638687147,5,69,outflow tract morphogenesis,BP,ZFPM1;WNT5A;FGF8;BMP4;CLDN5
12885,GO:0046935,0.00368763056492751,0.999921200631488,2,6,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R2;PIK3R1
1265,GO:0002762,0.00368764637837703,0.999582877964103,4,44,negative regulation of myeloid leukocyte differentiation,BP,ZFPM1;FSTL3;PIK3R1;CLDN18
5027,GO:0010828,0.00369353826270253,0.999582024947496,4,44,positive regulation of glucose transport,BP,PIK3R2;PIK3R1;RHOQ;AKT1
8829,GO:0032925,0.00369387627370589,0.999750167524074,3,23,regulation of activin receptor signaling pathway,BP,ACVR1;FSTL3;FGF10
14969,GO:0060449,0.0037168733918089,0.999915832998432,2,7,bud elongation involved in lung branching,BP,FGF10;BMP4
17577,GO:0090385,0.00372563429239838,0.999915532457291,2,7,phagosome-lysosome fusion,BP,RAB39A;RAB20
7671,GO:0030916,0.00372825965537894,0.999912187336331,2,8,otic vesicle formation,BP,FGF10;FGF8
18425,GO:0120025,0.00376567034096789,0.997891803266484,38,1661,plasma membrane bounded cell projection,CC,ITGA3;ITGA5;ADRA2C;SYT5;ACTN3;ACTN2;MARK4;RAB27A;CDH23;ADORA1;PRKACB;SPTBN5;SPTBN4;TTYH1;RAB39B;CDH2;FSTL3;PRKAR1B;PLEKHH2;DRP2;ESPN;VAMP1;MSN;GJB2;AKT1;RAB17;NRTN;KITLG;CDH1;MYO7A;BCAR1;PIK3CA;LZTS1;AMOT;KCND1;ACTA2;PARVB;PDE4B
843,GO:0002040,0.00376645223827324,0.999415251190781,5,67,sprouting angiogenesis,BP,ITGA5;NOTCH1;BMP4;DLL1;EFNB2
12461,GO:0045988,0.00377580686043948,0.999918329467828,2,6,negative regulation of striated muscle contraction,BP,ADORA1;PIK3CG
10658,GO:0042110,0.00377727674148955,0.998581369670073,14,446,T cell activation,BP,WNT4;RAB27A;ZFPM1;FZD7;PIK3R1;SDC4;BMP4;MSN;AKT1;JAG2;PIK3CA;PIK3CG;FZD8;EFNB2
4001,GO:0008201,0.00379004583275184,0.999143493998702,7,147,heparin binding,MF,CRISPLD2;SERPINA5;FGF10;HBEGF;BMP7;BMP4;CTGF
13316,GO:0048631,0.00380594325477417,0.999917340120237,2,6,regulation of skeletal muscle tissue growth,BP,ACTN3;DLL1
12093,GO:0045214,0.003809677839593,0.999565714533589,4,43,sarcomere organization,BP,FHOD3;ACTN2;CASQ2;EDN1
4220,GO:0008543,0.00384682264851274,0.999254799250416,6,106,fibroblast growth factor receptor signaling pathway,BP,WNT4;FGF10;FGF17;WNT5A;FGF8;CTGF
3752,GO:0007276,0.00386047432412262,0.998391506164589,17,603,gamete generation,BP,WNT3;WNT4;NOTCH1;DHH;SERPINA5;ACVR1;TYRO3;FSTL3;JAM3;BMP4;WT1;SLC2A14;AKT1;NPPC;JAG2;INHBB;CLDN11
21079,GO:2000243,0.00386621765543726,0.99955522767173,4,47,positive regulation of reproductive process,BP,WNT4;WNT5A;WT1;INHBB
2447,GO:0005104,0.00389110101900049,0.999728909723346,3,26,fibroblast growth factor receptor binding,MF,FGF10;FGF17;FGF8
15116,GO:0060684,0.00390535037385798,0.999909286928258,2,7,epithelial-mesenchymal cell signaling,BP,WNT6;BMP4
7313,GO:0030216,0.00392264214548336,0.998889990384225,9,287,keratinocyte differentiation,BP,POU3F1;NOTCH1;DSC2;WNT5A;DSG3;PKP3;PKP1;DSC3;VDR
4937,GO:0010700,0.00394198988292872,0.999907994978204,2,7,negative regulation of norepinephrine secretion,BP,ADRA2B;ADRA2C
4009,GO:0008211,0.00395796872176719,0.999724519920686,3,24,glucocorticoid metabolic process,BP,WNT4;DKK3;BMP2
17328,GO:0090003,0.00400115949688606,0.999536955533655,4,44,regulation of establishment of protein localization to plasma membrane,BP,ITGA3;PIK3R1;RHOQ;AKT1
8407,GO:0032330,0.00402415260319172,0.99953417016724,4,43,regulation of chondrocyte differentiation,BP,SCIN;BMP6;BMP4;CTGF
18174,GO:0098802,0.00402500371279331,0.998966060957238,8,169,plasma membrane receptor complex,CC,ITGA3;ITGA5;TF;ITGB5;ITGB4;ITGB8;ACVR1;BMP2
18723,GO:1901215,0.00402649572714785,0.998964610834003,8,177,negative regulation of neuron death,BP,TYRO3;HRAS;FGF8;CLCF1;CHGA;AKT1;PIK3CA;GDNF
14320,GO:0051904,0.00403704071263969,0.999718162121021,3,23,pigment granule transport,BP,RAB27A;RAB17;MYO7A
15423,GO:0061213,0.00404505750866627,0.999718651457201,3,22,positive regulation of mesonephros development,BP,WT1;WNT2B;GDNF
12267,GO:0045638,0.0040657936947622,0.999351627877237,5,85,negative regulation of myeloid cell differentiation,BP,ZFPM1;FSTL3;PIK3R1;DLL1;CLDN18
11307,GO:0043269,0.00406596022110356,0.998297626049221,17,582,regulation of ion transport,BP,ACTN2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;TTYH1;TSPAN13;PDGFB;KCNH2;WNK4;AKT1;PIK3CG;KCNG2;KCND1;GDNF;PDE4B
15070,GO:0060592,0.00406625532088287,0.999903566833066,2,7,mammary gland formation,BP,FGF10;BMP4
13644,GO:0050767,0.00407510900367035,0.998203844935048,19,647,regulation of neurogenesis,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;CDH2;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;LZTS1
5183,GO:0014015,0.00412641874549322,0.999517110069206,4,46,positive regulation of gliogenesis,BP,LIF;NOTCH1;CLCF1;BMP2
16895,GO:0072170,0.00413299502101029,0.999710316261374,3,22,metanephric tubule development,BP,LIF;WNT4;WNT7B
14950,GO:0060430,0.00415426894848825,0.999900387552776,2,7,lung saccule development,BP,STRA6;FGF10
8062,GO:0031659,0.00415628622664942,0.999900314269283,2,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,FGF10;AKT1
14938,GO:0060415,0.00416385683515156,0.999335865315745,5,73,muscle tissue morphogenesis,BP,WNT2;NOTCH1;ZFPM1;WNT5A;BMP2
8922,GO:0033080,0.00418116195021232,0.999899409067182,2,7,immature T cell proliferation in thymus,BP,WNT4;BMP4
11429,GO:0043491,0.00419980386978579,0.999033473027452,7,144,protein kinase B signaling,BP,TYRO3;SESN2;HBEGF;AKT1;PIK3CA;PIK3CG;GAS6
5635,GO:0015837,0.00421264134050319,0.999324276298248,5,79,amine transport,BP,ADRA2B;ADRA2C;ADORA1;CHGA;GDNF
21095,GO:2000273,0.00422054257123075,0.999502958397923,4,46,positive regulation of receptor activity,BP,ADRA2B;ADRA2C;ACTN2;ADORA1
14727,GO:0060122,0.00425900907536278,0.999695698878306,3,24,inner ear receptor stereocilium organization,BP,CDH23;SDC4;MYO7A
6371,GO:0018193,0.00426351989447312,0.997805847709099,28,1149,peptidyl-amino acid modification,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACVR1;NMT2;ADORA1;SPTBN4;MAPK12;TYRO3;FGF10;FGF17;PDGFB;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP7;PKN3;DDR1;AKT1;KITLG;PIK3CA;GAS6;ARAF;UNC119;RAB3D
12082,GO:0045198,0.00428305198384024,0.999895672200457,2,7,establishment of epithelial cell apical/basal polarity,BP,WNT5A;MSN
12438,GO:0045939,0.0043269366043782,0.999690338446241,3,23,negative regulation of steroid metabolic process,BP,WNT4;DKK3;BMP2
14579,GO:0055026,0.00434611609633436,0.999688473036386,3,23,negative regulation of cardiac muscle tissue development,BP,FZD7;FGF8;BMP2
19344,GO:1902904,0.00434801179529497,0.999136630573856,6,105,negative regulation of supramolecular fiber organization,BP,FHOD3;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
3616,GO:0007045,0.00435277865809299,0.99930001872197,5,69,cell-substrate adherens junction assembly,BP,WNT4;ACTN3;ACTN2;SDC4;LAMA5
13090,GO:0048041,0.00435277865809299,0.99930001872197,5,69,focal adhesion assembly,BP,WNT4;ACTN3;ACTN2;SDC4;LAMA5
14109,GO:0051495,0.00438481767334535,0.998855800053777,8,182,positive regulation of cytoskeleton organization,BP,WNT4;ACTN2;EDN1;HRAS;SCIN;PSRC1;SDC4;CTGF
20418,GO:1905209,0.00440579005458845,0.999682649919096,3,23,positive regulation of cardiocyte differentiation,BP,EDN1;BMP4;EFNB2
14590,GO:0055067,0.00441447706304211,0.998975120020566,7,142,monovalent inorganic cation homeostasis,BP,ADORA1;EDN1;RAB39A;KCNH2;NPR1;RAB20;RAB38
12240,GO:0045604,0.00443138953494379,0.999469727237777,4,48,regulation of epidermal cell differentiation,BP,NOTCH1;BMP4;DLL1;VDR
17443,GO:0090189,0.00445656980486495,0.99967767198044,3,23,regulation of branching involved in ureteric bud morphogenesis,BP,BMP4;WNT2B;GDNF
3837,GO:0007530,0.00445972002358473,0.999677362479326,3,23,sex determination,BP,WNT4;DHH;WT1
1409,GO:0003071,0.00448243623021541,0.999673820039976,3,24,renal system process involved in regulation of systemic arterial blood pressure,BP,ADORA1;PDGFB;GAS6
14884,GO:0060348,0.00449413367077262,0.998823539359316,8,174,bone development,BP,ZFPM1;FGF8;BMP6;BMP4;BMP2;NPPC;NAB2;CLDN18
13453,GO:0048872,0.00454390744075377,0.998689872476441,9,225,homeostasis of number of cells,BP,PMAIP1;ZFPM1;CDH2;JAM3;BMP4;SFXN1;AKT1;KITLG;PDE4B
17576,GO:0090383,0.00459407911769999,0.999659304016925,3,27,phagosome acidification,BP,RAB39A;RAB20;RAB38
18960,GO:1901897,0.00459838483541374,0.999883814482342,2,7,regulation of relaxation of cardiac muscle,BP,CHGA;PDE4B
1564,GO:0003339,0.00460806969219779,0.999878966513635,2,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF;GDNF
5133,GO:0010959,0.00460932130605622,0.99846629026631,11,313,regulation of metal ion transport,BP,ACTN2;ADORA1;CASQ2;SPTBN4;TSPAN13;PDGFB;KCNH2;WNK4;AKT1;PIK3CG;PDE4B
1146,GO:0002573,0.00464974659378029,0.998774389162672,8,185,myeloid leukocyte differentiation,BP,LIF;ZFPM1;FSTL3;PIK3R1;BMP4;KITLG;TSPAN2;CLDN18
14321,GO:0051905,0.00465626848739243,0.999656519104904,3,24,establishment of pigment granule localization,BP,RAB27A;RAB17;MYO7A
13759,GO:0050921,0.00466090844999255,0.99905683652099,6,125,positive regulation of chemotaxis,BP,ARTN;EDN1;FGF10;PDGFB;WNT5A;GAS6
1264,GO:0002761,0.00471374881511668,0.999047112532791,6,110,regulation of myeloid leukocyte differentiation,BP,LIF;ZFPM1;FSTL3;PIK3R1;KITLG;CLDN18
9663,GO:0035050,0.00471965469220993,0.999224271970668,5,74,embryonic heart tube development,BP,NOTCH1;ACVR1;WNT5A;FGF8;DLL1
12350,GO:0045786,0.00473374956018226,0.998045195888605,16,544,negative regulation of cell cycle,BP,LIF;GADD45A;PRKACB;MAPK12;FGF10;FOXO4;HRAS;RHOB;BMP7;BMP4;BMP2;CDKN1A;HMGN5;AKT1;NPPC;GAS6
12589,GO:0046323,0.00473819835461363,0.999220502793792,5,74,glucose import,BP,PIK3R2;PIK3R1;SESN2;RHOQ;AKT1
15441,GO:0061303,0.00476063450160945,0.999872842495276,2,8,cornea development in camera-type eye,BP,WNT6;WNT2B
4688,GO:0009948,0.00480805862165397,0.999410063043386,4,50,anterior/posterior axis specification,BP,WNT3;WNT5A;BMP4;WT1
21179,GO:2000377,0.0048384715767417,0.998856229662581,7,150,regulation of reactive oxygen species metabolic process,BP,RAB27A;GADD45A;EDN1;PDGFB;BMP7;CDKN1A;AKT1
9749,GO:0035272,0.00484856960836223,0.999404915880792,4,48,exocrine system development,BP,FGF10;FGF8;BMP7;LAMA5
13575,GO:0050674,0.00485306451334502,1,1,1,urothelial cell proliferation,BP,FGF10
13576,GO:0050675,0.00485306451334502,1,1,1,regulation of urothelial cell proliferation,BP,FGF10
13577,GO:0050677,0.00485306451334502,1,1,1,positive regulation of urothelial cell proliferation,BP,FGF10
14952,GO:0060432,0.00485306451334502,1,1,1,lung pattern specification process,BP,FGF10
14956,GO:0060436,0.00485306451334502,1,1,1,bronchiole morphogenesis,BP,FGF10
15003,GO:0060495,0.00485306451334502,1,1,1,cell-cell signaling involved in lung development,BP,FGF10
15004,GO:0060496,0.00485306451334502,1,1,1,mesenchymal-epithelial cell signaling involved in lung development,BP,FGF10
15234,GO:0060879,0.00485306451334502,1,1,1,semicircular canal fusion,BP,FGF10
15377,GO:0061115,0.00485306451334502,1,1,1,lung proximal/distal axis specification,BP,FGF10
11460,GO:0043534,0.00485646498459413,0.999195582370621,5,76,blood vessel endothelial cell migration,BP,NOTCH1;PDGFB;AKT1;AMOT;EFNB2
19738,GO:1903706,0.00485936312607944,0.998370933136387,11,323,regulation of hemopoiesis,BP,LIF;NOTCH1;ZFPM1;FSTL3;PIK3R1;SCIN;BMP4;DLL1;KITLG;GAS6;CLDN18
13646,GO:0050769,0.00486882357342021,0.998195088731412,13,378,positive regulation of neurogenesis,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2
13805,GO:0051015,0.00487732494943101,0.998847376384507,7,139,actin filament binding,MF,TAGLN;ACTN2;SCIN;SPTB;ESPN;MYO7A;MYH11
15119,GO:0060687,0.00487777657137029,0.999872947235639,2,7,regulation of branching involved in prostate gland morphogenesis,BP,BMP7;BMP4
10756,GO:0042310,0.00488483723502202,0.999190570988599,5,74,vasoconstriction,BP,ADRA2B;ADRA2C;EDN1;AKT1;ACTA2
12794,GO:0046718,0.00489076285530452,0.999004063839497,6,109,viral entry into host cell,BP,ITGA5;ITGB5;TYRO3;CLDN1;GAS6;EFNB2
3083,GO:0006275,0.00489712294337047,0.999001997367643,6,111,regulation of DNA replication,BP,FGF10;PDGFB;HRAS;BMP6;BMP4;KITLG
13103,GO:0048103,0.00493197696280763,0.999631707304774,3,22,somatic stem cell division,BP,NOTCH1;WNT7A;FZD7
2892,GO:0005952,0.00497333105770587,0.999869154422534,2,7,cAMP-dependent protein kinase complex,CC,PRKACB;PRKAR1B
12359,GO:0045807,0.00497396666694844,0.99898283424011,6,112,positive regulation of endocytosis,BP,RAB27A;TF;MFGE8;WNT5A;DLL1;GAS6
19174,GO:1902473,0.00497560302860517,0.999869063775296,2,7,regulation of protein localization to synapse,BP,WNT7A;WNT5A
19175,GO:1902474,0.00497560302860517,0.999869063775296,2,7,positive regulation of protein localization to synapse,BP,WNT7A;WNT5A
13776,GO:0050957,0.00502585110889326,0.999867053458607,2,7,equilibrioception,BP,CDH23;MYO7A
2655,GO:0005539,0.00505759219247938,0.998647109023139,8,192,glycosaminoglycan binding,MF,CRISPLD2;SERPINA5;FGF10;HBEGF;BMP7;BMP4;CTGF;HAPLN3
16458,GO:0071407,0.00505981694192558,0.997896471614855,16,527,cellular response to organic cyclic compound,BP,CASQ2;EDN1;PDGFB;RALB;BMP7;BMP4;BMP2;WT1;MSN;GJB2;AKT1;CDH1;PIK3CG;VDR;HEY1;PDE4B
8914,GO:0033059,0.00506340021988108,0.999369594530959,4,50,cellular pigmentation,BP,RAB27A;RAB17;MYO7A;RAB38
7598,GO:0030823,0.00506920083364579,0.999609452097922,3,28,regulation of cGMP metabolic process,BP,WNT5A;NPR1;NPPC
9643,GO:0035014,0.00510703227704084,0.999863783366422,2,7,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R2;PIK3R1
4749,GO:0010171,0.00513927646772895,0.999360223433246,4,46,body morphogenesis,BP,WNT3;STRA6;CRISPLD2;CLDN5
7249,GO:0030133,0.00517299365697402,0.99815476216448,12,361,transport vesicle,CC,TMEM163;SYT5;RAB27A;CRISPLD2;EDN1;RAB40B;RAB40A;SYCN;VAMP1;CHGA;RAB3D;PDE4B
10904,GO:0042552,0.00522258075103889,0.99892257669915,6,107,myelination,BP,POU3F1;DHH;JAM3;AKT1;NAB2;TSPAN2
16819,GO:0072050,0.00522473532508867,0.999853585523334,2,8,S-shaped body morphogenesis,BP,BMP4;WT1
13774,GO:0050954,0.00531004198492387,0.998723869029312,7,146,sensory perception of mechanical stimulus,BP,CDH23;SLC52A3;SPTBN4;ESPN;GJB2;GJB6;MYO7A
4266,GO:0008643,0.00539185084267284,0.998543795504536,8,181,carbohydrate transport,BP,SLC45A4;EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;SLC2A14;AKT1
14651,GO:0060019,0.00540943794362252,0.999841308021769,2,9,radial glial cell differentiation,BP,CDH2;FGF10
9642,GO:0035005,0.00541813388553245,0.999851001011136,2,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,PIK3CA;PIK3CG
14863,GO:0060324,0.00544547036665059,0.999310909701194,4,46,face development,BP,STRA6;CRISPLD2;WNT5A;CLDN5
11305,GO:0043267,0.00546076562925233,0.999571871080612,3,25,negative regulation of potassium ion transport,BP,ACTN2;CASQ2;KCNH2
10717,GO:0042246,0.0054868275504809,0.999299231696747,4,53,tissue regeneration,BP,NOTCH1;WNT7A;FZD7;FGF10
16599,GO:0071621,0.00549231413216659,0.999053992859284,5,105,granulocyte chemotaxis,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
15251,GO:0060923,0.00549658972849303,0.999841878254912,2,8,cardiac muscle cell fate commitment,BP,ACVR1;WT1
5832,GO:0016242,0.00553014473771819,0.999566043593813,3,24,negative regulation of macroautophagy,BP,AKT1;PIK3CA;LZTS1
15870,GO:0070316,0.00558991210562617,0.999837788334455,2,8,regulation of G0 to G1 transition,BP,FOXO4;CTGF
21403,GO:2000698,0.00559084007351936,0.999837747485114,2,8,positive regulation of epithelial cell differentiation involved in kidney development,BP,LIF;GDNF
13789,GO:0050994,0.00559514181342149,0.999280814887625,4,54,regulation of lipid catabolic process,BP,ADORA1;SESN2;AKT1;PIK3CG
13302,GO:0048596,0.0056067186713316,0.999559613139315,3,23,embryonic camera-type eye morphogenesis,BP,STRA6;WNT5A;BMP7
12234,GO:0045598,0.00561281554905287,0.998823779248431,6,110,regulation of fat cell differentiation,BP,ZFPM1;WNT5B;WNT5A;AXIN1;BMP2;AKT1
14134,GO:0051549,0.00561837149483693,0.999836533934671,2,8,positive regulation of keratinocyte migration,BP,FGF10;HBEGF
9388,GO:0034350,0.00564699698036802,0.999835268858128,2,8,regulation of glial cell apoptotic process,BP,DLL1;GAS6
9389,GO:0034351,0.00564699698036802,0.999835268858128,2,8,negative regulation of glial cell apoptotic process,BP,DLL1;GAS6
7887,GO:0031329,0.0056551002269964,0.99755084779517,17,606,regulation of cellular catabolic process,BP,PRR5L;PIK3R2;RALB;SESN2;AXIN1;MSN;AKT1;PKP3;PKP1;RAB12;PIK3CA;PIK3CG;LZTS1;ARAF;SH3BP4;RNF144A;PIM2
8060,GO:0031657,0.00568804135370068,0.999833449083506,2,8,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,FGF10;AKT1
7225,GO:0030099,0.00570820949554108,0.998043944452272,11,329,myeloid cell differentiation,BP,LIF;ZFPM1;FSTL3;PIK3R1;SCIN;BMP4;DLL1;SFXN1;KITLG;TSPAN2;CLDN18
4721,GO:0010035,0.00574204975939985,0.997736344477956,14,473,response to inorganic substance,BP,TF;GUCY1B3;CASQ2;EDN1;FSTL3;WNT5A;KHK;RHOB;BMP7;BMP6;AKT1;PTGES;CDH1;CLDN1
16886,GO:0072161,0.0057422558076814,0.999831034847235,2,8,mesenchymal cell differentiation involved in kidney development,BP,WNT4;BMP4
21533,GO:2001012,0.0057422558076814,0.999831034847235,2,8,mesenchymal cell differentiation involved in renal system development,BP,WNT4;BMP4
16923,GO:0072201,0.00575864622837565,0.999830302606152,2,8,negative regulation of mesenchymal cell proliferation,BP,WNT5A;BMP4
12295,GO:0045671,0.00580202529914911,0.999535070840053,3,25,negative regulation of osteoclast differentiation,BP,FSTL3;PIK3R1;CLDN18
10630,GO:0042058,0.00581370639545195,0.998994103236662,5,78,regulation of epidermal growth factor receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;AKT1;EPN1
3323,GO:0006606,0.00582207916762715,0.998121689211876,10,267,protein import into nucleus,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
11889,GO:0044744,0.00582207916762715,0.998121689211876,10,267,protein targeting to nucleus,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
11125,GO:0042995,0.0058670966741337,0.996597686808365,39,1762,cell projection,CC,ITGA3;ITGA5;ADRA2C;SYT5;ACTN3;ACTN2;MARK4;RAB27A;CDH23;ADORA1;PRKACB;SPTBN5;SPTBN4;TTYH1;RAB39B;CDH2;FSTL3;PRKAR1B;PLEKHH2;SCIN;DRP2;ESPN;VAMP1;MSN;GJB2;AKT1;RAB17;NRTN;KITLG;CDH1;MYO7A;BCAR1;PIK3CA;LZTS1;AMOT;KCND1;ACTA2;PARVB;PDE4B
13903,GO:0051150,0.00590351830155845,0.999523969359515,3,25,regulation of smooth muscle cell differentiation,BP,PDGFB;FOXO4;BMP4
14295,GO:0051875,0.0059610485304,0.999516030948112,3,26,pigment granule localization,BP,RAB27A;RAB17;MYO7A
14886,GO:0060350,0.00601604370245821,0.999215104972121,4,48,endochondral bone morphogenesis,BP,BMP6;BMP4;NPPC;NAB2
15029,GO:0060539,0.00605759469844512,0.999816757051489,2,8,diaphragm development,BP,STRA6;WT1
3579,GO:0006996,0.00607183237036611,0.996069763141024,66,3492,organelle organization,BP,FHOD3;LIF;SYT5;WNT4;TUBG2;ACTN2;RAB6C;NOTCH1;MARK4;RAB27A;ITGB5;PMAIP1;GADD45A;ZFPM1;CASQ2;EDN1;SPTBN5;SPTBN4;TTYH1;RAB39A;CDH2;FGF10;PIK3R1;REEP1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;PSTPIP2;SNX18;SESN2;AXIN1;RHOQ;RHOJ;NUAK2;SCIN;PSRC1;FGF8;SDC4;SPTB;BMP7;BMP4;CAMSAP3;DAAM2;HMGN5;RAB20;ESPN;VAMP1;RND3;CHGA;MSN;CTGF;AKT1;PKP1;RAB17;MYO7A;BCAR1;SIN3B;MYH11;AMOT;LAMA5;RAB38;PIM2;PARVB
646,GO:0001776,0.00607786976863709,0.998934945789568,5,83,leukocyte homeostasis,BP,PMAIP1;JAM3;AKT1;KITLG;PDE4B
18811,GO:1901522,0.00608129602628516,0.999502696205678,3,26,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,NOTCH1;SESN2;BMP2
19032,GO:1902106,0.00611005582693113,0.998927535445072,5,84,negative regulation of leukocyte differentiation,BP,ZFPM1;FSTL3;PIK3R1;BMP4;CLDN18
4903,GO:0010639,0.00611361751434473,0.997886984371734,11,311,negative regulation of organelle organization,BP,FHOD3;LIF;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB;BMP7;BMP4;ESPN;AKT1
9032,GO:0033278,0.00612893033775984,0.99981347205604,2,8,cell proliferation in midbrain,BP,WNT2;WNT5A
3917,GO:0008064,0.00621599040344398,0.998460569955848,7,152,regulation of actin polymerization or depolymerization,BP,FHOD3;ACTN2;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
3683,GO:0007176,0.00622824309893109,0.999487979753905,3,25,regulation of epidermal growth factor-activated receptor activity,BP,ADRA2B;ADRA2C;ADORA1
13315,GO:0048630,0.00623774796357227,0.999808422351536,2,8,skeletal muscle tissue growth,BP,ACTN3;DLL1
14356,GO:0051962,0.00624671696214844,0.997515421265691,14,434,positive regulation of nervous system development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2
19233,GO:1902593,0.00629121399299438,0.997947087535031,10,270,single-organism nuclear import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
16950,GO:0072239,0.00632177483991067,0.999804491308416,2,8,metanephric glomerulus vasculature development,BP,PDGFB;WT1
10846,GO:0042471,0.00632699561063859,0.998639101491966,6,115,ear morphogenesis,BP,EDN1;FGF10;WNT5A;FGF8;GJB6;MYO7A
5592,GO:0015758,0.00633857362488777,0.998425415789224,7,148,glucose transport,BP,EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;SLC2A14;AKT1
14600,GO:0055080,0.00634629033539849,0.997217988383995,17,624,cation homeostasis,BP,CDH23;TF;ADORA1;CASQ2;EDN1;RAB39A;PRND;LPAR2;KCNH2;NPR1;BMP6;RAB20;SFXN1;PIK3CG;VDR;RAB38;CLDN16
13431,GO:0048843,0.00636444467016737,0.99980248454304,2,8,negative regulation of axon extension involved in axon guidance,BP,WNT3;WNT5A
13616,GO:0050719,0.00642323925602387,1,1,1,interleukin-1 alpha biosynthetic process,BP,CCL20
13618,GO:0050721,0.00642323925602387,1,1,1,regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
13621,GO:0050726,0.00642323925602387,1,1,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
11825,GO:0044464,0.00645098966946101,0.996785989242809,225,15425,cell part,CC,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;FBXO41;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;LGALS4;BMP6;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;PM20D2;SHC4;SLC18B1;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
14696,GO:0060068,0.00645395697806858,0.999792569140798,2,9,vagina development,BP,TYRO3;WNT5A
7604,GO:0030832,0.00647291017950608,0.998384587503381,7,153,regulation of actin filament length,BP,FHOD3;ACTN2;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
16927,GO:0072205,0.00659166898727829,0.999791679640957,2,8,metanephric collecting duct development,BP,WNT7B;BMP4
19146,GO:1902373,0.00660454625803009,0.999791061368314,2,8,negative regulation of mRNA catabolic process,BP,PKP3;PKP1
1411,GO:0003073,0.00661800353964037,0.998815999502291,5,84,regulation of systemic arterial blood pressure,BP,ADORA1;EDN1;KCNK6;PDGFB;GAS6
14941,GO:0060420,0.0066263143191184,0.999108683739487,4,51,regulation of heart growth,BP,WNT2;NOTCH1;EDN1;WT1
8830,GO:0032926,0.00669230599700325,0.999780829546684,2,9,negative regulation of activin receptor signaling pathway,BP,ACVR1;FSTL3
3676,GO:0007168,0.00671293885185969,0.999775043157401,2,10,receptor guanylyl cyclase signaling pathway,BP,NPR1;NPPC
12818,GO:0046824,0.00674926167527289,0.99852891715001,6,114,positive regulation of nucleocytoplasmic transport,BP,PIK3R2;PIK3R1;BMP6;BMP4;CDH1;GAS6
8854,GO:0032965,0.0067514751910097,0.999421718241751,3,29,regulation of collagen biosynthetic process,BP,WNT4;BMP4;CTGF
3551,GO:0006950,0.00680421212324629,0.995591179190493,64,3506,response to stress,BP,ITGA5;ADRA2B;ADRA2C;WNT4;NOTCH1;RAB27A;ITGB4;PMAIP1;GADD45A;DSC2;SERPINA5;WNT7A;WNT7B;ZFPM1;SLC52A3;ACVR1;GUCY1B3;ADORA1;EDN1;PLAU;PRKACB;CCL20;MAPK12;FZD7;TYRO3;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;SESN2;AXIN1;RHOB;NUAK2;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP2;CDKN1A;CHGA;DDR1;CTGF;GJB2;AKT1;WNT2B;PTGES;NPPC;INHBB;CLDN1;CLDN3;PIK3CA;PIK3CG;GAS6;TSPAN2;FZD8
16584,GO:0071600,0.00681581978463312,0.999769788873234,2,10,otic vesicle morphogenesis,BP,FGF10;FGF8
4267,GO:0008645,0.00681898701267384,0.998282333587084,7,150,hexose transport,BP,EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;SLC2A14;AKT1
10116,GO:0035904,0.00683094738465374,0.999075924188355,4,48,aorta development,BP,NOTCH1;FGF8;HEY1;EFNB2
19644,GO:1903523,0.00684899562720915,0.999411853621078,3,28,negative regulation of blood circulation,BP,ADORA1;SPTBN4;PIK3CG
8921,GO:0033079,0.0068564002059746,0.999772618373156,2,9,immature T cell proliferation,BP,WNT4;BMP4
3546,GO:0006940,0.00691304909524984,0.999056300546121,4,54,regulation of smooth muscle contraction,BP,ADRA2B;ADRA2C;ADORA1;EDN1
12855,GO:0046886,0.00692419821646955,0.9997755124914,2,8,positive regulation of hormone biosynthetic process,BP,WNT4;BMP6
7832,GO:0031252,0.00692707029975099,0.99743601649721,12,347,cell leading edge,CC,ITGA5;ITGB4;ADORA1;CDH2;PLEKHH2;KITLG;CDH1;BCAR1;PIK3CA;AMOT;ACTA2;PARVB
5262,GO:0014807,0.00695903190664147,0.999767429907228,2,9,regulation of somitogenesis,BP,NOTCH1;DLL1
8787,GO:0032869,0.00698527609637071,0.998027063327965,8,191,cellular response to insulin stimulus,BP,PIK3R2;PIK3R1;FOXO4;RHOQ;AKT1;BCAR1;INHBB;PIK3CA
13714,GO:0050865,0.00701556957438659,0.997168576094607,14,479,regulation of cell activation,BP,TYRO3;FGF10;PIK3R1;PDGFB;WNT5A;SDC4;CLCF1;BMP4;CDKN1A;CTGF;AKT1;PIK3CA;GAS6;EFNB2
10300,GO:0036293,0.00702928916705467,0.99752146881086,11,334,response to decreased oxygen levels,BP,NOTCH1;PMAIP1;ADORA1;EDN1;PLAU;BMP7;BMP2;CTGF;AKT1;NPPC;CLDN3
12852,GO:0046883,0.00705212393143118,0.997820657469702,9,243,regulation of hormone secretion,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;BMP6;INHBB;RAB11FIP1;KCNG2
11176,GO:0043068,0.00706469941051825,0.9969542976885,16,566,positive regulation of programmed cell death,BP,NOTCH1;MARK4;PMAIP1;GADD45A;PIK3R2;WNT5A;RHOB;SCIN;BMP7;BMP4;BMP2;CDKN1A;CTGF;AKT1;INHBB;VDR
4675,GO:0009895,0.00707375218191157,0.997996494933779,8,198,negative regulation of catabolic process,BP,ACTN3;ADORA1;AKT1;PKP3;PKP1;PIK3CA;PIK3CG;LZTS1
14354,GO:0051960,0.00708311930500713,0.99663794758606,20,729,regulation of nervous system development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;PRKACB;CDH2;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;LZTS1
781,GO:0001958,0.00710596094214016,0.999385215530225,3,26,endochondral ossification,BP,BMP6;BMP4;NAB2
10219,GO:0036075,0.00710596094214016,0.999385215530225,3,26,replacement ossification,BP,BMP6;BMP4;NAB2
5035,GO:0010837,0.00711217885907702,0.999380850035092,3,28,regulation of keratinocyte proliferation,BP,FGF10;VDR;EFNB2
13716,GO:0050867,0.00714916922255015,0.997620421891743,10,294,positive regulation of cell activation,BP,FGF10;PIK3R1;WNT5A;CLCF1;CDKN1A;CTGF;AKT1;PIK3CA;GAS6;EFNB2
11309,GO:0043271,0.00715819273146829,0.998418391468104,6,120,negative regulation of ion transport,BP,ACTN2;ADORA1;CASQ2;KCNH2;WNK4;AKT1
11298,GO:0043256,0.00717116284795737,0.999763237399928,2,8,laminin complex,CC,LAMA1;LAMA5
20953,GO:2000018,0.00720866493713604,0.99975464204977,2,9,regulation of male gonad development,BP,WNT4;WT1
12502,GO:0046068,0.00722566086795363,0.999000258914181,4,55,cGMP metabolic process,BP,GUCY1B3;WNT5A;NPR1;NPPC
18079,GO:0098590,0.00727533725756853,0.996294086894279,24,932,plasma membrane region,CC,ITGA3;ITGA5;NOTCH1;RAB27A;TF;CRB2;SLC52A3;ADORA1;SPTBN5;TTYH1;CDH2;PDGFB;DLL1;DRP2;MSN;GJB6;RAB17;CDH1;MYO7A;CLDN1;CLDN3;CLDN5;LZTS1;SHC4
2601,GO:0005381,0.00729459348256923,0.999750185688927,2,9,iron ion transmembrane transporter activity,MF,TF;TTYH1
7694,GO:0030971,0.00730858180968837,0.998988053110231,4,52,receptor tyrosine kinase binding,MF,PIK3R2;PIK3R1;GAS6;SHC4
2700,GO:0005623,0.00731199627023359,0.996325814099462,225,15450,cell,CC,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;FBXO41;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;LGALS4;BMP6;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;PM20D2;SHC4;SLC18B1;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
15344,GO:0061072,0.00732435909926332,0.999748635543701,2,9,iris morphogenesis,BP,WNT2;WNT2B
5590,GO:0015749,0.00734519330084,0.998123319401391,7,152,monosaccharide transport,BP,EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;SLC2A14;AKT1
13278,GO:0048545,0.00737076306918106,0.997247067428792,12,376,response to steroid hormone,BP,NOTCH1;WNT7B;EDN1;BMP7;BMP6;BMP4;CDKN1A;CTGF;GJB2;CLDN1;VDR;HEY1
2873,GO:0005913,0.00737565097320626,0.998647297496193,5,81,cell-cell adherens junction,CC,DSC2;CDH2;CAMSAP3;PKP3;CDH1
13386,GO:0048739,0.00740245645794813,0.999744552611252,2,9,cardiac muscle fiber development,BP,BMP4;MYH11
8291,GO:0032102,0.00741241562571726,0.99769087280567,9,246,negative regulation of response to external stimulus,BP,WNT3;WNT4;NOTCH1;ADORA1;EDN1;PLAU;TYRO3;PDGFB;WNT5A
7189,GO:0030018,0.00741518480319134,0.998350497313434,6,117,Z disc,CC,FHOD3;ACTN2;CASQ2;MYZAP;PARVB;PDE4B
3392,GO:0006694,0.00741623866744399,0.998099247141421,7,162,steroid biosynthetic process,BP,WNT4;DHH;HMGCS2;DKK3;BMP6;BMP2;VDR
16937,GO:0072217,0.00741672467712327,0.999743804210618,2,9,negative regulation of metanephros development,BP,BMP4;WT1
2804,GO:0005794,0.00741725807553706,0.995855059414065,32,1399,Golgi apparatus,CC,ITGA5;WNT3;WNT4;RAB6C;NOTCH1;RAB27A;WNT6;WNT7A;WNT7B;NMT2;RAB39B;RAB39A;FSTL3;PDGFB;HRAS;WNT5B;WNT5A;RHOQ;SDC4;SPTB;B3GNT2;PKN3;RAB20;RND3;CTGF;RAB12;CDH1;GAS6;GPSM1;RAB38;FZD8;RNF144A
2854,GO:0005884,0.00748391331972556,0.998622618844448,5,81,actin filament,CC,ACTN3;ACTN2;RHOQ;ESPN;AMOT
19345,GO:1902905,0.00748841035234739,0.998077980637803,7,159,positive regulation of supramolecular fiber organization,BP,WNT4;ACTN2;EDN1;SCIN;PSRC1;SDC4;CTGF
10592,GO:0040020,0.00750784685486936,0.999333435808273,3,28,regulation of meiotic nuclear division,BP,LIF;WNT4;WNT5A
11439,GO:0043506,0.007528076728514,0.99861310765983,5,80,regulation of JUN kinase activity,BP,WNT7B;EDN1;WNT5A;AXIN1;FZD8
5002,GO:0010800,0.00755349124789806,0.999329797479314,3,27,positive regulation of peptidyl-threonine phosphorylation,BP,WNT5A;AXIN1;BMP7
9377,GO:0034333,0.00762345829625551,0.998591873804743,5,79,adherens junction assembly,BP,WNT4;ACTN3;ACTN2;SDC4;LAMA5
967,GO:0002262,0.00765949002887106,0.998282047247361,6,124,myeloid cell homeostasis,BP,ZFPM1;JAM3;BMP4;SFXN1;KITLG;PDE4B
15339,GO:0061053,0.00766735575132228,0.998578902447346,5,84,somite development,BP,WNT4;NOTCH1;CRB2;WNT5A;DLL1
7202,GO:0030038,0.00771053243975597,0.998570671975206,5,81,contractile actin filament bundle assembly,BP,WNT4;ITGB5;PIK3R1;SDC4;CTGF
11223,GO:0043149,0.00771053243975597,0.998570671975206,5,81,stress fiber assembly,BP,WNT4;ITGB5;PIK3R1;SDC4;CTGF
6676,GO:0019725,0.00775747843983764,0.996283514393218,20,797,cellular homeostasis,BP,CDH23;TF;CASQ2;EDN1;RAB39A;PRND;TYRO3;LPAR2;PIK3R2;PIK3R1;SESN2;BMP6;RAB20;GJB6;PIK3CA;PIK3CG;GAS6;VDR;RAB38;CLDN16
17363,GO:0090075,0.00778148926511438,0.999298265404469,3,29,relaxation of muscle,BP,ADORA1;CHGA;PDE4B
8646,GO:0032649,0.00781169204735977,0.998541564602674,5,92,regulation of interferon-gamma production,BP,ZFPM1;HRAS;WNT5A;GAS6;PDE4B
15914,GO:0070382,0.00783088025033882,0.997973111564193,7,159,exocytic vesicle,CC,TMEM163;SYT5;RAB27A;RAB40B;RAB40A;VAMP1;PDE4B
17403,GO:0090133,0.00785922838863404,1,1,1,mesendoderm migration,BP,FGF8
17404,GO:0090134,0.00785922838863404,1,1,1,cell migration involved in mesendoderm migration,BP,FGF8
15448,GO:0061314,0.00789040172591166,0.999718532553917,2,9,Notch signaling involved in heart development,BP,NOTCH1;HEY1
8423,GO:0032355,0.0079012161782634,0.998215868282157,6,125,response to estradiol,BP,DHH;WNT7A;FGF10;BMP7;CTGF;GJB2
18856,GO:1901617,0.00790662505363933,0.997717398135629,8,199,organic hydroxy compound biosynthetic process,BP,WNT4;PNMT;HMGCS2;DKK3;WNT5A;BMP6;BMP2;VDR
20703,GO:1990124,0.00791555491039586,0.99971716767107,2,9,messenger ribonucleoprotein complex,CC,PKP3;PKP1
13907,GO:0051154,0.00800178339580375,0.999271034388778,3,29,negative regulation of striated muscle cell differentiation,BP,NOTCH1;FZD7;BMP2
18154,GO:0098771,0.00802618612323675,0.996393728526928,17,638,inorganic ion homeostasis,BP,CDH23;TF;ADORA1;CASQ2;EDN1;RAB39A;PRND;LPAR2;KCNH2;NPR1;BMP6;RAB20;SFXN1;PIK3CG;VDR;RAB38;CLDN16
13768,GO:0050930,0.00809219866396034,0.999691893791185,2,12,induction of positive chemotaxis,BP,ARTN;FGF10
14332,GO:0051930,0.0081279228533506,0.999253511339041,3,30,regulation of sensory perception of pain,BP,ADRA2C;ADORA1;EDN1
14333,GO:0051931,0.0081279228533506,0.999253511339041,3,30,regulation of sensory perception,BP,ADRA2C;ADORA1;EDN1
7093,GO:0022402,0.00814136062672522,0.995548052365796,29,1261,cell cycle process,BP,LIF;WNT4;RAB6C;MARK4;GADD45A;ACVR1;EDN1;PHLDA1;TTYH1;MAPK12;FGF10;PDGFB;FOXO4;RALB;HRAS;WNT5A;SNX18;RHOB;PSRC1;FGF8;BMP7;BMP4;CDKN1A;HMGN5;CTGF;AKT1;GAS6;LZTS1;PIM2
17329,GO:0090004,0.00816815740135626,0.9992502821616,3,29,positive regulation of establishment of protein localization to plasma membrane,BP,ITGA3;PIK3R1;AKT1
6234,GO:0017022,0.00819313255177017,0.998822986352989,4,57,myosin binding,MF,RAB27A;SPTBN5;RAB39B;RAB3D
4600,GO:0009617,0.0082803471935157,0.996715058965998,13,497,response to bacterium,BP,NOTCH1;EDN1;CCL20;FGF10;WNT5A;BMP6;CHGA;GJB2;GJB6;AKT1;PTGES;CLDN1;PDE4B
8230,GO:0032006,0.00828322262778024,0.998436447253308,5,83,regulation of TOR signaling,BP,SESN2;PIK3CA;GAS6;ARAF;SH3BP4
12185,GO:0045444,0.00828765330660282,0.997587984771551,8,199,fat cell differentiation,BP,ZFPM1;FGF10;WNT5B;WNT5A;AXIN1;BMP2;AKT1;INHBB
11676,GO:0044233,0.0083294378582818,0.99968779832039,2,10,ER-mitochondrion membrane contact site,CC,RAB38;ACSL4
11870,GO:0044710,0.00833158342235669,0.994438716494709,73,4067,single-organism metabolic process,BP,ARTN;LIF;ADRA2B;ADRA2C;WNT4;ACTN3;ACTN2;GLDC;STRA6;ITGB8;PMAIP1;GADD45A;DHH;WNT7A;WNT7B;SLC52A3;HMGCS2;ACVR1;GUCY1B3;ADORA1;DKK3;EDN1;CCL20;SPTBN5;SPTBN4;MBOAT2;MAPK12;FZD7;TYRO3;CDH2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;HRAS;WNT5A;KHK;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CHGA;CTGF;AKT1;NRTN;PTGES;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;SIN3B;VDR;ARAF;GDNF;ACSL4;FZD8;DUSP5;PDE4B
20271,GO:1904861,0.00833441786263633,0.999694105245816,2,9,excitatory synapse assembly,BP,WNT7A;WNT5A
13841,GO:0051054,0.00834819931103873,0.997566694994743,8,202,positive regulation of DNA metabolic process,BP,FGF10;PDGFB;HRAS;CLCF1;BMP6;BMP4;AKT1;KITLG
5741,GO:0016049,0.00836262906050144,0.996554562766994,14,473,cell growth,BP,WNT3;EDN1;WNT5A;SESN2;NPR1;PSRC1;HBEGF;WT1;CDKN1A;DDR1;CTGF;AKT1;BCAR1;SH3BP4
14338,GO:0051937,0.00837266324025202,0.998787132472051,4,60,catecholamine transport,BP,ADRA2B;ADRA2C;CHGA;GDNF
7208,GO:0030048,0.00837878315317642,0.998086755100661,6,119,actin filament-based movement,BP,ACTN3;ACTN2;DSC2;KCNH2;MYO7A;PDE4B
12830,GO:0046847,0.00842790250215522,0.998785426308382,4,51,filopodium assembly,BP,TTYH1;RHOQ;ESPN;RAB17
16372,GO:0071281,0.00847259286350273,0.999679604916292,2,10,cellular response to iron ion,BP,TF;BMP6
14765,GO:0060174,0.00847797203324477,0.999679295608928,2,10,limb bud formation,BP,WNT3;FGF10
1542,GO:0003306,0.00850259059916059,0.999677878697219,2,10,Wnt signaling pathway involved in heart development,BP,WNT5A;BMP2
587,GO:0001678,0.00852049587228897,0.998045532214172,6,124,cellular glucose homeostasis,BP,PIK3R2;PIK3R1;SESN2;GJB6;PIK3CA;GAS6
14864,GO:0060325,0.00852063494095338,0.999207859717849,3,28,face morphogenesis,BP,STRA6;CRISPLD2;CLDN5
12300,GO:0045685,0.00855321178352607,0.998756883705909,4,56,regulation of glial cell differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
831,GO:0002027,0.00858592266981235,0.998362151091109,5,88,regulation of heart rate,BP,DSC2;CASQ2;EDN1;SPTBN4;KCNH2
2107,GO:0004603,0.00860184831632634,1,1,1,phenylethanolamine N-methyltransferase activity,MF,PNMT
14048,GO:0051385,0.00864782117123412,0.99918578481767,3,31,response to mineralocorticoid,BP,EDN1;CDKN1A;CTGF
11972,GO:0045023,0.00865119624930604,0.999669279862279,2,10,G0 to G1 transition,BP,FOXO4;CTGF
19723,GO:1903670,0.00871485554098303,0.999183113001019,3,28,regulation of sprouting angiogenesis,BP,ITGA5;NOTCH1;DLL1
5891,GO:0016342,0.0087367782397178,0.999671367468091,2,9,catenin complex,CC,CDH2;CDH1
13902,GO:0051149,0.00875303236393874,0.998321879183597,5,89,positive regulation of muscle cell differentiation,BP,EDN1;MAPK12;CDH2;BMP4;EFNB2
13915,GO:0051170,0.00879389041693056,0.996983173701274,10,288,nuclear import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
2343,GO:0004935,0.00880454899520284,0.999660324245196,2,10,adrenergic receptor activity,MF,ADRA2B;ADRA2C
15716,GO:0070075,0.00880720219238749,0.999980604003879,1,2,tear secretion,BP,FGF10
7038,GO:0021915,0.00882886629328408,0.997663643098165,7,155,neural tube development,BP,NOTCH1;PRKACB;WNT5A;FGF8;SDC4;BMP7;BMP4
17357,GO:0090068,0.00886310838935038,0.997159691659921,9,246,positive regulation of cell cycle process,BP,WNT4;GADD45A;EDN1;PDGFB;FOXO4;WNT5A;FGF8;CDKN1A;CTGF
10576,GO:0039706,0.00887831780611874,0.999655986718707,2,10,co-receptor binding,MF,BMP4;BMP2
14971,GO:0060452,0.0089025521528171,0.999648666221465,2,11,positive regulation of cardiac muscle contraction,BP,CHGA;CTGF
14582,GO:0055038,0.00893260160831598,0.998685390783117,4,56,recycling endosome membrane,CC,SYT5;FZD7;RAB12;RAB17
14576,GO:0055023,0.00894198980009149,0.999151709188637,3,29,positive regulation of cardiac muscle tissue growth,BP,WNT2;NOTCH1;EDN1
15865,GO:0070306,0.00895167038947984,0.99914840329246,3,30,lens fiber cell differentiation,BP,WNT7A;WNT7B;WNT5B
16153,GO:0070851,0.00896857412060013,0.997918033981862,6,130,growth factor receptor binding,MF,ITGA5;FGF10;FGF17;PDGFB;FGF8;HBEGF
7256,GO:0030141,0.00903566102470918,0.995693170488455,19,787,secretory granule,CC,SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;SERPINA5;EDN1;PLAU;SYCN;FSTL3;PDGFB;VAMP1;CHGA;PKP1;NPPC;RAB44;GAS6;RAB3D
13669,GO:0050801,0.00904855957240767,0.995781518870872,18,698,ion homeostasis,BP,CDH23;TF;ADORA1;CASQ2;EDN1;RAB39A;PRND;LPAR2;KCNH2;NPR1;BMP6;RAB20;SFXN1;WNK4;PIK3CG;VDR;RAB38;CLDN16
16066,GO:0070661,0.00918929401457066,0.997034549923348,9,268,leukocyte proliferation,BP,WNT4;FGF10;SDC4;CLCF1;BMP4;CDKN1A;MSN;KITLG;PIK3CG
12340,GO:0045765,0.00924682978141634,0.997255676186526,8,207,regulation of angiogenesis,BP,ITGA5;NOTCH1;FOXO4;WNT5A;RHOB;NPR1;DLL1;AMOT
17971,GO:0097530,0.00927622241932732,0.998184167729725,5,115,granulocyte migration,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
19134,GO:1902337,0.00928288537006553,0.999631861210278,2,10,regulation of apoptotic process involved in morphogenesis,BP,BMP7;VDR
20221,GO:1904748,0.00928288537006553,0.999631861210278,2,10,regulation of apoptotic process involved in development,BP,BMP7;VDR
14132,GO:0051547,0.00931999189597404,0.999629620109754,2,10,regulation of keratinocyte migration,BP,FGF10;HBEGF
4811,GO:0010469,0.00937705894768352,0.99780493050886,6,124,regulation of receptor activity,BP,ADRA2B;ADRA2C;ACTN2;ADORA1;CASQ2;PLAU
14953,GO:0060433,0.00937770322373885,0.999619754502647,2,11,bronchus development,BP,WNT7B;BMP4
12081,GO:0045197,0.00940844925904559,0.999088517458286,3,30,establishment or maintenance of epithelial cell apical/basal polarity,BP,CRB2;WNT5A;MSN
13293,GO:0048570,0.00946396987657711,0.999620879703634,2,10,notochord morphogenesis,BP,CRB2;WNT5A
16739,GO:0071887,0.00950852718334782,0.998135405391628,5,97,leukocyte apoptotic process,BP,WNT5A;BMP4;AKT1;KITLG;GAS6
16925,GO:0072203,0.00953217122488558,0.999616714746911,2,10,cell proliferation involved in metanephros development,BP,BMP7;WT1
15327,GO:0061041,0.00953380940871262,0.997759516460201,6,126,regulation of wound healing,BP,WNT4;EDN1;PLAU;PDGFB;HRAS;HBEGF
4986,GO:0010762,0.00954149472101786,0.999073100200785,3,29,regulation of fibroblast migration,BP,PRR5L;SDC4;AKT1
17797,GO:0097191,0.00954881884260192,0.99714977829495,8,209,extrinsic apoptotic signaling pathway,BP,PMAIP1;ACVR1;FGF10;PIK3R1;BMP4;AKT1;KITLG;GDNF
17239,GO:0085029,0.00958205525988779,0.999067713182108,3,29,extracellular matrix assembly,BP,NOTCH1;GAS6;MYH11
15228,GO:0060856,0.00962130474787377,0.999611247678746,2,10,establishment of blood-brain barrier,BP,WNT7A;WNT7B
18687,GO:1901099,0.0096872167706255,0.99904544278587,3,33,negative regulation of signal transduction in absence of ligand,BP,FGF10;AKT1;GDNF
21642,GO:2001240,0.0096872167706255,0.99904544278587,3,33,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,FGF10;AKT1;GDNF
15081,GO:0060606,0.00969732480799164,0.998095935823106,5,86,tube closure,BP,PRKACB;FGF10;WNT5A;SDC4;BMP4
13433,GO:0048845,0.00972768467643038,0.999604687613638,2,10,venous blood vessel morphogenesis,BP,NOTCH1;EFNB2
526,GO:0001569,0.00973073907199636,0.999045599323544,3,30,branching involved in blood vessel morphogenesis,BP,ACVR1;EDN1;FGF8
18898,GO:1901681,0.00973663132615426,0.997082554876825,8,215,sulfur compound binding,MF,CRISPLD2;SERPINA5;FGF10;HBEGF;BMP7;BMP4;CTGF;PTGES
4942,GO:0010712,0.00976330547489312,0.999033414742298,3,34,regulation of collagen metabolic process,BP,WNT4;BMP4;CTGF
13369,GO:0048705,0.00979926600971684,0.997063020626435,8,204,skeletal system morphogenesis,BP,WNT7A;AXIN1;BMP7;BMP6;BMP4;CTGF;NPPC;NAB2
15006,GO:0060502,0.0100045793400563,0.999587434305864,2,10,epithelial cell proliferation involved in lung morphogenesis,BP,WNT2;BMP4
13255,GO:0048505,0.0101143254933573,0.999573387104203,2,11,regulation of timing of cell differentiation,BP,NOTCH1;DLL1
15823,GO:0070243,0.0101349032107062,0.999572065340069,2,11,regulation of thymocyte apoptotic process,BP,WNT5A;BMP4
18956,GO:1901890,0.0102066801321359,0.998981239796164,3,30,positive regulation of cell junction assembly,BP,WNT4;SDC4;CLDN1
19260,GO:1902668,0.0102663786198147,0.999570887010297,2,10,negative regulation of axon guidance,BP,WNT3;WNT5A
7064,GO:0021978,0.0102675204835644,0.99956351288677,2,11,telencephalon regionalization,BP,BMP4;BMP2
3354,GO:0006650,0.0103215922880472,0.996160592622333,11,337,glycerophospholipid metabolic process,BP,MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
12367,GO:0045823,0.0103279909321816,0.99895813447974,3,33,positive regulation of heart contraction,BP,EDN1;CHGA;CTGF
19145,GO:1902369,0.0104043184856511,0.999562077555333,2,10,negative regulation of RNA catabolic process,BP,PKP3;PKP1
8694,GO:0032729,0.0104625535255614,0.998380494598392,4,63,positive regulation of interferon-gamma production,BP,ZFPM1;HRAS;WNT5A;PDE4B
13834,GO:0051047,0.0105256046696663,0.996071151964704,11,358,positive regulation of secretion,BP,RAB27A;ADORA1;EDN1;WNT5A;NPR1;SCIN;SDC4;BMP6;INHBB;RAB3D;GDNF
5181,GO:0014013,0.010565863532217,0.997877188813459,5,92,regulation of gliogenesis,BP,LIF;NOTCH1;CDH2;CLCF1;BMP2
8972,GO:0033162,0.010578601260224,0.999536913251238,2,12,melanosome membrane,CC,RAB27A;RAB38
11964,GO:0045009,0.010578601260224,0.999536913251238,2,12,chitosome,CC,RAB27A;RAB38
11005,GO:0042733,0.0106069819539734,0.998356890616022,4,58,embryonic digit morphogenesis,BP,NOTCH1;WNT7A;WNT5A;BMP4
12126,GO:0045294,0.0106322037743457,0.999547387682927,2,10,alpha-catenin binding,MF,CDH2;PKP3
16828,GO:0072070,0.0106516576390294,0.999538409558551,2,11,loop of Henle development,BP,WNT7B;DLL1
14959,GO:0060439,0.0106763528384822,0.999536779050788,2,11,trachea morphogenesis,BP,WNT7B;BMP4
771,GO:0001947,0.0107144016231682,0.998335377829348,4,58,heart looping,BP,NOTCH1;WNT5A;FGF8;DLL1
14692,GO:0060064,0.0107264777003462,1,1,1,Spemann organizer formation at the anterior end of the primitive streak,BP,WNT3
20523,GO:1905474,0.0107264777003462,1,1,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,WNT3
5806,GO:0016197,0.0107400062178993,0.996450604068331,9,246,endosomal transport,BP,ACTN2;RAB6C;SNX18;GPRASP1;RHOB;MSN;RAB12;RAB17;RAB38
12375,GO:0045836,0.0107514792583287,0.999531806500783,2,11,positive regulation of meiotic nuclear division,BP,WNT4;WNT5A
13886,GO:0051129,0.0107826914005325,0.995129312458658,16,581,negative regulation of cellular component organization,BP,ITGA3;FHOD3;LIF;WNT3;SPTBN5;SPTBN4;PLEKHH2;WNT5A;RHOQ;SCIN;SPTB;BMP7;BMP4;ESPN;AKT1;UNC119
11685,GO:0044246,0.0107982545683378,0.998888808864126,3,35,regulation of multicellular organismal metabolic process,BP,WNT4;BMP4;CTGF
17228,GO:0080135,0.010831668707481,0.995104852889872,16,579,regulation of cellular response to stress,BP,PMAIP1;GADD45A;WNT7A;WNT7B;EDN1;FZD7;FGF10;PIK3R1;HRAS;WNT5A;AXIN1;BMP7;BMP2;CTGF;AKT1;FZD8
6544,GO:0019229,0.0108697570557289,0.998304149926778,4,58,regulation of vasoconstriction,BP,ADRA2B;ADRA2C;EDN1;AKT1
8290,GO:0032101,0.0109618719306335,0.994906508968772,17,672,regulation of response to external stimulus,BP,ARTN;WNT3;WNT4;NOTCH1;NMT2;ADORA1;EDN1;PLAU;TYRO3;FGF10;PDGFB;WNT5A;JAM3;BMP6;PIK3CG;GAS6;EFNB2
19039,GO:1902117,0.010973065354517,0.998284536248915,4,57,positive regulation of organelle assembly,BP,EDN1;RALB;SDC4;MSN
1590,GO:0003401,0.0109941254447796,0.998869747585734,3,31,axis elongation,BP,FGF10;WNT5A;BMP4
18674,GO:1901077,0.0110733354553737,0.999503537623205,2,12,regulation of relaxation of muscle,BP,CHGA;PDE4B
5121,GO:0010942,0.0111514571922492,0.994942562641762,16,598,positive regulation of cell death,BP,NOTCH1;MARK4;PMAIP1;GADD45A;PIK3R2;WNT5A;RHOB;SCIN;BMP7;BMP4;BMP2;CDKN1A;CTGF;AKT1;INHBB;VDR
5169,GO:0012505,0.0111690525799251,0.992433281431991,73,4018,endomembrane system,CC,ITGA5;TMEM163;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN2;RAB6C;TSPAN15;NOTCH1;RAB27A;TF;CRISPLD2;SERPINA5;WNT6;WNT7A;WNT7B;NMT2;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;MBOAT2;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;FZD7;TYRO3;FSTL3;PIK3R1;REEP1;PDGFB;HRAS;WNT5B;WNT5A;SNX18;RHOQ;RHOB;SDC4;SPTB;B3GNT2;PKN3;RAB20;VAMP1;RND3;CHGA;CTGF;GJB1;TPD52;PKP1;RAB12;RAB17;CYTIP;PTGES;NPPC;CDH1;EPN1;RAB44;RAB11FIP1;GAS6;GPSM1;SH3BP4;RAB38;RAB3D;ACSL4;FZD8;RNF144A;PDE4B
13904,GO:0051151,0.0111710046543446,0.999503700329173,2,11,negative regulation of smooth muscle cell differentiation,BP,PDGFB;FOXO4
1448,GO:0003157,0.0112557104634192,0.999497956382558,2,11,endocardium development,BP,NOTCH1;ACVR1
12127,GO:0045295,0.0112681695915382,0.999505507534703,2,10,gamma-catenin binding,MF,CDH2;CDH1
20524,GO:1905475,0.0114023362594175,0.997213439971612,6,131,regulation of protein localization to membrane,BP,ITGA3;PMAIP1;CDH2;PIK3R1;RHOQ;AKT1
10599,GO:0040034,0.0114075872703411,0.999480533803965,2,12,regulation of development, heterochronic,BP,NOTCH1;DLL1
21197,GO:2000401,0.0114432448436543,0.998789890544717,3,39,regulation of lymphocyte migration,BP,CCL20;WNT5A;MSN
18156,GO:0098773,0.0114541907197283,0.997650557307312,5,95,skin epidermis development,BP,NOTCH1;FGF10;WNT5A;DLL1;LAMA5
21416,GO:2000726,0.011495157242162,0.999481595064038,2,11,negative regulation of cardiac muscle cell differentiation,BP,FZD7;BMP2
9676,GO:0035089,0.0115370200895879,0.999478715817774,2,11,establishment of apical/basal cell polarity,BP,WNT5A;MSN
20876,GO:1990782,0.0115522903426314,0.998164108747475,4,59,protein tyrosine kinase binding,MF,PIK3R2;PIK3R1;GAS6;SHC4
11756,GO:0044344,0.0115979704181844,0.997154302703277,6,133,cellular response to fibroblast growth factor stimulus,BP,WNT4;FGF10;FGF17;WNT5A;FGF8;CTGF
13676,GO:0050808,0.0116360570463179,0.996106201505693,9,238,synapse organization,BP,WNT7A;WNT7B;RAB39B;CDH2;WNT5A;DRP2;RAB17;CDH1;GDNF
5095,GO:0010907,0.0116565224493112,0.998773005521398,3,32,positive regulation of glucose metabolic process,BP,ACTN3;PMAIP1;AKT1
8839,GO:0032941,0.0117055161399712,0.998753482023462,3,38,secretion by tissue,BP,ADORA1;FGF10;WNK4
11418,GO:0043473,0.0118070846420222,0.997560022921731,5,95,pigmentation,BP,RAB27A;RAB17;KITLG;MYO7A;RAB38
3463,GO:0006812,0.0118407360448053,0.993703374918633,24,1043,cation transport,BP,ACTN2;CDH23;TF;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;TTYH1;TSPAN13;PDGFB;KCNH2;SFXN1;WNK4;CTGF;AKT1;PIK3CG;KCNG2;GAS6;VDR;KCND1;GDNF;CLDN16;PDE4B
5831,GO:0016241,0.0118818731490626,0.997070892834935,6,130,regulation of macroautophagy,BP,RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1
9971,GO:0035659,0.011924549177004,1,1,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,WNT7A
20291,GO:1904889,0.011924549177004,1,1,1,regulation of excitatory synapse assembly,BP,WNT7A
20292,GO:1904891,0.011924549177004,1,1,1,positive regulation of excitatory synapse assembly,BP,WNT7A
8618,GO:0032609,0.0119290325620039,0.997524533419788,5,101,interferon-gamma production,BP,ZFPM1;HRAS;WNT5A;GAS6;PDE4B
15242,GO:0060911,0.0119806327664307,0.999440258064106,2,12,cardiac cell fate commitment,BP,ACVR1;WT1
12590,GO:0046324,0.0120481847456071,0.998059107323869,4,61,regulation of glucose import,BP,PIK3R2;PIK3R1;RHOQ;AKT1
8075,GO:0031674,0.0120620875547478,0.99701629931898,6,131,I band,CC,FHOD3;ACTN2;CASQ2;MYZAP;PARVB;PDE4B
8853,GO:0032964,0.012086564546958,0.998703548229893,3,35,collagen biosynthetic process,BP,WNT4;BMP4;CTGF
13204,GO:0048333,0.0120905203996917,0.998710046130752,3,32,mesodermal cell differentiation,BP,ITGA3;ITGB4;BMP4
13807,GO:0051017,0.0121063295179544,0.99700560452556,6,126,actin filament bundle assembly,BP,WNT4;ITGB5;PIK3R1;SDC4;ESPN;CTGF
15551,GO:0061572,0.0121063295179544,0.99700560452556,6,126,actin filament bundle organization,BP,WNT4;ITGB5;PIK3R1;SDC4;ESPN;CTGF
7469,GO:0030513,0.012115799844843,0.998706352087999,3,32,positive regulation of BMP signaling pathway,BP,NOTCH1;CRB2;BMP4
1207,GO:0002687,0.0121220444652779,0.99746761145627,5,113,positive regulation of leukocyte migration,BP,EDN1;CCL20;WNT5A;KITLG;GAS6
20934,GO:1990967,0.0121613057993879,1,1,1,multi-organism toxin transport,BP,RAB40B
10071,GO:0035815,0.012237276538431,0.999415285950631,2,13,positive regulation of renal sodium excretion,BP,EDN1;NPR1
13229,GO:0048390,0.012282390382799,1,1,1,intermediate mesoderm morphogenesis,BP,BMP4
13230,GO:0048391,0.012282390382799,1,1,1,intermediate mesoderm formation,BP,BMP4
13231,GO:0048392,0.012282390382799,1,1,1,intermediate mesodermal cell differentiation,BP,BMP4
14572,GO:0055018,0.012282390382799,1,1,1,regulation of cardiac muscle fiber development,BP,BMP4
14573,GO:0055020,0.012282390382799,1,1,1,positive regulation of cardiac muscle fiber development,BP,BMP4
15007,GO:0060503,0.012282390382799,1,1,1,bud dilation involved in lung branching,BP,BMP4
15390,GO:0061149,0.012282390382799,1,1,1,BMP signaling pathway involved in ureter morphogenesis,BP,BMP4
15391,GO:0061150,0.012282390382799,1,1,1,renal system segmentation,BP,BMP4
15392,GO:0061151,0.012282390382799,1,1,1,BMP signaling pathway involved in renal system segmentation,BP,BMP4
15396,GO:0061155,0.012282390382799,1,1,1,pulmonary artery endothelial tube morphogenesis,BP,BMP4
15425,GO:0061216,0.012282390382799,1,1,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,BMP4
16743,GO:0071893,0.012282390382799,1,1,1,BMP signaling pathway involved in nephric duct formation,BP,BMP4
16847,GO:0072096,0.012282390382799,1,1,1,negative regulation of branch elongation involved in ureteric bud branching,BP,BMP4
16848,GO:0072097,0.012282390382799,1,1,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,BMP4
16850,GO:0072099,0.012282390382799,1,1,1,anterior/posterior pattern specification involved in ureteric bud development,BP,BMP4
16851,GO:0072100,0.012282390382799,1,1,1,specification of ureteric bud anterior/posterior symmetry,BP,BMP4
16852,GO:0072101,0.012282390382799,1,1,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,BMP4
16915,GO:0072192,0.012282390382799,1,1,1,ureter epithelial cell differentiation,BP,BMP4
16922,GO:0072200,0.012282390382799,1,1,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
18971,GO:1901964,0.012282390382799,1,1,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
20942,GO:2000004,0.012282390382799,1,1,1,regulation of metanephric S-shaped body morphogenesis,BP,BMP4
20943,GO:2000005,0.012282390382799,1,1,1,negative regulation of metanephric S-shaped body morphogenesis,BP,BMP4
20944,GO:2000006,0.012282390382799,1,1,1,regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
20945,GO:2000007,0.012282390382799,1,1,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
13760,GO:0050922,0.0123044478770651,0.998671446883551,3,35,negative regulation of chemotaxis,BP,WNT3;NOTCH1;WNT5A
3852,GO:0007588,0.0123252838315887,0.99799541796975,4,66,excretion,BP,ADORA1;EDN1;NPR1;CLDN16
12241,GO:0045605,0.0123719973407145,0.999405447507942,2,13,negative regulation of epidermal cell differentiation,BP,NOTCH1;DLL1
1203,GO:0002683,0.0123894382894547,0.995265138072558,11,373,negative regulation of immune system process,BP,NOTCH1;ZFPM1;ADORA1;TYRO3;FSTL3;PIK3R1;SDC4;BMP4;DLL1;KITLG;CLDN18
13694,GO:0050839,0.0123968825559724,0.994830818516619,13,438,cell adhesion molecule binding,MF,ITGA3;ITGA5;ACTN3;ACTN2;MFGE8;CGN;JAM3;MB21D2;MSN;CTGF;PKP3;CDH1;LAMA5
15841,GO:0070268,0.0124612591420056,0.99738060520346,5,110,cornification,BP,DSC2;DSG3;PKP3;PKP1;DSC3
15307,GO:0061013,0.0124637933589881,0.998655204392622,3,32,regulation of mRNA catabolic process,BP,PRR5L;PKP3;PKP1
15487,GO:0061384,0.0124682222949876,0.998651937789568,3,33,heart trabecula morphogenesis,BP,NOTCH1;BMP7;HEY1
5186,GO:0014020,0.0124809645678658,0.997388373635544,5,91,primary neural tube formation,BP,PRKACB;WNT5A;SDC4;BMP7;BMP4
10753,GO:0042307,0.0125012162991282,0.997380685167335,5,94,positive regulation of protein import into nucleus,BP,PIK3R2;PIK3R1;BMP6;BMP4;CDH1
2857,GO:0005887,0.0125348206647604,0.992656176650114,33,1513,integral component of plasma membrane,CC,ITGA3;ITGA5;ADRA2B;ADRA2C;TSPAN15;TSPAN17;ITGB5;ITGB4;ITGB8;SLC52A3;ACVR1;ADORA1;KCNK6;MPZL1;TSPAN13;TYRO3;LPAR2;KCNH2;NPR1;SDC4;HBEGF;BMP2;DLL1;VAMP1;DDR1;JAG2;CLDN1;CLDN3;KCNG2;SLC18B1;KCND1;TSPAN2;EFNB2
245,GO:0000578,0.012593757648294,0.998628487795156,3,35,embryonic axis specification,BP,WNT7A;WNT5A;WT1
10836,GO:0042446,0.0126019376495263,0.997938170985371,4,65,hormone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
8111,GO:0031731,0.0126090086647022,0.99994692803936,1,3,CCR6 chemokine receptor binding,MF,CCL20
18977,GO:1901981,0.0126150190144461,0.996852496956208,6,125,phosphatidylinositol phosphate binding,MF,SYT5;ACTN2;FZD7;SNX18;SCIN;AKT1
3971,GO:0008154,0.0126288231986534,0.996412820243142,7,174,actin polymerization or depolymerization,BP,FHOD3;ACTN2;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
20912,GO:1990909,0.0126424645967267,0.999400698006941,2,11,Wnt signalosome,CC,WNT3;WNT2
8184,GO:0031932,0.0126568032806079,0.999391399602869,2,12,TORC2 complex,CC,PRR5L;SESN2
4676,GO:0009896,0.012693874311405,0.994900436406594,12,406,positive regulation of catabolic process,BP,ACTN3;PRR5L;RALB;WNT5A;SESN2;AXIN1;MSN;AKT1;RAB12;SH3BP4;RNF144A;PIM2
7819,GO:0031226,0.012742086611369,0.992468549116418,34,1576,intrinsic component of plasma membrane,CC,ITGA3;ITGA5;ADRA2B;ADRA2C;TSPAN15;TSPAN17;ITGB5;ITGB4;ITGB8;SLC52A3;ACVR1;ADORA1;KCNK6;MPZL1;TSPAN13;TYRO3;LPAR2;KCNH2;NPR1;SDC4;SPTB;HBEGF;BMP2;DLL1;VAMP1;DDR1;JAG2;CLDN1;CLDN3;KCNG2;SLC18B1;KCND1;TSPAN2;EFNB2
8420,GO:0032352,0.0128380625475063,0.999386501031917,2,11,positive regulation of hormone metabolic process,BP,WNT4;BMP6
2756,GO:0005737,0.0128787895644483,0.99102162978726,164,10558,cytoplasm,CC,ITGA3;ITGA5;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;PNMT;TF;ITGB5;PMAIP1;GADD45A;CRISPLD2;FBXO41;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;SDC4;SPTB;HBEGF;LGALS4;BMP6;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;PKN3;RAB20;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP1;RAB12;RAB17;CYTIP;PTGES;KITLG;NPPC;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;DTX4;MYH11;LZTS1;DSC3;GPSM1;AMOT;ARAF;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;FZD8;HEY1;ACTA2;RNF144A;PIM2;PARVB;PDE4B
5037,GO:0010839,0.0129083136691187,0.999372863866874,2,12,negative regulation of keratinocyte proliferation,BP,VDR;EFNB2
11454,GO:0043524,0.0129387494002152,0.996749487974727,6,133,negative regulation of neuron apoptotic process,BP,TYRO3;HRAS;FGF8;CLCF1;PIK3CA;GDNF
2782,GO:0005768,0.0129582812020902,0.993474192923376,20,803,endosome,CC,TMEM163;ADRA2C;SYT5;RIN3;TSPAN15;RAB27A;TF;RAB40B;RAB40A;FZD7;SNX18;RHOB;RAB20;RAB12;RAB17;CYTIP;CDH1;RAB11FIP1;RAB38;RNF144A
5111,GO:0010927,0.0129693000838427,0.997257792594298,5,94,cellular component assembly involved in morphogenesis,BP,FHOD3;ACTN2;CASQ2;EDN1;MYH11
9985,GO:0035690,0.0129713796262968,0.997859665757488,4,65,cellular response to drug,BP,EDN1;KCNH2;GAS6;PDE4B
13130,GO:0048185,0.0130236229639597,0.999364300953392,2,12,activin binding,MF,ACVR1;FSTL3
13438,GO:0048854,0.013040140178496,0.998566524082846,3,33,brain morphogenesis,BP,CDH2;WNT5A;FGF8
784,GO:0001961,0.0130553851512829,0.998561618597191,3,34,positive regulation of cytokine-mediated signaling pathway,BP,EDN1;WNT5A;GAS6
11483,GO:0043560,0.0130772568913253,0.999368982157946,2,11,insulin receptor substrate binding,MF,PIK3R1;PIK3CA
15964,GO:0070473,0.0130872440597734,1,1,1,negative regulation of uterine smooth muscle contraction,BP,ADRA2C
18876,GO:1901654,0.0131655242326789,0.996227815569663,7,180,response to ketone,BP,EDN1;CDKN1A;MSN;GJB2;AKT1;CLDN1;GAS6
775,GO:0001952,0.0131794436254948,0.997202243716168,5,94,regulation of cell-matrix adhesion,BP,WNT4;PLAU;PIK3R1;SDC4;DDR1
12414,GO:0045913,0.0132705029283843,0.99779940686526,4,62,positive regulation of carbohydrate metabolic process,BP,ACTN3;PMAIP1;PDGFB;AKT1
20143,GO:1904591,0.013283423251857,0.997173042799223,5,96,positive regulation of protein import,BP,PIK3R2;PIK3R1;BMP6;BMP4;CDH1
6242,GO:0017046,0.0132890351545397,0.998523715736599,3,35,peptide hormone binding,MF,ACVR1;PIK3R1;NPR1
16903,GO:0072178,0.0133116061069981,0.999342738339955,2,12,nephric duct morphogenesis,BP,BMP4;EFNB2
3134,GO:0006357,0.0133515119860367,0.991866619082168,38,1840,regulation of transcription from RNA polymerase II promoter,BP,ITGA3;LIF;WNT2;POU3F1;NOTCH1;CRB2;WNT7A;ZFPM1;ACVR1;EDN1;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;TLE1;SIN3B;ZCCHC12;VDR;GDNF;FZD8;HEY1
11306,GO:0043268,0.0133722963200742,0.998516254843926,3,33,positive regulation of potassium ion transport,BP,ACTN2;ADORA1;KCNH2
17268,GO:0086030,0.0134898594376526,1,1,1,adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,CHGA
16509,GO:0071479,0.013527574579844,0.997741446698975,4,64,cellular response to ionizing radiation,BP,GADD45A;HRAS;RHOB;CDKN1A
13769,GO:0050931,0.0136486558578367,0.998471296934962,3,34,pigment cell differentiation,BP,RAB27A;KITLG;RAB38
15331,GO:0061045,0.0136792453171507,0.997708619926813,4,64,negative regulation of wound healing,BP,WNT4;EDN1;PLAU;PDGFB
8019,GO:0031583,0.0137123441355245,1,1,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,EDN1
8096,GO:0031707,0.0137123441355245,1,1,1,endothelin A receptor binding,MF,EDN1
9568,GO:0034696,0.0137123441355245,1,1,1,response to prostaglandin F,BP,EDN1
10758,GO:0042313,0.0137123441355245,1,1,1,protein kinase C deactivation,BP,EDN1
11243,GO:0043179,0.0137123441355245,1,1,1,rhythmic excitation,BP,EDN1
15177,GO:0060760,0.0137173961527698,0.998458110695013,3,35,positive regulation of response to cytokine stimulus,BP,EDN1;WNT5A;GAS6
18722,GO:1901214,0.0137720794523103,0.995256411248831,9,262,regulation of neuron death,BP,RRAS2;TYRO3;HRAS;FGF8;CLCF1;CHGA;AKT1;PIK3CA;GDNF
16675,GO:0071774,0.0137734414377229,0.996489301563189,6,139,response to fibroblast growth factor,BP,WNT4;FGF10;FGF17;WNT5A;FGF8;CTGF
15479,GO:0061371,0.013778394780638,0.997688428852455,4,63,determination of heart left/right asymmetry,BP,NOTCH1;WNT5A;FGF8;DLL1
6759,GO:0019901,0.0138025244569938,0.993765191903919,15,528,protein kinase binding,MF,CDH2;PIK3R2;PIK3R1;PRKAR1B;AXIN1;NPR1;SDC4;CDKN1A;MSN;AKT1;BCAR1;GAS6;SHC4;ARAF;ACTA2
5195,GO:0014037,0.013839627846189,0.998444719004786,3,33,Schwann cell differentiation,BP,POU3F1;AKT1;NAB2
21639,GO:2001237,0.0138574086026772,0.997016543836237,5,100,negative regulation of extrinsic apoptotic signaling pathway,BP,ACVR1;FGF10;BMP4;AKT1;GDNF
12288,GO:0045664,0.0139636546521011,0.993683613762154,15,529,regulation of neuron differentiation,BP,ITGA3;ADRA2B;ADRA2C;WNT3;NOTCH1;WNT7A;WNT5A;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;LZTS1
7055,GO:0021953,0.0140568722180932,0.995923978348689,7,172,central nervous system neuron differentiation,BP,WNT3;WNT2;WNT7A;SPTBN4;WNT5A;AXIN1;FGF8
11313,GO:0043277,0.0140878874029398,0.998400733457338,3,35,apoptotic cell clearance,BP,MFGE8;TYRO3;GAS6
7252,GO:0030136,0.0140964149481051,0.995908604303186,7,176,clathrin-coated vesicle,CC,RAB27A;TF;EDN1;WNT5A;SNX18;HBEGF;SH3BP4
14962,GO:0060442,0.0141538958795495,0.99927824165376,2,12,branching involved in prostate gland morphogenesis,BP,BMP7;BMP4
7625,GO:0030859,0.0141769036917691,0.999276450318138,2,12,polarized epithelial cell differentiation,BP,WNT5A;MSN
15895,GO:0070352,0.0142508635706967,0.999949076774984,1,2,positive regulation of white fat cell proliferation,BP,FGF10
12462,GO:0045989,0.0142552002575044,0.999254976607117,2,14,positive regulation of striated muscle contraction,BP,CHGA;CTGF
10601,GO:0040037,0.014256593410473,0.999270233825424,2,12,negative regulation of fibroblast growth factor receptor signaling pathway,BP,WNT4;WNT5A
14558,GO:0055002,0.0143144865704612,0.996323480124403,6,134,striated muscle cell development,BP,FHOD3;ACTN2;CASQ2;EDN1;BMP4;MYH11
755,GO:0001928,0.0143278679650243,1,1,1,regulation of exocyst assembly,BP,RALB
14768,GO:0060178,0.0143278679650243,1,1,1,regulation of exocyst localization,BP,RALB
12141,GO:0045335,0.0144037276828468,0.996867372924944,5,102,phagocytic vesicle,CC,ITGB5;RAB39A;RAB20;RAB11FIP1;RAB38
7322,GO:0030225,0.01442136689099,0.998345949016074,3,36,macrophage differentiation,BP,LIF;BMP4;TSPAN2
14918,GO:0060391,0.0144519900722092,0.999254912383408,2,12,positive regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
13437,GO:0048853,0.0145202167544917,0.999233738666021,2,14,forebrain morphogenesis,BP,WNT5A;FGF8
10188,GO:0036024,0.0145207074850369,1,1,1,protein C inhibitor-TMPRSS7 complex,CC,SERPINA5
10189,GO:0036025,0.0145207074850369,1,1,1,protein C inhibitor-TMPRSS11E complex,CC,SERPINA5
10190,GO:0036026,0.0145207074850369,1,1,1,protein C inhibitor-PLAT complex,CC,SERPINA5
10191,GO:0036027,0.0145207074850369,1,1,1,protein C inhibitor-PLAU complex,CC,SERPINA5
10192,GO:0036028,0.0145207074850369,1,1,1,protein C inhibitor-thrombin complex,CC,SERPINA5
10193,GO:0036029,0.0145207074850369,1,1,1,protein C inhibitor-KLK3 complex,CC,SERPINA5
10194,GO:0036030,0.0145207074850369,1,1,1,protein C inhibitor-plasma kallikrein complex,CC,SERPINA5
17789,GO:0097179,0.0145207074850369,1,1,1,protease inhibitor complex,CC,SERPINA5
17790,GO:0097180,0.0145207074850369,1,1,1,serine protease inhibitor complex,CC,SERPINA5
17791,GO:0097181,0.0145207074850369,1,1,1,protein C inhibitor-coagulation factor V complex,CC,SERPINA5
17792,GO:0097182,0.0145207074850369,1,1,1,protein C inhibitor-coagulation factor Xa complex,CC,SERPINA5
17793,GO:0097183,0.0145207074850369,1,1,1,protein C inhibitor-coagulation factor XI complex,CC,SERPINA5
10446,GO:0038034,0.0146004537120034,0.997500366741804,4,69,signal transduction in absence of ligand,BP,FGF10;AKT1;KITLG;GDNF
17798,GO:0097192,0.0146004537120034,0.997500366741804,4,69,extrinsic apoptotic signaling pathway in absence of ligand,BP,FGF10;AKT1;KITLG;GDNF
10066,GO:0035810,0.0146488809311146,0.999230715976878,2,13,positive regulation of urine volume,BP,EDN1;NPR1
5845,GO:0016264,0.0146596984064776,0.999238503397126,2,12,gap junction assembly,BP,GJB1;GJB2
14129,GO:0051543,0.0146715560604927,1,1,1,regulation of elastin biosynthetic process,BP,HBEGF
14130,GO:0051545,0.0146715560604927,1,1,1,negative regulation of elastin biosynthetic process,BP,HBEGF
6296,GO:0017145,0.0147079183811767,0.998306295282925,3,34,stem cell division,BP,NOTCH1;WNT7A;FZD7
13063,GO:0048009,0.0147389089041641,0.998295790669236,3,36,insulin-like growth factor receptor signaling pathway,BP,PIK3R1;BMP2;AKT1
16800,GO:0072017,0.0147760748520992,0.999229254892971,2,12,distal tubule development,BP,NOTCH1;WNK4
7888,GO:0031330,0.01478985593041,0.996170204023851,6,141,negative regulation of cellular catabolic process,BP,AKT1;PKP3;PKP1;PIK3CA;PIK3CG;LZTS1
7541,GO:0030670,0.0147968311770655,0.997456734140582,4,69,phagocytic vesicle membrane,CC,RAB39A;RAB20;RAB11FIP1;RAB38
1992,GO:0004454,0.0148629330196313,1,1,1,ketohexokinase activity,MF,KHK
8481,GO:0032420,0.0149236342525421,0.998266420161142,3,36,stereocilium,CC,CDH23;ESPN;MYO7A
629,GO:0001756,0.0149723200033913,0.997421493232916,4,66,somitogenesis,BP,NOTCH1;CRB2;WNT5A;DLL1
2925,GO:0006000,0.0150106406591356,0.99919388811953,2,14,fructose metabolic process,BP,KHK;PFKFB3
18509,GO:1900141,0.0151261390554543,1,1,1,regulation of oligodendrocyte apoptotic process,BP,GAS6
18510,GO:1900142,0.0151261390554543,1,1,1,negative regulation of oligodendrocyte apoptotic process,BP,GAS6
21282,GO:2000533,0.0151261390554543,1,1,1,negative regulation of renal albumin absorption,BP,GAS6
4457,GO:0009187,0.0151793659068005,0.995523535903872,7,192,cyclic nucleotide metabolic process,BP,GUCY1B3;EDN1;WNT5A;NPR1;CHGA;NPPC;PDE4B
15237,GO:0060900,0.0151812644896072,0.999196749600479,2,12,embryonic camera-type eye formation,BP,STRA6;WNT5A
3735,GO:0007257,0.015188120531464,0.998229960478522,3,34,activation of JUN kinase activity,BP,WNT7B;WNT5A;AXIN1
9675,GO:0035088,0.015190725547275,0.998223706995817,3,36,establishment or maintenance of apical/basal cell polarity,BP,CRB2;WNT5A;MSN
15431,GO:0061245,0.015190725547275,0.998223706995817,3,36,establishment or maintenance of bipolar cell polarity,BP,CRB2;WNT5A;MSN
650,GO:0001780,0.0152255551172938,0.999184005944882,2,13,neutrophil homeostasis,BP,JAM3;PDE4B
4271,GO:0008654,0.0152509934438822,0.994656905044272,9,266,phospholipid biosynthetic process,BP,MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;PIK3CA;PIK3CG
18062,GO:0098552,0.0153596058859797,0.993666179682193,12,412,side of membrane,CC,ITGA3;ITGA5;TF;SERPINA5;MFGE8;PTPN7;SNX18;FGF8;SPTB;CDH1;AMOT;MYZAP
578,GO:0001666,0.01540626685357,0.994238118193165,10,326,response to hypoxia,BP,NOTCH1;PMAIP1;ADORA1;EDN1;PLAU;BMP7;BMP2;AKT1;NPPC;CLDN3
16239,GO:0070986,0.0154619790199939,0.999164577714003,2,13,left/right axis specification,BP,NOTCH1;DLL1
12459,GO:0045986,0.0154797635074426,0.999155109359061,2,14,negative regulation of smooth muscle contraction,BP,ADRA2C;ADORA1
5639,GO:0015844,0.0156593519495744,0.997259227428072,4,72,monoamine transport,BP,ADRA2B;ADRA2C;CHGA;GDNF
16307,GO:0071156,0.0157110626780103,0.996505630748172,5,105,regulation of cell cycle arrest,BP,GADD45A;FGF10;FOXO4;CDKN1A;HMGN5
6238,GO:0017038,0.0157289793163434,0.994100651604227,10,316,protein import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
19614,GO:1903435,0.0158202517846849,1,1,1,positive regulation of constitutive secretory pathway,BP,RAB27A
19444,GO:1903076,0.0158696773058374,0.997219445586207,4,66,regulation of protein localization to plasma membrane,BP,ITGA3;PIK3R1;RHOQ;AKT1
8361,GO:0032242,0.0158884787754305,1,1,1,regulation of nucleoside transport,BP,ADORA1
8362,GO:0032244,0.0158884787754305,1,1,1,positive regulation of nucleoside transport,BP,ADORA1
8808,GO:0032900,0.0158884787754305,1,1,1,negative regulation of neurotrophin production,BP,ADORA1
15386,GO:0061143,0.0159024787391168,1,1,1,alveolar primary septum development,BP,STRA6
15138,GO:0060709,0.0159315920441284,1,1,1,glycogen cell differentiation involved in embryonic placenta development,BP,AKT1
18383,GO:0100002,0.0159315920441284,1,1,1,negative regulation of protein kinase activity by protein phosphorylation,BP,AKT1
3002,GO:0006113,0.0159449957044352,1,1,1,fermentation,BP,ACTN3
6659,GO:0019659,0.0159449957044352,1,1,1,glucose catabolic process to lactate,BP,ACTN3
6660,GO:0019660,0.0159449957044352,1,1,1,glycolytic fermentation,BP,ACTN3
6661,GO:0019661,0.0159449957044352,1,1,1,glucose catabolic process to lactate via pyruvate,BP,ACTN3
11414,GO:0043465,0.0159449957044352,1,1,1,regulation of fermentation,BP,ACTN3
19269,GO:1902690,0.0159449957044352,1,1,1,positive regulation of NAD metabolic process,BP,ACTN3
19901,GO:1904023,0.0159449957044352,1,1,1,regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
19902,GO:1904025,0.0159449957044352,1,1,1,positive regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
16957,GO:0072255,0.0159541015474937,1,1,1,metanephric glomerular mesangial cell development,BP,PDGFB
17668,GO:0090677,0.0159541015474937,1,1,1,reversible differentiation,BP,PDGFB
17669,GO:0090678,0.0159541015474937,1,1,1,cell dedifferentiation involved in phenotypic switching,BP,PDGFB
18568,GO:1900241,0.0159541015474937,1,1,1,positive regulation of phenotypic switching,BP,PDGFB
20409,GO:1905174,0.0159541015474937,1,1,1,regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
20410,GO:1905176,0.0159541015474937,1,1,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
20926,GO:1990936,0.0159541015474937,1,1,1,vascular smooth muscle cell dedifferentiation,BP,PDGFB
16435,GO:0071377,0.0160118748030851,0.998082435230043,3,39,cellular response to glucagon stimulus,BP,PRKACB;PRKAR1B;GJB2
15266,GO:0060957,0.0160796090332999,1,1,1,endocardial cell fate commitment,BP,ACVR1
15507,GO:0061445,0.0160796090332999,1,1,1,endocardial cushion cell fate commitment,BP,ACVR1
5323,GO:0014909,0.0160901245738592,0.997172332848148,4,64,smooth muscle cell migration,BP,PLAU;PDGFB;FOXO4;DDR1
16981,GO:0072299,0.0161380478731299,1,1,1,negative regulation of metanephric glomerulus development,BP,WT1
16984,GO:0072302,0.0161380478731299,1,1,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,WT1
13976,GO:0051258,0.0161789379547494,0.994693009699234,8,227,protein polymerization,BP,FHOD3;TUBG2;CASQ2;SPTBN5;SPTBN4;SCIN;PSRC1;SPTB
19725,GO:1903672,0.0162563275686727,0.999098134527011,2,13,positive regulation of sprouting angiogenesis,BP,ITGA5;DLL1
15829,GO:0070252,0.016291571868063,0.996346049808007,5,102,actin-mediated cell contraction,BP,ACTN3;ACTN2;DSC2;KCNH2;PDE4B
13829,GO:0051042,0.0163004134378256,1,1,1,negative regulation of calcium-independent cell-cell adhesion,BP,BMP2
15200,GO:0060804,0.0163004134378256,1,1,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,BMP2
12248,GO:0045618,0.0163145392376639,0.999084537454882,2,14,positive regulation of keratinocyte differentiation,BP,NOTCH1;VDR
1216,GO:0002696,0.0163174625472801,0.994213562328563,9,286,positive regulation of leukocyte activation,BP,FGF10;PIK3R1;WNT5A;CLCF1;CDKN1A;AKT1;PIK3CA;GAS6;EFNB2
12432,GO:0045933,0.0163270936789006,0.998030410898781,3,39,positive regulation of muscle contraction,BP,EDN1;CHGA;CTGF
12085,GO:0045202,0.0163335116894108,0.991581509872111,20,797,synapse,CC,ITGA3;ITGA5;TMEM163;ADRA2C;SYT5;ACTN2;RAB27A;WNT7A;ADORA1;RAB40B;RAB40A;CDH2;DRP2;VAMP1;AKT1;MYO7A;LZTS1;SHC4;LAMA5;PDE4B
8614,GO:0032605,0.0163470734062378,1,1,1,hepatocyte growth factor production,BP,INHBB
8643,GO:0032646,0.0163470734062378,1,1,1,regulation of hepatocyte growth factor production,BP,INHBB
8668,GO:0032686,0.0163470734062378,1,1,1,negative regulation of hepatocyte growth factor production,BP,INHBB
12809,GO:0046789,0.0163470734062378,1,1,1,host cell surface receptor binding,MF,INHBB
12813,GO:0046812,0.0163470734062378,1,1,1,host cell surface binding,MF,INHBB
13125,GO:0048175,0.0163470734062378,1,1,1,hepatocyte growth factor biosynthetic process,BP,INHBB
13126,GO:0048176,0.0163470734062378,1,1,1,regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
13127,GO:0048178,0.0163470734062378,1,1,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
5175,GO:0014004,0.0163578417130236,1,1,1,microglia differentiation,BP,TSPAN2
5176,GO:0014005,0.0163578417130236,1,1,1,microglia development,BP,TSPAN2
12171,GO:0045403,0.0163828806340783,1,1,1,negative regulation of interleukin-4 biosynthetic process,BP,ZFPM1
14906,GO:0060377,0.0163828806340783,1,1,1,negative regulation of mast cell differentiation,BP,ZFPM1
6910,GO:0021679,0.0164301112664264,1,1,1,cerebellar molecular layer development,BP,DLL1
6918,GO:0021687,0.0164301112664264,1,1,1,cerebellar molecular layer morphogenesis,BP,DLL1
6919,GO:0021688,0.0164301112664264,1,1,1,cerebellar molecular layer formation,BP,DLL1
15227,GO:0060853,0.0164301112664264,1,1,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,DLL1
3340,GO:0006629,0.0164577825537767,0.990567546548816,28,1307,lipid metabolic process,BP,WNT4;STRA6;ITGB8;DHH;HMGCS2;ADORA1;DKK3;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;SESN2;FGF8;SDC4;HBEGF;BMP6;BMP2;AKT1;PTGES;KITLG;PIK3CA;PIK3CG;SIN3B;VDR;ACSL4
15400,GO:0061162,0.0164680788988707,0.99908012224173,2,13,establishment of monopolar cell polarity,BP,WNT5A;MSN
15458,GO:0061339,0.0164680788988707,0.99908012224173,2,13,establishment or maintenance of monopolar cell polarity,BP,WNT5A;MSN
7016,GO:0021881,0.0164768880224928,1,1,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,AXIN1
15647,GO:0061772,0.0164854419737334,1,1,1,drug transport across blood-nerve barrier,BP,CLDN1
19660,GO:1903544,0.0164854419737334,1,1,1,response to butyrate,BP,CLDN1
19661,GO:1903545,0.0164854419737334,1,1,1,cellular response to butyrate,BP,CLDN1
18995,GO:1902010,0.0165135743467238,1,1,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
17407,GO:0090138,0.016556761691528,1,1,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,JAM3
1950,GO:0004375,0.0165708415030953,1,1,1,glycine dehydrogenase (decarboxylating) activity,MF,GLDC
6040,GO:0016642,0.0165708415030953,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,GLDC
609,GO:0001715,0.0165715851861805,1,1,1,ectodermal cell fate specification,BP,FZD7
10973,GO:0042665,0.0165715851861805,1,1,1,regulation of ectodermal cell fate specification,BP,FZD7
10974,GO:0042666,0.0165715851861805,1,1,1,negative regulation of ectodermal cell fate specification,BP,FZD7
21185,GO:2000383,0.0165715851861805,1,1,1,regulation of ectoderm development,BP,FZD7
21186,GO:2000384,0.0165715851861805,1,1,1,negative regulation of ectoderm development,BP,FZD7
3845,GO:0007568,0.0165726105078073,0.994109946696451,9,278,aging,BP,EDN1;FOXO4;HRAS;CDKN1A;CTGF;GJB2;GJB6;AKT1;CLDN1
8194,GO:0031945,0.0165728555536344,1,1,1,positive regulation of glucocorticoid metabolic process,BP,WNT4
8197,GO:0031948,0.0165728555536344,1,1,1,positive regulation of glucocorticoid biosynthetic process,BP,WNT4
15477,GO:0061369,0.0165728555536344,1,1,1,negative regulation of testicular blood vessel morphogenesis,BP,WNT4
20954,GO:2000019,0.0165728555536344,1,1,1,negative regulation of male gonad development,BP,WNT4
20986,GO:2000066,0.0165728555536344,1,1,1,positive regulation of cortisol biosynthetic process,BP,WNT4
21068,GO:2000225,0.0165728555536344,1,1,1,negative regulation of testosterone biosynthetic process,BP,WNT4
5884,GO:0016332,0.0165729579119896,1,1,1,establishment or maintenance of polarity of embryonic epithelium,BP,WNT7B
16825,GO:0072060,0.0165729579119896,1,1,1,outer medullary collecting duct development,BP,WNT7B
18893,GO:1901676,0.0165730242364785,1,1,1,positive regulation of histone H3-K27 acetylation,BP,LIF
14213,GO:0051695,0.0165733324969369,1,1,1,actin filament uncapping,BP,ACTN2
4147,GO:0008434,0.0165733324970843,1,1,1,calcitriol receptor activity,MF,VDR
10529,GO:0038186,0.0165733324970843,1,1,1,lithocholic acid receptor activity,MF,VDR
19025,GO:1902098,0.0165733324970843,1,1,1,calcitriol binding,MF,VDR
19041,GO:1902121,0.0165733324970843,1,1,1,lithocholic acid binding,MF,VDR
20707,GO:1990134,0.0165733324974048,1,1,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,JAG2
13014,GO:0047676,0.016573332497571,1,1,1,arachidonate-CoA ligase activity,MF,ACSL4
14624,GO:0055111,0.0165733324981148,1,1,1,ingression involved in gastrulation with mouth forming second,BP,CRB2
20812,GO:1990578,0.0165733324983119,1,1,1,perinuclear endoplasmic reticulum membrane,CC,PIK3R1
2455,GO:0005115,0.0165733324983451,1,1,1,receptor tyrosine kinase-like orphan receptor binding,MF,WNT5A
10418,GO:0036517,0.0165733324983451,1,1,1,chemoattraction of serotonergic neuron axon,BP,WNT5A
15462,GO:0061347,0.0165733324983451,1,1,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,WNT5A
15463,GO:0061348,0.0165733324983451,1,1,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,WNT5A
15464,GO:0061349,0.0165733324983451,1,1,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,WNT5A
15465,GO:0061350,0.0165733324983451,1,1,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,WNT5A
15467,GO:0061354,0.0165733324983451,1,1,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,WNT5A
15586,GO:0061642,0.0165733324983451,1,1,1,chemoattraction of axon,BP,WNT5A
19148,GO:1902379,0.0165733324983451,1,1,1,chemoattractant activity involved in axon guidance,MF,WNT5A
20314,GO:1904934,0.0165733324983451,1,1,1,negative regulation of cell proliferation in midbrain,BP,WNT5A
20325,GO:1904955,0.0165733324983451,1,1,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
20718,GO:1990172,0.0165733324983928,1,1,1,G-protein coupled receptor catabolic process,BP,GPRASP1
905,GO:0002140,0.016573332500198,1,1,1,stereocilia tip link,CC,MYO7A
7975,GO:0031477,0.016573332500198,1,1,1,myosin VII complex,CC,MYO7A
20778,GO:1990427,0.016573332500198,1,1,1,stereocilia tip-link density,CC,MYO7A
20782,GO:1990435,0.016573332500198,1,1,1,upper tip-link density,CC,MYO7A
1523,GO:0003270,0.0165733325024178,1,1,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
15221,GO:0060843,0.0165733325024178,1,1,1,venous endothelial cell differentiation,BP,NOTCH1
8245,GO:0032029,0.0165733325050705,1,1,1,myosin tail binding,MF,SPTBN5
10845,GO:0042470,0.0167578267009812,0.99621293624397,5,104,melanosome,CC,RAB27A;RAB17;MYO7A;MYH11;RAB38
13404,GO:0048770,0.0167578267009812,0.99621293624397,5,104,pigment granule,CC,RAB27A;RAB17;MYO7A;MYH11;RAB38
13305,GO:0048599,0.0167790553525359,0.997955141757214,3,39,oocyte development,BP,WNT4;NPPC;INHBB
4825,GO:0010508,0.0167817278261888,0.99620989928931,5,100,positive regulation of autophagy,BP,RALB;SESN2;RAB12;SH3BP4;PIM2
20041,GO:1904375,0.0167925994231924,0.997006383210091,4,67,regulation of protein localization to cell periphery,BP,ITGA3;PIK3R1;RHOQ;AKT1
8569,GO:0032536,0.0168070118384845,0.999051031358598,2,13,regulation of cell projection size,BP,WNT7A;WNT7B
18651,GO:1901017,0.0168108213969203,0.999041645613225,2,14,negative regulation of potassium ion transmembrane transporter activity,BP,ACTN2;CASQ2
15141,GO:0060712,0.0168733741573125,0.99902833997579,2,15,spongiotrophoblast layer development,BP,LIF;AKT1
16714,GO:0071850,0.0168798901589155,0.999035621579569,2,14,mitotic cell cycle arrest,BP,GADD45A;CDKN1A
13405,GO:0048771,0.0168812551260618,0.995498156473208,6,144,tissue remodeling,BP,LIF;FGF10;FGF8;VDR;RAB3D;CLDN18
14589,GO:0055065,0.0169086567544381,0.99239903308941,14,537,metal ion homeostasis,BP,CDH23;TF;ADORA1;CASQ2;EDN1;PRND;LPAR2;KCNH2;NPR1;BMP6;SFXN1;PIK3CG;VDR;CLDN16
4806,GO:0010464,0.0169223703438744,0.997943157383559,3,35,regulation of mesenchymal cell proliferation,BP,WNT2;WNT5A;BMP4
10126,GO:0035924,0.0169722558565449,0.997928437026331,3,37,cellular response to vascular endothelial growth factor stimulus,BP,NOTCH1;DLL1;AKT1
4823,GO:0010506,0.0170299548625258,0.993922997566416,9,267,regulation of autophagy,BP,PIK3R2;RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1;SH3BP4;PIM2
3034,GO:0006182,0.0171517694745081,0.997887266291827,3,41,cGMP biosynthetic process,BP,GUCY1B3;NPR1;NPPC
6830,GO:0021532,0.0171716933106546,0.997891935533886,3,38,neural tube patterning,BP,PRKACB;FGF8;BMP4
11511,GO:0043616,0.0171928242533402,0.997888369985151,3,38,keratinocyte proliferation,BP,FGF10;VDR;EFNB2
13839,GO:0051052,0.0172352552911831,0.993092952541647,11,364,regulation of DNA metabolic process,BP,FGF10;PDGFB;HRAS;CLCF1;BMP6;BMP4;CDKN1A;AKT1;KITLG;NPPC;PIK3CA
3894,GO:0008021,0.0172632291803145,0.995372918146545,6,145,synaptic vesicle,CC,TMEM163;SYT5;RAB40B;RAB40A;VAMP1;PDE4B
3779,GO:0007351,0.017307786652085,0.998998006048749,2,14,tripartite regional subdivision,BP,WNT5A;WT1
4241,GO:0008595,0.017307786652085,0.998998006048749,2,14,anterior/posterior axis specification, embryo,BP,WNT5A;WT1
5115,GO:0010934,0.0173687824129996,0.99899260281254,2,14,macrophage cytokine production,BP,WNT5A;GAS6
17384,GO:0090101,0.0174150730858932,0.996028044755011,5,102,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,NOTCH1;RASL11B;ACVR1;FSTL3;WNT5A
21003,GO:2000107,0.017487569392949,0.997827742057364,3,42,negative regulation of leukocyte apoptotic process,BP,BMP4;KITLG;GAS6
5973,GO:0016525,0.0175288103966214,0.996830354534224,4,70,negative regulation of angiogenesis,BP,NOTCH1;FOXO4;NPR1;AMOT
8292,GO:0032103,0.0175414510418789,0.994151570324897,8,258,positive regulation of response to external stimulus,BP,ARTN;EDN1;FGF10;PDGFB;WNT5A;BMP6;PIK3CG;GAS6
5082,GO:0010893,0.0176944557293042,0.998963580509478,2,14,positive regulation of steroid biosynthetic process,BP,WNT4;BMP6
5217,GO:0014061,0.0177157842088258,0.998953222634163,2,15,regulation of norepinephrine secretion,BP,ADRA2B;ADRA2C
15798,GO:0070201,0.0177182245483617,0.990953008817702,19,791,regulation of establishment of protein localization,BP,ITGA3;ADRA2C;PMAIP1;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;RHOQ;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6
19446,GO:1903078,0.0177217474642491,0.997798572836659,3,38,positive regulation of protein localization to plasma membrane,BP,ITGA3;PIK3R1;AKT1
20043,GO:1904377,0.0177217474642491,0.997798572836659,3,38,positive regulation of protein localization to cell periphery,BP,ITGA3;PIK3R1;AKT1
12349,GO:0045785,0.0177219510694445,0.992866059766989,11,378,positive regulation of cell adhesion,BP,ITGA3;ITGA5;WNT4;FSTL3;PIK3R1;WNT5A;SDC4;BMP7;AKT1;PIK3CA;EFNB2
11675,GO:0044232,0.0177573956421711,0.99895793816643,2,14,organelle membrane contact site,CC,RAB38;ACSL4
14725,GO:0060119,0.0178368143420316,0.997778898724617,3,38,inner ear receptor cell development,BP,CDH23;SDC4;MYO7A
16550,GO:0071548,0.0178570344959123,0.997766964368596,3,41,response to dexamethasone,BP,EDN1;GJB2;CLDN1
7681,GO:0030949,0.0179051082229453,0.998936070712107,2,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,ITGA5;FGF10
14084,GO:0051446,0.017935111521413,0.998941948301541,2,14,positive regulation of meiotic cell cycle,BP,WNT4;WNT5A
696,GO:0001841,0.0179556643597522,0.995875122773487,5,100,neural tube formation,BP,PRKACB;WNT5A;SDC4;BMP7;BMP4
9610,GO:0034766,0.0179952936568051,0.99671605512402,4,73,negative regulation of ion transmembrane transport,BP,ACTN2;CASQ2;KCNH2;AKT1
16583,GO:0071599,0.018028495915622,0.998924839487471,2,15,otic vesicle development,BP,FGF10;FGF8
12659,GO:0046474,0.0180519245274661,0.993960364528898,8,227,glycerophospholipid biosynthetic process,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;PIK3CA;PIK3CG
6758,GO:0019900,0.0181178665535951,0.991314680503721,16,596,kinase binding,MF,GADD45A;CDH2;PIK3R2;PIK3R1;PRKAR1B;AXIN1;NPR1;SDC4;CDKN1A;MSN;AKT1;BCAR1;GAS6;SHC4;ARAF;ACTA2
21243,GO:2000479,0.0181434963004109,0.998923089809776,2,14,regulation of cAMP-dependent protein kinase activity,BP,PRKAR1B;SESN2
6757,GO:0019899,0.0181544264501421,0.98876245944254,37,1773,enzyme binding,MF,ITGA3;RIN3;TSPAN15;TSPAN17;NOTCH1;GLDC;GADD45A;CRB2;SERPINA5;PRKACB;SPTBN4;CDH2;PRR5L;PIK3R2;PIK3R1;KCNH2;PRKAR1B;FOXO4;RALB;MAGEC2;AXIN1;NPR1;SDC4;DAAM2;CDKN1A;MSN;AKT1;PKP3;BCAR1;RAB11FIP1;GAS6;SHC4;ARAF;SH3BP4;FZD8;ACTA2;RNF144A
21671,GO:2001275,0.0182783576524993,0.998910822488802,2,14,positive regulation of glucose import in response to insulin stimulus,BP,PIK3R2;PIK3R1
12666,GO:0046486,0.0184175312884678,0.99220995021404,12,423,glycerolipid metabolic process,BP,MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG;ACSL4
12757,GO:0046651,0.0185447781780437,0.993755976883408,8,253,lymphocyte proliferation,BP,WNT4;FGF10;SDC4;CLCF1;BMP4;CDKN1A;MSN;PIK3CG
15855,GO:0070293,0.0185628765920719,0.998875719846001,2,15,renal absorption,BP,WNK4;GAS6
21001,GO:2000105,0.0186688771771815,0.998875024036272,2,14,positive regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
15098,GO:0060661,0.0187777901431215,0.999911381986097,1,2,submandibular salivary gland formation,BP,FGF10
16404,GO:0071335,0.0187777901431215,0.999911381986097,1,2,hair follicle cell proliferation,BP,FGF10
16405,GO:0071336,0.0187777901431215,0.999911381986097,1,2,regulation of hair follicle cell proliferation,BP,FGF10
16406,GO:0071338,0.0187777901431215,0.999911381986097,1,2,positive regulation of hair follicle cell proliferation,BP,FGF10
4708,GO:0009994,0.0188689590666315,0.997591125775909,3,41,oocyte differentiation,BP,WNT4;NPPC;INHBB
14581,GO:0055037,0.0189540415260684,0.994815708188474,6,142,recycling endosome,CC,SYT5;TF;FZD7;RAB12;RAB17;RAB11FIP1
10371,GO:0036461,0.019005922330683,0.999909205108957,1,2,BLOC-2 complex binding,MF,RAB38
3618,GO:0007050,0.0190190484604009,0.993573832144707,8,233,cell cycle arrest,BP,GADD45A;MAPK12;FGF10;FOXO4;HRAS;CDKN1A;HMGN5;GAS6
13967,GO:0051249,0.0190384019219632,0.992252406671311,11,390,regulation of lymphocyte activation,BP,TYRO3;FGF10;PIK3R1;SDC4;CLCF1;BMP4;CDKN1A;AKT1;PIK3CA;GAS6;EFNB2
11495,GO:0043584,0.0191455586119789,0.998821283068131,2,15,nose development,BP,STRA6;AXIN1
7862,GO:0031295,0.0191539115597637,0.99643448393852,4,76,T cell costimulation,BP,PIK3R1;AKT1;PIK3CA;EFNB2
7603,GO:0030828,0.019176234348906,0.998790624257662,2,19,positive regulation of cGMP biosynthetic process,BP,NPR1;NPPC
1450,GO:0003159,0.0192487940880331,0.998811543759924,2,15,morphogenesis of an endothelium,BP,RHOB;BMP4
15395,GO:0061154,0.0192487940880331,0.998811543759924,2,15,endothelial tube morphogenesis,BP,RHOB;BMP4
8840,GO:0032943,0.019500358529454,0.993373288129391,8,255,mononuclear cell proliferation,BP,WNT4;FGF10;SDC4;CLCF1;BMP4;CDKN1A;MSN;PIK3CG
8741,GO:0032794,0.019511446255215,0.998796404099654,2,14,GTPase activating protein binding,MF,AKT1;CDH1
12848,GO:0046879,0.0195723921932324,0.992845011136075,9,285,hormone secretion,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;BMP6;INHBB;RAB11FIP1;KCNG2
14103,GO:0051489,0.0196017583659533,0.997474616540364,3,37,regulation of filopodium assembly,BP,RHOQ;ESPN;RAB17
19652,GO:1903533,0.0196206238091435,0.992824702754514,9,284,regulation of protein targeting,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CDH1;GAS6
15233,GO:0060876,0.0197142188107628,0.999902276416691,1,2,semicircular canal formation,BP,FGF10
6755,GO:0019897,0.0197459386857721,0.994546126945479,6,147,extrinsic component of plasma membrane,CC,TF;MFGE8;CDH2;SNX18;CDH1;MYZAP
5001,GO:0010799,0.0197734500005956,0.9974405222481,3,38,regulation of peptidyl-threonine phosphorylation,BP,WNT5A;AXIN1;BMP7
9269,GO:0034109,0.0198845704460132,0.996264481360684,4,71,homotypic cell-cell adhesion,BP,DSC2;TYRO3;PIK3CG;GAS6
3638,GO:0007088,0.0199041621531522,0.994491948294271,6,148,regulation of mitotic nuclear division,BP,EDN1;PDGFB;PSRC1;FGF8;BMP7;BMP4
7768,GO:0031100,0.0199124072128434,0.996248456996284,4,77,animal organ regeneration,BP,NOTCH1;CDKN1A;CLDN1;GAS6
14131,GO:0051546,0.0199589584659535,0.998743782483125,2,15,keratinocyte migration,BP,FGF10;HBEGF
10539,GO:0038201,0.0200469386237037,0.998735295470253,2,15,TOR complex,CC,PRR5L;SESN2
19031,GO:1902105,0.0201979521985833,0.993097833831248,8,239,regulation of leukocyte differentiation,BP,LIF;ZFPM1;FSTL3;PIK3R1;BMP4;KITLG;GAS6;CLDN18
11743,GO:0044331,0.0202051227998165,0.998719985394553,2,15,cell-cell adhesion mediated by cadherin,BP,CDH2;WNT5A
4985,GO:0010761,0.0204808391290025,0.997313601181506,3,38,fibroblast migration,BP,PRR5L;SDC4;AKT1
9387,GO:0034349,0.0205008055320602,0.998691192807829,2,15,glial cell apoptotic process,BP,DLL1;GAS6
13151,GO:0048243,0.0205373709083948,0.998678430190783,2,16,norepinephrine secretion,BP,ADRA2B;ADRA2C
21638,GO:2001236,0.0205994639378412,0.994253602636473,6,151,regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1;ACVR1;FGF10;BMP4;AKT1;GDNF
19419,GO:1903034,0.0206577917175849,0.994235101856631,6,149,regulation of response to wounding,BP,WNT4;EDN1;PLAU;PDGFB;HRAS;HBEGF
7861,GO:0031294,0.0207192112950033,0.996046705209408,4,79,lymphocyte costimulation,BP,PIK3R1;AKT1;PIK3CA;EFNB2
20658,GO:1905939,0.020731996743057,0.998651018088469,2,17,regulation of gonad development,BP,WNT4;WT1
1214,GO:0002694,0.0207493200517939,0.99107147379222,12,446,regulation of leukocyte activation,BP,TYRO3;FGF10;PIK3R1;WNT5A;SDC4;CLCF1;BMP4;CDKN1A;AKT1;PIK3CA;GAS6;EFNB2
16901,GO:0072176,0.0207815684646469,0.99866364363012,2,15,nephric duct development,BP,BMP4;EFNB2
15822,GO:0070242,0.0207919168189978,0.998653266404335,2,16,thymocyte apoptotic process,BP,WNT5A;BMP4
11618,GO:0044060,0.0208078242340028,0.99723786636202,3,43,regulation of endocrine process,BP,BMP6;INHBB;RAB11FIP1
4902,GO:0010638,0.0208726667645057,0.990080747384888,15,584,positive regulation of organelle organization,BP,LIF;WNT4;ACTN2;PMAIP1;EDN1;PDGFB;RALB;HRAS;WNT5A;SCIN;PSRC1;FGF8;SDC4;MSN;CTGF
14599,GO:0055078,0.020873244840373,0.997225898597196,3,43,sodium ion homeostasis,BP,ADORA1;EDN1;NPR1
6718,GO:0019828,0.0208969622197446,0.999890132700177,1,2,aspartic-type endopeptidase inhibitor activity,MF,CRB2
11821,GO:0044456,0.0209016219731553,0.989568745324378,17,663,synapse part,CC,ITGA3;TMEM163;ADRA2C;SYT5;ACTN2;WNT7A;ADORA1;RAB40B;RAB40A;CDH2;DRP2;VAMP1;AKT1;LZTS1;SHC4;LAMA5;PDE4B
5271,GO:0014821,0.0209373831960356,0.998630501380871,2,17,phasic smooth muscle contraction,BP,EDN1;GDNF
21002,GO:2000106,0.0209743987327032,0.99598325108964,4,79,regulation of leukocyte apoptotic process,BP,WNT5A;BMP4;KITLG;GAS6
8894,GO:0033026,0.0210963415052051,0.999888014807023,1,2,negative regulation of mast cell apoptotic process,BP,KITLG
16779,GO:0071963,0.0212297279664463,0.999886586508052,1,2,establishment or maintenance of cell polarity regulating cell shape,BP,PARVB
7097,GO:0022407,0.0212376280453262,0.991216252143795,11,389,regulation of cell-cell adhesion,BP,WNT4;FSTL3;PIK3R1;WNT5A;SDC4;BMP7;BMP4;AKT1;CDH1;PIK3CA;EFNB2
15320,GO:0061033,0.0213461365226639,0.999885332531353,1,2,secretion by lung epithelial cell involved in lung growth,BP,FGF10
15072,GO:0060595,0.0213462994584523,0.999885330771291,1,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,FGF10
15085,GO:0060615,0.0213462994584523,0.999885330771291,1,2,mammary gland bud formation,BP,FGF10
15103,GO:0060667,0.0213462994584523,0.999885330771291,1,2,branch elongation involved in salivary gland morphogenesis,BP,FGF10
15246,GO:0060915,0.0213462994584523,0.999885330771291,1,2,mesenchymal cell differentiation involved in lung development,BP,FGF10
12298,GO:0045683,0.0213646416423651,0.998587470817522,2,17,negative regulation of epidermis development,BP,NOTCH1;DLL1
10819,GO:0042418,0.0213680464212377,0.999885095734125,1,2,epinephrine biosynthetic process,BP,PNMT
14106,GO:0051492,0.0213705288756259,0.995899197746501,4,70,regulation of stress fiber assembly,BP,WNT4;PIK3R1;SDC4;CTGF
2492,GO:0005161,0.021434121587358,0.99861008070231,2,14,platelet-derived growth factor receptor binding,MF,ITGA5;PDGFB
21202,GO:2000406,0.0215535001153607,0.998547607320485,2,20,positive regulation of T cell migration,BP,CCL20;WNT5A
20417,GO:1905208,0.0215806246043337,0.9985841317666,2,15,negative regulation of cardiocyte differentiation,BP,FZD7;BMP2
6965,GO:0021784,0.0216408928687008,0.999882126185458,1,2,postganglionic parasympathetic fiber development,BP,GDNF
14215,GO:0051701,0.0216632630646641,0.993144837757973,7,190,interaction with host,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
3776,GO:0007346,0.0218257174334945,0.990186508580487,13,492,regulation of mitotic cell cycle,BP,GADD45A;EDN1;FGF10;PDGFB;FOXO4;HRAS;PSRC1;FGF8;BMP7;BMP4;CDKN1A;AKT1;PIM2
21019,GO:2000136,0.0220346747221242,0.99852801683527,2,16,regulation of cell proliferation involved in heart morphogenesis,BP,NOTCH1;BMP4
11477,GO:0043551,0.022273681114156,0.996980286970754,3,39,regulation of phosphatidylinositol 3-kinase activity,BP,PIK3R2;PIK3R1;PDGFB
14936,GO:0060413,0.0223649345585141,0.998504513753222,2,15,atrial septum morphogenesis,BP,ZFPM1;ACVR1
9099,GO:0033554,0.0224013039373089,0.986083665958096,35,1745,cellular response to stress,BP,WNT4;NOTCH1;PMAIP1;GADD45A;DSC2;WNT7A;WNT7B;SLC52A3;GUCY1B3;EDN1;MAPK12;FZD7;PRR5L;FGF10;PIK3R2;PIK3R1;FOXO4;RALB;HRAS;WNT5A;JAM3;SESN2;AXIN1;RHOB;NUAK2;BMP7;BMP2;CDKN1A;CTGF;GJB2;AKT1;WNT2B;INHBB;GAS6;FZD8
9607,GO:0034763,0.0225129308104073,0.995595588365375,4,79,negative regulation of transmembrane transport,BP,ACTN2;CASQ2;KCNH2;AKT1
15285,GO:0060986,0.0225158489000943,0.996917515964511,3,44,endocrine hormone secretion,BP,BMP6;INHBB;RAB11FIP1
19227,GO:1902582,0.0227257548677977,0.988545479338897,17,694,single-organism intracellular transport,BP,SYT5;RAB27A;WNT7A;FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CHGA;AKT1;RAB17;CDH1;MYO7A;PIK3CG;GAS6
14940,GO:0060419,0.023030199891405,0.995473791414298,4,73,heart growth,BP,WNT2;NOTCH1;EDN1;WT1
14247,GO:0051767,0.023060479002778,0.998412079438279,2,17,nitric-oxide synthase biosynthetic process,BP,EDN1;CCL20
14248,GO:0051769,0.023060479002778,0.998412079438279,2,17,regulation of nitric-oxide synthase biosynthetic process,BP,EDN1;CCL20
14220,GO:0051707,0.0230905856991843,0.988330808978518,17,790,response to other organism,BP,NOTCH1;PMAIP1;EDN1;CCL20;FGF10;HRAS;WNT5A;BMP6;CHGA;GJB2;GJB6;AKT1;PTGES;CLDN1;ACTA2;PIM2;PDE4B
18771,GO:1901338,0.0232462753417642,0.998376132552216,2,19,catecholamine binding,MF,ADRA2B;ADRA2C
13643,GO:0050766,0.0232681197966504,0.996771461979262,3,45,positive regulation of phagocytosis,BP,RAB27A;MFGE8;GAS6
19420,GO:1903035,0.0233080206356958,0.995398790337158,4,75,negative regulation of response to wounding,BP,WNT4;EDN1;PLAU;PDGFB
11262,GO:0043207,0.0234160885950348,0.988147112576536,17,791,response to external biotic stimulus,BP,NOTCH1;PMAIP1;EDN1;CCL20;FGF10;HRAS;WNT5A;BMP6;CHGA;GJB2;GJB6;AKT1;PTGES;CLDN1;ACTA2;PIM2;PDE4B
5017,GO:0010818,0.0235922855703437,0.998331886704818,2,20,T cell chemotaxis,BP,WNT5A;PIK3CG
15721,GO:0070080,0.0237223168890171,0.999858210873302,1,2,titin Z domain binding,MF,ACTN2
16015,GO:0070557,0.023759112936471,0.999857767994181,1,2,PCNA-p21 complex,CC,CDKN1A
16003,GO:0070542,0.0237597350805358,0.995276889118982,4,78,response to fatty acid,BP,EDN1;CTGF;AKT1;CLDN1
11056,GO:0042813,0.0237602300035411,0.998359089109484,2,15,Wnt-activated receptor activity,MF,FZD7;FZD8
11800,GO:0044430,0.0238029460149152,0.985669932390046,30,1452,cytoskeletal part,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;PRKACB;SPTBN5;SPTBN4;CDH2;CGN;PLEKHH2;RHOQ;SCIN;PSRC1;SPTB;CAMSAP3;ESPN;AKT1;PKP1;CDH1;MYO7A;CLDN5;MYH11;AMOT;UNC119;RAB3D;MYZAP;FAM110B;PDE4B
17406,GO:0090136,0.0238643996567676,0.998348040325139,2,15,epithelial cell-cell adhesion,BP,ITGB5;CAMSAP3
796,GO:0001974,0.0238878639690342,0.996662471062572,3,42,blood vessel remodeling,BP,LIF;FGF10;FGF8
14917,GO:0060390,0.0238955773243833,0.998333193567133,2,16,regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
1204,GO:0002684,0.0239535206622024,0.987146158025501,20,904,positive regulation of immune system process,BP,LIF;EDN1;PRKACB;CCL20;TYRO3;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;SCIN;CLCF1;CDKN1A;AKT1;KITLG;BCAR1;PIK3CA;GAS6;EFNB2;PDE4B
4071,GO:0008307,0.0240202104254695,0.996623487768488,3,46,structural constituent of muscle,MF,ACTN3;ACTN2;MYH11
4947,GO:0010717,0.024049148602326,0.995211085509171,4,73,regulation of epithelial to mesenchymal transition,BP,NOTCH1;CRB2;ACVR1;BMP2
5881,GO:0016327,0.0240746416707246,0.998294670038357,2,18,apicolateral plasma membrane,CC,CLDN3;CLDN5
7891,GO:0031333,0.024220984478766,0.993976338322679,5,114,negative regulation of protein complex assembly,BP,FHOD3;SPTBN5;SPTBN4;SCIN;SPTB
13701,GO:0050852,0.0242228122369296,0.992979694585306,6,168,T cell receptor signaling pathway,BP,PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
21040,GO:2000177,0.0242669602695325,0.995156508673995,4,72,regulation of neural precursor cell proliferation,BP,NOTCH1;LIMS2;CDH2;WNT5A
13732,GO:0050886,0.0244255704527427,0.995101876420528,4,79,endocrine process,BP,EDN1;BMP6;INHBB;RAB11FIP1
15812,GO:0070231,0.0244621934651585,0.996531444654733,3,48,T cell apoptotic process,BP,WNT5A;BMP4;AKT1
3720,GO:0007220,0.0246404302430308,0.998252823442261,2,16,Notch receptor processing,BP,DLL1;JAG2
4681,GO:0009914,0.0247601391078795,0.990574221039849,9,297,hormone transport,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;BMP6;INHBB;RAB11FIP1;KCNG2
14110,GO:0051496,0.024828713478027,0.996475914630268,3,43,positive regulation of stress fiber assembly,BP,WNT4;SDC4;CTGF
15219,GO:0060841,0.0248754165414718,0.998227189352078,2,16,venous blood vessel development,BP,NOTCH1;EFNB2
6352,GO:0018107,0.0248845834785783,0.993775567249657,5,108,peptidyl-threonine phosphorylation,BP,ACVR1;WNT5A;AXIN1;BMP7;AKT1
13228,GO:0048389,0.0249321728959854,0.999843282422756,1,2,intermediate mesoderm development,BP,BMP4
15428,GO:0061227,0.0249321728959854,0.999843282422756,1,2,pattern specification involved in mesonephros development,BP,BMP4
16849,GO:0072098,0.0249321728959854,0.999843282422756,1,2,anterior/posterior pattern specification involved in kidney development,BP,BMP4
19268,GO:1902688,0.0250379518847583,0.99984194124479,1,2,regulation of NAD metabolic process,BP,ACTN3
12379,GO:0045840,0.02508295885325,0.996418884991558,3,45,positive regulation of mitotic nuclear division,BP,EDN1;PDGFB;FGF8
14088,GO:0051452,0.0250953165684992,0.996406918943597,3,48,intracellular pH reduction,BP,RAB39A;RAB20;RAB38
12235,GO:0045599,0.025145055062644,0.996417593238947,3,42,negative regulation of fat cell differentiation,BP,ZFPM1;WNT5A;AXIN1
9356,GO:0034260,0.025274397062186,0.996388267776261,3,43,negative regulation of GTPase activity,BP,HRAS;AMOT;SH3BP4
16942,GO:0072224,0.0252994154574675,0.998180600445754,2,16,metanephric glomerulus development,BP,PDGFB;WT1
20723,GO:1990182,0.0253025152843045,0.998159432600276,2,18,exosomal secretion,BP,RAB27A;SDC4
5868,GO:0016307,0.0253102436942054,0.998179405001702,2,16,phosphatidylinositol phosphate kinase activity,MF,PIK3CA;PIK3CG
19754,GO:1903729,0.0253194649302207,0.994872465342395,4,76,regulation of plasma membrane organization,BP,ITGA3;PIK3R1;RHOQ;AKT1
4087,GO:0008333,0.0253622600530071,0.996374786243021,3,42,endosome to lysosome transport,BP,GPRASP1;RHOB;RAB12
21641,GO:2001239,0.0253786295980753,0.996353874336957,3,47,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,FGF10;AKT1;GDNF
17722,GO:0097059,0.0254351705865012,0.999836853201583,1,2,CNTFR-CLCF1 complex,CC,CLCF1
5266,GO:0014812,0.0254549094382119,0.994840702852567,4,74,muscle cell migration,BP,PLAU;PDGFB;FOXO4;DDR1
13580,GO:0050680,0.0254603701836475,0.993587354025329,5,113,negative regulation of epithelial cell proliferation,BP,LIMS2;WNT5A;BMP4;VDR;EFNB2
12458,GO:0045981,0.0254724067493086,0.993565297878893,5,130,positive regulation of nucleotide metabolic process,BP,ACTN3;WNT5A;NPR1;CHGA;NPPC
18621,GO:1900544,0.0254724067493086,0.993565297878893,5,130,positive regulation of purine nucleotide metabolic process,BP,ACTN3;WNT5A;NPR1;CHGA;NPPC
21067,GO:2000224,0.0254892196307155,0.999836154566857,1,2,regulation of testosterone biosynthetic process,BP,WNT4
10861,GO:0042493,0.0256590646511273,0.989077149470832,11,405,response to drug,BP,ITGA3;RAB6C;EDN1;KCNH2;FGF8;CDKN1A;NPPC;CDH1;CLDN1;GAS6;PDE4B
14629,GO:0055119,0.0256602648698417,0.998129331500641,2,17,relaxation of cardiac muscle,BP,CHGA;PDE4B
32,GO:0000060,0.0256674093837052,0.996296453863955,3,47,protein import into nucleus, translocation,BP,CDKN1A;AKT1;GAS6
8482,GO:0032421,0.0257046184454602,0.996299323379905,3,44,stereocilium bundle,CC,CDH23;ESPN;MYO7A
15028,GO:0060538,0.0257392684883583,0.992447959184591,6,154,skeletal muscle organ development,BP,ACTN3;NOTCH1;STRA6;IGSF8;WT1;DLL1
12186,GO:0045445,0.0257748345252365,0.994746048484262,4,79,myoblast differentiation,BP,NOTCH1;MAPK12;BMP4;DLL1
13698,GO:0050849,0.0258370700313287,0.998099415169331,2,18,negative regulation of calcium-mediated signaling,BP,ACTN3;CASQ2
13429,GO:0048841,0.0259243727228857,0.998111147586301,2,16,regulation of axon extension involved in axon guidance,BP,WNT3;WNT5A
3969,GO:0008150,0.0259291317249393,0.986375641012649,228,16026,biological_process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;RHBDL3;FBXO41;SLC45A4;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;SEMA6C;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;HAPLN3;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;PM20D2;SHC4;SLC18B1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
3778,GO:0007350,0.0259320848160425,0.998098824386116,2,17,blastoderm segmentation,BP,WNT5A;WT1
19607,GO:1903428,0.0260502442149242,0.996219936738037,3,47,positive regulation of reactive oxygen species biosynthetic process,BP,RAB27A;EDN1;AKT1
3524,GO:0006904,0.026266352766516,0.996190997671948,3,43,vesicle docking involved in exocytosis,BP,RAB40B;RAB40A;RALB
10167,GO:0035993,0.0263526261252641,0.999824789118851,1,2,deltoid tuberosity development,BP,BMP4
20313,GO:1904933,0.0264842129388869,0.999823023056982,1,2,regulation of cell proliferation in midbrain,BP,WNT5A
12385,GO:0045851,0.0265429225016014,0.996114397903316,3,49,pH reduction,BP,RAB39A;RAB20;RAB38
13362,GO:0048697,0.0265917969733269,0.99982157247296,1,2,positive regulation of collateral sprouting in absence of injury,BP,WNT3
10763,GO:0042323,0.0266834069767503,0.999820332540002,1,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADORA1
15833,GO:0070256,0.0266834069767503,0.999820332540002,1,2,negative regulation of mucus secretion,BP,ADORA1
12063,GO:0045168,0.026726827879562,0.999819743321805,1,2,cell-cell signaling involved in cell fate commitment,BP,DLL1
12597,GO:0046331,0.026726827879562,0.999819743321805,1,2,lateral inhibition,BP,DLL1
7601,GO:0030826,0.026732286807313,0.997964774590162,2,22,regulation of cGMP biosynthetic process,BP,NPR1;NPPC
18287,GO:0099054,0.0268199533798463,0.998010010208664,2,16,presynapse assembly,BP,WNT7A;WNT5A
8281,GO:0032092,0.0268614638203979,0.994455103198769,4,79,positive regulation of protein binding,BP,RALB;WNT5A;BMP4;BMP2
18635,GO:1900745,0.0268702742704118,0.997981477053545,2,18,positive regulation of p38MAPK cascade,BP,GADD45A;BMP2
13969,GO:0051251,0.0268901402830825,0.990300591388184,8,261,positive regulation of lymphocyte activation,BP,FGF10;PIK3R1;CLCF1;CDKN1A;AKT1;PIK3CA;GAS6;EFNB2
9086,GO:0033500,0.0269162777082994,0.991089223840433,7,204,carbohydrate homeostasis,BP,PIK3R2;PIK3R1;SESN2;GJB6;AKT1;PIK3CA;GAS6
10934,GO:0042593,0.0269162777082994,0.991089223840433,7,204,glucose homeostasis,BP,PIK3R2;PIK3R1;SESN2;GJB6;AKT1;PIK3CA;GAS6
11286,GO:0043241,0.0269318331863314,0.991070193234474,7,227,protein complex disassembly,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;AXIN1;SCIN;SPTB
20507,GO:1905438,0.0269325669537672,0.999816938164748,1,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
10108,GO:0035886,0.0269609156084285,0.99797100989701,2,18,vascular smooth muscle cell differentiation,BP,NOTCH1;PDGFB
14023,GO:0051341,0.0270580625765802,0.994389448559482,4,86,regulation of oxidoreductase activity,BP,EDN1;AKT1;VDR;GDNF
11750,GO:0044338,0.027122764824496,0.999814325370549,1,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,WNT3
2898,GO:0005960,0.0271745382823807,0.999813610895625,1,2,glycine cleavage complex,CC,GLDC
10065,GO:0035809,0.0271963157836607,0.997925291638275,2,20,regulation of urine volume,BP,EDN1;NPR1
9325,GO:0034199,0.0272272882257318,0.997951057609903,2,17,activation of protein kinase A activity,BP,PRKACB;PRKAR1B
21675,GO:2001287,0.0272403800504219,0.999812700268139,1,2,negative regulation of caveolin-mediated endocytosis,BP,UNC119
5123,GO:0010948,0.0272734754879387,0.990135752587993,8,262,negative regulation of cell cycle process,BP,LIF;GADD45A;FGF10;FOXO4;BMP7;BMP4;CDKN1A;HMGN5
12712,GO:0046579,0.0275286317440804,0.995927627465224,3,45,positive regulation of Ras protein signal transduction,BP,FGF10;HRAS;KITLG
2836,GO:0005856,0.0275745985847132,0.982286994995049,38,1934,cytoskeleton,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;PRKACB;SPTBN5;SPTBN4;CDH2;CGN;PLEKHH2;PTPN7;FRMPD1;PSTPIP2;RHOQ;SCIN;PSRC1;SPTB;CAMSAP3;ESPN;MSN;AKT1;PKP1;KITLG;CDH1;MYO7A;BCAR1;CLDN5;MYH11;AMOT;UNC119;RAB3D;MYZAP;FAM110B;ACTA2;PARVB;PDE4B
16250,GO:0070997,0.0277190668549196,0.989240194410297,9,296,neuron death,BP,RRAS2;TYRO3;HRAS;FGF8;CLCF1;CHGA;AKT1;PIK3CA;GDNF
7996,GO:0031527,0.0277270330601799,0.997892991972178,2,17,filopodium membrane,CC,ITGA3;TTYH1
20490,GO:1905384,0.0277736871490974,0.999805241395259,1,2,regulation of protein localization to presynapse,BP,WNT7A
20491,GO:1905386,0.0277736871490974,0.999805241395259,1,2,positive regulation of protein localization to presynapse,BP,WNT7A
21401,GO:2000696,0.0277900936611575,0.997874362850009,2,18,regulation of epithelial cell differentiation involved in kidney development,BP,LIF;GDNF
8803,GO:0032891,0.0278093482981099,0.997883372098704,2,17,negative regulation of organic acid transport,BP,ADORA1;AKT1
13094,GO:0048066,0.0278499966626513,0.995861742033223,3,45,developmental pigmentation,BP,RAB27A;KITLG;RAB38
7889,GO:0031331,0.0278657446883969,0.988544088355771,10,352,positive regulation of cellular catabolic process,BP,PRR5L;RALB;SESN2;AXIN1;MSN;AKT1;RAB12;SH3BP4;RNF144A;PIM2
16308,GO:0071157,0.0279727834727206,0.997833612416136,2,20,negative regulation of cell cycle arrest,BP,FGF10;HMGN5
2479,GO:0005146,0.0280223699639306,0.999801712795813,1,2,leukemia inhibitory factor receptor binding,MF,LIF
18962,GO:1901899,0.0280443165292718,0.999801399849462,1,2,positive regulation of relaxation of cardiac muscle,BP,CHGA
9189,GO:0033762,0.0280552025845441,0.995808460881163,3,48,response to glucagon,BP,PRKACB;PRKAR1B;GJB2
19242,GO:1902612,0.0281961242741318,0.999799228297264,1,2,regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
19243,GO:1902613,0.0281961242741318,0.999799228297264,1,2,negative regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
20741,GO:1990262,0.0281961242741318,0.999799228297264,1,2,anti-Mullerian hormone signaling pathway,BP,DKK3
21567,GO:2001074,0.0282378112651622,0.999798629884323,1,2,regulation of metanephric ureteric bud development,BP,WT1
21568,GO:2001076,0.0282378112651622,0.999798629884323,1,2,positive regulation of metanephric ureteric bud development,BP,WT1
10061,GO:0035801,0.028252561663827,0.999798417927323,1,2,adrenal cortex development,BP,WT1
10062,GO:0035802,0.028252561663827,0.999798417927323,1,2,adrenal cortex formation,BP,WT1
13416,GO:0048807,0.0282550694485206,0.999731605141702,1,3,female genitalia morphogenesis,BP,FGF10
16100,GO:0070724,0.0282967198108599,0.999797782717233,1,2,BMP receptor complex,CC,BMP2
18036,GO:0097734,0.028376363474205,0.997794700642079,2,19,extracellular exosome biogenesis,BP,RAB27A;SDC4
7615,GO:0030849,0.0284283574548924,0.999795883108379,1,2,autosome,CC,SIN3B
6767,GO:0019912,0.0284972495593994,0.999794885362897,1,2,cyclin-dependent protein kinase activating kinase activity,MF,CDKN1A
14955,GO:0060435,0.0285643195625597,0.999725659200486,1,3,bronchiole development,BP,FGF10
18970,GO:1901963,0.0285696728139794,0.999793833815461,1,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
20869,GO:1990769,0.0286061616197518,0.999793302983789,1,2,proximal neuron projection,CC,SYT5
15291,GO:0060994,0.0286414427654742,0.99979278906237,1,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,BMP4
21020,GO:2000137,0.0286529948930109,0.999792620648049,1,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
19108,GO:1902271,0.0286677645949263,0.99979240522475,1,2,D3 vitamins binding,MF,VDR
7187,GO:0030016,0.0286696388979226,0.990382328738132,7,208,myofibril,CC,FHOD3;ACTN2;CASQ2;SDC4;MYZAP;PARVB;PDE4B
1404,GO:0003064,0.0287141812670453,0.999791727476264,1,2,regulation of heart rate by hormone,BP,KCNH2
16891,GO:0072166,0.0287386525509994,0.999791369709988,1,2,posterior mesonephric tubule development,BP,WT1
21041,GO:2000178,0.0287387300379258,0.997761831658981,2,18,negative regulation of neural precursor cell proliferation,BP,LIMS2;WNT5A
6385,GO:0018210,0.028798938514931,0.992512308204482,5,112,peptidyl-threonine modification,BP,ACVR1;WNT5A;AXIN1;BMP7;AKT1
11123,GO:0042993,0.0287993096639006,0.99565755594087,3,47,positive regulation of transcription factor import into nucleus,BP,PIK3R2;PIK3R1;CDH1
7470,GO:0030514,0.0288821625715686,0.995648085806014,3,45,negative regulation of BMP signaling pathway,BP,NOTCH1;FSTL3;WNT5A
11173,GO:0043065,0.0289996276921058,0.986019871407804,14,560,positive regulation of apoptotic process,BP,NOTCH1;PMAIP1;GADD45A;PIK3R2;WNT5A;RHOB;SCIN;BMP7;BMP4;BMP2;CTGF;AKT1;INHBB;VDR
11308,GO:0043270,0.0290092699123983,0.990239756624535,7,216,positive regulation of ion transport,BP,ACTN2;ADORA1;EDN1;PDGFB;KCNH2;AKT1;GDNF
12285,GO:0045661,0.0290143844550866,0.99560893683748,3,48,regulation of myoblast differentiation,BP,NOTCH1;BMP4;DLL1
16836,GO:0072079,0.0290803673879872,0.997710047595464,2,19,nephron tubule formation,BP,WNT6;GDNF
8969,GO:0033158,0.0290945410896638,0.997708331563546,2,19,regulation of protein import into nucleus, translocation,BP,CDKN1A;GAS6
1048,GO:0002386,0.0293168765360488,0.999782825489312,1,2,immune response in mucosal-associated lymphoid tissue,BP,RAB17
1055,GO:0002415,0.0293168765360488,0.999782825489312,1,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,RAB17
14662,GO:0060031,0.0293281717870057,0.999782656850036,1,2,mediolateral intercalation,BP,WNT5A
15188,GO:0060775,0.0293281717870057,0.999782656850036,1,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,WNT5A
17831,GO:0097241,0.0293480675254788,0.999782359643008,1,2,hematopoietic stem cell migration to bone marrow,BP,GAS6
12163,GO:0045360,0.0293877929710831,0.999709504365563,1,3,regulation of interleukin-1 biosynthetic process,BP,CCL20
12164,GO:0045362,0.0293877929710831,0.999709504365563,1,3,positive regulation of interleukin-1 biosynthetic process,BP,CCL20
11629,GO:0044092,0.0295627481688635,0.983296601977197,22,1056,negative regulation of molecular function,BP,ACTN2;NOTCH1;GADD45A;CRB2;SERPINA5;ZFPM1;CASQ2;PDGFB;PRKAR1B;RALB;HRAS;BMP7;BMP4;CAMSAP3;CDKN1A;AKT1;CST9L;GAS6;AMOT;SH3BP4;DUSP5;HEY1
14574,GO:0055021,0.0296030214713502,0.995492911673515,3,46,regulation of cardiac muscle tissue growth,BP,WNT2;NOTCH1;EDN1
16997,GO:0072320,0.029707751817693,0.999776951043344,1,2,volume-sensitive chloride channel activity,MF,TTYH1
10308,GO:0036304,0.0297907989976416,0.999775692679441,1,2,umbilical cord morphogenesis,BP,HEY1
15314,GO:0061027,0.0297907989976416,0.999775692679441,1,2,umbilical cord development,BP,HEY1
12373,GO:0045834,0.0298094251149037,0.992164335136487,5,123,positive regulation of lipid metabolic process,BP,WNT4;PDGFB;SESN2;BMP6;AKT1
21410,GO:2000707,0.0298405327816069,0.999774937372792,1,2,positive regulation of dense core granule biogenesis,BP,CHGA
11304,GO:0043266,0.0299711482067152,0.99359741492864,4,81,regulation of potassium ion transport,BP,ACTN2;ADORA1;CASQ2;KCNH2
5016,GO:0010817,0.0300703433223099,0.986348714383613,12,465,regulation of hormone levels,BP,LIF;ADRA2B;ADRA2C;WNT4;ADORA1;DKK3;EDN1;BMP6;BMP2;INHBB;RAB11FIP1;KCNG2
14825,GO:0060279,0.0301230145729991,0.999770622867477,1,2,positive regulation of ovulation,BP,INHBB
3617,GO:0007049,0.0301557714943797,0.981066186577035,33,1635,cell cycle,BP,LIF;WNT4;RAB6C;MARK4;GADD45A;ACVR1;EDN1;PHLDA1;PRKACB;TTYH1;MAPK12;FGF10;PDGFB;FOXO4;RALB;HRAS;WNT5A;SNX18;RHOB;PSRC1;FGF8;BMP7;BMP4;BMP2;CDKN1A;HMGN5;CTGF;AKT1;NPPC;JAG2;GAS6;LZTS1;PIM2
1005,GO:0002320,0.0303018439373975,0.997560479250821,2,19,lymphoid progenitor cell differentiation,BP,NOTCH1;BMP4
8487,GO:0032427,0.0303347277759306,0.99976736197722,1,2,GBD domain binding,MF,RHOQ
20379,GO:1905069,0.0303423241740517,0.999767244540111,1,2,allantois development,BP,BMP7
649,GO:0001779,0.030409127219309,0.99753686510878,2,20,natural killer cell differentiation,BP,TYRO3;GAS6
15319,GO:0061032,0.0305963342026745,0.999763300321414,1,2,visceral serous pericardium development,BP,WT1
305,GO:0000806,0.0306096116958215,0.99976309322535,1,2,Y chromosome,CC,SIN3B
14304,GO:0051885,0.030706867249365,0.999761573474577,1,2,positive regulation of timing of anagen,BP,WNT5A
20451,GO:1905276,0.0307116317098109,0.997521212891121,2,18,regulation of epithelial tube formation,BP,WNT5A;GDNF
21199,GO:2000403,0.0307342349272994,0.997456681521623,2,25,positive regulation of lymphocyte migration,BP,CCL20;WNT5A
14695,GO:0060067,0.0307520489271989,0.999760865770058,1,2,cervix development,BP,WNT5A
7661,GO:0030903,0.0307595985974843,0.997503557242647,2,19,notochord development,BP,CRB2;WNT5A
7294,GO:0030195,0.0308504008246449,0.995219659267073,3,48,negative regulation of blood coagulation,BP,EDN1;PLAU;PDGFB
18456,GO:1900047,0.0308504008246449,0.995219659267073,3,48,negative regulation of hemostasis,BP,EDN1;PLAU;PDGFB
15222,GO:0060844,0.0308632092442982,0.999759120072166,1,2,arterial endothelial cell fate commitment,BP,DLL1
17315,GO:0086097,0.0308978555996355,0.999758574656136,1,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,ACTN2
4048,GO:0008277,0.0309259087889426,0.99179230089473,5,123,regulation of G-protein coupled receptor protein signaling pathway,BP,NMT2;EDN1;GPRASP1;CHGA;GPSM1
11801,GO:0044431,0.0309459414523491,0.982936293644945,20,878,Golgi apparatus part,CC,WNT3;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;RAB39A;PDGFB;HRAS;WNT5B;WNT5A;RHOQ;SDC4;B3GNT2;RND3;RAB12;CDH1;GAS6;GPSM1;RAB38
8372,GO:0032271,0.0309466540924381,0.990517510088659,6,166,regulation of protein polymerization,BP,FHOD3;SPTBN5;SPTBN4;SCIN;PSRC1;SPTB
8802,GO:0032890,0.0309629545455438,0.995195486147576,3,48,regulation of organic acid transport,BP,ADORA1;EDN1;AKT1
14128,GO:0051542,0.0310027235592254,0.999756919966339,1,2,elastin biosynthetic process,BP,HBEGF
1976,GO:0004421,0.0310954666705129,0.999755451807904,1,2,hydroxymethylglutaryl-CoA synthase activity,MF,HMGCS2
17740,GO:0097102,0.0312470116258695,0.999753043128469,1,2,endothelial tip cell fate specification,BP,DLL1
16386,GO:0071307,0.0312485981153912,0.999753017849117,1,2,cellular response to vitamin K,BP,GAS6
16751,GO:0071901,0.0312776970768572,0.991674296144833,5,123,negative regulation of protein serine/threonine kinase activity,BP,PRKAR1B;BMP7;BMP4;CDKN1A;DUSP5
16931,GO:0072209,0.0313525124771981,0.999751359199686,1,2,metanephric mesangial cell differentiation,BP,PDGFB
16956,GO:0072254,0.0313525124771981,0.999751359199686,1,2,metanephric glomerular mesangial cell differentiation,BP,PDGFB
6963,GO:0021782,0.0313804671173209,0.993196319183217,4,83,glial cell development,BP,POU3F1;DLL1;AKT1;TSPAN2
1958,GO:0004383,0.0313926046902333,0.997449652336212,2,17,guanylate cyclase activity,MF,GUCY1B3;NPR1
3922,GO:0008074,0.0313926046902333,0.997449652336212,2,17,guanylate cyclase complex, soluble,CC,GUCY1B3;NPR1
17694,GO:0097018,0.0314498028848413,0.999749801167058,1,2,renal albumin absorption,BP,GAS6
21281,GO:2000532,0.0314498028848413,0.999749801167058,1,2,regulation of renal albumin absorption,BP,GAS6
4829,GO:0010512,0.0314651944653245,0.99974955422945,1,2,negative regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
481,GO:0001502,0.0314766191374964,0.997392783926512,2,21,cartilage condensation,BP,WNT7A;CTGF
8571,GO:0032542,0.0315334897358359,0.999748457028835,1,2,sulfiredoxin activity,MF,SESN2
11969,GO:0045017,0.0316066981830976,0.988250280593253,8,254,glycerolipid biosynthetic process,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;PIK3CA;PIK3CG
21507,GO:2000857,0.0316467201028478,0.999746632551419,1,2,positive regulation of mineralocorticoid secretion,BP,BMP6
21509,GO:2000860,0.0316467201028478,0.999746632551419,1,2,positive regulation of aldosterone secretion,BP,BMP6
1479,GO:0003195,0.031675010231474,0.99974617566733,1,2,tricuspid valve formation,BP,ZFPM1
4603,GO:0009628,0.0317604493335794,0.981477422051575,24,1129,response to abiotic stimulus,BP,NOTCH1;STRA6;PMAIP1;GADD45A;SLC52A3;NMT2;ADORA1;EDN1;PLAU;PIK3R1;HRAS;RHOB;BMP7;BMP6;BMP2;CDKN1A;CTGF;GJB6;AKT1;NPPC;INHBB;CLDN1;CLDN3;UNC119
15142,GO:0060713,0.0317746563939212,0.997375660737346,2,19,labyrinthine layer morphogenesis,BP,WNT7B;BMP7
17444,GO:0090190,0.0317996921935166,0.997372477277134,2,19,positive regulation of branching involved in ureteric bud morphogenesis,BP,WNT2B;GDNF
4677,GO:0009897,0.031821855684808,0.989088495202792,7,213,external side of plasma membrane,CC,ITGA3;ITGA5;TF;SERPINA5;MFGE8;FGF8;AMOT
6305,GO:0017157,0.0318693412506309,0.990172255865559,6,162,regulation of exocytosis,BP,SYT5;NOTCH1;RAB27A;RALB;SDC4;RAB3D
16508,GO:0071478,0.0319481910386814,0.990140356757109,6,164,cellular response to radiation,BP,GADD45A;NMT2;PIK3R1;HRAS;RHOB;CDKN1A
16529,GO:0071505,0.0319811865639101,0.999741204171653,1,2,response to mycophenolic acid,BP,PDGFB
16530,GO:0071506,0.0319811865639101,0.999741204171653,1,2,cellular response to mycophenolic acid,BP,PDGFB
14958,GO:0060438,0.0319859164593283,0.99734875413726,2,19,trachea development,BP,WNT7B;BMP4
15203,GO:0060809,0.0320007138557796,0.999740885437426,1,2,mesodermal to mesenchymal transition involved in gastrulation,BP,WNT5A
11341,GO:0043316,0.0320680143531191,0.999739785397217,1,2,cytotoxic T cell degranulation,BP,RAB27A
17861,GO:0097325,0.0321278326507144,0.999738805666818,1,2,melanocyte proliferation,BP,WNT5A
4931,GO:0010676,0.0321295445661103,0.994942871401027,3,48,positive regulation of cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1;AKT1
19612,GO:1903433,0.0321310981982318,0.999738752128376,1,2,regulation of constitutive secretory pathway,BP,RAB27A
5362,GO:0015091,0.0321315345283703,0.999738744974349,1,2,ferric iron transmembrane transporter activity,MF,TF
17067,GO:0072510,0.0321315345283703,0.999738744974349,1,2,trivalent inorganic cation transmembrane transporter activity,MF,TF
16983,GO:0072301,0.0321621491998774,0.999738242770544,1,2,regulation of metanephric glomerular mesangial cell proliferation,BP,WT1
8807,GO:0032899,0.0321988541143257,0.999737640016058,1,2,regulation of neurotrophin production,BP,ADORA1
18613,GO:1900453,0.0321995588602905,0.999737628436086,1,2,negative regulation of long term synaptic depression,BP,ADORA1
5241,GO:0014728,0.032255142879176,0.999736714293864,1,2,regulation of the force of skeletal muscle contraction,BP,ACTN3
5298,GO:0014862,0.032255142879176,0.999736714293864,1,2,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,ACTN3
14967,GO:0060447,0.0322809523544589,0.999649028437443,1,3,bud outgrowth involved in lung branching,BP,FGF10
19121,GO:1902303,0.0322917210565108,0.999736111842545,1,2,negative regulation of potassium ion export,BP,KCNH2
20952,GO:2000017,0.0323045311435118,0.99973590069187,1,2,positive regulation of determination of dorsal identity,BP,ACVR1
5658,GO:0015874,0.0323098022025014,0.997296012651029,2,20,norepinephrine transport,BP,ADRA2B;ADRA2C
7329,GO:0030237,0.0323163133380452,0.999735706408317,1,2,female sex determination,BP,WNT4
8968,GO:0033157,0.0323188112524198,0.986385581583593,10,356,regulation of intracellular protein transport,BP,FZD7;PRR5L;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CDH1;GAS6
15890,GO:0070346,0.0323242013792838,0.999604452719322,1,4,positive regulation of fat cell proliferation,BP,FGF10
2450,GO:0005110,0.0323452655534144,0.999735228689674,1,2,frizzled-2 binding,MF,WNT5A
10419,GO:0036518,0.0323663357111908,0.999734880751204,1,2,chemorepulsion of dopaminergic neuron axon,BP,WNT5A
15505,GO:0061443,0.0323875341759534,0.99973453045956,1,2,endocardial cushion cell differentiation,BP,ACVR1
6570,GO:0019320,0.0323945905610135,0.994880870184393,3,49,hexose catabolic process,BP,ACTN3;KHK;PFKFB3
13827,GO:0051040,0.032434500079284,0.999733753539266,1,2,regulation of calcium-independent cell-cell adhesion,BP,BMP2
15169,GO:0060748,0.0324925743608572,0.999732791265786,1,2,tertiary branching involved in mammary gland duct morphogenesis,BP,WNT4
15075,GO:0060599,0.0324930436163123,0.999732783483176,1,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,WNT5A
6520,GO:0019200,0.0324978076307956,0.997283149833618,2,19,carbohydrate kinase activity,MF,KHK;PFKFB3
16071,GO:0070666,0.0325184825092489,0.999732361406224,1,2,regulation of mast cell proliferation,BP,KITLG
16073,GO:0070668,0.0325184825092489,0.999732361406224,1,2,positive regulation of mast cell proliferation,BP,KITLG
16198,GO:0070925,0.0325684541159362,0.9832344038934,16,664,organelle assembly,BP,FHOD3;ACTN2;NOTCH1;MARK4;CASQ2;EDN1;RAB39A;RALB;SDC4;RAB20;MSN;RAB17;MYO7A;MYH11;LAMA5;RAB38
10460,GO:0038060,0.0325711663504535,0.999731486209665,1,2,nitric oxide-cGMP-mediated signaling pathway,BP,GUCY1B3
10462,GO:0038062,0.0326546356919535,0.999730096623081,1,2,protein tyrosine kinase collagen receptor activity,MF,DDR1
14905,GO:0060375,0.0326857997347345,0.999729576873277,1,2,regulation of mast cell differentiation,BP,ZFPM1
491,GO:0001516,0.0327267705962931,0.997213695605243,2,23,prostaglandin biosynthetic process,BP,EDN1;PTGES
12645,GO:0046457,0.0327267705962931,0.997213695605243,2,23,prostanoid biosynthetic process,BP,EDN1;PTGES
6922,GO:0021693,0.0327322507430479,0.999728801225865,1,2,cerebellar Purkinje cell layer structural organization,BP,DLL1
6927,GO:0021698,0.0327322507430479,0.999728801225865,1,2,cerebellar cortex structural organization,BP,DLL1
9561,GO:0034684,0.0327693136860902,0.999728181531911,1,2,integrin alphav-beta5 complex,CC,ITGB5
15207,GO:0060823,0.0327782553608909,0.999728031919059,1,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,AXIN1
16821,GO:0072053,0.0327897778635448,0.999727839061856,1,2,renal inner medulla development,BP,WNT7B
16822,GO:0072054,0.0327897778635448,0.999727839061856,1,2,renal outer medulla development,BP,WNT7B
17613,GO:0090526,0.0328143361122242,0.999727427787678,1,2,regulation of gluconeogenesis involved in cellular glucose homeostasis,BP,SESN2
1460,GO:0003169,0.032824430417127,0.999727258647943,1,2,coronary vein morphogenesis,BP,NOTCH1
4634,GO:0009749,0.0328499919891432,0.989790803488914,6,170,response to glucose,BP,KHK;SESN2;CTGF;GJB6;PIK3CA;GAS6
17865,GO:0097338,0.0328563719673039,0.999726723085214,1,2,response to clozapine,BP,PRKACB
11606,GO:0044028,0.0328621857160558,0.999726625548852,1,2,DNA hypomethylation,BP,PIK3CA
11607,GO:0044029,0.0328621857160558,0.999726625548852,1,2,hypomethylation of CpG island,BP,PIK3CA
9549,GO:0034667,0.0328671390148729,0.999726542434163,1,2,integrin alpha3-beta1 complex,CC,ITGA3
11586,GO:0043974,0.0328728046752668,0.999726447350535,1,2,histone H3-K27 acetylation,BP,LIF
18891,GO:1901674,0.0328728046752668,0.999726447350535,1,2,regulation of histone H3-K27 acetylation,BP,LIF
1954,GO:0004379,0.0328731078456574,0.999726442262121,1,2,glycylpeptide N-tetradecanoyltransferase activity,MF,NMT2
6329,GO:0018008,0.0328731078456574,0.999726442262121,1,2,N-terminal peptidyl-glycine N-myristoylation,BP,NMT2
6502,GO:0019107,0.0328731078456574,0.999726442262121,1,2,myristoyltransferase activity,MF,NMT2
15459,GO:0061341,0.0328731078471083,0.999726442262096,1,2,non-canonical Wnt signaling pathway involved in heart development,BP,WNT5A
15461,GO:0061346,0.0328731078471083,0.999726442262096,1,2,planar cell polarity pathway involved in heart morphogenesis,BP,WNT5A
12089,GO:0045210,0.0328731078473153,0.999726442262093,1,2,FasL biosynthetic process,BP,PHLDA1
18961,GO:1901898,0.0328731078487996,0.999726442262068,1,2,negative regulation of relaxation of cardiac muscle,BP,PDE4B
16833,GO:0072076,0.0328731078494151,0.999726442262058,1,2,nephrogenic mesenchyme development,BP,BMP7
16874,GO:0072134,0.0328731078494151,0.999726442262058,1,2,nephrogenic mesenchyme morphogenesis,BP,BMP7
2695,GO:0005608,0.0328731078519628,0.999726442262015,1,2,laminin-3 complex,CC,LAMA1
9563,GO:0034686,0.0328731078524139,0.999726442262007,1,2,integrin alphav-beta8 complex,CC,ITGB8
1582,GO:0003365,0.0328731078524152,0.999726442262007,1,2,establishment of cell polarity involved in ameboidal cell migration,BP,AMOT
3141,GO:0006366,0.032967036896783,0.978421063170665,39,2029,transcription from RNA polymerase II promoter,BP,ITGA3;LIF;WNT2;POU3F1;NOTCH1;CRB2;WNT7A;ZFPM1;ACVR1;EDN1;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;TLE1;SIN3B;ZCCHC12;VDR;GDNF;FZD8;HEY1
11518,GO:0043624,0.0330115909384487,0.989710774141708,6,192,cellular protein complex disassembly,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SCIN;SPTB
338,GO:0000930,0.0330300689745329,0.997214324510992,2,19,gamma-tubulin complex,CC,TUBG2;PDE4B
3612,GO:0007041,0.0331257290970355,0.992706238505404,4,79,lysosomal transport,BP,SPTBN5;GPRASP1;RHOB;RAB12
7176,GO:0023061,0.0331476100654227,0.985322319040982,11,407,signal release,BP,LIF;ADRA2B;ADRA2C;SYT5;WNT7A;ADORA1;EDN1;BMP6;INHBB;RAB11FIP1;KCNG2
16429,GO:0071371,0.0331665337286147,0.997209676572884,2,18,cellular response to gonadotropin stimulus,BP,NOTCH1;WT1
4687,GO:0009946,0.0333253411380363,0.999625772396631,1,3,proximal/distal axis specification,BP,FGF10
5945,GO:0016480,0.0333270404911594,0.999625733938939,1,3,negative regulation of transcription from RNA polymerase III promoter,BP,NAB2
15486,GO:0061383,0.0333341023486537,0.994682562181665,3,47,trabecula morphogenesis,BP,NOTCH1;BMP7;HEY1
18877,GO:1901655,0.0335124765657285,0.992584732027872,4,83,cellular response to ketone,BP,MSN;GJB2;AKT1;GAS6
5277,GO:0014829,0.0336883561779555,0.997128348130041,2,19,vascular smooth muscle contraction,BP,EDN1;ACTA2
21669,GO:2001273,0.0337087798045841,0.997125665626655,2,19,regulation of glucose import in response to insulin stimulus,BP,PIK3R2;PIK3R1
12068,GO:0045178,0.0337274004952864,0.994595346036881,3,47,basal part of cell,CC,TF;EDN1;CLDN11
15097,GO:0060648,0.0337553937917122,0.999615975970343,1,3,mammary gland bud morphogenesis,BP,FGF10
7289,GO:0030185,0.0339256651385506,0.999612061736248,1,3,nitric oxide transport,BP,EDN1
15451,GO:0061318,0.0339557741515443,0.997093153145598,2,19,renal filtration cell differentiation,BP,BMP4;WT1
16862,GO:0072112,0.0339557741515443,0.997093153145598,2,19,glomerular visceral epithelial cell differentiation,BP,BMP4;WT1
15045,GO:0060560,0.0341785907483384,0.988113140622745,7,202,developmental growth involved in morphogenesis,BP,WNT3;NOTCH1;WNT7B;FGF10;WNT5A;BMP4;DDR1
5879,GO:0016323,0.0342397676248696,0.988088239896975,7,201,basolateral plasma membrane,CC,ITGA3;TF;ADORA1;CDH2;PDGFB;MSN;RAB17
18140,GO:0098743,0.0342746111060982,0.997017400005637,2,22,cell aggregation,BP,WNT7A;CTGF
1611,GO:0003674,0.0343152627342726,0.981498405786499,228,16005,molecular_function,MF,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;RHBDL3;FBXO41;SLC45A4;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;MB21D2;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;HPCAL1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;HAPLN3;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;PM20D2;SHC4;SLC18B1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
20489,GO:1905383,0.0343970658475685,0.999601119908719,1,3,protein localization to presynapse,BP,WNT7A
21200,GO:2000404,0.0344169616676587,0.996972784076484,2,25,regulation of T cell migration,BP,CCL20;WNT5A
8354,GO:0032231,0.0344631079355122,0.992310279600638,4,82,regulation of actin filament bundle assembly,BP,WNT4;PIK3R1;SDC4;CTGF
9968,GO:0035650,0.0346293121932633,0.999595672326686,1,3,AP-1 adaptor complex binding,MF,RAB38
2161,GO:0004674,0.0347258590711865,0.983907960146667,12,431,protein serine/threonine kinase activity,MF,MARK4;ACVR1;PRKACB;MAPK12;NUAK2;PKN3;WNK4;AKT1;PIK3CA;PIK3CG;ARAF;PIM2
13765,GO:0050927,0.0347382997244691,0.996955005419454,2,22,positive regulation of positive chemotaxis,BP,ARTN;FGF10
1531,GO:0003283,0.0347909375761264,0.99698224466729,2,19,atrial septum development,BP,ZFPM1;ACVR1
18631,GO:1900738,0.0348550318582828,0.999590341864672,1,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA
19339,GO:1902895,0.0349121981746313,0.996966017029417,2,19,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB;BMP2
1208,GO:0002688,0.034968776654699,0.992123610932379,4,101,regulation of leukocyte chemotaxis,BP,EDN1;WNT5A;JAM3;GAS6
10165,GO:0035990,0.03497028056306,0.999587606542036,1,3,tendon cell differentiation,BP,BMP4
10166,GO:0035992,0.03497028056306,0.999587606542036,1,3,tendon formation,BP,BMP4
3889,GO:0008013,0.035092162835489,0.992136298894217,4,78,beta-catenin binding,MF,CDH2;FOXO4;AXIN1;CDH1
16141,GO:0070838,0.0351026536553844,0.984315611303574,11,411,divalent metal ion transport,BP,CDH23;TF;CASQ2;TSPAN13;PDGFB;CTGF;PIK3CG;GAS6;VDR;CLDN16;PDE4B
10709,GO:0042222,0.035234475589915,0.999529434301079,1,4,interleukin-1 biosynthetic process,BP,CCL20
4594,GO:0009607,0.0352466510820015,0.981272988588079,17,827,response to biotic stimulus,BP,NOTCH1;PMAIP1;EDN1;CCL20;FGF10;HRAS;WNT5A;BMP6;CHGA;GJB2;GJB6;AKT1;PTGES;CLDN1;ACTA2;PIM2;PDE4B
9969,GO:0035651,0.0352655494585452,0.999580556402892,1,3,AP-3 adaptor complex binding,MF,RAB38
9273,GO:0034113,0.0352940045739968,0.994234519383895,3,49,heterotypic cell-cell adhesion,BP,ITGA5;DSC2;BMP7
18541,GO:1900194,0.0353322156340469,0.999578956211166,1,3,negative regulation of oocyte maturation,BP,NPPC
13390,GO:0048745,0.0353616066018736,0.996905601482662,2,19,smooth muscle tissue development,BP,STRA6;BMP4
13684,GO:0050819,0.0353728349340178,0.994208002750684,3,51,negative regulation of coagulation,BP,EDN1;PLAU;PDGFB
12439,GO:0045940,0.0357742788121824,0.996804112380811,2,23,positive regulation of steroid metabolic process,BP,WNT4;BMP6
2541,GO:0005251,0.0358699758734104,0.996823522308457,2,20,delayed rectifier potassium channel activity,MF,KCNH2;KCNG2
6926,GO:0021697,0.035925113850241,0.996815990340709,2,20,cerebellar cortex formation,BP,WNT7A;DLL1
11736,GO:0044321,0.0359687539486126,0.996810024435546,2,20,response to leptin,BP,EDN1;INHBB
13490,GO:0050220,0.0360263368121475,0.999562111196172,1,3,prostaglandin-E synthase activity,MF,PTGES
10954,GO:0042629,0.0360898864483824,0.99677048989486,2,22,mast cell granule,CC,CHGA;PIK3CG
16946,GO:0072234,0.0361230413543602,0.996788899908559,2,20,metanephric nephron tubule development,BP,LIF;WNT7B
20517,GO:1905457,0.0361698594695431,0.999558586267658,1,3,negative regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
21523,GO:2000974,0.0361698594695431,0.999558586267658,1,3,negative regulation of pro-B cell differentiation,BP,NOTCH1
13146,GO:0048237,0.036177597542282,0.999558395811809,1,3,rough endoplasmic reticulum lumen,CC,EDN1
14250,GO:0051771,0.0362318246248994,0.999557059958204,1,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,EDN1
14256,GO:0051784,0.0364306065201455,0.993966136048245,3,51,negative regulation of nuclear division,BP,LIF;BMP7;BMP4
2658,GO:0005543,0.0365299540226125,0.984297031500715,10,353,phospholipid binding,MF,SYT5;ACTN2;SERPINA5;MFGE8;SPTBN4;FZD7;SNX18;SCIN;AKT1;GAS6
767,GO:0001942,0.0366504034098346,0.991653814307245,4,86,hair follicle development,BP,NOTCH1;FGF10;WNT5A;LAMA5
15274,GO:0060972,0.0367447435151701,0.996690901531344,2,21,left/right pattern formation,BP,NOTCH1;DLL1
3664,GO:0007156,0.0368240949780372,0.988268932097264,6,152,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CDH23;DSC2;CDH2;DSG3;CDH1;DSC3
14885,GO:0060349,0.036856289031768,0.991594681958422,4,85,bone morphogenesis,BP,BMP6;BMP4;NPPC;NAB2
7483,GO:0030538,0.0368987235819052,0.999540463513487,1,3,embryonic genitalia morphogenesis,BP,FGF10
16653,GO:0071702,0.0370039673932106,0.974748432462718,47,2596,organic substance transport,BP,ADRA2B;ADRA2C;NOTCH1;RAB27A;TF;SLC45A4;SERPINA5;SLC52A3;RABIF;ADORA1;EDN1;RAB40B;RAB40A;FLVCR2;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;SESN2;RHOQ;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;SLC2A14;CHGA;GJB1;AKT1;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;UNC119;RAB38;RAB3D;GDNF;ACSL4
17515,GO:0090288,0.0370228051616322,0.989694883402233,5,124,negative regulation of cellular response to growth factor stimulus,BP,WNT4;NOTCH1;RASL11B;FSTL3;WNT5A
17068,GO:0072511,0.0370297485024043,0.983313738621961,11,415,divalent inorganic cation transport,BP,CDH23;TF;CASQ2;TSPAN13;PDGFB;CTGF;PIK3CG;GAS6;VDR;CLDN16;PDE4B
17721,GO:0097058,0.0370779953970606,0.99953594921617,1,3,CRLF-CLCF1 complex,CC,CLCF1
11476,GO:0043550,0.037150381993815,0.99381402453366,3,48,regulation of lipid kinase activity,BP,PIK3R2;PIK3R1;PDGFB
15887,GO:0070343,0.0372035669366371,0.999474925325574,1,4,white fat cell proliferation,BP,FGF10
15893,GO:0070350,0.0372035669366371,0.999474925325574,1,4,regulation of white fat cell proliferation,BP,FGF10
16670,GO:0071733,0.0372820959696779,0.999530782378041,1,3,transcriptional activation by promoter-enhancer looping,BP,ZFPM1
17456,GO:0090202,0.0372820959696779,0.999530782378041,1,3,gene looping,BP,ZFPM1
17634,GO:0090579,0.0372820959696779,0.999530782378041,1,3,dsDNA loop formation,BP,ZFPM1
8891,GO:0033023,0.0372851384819416,0.999530705136273,1,3,mast cell homeostasis,BP,KITLG
8892,GO:0033024,0.0372851384819416,0.999530705136273,1,3,mast cell apoptotic process,BP,KITLG
8893,GO:0033025,0.0372851384819416,0.999530705136273,1,3,regulation of mast cell apoptotic process,BP,KITLG
16992,GO:0072311,0.0373692635189351,0.99661643075014,2,20,glomerular epithelial cell differentiation,BP,BMP4;WT1
4633,GO:0009746,0.0374239494338439,0.98800569434665,6,175,response to hexose,BP,KHK;SESN2;CTGF;GJB6;PIK3CA;GAS6
4713,GO:0010008,0.0375220222259693,0.983058082121045,11,411,endosome membrane,CC,TMEM163;SYT5;TSPAN15;RAB27A;TF;FZD7;SNX18;RHOB;RAB12;RAB17;RNF144A
15071,GO:0060594,0.0375672938267251,0.999523513810335,1,3,mammary gland specification,BP,FGF10
10815,GO:0042414,0.03758868180947,0.999522966424301,1,3,epinephrine metabolic process,BP,PNMT
11052,GO:0042803,0.0375982936141449,0.980287643738601,16,705,protein homodimerization activity,MF,ADRA2C;ACTN3;ACTN2;GADD45A;ACVR1;CASQ2;PDGFB;KCNH2;JAM3;AXIN1;GJB1;TPD52;NPPC;MYO7A;INHBB;GDNF
8356,GO:0032233,0.0376519459935201,0.993683298737264,3,51,positive regulation of actin filament bundle assembly,BP,WNT4;SDC4;CTGF
15737,GO:0070101,0.0377263016165082,0.999519436652505,1,3,positive regulation of chemokine-mediated signaling pathway,BP,EDN1
8097,GO:0031708,0.03776122961022,0.999518538688137,1,3,endothelin B receptor binding,MF,EDN1
8465,GO:0032402,0.0378181074224256,0.996528892870456,2,22,melanosome transport,BP,RAB27A;RAB17
7761,GO:0031091,0.0378238494758304,0.991291770489007,4,90,platelet alpha granule,CC,ACTN2;SERPINA5;PDGFB;GAS6
11120,GO:0042990,0.0380628187495004,0.991221783250349,4,89,regulation of transcription factor import into nucleus,BP,PIK3R2;PIK3R1;BMP7;CDH1
5011,GO:0010812,0.0383098726048026,0.993544073734687,3,48,negative regulation of cell-substrate adhesion,BP,NOTCH1;FZD7;PIK3R1
13764,GO:0050926,0.03841953590005,0.99643242070621,2,23,regulation of positive chemotaxis,BP,ARTN;FGF10
6208,GO:0016936,0.0384215008292155,0.999439690492137,1,4,galactoside binding,MF,LGALS4
7452,GO:0030485,0.0384565093305128,0.999500486242231,1,3,smooth muscle contractile fiber,CC,ACTA2
12826,GO:0046835,0.0384941284770842,0.996444706624459,2,21,carbohydrate phosphorylation,BP,KHK;PFKFB3
16920,GO:0072198,0.0385293630832011,0.999498575075072,1,3,mesenchymal cell proliferation involved in ureter development,BP,BMP4
16921,GO:0072199,0.0385293630832011,0.999498575075072,1,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
8649,GO:0032652,0.0385850646984857,0.99343612237357,3,58,regulation of interleukin-1 production,BP,CCL20;WNT5A;GAS6
13908,GO:0051155,0.038719596332294,0.993415667549,3,55,positive regulation of striated muscle cell differentiation,BP,EDN1;BMP4;EFNB2
14687,GO:0060057,0.0388808037266889,0.999489303582512,1,3,apoptotic process involved in mammary gland involution,BP,VDR
14688,GO:0060058,0.0388808037266889,0.999489303582512,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,VDR
19136,GO:1902339,0.0388808037266889,0.999489303582512,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,VDR
19641,GO:1903519,0.0388808037266889,0.999489303582512,1,3,regulation of mammary gland involution,BP,VDR
19642,GO:1903521,0.0388808037266889,0.999489303582512,1,3,positive regulation of mammary gland involution,BP,VDR
20220,GO:1904747,0.0388808037266889,0.999489303582512,1,3,positive regulation of apoptotic process involved in development,BP,VDR
19104,GO:1902263,0.0388808037324561,0.999489303582359,1,3,apoptotic process involved in embryonic digit morphogenesis,BP,NOTCH1
15062,GO:0060584,0.038941488977037,0.999487693868184,1,3,regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
15063,GO:0060585,0.038941488977037,0.999487693868184,1,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
20950,GO:2000015,0.0389930379214494,0.999486324474813,1,3,regulation of determination of dorsal identity,BP,ACVR1
19746,GO:1903719,0.0390724011970976,0.999484212558762,1,3,regulation of I-kappaB phosphorylation,BP,AKT1
19747,GO:1903721,0.0390724011970976,0.999484212558762,1,3,positive regulation of I-kappaB phosphorylation,BP,AKT1
728,GO:0001889,0.0393613461809173,0.98885390284718,5,130,liver development,BP,WNT4;NOTCH1;LIMS2;CLDN1;PIK3CA
20996,GO:2000097,0.0394113842400368,0.99947514230876,1,3,regulation of smooth muscle cell-matrix adhesion,BP,PLAU
16655,GO:0071705,0.0394294286369647,0.973588518201842,41,2230,nitrogen compound transport,BP,ADRA2B;ADRA2C;NOTCH1;RAB27A;TF;SLC52A3;RABIF;ADORA1;EDN1;RAB40B;RAB40A;FLVCR2;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;CHGA;GJB1;AKT1;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;UNC119;RAB38;RAB3D;GDNF
461,GO:0001191,0.0395581923136856,0.990771059507627,4,87,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,POU3F1;NOTCH1;TLE1;SIN3B
11121,GO:0042991,0.0396294858183582,0.990741704817219,4,90,transcription factor import into nucleus,BP,PIK3R2;PIK3R1;BMP7;CDH1
97,GO:0000186,0.0397040449100329,0.993209689729877,3,49,activation of MAPKK activity,BP,ADORA1;BMP4;ARAF
6357,GO:0018125,0.0397163110633691,0.999466914532334,1,3,peptidyl-cysteine methylation,BP,RAB3D
7094,GO:0022404,0.0397539839934677,0.990708421613562,4,88,molting cycle process,BP,NOTCH1;FGF10;WNT5A;LAMA5
7095,GO:0022405,0.0397539839934677,0.990708421613562,4,88,hair cycle process,BP,NOTCH1;FGF10;WNT5A;LAMA5
3473,GO:0006826,0.0398629399811591,0.993135737855368,3,57,iron ion transport,BP,TF;TTYH1;SFXN1
7333,GO:0030241,0.0399040898210934,0.999461815316808,1,3,skeletal muscle myosin thick filament assembly,BP,MYH11
12851,GO:0046882,0.0400916271562994,0.999456697984823,1,3,negative regulation of follicle-stimulating hormone secretion,BP,INHBB
9703,GO:0035162,0.040229459784154,0.996194219183099,2,21,embryonic hemopoiesis,BP,ZFPM1;KITLG
17422,GO:0090162,0.0402773057971438,0.996187225353668,2,21,establishment of epithelial cell polarity,BP,WNT5A;MSN
3269,GO:0006546,0.0404136399424007,0.999447853686344,1,3,glycine catabolic process,BP,GLDC
6619,GO:0019464,0.0404136399424007,0.999447853686344,1,3,glycine decarboxylation via glycine cleavage system,BP,GLDC
9106,GO:0033563,0.0404750332056626,0.999446159223081,1,3,dorsal/ventral axon guidance,BP,FGF8
698,GO:0001843,0.0405969062725628,0.990456693270226,4,85,neural tube closure,BP,PRKACB;WNT5A;SDC4;BMP4
16452,GO:0071398,0.0406038846460235,0.992979381705557,3,52,cellular response to fatty acid,BP,EDN1;AKT1;CLDN1
10173,GO:0036003,0.0406122538099492,0.996113229791958,2,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,NOTCH1;SESN2
10524,GO:0038181,0.0406425722837732,0.999441521663395,1,3,bile acid receptor activity,MF,VDR
10526,GO:0038183,0.0406425722837732,0.999441521663395,1,3,bile acid signaling pathway,BP,VDR
7605,GO:0030833,0.0406856714342733,0.988371731388798,5,133,regulation of actin filament polymerization,BP,FHOD3;SPTBN5;SPTBN4;SCIN;SPTB
15992,GO:0070527,0.0406973224512377,0.992952186575025,3,53,platelet aggregation,BP,TYRO3;PIK3CG;GAS6
4701,GO:0009975,0.0408436477742577,0.996118582192816,2,20,cyclase activity,MF,GUCY1B3;NPR1
7817,GO:0031224,0.0409395009200344,0.969829000933451,83,5117,intrinsic component of membrane,CC,ITGA3;ITGA5;TMEM163;ADRA2B;ADRA2C;SYT5;TSPAN15;TSPAN17;NOTCH1;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;RHBDL3;SLC45A4;DSC2;SLC52A3;TMEM206;ACVR1;ADORA1;CASQ2;KCNK6;FLVCR2;MBOAT2;SLC25A53;TTYH1;MPZL1;TSPAN13;PRND;FZD7;TYRO3;LPAR2;CDH2;HRCT1;REEP1;KCNH2;JAM3;NPR1;SDC4;SPTB;HBEGF;PGBD5;BMP2;B3GNT2;DLL1;SLC2A14;VAMP1;SFXN1;DDR1;DSG3;GJB1;GJB2;GJB6;PTGES;KITLG;SEMA6C;JAG2;CDH1;GJA3;TPBGL;CLDN1;CLDN2;CLDN3;CLDN5;KCNG2;CLDN23;SLC18B1;DSC3;KCND1;TSPAN2;ACSL4;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;EFNB2;PDE4B
13844,GO:0051057,0.0410369039453044,0.992874970869762,3,52,positive regulation of small GTPase mediated signal transduction,BP,FGF10;HRAS;KITLG
13843,GO:0051056,0.0410707841291333,0.982907848732259,9,295,regulation of small GTPase mediated signal transduction,BP,ITGA3;FGF10;PIK3R2;HRAS;RHOQ;RHOJ;RHOB;KITLG;AMOT
11774,GO:0044381,0.0410819405718732,0.996068911310882,2,21,glucose import in response to insulin stimulus,BP,PIK3R2;PIK3R1
16913,GO:0072190,0.0410937388939603,0.999428935200793,1,3,ureter urothelium development,BP,BMP4
14691,GO:0060061,0.0411465867713142,0.999427451521648,1,3,Spemann organizer formation,BP,WNT3
6154,GO:0016849,0.0411563943856681,0.996072559293746,2,20,phosphorus-oxygen lyase activity,MF,GUCY1B3;NPR1
7569,GO:0030742,0.0411644654112315,0.996020206135013,2,24,GTP-dependent protein binding,MF,RAB38;RAB3D
21050,GO:2000191,0.0411773746983793,0.996029365216738,2,23,regulation of fatty acid transport,BP,EDN1;AKT1
14776,GO:0060197,0.041251806110303,0.999424491698309,1,3,cloacal septation,BP,BMP4
7576,GO:0030801,0.0413424738305922,0.990181379298863,4,104,positive regulation of cyclic nucleotide metabolic process,BP,WNT5A;NPR1;CHGA;NPPC
2692,GO:0005605,0.0413541128979121,0.996028593867936,2,21,basal lamina,CC,LAMA1;LAMA5
12236,GO:0045600,0.041527931030074,0.99274654473413,3,54,positive regulation of fat cell differentiation,BP,WNT5B;BMP2;AKT1
8719,GO:0032768,0.0415550734700609,0.992731147995956,3,56,regulation of monooxygenase activity,BP,AKT1;VDR;GDNF
8464,GO:0032401,0.0416217760805316,0.995962959287358,2,23,establishment of melanosome localization,BP,RAB27A;RAB17
14653,GO:0060021,0.0416548079472487,0.990122693003992,4,87,palate development,BP,WNT7A;WNT5A;JAG2;CLDN5
15105,GO:0060669,0.0417720812196816,0.995952793238475,2,22,embryonic placenta morphogenesis,BP,WNT7B;BMP7
3822,GO:0007500,0.0419110504749329,0.999405770098702,1,3,mesodermal cell fate determination,BP,BMP4
10620,GO:0042035,0.0419506546482053,0.990005489511818,4,97,regulation of cytokine biosynthetic process,BP,ZFPM1;CCL20;WNT5A;INHBB
4951,GO:0010721,0.0419711779677999,0.983513788289879,8,264,negative regulation of cell development,BP,WNT3;NOTCH1;WNT7A;WNT5A;BMP7;DLL1;NPPC;CLDN18
9362,GO:0034284,0.0420404601381582,0.986146487888337,6,180,response to monosaccharide,BP,KHK;SESN2;CTGF;GJB6;PIK3CA;GAS6
12290,GO:0045666,0.042111058861143,0.982389266871791,9,305,positive regulation of neuron differentiation,BP,ITGA3;ADRA2B;ADRA2C;WNT3;WNT5A;BMP7;BMP6;BMP4;BMP2
16826,GO:0072061,0.0422030978028739,0.999397378729354,1,3,inner medullary collecting duct development,BP,WNT7B
14694,GO:0060066,0.0422292279588859,0.999396625010624,1,3,oviduct development,BP,WNT7A
20526,GO:1905477,0.0422394817705924,0.989924232152295,4,93,positive regulation of protein localization to membrane,BP,ITGA3;PMAIP1;PIK3R1;AKT1
17696,GO:0097021,0.0422982485787634,0.99939463181609,1,3,lymphocyte migration into lymphoid organs,BP,ARTN
11461,GO:0043535,0.0423144580583691,0.992554571613829,3,54,regulation of blood vessel endothelial cell migration,BP,NOTCH1;PDGFB;AKT1
5094,GO:0010906,0.0424181296621831,0.989878396088239,4,89,regulation of glucose metabolic process,BP,ACTN3;PMAIP1;SESN2;AKT1
1603,GO:0003419,0.0424789155808188,0.99931390332786,1,4,growth plate cartilage chondrocyte proliferation,BP,NPPC
11989,GO:0045055,0.0426664587640857,0.977265593184087,16,723,regulated exocytosis,BP,SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;PLAU;PDGFB;SCIN;CHGA;PKP1;RAB44;PIK3CG;RAB11FIP1;GAS6;RAB3D
13361,GO:0048696,0.042726202183372,0.999382198452299,1,3,regulation of collateral sprouting in absence of injury,BP,WNT3
15372,GO:0061107,0.0428519611954489,0.99937852026564,1,3,seminal vesicle development,BP,SERPINA5
1443,GO:0003148,0.0428988150026507,0.995782802477183,2,22,outflow tract septum morphogenesis,BP,FGF8;BMP4
1052,GO:0002407,0.0429672415234142,0.995736807276304,2,25,dendritic cell chemotaxis,BP,PIK3CG;GAS6
15303,GO:0061008,0.0429697118126929,0.987537538508791,5,133,hepaticobiliary system development,BP,WNT4;NOTCH1;LIMS2;CLDN1;PIK3CA
17855,GO:0097305,0.0429762487857903,0.985756527364891,6,187,response to alcohol,BP,AKT1;NPPC;CDH1;CLDN1;CLDN3;CLDN18
13435,GO:0048850,0.0430556361123899,0.999372539584988,1,3,hypophysis morphogenesis,BP,WNT5A
19259,GO:1902667,0.0431376165723737,0.995760715401584,2,21,regulation of axon guidance,BP,WNT3;WNT5A
18537,GO:1900186,0.0432783083743912,0.999365967644047,1,3,negative regulation of clathrin-dependent endocytosis,BP,UNC119
15531,GO:0061515,0.0433816117311149,0.992296674117705,3,53,myeloid cell development,BP,ZFPM1;TSPAN2;CLDN18
3670,GO:0007162,0.0434328555649993,0.984088423538196,7,223,negative regulation of cell adhesion,BP,NOTCH1;FZD7;PIK3R1;SDC4;BMP4;BMP2;CDH1
6568,GO:0019318,0.0434728583866741,0.984069752513755,7,224,hexose metabolic process,BP,ACTN3;PMAIP1;KHK;SESN2;PFKFB3;AKT1;PIK3CA
8450,GO:0032386,0.0435769011743507,0.979088229773283,12,480,regulation of intracellular transport,BP,FZD7;PRR5L;PIK3R2;PIK3R1;REEP1;BMP7;BMP6;BMP4;CDKN1A;MSN;CDH1;GAS6
20773,GO:1990418,0.0436372371454789,0.999355300708599,1,3,response to insulin-like growth factor stimulus,BP,AKT1
16875,GO:0072135,0.0436451005222482,0.999355066002279,1,3,kidney mesenchymal cell proliferation,BP,BMP7
16876,GO:0072136,0.0436451005222482,0.999355066002279,1,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,BMP7
13076,GO:0048022,0.0439262087168346,0.999346646848641,1,3,negative regulation of melanin biosynthetic process,BP,WNT5A
18598,GO:1900377,0.0439262087168346,0.999346646848641,1,3,negative regulation of secondary metabolite biosynthetic process,BP,WNT5A
13434,GO:0048846,0.0439411982309157,0.995637947155738,2,21,axon extension involved in axon guidance,BP,WNT3;WNT5A
19112,GO:1902284,0.0439411982309157,0.995637947155738,2,21,neuron projection extension involved in neuron projection guidance,BP,WNT3;WNT5A
18676,GO:1901079,0.0441547441845123,0.999339761185263,1,3,positive regulation of relaxation of muscle,BP,CHGA
16284,GO:0071062,0.0442290380199039,0.999337514815061,1,3,alphav-beta3 integrin-vitronectin complex,CC,ITGA5
14824,GO:0060278,0.0442345431420508,0.999337348205655,1,3,regulation of ovulation,BP,INHBB
5726,GO:0016021,0.0442746115414891,0.967290288805166,81,4993,integral component of membrane,CC,ITGA3;ITGA5;TMEM163;ADRA2B;ADRA2C;SYT5;TSPAN15;TSPAN17;NOTCH1;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;CRB2;RHBDL3;SLC45A4;DSC2;SLC52A3;TMEM206;ACVR1;ADORA1;CASQ2;KCNK6;FLVCR2;MBOAT2;SLC25A53;TTYH1;MPZL1;TSPAN13;FZD7;TYRO3;LPAR2;CDH2;HRCT1;REEP1;KCNH2;JAM3;NPR1;SDC4;HBEGF;PGBD5;BMP2;B3GNT2;DLL1;SLC2A14;VAMP1;SFXN1;DDR1;DSG3;GJB1;GJB2;GJB6;PTGES;KITLG;SEMA6C;JAG2;CDH1;GJA3;TPBGL;CLDN1;CLDN2;CLDN3;CLDN5;KCNG2;CLDN23;SLC18B1;DSC3;KCND1;TSPAN2;ACSL4;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;EFNB2;PDE4B
13128,GO:0048179,0.0442834330019039,0.999335867643848,1,3,activin receptor complex,CC,ACVR1
3923,GO:0008076,0.0443159144417875,0.989283943576968,4,87,voltage-gated potassium channel complex,CC,KCNK6;KCNH2;KCNG2;KCND1
4235,GO:0008585,0.0443257788390394,0.989269462526861,4,91,female gonad development,BP,WNT4;WT1;KITLG;INHBB
2532,GO:0005242,0.044375956386273,0.995556107795735,2,22,inward rectifier potassium channel activity,MF,KCNK6;KCNH2
16919,GO:0072197,0.0443818009377765,0.999332883598031,1,3,ureter morphogenesis,BP,BMP4
15389,GO:0061146,0.0445694085321446,0.999327173492485,1,3,Peyer's patch morphogenesis,BP,ARTN
4744,GO:0010159,0.0445748422975397,0.999327007738001,1,3,specification of animal organ position,BP,BMP4
7637,GO:0030878,0.0445936959604062,0.995496170110673,2,24,thyroid gland development,BP,FGF10;FGF8
3918,GO:0008065,0.0446193852347609,0.999325648190984,1,3,establishment of blood-nerve barrier,BP,CLDN1
7081,GO:0022011,0.0446459410124972,0.995514206796645,2,22,myelination in peripheral nervous system,BP,POU3F1;AKT1
8389,GO:0032292,0.0446459410124972,0.995514206796645,2,22,peripheral nervous system axon ensheathment,BP,POU3F1;AKT1
7030,GO:0021898,0.0446755381671173,0.999323932286595,1,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,AXIN1
10241,GO:0036118,0.044717704901875,0.999322642305264,1,3,hyaluranon cable assembly,BP,BMP7
18481,GO:1900104,0.044717704901875,0.999322642305264,1,3,regulation of hyaluranon cable assembly,BP,BMP7
18482,GO:1900106,0.044717704901875,0.999322642305264,1,3,positive regulation of hyaluranon cable assembly,BP,BMP7
7179,GO:0030003,0.0447981070941777,0.977708398162554,13,556,cellular cation homeostasis,BP,CDH23;TF;CASQ2;EDN1;RAB39A;PRND;LPAR2;BMP6;RAB20;PIK3CG;VDR;RAB38;CLDN16
3351,GO:0006644,0.0449103030654062,0.979126698957568,11,427,phospholipid metabolic process,BP,MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
11376,GO:0043393,0.045000094286018,0.98492978015831,6,180,regulation of protein binding,BP,ZFPM1;PDGFB;RALB;WNT5A;BMP4;BMP2
8343,GO:0032217,0.0451199583183457,0.999310273312585,1,3,riboflavin transporter activity,MF,SLC52A3
8344,GO:0032218,0.0451199583183457,0.999310273312585,1,3,riboflavin transport,BP,SLC52A3
8095,GO:0031705,0.0451865381958259,0.999222743322905,1,4,bombesin receptor binding,MF,EDN1
13926,GO:0051183,0.0452995923490885,0.995385388131084,2,24,vitamin transporter activity,MF,STRA6;SLC52A3
11411,GO:0043457,0.0452999911302975,0.995398119000772,2,23,regulation of cellular respiration,BP,ACTN3;PIK3CA
14675,GO:0060045,0.0453194630176789,0.995409052923523,2,22,positive regulation of cardiac muscle cell proliferation,BP,WNT2;NOTCH1
19341,GO:1902897,0.0453773306637811,0.999302299363845,1,3,regulation of postsynaptic density protein 95 clustering,BP,CDH2
1453,GO:0003162,0.0453951705401266,0.999301744912061,1,3,atrioventricular node development,BP,NOTCH1
15223,GO:0060846,0.0454635713236414,0.999299616976339,1,3,blood vessel endothelial cell fate commitment,BP,DLL1
15224,GO:0060847,0.0454635713236414,0.999299616976339,1,3,endothelial cell fate specification,BP,DLL1
17739,GO:0097101,0.0454635713236414,0.999299616976339,1,3,blood vessel endothelial cell fate specification,BP,DLL1
12613,GO:0046365,0.0454797001558278,0.991748105054186,3,58,monosaccharide catabolic process,BP,ACTN3;KHK;PFKFB3
5173,GO:0014002,0.0455393674428871,0.995347534912302,2,24,astrocyte development,BP,DLL1;TSPAN2
10656,GO:0042108,0.0456004237857449,0.991708926697422,3,60,positive regulation of cytokine biosynthetic process,BP,ZFPM1;CCL20;WNT5A
9144,GO:0033627,0.045734969786999,0.991697636347522,3,55,cell adhesion mediated by integrin,BP,ITGA5;PLAU;PIK3CG
11543,GO:0043696,0.04576926975914,0.999290066349913,1,3,dedifferentiation,BP,PDGFB
11544,GO:0043697,0.04576926975914,0.999290066349913,1,3,cell dedifferentiation,BP,PDGFB
15312,GO:0061025,0.045805377976293,0.983026657587212,7,223,membrane fusion,BP,SYT5;SERPINA5;RABIF;RAB39A;RAB20;VAMP1;GAS6
904,GO:0002139,0.0458470382600347,0.99928762616905,1,3,stereocilia coupling link,CC,MYO7A
19428,GO:1903047,0.0458648426742437,0.973967064742049,19,874,mitotic cell cycle process,BP,MARK4;GADD45A;ACVR1;EDN1;PHLDA1;TTYH1;FGF10;PDGFB;FOXO4;HRAS;SNX18;PSRC1;FGF8;BMP7;BMP4;CDKN1A;AKT1;LZTS1;PIM2
10140,GO:0035939,0.0458723962930239,0.999286829573161,1,3,microsatellite binding,MF,HEY1
21481,GO:2000820,0.0458723962948009,0.999286829573105,1,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,HEY1
15374,GO:0061110,0.0459040597622357,0.999285834260446,1,3,dense core granule biogenesis,BP,CHGA
21408,GO:2000705,0.0459040597622357,0.999285834260446,1,3,regulation of dense core granule biogenesis,BP,CHGA
14310,GO:0051894,0.045916054916066,0.995300895036288,2,23,positive regulation of focal adhesion assembly,BP,WNT4;SDC4
3611,GO:0007040,0.045950512555536,0.991643015937072,3,55,lysosome organization,BP,RAB39A;RAB20;MYO7A
17234,GO:0080171,0.045950512555536,0.991643015937072,3,55,lytic vacuole organization,BP,RAB39A;RAB20;MYO7A
13199,GO:0048320,0.0459893816676585,0.999283148714611,1,3,axial mesoderm formation,BP,AXIN1
11458,GO:0043532,0.0460142001035211,0.999193720690509,1,4,angiostatin binding,MF,AMOT
9665,GO:0035054,0.0460948493046681,0.999279821958904,1,3,embryonic heart tube anterior/posterior pattern specification,BP,BMP2
7760,GO:0031090,0.0461617143073011,0.967886974549864,48,2705,organelle membrane,CC,TMEM163;SYT5;WNT3;WNT4;TSPAN15;NOTCH1;RAB27A;TF;PMAIP1;SERPINA5;WNT6;WNT7A;WNT7B;HMGCS2;CASQ2;PLAU;SPTBN5;SLC25A53;TTYH1;RAB39A;SYCN;FZD7;REEP1;PDGFB;HRAS;WNT5B;WNT5A;SNX18;RHOQ;RHOB;HBEGF;B3GNT2;RAB20;VAMP1;SFXN1;RND3;CHGA;PKP1;RAB12;RAB17;MYO7A;RAB44;RAB11FIP1;GPSM1;RAB38;RAB3D;ACSL4;RNF144A
8452,GO:0032388,0.0462423777443661,0.981476790775134,8,278,positive regulation of intracellular transport,BP,PRR5L;PIK3R2;PIK3R1;BMP6;BMP4;MSN;CDH1;GAS6
15408,GO:0061184,0.0462936507194623,0.999273529795987,1,3,positive regulation of dermatome development,BP,WNT4
17833,GO:0097252,0.0462941110046085,0.999273515195299,1,3,oligodendrocyte apoptotic process,BP,GAS6
6807,GO:0021502,0.0464148170277175,0.999269681111135,1,3,neural fold elevation formation,BP,BMP7
4192,GO:0008506,0.0464513779372206,0.9992685177632,1,3,sucrose:proton symporter activity,MF,SLC45A4
4200,GO:0008515,0.0464513779372206,0.9992685177632,1,3,sucrose transmembrane transporter activity,MF,SLC45A4
5396,GO:0015154,0.0464513779372206,0.9992685177632,1,3,disaccharide transmembrane transporter activity,MF,SLC45A4
5397,GO:0015157,0.0464513779372206,0.9992685177632,1,3,oligosaccharide transmembrane transporter activity,MF,SLC45A4
5595,GO:0015766,0.0464513779372206,0.9992685177632,1,3,disaccharide transport,BP,SLC45A4
5596,GO:0015770,0.0464513779372206,0.9992685177632,1,3,sucrose transport,BP,SLC45A4
5597,GO:0015772,0.0464513779372206,0.9992685177632,1,3,oligosaccharide transport,BP,SLC45A4
7033,GO:0021904,0.0464593445796266,0.995214540511501,2,23,dorsal/ventral neural tube patterning,BP,PRKACB;BMP4
17847,GO:0097278,0.0464913585200467,0.999176742127023,1,4,complement-dependent cytotoxicity,BP,RAB27A
11891,GO:0044752,0.0466184915427686,0.99926318825914,1,3,response to human chorionic gonadotropin,BP,GJB2
17693,GO:0097017,0.0466457767827896,0.999262316215102,1,3,renal protein absorption,BP,GAS6
754,GO:0001927,0.0467318796096823,0.999259560889466,1,3,exocyst assembly,BP,RALB
16952,GO:0072243,0.0468360854746575,0.99515432120271,2,23,metanephric nephron epithelium development,BP,LIF;WNT7B
21381,GO:2000669,0.0468807395655657,0.999254784931626,1,3,negative regulation of dendritic cell apoptotic process,BP,GAS6
16441,GO:0071385,0.0469437806083459,0.99137525835126,3,58,cellular response to glucocorticoid stimulus,BP,EDN1;GJB2;HEY1
9250,GO:0034059,0.0470099042997718,0.999250628155372,1,3,response to anoxia,BP,CTGF
5148,GO:0010979,0.0470539195427965,0.999249208959377,1,3,regulation of vitamin D 24-hydroxylase activity,BP,VDR
5149,GO:0010980,0.0470539195427965,0.999249208959377,1,3,positive regulation of vitamin D 24-hydroxylase activity,BP,VDR
935,GO:0002193,0.0470659018948417,0.999248822371431,1,3,MAML1-RBP-Jkappa- ICN1 complex,CC,NOTCH1
607,GO:0001712,0.0471117284175395,0.999247342927282,1,3,ectodermal cell fate commitment,BP,FZD7
16794,GO:0072010,0.0472599714478316,0.995086236989151,2,23,glomerular epithelium development,BP,BMP4;WT1
20374,GO:1905064,0.0472861230365406,0.99924169924529,1,3,negative regulation of vascular smooth muscle cell differentiation,BP,PDGFB
601,GO:0001706,0.0473184348380448,0.991299223302005,3,54,endoderm formation,BP,ITGA5;ITGB5;DUSP5
6657,GO:0019637,0.0473352548779677,0.971893547224779,22,1112,organophosphate metabolic process,BP,ACTN3;GUCY1B3;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;WNT5A;KHK;RHOQ;NPR1;PFKFB3;FGF8;HBEGF;CHGA;KITLG;NPPC;PIK3CA;PIK3CG;PDE4B
7188,GO:0030017,0.0473485309986406,0.983942270380147,6,186,sarcomere,CC,FHOD3;ACTN2;CASQ2;MYZAP;PARVB;PDE4B
3924,GO:0008078,0.0473833256203759,0.99914451937066,1,4,mesodermal cell migration,BP,FGF8
8970,GO:0033159,0.0474568058989273,0.999236154821257,1,3,negative regulation of protein import into nucleus, translocation,BP,GAS6
7015,GO:0021879,0.0474914406900982,0.991249447028685,3,55,forebrain neuron differentiation,BP,WNT5A;AXIN1;FGF8
10056,GO:0035793,0.0475191511926555,0.999234124464181,1,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
18566,GO:1900238,0.0475191511926555,0.999234124464181,1,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
21327,GO:2000591,0.0475191511926555,0.999234124464181,1,3,positive regulation of metanephric mesenchymal cell migration,BP,PDGFB
12096,GO:0045218,0.0475405033433232,0.999233428469968,1,3,zonula adherens maintenance,BP,CAMSAP3
6379,GO:0018201,0.0476441968261124,0.999230043885418,1,3,peptidyl-glycine modification,BP,NMT2
6211,GO:0016941,0.0477775467798012,0.999225680104211,1,3,natriuretic peptide receptor activity,MF,NPR1
3689,GO:0007184,0.0478069853024934,0.994997862817552,2,23,SMAD protein import into nucleus,BP,BMP6;BMP4
10648,GO:0042097,0.0478213745113056,0.999224243121223,1,3,interleukin-4 biosynthetic process,BP,ZFPM1
12170,GO:0045402,0.0478213745113056,0.999224243121223,1,3,regulation of interleukin-4 biosynthetic process,BP,ZFPM1
19559,GO:1903348,0.0478391945594489,0.999223658464652,1,3,positive regulation of bicellular tight junction assembly,BP,CLDN1
15264,GO:0060948,0.047861987421544,0.999222910327308,1,3,cardiac vascular smooth muscle cell development,BP,NOTCH1
11886,GO:0044729,0.0482045995639417,0.999211620278124,1,3,hemi-methylated DNA-binding,MF,WT1
16961,GO:0072262,0.0482046006870058,0.99921162024098,1,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,WT1
11496,GO:0043585,0.0482549343711461,0.999209954589157,1,3,nose morphogenesis,BP,STRA6
8742,GO:0032795,0.0482658497758913,0.999112016216834,1,4,heterotrimeric G-protein binding,MF,ADORA1
10274,GO:0036166,0.0483048669368493,0.999208300435623,1,3,phenotypic switching,BP,PDGFB
18567,GO:1900239,0.0483048669368493,0.999208300435623,1,3,regulation of phenotypic switching,BP,PDGFB
17796,GO:0097190,0.0483126932933972,0.975690595902862,13,565,apoptotic signaling pathway,BP,WNT4;PMAIP1;ACVR1;ADORA1;FGF10;PIK3R1;HRAS;BMP4;CDKN1A;AKT1;KITLG;INHBB;GDNF
15587,GO:0061643,0.0483154990136936,0.99920794799046,1,3,chemorepulsion of axon,BP,WNT5A
2539,GO:0005249,0.0483755529461027,0.98796829982354,4,88,voltage-gated potassium channel activity,MF,KCNK6;KCNH2;KCNG2;KCND1
1526,GO:0003274,0.0484262650272168,0.999204271412778,1,3,endocardial cushion fusion,BP,ACVR1
625,GO:0001743,0.0484667073270858,0.999202926870978,1,3,optic placode formation,BP,AXIN1
1595,GO:0003408,0.0484694243097018,0.999202836500769,1,3,optic cup formation involved in camera-type eye development,BP,WNT5A
3782,GO:0007356,0.0485015419545176,0.999103231037805,1,4,thorax and anterior abdomen determination,BP,WT1
16809,GO:0072034,0.0485333954671337,0.9992007072273,1,3,renal vesicle induction,BP,WNT4
2889,GO:0005944,0.048544389759381,0.99920034099099,1,3,phosphatidylinositol 3-kinase complex, class IB,CC,PIK3CG
16067,GO:0070662,0.0485550516776869,0.999199985744631,1,3,mast cell proliferation,BP,KITLG
16374,GO:0071284,0.048590859192088,0.99919879207728,1,3,cellular response to lead ion,BP,CLDN1
17333,GO:0090022,0.0486035861784319,0.994780537210254,2,31,regulation of neutrophil chemotaxis,BP,EDN1;JAM3
7473,GO:0030517,0.0487251094052787,0.994833967301069,2,24,negative regulation of axon extension,BP,WNT3;WNT5A
20878,GO:1990785,0.0487330575754078,0.999194042817661,1,3,response to water-immersion restraint stress,BP,FOXO4
20272,GO:1904862,0.0487598180829676,0.999193147443483,1,3,inhibitory synapse assembly,BP,WNT5A
9506,GO:0034599,0.0488400554792306,0.981633959865317,7,240,cellular response to oxidative stress,BP,GUCY1B3;PRR5L;SESN2;RHOB;BMP7;GJB2;AKT1
15281,GO:0060979,0.0488849314802762,0.999188954556652,1,3,vasculogenesis involved in coronary vascular morphogenesis,BP,NOTCH1
16059,GO:0070644,0.0489038228819478,0.999188320489285,1,3,vitamin D response element binding,MF,VDR
2503,GO:0005173,0.0489038228846569,0.999188320489194,1,3,stem cell factor receptor binding,MF,KITLG
8363,GO:0032252,0.048903822890509,0.999188320488997,1,3,secretory granule localization,BP,PIK3CG
2693,GO:0005606,0.0489038228917123,0.999188320488957,1,3,laminin-1 complex,CC,LAMA1
2696,GO:0005610,0.0489038228921722,0.999188320488941,1,3,laminin-5 complex,CC,LAMA5
16884,GO:0072156,0.0489038228934631,0.999188320488898,1,3,distal tubule morphogenesis,BP,WNK4
11301,GO:0043260,0.0489038228936749,0.999188320488891,1,3,laminin-11 complex,CC,LAMA5
11300,GO:0043259,0.048903822893724,0.999188320488889,1,3,laminin-10 complex,CC,LAMA5
13327,GO:0048643,0.0490303360875859,0.994783733625132,2,24,positive regulation of skeletal muscle tissue development,BP,ACTN3;DLL1
9574,GO:0034705,0.0490362895387628,0.987744585054061,4,90,potassium channel complex,CC,KCNK6;KCNH2;KCNG2;KCND1
8463,GO:0032400,0.0490858485007038,0.994761328199792,2,25,melanosome localization,BP,RAB27A;RAB17
5085,GO:0010897,0.0492206880802374,0.999076152632436,1,4,negative regulation of triglyceride catabolic process,BP,PIK3CG
8866,GO:0032984,0.049441322367446,0.981343862691497,7,258,macromolecular complex disassembly,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;AXIN1;SCIN;SPTB
5829,GO:0016239,0.049464962170489,0.990737586370127,3,55,positive regulation of macroautophagy,BP,RALB;SESN2;RAB12
2448,GO:0005105,0.0494802699258916,0.999066277397888,1,4,type 1 fibroblast growth factor receptor binding,MF,FGF17
18321,GO:0099512,0.0497075071282398,0.971964003794372,18,861,supramolecular fiber,CC,FHOD3;TUBG2;ACTN3;ACTN2;CASQ2;RHOQ;PSRC1;SDC4;CAMSAP3;ESPN;PKP1;MYH11;AMOT;RAB3D;MYZAP;ACTA2;PARVB;PDE4B
7141,GO:0022843,0.0498253843365691,0.984963879364072,5,130,voltage-gated cation channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
19785,GO:1903792,0.04997976247314,0.994641167871293,2,23,negative regulation of anion transport,BP,ADORA1;AKT1
13417,GO:0048808,0.0500262796275976,0.999045330551093,1,4,male genitalia morphogenesis,BP,FGF10
17637,GO:0090598,0.0500262796275976,0.999045330551093,1,4,male anatomical structure morphogenesis,BP,FGF10
12702,GO:0046545,0.0501825077776936,0.987349808363945,4,95,development of primary female sexual characteristics,BP,WNT4;WT1;KITLG;INHBB
10847,GO:0042472,0.0503048384253149,0.987309083366245,4,95,inner ear morphogenesis,BP,FGF10;WNT5A;FGF8;MYO7A
3464,GO:0006813,0.0504006958680027,0.98093271285999,7,224,potassium ion transport,BP,ACTN2;ADORA1;CASQ2;KCNK6;KCNH2;KCNG2;KCND1
15101,GO:0060665,0.0504076941992158,0.99903055727983,1,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,FGF10
8721,GO:0032770,0.0504906653292169,0.994502603777062,2,27,positive regulation of monooxygenase activity,BP,AKT1;GDNF
1054,GO:0002414,0.0505779947473585,0.999023923619471,1,4,immunoglobulin transcytosis in epithelial cells,BP,RAB17
12858,GO:0046889,0.050667587825945,0.990395284301485,3,60,positive regulation of lipid biosynthetic process,BP,WNT4;BMP6;AKT1
15053,GO:0060574,0.0506764097190792,0.999020079554125,1,4,intestinal epithelial cell maturation,BP,CDKN1A
16510,GO:0071480,0.0507270742398682,0.994474503847056,2,26,cellular response to gamma radiation,BP,HRAS;CDKN1A
18629,GO:1900736,0.0507775616787191,0.999016120536065,1,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA
1544,GO:0003308,0.0509470223139811,0.999009469680871,1,4,negative regulation of Wnt signaling pathway involved in heart development,BP,BMP2
7387,GO:0030318,0.0512456395209288,0.994413827316483,2,24,melanocyte differentiation,BP,RAB27A;KITLG
3667,GO:0007159,0.0512647398535193,0.977748432514881,9,346,leukocyte cell-cell adhesion,BP,ITGA5;PIK3R1;SDC4;BMP7;BMP4;MSN;AKT1;PIK3CA;EFNB2
13185,GO:0048295,0.051283884986809,0.998996180747555,1,4,positive regulation of isotype switching to IgE isotypes,BP,CLCF1
12845,GO:0046875,0.0512889128923049,0.994392357320719,2,25,ephrin receptor binding,MF,PIK3CG;EFNB2
7679,GO:0030947,0.051315107443727,0.994374865375557,2,26,regulation of vascular endothelial growth factor receptor signaling pathway,BP,ITGA5;FGF10
14829,GO:0060283,0.0513223418293321,0.998994657901998,1,4,negative regulation of oocyte development,BP,NPPC
20634,GO:1905880,0.0513223418293321,0.998994657901998,1,4,negative regulation of oogenesis,BP,NPPC
17930,GO:0097460,0.0513292841126205,0.998994382870039,1,4,ferrous iron import into cell,BP,TF
8084,GO:0031694,0.0514075101427155,0.998991281136713,1,4,alpha-2A adrenergic receptor binding,MF,ADRA2C
16440,GO:0071384,0.0515703028136401,0.990150464508003,3,61,cellular response to corticosteroid stimulus,BP,EDN1;GJB2;HEY1
2998,GO:0006109,0.0517179487229676,0.984218690324365,5,137,regulation of carbohydrate metabolic process,BP,ACTN3;PMAIP1;PDGFB;SESN2;AKT1
11871,GO:0044711,0.0518782780345245,0.967296593396673,27,1404,single-organism biosynthetic process,BP,WNT4;DHH;HMGCS2;GUCY1B3;DKK3;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;WNT5A;SESN2;NPR1;FGF8;BMP6;BMP4;BMP2;B3GNT2;CTGF;AKT1;PTGES;NPPC;PIK3CA;PIK3CG;VDR
1507,GO:0003241,0.0518912606783927,0.99897199149808,1,4,growth involved in heart morphogenesis,BP,NOTCH1
3531,GO:0006914,0.0519665451202679,0.975263580643003,11,438,autophagy,BP,ITGB4;RAB39A;PIK3R2;RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1;SH3BP4;PIM2
957,GO:0002244,0.0520018358231789,0.986740669441646,4,95,hematopoietic progenitor cell differentiation,BP,NOTCH1;FSTL3;JAM3;BMP4
2930,GO:0006006,0.0521183336422626,0.981910634108239,6,187,glucose metabolic process,BP,ACTN3;PMAIP1;SESN2;PFKFB3;AKT1;PIK3CA
19926,GO:1904063,0.0521971961466084,0.98997335977821,3,63,negative regulation of cation transmembrane transport,BP,ACTN2;CASQ2;KCNH2
12435,GO:0045936,0.0522178046962361,0.973430791951392,13,541,negative regulation of phosphate metabolic process,BP,LIF;ACTN3;GADD45A;EDN1;PRR5L;PDGFB;PRKAR1B;BMP7;BMP4;CAMSAP3;CDKN1A;AKT1;DUSP5
18467,GO:1900078,0.0522376788029655,0.994230628577025,2,25,positive regulation of cellular response to insulin stimulus,BP,PIK3R2;PIK3R1
11142,GO:0043015,0.0523366038984462,0.994228255767114,2,24,gamma-tubulin binding,MF,MARK4;PDE4B
7099,GO:0022409,0.0524324580265223,0.979972899392291,7,244,positive regulation of cell-cell adhesion,BP,FSTL3;PIK3R1;WNT5A;BMP7;AKT1;PIK3CA;EFNB2
16856,GO:0072106,0.0525884758590803,0.998943861148114,1,4,regulation of ureteric bud formation,BP,GDNF
16857,GO:0072107,0.0525884758590803,0.998943861148114,1,4,positive regulation of ureteric bud formation,BP,GDNF
20453,GO:1905278,0.0525884758590803,0.998943861148114,1,4,positive regulation of epithelial tube formation,BP,GDNF
16068,GO:0070663,0.0526530258907393,0.981661784405208,6,202,regulation of leukocyte proliferation,BP,FGF10;SDC4;CLCF1;BMP4;CDKN1A;KITLG
5324,GO:0014910,0.052722774174523,0.989867961921222,3,56,regulation of smooth muscle cell migration,BP,PLAU;PDGFB;FOXO4
15916,GO:0070384,0.0527971835141652,0.998935364936131,1,4,Harderian gland development,BP,FGF10
4855,GO:0010563,0.052820288239751,0.97307820018276,13,542,negative regulation of phosphorus metabolic process,BP,LIF;ACTN3;GADD45A;EDN1;PRR5L;PDGFB;PRKAR1B;BMP7;BMP4;CAMSAP3;CDKN1A;AKT1;DUSP5
18675,GO:1901078,0.053040574790474,0.998925412813928,1,4,negative regulation of relaxation of muscle,BP,PDE4B
13222,GO:0048382,0.0531582588839199,0.998920583792181,1,4,mesendoderm development,BP,FGF8
15137,GO:0060708,0.0531700684264865,0.998920098590596,1,4,spongiotrophoblast differentiation,BP,LIF
8151,GO:0031849,0.0532400156671404,0.998846091584568,1,5,olfactory receptor binding,MF,REEP1
3499,GO:0006873,0.0533175219094326,0.972778033309754,13,570,cellular ion homeostasis,BP,CDH23;TF;CASQ2;EDN1;RAB39A;PRND;LPAR2;BMP6;RAB20;PIK3CG;VDR;RAB38;CLDN16
17227,GO:0080134,0.0534140670228148,0.966830018952049,25,1266,regulation of response to stress,BP,WNT4;PMAIP1;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;PLAU;PRKACB;FZD7;TYRO3;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP2;CTGF;AKT1;PIK3CG;FZD8
11988,GO:0045054,0.0535169367579842,0.99890579754923,1,4,constitutive secretory pathway,BP,RAB27A
18298,GO:0099081,0.0536233766558429,0.969472426923565,18,868,supramolecular polymer,CC,FHOD3;TUBG2;ACTN3;ACTN2;CASQ2;RHOQ;PSRC1;SDC4;CAMSAP3;ESPN;PKP1;MYH11;AMOT;RAB3D;MYZAP;ACTA2;PARVB;PDE4B
8276,GO:0032079,0.0536546593949383,0.998900092679102,1,4,positive regulation of endodeoxyribonuclease activity,BP,AKT1
5275,GO:0014826,0.053711257130512,0.998897743835993,1,4,vein smooth muscle contraction,BP,EDN1
7381,GO:0030311,0.0537188910553807,0.998897426826872,1,4,poly-N-acetyllactosamine biosynthetic process,BP,B3GNT2
10621,GO:0042036,0.0537929074569629,0.993922922069614,2,28,negative regulation of cytokine biosynthetic process,BP,ZFPM1;INHBB
11692,GO:0044255,0.0538061747179682,0.967999952488618,21,1021,cellular lipid metabolic process,BP,STRA6;ITGB8;HMGCS2;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;SESN2;FGF8;SDC4;HBEGF;AKT1;PTGES;KITLG;PIK3CA;PIK3CG;SIN3B;ACSL4
10070,GO:0035814,0.0538791004877143,0.998817907347681,1,5,negative regulation of renal sodium excretion,BP,ADORA1
10910,GO:0042562,0.0539129912179294,0.989514177735329,3,62,hormone binding,MF,ACVR1;PIK3R1;NPR1
7743,GO:0031069,0.0539420056752431,0.99392181121682,2,26,hair follicle morphogenesis,BP,NOTCH1;FGF10
16337,GO:0071222,0.0539833768062565,0.983311981868744,5,148,cellular response to lipopolysaccharide,BP,CCL20;WNT5A;BMP6;AKT1;PDE4B
2188,GO:0004713,0.0539862157777847,0.981111685543195,6,180,protein tyrosine kinase activity,MF,TYRO3;FGF10;FGF17;FGF8;HBEGF;DDR1
1495,GO:0003219,0.0539888583589453,0.998886186069768,1,4,cardiac right ventricle formation,BP,NOTCH1
21544,GO:2001027,0.0540362122674015,0.998884208357104,1,4,negative regulation of endothelial cell chemotaxis,BP,NOTCH1
20631,GO:1905874,0.0542055453880946,0.998877121550719,1,4,regulation of postsynaptic density organization,BP,CDH2
18297,GO:0099080,0.0542057975486546,0.969099660513897,18,869,supramolecular complex,CC,FHOD3;TUBG2;ACTN3;ACTN2;CASQ2;RHOQ;PSRC1;SDC4;CAMSAP3;ESPN;PKP1;MYH11;AMOT;RAB3D;MYZAP;ACTA2;PARVB;PDE4B
19585,GO:1903393,0.0542199045862893,0.993887301780464,2,25,positive regulation of adherens junction organization,BP,WNT4;SDC4
7539,GO:0030667,0.0543651722040071,0.977502072804525,8,288,secretory granule membrane,CC,RAB27A;SERPINA5;PLAU;SYCN;VAMP1;PKP1;RAB44;RAB3D
11385,GO:0043403,0.0543944537575207,0.993817110846088,2,28,skeletal muscle tissue regeneration,BP,WNT7A;FZD7
15993,GO:0070528,0.054413153239888,0.993839192020922,2,26,protein kinase C signaling,BP,PDGFB;WNT5A
16914,GO:0072191,0.054466477900235,0.998866156229588,1,4,ureter smooth muscle development,BP,BMP4
16916,GO:0072193,0.054466477900235,0.998866156229588,1,4,ureter smooth muscle cell differentiation,BP,BMP4
4857,GO:0010565,0.0547572770515278,0.982993034506672,5,156,regulation of cellular ketone metabolic process,BP,WNT4;DKK3;BMP6;BMP2;AKT1
21636,GO:2001234,0.054910845315594,0.980685846444525,6,197,negative regulation of apoptotic signaling pathway,BP,WNT4;ACVR1;FGF10;BMP4;AKT1;GDNF
5201,GO:0014044,0.0551126136726553,0.993730302535443,2,25,Schwann cell development,BP,POU3F1;AKT1
11206,GO:0043125,0.0552998946726054,0.998830767588171,1,4,ErbB-3 class receptor binding,MF,PIK3R1
15872,GO:0070318,0.0553890818970094,0.998826947519425,1,4,positive regulation of G0 to G1 transition,BP,CTGF
19803,GO:1903828,0.0555420724643544,0.982706331070368,5,142,negative regulation of cellular protein localization,BP,ACTN2;RHOQ;BMP7;GAS6;CLDN18
11807,GO:0044440,0.0555917913771629,0.973240827222183,11,443,endosomal part,CC,TMEM163;SYT5;TSPAN15;RAB27A;TF;FZD7;SNX18;RHOB;RAB12;RAB17;RNF144A
11698,GO:0044262,0.0555991601306699,0.978499104848221,7,234,cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1;KHK;SESN2;PFKFB3;B3GNT2;AKT1
11579,GO:0043954,0.0556188788273423,0.99362589051661,2,26,cellular component maintenance,BP,ITGA3;CAMSAP3
3742,GO:0007265,0.0556609721223772,0.975486657496052,9,318,Ras protein signal transduction,BP,ITGA3;RRAS2;FGF10;RALB;HRAS;RHOJ;RHOB;CDKN1A;KITLG
3509,GO:0006885,0.0557108568323676,0.985463623049613,4,99,regulation of pH,BP,EDN1;RAB39A;RAB20;RAB38
15135,GO:0060706,0.0558266712063023,0.993588860165615,2,26,cell differentiation involved in embryonic placenta development,BP,LIF;AKT1
6762,GO:0019904,0.055834881773207,0.96983497055405,15,652,protein domain specific binding,MF,ITGA3;WNT3;ACTN2;RAB27A;FZD7;KCNH2;WNT5A;AXIN1;RHOQ;WT1;ESPN;MYO7A;BCAR1;SHC4;FZD8
21366,GO:2000653,0.055842825801779,0.998807413922706,1,4,regulation of genetic imprinting,BP,PIK3CA
7494,GO:0030552,0.0558673479661663,0.993612512188405,2,24,cAMP binding,MF,PRKAR1B;PDE4B
10761,GO:0042321,0.0560063568398065,0.998721586015602,1,5,negative regulation of circadian sleep/wake cycle, sleep,BP,ADORA1
19505,GO:1903232,0.0560723414474482,0.998718536522311,1,5,melanosome assembly,BP,RAB38
4798,GO:0010453,0.0561095028713562,0.99351175375313,2,28,regulation of cell fate commitment,BP,FZD7;BMP4
3209,GO:0006469,0.0562590324596241,0.978183265606062,7,238,negative regulation of protein kinase activity,BP,GADD45A;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
7574,GO:0030799,0.0563020147355256,0.982375527286074,5,158,regulation of cyclic nucleotide metabolic process,BP,EDN1;WNT5A;NPR1;CHGA;NPPC
3694,GO:0007189,0.0563116747454358,0.988855368193249,3,62,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C;CHGA
4824,GO:0010507,0.0563783990892199,0.988853139119555,3,59,negative regulation of autophagy,BP,AKT1;PIK3CA;LZTS1
1281,GO:0002790,0.0563968903873776,0.971824845284652,12,511,peptide secretion,BP,ADRA2C;NOTCH1;ADORA1;EDN1;RAB40B;RAB40A;WNT5A;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6
19751,GO:1903725,0.0564102437905848,0.988844319429111,3,59,regulation of phospholipid metabolic process,BP,PIK3R2;PIK3R1;PDGFB
13436,GO:0048852,0.0564368515989674,0.998781591397295,1,4,diencephalon morphogenesis,BP,WNT5A
15454,GO:0061325,0.0564826332181151,0.998779589490468,1,4,cell proliferation involved in outflow tract morphogenesis,BP,BMP4
14841,GO:0060298,0.0564917543198096,0.998779190448118,1,4,positive regulation of sarcomere organization,BP,EDN1
18790,GO:1901381,0.0565028462620759,0.993467812212662,2,26,positive regulation of potassium ion transmembrane transport,BP,ACTN2;KCNH2
2644,GO:0005520,0.0566798230315054,0.993409010023618,2,28,insulin-like growth factor binding,MF,ITGB4;CTGF
17445,GO:0090191,0.0567718347201508,0.998766904568914,1,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,BMP4
10641,GO:0042089,0.056829821390605,0.985050517279274,4,108,cytokine biosynthetic process,BP,ZFPM1;CCL20;WNT5A;INHBB
8621,GO:0032612,0.0568625986844654,0.988673875318333,3,68,interleukin-1 production,BP,CCL20;WNT5A;GAS6
11462,GO:0043536,0.0569338097466235,0.993376130187264,2,27,positive regulation of blood vessel endothelial cell migration,BP,PDGFB;AKT1
10429,GO:0038001,0.0570112831245495,0.998756351045267,1,4,paracrine signaling,BP,PDGFB
7203,GO:0030041,0.0570244966355958,0.982107433112913,5,146,actin filament polymerization,BP,FHOD3;SPTBN5;SPTBN4;SCIN;SPTB
139,GO:0000278,0.0570489532327536,0.966291021760676,20,952,mitotic cell cycle,BP,RAB6C;MARK4;GADD45A;ACVR1;EDN1;PHLDA1;TTYH1;FGF10;PDGFB;FOXO4;HRAS;SNX18;PSRC1;FGF8;BMP7;BMP4;CDKN1A;AKT1;LZTS1;PIM2
17928,GO:0097458,0.0571084327013226,0.963969940886624,26,1285,neuron part,CC,ITGA3;TMEM163;ADRA2C;SYT5;ACTN2;MARK4;RAB27A;CDH23;WNT7A;ADORA1;RAB40B;RAB40A;SPTBN5;SPTBN4;RAB39B;FSTL3;DRP2;ESPN;VAMP1;RAB17;NRTN;MYO7A;LZTS1;KCND1;ACSL4;PDE4B
10078,GO:0035844,0.0571442097395319,0.99875047249992,1,4,cloaca development,BP,BMP4
15777,GO:0070172,0.0571868431044279,0.998666467545907,1,5,positive regulation of tooth mineralization,BP,WNT6
4212,GO:0008532,0.0573966584535649,0.998739269094217,1,4,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT2
21152,GO:2000346,0.0574233554736292,0.998738081311929,1,4,negative regulation of hepatocyte proliferation,BP,LIMS2
4953,GO:0010724,0.0575790254138172,0.998731143951863,1,4,regulation of definitive erythrocyte differentiation,BP,ZFPM1
15171,GO:0060750,0.0575896171791886,0.998730671226288,1,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,WNT5A
8038,GO:0031625,0.0575919307415341,0.97588987685814,8,286,ubiquitin protein ligase binding,MF,PRKACB;PRR5L;KCNH2;RALB;MAGEC2;AXIN1;CDKN1A;FZD8
18165,GO:0098793,0.0576723560194362,0.974417736548374,9,337,presynapse,CC,TMEM163;ADRA2C;SYT5;WNT7A;ADORA1;RAB40B;RAB40A;VAMP1;PDE4B
15703,GO:0070053,0.0576767199966879,0.998726780280119,1,4,thrombospondin receptor activity,MF,SDC4
8929,GO:0033088,0.0577423008746532,0.998723846706069,1,4,negative regulation of immature T cell proliferation in thymus,BP,BMP4
17540,GO:0090316,0.0578747052476699,0.97741320560502,7,241,positive regulation of intracellular protein transport,BP,PRR5L;PIK3R2;PIK3R1;BMP6;BMP4;CDH1;GAS6
13641,GO:0050764,0.0578846858119097,0.988406477012575,3,64,regulation of phagocytosis,BP,RAB27A;MFGE8;GAS6
15025,GO:0060535,0.0578893467680522,0.99871725644544,1,4,trachea cartilage morphogenesis,BP,WNT7B
5188,GO:0014028,0.0579527642403846,0.998714408848107,1,4,notochord formation,BP,CRB2
4754,GO:0010193,0.0582736082269054,0.998614671468593,1,5,response to ozone,BP,EDN1
13700,GO:0050851,0.058324955851914,0.979171076198527,6,205,antigen receptor-mediated signaling pathway,BP,PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
3693,GO:0007188,0.0583565052575141,0.98156644906569,5,149,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;PRKACB;CHGA
16972,GO:0072278,0.0585264236945647,0.998688503030483,1,4,metanephric comma-shaped body morphogenesis,BP,BMP4
11453,GO:0043523,0.0585295438571172,0.979098478222516,6,191,regulation of neuron apoptotic process,BP,TYRO3;HRAS;FGF8;CLCF1;PIK3CA;GDNF
2926,GO:0006001,0.0585511145823527,0.998687382068427,1,4,fructose catabolic process,BP,KHK
15576,GO:0061624,0.0585511145823527,0.998687382068427,1,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,KHK
15871,GO:0070317,0.058689368452595,0.998681096291857,1,4,negative regulation of G0 to G1 transition,BP,FOXO4
16846,GO:0072095,0.0589076105782089,0.998671142466233,1,4,regulation of branch elongation involved in ureteric bud branching,BP,BMP4
15340,GO:0061054,0.0589306226708869,0.99867009066841,1,4,dermatome development,BP,WNT4
15407,GO:0061183,0.0589306226708869,0.99867009066841,1,4,regulation of dermatome development,BP,WNT4
7398,GO:0030330,0.059021583149678,0.984293729572806,4,104,DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1;GADD45A;SESN2;CDKN1A
11751,GO:0044339,0.0591078476229397,0.998661976067542,1,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,WNT3
5026,GO:0010827,0.059114014708919,0.984276590668862,4,99,regulation of glucose transport,BP,PIK3R2;PIK3R1;RHOQ;AKT1
15769,GO:0070164,0.0591218022689945,0.998661336050676,1,4,negative regulation of adiponectin secretion,BP,RAB11FIP1
20781,GO:1990430,0.059223708203369,0.998656657470126,1,4,extracellular matrix protein binding,MF,ITGB8
10655,GO:0042107,0.0592333118633041,0.984202350647064,4,110,cytokine metabolic process,BP,ZFPM1;CCL20;WNT5A;INHBB
14798,GO:0060235,0.0592373805595808,0.998656029124576,1,4,lens induction in camera-type eye,BP,BMP4
16871,GO:0072131,0.0592829591352918,0.998653933364247,1,4,kidney mesenchyme morphogenesis,BP,BMP7
16873,GO:0072133,0.0592829591352918,0.998653933364247,1,4,metanephric mesenchyme morphogenesis,BP,BMP7
11622,GO:0044070,0.0593012073794767,0.984204201540775,4,101,regulation of anion transport,BP,ADORA1;EDN1;TTYH1;AKT1
14731,GO:0060126,0.0594344798075258,0.998558226109154,1,5,somatotropin secreting cell differentiation,BP,WNT4
8325,GO:0032190,0.0594956509499373,0.998555219726519,1,5,acrosin binding,MF,SERPINA5
18436,GO:1900019,0.0595654066852732,0.998640908710129,1,4,regulation of protein kinase C activity,BP,WNT5A
18437,GO:1900020,0.0595654066852732,0.998640908710129,1,4,positive regulation of protein kinase C activity,BP,WNT5A
10600,GO:0040036,0.0595892282188615,0.992904732508306,2,26,regulation of fibroblast growth factor receptor signaling pathway,BP,WNT4;WNT5A
14127,GO:0051541,0.0595896020143823,0.998550596056199,1,5,elastin metabolic process,BP,HBEGF
12331,GO:0045746,0.0596179024491535,0.992884317878756,2,27,negative regulation of Notch signaling pathway,BP,BMP7;HEY1
13444,GO:0048861,0.0597592597184868,0.998631932221665,1,4,leukemia inhibitory factor signaling pathway,BP,LIF
15009,GO:0060510,0.0598374955789008,0.998538359970942,1,5,Type II pneumocyte differentiation,BP,FGF10
17243,GO:0086003,0.0599954968123954,0.987850832951701,3,57,cardiac muscle cell contraction,BP,DSC2;KCNH2;PDE4B
8360,GO:0032241,0.0600114519306465,0.998620208915283,1,4,positive regulation of nucleobase-containing compound transport,BP,ADORA1
5894,GO:0016361,0.0601257885743379,0.998614876995424,1,4,activin receptor activity, type I,MF,ACVR1
13601,GO:0050704,0.0603220842731152,0.99269095152791,2,32,regulation of interleukin-1 secretion,BP,WNT5A;GAS6
1682,GO:0003873,0.0603334550094507,0.998605165786357,1,4,6-phosphofructo-2-kinase activity,MF,PFKFB3
1914,GO:0004331,0.0603334550094507,0.998605165786357,1,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,PFKFB3
2928,GO:0006003,0.0603334550094507,0.998605165786357,1,4,fructose 2,6-bisphosphate metabolic process,BP,PFKFB3
12294,GO:0045670,0.0603557187868037,0.987712097650612,3,63,regulation of osteoclast differentiation,BP,FSTL3;PIK3R1;CLDN18
9599,GO:0034754,0.0604195109523429,0.983781835929953,4,110,cellular hormone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
432,GO:0001106,0.0604268746675496,0.992733539325249,2,27,RNA polymerase II transcription corepressor activity,MF,TLE1;SIN3B
17163,GO:0072679,0.0605085833912187,0.998504970259672,1,5,thymocyte migration,BP,CCL20
15856,GO:0070294,0.0605581551529989,0.998594618794753,1,4,renal sodium ion absorption,BP,WNK4
6526,GO:0019207,0.0605654486373325,0.978182295514848,6,196,kinase regulator activity,MF,PIK3R2;PIK3R1;PRKAR1B;CDKN1A;PIK3CA;GAS6
8695,GO:0032730,0.0606695295885208,0.998496904950976,1,5,positive regulation of interleukin-1 alpha production,BP,CCL20
18619,GO:1900542,0.0608498596505717,0.978036372047255,6,210,regulation of purine nucleotide metabolic process,BP,ACTN3;EDN1;WNT5A;NPR1;CHGA;NPPC
600,GO:0001705,0.0608519357217953,0.998580767780232,1,4,ectoderm formation,BP,FZD7
10586,GO:0040014,0.0608907684701405,0.987548311168264,3,65,regulation of multicellular organism growth,BP,SPTBN4;NPPC;PIK3CA
16380,GO:0071295,0.0608911609270462,0.99263202303043,2,28,cellular response to vitamin,BP,GAS6;VDR
21054,GO:2000195,0.0609055512973396,0.99857823241599,1,4,negative regulation of female gonad development,BP,WT1
19665,GO:1903553,0.0609114515644369,0.998577953263271,1,4,positive regulation of extracellular exosome assembly,BP,SDC4
8051,GO:0031644,0.0609410452410598,0.987533885168513,3,65,regulation of neurological system process,BP,ADRA2C;ADORA1;EDN1
16329,GO:0071214,0.060999066390438,0.974162232225211,8,288,cellular response to abiotic stimulus,BP,GADD45A;NMT2;PIK3R1;HRAS;RHOB;BMP6;CDKN1A;AKT1
17980,GO:0097546,0.061039696762027,0.992618540003183,2,27,ciliary base,CC,PRKACB;PRKAR1B
14703,GO:0060076,0.0611166057536463,0.992636693431158,2,25,excitatory synapse,CC,ITGA3;PDE4B
19247,GO:1902622,0.0612291653526205,0.992499147805254,2,34,regulation of neutrophil migration,BP,EDN1;JAM3
6996,GO:0021846,0.0616386408493797,0.992505497835158,2,27,cell proliferation in forebrain,BP,WNT7A;FGF8
1525,GO:0003273,0.0616714640329128,0.998541760355116,1,4,cell migration involved in endocardial cushion formation,BP,NOTCH1
13198,GO:0048319,0.0618035740548323,0.99853542142383,1,4,axial mesoderm morphogenesis,BP,AXIN1
17116,GO:0072583,0.0618289785423754,0.987313301953395,3,59,clathrin-dependent endocytosis,BP,SYT5;DLL1;UNC119
14750,GO:0060157,0.0618484429878329,0.998437148686569,1,5,urinary bladder development,BP,WNT5A
11777,GO:0044389,0.061882305088912,0.973708582352931,8,291,ubiquitin-like protein ligase binding,MF,PRKACB;PRR5L;KCNH2;RALB;MAGEC2;AXIN1;CDKN1A;FZD8
16334,GO:0071219,0.0618848735920565,0.980120911720262,5,154,cellular response to molecule of bacterial origin,BP,CCL20;WNT5A;BMP6;AKT1;PDE4B
17401,GO:0090131,0.0619258883857303,0.998433181331502,1,5,mesenchyme migration,BP,ACTA2
14656,GO:0060024,0.0619480506925076,0.99852847294874,1,4,rhythmic synaptic transmission,BP,EDN1
16172,GO:0070885,0.0619790688345398,0.998526978956336,1,4,negative regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
3850,GO:0007585,0.061989612445641,0.987237255771516,3,64,respiratory gaseous exchange,BP,ADORA1;EDN1;JAG2
12633,GO:0046427,0.0620337984531858,0.987185575479948,3,72,positive regulation of JAK-STAT cascade,BP,LIF;NOTCH1;CLCF1
20295,GO:1904894,0.0620337984531858,0.987185575479948,3,72,positive regulation of STAT cascade,BP,LIF;NOTCH1;CLCF1
2540,GO:0005250,0.0620518848730628,0.99852346870388,1,4,A-type (transient outward) potassium channel activity,MF,KCND1
7940,GO:0031424,0.062091045366959,0.979949831811379,5,220,keratinization,BP,DSC2;DSG3;PKP3;PKP1;DSC3
14597,GO:0055076,0.0621790199419549,0.983158456156621,4,108,transition metal ion homeostasis,BP,TF;PRND;BMP6;SFXN1
16712,GO:0071847,0.062214726038184,0.998515603067739,1,4,TNFSF11-mediated signaling pathway,BP,CLDN18
14303,GO:0051884,0.0624941683220123,0.998502055275435,1,4,regulation of timing of anagen,BP,WNT5A
8226,GO:0031999,0.0625011623359074,0.998501715383759,1,4,negative regulation of fatty acid beta-oxidation,BP,AKT1
10325,GO:0036336,0.0625257196092779,0.99229485761042,2,30,dendritic cell migration,BP,PIK3CG;GAS6
14105,GO:0051491,0.0625403831491048,0.992350330118977,2,26,positive regulation of filopodium assembly,BP,RHOQ;ESPN
140,GO:0000280,0.0626753908935262,0.967218691513856,13,560,nuclear division,BP,LIF;WNT4;MARK4;EDN1;TTYH1;PDGFB;WNT5A;SNX18;PSRC1;FGF8;BMP7;BMP4;PIM2
15021,GO:0060528,0.062723927898814,0.998490868804141,1,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,NOTCH1
15495,GO:0061419,0.0628151479660502,0.998486415647381,1,4,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NOTCH1
8274,GO:0032077,0.0629051123935122,0.998382572548995,1,5,positive regulation of deoxyribonuclease activity,BP,AKT1
10442,GO:0038028,0.0629574638829631,0.998479454642898,1,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,PIK3CA
15808,GO:0070227,0.0630217757314733,0.986912009253194,3,69,lymphocyte apoptotic process,BP,WNT5A;BMP4;AKT1
19432,GO:1903053,0.0630572901357485,0.992235208043607,2,27,regulation of extracellular matrix organization,BP,NOTCH1;DDR1
9609,GO:0034765,0.063220494934437,0.970102953214143,10,397,regulation of ion transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TSPAN13;KCNH2;AKT1;PIK3CG;KCNG2;KCND1;PDE4B
17374,GO:0090087,0.0632216286876213,0.964526350042213,16,747,regulation of peptide transport,BP,ADRA2C;ADORA1;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;BMP7;BMP6;BMP4;CDKN1A;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6
16287,GO:0071072,0.0632699701338697,0.998464111636472,1,4,negative regulation of phospholipid biosynthetic process,BP,PDGFB
7666,GO:0030910,0.0632880781147254,0.998463220169073,1,4,olfactory placode formation,BP,AXIN1
16650,GO:0071698,0.0632880781147254,0.998463220169073,1,4,olfactory placode development,BP,AXIN1
16651,GO:0071699,0.0632880781147254,0.998463220169073,1,4,olfactory placode morphogenesis,BP,AXIN1
10052,GO:0035788,0.0633080887237038,0.998462234724885,1,4,cell migration involved in metanephros development,BP,PDGFB
10053,GO:0035789,0.0633080887237038,0.998462234724885,1,4,metanephric mesenchymal cell migration,BP,PDGFB
21325,GO:2000589,0.0633080887237038,0.998462234724885,1,4,regulation of metanephric mesenchymal cell migration,BP,PDGFB
5634,GO:0015833,0.063366941263692,0.957098994565051,35,1934,peptide transport,BP,ADRA2C;NOTCH1;RAB27A;TF;RABIF;ADORA1;EDN1;RAB40B;RAB40A;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;AKT1;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;UNC119;RAB38;RAB3D
7763,GO:0031093,0.063576353134526,0.986765267543421,3,66,platelet alpha granule lumen,CC,ACTN2;PDGFB;GAS6
3231,GO:0006499,0.0635816302342736,0.99844873132152,1,4,N-terminal protein myristoylation,BP,NMT2
10226,GO:0036091,0.0636151719092288,0.998345358243969,1,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2
13175,GO:0048278,0.0636222191569681,0.986774555437285,3,62,vesicle docking,BP,RAB40B;RAB40A;RALB
18634,GO:1900744,0.0637131053557328,0.992093589797934,2,28,regulation of p38MAPK cascade,BP,GADD45A;BMP2
4631,GO:0009743,0.0637592834727148,0.976733550734424,6,200,response to carbohydrate,BP,KHK;SESN2;CTGF;GJB6;PIK3CA;GAS6
11390,GO:0043409,0.0638393543972624,0.979332977190443,5,145,negative regulation of MAPK cascade,BP,LIF;BMP7;BMP4;AKT1;DUSP5
917,GO:0002159,0.0638709780045902,0.998434381592993,1,4,desmosome assembly,BP,PKP3
8806,GO:0032898,0.0638747834793508,0.998434192414199,1,4,neurotrophin production,BP,ADORA1
7199,GO:0030035,0.0639051269830289,0.99843268354934,1,4,microspike assembly,BP,ACTN2
18501,GO:1900127,0.0639194819870588,0.998431969470304,1,4,positive regulation of hyaluronan biosynthetic process,BP,PDGFB
20899,GO:1990851,0.0639292404238097,0.998431483948634,1,4,Wnt-Frizzled-LRP5/6 complex,CC,FZD8
16812,GO:0072039,0.0639480097046866,0.998430549883815,1,4,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
16813,GO:0072040,0.0639480097046866,0.998430549883815,1,4,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
18694,GO:1901145,0.0639480097046866,0.998430549883815,1,4,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
20177,GO:1904673,0.0639480097046866,0.998430549883815,1,4,negative regulation of somatic stem cell population maintenance,BP,BMP7
3802,GO:0007416,0.0639510984747246,0.979307783246451,5,136,synapse assembly,BP,WNT7A;CDH2;WNT5A;RAB17;CDH1
3607,GO:0007034,0.0639912307220043,0.982526691983046,4,101,vacuolar transport,BP,SPTBN5;GPRASP1;RHOB;RAB12
4972,GO:0010746,0.0640594200279818,0.998424999595967,1,4,regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
4973,GO:0010748,0.0640594200279818,0.998424999595967,1,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
1534,GO:0003289,0.0641131171142407,0.998422320893761,1,4,atrial septum primum morphogenesis,BP,ACVR1
3781,GO:0007354,0.0641313645652896,0.998318031638139,1,5,zygotic determination of anterior/posterior axis, embryo,BP,WT1
5053,GO:0010861,0.0641650199454447,0.998419729474536,1,4,thyroid hormone receptor activator activity,MF,ACTN2
7419,GO:0030375,0.0641650199454447,0.998419729474536,1,4,thyroid hormone receptor coactivator activity,MF,ACTN2
2413,GO:0005025,0.0642002270056904,0.998417970401838,1,4,transforming growth factor beta receptor activity, type I,MF,ACVR1
15460,GO:0061343,0.0642002270065233,0.998417970401797,1,4,cell adhesion involved in heart morphogenesis,BP,ACVR1
2642,GO:0005518,0.064275031132553,0.986589777035668,3,61,collagen binding,MF,ITGA3;PDGFB;DDR1
19380,GO:1902965,0.0644024751765579,0.998407845855505,1,4,regulation of protein localization to early endosome,BP,MSN
19381,GO:1902966,0.0644024751765579,0.998407845855505,1,4,positive regulation of protein localization to early endosome,BP,MSN
20586,GO:1905666,0.0644024751765579,0.998407845855505,1,4,regulation of protein localization to endosome,BP,MSN
20587,GO:1905668,0.0644024751765579,0.998407845855505,1,4,positive regulation of protein localization to endosome,BP,MSN
10464,GO:0038064,0.0644585824331585,0.998405031241103,1,4,collagen receptor activity,MF,DDR1
5237,GO:0014719,0.064467366849446,0.998300120562344,1,5,skeletal muscle satellite cell activation,BP,WNT7A
11714,GO:0044291,0.0645514505490065,0.986515161786392,3,60,cell-cell contact zone,CC,DSC2;CDH2;JAM3
21577,GO:2001137,0.0645709063269567,0.99839938884407,1,4,positive regulation of endocytic recycling,BP,ACTN2
2931,GO:0006007,0.0645767801168874,0.991897640444268,2,30,glucose catabolic process,BP,ACTN3;PFKFB3
7227,GO:0030101,0.0645985199192016,0.986418358709844,3,76,natural killer cell activation,BP,RAB27A;TYRO3;GAS6
10417,GO:0036515,0.064669566441035,0.998394424371126,1,4,serotonergic neuron axon guidance,BP,WNT5A
17755,GO:0097118,0.0646699008346268,0.99839440753135,1,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,CDH2
13380,GO:0048730,0.064778892307017,0.991871835708477,2,29,epidermis morphogenesis,BP,NOTCH1;FGF10
1543,GO:0003307,0.0648756629545391,0.998278224591198,1,5,regulation of Wnt signaling pathway involved in heart development,BP,BMP2
4057,GO:0008289,0.0648844441841105,0.964997942367798,14,631,lipid binding,MF,SYT5;ACTN2;SERPINA5;MFGE8;SPTBN4;FZD7;LPAR2;SNX18;SCIN;AKT1;EPN1;GAS6;VDR;UNC119
14040,GO:0051373,0.0650005420178776,0.998271498867282,1,5,FATZ binding,MF,ACTN2
10984,GO:0042695,0.0650188735188237,0.998270510437318,1,5,thelarche,BP,WNT5A
15166,GO:0060744,0.0650188735188237,0.998270510437318,1,5,mammary gland branching involved in thelarche,BP,WNT5A
9566,GO:0034694,0.0650417119292332,0.991806568752318,2,30,response to prostaglandin,BP,EDN1;AKT1
18788,GO:1901379,0.0653127814567886,0.986278186922077,3,62,regulation of potassium ion transmembrane transport,BP,ACTN2;CASQ2;KCNH2
1389,GO:0003016,0.065397621377473,0.991750531990542,2,29,respiratory system process,BP,ADORA1;JAG2
411,GO:0001076,0.0657886563453852,0.978519544314393,5,146,transcription factor activity, RNA polymerase II transcription factor binding,MF,LIF;POU3F1;NOTCH1;TLE1;SIN3B
13422,GO:0048818,0.0658652748072295,0.998224556445428,1,5,positive regulation of hair follicle maturation,BP,WNT5A
16688,GO:0071804,0.0659237318372463,0.975761347247118,6,189,cellular potassium ion transport,BP,ACTN2;CASQ2;KCNK6;KCNH2;KCNG2;KCND1
16689,GO:0071805,0.0659237318372463,0.975761347247118,6,189,potassium ion transmembrane transport,BP,ACTN2;CASQ2;KCNK6;KCNH2;KCNG2;KCND1
7368,GO:0030295,0.0660338706103274,0.986046613114908,3,65,protein kinase activator activity,MF,CDKN1A;PIK3CA;GAS6
15606,GO:0061695,0.0661112404940419,0.973416149266988,7,248,transferase complex, transferring phosphorus-containing groups,CC,ACVR1;PIK3R2;PIK3R1;SESN2;CDKN1A;PIK3CA;PIK3CG
19605,GO:1903426,0.0662498232181384,0.985965824563984,3,68,regulation of reactive oxygen species biosynthetic process,BP,RAB27A;EDN1;AKT1
14957,GO:0060437,0.0662724313135233,0.998202229887466,1,5,lung growth,BP,FGF10
5010,GO:0010811,0.0664934561097874,0.981603202013278,4,104,positive regulation of cell-substrate adhesion,BP,ITGA3;ITGA5;WNT4;SDC4
7287,GO:0030183,0.0665584093534363,0.981551212201529,4,113,B cell differentiation,BP,PIK3R1;CLCF1;DLL1;TPD52
19199,GO:1902532,0.0666020255806697,0.966955239632145,11,451,negative regulation of intracellular signal transduction,BP,ITGA3;LIF;ACTN3;CASQ2;SESN2;BMP7;BMP4;AKT1;TLE1;SH3BP4;DUSP5
8590,GO:0032571,0.066689005585171,0.998179238448978,1,5,response to vitamin K,BP,GAS6
10164,GO:0035989,0.0666984145623561,0.998178717416991,1,5,tendon development,BP,BMP4
9423,GO:0034392,0.0668148942089616,0.998172260886717,1,5,negative regulation of smooth muscle cell apoptotic process,BP,EDN1
15813,GO:0070232,0.0669674701968162,0.991387345344206,2,33,regulation of T cell apoptotic process,BP,WNT5A;BMP4
16051,GO:0070627,0.067055325801201,0.998158896479688,1,5,ferrous iron import,BP,TF
14028,GO:0051346,0.0673067533251433,0.969224619014069,9,384,negative regulation of hydrolase activity,BP,CRB2;SERPINA5;HRAS;CAMSAP3;AKT1;CST9L;GAS6;AMOT;SH3BP4
19337,GO:1902893,0.0673684762507089,0.991392134408654,2,27,regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB;BMP2
850,GO:0002053,0.0674255009451412,0.991380766460572,2,27,positive regulation of mesenchymal cell proliferation,BP,WNT2;WNT5A
15100,GO:0060664,0.0675369437051867,0.998055652470398,1,6,epithelial cell proliferation involved in salivary gland morphogenesis,BP,FGF10
6925,GO:0021696,0.0678062805598854,0.991287735524247,2,28,cerebellar cortex morphogenesis,BP,WNT7A;DLL1
3013,GO:0006140,0.0679127388893992,0.974803615186796,6,217,regulation of nucleotide metabolic process,BP,ACTN3;EDN1;WNT5A;NPR1;CHGA;NPPC
1423,GO:0003100,0.0679135630149109,0.998110782850636,1,5,regulation of systemic arterial blood pressure by endothelin,BP,EDN1
3390,GO:0006692,0.067925831665148,0.991194394854741,2,33,prostanoid metabolic process,BP,EDN1;PTGES
3391,GO:0006693,0.067925831665148,0.991194394854741,2,33,prostaglandin metabolic process,BP,EDN1;PTGES
630,GO:0001757,0.0680684873224189,0.998102029610337,1,5,somite specification,BP,DLL1
7011,GO:0021872,0.0680836630520895,0.98544613188894,3,63,forebrain generation of neurons,BP,WNT5A;AXIN1;FGF8
11257,GO:0043200,0.0681251517291717,0.980994069907475,4,106,response to amino acid,BP,EDN1;SESN2;CTGF;SH3BP4
13734,GO:0050891,0.06825489541388,0.985401137920172,3,62,multicellular organismal water homeostasis,BP,PRKACB;PRKAR1B;CLDN1
8884,GO:0033010,0.0684009504780791,0.998083175135398,1,5,paranodal junction,CC,JAM3
9693,GO:0035115,0.0684756485748173,0.991122240297314,2,30,embryonic forelimb morphogenesis,BP,WNT3;WNT7A
2461,GO:0005127,0.0685204056104272,0.998076377241939,1,5,ciliary neurotrophic factor receptor binding,MF,CLCF1
17144,GO:0072656,0.0685267329720495,0.99807601682228,1,5,maintenance of protein location in mitochondrion,BP,AKT1
21674,GO:2001286,0.0686037492787771,0.998071627028363,1,5,regulation of caveolin-mediated endocytosis,BP,UNC119
4916,GO:0010656,0.0688092719019349,0.991054665267717,2,30,negative regulation of muscle cell apoptotic process,BP,EDN1;BMP7
21556,GO:2001046,0.068961626954038,0.998051161085979,1,5,positive regulation of integrin-mediated signaling pathway,BP,LIMS2
8928,GO:0033087,0.0689761422306932,0.998050328654879,1,5,negative regulation of immature T cell proliferation,BP,BMP4
10750,GO:0042303,0.0691169187639089,0.980618648475002,4,108,molting cycle,BP,NOTCH1;FGF10;WNT5A;LAMA5
10957,GO:0042633,0.0691169187639089,0.980618648475002,4,108,hair cycle,BP,NOTCH1;FGF10;WNT5A;LAMA5
16194,GO:0070915,0.069137649975881,0.998041054065385,1,5,lysophosphatidic acid receptor activity,MF,LPAR2
7380,GO:0030309,0.0692716785508421,0.998033340268618,1,5,poly-N-acetyllactosamine metabolic process,BP,B3GNT2
7882,GO:0031324,0.0692748967907053,0.951460894137681,41,2336,negative regulation of cellular metabolic process,BP,LIF;WNT4;ACTN3;NOTCH1;GADD45A;CRB2;SERPINA5;ZFPM1;DKK3;EDN1;PRR5L;PDGFB;PRKAR1B;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;AKT1;PKP3;PKP1;NPPC;CST9L;NAB2;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;LZTS1;VDR;FZD8;DUSP5;HEY1
16904,GO:0072179,0.0694311283442015,0.998024143071295,1,5,nephric duct formation,BP,BMP4
14848,GO:0060306,0.0698410631022938,0.990859842163301,2,29,regulation of membrane repolarization,BP,CASQ2;KCNH2
15825,GO:0070245,0.0701176288888941,0.997984292814863,1,5,positive regulation of thymocyte apoptotic process,BP,WNT5A
19120,GO:1902302,0.0701910835564062,0.997980004624974,1,5,regulation of potassium ion export,BP,KCNH2
2783,GO:0005769,0.0701938053764004,0.969392900787632,8,293,early endosome,CC,TMEM163;RIN3;TF;RHOB;RAB20;RAB17;CYTIP;RAB38
8647,GO:0032650,0.0703930666243277,0.997885246230158,1,6,regulation of interleukin-1 alpha production,BP,CCL20
14993,GO:0060482,0.070437906654714,0.997882512197034,1,6,lobar bronchus development,BP,WNT7B
14593,GO:0055072,0.0706122962819124,0.984648580546754,3,68,iron ion homeostasis,BP,TF;BMP6;SFXN1
21349,GO:2000630,0.0706326183089978,0.997954129500108,1,5,positive regulation of miRNA metabolic process,BP,HRAS
19004,GO:1902035,0.0707373031317814,0.997947969813463,1,5,positive regulation of hematopoietic stem cell proliferation,BP,KITLG
9160,GO:0033673,0.0708292083656548,0.971070402366479,7,251,negative regulation of kinase activity,BP,GADD45A;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
15172,GO:0060751,0.0708980417456109,0.997938493339934,1,5,branch elongation involved in mammary gland duct branching,BP,WNT5A
6971,GO:0021797,0.0710414581048597,0.99793001912913,1,5,forebrain anterior/posterior pattern specification,BP,AXIN1
14738,GO:0060136,0.0710864649144743,0.997927356067563,1,5,embryonic process involved in female pregnancy,BP,ACSL4
11076,GO:0042886,0.0711969929663361,0.951292750105488,35,1954,amide transport,BP,ADRA2C;NOTCH1;RAB27A;TF;RABIF;ADORA1;EDN1;RAB40B;RAB40A;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;AKT1;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;UNC119;RAB38;RAB3D
16797,GO:0072014,0.0717307223899391,0.997889041864813,1,5,proximal tubule development,BP,DLL1
5207,GO:0014050,0.0717704254662624,0.997886668881557,1,5,negative regulation of glutamate secretion,BP,ADORA1
18168,GO:0098796,0.0719857468396602,0.961516115765904,13,631,membrane protein complex,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8;CDH2;VAMP1;GJB1;GJB2;GJB6;CDH1;GJA3;FZD8
11517,GO:0043623,0.0719987138555685,0.962586914553872,12,548,cellular protein complex assembly,BP,FHOD3;TUBG2;CASQ2;SPTBN5;SPTBN4;RALB;AXIN1;SCIN;PSRC1;SPTB;VAMP1;MYH11
10114,GO:0035900,0.0724352135837973,0.997758885262593,1,6,response to isolation stress,BP,HRAS
16948,GO:0072236,0.072704480439266,0.997830445597382,1,5,metanephric loop of Henle development,BP,WNT7B
4672,GO:0009892,0.0727290057412775,0.9481134260178,45,2643,negative regulation of metabolic process,BP,LIF;WNT4;ACTN3;NOTCH1;ITGB8;GADD45A;CRB2;SERPINA5;ZFPM1;ADORA1;DKK3;EDN1;PRR5L;PDGFB;PRKAR1B;HRAS;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;CTGF;AKT1;PKP3;PKP1;NPPC;CST9L;NAB2;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;LZTS1;VDR;FZD8;DUSP5;HEY1
1420,GO:0003096,0.0730727776793841,0.997808067599776,1,5,renal sodium ion transport,BP,WNK4
18826,GO:1901552,0.0730729352620319,0.997808057999607,1,5,positive regulation of endothelial cell development,BP,CLDN5
19467,GO:1903142,0.0730729352620319,0.997808057999607,1,5,positive regulation of establishment of endothelial barrier,BP,CLDN5
12814,GO:0046813,0.0731413665232591,0.997803887016836,1,5,receptor-mediated virion attachment to host cell,BP,GAS6
9606,GO:0034762,0.0731611041341597,0.964474011901795,10,411,regulation of transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TSPAN13;KCNH2;AKT1;PIK3CG;KCNG2;KCND1;PDE4B
18095,GO:0098632,0.0731691209163776,0.990138671453735,2,31,protein binding involved in cell-cell adhesion,MF,DSC2;PKP3
14859,GO:0060318,0.0732018871227878,0.99780019479367,1,5,definitive erythrocyte differentiation,BP,ZFPM1
7365,GO:0030291,0.0732331252385511,0.990097199197974,2,33,protein serine/threonine kinase inhibitor activity,MF,PRKAR1B;CDKN1A
11232,GO:0043167,0.0733058863425354,0.943498585789092,97,5840,ion binding,MF,ITGA3;ITGA5;TMEM163;SYT5;TUBG2;ACTN3;ACTN2;RAB6C;NOTCH1;GLDC;MARK4;RAB27A;CDH23;RASL11B;TF;CRB2;CRISPLD2;RHBDL3;DHH;DSC2;SERPINA5;ZFPM1;ACVR1;RABIF;GUCY1B3;CASQ2;RAB40B;RAB40A;PRKACB;MFGE8;SPTBN4;TTYH1;RRAS2;RAB39B;RAB39A;PRND;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FGF10;PRKAR1B;RALB;HRAS;SNX18;KHK;SESN2;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;HBEGF;BMP7;BMP4;WT1;CDKN1A;DLL1;PKN3;RAB20;DRP2;WNK4;RND3;DDR1;DSG3;CTGF;RRAD;TPD52;AKT1;RAB12;RAB17;PTGES;JAG2;CDH1;MYO7A;HPCAL1;RAB44;PIK3CA;PIK3CG;GAS6;DTX4;ZCCHC12;MYH11;DSC3;VDR;ARAF;KCND1;RAB38;RAB3D;ACSL4;ACTA2;RNF144A;PIM2;PDE4B
5889,GO:0016339,0.0733351608133161,0.990153427738772,2,28,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,CDH23;CDH2
16866,GO:0072126,0.0734422748715089,0.997785497709164,1,5,positive regulation of glomerular mesangial cell proliferation,BP,PDGFB
20104,GO:1904502,0.0736205065113759,0.9977745682125,1,5,regulation of lipophagy,BP,SESN2
20105,GO:1904504,0.0736205065113759,0.9977745682125,1,5,positive regulation of lipophagy,BP,SESN2
766,GO:0001941,0.0737723121305433,0.990026934128674,2,30,postsynaptic membrane organization,BP,CDH2;GDNF
864,GO:0002069,0.0739150571131375,0.997664956570181,1,6,columnar/cuboidal epithelial cell maturation,BP,CDKN1A
14860,GO:0060319,0.0739622299233497,0.997753535485103,1,5,primitive erythrocyte differentiation,BP,ZFPM1
16854,GO:0072103,0.0739728458051959,0.997752880454241,1,5,glomerulus vasculature morphogenesis,BP,BMP4
16855,GO:0072104,0.0739728458051959,0.997752880454241,1,5,glomerular capillary formation,BP,BMP4
12410,GO:0045907,0.0741177710558727,0.98993814110344,2,31,positive regulation of vasoconstriction,BP,ADRA2C;AKT1
13341,GO:0048669,0.0741397464487946,0.997742569250798,1,5,collateral sprouting in absence of injury,BP,WNT3
19332,GO:1902882,0.0742809028197117,0.983507053787208,3,69,regulation of response to oxidative stress,BP,SESN2;BMP7;AKT1
16887,GO:0072162,0.0744305451997112,0.997724545386517,1,5,metanephric mesenchymal cell differentiation,BP,WNT4
14191,GO:0051649,0.0744413448471034,0.948868228352762,35,1947,establishment of localization in cell,BP,SYT5;RAB6C;RAB27A;PMAIP1;WNT7A;NMT2;ADORA1;CASQ2;SPTBN5;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;GPRASP1;RHOB;PSRC1;SPTB;BMP7;BMP6;BMP4;CDKN1A;CHGA;MSN;AKT1;RAB12;RAB17;CDH1;MYO7A;PIK3CG;GAS6;GDNF
15114,GO:0060681,0.0745058002619606,0.997719868993646,1,5,branch elongation involved in ureteric bud branching,BP,BMP4
11296,GO:0043254,0.0745141285197102,0.965272945313579,9,360,regulation of protein complex assembly,BP,FHOD3;PMAIP1;SPTBN5;SPTBN4;RALB;SCIN;PSRC1;SPTB;MSN
12246,GO:0045616,0.0745367817394374,0.989834258903824,2,32,regulation of keratinocyte differentiation,BP,NOTCH1;VDR
2508,GO:0005179,0.0745654459896966,0.983262416879271,3,111,hormone activity,MF,EDN1;NPPC;INHBB
15973,GO:0070487,0.0745676970932657,0.997716018976865,1,5,monocyte aggregation,BP,BMP7
7794,GO:0031133,0.074569586368931,0.997715901410187,1,5,regulation of axon diameter,BP,WNT7A
21500,GO:2000848,0.074612328882319,0.997553516048324,1,7,positive regulation of corticosteroid hormone secretion,BP,BMP6
8619,GO:0032610,0.0747739697563668,0.997542744120077,1,7,interleukin-1 alpha production,BP,CCL20
19540,GO:1903305,0.074811465494762,0.978464930871991,4,108,regulation of regulated secretory pathway,BP,SYT5;NOTCH1;RAB27A;RAB3D
17442,GO:0090188,0.0748969730302816,0.997695481500486,1,5,negative regulation of pancreatic juice secretion,BP,WNK4
3466,GO:0006816,0.0749437890693715,0.965032197656716,9,362,calcium ion transport,BP,CDH23;CASQ2;TSPAN13;PDGFB;CTGF;PIK3CG;GAS6;VDR;PDE4B
4598,GO:0009612,0.0750347100706595,0.971481601605913,6,202,response to mechanical stimulus,BP,STRA6;GADD45A;EDN1;BMP6;AKT1;INHBB
4724,GO:0010039,0.0750549800947962,0.989723559963958,2,32,response to iron ion,BP,TF;BMP6
12200,GO:0045505,0.0752963651235418,0.997457027057697,1,8,dynein intermediate chain binding,MF,SPTBN5
18540,GO:1900193,0.0753297419950926,0.997573304743896,1,6,regulation of oocyte maturation,BP,NPPC
2631,GO:0005499,0.0753335889159293,0.997573053036875,1,6,vitamin D binding,MF,VDR
4787,GO:0010385,0.0758074869617966,0.997638197279052,1,5,double-stranded methylated DNA binding,MF,WT1
1210,GO:0002690,0.0760542683271623,0.982873505505789,3,84,positive regulation of leukocyte chemotaxis,BP,EDN1;WNT5A;GAS6
11182,GO:0043086,0.0761039137944511,0.956188234903417,16,811,negative regulation of catalytic activity,BP,NOTCH1;GADD45A;CRB2;SERPINA5;PRKAR1B;HRAS;BMP7;BMP4;CAMSAP3;CDKN1A;AKT1;CST9L;GAS6;AMOT;SH3BP4;DUSP5
17546,GO:0090324,0.0761074105497406,0.997619168865049,1,5,negative regulation of oxidative phosphorylation,BP,ACTN3
4693,GO:0009954,0.0761280391979952,0.98950820049649,2,31,proximal/distal pattern formation,BP,FGF10;DLL1
4103,GO:0008361,0.0761311763889385,0.974087281722425,5,149,regulation of cell size,BP,WNT3;EDN1;WNT5A;MSN;AKT1
5338,GO:0015031,0.0761700077671873,0.94783432658555,34,1900,protein transport,BP,ADRA2C;NOTCH1;RAB27A;TF;RABIF;ADORA1;RAB40B;RAB40A;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;AKT1;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;UNC119;RAB38;RAB3D
8632,GO:0032633,0.0764008849362749,0.989433940209044,2,32,interleukin-4 production,BP,NOTCH1;ZFPM1
14712,GO:0060087,0.0764321578170252,0.997500621783008,1,6,relaxation of vascular smooth muscle,BP,ADORA1
6298,GO:0017147,0.0766166463729564,0.989419179747573,2,30,Wnt-protein binding,MF,FZD7;FZD8
6972,GO:0021798,0.0768970388568516,0.997469640154532,1,6,forebrain dorsal/ventral pattern formation,BP,FGF8
17130,GO:0072602,0.0769477782683889,0.997565432409452,1,5,interleukin-4 secretion,BP,NOTCH1
18660,GO:1901031,0.0772087551406364,0.989258644154119,2,32,regulation of response to reactive oxygen species,BP,SESN2;BMP7
16818,GO:0072049,0.0772903280678265,0.997443275912461,1,6,comma-shaped body morphogenesis,BP,BMP4
17731,GO:0097070,0.0775385365373165,0.997527286148337,1,5,ductus arteriosus closure,BP,STRA6
13289,GO:0048566,0.0776634629473873,0.989144707357238,2,33,embryonic digestive tract development,BP,STRA6;FGF10
14571,GO:0055017,0.0777220973937334,0.982432140451674,3,67,cardiac muscle tissue growth,BP,WNT2;NOTCH1;EDN1
21621,GO:2001205,0.0777239086011656,0.997515253211268,1,5,negative regulation of osteoclast development,BP,CLDN18
5677,GO:0015911,0.0778315333065606,0.99750825319206,1,5,plasma membrane long-chain fatty acid transport,BP,AKT1
11824,GO:0044463,0.077973578988661,0.952171123074419,20,964,cell projection part,CC,ITGA3;ITGA5;ADRA2C;ACTN2;MARK4;RAB27A;ADORA1;PRKACB;SPTBN5;SPTBN4;TTYH1;FSTL3;PRKAR1B;ESPN;VAMP1;MSN;AKT1;MYO7A;LZTS1;PDE4B
2820,GO:0005829,0.0779963002715024,0.940704866943288,75,4626,cytosol,CC,LIF;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;NOTCH1;MARK4;RAB27A;PNMT;PMAIP1;FBXO41;RABIF;NMT2;GUCY1B3;PHLDA1;RHPN1;PRKACB;SPTBN5;SPTBN4;RAB39A;MAPK12;LIMS2;PIK3R2;PIK3R1;PRKAR1B;PTPN7;FOXO4;FRMPD1;HRAS;MAGEC2;PSTPIP2;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;PSRC1;SPTB;LGALS4;WT1;CDKN1A;VAMP1;WNK4;MSN;DSG3;CTGF;GJB2;GJB6;AKT1;RAB12;CYTIP;EPN1;MYO7A;BCAR1;SPSB1;TLE1;PIK3CA;PIK3CG;RAB11FIP1;DTX4;MYH11;GPSM1;AMOT;ARAF;UNC119;RAB38;FAM110B;ACTA2;PARVB;PDE4B
10962,GO:0042640,0.0780200643470161,0.997495966421673,1,5,anagen,BP,WNT5A
12871,GO:0046912,0.078049844384347,0.997494022768974,1,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,HMGCS2
7251,GO:0030135,0.0780673826081686,0.967393438886987,7,257,coated vesicle,CC,RAB27A;TF;EDN1;WNT5A;SNX18;HBEGF;SH3BP4
154,GO:0000302,0.0783107466593645,0.969879314315421,6,224,response to reactive oxygen species,BP,GUCY1B3;EDN1;SESN2;RHOB;BMP7;AKT1
7229,GO:0030104,0.0783590843817794,0.982235437632696,3,66,water homeostasis,BP,PRKACB;PRKAR1B;CLDN1
134,GO:0000271,0.0784400767475106,0.98220259878317,3,67,polysaccharide biosynthetic process,BP,PDGFB;B3GNT2;AKT1
11617,GO:0044058,0.0785359583691029,0.988890107048328,2,38,regulation of digestive system process,BP,FGF10;WNK4
15478,GO:0061370,0.078549682571772,0.997357905534296,1,6,testosterone biosynthetic process,BP,WNT4
20287,GO:1904885,0.0785782043120747,0.997459408743703,1,5,beta-catenin destruction complex assembly,BP,AXIN1
14160,GO:0051592,0.0787669319273026,0.976915250003836,4,113,response to calcium ion,BP,CASQ2;EDN1;WNT5A;PTGES
4709,GO:0009996,0.0787986710208686,0.997340855432646,1,6,negative regulation of cell fate specification,BP,FZD7
10051,GO:0035787,0.078836364119331,0.997442406875917,1,5,cell migration involved in kidney development,BP,PDGFB
1474,GO:0003186,0.0790131825975133,0.997430728158156,1,5,tricuspid valve morphogenesis,BP,ZFPM1
7018,GO:0021884,0.0790567688562151,0.988869764655122,2,31,forebrain neuron development,BP,WNT5A;FGF8
6416,GO:0018377,0.0790654360938026,0.99742727159229,1,5,protein myristoylation,BP,NMT2
11119,GO:0042989,0.0790809560406053,0.997246726357889,1,7,sequestering of actin monomers,BP,SCIN
7206,GO:0030046,0.0791792568375276,0.997419734041329,1,5,parallel actin filament bundle assembly,BP,ESPN
7115,GO:0022614,0.0792810052802469,0.997412986304741,1,5,membrane to membrane docking,BP,MSN
14355,GO:0051961,0.0793754548870316,0.966728624201303,7,251,negative regulation of nervous system development,BP,WNT3;NOTCH1;WNT7A;PRKACB;WNT5A;BMP7;DLL1
13241,GO:0048477,0.0793822414952735,0.981867866322369,3,72,oogenesis,BP,WNT4;NPPC;INHBB
1532,GO:0003284,0.0793862048925381,0.99740600011481,1,5,septum primum development,BP,ACVR1
15179,GO:0060762,0.0794420956520599,0.997296533001843,1,6,regulation of branching involved in mammary gland duct morphogenesis,BP,WNT5A
20349,GO:1905007,0.0794478997458419,0.997401898496784,1,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,ACVR1
8697,GO:0032732,0.0795173707063943,0.988695625683884,2,36,positive regulation of interleukin-1 production,BP,CCL20;WNT5A
14904,GO:0060374,0.0796633081075436,0.997387551374102,1,5,mast cell differentiation,BP,ZFPM1
8683,GO:0032713,0.0796851671824553,0.997279690478236,1,6,negative regulation of interleukin-4 production,BP,ZFPM1
10416,GO:0036514,0.0796932782265447,0.997385551998224,1,5,dopaminergic neuron axon guidance,BP,WNT5A
20317,GO:1904938,0.0796932782265447,0.997385551998224,1,5,planar cell polarity pathway involved in axon guidance,BP,WNT5A
8352,GO:0032229,0.0797633400213277,0.997274262367621,1,6,negative regulation of synaptic transmission, GABAergic,BP,ADORA1
1602,GO:0003418,0.0799758255952209,0.997259479695795,1,6,growth plate cartilage chondrocyte differentiation,BP,NPPC
16639,GO:0071680,0.0799870986543193,0.997365908671073,1,5,response to indole-3-methanol,BP,CDH1
16640,GO:0071681,0.0799870986543193,0.997365908671073,1,5,cellular response to indole-3-methanol,BP,CDH1
3554,GO:0006954,0.0800059073022764,0.956518507695088,13,635,inflammatory response,BP,NOTCH1;ACVR1;ADORA1;CCL20;TYRO3;WNT5A;JAM3;BMP6;BMP2;AKT1;PTGES;PIK3CG;TSPAN2
10502,GO:0038132,0.0800272737333925,0.997363216862407,1,5,neuregulin binding,MF,ITGB4
2487,GO:0005154,0.0800698630281231,0.98862911322512,2,32,epidermal growth factor receptor binding,MF,ITGA5;HBEGF
19780,GO:1903779,0.0801547560386359,0.981630587769967,3,70,regulation of cardiac conduction,BP,CASQ2;NPR1;NPPC
12265,GO:0045636,0.0801740423030945,0.997353370997034,1,5,positive regulation of melanocyte differentiation,BP,KITLG
21473,GO:2000809,0.0801754747809932,0.997353274806758,1,5,positive regulation of synaptic vesicle clustering,BP,CDH2
14358,GO:0051964,0.0801756924880833,0.997353260187661,1,5,negative regulation of synapse assembly,BP,WNT5A
15111,GO:0060676,0.0802159069654628,0.997242727471278,1,6,ureteric bud formation,BP,GDNF
15568,GO:0061614,0.0802398128439667,0.988625529345819,2,30,pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB;BMP2
13923,GO:0051180,0.0802716318735679,0.988554052486871,2,34,vitamin transport,BP,STRA6;SLC52A3
17245,GO:0086005,0.0802974548189924,0.988612728058872,2,30,ventricular cardiac muscle cell action potential,BP,DSC2;KCNH2
10879,GO:0042517,0.0804551433811456,0.988486208387398,2,36,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,LIF;CLCF1
9129,GO:0033603,0.0806634055574055,0.997211361421158,1,6,positive regulation of dopamine secretion,BP,GDNF
9824,GO:0035418,0.0807526783579608,0.988493589452043,2,31,protein localization to synapse,BP,WNT7A;WNT5A
17587,GO:0090407,0.0807968834615146,0.95602843087057,13,615,organophosphate biosynthetic process,BP,GUCY1B3;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;NPR1;FGF8;NPPC;PIK3CA;PIK3CG
15824,GO:0070244,0.0810486934865893,0.997184208926452,1,6,negative regulation of thymocyte apoptotic process,BP,BMP4
10649,GO:0042098,0.0813726334610805,0.971717939509862,5,171,T cell proliferation,BP,WNT4;SDC4;BMP4;MSN;PIK3CG
9572,GO:0034703,0.0813848160144087,0.968435385865278,6,197,cation channel complex,CC,CASQ2;KCNK6;KCNH2;KCNG2;KCND1;PDE4B
5936,GO:0016459,0.0815084839015118,0.981190701510454,3,70,myosin complex,CC,CGN;MYO7A;MYH11
19473,GO:1903169,0.0815833273784824,0.975789432555607,4,118,regulation of calcium ion transmembrane transport,BP,CASQ2;TSPAN13;PIK3CG;PDE4B
8428,GO:0032364,0.0816714008324435,0.997140037139936,1,6,oxygen homeostasis,BP,WNT7B
8926,GO:0033084,0.081874692344649,0.997125539672117,1,6,regulation of immature T cell proliferation in thymus,BP,BMP4
2921,GO:0005996,0.0820599627842052,0.965324992325824,7,262,monosaccharide metabolic process,BP,ACTN3;PMAIP1;KHK;SESN2;PFKFB3;AKT1;PIK3CA
1451,GO:0003160,0.0820809424418614,0.997110792480997,1,6,endocardium morphogenesis,BP,NOTCH1
4632,GO:0009744,0.0821181372795692,0.997108128841119,1,6,response to sucrose,BP,KHK
9363,GO:0034285,0.0821181372795692,0.997108128841119,1,6,response to disaccharide,BP,KHK
19651,GO:1903532,0.0823492297898757,0.962836677949342,8,327,positive regulation of secretion by cell,BP,RAB27A;EDN1;WNT5A;SDC4;BMP6;INHBB;RAB3D;GDNF
11388,GO:0043407,0.0823829217562486,0.980898293076677,3,71,negative regulation of MAP kinase activity,BP,BMP7;BMP4;DUSP5
21522,GO:2000973,0.082451176603415,0.997084222273426,1,6,regulation of pro-B cell differentiation,BP,NOTCH1
16444,GO:0071389,0.0825287364924039,0.997078640177306,1,6,cellular response to mineralocorticoid stimulus,BP,EDN1
8232,GO:0032008,0.0826900681815945,0.988040764540229,2,32,positive regulation of TOR signaling,BP,PIK3CA;GAS6
13866,GO:0051098,0.082926571895252,0.962529480541992,8,318,regulation of binding,BP,LIF;ZFPM1;PDGFB;RALB;WNT5A;BMP4;BMP2;HEY1
5325,GO:0014911,0.0832456698916275,0.987914566375914,2,32,positive regulation of smooth muscle cell migration,BP,PDGFB;FOXO4
14634,GO:0055131,0.0833109083107377,0.997022037424626,1,6,C3HC4-type RING finger domain binding,MF,KCNH2
2870,GO:0005905,0.0835090520576832,0.980555900538674,3,67,clathrin-coated pit,CC,TF;EPN1;SH3BP4
21021,GO:2000138,0.083876805578741,0.996980735176555,1,6,positive regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
8755,GO:0032808,0.0839653069336799,0.996974249246719,1,6,lacrimal gland development,BP,FGF10
7209,GO:0030049,0.084233720290392,0.987590244993999,2,39,muscle filament sliding,BP,ACTN3;ACTN2
9029,GO:0033275,0.084233720290392,0.987590244993999,2,39,actin-myosin filament sliding,BP,ACTN3;ACTN2
6528,GO:0019209,0.0842548835428267,0.980275064859595,3,72,kinase activator activity,MF,CDKN1A;PIK3CA;GAS6
7649,GO:0030890,0.0842957517670379,0.987587762617632,2,38,positive regulation of B cell proliferation,BP,CLCF1;CDKN1A
14661,GO:0060029,0.084335973054622,0.996947006259466,1,6,convergent extension involved in organogenesis,BP,WNT5A
12846,GO:0046877,0.0846115011800992,0.99677696238707,1,8,regulation of saliva secretion,BP,FGF10
4894,GO:0010629,0.0846185814083982,0.94313577293559,29,1614,negative regulation of gene expression,BP,WNT4;NOTCH1;ITGB8;ZFPM1;DKK3;EDN1;PRR5L;PDGFB;HRAS;WNT5A;SESN2;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;CTGF;AKT1;PKP3;PKP1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
7075,GO:0021999,0.0846191950698873,0.996926104992568,1,6,neural plate anterior/posterior regionalization,BP,AXIN1
20642,GO:1905898,0.085132898115374,0.987449236914085,2,34,positive regulation of response to endoplasmic reticulum stress,BP,PMAIP1;PIK3R1
10133,GO:0035931,0.0851754312971598,0.996884840868908,1,6,mineralocorticoid secretion,BP,BMP6
10134,GO:0035932,0.0851754312971598,0.996884840868908,1,6,aldosterone secretion,BP,BMP6
21506,GO:2000855,0.0851754312971598,0.996884840868908,1,6,regulation of mineralocorticoid secretion,BP,BMP6
21508,GO:2000858,0.0851754312971598,0.996884840868908,1,6,regulation of aldosterone secretion,BP,BMP6
697,GO:0001842,0.0852655409125552,0.99687812931294,1,6,neural fold formation,BP,BMP7
4930,GO:0010675,0.0853214040009061,0.974310769084039,4,114,regulation of cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1;SESN2;AKT1
3417,GO:0006734,0.0853303948485298,0.987388459506064,2,35,NADH metabolic process,BP,ACTN3;PFKFB3
9644,GO:0035019,0.0853568803313242,0.979909062259846,3,72,somatic stem cell population maintenance,BP,WNT7A;FGF10;BMP7
16411,GO:0071346,0.0854237146286902,0.974199252484413,4,136,cellular response to interferon-gamma,BP,EDN1;CCL20;WNT5A;CLDN1
6479,GO:0019064,0.0855196377439034,0.996859163354463,1,6,fusion of virus membrane with host plasma membrane,BP,GAS6
10570,GO:0039663,0.0855196377439034,0.996859163354463,1,6,membrane fusion involved in viral entry into host cell,BP,GAS6
11920,GO:0044800,0.0855196377439034,0.996859163354463,1,6,multi-organism membrane fusion,BP,GAS6
11474,GO:0043548,0.0856234842867102,0.987368813599214,2,32,phosphatidylinositol 3-kinase binding,MF,TYRO3;PIK3R1
15847,GO:0070278,0.085647986165782,0.996849560727802,1,6,extracellular matrix constituent secretion,BP,CTGF
4828,GO:0010511,0.0857479636576768,0.996842070206412,1,6,regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
7881,GO:0031323,0.0857723788055849,0.933474964435535,91,5697,regulation of cellular metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;RAB27A;PMAIP1;GADD45A;CRB2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;DKK3;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;CHGA;MSN;CTGF;AKT1;PKP3;PKP1;RAB12;KITLG;NPPC;CST9L;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;PM20D2;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2
18818,GO:1901533,0.085849666733799,0.996746312311732,1,7,negative regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
17156,GO:0072672,0.085852721626437,0.996834211637361,1,6,neutrophil extravasation,BP,PIK3CG
13949,GO:0051223,0.0860375010876187,0.950560805814624,15,719,regulation of protein transport,BP,ADRA2C;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;BMP7;BMP6;BMP4;CDKN1A;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6
18145,GO:0098751,0.0861494897275967,0.987246850847952,2,32,bone cell development,BP,ZFPM1;CLDN18
19664,GO:1903551,0.0861670923598473,0.996810567929186,1,6,regulation of extracellular exosome assembly,BP,SDC4
15337,GO:0061051,0.0862745474526128,0.996713458587039,1,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
12849,GO:0046880,0.0864385068938154,0.996790081630571,1,6,regulation of follicle-stimulating hormone secretion,BP,INHBB
12850,GO:0046881,0.0864385068938154,0.996790081630571,1,6,positive regulation of follicle-stimulating hormone secretion,BP,INHBB
11030,GO:0042770,0.0865920693930169,0.973782861958953,4,118,signal transduction in response to DNA damage,BP,PMAIP1;GADD45A;SESN2;CDKN1A
8258,GO:0032052,0.0866191328402935,0.996567260125804,1,9,bile acid binding,MF,VDR
6761,GO:0019903,0.086656000197085,0.973792356823437,4,109,protein phosphatase binding,MF,CDH2;PIK3R2;PIK3R1;AKT1
16811,GO:0072038,0.086708971530493,0.996769599426857,1,6,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,BMP7
14960,GO:0060440,0.0867215467454123,0.996768645467525,1,6,trachea formation,BP,BMP4
15427,GO:0061218,0.08675129449052,0.996766388214277,1,6,negative regulation of mesonephros development,BP,BMP4
9861,GO:0035502,0.0868011771393277,0.996762601295369,1,6,metanephric part of ureteric bud development,BP,WT1
15619,GO:0061724,0.0868136596253299,0.996761653308774,1,6,lipophagy,BP,SESN2
8378,GO:0032277,0.0868657924905751,0.996667456426225,1,7,negative regulation of gonadotropin secretion,BP,INHBB
5798,GO:0016176,0.0869008053763886,0.996664721844512,1,7,superoxide-generating NADPH oxidase activator activity,MF,PDGFB
12095,GO:0045217,0.0874033954696703,0.996716701683126,1,6,cell-cell junction maintenance,BP,CAMSAP3
10476,GO:0038095,0.087492489321814,0.973396612224438,4,124,Fc-epsilon receptor signaling pathway,BP,PIK3R2;PIK3R1;HRAS;PIK3CA
10541,GO:0038203,0.0875064633870383,0.996708812532783,1,6,TORC2 signaling,BP,PRR5L
16477,GO:0071438,0.0875676413140963,0.996704125136013,1,6,invadopodium membrane,CC,ITGA3
10766,GO:0042326,0.0876002003721008,0.956025729958396,10,421,negative regulation of phosphorylation,BP,LIF;ACTN3;GADD45A;PRR5L;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
1403,GO:0003062,0.0876016496325513,0.996701517954452,1,6,regulation of heart rate by chemical signal,BP,KCNH2
12694,GO:0046533,0.0876433924309945,0.996698316363288,1,6,negative regulation of photoreceptor cell differentiation,BP,NOTCH1
17267,GO:0086029,0.0877066040205037,0.996693465092782,1,6,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,CASQ2
17297,GO:0086068,0.0877066040205037,0.996693465092782,1,6,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,CASQ2
18078,GO:0098589,0.0878502434951554,0.957719338192177,9,355,membrane region,CC,TF;CRB2;CDH2;RHOQ;SDC4;DLL1;CDH1;EPN1;SH3BP4
14018,GO:0051321,0.0879470888903543,0.96518043789496,6,211,meiotic cell cycle,BP,LIF;WNT4;PRKACB;WNT5A;NPPC;PIM2
3230,GO:0006498,0.0880583876794353,0.996666399457727,1,6,N-terminal protein lipidation,BP,NMT2
8512,GO:0032456,0.0882678827692968,0.986751165295029,2,32,endocytic recycling,BP,ACTN2;RAB17
17262,GO:0086023,0.0882829391918988,0.996649063030204,1,6,adrenergic receptor signaling pathway involved in heart process,BP,CHGA
19167,GO:1902455,0.0883567866110979,0.996643351475937,1,6,negative regulation of stem cell population maintenance,BP,BMP7
6760,GO:0019902,0.0886622412039439,0.968458284432908,5,153,phosphatase binding,MF,SPTBN4;CDH2;PIK3R2;PIK3R1;AKT1
9033,GO:0033280,0.0886763139625922,0.986603805874298,2,35,response to vitamin D,BP,BMP7;VDR
17712,GO:0097048,0.0886809139759541,0.996618222956029,1,6,dendritic cell apoptotic process,BP,GAS6
21380,GO:2000668,0.0886809139759541,0.996618222956029,1,6,regulation of dendritic cell apoptotic process,BP,GAS6
3687,GO:0007182,0.0887097801013573,0.996615980347961,1,6,common-partner SMAD protein phosphorylation,BP,BMP4
15760,GO:0070141,0.0887292940045315,0.996614463876898,1,6,response to UV-A,BP,AKT1
15767,GO:0070162,0.0888374685270251,0.99660605099137,1,6,adiponectin secretion,BP,RAB11FIP1
15768,GO:0070163,0.0888374685270251,0.99660605099137,1,6,regulation of adiponectin secretion,BP,RAB11FIP1
12341,GO:0045766,0.0889378749938579,0.972824540207136,4,119,positive regulation of angiogenesis,BP,ITGA5;WNT5A;RHOB;DLL1
1591,GO:0003402,0.0890377872366546,0.996590443328091,1,6,planar cell polarity pathway involved in axis elongation,BP,WNT5A
11752,GO:0044340,0.089094079366493,0.996586050689314,1,6,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,WNT3
13876,GO:0051119,0.0892659952630599,0.98647978487295,2,34,sugar transmembrane transporter activity,MF,SLC45A4;SLC2A14
15950,GO:0070444,0.0893102996089483,0.996569151120395,1,6,oligodendrocyte progenitor proliferation,BP,CDH2
15951,GO:0070445,0.0893102996089483,0.996569151120395,1,6,regulation of oligodendrocyte progenitor proliferation,BP,CDH2
1465,GO:0003175,0.0894370279641643,0.996559226031802,1,6,tricuspid valve development,BP,ZFPM1
14190,GO:0051648,0.089483541573471,0.961432640004955,7,255,vesicle localization,BP,SYT5;RAB27A;WNT7A;CDH2;RAB17;MYO7A;PIK3CG
16899,GO:0072174,0.0895120988370817,0.996553339629962,1,6,metanephric tubule formation,BP,WNT4
15577,GO:0061626,0.0895210229909593,0.996456777981164,1,7,pharyngeal arch artery morphogenesis,BP,BMP4
1034,GO:0002367,0.0895938176284953,0.978443652998482,3,78,cytokine production involved in immune response,BP,WNT5A;CHGA;GAS6
7633,GO:0030868,0.0896388825487485,0.996447271283431,1,7,smooth endoplasmic reticulum membrane,CC,TTYH1
17909,GO:0097425,0.0896388825487485,0.996447271283431,1,7,smooth endoplasmic reticulum part,CC,TTYH1
10466,GO:0038066,0.0896591475444753,0.986386140997471,2,34,p38MAPK cascade,BP,GADD45A;BMP2
8799,GO:0032885,0.0897310659358311,0.986386242774558,2,33,regulation of polysaccharide biosynthetic process,BP,PDGFB;AKT1
845,GO:0002042,0.0897403170178468,0.98638403791069,2,33,cell migration involved in sprouting angiogenesis,BP,NOTCH1;EFNB2
9995,GO:0035701,0.0897440231390378,0.99653512117861,1,6,hematopoietic stem cell migration,BP,GAS6
7351,GO:0030274,0.0898333736300893,0.996528089093585,1,6,LIM domain binding,MF,ACTN2
15963,GO:0070472,0.0899980949925634,0.996418215296968,1,7,regulation of uterine smooth muscle contraction,BP,ADRA2C
7542,GO:0030672,0.0900086009671329,0.97832734435142,3,74,synaptic vesicle membrane,CC,TMEM163;SYT5;VAMP1
18317,GO:0099501,0.0900086009671329,0.97832734435142,3,74,exocytic vesicle membrane,CC,TMEM163;SYT5;VAMP1
17686,GO:0097009,0.0901248991184537,0.986292257646104,2,33,energy homeostasis,BP,DLL1;PIK3CA
12031,GO:0045110,0.0901801726972302,0.996500725142925,1,6,intermediate filament bundle assembly,BP,PKP1
19135,GO:1902338,0.0901906731862537,0.996499894870109,1,6,negative regulation of apoptotic process involved in morphogenesis,BP,BMP7
20219,GO:1904746,0.0901906731862537,0.996499894870109,1,6,negative regulation of apoptotic process involved in development,BP,BMP7
14939,GO:0060416,0.0902431815045307,0.986230182568719,2,35,response to growth hormone,BP,PIK3R1;AKT1
10681,GO:0042149,0.0902563418728182,0.986243425353809,2,34,cellular response to glucose starvation,BP,PMAIP1;NUAK2
14058,GO:0051402,0.090499873444113,0.963897782070742,6,215,neuron apoptotic process,BP,TYRO3;HRAS;FGF8;CLCF1;PIK3CA;GDNF
16077,GO:0070672,0.0908394963406452,0.996448394144356,1,6,response to interleukin-15,BP,ACSL4
12191,GO:0045471,0.0908567302557512,0.97199867629681,4,130,response to ethanol,BP,NPPC;CLDN1;CLDN3;CLDN18
3344,GO:0006636,0.0908889042719387,0.98603067683392,2,38,unsaturated fatty acid biosynthetic process,BP,EDN1;PTGES
7056,GO:0021954,0.0909031093367777,0.978049958452544,3,70,central nervous system neuron development,BP,SPTBN4;WNT5A;FGF8
12279,GO:0045654,0.0909482222041481,0.996340769630726,1,7,positive regulation of megakaryocyte differentiation,BP,SCIN
1125,GO:0002526,0.0911023610370489,0.97189410677742,4,131,acute inflammatory response,BP,ACVR1;ADORA1;PTGES;PIK3CG
17440,GO:0090186,0.0911470894194678,0.996324451039409,1,7,regulation of pancreatic juice secretion,BP,WNK4
20347,GO:1905005,0.0912279292149511,0.996417375172215,1,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,ACVR1
15005,GO:0060501,0.0912482833689495,0.996415745895304,1,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
8714,GO:0032762,0.0913382438324449,0.996308729837515,1,7,mast cell cytokine production,BP,CHGA
8379,GO:0032278,0.091455729953066,0.996299050098947,1,7,positive regulation of gonadotropin secretion,BP,INHBB
15043,GO:0060558,0.0914669251025858,0.996298127038828,1,7,regulation of calcidiol 1-monooxygenase activity,BP,VDR
5306,GO:0014883,0.0915089975997049,0.996294657018377,1,7,transition between fast and slow fiber,BP,ACTN3
11260,GO:0043203,0.0915417695086479,0.996291952915462,1,7,axon hillock,CC,SPTBN4
18443,GO:1900029,0.0918266694632575,0.996268401886289,1,7,positive regulation of ruffle assembly,BP,HRAS
14702,GO:0060075,0.0920187719563731,0.996353788150249,1,6,regulation of resting membrane potential,BP,KCNK6
8068,GO:0031666,0.0920814342924272,0.996171292532207,1,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
18859,GO:1901621,0.09213200034282,0.996344636575708,1,6,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
14673,GO:0060043,0.0924560394952895,0.985712859733976,2,34,regulation of cardiac muscle cell proliferation,BP,WNT2;NOTCH1
13274,GO:0048537,0.0925255180056768,0.996210304376163,1,7,mucosal-associated lymphoid tissue development,BP,ARTN
13277,GO:0048541,0.0925255180056768,0.996210304376163,1,7,Peyer's patch development,BP,ARTN
16360,GO:0071260,0.0925293548903143,0.977461751843032,3,74,cellular response to mechanical stimulus,BP,GADD45A;BMP6;AKT1
16102,GO:0070728,0.0927080624509224,0.996297892373563,1,6,leucine binding,MF,SESN2
1067,GO:0002433,0.0928652124987139,0.977367319565416,3,71,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3R2;PIK3R1;PIK3CA
10477,GO:0038096,0.0928652124987139,0.977367319565416,3,71,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3R2;PIK3R1;PIK3CA
4803,GO:0010459,0.092948584360834,0.996037321233831,1,9,negative regulation of heart rate,BP,SPTBN4
5299,GO:0014866,0.0931312531568705,0.996159570698505,1,7,skeletal myofibril assembly,BP,MYH11
13393,GO:0048752,0.093169318785227,0.996156370793507,1,7,semicircular canal morphogenesis,BP,FGF10
21493,GO:2000833,0.0932026496992724,0.996015226043856,1,9,positive regulation of steroid hormone secretion,BP,BMP6
8454,GO:0032391,0.0933336769230501,0.985499036265003,2,34,photoreceptor connecting cilium,CC,SPTBN5;MYO7A
11482,GO:0043559,0.0934347324560824,0.996238486958881,1,6,insulin binding,MF,PIK3R1
15195,GO:0060795,0.0934756211342022,0.985447061188198,2,35,cell fate commitment involved in formation of primary germ layer,BP,FZD7;BMP4
603,GO:0001708,0.0935723078672901,0.977080307313915,3,77,cell fate specification,BP,NOTCH1;FZD7;DLL1
7824,GO:0031232,0.0936777727056411,0.996113496008225,1,7,extrinsic component of external side of plasma membrane,CC,TF
19362,GO:1902946,0.0937770568558881,0.996210331575654,1,6,protein localization to early endosome,BP,MSN
304,GO:0000805,0.0939341263875435,0.996091785620862,1,7,X chromosome,CC,SIN3B
549,GO:0001609,0.0939554342844211,0.996089978244914,1,7,G-protein coupled adenosine receptor activity,MF,ADORA1
7316,GO:0030219,0.0940034270645487,0.985167111714581,2,47,megakaryocyte differentiation,BP,ZFPM1;SCIN
12076,GO:0045188,0.0940155703385236,0.996005653199868,1,8,regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADORA1
3570,GO:0006979,0.0940222141645628,0.95409432997293,9,397,response to oxidative stress,BP,GUCY1B3;EDN1;PRR5L;SESN2;RHOB;FGF8;BMP7;GJB2;AKT1
20750,GO:1990316,0.0941721587446359,0.99617769969369,1,6,ATG1/ULK1 kinase complex,CC,SESN2
13598,GO:0050701,0.0942070916190035,0.985193463180719,2,40,interleukin-1 secretion,BP,WNT5A;GAS6
16980,GO:0072298,0.0942147928801611,0.996174169802181,1,6,regulation of metanephric glomerulus development,BP,WT1
20176,GO:1904672,0.0942398729803771,0.996172092505068,1,6,regulation of somatic stem cell population maintenance,BP,BMP7
13075,GO:0048021,0.094241546499671,0.996065667625765,1,7,regulation of melanin biosynthetic process,BP,WNT5A
18597,GO:1900376,0.094241546499671,0.996065667625765,1,7,regulation of secondary metabolite biosynthetic process,BP,WNT5A
20322,GO:1904951,0.094303848230307,0.950276840237052,11,498,positive regulation of establishment of protein localization,BP,ITGA3;PMAIP1;PRR5L;PIK3R2;PIK3R1;WNT5A;BMP6;BMP4;AKT1;CDH1;GAS6
13675,GO:0050807,0.0943570140303301,0.970608598056411,4,113,regulation of synapse organization,BP,WNT7A;CDH2;WNT5A;RAB17
12700,GO:0046543,0.0945652177161183,0.996038071297218,1,7,development of secondary female sexual characteristics,BP,WNT5A
21290,GO:2000542,0.0945655041859426,0.996038046828312,1,7,negative regulation of gastrulation,BP,FZD7
1147,GO:0002576,0.0945813283942534,0.9704635933535,4,126,platelet degranulation,BP,ACTN2;TF;PDGFB;GAS6
13178,GO:0048285,0.0947063350196042,0.947148497188085,13,599,organelle fission,BP,LIF;WNT4;MARK4;EDN1;TTYH1;PDGFB;WNT5A;SNX18;PSRC1;FGF8;BMP7;BMP4;PIM2
17462,GO:0090209,0.0947180784016621,0.995944588726162,1,8,negative regulation of triglyceride metabolic process,BP,PIK3CG
78,GO:0000155,0.0949196452741789,0.996115566033497,1,6,phosphorelay sensor kinase activity,MF,KCNH2
7314,GO:0030217,0.0950020272941482,0.961621337826483,6,216,T cell differentiation,BP,WNT4;ZFPM1;FZD7;BMP4;JAG2;FZD8
3692,GO:0007187,0.0950304825898999,0.965440017063796,5,176,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,ADRA2B;ADRA2C;ADORA1;PRKACB;CHGA
12644,GO:0046456,0.0950352239650046,0.984951704388517,2,43,icosanoid biosynthetic process,BP,EDN1;PTGES
18838,GO:1901570,0.0950352239650046,0.984951704388517,2,43,fatty acid derivative biosynthetic process,BP,EDN1;PTGES
7532,GO:0030658,0.0950545875058702,0.965438289257626,5,172,transport vesicle membrane,CC,TMEM163;SYT5;SYCN;VAMP1;CHGA
6540,GO:0019222,0.0950609616650001,0.9255735819394,96,6101,regulation of metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;RAB27A;ITGB8;PMAIP1;GADD45A;CRB2;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;DKK3;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;CHGA;MSN;CTGF;AKT1;PKP3;PKP1;RAB12;KITLG;NPPC;CST9L;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;PM20D2;SHC4;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
2498,GO:0005168,0.0951249277673401,0.996098411056304,1,6,neurotrophin TRKA receptor binding,MF,PIK3R1
13608,GO:0050711,0.0951256911736525,0.995908937026403,1,8,negative regulation of interleukin-1 secretion,BP,GAS6
17301,GO:0086073,0.0951325036152093,0.996097777208299,1,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,DSC2
17309,GO:0086083,0.0951325036152093,0.996097777208299,1,6,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,DSC2
11246,GO:0043184,0.0951916074278222,0.995984380398357,1,7,vascular endothelial growth factor receptor 2 binding,MF,ITGA5
7623,GO:0030857,0.0952389948953905,0.984980285171322,2,37,negative regulation of epithelial cell differentiation,BP,NOTCH1;DLL1
4143,GO:0008429,0.0952949676476953,0.995894083697499,1,8,phosphatidylethanolamine binding,MF,MFGE8
14153,GO:0051584,0.0953276622127742,0.995891211659861,1,8,regulation of dopamine uptake involved in synaptic transmission,BP,GDNF
14341,GO:0051940,0.0953276622127742,0.995891211659861,1,8,regulation of catecholamine uptake involved in synaptic transmission,BP,GDNF
7213,GO:0030056,0.0954254774407059,0.996073223906239,1,6,hemidesmosome,CC,ITGB4
13180,GO:0048289,0.0958051678545583,0.995931424987088,1,7,isotype switching to IgE isotypes,BP,CLCF1
13183,GO:0048293,0.0958051678545583,0.995931424987088,1,7,regulation of isotype switching to IgE isotypes,BP,CLCF1
19752,GO:1903726,0.0958136682999576,0.995930688794849,1,7,negative regulation of phospholipid metabolic process,BP,PDGFB
4243,GO:0008603,0.0958502224558669,0.995927522185175,1,7,cAMP-dependent protein kinase regulator activity,MF,PRKAR1B
6872,GO:0021587,0.0959350697048274,0.984858122117085,2,34,cerebellum morphogenesis,BP,WNT7A;DLL1
12422,GO:0045921,0.0960284881967404,0.976221676289394,3,77,positive regulation of exocytosis,BP,RAB27A;SDC4;RAB3D
1200,GO:0002679,0.0961784778861636,0.995816105330891,1,8,respiratory burst involved in defense response,BP,PIK3CG
13324,GO:0048640,0.0962710120102587,0.976157303155616,3,74,negative regulation of developmental growth,BP,WNT3;WNT5A;BMP4
13070,GO:0048016,0.0963901486711271,0.984726823821199,2,35,inositol phosphate-mediated signaling,BP,ACTN3;EDN1
10897,GO:0042538,0.0964414508496719,0.995792748204437,1,8,hyperosmotic salinity response,BP,CLDN1
16070,GO:0070665,0.0964973650441818,0.969634321880622,4,133,positive regulation of leukocyte proliferation,BP,FGF10;CLCF1;CDKN1A;KITLG
14840,GO:0060297,0.0966162749202089,0.995860866020869,1,7,regulation of sarcomere organization,BP,EDN1
4678,GO:0009898,0.0969125600886923,0.964583415605229,5,164,cytoplasmic side of plasma membrane,CC,PTPN7;SNX18;SPTB;CDH1;MYZAP
8768,GO:0032825,0.0969129503591549,0.995834900375001,1,7,positive regulation of natural killer cell differentiation,BP,GAS6
15241,GO:0060907,0.0969223771761936,0.995834073936419,1,7,positive regulation of macrophage cytokine production,BP,WNT5A
694,GO:0001839,0.096934880279478,0.995832977671697,1,7,neural plate morphogenesis,BP,FGF8
16600,GO:0071622,0.0970981027815051,0.984391906548111,2,47,regulation of granulocyte chemotaxis,BP,EDN1;JAM3
5554,GO:0015684,0.0976238454689342,0.995772337689838,1,7,ferrous iron transport,BP,TF
1416,GO:0003091,0.0978163218528886,0.98436953997972,2,35,renal water homeostasis,BP,PRKACB;PRKAR1B
17993,GO:0097623,0.0979906116243097,0.995739870491075,1,7,potassium ion export across plasma membrane,BP,KCNH2
18121,GO:0098668,0.0979906116243097,0.995739870491075,1,7,potassium ion export from cell,BP,KCNH2
5274,GO:0014824,0.0979914140290536,0.995739799318228,1,7,artery smooth muscle contraction,BP,EDN1
3437,GO:0006771,0.0980465548708319,0.995734906874824,1,7,riboflavin metabolic process,BP,SLC52A3
14749,GO:0060155,0.0980797800520884,0.995645709965305,1,8,platelet dense granule organization,BP,RAB38
14007,GO:0051301,0.0980876701862328,0.94635253579263,12,547,cell division,BP,NOTCH1;MARK4;WNT7A;FZD7;PDGFB;RALB;SNX18;RHOB;PSRC1;FGF8;DLL1;BCAR1
3691,GO:0007186,0.0981097104706757,0.939575200610926,18,1157,G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C;ACTN2;NMT2;ADORA1;EDN1;PRKACB;CCL20;FZD7;LPAR2;GPRASP1;NPR1;CHGA;AKT1;BCAR1;PIK3CG;GPSM1;FZD8
4812,GO:0010470,0.0982339585697906,0.984246757890506,2,36,regulation of gastrulation,BP,CRB2;FZD7
9059,GO:0033365,0.098786162255387,0.940034292045704,17,884,protein localization to organelle,BP,LIF;TSPAN17;PMAIP1;FZD7;PIK3R2;PIK3R1;SESN2;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;CDH1;GAS6;SH3BP4;CLDN18
1501,GO:0003228,0.0988412982973491,0.995664067625284,1,7,atrial cardiac muscle tissue development,BP,WNT2
14564,GO:0055009,0.0988412982973491,0.995664067625284,1,7,atrial cardiac muscle tissue morphogenesis,BP,WNT2
13287,GO:0048563,0.0989295784023468,0.995568406743434,1,8,post-embryonic animal organ morphogenesis,BP,MYO7A
16518,GO:0071493,0.0991806888070647,0.995545428652061,1,8,cellular response to UV-B,BP,CDKN1A
16331,GO:0071216,0.0992653293079872,0.963437647025478,5,175,cellular response to biotic stimulus,BP,CCL20;WNT5A;BMP6;AKT1;PDE4B
19609,GO:1903430,0.0993041396645921,0.995534109499836,1,8,negative regulation of cell maturation,BP,NPPC
1255,GO:0002741,0.0994519368958044,0.995609225837896,1,7,positive regulation of cytokine secretion involved in immune response,BP,WNT5A
16490,GO:0071456,0.0995400373443528,0.963292124996857,5,181,cellular response to hypoxia,BP,NOTCH1;PMAIP1;EDN1;BMP7;AKT1
7309,GO:0030212,0.0995750956910821,0.983924571694482,2,35,hyaluronan metabolic process,BP,PDGFB;AKT1
13370,GO:0048706,0.099717286074989,0.968311153512334,4,121,embryonic skeletal system development,BP,WNT5A;AXIN1;BMP7;BMP4
8384,GO:0032287,0.0997596247914803,0.995581456246523,1,7,peripheral nervous system myelin maintenance,BP,AKT1
15236,GO:0060897,0.0997733518913823,0.995580215217872,1,7,neural plate regionalization,BP,AXIN1
16154,GO:0070852,0.0998205744634101,0.995575944571595,1,7,cell body fiber,CC,SPTBN4
21348,GO:2000628,0.0998399974653553,0.995574187399114,1,7,regulation of miRNA metabolic process,BP,HRAS
8269,GO:0032071,0.099981203518038,0.99547176402501,1,8,regulation of endodeoxyribonuclease activity,BP,AKT1
17453,GO:0090199,0.0999884893681416,0.983698893490975,2,43,regulation of release of cytochrome c from mitochondria,BP,PMAIP1;AKT1
2160,GO:0004673,0.100016737511245,0.995558181272955,1,7,protein histidine kinase activity,MF,KCNH2
18954,GO:1901888,0.100027391787991,0.974832229517906,3,73,regulation of cell junction assembly,BP,WNT4;SDC4;CLDN1
10224,GO:0036089,0.100035478401545,0.995556482275541,1,7,cleavage furrow formation,BP,SNX18
17313,GO:0086091,0.100105147638148,0.983808665964187,2,34,regulation of heart rate by cardiac conduction,BP,DSC2;KCNH2
2171,GO:0004691,0.100230493992191,0.995538782620977,1,7,cAMP-dependent protein kinase activity,MF,PRKACB
19003,GO:1902033,0.100325628319568,0.995530134912551,1,7,regulation of hematopoietic stem cell proliferation,BP,KITLG
10034,GO:0035754,0.100398626014397,0.9954331027121,1,8,B cell chemotaxis,BP,GAS6
16781,GO:0071971,0.100471158743963,0.995516889324318,1,7,extracellular exosome assembly,BP,SDC4
626,GO:0001750,0.100504651693325,0.974624321188564,3,78,photoreceptor outer segment,CC,RAB27A;SPTBN5;MYO7A
11726,GO:0044306,0.100613060825662,0.967916083814613,4,124,neuron projection terminus,CC,ADRA2C;ADORA1;FSTL3;VAMP1
18912,GO:1901724,0.100999634183238,0.995468617954358,1,7,positive regulation of cell proliferation involved in kidney development,BP,PDGFB
18535,GO:1900181,0.101099026673743,0.974417688217149,3,77,negative regulation of protein localization to nucleus,BP,BMP7;GAS6;CLDN18
12874,GO:0046916,0.101177262274721,0.974355951321849,3,82,cellular transition metal ion homeostasis,BP,TF;PRND;BMP6
20969,GO:2000049,0.101227074922954,0.995447760437054,1,7,positive regulation of cell-cell adhesion mediated by cadherin,BP,WNT5A
8798,GO:0032881,0.101288724216234,0.983468036657108,2,36,regulation of polysaccharide metabolic process,BP,PDGFB;AKT1
8890,GO:0033018,0.101376919910071,0.995433991590387,1,7,sarcoplasmic reticulum lumen,CC,CASQ2
12853,GO:0046884,0.10158488875492,0.995414845997992,1,7,follicle-stimulating hormone secretion,BP,INHBB
11344,GO:0043320,0.101588945643855,0.995414472106101,1,7,natural killer cell degranulation,BP,RAB27A
13209,GO:0048341,0.1016211109668,0.995411507116255,1,7,paraxial mesoderm formation,BP,WNT5A
10475,GO:0038094,0.101690434540271,0.974219351979387,3,75,Fc-gamma receptor signaling pathway,BP,PIK3R2;PIK3R1;PIK3CA
4002,GO:0008202,0.101754892227841,0.954749698195366,7,288,steroid metabolic process,BP,WNT4;DHH;HMGCS2;DKK3;BMP6;BMP2;VDR
9145,GO:0033628,0.101979087611282,0.983240160997743,2,39,regulation of cell adhesion mediated by integrin,BP,PLAU;PIK3CG
12268,GO:0045639,0.102079054615243,0.974050077587269,3,79,positive regulation of myeloid cell differentiation,BP,LIF;SCIN;KITLG
15263,GO:0060947,0.102186724610663,0.995359205804336,1,7,cardiac vascular smooth muscle cell differentiation,BP,NOTCH1
17803,GO:0097197,0.10223404236704,0.995354816409406,1,7,tetraspanin-enriched microdomain,CC,TSPAN15
654,GO:0001784,0.102298928546259,0.983225988753331,2,35,phosphotyrosine binding,MF,PIK3R2;PIK3R1
621,GO:0001738,0.102399725160468,0.96712154650806,4,131,morphogenesis of a polarized epithelium,BP,FZD7;WNT5A;MSN;LAMA5
14313,GO:0051897,0.102426494086486,0.973910857002263,3,81,positive regulation of protein kinase B signaling,BP,HBEGF;PIK3CG;GAS6
1623,GO:0003696,0.10245616795738,0.99533418219197,1,7,satellite DNA binding,MF,HEY1
14660,GO:0060028,0.102590936760078,0.995321639691644,1,7,convergent extension involved in axis elongation,BP,WNT5A
12693,GO:0046532,0.102769879394346,0.995304958948025,1,7,regulation of photoreceptor cell differentiation,BP,NOTCH1
10801,GO:0042391,0.102774418852331,0.94893543571751,9,373,regulation of membrane potential,BP,ACTN2;PMAIP1;DSC2;WNT7A;ADORA1;CASQ2;EDN1;KCNK6;KCNH2
17244,GO:0086004,0.102793630163142,0.983097884793034,2,35,regulation of cardiac muscle cell contraction,BP,DSC2;PDE4B
6915,GO:0021684,0.102863024498587,0.995296263862928,1,7,cerebellar granular layer formation,BP,WNT7A
6932,GO:0021707,0.102863024498587,0.995296263862928,1,7,cerebellar granule cell differentiation,BP,WNT7A
15501,GO:0061438,0.103048172898322,0.995278955372874,1,7,renal system vasculature morphogenesis,BP,BMP4
15502,GO:0061439,0.103048172898322,0.995278955372874,1,7,kidney vasculature morphogenesis,BP,BMP4
3813,GO:0007442,0.103075971277485,0.995276353795719,1,7,hindgut morphogenesis,BP,WNT5A
12264,GO:0045634,0.103290971926273,0.995256207208326,1,7,regulation of melanocyte differentiation,BP,KITLG
13167,GO:0048263,0.103333528751371,0.995156438906027,1,8,determination of dorsal identity,BP,ACVR1
13197,GO:0048318,0.103405561629541,0.995149541990566,1,8,axial mesoderm development,BP,AXIN1
9720,GO:0035234,0.103415843616336,0.995148557106437,1,8,ectopic germ cell programmed cell death,BP,KITLG
16389,GO:0071313,0.103425795860193,0.995243550751619,1,7,cellular response to caffeine,BP,CASQ2
17732,GO:0097084,0.103491901375069,0.995141268499843,1,8,vascular smooth muscle cell development,BP,NOTCH1
15962,GO:0070471,0.103945522202365,0.995097679620404,1,8,uterine smooth muscle contraction,BP,ADRA2C
21362,GO:2000648,0.103982830967455,0.982769291206909,2,36,positive regulation of stem cell proliferation,BP,NOTCH1;KITLG
21265,GO:2000510,0.104129156517506,0.99500441656214,1,9,positive regulation of dendritic cell chemotaxis,BP,GAS6
14981,GO:0060462,0.10434567983848,0.995156728121262,1,7,lung lobe development,BP,LIF
14982,GO:0060463,0.10434567983848,0.995156728121262,1,7,lung lobe morphogenesis,BP,LIF
13671,GO:0050803,0.10435214424796,0.966333655731389,4,117,regulation of synapse structure or activity,BP,WNT7A;CDH2;WNT5A;RAB17
3723,GO:0007224,0.104426557461109,0.966292262573985,4,119,smoothened signaling pathway,BP,DHH;PRKACB;FGF10;BMP4
19743,GO:1903715,0.104522696761545,0.995139926491061,1,7,regulation of aerobic respiration,BP,ACTN3
20373,GO:1905063,0.104584897779725,0.995134015449704,1,7,regulation of vascular smooth muscle cell differentiation,BP,PDGFB
672,GO:0001816,0.104614378132081,0.940651066425953,13,635,cytokine production,BP,NOTCH1;ZFPM1;CCL20;PIK3R1;HRAS;WNT5A;DLL1;CHGA;INHBB;PIK3CG;GAS6;DTX4;PDE4B
9678,GO:0035091,0.10477754099719,0.956586727225431,6,211,phosphatidylinositol binding,MF,SYT5;ACTN2;FZD7;SNX18;SCIN;AKT1
4152,GO:0008443,0.104858158312418,0.995108002743225,1,7,phosphofructokinase activity,MF,PFKFB3
1437,GO:0003139,0.105068827117351,0.994988866300671,1,8,secondary heart field specification,BP,BMP4
12598,GO:0046332,0.105129578674677,0.972985738215647,3,73,SMAD binding,MF,ACVR1;AXIN1;BMP2
8927,GO:0033085,0.105150874527627,0.994980869637691,1,8,negative regulation of T cell differentiation in thymus,BP,BMP4
11489,GO:0043569,0.105303080100533,0.995065494086509,1,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,BMP2
13158,GO:0048251,0.105404565920624,0.995055771057326,1,7,elastic fiber assembly,BP,MYH11
7672,GO:0030917,0.105530922144528,0.994866126798726,1,9,midbrain-hindbrain boundary development,BP,FGF8
7096,GO:0022406,0.10562246433138,0.960392626186742,5,169,membrane docking,BP,MARK4;RAB40B;RAB40A;RALB;MSN
12873,GO:0046915,0.105906178191187,0.982227509928854,2,38,transition metal ion transmembrane transporter activity,MF,TF;TTYH1
9698,GO:0035136,0.105967790376305,0.982211187070518,2,38,forelimb morphogenesis,BP,WNT3;WNT7A
2868,GO:0005902,0.106088438907331,0.972594394417626,3,78,microvillus,CC,ESPN;MSN;MYO7A
6223,GO:0017002,0.106100742889068,0.994988803213333,1,7,activin-activated receptor activity,MF,ACVR1
3999,GO:0008199,0.106503459286319,0.9947058386111,1,10,ferric iron binding,MF,TF
18094,GO:0098631,0.106503809910964,0.982068935238181,2,38,protein binding involved in cell adhesion,MF,DSC2;PKP3
11153,GO:0043029,0.10651864739577,0.982032253729101,2,40,T cell homeostasis,BP,PMAIP1;AKT1
8280,GO:0032091,0.106521747302924,0.972413252400244,3,81,negative regulation of protein binding,BP,ZFPM1;PDGFB;RALB
19206,GO:1902554,0.106574584178966,0.972400755052225,3,80,serine/threonine protein kinase complex,CC,ACVR1;SESN2;CDKN1A
8925,GO:0033083,0.106752006477623,0.994823485072386,1,8,regulation of immature T cell proliferation,BP,BMP4
11841,GO:0044557,0.106802546281426,0.994818475935005,1,8,relaxation of smooth muscle,BP,ADORA1
8072,GO:0031670,0.106803649828266,0.981972308551294,2,39,cellular response to nutrient,BP,GAS6;VDR
17218,GO:0080090,0.106815986730846,0.91612842226728,88,5552,regulation of primary metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;PMAIP1;GADD45A;CRB2;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;DKK3;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;MSN;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;CST9L;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;PM20D2;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2
5242,GO:0014731,0.106860000701651,0.994915230991091,1,7,spectrin-associated cytoskeleton,CC,SPTB
15919,GO:0070391,0.107017857048662,0.994717281782918,1,9,response to lipoteichoic acid,BP,CCL20
16338,GO:0071223,0.107017857048662,0.994717281782918,1,9,cellular response to lipoteichoic acid,BP,CCL20
19413,GO:1903025,0.10714579200165,0.994640418345165,1,10,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,LIF
7445,GO:0030432,0.107173164741328,0.99470160718343,1,9,peristalsis,BP,GDNF
12184,GO:0045429,0.107193385090192,0.981852240059638,2,40,positive regulation of nitric oxide biosynthetic process,BP,EDN1;AKT1
20065,GO:1904407,0.107193385090192,0.981852240059638,2,40,positive regulation of nitric oxide metabolic process,BP,EDN1;AKT1
21218,GO:2000427,0.107260433449835,0.994772978247662,1,8,positive regulation of apoptotic cell clearance,BP,MFGE8
12060,GO:0045162,0.107298924661143,0.994872443691116,1,7,clustering of voltage-gated sodium channels,BP,SPTBN4
1516,GO:0003256,0.107333524539315,0.994869062853281,1,7,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,NOTCH1
18499,GO:1900125,0.107429787587827,0.994859650633343,1,7,regulation of hyaluronan biosynthetic process,BP,PDGFB
13801,GO:0051011,0.107540161899367,0.994848847580409,1,7,microtubule minus-end binding,MF,CAMSAP3
21051,GO:2000192,0.107612705733759,0.994841740789947,1,7,negative regulation of fatty acid transport,BP,AKT1
1004,GO:0002318,0.107710339023481,0.994832168018791,1,7,myeloid progenitor cell differentiation,BP,JAM3
8399,GO:0032306,0.1079314771444,0.994559828084957,1,10,regulation of prostaglandin secretion,BP,EDN1
8400,GO:0032308,0.1079314771444,0.994559828084957,1,10,positive regulation of prostaglandin secretion,BP,EDN1
20792,GO:1990459,0.108050346801301,0.994694000775681,1,8,transferrin receptor binding,MF,TF
13771,GO:0050942,0.10806336128253,0.994797477421282,1,7,positive regulation of pigment cell differentiation,BP,KITLG
15735,GO:0070099,0.108123489781975,0.994686656476978,1,8,regulation of chemokine-mediated signaling pathway,BP,EDN1
7493,GO:0030551,0.108127458640763,0.981653487447691,2,37,cyclic nucleotide binding,MF,PRKAR1B;PDE4B
4928,GO:0010668,0.108203603427471,0.994783662523699,1,7,ectodermal cell differentiation,BP,FZD7
9113,GO:0033574,0.108256508377035,0.981522829245134,2,43,response to testosterone,BP,EDN1;MSN
12430,GO:0045931,0.108296896455668,0.964569242888639,4,126,positive regulation of mitotic cell cycle,BP,EDN1;FGF10;PDGFB;FGF8
10028,GO:0035747,0.108363094235295,0.994461805351394,1,11,natural killer cell chemotaxis,BP,PIK3CG
3721,GO:0007221,0.108628650024401,0.994741675305568,1,7,positive regulation of transcription of Notch receptor target,BP,NOTCH1
18281,GO:0099024,0.108641534607117,0.981463543670756,2,40,plasma membrane invagination,BP,MFGE8;SNX18
20848,GO:1990712,0.108717903836563,0.994626774493811,1,8,HFE-transferrin receptor complex,CC,TF
5243,GO:0014732,0.108722022198526,0.994626358382406,1,8,skeletal muscle atrophy,BP,ACTN3
17274,GO:0086042,0.1087342586341,0.994731215722926,1,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,DSC2
11254,GO:0043197,0.108777027415478,0.964383899089815,4,120,dendritic spine,CC,ACTN2;ADORA1;LZTS1;PDE4B
13978,GO:0051260,0.108801426622616,0.950845628378181,7,283,protein homooligomerization,BP,ACTN2;SPTBN5;PRND;CLDN1;CLDN3;KCNG2;KCND1
11015,GO:0042748,0.109036850659771,0.994511621449907,1,9,circadian sleep/wake cycle, non-REM sleep,BP,ADORA1
2875,GO:0005915,0.109041753611252,0.994700699239336,1,7,zonula adherens,CC,CAMSAP3
11297,GO:0043255,0.109073377032472,0.971496649951287,3,77,regulation of carbohydrate biosynthetic process,BP,PDGFB;SESN2;AKT1
6867,GO:0021575,0.109116598012677,0.981369271429853,2,38,hindbrain morphogenesis,BP,WNT7A;DLL1
11351,GO:0043331,0.10913447445729,0.971416701541342,3,85,response to dsRNA,BP,PMAIP1;RALB;BMP4
21264,GO:2000508,0.109279514753577,0.994420092964842,1,10,regulation of dendritic cell chemotaxis,BP,GAS6
7383,GO:0030314,0.109533427269403,0.994651712991666,1,7,junctional membrane complex,CC,CASQ2
1065,GO:0002431,0.109726534512654,0.971252925776753,3,77,Fc receptor mediated stimulatory signaling pathway,BP,PIK3R2;PIK3R1;PIK3CA
18612,GO:1900452,0.109797355365036,0.994625320187426,1,7,regulation of long term synaptic depression,BP,ADORA1
10748,GO:0042297,0.109797940265179,0.994625261621977,1,7,vocal learning,BP,STRA6
18083,GO:0098596,0.109797940265179,0.994625261621977,1,7,imitative learning,BP,STRA6
3567,GO:0006975,0.109808421149246,0.994516002633205,1,8,DNA damage induced protein phosphorylation,BP,MAPK12
20955,GO:2000020,0.109809979339533,0.994515843511303,1,8,positive regulation of male gonad development,BP,WT1
80,GO:0000160,0.10991581355661,0.994613452280505,1,7,phosphorelay signal transduction system,BP,KCNH2
15384,GO:0061140,0.109948562519015,0.994350053695274,1,10,lung secretory cell differentiation,BP,FGF10
2497,GO:0005167,0.110127878283625,0.994592172075086,1,7,neurotrophin TRK receptor binding,MF,PIK3R1
12563,GO:0046189,0.110150142244577,0.981055228997221,2,40,phenol-containing compound biosynthetic process,BP,PNMT;WNT5A
21244,GO:2000480,0.110156334124575,0.994480413991136,1,8,negative regulation of cAMP-dependent protein kinase activity,BP,PRKAR1B
19405,GO:1903011,0.110356981137686,0.994459834742296,1,8,negative regulation of bone development,BP,CLDN18
16346,GO:0071233,0.110369387476588,0.994567883737607,1,7,cellular response to leucine,BP,SESN2
16958,GO:0072257,0.110390213114496,0.994565786657881,1,7,metanephric nephron tubule epithelial cell differentiation,BP,LIF
16988,GO:0072307,0.110390213114496,0.994565786657881,1,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,LIF
21471,GO:2000807,0.110423254547385,0.994562458615265,1,7,regulation of synaptic vesicle clustering,BP,CDH2
15700,GO:0070050,0.110494491833997,0.99444570791598,1,8,neuron cellular homeostasis,BP,TYRO3
19792,GO:1903800,0.110545422402992,0.99444047091574,1,8,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
5036,GO:0010838,0.110611129595524,0.994348413776149,1,9,positive regulation of keratinocyte proliferation,BP,FGF10
1138,GO:0002548,0.110654468389313,0.980707192220593,2,59,monocyte chemotaxis,BP,CCL20;PDGFB
11415,GO:0043467,0.110710362006013,0.970861316246534,3,80,regulation of generation of precursor metabolites and energy,BP,ACTN3;AKT1;PIK3CA
2453,GO:0005113,0.110851948904168,0.994408897444814,1,8,patched binding,MF,DHH
12344,GO:0045776,0.111004718460924,0.980776343510758,2,43,negative regulation of blood pressure,BP,ADORA1;KCNK6
14357,GO:0051963,0.111129868160213,0.970743633864878,3,75,regulation of synapse assembly,BP,WNT7A;WNT5A;RAB17
12588,GO:0046322,0.111351176163796,0.994357274879204,1,8,negative regulation of fatty acid oxidation,BP,AKT1
9953,GO:0035630,0.111424027850371,0.994349720911307,1,8,bone mineralization involved in bone maturation,BP,BMP2
10625,GO:0042045,0.111451036981637,0.99434691900042,1,8,epithelial fluid transport,BP,EDN1
13423,GO:0048819,0.111484378649187,0.994343459154237,1,8,regulation of hair follicle maturation,BP,WNT5A
832,GO:0002028,0.111507193715255,0.970546962729267,3,82,regulation of sodium ion transport,BP,SPTBN4;WNK4;AKT1
19110,GO:1902282,0.111588214943957,0.994332677027769,1,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,KCNH2
16309,GO:0071158,0.11168701490862,0.970472085242325,3,83,positive regulation of cell cycle arrest,BP,GADD45A;FOXO4;CDKN1A
8486,GO:0032426,0.111773685820667,0.994313391429998,1,8,stereocilium tip,CC,ESPN
2860,GO:0005891,0.112088965563862,0.980560731955887,2,38,voltage-gated calcium channel complex,CC,CASQ2;PDE4B
20516,GO:1905456,0.112435723221622,0.994244272061798,1,8,regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
12868,GO:0046907,0.112505168865832,0.922109831941192,29,1646,intracellular transport,BP,SYT5;RAB6C;RAB27A;WNT7A;NMT2;ADORA1;SPTBN5;SPTBN4;FZD7;PRR5L;PIK3R2;PIK3R1;REEP1;GPRASP1;RHOB;SPTB;BMP7;BMP6;BMP4;CDKN1A;CHGA;MSN;AKT1;RAB12;RAB17;CDH1;MYO7A;PIK3CG;GAS6
5647,GO:0015858,0.112595816242949,0.994227492109158,1,8,nucleoside transport,BP,ADORA1
10878,GO:0042516,0.112652531646704,0.980323263557598,2,43,regulation of tyrosine phosphorylation of Stat3 protein,BP,LIF;CLCF1
15775,GO:0070170,0.112733486235721,0.994124427804817,1,9,regulation of tooth mineralization,BP,WNT6
5270,GO:0014820,0.112947037302267,0.994190589758799,1,8,tonic smooth muscle contraction,BP,EDN1
10999,GO:0042726,0.113000301285067,0.994184982634283,1,8,flavin-containing compound metabolic process,BP,SLC52A3
3501,GO:0006875,0.113098458915083,0.940365884523732,10,472,cellular metal ion homeostasis,BP,CDH23;TF;CASQ2;EDN1;PRND;LPAR2;BMP6;PIK3CG;VDR;CLDN16
6742,GO:0019869,0.113332585573757,0.994060376915535,1,9,chloride channel inhibitor activity,MF,WNK4
3665,GO:0007157,0.11333264136257,0.980200054343386,2,39,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ITGA5;CDH2
6478,GO:0019062,0.113642439341575,0.994117161641611,1,8,virion attachment to host cell,BP,GAS6
11858,GO:0044650,0.113642439341575,0.994117161641611,1,8,adhesion of symbiont to host cell,BP,GAS6
14686,GO:0060056,0.113749234022813,0.994015618022504,1,9,mammary gland involution,BP,VDR
4424,GO:0009150,0.113932207292688,0.939816209530375,10,507,purine ribonucleotide metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
4635,GO:0009750,0.114055909277733,0.994073274106373,1,8,response to fructose,BP,KHK
11729,GO:0044309,0.114209511033024,0.961955897961022,4,122,neuron spine,CC,ACTN2;ADORA1;LZTS1;PDE4B
10301,GO:0036294,0.114332275969315,0.956046968613123,5,188,cellular response to decreased oxygen levels,BP,NOTCH1;PMAIP1;EDN1;BMP7;AKT1
17345,GO:0090037,0.114365015167408,0.994040352668503,1,8,positive regulation of protein kinase C signaling,BP,WNT5A
5102,GO:0010917,0.114440171015049,0.993941005814398,1,9,negative regulation of mitochondrial membrane potential,BP,PMAIP1
15041,GO:0060556,0.114496890382421,0.993934859372536,1,9,regulation of vitamin D biosynthetic process,BP,VDR
2305,GO:0004872,0.114516140341825,0.92268755676961,25,1537,receptor activity,MF,ITGA5;ADRA2B;ADRA2C;NOTCH1;STRA6;ITGB5;ITGB4;ITGB8;ACVR1;GUCY1B3;ADORA1;KCNK6;FZD7;TYRO3;LPAR2;KCNH2;NPR1;SDC4;DDR1;CLDN1;CLDN3;VDR;AMOT;FZD8;EFNB2
14714,GO:0060089,0.114516140341825,0.92268755676961,25,1537,molecular transducer activity,MF,ITGA5;ADRA2B;ADRA2C;NOTCH1;STRA6;ITGB5;ITGB4;ITGB8;ACVR1;GUCY1B3;ADORA1;KCNK6;FZD7;TYRO3;LPAR2;KCNH2;NPR1;SDC4;DDR1;CLDN1;CLDN3;VDR;AMOT;FZD8;EFNB2
12011,GO:0045080,0.114553163532843,0.993855625391903,1,10,positive regulation of chemokine biosynthetic process,BP,WNT5A
19544,GO:1903312,0.11458941088537,0.979870253563463,2,38,negative regulation of mRNA metabolic process,BP,PKP3;PKP1
2809,GO:0005801,0.114635995062928,0.979820779306759,2,40,cis-Golgi network,CC,PIK3R1;CTGF
15610,GO:0061700,0.114799767424543,0.993993887600512,1,8,GATOR2 complex,CC,SESN2
9453,GO:0034446,0.114834734903392,0.969315505997751,3,78,substrate adhesion-dependent cell spreading,BP,FZD7;TYRO3;LAMA5
12048,GO:0045136,0.115110539192013,0.993868152238408,1,9,development of secondary sexual characteristics,BP,WNT5A
758,GO:0001933,0.115494876412659,0.941209158804188,9,389,negative regulation of protein phosphorylation,BP,LIF;GADD45A;PRR5L;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
3854,GO:0007595,0.11561351239174,0.979547763545255,2,40,lactation,BP,DDR1;VDR
8596,GO:0032585,0.115748550552772,0.993798391654733,1,9,multivesicular body membrane,CC,RAB27A
2548,GO:0005267,0.115751162295753,0.961251827482003,4,124,potassium channel activity,MF,KCNK6;KCNH2;KCNG2;KCND1
16897,GO:0072172,0.115782464987387,0.993794671861895,1,9,mesonephric tubule formation,BP,GDNF
10925,GO:0042583,0.115908715980522,0.993874510182503,1,8,chromaffin granule,CC,CHGA
14811,GO:0060255,0.116205392708055,0.908177739316402,89,5664,regulation of macromolecule metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;ITGB8;PMAIP1;GADD45A;CRB2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;DKK3;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;MSN;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;CST9L;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;PM20D2;SHC4;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
18864,GO:1901626,0.116676386241835,0.993696203809622,1,9,regulation of postsynaptic membrane organization,BP,CDH2
13571,GO:0050670,0.116728902389392,0.95483006205687,5,194,regulation of lymphocyte proliferation,BP,FGF10;SDC4;CLCF1;BMP4;CDKN1A
19594,GO:1903409,0.116748350298098,0.968521364717833,3,86,reactive oxygen species biosynthetic process,BP,RAB27A;EDN1;AKT1
2707,GO:0005641,0.116875398462604,0.993769442987622,1,8,nuclear envelope lumen,CC,PTGES
604,GO:0001709,0.116988362639421,0.979143932260323,2,41,cell fate determination,BP,BMP4;DLL1
15284,GO:0060982,0.117100193514002,0.993744876134817,1,8,coronary artery morphogenesis,BP,NOTCH1
18854,GO:1901615,0.117211050496339,0.937779992512474,10,457,organic hydroxy compound metabolic process,BP,WNT4;ACTN3;PNMT;HMGCS2;DKK3;WNT5A;NPR1;BMP6;BMP2;VDR
9080,GO:0033483,0.117408543636843,0.993614949433664,1,9,gas homeostasis,BP,WNT7B
9375,GO:0034331,0.117414460038145,0.993710446384533,1,8,cell junction maintenance,BP,CAMSAP3
14739,GO:0060137,0.117453029753689,0.993609994819743,1,9,maternal process involved in parturition,BP,EDN1
5019,GO:0010820,0.11765757615377,0.993510023877257,1,10,positive regulation of T cell chemotaxis,BP,WNT5A
12378,GO:0045839,0.117806572376803,0.978912449221511,2,41,negative regulation of mitotic nuclear division,BP,BMP7;BMP4
19453,GO:1903115,0.117806853776162,0.978948495747564,2,39,regulation of actin filament-based movement,BP,DSC2;PDE4B
13166,GO:0048262,0.117816856849664,0.993569398208652,1,9,determination of dorsal/ventral asymmetry,BP,ACVR1
10869,GO:0042503,0.11790923420551,0.978835329288368,2,44,tyrosine phosphorylation of Stat3 protein,BP,LIF;CLCF1
15536,GO:0061525,0.117947633930918,0.993651807346342,1,8,hindgut development,BP,WNT5A
15024,GO:0060534,0.118081002072213,0.993637094755108,1,8,trachea cartilage development,BP,WNT7B
17584,GO:0090400,0.11809365828019,0.993635697649585,1,8,stress-induced premature senescence,BP,CDKN1A
15301,GO:0061004,0.118172838884188,0.993529546538043,1,9,pattern specification involved in kidney development,BP,BMP4
16817,GO:0072048,0.118172838884188,0.993529546538043,1,9,renal system pattern specification,BP,BMP4
5441,GO:0015232,0.118182983426054,0.993625832566284,1,8,heme transporter activity,MF,FLVCR2
16462,GO:0071415,0.118291681836043,0.993613817087384,1,8,cellular response to purine-containing compound,BP,CASQ2
10394,GO:0036490,0.118345813242985,0.993607828996496,1,8,regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
14894,GO:0060363,0.11839068042923,0.993505095841375,1,9,cranial suture morphogenesis,BP,BMP4
7327,GO:0030234,0.118447885490531,0.925194817369057,18,961,enzyme regulator activity,MF,RIN3;NOTCH1;CRB2;SERPINA5;PIK3R2;PIK3R1;PDGFB;PRKAR1B;SESN2;AXIN1;BMP2;CDKN1A;AKT1;CST9L;PIK3CA;GAS6;GPSM1;SH3BP4
2525,GO:0005225,0.11862017181411,0.993577433801636,1,8,volume-sensitive anion channel activity,MF,TTYH1
8841,GO:0032944,0.118814474307486,0.953774707408879,5,195,regulation of mononuclear cell proliferation,BP,FGF10;SDC4;CLCF1;BMP4;CDKN1A
15124,GO:0060693,0.118896224826165,0.993448166857754,1,9,regulation of branching involved in salivary gland morphogenesis,BP,FGF10
10860,GO:0042492,0.118992313989814,0.993536084624498,1,8,gamma-delta T cell differentiation,BP,JAG2
16853,GO:0072102,0.119043298146828,0.993530408868848,1,8,glomerulus morphogenesis,BP,BMP4
6723,GO:0019838,0.119141131462308,0.959697484984857,4,127,growth factor binding,MF,ITGB4;ACVR1;PDGFB;CTGF
5674,GO:0015908,0.119207520070401,0.967555319927594,3,88,fatty acid transport,BP,EDN1;AKT1;ACSL4
15064,GO:0060586,0.119211560735713,0.993412525183527,1,9,multicellular organismal iron ion homeostasis,BP,BMP6
18858,GO:1901620,0.11931415904461,0.993500211745695,1,8,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
6523,GO:0019203,0.119411617618669,0.993389860652518,1,9,carbohydrate phosphatase activity,MF,PFKFB3
13501,GO:0050308,0.119411617618669,0.993389860652518,1,9,sugar-phosphatase activity,MF,PFKFB3
21323,GO:2000587,0.119445270367994,0.993485568202188,1,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
7105,GO:0022600,0.119670557475705,0.967355225082428,3,91,digestive system process,BP,FGF10;WNK4;VDR
15112,GO:0060677,0.119780160084233,0.99344808658352,1,8,ureteric bud elongation,BP,BMP4
16783,GO:0071985,0.119935048879168,0.99333036772115,1,9,multivesicular body sorting pathway,BP,RAB27A
17058,GO:0072497,0.119953968311894,0.993428589083604,1,8,mesenchymal stem cell differentiation,BP,WNT3
14659,GO:0060027,0.120051626910953,0.993417620571584,1,8,convergent extension involved in gastrulation,BP,WNT5A
10121,GO:0035912,0.120321318214815,0.993387280356541,1,8,dorsal aorta morphogenesis,BP,HEY1
2298,GO:0004862,0.120329491409048,0.993285350811547,1,9,cAMP-dependent protein kinase inhibitor activity,MF,PRKAR1B
8231,GO:0032007,0.12035478041932,0.978203312473811,2,40,negative regulation of TOR signaling,BP,SESN2;SH3BP4
19820,GO:1903867,0.120408779731585,0.993377425226067,1,8,extraembryonic membrane development,BP,BMP7
14827,GO:0060281,0.120563974250766,0.993258514470838,1,9,regulation of oocyte development,BP,NPPC
20633,GO:1905879,0.120563974250766,0.993258514470838,1,9,regulation of oogenesis,BP,NPPC
13977,GO:0051259,0.120608260494755,0.935601772760324,10,478,protein oligomerization,BP,ACTN2;PMAIP1;SPTBN5;PRND;HRAS;GJB1;CLDN1;CLDN3;KCNG2;KCND1
13344,GO:0048672,0.120636018414971,0.993250257804836,1,9,positive regulation of collateral sprouting,BP,WNT3
18650,GO:1901016,0.12070588731704,0.978084169655649,2,41,regulation of potassium ion transmembrane transporter activity,BP,ACTN2;CASQ2
5392,GO:0015144,0.120806417222374,0.978055226264801,2,41,carbohydrate transmembrane transporter activity,MF,SLC45A4;SLC2A14
18804,GO:1901476,0.120806417222374,0.978055226264801,2,41,carbohydrate transporter activity,MF,SLC45A4;SLC2A14
15832,GO:0070255,0.120813208801221,0.993229928230628,1,9,regulation of mucus secretion,BP,ADORA1
11321,GO:0043295,0.120839959818031,0.993078897786971,1,11,glutathione binding,MF,PTGES
7292,GO:0030193,0.120845726115172,0.966952141593209,3,83,regulation of blood coagulation,BP,EDN1;PLAU;PDGFB
18455,GO:1900046,0.120845726115172,0.966952141593209,3,83,regulation of hemostasis,BP,EDN1;PLAU;PDGFB
17249,GO:0086009,0.120858370495107,0.97805854959707,2,40,membrane repolarization,BP,CASQ2;KCNH2
7023,GO:0021891,0.120950810861739,0.993316177498116,1,8,olfactory bulb interneuron development,BP,WNT5A
21463,GO:2000794,0.121133202366552,0.993295501283467,1,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
17688,GO:0097011,0.121199887627149,0.993185452016486,1,9,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,AKT1
17689,GO:0097012,0.121199887627149,0.993185452016486,1,9,response to granulocyte macrophage colony-stimulating factor,BP,AKT1
9839,GO:0035457,0.121272819932627,0.993279651334238,1,8,cellular response to interferon-alpha,BP,GAS6
18527,GO:1900165,0.121307940972531,0.993275661158207,1,8,negative regulation of interleukin-6 secretion,BP,GAS6
18411,GO:0102391,0.121495422047952,0.993254339991513,1,8,decanoate--CoA ligase activity,MF,ACSL4
1522,GO:0003266,0.121679579182672,0.993130064920525,1,9,regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
14442,GO:0052547,0.121881101163407,0.940030323722153,8,384,regulation of peptidase activity,BP,PMAIP1;CRB2;SERPINA5;MAPK12;CTGF;AKT1;CST9L;GAS6
41,GO:0000082,0.121918641667298,0.947349812480879,6,236,G1/S transition of mitotic cell cycle,BP,GADD45A;ACVR1;FGF10;CDKN1A;AKT1;PIM2
677,GO:0001821,0.121960834575673,0.993014549074456,1,10,histamine secretion,BP,EDN1
14182,GO:0051639,0.122046670791582,0.99319144417783,1,8,actin filament network formation,BP,FHOD3
20660,GO:1905941,0.12210224513917,0.992997942547074,1,10,positive regulation of gonad development,BP,WT1
21635,GO:2001233,0.122590789434934,0.9396263856996,8,362,regulation of apoptotic signaling pathway,BP,WNT4;PMAIP1;ACVR1;FGF10;BMP4;AKT1;INHBB;GDNF
18067,GO:0098562,0.122700592322522,0.951846860296503,5,177,cytoplasmic side of membrane,CC,PTPN7;SNX18;SPTB;CDH1;MYZAP
5311,GO:0014891,0.122710423946635,0.993010242808757,1,9,striated muscle atrophy,BP,ACTN3
3530,GO:0006913,0.12272074742945,0.934268233739306,10,457,nucleocytoplasmic transport,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
8268,GO:0032070,0.122727385686332,0.992924281260737,1,10,regulation of deoxyribonuclease activity,BP,AKT1
15230,GO:0060872,0.122894648763347,0.992988714494398,1,9,semicircular canal development,BP,FGF10
8260,GO:0032055,0.122984512348316,0.992978200514561,1,9,negative regulation of translation in response to stress,BP,SESN2
13941,GO:0051205,0.123046083828507,0.977339870095959,2,45,protein insertion into membrane,BP,PMAIP1;REEP1
4365,GO:0009071,0.123142686992515,0.992875121923402,1,10,serine family amino acid catabolic process,BP,GLDC
13804,GO:0051014,0.123311075568552,0.992939923151819,1,9,actin filament severing,BP,SCIN
21421,GO:2000736,0.123471386275764,0.977301386366893,2,40,regulation of stem cell differentiation,BP,NOTCH1;GDNF
438,GO:0001135,0.12360425723218,0.99301206988391,1,8,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,LIF
1444,GO:0003149,0.123732328613441,0.992890385460378,1,9,membranous septum morphogenesis,BP,BMP4
21357,GO:2000643,0.123738934280506,0.992996445067951,1,8,positive regulation of early endosome to late endosome transport,BP,MSN
10876,GO:0042511,0.123743680733895,0.992733869793012,1,11,positive regulation of tyrosine phosphorylation of Stat1 protein,BP,LIF
3462,GO:0006811,0.123831910327631,0.91445191106276,27,1514,ion transport,BP,ACTN2;CDH23;TF;SLC52A3;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;TTYH1;TSPAN13;PDGFB;KCNH2;SFXN1;WNK4;CTGF;AKT1;PIK3CG;KCNG2;GAS6;VDR;KCND1;GDNF;ACSL4;CLDN16;CLDN15;PDE4B
9571,GO:0034702,0.124070150458587,0.942152686133577,7,275,ion channel complex,CC,CASQ2;KCNK6;TTYH1;KCNH2;KCNG2;KCND1;PDE4B
13971,GO:0051253,0.12447982720936,0.917269983162153,22,1206,negative regulation of RNA metabolic process,BP,WNT4;NOTCH1;ZFPM1;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;PKP3;PKP1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
733,GO:0001894,0.124520145853423,0.950878561510006,5,189,tissue homeostasis,BP,CDH23;TF;CTGF;RAB3D;CLDN18
18084,GO:0098597,0.124558600961907,0.99290095411573,1,8,observational learning,BP,STRA6
867,GO:0002072,0.124589652052926,0.99289732330198,1,8,optic cup morphogenesis involved in camera-type eye development,BP,WNT5A
16808,GO:0072033,0.124750752227305,0.992878470133949,1,8,renal vesicle formation,BP,WNT4
17626,GO:0090557,0.124927888318498,0.992857709978609,1,8,establishment of endothelial intestinal barrier,BP,CLDN1
16448,GO:0071394,0.1251146381385,0.992726552237254,1,9,cellular response to testosterone stimulus,BP,MSN
17741,GO:0097104,0.125173589059433,0.992828861494438,1,8,postsynaptic membrane assembly,BP,CDH2
5018,GO:0010819,0.1253502523506,0.992539184146313,1,11,regulation of T cell chemotaxis,BP,WNT5A
13868,GO:0051100,0.125818565937796,0.956567618707873,4,137,negative regulation of binding,BP,ZFPM1;PDGFB;RALB;HEY1
15055,GO:0060576,0.125934614963208,0.99253999662806,1,10,intestinal epithelial cell development,BP,CDKN1A
8554,GO:0032507,0.125950092431488,0.964919036794425,3,85,maintenance of protein location in cell,BP,SPTBN4;SCIN;AKT1
17318,GO:0086103,0.125999546817404,0.992620641133571,1,9,G-protein coupled receptor signaling pathway involved in heart process,BP,CHGA
17921,GO:0097449,0.126019998217972,0.992618183869209,1,9,astrocyte projection,CC,GJB2
8000,GO:0031532,0.126087361738366,0.964864228479786,3,85,actin cytoskeleton reorganization,BP,FGF10;HRAS;PARVB
11940,GO:0044851,0.126202201843712,0.992596272855681,1,9,hair cycle phase,BP,WNT5A
19542,GO:1903307,0.126314017721339,0.976393558257816,2,44,positive regulation of regulated secretory pathway,BP,RAB27A;RAB3D
5084,GO:0010896,0.126371393546324,0.992353413821742,1,12,regulation of triglyceride catabolic process,BP,PIK3CG
6546,GO:0019233,0.12663841021007,0.964621200369172,3,88,sensory perception of pain,BP,ADRA2C;ADORA1;EDN1
12894,GO:0046951,0.126755242169485,0.992529557413197,1,9,ketone body biosynthetic process,BP,HMGCS2
17929,GO:0097459,0.127293725954116,0.99246429538614,1,9,iron ion import into cell,BP,TF
2434,GO:0005080,0.127332966760097,0.976125458475785,2,42,protein kinase C binding,MF,SDC4;AKT1
14168,GO:0051601,0.127528583156339,0.992435738098299,1,9,exocyst localization,BP,RALB
13645,GO:0050768,0.127705660015103,0.944165367221595,6,232,negative regulation of neurogenesis,BP,WNT3;NOTCH1;WNT7A;WNT5A;BMP7;DLL1
20966,GO:2000045,0.12773889854477,0.955672024689166,4,136,regulation of G1/S transition of mitotic cell cycle,BP,GADD45A;FGF10;CDKN1A;AKT1
2303,GO:0004869,0.127778817367145,0.975789455925224,2,57,cysteine-type endopeptidase inhibitor activity,MF,CST9L;GAS6
6589,GO:0019371,0.127836428510435,0.992232571863942,1,11,cyclooxygenase pathway,BP,PTGES
9027,GO:0033273,0.128033535323446,0.964046595415871,3,90,response to vitamin,BP,BMP7;GAS6;VDR
7385,GO:0030316,0.128052672472601,0.964068581956326,3,86,osteoclast differentiation,BP,FSTL3;PIK3R1;CLDN18
977,GO:0002279,0.12811474006116,0.975840386383913,2,45,mast cell activation involved in immune response,BP,CHGA;PIK3CG
11328,GO:0043303,0.12811474006116,0.975840386383913,2,45,mast cell degranulation,BP,CHGA;PIK3CG
13099,GO:0048087,0.128303635129007,0.992341092762726,1,9,positive regulation of developmental pigmentation,BP,KITLG
6929,GO:0021700,0.128366395116272,0.943786866095725,6,237,developmental maturation,BP,SPTBN4;WNT5A;BMP2;CDKN1A;NPPC;RAB38
18085,GO:0098598,0.128367620388446,0.992333251528549,1,9,learned vocalization behavior or vocal learning,BP,STRA6
15885,GO:0070341,0.128496837885732,0.992150033863305,1,11,fat cell proliferation,BP,FGF10
15888,GO:0070344,0.128496837885732,0.992150033863305,1,11,regulation of fat cell proliferation,BP,FGF10
4799,GO:0010454,0.128595187528287,0.992137702859258,1,11,negative regulation of cell fate commitment,BP,FZD7
17527,GO:0090303,0.128600495791405,0.975678867912894,2,46,positive regulation of wound healing,BP,HRAS;HBEGF
7328,GO:0030235,0.128640342756209,0.992299782704338,1,9,nitric-oxide synthase regulator activity,MF,AKT1
9967,GO:0035646,0.129049226974571,0.992156572013555,1,10,endosome to melanosome transport,BP,RAB38
11423,GO:0043485,0.129049226974571,0.992156572013555,1,10,endosome to pigment granule transport,BP,RAB38
13397,GO:0048757,0.129049226974571,0.992156572013555,1,10,pigment granule maturation,BP,RAB38
2301,GO:0004866,0.129308963116208,0.954830267900054,4,164,endopeptidase inhibitor activity,MF,CRB2;SERPINA5;CST9L;GAS6
15235,GO:0060896,0.129379272886871,0.992208714429652,1,9,neural plate pattern specification,BP,AXIN1
19090,GO:1902237,0.129626468597653,0.992084399408341,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
8246,GO:0032036,0.129671477791127,0.991938255168574,1,12,myosin heavy chain binding,MF,SPTBN5
2170,GO:0004690,0.129706477921093,0.992168208395478,1,9,cyclic nucleotide-dependent protein kinase activity,MF,PRKACB
5667,GO:0015886,0.129733500055847,0.992164858270225,1,9,heme transport,BP,FLVCR2
3843,GO:0007566,0.129758215200442,0.975299989156861,2,48,embryo implantation,BP,LIF;DDR1
14269,GO:0051798,0.129787686567682,0.991987377706749,1,11,positive regulation of hair follicle development,BP,WNT5A
21016,GO:2000121,0.129820958943418,0.992060003859136,1,10,regulation of removal of superoxide radicals,BP,BMP7
9382,GO:0034341,0.129917705344646,0.954560868299477,4,158,response to interferon-gamma,BP,EDN1;CCL20;WNT5A;CLDN1
7608,GO:0030836,0.129973967720541,0.992135012547666,1,9,positive regulation of actin filament depolymerization,BP,ACTN2
19925,GO:1904062,0.130180227441936,0.942758098164963,6,245,regulation of cation transmembrane transport,BP,ACTN2;CASQ2;TSPAN13;KCNH2;PIK3CG;PDE4B
1428,GO:0003128,0.130336047596377,0.991995203635466,1,10,heart field specification,BP,BMP4
12289,GO:0045665,0.130380987060617,0.947864944366556,5,181,negative regulation of neuron differentiation,BP,WNT3;NOTCH1;WNT5A;BMP7;DLL1
6914,GO:0021683,0.130396728191521,0.992082396535902,1,9,cerebellar granular layer morphogenesis,BP,WNT7A
13770,GO:0050932,0.130482208070126,0.992071735395522,1,9,regulation of pigment cell differentiation,BP,KITLG
7032,GO:0021903,0.130498103074052,0.991897110954981,1,11,rostrocaudal neural tube patterning,BP,FGF8
16687,GO:0071803,0.130830520534329,0.991932735949804,1,10,positive regulation of podosome assembly,BP,MSN
3021,GO:0006163,0.130870290421148,0.928955489570506,10,523,purine nucleotide metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
5938,GO:0016461,0.130887503280428,0.991925520776699,1,10,unconventional myosin complex,CC,MYO7A
11802,GO:0044432,0.130927746165897,0.913260547668012,21,1135,endoplasmic reticulum part,CC,WNT3;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;CASQ2;EDN1;MBOAT2;TTYH1;TYRO3;PIK3R1;REEP1;PDGFB;WNT5B;WNT5A;GJB1;PTGES;GAS6;GPSM1;ACSL4
10374,GO:0036465,0.130973519548651,0.975051179907427,2,41,synaptic vesicle recycling,BP,SYT5;WNT7A
14152,GO:0051583,0.131283069333027,0.991796752499537,1,11,dopamine uptake involved in synaptic transmission,BP,GDNF
14336,GO:0051934,0.131283069333027,0.991796752499537,1,11,catecholamine uptake involved in synaptic transmission,BP,GDNF
17602,GO:0090493,0.131283069333027,0.991796752499537,1,11,catecholamine uptake,BP,GDNF
17603,GO:0090494,0.131283069333027,0.991796752499537,1,11,dopamine uptake,BP,GDNF
1001,GO:0002315,0.131296199655027,0.991969834649965,1,9,marginal zone B cell differentiation,BP,DLL1
9513,GO:0034614,0.131314038322292,0.953948764432417,4,144,cellular response to reactive oxygen species,BP,GUCY1B3;RHOB;BMP7;AKT1
4853,GO:0010561,0.131730819299789,0.991818342466322,1,10,negative regulation of glycoprotein biosynthetic process,BP,HBEGF
12064,GO:0045171,0.13179032393863,0.974764628807317,2,43,intercellular bridge,CC,PRKACB;UNC119
3504,GO:0006879,0.131790575914637,0.97471296534753,2,46,cellular iron ion homeostasis,BP,TF;BMP6
13914,GO:0051169,0.131799306205422,0.928397177959095,10,465,nuclear transport,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
18636,GO:1900746,0.131821266782324,0.991806803136928,1,10,regulation of vascular endothelial growth factor signaling pathway,BP,DLL1
12376,GO:0045837,0.131887096798464,0.991719084166057,1,11,negative regulation of membrane potential,BP,PMAIP1
7688,GO:0030957,0.132043017330983,0.991778475837921,1,10,Tat protein binding,MF,DLL1
14787,GO:0060215,0.13212011856846,0.991865992317466,1,9,primitive hemopoiesis,BP,ZFPM1
15437,GO:0061299,0.13223412349395,0.99185156833405,1,9,retina vasculature morphogenesis in camera-type eye,BP,RHOJ
15831,GO:0070254,0.132333079950235,0.991661490353609,1,11,mucus secretion,BP,ADORA1
16017,GO:0070561,0.132414556211854,0.991828712315194,1,9,vitamin D receptor signaling pathway,BP,VDR
11179,GO:0043083,0.132520516204116,0.991815274270525,1,9,synaptic cleft,CC,LAMA5
4512,GO:0009259,0.132640659857242,0.927802945208357,10,522,ribonucleotide metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
14856,GO:0060315,0.132652185899108,0.991620152242138,1,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,CASQ2
9131,GO:0033605,0.132690313799517,0.991615205814907,1,11,positive regulation of catecholamine secretion,BP,GDNF
10514,GO:0038166,0.132699690737632,0.991694287452538,1,10,angiotensin-activated signaling pathway,BP,ACTN2
15972,GO:0070486,0.132701620277613,0.991613738701736,1,11,leukocyte aggregation,BP,BMP7
21053,GO:2000194,0.132730317895575,0.991610014330645,1,11,regulation of female gonad development,BP,WT1
11409,GO:0043455,0.132800146709862,0.991600948321256,1,11,regulation of secondary metabolic process,BP,WNT5A
2502,GO:0005172,0.132889192272063,0.991669908457518,1,10,vascular endothelial growth factor receptor binding,MF,ITGA5
13683,GO:0050818,0.132896610442552,0.962094051561,3,87,regulation of coagulation,BP,EDN1;PLAU;PDGFB
15185,GO:0060768,0.132994841964993,0.991656300478834,1,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
12944,GO:0047144,0.133039391556405,0.991749301345342,1,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
9349,GO:0034244,0.133183532497407,0.991631967467877,1,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
14584,GO:0055056,0.13337144079357,0.991706935984077,1,9,D-glucose transmembrane transporter activity,MF,SLC2A14
18935,GO:1901841,0.133641914792709,0.991572700090929,1,10,regulation of high voltage-gated calcium channel activity,BP,PDE4B
2646,GO:0005522,0.133796683917252,0.991652513028323,1,9,profilin binding,MF,RHOQ
13264,GO:0048521,0.133902737706066,0.991331459227449,1,13,negative regulation of behavior,BP,ADORA1
16487,GO:0071453,0.133970415745612,0.945933698360855,5,197,cellular response to oxygen levels,BP,NOTCH1;PMAIP1;EDN1;BMP7;AKT1
15351,GO:0061081,0.13414991075891,0.991424691503254,1,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,WNT5A
1490,GO:0003211,0.134152544742345,0.991506417455023,1,10,cardiac ventricle formation,BP,NOTCH1
5300,GO:0014870,0.134319145077966,0.991484732526212,1,10,response to muscle inactivity,BP,ACTN3
5304,GO:0014877,0.134319145077966,0.991484732526212,1,10,response to muscle inactivity involved in regulation of muscle adaptation,BP,ACTN3
5312,GO:0014894,0.134319145077966,0.991484732526212,1,10,response to denervation involved in regulation of muscle adaptation,BP,ACTN3
18639,GO:1900750,0.134366061037922,0.991327730093637,1,12,oligopeptide binding,MF,PTGES
21575,GO:2001135,0.134680659926307,0.991538779725416,1,9,regulation of endocytic recycling,BP,ACTN2
4018,GO:0008227,0.134708706142105,0.973728519043166,2,52,G-protein coupled amine receptor activity,MF,ADRA2B;ADRA2C
10118,GO:0035907,0.134760838912076,0.991528423619197,1,9,dorsal aorta development,BP,HEY1
14713,GO:0060088,0.134777386196398,0.991424936747496,1,10,auditory receptor cell stereocilium organization,BP,MYO7A
6018,GO:0016600,0.135098413453107,0.991484748337631,1,9,flotillin complex,CC,CDH1
9049,GO:0033327,0.13514060958414,0.991377382928765,1,10,Leydig cell differentiation,BP,DHH
19868,GO:1903960,0.135153900316967,0.991477558117883,1,9,negative regulation of anion transmembrane transport,BP,AKT1
14463,GO:0052652,0.135208284004726,0.952055342880194,4,152,cyclic purine nucleotide metabolic process,BP,GUCY1B3;EDN1;NPR1;NPPC
1521,GO:0003264,0.135413837815944,0.991341519952386,1,10,regulation of cardioblast proliferation,BP,NOTCH1
9037,GO:0033293,0.135478945184896,0.973452082662608,2,55,monocarboxylic acid binding,MF,SERPINA5;VDR
9458,GO:0034452,0.135527905613772,0.991429009342212,1,9,dynactin binding,MF,SPTBN5
777,GO:0001954,0.135679190841881,0.973532668457257,2,45,positive regulation of cell-matrix adhesion,BP,WNT4;SDC4
8377,GO:0032276,0.135736899933625,0.991214986659672,1,11,regulation of gonadotropin secretion,BP,INHBB
21216,GO:2000425,0.135748487713398,0.991297487931134,1,10,regulation of apoptotic cell clearance,BP,MFGE8
2412,GO:0005024,0.13584182399789,0.991388147877145,1,9,transforming growth factor beta-activated receptor activity,MF,ACVR1
13985,GO:0051271,0.135972210237946,0.939511212345924,6,239,negative regulation of cellular component movement,BP,WNT3;WNT4;NOTCH1;ADORA1;WNT5A;RHOB
14329,GO:0051924,0.135993735234067,0.944863689325734,5,197,regulation of calcium ion transport,BP,CASQ2;TSPAN13;PDGFB;PIK3CG;PDE4B
17550,GO:0090329,0.136123096205059,0.973431559497102,2,43,regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
1195,GO:0002674,0.136224244333595,0.991079581415088,1,12,negative regulation of acute inflammatory response,BP,ADORA1
1369,GO:0002934,0.136410993258582,0.991313799622719,1,9,desmosome organization,BP,PKP3
17756,GO:0097119,0.136478624355061,0.991304942804709,1,9,postsynaptic density protein 95 clustering,BP,CDH2
14174,GO:0051608,0.136520653806662,0.991110434951575,1,11,histamine transport,BP,EDN1
6530,GO:0019211,0.136602644327689,0.991184566396299,1,10,phosphatase activator activity,MF,BMP2
17117,GO:0072584,0.136604382017275,0.991184335886039,1,10,caveolin-mediated endocytosis,BP,UNC119
6519,GO:0019199,0.136699110518675,0.960588946021782,3,80,transmembrane receptor protein kinase activity,MF,ACVR1;TYRO3;DDR1
12433,GO:0045934,0.136765498118268,0.90644525694784,24,1347,negative regulation of nucleobase-containing compound metabolic process,BP,WNT4;ACTN3;NOTCH1;ZFPM1;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;PKP3;PKP1;NPPC;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
1139,GO:0002551,0.136811898572112,0.991071416892876,1,11,mast cell chemotaxis,BP,CHGA
16898,GO:0072173,0.137008522678279,0.991130638827381,1,10,metanephric tubule morphogenesis,BP,WNT4
5060,GO:0010870,0.137048824539849,0.991039609377871,1,11,positive regulation of receptor biosynthetic process,BP,EDN1
7659,GO:0030901,0.137075121717874,0.960330554736886,3,92,midbrain development,BP,WNT3;WNT2;WNT5A
21560,GO:2001054,0.137119221369406,0.991115900547829,1,10,negative regulation of mesenchymal cell apoptotic process,BP,BMP7
8900,GO:0033033,0.137198677985731,0.990947975158689,1,12,negative regulation of myeloid cell apoptotic process,BP,KITLG
1597,GO:0003413,0.137347249453362,0.99108550044891,1,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,NPPC
8432,GO:0032368,0.137533773780522,0.960117971042249,3,95,regulation of lipid transport,BP,EDN1;BMP6;AKT1
8065,GO:0031663,0.137738421836652,0.972824299097093,2,49,lipopolysaccharide-mediated signaling pathway,BP,BMP6;AKT1
4460,GO:0009190,0.137936489810043,0.950733567934876,4,153,cyclic nucleotide biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
1081,GO:0002448,0.137947077811601,0.972790238073588,2,47,mast cell mediated immunity,BP,CHGA;PIK3CG
11991,GO:0045058,0.138166636647344,0.972738068430039,2,46,T cell selection,BP,ZFPM1;JAG2
3773,GO:0007342,0.138218409700068,0.990809161236526,1,12,fusion of sperm to egg plasma membrane,BP,SERPINA5
2191,GO:0004716,0.138229246675302,0.991074024657618,1,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,TYRO3
19720,GO:1903651,0.138269377695669,0.991068693602104,1,9,positive regulation of cytoplasmic transport,BP,MSN
17736,GO:0097091,0.138340681303526,0.99105921738886,1,9,synaptic vesicle clustering,BP,CDH2
12352,GO:0045792,0.138342203172228,0.990864918846563,1,11,negative regulation of cell size,BP,AKT1
10791,GO:0042368,0.138413445934544,0.990855244649839,1,11,vitamin D biosynthetic process,BP,VDR
15278,GO:0060976,0.138665933729138,0.972656903612284,2,42,coronary vasculature development,BP,NOTCH1;BMP4
12004,GO:0045073,0.138710139515338,0.990680036233472,1,13,regulation of chemokine biosynthetic process,BP,WNT5A
5230,GO:0014701,0.138819659124634,0.9909954237241,1,9,junctional sarcoplasmic reticulum membrane,CC,CASQ2
2304,GO:0004871,0.138897179143543,0.903383301864672,26,1637,signal transducer activity,MF,ADRA2B;ADRA2C;WNT3;WNT2;WNT4;WNT7A;ACVR1;ADORA1;MAPK12;FZD7;TYRO3;LPAR2;PIK3R1;KCNH2;WNT5A;AXIN1;NPR1;SDC4;DDR1;PKP1;BCAR1;CLDN3;GAS6;VDR;ARAF;FZD8
13378,GO:0048715,0.13903888458172,0.990770082845559,1,11,negative regulation of oligodendrocyte differentiation,BP,NOTCH1
21388,GO:2000677,0.139205871688085,0.97239356904672,2,47,regulation of transcription regulatory region DNA binding,BP,LIF;HEY1
20947,GO:2000009,0.139303178478056,0.990733970324761,1,11,negative regulation of protein localization to cell surface,BP,ACTN2
13723,GO:0050877,0.139428761791396,0.90875688529695,19,1203,neurological system process,BP,ITGA3;ITGA5;ADRA2C;CDH23;STRA6;SLC52A3;ADORA1;EDN1;SPTBN4;PRKAR1B;JAM3;B3GNT2;ESPN;GJB2;GJB6;MYO7A;GJA3;CLDN5;UNC119
10463,GO:0038063,0.139486105063358,0.990906262544822,1,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,DDR1
16439,GO:0071383,0.139644115407571,0.937419991201561,6,240,cellular response to steroid hormone stimulus,BP,EDN1;BMP7;BMP4;GJB2;VDR;HEY1
14877,GO:0060340,0.139678416903465,0.990771565308956,1,10,positive regulation of type I interferon-mediated signaling pathway,BP,WNT5A
3398,GO:0006702,0.139724390570698,0.990676262808513,1,11,androgen biosynthetic process,BP,WNT4
19898,GO:1904019,0.140269510020153,0.959025992573966,3,88,epithelial cell apoptotic process,BP,JAG2;PIK3CG;GAS6
14350,GO:0051956,0.140324990691445,0.990683474105196,1,10,negative regulation of amino acid transport,BP,ADORA1
4529,GO:0009306,0.140542767818241,0.922647479890998,10,480,protein secretion,BP,ADRA2C;NOTCH1;RAB40B;RAB40A;WNT5A;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6
9911,GO:0035579,0.140584353027308,0.95888528338148,3,89,specific granule membrane,CC,PLAU;VAMP1;RAB44
14089,GO:0051453,0.140737902889394,0.958812529827493,3,90,regulation of intracellular pH,BP,RAB39A;RAB20;RAB38
12699,GO:0046541,0.140777024519056,0.990392298952577,1,13,saliva secretion,BP,FGF10
12496,GO:0046058,0.140819669416794,0.949341074650533,4,150,cAMP metabolic process,BP,EDN1;CHGA;NPPC;PDE4B
21554,GO:2001044,0.140995107336001,0.990501022227981,1,11,regulation of integrin-mediated signaling pathway,BP,LIMS2
695,GO:0001840,0.141042701346214,0.99058517245709,1,10,neural plate development,BP,FGF8
15381,GO:0061135,0.141105350762111,0.949130651144719,4,170,endopeptidase regulator activity,MF,CRB2;SERPINA5;CST9L;GAS6
691,GO:0001836,0.141183730580385,0.971662156958057,2,54,release of cytochrome c from mitochondria,BP,PMAIP1;AKT1
17126,GO:0072594,0.141193755384988,0.917630282517314,12,641,establishment of protein localization to organelle,BP,TSPAN17;PMAIP1;FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
17941,GO:0097479,0.141220817698694,0.949227099553692,4,132,synaptic vesicle localization,BP,SYT5;RAB27A;WNT7A;CDH2
10103,GO:0035878,0.14125315910829,0.990556243473021,1,10,nail development,BP,ITGB4
16137,GO:0070830,0.141743034575517,0.971622930454562,2,45,bicellular tight junction assembly,BP,CLDN1;CLDN3
1011,GO:0002328,0.141808248453751,0.990479716979631,1,10,pro-B cell differentiation,BP,NOTCH1
4647,GO:0009791,0.142150402953964,0.958241318766474,3,87,post-embryonic development,BP,BMP4;NPPC;MYO7A
11513,GO:0043619,0.142676176177432,0.990266537912436,1,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2
96,GO:0000185,0.142861590839502,0.99024049000172,1,11,activation of MAPKKK activity,BP,GADD45A
18207,GO:0098862,0.142985473862435,0.948341860591877,4,136,cluster of actin-based cell projections,CC,CDH23;SCIN;ESPN;MYO7A
2430,GO:0005068,0.143144062372984,0.990200736262014,1,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,PIK3R1
9600,GO:0034755,0.143183696381277,0.990195151511382,1,11,iron ion transmembrane transport,BP,TTYH1
5269,GO:0014819,0.143423683740686,0.990161299381827,1,11,regulation of skeletal muscle contraction,BP,ACTN3
11718,GO:0044297,0.143477202815861,0.920710835945746,10,472,cell body,CC,SYT5;ADORA1;SPTBN4;DRP2;GJB2;RAB17;LZTS1;KCND1;ACSL4;ACTA2
12399,GO:0045892,0.143879145649468,0.904440778873057,20,1103,negative regulation of transcription, DNA-templated,BP,WNT4;NOTCH1;ZFPM1;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
17447,GO:0090193,0.143957917231184,0.990180269357728,1,10,positive regulation of glomerulus development,BP,PDGFB
7014,GO:0021877,0.144068932779793,0.990164671545863,1,10,forebrain neuron fate commitment,BP,AXIN1
10959,GO:0042635,0.144218252390387,0.98996976936343,1,12,positive regulation of hair cycle,BP,WNT5A
21620,GO:2001204,0.144279631640883,0.990040057906138,1,11,regulation of osteoclast development,BP,CLDN18
3204,GO:0006461,0.144351048426173,0.901378370701299,23,1312,protein complex assembly,BP,FHOD3;TUBG2;ACTN2;PMAIP1;CASQ2;SPTBN5;SPTBN4;PRND;RALB;HRAS;AXIN1;SCIN;PSRC1;SPTB;VAMP1;MSN;GJB1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;KCND1
15843,GO:0070271,0.144351048426173,0.901378370701299,23,1312,protein complex biogenesis,BP,FHOD3;TUBG2;ACTN2;PMAIP1;CASQ2;SPTBN5;SPTBN4;PRND;RALB;HRAS;AXIN1;SCIN;PSRC1;SPTB;VAMP1;MSN;GJB1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;KCND1
12374,GO:0045835,0.144411465198112,0.990021314337013,1,11,negative regulation of meiotic nuclear division,BP,LIF
7531,GO:0030656,0.144598900039477,0.989915205867988,1,12,regulation of vitamin metabolic process,BP,VDR
8201,GO:0031957,0.14460892991286,0.99008861423195,1,10,very long-chain fatty acid-CoA ligase activity,MF,ACSL4
14668,GO:0060038,0.144609159326049,0.970721620687443,2,44,cardiac muscle cell proliferation,BP,WNT2;NOTCH1
8023,GO:0031588,0.144795832822913,0.990062217068218,1,10,nucleotide-activated protein kinase complex,CC,SESN2
2297,GO:0004861,0.144801548412295,0.989886093537278,1,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN1A
2495,GO:0005165,0.145294371365632,0.989895305029188,1,11,neurotrophin receptor binding,MF,PIK3R1
3535,GO:0006924,0.145474088269286,0.989869553011299,1,11,activation-induced cell death of T cells,BP,AKT1
4777,GO:0010324,0.145537314092656,0.970346471382179,2,48,membrane invagination,BP,MFGE8;SNX18
13208,GO:0048340,0.145553155918155,0.989954875860313,1,10,paraxial mesoderm morphogenesis,BP,WNT5A
9765,GO:0035306,0.145590891988897,0.970383731191118,2,45,positive regulation of dephosphorylation,BP,ADORA1;BMP2
11937,GO:0044843,0.145622616319468,0.933961132839369,6,249,cell cycle G1/S phase transition,BP,GADD45A;ACVR1;FGF10;CDKN1A;AKT1;PIM2
11903,GO:0044773,0.145707315585913,0.956669528516439,3,94,mitotic DNA damage checkpoint,BP,GADD45A;FOXO4;CDKN1A
20967,GO:2000047,0.145750428065301,0.989829887926543,1,11,regulation of cell-cell adhesion mediated by cadherin,BP,WNT5A
12132,GO:0045309,0.14577538431769,0.970343733831326,2,44,protein phosphorylated amino acid binding,MF,PIK3R2;PIK3R1
8776,GO:0032836,0.145852550153721,0.989912271781883,1,10,glomerular basement membrane development,BP,WT1
4607,GO:0009636,0.145881444558623,0.93950863488976,5,214,response to toxic substance,BP,SESN2;BMP7;CDKN1A;CDH1;CLDN1
11921,GO:0044801,0.146031407226536,0.939490270463174,5,192,single-organism membrane fusion,BP,SYT5;SERPINA5;RAB39A;RAB20;VAMP1
10619,GO:0042033,0.146072071486063,0.989575311012825,1,14,chemokine biosynthetic process,BP,WNT5A
19204,GO:1902547,0.146218242046085,0.989762551875356,1,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,DLL1
3812,GO:0007440,0.146331015151112,0.98984398725273,1,10,foregut morphogenesis,BP,NOTCH1
7357,GO:0030280,0.146443498441857,0.989520676125659,1,14,structural constituent of epidermis,MF,PKP1
12448,GO:0045955,0.146449512249704,0.989827038095628,1,10,negative regulation of calcium ion-dependent exocytosis,BP,NOTCH1
4920,GO:0010660,0.146462069576724,0.970062657992479,2,47,regulation of muscle cell apoptotic process,BP,EDN1;BMP7
7434,GO:0030414,0.146720246301553,0.946351472861495,4,172,peptidase inhibitor activity,MF,CRB2;SERPINA5;CST9L;GAS6
7540,GO:0030669,0.147011469185469,0.969832173037813,2,50,clathrin-coated endocytic vesicle membrane,CC,WNT5A;HBEGF
12009,GO:0045078,0.147079209424926,0.989555826927265,1,12,positive regulation of interferon-gamma biosynthetic process,BP,ZFPM1
12347,GO:0045779,0.147086898075075,0.989554702527893,1,12,negative regulation of bone resorption,BP,CLDN18
8766,GO:0032823,0.147162174503416,0.989543690604538,1,12,regulation of natural killer cell differentiation,BP,GAS6
15184,GO:0060767,0.147372225868818,0.98959544256984,1,11,epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
7315,GO:0030218,0.147489895586979,0.955903226621122,3,94,erythrocyte differentiation,BP,ZFPM1;BMP4;SFXN1
5126,GO:0010951,0.1475704788274,0.938561290826664,5,225,negative regulation of endopeptidase activity,BP,CRB2;SERPINA5;AKT1;CST9L;GAS6
9174,GO:0033690,0.147888820519251,0.989520169048747,1,11,positive regulation of osteoblast proliferation,BP,BMP2
7526,GO:0030641,0.148030213095351,0.955686068836311,3,92,regulation of cellular pH,BP,RAB39A;RAB20;RAB38
6448,GO:0018958,0.148281900472136,0.955569243597927,3,93,phenol-containing compound metabolic process,BP,PNMT;WNT5A;NPR1
17331,GO:0090009,0.14838738610904,0.989447249576238,1,11,primitive streak formation,BP,WNT5A
21322,GO:2000586,0.148406838537757,0.989544902767283,1,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
6668,GO:0019693,0.148669646078172,0.917193655147416,10,535,ribose phosphate metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
10162,GO:0035987,0.148754309172336,0.969349141428248,2,45,endodermal cell differentiation,BP,ITGA5;ITGB5
7786,GO:0031122,0.149170124451728,0.969232733609755,2,44,cytoplasmic microtubule organization,BP,TUBG2;AXIN1
21459,GO:2000786,0.149224132599887,0.98942588249854,1,10,positive regulation of autophagosome assembly,BP,RALB
6924,GO:0021695,0.149327100970335,0.969160290231855,2,45,cerebellar cortex development,BP,WNT7A;DLL1
12364,GO:0045820,0.149750778583445,0.98924647118175,1,11,negative regulation of glycolytic process,BP,ACTN3
13936,GO:0051195,0.149750778583445,0.98924647118175,1,11,negative regulation of cofactor metabolic process,BP,ACTN3
13939,GO:0051198,0.149750778583445,0.98924647118175,1,11,negative regulation of coenzyme metabolic process,BP,ACTN3
14149,GO:0051580,0.149891992589261,0.989140194804837,1,12,regulation of neurotransmitter uptake,BP,GDNF
15336,GO:0061050,0.149982600031614,0.98912666305789,1,12,regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
13368,GO:0048704,0.15010080896543,0.954780770739784,3,93,embryonic skeletal system morphogenesis,BP,AXIN1;BMP7;BMP4
11270,GO:0043220,0.150371074400073,0.989154458990195,1,11,Schmidt-Lanterman incisure,CC,JAM3
19338,GO:1902894,0.150874290096371,0.989183392732696,1,10,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB
12073,GO:0045185,0.151196858398694,0.954303394642665,3,93,maintenance of protein location,BP,SPTBN4;SCIN;AKT1
2851,GO:0005881,0.151275119462357,0.96847512177926,2,47,cytoplasmic microtubule,CC,TUBG2;RAB3D
4987,GO:0010763,0.151293303583865,0.989016889378186,1,11,positive regulation of fibroblast migration,BP,AKT1
9902,GO:0035567,0.151336149699129,0.94412747034748,4,149,non-canonical Wnt signaling pathway,BP,WNT4;WNT7A;FZD7;WNT5A
1063,GO:0002429,0.151375398851828,0.925761750055953,7,318,immune response-activating cell surface receptor signaling pathway,BP,PRKACB;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
2876,GO:0005916,0.151381168009565,0.989108320639649,1,10,fascia adherens,CC,CDH2
13325,GO:0048641,0.151425020465619,0.968444454200008,2,46,regulation of skeletal muscle tissue development,BP,ACTN3;DLL1
13244,GO:0048484,0.15145181100466,0.988993151937061,1,11,enteric nervous system development,BP,GDNF
8402,GO:0032310,0.1515040142742,0.988824368968401,1,13,prostaglandin secretion,BP,EDN1
17353,GO:0090051,0.151679525237697,0.988959002703031,1,11,negative regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
1122,GO:0002523,0.151810117670836,0.988714358762253,1,14,leukocyte migration involved in inflammatory response,BP,JAM3
10313,GO:0036312,0.151892838007666,0.989032258846644,1,10,phosphatidylinositol 3-kinase regulatory subunit binding,MF,PIK3R1
12893,GO:0046950,0.151916605555212,0.988923389155396,1,11,cellular ketone body metabolic process,BP,HMGCS2
13636,GO:0050755,0.152043633880044,0.988623449210195,1,15,chemokine metabolic process,BP,WNT5A
7764,GO:0031094,0.152076396264429,0.989004903588659,1,10,platelet dense tubular network,CC,SERPINA5
6674,GO:0019722,0.152152432420131,0.943725212832909,4,147,calcium-mediated signaling,BP,ACTN3;CASQ2;EDN1;CCL20
2982,GO:0006089,0.152402345203939,0.988761975040125,1,12,lactate metabolic process,BP,ACTN3
21248,GO:2000484,0.152415119723786,0.98868539885517,1,13,positive regulation of interleukin-8 secretion,BP,WNT5A
15689,GO:0070016,0.152738416722858,0.988905943182051,1,10,armadillo repeat domain binding,MF,AXIN1
430,GO:0001104,0.152793514177142,0.953604960697679,3,93,RNA polymerase II transcription cofactor activity,MF,POU3F1;TLE1;SIN3B
3306,GO:0006584,0.152830460789121,0.967918374705385,2,49,catecholamine metabolic process,BP,PNMT;NPR1
4621,GO:0009712,0.152830460789121,0.967918374705385,2,49,catechol-containing compound metabolic process,BP,PNMT;NPR1
3641,GO:0007093,0.152848292285372,0.943373952259017,4,147,mitotic cell cycle checkpoint,BP,GADD45A;FOXO4;HRAS;CDKN1A
20001,GO:1904262,0.152895917967362,0.98877563350407,1,11,negative regulation of TORC1 signaling,BP,SESN2
12353,GO:0045793,0.152951431475547,0.988767226623221,1,11,positive regulation of cell size,BP,EDN1
17248,GO:0086008,0.153022616047887,0.988756441643936,1,11,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,KCNH2
17709,GO:0097038,0.153297746129829,0.988714705702576,1,11,perinuclear endoplasmic reticulum,CC,PIK3R1
11783,GO:0044406,0.15343993414096,0.988693104222181,1,11,adhesion of symbiont to host,BP,GAS6
3593,GO:0007016,0.153609513833856,0.988775010755676,1,10,cytoskeletal anchoring at plasma membrane,BP,SPTBN4
2178,GO:0004702,0.153634558786533,0.953289518195027,3,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,ACVR1;MAPK12;ARAF
846,GO:0002043,0.153655322717807,0.98866034012825,1,11,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,BMP4
4102,GO:0008360,0.153864307920792,0.94288890711769,4,141,regulation of cell shape,BP,RHOQ;RHOJ;MSN;PARVB
9677,GO:0035090,0.153973746301869,0.988521718564737,1,12,maintenance of apical/basal cell polarity,BP,CRB2
12083,GO:0045199,0.153973746301869,0.988521718564737,1,12,maintenance of epithelial cell apical/basal polarity,BP,CRB2
16474,GO:0071435,0.153991479174919,0.988518991912951,1,12,potassium ion export,BP,KCNH2
5231,GO:0014704,0.154060099552711,0.967561330099322,2,46,intercalated disc,CC,DSC2;CDH2
19411,GO:1903019,0.154135204531864,0.988420547596869,1,13,negative regulation of glycoprotein metabolic process,BP,HBEGF
3503,GO:0006878,0.154364150090633,0.988385049921937,1,13,cellular copper ion homeostasis,BP,PRND
5827,GO:0016236,0.154432025948231,0.928805920166811,6,252,macroautophagy,BP,RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1
11938,GO:0044848,0.154456063850562,0.988538092175452,1,11,biological phase,BP,WNT5A
10700,GO:0042180,0.154554471937034,0.934736636345074,5,217,cellular ketone metabolic process,BP,WNT4;DKK3;BMP6;BMP2;AKT1
3456,GO:0006801,0.154802934124305,0.967171988674874,2,54,superoxide metabolic process,BP,EDN1;BMP7
15809,GO:0070228,0.154896257008769,0.967140311141336,2,54,regulation of lymphocyte apoptotic process,BP,WNT5A;BMP4
1266,GO:0002763,0.155017593164853,0.967162926009833,2,50,positive regulation of myeloid leukocyte differentiation,BP,LIF;KITLG
9276,GO:0034116,0.155373642853208,0.988305407002662,1,12,positive regulation of heterotypic cell-cell adhesion,BP,BMP7
12429,GO:0045930,0.155475124255228,0.928162965670922,6,264,negative regulation of mitotic cell cycle,BP,GADD45A;FOXO4;HRAS;BMP7;BMP4;CDKN1A
2842,GO:0005865,0.155754337628848,0.9879930867811,1,16,striated muscle thin filament,CC,FHOD3
19348,GO:1902911,0.156078986919565,0.952148071655723,3,94,protein kinase complex,CC,ACVR1;SESN2;CDKN1A
16424,GO:0071360,0.156691300071468,0.988099839257496,1,12,cellular response to exogenous dsRNA,BP,RALB
8434,GO:0032370,0.157016163041202,0.966432744934531,2,53,positive regulation of lipid transport,BP,EDN1;BMP6
8018,GO:0031581,0.1570559810829,0.988136353601673,1,11,hemidesmosome assembly,BP,ITGB4
19037,GO:1902115,0.157104654271355,0.941241004780741,4,141,regulation of organelle assembly,BP,EDN1;RALB;SDC4;MSN
11420,GO:0043476,0.157696213333541,0.987941780660448,1,12,pigment accumulation,BP,RAB38
11421,GO:0043482,0.157696213333541,0.987941780660448,1,12,cellular pigment accumulation,BP,RAB38
15001,GO:0060491,0.157707575648381,0.940927688127986,4,142,regulation of cell projection assembly,BP,HRAS;RHOQ;ESPN;RAB17
1486,GO:0003207,0.158060568970901,0.987884198327705,1,12,cardiac chamber formation,BP,NOTCH1
19307,GO:1902806,0.158118890036607,0.940687636961808,4,148,regulation of cell cycle G1/S phase transition,BP,GADD45A;FGF10;CDKN1A;AKT1
981,GO:0002285,0.158351386605351,0.94053690955416,4,155,lymphocyte activation involved in immune response,BP,RAB27A;ZFPM1;CLCF1;DLL1
795,GO:0001973,0.15850757059127,0.987813355117962,1,12,adenosine receptor signaling pathway,BP,ADORA1
4755,GO:0010212,0.158723355016222,0.940397209884283,4,144,response to ionizing radiation,BP,GADD45A;HRAS;RHOB;CDKN1A
10151,GO:0035970,0.159020479526705,0.987827907103526,1,11,peptidyl-threonine dephosphorylation,BP,DUSP5
13989,GO:0051280,0.159085694928014,0.987640078410552,1,13,negative regulation of release of sequestered calcium ion into cytosol,BP,CASQ2
20972,GO:2000052,0.159286302670001,0.987785845956271,1,11,positive regulation of non-canonical Wnt signaling pathway,BP,WNT5A
14196,GO:0051656,0.159331157880899,0.913112860420402,9,416,establishment of organelle localization,BP,SYT5;RAB27A;WNT7A;FGF10;PSRC1;CHGA;RAB17;MYO7A;PIK3CG
17725,GO:0097062,0.159497719875007,0.987655647190356,1,12,dendritic spine maintenance,BP,ITGA3
13721,GO:0050872,0.159874224534713,0.98751325884363,1,13,white fat cell differentiation,BP,FGF10
3817,GO:0007494,0.160152107167372,0.987648313423689,1,11,midgut development,BP,WNT5A
21559,GO:2001053,0.160381873158772,0.987513908314473,1,12,regulation of mesenchymal cell apoptotic process,BP,BMP7
18895,GO:1901678,0.160397911339363,0.987511329262543,1,12,iron coordination entity transport,BP,FLVCR2
6912,GO:0021681,0.160477129044652,0.987498586334364,1,12,cerebellar granular layer development,BP,WNT7A
4877,GO:0010605,0.160572430071098,0.87940214351132,39,2423,negative regulation of macromolecule metabolic process,BP,LIF;WNT4;NOTCH1;ITGB8;GADD45A;CRB2;SERPINA5;ZFPM1;DKK3;EDN1;PRR5L;PDGFB;PRKAR1B;HRAS;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;CTGF;AKT1;PKP3;PKP1;NPPC;CST9L;NAB2;INHBB;TLE1;GAS6;SIN3B;VDR;FZD8;DUSP5;HEY1
5116,GO:0010935,0.16057306728849,0.987483144470002,1,12,regulation of macrophage cytokine production,BP,WNT5A
13733,GO:0050890,0.160621397787338,0.92514706355202,6,246,cognition,BP,ITGA3;ITGA5;STRA6;ADORA1;PRKAR1B;CLDN5
16375,GO:0071285,0.160812265590596,0.987361494562897,1,13,cellular response to lithium ion,BP,CDH1
15026,GO:0060536,0.160941300025894,0.98742378070928,1,12,cartilage morphogenesis,BP,WNT7B
7266,GO:0030157,0.161363820880653,0.987271802891818,1,13,pancreatic juice secretion,BP,WNK4
12189,GO:0045453,0.161369656894095,0.964962795669547,2,51,bone resorption,BP,RAB3D;CLDN18
12183,GO:0045428,0.161483985532247,0.964905722381467,2,52,regulation of nitric oxide biosynthetic process,BP,EDN1;AKT1
3555,GO:0006955,0.16151553460327,0.883565810931501,29,1821,immune response,BP,LIF;NOTCH1;RAB27A;CRISPLD2;ZFPM1;EDN1;PLAU;PRKACB;CCL20;TYRO3;PIK3R2;PIK3R1;HRAS;WNT5A;JAM3;CLCF1;BMP6;DLL1;CHGA;PKP1;RAB17;BCAR1;RAB44;CLDN1;PIK3CA;PIK3CG;GAS6;RAB3D;PDE4B
8221,GO:0031994,0.161611192018157,0.987315401468378,1,12,insulin-like growth factor I binding,MF,ITGB4
8733,GO:0032785,0.161684355227719,0.987303534625946,1,12,negative regulation of DNA-templated transcription, elongation,BP,AXIN1
10668,GO:0042130,0.162000741134886,0.964742794679554,2,51,negative regulation of T cell proliferation,BP,SDC4;BMP4
16286,GO:0071071,0.162006191988771,0.987251263416717,1,12,regulation of phospholipid biosynthetic process,BP,PDGFB
17307,GO:0086080,0.162052398364045,0.987343571500766,1,11,protein binding involved in heterotypic cell-cell adhesion,MF,DSC2
9148,GO:0033631,0.162118586407914,0.987232981850463,1,12,cell-cell adhesion mediated by integrin,BP,ITGA5
10890,GO:0042531,0.162344184254749,0.964513812204554,2,58,positive regulation of tyrosine phosphorylation of STAT protein,BP,LIF;CLCF1
20618,GO:1905809,0.162392945997485,0.987188297056061,1,12,negative regulation of synapse organization,BP,WNT5A
9026,GO:0033270,0.162416224914328,0.987284773895265,1,11,paranode region of axon,CC,SPTBN4
7636,GO:0030877,0.16250099283416,0.987271053748117,1,11,beta-catenin destruction complex,CC,AXIN1
16430,GO:0071372,0.162530974129869,0.987266199221907,1,11,cellular response to follicle-stimulating hormone stimulus,BP,NOTCH1
15136,GO:0060707,0.162636917387053,0.98714849158522,1,12,trophoblast giant cell differentiation,BP,LIF
10787,GO:0042362,0.162637010733017,0.987063469976461,1,13,fat-soluble vitamin biosynthetic process,BP,VDR
14908,GO:0060379,0.16272438861301,0.987234858087025,1,11,cardiac muscle cell myoblast differentiation,BP,NOTCH1
7378,GO:0030307,0.162748769159631,0.938287123224473,4,151,positive regulation of cell growth,BP,WNT3;EDN1;HBEGF;AKT1
4890,GO:0010623,0.162840116499648,0.987030068751539,1,13,programmed cell death involved in cell development,BP,KITLG
14361,GO:0051967,0.162935506802919,0.986941286657913,1,14,negative regulation of synaptic transmission, glutamatergic,BP,ADORA1
15930,GO:0070411,0.163068614921471,0.98717897744133,1,11,I-SMAD binding,MF,AXIN1
20321,GO:1904950,0.163114160084226,0.929976483922394,5,205,negative regulation of establishment of protein localization,BP,RHOQ;BMP7;INHBB;RAB11FIP1;GAS6
19421,GO:1903036,0.163127589214979,0.964314210867721,2,53,positive regulation of response to wounding,BP,HRAS;HBEGF
2429,GO:0005057,0.163150457429933,0.93814569861808,4,138,signal transducer activity, downstream of receptor,MF,ACVR1;MAPK12;TYRO3;ARAF
17850,GO:0097286,0.163655303153587,0.986981623578434,1,12,iron ion import,BP,TF
10585,GO:0040013,0.163813562284158,0.923216776276362,6,253,negative regulation of locomotion,BP,WNT3;WNT4;NOTCH1;ADORA1;WNT5A;RHOB
9691,GO:0035112,0.163915020704402,0.986852532753111,1,13,genitalia morphogenesis,BP,FGF10
6105,GO:0016775,0.164011014666941,0.986836615293409,1,13,phosphotransferase activity, nitrogenous group as acceptor,MF,KCNH2
15018,GO:0060525,0.164197317488604,0.986994832481972,1,11,prostate glandular acinus development,BP,NOTCH1
5742,GO:0016050,0.164317779073539,0.9134256405693,8,365,vesicle organization,BP,SYT5;RAB27A;RAB39A;SDC4;RAB20;VAMP1;MYO7A;RAB38
18824,GO:1901550,0.164378170148337,0.986862480253701,1,12,regulation of endothelial cell development,BP,CLDN5
19465,GO:1903140,0.164378170148337,0.986862480253701,1,12,regulation of establishment of endothelial barrier,BP,CLDN5
13391,GO:0048747,0.164734242947867,0.96380193180629,2,50,muscle fiber development,BP,BMP4;MYH11
11990,GO:0045056,0.164742068038262,0.986802283008221,1,12,transcytosis,BP,RAB17
13504,GO:0050321,0.164744113847486,0.986801944167861,1,12,tau-protein kinase activity,MF,MARK4
20227,GO:1904754,0.164957146048274,0.986870077982412,1,11,positive regulation of vascular associated smooth muscle cell migration,BP,PDGFB
17972,GO:0097531,0.165204597874759,0.986637839505926,1,13,mast cell migration,BP,CHGA
16395,GO:0071320,0.165269756794605,0.963673416177425,2,47,cellular response to cAMP,BP,WT1;PIK3CG
4917,GO:0010657,0.165282575925185,0.963589734473487,2,51,muscle cell apoptotic process,BP,EDN1;BMP7
4666,GO:0009886,0.16533970451462,0.986615238999702,1,13,post-embryonic animal morphogenesis,BP,MYO7A
19078,GO:1902224,0.165455480894623,0.986683841069086,1,12,ketone body metabolic process,BP,HMGCS2
641,GO:0001771,0.165577446668362,0.986575420190089,1,13,immunological synapse formation,BP,MSN
10089,GO:0035859,0.165641328729603,0.986652893473617,1,12,Seh1-associated complex,CC,SESN2
7725,GO:0031045,0.165707359909806,0.986641888642246,1,12,dense core granule,CC,SYT5
2534,GO:0005244,0.165943746226251,0.928416515878896,5,192,voltage-gated ion channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
7131,GO:0022832,0.165943746226251,0.928416515878896,5,192,voltage-gated channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
6811,GO:0021510,0.165968513971168,0.947662374875035,3,98,spinal cord development,BP,NOTCH1;DLL1;AKT1
4778,GO:0010332,0.166053674755122,0.963298643407097,2,52,response to gamma radiation,BP,HRAS;CDKN1A
11449,GO:0043517,0.166327323984149,0.986449411143698,1,13,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
8955,GO:0033141,0.166428150349557,0.98602633310359,1,21,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
17583,GO:0090399,0.166473833200975,0.986513792555017,1,12,replicative senescence,BP,CDKN1A
11258,GO:0043201,0.166562209552604,0.986604452323092,1,11,response to leucine,BP,SESN2
13998,GO:0051291,0.166581408710125,0.947243104691291,3,118,protein heterooligomerization,BP,HRAS;CLDN1;CLDN3
4808,GO:0010466,0.166633912053161,0.927893549150094,5,235,negative regulation of peptidase activity,BP,CRB2;SERPINA5;AKT1;CST9L;GAS6
11267,GO:0043217,0.166665522761767,0.986481654461767,1,12,myelin maintenance,BP,AKT1
16677,GO:0071786,0.166709600353034,0.986474258762769,1,12,endoplasmic reticulum tubular network organization,BP,REEP1
15815,GO:0070234,0.16676427710864,0.986232823586581,1,15,positive regulation of T cell apoptotic process,BP,WNT5A
13234,GO:0048407,0.166767263300034,0.986570312515908,1,11,platelet-derived growth factor binding,MF,PDGFB
4584,GO:0009566,0.166809236411298,0.936105051291889,4,166,fertilization,BP,IGSF8;SERPINA5;MFGE8;SPTBN4
18480,GO:1900103,0.167224267140367,0.986297862704679,1,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
6773,GO:0019934,0.16725076549188,0.986383281339589,1,12,cGMP-mediated signaling,BP,GUCY1B3
10923,GO:0042581,0.167254852307482,0.935913847039748,4,156,specific granule,CC,RAB27A;PLAU;VAMP1;RAB44
10132,GO:0035930,0.167307539702472,0.986206685715237,1,14,corticosteroid hormone secretion,BP,BMP6
21498,GO:2000846,0.167307539702472,0.986206685715237,1,14,regulation of corticosteroid hormone secretion,BP,BMP6
5643,GO:0015850,0.167481344158951,0.927473087926518,5,212,organic hydroxy compound transport,BP,ADRA2B;ADRA2C;BMP6;CHGA;GDNF
12276,GO:0045651,0.1676169906731,0.98623122407949,1,13,positive regulation of macrophage differentiation,BP,LIF
3830,GO:0007519,0.167707367408285,0.935719796380493,4,147,skeletal muscle tissue development,BP,ACTN3;NOTCH1;IGSF8;DLL1
865,GO:0002070,0.167769778953377,0.986205251752188,1,13,epithelial cell maturation,BP,CDKN1A
10465,GO:0038065,0.167791175922297,0.986399143437317,1,11,collagen-activated signaling pathway,BP,DDR1
7310,GO:0030213,0.168071008651392,0.986244764985469,1,12,hyaluronan biosynthetic process,BP,PDGFB
4913,GO:0010649,0.16811223749108,0.986237782780221,1,12,regulation of cell communication by electrical coupling,BP,CASQ2
6231,GO:0017017,0.168125400242329,0.986144698684572,1,13,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP5
14809,GO:0060253,0.168400169931286,0.986097815406044,1,13,negative regulation of glial cell proliferation,BP,NOTCH1
9265,GO:0034101,0.16851439600725,0.946461472089952,3,102,erythrocyte homeostasis,BP,ZFPM1;BMP4;SFXN1
18239,GO:0098915,0.168765524610923,0.986126893950992,1,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,KCNH2
3322,GO:0006605,0.168875471929279,0.898170482240047,12,662,protein targeting,BP,RAB27A;ADORA1;FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
1073,GO:0002440,0.168937310614109,0.935011528436141,4,160,production of molecular mediator of immune response,BP,WNT5A;CLCF1;CHGA;GAS6
624,GO:0001741,0.169023104625079,0.985991211808221,1,13,XY body,CC,SIN3B
7901,GO:0031344,0.169133810771616,0.900521013830445,11,527,regulation of cell projection organization,BP,ITGA3;WNT3;WNT7A;HRAS;WNT5A;RHOQ;BMP7;ESPN;AKT1;RAB17;LZTS1
5455,GO:0015271,0.169496949407861,0.986002176822716,1,12,outward rectifier potassium channel activity,MF,KCND1
17242,GO:0086002,0.169538291893213,0.962154303457232,2,47,cardiac muscle cell action potential involved in contraction,BP,DSC2;KCNH2
8474,GO:0032413,0.169619722108734,0.961972702204236,2,55,negative regulation of ion transmembrane transporter activity,BP,ACTN2;CASQ2
5291,GO:0014854,0.169768188322245,0.98586313235935,1,13,response to inactivity,BP,ACTN3
5310,GO:0014889,0.1700299655124,0.985817984911338,1,13,muscle atrophy,BP,ACTN3
7816,GO:0031223,0.170107432069831,0.985897624270762,1,12,auditory behavior,BP,STRA6
17330,GO:0090005,0.170341194088329,0.985857479383908,1,12,negative regulation of establishment of protein localization to plasma membrane,BP,RHOQ
13062,GO:0048008,0.170525614085304,0.961799322635756,2,47,platelet-derived growth factor receptor signaling pathway,BP,PDGFB;BCAR1
7196,GO:0030031,0.170745675158857,0.902211081205484,10,474,cell projection assembly,BP,ACTN2;NOTCH1;MARK4;TTYH1;HRAS;RHOQ;ESPN;RAB17;LAMA5;PARVB
13648,GO:0050771,0.170951025225316,0.961602633556414,2,49,negative regulation of axonogenesis,BP,WNT3;WNT5A
14883,GO:0060347,0.171112394909871,0.985549871936401,1,14,heart trabecula formation,BP,HEY1
2639,GO:0005513,0.171225269661854,0.985610856994352,1,13,detection of calcium ion,BP,CASQ2
16369,GO:0071277,0.171240807880992,0.961457932501265,2,51,cellular response to calcium ion,BP,EDN1;WNT5A
6229,GO:0017015,0.171252819710978,0.945236451359765,3,97,regulation of transforming growth factor beta receptor signaling pathway,BP,ITGA3;RASL11B;DKK3
1253,GO:0002739,0.17132961689138,0.985511880412508,1,14,regulation of cytokine secretion involved in immune response,BP,WNT5A
11904,GO:0044774,0.171486197242578,0.945093975692354,3,101,mitotic DNA integrity checkpoint,BP,GADD45A;FOXO4;CDKN1A
12059,GO:0045161,0.171966793580934,0.985576617398722,1,12,neuronal ion channel clustering,BP,SPTBN4
7647,GO:0030888,0.172061103374767,0.961072658106753,2,56,regulation of B cell proliferation,BP,CLCF1;CDKN1A
11251,GO:0043194,0.172528063187364,0.985478956845549,1,12,axon initial segment,CC,SPTBN4
5225,GO:0014069,0.172536976034152,0.924648225843606,5,190,postsynaptic density,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
11019,GO:0042754,0.172552975895278,0.985378899459242,1,13,negative regulation of circadian rhythm,BP,ADORA1
7656,GO:0030898,0.172684832814677,0.985451615912444,1,12,actin-dependent ATPase activity,MF,MYO7A
1415,GO:0003085,0.172791146396143,0.985254873651337,1,14,negative regulation of systemic arterial blood pressure,BP,KCNK6
13993,GO:0051284,0.173032377768918,0.985212220861555,1,14,positive regulation of sequestering of calcium ion,BP,CASQ2
17747,GO:0097110,0.173304395247661,0.960728027182539,2,50,scaffold protein binding,MF,KCNH2;DLL1
18747,GO:1901264,0.173314464388041,0.960649105983097,2,54,carbohydrate derivative transport,BP,ADORA1;GJB1
756,GO:0001931,0.173395244532005,0.985230719793503,1,13,uropod,CC,MSN
7834,GO:0031254,0.173395244532005,0.985230719793503,1,13,cell trailing edge,CC,MSN
9425,GO:0034394,0.173642513692209,0.960565460707557,2,52,protein localization to cell surface,BP,ACTN2;FGF10
13744,GO:0050905,0.173663001496564,0.944113544002274,3,97,neuromuscular process,BP,CDH23;STRA6;MYO7A
16476,GO:0071437,0.173935147004342,0.985232571325843,1,12,invadopodium,CC,ITGA3
4990,GO:0010766,0.174001968799273,0.98512348287499,1,13,negative regulation of sodium ion transport,BP,WNK4
13867,GO:0051099,0.174087547511782,0.932313820488361,4,153,positive regulation of binding,BP,RALB;WNT5A;BMP4;BMP2
16798,GO:0072015,0.174257102626935,0.985175883098144,1,12,glomerular visceral epithelial cell development,BP,BMP4
13606,GO:0050709,0.174286191823688,0.943754998512612,3,105,negative regulation of protein secretion,BP,INHBB;RAB11FIP1;GAS6
17769,GO:0097152,0.174307140979041,0.985069387245619,1,13,mesenchymal cell apoptotic process,BP,BMP7
3761,GO:0007292,0.174441904406957,0.943689777751742,3,104,female gamete generation,BP,WNT4;NPPC;INHBB
885,GO:0002093,0.174462615387505,0.985041786951878,1,13,auditory receptor cell morphogenesis,BP,MYO7A
18040,GO:0097755,0.174465481542962,0.960210494303333,2,55,positive regulation of blood vessel diameter,BP,ADORA1;NPPC
22,GO:0000041,0.17455886826573,0.943619438504326,3,106,transition metal ion transport,BP,TF;TTYH1;SFXN1
9916,GO:0035584,0.174834646543415,0.984754824409312,1,16,calcium-mediated signaling using intracellular calcium source,BP,CCL20
7930,GO:0031406,0.174971320916538,0.93179975968823,4,162,carboxylic acid binding,MF,GLDC;SERPINA5;SESN2;VDR
989,GO:0002295,0.175090120247607,0.984772591608477,1,15,T-helper cell lineage commitment,BP,ZFPM1
12834,GO:0046851,0.175142994278857,0.98483621916908,1,14,negative regulation of bone remodeling,BP,CLDN18
12217,GO:0045576,0.175242256178494,0.959924982548436,2,55,mast cell activation,BP,CHGA;PIK3CG
5005,GO:0010804,0.175440104931256,0.984645291727909,1,16,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
7418,GO:0030374,0.175467035761705,0.959936232427511,2,50,ligand-dependent nuclear receptor transcription coactivator activity,MF,ACTN2;ZCCHC12
18033,GO:0097731,0.175503756576498,0.943224042112171,3,100,9+0 non-motile cilium,CC,RAB27A;SPTBN5;MYO7A
18035,GO:0097733,0.175503756576498,0.943224042112171,3,100,photoreceptor cell cilium,CC,RAB27A;SPTBN5;MYO7A
7022,GO:0021889,0.17555794457989,0.984846565705833,1,13,olfactory bulb interneuron differentiation,BP,WNT5A
14976,GO:0060457,0.175759298389834,0.984587377630359,1,16,negative regulation of digestive system process,BP,WNK4
11156,GO:0043032,0.175797902291907,0.984644817366621,1,15,positive regulation of macrophage activation,BP,WNT5A
18711,GO:1901201,0.175992674178372,0.984868284446984,1,12,regulation of extracellular matrix assembly,BP,NOTCH1
14443,GO:0052548,0.176127512318911,0.910134764832827,7,358,regulation of endopeptidase activity,BP,PMAIP1;CRB2;SERPINA5;CTGF;AKT1;CST9L;GAS6
18355,GO:0099572,0.17623948346311,0.922496596533113,5,192,postsynaptic specialization,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
1452,GO:0003161,0.176386167027703,0.98469804900022,1,13,cardiac conduction system development,BP,NOTCH1
8398,GO:0032305,0.176605252485114,0.984498369051452,1,15,positive regulation of icosanoid secretion,BP,EDN1
21052,GO:2000193,0.176605252485114,0.984498369051452,1,15,positive regulation of fatty acid transport,BP,EDN1
17074,GO:0072521,0.176717135302919,0.897980156921674,10,555,purine-containing compound metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
11880,GO:0044723,0.176904816676955,0.901242645200484,9,436,single-organism carbohydrate metabolic process,BP,ACTN3;PMAIP1;PDGFB;KHK;SESN2;PFKFB3;B3GNT2;AKT1;PIK3CA
13666,GO:0050795,0.176991849189983,0.95917160650813,2,62,regulation of behavior,BP,STRA6;ADORA1
5549,GO:0015672,0.177463906102522,0.897496459514296,10,513,monovalent inorganic cation transport,BP,ACTN2;ADORA1;CASQ2;KCNK6;SPTBN4;KCNH2;WNK4;AKT1;KCNG2;KCND1
14183,GO:0051640,0.177481479227194,0.897516734009802,10,482,organelle localization,BP,SYT5;RAB27A;WNT7A;CDH2;FGF10;PSRC1;CHGA;RAB17;MYO7A;PIK3CG
14309,GO:0051893,0.177624357785632,0.959139941662535,2,50,regulation of focal adhesion assembly,BP,WNT4;SDC4
17390,GO:0090109,0.177624357785632,0.959139941662535,2,50,regulation of cell-substrate junction assembly,BP,WNT4;SDC4
15164,GO:0060742,0.177671401441191,0.984567531375333,1,12,epithelial cell differentiation involved in prostate gland development,BP,NOTCH1
8375,GO:0032274,0.178026528183057,0.984314330731848,1,14,gonadotropin secretion,BP,INHBB
19809,GO:1903844,0.178059654619292,0.942026687950256,3,99,regulation of cellular response to transforming growth factor beta stimulus,BP,ITGA3;RASL11B;DKK3
5244,GO:0014733,0.178078233047247,0.984392209523813,1,13,regulation of skeletal muscle adaptation,BP,ACTN3
21081,GO:2000251,0.178161922051339,0.984213892374748,1,15,positive regulation of actin cytoskeleton reorganization,BP,HRAS
11281,GO:0043234,0.178192288303927,0.862176563085981,46,2889,protein complex,CC,ITGA3;ITGA5;WNT3;WNT2;POU3F1;TUBG2;NOTCH1;STRA6;ITGB5;ITGB4;ITGB8;CRB2;SERPINA5;ZFPM1;GUCY1B3;CASQ2;CDH2;PRR5L;PIK3R1;CGN;RALB;SESN2;AXIN1;NPR1;SCIN;CLCF1;SPTB;CDKN1A;ESPN;VAMP1;GJB1;GJB2;GJB6;AKT1;NPPC;CDH1;MYO7A;GJA3;MYH11;VDR;AMOT;LAMA1;LAMA5;FZD8;ACTA2;PDE4B
11241,GO:0043177,0.178223954523427,0.930049220229245,4,163,organic acid binding,MF,GLDC;SERPINA5;SESN2;VDR
3704,GO:0007200,0.178418891272592,0.941775174626289,3,109,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,ACTN2;EDN1;CHGA
10967,GO:0042659,0.178570645338533,0.984302595587112,1,13,regulation of cell fate specification,BP,FZD7
16643,GO:0071688,0.178834476150529,0.984254467688514,1,13,striated muscle myosin thick filament assembly,BP,MYH11
14193,GO:0051651,0.179016967045507,0.941546508858641,3,102,maintenance of location in cell,BP,SPTBN4;SCIN;AKT1
7903,GO:0031346,0.179111804944941,0.908307569951538,7,305,positive regulation of cell projection organization,BP,ITGA3;WNT3;HRAS;WNT5A;RHOQ;BMP7;ESPN
879,GO:0002087,0.179125469107902,0.98420129306008,1,13,regulation of respiratory gaseous exchange by neurological system process,BP,ADORA1
6533,GO:0019215,0.179258510513014,0.984176949630234,1,13,intermediate filament binding,MF,PKP1
5580,GO:0015732,0.179415409281196,0.983982801867537,1,15,prostaglandin transport,BP,EDN1
19724,GO:1903671,0.179506408599911,0.984131536403873,1,13,negative regulation of sprouting angiogenesis,BP,NOTCH1
18652,GO:1901018,0.179588986191058,0.98402757918875,1,14,positive regulation of potassium ion transmembrane transporter activity,BP,ACTN2
19632,GO:1903507,0.180131613784989,0.876530918337592,20,1143,negative regulation of nucleic acid-templated transcription,BP,WNT4;NOTCH1;ZFPM1;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
14069,GO:0051428,0.180182678339497,0.983612529961658,1,19,peptide hormone receptor binding,MF,NPPC
21625,GO:2001212,0.180466088743719,0.983865384427741,1,14,regulation of vasculogenesis,BP,HEY1
18953,GO:1901881,0.180536092809271,0.983852401240593,1,14,positive regulation of protein depolymerization,BP,ACTN2
15316,GO:0061029,0.180819067315058,0.983889899724886,1,13,eyelid development in camera-type eye,BP,STRA6
7945,GO:0031432,0.180823984593317,0.983798948849599,1,14,titin binding,MF,ACTN2
12741,GO:0046629,0.181132303193963,0.983831948394675,1,13,gamma-delta T cell activation,BP,JAG2
14592,GO:0055070,0.181211612218777,0.983580023127695,1,16,copper ion homeostasis,BP,PRND
6004,GO:0016580,0.181238724870137,0.983812233994897,1,13,Sin3 complex,CC,SIN3B
11102,GO:0042953,0.181404711654832,0.983690837144965,1,14,lipoprotein transport,BP,UNC119
11955,GO:0044872,0.181404711654832,0.983690837144965,1,14,lipoprotein localization,BP,UNC119
17582,GO:0090398,0.181533392522293,0.957600150881876,2,54,cellular senescence,BP,HRAS;CDKN1A
10659,GO:0042113,0.181574839283317,0.919284736504401,5,218,B cell activation,BP,PIK3R1;CLCF1;CDKN1A;DLL1;TPD52
16912,GO:0072189,0.181606914822571,0.983743927840455,1,13,ureter development,BP,BMP4
5893,GO:0016358,0.18166715342446,0.919315816770036,5,194,dendrite development,BP,WNT7A;BMP7;RAB17;LZTS1;ACSL4
5654,GO:0015868,0.18182848146686,0.98361170148403,1,14,purine ribonucleotide transport,BP,GJB1
18705,GO:1901185,0.181842522160547,0.957522464203212,2,52,negative regulation of ERBB signaling pathway,BP,HBEGF;EPN1
7537,GO:0030665,0.181885352143995,0.940153175484606,3,105,clathrin-coated vesicle membrane,CC,TF;WNT5A;HBEGF
9096,GO:0033549,0.181922766965225,0.983594066392043,1,14,MAP kinase phosphatase activity,MF,DUSP5
3528,GO:0006910,0.182178717512365,0.983466984642656,1,15,phagocytosis, recognition,BP,MFGE8
13731,GO:0050885,0.182230468254647,0.957396827534152,2,51,neuromuscular process controlling balance,BP,CDH23;MYO7A
21151,GO:2000345,0.182624349845119,0.983462522344665,1,14,regulation of hepatocyte proliferation,BP,LIMS2
19183,GO:1902495,0.182719468689922,0.905960702918039,7,310,transmembrane transporter complex,CC,CASQ2;KCNK6;TTYH1;KCNH2;KCNG2;KCND1;PDE4B
19017,GO:1902074,0.182791296755632,0.983431137191056,1,14,response to salt,BP,EDN1
4945,GO:0010715,0.182804730277208,0.983520639440002,1,13,regulation of extracellular matrix disassembly,BP,DDR1
508,GO:0001541,0.182836428638271,0.957089723872273,2,55,ovarian follicle development,BP,KITLG;INHBB
13778,GO:0050961,0.183113335648883,0.983370505078324,1,14,detection of temperature stimulus involved in sensory perception,BP,ADORA1
13780,GO:0050965,0.183113335648883,0.983370505078324,1,14,detection of temperature stimulus involved in sensory perception of pain,BP,ADORA1
8380,GO:0032279,0.183257967914973,0.918379143564018,5,194,asymmetric synapse,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
16423,GO:0071359,0.183302735242095,0.956970857932014,2,52,cellular response to dsRNA,BP,RALB;BMP4
10985,GO:0042698,0.183338070603423,0.93947261281527,3,103,ovulation cycle,BP,TYRO3;KITLG;INHBB
14249,GO:0051770,0.183351297125565,0.983325626120174,1,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL20
5205,GO:0014048,0.183605214196928,0.983277666171902,1,14,regulation of glutamate secretion,BP,ADORA1
11268,GO:0043218,0.183648045093437,0.983269568947933,1,14,compact myelin,CC,JAM3
16685,GO:0071801,0.184080789589893,0.983187639783816,1,14,regulation of podosome assembly,BP,MSN
8493,GO:0032433,0.184419524002101,0.983217023732055,1,13,filopodium tip,CC,TTYH1
2906,GO:0005976,0.18461312904654,0.938894343175937,3,99,polysaccharide metabolic process,BP,PDGFB;B3GNT2;AKT1
12042,GO:0045125,0.184752076366221,0.982978709403085,1,15,bioactive lipid receptor activity,MF,LPAR2
6921,GO:0021692,0.184919817255012,0.983122351940566,1,13,cerebellar Purkinje cell layer morphogenesis,BP,DLL1
15275,GO:0060973,0.185022042682206,0.983008693060405,1,14,cell migration involved in heart development,BP,NOTCH1
10055,GO:0035791,0.185178196177509,0.983073345851247,1,13,platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
2849,GO:0005876,0.185574813985385,0.956106734218905,2,52,spindle microtubule,CC,TUBG2;PSRC1
17455,GO:0090201,0.185895213704093,0.982687274909119,1,16,negative regulation of release of cytochrome c from mitochondria,BP,AKT1
3629,GO:0007067,0.186056728275048,0.894946056243841,9,438,mitotic nuclear division,BP,MARK4;EDN1;TTYH1;PDGFB;SNX18;PSRC1;FGF8;BMP7;BMP4
2514,GO:0005200,0.186106412271169,0.938127605471134,3,104,structural constituent of cytoskeleton,MF,SPTBN4;SPTB;MSN
9421,GO:0034390,0.186221664891095,0.982696431564116,1,15,smooth muscle cell apoptotic process,BP,EDN1
9422,GO:0034391,0.186221664891095,0.982696431564116,1,15,regulation of smooth muscle cell apoptotic process,BP,EDN1
3525,GO:0006906,0.186318697151512,0.925700949011426,4,152,vesicle fusion,BP,SYT5;RAB39A;RAB20;VAMP1
17743,GO:0097106,0.186329166696585,0.982854113433968,1,13,postsynaptic density organization,BP,CDH2
18300,GO:0099084,0.186329166696585,0.982854113433968,1,13,postsynaptic specialization organization,BP,CDH2
874,GO:0002082,0.186526836225177,0.982637500719661,1,15,regulation of oxidative phosphorylation,BP,ACTN3
7330,GO:0030238,0.186614486126333,0.982703619634598,1,14,male sex determination,BP,DHH
5273,GO:0014823,0.186688633723223,0.95558505286336,2,57,response to activity,BP,EDN1;BMP6
10930,GO:0042588,0.186700332436717,0.982603949176489,1,15,zymogen granule,CC,RAB3D
13715,GO:0050866,0.187031089275348,0.925263415330158,4,161,negative regulation of cell activation,BP,TYRO3;PDGFB;SDC4;BMP4
16991,GO:0072310,0.187035936693321,0.982718736576087,1,13,glomerular epithelial cell development,BP,BMP4
15279,GO:0060977,0.187056970319258,0.982714698933158,1,13,coronary vasculature morphogenesis,BP,NOTCH1
11362,GO:0043373,0.187139425446609,0.982445832869316,1,16,CD4-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
10875,GO:0042510,0.18739450727146,0.982331517634439,1,17,regulation of tyrosine phosphorylation of Stat1 protein,BP,LIF
18270,GO:0098984,0.187675202161133,0.915754247093518,5,196,neuron to neuron synapse,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
2002,GO:0004467,0.187837562554351,0.982564495507438,1,13,long-chain fatty acid-CoA ligase activity,MF,ACSL4
16725,GO:0071872,0.18799336597321,0.982534431494044,1,13,cellular response to epinephrine stimulus,BP,PDE4B
16907,GO:0072182,0.187997320027458,0.982533668151399,1,13,regulation of nephron tubule epithelial cell differentiation,BP,LIF
8852,GO:0032963,0.188132246876615,0.937143105455002,3,104,collagen metabolic process,BP,WNT4;BMP4;CTGF
3859,GO:0007600,0.188224925036771,0.881667174880834,13,886,sensory perception,BP,ADRA2C;CDH23;SLC52A3;ADORA1;EDN1;SPTBN4;B3GNT2;ESPN;GJB2;GJB6;MYO7A;GJA3;UNC119
17434,GO:0090179,0.188311027612532,0.982473048536698,1,13,planar cell polarity pathway involved in neural tube closure,BP,WNT5A
10163,GO:0035988,0.188529942033692,0.982332784754858,1,14,chondrocyte proliferation,BP,CTGF
8358,GO:0032239,0.188582484403235,0.982420501817337,1,13,regulation of nucleobase-containing compound transport,BP,ADORA1
2183,GO:0004707,0.18879968322293,0.982280221544423,1,14,MAP kinase activity,MF,MAPK12
13884,GO:0051127,0.189127859600879,0.982314675191522,1,13,positive regulation of actin nucleation,BP,SCIN
5031,GO:0010832,0.189175271568083,0.982121528868259,1,15,negative regulation of myotube differentiation,BP,NOTCH1
19657,GO:1903541,0.189236179144461,0.982109566881551,1,15,regulation of exosomal secretion,BP,SDC4
19659,GO:1903543,0.189236179144461,0.982109566881551,1,15,positive regulation of exosomal secretion,BP,SDC4
8272,GO:0032075,0.189245874097511,0.982107662436151,1,15,positive regulation of nuclease activity,BP,AKT1
12856,GO:0046887,0.189411547819133,0.936453631261281,3,112,positive regulation of hormone secretion,BP,EDN1;BMP6;INHBB
13935,GO:0051194,0.18942962714419,0.982157139070363,1,14,positive regulation of cofactor metabolic process,BP,ACTN3
13938,GO:0051197,0.18942962714419,0.982157139070363,1,14,positive regulation of coenzyme metabolic process,BP,ACTN3
15213,GO:0060831,0.189959323217715,0.982152674798169,1,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
8953,GO:0033139,0.190003763552251,0.981539937662072,1,23,regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
60,GO:0000122,0.190278893154597,0.878080137056276,14,742,negative regulation of transcription from RNA polymerase II promoter,BP,NOTCH1;ZFPM1;EDN1;PDGFB;AXIN1;BMP6;BMP4;BMP2;WT1;TLE1;SIN3B;VDR;FZD8;HEY1
11323,GO:0043297,0.190587911741015,0.954133498404634,2,54,apical junction assembly,BP,CLDN1;CLDN3
4188,GO:0008499,0.19063283043551,0.981920770924857,1,14,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,B3GNT2
460,GO:0001190,0.190707497589669,0.954067298105929,2,55,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,POU3F1;NOTCH1
18180,GO:0098811,0.190707497589669,0.954067298105929,2,55,transcriptional repressor activity, RNA polymerase II activating transcription factor binding,MF,POU3F1;NOTCH1
17849,GO:0097284,0.190984864078413,0.981851296565829,1,14,hepatocyte apoptotic process,BP,PIK3CG
10178,GO:0036010,0.191060842026433,0.981936828390238,1,13,protein localization to endosome,BP,MSN
16647,GO:0071695,0.191405868185855,0.953835319027358,2,53,anatomical structure maturation,BP,WNT5A;BMP2
2490,GO:0005159,0.192123109667732,0.981460636209427,1,16,insulin-like growth factor receptor binding,MF,PIK3R1
1492,GO:0003214,0.192172747630363,0.981615803286578,1,14,cardiac left ventricle morphogenesis,BP,NOTCH1
1283,GO:0002792,0.192227320720259,0.935077981509432,3,111,negative regulation of peptide secretion,BP,INHBB;RAB11FIP1;GAS6
7723,GO:0031034,0.192444082054177,0.98156178209002,1,14,myosin filament assembly,BP,MYH11
17294,GO:0086065,0.192543969670043,0.953412043505343,2,52,cell communication involved in cardiac conduction,BP,DSC2;CASQ2
16633,GO:0071674,0.192724033055855,0.952972398318197,2,77,mononuclear cell migration,BP,CCL20;PDGFB
12003,GO:0045072,0.19291292118873,0.981301835146016,1,16,regulation of interferon-gamma biosynthetic process,BP,ZFPM1
14030,GO:0051348,0.192967665505593,0.899177344234979,7,345,negative regulation of transferase activity,BP,GADD45A;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
15734,GO:0070098,0.19305547984836,0.95285165683678,2,76,chemokine-mediated signaling pathway,BP,EDN1;CCL20
20753,GO:1990351,0.193286101853446,0.899021651498704,7,317,transporter complex,CC,CASQ2;KCNK6;TTYH1;KCNH2;KCNG2;KCND1;PDE4B
9909,GO:0035577,0.193330028336207,0.953003421048067,2,57,azurophil granule membrane,CC,RAB44;RAB3D
12277,GO:0045652,0.193382396651999,0.98070674209676,1,28,regulation of megakaryocyte differentiation,BP,SCIN
3568,GO:0006977,0.193601338175944,0.952861222032197,2,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,GADD45A;CDKN1A
9342,GO:0034236,0.193604191556562,0.981329843996161,1,14,protein kinase A catalytic subunit binding,MF,PRKAR1B
3267,GO:0006544,0.193791441346624,0.981202675060068,1,15,glycine metabolic process,BP,GLDC
3861,GO:0007602,0.193809461312718,0.952779211459174,2,59,phototransduction,BP,NMT2;UNC119
5302,GO:0014874,0.193883648170389,0.98118406758997,1,15,response to stimulus involved in regulation of muscle adaptation,BP,ACTN3
19790,GO:1903798,0.194544061784041,0.981140787743564,1,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
8173,GO:0031902,0.19461198543199,0.933914520551475,3,109,late endosome membrane,CC,TSPAN15;RAB27A;RHOB
2294,GO:0004857,0.194797717661913,0.89791920073834,7,373,enzyme inhibitor activity,MF,NOTCH1;CRB2;SERPINA5;PRKAR1B;CDKN1A;CST9L;GAS6
19262,GO:1902679,0.194816431029164,0.864937096674494,20,1159,negative regulation of RNA biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
21491,GO:2000831,0.194964981508822,0.980815899149047,1,17,regulation of steroid hormone secretion,BP,BMP6
5651,GO:0015865,0.195399495942102,0.980876739536512,1,15,purine nucleotide transport,BP,GJB1
13292,GO:0048569,0.195510431353014,0.98085414233158,1,15,post-embryonic animal organ development,BP,MYO7A
19583,GO:1903391,0.195591538380941,0.952190783083698,2,53,regulation of adherens junction organization,BP,WNT4;SDC4
3643,GO:0007095,0.195773250982163,0.980891978641598,1,14,mitotic G2 DNA damage checkpoint,BP,FOXO4
7947,GO:0031434,0.195877356181538,0.98087082486897,1,14,mitogen-activated protein kinase kinase binding,MF,ARAF
8675,GO:0032693,0.196199407832366,0.980633179106479,1,16,negative regulation of interleukin-10 production,BP,DLL1
734,GO:0001895,0.196334168072114,0.951762459466573,2,60,retina homeostasis,BP,CDH23;TF
12315,GO:0045725,0.196514079027091,0.980649045855623,1,15,positive regulation of glycogen biosynthetic process,BP,AKT1
19740,GO:1903708,0.196831166578215,0.919808634883337,4,162,positive regulation of hemopoiesis,BP,LIF;SCIN;KITLG;GAS6
37,GO:0000075,0.196862786706969,0.910166960191343,5,214,cell cycle checkpoint,BP,GADD45A;FOXO4;HRAS;CDKN1A;AKT1
10344,GO:0036379,0.197060731069068,0.9802641795273,1,19,myofilament,CC,FHOD3
528,GO:0001573,0.197323177682374,0.980482844182494,1,15,ganglioside metabolic process,BP,ITGB8
3887,GO:0007638,0.197409304442153,0.980558072926897,1,14,mechanosensory behavior,BP,STRA6
2214,GO:0004745,0.197523222700548,0.980224715961814,1,18,retinol dehydrogenase activity,MF,BMP2
5292,GO:0014855,0.197707009545917,0.951328999368785,2,54,striated muscle cell proliferation,BP,WNT2;NOTCH1
1601,GO:0003417,0.197979939954268,0.98034736871435,1,15,growth plate cartilage development,BP,NPPC
15193,GO:0060788,0.198636601553907,0.980211406380813,1,15,ectodermal placode formation,BP,AXIN1
16649,GO:0071697,0.198636601553907,0.980211406380813,1,15,ectodermal placode morphogenesis,BP,AXIN1
8544,GO:0032495,0.19865367771045,0.980302006952369,1,14,response to muramyl dipeptide,BP,NOTCH1
12807,GO:0046785,0.198990133681216,0.95077506692645,2,56,microtubule polymerization,BP,TUBG2;PSRC1
17298,GO:0086069,0.199241268319482,0.980180461716268,1,14,bundle of His cell to Purkinje myocyte communication,BP,DSC2
437,GO:0001134,0.199319624653196,0.980164222793192,1,14,transcription factor activity, transcription factor recruiting,MF,LIF
12075,GO:0045187,0.199443219136405,0.979712102214525,1,20,regulation of circadian sleep/wake cycle, sleep,BP,ADORA1
11205,GO:0043124,0.199572861120881,0.950541248881084,2,56,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,BMP7;TLE1
8763,GO:0032816,0.199620369846796,0.979923641201401,1,16,positive regulation of natural killer cell activation,BP,GAS6
17052,GO:0072431,0.199629227037128,0.950444373157449,2,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
19151,GO:1902400,0.199629227037128,0.950444373157449,2,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
6013,GO:0016594,0.199779653486746,0.979973524398722,1,15,glycine binding,MF,GLDC
10097,GO:0035869,0.199787605870653,0.950454966375368,2,56,ciliary transition zone,CC,SPTBN5;MYO7A
10647,GO:0042095,0.199813407277417,0.979809747165167,1,17,interferon-gamma biosynthetic process,BP,ZFPM1
10016,GO:0035729,0.200032555876291,0.979920684354145,1,15,cellular response to hepatocyte growth factor stimulus,BP,BCAR1
13966,GO:0051248,0.200237830418953,0.863370870421072,18,1048,negative regulation of protein metabolic process,BP,LIF;GADD45A;CRB2;SERPINA5;ZFPM1;EDN1;PRR5L;PRKAR1B;SESN2;HBEGF;BMP7;BMP4;CDKN1A;AKT1;CST9L;INHBB;GAS6;DUSP5
16403,GO:0071333,0.200388749526527,0.931018112261367,3,110,cellular response to glucose stimulus,BP,GJB6;PIK3CA;GAS6
16110,GO:0070742,0.200550210293185,0.979812293020882,1,15,C2H2 zinc finger domain binding,MF,WT1
1032,GO:0002363,0.20062128120327,0.979639386863797,1,17,alpha-beta T cell lineage commitment,BP,ZFPM1
8348,GO:0032225,0.201154622051784,0.979600927102102,1,16,regulation of synaptic transmission, dopaminergic,BP,GDNF
17429,GO:0090174,0.201193188012792,0.917371543106216,4,157,organelle membrane fusion,BP,SYT5;RAB39A;RAB20;VAMP1
11538,GO:0043679,0.201264631859264,0.930584904299157,3,109,axon terminus,CC,ADRA2C;ADORA1;VAMP1
3606,GO:0007033,0.201362891334858,0.917275235694563,4,157,vacuole organization,BP,RAB39A;RALB;RAB20;MYO7A
9573,GO:0034704,0.201394034032137,0.94982805663523,2,55,calcium channel complex,CC,CASQ2;PDE4B
17893,GO:0097386,0.201474375089218,0.979617995626627,1,15,glial cell projection,CC,GJB2
15814,GO:0070233,0.201478286948368,0.979457817533739,1,17,negative regulation of T cell apoptotic process,BP,BMP4
20215,GO:1904738,0.201670421087321,0.979673676195441,1,14,vascular associated smooth muscle cell migration,BP,PDGFB
20225,GO:1904752,0.201670421087321,0.979673676195441,1,14,regulation of vascular associated smooth muscle cell migration,BP,PDGFB
8674,GO:0032692,0.201684498052417,0.979347520601238,1,18,negative regulation of interleukin-1 production,BP,GAS6
17433,GO:0090178,0.201774948022164,0.979651713257162,1,14,regulation of establishment of planar polarity involved in neural tube closure,BP,WNT5A
11620,GO:0044065,0.201969587046218,0.979513466170648,1,15,regulation of respiratory system process,BP,ADORA1
6475,GO:0019058,0.202038097361104,0.887988243520494,8,438,viral life cycle,BP,ITGA5;NOTCH1;ITGB5;NMT2;TYRO3;CLDN1;GAS6;EFNB2
7180,GO:0030004,0.202210402327325,0.930133553350687,3,106,cellular monovalent inorganic cation homeostasis,BP,RAB39A;RAB20;RAB38
16512,GO:0071482,0.202274547317649,0.930092029179677,3,107,cellular response to light stimulus,BP,NMT2;PIK3R1;CDKN1A
8479,GO:0032418,0.202653811842759,0.949221449083268,2,60,lysosome localization,BP,CHGA;PIK3CG
2590,GO:0005351,0.202708476488403,0.979356961579664,1,15,sugar:proton symporter activity,MF,SLC45A4
2607,GO:0005402,0.202708476488403,0.979356961579664,1,15,cation:sugar symporter activity,MF,SLC45A4
7706,GO:0031000,0.202866265991173,0.979323456312992,1,15,response to caffeine,BP,CASQ2
20050,GO:1904385,0.202948406693401,0.979220081572581,1,16,cellular response to angiotensin,BP,ACTN2
12902,GO:0046965,0.203096399565567,0.979274536503112,1,15,retinoid X receptor binding,MF,VDR
8396,GO:0032303,0.203214118681726,0.979087375816762,1,17,regulation of icosanoid secretion,BP,EDN1
7827,GO:0031235,0.203239206150279,0.979342692742073,1,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,SPTB
12692,GO:0046530,0.203310493570086,0.949051356156821,2,55,photoreceptor cell differentiation,BP,NOTCH1;MYO7A
2645,GO:0005521,0.203450803916153,0.979199077507242,1,15,lamin binding,MF,PKP1
7722,GO:0031033,0.203561793800922,0.979175415162112,1,15,myosin filament organization,BP,MYH11
8494,GO:0032434,0.204011998305021,0.929220007714,3,106,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,AKT1;ARAF;RNF144A
66,GO:0000132,0.204027651401994,0.978989099798815,1,16,establishment of mitotic spindle orientation,BP,FGF10
1040,GO:0002374,0.204118538959857,0.978892940429066,1,17,cytokine secretion involved in immune response,BP,WNT5A
14658,GO:0060026,0.204368950743703,0.979002894781359,1,15,convergent extension,BP,WNT5A
3796,GO:0007405,0.204678552688469,0.948538315355163,2,53,neuroblast proliferation,BP,ARTN;NOTCH1
16669,GO:0071732,0.204814689308948,0.978819782118079,1,16,cellular response to nitric oxide,BP,GUCY1B3
3731,GO:0007252,0.205051925937893,0.978856312674025,1,15,I-kappaB phosphorylation,BP,AKT1
17045,GO:0072413,0.205511627409504,0.948036750898482,2,61,signal transduction involved in mitotic cell cycle checkpoint,BP,GADD45A;CDKN1A
19152,GO:1902402,0.205511627409504,0.948036750898482,2,61,signal transduction involved in mitotic DNA damage checkpoint,BP,GADD45A;CDKN1A
19153,GO:1902403,0.205511627409504,0.948036750898482,2,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,GADD45A;CDKN1A
18861,GO:1901623,0.205867696591547,0.978327194247221,1,20,regulation of lymphocyte chemotaxis,BP,WNT5A
8225,GO:0031998,0.205919707677078,0.978669267179903,1,15,regulation of fatty acid beta-oxidation,BP,AKT1
7184,GO:0030011,0.20601597880899,0.978559921300562,1,16,maintenance of cell polarity,BP,CRB2
14596,GO:0055075,0.206400751995666,0.978565194852588,1,15,potassium ion homeostasis,BP,KCNH2
11571,GO:0043931,0.206454425566596,0.978553565674222,1,15,ossification involved in bone maturation,BP,BMP2
13917,GO:0051172,0.206817244961979,0.849820066773264,25,1487,negative regulation of nitrogen compound metabolic process,BP,WNT4;ACTN3;NOTCH1;ZFPM1;DKK3;EDN1;PDGFB;WNT5A;SESN2;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;PKP3;PKP1;NPPC;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
15452,GO:0061323,0.206859765300891,0.978376364811904,1,16,cell proliferation involved in heart morphogenesis,BP,BMP4
17856,GO:0097306,0.206981517475236,0.947571801709727,2,54,cellular response to alcohol,BP,AKT1;CDH1
18236,GO:0098911,0.207325725543089,0.978466856914852,1,14,regulation of ventricular cardiac muscle cell action potential,BP,DSC2
11696,GO:0044259,0.207346647020529,0.927490413855455,3,109,multicellular organismal macromolecule metabolic process,BP,WNT4;BMP4;CTGF
9615,GO:0034774,0.20746015862166,0.895735340604058,6,312,secretory granule lumen,CC,ACTN2;RAB27A;TF;CRISPLD2;PDGFB;GAS6
794,GO:0001972,0.207662948209934,0.978121520689519,1,17,retinoic acid binding,MF,SERPINA5
4837,GO:0010523,0.207730817885409,0.978106602337902,1,17,negative regulation of calcium ion transport into cytosol,BP,CASQ2
16196,GO:0070920,0.207905017095712,0.978237973592425,1,15,regulation of production of small RNA involved in gene silencing by RNA,BP,BMP4
18817,GO:1901532,0.207978525305665,0.978131678336189,1,16,regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
6127,GO:0016805,0.208238087076295,0.978074694928834,1,16,dipeptidase activity,MF,PM20D2
6304,GO:0017156,0.208340834474579,0.927027124560383,3,104,calcium ion regulated exocytosis,BP,SYT5;NOTCH1;SCIN
18118,GO:0098662,0.208697963833118,0.868956907726976,12,648,inorganic cation transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TTYH1;TSPAN13;KCNH2;PIK3CG;KCNG2;GAS6;KCND1;CLDN16;PDE4B
4690,GO:0009950,0.208707355368471,0.977971468357134,1,16,dorsal/ventral axis specification,BP,WNT3
7361,GO:0030285,0.208931552666727,0.978013123060939,1,15,integral component of synaptic vesicle membrane,CC,TMEM163
17432,GO:0090177,0.208971874625825,0.978004265327118,1,15,establishment of planar polarity involved in neural tube closure,BP,WNT5A
13165,GO:0048261,0.209045335305698,0.97781656848472,1,17,negative regulation of receptor-mediated endocytosis,BP,UNC119
7270,GO:0030162,0.209372052977489,0.868415864300013,12,693,regulation of proteolysis,BP,PMAIP1;CRB2;SERPINA5;PRKACB;MAPK12;AXIN1;CTGF;AKT1;CST9L;GAS6;ARAF;RNF144A
10874,GO:0042509,0.209583965327909,0.946256100966619,2,67,regulation of tyrosine phosphorylation of STAT protein,BP,LIF;CLCF1
4757,GO:0010224,0.209620787831401,0.97768894743599,1,17,response to UV-B,BP,CDKN1A
6263,GO:0017081,0.209731682055127,0.97766430806443,1,17,chloride channel regulator activity,MF,WNK4
16166,GO:0070875,0.2098423622866,0.977720705557007,1,16,positive regulation of glycogen metabolic process,BP,AKT1
3786,GO:0007379,0.210082638385008,0.977586232194901,1,17,segment specification,BP,DLL1
8471,GO:0032410,0.210159672970579,0.946079569086707,2,63,negative regulation of transporter activity,BP,ACTN2;CASQ2
18179,GO:0098810,0.21054427464871,0.977483307906972,1,17,neurotransmitter reuptake,BP,GDNF
11869,GO:0044708,0.210568972810885,0.882118197308235,8,396,single-organism behavior,BP,ITGA3;ITGA5;STRA6;ADORA1;SPTBN4;PRKAR1B;CLDN5;GDNF
16648,GO:0071696,0.210718847426474,0.977526001356668,1,16,ectodermal placode development,BP,AXIN1
7812,GO:0031210,0.210885642290178,0.97726935274657,1,19,phosphatidylcholine binding,MF,SERPINA5
13792,GO:0050997,0.210885642290178,0.97726935274657,1,19,quaternary ammonium group binding,MF,SERPINA5
11740,GO:0044325,0.210951731094229,0.925652146322477,3,107,ion channel binding,MF,ACTN3;ACTN2;PDE4B
13269,GO:0048531,0.211093960216393,0.977442391012719,1,16,beta-1,3-galactosyltransferase activity,MF,B3GNT2
21009,GO:2000113,0.211133907108929,0.849403676886828,22,1293,negative regulation of cellular macromolecule biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;DKK3;EDN1;PDGFB;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
15773,GO:0070168,0.211178995466258,0.977268490416792,1,18,negative regulation of biomineral tissue development,BP,GAS6
6771,GO:0019932,0.211273804015019,0.901270203809029,5,225,second-messenger-mediated signaling,BP,ACTN3;GUCY1B3;CASQ2;EDN1;CCL20
8066,GO:0031664,0.211414831754922,0.977150141711751,1,19,regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
11066,GO:0042832,0.211595052717151,0.977109465652912,1,19,defense response to protozoan,BP,HRAS
9024,GO:0033268,0.211607012692238,0.9774211745778,1,15,node of Ranvier,CC,SPTBN4
3650,GO:0007126,0.211607399426904,0.911362326086804,4,163,meiotic nuclear division,BP,LIF;WNT4;WNT5A;PIM2
7161,GO:0023019,0.211704551405997,0.97715023682694,1,18,signal transduction involved in regulation of gene expression,BP,FGF8
5356,GO:0015079,0.211709669052975,0.911337022918544,4,157,potassium ion transmembrane transporter activity,MF,KCNK6;KCNH2;KCNG2;KCND1
17344,GO:0090036,0.211884761222976,0.97735923122027,1,15,regulation of protein kinase C signaling,BP,WNT5A
14118,GO:0051531,0.211978569405945,0.977244547001113,1,16,NFAT protein import into nucleus,BP,PIK3R1
16401,GO:0071331,0.212163536067845,0.924970162429946,3,113,cellular response to hexose stimulus,BP,GJB6;PIK3CA;GAS6
999,GO:0002313,0.212269853189637,0.977096305551876,1,17,mature B cell differentiation involved in immune response,BP,DLL1
13066,GO:0048012,0.212286418547798,0.977175475251357,1,16,hepatocyte growth factor receptor signaling pathway,BP,BCAR1
11134,GO:0043005,0.21242406021209,0.855354256535368,17,931,neuron projection,CC,ITGA3;ADRA2C;SYT5;ACTN2;MARK4;RAB27A;ADORA1;SPTBN4;RAB39B;FSTL3;DRP2;VAMP1;RAB17;NRTN;LZTS1;KCND1;PDE4B
9176,GO:0033692,0.212485987180051,0.94519931913042,2,58,cellular polysaccharide biosynthetic process,BP,B3GNT2;AKT1
3207,GO:0006465,0.212709802042198,0.976856989753219,1,19,signal peptide processing,BP,GAS6
18102,GO:0098641,0.213252590917022,0.976799974387515,1,18,cadherin binding involved in cell-cell adhesion,MF,PKP3
9854,GO:0035493,0.213447375789867,0.97691396551484,1,16,SNARE complex assembly,BP,VAMP1
1270,GO:0002768,0.213930555836066,0.885083185693894,7,350,immune response-regulating cell surface receptor signaling pathway,BP,PRKACB;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
3892,GO:0008017,0.213961104328349,0.899657168808055,5,208,microtubule binding,MF,MARK4;REEP1;PSRC1;CAMSAP3;LZTS1
3569,GO:0006978,0.214089189267952,0.976684380700482,1,17,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,CDKN1A
19010,GO:1902043,0.214685263337602,0.976633336110526,1,16,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1
16885,GO:0072160,0.214713016271019,0.976723200756515,1,15,nephron tubule epithelial cell differentiation,BP,LIF
11016,GO:0042749,0.214720138710293,0.976232598935507,1,22,regulation of circadian sleep/wake cycle,BP,ADORA1
11735,GO:0044320,0.21479739782994,0.976607823793903,1,16,cellular response to leptin stimulus,BP,INHBB
3754,GO:0007283,0.214909183697193,0.87450095304836,9,488,spermatogenesis,BP,NOTCH1;DHH;SERPINA5;TYRO3;FSTL3;JAM3;SLC2A14;JAG2;CLDN11
15170,GO:0060749,0.215001097030492,0.976476403918662,1,17,mammary gland alveolus development,BP,DDR1
15482,GO:0061377,0.215001097030492,0.976476403918662,1,17,mammary gland lobule development,BP,DDR1
11264,GO:0043209,0.215221531442513,0.909235567387115,4,167,myelin sheath,CC,JAM3;MSN;TSPAN2;CLDN11
16132,GO:0070822,0.21524975121707,0.976504752165474,1,16,Sin3-type complex,CC,SIN3B
966,GO:0002260,0.21557579385586,0.943801370338538,2,63,lymphocyte homeostasis,BP,PMAIP1;AKT1
13246,GO:0048486,0.215853268985865,0.976204994586334,1,18,parasympathetic nervous system development,BP,GDNF
15096,GO:0060644,0.215969642433056,0.976254405885751,1,17,mammary gland epithelial cell differentiation,BP,AKT1
16399,GO:0071326,0.216455131240886,0.922721560541358,3,114,cellular response to monosaccharide stimulus,BP,GJB6;PIK3CA;GAS6
13096,GO:0048070,0.216494386210413,0.976219876760137,1,16,regulation of developmental pigmentation,BP,KITLG
14268,GO:0051797,0.216781538076093,0.975990634596888,1,18,regulation of hair follicle development,BP,WNT5A
17043,GO:0072401,0.216802089409158,0.943280030111118,2,63,signal transduction involved in DNA integrity checkpoint,BP,GADD45A;CDKN1A
17047,GO:0072422,0.216802089409158,0.943280030111118,2,63,signal transduction involved in DNA damage checkpoint,BP,GADD45A;CDKN1A
13145,GO:0048232,0.216940371784048,0.873034788236002,9,489,male gamete generation,BP,NOTCH1;DHH;SERPINA5;TYRO3;FSTL3;JAM3;SLC2A14;JAG2;CLDN11
8251,GO:0032042,0.217001740891978,0.976103213965298,1,16,mitochondrial DNA metabolic process,BP,SESN2
11252,GO:0043195,0.217151233719814,0.943167870749654,2,61,terminal bouton,CC,ADORA1;VAMP1
10088,GO:0035855,0.217273475174318,0.976139088072694,1,15,megakaryocyte development,BP,ZFPM1
9837,GO:0035455,0.217313385206703,0.975867345082322,1,18,response to interferon-alpha,BP,GAS6
3867,GO:0007611,0.217535703420441,0.897388496122271,5,214,learning or memory,BP,ITGA3;ITGA5;STRA6;PRKAR1B;CLDN5
3460,GO:0006809,0.217602536106753,0.942938634450259,2,63,nitric oxide biosynthetic process,BP,EDN1;AKT1
15054,GO:0060575,0.217666591970673,0.975862705744321,1,17,intestinal epithelial cell differentiation,BP,CDKN1A
19055,GO:1902176,0.217749024791123,0.975696804716373,1,19,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,AKT1
18925,GO:1901798,0.217906775228953,0.975659985464541,1,19,positive regulation of signal transduction by p53 class mediator,BP,PMAIP1
1282,GO:0002791,0.217925723514494,0.876920745441406,8,412,regulation of peptide secretion,BP,ADRA2C;ADORA1;WNT5A;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6
3849,GO:0007584,0.218090539514732,0.907526881918824,4,172,response to nutrient,BP,BMP7;GAS6;VDR;ACSL4
21474,GO:2000810,0.2181432611805,0.975839588139833,1,16,regulation of bicellular tight junction assembly,BP,CLDN1
4906,GO:0010642,0.218173294658893,0.975832630781642,1,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFB
17737,GO:0097094,0.21856154111966,0.975654717535448,1,17,craniofacial suture morphogenesis,BP,BMP4
13424,GO:0048820,0.218687069469688,0.975713443471291,1,16,hair follicle maturation,BP,WNT5A
7301,GO:0030203,0.218834505043557,0.907160515425206,4,159,glycosaminoglycan metabolic process,BP,PDGFB;SDC4;B3GNT2;AKT1
8054,GO:0031647,0.218858861661314,0.896494203086497,5,230,regulation of protein stability,BP,TF;PIK3R1;BMP2;CDKN1A;PIM2
17110,GO:0072574,0.218948294744687,0.975564533255562,1,17,hepatocyte proliferation,BP,LIMS2
17111,GO:0072575,0.218948294744687,0.975564533255562,1,17,epithelial cell proliferation involved in liver morphogenesis,BP,LIMS2
8081,GO:0031690,0.21936987461986,0.975466020415615,1,17,adrenergic receptor binding,MF,ADRA2C
10131,GO:0035929,0.219416322706298,0.975306113903181,1,19,steroid hormone secretion,BP,BMP6
1839,GO:0004115,0.219466417416777,0.975632519935848,1,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,PDE4B
16421,GO:0071356,0.219505878639845,0.895992814721096,5,260,cellular response to tumor necrosis factor,BP,EDN1;CCL20;CLDN1;GAS6;CLDN18
18992,GO:1902001,0.219771038393667,0.975460928313809,1,16,fatty acid transmembrane transport,BP,AKT1
15811,GO:0070230,0.220309906684404,0.975031510685765,1,20,positive regulation of lymphocyte apoptotic process,BP,WNT5A
16724,GO:0071871,0.220381588263318,0.975318068955412,1,16,response to epinephrine,BP,PDE4B
11032,GO:0042772,0.220770200331681,0.975057590058336,1,18,DNA damage response, signal transduction resulting in transcription,BP,CDKN1A
16843,GO:0072091,0.22095323023556,0.94159901962546,2,58,regulation of stem cell proliferation,BP,NOTCH1;KITLG
3070,GO:0006260,0.2211282858261,0.886810518788922,6,281,DNA replication,BP,FGF10;PDGFB;HRAS;BMP6;BMP4;KITLG
10198,GO:0036035,0.22131055628811,0.975009733532881,1,17,osteoclast development,BP,CLDN18
16715,GO:0071855,0.221518906713691,0.974426681198,1,27,neuropeptide receptor binding,MF,EDN1
4850,GO:0010558,0.221675199032549,0.839624439320251,23,1374,negative regulation of macromolecule biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;DKK3;EDN1;PDGFB;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;INHBB;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
8842,GO:0032945,0.221989405684151,0.941034185574092,2,64,negative regulation of mononuclear cell proliferation,BP,SDC4;BMP4
13573,GO:0050672,0.221989405684151,0.941034185574092,2,64,negative regulation of lymphocyte proliferation,BP,SDC4;BMP4
18604,GO:1900407,0.222341759407708,0.940899563998266,2,63,regulation of cellular response to oxidative stress,BP,BMP7;AKT1
20197,GO:1904707,0.222538625552443,0.974718615411313,1,17,positive regulation of vascular smooth muscle cell proliferation,BP,PDGFB
2175,GO:0004697,0.222833310746599,0.974739828799877,1,16,protein kinase C activity,MF,PKN3
12140,GO:0045334,0.222869406977587,0.940634967535391,2,65,clathrin-coated endocytic vesicle,CC,WNT5A;HBEGF
17041,GO:0072395,0.222902870420828,0.940637999405576,2,64,signal transduction involved in cell cycle checkpoint,BP,GADD45A;CDKN1A
10831,GO:0042438,0.222906310958366,0.974549894698594,1,18,melanin biosynthetic process,BP,WNT5A
10873,GO:0042508,0.223060153598488,0.974374986130296,1,20,tyrosine phosphorylation of Stat1 protein,BP,LIF
8516,GO:0032461,0.223189309243101,0.974409414132967,1,19,positive regulation of protein oligomerization,BP,PMAIP1
12036,GO:0045117,0.223195270303598,0.974480786792872,1,18,azole transport,BP,EDN1
21355,GO:2000641,0.22381285798236,0.97441460143074,1,17,regulation of early endosome to late endosome transport,BP,MSN
14559,GO:0055003,0.223816346583629,0.97441376636645,1,17,cardiac myofibril assembly,BP,FHOD3
16232,GO:0070977,0.223844015093002,0.974407142843916,1,17,bone maturation,BP,BMP2
16676,GO:0071782,0.223990128008312,0.974464444425813,1,16,endoplasmic reticulum tubular network,CC,REEP1
21543,GO:2001026,0.224123565173381,0.974184670311576,1,19,regulation of endothelial cell chemotaxis,BP,NOTCH1
3844,GO:0007567,0.224398091311001,0.974192015276666,1,18,parturition,BP,EDN1
2162,GO:0004675,0.224509665598315,0.974340234013485,1,16,transmembrane receptor protein serine/threonine kinase activity,MF,ACVR1
10015,GO:0035728,0.224724024157208,0.97419598857069,1,17,response to hepatocyte growth factor,BP,BCAR1
1498,GO:0003222,0.224843565442768,0.974260231196021,1,16,ventricular trabecula myocardium morphogenesis,BP,NOTCH1
6663,GO:0019674,0.224929775944758,0.939754866673365,2,64,NAD metabolic process,BP,ACTN3;PFKFB3
5071,GO:0010881,0.224954436862464,0.974057846343597,1,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,CASQ2
3512,GO:0006888,0.225068071498344,0.903408785189285,4,169,ER to Golgi vesicle-mediated transport,BP,SPTBN5;SPTBN4;SPTB;GAS6
15436,GO:0061298,0.225086293669557,0.974201987484122,1,16,retina vasculature development in camera-type eye,BP,RHOJ
8422,GO:0032354,0.225118830931558,0.974194174536873,1,16,response to follicle-stimulating hormone,BP,NOTCH1
13283,GO:0048557,0.225254260875672,0.97398538231605,1,18,embryonic digestive tract morphogenesis,BP,FGF10
7369,GO:0030296,0.225574478628367,0.973991021830465,1,17,protein tyrosine kinase activator activity,MF,GAS6
998,GO:0002312,0.225604859125843,0.939477952502279,2,63,B cell activation involved in immune response,BP,CLCF1;DLL1
16171,GO:0070884,0.226426348748388,0.973784822112668,1,17,regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
4773,GO:0010288,0.226538368821045,0.973673774041679,1,18,response to lead ion,BP,CLDN1
9267,GO:0034104,0.226841407032782,0.973524741295082,1,19,negative regulation of tissue remodeling,BP,CLDN18
9957,GO:0035635,0.226956410831068,0.973656066824057,1,17,entry of bacterium into host cell,BP,CDH1
5740,GO:0016048,0.22790850301017,0.973339044843651,1,18,detection of temperature stimulus,BP,ADORA1
4847,GO:0010544,0.228439689334795,0.973293928711523,1,17,negative regulation of platelet activation,BP,PDGFB
17724,GO:0097061,0.228544475505731,0.93828884337319,2,58,dendritic spine organization,BP,ITGA3;WNT7A
13263,GO:0048520,0.228957437499136,0.972765047856501,1,23,positive regulation of behavior,BP,STRA6
20873,GO:1990776,0.229174200325916,0.973027766477981,1,18,response to angiotensin,BP,ACTN2
3938,GO:0008105,0.229486651500277,0.973036680776604,1,17,asymmetric protein localization,BP,WNT7A
13270,GO:0048532,0.229901751011541,0.972934311999756,1,17,anatomical structure arrangement,BP,DLL1
7543,GO:0030673,0.230004695127428,0.973006208066208,1,16,axolemma,CC,ADORA1
8639,GO:0032642,0.230225652205638,0.937384972642419,2,66,regulation of chemokine production,BP,ZFPM1;WNT5A
16053,GO:0070633,0.23025188204483,0.972761162896622,1,18,transepithelial transport,BP,EDN1
13572,GO:0050671,0.230785691939832,0.91496177185784,3,127,positive regulation of lymphocyte proliferation,BP,FGF10;CLCF1;CDKN1A
18620,GO:1900543,0.230802488718856,0.937146289589643,2,65,negative regulation of purine nucleotide metabolic process,BP,ACTN3;EDN1
8408,GO:0032331,0.230811840530678,0.972622067978589,1,18,negative regulation of chondrocyte differentiation,BP,BMP4
6666,GO:0019682,0.230865363925228,0.972460799585554,1,20,glyceraldehyde-3-phosphate metabolic process,BP,KHK
5365,GO:0015095,0.231870679053615,0.972445843555696,1,17,magnesium ion transmembrane transporter activity,MF,CLDN16
19805,GO:1903830,0.231870679053615,0.972445843555696,1,17,magnesium ion transmembrane transport,BP,CLDN16
1666,GO:0003841,0.231920758044424,0.9724333568677,1,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
10695,GO:0042171,0.231920758044424,0.9724333568677,1,17,lysophosphatidic acid acyltransferase activity,MF,MBOAT2
16597,GO:0071617,0.231920758044424,0.9724333568677,1,17,lysophospholipid acyltransferase activity,MF,MBOAT2
20662,GO:1905952,0.231987212628354,0.914338899043307,3,123,regulation of lipid localization,BP,EDN1;BMP6;AKT1
7317,GO:0030220,0.232053921785531,0.972312141788572,1,18,platelet formation,BP,ZFPM1
13720,GO:0050871,0.232397738654979,0.936365286808106,2,69,positive regulation of B cell activation,BP,CLCF1;CDKN1A
10754,GO:0042308,0.23260060681828,0.936362428995469,2,64,negative regulation of protein import into nucleus,BP,BMP7;GAS6
20142,GO:1904590,0.23260060681828,0.936362428995469,2,64,negative regulation of protein import,BP,BMP7;GAS6
9649,GO:0035024,0.232751120175259,0.972225860796006,1,17,negative regulation of Rho protein signal transduction,BP,ITGA3
10328,GO:0036342,0.232848039338283,0.9721129865395,1,18,post-anal tail morphogenesis,BP,WNT5A
10168,GO:0035994,0.23300762807995,0.971993530476797,1,19,response to muscle stretch,BP,EDN1
16668,GO:0071731,0.233028849986089,0.971988178848487,1,19,response to nitric oxide,BP,GUCY1B3
10719,GO:0042249,0.233035336406412,0.972154642373577,1,17,establishment of planar polarity of embryonic epithelium,BP,WNT5A
5533,GO:0015631,0.23310067859774,0.878785034428265,6,275,tubulin binding,MF,MARK4;REEP1;PSRC1;CAMSAP3;LZTS1;PDE4B
1047,GO:0002385,0.233105042498063,0.971445924148906,1,30,mucosal immune response,BP,RAB17
9266,GO:0034103,0.233229973605552,0.936043606168044,2,66,regulation of tissue remodeling,BP,VDR;CLDN18
3738,GO:0007260,0.233326350500669,0.935917127292197,2,71,tyrosine phosphorylation of STAT protein,BP,LIF;CLCF1
8047,GO:0031640,0.233475995436091,0.971350590957839,1,30,killing of cells of other organism,BP,CHGA
11767,GO:0044364,0.233475995436091,0.971350590957839,1,30,disruption of cells of other organism,BP,CHGA
12457,GO:0045980,0.233491520049288,0.93592625510357,2,66,negative regulation of nucleotide metabolic process,BP,ACTN3;EDN1
17509,GO:0090281,0.233564228488709,0.971716422076782,1,21,negative regulation of calcium ion import,BP,CASQ2
17889,GO:0097381,0.233782305625442,0.971797811819005,1,19,photoreceptor disc membrane,CC,SPTBN5
2939,GO:0006022,0.23386622788998,0.898143473371836,4,164,aminoglycan metabolic process,BP,PDGFB;SDC4;B3GNT2;AKT1
4867,GO:0010586,0.234017509770408,0.971907757972071,1,17,miRNA metabolic process,BP,HRAS
3769,GO:0007338,0.234250247038046,0.913034059759466,3,132,single fertilization,BP,IGSF8;SERPINA5;MFGE8
6611,GO:0019430,0.234450802925185,0.971431337930503,1,22,removal of superoxide radicals,BP,BMP7
16438,GO:0071380,0.234632328568282,0.971752603016485,1,17,cellular response to prostaglandin E stimulus,BP,AKT1
1538,GO:0003298,0.234637547495587,0.971580867658771,1,19,physiological muscle hypertrophy,BP,EDN1
1541,GO:0003301,0.234637547495587,0.971580867658771,1,19,physiological cardiac muscle hypertrophy,BP,EDN1
15335,GO:0061049,0.234637547495587,0.971580867658771,1,19,cell growth involved in cardiac muscle cell development,BP,EDN1
8843,GO:0032946,0.234726078600355,0.912802313964021,3,128,positive regulation of mononuclear cell proliferation,BP,FGF10;CLCF1;CDKN1A
18350,GO:0099565,0.234843304227798,0.912896350692958,3,110,chemical synaptic transmission, postsynaptic,BP,WNT7A;ADORA1;AKT1
11358,GO:0043369,0.235181426599187,0.971369723888373,1,20,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
14782,GO:0060205,0.235269396515933,0.877174545568437,6,329,cytoplasmic vesicle lumen,CC,ACTN2;RAB27A;TF;CRISPLD2;PDGFB;GAS6
7781,GO:0031116,0.235559042564495,0.971346092874586,1,19,positive regulation of microtubule polymerization,BP,PSRC1
3304,GO:0006582,0.235797325711909,0.971285210959487,1,19,melanin metabolic process,BP,WNT5A
3408,GO:0006720,0.235963921755402,0.91212987052479,3,127,isoprenoid metabolic process,BP,STRA6;HMGCS2;SDC4
8781,GO:0032845,0.236071361365367,0.89672883403015,4,177,negative regulation of homeostatic process,BP,ADORA1;CASQ2;KITLG;CLDN18
13342,GO:0048670,0.236135105834625,0.971280265044428,1,18,regulation of collateral sprouting,BP,WNT3
13712,GO:0050863,0.236149770777784,0.876637539869245,6,302,regulation of T cell activation,BP,PIK3R1;SDC4;BMP4;AKT1;PIK3CA;EFNB2
21389,GO:2000678,0.236431695258909,0.970982851298553,1,21,negative regulation of transcription regulatory region DNA binding,BP,HEY1
523,GO:0001562,0.236616891923179,0.970935117686091,1,21,response to protozoan,BP,HRAS
11627,GO:0044090,0.236803942486629,0.971200806328426,1,17,positive regulation of vacuole organization,BP,RALB
16069,GO:0070664,0.236924704262265,0.934359245957361,2,67,negative regulation of leukocyte proliferation,BP,SDC4;BMP4
4616,GO:0009651,0.237012675155048,0.970899738615103,1,20,response to salt stress,BP,CLDN1
5224,GO:0014068,0.237168248723467,0.934324534283934,2,63,positive regulation of phosphatidylinositol 3-kinase signaling,BP,PRR5L;PDGFB
14312,GO:0051896,0.237327372251156,0.911436172525719,3,120,regulation of protein kinase B signaling,BP,HBEGF;PIK3CG;GAS6
10849,GO:0042474,0.237479621776277,0.970779223251349,1,20,middle ear morphogenesis,BP,EDN1
13692,GO:0050832,0.237562622880449,0.970258564781527,1,31,defense response to fungus,BP,CHGA
881,GO:0002089,0.237690430065684,0.970881542445776,1,18,lens morphogenesis in camera-type eye,BP,BMP4
8215,GO:0031983,0.237765439508185,0.875469681904564,6,330,vesicle lumen,CC,ACTN2;RAB27A;TF;CRISPLD2;PDGFB;GAS6
11724,GO:0044304,0.238185855315071,0.933904325805436,2,61,main axon,CC,ADORA1;SPTBN4
2941,GO:0006024,0.238193112334541,0.911053768455,3,110,glycosaminoglycan biosynthetic process,BP,PDGFB;SDC4;B3GNT2
6751,GO:0019887,0.238401754465555,0.895309893506843,4,176,protein kinase regulator activity,MF,PRKAR1B;CDKN1A;PIK3CA;GAS6
1222,GO:0002702,0.238417424706905,0.933597233232585,2,72,positive regulation of production of molecular mediator of immune response,BP,WNT5A;CLCF1
12371,GO:0045830,0.23843026705134,0.970533020399554,1,20,positive regulation of isotype switching,BP,CLCF1
19404,GO:1903010,0.238567884982243,0.97057209547128,1,19,regulation of bone development,BP,CLDN18
14849,GO:0060307,0.238603133696863,0.970646150047547,1,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,KCNH2
605,GO:0001710,0.238716326448103,0.970533615762817,1,19,mesodermal cell fate commitment,BP,BMP4
1136,GO:0002544,0.238894726813046,0.970282831408089,1,22,chronic inflammatory response,BP,PTGES
21246,GO:2000482,0.238999317953158,0.970317200660388,1,21,regulation of interleukin-8 secretion,BP,WNT5A
7101,GO:0022411,0.239074126399065,0.856811105486896,9,500,cellular component disassembly,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;AXIN1;SCIN;SPTB;DDR1;CDH1
18068,GO:0098563,0.239083048947077,0.970521957202181,1,18,intrinsic component of synaptic vesicle membrane,CC,TMEM163
13074,GO:0048020,0.239332378895608,0.96966399892149,1,36,CCR chemokine receptor binding,MF,CCL20
5145,GO:0010975,0.239959371981249,0.861157515511116,8,391,regulation of neuron projection development,BP,ITGA3;WNT3;WNT7A;WNT5A;BMP7;AKT1;RAB17;LZTS1
14723,GO:0060117,0.24025161087012,0.970218345333338,1,18,auditory receptor cell development,BP,MYO7A
7565,GO:0030728,0.240328237531126,0.970038064996896,1,20,ovulation,BP,INHBB
13968,GO:0051250,0.240383831720741,0.909718491365651,3,123,negative regulation of lymphocyte activation,BP,TYRO3;SDC4;BMP4
21422,GO:2000737,0.240518035667536,0.970148883272192,1,18,negative regulation of stem cell differentiation,BP,NOTCH1
13670,GO:0050802,0.24064557377102,0.969714072659841,1,24,circadian sleep/wake cycle, sleep,BP,ADORA1
15380,GO:0061134,0.240776040910344,0.893709672329535,4,207,peptidase regulator activity,MF,CRB2;SERPINA5;CST9L;GAS6
12567,GO:0046209,0.241514528115875,0.932263122552943,2,67,nitric oxide metabolic process,BP,EDN1;AKT1
2940,GO:0006023,0.241579650157919,0.909166067924479,3,111,aminoglycan biosynthetic process,BP,PDGFB;SDC4;B3GNT2
10330,GO:0036344,0.241593904765383,0.969782189413203,1,19,platelet morphogenesis,BP,ZFPM1
13516,GO:0050431,0.24192684698798,0.969875728466411,1,17,transforming growth factor beta binding,MF,ACVR1
13207,GO:0048339,0.24201411981086,0.969757164691338,1,18,paraxial mesoderm development,BP,WNT5A
10303,GO:0036296,0.24203389562328,0.96966637269663,1,19,response to increased oxygen levels,BP,CDKN1A
14612,GO:0055093,0.24203389562328,0.96966637269663,1,19,response to hyperoxia,BP,CDKN1A
16384,GO:0071305,0.242670653880493,0.969498328318587,1,19,cellular response to vitamin D,BP,VDR
1194,GO:0002673,0.243083782373037,0.931486984523491,2,70,regulation of acute inflammatory response,BP,ADORA1;PIK3CG
12274,GO:0045649,0.243264028282523,0.969263492209187,1,20,regulation of macrophage differentiation,BP,LIF
8012,GO:0031571,0.243318807864221,0.931413150708954,2,68,mitotic G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
11929,GO:0044819,0.243318807864221,0.931413150708954,2,68,mitotic G1/S transition checkpoint,BP,GADD45A;CDKN1A
16344,GO:0071230,0.243663518995225,0.931372098499098,2,62,cellular response to amino acid stimulus,BP,SESN2;SH3BP4
19050,GO:1902170,0.243738318177202,0.969215413479359,1,19,cellular response to reactive nitrogen species,BP,GUCY1B3
19681,GO:1903579,0.243843899499601,0.969187357564672,1,19,negative regulation of ATP metabolic process,BP,ACTN3
6016,GO:0016597,0.244047740221708,0.931132355978691,2,65,amino acid binding,MF,GLDC;SESN2
5453,GO:0015267,0.244097461456739,0.85312504405838,9,461,channel activity,MF,KCNK6;TTYH1;KCNH2;GJB1;GJB2;GJA3;KCNG2;GAS6;KCND1
10835,GO:0042445,0.244422551523726,0.891553641549758,4,185,hormone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
5559,GO:0015693,0.244614940969301,0.969069469197714,1,18,magnesium ion transport,BP,CLDN16
17112,GO:0072576,0.244649755362996,0.968972753405832,1,19,liver morphogenesis,BP,LIMS2
6037,GO:0016638,0.24468304558447,0.968963870304396,1,19,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,GLDC
17351,GO:0090049,0.245231718337084,0.968817260807318,1,19,regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
16397,GO:0071322,0.245445371944482,0.906907914398505,3,121,cellular response to carbohydrate stimulus,BP,GJB6;PIK3CA;GAS6
10867,GO:0042501,0.245695351995954,0.968183730757643,1,28,serine phosphorylation of STAT protein,BP,LIF
8078,GO:0031683,0.245883715016638,0.96856308527491,1,20,G-protein beta/gamma-subunit complex binding,MF,ADORA1
7125,GO:0022803,0.246210725327455,0.85154350136598,9,462,passive transmembrane transporter activity,MF,KCNK6;TTYH1;KCNH2;GJB1;GJB2;GJA3;KCNG2;GAS6;KCND1
2592,GO:0005355,0.246311559260058,0.968527602132471,1,19,glucose transmembrane transporter activity,MF,SLC2A14
9828,GO:0035428,0.246311559260058,0.968527602132471,1,19,hexose transmembrane transport,BP,SLC2A14
20172,GO:1904659,0.246311559260058,0.968527602132471,1,19,glucose transmembrane transport,BP,SLC2A14
20661,GO:1905950,0.246311559260058,0.968527602132471,1,19,monosaccharide transmembrane transport,BP,SLC2A14
9274,GO:0034114,0.246332436130243,0.968442237848231,1,20,regulation of heterotypic cell-cell adhesion,BP,BMP7
8242,GO:0032026,0.246472108869263,0.968573167117828,1,18,response to magnesium ion,BP,BMP6
19427,GO:1903046,0.246517240390848,0.890311749760955,4,174,meiotic cell cycle process,BP,LIF;WNT4;WNT5A;PIM2
17334,GO:0090023,0.246589540176772,0.968022950556574,1,26,positive regulation of neutrophil chemotaxis,BP,EDN1
13615,GO:0050718,0.246712321918436,0.968201648644367,1,22,positive regulation of interleukin-1 beta secretion,BP,WNT5A
19608,GO:1903429,0.246824309650424,0.968309473956216,1,20,regulation of cell maturation,BP,NPPC
12039,GO:0045121,0.247407047130634,0.868960084137375,6,281,membrane raft,CC,CRB2;CDH2;RHOQ;SDC4;DLL1;CDH1
70,GO:0000145,0.248041552243865,0.968150342401972,1,18,exocyst,CC,RALB
21540,GO:2001022,0.248157963271792,0.929178880713238,2,67,positive regulation of response to DNA damage stimulus,BP,PMAIP1;FGF10
19568,GO:1903364,0.248209199649947,0.889193341059016,4,186,positive regulation of cellular protein catabolic process,BP,AXIN1;MSN;AKT1;RNF144A
19635,GO:1903510,0.248218998062237,0.905432936029532,3,112,mucopolysaccharide metabolic process,BP,PDGFB;B3GNT2;AKT1
13927,GO:0051184,0.248314651992761,0.967986359224555,1,19,cofactor transporter activity,MF,FLVCR2
2986,GO:0006096,0.248513007503785,0.929012377369326,2,67,glycolytic process,BP,ACTN3;PFKFB3
3432,GO:0006757,0.248513007503785,0.929012377369326,2,67,ATP generation from ADP,BP,ACTN3;PFKFB3
3565,GO:0006972,0.248518253384835,0.967776488275934,1,21,hyperosmotic response,BP,CLDN1
16485,GO:0071450,0.248746103112066,0.967530560740531,1,24,cellular response to oxygen radical,BP,BMP7
16486,GO:0071451,0.248746103112066,0.967530560740531,1,24,cellular response to superoxide,BP,BMP7
14001,GO:0051294,0.248900054655826,0.96774579826835,1,20,establishment of spindle orientation,BP,FGF10
19718,GO:1903649,0.249354890150181,0.967703264864443,1,19,regulation of cytoplasmic transport,BP,MSN
10784,GO:0042359,0.249406817593219,0.967607348582998,1,20,vitamin D metabolic process,BP,VDR
11908,GO:0044783,0.249431752101223,0.928543537369796,2,69,G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
3866,GO:0007610,0.24954041895171,0.844663673792764,10,547,behavior,BP,ITGA3;ITGA5;CDH23;STRA6;ADORA1;SPTBN4;PRKAR1B;ESPN;CLDN5;GDNF
532,GO:0001578,0.250104606073274,0.928303551336267,2,65,microtubule bundle formation,BP,MARK4;PSRC1
18205,GO:0098857,0.250159786677676,0.867045764531154,6,282,membrane microdomain,CC,CRB2;CDH2;RHOQ;SDC4;DLL1;CDH1
15499,GO:0061436,0.250160939945946,0.967482952947588,1,19,establishment of skin barrier,BP,CLDN1
18465,GO:1900076,0.250746614598972,0.928000813306627,2,65,regulation of cellular response to insulin stimulus,BP,PIK3R2;PIK3R1
9459,GO:0034453,0.250909714467253,0.967369527645271,1,18,microtubule anchoring,BP,CAMSAP3
13795,GO:0051000,0.25093026829378,0.967189155036314,1,20,positive regulation of nitric-oxide synthase activity,BP,AKT1
3492,GO:0006862,0.251085396866411,0.967146404675732,1,20,nucleotide transport,BP,GJB1
7589,GO:0030814,0.25145473442467,0.903408489857082,3,133,regulation of cAMP metabolic process,BP,EDN1;CHGA;NPPC
4924,GO:0010664,0.252157949806379,0.966849985162873,1,20,negative regulation of striated muscle cell apoptotic process,BP,BMP7
14171,GO:0051604,0.252333573350467,0.874648833039466,5,251,protein maturation,BP,TSPAN15;RHBDL3;PLAU;PRKACB;GAS6
962,GO:0002251,0.25245807167697,0.966171256175802,1,32,organ or tissue specific immune response,BP,RAB17
11158,GO:0043034,0.252484998929086,0.966843079121924,1,19,costamere,CC,SDC4
11436,GO:0043502,0.252596542982814,0.927085144443169,2,67,regulation of muscle adaptation,BP,ACTN3;EDN1
6541,GO:0019226,0.252830254548746,0.926954918008124,2,68,transmission of nerve impulse,BP,SPTBN4;JAM3
1493,GO:0003215,0.253215942184391,0.966640399887491,1,19,cardiac right ventricle morphogenesis,BP,NOTCH1
6831,GO:0021533,0.253347689491783,0.966603795428016,1,19,cell differentiation in hindbrain,BP,WNT7A
4622,GO:0009713,0.253480383088022,0.966482471318862,1,20,catechol-containing compound biosynthetic process,BP,PNMT
10822,GO:0042423,0.253480383088022,0.966482471318862,1,20,catecholamine biosynthetic process,BP,PNMT
11712,GO:0044283,0.253507373689973,0.846007884467179,9,496,small molecule biosynthetic process,BP,WNT4;HMGCS2;DKK3;EDN1;SESN2;BMP6;BMP2;PTGES;VDR
16684,GO:0071800,0.253522628564216,0.966470693901993,1,20,podosome assembly,BP,MSN
5059,GO:0010869,0.254067300072479,0.96631864164808,1,20,regulation of receptor biosynthetic process,BP,EDN1
3343,GO:0006635,0.254067470166544,0.926347240998678,2,69,fatty acid beta-oxidation,BP,SESN2;AKT1
21656,GO:2001257,0.254122076237378,0.901976493263495,3,122,regulation of cation channel activity,BP,ACTN2;CASQ2;PDE4B
12821,GO:0046827,0.254240510281949,0.966270207627641,1,20,positive regulation of protein export from nucleus,BP,GAS6
10579,GO:0040001,0.254263307949307,0.966263829935155,1,20,establishment of mitotic spindle localization,BP,FGF10
8553,GO:0032506,0.254614863714531,0.966250586496444,1,19,cytokinetic process,BP,SNX18
18441,GO:1900027,0.255138374584636,0.965941167046428,1,21,regulation of ruffle assembly,BP,HRAS
7100,GO:0022410,0.255139391469195,0.965643698852824,1,26,circadian sleep/wake cycle process,BP,ADORA1
8046,GO:0031639,0.255340017198772,0.965813976638748,1,22,plasminogen activation,BP,PLAU
21261,GO:2000505,0.255481776658285,0.966007755079397,1,19,regulation of energy homeostasis,BP,DLL1
11608,GO:0044030,0.255522858490957,0.965910426638525,1,20,regulation of DNA methylation,BP,PIK3CA
19445,GO:1903077,0.255690741228163,0.965949077103876,1,19,negative regulation of protein localization to plasma membrane,BP,RHOQ
2660,GO:0005545,0.256133523137223,0.965920394162058,1,18,1-phosphatidylinositol binding,MF,SCIN
2656,GO:0005540,0.256183459012619,0.965724257368401,1,20,hyaluronic acid binding,MF,HAPLN3
11288,GO:0043243,0.256716092927972,0.965495429115377,1,21,positive regulation of protein complex disassembly,BP,ACTN2
10474,GO:0038093,0.256787296924435,0.883801269023508,4,185,Fc receptor signaling pathway,BP,PIK3R2;PIK3R1;HRAS;PIK3CA
14062,GO:0051412,0.256865982597211,0.965452914541749,1,21,response to corticosterone,BP,CDKN1A
519,GO:0001556,0.257121055598953,0.965380498920711,1,21,oocyte maturation,BP,NPPC
3042,GO:0006198,0.257229189260974,0.965611999475227,1,18,cAMP catabolic process,BP,PDE4B
16700,GO:0071822,0.257255295404422,0.808656829915513,24,1516,protein complex subunit organization,BP,FHOD3;TUBG2;ACTN2;PMAIP1;CASQ2;SPTBN5;SPTBN4;PRND;PLEKHH2;RALB;HRAS;AXIN1;SCIN;PSRC1;SPTB;VAMP1;MSN;GJB1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;KCND1
5394,GO:0015149,0.257611455610486,0.965319893824357,1,20,hexose transmembrane transporter activity,MF,SLC2A14
6306,GO:0017158,0.257737354050033,0.924668448247796,2,65,regulation of calcium ion-dependent exocytosis,BP,SYT5;NOTCH1
3998,GO:0008198,0.257934089412316,0.965077279362667,1,22,ferrous iron binding,MF,TF
8611,GO:0032602,0.257974501364835,0.924402100070912,2,73,chemokine production,BP,ZFPM1;WNT5A
1016,GO:0002335,0.257989004139229,0.965133454939046,1,21,mature B cell differentiation,BP,DLL1
13772,GO:0050951,0.258004238990179,0.965208207102123,1,20,sensory perception of temperature stimulus,BP,ADORA1
21563,GO:2001057,0.258253588290198,0.924320391984809,2,70,reactive nitrogen species metabolic process,BP,EDN1;AKT1
20664,GO:1905954,0.258361058620101,0.924215463559374,2,73,positive regulation of lipid localization,BP,EDN1;BMP6
19566,GO:1903362,0.25855659801644,0.870465073285898,5,251,regulation of cellular protein catabolic process,BP,AXIN1;MSN;AKT1;ARAF;RNF144A
8409,GO:0032332,0.258668322998969,0.965106838773386,1,19,positive regulation of chondrocyte differentiation,BP,BMP6
9486,GO:0034505,0.258793565961191,0.964903579352161,1,21,tooth mineralization,BP,WNT6
14788,GO:0060216,0.258938099205594,0.965029963638477,1,19,definitive hemopoiesis,BP,ZFPM1
2794,GO:0005783,0.259825876084307,0.804297106367273,26,1601,endoplasmic reticulum,CC,ITGA5;WNT3;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ADORA1;CASQ2;EDN1;MBOAT2;TTYH1;RRAS2;TYRO3;PIK3R1;REEP1;PDGFB;WNT5B;WNT5A;GJB1;TPD52;PTGES;GAS6;GPSM1;RAB38;ACSL4
13672,GO:0050804,0.259884400395916,0.860201009461294,6,292,modulation of synaptic transmission,BP,WNT7A;ADORA1;EDN1;HRAS;LZTS1;GDNF
1007,GO:0002323,0.259974078990255,0.964083739386264,1,30,natural killer cell activation involved in immune response,BP,RAB27A
16602,GO:0071624,0.260147328028947,0.964071927957898,1,29,positive regulation of granulocyte chemotaxis,BP,EDN1
11840,GO:0044550,0.260316760381277,0.964466074791813,1,21,secondary metabolite biosynthetic process,BP,WNT5A
12423,GO:0045922,0.261237113423467,0.964126578989736,1,22,negative regulation of fatty acid metabolic process,BP,AKT1
4804,GO:0010460,0.261626427207033,0.9640135863462,1,22,positive regulation of heart rate,BP,EDN1
6085,GO:0016740,0.261744092225611,0.794059610801985,37,2269,transferase activity,MF,TSPAN17;MARK4;PNMT;FBXO41;HMGCS2;ACVR1;NMT2;PRKACB;MBOAT2;MAPK12;TYRO3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;KHK;NPR1;NUAK2;PFKFB3;FGF8;HBEGF;B3GNT2;CDKN1A;PKN3;WNK4;DDR1;AKT1;KITLG;SPSB1;PIK3CA;PIK3CG;DTX4;ARAF;RNF144A;PIM2
9532,GO:0034644,0.262014392507241,0.922514877152448,2,69,cellular response to UV,BP,PIK3R1;CDKN1A
7577,GO:0030802,0.262220576136633,0.897162273326602,3,138,regulation of cyclic nucleotide biosynthetic process,BP,EDN1;NPR1;NPPC
11487,GO:0043567,0.262425553681155,0.963713174814528,1,23,regulation of insulin-like growth factor receptor signaling pathway,BP,BMP2
11994,GO:0045061,0.262549768616563,0.963819227804511,1,21,thymic T cell selection,BP,JAG2
1600,GO:0003416,0.262659305038273,0.963787330370294,1,21,endochondral bone growth,BP,NPPC
4536,GO:0009314,0.262695748371531,0.844321046271974,8,421,response to radiation,BP,GADD45A;NMT2;PIK3R1;HRAS;RHOB;CDKN1A;AKT1;UNC119
17253,GO:0086013,0.262830530445856,0.963819512164298,1,20,membrane repolarization during cardiac muscle cell action potential,BP,KCNH2
13613,GO:0050716,0.262838154936274,0.963530190849356,1,24,positive regulation of interleukin-1 secretion,BP,WNT5A
10775,GO:0042347,0.26344696894224,0.963482569938359,1,22,negative regulation of NF-kappaB import into nucleus,BP,BMP7
4712,GO:0010002,0.263562906043909,0.963697396762631,1,19,cardioblast differentiation,BP,NOTCH1
7777,GO:0031112,0.263768315425636,0.963388388841072,1,22,positive regulation of microtubule polymerization or depolymerization,BP,PSRC1
20641,GO:1905897,0.264020098669666,0.921534200949983,2,69,regulation of response to endoplasmic reticulum stress,BP,PMAIP1;PIK3R1
18186,GO:0098827,0.264067451664238,0.963458721891554,1,20,endoplasmic reticulum subcompartment,CC,REEP1
17241,GO:0086001,0.264132162371868,0.921585054206408,2,64,cardiac muscle cell action potential,BP,DSC2;KCNH2
21352,GO:2000637,0.264383398389986,0.963366244756023,1,20,positive regulation of gene silencing by miRNA,BP,BMP4
5539,GO:0015645,0.264727010556654,0.96326552180819,1,20,fatty acid ligase activity,MF,ACSL4
17794,GO:0097186,0.264837045857459,0.963149906032804,1,21,amelogenesis,BP,ITGB4
15245,GO:0060914,0.264895173759291,0.963057056088625,1,22,heart formation,BP,BMP4
19611,GO:1903432,0.265211276543975,0.963039743388821,1,21,regulation of TORC1 signaling,BP,SESN2
18166,GO:0098794,0.265279800133418,0.842423707390438,8,400,postsynapse,CC,ACTN2;ADORA1;CDH2;DRP2;AKT1;LZTS1;SHC4;PDE4B
4563,GO:0009411,0.26599327585736,0.895079598177628,3,123,response to UV,BP,PIK3R1;CDKN1A;AKT1
10115,GO:0035902,0.266231723104364,0.962528088158618,1,24,response to immobilization stress,BP,FOXO4
12320,GO:0045732,0.266375046364032,0.865149606131066,5,251,positive regulation of protein catabolic process,BP,WNT5A;AXIN1;MSN;AKT1;RNF144A
11480,GO:0043555,0.266714507699996,0.962595384089641,1,21,regulation of translation in response to stress,BP,SESN2
14923,GO:0060396,0.266758194050946,0.962505609759735,1,22,growth hormone receptor signaling pathway,BP,PIK3R1
18653,GO:1901019,0.267198361882597,0.919893777492217,2,73,regulation of calcium ion transmembrane transporter activity,BP,CASQ2;PDE4B
9511,GO:0034612,0.267418591951099,0.864347344183476,5,278,response to tumor necrosis factor,BP,EDN1;CCL20;CLDN1;GAS6;CLDN18
20042,GO:1904376,0.267970760915502,0.962307059563334,1,20,negative regulation of protein localization to cell periphery,BP,RHOQ
11317,GO:0043281,0.268661271631456,0.876152822058274,4,192,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;CTGF;AKT1;GAS6
18114,GO:0098657,0.268790640281774,0.919221355959444,2,67,import into cell,BP,TF;GDNF
11521,GO:0043627,0.268914752617306,0.919042216709725,2,73,response to estrogen,BP,DHH;WNT7A
11897,GO:0044766,0.268986471036633,0.919043501154683,2,71,multi-organism transport,BP,NMT2;RAB40B
19224,GO:1902579,0.268986471036633,0.919043501154683,2,71,multi-organism localization,BP,NMT2;RAB40B
849,GO:0002052,0.26903965466688,0.961988196827295,1,20,positive regulation of neuroblast proliferation,BP,NOTCH1
4388,GO:0009110,0.269340233433595,0.96173377906417,1,22,vitamin biosynthetic process,BP,VDR
19422,GO:1903037,0.270428050108224,0.852632372139791,6,317,regulation of leukocyte cell-cell adhesion,BP,PIK3R1;SDC4;BMP4;AKT1;PIK3CA;EFNB2
12832,GO:0046849,0.270447458116944,0.918296793984617,2,72,bone remodeling,BP,RAB3D;CLDN18
116,GO:0000242,0.270468964637193,0.961559467283777,1,20,pericentriolar material,CC,TUBG2
16131,GO:0070821,0.270499408631595,0.918289743298596,2,71,tertiary granule membrane,CC,PLAU;VAMP1
5743,GO:0016051,0.270942478104366,0.87470387932856,4,186,carbohydrate biosynthetic process,BP,PDGFB;SESN2;B3GNT2;AKT1
17544,GO:0090322,0.27145238059772,0.960956766263604,1,24,regulation of superoxide metabolic process,BP,BMP7
483,GO:0001504,0.271642993908828,0.961038000271879,1,22,neurotransmitter uptake,BP,GDNF
18319,GO:0099504,0.271808960547908,0.891692446341533,3,118,synaptic vesicle cycle,BP,SYT5;WNT7A;CDH2
9961,GO:0035640,0.2720248644388,0.960921939175805,1,22,exploration behavior,BP,ITGA3
20956,GO:2000021,0.272344746830588,0.873774205887239,4,189,regulation of ion homeostasis,BP,ADORA1;CASQ2;EDN1;NPR1
11348,GO:0043325,0.272385081380036,0.960892359880381,1,21,phosphatidylinositol-3,4-bisphosphate binding,MF,AKT1
19541,GO:1903306,0.272574329975944,0.960834790670183,1,21,negative regulation of regulated secretory pathway,BP,NOTCH1
20970,GO:2000050,0.272699598930389,0.96088498918068,1,20,regulation of non-canonical Wnt signaling pathway,BP,WNT5A
4587,GO:0009583,0.27283481815806,0.917082452807958,2,73,detection of light stimulus,BP,NMT2;UNC119
12319,GO:0045730,0.272850592232728,0.960467996584394,1,25,respiratory burst,BP,PIK3CG
18478,GO:1900101,0.273191119848086,0.960566283678788,1,22,regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
12479,GO:0046031,0.273278261841766,0.916878094895859,2,72,ADP metabolic process,BP,ACTN3;PFKFB3
4237,GO:0008589,0.273354845616424,0.916963436471409,2,66,regulation of smoothened signaling pathway,BP,PRKACB;FGF10
12301,GO:0045686,0.273436612207551,0.960417544087178,1,23,negative regulation of glial cell differentiation,BP,NOTCH1
9105,GO:0033561,0.273544370901185,0.960538959740865,1,21,regulation of water loss via skin,BP,CLDN1
13414,GO:0048799,0.273700160014789,0.960491332771801,1,21,animal organ maturation,BP,BMP2
11902,GO:0044772,0.27440344308572,0.830028474719647,9,501,mitotic cell cycle phase transition,BP,GADD45A;ACVR1;PHLDA1;FGF10;FOXO4;CDKN1A;AKT1;LZTS1;PIM2
2185,GO:0004709,0.274451836849597,0.960350547107867,1,20,MAP kinase kinase kinase activity,MF,ARAF
2189,GO:0004714,0.274860546181973,0.916252145412689,2,64,transmembrane receptor protein tyrosine kinase activity,MF,TYRO3;DDR1
12412,GO:0045911,0.274877934903373,0.959974262428316,1,23,positive regulation of DNA recombination,BP,CLCF1
10905,GO:0042554,0.274954318043628,0.959882464899311,1,24,superoxide anion generation,BP,EDN1
14008,GO:0051302,0.27504495291352,0.889635217763521,3,131,regulation of cell division,BP,PDGFB;FGF8;DLL1
11012,GO:0042745,0.275378880912887,0.959526427984283,1,28,circadian sleep/wake cycle,BP,ADORA1
12817,GO:0046823,0.276207902275475,0.915379565751958,2,73,negative regulation of nucleocytoplasmic transport,BP,BMP7;GAS6
13245,GO:0048485,0.276339490446568,0.959679548513097,1,21,sympathetic nervous system development,BP,GDNF
7833,GO:0031253,0.276400936304089,0.848398040773195,6,295,cell projection membrane,CC,ITGA3;ITGA5;ADORA1;SPTBN5;TTYH1;MSN
14744,GO:0060148,0.27659040109064,0.959601892726988,1,21,positive regulation of posttranscriptional gene silencing,BP,BMP4
872,GO:0002080,0.276698474093994,0.959277756770277,1,25,acrosomal membrane,CC,SERPINA5
5072,GO:0010882,0.277001145203036,0.95931621553553,1,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,CASQ2
6835,GO:0021537,0.277102638405869,0.85781397612254,5,235,telencephalon development,BP,CDH2;WNT5A;FGF8;BMP4;BMP2
9920,GO:0035588,0.277308068607619,0.959220592166044,1,23,G-protein coupled purinergic receptor signaling pathway,BP,ADORA1
3740,GO:0007263,0.277869356675808,0.959045394136072,1,23,nitric oxide mediated signal transduction,BP,GUCY1B3
16436,GO:0071378,0.27817071953362,0.958951153917438,1,23,cellular response to growth hormone stimulus,BP,PIK3R1
11677,GO:0044236,0.278262301453721,0.887719125665366,3,129,multicellular organism metabolic process,BP,WNT4;BMP4;CTGF
18209,GO:0098869,0.278852533162488,0.913773335339483,2,90,cellular oxidant detoxification,BP,SESN2;BMP7
12030,GO:0045109,0.279019855380078,0.958761632168174,1,22,intermediate filament organization,BP,PKP1
3791,GO:0007398,0.279129487801924,0.958811328553916,1,21,ectoderm development,BP,FZD7
7997,GO:0031528,0.279201730851315,0.958704590729513,1,22,microvillus membrane,CC,MSN
11928,GO:0044818,0.27926073270671,0.958686076506869,1,22,mitotic G2/M transition checkpoint,BP,FOXO4
12330,GO:0045745,0.279343483724363,0.958512842482315,1,24,positive regulation of G-protein coupled receptor protein signaling pathway,BP,CHGA
4759,GO:0010226,0.279371034221184,0.958574590922981,1,23,response to lithium ion,BP,CDH1
18032,GO:0097730,0.27971222812274,0.886871766749549,3,126,non-motile cilium,CC,RAB27A;SPTBN5;MYO7A
1487,GO:0003208,0.280040647016866,0.913465160690652,2,71,cardiac ventricle morphogenesis,BP,NOTCH1;HEY1
18370,GO:0099623,0.280115102719104,0.958417460060935,1,22,regulation of cardiac muscle cell membrane repolarization,BP,KCNH2
8899,GO:0033032,0.280158294303741,0.958255738743966,1,24,regulation of myeloid cell apoptotic process,BP,KITLG
155,GO:0000303,0.280444045275957,0.957984132140014,1,27,response to superoxide,BP,BMP7
1029,GO:0002360,0.280576058009899,0.958123571946901,1,24,T cell lineage commitment,BP,ZFPM1
5393,GO:0015145,0.280657904041996,0.958246292860781,1,22,monosaccharide transmembrane transporter activity,MF,SLC2A14
11808,GO:0044441,0.281079091072918,0.836978245643346,7,364,ciliary part,CC,MARK4;RAB27A;PRKACB;SPTBN5;PRKAR1B;AKT1;MYO7A
673,GO:0001817,0.28164816751621,0.819650732819778,10,576,regulation of cytokine production,BP,ZFPM1;CCL20;PIK3R1;HRAS;WNT5A;DLL1;INHBB;GAS6;DTX4;PDE4B
6842,GO:0021544,0.281867459789637,0.957863447027404,1,22,subpallium development,BP,FGF8
5163,GO:0010996,0.281946752117999,0.957760002578879,1,23,response to auditory stimulus,BP,STRA6
11435,GO:0043501,0.282545247146962,0.957569445554768,1,23,skeletal muscle adaptation,BP,ACTN3
9528,GO:0034637,0.282805906566613,0.912023813412347,2,72,cellular carbohydrate biosynthetic process,BP,B3GNT2;AKT1
21173,GO:2000369,0.282838779103973,0.957640895985641,1,21,regulation of clathrin-dependent endocytosis,BP,UNC119
19249,GO:1902624,0.282884888479164,0.957102864757391,1,29,positive regulation of neutrophil migration,BP,EDN1
1033,GO:0002366,0.282914908040203,0.814501364480374,11,663,leukocyte activation involved in immune response,BP,RAB27A;CRISPLD2;ZFPM1;PLAU;CLCF1;DLL1;CHGA;PKP1;RAB44;PIK3CG;RAB3D
13697,GO:0050848,0.283907812204502,0.911361224923512,2,77,regulation of calcium-mediated signaling,BP,ACTN3;CASQ2
17133,GO:0072606,0.284295739837547,0.956869347403731,1,25,interleukin-8 secretion,BP,WNT5A
14192,GO:0051650,0.284683818435747,0.852495425582275,5,239,establishment of vesicle localization,BP,SYT5;RAB27A;WNT7A;RAB17;MYO7A
19033,GO:1902107,0.284703561504416,0.883781242898218,3,132,positive regulation of leukocyte differentiation,BP,LIF;KITLG;GAS6
13948,GO:0051222,0.284850833703082,0.827473728140592,8,443,positive regulation of protein transport,BP,PRR5L;PIK3R2;PIK3R1;WNT5A;BMP6;BMP4;CDH1;GAS6
18372,GO:0099625,0.284941404572872,0.95688162193403,1,22,ventricular cardiac muscle cell membrane repolarization,BP,KCNH2
8498,GO:0032438,0.284968533749755,0.956652306199925,1,25,melanosome organization,BP,RAB38
13950,GO:0051224,0.284995060908373,0.865411132618748,4,193,negative regulation of protein transport,BP,BMP7;INHBB;RAB11FIP1;GAS6
7109,GO:0022604,0.285010080882713,0.827405562190685,8,414,regulation of cell morphogenesis,BP,WNT3;WNT7A;WNT5A;RHOQ;RHOJ;MSN;LZTS1;PARVB
8780,GO:0032844,0.285340920876219,0.82710396831497,8,439,regulation of homeostatic process,BP,ZFPM1;ADORA1;CASQ2;EDN1;NPR1;DLL1;KITLG;CLDN18
16412,GO:0071347,0.285761693715478,0.910229686380786,2,88,cellular response to interleukin-1,BP,EDN1;CCL20
9567,GO:0034695,0.286009637728792,0.956383103807265,1,24,response to prostaglandin E,BP,AKT1
17386,GO:0090103,0.286071227958866,0.956436973559392,1,23,cochlea morphogenesis,BP,WNT5A
14799,GO:0060236,0.286349433642195,0.956346903325205,1,23,regulation of mitotic spindle organization,BP,PSRC1
8748,GO:0032801,0.286410075963023,0.956408019452011,1,22,receptor catabolic process,BP,GPRASP1
968,GO:0002263,0.286413291804257,0.811687821821257,11,665,cell activation involved in immune response,BP,RAB27A;CRISPLD2;ZFPM1;PLAU;CLCF1;DLL1;CHGA;PKP1;RAB44;PIK3CG;RAB3D
16437,GO:0071379,0.286448922711697,0.956395452903867,1,22,cellular response to prostaglandin stimulus,BP,AKT1
11492,GO:0043576,0.28655835080376,0.956360042982024,1,22,regulation of respiratory gaseous exchange,BP,ADORA1
3902,GO:0008037,0.286609106247961,0.882623550891851,3,131,cell recognition,BP,MFGE8;MSN;LAMA5
4585,GO:0009581,0.286738482104854,0.882553467044417,3,130,detection of external stimulus,BP,NMT2;ADORA1;UNC119
18208,GO:0098868,0.286866533323958,0.956179211236005,1,23,bone growth,BP,NPPC
10266,GO:0036152,0.287269412187711,0.95584223228497,1,26,phosphatidylethanolamine acyl-chain remodeling,BP,MBOAT2
20288,GO:1904886,0.28751812381104,0.956048773800118,1,22,beta-catenin destruction complex disassembly,BP,AXIN1
11151,GO:0043027,0.287546979774553,0.955814814468096,1,25,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,GAS6
9348,GO:0034243,0.287972795025273,0.955819238489831,1,23,regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
8433,GO:0032369,0.288045847087707,0.955651735484059,1,25,negative regulation of lipid transport,BP,AKT1
20863,GO:1990748,0.288124414745279,0.908942390483983,2,92,cellular detoxification,BP,SESN2;BMP7
13121,GO:0048169,0.288206326551668,0.955824809732307,1,22,regulation of long-term neuronal synaptic plasticity,BP,HRAS
20195,GO:1904705,0.289698244642265,0.955178761709482,1,24,regulation of vascular smooth muscle cell proliferation,BP,PDGFB
20903,GO:1990874,0.289698244642265,0.955178761709482,1,24,vascular smooth muscle cell proliferation,BP,PDGFB
18689,GO:1901135,0.290040566570439,0.787854427920756,19,1210,carbohydrate derivative metabolic process,BP,ACTN3;ITGB8;GUCY1B3;EDN1;PHLDA1;PDGFB;WNT5A;KHK;RHOQ;NPR1;PFKFB3;SDC4;HBEGF;BMP2;B3GNT2;CHGA;AKT1;NPPC;PDE4B
12631,GO:0046425,0.290221744458724,0.880280946776192,3,145,regulation of JAK-STAT cascade,BP,LIF;NOTCH1;CLCF1
20293,GO:1904892,0.290221744458724,0.880280946776192,3,145,regulation of STAT cascade,BP,LIF;NOTCH1;CLCF1
368,GO:0000983,0.290478453425612,0.955080812713031,1,22,transcription factor activity, RNA polymerase II core promoter sequence-specific,MF,HEY1
12803,GO:0046777,0.29061555980003,0.848345473200165,5,230,protein autophosphorylation,BP,TYRO3;PDGFB;DDR1;AKT1;PIM2
4481,GO:0009214,0.290630279371295,0.955121957377404,1,21,cyclic nucleotide catabolic process,BP,PDE4B
5203,GO:0014046,0.290645539245925,0.954671901876837,1,27,dopamine secretion,BP,GDNF
5215,GO:0014059,0.290645539245925,0.954671901876837,1,27,regulation of dopamine secretion,BP,GDNF
9268,GO:0034105,0.291228852759347,0.954538303597354,1,26,positive regulation of tissue remodeling,BP,VDR
4904,GO:0010640,0.291232182049998,0.954832455052827,1,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFB
782,GO:0001959,0.29125023886703,0.879675741098837,3,141,regulation of cytokine-mediated signaling pathway,BP,EDN1;WNT5A;GAS6
13650,GO:0050773,0.291382943263978,0.879771822480145,3,122,regulation of dendrite development,BP,BMP7;RAB17;LZTS1
8923,GO:0033081,0.291718334459968,0.954511332666622,1,24,regulation of T cell differentiation in thymus,BP,BMP4
13249,GO:0048489,0.29267421692943,0.878939533958994,3,125,synaptic vesicle transport,BP,SYT5;RAB27A;WNT7A
17942,GO:0097480,0.29267421692943,0.878939533958994,3,125,establishment of synaptic vesicle localization,BP,SYT5;RAB27A;WNT7A
18276,GO:0099003,0.29267421692943,0.878939533958994,3,125,vesicle-mediated transport in synapse,BP,SYT5;RAB27A;WNT7A
112,GO:0000226,0.293080121094974,0.821165589447345,8,418,microtubule cytoskeleton organization,BP,TUBG2;RAB6C;MARK4;GADD45A;FGF10;AXIN1;PSRC1;CAMSAP3
3881,GO:0007626,0.293131329587744,0.859990452890305,4,186,locomotory behavior,BP,CDH23;SPTBN4;ESPN;GDNF
10468,GO:0038084,0.293254427619156,0.954077635208783,1,23,vascular endothelial growth factor signaling pathway,BP,DLL1
17454,GO:0090200,0.293527753248601,0.953653687356507,1,28,positive regulation of release of cytochrome c from mitochondria,BP,PMAIP1
4066,GO:0008299,0.293580945606538,0.953819500932434,1,25,isoprenoid biosynthetic process,BP,HMGCS2
12487,GO:0046039,0.293770477209104,0.953689973636633,1,26,GTP metabolic process,BP,RHOQ
16741,GO:0071889,0.293803790342195,0.953894294813392,1,23,14-3-3 protein binding,MF,AKT1
9918,GO:0035586,0.294225034092816,0.953603565873919,1,25,purinergic receptor activity,MF,ADORA1
8747,GO:0032800,0.294312404787815,0.953646068153778,1,24,receptor biosynthetic process,BP,EDN1
12321,GO:0045736,0.295300614649872,0.953314015691341,1,24,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN1A
10650,GO:0042100,0.295591030379063,0.905040984257381,2,88,B cell proliferation,BP,CLCF1;CDKN1A
14887,GO:0060351,0.295739418902789,0.953245011480639,1,23,cartilage development involved in endochondral bone morphogenesis,BP,NPPC
13298,GO:0048588,0.295939055865972,0.858113776484569,4,182,developmental cell growth,BP,WNT3;EDN1;WNT5A;DDR1
13757,GO:0050919,0.29601337149997,0.95323893938645,1,22,negative chemotaxis,BP,WNT5A
15324,GO:0061037,0.296659934121298,0.952855069051415,1,24,negative regulation of cartilage development,BP,BMP4
17001,GO:0072331,0.296793445205038,0.843834474689245,5,255,signal transduction by p53 class mediator,BP,PMAIP1;GADD45A;SESN2;CDKN1A;AKT1
13394,GO:0048753,0.296834076480032,0.952655603281145,1,26,pigment granule organization,BP,RAB38
20960,GO:2000036,0.29687860560957,0.952947216928455,1,22,regulation of stem cell population maintenance,BP,BMP7
17002,GO:0072332,0.296902100898483,0.904464013951429,2,80,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PMAIP1;CDKN1A
14807,GO:0060251,0.297033519418084,0.952728489415751,1,24,regulation of glial cell proliferation,BP,NOTCH1
14855,GO:0060314,0.297502014683741,0.952496086782738,1,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,CASQ2
17251,GO:0086011,0.29751333886058,0.952645446546106,1,23,membrane repolarization during action potential,BP,KCNH2
4586,GO:0009582,0.297572011882407,0.875804865215165,3,133,detection of abiotic stimulus,BP,NMT2;ADORA1;UNC119
13791,GO:0050996,0.297603737397842,0.952330978016091,1,27,positive regulation of lipid catabolic process,BP,SESN2
18594,GO:1900371,0.297637180101016,0.875645533387904,3,147,regulation of purine nucleotide biosynthetic process,BP,EDN1;NPR1;NPPC
9172,GO:0033688,0.29774717336738,0.952566089665537,1,23,regulation of osteoblast proliferation,BP,BMP2
7885,GO:0031327,0.298516842648211,0.774381517419808,23,1445,negative regulation of cellular biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;DKK3;EDN1;PDGFB;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;INHBB;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
13605,GO:0050708,0.298831760174102,0.823495873394597,7,386,regulation of protein secretion,BP,ADRA2C;WNT5A;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6
10040,GO:0035767,0.298901507765475,0.951950243048644,1,26,endothelial cell chemotaxis,BP,NOTCH1
13603,GO:0050706,0.29899591853268,0.951795812379695,1,28,regulation of interleukin-1 beta secretion,BP,WNT5A
1196,GO:0002675,0.299104858565565,0.951817188819011,1,27,positive regulation of acute inflammatory response,BP,PIK3CG
7400,GO:0030332,0.299169907794676,0.952000927472955,1,24,cyclin binding,MF,CDKN1A
12460,GO:0045987,0.299451584206155,0.951830178084014,1,25,positive regulation of smooth muscle contraction,BP,EDN1
5070,GO:0010880,0.299470197666471,0.951823794970717,1,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,CASQ2
8864,GO:0032982,0.300060832624743,0.95186542654157,1,22,myosin filament,CC,MYH11
7583,GO:0030808,0.300160899935477,0.874049924170696,3,148,regulation of nucleotide biosynthetic process,BP,EDN1;NPR1;NPPC
7054,GO:0021952,0.300947349578471,0.951561567017686,1,22,central nervous system projection neuron axonogenesis,BP,SPTBN4
13924,GO:0051181,0.301481766903567,0.951131134030678,1,25,cofactor transport,BP,FLVCR2
10958,GO:0042634,0.301570496415348,0.951100451593786,1,25,regulation of hair cycle,BP,WNT5A
4885,GO:0010613,0.301978315103518,0.95103489095391,1,24,positive regulation of cardiac muscle hypertrophy,BP,EDN1
5253,GO:0014742,0.301978315103518,0.95103489095391,1,24,positive regulation of muscle hypertrophy,BP,EDN1
10624,GO:0042044,0.302291548730809,0.950780803378196,1,26,fluid transport,BP,EDN1
19682,GO:1903580,0.302368863229078,0.950753946222117,1,26,positive regulation of ATP metabolic process,BP,ACTN3
8978,GO:0033173,0.302434455406288,0.950876954057589,1,24,calcineurin-NFAT signaling cascade,BP,ACTN3
16368,GO:0071276,0.30263270651147,0.950379991680912,1,31,cellular response to cadmium ion,BP,AKT1
7098,GO:0022408,0.303089197809958,0.872289212399185,3,137,negative regulation of cell-cell adhesion,BP,SDC4;BMP4;CDH1
14880,GO:0060343,0.303508723027605,0.950427483525467,1,25,trabecula formation,BP,HEY1
19906,GO:1904030,0.303886648156773,0.950295654897819,1,25,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
11226,GO:0043154,0.303961831404214,0.900630712534578,2,81,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,AKT1;GAS6
3418,GO:0006735,0.303994903656967,0.950187168048333,1,26,NADH regeneration,BP,PFKFB3
15573,GO:0061621,0.303994903656967,0.950187168048333,1,26,canonical glycolysis,BP,PFKFB3
15617,GO:0061718,0.303994903656967,0.950187168048333,1,26,glucose catabolic process to pyruvate,BP,PFKFB3
7268,GO:0030159,0.304554486494363,0.950139099731235,1,24,receptor signaling complex scaffold activity,MF,AXIN1
10265,GO:0036151,0.304628387623498,0.949899659880018,1,27,phosphatidylcholine acyl-chain remodeling,BP,MBOAT2
1838,GO:0004114,0.304856585603549,0.950033447309334,1,24,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
13882,GO:0051125,0.304863969525591,0.950030863352588,1,24,regulation of actin nucleation,BP,SCIN
16531,GO:0071514,0.305502339660631,0.949729817131093,1,25,genetic imprinting,BP,PIK3CA
14835,GO:0060292,0.305632111028483,0.949845840041665,1,23,long term synaptic depression,BP,ADORA1
4257,GO:0008625,0.305708922231119,0.899711719315472,2,79,extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;PIK3R1
1260,GO:0002757,0.306064974338839,0.810947960808527,8,454,immune response-activating signal transduction,BP,PRKACB;TYRO3;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
15983,GO:0070507,0.306081030508845,0.870454117768063,3,130,regulation of microtubule cytoskeleton organization,BP,RAB6C;PSRC1;CAMSAP3
3597,GO:0007020,0.30651537283846,0.949535734418391,1,23,microtubule nucleation,BP,TUBG2
8761,GO:0032814,0.306629850751555,0.949194315766751,1,27,regulation of natural killer cell activation,BP,GAS6
12667,GO:0046487,0.30722964622528,0.94891982102247,1,28,glyoxylate metabolic process,BP,GLDC
11463,GO:0043537,0.307319097283496,0.949089201042787,1,25,negative regulation of blood vessel endothelial cell migration,BP,NOTCH1
21230,GO:2000463,0.307340157296967,0.949245175173486,1,23,positive regulation of excitatory postsynaptic potential,BP,WNT7A
769,GO:0001945,0.307451325509414,0.949120742483486,1,24,lymph vessel development,BP,EFNB2
71,GO:0000146,0.307836403597614,0.949163113349398,1,22,microfilament motor activity,MF,MYO7A
11105,GO:0042974,0.308116536879558,0.948885235016065,1,24,retinoic acid receptor binding,MF,VDR
15810,GO:0070229,0.308171138510647,0.948584910185918,1,28,negative regulation of lymphocyte apoptotic process,BP,BMP4
743,GO:0001913,0.308514036813441,0.948462623150724,1,28,T cell mediated cytotoxicity,BP,RAB27A
13340,GO:0048668,0.308683835485116,0.948683901589912,1,24,collateral sprouting,BP,WNT3
17470,GO:0090224,0.30948100180163,0.948320847132704,1,25,regulation of spindle organization,BP,PSRC1
14253,GO:0051781,0.309756818302407,0.897429928724943,2,82,positive regulation of cell division,BP,PDGFB;FGF8
8496,GO:0032436,0.309824697260402,0.897525591933583,2,75,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,AKT1;RNF144A
8267,GO:0032069,0.309886088930714,0.948102712787772,1,26,regulation of nuclease activity,BP,AKT1
18027,GO:0097720,0.309970593357114,0.948145930655719,1,25,calcineurin-mediated signaling,BP,ACTN3
9821,GO:0035412,0.310033814040271,0.948202978468956,1,24,regulation of catenin import into nucleus,BP,FZD7
19543,GO:1903311,0.310138259333359,0.867847467994374,3,131,regulation of mRNA metabolic process,BP,PRR5L;PKP3;PKP1
830,GO:0002026,0.310418203018903,0.94784383431006,1,27,regulation of the force of heart contraction,BP,CHGA
18146,GO:0098754,0.310473601088598,0.896824677392599,2,96,detoxification,BP,SESN2;BMP7
17149,GO:0072661,0.310815172367636,0.947923452303709,1,24,protein targeting to plasma membrane,BP,GAS6
15569,GO:0061615,0.310916815048975,0.947664581110354,1,27,glycolytic process through fructose-6-phosphate,BP,PFKFB3
15572,GO:0061620,0.310916815048975,0.947664581110354,1,27,glycolytic process through glucose-6-phosphate,BP,PFKFB3
14997,GO:0060487,0.311101048893149,0.947666757340513,1,26,lung epithelial cell differentiation,BP,FGF10
21158,GO:2000352,0.311277881446291,0.947603132079682,1,26,negative regulation of endothelial cell apoptotic process,BP,GAS6
4995,GO:0010771,0.311310476214275,0.896724010389489,2,74,negative regulation of cell morphogenesis involved in differentiation,BP,WNT3;WNT5A
99,GO:0000188,0.312119091873073,0.947299855178615,1,26,inactivation of MAPK activity,BP,DUSP5
5981,GO:0016538,0.312188924622994,0.947082044352652,1,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN1A
21011,GO:2000116,0.312228365883837,0.84676355546694,4,206,regulation of cysteine-type endopeptidase activity,BP,PMAIP1;CTGF;AKT1;GAS6
3888,GO:0008009,0.312385210315142,0.946372223474731,1,47,chemokine activity,MF,CCL20
8895,GO:0033028,0.312564625340221,0.947005507602949,1,28,myeloid cell apoptotic process,BP,KITLG
6376,GO:0018198,0.312599241087126,0.94705714730284,1,27,peptidyl-cysteine modification,BP,RAB3D
6613,GO:0019433,0.312608800346936,0.946727090783263,1,33,triglyceride catabolic process,BP,PIK3CG
156,GO:0000305,0.312889448829801,0.946771948750027,1,30,response to oxygen radical,BP,BMP7
8938,GO:0033120,0.313227574825235,0.946973703429147,1,25,positive regulation of RNA splicing,BP,PIK3R1
4394,GO:0009117,0.313336429926847,0.79409186182391,10,641,nucleotide metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
303,GO:0000803,0.313379254516854,0.946843662660189,1,26,sex chromosome,CC,SIN3B
7559,GO:0030695,0.313566065956322,0.820851648299189,6,300,GTPase regulator activity,MF,RIN3;PIK3R2;SESN2;AXIN1;GPSM1;SH3BP4
8804,GO:0032892,0.313640142066026,0.946614709837129,1,28,positive regulation of organic acid transport,BP,EDN1
3135,GO:0006359,0.313850072722903,0.946747952152592,1,25,regulation of transcription from RNA polymerase III promoter,BP,NAB2
785,GO:0001963,0.313904902821715,0.946401804931353,1,30,synaptic transmission, dopaminergic,BP,GDNF
15176,GO:0060759,0.314125813173135,0.865128960351584,3,147,regulation of response to cytokine stimulus,BP,EDN1;WNT5A;GAS6
1,GO:0000002,0.31413551898354,0.946644250411486,1,25,mitochondrial genome maintenance,BP,SESN2
4092,GO:0008344,0.314168979489833,0.895049985664635,2,78,adult locomotory behavior,BP,SPTBN4;GDNF
3906,GO:0008045,0.314285119258049,0.946589854978183,1,25,motor neuron axon guidance,BP,FGF8
5907,GO:0016411,0.314428485342817,0.946462113040359,1,26,acylglycerol O-acyltransferase activity,MF,MBOAT2
3552,GO:0006952,0.314494968782042,0.763312633551276,21,1444,defense response,BP,NOTCH1;RAB27A;PMAIP1;ACVR1;ADORA1;EDN1;PRKACB;CCL20;TYRO3;HRAS;WNT5A;JAM3;BMP6;BMP2;CHGA;AKT1;PTGES;INHBB;CLDN1;PIK3CG;TSPAN2
9334,GO:0034219,0.314901071429691,0.946289748289696,1,26,carbohydrate transmembrane transport,BP,SLC2A14
13719,GO:0050870,0.314912141337641,0.844876577855072,4,208,positive regulation of T cell activation,BP,PIK3R1;AKT1;PIK3CA;EFNB2
3705,GO:0007202,0.314965182704438,0.946266340766277,1,26,activation of phospholipase C activity,BP,LPAR2
1215,GO:0002695,0.31533596158079,0.864377664082378,3,143,negative regulation of leukocyte activation,BP,TYRO3;SDC4;BMP4
6911,GO:0021680,0.315579653736025,0.946200340995655,1,24,cerebellar Purkinje cell layer development,BP,DLL1
2515,GO:0005201,0.31569661312414,0.894256147746503,2,75,extracellular matrix structural constituent,MF,HAPLN3;LAMA1
2838,GO:0005859,0.316104011404048,0.945778872452979,1,27,muscle myosin complex,CC,MYH11
13686,GO:0050821,0.31613928418225,0.863855651215682,3,143,protein stabilization,BP,PIK3R1;CDKN1A;PIM2
6172,GO:0016878,0.316382721311778,0.945823811591978,1,25,acid-thiol ligase activity,MF,ACSL4
1836,GO:0004112,0.316394649091567,0.945819437698664,1,25,cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
8659,GO:0032673,0.316830905948179,0.945511568840846,1,27,regulation of interleukin-4 production,BP,ZFPM1
18654,GO:1901020,0.316845332922826,0.945321702305493,1,30,negative regulation of calcium ion transmembrane transporter activity,BP,CASQ2
7472,GO:0030516,0.316892423079606,0.893584574088557,2,75,regulation of axon extension,BP,WNT3;WNT5A
2632,GO:0005501,0.317455642840281,0.945042219451425,1,31,retinoid binding,MF,SERPINA5
2641,GO:0005516,0.318334927681368,0.842582041877526,4,189,calmodulin binding,MF,CAMSAP3;RRAD;MYO7A;MYH11
11881,GO:0044724,0.318357672453116,0.862455446402817,3,138,single-organism carbohydrate catabolic process,BP,ACTN3;KHK;PFKFB3
11002,GO:0042730,0.319448487727449,0.944542748321754,1,27,fibrinolysis,BP,PLAU
4670,GO:0009890,0.319945566419787,0.755565193669587,23,1465,negative regulation of biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;DKK3;EDN1;PDGFB;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;INHBB;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
9762,GO:0035303,0.320135682531544,0.861362712007338,3,131,regulation of dephosphorylation,BP,ADORA1;BMP2;CAMSAP3
6537,GO:0019219,0.32026316244305,0.731695452399189,60,3966,regulation of nucleobase-containing compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
11448,GO:0043516,0.320278882660082,0.944165999173509,1,28,regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
4007,GO:0008209,0.320301836097672,0.944157423440525,1,28,androgen metabolic process,BP,WNT4
8200,GO:0031954,0.320715667051239,0.94422158607461,1,25,positive regulation of protein autophosphorylation,BP,PDGFB
3023,GO:0006165,0.321330489915564,0.890916684900289,2,83,nucleoside diphosphate phosphorylation,BP,ACTN3;PFKFB3
1234,GO:0002714,0.321511822260136,0.943582177163578,1,30,positive regulation of B cell mediated immunity,BP,CLCF1
1346,GO:0002891,0.321511822260136,0.943582177163578,1,30,positive regulation of immunoglobulin mediated immune response,BP,CLCF1
1647,GO:0003774,0.321651961227095,0.860379128113372,3,130,motor activity,MF,CGN;MYO7A;MYH11
13163,GO:0048259,0.321703681663232,0.890759918290449,2,80,regulation of receptor-mediated endocytosis,BP,TF;UNC119
14990,GO:0060479,0.322477697004777,0.943409329308869,1,27,lung cell differentiation,BP,FGF10
9124,GO:0033598,0.32327901630507,0.94310730014023,1,27,mammary gland epithelial cell proliferation,BP,WNT5A
14227,GO:0051721,0.323454248748369,0.943195069204258,1,25,protein phosphatase 2A binding,MF,AKT1
11154,GO:0043030,0.323605941404222,0.942791376022245,1,30,regulation of macrophage activation,BP,WNT5A
11711,GO:0044282,0.323712082872881,0.81298804700281,6,336,small molecule catabolic process,BP,ACTN3;GLDC;KHK;SESN2;PFKFB3;AKT1
11434,GO:0043500,0.323906038881933,0.889464513478628,2,82,muscle adaptation,BP,ACTN3;EDN1
15308,GO:0061014,0.32392638168583,0.942936832086201,1,26,positive regulation of mRNA catabolic process,BP,PRR5L
3430,GO:0006753,0.324497728779384,0.784915673170086,10,647,nucleoside phosphate metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
14102,GO:0051482,0.32457399220774,0.942548092976938,1,28,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,EDN1
19054,GO:1902175,0.32490798068706,0.942356673650174,1,29,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,AKT1
2909,GO:0005979,0.325242544808429,0.942438113008584,1,26,regulation of glycogen biosynthetic process,BP,AKT1
5136,GO:0010962,0.325242544808429,0.942438113008584,1,26,regulation of glucan biosynthetic process,BP,AKT1
3860,GO:0007601,0.3253445096822,0.837516102943811,4,206,visual perception,BP,CDH23;MYO7A;GJA3;UNC119
497,GO:0001523,0.326156091528656,0.88805208944919,2,89,retinoid metabolic process,BP,STRA6;SDC4
3707,GO:0007205,0.326158517450225,0.941944507135787,1,28,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,EDN1
9523,GO:0034629,0.326407081634493,0.941919425042842,1,27,cellular protein complex localization,BP,RALB
9731,GO:0035250,0.326494574009917,0.941885996797007,1,27,UDP-galactosyltransferase activity,MF,B3GNT2
9171,GO:0033687,0.326499563396832,0.941959471110729,1,26,osteoblast proliferation,BP,BMP2
7107,GO:0022602,0.326573672317366,0.887951090944681,2,81,ovulation cycle process,BP,KITLG;INHBB
8696,GO:0032731,0.326586071514572,0.94165506630547,1,30,positive regulation of interleukin-1 beta production,BP,WNT5A
9743,GO:0035264,0.326802686284323,0.856878857116803,3,140,multicellular organism growth,BP,SPTBN4;NPPC;PIK3CA
17799,GO:0097193,0.326947883904815,0.821687344988001,5,273,intrinsic apoptotic signaling pathway,BP,PMAIP1;PIK3R1;HRAS;CDKN1A;AKT1
12079,GO:0045191,0.327025447286249,0.941612733798324,1,28,regulation of isotype switching,BP,CLCF1
7091,GO:0022400,0.327150467008525,0.941564799000549,1,28,regulation of rhodopsin mediated signaling pathway,BP,NMT2
4766,GO:0010259,0.327455339559175,0.941518187634739,1,27,multicellular organism aging,BP,EDN1
14349,GO:0051955,0.327466549473418,0.941513888259462,1,27,regulation of amino acid transport,BP,ADORA1
7617,GO:0030851,0.327508609487327,0.941361832806742,1,29,granulocyte differentiation,BP,ZFPM1
14609,GO:0055090,0.327695288681344,0.94111795512203,1,32,acylglycerol homeostasis,BP,SESN2
15878,GO:0070328,0.327695288681344,0.94111795512203,1,32,triglyceride homeostasis,BP,SESN2
21012,GO:2000117,0.328595594223892,0.886692088781804,2,86,negative regulation of cysteine-type endopeptidase activity,BP,AKT1;GAS6
9057,GO:0033363,0.328761905303276,0.94087889491817,1,29,secretory granule organization,BP,RAB38
10540,GO:0038202,0.328947370257773,0.940944341809931,1,27,TORC1 signaling,BP,SESN2
20525,GO:1905476,0.328984066779719,0.941006708361301,1,26,negative regulation of protein localization to membrane,BP,RHOQ
330,GO:0000910,0.329007670658726,0.855442416406413,3,137,cytokinesis,BP,RALB;SNX18;RHOB
13065,GO:0048011,0.32907780996062,0.940970584332656,1,26,neurotrophin TRK receptor signaling pathway,BP,BCAR1
16038,GO:0070588,0.329106076376111,0.820126245789849,5,259,calcium ion transmembrane transport,BP,CASQ2;TSPAN13;PIK3CG;GAS6;PDE4B
21004,GO:2000108,0.329518402977362,0.940524405289423,1,30,positive regulation of leukocyte apoptotic process,BP,WNT5A
982,GO:0002286,0.329664112948779,0.885975580731681,2,92,T cell activation involved in immune response,BP,RAB27A;ZFPM1
13946,GO:0051219,0.32974444065196,0.88619924553801,2,77,phosphoprotein binding,MF,PIK3R2;PIK3R1
4922,GO:0010662,0.329828103054829,0.940604088136357,1,27,regulation of striated muscle cell apoptotic process,BP,BMP7
12586,GO:0046320,0.330257407374372,0.940437825942281,1,27,regulation of fatty acid oxidation,BP,AKT1
12396,GO:0045879,0.330309896202472,0.940577948792711,1,25,negative regulation of smoothened signaling pathway,BP,PRKACB
11900,GO:0044770,0.33064696731747,0.785143798474652,9,530,cell cycle phase transition,BP,GADD45A;ACVR1;PHLDA1;FGF10;FOXO4;CDKN1A;AKT1;LZTS1;PIM2
7908,GO:0031365,0.330888883637374,0.940120932996551,1,28,N-terminal protein amino acid modification,BP,NMT2
13372,GO:0048709,0.331693427611593,0.884963817368942,2,82,oligodendrocyte differentiation,BP,NOTCH1;TSPAN2
18632,GO:1900739,0.331809233789774,0.939695113773769,1,29,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
18633,GO:1900740,0.331809233789774,0.939695113773769,1,29,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
9820,GO:0035411,0.331840902507948,0.939900086278863,1,26,catenin import into nucleus,BP,FZD7
8191,GO:0031941,0.333118058510747,0.939323086184462,1,27,filamentous actin,CC,ESPN
18304,GO:0099106,0.333332697255137,0.883950005727902,2,85,ion channel regulator activity,MF,TSPAN13;WNK4
5263,GO:0014808,0.333399595979731,0.939071927455928,1,29,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,CASQ2
12773,GO:0046685,0.334721176475543,0.938551244835409,1,29,response to arsenic-containing substance,BP,CDKN1A
11283,GO:0043236,0.334941733669295,0.938532596529733,1,28,laminin binding,MF,ITGA3
15382,GO:0061136,0.334954188952031,0.851402132206698,3,143,regulation of proteasomal protein catabolic process,BP,AKT1;ARAF;RNF144A
13337,GO:0048665,0.334958399157409,0.938393594979845,1,30,neuron fate specification,BP,DLL1
12389,GO:0045861,0.335311579619632,0.815288665579233,5,304,negative regulation of proteolysis,BP,CRB2;SERPINA5;AKT1;CST9L;GAS6
7979,GO:0031492,0.335371839294798,0.938229879351805,1,30,nucleosomal DNA binding,MF,HMGN5
14348,GO:0051954,0.335859279299757,0.938036538032892,1,30,positive regulation of amine transport,BP,GDNF
17907,GO:0097421,0.336145491831245,0.937806240006305,1,32,liver regeneration,BP,CLDN1
13773,GO:0050953,0.336412521030763,0.829545527691613,4,209,sensory perception of light stimulus,BP,CDH23;MYO7A;GJA3;UNC119
19088,GO:1902235,0.337053868534844,0.937625938599211,1,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
5107,GO:0010922,0.33721626702114,0.937705231050266,1,27,positive regulation of phosphatase activity,BP,BMP2
5572,GO:0015718,0.337543491892053,0.849626502126024,3,146,monocarboxylic acid transport,BP,EDN1;AKT1;ACSL4
13956,GO:0051233,0.337569336350209,0.937489951974334,1,28,spindle midzone,CC,UNC119
7579,GO:0030804,0.337784287513985,0.88115095336732,2,96,positive regulation of cyclic nucleotide biosynthetic process,BP,NPR1;NPPC
7118,GO:0022617,0.338122301548619,0.881128621870016,2,85,extracellular matrix disassembly,BP,DDR1;CDH1
15515,GO:0061462,0.338267278603121,0.937286346090896,1,27,protein localization to lysosome,BP,SH3BP4
17132,GO:0072604,0.33835186941432,0.937107591753747,1,29,interleukin-6 secretion,BP,GAS6
6724,GO:0019840,0.338845699369967,0.936672045523498,1,33,isoprenoid binding,MF,SERPINA5
4000,GO:0008200,0.340442260160833,0.936139853001924,1,31,ion channel inhibitor activity,MF,WNK4
14000,GO:0051293,0.341762924653973,0.93580482301205,1,28,establishment of spindle localization,BP,FGF10
7902,GO:0031345,0.34181504028262,0.846762050965609,3,142,negative regulation of cell projection organization,BP,ITGA3;WNT3;WNT5A
19637,GO:1903514,0.341839767198301,0.93563585009161,1,30,calcium ion transport from endoplasmic reticulum to cytosol,BP,CASQ2
11198,GO:0043114,0.342112827314162,0.935591616359382,1,29,regulation of vascular permeability,BP,NPR1
7977,GO:0031490,0.342274788473444,0.878620600680825,2,87,chromatin DNA binding,MF,NOTCH1;HMGN5
8671,GO:0032689,0.342382278877654,0.935353032743273,1,31,negative regulation of interferon-gamma production,BP,GAS6
13160,GO:0048255,0.342444492279891,0.935528485602148,1,28,mRNA stabilization,BP,GDNF
4908,GO:0010644,0.342532273806244,0.935569776336803,1,27,cell communication by electrical coupling,BP,CASQ2
13177,GO:0048284,0.342713820511948,0.824984584471922,4,204,organelle fusion,BP,SYT5;RAB39A;RAB20;VAMP1
3646,GO:0007098,0.342829764162558,0.878424047803227,2,80,centrosome cycle,BP,RAB6C;GADD45A
12886,GO:0046939,0.342909983868938,0.878222719561191,2,88,nucleotide phosphorylation,BP,ACTN3;PFKFB3
7892,GO:0031334,0.343187707367664,0.824602967883909,4,210,positive regulation of protein complex assembly,BP,PMAIP1;SCIN;PSRC1;MSN
9281,GO:0034122,0.343269984802224,0.935192870936267,1,28,negative regulation of toll-like receptor signaling pathway,BP,TYRO3
5562,GO:0015696,0.344012547867128,0.877527059211033,2,90,ammonium transport,BP,EDN1;GDNF
12421,GO:0045920,0.344037445476159,0.934879940982205,1,28,negative regulation of exocytosis,BP,NOTCH1
9670,GO:0035066,0.344174345732558,0.934751748368889,1,29,positive regulation of histone acetylation,BP,LIF
7774,GO:0031109,0.344443961634915,0.87739486769494,2,83,microtubule polymerization or depolymerization,BP,TUBG2;PSRC1
17460,GO:0090207,0.345318330628897,0.934036217936128,1,33,regulation of triglyceride metabolic process,BP,PIK3CG
19424,GO:1903039,0.345344328170492,0.822982397104836,4,217,positive regulation of leukocyte cell-cell adhesion,BP,PIK3R1;AKT1;PIK3CA;EFNB2
18793,GO:1901385,0.345435291841875,0.934043926430301,1,32,regulation of voltage-gated calcium channel activity,BP,PDE4B
10757,GO:0042311,0.345630596980511,0.93408664891904,1,30,vasodilation,BP,ADORA1
11357,GO:0043368,0.345675397840076,0.934004599940713,1,31,positive T cell selection,BP,ZFPM1
699,GO:0001844,0.345842186301857,0.933935874225263,1,31,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
17788,GO:0097178,0.346168525262288,0.933865076117546,1,30,ruffle assembly,BP,HRAS
3882,GO:0007628,0.346194212441939,0.933995827115322,1,28,adult walking behavior,BP,SPTBN4
3851,GO:0007586,0.346417861223745,0.843401392470499,3,167,digestion,BP,FGF10;WNK4;VDR
19271,GO:1902692,0.346899116651225,0.93378424460638,1,27,regulation of neuroblast proliferation,BP,NOTCH1
6360,GO:0018146,0.346949416850134,0.93368460816014,1,28,keratan sulfate biosynthetic process,BP,B3GNT2
2789,GO:0005776,0.347050210131183,0.875844187138424,2,82,autophagosome,CC,RALB;RAB12
13237,GO:0048469,0.34740895412088,0.842853440433631,3,150,cell maturation,BP,SPTBN4;CDKN1A;NPPC
5468,GO:0015295,0.347415582248656,0.933492076163674,1,28,solute:proton symporter activity,MF,SLC45A4
13376,GO:0048713,0.347713322830362,0.933226365751173,1,30,regulation of oligodendrocyte differentiation,BP,NOTCH1
10383,GO:0036477,0.347757227625539,0.760872646318255,11,644,somatodendritic compartment,CC,SYT5;ACTN2;RAB27A;ADORA1;SPTBN4;DRP2;RAB17;LZTS1;KCND1;ACSL4;PDE4B
5228,GO:0014074,0.347857404906848,0.842619159182841,3,142,response to purine-containing compound,BP,CASQ2;WT1;PIK3CG
5744,GO:0016052,0.348084903406714,0.842423801408758,3,146,carbohydrate catabolic process,BP,ACTN3;KHK;PFKFB3
6763,GO:0019905,0.348095000287698,0.875232671738039,2,81,syntaxin binding,MF,SYT5;VAMP1
18226,GO:0098901,0.348574235596378,0.933091764163529,1,27,regulation of cardiac muscle cell action potential,BP,DSC2
19474,GO:1903170,0.348681008855101,0.932642135855008,1,33,negative regulation of calcium ion transmembrane transport,BP,CASQ2
7444,GO:0030431,0.349383820163404,0.932244101665471,1,35,sleep,BP,ADORA1
12843,GO:0046873,0.349417469998183,0.776030291513848,8,436,metal ion transmembrane transporter activity,MF,TF;KCNK6;TTYH1;KCNH2;KCNG2;GAS6;KCND1;CLDN16
13132,GO:0048193,0.349512800958003,0.792851260507436,6,326,Golgi vesicle transport,BP,RAB6C;RABIF;SPTBN5;SPTBN4;SPTB;GAS6
16658,GO:0071709,0.349970880515761,0.932430922309275,1,28,membrane assembly,BP,CDH2
10289,GO:0036257,0.349975939806866,0.932219220998124,1,31,multivesicular body organization,BP,RAB27A
16164,GO:0070873,0.350027828053436,0.93233243418254,1,29,regulation of glycogen metabolic process,BP,AKT1
20709,GO:1990138,0.350115022246729,0.841111345172924,3,137,neuron projection extension,BP,WNT3;WNT5A;DDR1
11974,GO:0045026,0.350622791522357,0.931886959822214,1,32,plasma membrane fusion,BP,SERPINA5
39,GO:0000077,0.351171639972457,0.840298259963758,3,145,DNA damage checkpoint,BP,GADD45A;FOXO4;CDKN1A
5836,GO:0016248,0.351390881720409,0.931564145091643,1,32,channel inhibitor activity,MF,WNK4
11923,GO:0044803,0.351411175161063,0.931617190474763,1,31,multi-organism membrane organization,BP,GAS6
8283,GO:0032094,0.351439023234208,0.931331856041617,1,36,response to food,BP,AKT1
3529,GO:0006911,0.352664594330745,0.931088882163104,1,31,phagocytosis, engulfment,BP,MFGE8
1587,GO:0003382,0.353383960823122,0.93092208955247,1,29,epithelial cell morphogenesis,BP,CLDN3
21657,GO:2001258,0.353397477619989,0.930603088069334,1,34,negative regulation of cation channel activity,BP,CASQ2
21080,GO:2000249,0.353494674445018,0.930675392296624,1,32,regulation of actin cytoskeleton reorganization,BP,HRAS
12345,GO:0045777,0.353966634519599,0.930361217608643,1,34,positive regulation of blood pressure,BP,ADORA1
8871,GO:0032991,0.353986400362577,0.698706541121423,66,4576,macromolecular complex,CC,ITGA3;ITGA5;WNT3;WNT2;POU3F1;TUBG2;TSPAN17;NOTCH1;GLDC;STRA6;TF;ITGB5;ITGB4;ITGB8;CRB2;SERPINA5;ZFPM1;ACVR1;GUCY1B3;CASQ2;PRKACB;KCNK6;TTYH1;CDH2;PRR5L;PIK3R2;PIK3R1;CGN;KCNH2;PRKAR1B;RALB;SESN2;AXIN1;NPR1;SCIN;CLCF1;SPTB;BMP2;CDKN1A;ESPN;VAMP1;DDR1;GJB1;GJB2;GJB6;AKT1;PKP3;PKP1;NPPC;CDH1;MYO7A;GJA3;PIK3CA;PIK3CG;KCNG2;SIN3B;MYH11;VDR;AMOT;LAMA1;LAMA5;KCND1;FZD8;ACTA2;RNF144A;PDE4B
6140,GO:0016829,0.354101360555753,0.838179011840561,3,154,lyase activity,MF,GLDC;GUCY1B3;NPR1
15858,GO:0070296,0.354176909395493,0.930385741210954,1,32,sarcoplasmic reticulum calcium ion transport,BP,CASQ2
5127,GO:0010952,0.354615266215446,0.837820420262871,3,154,positive regulation of peptidase activity,BP,PMAIP1;MAPK12;CTGF
4918,GO:0010658,0.35486232653702,0.930223803995014,1,30,striated muscle cell apoptotic process,BP,BMP7
21436,GO:2000758,0.355062417325181,0.930138655266798,1,30,positive regulation of peptidyl-lysine acetylation,BP,LIF
10590,GO:0040018,0.35514090818589,0.929975259909766,1,32,positive regulation of multicellular organism growth,BP,SPTBN4
9919,GO:0035587,0.355440682042808,0.929910312004062,1,31,purinergic receptor signaling pathway,BP,ADORA1
776,GO:0001953,0.355785688408475,0.929979535472322,1,28,negative regulation of cell-matrix adhesion,BP,PIK3R1
7631,GO:0030866,0.355973125057209,0.929899665802085,1,28,cortical actin cytoskeleton organization,BP,RHOQ
674,GO:0001818,0.356055525325709,0.815039673814825,4,218,negative regulation of cytokine production,BP,ZFPM1;DLL1;INHBB;GAS6
13940,GO:0051204,0.356702689574707,0.929307238338406,1,32,protein insertion into mitochondrial membrane,BP,PMAIP1
4846,GO:0010543,0.356859875198104,0.929443451782964,1,29,regulation of platelet activation,BP,PDGFB
737,GO:0001906,0.357030352502973,0.869349275404164,2,106,cell killing,BP,RAB27A;CHGA
17657,GO:0090659,0.357048882502061,0.929362523179762,1,29,walking behavior,BP,SPTBN4
20895,GO:1990841,0.357484563730882,0.929253668675174,1,28,promoter-specific chromatin binding,MF,FOXO4
1172,GO:0002639,0.357719703674122,0.928700839211372,1,35,positive regulation of immunoglobulin production,BP,CLCF1
18302,GO:0099094,0.358092789733711,0.869106631615481,2,81,ligand-gated cation channel activity,MF,KCNK6;KCNH2
2784,GO:0005770,0.358184495543537,0.813474563687887,4,213,late endosome,CC,TSPAN15;RAB27A;TF;RHOB
15293,GO:0060996,0.358501435784222,0.868853283003957,2,81,dendritic spine development,BP,WNT7A;ACSL4
14806,GO:0060249,0.358819499046642,0.78533570421676,6,354,anatomical structure homeostasis,BP,CDH23;TF;TYRO3;CTGF;RAB3D;CLDN18
7778,GO:0031113,0.358924591488013,0.92841466723163,1,31,regulation of microtubule polymerization,BP,PSRC1
15267,GO:0060964,0.358982383237071,0.928531518047651,1,29,regulation of gene silencing by miRNA,BP,BMP4
370,GO:0000988,0.359042603673787,0.75598283203346,10,590,transcription factor activity, protein binding,MF,LIF;WNT4;POU3F1;ACTN2;NOTCH1;NAB2;TLE1;SIN3B;ZCCHC12;HEY1
16551,GO:0071549,0.359430608373916,0.928071037971958,1,33,cellular response to dexamethasone stimulus,BP,GJB2
17127,GO:0072595,0.359532720648715,0.92822043923077,1,30,maintenance of protein localization in organelle,BP,AKT1
1206,GO:0002686,0.359836361020969,0.927895052662109,1,33,negative regulation of leukocyte migration,BP,ADORA1
7660,GO:0030902,0.360043822029237,0.83413677572239,3,141,hindbrain development,BP,WNT7A;BMP7;DLL1
4426,GO:0009152,0.36041030600324,0.811670960393777,4,239,purine ribonucleotide biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
20946,GO:2000008,0.360465465931348,0.92774726026176,1,31,regulation of protein localization to cell surface,BP,ACTN2
13717,GO:0050868,0.361584509634807,0.866737319046522,2,91,negative regulation of T cell activation,BP,SDC4;BMP4
8514,GO:0032459,0.3617012393141,0.927025355916483,1,34,regulation of protein oligomerization,BP,PMAIP1
4685,GO:0009925,0.361713795627731,0.927347850014258,1,29,basal plasma membrane,CC,TF
5672,GO:0015893,0.361953477951521,0.927243437743862,1,29,drug transport,BP,CLDN1
18333,GO:0099531,0.362163003782908,0.832600316032196,3,145,presynaptic process involved in chemical synaptic transmission,BP,SYT5;WNT7A;GDNF
5768,GO:0016101,0.362682217198155,0.865966724073566,2,96,diterpenoid metabolic process,BP,STRA6;SDC4
4409,GO:0009135,0.362725281794739,0.866077676022024,2,88,purine nucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3
4449,GO:0009179,0.362725281794739,0.866077676022024,2,88,purine ribonucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3
7057,GO:0021955,0.363361054852108,0.926708925373943,1,28,central nervous system neuron axonogenesis,BP,SPTBN4
14604,GO:0055085,0.363362786705561,0.71987147000565,21,1348,transmembrane transport,BP,ACTN2;CASQ2;KCNK6;FLVCR2;SLC25A53;TTYH1;TSPAN13;KCNH2;SLC2A14;SFXN1;GJB1;GJB2;AKT1;GJA3;PIK3CG;KCNG2;GAS6;SLC18B1;KCND1;CLDN16;PDE4B
2536,GO:0005246,0.363424111819695,0.926327960584745,1,33,calcium channel regulator activity,MF,TSPAN13
11895,GO:0044764,0.364277537142661,0.735302431657587,14,934,multi-organism cellular process,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;NMT2;MFGE8;TYRO3;PIK3R1;INHBB;CLDN1;GAS6;ACTA2;PIM2;EFNB2
5947,GO:0016485,0.36434039841929,0.808790256086418,4,222,protein processing,BP,RHBDL3;PLAU;PRKACB;GAS6
4109,GO:0008378,0.364530131146362,0.925969237769812,1,31,galactosyltransferase activity,MF,B3GNT2
7403,GO:0030336,0.364696089552406,0.808589022108413,4,210,negative regulation of cell migration,BP,WNT4;NOTCH1;ADORA1;RHOB
11562,GO:0043902,0.364852931461923,0.83056569891125,3,159,positive regulation of multi-organism process,BP,NOTCH1;BMP6;INHBB
11941,GO:0044853,0.36495668112337,0.864798148759511,2,82,plasma membrane raft,CC,CDH2;CDH1
17541,GO:0090317,0.365171283091497,0.864503437186559,2,90,negative regulation of intracellular protein transport,BP,BMP7;GAS6
8048,GO:0031641,0.365230430877476,0.925731238048383,1,30,regulation of myelination,BP,AKT1
14100,GO:0051480,0.365244687978213,0.79221368984181,5,291,regulation of cytosolic calcium ion concentration,BP,CDH23;CASQ2;EDN1;LPAR2;PIK3CG
18112,GO:0098655,0.365289626052537,0.741544434718939,12,745,cation transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TTYH1;TSPAN13;KCNH2;PIK3CG;KCNG2;GAS6;KCND1;CLDN16;PDE4B
12648,GO:0046461,0.36540083220694,0.925148841731198,1,39,neutral lipid catabolic process,BP,PIK3CG
12651,GO:0046464,0.36540083220694,0.925148841731198,1,39,acylglycerol catabolic process,BP,PIK3CG
4989,GO:0010765,0.36557083536537,0.92550990920698,1,31,positive regulation of sodium ion transport,BP,AKT1
9103,GO:0033559,0.365655113919222,0.864096047081588,2,96,unsaturated fatty acid metabolic process,BP,EDN1;PTGES
13735,GO:0050892,0.365815971403416,0.925272210047003,1,33,intestinal absorption,BP,VDR
12390,GO:0045862,0.366008978627333,0.779527936289523,6,357,positive regulation of proteolysis,BP,PMAIP1;MAPK12;AXIN1;CTGF;AKT1;RNF144A
8704,GO:0032743,0.36643725278216,0.925197593500159,1,30,positive regulation of interleukin-2 production,BP,PDE4B
2759,GO:0005741,0.366638519529528,0.829346539608886,3,153,mitochondrial outer membrane,CC,PMAIP1;VAMP1;ACSL4
18973,GO:1901976,0.367208102000627,0.924783893032492,1,31,regulation of cell cycle checkpoint,BP,AKT1
17259,GO:0086019,0.367966228492411,0.92459520334378,1,29,cell-cell signaling involved in cardiac conduction,BP,CASQ2
5748,GO:0016056,0.368311232665286,0.924224831588059,1,32,rhodopsin mediated signaling pathway,BP,NMT2
3987,GO:0008180,0.368407607965008,0.924181766862332,1,32,COP9 signalosome,CC,AMOT
11699,GO:0044264,0.368745406636905,0.86231897236937,2,86,cellular polysaccharide metabolic process,BP,B3GNT2;AKT1
13067,GO:0048013,0.369583092112905,0.861766563351859,2,87,ephrin receptor signaling pathway,BP,HRAS;EFNB2
7439,GO:0030425,0.369666309836822,0.759112029461136,8,454,dendrite,CC,ACTN2;RAB27A;ADORA1;DRP2;RAB17;LZTS1;KCND1;PDE4B
4261,GO:0008630,0.369673348620365,0.861564319816886,2,95,intrinsic apoptotic signaling pathway in response to DNA damage,BP,PIK3R1;CDKN1A
4519,GO:0009266,0.36995237455796,0.804572771296953,4,214,response to temperature stimulus,BP,SLC52A3;ADORA1;CDKN1A;AKT1
3022,GO:0006164,0.369974405542239,0.804411396455502,4,242,purine nucleotide biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
586,GO:0001676,0.370118098376928,0.861332334386941,2,92,long-chain fatty acid metabolic process,BP,PTGES;ACSL4
7272,GO:0030165,0.37054751434512,0.861214013803136,2,84,PDZ domain binding,MF,FZD7;FZD8
8351,GO:0032228,0.370705477197687,0.923219126915262,1,31,regulation of synaptic transmission, GABAergic,BP,ADORA1
11427,GO:0043489,0.371067504462348,0.92305606553058,1,31,RNA stabilization,BP,GDNF
16130,GO:0070820,0.371079513844769,0.826098316896467,3,161,tertiary granule,CC,PLAU;VAMP1;PKP1
12222,GO:0045581,0.371149720840576,0.922825405446393,1,34,negative regulation of T cell differentiation,BP,BMP4
3737,GO:0007259,0.371396827719268,0.825830033615429,3,166,JAK-STAT cascade,BP,LIF;NOTCH1;CLCF1
18021,GO:0097696,0.371396827719268,0.825830033615429,3,166,STAT cascade,BP,LIF;NOTCH1;CLCF1
11478,GO:0043552,0.37146917089914,0.922948217654949,1,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,PDGFB
4455,GO:0009185,0.371708911271258,0.860353103895799,2,90,ribonucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3
580,GO:0001669,0.373038162088429,0.859304052841959,2,102,acrosomal vesicle,CC,NOTCH1;SERPINA5
7585,GO:0030810,0.37330148995186,0.859120536780065,2,103,positive regulation of nucleotide biosynthetic process,BP,NPR1;NPPC
18596,GO:1900373,0.37330148995186,0.859120536780065,2,103,positive regulation of purine nucleotide biosynthetic process,BP,NPR1;NPPC
2489,GO:0005158,0.37353387383012,0.921939741493701,1,31,insulin receptor binding,MF,PIK3R1
2999,GO:0006110,0.373817487418335,0.92174120398223,1,32,regulation of glycolytic process,BP,ACTN3
19429,GO:1903050,0.373946597653974,0.801435145487853,4,229,regulation of proteolysis involved in cellular protein catabolic process,BP,AXIN1;AKT1;ARAF;RNF144A
13599,GO:0050702,0.374160967132864,0.921399650328146,1,35,interleukin-1 beta secretion,BP,WNT5A
13411,GO:0048791,0.374324835719353,0.92165414281362,1,30,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT5
12001,GO:0045070,0.37491724439015,0.921239476134198,1,32,positive regulation of viral genome replication,BP,NOTCH1
12711,GO:0046578,0.375297480196423,0.800576517142767,4,199,regulation of Ras protein signal transduction,BP,ITGA3;FGF10;HRAS;KITLG
10844,GO:0042462,0.375466775801788,0.921058223610995,1,31,eye photoreceptor cell development,BP,MYO7A
5937,GO:0016460,0.375668106185295,0.920829869374751,1,33,myosin II complex,CC,MYH11
9112,GO:0033572,0.375719286426133,0.920685800633028,1,35,transferrin transport,BP,TF
13119,GO:0048167,0.376460758914917,0.822372998492239,3,144,regulation of synaptic plasticity,BP,ADORA1;HRAS;LZTS1
18116,GO:0098660,0.376738830100105,0.731518379830268,12,744,inorganic ion transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TTYH1;TSPAN13;KCNH2;PIK3CG;KCNG2;GAS6;KCND1;CLDN16;PDE4B
13623,GO:0050728,0.376829656957319,0.856905243968187,2,99,negative regulation of inflammatory response,BP,ADORA1;TYRO3
7321,GO:0030224,0.376947844864156,0.920241688538995,1,33,monocyte differentiation,BP,BMP4
19462,GO:1903131,0.376947844864156,0.920241688538995,1,33,mononuclear cell differentiation,BP,BMP4
17507,GO:0090279,0.376967502984301,0.856864474202267,2,96,regulation of calcium ion import,BP,CASQ2;PDGFB
2296,GO:0004860,0.37703059481241,0.856893226425059,2,92,protein kinase inhibitor activity,MF,PRKAR1B;CDKN1A
2801,GO:0005790,0.377104675643525,0.920169430172054,1,33,smooth endoplasmic reticulum,CC,TTYH1
963,GO:0002252,0.377119541868677,0.718102549346252,16,1065,immune effector process,BP,RAB27A;PMAIP1;CRISPLD2;ZFPM1;PLAU;PIK3R2;PIK3R1;WNT5A;CLCF1;DLL1;CHGA;PKP1;RAB44;PIK3CA;PIK3CG;RAB3D
1267,GO:0002764,0.377359096828107,0.752541794090668,8,487,immune response-regulating signaling pathway,BP,PRKACB;TYRO3;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
13624,GO:0050729,0.377534514944649,0.8564331741257,2,100,positive regulation of inflammatory response,BP,WNT5A;PIK3CG
4356,GO:0009062,0.377721421716667,0.856445887700759,2,92,fatty acid catabolic process,BP,SESN2;AKT1
14081,GO:0051443,0.3777660436346,0.856223876203814,2,104,positive regulation of ubiquitin-protein transferase activity,BP,MAGEC2;AXIN1
18927,GO:1901800,0.378300411134593,0.856107759252185,2,90,positive regulation of proteasomal protein catabolic process,BP,AKT1;RNF144A
1367,GO:0002931,0.37906380866608,0.919330645190351,1,32,response to ischemia,BP,GJB2
21018,GO:2000134,0.379349083133094,0.855389246609382,2,92,negative regulation of G1/S transition of mitotic cell cycle,BP,GADD45A;CDKN1A
2125,GO:0004629,0.379525387232983,0.919264612289305,1,30,phospholipase C activity,MF,ADORA1
3388,GO:0006690,0.379749196332097,0.854978687561399,2,101,icosanoid metabolic process,BP,EDN1;PTGES
18836,GO:1901568,0.379749196332097,0.854978687561399,2,101,fatty acid derivative metabolic process,BP,EDN1;PTGES
891,GO:0002102,0.379811586243236,0.919131873847683,1,30,podosome,CC,SCIN
18369,GO:0099622,0.380496036892837,0.918665029599421,1,32,cardiac muscle cell membrane repolarization,BP,KCNH2
12041,GO:0045124,0.381205603889358,0.918202304792236,1,34,regulation of bone resorption,BP,CLDN18
12595,GO:0046329,0.381992788943436,0.917965955147223,1,32,negative regulation of JNK cascade,BP,AKT1
19867,GO:1903959,0.38220139829569,0.917868239621446,1,32,regulation of anion transmembrane transport,BP,AKT1
13248,GO:0048488,0.382713610895012,0.917700868180279,1,31,synaptic vesicle endocytosis,BP,SYT5
1382,GO:0003009,0.382886208749581,0.917241787068629,1,37,skeletal muscle contraction,BP,ACTN3
13690,GO:0050829,0.382966434972079,0.917057572604455,1,40,defense response to Gram-negative bacterium,BP,CHGA
21094,GO:2000272,0.383017974973916,0.917352089438671,1,34,negative regulation of receptor activity,BP,CASQ2
18322,GO:0099513,0.383142960770742,0.735123830919554,10,647,polymeric cytoskeletal fiber,CC,TUBG2;ACTN3;ACTN2;RHOQ;PSRC1;CAMSAP3;ESPN;PKP1;AMOT;RAB3D
6955,GO:0021772,0.383463896207757,0.917275392090145,1,32,olfactory bulb development,BP,WNT5A
11628,GO:0044091,0.384083514802348,0.91698350191347,1,32,membrane biogenesis,BP,CDH2
4601,GO:0009620,0.38422429625472,0.916225625275006,1,46,response to fungus,BP,CHGA
3000,GO:0006111,0.384459393452829,0.916737108253422,1,33,regulation of gluconeogenesis,BP,SESN2
12768,GO:0046676,0.384612233433696,0.916480758520381,1,36,negative regulation of insulin secretion,BP,INHBB
14875,GO:0060338,0.384620772467865,0.916274357922743,1,40,regulation of type I interferon-mediated signaling pathway,BP,WNT5A
5177,GO:0014009,0.384642014415032,0.916650788608684,1,33,glial cell proliferation,BP,NOTCH1
19353,GO:1902930,0.384663058908171,0.916575823824035,1,34,regulation of alcohol biosynthetic process,BP,VDR
11457,GO:0043531,0.384781669445894,0.916653881920242,1,32,ADP binding,MF,MYO7A
4428,GO:0009154,0.385068879396564,0.916448814271391,1,33,purine ribonucleotide catabolic process,BP,PDE4B
11150,GO:0043025,0.385448539619859,0.753738797586704,7,412,neuronal cell body,CC,SYT5;ADORA1;SPTBN4;DRP2;RAB17;KCND1;ACSL4
10798,GO:0042379,0.385599982636702,0.915263738997457,1,57,chemokine receptor binding,MF,CCL20
3846,GO:0007569,0.38629405105554,0.850820036489015,2,93,cell aging,BP,HRAS;CDKN1A
8370,GO:0032269,0.387389434115161,0.711662130170232,15,986,negative regulation of cellular protein metabolic process,BP,LIF;GADD45A;CRB2;SERPINA5;EDN1;PRR5L;PRKAR1B;SESN2;BMP7;BMP4;CDKN1A;AKT1;CST9L;GAS6;DUSP5
1240,GO:0002720,0.387890578201954,0.914977994685273,1,35,positive regulation of cytokine production involved in immune response,BP,WNT5A
2905,GO:0005975,0.388332762076406,0.736402829403656,9,549,carbohydrate metabolic process,BP,ACTN3;PMAIP1;PDGFB;KHK;SESN2;PFKFB3;B3GNT2;AKT1;PIK3CA
1631,GO:0003714,0.388500567025166,0.790223017810352,4,216,transcription corepressor activity,MF,WNT4;NAB2;TLE1;SIN3B
10818,GO:0042417,0.388749228070288,0.914628962667039,1,34,dopamine metabolic process,BP,NPR1
19423,GO:1903038,0.389401805786267,0.848673228977856,2,98,negative regulation of leukocyte cell-cell adhesion,BP,SDC4;BMP4
18980,GO:1901985,0.39002326970947,0.914016463022676,1,34,positive regulation of protein acetylation,BP,LIF
6599,GO:0019395,0.390027231981424,0.848308919693426,2,95,fatty acid oxidation,BP,SESN2;AKT1
8011,GO:0031570,0.390246135068308,0.812149213820089,3,155,DNA integrity checkpoint,BP,GADD45A;FOXO4;CDKN1A
14743,GO:0060147,0.390386949900245,0.913979197734107,1,32,regulation of posttranscriptional gene silencing,BP,BMP4
15269,GO:0060966,0.390386949900245,0.913979197734107,1,32,regulation of gene silencing by RNA,BP,BMP4
8664,GO:0032680,0.390848620271885,0.847676741174868,2,100,regulation of tumor necrosis factor production,BP,PIK3R1;GAS6
4932,GO:0010677,0.39138463315756,0.913359092888832,1,34,negative regulation of cellular carbohydrate metabolic process,BP,ACTN3
2785,GO:0005771,0.391808252765777,0.912919943872231,1,38,multivesicular body,CC,RAB27A
15489,GO:0061387,0.392533579189997,0.846751350564742,2,89,regulation of extent of cell growth,BP,WNT3;WNT5A
9766,GO:0035307,0.392551700451716,0.912860815813463,1,33,positive regulation of protein dephosphorylation,BP,ADORA1
7147,GO:0022857,0.39267468502482,0.704093638299613,16,1011,transmembrane transporter activity,MF,TF;SLC45A4;KCNK6;SLC25A53;TTYH1;KCNH2;SLC2A14;SFXN1;GJB1;GJB2;GJA3;KCNG2;GAS6;SLC18B1;KCND1;CLDN16
20260,GO:1904837,0.392778977408628,0.912215428114941,1,43,beta-catenin-TCF complex assembly,BP,TLE1
14194,GO:0051653,0.392880952311674,0.912700868653655,1,33,spindle localization,BP,FGF10
166,GO:0000323,0.392953205878191,0.726562319372118,10,624,lytic vacuole,CC,RAB27A;RAB39A;SDC4;CHGA;RAB12;MYO7A;RAB44;PIK3CG;RAB38;RAB3D
2778,GO:0005764,0.392953205878191,0.726562319372118,10,624,lysosome,CC,RAB27A;RAB39A;SDC4;CHGA;RAB12;MYO7A;RAB44;PIK3CG;RAB38;RAB3D
19308,GO:1902807,0.392995123434679,0.84632700439734,2,95,negative regulation of cell cycle G1/S phase transition,BP,GADD45A;CDKN1A
1305,GO:0002833,0.393021542121496,0.912329300833798,1,38,positive regulation of response to biotic stimulus,BP,BMP6
13334,GO:0048662,0.393030381155924,0.912436126744235,1,36,negative regulation of smooth muscle cell proliferation,BP,NPR1
13655,GO:0050778,0.393289034830277,0.72624259455416,10,643,positive regulation of immune response,BP,PRKACB;TYRO3;PIK3R2;PIK3R1;HRAS;WNT5A;CLCF1;BCAR1;PIK3CA;PDE4B
12329,GO:0045744,0.393621114506895,0.912208538305737,1,35,negative regulation of G-protein coupled receptor protein signaling pathway,BP,GPRASP1
7071,GO:0021988,0.39362375100928,0.912339380262328,1,33,olfactory lobe development,BP,WNT5A
4851,GO:0010559,0.393862425327403,0.912030147530744,1,36,regulation of glycoprotein biosynthetic process,BP,HBEGF
10771,GO:0042339,0.394111075882276,0.912101734500376,1,33,keratan sulfate metabolic process,BP,B3GNT2
17466,GO:0090218,0.394313293484747,0.91200300930919,1,33,positive regulation of lipid kinase activity,BP,PDGFB
4514,GO:0009261,0.394950952433184,0.911622794892349,1,34,ribonucleotide catabolic process,BP,PDE4B
3348,GO:0006641,0.394973790002579,0.844849629193697,2,104,triglyceride metabolic process,BP,PIK3CG;ACSL4
21458,GO:2000785,0.395488460551585,0.911359314930012,1,34,regulation of autophagosome assembly,BP,RALB
10737,GO:0042277,0.395808585575359,0.784381197076024,4,231,peptide binding,MF,ACVR1;PIK3R1;NPR1;PTGES
19927,GO:1904064,0.395932796146244,0.844299949998035,2,98,positive regulation of cation transmembrane transport,BP,ACTN2;KCNH2
18659,GO:1901030,0.396516019070856,0.910669793318812,1,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
6529,GO:0019210,0.397113134077549,0.843538128515782,2,96,kinase inhibitor activity,MF,PRKAR1B;CDKN1A
9447,GO:0034440,0.39737024223816,0.843346585151607,2,97,lipid oxidation,BP,SESN2;AKT1
11324,GO:0043299,0.397734758420704,0.735007625547051,8,519,leukocyte degranulation,BP,RAB27A;CRISPLD2;PLAU;CHGA;PKP1;RAB44;PIK3CG;RAB3D
7535,GO:0030662,0.39792126295356,0.806340291172839,3,163,coated vesicle membrane,CC,TF;WNT5A;HBEGF
8800,GO:0032886,0.398312932411963,0.806148944377209,3,152,regulation of microtubule-based process,BP,RAB6C;PSRC1;CAMSAP3
6847,GO:0021549,0.398333974383264,0.842847763296511,2,89,cerebellum development,BP,WNT7A;DLL1
13406,GO:0048786,0.398353987367263,0.910169159247044,1,31,presynaptic active zone,CC,ADORA1
11971,GO:0045022,0.398607235717622,0.909821243856571,1,34,early endosome to late endosome transport,BP,MSN
3927,GO:0008081,0.398686435194968,0.842588276239074,2,90,phosphoric diester hydrolase activity,MF,ADORA1;PDE4B
12368,GO:0045824,0.398873100683991,0.909561474606977,1,36,negative regulation of innate immune response,BP,TYRO3
17701,GO:0097028,0.398907983942451,0.909326807719594,1,40,dendritic cell differentiation,BP,GAS6
5657,GO:0015872,0.399293751960006,0.909184845019291,1,39,dopamine transport,BP,GDNF
4560,GO:0009408,0.399849222508459,0.804942404663237,3,157,response to heat,BP,SLC52A3;CDKN1A;AKT1
8637,GO:0032640,0.400338838210521,0.841248418008211,2,102,tumor necrosis factor production,BP,PIK3R1;GAS6
5553,GO:0015682,0.400787838210725,0.90849181180195,1,38,ferric iron transport,BP,TF
17069,GO:0072512,0.400787838210725,0.90849181180195,1,38,trivalent inorganic cation transport,BP,TF
13647,GO:0050770,0.40121597627576,0.803990293339593,3,149,regulation of axonogenesis,BP,WNT3;WNT7A;WNT5A
9431,GO:0034405,0.402021570619975,0.90811917594622,1,34,response to fluid shear stress,BP,AKT1
2699,GO:0005622,0.40231063253222,0.657749393426166,191,13536,intracellular,CC,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;PNMT;TF;ITGB5;ITGB4;PMAIP1;GADD45A;CRISPLD2;FBXO41;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;LGALS4;BMP6;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;NPPC;NAB2;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;DTX4;ZCCHC12;MYH11;LZTS1;PM20D2;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2;PARVB;PDE4B
18991,GO:1901998,0.402590179705878,0.907703599875779,1,36,toxin transport,BP,RAB40B
4513,GO:0009260,0.402774884494249,0.778731928029361,4,252,ribonucleotide biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
16721,GO:0071868,0.40312046884474,0.907638561466945,1,33,cellular response to monoamine stimulus,BP,PDE4B
16723,GO:0071870,0.40312046884474,0.907638561466945,1,33,cellular response to catecholamine stimulus,BP,PDE4B
2691,GO:0005604,0.403391177093859,0.839404976001017,2,89,basement membrane,CC,LAMA1;LAMA5
4747,GO:0010165,0.403755253318395,0.90724759234435,1,34,response to X-ray,BP,CDKN1A
2626,GO:0005484,0.404045187599899,0.906852853246136,1,38,SNAP receptor activity,MF,VAMP1
10640,GO:0042088,0.404191888024522,0.906778627910805,1,38,T-helper 1 type immune response,BP,HRAS
14159,GO:0051591,0.404253731527893,0.838732338248264,2,93,response to cAMP,BP,WT1;PIK3CG
7630,GO:0030865,0.404804635903765,0.906789472276787,1,33,cortical cytoskeleton organization,BP,RHOQ
6061,GO:0016684,0.405092363732071,0.905953527349137,1,46,oxidoreductase activity, acting on peroxide as acceptor,MF,SESN2
12195,GO:0045494,0.405382942169257,0.906424783538926,1,34,photoreceptor cell maintenance,BP,CDH23
10697,GO:0042176,0.405628885348224,0.746636682916884,6,371,regulation of protein catabolic process,BP,WNT5A;AXIN1;MSN;AKT1;ARAF;RNF144A
19666,GO:1903555,0.40594542353946,0.837392511128733,2,103,regulation of tumor necrosis factor superfamily cytokine production,BP,PIK3R1;GAS6
7220,GO:0030072,0.406002288549331,0.776249845156186,4,231,peptide hormone secretion,BP,ADRA2C;EDN1;INHBB;KCNG2
11255,GO:0043198,0.406214970137463,0.906074834853675,1,33,dendritic shaft,CC,LZTS1
9324,GO:0034198,0.406678518395875,0.905633868723785,1,36,cellular response to amino acid starvation,BP,CDKN1A
8685,GO:0032715,0.406774246014121,0.905585074868961,1,36,negative regulation of interleukin-6 production,BP,GAS6
16014,GO:0070555,0.407181727820204,0.836393295638279,2,113,response to interleukin-1,BP,EDN1;CCL20
10522,GO:0038179,0.407402311702414,0.905397884707526,1,34,neurotrophin signaling pathway,BP,BCAR1
20663,GO:1905953,0.407483348442241,0.905103890937129,1,38,negative regulation of lipid localization,BP,AKT1
21026,GO:2000146,0.407487774321339,0.77509499390191,4,224,negative regulation of cell motility,BP,WNT4;NOTCH1;ADORA1;RHOB
15067,GO:0060589,0.407541547183847,0.745114398874205,6,338,nucleoside-triphosphatase regulator activity,MF,RIN3;PIK3R2;SESN2;AXIN1;GPSM1;SH3BP4
10214,GO:0036064,0.407824078992329,0.836294166432489,2,92,ciliary basal body,CC,MARK4;AKT1
4566,GO:0009416,0.408050532765866,0.757556593312774,5,289,response to light stimulus,BP,NMT2;PIK3R1;CDKN1A;AKT1;UNC119
15083,GO:0060612,0.40825404876156,0.90496272728802,1,34,adipose tissue development,BP,PIK3CA
5182,GO:0014014,0.40847414840606,0.904596236501435,1,38,negative regulation of gliogenesis,BP,NOTCH1
17075,GO:0072522,0.408597416734083,0.774045143602116,4,254,purine-containing compound biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
13667,GO:0050796,0.408843900753058,0.798039287499978,3,164,regulation of insulin secretion,BP,ADRA2C;INHBB;KCNG2
3908,GO:0008047,0.40905667654,0.725206972779144,8,484,enzyme activator activity,MF,RIN3;PIK3R2;PDGFB;AXIN1;BMP2;CDKN1A;PIK3CA;GAS6
13273,GO:0048536,0.409331743057306,0.904275840413716,1,36,spleen development,BP,FGF10
973,GO:0002275,0.409508061850541,0.72473827044495,8,524,myeloid cell activation involved in immune response,BP,RAB27A;CRISPLD2;PLAU;CHGA;PKP1;RAB44;PIK3CG;RAB3D
19431,GO:1903052,0.409722017982101,0.797297991264641,3,172,positive regulation of proteolysis involved in cellular protein catabolic process,BP,AXIN1;AKT1;RNF144A
19909,GO:1904036,0.409724468860993,0.904073831671744,1,36,negative regulation of epithelial cell apoptotic process,BP,GAS6
21099,GO:2000278,0.409900443849763,0.834816403683403,2,94,regulation of DNA biosynthetic process,BP,PDGFB;CDKN1A
14605,GO:0055086,0.409965412591831,0.711402382635316,10,695,nucleobase-containing small molecule metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
3409,GO:0006721,0.409970089959364,0.834560718227254,2,106,terpenoid metabolic process,BP,STRA6;SDC4
9714,GO:0035196,0.410269451179301,0.903928240085759,1,34,production of miRNAs involved in gene silencing by miRNA,BP,BMP4
5055,GO:0010863,0.410790314880971,0.903590091313717,1,35,positive regulation of phospholipase C activity,BP,LPAR2
11350,GO:0043330,0.410838329155204,0.903081083955397,1,44,response to exogenous dsRNA,BP,RALB
18183,GO:0098815,0.411010849426553,0.903620001033397,1,33,modulation of excitatory postsynaptic potential,BP,WNT7A
18605,GO:1900408,0.411118900835643,0.903233133879311,1,38,negative regulation of cellular response to oxidative stress,BP,AKT1
19333,GO:1902883,0.411118900835643,0.903233133879311,1,38,negative regulation of response to oxidative stress,BP,AKT1
19489,GO:1903202,0.411118900835643,0.903233133879311,1,38,negative regulation of oxidative stress-induced cell death,BP,AKT1
12622,GO:0046390,0.411453395803375,0.771732079680075,4,255,ribose phosphate biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
972,GO:0002274,0.41167800743423,0.715848183014076,9,596,myeloid leukocyte activation,BP,RAB27A;CRISPLD2;PLAU;WNT5A;CHGA;PKP1;RAB44;PIK3CG;RAB3D
14315,GO:0051899,0.411782049284434,0.833488316921108,2,95,membrane depolarization,BP,EDN1;KCNH2
11512,GO:0043618,0.411931511675429,0.833135513040992,2,110,regulation of transcription from RNA polymerase II promoter in response to stress,BP,NOTCH1;SESN2
8037,GO:0031624,0.411979813718193,0.903119370850397,1,33,ubiquitin conjugating enzyme binding,MF,RNF144A
16388,GO:0071312,0.413083709966716,0.90227248017664,1,37,cellular response to alkaloid,BP,CASQ2
612,GO:0001726,0.413546628391177,0.794518838159626,3,154,ruffle,CC,ITGA5;BCAR1;AMOT
3500,GO:0006874,0.413698845432608,0.739737658259981,6,379,cellular calcium ion homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;PIK3CG;VDR
964,GO:0002253,0.41383236268994,0.720969680516577,8,507,activation of immune response,BP,PRKACB;TYRO3;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
1077,GO:0002444,0.414116080008686,0.720683232333192,8,528,myeloid leukocyte mediated immunity,BP,RAB27A;CRISPLD2;PLAU;CHGA;PKP1;RAB44;PIK3CG;RAB3D
11782,GO:0044403,0.414316045257789,0.690330477536784,14,968,symbiosis, encompassing mutualism through parasitism,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;NMT2;MFGE8;TYRO3;PIK3R1;CDH1;CLDN1;GAS6;ACTA2;PIM2;EFNB2
13858,GO:0051090,0.415095760632322,0.738589541410288,6,362,regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2;EDN1;WNT5A;BMP7;AKT1;GAS6
1070,GO:0002437,0.415395974528641,0.900840946362113,1,41,inflammatory response to antigenic stimulus,BP,NOTCH1
8013,GO:0031572,0.415556618808235,0.90118211804659,1,34,G2 DNA damage checkpoint,BP,FOXO4
806,GO:0001990,0.416389915739335,0.900481494624492,1,38,regulation of systemic arterial blood pressure by hormone,BP,EDN1
158,GO:0000307,0.416546358672954,0.900341672230817,1,39,cyclin-dependent protein kinase holoenzyme complex,CC,CDKN1A
572,GO:0001659,0.41761836203216,0.899894342999313,1,37,temperature homeostasis,BP,ADORA1
11790,GO:0044419,0.418085875932281,0.686874695247768,14,970,interspecies interaction between organisms,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;NMT2;MFGE8;TYRO3;PIK3R1;CDH1;CLDN1;GAS6;ACTA2;PIM2;EFNB2
18115,GO:0098659,0.418710602525539,0.899521570956727,1,34,inorganic cation import into cell,BP,TF
18358,GO:0099587,0.418710602525539,0.899521570956727,1,34,inorganic ion import into cell,BP,TF
13859,GO:0051091,0.418799757552289,0.765880472077354,4,230,positive regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2;EDN1;WNT5A;AKT1
8055,GO:0031648,0.418843823448091,0.899245706038919,1,37,protein destabilization,BP,BMP2
3869,GO:0007613,0.419152452348875,0.828312125344509,2,95,memory,BP,ITGA3;ITGA5
8661,GO:0032675,0.419421419007778,0.82801066908011,2,101,regulation of interleukin-6 production,BP,WNT5A;GAS6
12413,GO:0045912,0.419723240770141,0.898778661168218,1,37,negative regulation of carbohydrate metabolic process,BP,ACTN3
431,GO:0001105,0.420047819343169,0.898605950790154,1,37,RNA polymerase II transcription coactivator activity,MF,POU3F1
7729,GO:0031050,0.420064471639093,0.898730812740797,1,35,dsRNA fragmentation,BP,BMP4
16195,GO:0070918,0.420064471639093,0.898730812740797,1,35,production of small RNA involved in gene silencing by RNA,BP,BMP4
12324,GO:0045739,0.420477629501246,0.898315292803329,1,38,positive regulation of DNA repair,BP,FGF10
4363,GO:0009069,0.42054918920799,0.898277118601713,1,38,serine family amino acid metabolic process,BP,GLDC
12819,GO:0046825,0.421251963497845,0.897901753898291,1,38,regulation of protein export from nucleus,BP,GAS6
13257,GO:0048512,0.42159529367279,0.897405511174887,1,44,circadian behavior,BP,ADORA1
8889,GO:0033017,0.421665792849898,0.897742343962395,1,37,sarcoplasmic reticulum membrane,CC,CASQ2
17506,GO:0090278,0.421902137356066,0.897385731937471,1,41,negative regulation of peptide hormone secretion,BP,INHBB
5023,GO:0010824,0.421999387307541,0.897629312168328,1,36,regulation of centrosome duplication,BP,RAB6C
2662,GO:0005547,0.42201369939331,0.897691002391799,1,35,phosphatidylinositol-3,4,5-trisphosphate binding,MF,AKT1
9778,GO:0035335,0.42221706741435,0.826097634358708,2,97,peptidyl-tyrosine dephosphorylation,BP,PTPN7;DUSP5
18985,GO:1901990,0.422292742849833,0.745522976583855,5,309,regulation of mitotic cell cycle phase transition,BP,GADD45A;FGF10;FOXO4;CDKN1A;AKT1
8374,GO:0032273,0.422985378459747,0.825442110175573,2,103,positive regulation of protein polymerization,BP,SCIN;PSRC1
14698,GO:0060071,0.423023388792197,0.82531909357914,2,109,Wnt signaling pathway, planar cell polarity pathway,BP,FZD7;WNT5A
16656,GO:0071706,0.423085657237287,0.825305387929507,2,107,tumor necrosis factor superfamily cytokine production,BP,PIK3R1;GAS6
6539,GO:0019221,0.423153643327521,0.712651667472484,8,552,cytokine-mediated signaling pathway,BP,EDN1;CCL20;PDGFB;WNT5A;CLCF1;AKT1;GAS6;CLDN18
19786,GO:1903793,0.423320461825692,0.896676477017922,1,40,positive regulation of anion transport,BP,EDN1
12553,GO:0046165,0.423365953648794,0.825187479007532,2,102,alcohol biosynthetic process,BP,HMGCS2;VDR
3862,GO:0007603,0.42338489383922,0.89675736020969,1,38,phototransduction, visible light,BP,NMT2
141,GO:0000281,0.423496433254599,0.89682587915591,1,36,mitotic cytokinesis,BP,SNX18
12292,GO:0045668,0.423643647215345,0.896558640926452,1,39,negative regulation of osteoblast differentiation,BP,NOTCH1
12271,GO:0045646,0.423965101180656,0.89644471341363,1,38,regulation of erythrocyte differentiation,BP,ZFPM1
8729,GO:0032781,0.424259894954062,0.8960158068824,1,43,positive regulation of ATPase activity,BP,FGF10
4874,GO:0010596,0.424342983919949,0.896240780107322,1,38,negative regulation of endothelial cell migration,BP,NOTCH1
18247,GO:0098927,0.425094589213642,0.895897434025198,1,37,vesicle-mediated transport between endosomal compartments,BP,MSN
3439,GO:0006775,0.425475758570598,0.895457203138333,1,41,fat-soluble vitamin metabolic process,BP,VDR
8401,GO:0032309,0.425518296198449,0.895333537337821,1,43,icosanoid secretion,BP,EDN1
772,GO:0001948,0.425771955030299,0.823500282433299,2,100,glycoprotein binding,MF,ITGA3;CDH1
428,GO:0001102,0.425964761872214,0.895302775300541,1,39,RNA polymerase II activating transcription factor binding,MF,ZFPM1
19410,GO:1903018,0.426143984174016,0.895094160002702,1,41,regulation of glycoprotein metabolic process,BP,HBEGF
21157,GO:2000351,0.426335740611706,0.895101195855917,1,39,regulation of endothelial cell apoptotic process,BP,GAS6
1220,GO:0002700,0.426485977635477,0.822822543192674,2,110,regulation of production of molecular mediator of immune response,BP,WNT5A;CLCF1
16720,GO:0071867,0.426957786203965,0.894953559306312,1,36,response to monoamine,BP,PDE4B
16722,GO:0071869,0.426957786203965,0.894953559306312,1,36,response to catecholamine,BP,PDE4B
7593,GO:0030818,0.427115394349341,0.894619501891253,1,40,negative regulation of cAMP biosynthetic process,BP,EDN1
12250,GO:0045620,0.427191228879313,0.89447176658617,1,42,negative regulation of lymphocyte differentiation,BP,BMP4
2197,GO:0004725,0.427500895839175,0.822294473701411,2,98,protein tyrosine phosphatase activity,MF,PTPN7;DUSP5
3069,GO:0006259,0.427538779536365,0.678202201147126,14,927,DNA metabolic process,BP,GADD45A;FGF10;PDGFB;HRAS;SESN2;CLCF1;BMP6;BMP4;CDKN1A;CTGF;AKT1;KITLG;NPPC;PIK3CA
8599,GO:0032589,0.42832502131215,0.894208322578214,1,36,neuron projection membrane,CC,ADORA1
8732,GO:0032784,0.428551967138587,0.893952729831517,1,38,regulation of DNA-templated transcription, elongation,BP,AXIN1
17430,GO:0090175,0.428721683397984,0.8212108765649,2,110,regulation of establishment of planar polarity,BP,FZD7;WNT5A
6753,GO:0019894,0.428817836081715,0.894010460617473,1,35,kinesin binding,MF,SPTBN5
11203,GO:0043122,0.428951763320395,0.757494553413194,4,234,regulation of I-kappaB kinase/NF-kappaB signaling,BP,BMP7;AKT1;TLE1;PIM2
8589,GO:0032570,0.429066539876723,0.893497314543962,1,41,response to progesterone,BP,GJB2
11152,GO:0043028,0.429455176847467,0.893283857597482,1,41,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,GAS6
14169,GO:0051602,0.429696633093999,0.893206222313129,1,40,response to electrical stimulus,BP,GJB6
13713,GO:0050864,0.429830645854154,0.820471583926285,2,106,regulation of B cell activation,BP,CLCF1;CDKN1A
18583,GO:1900274,0.430155842847646,0.893137281063969,1,37,regulation of phospholipase C activity,BP,LPAR2
12090,GO:0045211,0.430209417911097,0.756554505066541,4,217,postsynaptic membrane,CC,ADORA1;DRP2;LZTS1;SHC4
9774,GO:0035329,0.430588209167835,0.89303976447131,1,35,hippo signaling,BP,AMOT
3877,GO:0007622,0.430825580972218,0.892332220811513,1,45,rhythmic behavior,BP,ADORA1
783,GO:0001960,0.430826240281514,0.892475972206554,1,42,negative regulation of cytokine-mediated signaling pathway,BP,GAS6
17103,GO:0072562,0.431525637118715,0.819120433266523,2,114,blood microparticle,CC,TF;MSN
13565,GO:0050663,0.432370596486115,0.779575230717154,3,174,cytokine secretion,BP,NOTCH1;WNT5A;GAS6
12993,GO:0047485,0.432399468116906,0.818606983899072,2,106,protein N-terminus binding,MF,GADD45A;MYO7A
9781,GO:0035338,0.43263086357398,0.891529817709028,1,41,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSL4
8045,GO:0031638,0.432683941264797,0.89150035225007,1,41,zymogen activation,BP,PLAU
747,GO:0001917,0.432823595820178,0.891478697625886,1,40,photoreceptor inner segment,CC,MYO7A
16428,GO:0071364,0.432931736758882,0.891604651156329,1,37,cellular response to epidermal growth factor stimulus,BP,AKT1
7925,GO:0031400,0.433085549241071,0.696698288774092,9,580,negative regulation of protein modification process,BP,LIF;GADD45A;PRR5L;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
8687,GO:0032720,0.433791947251163,0.890830681512932,1,42,negative regulation of tumor necrosis factor production,BP,GAS6
2869,GO:0005903,0.433838857421848,0.817700961872122,2,98,brush border,CC,SCIN;ESPN
14334,GO:0051932,0.434230062655222,0.890817561703175,1,38,synaptic transmission, GABAergic,BP,ADORA1
2983,GO:0006090,0.435120119002604,0.816672747405699,2,103,pyruvate metabolic process,BP,ACTN3;PFKFB3
6486,GO:0019079,0.435872061989049,0.81608763608697,2,105,viral genome replication,BP,NOTCH1;GAS6
8710,GO:0032757,0.4376200170245,0.888632448050624,1,43,positive regulation of interleukin-8 production,BP,WNT5A
12358,GO:0045806,0.438075594081196,0.88848160949364,1,41,negative regulation of endocytosis,BP,UNC119
11031,GO:0042771,0.438199938105774,0.888304911885279,1,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CDKN1A
11514,GO:0043620,0.43835290822959,0.814109227875427,2,115,regulation of DNA-templated transcription in response to stress,BP,NOTCH1;SESN2
13869,GO:0051101,0.438403890052894,0.814177638649532,2,108,regulation of DNA binding,BP,LIF;HEY1
6115,GO:0016787,0.43869221898909,0.632765317396077,35,2385,hydrolase activity,MF,TUBG2;RAB6C;RAB27A;RASL11B;RHBDL3;DHH;ADORA1;PLAU;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;CGN;PTPN7;RALB;HRAS;RHOQ;RHOJ;RHOB;PFKFB3;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;SIN3B;MYH11;PM20D2;RAB38;RAB3D;DUSP5;PDE4B
940,GO:0002204,0.438867540195427,0.888091333727715,1,40,somatic recombination of immunoglobulin genes involved in immune response,BP,CLCF1
941,GO:0002208,0.438867540195427,0.888091333727715,1,40,somatic diversification of immunoglobulins involved in immune response,BP,CLCF1
12078,GO:0045190,0.438867540195427,0.888091333727715,1,40,isotype switching,BP,CLCF1
12892,GO:0046949,0.439409368690744,0.887672171872706,1,42,fatty-acyl-CoA biosynthetic process,BP,ACSL4
3636,GO:0007080,0.439992358407051,0.887453849134097,1,40,mitotic metaphase plate congression,BP,PSRC1
8650,GO:0032653,0.440158771051965,0.887246613036717,1,42,regulation of interleukin-10 production,BP,DLL1
1232,GO:0002712,0.440165667848572,0.887190274087113,1,43,regulation of B cell mediated immunity,BP,CLCF1
1344,GO:0002889,0.440165667848572,0.887190274087113,1,43,regulation of immunoglobulin mediated immune response,BP,CLCF1
14706,GO:0060079,0.440335965185985,0.81293034694044,2,98,excitatory postsynaptic potential,BP,WNT7A;ADORA1
2786,GO:0005773,0.440355791542729,0.67867871746319,11,715,vacuole,CC,RAB27A;RAB39A;RALB;SDC4;CHGA;RAB12;MYO7A;RAB44;PIK3CG;RAB38;RAB3D
7578,GO:0030803,0.441174882370664,0.886668016416853,1,42,negative regulation of cyclic nucleotide biosynthetic process,BP,EDN1
3656,GO:0007140,0.441704340914859,0.886479308860067,1,40,male meiosis,BP,PIM2
7770,GO:0031103,0.441763756265301,0.886445393877364,1,40,axon regeneration,BP,JAM3
11778,GO:0044390,0.443031830641064,0.885846313734977,1,38,ubiquitin-like protein conjugating enzyme binding,MF,RNF144A
675,GO:0001819,0.443166990563696,0.714068819092033,6,387,positive regulation of cytokine production,BP,ZFPM1;CCL20;PIK3R1;HRAS;WNT5A;PDE4B
3498,GO:0006869,0.443301090190795,0.727499960754676,5,309,lipid transport,BP,SERPINA5;EDN1;BMP6;AKT1;ACSL4
7089,GO:0022037,0.443589269164476,0.810517931186923,2,98,metencephalon development,BP,WNT7A;DLL1
5309,GO:0014888,0.443653490990596,0.885363449140929,1,40,striated muscle adaptation,BP,ACTN3
7998,GO:0031529,0.44370179442828,0.885277059053457,1,41,ruffle organization,BP,HRAS
3142,GO:0006367,0.444318195587775,0.769978798968962,3,173,transcription initiation from RNA polymerase II promoter,BP,NOTCH1;CTGF;VDR
16662,GO:0071715,0.44444602721973,0.884639862412241,1,45,icosanoid transport,BP,EDN1
18839,GO:1901571,0.44444602721973,0.884639862412241,1,45,fatty acid derivative transport,BP,EDN1
8209,GO:0031968,0.444551430562579,0.769780738002331,3,174,organelle outer membrane,CC,PMAIP1;VAMP1;ACSL4
9611,GO:0034767,0.444744403556116,0.809492801498207,2,107,positive regulation of ion transmembrane transport,BP,ACTN2;KCNH2
402,GO:0001047,0.445245408606042,0.769339149233261,3,161,core promoter binding,MF,NOTCH1;GADD45A;ZFPM1
11416,GO:0043470,0.446456656096367,0.883687488906584,1,41,regulation of carbohydrate catabolic process,BP,ACTN3
4264,GO:0008637,0.447148389755167,0.80759884463275,2,113,apoptotic mitochondrial changes,BP,PMAIP1;AKT1
4728,GO:0010043,0.44728492258907,0.882703440843587,1,52,response to zinc ion,BP,KHK
21658,GO:2001259,0.447456508294935,0.88310722171446,1,41,positive regulation of cation channel activity,BP,ACTN2
11122,GO:0042992,0.447933434555291,0.882829806560348,1,41,negative regulation of transcription factor import into nucleus,BP,BMP7
6160,GO:0016860,0.448235760452029,0.882441177694368,1,45,intramolecular oxidoreductase activity,MF,PTGES
14595,GO:0055074,0.448261464886319,0.709535737395817,6,392,calcium ion homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;PIK3CG;VDR
19667,GO:1903556,0.448284479115373,0.882462256976095,1,44,negative regulation of tumor necrosis factor superfamily cytokine production,BP,GAS6
17152,GO:0072665,0.448285254098802,0.882684730958207,1,40,protein localization to vacuole,BP,SH3BP4
8634,GO:0032635,0.448988491416713,0.806312441461652,2,107,interleukin-6 production,BP,WNT5A;GAS6
8648,GO:0032651,0.449449184277772,0.881684166844323,1,46,regulation of interleukin-1 beta production,BP,WNT5A
13970,GO:0051252,0.449501022210703,0.611761795673645,53,3624,regulation of RNA metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;PKP3;PKP1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
17723,GO:0097060,0.450102442035644,0.72166816789806,5,285,synaptic membrane,CC,ITGA3;ADORA1;DRP2;LZTS1;SHC4
3961,GO:0008138,0.45019273987932,0.881345650164264,1,44,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP5
4406,GO:0009132,0.450291106461099,0.805297450371956,2,109,nucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3
10631,GO:0042059,0.450753983312904,0.881241300996942,1,40,negative regulation of epidermal growth factor receptor signaling pathway,BP,EPN1
7826,GO:0031234,0.450984678007324,0.804841997347005,2,105,extrinsic component of cytoplasmic side of plasma membrane,CC,SNX18;MYZAP
6171,GO:0016877,0.45098623885443,0.881168589012975,1,39,ligase activity, forming carbon-sulfur bonds,MF,ACSL4
11965,GO:0045010,0.451921679537308,0.880436116117458,1,42,actin nucleation,BP,SCIN
5022,GO:0010823,0.452331900486529,0.880138878180229,1,43,negative regulation of mitochondrion organization,BP,AKT1
13346,GO:0048675,0.452691466344397,0.803663835355667,2,99,axon extension,BP,WNT3;WNT5A
825,GO:0002020,0.452772031536278,0.803437359570453,2,108,protease binding,MF,ITGA3;SERPINA5
19753,GO:1903727,0.452858637312065,0.879941070418557,1,41,positive regulation of phospholipid metabolic process,BP,PDGFB
5146,GO:0010976,0.453142338196338,0.737132464450042,4,227,positive regulation of neuron projection development,BP,ITGA3;WNT3;WNT5A;BMP7
6741,GO:0019867,0.453218078992086,0.762677654428979,3,176,outer membrane,CC,PMAIP1;VAMP1;ACSL4
4883,GO:0010611,0.454467924550132,0.878987710233169,1,41,regulation of cardiac muscle hypertrophy,BP,EDN1
1968,GO:0004407,0.455219005098198,0.878602785811231,1,40,histone deacetylase activity,MF,SIN3B
9102,GO:0033558,0.455219005098198,0.878602785811231,1,40,protein deacetylase activity,MF,SIN3B
2187,GO:0004712,0.455965976053643,0.878157855141676,1,40,protein serine/threonine/tyrosine kinase activity,MF,AKT1
20697,GO:1990090,0.456039436757753,0.877993314820533,1,42,cellular response to nerve growth factor stimulus,BP,AKT1
12833,GO:0046850,0.456135343837498,0.877936052915018,1,42,regulation of bone remodeling,BP,CLDN18
5106,GO:0010921,0.456559382914712,0.800682032099128,2,101,regulation of phosphatase activity,BP,BMP2;CAMSAP3
10843,GO:0042461,0.457176122651272,0.877434883551254,1,40,photoreceptor cell development,BP,MYO7A
3602,GO:0007029,0.457620550868316,0.877168701962019,1,40,endoplasmic reticulum organization,BP,REEP1
3470,GO:0006821,0.457707466101671,0.799765940247759,2,103,chloride transport,BP,TTYH1;WNK4
8622,GO:0032613,0.457836340867591,0.876807143174237,1,44,interleukin-10 production,BP,DLL1
3161,GO:0006402,0.457952003297625,0.758475302300296,3,217,mRNA catabolic process,BP,PRR5L;PKP3;PKP1
3722,GO:0007223,0.457961581982492,0.877029766011092,1,39,Wnt signaling pathway, calcium modulating pathway,BP,WNT5A
7590,GO:0030815,0.458208087783157,0.876583706330379,1,44,negative regulation of cAMP metabolic process,BP,EDN1
10773,GO:0042345,0.458395085686881,0.876419527894507,1,45,regulation of NF-kappaB import into nucleus,BP,BMP7
10776,GO:0042348,0.458395085686881,0.876419527894507,1,45,NF-kappaB import into nucleus,BP,BMP7
12793,GO:0046717,0.458951095925885,0.79867283222614,2,111,acid secretion,BP,ADORA1;EDN1
3743,GO:0007266,0.459665117764371,0.757446261425694,3,165,Rho protein signal transduction,BP,ITGA3;RHOJ;RHOB
18657,GO:1901028,0.460010782600779,0.87544458193639,1,45,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
11316,GO:0043280,0.460049053063573,0.797796933767525,2,113,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;CTGF
13947,GO:0051220,0.460725127457633,0.875118838100297,1,43,cytoplasmic sequestering of protein,BP,AKT1
947,GO:0002223,0.460913650376907,0.797041401935811,2,119,stimulatory C-type lectin receptor signaling pathway,BP,PRKACB;HRAS
2535,GO:0005245,0.461181082874119,0.874959976373731,1,41,voltage-gated calcium channel activity,MF,GAS6
4262,GO:0008631,0.461244503788999,0.874749216995796,1,44,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,AKT1
8790,GO:0032873,0.461550563537597,0.874735905158299,1,41,negative regulation of stress-activated MAPK cascade,BP,AKT1
15862,GO:0070303,0.461550563537597,0.874735905158299,1,41,negative regulation of stress-activated protein kinase signaling cascade,BP,AKT1
5932,GO:0016447,0.462435855644623,0.874079853225883,1,43,somatic recombination of immunoglobulin gene segments,BP,CLCF1
9608,GO:0034764,0.46322275530512,0.795362828906126,2,112,positive regulation of transmembrane transport,BP,ACTN2;KCNH2
15178,GO:0060761,0.463453767379643,0.873300545461371,1,46,negative regulation of response to cytokine stimulus,BP,GAS6
13243,GO:0048483,0.463608351222492,0.873364645898797,1,43,autonomic nervous system development,BP,GDNF
14077,GO:0051438,0.463704561096925,0.794827987478135,2,123,regulation of ubiquitin-protein transferase activity,BP,MAGEC2;AXIN1
627,GO:0001754,0.465832140402631,0.87212101473505,1,41,eye photoreceptor cell differentiation,BP,MYO7A
5730,GO:0016032,0.465888955875654,0.645943055848874,13,928,viral process,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;NMT2;MFGE8;TYRO3;PIK3R1;CLDN1;GAS6;ACTA2;PIM2;EFNB2
13794,GO:0050999,0.466696948906932,0.871358975933876,1,45,regulation of nitric-oxide synthase activity,BP,AKT1
16152,GO:0070849,0.466777297284845,0.871539214443607,1,41,response to epidermal growth factor,BP,AKT1
9779,GO:0035336,0.466993635782109,0.871175769260437,1,45,long-chain fatty-acyl-CoA metabolic process,BP,ACSL4
7584,GO:0030809,0.467562596908333,0.870823973430322,1,45,negative regulation of nucleotide biosynthetic process,BP,EDN1
18595,GO:1900372,0.467562596908333,0.870823973430322,1,45,negative regulation of purine nucleotide biosynthetic process,BP,EDN1
8198,GO:0031952,0.468042257962844,0.870822979571065,1,40,regulation of protein autophosphorylation,BP,PDGFB
945,GO:0002220,0.468489849107378,0.791126689077178,2,121,innate immune response activating cell surface receptor signaling pathway,BP,PRKACB;HRAS
3706,GO:0007204,0.468505175261853,0.723644664803057,4,258,positive regulation of cytosolic calcium ion concentration,BP,CASQ2;EDN1;LPAR2;PIK3CG
12769,GO:0046677,0.469230131197261,0.869737742892345,1,46,response to antibiotic,BP,GJB2
3347,GO:0006639,0.470452323374339,0.789616079883431,2,119,acylglycerol metabolic process,BP,PIK3CG;ACSL4
7575,GO:0030800,0.4715075554946,0.868315977891071,1,46,negative regulation of cyclic nucleotide metabolic process,BP,EDN1
5254,GO:0014743,0.472054039847385,0.868137611636689,1,43,regulation of muscle hypertrophy,BP,EDN1
5204,GO:0014047,0.473275791881436,0.86743073428904,1,42,glutamate secretion,BP,ADORA1
12026,GO:0045104,0.473330975743558,0.867335731173257,1,43,intermediate filament cytoskeleton organization,BP,PKP1
13702,GO:0050853,0.473620937251553,0.867095603900464,1,44,B cell receptor signaling pathway,BP,BCAR1
17062,GO:0072503,0.473636418344765,0.686616776774385,6,403,cellular divalent inorganic cation homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;PIK3CG;VDR
10903,GO:0042551,0.474046216844683,0.86694571518082,1,42,neuron maturation,BP,SPTBN4
18666,GO:1901068,0.474151808495308,0.866653009214566,1,46,guanosine-containing compound metabolic process,BP,RHOQ
13725,GO:0050879,0.474338585280106,0.866484516094421,1,47,multicellular organismal movement,BP,ACTN3
13727,GO:0050881,0.474338585280106,0.866484516094421,1,47,musculoskeletal movement,BP,ACTN3
3346,GO:0006638,0.475799407665452,0.785377790149226,2,120,neutral lipid metabolic process,BP,PIK3CG;ACSL4
371,GO:0000989,0.475965030404857,0.657168557260684,9,582,transcription factor activity, transcription factor binding,MF,LIF;WNT4;POU3F1;ACTN2;NOTCH1;NAB2;TLE1;SIN3B;ZCCHC12
17508,GO:0090280,0.476177248095109,0.86522384387624,1,49,positive regulation of calcium ion import,BP,PDGFB
15672,GO:0065003,0.476529774594693,0.61036733457488,23,1645,macromolecular complex assembly,BP,FHOD3;TUBG2;ACTN2;PMAIP1;CASQ2;SPTBN5;SPTBN4;PRND;RALB;HRAS;AXIN1;SCIN;PSRC1;SPTB;VAMP1;MSN;GJB1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;KCND1
3342,GO:0006633,0.476882620176192,0.784546361623054,2,118,fatty acid biosynthetic process,BP,EDN1;PTGES
3895,GO:0008022,0.476955141318067,0.742766893679753,3,176,protein C-terminus binding,MF,HRAS;CTGF;LAMA1
16999,GO:0072329,0.477074703585409,0.784455940748014,2,114,monocarboxylic acid catabolic process,BP,SESN2;AKT1
12040,GO:0045123,0.477421680342797,0.864578367773253,1,46,cellular extravasation,BP,PIK3CG
9023,GO:0033267,0.478209643970696,0.741712447527728,3,174,axon part,CC,ADORA1;SPTBN4;VAMP1
620,GO:0001736,0.478415779739203,0.78329488286655,2,120,establishment of planar polarity,BP,FZD7;WNT5A
3672,GO:0007164,0.478415779739203,0.78329488286655,2,120,establishment of tissue polarity,BP,FZD7;WNT5A
3040,GO:0006195,0.479033538409507,0.863548238627803,1,46,purine nucleotide catabolic process,BP,PDE4B
8735,GO:0032787,0.479150671896897,0.661586119958182,8,540,monocarboxylic acid metabolic process,BP,ACTN3;GLDC;EDN1;SESN2;PFKFB3;AKT1;PTGES;ACSL4
18982,GO:1901987,0.47938045650833,0.695380631753369,5,330,regulation of cell cycle phase transition,BP,GADD45A;FGF10;FOXO4;CDKN1A;AKT1
11235,GO:0043170,0.479653467211868,0.571701274335384,122,8633,macromolecule metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;TSPAN15;TSPAN17;NOTCH1;MARK4;RAB27A;ITGB8;PMAIP1;GADD45A;CRB2;RHBDL3;FBXO41;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;NMT2;ADORA1;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;VDR;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
20696,GO:1990089,0.479705186857576,0.863171473197154,1,45,response to nerve growth factor,BP,AKT1
9005,GO:0033218,0.479956263005089,0.713530018296961,4,260,amide binding,MF,ACVR1;PIK3R1;NPR1;PTGES
11682,GO:0044242,0.480775136437238,0.739381595872329,3,189,cellular lipid catabolic process,BP,SESN2;AKT1;PIK3CG
3341,GO:0006631,0.481019958760946,0.693891598548434,5,330,fatty acid metabolic process,BP,EDN1;SESN2;AKT1;PTGES;ACSL4
11697,GO:0044260,0.48157734633069,0.569910993173898,113,7982,cellular macromolecule metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN2;TSPAN17;NOTCH1;MARK4;PMAIP1;GADD45A;CRB2;FBXO41;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;NMT2;ADORA1;DKK3;EDN1;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;VDR;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2
1045,GO:0002381,0.481588368972849,0.861905332287821,1,46,immunoglobulin production involved in immunoglobulin mediated immune response,BP,CLCF1
8473,GO:0032412,0.481591893427664,0.738719970278902,3,184,regulation of ion transmembrane transporter activity,BP,ACTN2;CASQ2;PDE4B
2517,GO:0005215,0.481612465567697,0.61317486442249,19,1294,transporter activity,MF,STRA6;TF;SLC45A4;SLC52A3;KCNK6;FLVCR2;SLC25A53;TTYH1;KCNH2;SLC2A14;SFXN1;GJB1;GJB2;GJA3;KCNG2;GAS6;SLC18B1;KCND1;CLDN16
12025,GO:0045103,0.482043941966786,0.861722436116371,1,44,intermediate filament-based process,BP,PKP1
13164,GO:0048260,0.482089833580128,0.861635851128996,1,45,positive regulation of receptor-mediated endocytosis,BP,TF
21042,GO:2000179,0.482942751791007,0.861200902979633,1,43,positive regulation of neural precursor cell proliferation,BP,NOTCH1
11625,GO:0044088,0.483620277442075,0.860701861886535,1,44,regulation of vacuole organization,BP,RALB
17113,GO:0072577,0.484607521546623,0.8599477510289,1,46,endothelial cell apoptotic process,BP,GAS6
13691,GO:0050830,0.484825092893625,0.85908305179426,1,65,defense response to Gram-positive bacterium,BP,CHGA
13808,GO:0051018,0.48502904510275,0.859909228223717,1,42,protein kinase A binding,MF,PRKAR1B
4810,GO:0010468,0.486273390017718,0.572884527412696,61,4258,regulation of gene expression,BP,ITGA3;LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;ITGB8;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;PRKACB;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;MSN;CTGF;AKT1;PKP3;PKP1;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;SHC4;VDR;GDNF;FZD8;HEY1;ACTA2;PIM2
2659,GO:0005544,0.486865492087927,0.858472260114025,1,46,calcium-dependent phospholipid binding,MF,SYT5
3745,GO:0007268,0.486907769227897,0.646836346273411,9,584,chemical synaptic transmission,BP,SYT5;WNT7A;ADORA1;EDN1;HRAS;AKT1;LZTS1;UNC119;GDNF
18240,GO:0098916,0.486907769227897,0.646836346273411,9,584,anterograde trans-synaptic signaling,BP,SYT5;WNT7A;ADORA1;EDN1;HRAS;AKT1;LZTS1;UNC119;GDNF
3958,GO:0008134,0.487633960357614,0.653653687597085,8,517,transcription factor binding,MF,ZFPM1;PIK3R1;FOXO4;DLL1;NAB2;TLE1;VDR;HEY1
12774,GO:0046686,0.48771857190861,0.857502654894366,1,55,response to cadmium ion,BP,AKT1
14004,GO:0051297,0.487833606934352,0.775890677410411,2,109,centrosome organization,BP,RAB6C;GADD45A
4107,GO:0008375,0.488568735125063,0.857408606339625,1,45,acetylglucosaminyltransferase activity,MF,B3GNT2
961,GO:0002250,0.488576040125445,0.686962888846685,5,338,adaptive immune response,BP,RAB27A;HRAS;JAM3;CLCF1;PIK3CG
18986,GO:1901991,0.488809479691943,0.732390906387119,3,194,negative regulation of mitotic cell cycle phase transition,BP,GADD45A;FOXO4;CDKN1A
4106,GO:0008374,0.488860280011159,0.857160556363926,1,46,O-acyltransferase activity,MF,MBOAT2
13607,GO:0050710,0.489393572168452,0.856703534799993,1,48,negative regulation of cytokine secretion,BP,GAS6
8584,GO:0032559,0.489454693570252,0.597861638676804,23,1461,adenyl ribonucleotide binding,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;PRKAR1B;KHK;NPR1;NUAK2;PFKFB3;PKN3;WNK4;DDR1;AKT1;MYO7A;PIK3CA;PIK3CG;MYH11;ARAF;ACSL4;ACTA2;PIM2;PDE4B
15584,GO:0061640,0.489852095457271,0.856620346366797,1,44,cytoskeleton-dependent cytokinesis,BP,SNX18
9780,GO:0035337,0.489962430791364,0.856327238271644,1,48,fatty-acyl-CoA metabolic process,BP,ACSL4
9681,GO:0035094,0.490143609440406,0.856258805603216,1,47,response to nicotine,BP,EDN1
3756,GO:0007286,0.490710676559064,0.773291140222156,2,125,spermatid development,BP,DHH;JAM3
18335,GO:0099536,0.491562941781452,0.642408928989284,9,586,synaptic signaling,BP,SYT5;WNT7A;ADORA1;EDN1;HRAS;AKT1;LZTS1;UNC119;GDNF
18336,GO:0099537,0.491562941781452,0.642408928989284,9,586,trans-synaptic signaling,BP,SYT5;WNT7A;ADORA1;EDN1;HRAS;AKT1;LZTS1;UNC119;GDNF
12713,GO:0046580,0.491758481744418,0.855418643562241,1,43,negative regulation of Ras protein signal transduction,BP,ITGA3
21646,GO:2001244,0.491882730900145,0.854822336355332,1,53,positive regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1
8451,GO:0032387,0.491950356430027,0.772379950060329,2,118,negative regulation of intracellular transport,BP,BMP7;GAS6
6677,GO:0019730,0.492204680919439,0.853881409819007,1,79,antimicrobial humoral response,BP,CHGA
11383,GO:0043401,0.493187341385986,0.728702071873433,3,178,steroid hormone mediated signaling pathway,BP,BMP7;BMP4;VDR
1397,GO:0003044,0.493267573992612,0.854128435940201,1,48,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,EDN1
13275,GO:0048538,0.493388710648944,0.854211038254726,1,45,thymus development,BP,FGF10
1170,GO:0002637,0.493583078692426,0.85377305396428,1,51,regulation of immunoglobulin production,BP,CLCF1
9510,GO:0034605,0.49376782997421,0.771023600553803,2,110,cellular response to heat,BP,SLC52A3;CDKN1A
12679,GO:0046503,0.49472070596583,0.852881126314198,1,54,glycerolipid catabolic process,BP,PIK3CG
2908,GO:0005978,0.494851487767338,0.853174425106982,1,46,glycogen biosynthetic process,BP,AKT1
4506,GO:0009250,0.494851487767338,0.853174425106982,1,46,glucan biosynthetic process,BP,AKT1
17385,GO:0090102,0.495046752842216,0.853100607769562,1,45,cochlea development,BP,WNT5A
6052,GO:0016667,0.495683364173838,0.852232928369275,1,54,oxidoreductase activity, acting on a sulfur group of donors,MF,SESN2
2637,GO:0005507,0.496387413766086,0.851757707699542,1,54,copper ion binding,MF,PRND
7277,GO:0030170,0.496439630719881,0.852050882556891,1,47,pyridoxal phosphate binding,MF,GLDC
15848,GO:0070279,0.496439630719881,0.852050882556891,1,47,vitamin B6 binding,MF,GLDC
14565,GO:0055010,0.49656311740401,0.85196757325319,1,47,ventricular cardiac muscle tissue morphogenesis,BP,NOTCH1
9263,GO:0034097,0.497709811681621,0.624516763472047,11,798,response to cytokine,BP,EDN1;CCL20;PDGFB;WNT5A;CLCF1;AKT1;PTGES;CLDN1;GAS6;ACSL4;CLDN18
13365,GO:0048701,0.497759650072705,0.851272066355974,1,45,embryonic cranial skeleton morphogenesis,BP,BMP4
5004,GO:0010803,0.499072065497131,0.850114796960803,1,50,regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
7156,GO:0022898,0.499100611925847,0.723391612546381,3,190,regulation of transmembrane transporter activity,BP,ACTN2;CASQ2;PDE4B
17504,GO:0090276,0.499701225034537,0.722851954926825,3,191,regulation of peptide hormone secretion,BP,ADRA2C;INHBB;KCNG2
9629,GO:0034976,0.499972164551643,0.695526820867705,4,254,response to endoplasmic reticulum stress,BP,PMAIP1;PIK3R2;PIK3R1;SESN2
13845,GO:0051058,0.500205180277082,0.849672373725049,1,44,negative regulation of small GTPase mediated signal transduction,BP,ITGA3
6726,GO:0019842,0.500517838870313,0.765240350449173,2,122,vitamin binding,MF,GLDC;VDR
6805,GO:0020037,0.501213668680623,0.764645384045608,2,123,heme binding,MF,GUCY1B3;FLVCR2
7985,GO:0031503,0.501395294080111,0.764554952151793,2,119,protein complex localization,BP,RALB;BMP7
8688,GO:0032722,0.501502978485765,0.848455174119111,1,50,positive regulation of chemokine production,BP,WNT5A
72,GO:0000149,0.501810278193817,0.764291123474652,2,114,SNARE binding,MF,SYT5;VAMP1
5930,GO:0016445,0.502226693227077,0.848060287420527,1,48,somatic diversification of immunoglobulins,BP,CLCF1
484,GO:0001505,0.50260959158637,0.720366835396086,3,180,regulation of neurotransmitter levels,BP,SYT5;WNT7A;GDNF
14015,GO:0051310,0.502636483781607,0.847778925692048,1,48,metaphase plate congression,BP,PSRC1
7496,GO:0030554,0.503110554140988,0.584473727190465,23,1472,adenyl nucleotide binding,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;PRKAR1B;KHK;NPR1;NUAK2;PFKFB3;PKN3;WNK4;DDR1;AKT1;MYO7A;PIK3CA;PIK3CG;MYH11;ARAF;ACSL4;ACTA2;PIM2;PDE4B
12549,GO:0046148,0.503141927394721,0.847281696851356,1,51,pigment biosynthetic process,BP,WNT5A
21562,GO:2001056,0.504089148958977,0.762254919933093,2,122,positive regulation of cysteine-type endopeptidase activity,BP,PMAIP1;CTGF
7978,GO:0031491,0.504561809130933,0.846400274660334,1,49,nucleosome binding,MF,HMGN5
6587,GO:0019369,0.50496254410492,0.846024739694077,1,51,arachidonic acid metabolic process,BP,PTGES
14672,GO:0060042,0.505270766504064,0.846073834548557,1,46,retina morphogenesis in camera-type eye,BP,DLL1
3729,GO:0007249,0.505468913338388,0.690457512876999,4,260,I-kappaB kinase/NF-kappaB signaling,BP,BMP7;AKT1;TLE1;PIM2
7769,GO:0031102,0.505707589196264,0.845607164405367,1,49,neuron projection regeneration,BP,JAM3
5835,GO:0016247,0.505736670520427,0.760840890143111,2,124,channel regulator activity,MF,TSPAN13;WNK4
2312,GO:0004879,0.505779937754308,0.845721299993058,1,46,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,MF,VDR
18053,GO:0098531,0.505779937754308,0.845721299993058,1,46,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,VDR
3393,GO:0006695,0.506379028084827,0.845090690131999,1,50,cholesterol biosynthetic process,BP,HMGCS2
21640,GO:2001238,0.506795443640973,0.844801153281916,1,50,positive regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1
10727,GO:0042267,0.50716089082546,0.844406401749234,1,53,natural killer cell mediated cytotoxicity,BP,RAB27A
10645,GO:0042093,0.507596246770103,0.844243367612303,1,50,T-helper cell differentiation,BP,ZFPM1
6683,GO:0019748,0.507644955608407,0.844113841218483,1,52,secondary metabolic process,BP,WNT5A
11375,GO:0043392,0.50836065055109,0.843660879203084,1,51,negative regulation of DNA binding,BP,HEY1
7807,GO:0031201,0.508459501859371,0.843591765952843,1,51,SNARE complex,CC,VAMP1
12727,GO:0046605,0.509048051622002,0.843388332410981,1,47,regulation of centrosome cycle,BP,RAB6C
3150,GO:0006383,0.509530551159618,0.842841660681326,1,51,transcription from RNA polymerase III promoter,BP,NAB2
12738,GO:0046626,0.509740352275694,0.842847926919662,1,48,regulation of insulin receptor signaling pathway,BP,PIK3R1
2546,GO:0005261,0.510901262608902,0.666315697604603,5,312,cation channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
19545,GO:1903313,0.510946955880251,0.841946784843687,1,49,positive regulation of mRNA metabolic process,BP,PRR5L
17076,GO:0072523,0.511610071542302,0.841428081886505,1,50,purine-containing compound catabolic process,BP,PDE4B
11197,GO:0043113,0.511638231136533,0.84156924671931,1,47,receptor clustering,BP,CDH2
4993,GO:0010769,0.511695369864181,0.684799627018566,4,244,regulation of cell morphogenesis involved in differentiation,BP,WNT3;WNT7A;WNT5A;LZTS1
19255,GO:1902653,0.51178648293323,0.841254123589461,1,51,secondary alcohol biosynthetic process,BP,HMGCS2
14330,GO:0051926,0.511905886618051,0.84107644554876,1,53,negative regulation of calcium ion transport,BP,CASQ2
9280,GO:0034121,0.512217322119801,0.841104643494325,1,48,regulation of toll-like receptor signaling pathway,BP,TYRO3
13695,GO:0050840,0.512518245799328,0.840892005008049,1,48,extracellular matrix binding,MF,ITGA3
13260,GO:0048515,0.513022115161539,0.754581371768875,2,130,spermatid differentiation,BP,DHH;JAM3
18983,GO:1901988,0.513081645877192,0.710796780301059,3,202,negative regulation of cell cycle phase transition,BP,GADD45A;FOXO4;CDKN1A
5029,GO:0010830,0.51333157550153,0.840113011431335,1,52,regulation of myotube differentiation,BP,NOTCH1
8316,GO:0032154,0.513721726852369,0.840039757292393,1,48,cleavage furrow,CC,RHOB
17991,GO:0097610,0.513721726852369,0.840039757292393,1,48,cell surface furrow,CC,RHOB
7534,GO:0030660,0.513835359488989,0.839853174562321,1,50,Golgi-associated vesicle membrane,CC,RHOQ
19680,GO:1903578,0.51482822330096,0.839049103539876,1,52,regulation of ATP metabolic process,BP,ACTN3
7221,GO:0030073,0.515019711085553,0.709113036049401,3,193,insulin secretion,BP,ADRA2C;INHBB;KCNG2
4832,GO:0010518,0.515150167431911,0.838917892147909,1,50,positive regulation of phospholipase activity,BP,LPAR2
19631,GO:1903506,0.516470947840035,0.547227612146226,50,3489,regulation of nucleic acid-templated transcription,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
3514,GO:0006891,0.5167490949414,0.837939812498584,1,47,intra-Golgi vesicle-mediated transport,BP,RAB6C
3478,GO:0006836,0.517737433833953,0.706731692350118,3,183,neurotransmitter transport,BP,SYT5;WNT7A;GDNF
988,GO:0002294,0.517749511657759,0.836959249428426,1,52,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,ZFPM1
6279,GO:0017112,0.517868656385393,0.837025532225455,1,49,Rab guanyl-nucleotide exchange factor activity,MF,RIN3
3434,GO:0006766,0.517954558471875,0.750408266267409,2,126,vitamin metabolic process,BP,SLC52A3;VDR
18225,GO:0098900,0.518082935785524,0.836926527879638,1,48,regulation of action potential,BP,DSC2
5147,GO:0010977,0.518322708768321,0.7502164273468,2,118,negative regulation of neuron projection development,BP,WNT3;WNT5A
7720,GO:0031023,0.51867055172093,0.749968181286457,2,115,microtubule organizing center organization,BP,RAB6C;GADD45A
15294,GO:0060997,0.519317470019857,0.836155713163558,1,46,dendritic spine morphogenesis,BP,WNT7A
9576,GO:0034707,0.519527813262592,0.835778297088989,1,50,chloride channel complex,CC,TTYH1
8656,GO:0032663,0.520111097770418,0.835356989210723,1,50,regulation of interleukin-2 production,BP,PDE4B
6816,GO:0021515,0.520644742930242,0.834870690022855,1,52,cell differentiation in spinal cord,BP,NOTCH1
17871,GO:0097345,0.521179147389529,0.83443592941345,1,53,mitochondrial outer membrane permeabilization,BP,PMAIP1
8620,GO:0032611,0.521285790838872,0.834226605195503,1,56,interleukin-1 beta production,BP,WNT5A
13622,GO:0050727,0.522728644095313,0.674301715223881,4,280,regulation of inflammatory response,BP,ADORA1;TYRO3;WNT5A;PIK3CG
5872,GO:0016311,0.523053666730633,0.640246842115845,6,389,dephosphorylation,BP,ADORA1;PTPN7;PFKFB3;BMP2;CAMSAP3;DUSP5
7152,GO:0022890,0.523467050246989,0.619223452772447,8,540,inorganic cation transmembrane transporter activity,MF,TF;KCNK6;TTYH1;KCNH2;KCNG2;GAS6;KCND1;CLDN16
17065,GO:0072507,0.523974595681618,0.639264530985201,6,422,divalent inorganic cation homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;PIK3CG;VDR
13674,GO:0050806,0.525037792237638,0.744342665041338,2,121,positive regulation of synaptic transmission,BP,WNT7A;ADORA1
983,GO:0002287,0.525336958861301,0.831400808204861,1,53,alpha-beta T cell activation involved in immune response,BP,ZFPM1
987,GO:0002293,0.525336958861301,0.831400808204861,1,53,alpha-beta T cell differentiation involved in immune response,BP,ZFPM1
13120,GO:0048168,0.525764380526119,0.831347626382649,1,48,regulation of neuronal synaptic plasticity,BP,HRAS
5066,GO:0010876,0.527094792655694,0.650809335231805,5,341,lipid localization,BP,SERPINA5;EDN1;BMP6;AKT1;ACSL4
143,GO:0000287,0.527630389455408,0.697598236163199,3,190,magnesium ion binding,MF,PRKACB;MAPK12;NUAK2
16747,GO:0071897,0.527663928444041,0.697567249062957,3,190,DNA biosynthetic process,BP,PDGFB;CDKN1A;CTGF
9669,GO:0035065,0.52774504093718,0.82977771752472,1,50,regulation of histone acetylation,BP,LIF
19036,GO:1902110,0.527804704090132,0.829535615129575,1,54,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1
19267,GO:1902686,0.527804704090132,0.829535615129575,1,54,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,PMAIP1
9912,GO:0035580,0.528641985789705,0.828667516267288,1,60,specific granule lumen,CC,RAB27A
6284,GO:0017124,0.528823477957489,0.741076249984941,2,118,SH3 domain binding,MF,ESPN;BCAR1
21580,GO:2001141,0.529306980328429,0.534404959137079,50,3508,regulation of RNA biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
17250,GO:0086010,0.530510455951949,0.827838982741784,1,48,membrane depolarization during action potential,BP,KCNH2
13916,GO:0051171,0.532338114808239,0.52741294513406,60,4223,regulation of nitrogen compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
13934,GO:0051193,0.532418105227012,0.826197495876939,1,52,regulation of cofactor metabolic process,BP,ACTN3
13937,GO:0051196,0.532418105227012,0.826197495876939,1,52,regulation of coenzyme metabolic process,BP,ACTN3
19488,GO:1903201,0.533149461882242,0.825552079222984,1,54,regulation of oxidative stress-induced cell death,BP,AKT1
8712,GO:0032760,0.533632952473376,0.825055836303704,1,57,positive regulation of tumor necrosis factor production,BP,PIK3R1
1142,GO:0002562,0.533645516537068,0.825276451132339,1,52,somatic diversification of immune receptors via germline recombination within a single locus,BP,CLCF1
5929,GO:0016444,0.533645516537068,0.825276451132339,1,52,somatic cell DNA recombination,BP,CLCF1
1502,GO:0003229,0.533742605331057,0.825203459104054,1,52,ventricular cardiac muscle tissue development,BP,NOTCH1
10682,GO:0042157,0.533793240203075,0.691741008795813,3,207,lipoprotein metabolic process,BP,NMT2;PRKACB;PRND
5780,GO:0016126,0.53474310830169,0.824306467057598,1,55,sterol biosynthetic process,BP,HMGCS2
951,GO:0002228,0.534798409913258,0.824177399812879,1,57,natural killer cell mediated immunity,BP,RAB27A
11403,GO:0043433,0.534922667052487,0.735537687592929,2,127,negative regulation of sequence-specific DNA binding transcription factor activity,BP,BMP7;GAS6
13192,GO:0048306,0.535211598659635,0.823745057462854,1,60,calcium-dependent protein binding,MF,CASQ2
7775,GO:0031110,0.536668573379961,0.822944216414914,1,53,regulation of microtubule polymerization or depolymerization,BP,PSRC1
11273,GO:0043226,0.536849298172445,0.520812094963117,174,12482,organelle,CC,ITGA3;ITGA5;FHOD3;BEX4;TMEM163;ADRA2C;SYT5;WNT3;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;CDH23;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;NMT2;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;PRKACB;MFGE8;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NUAK2;PFKFB3;SCIN;PSRC1;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;WNT2B;CYTIP;PTGES;KITLG;NPPC;NAB2;CDH1;EPN1;MYO7A;BCAR1;HPCAL1;RAB44;TLE1;CLDN2;CLDN3;CLDN5;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;ZCCHC12;MYH11;LZTS1;PM20D2;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;CLDN11;RNF144A;PARVB;PDE4B
10660,GO:0042116,0.537449153329854,0.822211918727641,1,56,macrophage activation,BP,WNT5A
6532,GO:0019213,0.537466778134653,0.822388386105933,1,52,deacetylase activity,MF,SIN3B
11791,GO:0044420,0.53752494581445,0.73341713159095,2,115,extracellular matrix component,CC,LAMA1;LAMA5
11413,GO:0043462,0.537561120524901,0.821924513578122,1,61,regulation of ATPase activity,BP,FGF10
11426,GO:0043488,0.537940538804607,0.732718154573583,2,136,regulation of mRNA stability,BP,AKT1;GDNF
12867,GO:0046906,0.539380628211954,0.731481924739169,2,132,tetrapyrrole binding,MF,GUCY1B3;FLVCR2
10057,GO:0035794,0.540041890072722,0.820232883564352,1,56,positive regulation of mitochondrial membrane permeability,BP,PMAIP1
2883,GO:0005929,0.540428150480605,0.611815624636577,7,479,cilium,CC,MARK4;RAB27A;PRKACB;SPTBN5;PRKAR1B;AKT1;MYO7A
4669,GO:0009889,0.542020185558897,0.518022135616617,59,4178,regulation of biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;CRB2;DHH;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;CCL20;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;NPPC;NAB2;CDH1;INHBB;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
20597,GO:1905710,0.542122570690786,0.818590201284447,1,57,positive regulation of membrane permeability,BP,PMAIP1
8470,GO:0032409,0.544075886527969,0.682104714319383,3,203,regulation of transporter activity,BP,ACTN2;CASQ2;PDE4B
4897,GO:0010633,0.544304099810893,0.817041482042822,1,54,negative regulation of epithelial cell migration,BP,NOTCH1
14300,GO:0051881,0.544859647005129,0.816348130857876,1,60,regulation of mitochondrial membrane potential,BP,PMAIP1
11580,GO:0043966,0.545114669889562,0.816412538320812,1,54,histone H3 acetylation,BP,LIF
8782,GO:0032846,0.545216259172417,0.68102338987302,3,203,positive regulation of homeostatic process,BP,CASQ2;EDN1;NPR1
6582,GO:0019362,0.546182976711904,0.725382299061533,2,129,pyridine nucleotide metabolic process,BP,ACTN3;PFKFB3
12673,GO:0046496,0.546182976711904,0.725382299061533,2,129,nicotinamide nucleotide metabolic process,BP,ACTN3;PFKFB3
4588,GO:0009584,0.547395190408789,0.814635301081479,1,54,detection of visible light,BP,NMT2
15706,GO:0070059,0.548247470400824,0.813919888304014,1,55,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,PMAIP1
19668,GO:1903557,0.548459678517054,0.813576660285066,1,59,positive regulation of tumor necrosis factor superfamily cytokine production,BP,PIK3R1
2812,GO:0005813,0.54847112128881,0.603872209021548,7,467,centrosome,CC,TUBG2;RAB6C;MARK4;PRKACB;CAMSAP3;UNC119;PDE4B
11515,GO:0043621,0.550902162580969,0.811930512609369,1,53,protein self-association,MF,SPTBN5
7135,GO:0022836,0.551761652672133,0.626852033817406,5,327,gated channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
13419,GO:0048813,0.55243112178637,0.719852334591465,2,118,dendrite morphogenesis,BP,WNT7A;LZTS1
21434,GO:2000756,0.55254150877155,0.810582603804876,1,54,regulation of peptidyl-lysine acetylation,BP,LIF
8662,GO:0032677,0.552650750204754,0.81022649629604,1,60,regulation of interleukin-8 production,BP,WNT5A
15908,GO:0070373,0.555129699225248,0.808522195273069,1,54,negative regulation of ERK1 and ERK2 cascade,BP,LIF
14928,GO:0060401,0.555331025849063,0.716981334223812,2,130,cytosolic calcium ion transport,BP,CASQ2;CTGF
4354,GO:0009060,0.555606069539039,0.807752683826727,1,63,aerobic respiration,BP,ACTN3
19008,GO:1902041,0.556502083289368,0.807326085620571,1,56,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1
5125,GO:0010950,0.556595439164109,0.715724728790245,2,136,positive regulation of endopeptidase activity,BP,PMAIP1;CTGF
3160,GO:0006401,0.556815930524921,0.669635086894,3,246,RNA catabolic process,BP,PRR5L;PKP3;PKP1
12139,GO:0045333,0.558475198068112,0.71365043488776,2,165,cellular respiration,BP,ACTN3;PIK3CA
10467,GO:0038083,0.558794083358985,0.805685237602126,1,52,peptidyl-tyrosine autophosphorylation,BP,DDR1
3132,GO:0006355,0.558870406282445,0.505097751712768,49,3465,regulation of transcription, DNA-templated,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
2791,GO:0005778,0.560050385438487,0.804418141296492,1,57,peroxisomal membrane,CC,ACSL4
8174,GO:0031903,0.560050385438487,0.804418141296492,1,57,microbody membrane,CC,ACSL4
5675,GO:0015909,0.560071759379239,0.804189913389846,1,62,long-chain fatty acid transport,BP,AKT1
19034,GO:1902108,0.561255596080086,0.803350627719905,1,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1
986,GO:0002292,0.562106545549162,0.80265751720018,1,59,T cell differentiation involved in immune response,BP,ZFPM1
12771,GO:0046683,0.564141045570647,0.708783144597967,2,129,response to organophosphorus,BP,WT1;PIK3CG
8628,GO:0032623,0.564297720198429,0.800955089918686,1,57,interleukin-2 production,BP,PDE4B
4473,GO:0009205,0.56443558719225,0.662219044642227,3,248,purine ribonucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
5846,GO:0016266,0.565564914779854,0.800010792775717,1,55,O-glycan processing,BP,B3GNT2
1087,GO:0002460,0.565669197047172,0.661232665736802,3,213,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,RAB27A;HRAS;CLCF1
6774,GO:0019935,0.566315874168918,0.799204666786546,1,59,cyclic-nucleotide-mediated signaling,BP,GUCY1B3
5946,GO:0016482,0.566710396226323,0.706410034728938,2,126,cytosolic transport,BP,RAB6C;MSN
7197,GO:0030032,0.56767927181897,0.798266022456751,1,55,lamellipodium assembly,BP,PARVB
3327,GO:0006612,0.567765681619623,0.704811152409536,2,178,protein targeting to membrane,BP,ADORA1;GAS6
21644,GO:2001242,0.567836243191365,0.705087961666594,2,144,regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1;AKT1
3510,GO:0006886,0.568386975368957,0.537806910419012,15,1108,intracellular protein transport,BP,RAB27A;ADORA1;FZD7;PRR5L;PIK3R2;PIK3R1;RHOB;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;MYO7A;GAS6
3520,GO:0006898,0.568510603437161,0.62992679923295,4,278,receptor-mediated endocytosis,BP,SYT5;TF;DLL1;UNC119
17077,GO:0072524,0.568606661742341,0.704492639966014,2,134,pyridine-containing compound metabolic process,BP,ACTN3;PFKFB3
13348,GO:0048678,0.569910088392652,0.796097977341796,1,62,response to axon injury,BP,JAM3
5736,GO:0016042,0.570511521910625,0.627839488311751,4,296,lipid catabolic process,BP,ADORA1;SESN2;AKT1;PIK3CG
11315,GO:0043279,0.572941781027091,0.700323188403319,2,137,response to alkaloid,BP,CASQ2;EDN1
10921,GO:0042578,0.572999182067725,0.605568987216202,5,340,phosphoric ester hydrolase activity,MF,ADORA1;PTPN7;PFKFB3;DUSP5;PDE4B
4438,GO:0009165,0.573026304113825,0.6252608745053,4,309,nucleotide biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
13958,GO:0051235,0.57320911705493,0.625190209999261,4,284,maintenance of location,BP,CASQ2;SPTBN4;SCIN;AKT1
1097,GO:0002479,0.574196197356696,0.792095210676628,1,74,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,ITGB5
5975,GO:0016529,0.574319313114432,0.792526941473317,1,59,sarcoplasmic reticulum,CC,CASQ2
3229,GO:0006497,0.574445336931865,0.698829520307559,2,141,protein lipidation,BP,NMT2;PRND
11425,GO:0043487,0.575061273647112,0.698199809419451,2,144,regulation of RNA stability,BP,AKT1;GDNF
18387,GO:0101003,0.575075798733627,0.791843848511528,1,60,ficolin-1-rich granule membrane,CC,PKP1
12018,GO:0045087,0.575347467370349,0.552872207445212,10,808,innate immune response,BP,RAB27A;EDN1;PRKACB;CCL20;TYRO3;HRAS;WNT5A;CHGA;CLDN1;PIK3CG
939,GO:0002200,0.575366276027719,0.791688141582281,1,58,somatic diversification of immune receptors,BP,CLCF1
1238,GO:0002718,0.576465003288648,0.790542207566913,1,63,regulation of cytokine production involved in immune response,BP,WNT5A
3071,GO:0006261,0.578905272246654,0.694664532739794,2,132,DNA-dependent DNA replication,BP,BMP6;BMP4
18011,GO:0097659,0.579352305047014,0.483317545417906,51,3636,nucleic acid-templated transcription,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
2814,GO:0005815,0.579521223643891,0.555306792499175,9,620,microtubule organizing center,CC,TUBG2;RAB6C;MARK4;PRKACB;CAMSAP3;AKT1;UNC119;FAM110B;PDE4B
8315,GO:0032153,0.579863590004525,0.787907754959347,1,57,cell division site,CC,RHOB
8317,GO:0032155,0.579863590004525,0.787907754959347,1,57,cell division site part,CC,RHOB
18753,GO:1901293,0.580847466488609,0.617350573021032,4,312,nucleoside phosphate biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
3868,GO:0007612,0.580972414634742,0.692726100555868,2,128,learning,BP,STRA6;CLDN5
4831,GO:0010517,0.581066524310947,0.786735903131222,1,60,regulation of phospholipase activity,BP,LPAR2
3747,GO:0007270,0.582619869833869,0.691062176062465,2,132,neuron-neuron synaptic transmission,BP,ADORA1;GDNF
1654,GO:0003824,0.583183864238193,0.471637254833934,77,5495,catalytic activity,MF,TUBG2;RAB6C;TSPAN17;GLDC;MARK4;RAB27A;PNMT;RASL11B;RHBDL3;FBXO41;DHH;HMGCS2;ACVR1;NMT2;GUCY1B3;ADORA1;PLAU;RAB40B;RAB40A;PRKACB;MBOAT2;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PTPN7;RALB;HRAS;KHK;SESN2;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;FGF8;HBEGF;BMP2;B3GNT2;CDKN1A;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;PTGES;KITLG;MYO7A;SPSB1;RAB44;PIK3CA;PIK3CG;SIN3B;DTX4;MYH11;PM20D2;ARAF;RAB38;RAB3D;ACSL4;DUSP5;RNF144A;PIM2;PDE4B
14360,GO:0051966,0.583340968147927,0.784866607758242,1,58,regulation of synaptic transmission, glutamatergic,BP,ADORA1
15271,GO:0060968,0.583506792281068,0.784463517684189,1,64,regulation of gene silencing,BP,BMP4
4418,GO:0009144,0.583601609867558,0.643174192543113,3,255,purine nucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
4467,GO:0009199,0.583618333408117,0.643162638031163,3,254,ribonucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
9518,GO:0034622,0.584123266379379,0.533280153987365,12,947,cellular macromolecular complex assembly,BP,FHOD3;TUBG2;CASQ2;SPTBN5;SPTBN4;RALB;AXIN1;SCIN;PSRC1;SPTB;VAMP1;MYH11
4705,GO:0009988,0.584139756568228,0.783914838168541,1,64,cell-cell recognition,BP,MSN
10667,GO:0042129,0.584528370633341,0.688994149834714,2,147,regulation of T cell proliferation,BP,SDC4;BMP4
336,GO:0000922,0.584641860836645,0.689106277231136,2,131,spindle pole,CC,PSRC1;UNC119
10932,GO:0042590,0.586468310907429,0.78146096405216,1,77,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,ITGB5
16410,GO:0071345,0.586578271143693,0.547913361135114,9,704,cellular response to cytokine stimulus,BP,EDN1;CCL20;PDGFB;WNT5A;CLCF1;AKT1;CLDN1;GAS6;CLDN18
5813,GO:0016209,0.586608823397975,0.781284851177279,1,79,antioxidant activity,MF,SESN2
14775,GO:0060193,0.586909737274638,0.78154262498745,1,63,positive regulation of lipase activity,BP,LPAR2
8635,GO:0032637,0.588153781818286,0.780335775597593,1,66,interleukin-8 production,BP,WNT5A
2943,GO:0006027,0.588260098707557,0.780489370607904,1,60,glycosaminoglycan catabolic process,BP,SDC4
7353,GO:0030276,0.588287979343657,0.780558637203846,1,58,clathrin binding,MF,SYT5
1627,GO:0003707,0.588577854822725,0.780304375191104,1,58,steroid hormone receptor activity,MF,VDR
7905,GO:0031348,0.588663162215515,0.684976985803547,2,144,negative regulation of defense response,BP,ADORA1;TYRO3
364,GO:0000979,0.589245186247932,0.779670458034405,1,59,RNA polymerase II core promoter sequence-specific DNA binding,MF,ZFPM1
4439,GO:0009166,0.589289041916929,0.779415385636696,1,64,nucleotide catabolic process,BP,PDE4B
486,GO:0001508,0.589293643388212,0.684542552759622,2,131,action potential,BP,DSC2;KCNH2
8277,GO:0032088,0.589663357496142,0.779085806782529,1,64,negative regulation of NF-kappaB transcription factor activity,BP,BMP7
14359,GO:0051965,0.589667670685951,0.779396175889926,1,57,positive regulation of synapse assembly,BP,WNT7A
18978,GO:1901983,0.590144610005727,0.77878752612669,1,61,regulation of protein acetylation,BP,LIF
635,GO:0001764,0.590393842686848,0.683473316576047,2,130,neuron migration,BP,ITGA3;GAS6
3105,GO:0006305,0.592470762195162,0.776821673109673,1,59,DNA alkylation,BP,PIK3CA
3106,GO:0006306,0.592470762195162,0.776821673109673,1,59,DNA methylation,BP,PIK3CA
10833,GO:0042440,0.592815448616983,0.776218682958241,1,66,pigment metabolic process,BP,WNT5A
11710,GO:0044281,0.593059099876908,0.489034232191559,26,1974,small molecule metabolic process,BP,WNT4;ACTN3;GLDC;PMAIP1;SLC52A3;HMGCS2;GUCY1B3;DKK3;EDN1;WNT5A;KHK;SESN2;RHOQ;NPR1;PFKFB3;BMP6;BMP2;B3GNT2;CHGA;AKT1;PTGES;NPPC;PIK3CA;VDR;ACSL4;PDE4B
3233,GO:0006501,0.593081444829459,0.775873290424342,1,69,C-terminal protein lipidation,BP,PRND
6230,GO:0017016,0.593900010552696,0.60420368815005,4,268,Ras GTPase binding,MF,RIN3;DAAM2;RAB11FIP1;SH3BP4
11356,GO:0043367,0.59505555649765,0.774341358953002,1,63,CD4-positive, alpha-beta T cell differentiation,BP,ZFPM1
12537,GO:0046128,0.59539408092555,0.773957250801932,1,65,purine ribonucleoside metabolic process,BP,RHOQ
9806,GO:0035384,0.596022162594874,0.773476047619545,1,63,thioester biosynthetic process,BP,ACSL4
16596,GO:0071616,0.596022162594874,0.773476047619545,1,63,acyl-CoA biosynthetic process,BP,ACSL4
3416,GO:0006733,0.596189911873009,0.677527611277835,2,143,oxidoreduction coenzyme metabolic process,BP,ACTN3;PFKFB3
4080,GO:0008324,0.596966038687524,0.537194220446343,9,649,cation transmembrane transporter activity,MF,TF;SLC45A4;KCNK6;TTYH1;KCNH2;KCNG2;GAS6;KCND1;CLDN16
9763,GO:0035304,0.597176779195272,0.772526549552351,1,61,regulation of protein dephosphorylation,BP,ADORA1
7019,GO:0021885,0.597190474446029,0.772656292146806,1,58,forebrain cell migration,BP,TYRO3
4350,GO:0009056,0.597201603914237,0.479806396167826,30,2223,catabolic process,BP,ACTN3;GLDC;ITGB4;PMAIP1;ADORA1;RAB39A;PRR5L;PIK3R2;RALB;WNT5A;MAGEC2;KHK;GPRASP1;SESN2;AXIN1;PFKFB3;SDC4;MSN;AKT1;PKP3;PKP1;RAB12;PIK3CA;PIK3CG;LZTS1;ARAF;SH3BP4;RNF144A;PIM2;PDE4B
6293,GO:0017137,0.597774844675466,0.676151677794669,2,129,Rab GTPase binding,MF,RIN3;RAB11FIP1
3129,GO:0006352,0.597869333695257,0.628818579426447,3,229,DNA-templated transcription, initiation,BP,NOTCH1;CTGF;VDR
7482,GO:0030534,0.59796885302215,0.675789703126726,2,140,adult behavior,BP,SPTBN4;GDNF
2780,GO:0005766,0.598016227044332,0.675599119517854,2,151,primary lysosome,CC,RAB44;RAB3D
10924,GO:0042582,0.598016227044332,0.675599119517854,2,151,azurophil granule,CC,RAB44;RAB3D
12249,GO:0045619,0.598062282123561,0.675654868293413,2,143,regulation of lymphocyte differentiation,BP,BMP4;GAS6
4848,GO:0010556,0.598501745259546,0.46200692329232,55,3946,regulation of macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;CCL20;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;NAB2;CDH1;INHBB;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
14156,GO:0051588,0.598554808629375,0.771240891840999,1,62,regulation of neurotransmitter transport,BP,GDNF
15925,GO:0070405,0.598897749166554,0.770691786998313,1,68,ammonium ion binding,MF,SERPINA5
9713,GO:0035195,0.600066473736091,0.769964524911109,1,60,gene silencing by miRNA,BP,BMP4
8709,GO:0032755,0.600691933696449,0.769180405230977,1,65,positive regulation of interleukin-6 production,BP,WNT5A
10683,GO:0042158,0.600783781271176,0.672830910173813,2,150,lipoprotein biosynthetic process,BP,NMT2;PRND
19908,GO:1904035,0.601337131655953,0.76867666572636,1,63,regulation of epithelial cell apoptotic process,BP,GAS6
3746,GO:0007269,0.602204362397911,0.671603553737396,2,135,neurotransmitter secretion,BP,SYT5;WNT7A
18380,GO:0099643,0.602204362397911,0.671603553737396,2,135,signal release from synapse,BP,SYT5;WNT7A
4638,GO:0009755,0.603914657947846,0.622654238494128,3,218,hormone-mediated signaling pathway,BP,BMP7;BMP4;VDR
2802,GO:0005791,0.604307161400938,0.765764471420014,1,68,rough endoplasmic reticulum,CC,EDN1
20290,GO:1904888,0.604945861932964,0.765466930678367,1,61,cranial skeletal system development,BP,BMP4
2942,GO:0006026,0.605187333059962,0.765155832972233,1,63,aminoglycan catabolic process,BP,SDC4
8999,GO:0033209,0.605441559083194,0.667981495069691,2,162,tumor necrosis factor-mediated signaling pathway,BP,GAS6;CLDN18
10122,GO:0035914,0.605985044178366,0.76446569097848,1,62,skeletal muscle cell differentiation,BP,NOTCH1
5746,GO:0016054,0.606001248315921,0.620443368083476,3,224,organic acid catabolic process,BP,GLDC;SESN2;AKT1
12625,GO:0046395,0.606001248315921,0.620443368083476,3,224,carboxylic acid catabolic process,BP,GLDC;SESN2;AKT1
9335,GO:0034220,0.606004541029582,0.502383671195808,14,1015,ion transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TTYH1;TSPAN13;KCNH2;SFXN1;AKT1;PIK3CG;KCNG2;GAS6;KCND1;CLDN16;PDE4B
17209,GO:0075733,0.606030987891622,0.764295416558191,1,65,intracellular transport of virus,BP,NMT2
57,GO:0000118,0.606513200938163,0.764024326116818,1,61,histone deacetylase complex,CC,SIN3B
3385,GO:0006687,0.606603166547043,0.763851710166886,1,63,glycosphingolipid metabolic process,BP,ITGB8
15494,GO:0061418,0.607455667183254,0.762595761990651,1,76,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NOTCH1
9,GO:0000018,0.607798147498041,0.762747055717115,1,63,regulation of DNA recombination,BP,CLCF1
1636,GO:0003725,0.607846430868455,0.762839528568284,1,60,double-stranded RNA binding,MF,MSN
3006,GO:0006119,0.608072850465528,0.761496307478974,1,99,oxidative phosphorylation,BP,ACTN3
8210,GO:0031970,0.60808138125492,0.762015583410242,1,76,organelle envelope lumen,CC,PTGES
9135,GO:0033613,0.609108698246347,0.761488372633778,1,64,activating transcription factor binding,MF,ZFPM1
5709,GO:0015980,0.609123748817597,0.617011211542592,3,252,energy derivation by oxidation of organic compounds,BP,ACTN3;AKT1;PIK3CA
21318,GO:2000573,0.609178090418702,0.761466896058452,1,63,positive regulation of DNA biosynthetic process,BP,PDGFB
7835,GO:0031256,0.609271480646919,0.66443729766649,2,134,leading edge membrane,CC,ITGA5;ADORA1
14671,GO:0060041,0.609384898754443,0.664305727855908,2,135,retina development in camera-type eye,BP,RHOJ;DLL1
7356,GO:0030279,0.609808108338219,0.76067804529419,1,68,negative regulation of ossification,BP,NOTCH1
8475,GO:0032414,0.610417812652466,0.760187078623137,1,66,positive regulation of ion transmembrane transporter activity,BP,ACTN2
14705,GO:0060078,0.61091117110584,0.662773249628109,2,133,regulation of postsynaptic membrane potential,BP,WNT7A;ADORA1
19226,GO:1902581,0.611661537185433,0.759024712178582,1,66,multi-organism cellular localization,BP,NMT2
19228,GO:1902583,0.611661537185433,0.759024712178582,1,66,multi-organism intracellular transport,BP,NMT2
2518,GO:0005216,0.611758504663786,0.550472057972149,6,423,ion channel activity,MF,KCNK6;TTYH1;KCNH2;KCNG2;GAS6;KCND1
10738,GO:0042278,0.611880390875035,0.758741892115341,1,68,purine nucleoside metabolic process,BP,RHOQ
980,GO:0002283,0.612891342144928,0.54914194370147,6,474,neutrophil activation involved in immune response,BP,RAB27A;CRISPLD2;PLAU;PKP1;RAB44;RAB3D
11337,GO:0043312,0.612891342144928,0.54914194370147,6,474,neutrophil degranulation,BP,RAB27A;CRISPLD2;PLAU;PKP1;RAB44;RAB3D
13996,GO:0051289,0.613094436078817,0.757565102115015,1,69,protein homotetramerization,BP,ACTN2
14009,GO:0051303,0.613948710351564,0.75696001710977,1,64,establishment of chromosome localization,BP,PSRC1
14005,GO:0051298,0.614137277089712,0.756917621656647,1,61,centrosome duplication,BP,RAB6C
1284,GO:0002793,0.614571672089874,0.611413091946259,3,232,positive regulation of peptide secretion,BP,ADORA1;WNT5A;BMP6
5974,GO:0016528,0.615499214532273,0.755412940149597,1,66,sarcoplasm,CC,CASQ2
43,GO:0000086,0.616674430473383,0.609226927620999,3,227,G2/M transition of mitotic cell cycle,BP,PHLDA1;FOXO4;CDKN1A
13604,GO:0050707,0.617214144628946,0.656012628466281,2,151,regulation of cytokine secretion,BP,WNT5A;GAS6
7468,GO:0030512,0.617596339707897,0.753507251459659,1,64,negative regulation of transforming growth factor beta receptor signaling pathway,BP,RASL11B
18280,GO:0099023,0.617604200781675,0.753543853908027,1,63,tethering complex,CC,RALB
13988,GO:0051279,0.617899780061213,0.753055024776375,1,68,regulation of release of sequestered calcium ion into cytosol,BP,CASQ2
10663,GO:0042119,0.619223290802333,0.54239561104073,6,477,neutrophil activation,BP,RAB27A;CRISPLD2;PLAU;PKP1;RAB44;RAB3D
12864,GO:0046902,0.619293386107325,0.751686917307269,1,69,regulation of mitochondrial membrane permeability,BP,PMAIP1
2648,GO:0005524,0.620161399571392,0.469044101203134,21,1426,ATP binding,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;KHK;NPR1;NUAK2;PFKFB3;PKN3;WNK4;DDR1;AKT1;MYO7A;PIK3CA;PIK3CG;MYH11;ARAF;ACSL4;ACTA2;PIM2
13465,GO:0050000,0.620371931397529,0.750813610041772,1,65,chromosome localization,BP,PSRC1
7456,GO:0030496,0.622284380508201,0.650841749800827,2,142,midbody,CC,RALB;PSRC1
9712,GO:0035194,0.623817923589703,0.747537638386785,1,64,posttranscriptional gene silencing by RNA,BP,BMP4
3128,GO:0006351,0.624646205189555,0.437054331287562,50,3617,transcription, DNA-templated,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
12811,GO:0046794,0.624892164933835,0.746329845114056,1,68,transport of virus,BP,NMT2
3563,GO:0006970,0.624944689430479,0.746278837851054,1,68,response to osmotic stress,BP,CLDN1
12128,GO:0045296,0.624997968663834,0.571283295038665,4,299,cadherin binding,MF,CGN;MB21D2;PKP3;CDH1
17818,GO:0097223,0.625516458226173,0.647181406791621,2,163,sperm part,CC,NOTCH1;SERPINA5
5144,GO:0010972,0.625893706109504,0.744955191108763,1,80,negative regulation of G2/M transition of mitotic cell cycle,BP,FOXO4
14874,GO:0060337,0.625967759864605,0.744882993679131,1,80,type I interferon signaling pathway,BP,WNT5A
16422,GO:0071357,0.625967759864605,0.744882993679131,1,80,cellular response to type I interferon,BP,WNT5A
10379,GO:0036473,0.627559733576879,0.743691087594822,1,69,cell death in response to oxidative stress,BP,AKT1
15985,GO:0070509,0.627627325763907,0.64511640712213,2,149,calcium ion import,BP,CASQ2;PDGFB
12888,GO:0046942,0.627897429425084,0.568169428857621,4,297,carboxylic acid transport,BP,ADORA1;EDN1;AKT1;ACSL4
19810,GO:1903845,0.628089518003928,0.743292947820733,1,66,negative regulation of cellular response to transforming growth factor beta stimulus,BP,RASL11B
10285,GO:0036230,0.628104751817634,0.532853640907801,6,482,granulocyte activation,BP,RAB27A;CRISPLD2;PLAU;PKP1;RAB44;RAB3D
1296,GO:0002824,0.628537377212827,0.742554115857829,1,74,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,CLCF1
1540,GO:0003300,0.628899723145873,0.742498570724795,1,66,cardiac muscle hypertrophy,BP,EDN1
18752,GO:1901292,0.629032916647747,0.742172120972445,1,71,nucleoside phosphate catabolic process,BP,PDE4B
5927,GO:0016441,0.630077599751844,0.741383442457381,1,65,posttranscriptional gene silencing,BP,BMP4
1228,GO:0002708,0.630258608721897,0.740894931527096,1,73,positive regulation of lymphocyte mediated immunity,BP,CLCF1
5108,GO:0010923,0.630453313762074,0.741013318196474,1,65,negative regulation of phosphatase activity,BP,CAMSAP3
13673,GO:0050805,0.631487229996251,0.739949751821475,1,66,negative regulation of synaptic transmission,BP,ADORA1
10000,GO:0035710,0.631655043552893,0.739623870522398,1,70,CD4-positive, alpha-beta T cell activation,BP,ZFPM1
10679,GO:0042147,0.632052358761111,0.739348827447317,1,67,retrograde transport, endosome to Golgi,BP,RAB6C
7136,GO:0022838,0.632188746664227,0.528560953426431,6,433,substrate-specific channel activity,MF,KCNK6;TTYH1;KCNH2;KCNG2;GAS6;KCND1
2984,GO:0006091,0.632663341156195,0.562822705792397,4,342,generation of precursor metabolites and energy,BP,ACTN3;PFKFB3;AKT1;PIK3CA
6423,GO:0018410,0.633677014988384,0.737408307109563,1,76,C-terminal protein amino acid modification,BP,PRND
1629,GO:0003712,0.633943920830807,0.515023945251099,7,521,transcription cofactor activity,MF,WNT4;POU3F1;ACTN2;NAB2;TLE1;SIN3B;ZCCHC12
12020,GO:0045089,0.634099265418946,0.561375834938658,4,313,positive regulation of innate immune response,BP,PRKACB;TYRO3;HRAS;WNT5A
2811,GO:0005811,0.634910221428138,0.73646693200511,1,68,lipid particle,CC,ACSL4
1076,GO:0002443,0.635562779032052,0.496129628619227,9,717,leukocyte mediated immunity,BP,RAB27A;CRISPLD2;PLAU;CLCF1;CHGA;PKP1;RAB44;PIK3CG;RAB3D
1079,GO:0002446,0.635706233278857,0.524614739943869,6,486,neutrophil mediated immunity,BP,RAB27A;CRISPLD2;PLAU;PKP1;RAB44;RAB3D
19295,GO:1902750,0.636070493289338,0.734837937202652,1,82,negative regulation of cell cycle G2/M phase transition,BP,FOXO4
13256,GO:0048511,0.636214972855414,0.559101253166948,4,306,rhythmic process,BP,ADORA1;TYRO3;KITLG;INHBB
13875,GO:0051117,0.636770935666022,0.734381700803641,1,74,ATPase binding,MF,RALB
3559,GO:0006959,0.637545512506189,0.63401881340083,2,199,humoral immune response,BP,NOTCH1;CHGA
3605,GO:0007032,0.63866262092681,0.732662151501886,1,69,endosome organization,BP,RAB27A
18430,GO:1900006,0.638680788601339,0.732811801111137,1,65,positive regulation of dendrite development,BP,BMP7
3978,GO:0008170,0.639622993305554,0.731653213506625,1,70,N-methyltransferase activity,MF,PNMT
2816,GO:0005819,0.639737094131048,0.555300652787723,4,295,spindle,CC,TUBG2;PSRC1;AKT1;UNC119
5315,GO:0014897,0.640013790372581,0.731337177081278,1,68,striated muscle hypertrophy,BP,EDN1
5458,GO:0015276,0.640774371014829,0.631117017835396,2,142,ligand-gated ion channel activity,MF,KCNK6;KCNH2
7133,GO:0022834,0.640774371014829,0.631117017835396,2,142,ligand-gated channel activity,MF,KCNK6;KCNH2
8724,GO:0032774,0.641877913275779,0.418599313860367,51,3751,RNA biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
4415,GO:0009141,0.642884046230267,0.580668684196616,3,275,nucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
3465,GO:0006814,0.64362159667975,0.580191196043118,3,220,sodium ion transport,BP,SPTBN4;WNK4;AKT1
1219,GO:0002699,0.64374063789045,0.627630226446809,2,162,positive regulation of immune effector process,BP,WNT5A;CLCF1
11936,GO:0044839,0.644000842390105,0.579659545441471,3,236,cell cycle G2/M phase transition,BP,PHLDA1;FOXO4;CDKN1A
11196,GO:0043112,0.645118413598873,0.626284000239922,2,149,receptor metabolic process,BP,EDN1;GPRASP1
2985,GO:0006094,0.645377420795353,0.725604997141995,1,75,gluconeogenesis,BP,SESN2
17628,GO:0090559,0.64562121215673,0.725388853533104,1,74,regulation of membrane permeability,BP,PMAIP1
20730,GO:1990204,0.6458107710322,0.724600597340334,1,96,oxidoreductase complex,CC,GLDC
12656,GO:0046470,0.646260823932269,0.724597412461779,1,78,phosphatidylcholine metabolic process,BP,MBOAT2
8844,GO:0032947,0.646652431144734,0.724556009194575,1,68,protein complex scaffold,MF,AXIN1
5642,GO:0015849,0.647434332263341,0.546771673121205,4,305,organic acid transport,BP,ADORA1;EDN1;AKT1;ACSL4
5314,GO:0014896,0.647634894891226,0.723460887762624,1,70,muscle hypertrophy,BP,EDN1
6908,GO:0021675,0.647817619811471,0.723233129072582,1,71,nerve development,BP,NRTN
9381,GO:0034340,0.648368095570259,0.722242586505986,1,84,response to type I interferon,BP,WNT5A
1293,GO:0002821,0.649110093889878,0.721649278697415,1,78,positive regulation of adaptive immune response,BP,CLCF1
4349,GO:0009055,0.649275341372887,0.72099226547819,1,97,electron carrier activity,MF,GLDC
24,GO:0000045,0.649446886049218,0.721623074558878,1,69,autophagosome assembly,BP,RALB
8472,GO:0032411,0.65100982974106,0.719805462330284,1,74,positive regulation of transporter activity,BP,ACTN2
739,GO:0001909,0.651443639063326,0.719125173349257,1,81,leukocyte mediated cytotoxicity,BP,RAB27A
7906,GO:0031349,0.651456138660919,0.522179497603968,5,406,positive regulation of defense response,BP,PRKACB;TYRO3;HRAS;WNT5A;PIK3CG
21538,GO:2001020,0.651565838834229,0.619106044850276,2,155,regulation of response to DNA damage stimulus,BP,PMAIP1;FGF10
1084,GO:0002456,0.652946979259109,0.717708539027226,1,76,T cell mediated immunity,BP,RAB27A
7844,GO:0031267,0.653274323686754,0.540356147661857,4,289,small GTPase binding,MF,RIN3;DAAM2;RAB11FIP1;SH3BP4
11009,GO:0042742,0.655189839213106,0.614490397903297,2,222,defense response to bacterium,BP,CCL20;CHGA
11815,GO:0044450,0.655214789405256,0.61515487486736,2,147,microtubule organizing center part,CC,TUBG2;PDE4B
14068,GO:0051427,0.655888595529073,0.614284103297565,2,156,hormone receptor binding,MF,NPPC;VDR
6299,GO:0017148,0.657554400075259,0.612497846572465,2,150,negative regulation of translation,BP,SESN2;BMP4
11006,GO:0042734,0.657944913339923,0.712821339882181,1,66,presynaptic membrane,CC,ADORA1
17986,GO:0097581,0.658058593860554,0.712528916185356,1,70,lamellipodium organization,BP,PARVB
7591,GO:0030816,0.658696545660798,0.711377641948232,1,84,positive regulation of cAMP metabolic process,BP,CHGA
2867,GO:0005901,0.658928545311183,0.711643399600543,1,69,caveola,CC,CDH1
3533,GO:0006919,0.659913056362821,0.710227262873816,1,79,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1
2907,GO:0005977,0.659993274239788,0.71038620389011,1,72,glycogen metabolic process,BP,AKT1
6569,GO:0019319,0.660108323286197,0.710050522583121,1,78,hexose biosynthetic process,BP,SESN2
11573,GO:0043933,0.661034333575478,0.420331935034643,24,1895,macromolecular complex subunit organization,BP,FHOD3;TUBG2;ACTN2;PMAIP1;CASQ2;SPTBN5;SPTBN4;PRND;PLEKHH2;RALB;HRAS;AXIN1;SCIN;PSRC1;SPTB;VAMP1;MSN;GJB1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;KCND1
9541,GO:0034655,0.661173122163969,0.531185853263671,4,364,nucleobase-containing compound catabolic process,BP,PRR5L;PKP3;PKP1;PDE4B
8207,GO:0031966,0.662230201950765,0.483763634845758,7,634,mitochondrial membrane,CC,PMAIP1;HMGCS2;SLC25A53;REEP1;VAMP1;SFXN1;ACSL4
3697,GO:0007193,0.662321121688021,0.707812863778149,1,74,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,ADORA1
14773,GO:0060191,0.662666891231385,0.707269098303134,1,79,regulation of lipase activity,BP,LPAR2
3374,GO:0006672,0.664579924874111,0.705372962821101,1,74,ceramide metabolic process,BP,ITGB8
7438,GO:0030424,0.665283811063191,0.506791162182942,5,378,axon,CC,ADRA2C;ADORA1;SPTBN4;VAMP1;NRTN
11885,GO:0044728,0.665462034824213,0.704415999717517,1,74,DNA methylation or demethylation,BP,PIK3CA
14822,GO:0060271,0.665516824964857,0.526500223773315,4,305,cilium assembly,BP,NOTCH1;MARK4;RAB17;LAMA5
2975,GO:0006073,0.66565334493735,0.704245507897199,1,73,cellular glucan metabolic process,BP,AKT1
11614,GO:0044042,0.66565334493735,0.704245507897199,1,73,glucan metabolic process,BP,AKT1
12000,GO:0045069,0.665840070237802,0.703832548004729,1,79,regulation of viral genome replication,BP,NOTCH1
20360,GO:1905037,0.666065808161313,0.703835489448077,1,72,autophagosome organization,BP,RALB
2302,GO:0004867,0.667006316724281,0.702224368110999,1,91,serine-type endopeptidase inhibitor activity,MF,SERPINA5
6535,GO:0019217,0.668961818969864,0.700455249694925,1,78,regulation of fatty acid metabolic process,BP,AKT1
4820,GO:0010498,0.66962353092779,0.501817135374825,5,398,proteasomal protein catabolic process,BP,PMAIP1;AXIN1;AKT1;ARAF;RNF144A
20980,GO:2000060,0.67314763386017,0.695485548704401,1,90,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1
9730,GO:0035249,0.673495924255661,0.695592364437006,1,74,synaptic transmission, glutamatergic,BP,ADORA1
15860,GO:0070301,0.673682450564848,0.695176628360382,1,80,cellular response to hydrogen peroxide,BP,RHOB
21637,GO:2001235,0.673774873122747,0.593774087024294,2,172,positive regulation of apoptotic signaling pathway,BP,PMAIP1;INHBB
17800,GO:0097194,0.674959638435315,0.693754388361545,1,80,execution phase of apoptosis,BP,AKT1
1092,GO:0002474,0.675135679246322,0.693197538849715,1,93,antigen processing and presentation of peptide antigen via MHC class I,BP,ITGB5
18691,GO:1901137,0.675579097321832,0.452123393466279,9,723,carbohydrate derivative biosynthetic process,BP,GUCY1B3;EDN1;PHLDA1;PDGFB;NPR1;SDC4;HBEGF;B3GNT2;NPPC
11907,GO:0044782,0.676582406593004,0.513831303117443,4,309,cilium organization,BP,NOTCH1;MARK4;RAB17;LAMA5
9764,GO:0035305,0.678000571980404,0.69055854449899,1,74,negative regulation of dephosphorylation,BP,CAMSAP3
13649,GO:0050772,0.678515771373533,0.69001736986492,1,73,positive regulation of axonogenesis,BP,WNT3
21645,GO:2001243,0.679441986592443,0.68859893453468,1,84,negative regulation of intrinsic apoptotic signaling pathway,BP,AKT1
6090,GO:0016746,0.679499074035211,0.539359712351897,3,247,transferase activity, transferring acyl groups,MF,HMGCS2;NMT2;MBOAT2
7884,GO:0031326,0.680955341477289,0.375355418290438,56,4131,regulation of cellular biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;CCL20;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;KITLG;NPPC;NAB2;CDH1;INHBB;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
18923,GO:1901796,0.681363732359919,0.585036680917378,2,163,regulation of signal transduction by p53 class mediator,BP,PMAIP1;AKT1
3594,GO:0007017,0.681580510030322,0.452997155327153,8,608,microtubule-based process,BP,TUBG2;RAB6C;MARK4;GADD45A;FGF10;AXIN1;PSRC1;CAMSAP3
3086,GO:0006282,0.681820281481454,0.686130179728846,1,77,regulation of DNA repair,BP,FGF10
11687,GO:0044248,0.682506622314726,0.397120480439829,24,1867,cellular catabolic process,BP,GLDC;ITGB4;PMAIP1;RAB39A;PRR5L;PIK3R2;RALB;MAGEC2;GPRASP1;SESN2;AXIN1;MSN;AKT1;PKP3;PKP1;RAB12;PIK3CA;PIK3CG;LZTS1;ARAF;SH3BP4;RNF144A;PIM2;PDE4B
12612,GO:0046364,0.68467120304373,0.682648250757467,1,84,monosaccharide biosynthetic process,BP,SESN2
13420,GO:0048814,0.686238493882029,0.681188868818721,1,74,regulation of dendrite morphogenesis,BP,LZTS1
6129,GO:0016811,0.688202498754366,0.678611189549135,1,83,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,SIN3B
7610,GO:0030838,0.688308902658629,0.678488013839012,1,83,positive regulation of actin filament polymerization,BP,SCIN
1888,GO:0004252,0.690048659946499,0.574524883594529,2,186,serine-type endopeptidase activity,MF,RHBDL3;PLAU
18690,GO:1901136,0.690183664640228,0.57451250941127,2,171,carbohydrate derivative catabolic process,BP,SDC4;PDE4B
7923,GO:0031398,0.690371265340115,0.574236211823477,2,176,positive regulation of protein ubiquitination,BP,MAGEC2;AXIN1
5589,GO:0015748,0.690552562588859,0.67591364322235,1,82,organophosphate ester transport,BP,GJB1
16046,GO:0070613,0.690785986668506,0.675641623746515,1,82,regulation of protein processing,BP,PRKACB
2779,GO:0005765,0.691508715245555,0.496405291516591,4,322,lysosomal membrane,CC,RAB12;MYO7A;RAB44;RAB3D
18202,GO:0098852,0.691508715245555,0.496405291516591,4,322,lytic vacuole membrane,CC,RAB12;MYO7A;RAB44;RAB3D
3435,GO:0006767,0.692973174671394,0.673021711153233,1,84,water-soluble vitamin metabolic process,BP,SLC52A3
12251,GO:0045621,0.693812539949971,0.672035997231275,1,84,positive regulation of lymphocyte differentiation,BP,GAS6
6527,GO:0019208,0.694116166524449,0.671773996922125,1,81,phosphatase regulator activity,MF,BMP2
14762,GO:0060170,0.695086852575863,0.670630430601013,1,81,ciliary membrane,CC,SPTBN5
17143,GO:0072655,0.69517303301557,0.56840887284853,2,183,establishment of protein localization to mitochondrion,BP,PMAIP1;AKT1
19547,GO:1903317,0.695754369037858,0.669777801380677,1,83,regulation of protein maturation,BP,PRKACB
14203,GO:0051668,0.696310458158246,0.669217953015798,1,80,localization within membrane,BP,CDH2
9353,GO:0034249,0.69637146333969,0.567188281315062,2,162,negative regulation of cellular amide metabolic process,BP,SESN2;BMP4
1225,GO:0002705,0.697083732312749,0.668083231769414,1,87,positive regulation of leukocyte mediated immunity,BP,CLCF1
9923,GO:0035591,0.697447428354623,0.667939744743642,1,78,signaling adaptor activity,MF,PIK3R1
4836,GO:0010522,0.69769529726409,0.667415670814204,1,85,regulation of calcium ion transport into cytosol,BP,CASQ2
3210,GO:0006470,0.699536883117008,0.515684863898994,3,241,protein dephosphorylation,BP,ADORA1;PTPN7;DUSP5
5999,GO:0016575,0.700755422121016,0.663923861931296,1,80,histone deacetylation,BP,SIN3B
1042,GO:0002377,0.701000701130975,0.663380833765752,1,88,immunoglobulin production,BP,CLCF1
2544,GO:0005254,0.701515883278112,0.663011520004193,1,80,chloride channel activity,MF,TTYH1
2808,GO:0005798,0.701712612125066,0.662676010127752,1,83,Golgi-associated vesicle,CC,RHOQ
16035,GO:0070585,0.702361939317578,0.559667222729029,2,185,protein localization to mitochondrion,BP,PMAIP1;AKT1
6841,GO:0021543,0.702651289988384,0.559571368223392,2,161,pallium development,BP,CDH2;FGF8
11795,GO:0044424,0.704799564315409,0.349512675702123,182,13251,intracellular part,CC,ITGA3;ITGA5;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;PNMT;TF;ITGB5;ITGB4;PMAIP1;GADD45A;CRISPLD2;FBXO41;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;RHPN1;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;SCIN;PSRC1;SDC4;SPTB;HBEGF;LGALS4;BMP6;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;WNT2B;CYTIP;PTGES;KITLG;NPPC;NAB2;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;DTX4;ZCCHC12;MYH11;LZTS1;PM20D2;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2;PARVB;PDE4B
5760,GO:0016079,0.705411490604333,0.658307278079846,1,80,synaptic vesicle exocytosis,BP,SYT5
7736,GO:0031058,0.70544777443525,0.65822906248042,1,81,positive regulation of histone modification,BP,LIF
2341,GO:0004930,0.706035335922311,0.433664336538778,7,775,G-protein coupled receptor activity,MF,ADRA2B;ADRA2C;ADORA1;FZD7;LPAR2;NPR1;FZD8
8597,GO:0032587,0.706372650443047,0.657138679382016,1,80,ruffle membrane,CC,ITGA5
2629,GO:0005496,0.707630041199262,0.655269291367398,1,91,steroid binding,MF,VDR
11810,GO:0044445,0.70867100678919,0.551582847013205,2,228,cytosolic part,CC,GUCY1B3;NPR1
3513,GO:0006890,0.709491520208893,0.653224012935274,1,83,retrograde vesicle-mediated transport, Golgi to ER,BP,RAB6C
10437,GO:0038023,0.710080607371042,0.388914569472766,14,1290,signaling receptor activity,MF,ADRA2B;ADRA2C;ACVR1;ADORA1;FZD7;TYRO3;LPAR2;KCNH2;NPR1;SDC4;DDR1;CLDN3;VDR;FZD8
6118,GO:0016791,0.710086723776745,0.50285352810797,3,247,phosphatase activity,MF,PTPN7;PFKFB3;DUSP5
1261,GO:0002758,0.712313267908994,0.500024501644524,3,264,innate immune response-activating signal transduction,BP,PRKACB;TYRO3;HRAS
5992,GO:0016567,0.713803142149073,0.402355729801942,10,800,protein ubiquitination,BP,TSPAN17;FBXO41;RAB40B;RAB40A;MAGEC2;AXIN1;AKT1;SPSB1;DTX4;RNF144A
2758,GO:0005740,0.714058164648373,0.424378398923839,7,669,mitochondrial envelope,CC,PMAIP1;HMGCS2;SLC25A53;REEP1;VAMP1;SFXN1;ACSL4
4395,GO:0009119,0.714111694318998,0.647219618285326,1,93,ribonucleoside metabolic process,BP,RHOQ
3001,GO:0006112,0.714352025325086,0.647148394344945,1,85,energy reserve metabolic process,BP,AKT1
20732,GO:1990234,0.714813208853382,0.407384475003125,9,719,transferase complex,CC,TSPAN17;ACVR1;PIK3R2;PIK3R1;SESN2;CDKN1A;PIK3CA;PIK3CG;RNF144A
17647,GO:0090630,0.714832854446323,0.646646305124754,1,82,activation of GTPase activity,BP,WNT5A
11805,GO:0044438,0.717355766526249,0.64321543507038,1,91,microbody part,CC,ACSL4
11806,GO:0044439,0.717355766526249,0.64321543507038,1,91,peroxisomal part,CC,ACSL4
14331,GO:0051928,0.718127392778075,0.642139784933116,1,95,positive regulation of calcium ion transport,BP,PDGFB
13810,GO:0051020,0.719464103766864,0.462915315569735,4,317,GTPase binding,MF,RIN3;DAAM2;RAB11FIP1;SH3BP4
11204,GO:0043123,0.723346049899831,0.533559522798473,2,178,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,AKT1;PIM2
2194,GO:0004721,0.723611399160551,0.53330785461669,2,170,phosphoprotein phosphatase activity,MF,PTPN7;DUSP5
5564,GO:0015698,0.725020557247707,0.531532819988816,2,168,inorganic anion transport,BP,TTYH1;WNK4
6243,GO:0017048,0.725077260817514,0.633651018639501,1,83,Rho GTPase binding,MF,DAAM2
2944,GO:0006029,0.725660429548847,0.6329356681281,1,82,proteoglycan metabolic process,BP,BMP2
11694,GO:0044257,0.725846813680922,0.40174686407222,8,652,cellular protein catabolic process,BP,PMAIP1;MAGEC2;AXIN1;MSN;AKT1;RAB12;ARAF;RNF144A
18848,GO:1901606,0.726944987161692,0.630947162660186,1,93,alpha-amino acid catabolic process,BP,GLDC
944,GO:0002218,0.728143834981604,0.480304463507341,3,271,activation of innate immune response,BP,PRKACB;TYRO3;HRAS
12743,GO:0046632,0.729181929975362,0.6281328041363,1,90,alpha-beta T cell differentiation,BP,ZFPM1
17000,GO:0072330,0.729779432257166,0.525243858959261,2,185,monocarboxylic acid biosynthetic process,BP,EDN1;PTGES
20978,GO:2000058,0.729824021801592,0.626928748788027,1,105,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1
3477,GO:0006835,0.729838249069062,0.627399492160387,1,86,dicarboxylic acid transport,BP,ADORA1
3469,GO:0006820,0.730564946688286,0.404918270036916,7,573,anion transport,BP,SLC52A3;ADORA1;EDN1;TTYH1;WNK4;AKT1;ACSL4
11700,GO:0044265,0.730783525437512,0.377353008111159,11,927,cellular macromolecule catabolic process,BP,PMAIP1;PRR5L;MAGEC2;AXIN1;MSN;AKT1;PKP3;PKP1;RAB12;ARAF;RNF144A
6246,GO:0017053,0.731510884844022,0.625249257389216,1,85,transcriptional repressor complex,CC,ZFPM1
3620,GO:0007052,0.731714509762463,0.624919718420365,1,87,mitotic spindle organization,BP,PSRC1
19319,GO:1902850,0.731714509762463,0.624919718420365,1,87,microtubule cytoskeleton organization involved in mitosis,BP,PSRC1
3345,GO:0006637,0.731896604254729,0.624508146001282,1,93,acyl-CoA metabolic process,BP,ACSL4
9805,GO:0035383,0.731896604254729,0.624508146001282,1,93,thioester metabolic process,BP,ACSL4
3515,GO:0006892,0.731980990328066,0.624570873151188,1,87,post-Golgi vesicle-mediated transport,BP,RABIF
13653,GO:0050776,0.732251834161089,0.380822024320606,10,860,regulation of immune response,BP,PRKACB;TYRO3;PIK3R2;PIK3R1;HRAS;WNT5A;CLCF1;BCAR1;PIK3CA;PDE4B
4351,GO:0009057,0.732336367955823,0.363567814302239,14,1153,macromolecule catabolic process,BP,PMAIP1;PRR5L;WNT5A;MAGEC2;GPRASP1;AXIN1;SDC4;MSN;AKT1;PKP3;PKP1;RAB12;ARAF;RNF144A
19838,GO:1903902,0.732817745745167,0.623273462341003,1,94,positive regulation of viral life cycle,BP,NOTCH1
3566,GO:0006974,0.734745746162257,0.383964994567988,9,751,cellular response to DNA damage stimulus,BP,PMAIP1;GADD45A;MAPK12;FGF10;PIK3R1;FOXO4;SESN2;CDKN1A;AKT1
19552,GO:1903322,0.734762582625909,0.518726902610563,2,191,positive regulation of protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1
18361,GO:0099600,0.734831298493985,0.364105914300274,13,1234,transmembrane receptor activity,MF,ADRA2B;ADRA2C;ACVR1;ADORA1;KCNK6;FZD7;TYRO3;LPAR2;KCNH2;NPR1;DDR1;CLDN3;FZD8
17780,GO:0097164,0.735669627062357,0.517552882407529,2,190,ammonium ion metabolic process,BP,MBOAT2;NPR1
5354,GO:0015077,0.735793946182105,0.442572260960879,4,354,monovalent inorganic cation transmembrane transporter activity,MF,KCNK6;KCNH2;KCNG2;KCND1
20447,GO:1905269,0.736648407203658,0.618386619956123,1,88,positive regulation of chromatin organization,BP,LIF
6778,GO:0019955,0.736767389547718,0.618140321534855,1,91,cytokine binding,MF,ACVR1
3883,GO:0007631,0.736938004582121,0.617526413556949,1,107,feeding behavior,BP,STRA6
11541,GO:0043687,0.737207757572171,0.617370009901891,1,98,post-translational protein modification,BP,PRND
11259,GO:0043202,0.737731866889425,0.616886637055017,1,90,lysosomal lumen,CC,SDC4
3143,GO:0006368,0.738791198244364,0.615284177980079,1,97,transcription elongation from RNA polymerase II promoter,BP,AXIN1
11560,GO:0043900,0.739906964443517,0.43734610189321,4,373,regulation of multi-organism process,BP,NOTCH1;BMP6;NPPC;INHBB
5750,GO:0016064,0.74117196586194,0.612067574773565,1,98,immunoglobulin mediated immune response,BP,CLCF1
3104,GO:0006304,0.74129873792066,0.611973597786152,1,95,DNA modification,BP,PIK3CA
12482,GO:0046034,0.741657201509523,0.509424050922878,2,224,ATP metabolic process,BP,ACTN3;PFKFB3
2810,GO:0005802,0.743543788771371,0.507256999639036,2,183,trans-Golgi network,CC,CDH1;RAB38
21008,GO:2000112,0.74362366721108,0.309512808544907,51,3834,regulation of cellular macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;KITLG;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
2121,GO:0004620,0.743799158810565,0.608596889903123,1,95,phospholipase activity,MF,ADORA1
11678,GO:0044237,0.744421235029554,0.299280821994642,133,9871,cellular metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;ACTN2;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;PNMT;STRA6;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;FBXO41;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;NMT2;GUCY1B3;ADORA1;DKK3;EDN1;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;RAB39A;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;KHK;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;CHGA;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;VDR;ARAF;SH3BP4;UNC119;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;RNF144A;PIM2;PDE4B
12783,GO:0046700,0.744799064237511,0.431069014611853,4,406,heterocycle catabolic process,BP,PRR5L;PKP3;PKP1;PDE4B
14715,GO:0060090,0.745250935739423,0.505039368801914,2,178,binding, bridging,MF,PIK3R1;GAS6
11017,GO:0042752,0.745570124192516,0.606164180050705,1,96,regulation of circadian rhythm,BP,ADORA1
3215,GO:0006476,0.748532769012528,0.602219687378635,1,92,protein deacetylation,BP,SIN3B
6675,GO:0019724,0.749011519512211,0.601351790079311,1,100,B cell mediated immunity,BP,CLCF1
7745,GO:0031072,0.749688680347482,0.600573007220037,1,94,heat shock protein binding,MF,ADORA1
4023,GO:0008236,0.749815844535346,0.498672099434991,2,207,serine-type peptidase activity,MF,RHBDL3;PLAU
18025,GO:0097711,0.750210995324091,0.599880001352578,1,93,ciliary basal body docking,BP,MARK4
13612,GO:0050715,0.750252680989863,0.599616648107233,1,101,positive regulation of cytokine secretion,BP,WNT5A
11704,GO:0044270,0.750806563867951,0.423409557205869,4,409,cellular nitrogen compound catabolic process,BP,PRR5L;PKP3;PKP1;PDE4B
5371,GO:0015108,0.751833183029117,0.597692181823359,1,91,chloride transmembrane transporter activity,MF,TTYH1
19177,GO:1902476,0.751833183029117,0.597692181823359,1,91,chloride transmembrane transport,BP,TTYH1
3586,GO:0007006,0.751875934641118,0.597322619852609,1,103,mitochondrial membrane organization,BP,PMAIP1
3228,GO:0006493,0.753576741931699,0.595182090945087,1,94,protein O-linked glycosylation,BP,B3GNT2
17066,GO:0072509,0.753778851084746,0.493630099129911,2,174,divalent inorganic cation transmembrane transporter activity,MF,GAS6;CLDN16
11275,GO:0043228,0.754252732770039,0.299013044380329,48,3749,non-membrane-bounded organelle,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;CASQ2;PHLDA1;MRO;PRKACB;SPTBN5;SPTBN4;CDH2;CGN;PLEKHH2;PTPN7;FRMPD1;MAGEC2;PSTPIP2;RHOQ;SCIN;PSRC1;SDC4;SPTB;CAMSAP3;WT1;CDKN1A;HMGN5;ESPN;MSN;AKT1;PKP1;KITLG;CDH1;MYO7A;BCAR1;CLDN5;SIN3B;MYH11;AMOT;UNC119;RAB3D;ACSL4;MYZAP;FAM110B;ACTA2;PARVB;PDE4B
11279,GO:0043232,0.754252732770039,0.299013044380329,48,3749,intracellular non-membrane-bounded organelle,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;CASQ2;PHLDA1;MRO;PRKACB;SPTBN5;SPTBN4;CDH2;CGN;PLEKHH2;PTPN7;FRMPD1;MAGEC2;PSTPIP2;RHOQ;SCIN;PSRC1;SDC4;SPTB;CAMSAP3;WT1;CDKN1A;HMGN5;ESPN;MSN;AKT1;PKP1;KITLG;CDH1;MYO7A;BCAR1;CLDN5;SIN3B;MYH11;AMOT;UNC119;RAB3D;ACSL4;MYZAP;FAM110B;ACTA2;PARVB;PDE4B
2543,GO:0005253,0.755441934116684,0.592574103788794,1,94,anion channel activity,MF,TTYH1
13943,GO:0051209,0.757122716490528,0.590080300083101,1,99,release of sequestered calcium ion into cytosol,BP,CASQ2
13992,GO:0051283,0.757122716490528,0.590080300083101,1,99,negative regulation of sequestering of calcium ion,BP,CASQ2
5570,GO:0015711,0.757622220707381,0.396180868764202,5,437,organic anion transport,BP,SLC52A3;ADORA1;EDN1;AKT1;ACSL4
6314,GO:0017171,0.75772536810644,0.487931906145185,2,210,serine hydrolase activity,MF,RHBDL3;PLAU
5319,GO:0014902,0.758094574418866,0.588734014499782,1,98,myotube differentiation,BP,NOTCH1
12019,GO:0045088,0.760889409845887,0.410503804394464,4,377,regulation of innate immune response,BP,PRKACB;TYRO3;HRAS;WNT5A
13991,GO:0051282,0.761154753091576,0.584339500273292,1,100,regulation of sequestering of calcium ion,BP,CASQ2
6023,GO:0016605,0.761388867745074,0.584135166007884,1,95,PML body,CC,SPTBN4
5906,GO:0016410,0.762262765198678,0.582756757800518,1,100,N-acyltransferase activity,MF,NMT2
11040,GO:0042787,0.764067442396151,0.479289799707253,2,200,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1;RNF144A
18782,GO:1901362,0.764154767268155,0.28485397882794,57,4382,organic cyclic compound biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;PNMT;CRB2;DHH;WNT6;WNT7A;ZFPM1;HMGCS2;ACVR1;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
2284,GO:0004842,0.764398151000588,0.387579114399897,5,423,ubiquitin-protein transferase activity,MF,TSPAN17;FBXO41;SPSB1;DTX4;RNF144A
4025,GO:0008238,0.764894983977468,0.579026442242085,1,98,exopeptidase activity,MF,PM20D2
4789,GO:0010389,0.765350927730535,0.578072403426733,1,111,regulation of G2/M transition of mitotic cell cycle,BP,FOXO4
9929,GO:0035601,0.765373370278004,0.578362248136787,1,97,protein deacylation,BP,SIN3B
14607,GO:0055088,0.76773400326494,0.574723867775192,1,106,lipid homeostasis,BP,SESN2
6024,GO:0016607,0.768031797044198,0.40124878306196,4,355,nuclear speck,CC,GADD45A;FOXO4;WT1;ZCCHC12
18134,GO:0098732,0.768242654068725,0.574175291985296,1,98,macromolecule deacylation,BP,SIN3B
6615,GO:0019439,0.770457215001765,0.397867372422964,4,420,aromatic compound catabolic process,BP,PRR5L;PKP3;PKP1;PDE4B
18840,GO:1901575,0.770527632235058,0.301489203746405,22,1816,organic substance catabolic process,BP,ACTN3;GLDC;PMAIP1;ADORA1;PRR5L;WNT5A;MAGEC2;KHK;GPRASP1;SESN2;AXIN1;PFKFB3;SDC4;MSN;AKT1;PKP3;PKP1;RAB12;PIK3CG;ARAF;RNF144A;PDE4B
10072,GO:0035821,0.771037839553192,0.56974874532793,1,113,modification of morphology or physiology of other organism,BP,CHGA
101,GO:0000209,0.771472954667729,0.42362837670807,3,284,protein polyubiquitination,BP,FBXO41;SPSB1;RNF144A
13942,GO:0051208,0.771873999109131,0.568733907209838,1,103,sequestering of calcium ion,BP,CASQ2
11261,GO:0043204,0.772112695921563,0.568358925036243,1,104,perikaryon,CC,DRP2
6028,GO:0016616,0.772250742096399,0.567925098171841,1,115,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,BMP2
11229,GO:0043161,0.77328520941088,0.394272984863439,4,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,AXIN1;AKT1;ARAF;RNF144A
13267,GO:0048524,0.775085243491515,0.563913520366355,1,106,positive regulation of viral process,BP,NOTCH1
5896,GO:0016363,0.776968331676769,0.56127415527216,1,99,nuclear matrix,CC,SPTBN4
6614,GO:0019438,0.777933435436849,0.27018877795588,55,4252,aromatic compound biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;PNMT;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
2787,GO:0005774,0.778603918197374,0.387213239998953,4,367,vacuolar membrane,CC,RAB12;MYO7A;RAB44;RAB3D
11210,GO:0043130,0.779116672932603,0.558001197784627,1,101,ubiquitin binding,MF,MARK4
17982,GO:0097553,0.779564872653073,0.55723067267768,1,105,calcium ion transmembrane import into cytosol,BP,CASQ2
19256,GO:1902656,0.779564872653073,0.55723067267768,1,105,calcium ion import into cytosol,BP,CASQ2
6746,GO:0019882,0.781616446301583,0.454361713702188,2,223,antigen processing and presentation,BP,RAB27A;ITGB5
4357,GO:0009063,0.781818532939061,0.553755425288108,1,108,cellular amino acid catabolic process,BP,GLDC
9540,GO:0034654,0.782371893460013,0.265556791775752,54,4183,nucleobase-containing compound biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
19759,GO:1903749,0.783942251548702,0.550458471986548,1,111,positive regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
3603,GO:0007030,0.784088044547957,0.550540596694989,1,98,Golgi organization,BP,SPTBN5
11422,GO:0043484,0.784767769443112,0.549374590606259,1,103,regulation of RNA splicing,BP,PIK3R1
16654,GO:0071704,0.78600051882581,0.25412303326699,136,10155,organic substance metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;PNMT;STRA6;ITGB8;PMAIP1;GADD45A;CRB2;RHBDL3;FBXO41;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;NMT2;GUCY1B3;ADORA1;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;KHK;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;CHGA;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;VDR;ARAF;UNC119;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2;PDE4B
69,GO:0000139,0.786626565815176,0.327456127294019,8,678,Golgi membrane,CC,NOTCH1;RAB39A;PDGFB;HRAS;B3GNT2;RND3;RAB12;GPSM1
4599,GO:0009615,0.786969309639236,0.402210069446963,3,310,response to virus,BP,PMAIP1;ACTA2;PIM2
10461,GO:0038061,0.787362688277792,0.545069737706693,1,118,NIK/NF-kappaB signaling,BP,AKT1
4393,GO:0009116,0.787734335171139,0.544533127620537,1,116,nucleoside metabolic process,BP,RHOQ
7153,GO:0022891,0.788767610440899,0.307875931061706,11,925,substrate-specific transmembrane transporter activity,MF,TF;SLC45A4;KCNK6;TTYH1;KCNH2;SLC2A14;SFXN1;KCNG2;GAS6;KCND1;CLDN16
18059,GO:0098542,0.788847078926592,0.373211132504096,4,451,defense response to other organism,BP,PMAIP1;CCL20;HRAS;CHGA
7592,GO:0030817,0.789370246400909,0.541961112920199,1,118,regulation of cAMP biosynthetic process,BP,EDN1
1082,GO:0002449,0.789567521253801,0.442911636326975,2,212,lymphocyte mediated immunity,BP,RAB27A;CLCF1
20362,GO:1905039,0.789677439165831,0.541850334194115,1,101,carboxylic acid transmembrane transport,BP,AKT1
5020,GO:0010821,0.790196187766755,0.441991490866525,2,212,regulation of mitochondrion organization,BP,PMAIP1;AKT1
19294,GO:1902749,0.791158000263189,0.539158307166015,1,119,regulation of cell cycle G2/M phase transition,BP,FOXO4
2803,GO:0005793,0.791598582075585,0.538668286543747,1,109,endoplasmic reticulum-Golgi intermediate compartment,CC,GJB2
3366,GO:0006664,0.793337570480361,0.535898988423727,1,111,glycolipid metabolic process,BP,ITGB8
2445,GO:0005096,0.793542417164232,0.39317409333669,3,271,GTPase activator activity,MF,RIN3;PIK3R2;AXIN1
6701,GO:0019787,0.794824591153685,0.347718659536826,5,443,ubiquitin-like protein transferase activity,MF,TSPAN17;FBXO41;SPSB1;DTX4;RNF144A
1226,GO:0002706,0.795431249704413,0.532496027308411,1,116,regulation of lymphocyte mediated immunity,BP,CLCF1
1294,GO:0002822,0.795637329743784,0.532150704289691,1,117,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,CLCF1
3415,GO:0006732,0.796109093376935,0.389392059110424,3,303,coenzyme metabolic process,BP,ACTN3;PFKFB3;ACSL4
3028,GO:0006171,0.796683326011235,0.530418283882206,1,121,cAMP biosynthetic process,BP,EDN1
19634,GO:1903509,0.796784891481176,0.530429069792908,1,112,liposaccharide metabolic process,BP,ITGB8
13611,GO:0050714,0.796992055512903,0.431947429863581,2,214,positive regulation of protein secretion,BP,WNT5A;BMP6
11469,GO:0043543,0.797066743271827,0.431913884157927,2,204,protein acylation,BP,LIF;NMT2
11706,GO:0044272,0.79784457655583,0.430716356338879,2,209,sulfur compound biosynthetic process,BP,B3GNT2;ACSL4
5467,GO:0015294,0.799129160632645,0.526892943536612,1,103,solute:cation symporter activity,MF,SLC45A4
17632,GO:0090575,0.800268932417274,0.524801323067583,1,115,RNA polymerase II transcription factor complex,CC,VDR
6091,GO:0016747,0.803532374633291,0.42217251426196,2,211,transferase activity, transferring acyl groups other than amino-acyl groups,MF,NMT2;MBOAT2
7271,GO:0030163,0.805136817691487,0.297416324635095,9,792,protein catabolic process,BP,PMAIP1;WNT5A;MAGEC2;AXIN1;MSN;AKT1;RAB12;ARAF;RNF144A
7070,GO:0021987,0.805441329389413,0.516593215323143,1,107,cerebral cortex development,BP,CDH2
13654,GO:0050777,0.806377953562033,0.514795810264543,1,120,negative regulation of immune response,BP,TYRO3
1630,GO:0003713,0.806645884779491,0.374347222344352,3,294,transcription coactivator activity,MF,POU3F1;ACTN2;ZCCHC12
12742,GO:0046631,0.806652990799616,0.514440140067632,1,115,alpha-beta T cell activation,BP,ZFPM1
11274,GO:0043227,0.806664164681029,0.232928471502015,156,11597,membrane-bounded organelle,CC,ITGA3;ITGA5;BEX4;TMEM163;ADRA2C;SYT5;WNT3;WNT4;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;NMT2;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;PRKACB;MFGE8;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;SNX18;KHK;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NUAK2;PFKFB3;SCIN;PSRC1;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP2;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;SLC2A14;VAMP1;SFXN1;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;WNT2B;CYTIP;PTGES;NPPC;NAB2;CDH1;EPN1;MYO7A;HPCAL1;RAB44;TLE1;CLDN2;CLDN3;CLDN5;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;ZCCHC12;MYH11;PM20D2;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;RAB38;RAB3D;ACSL4;FAM110B;FZD8;DUSP5;HEY1;ACTA2;CLDN11;RNF144A;PDE4B
18386,GO:0101002,0.8068503727978,0.513950823666,1,124,ficolin-1-rich granule,CC,CRISPLD2
20249,GO:1904813,0.8068503727978,0.513950823666,1,124,ficolin-1-rich granule lumen,CC,CRISPLD2
4210,GO:0008528,0.809025863815275,0.51038642850366,1,123,G-protein coupled peptide receptor activity,MF,NPR1
5353,GO:0015075,0.809135975818645,0.287019919418918,10,861,ion transmembrane transporter activity,MF,TF;SLC45A4;KCNK6;TTYH1;KCNH2;SFXN1;KCNG2;GAS6;KCND1;CLDN16
2721,GO:0005667,0.810668806064784,0.36846491755218,3,304,transcription factor complex,CC,POU3F1;ZFPM1;VDR
566,GO:0001653,0.81219795707776,0.505101937001728,1,124,peptide receptor activity,MF,NPR1
13960,GO:0051238,0.812312171871701,0.504982237714021,1,120,sequestering of metal ion,BP,CASQ2
12221,GO:0045580,0.812340969871001,0.50497144895859,1,118,regulation of T cell differentiation,BP,BMP4
10900,GO:0042542,0.813247288091521,0.503365002935383,1,123,response to hydrogen peroxide,BP,RHOB
418,GO:0001085,0.813597473980257,0.502947952232038,1,114,RNA polymerase II transcription factor binding,MF,ZFPM1
401,GO:0001046,0.813821957179053,0.502677987631797,1,109,core promoter sequence-specific DNA binding,MF,ZFPM1
2847,GO:0005874,0.814004245182784,0.338568169009157,4,376,microtubule,CC,TUBG2;PSRC1;CAMSAP3;RAB3D
8530,GO:0032479,0.815340511470502,0.499997627742432,1,115,regulation of type I interferon production,BP,DTX4
19757,GO:1903747,0.815515156383604,0.499553302827245,1,123,regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
3131,GO:0006354,0.81573909476341,0.499193053298191,1,122,DNA-templated transcription, elongation,BP,AXIN1
5864,GO:0016298,0.815804557424011,0.499137282333514,1,119,lipase activity,MF,ADORA1
4003,GO:0008203,0.816009561039718,0.498791034229803,1,119,cholesterol metabolic process,BP,HMGCS2
19800,GO:1903825,0.817079178768498,0.49714147137363,1,111,organic acid transmembrane transport,BP,AKT1
8615,GO:0032606,0.817281555971266,0.496695174799347,1,116,type I interferon production,BP,DTX4
6359,GO:0018130,0.81741100649512,0.226059703794946,54,4246,heterocycle biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
13980,GO:0051262,0.817417184188203,0.496073029860581,1,140,protein tetramerization,BP,ACTN2
7691,GO:0030968,0.817920048299605,0.49555313572259,1,119,endoplasmic reticulum unfolded protein response,BP,PIK3R1
10696,GO:0042175,0.818416237273723,0.270744690475822,11,971,nuclear outer membrane-endoplasmic reticulum membrane network,CC,NOTCH1;CASQ2;MBOAT2;TTYH1;TYRO3;PIK3R1;REEP1;GJB1;PTGES;GPSM1;ACSL4
8503,GO:0032446,0.818667969099063,0.274835928194494,10,882,protein modification by small protein conjugation,BP,TSPAN17;FBXO41;RAB40B;RAB40A;MAGEC2;AXIN1;AKT1;SPSB1;DTX4;RNF144A
2790,GO:0005777,0.81913286529533,0.493397101808243,1,124,peroxisome,CC,ACSL4
10922,GO:0042579,0.81913286529533,0.493397101808243,1,124,microbody,CC,ACSL4
8216,GO:0031984,0.819544503892705,0.355438053772289,3,300,organelle subcompartment,CC,REEP1;CDH1;RAB38
4288,GO:0008757,0.820387325721214,0.491360590977742,1,118,S-adenosylmethionine-dependent methyltransferase activity,MF,PNMT
18781,GO:1901361,0.822053650669856,0.326920236646206,4,452,organic cyclic compound catabolic process,BP,PRR5L;PKP3;PKP1;PDE4B
8172,GO:0031901,0.823008932087038,0.486907222553,1,115,early endosome membrane,CC,TMEM163
1291,GO:0002819,0.82497968248539,0.48325342761549,1,128,regulation of adaptive immune response,BP,CLCF1
12634,GO:0046434,0.826146989605831,0.481320998131569,1,122,organophosphate catabolic process,BP,PDE4B
10800,GO:0042383,0.827217079009449,0.479542263550301,1,117,sarcolemma,CC,CDH2
413,GO:0001078,0.828033924070422,0.478108435828704,1,117,transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,ZFPM1
9517,GO:0034620,0.828126790038929,0.477833444396038,1,123,cellular response to unfolded protein,BP,PIK3R1
19254,GO:1902652,0.828578745239221,0.477020573732967,1,124,secondary alcohol metabolic process,BP,HMGCS2
13840,GO:0051053,0.830188089125735,0.474269773738964,1,119,negative regulation of DNA metabolic process,BP,NPPC
6026,GO:0016614,0.830250518965643,0.473892004603487,1,135,oxidoreductase activity, acting on CH-OH group of donors,MF,BMP2
14929,GO:0060402,0.83089595230548,0.472924028550627,1,124,calcium ion transport into cytosol,BP,CASQ2
2547,GO:0005262,0.830921477142262,0.473068749942362,1,114,calcium channel activity,MF,GAS6
8364,GO:0032259,0.831869815864184,0.336888228340443,3,313,methylation,BP,PNMT;PIK3CA;RAB3D
4381,GO:0009100,0.833040503887446,0.311147760847953,4,396,glycoprotein metabolic process,BP,PHLDA1;HBEGF;BMP2;B3GNT2
5694,GO:0015931,0.837279138825386,0.369086296001909,2,224,nucleobase-containing compound transport,BP,ADORA1;GJB1
8321,GO:0032182,0.83941907122109,0.457630892386517,1,121,ubiquitin-like protein binding,MF,MARK4
4440,GO:0009167,0.839471688457212,0.365251368066985,2,267,purine ribonucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
4400,GO:0009126,0.840505828029136,0.363544434922357,2,268,purine nucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
6155,GO:0016853,0.841210354161345,0.454031354952094,1,141,isomerase activity,MF,PTGES
9429,GO:0034399,0.842308592812045,0.452325438952955,1,121,nuclear periphery,CC,SPTBN4
948,GO:0002224,0.842651452870754,0.451603630797678,1,126,toll-like receptor signaling pathway,BP,TYRO3
2317,GO:0004888,0.842778961249675,0.239242825153287,11,1184,transmembrane signaling receptor activity,MF,ADRA2B;ADRA2C;ACVR1;ADORA1;FZD7;TYRO3;LPAR2;NPR1;DDR1;CLDN3;FZD8
1303,GO:0002831,0.84539671288083,0.446378939694455,1,134,regulation of response to biotic stimulus,BP,BMP6
18879,GO:1901657,0.846817053895578,0.443636179168362,1,140,glycosyl compound metabolic process,BP,RHOQ
4809,GO:0010467,0.848496794162761,0.188138276745913,64,5049,gene expression,BP,ITGA3;LIF;WNT3;WNT2;WNT4;POU3F1;TSPAN15;NOTCH1;RAB27A;ITGB8;CRB2;RHBDL3;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;PLAU;PRKACB;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;MSN;CTGF;AKT1;PKP3;PKP1;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;SHC4;VDR;GDNF;FZD8;HEY1;ACTA2;PIM2
11679,GO:0044238,0.84979147136028,0.182652028881916,129,9787,primary metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;STRA6;ITGB8;PMAIP1;GADD45A;CRB2;RHBDL3;FBXO41;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;ACVR1;NMT2;GUCY1B3;ADORA1;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;KHK;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;CHGA;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;VDR;ARAF;UNC119;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;RNF144A;PIM2;PDE4B
18117,GO:0098661,0.850841453101821,0.436305548949167,1,123,inorganic anion transmembrane transport,BP,TTYH1
13860,GO:0051092,0.851164920059529,0.43553954928405,1,132,positive regulation of NF-kappaB transcription factor activity,BP,WNT5A
36,GO:0000070,0.852941448871503,0.432194500204524,1,129,mitotic sister chromatid segregation,BP,PSRC1
3173,GO:0006417,0.854037678963318,0.302354527614337,3,329,regulation of translation,BP,SESN2;BMP4;AKT1
9648,GO:0035023,0.855237861950733,0.427879379598821,1,123,regulation of Rho protein signal transduction,BP,ITGA3
7734,GO:0031056,0.855948316576944,0.426418752487945,1,128,regulation of histone modification,BP,LIF
5779,GO:0016125,0.856320184544008,0.425558466307252,1,137,sterol metabolic process,BP,HMGCS2
4434,GO:0009161,0.858813396726779,0.332600854669947,2,279,ribonucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
6128,GO:0016810,0.859869403494665,0.418601665105043,1,139,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,SIN3B
11804,GO:0044437,0.861276417573724,0.253959203867903,5,517,vacuolar part,CC,SDC4;RAB12;MYO7A;RAB44;RAB3D
11793,GO:0044422,0.861343899161631,0.169432732444669,110,8458,organelle part,CC,FHOD3;TMEM163;SYT5;WNT3;WNT4;POU3F1;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;CDH23;TF;PMAIP1;GADD45A;CRISPLD2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;CASQ2;EDN1;PLAU;RAB40B;PHLDA1;MRO;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RAB39A;SYCN;MAPK12;FZD7;TYRO3;CDH2;FSTL3;PIK3R1;CGN;REEP1;PDGFB;PRKAR1B;PLEKHH2;FOXO4;HRAS;WNT5B;WNT5A;MAGEC2;SNX18;RHOQ;RHOB;PFKFB3;SCIN;PSRC1;SDC4;SPTB;HBEGF;CAMSAP3;B3GNT2;WT1;CDKN1A;HMGN5;RAB20;ESPN;VAMP1;SFXN1;RND3;CHGA;GJB1;AKT1;PKP3;PKP1;RAB12;RAB17;CYTIP;PTGES;CDH1;MYO7A;RAB44;TLE1;CLDN5;RAB11FIP1;GAS6;SIN3B;ZCCHC12;MYH11;PM20D2;GPSM1;VDR;AMOT;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;DUSP5;HEY1;ACTA2;RNF144A;PARVB;PDE4B
10150,GO:0035967,0.86144394768062,0.41551329390628,1,138,cellular response to topologically incorrect protein,BP,PIK3R1
11919,GO:0044798,0.861614244861834,0.415148487829726,1,140,nuclear transcription factor complex,CC,VDR
7921,GO:0031396,0.862136940005154,0.326956015546995,2,252,regulation of protein ubiquitination,BP,MAGEC2;AXIN1
18833,GO:1901565,0.862823790711259,0.288170621869027,3,346,organonitrogen compound catabolic process,BP,GLDC;SDC4;PDE4B
3996,GO:0008194,0.863746621027621,0.411017517601353,1,133,UDP-glycosyltransferase activity,MF,B3GNT2
7818,GO:0031225,0.863950718646036,0.410354869866181,1,152,anchored component of membrane,CC,PRND
3367,GO:0006665,0.8641258289111,0.41024590489607,1,134,sphingolipid metabolic process,BP,ITGB8
4994,GO:0010770,0.864448572611862,0.409663861662556,1,130,positive regulation of cell morphogenesis involved in differentiation,BP,WNT3
9738,GO:0035257,0.864860931680963,0.408791951057553,1,133,nuclear hormone receptor binding,MF,VDR
2852,GO:0005882,0.866010959717645,0.405879686608584,1,189,intermediate filament,CC,PKP1
2636,GO:0005506,0.866063704475259,0.406184406023378,1,147,iron ion binding,MF,TF
4386,GO:0009108,0.866605399724914,0.405146001453525,1,143,coenzyme biosynthetic process,BP,ACSL4
3970,GO:0008152,0.866693496374688,0.163801418772967,140,10623,metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;PNMT;STRA6;ITGB4;ITGB8;PMAIP1;GADD45A;CRB2;RHBDL3;FBXO41;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;NMT2;GUCY1B3;ADORA1;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;RAB39A;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;KHK;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;CHGA;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;VDR;ARAF;SH3BP4;UNC119;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2;PDE4B
4382,GO:0009101,0.867684682078425,0.280275531443004,3,332,glycoprotein biosynthetic process,BP,PHLDA1;HBEGF;B3GNT2
14172,GO:0051606,0.869935988776432,0.254939989291611,4,625,detection of stimulus,BP,NMT2;ADORA1;CASQ2;UNC119
7726,GO:0031047,0.871750349022708,0.3944990602151,1,158,gene silencing by RNA,BP,BMP4
3495,GO:0006865,0.872462946269609,0.393326287751157,1,135,amino acid transport,BP,ADORA1
2800,GO:0005789,0.872594079966676,0.20325385707952,10,951,endoplasmic reticulum membrane,CC,NOTCH1;CASQ2;MBOAT2;TTYH1;TYRO3;REEP1;GJB1;PTGES;GPSM1;ACSL4
5368,GO:0015103,0.87305104585722,0.392113423356496,1,135,inorganic anion transmembrane transporter activity,MF,TTYH1
5997,GO:0016573,0.873883729688907,0.390347630462165,1,138,histone acetylation,BP,LIF
4397,GO:0009123,0.874379083659764,0.305068066834931,2,291,nucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
11561,GO:0043901,0.875802093000692,0.386154702176084,1,154,negative regulation of multi-organism process,BP,NPPC
4880,GO:0010608,0.876167659948505,0.245334595419896,4,450,posttranscriptional regulation of gene expression,BP,SESN2;BMP4;AKT1;GDNF
5358,GO:0015085,0.876590661973365,0.3847850701218,1,133,calcium ion transmembrane transporter activity,MF,GAS6
3619,GO:0007051,0.877729771400385,0.382307035533332,1,139,spindle organization,BP,PSRC1
1096,GO:0002478,0.880760902956624,0.375587895125004,1,165,antigen processing and presentation of exogenous peptide antigen,BP,ITGB5
1223,GO:0002703,0.881101324953115,0.374991746343742,1,153,regulation of leukocyte mediated immunity,BP,CLCF1
6417,GO:0018393,0.881344390443374,0.37459740871517,1,143,internal peptidyl-lysine acetylation,BP,LIF
2757,GO:0005739,0.883604327333696,0.172711525000059,16,1569,mitochondrion,CC,GLDC;PMAIP1;HMGCS2;SLC25A53;MAPK12;PRR5L;REEP1;SESN2;VAMP1;SFXN1;AKT1;ARAF;RAB38;RAB3D;ACSL4;FAM110B
11394,GO:0043414,0.884921993958762,0.285920830048532,2,251,macromolecule methylation,BP,PIK3CA;RAB3D
13929,GO:0051186,0.885543451792538,0.250190784768838,3,373,cofactor metabolic process,BP,ACTN3;PFKFB3;ACSL4
7440,GO:0030426,0.886351483340233,0.363835298441034,1,141,growth cone,CC,ITGA3
5466,GO:0015293,0.887799929228083,0.360673014929836,1,141,symporter activity,MF,SLC45A4
6418,GO:0018394,0.888114040096121,0.359894191425266,1,148,peptidyl-lysine acetylation,BP,LIF
7904,GO:0031347,0.888160208152833,0.203327693942159,6,661,regulation of defense response,BP,ADORA1;PRKACB;TYRO3;HRAS;WNT5A;PIK3CG
3214,GO:0006475,0.888279339356145,0.359531646953018,1,148,internal protein amino acid acetylation,BP,LIF
11811,GO:0044446,0.891390230850261,0.134868627064848,106,8256,intracellular organelle part,CC,FHOD3;TMEM163;SYT5;WNT3;WNT4;POU3F1;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;TF;PMAIP1;GADD45A;CRISPLD2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;CASQ2;EDN1;PLAU;RAB40B;PHLDA1;MRO;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RAB39A;SYCN;MAPK12;FZD7;TYRO3;CDH2;FSTL3;PIK3R1;CGN;REEP1;PDGFB;PLEKHH2;FOXO4;HRAS;WNT5B;WNT5A;MAGEC2;SNX18;RHOQ;RHOB;PFKFB3;SCIN;PSRC1;SDC4;SPTB;HBEGF;CAMSAP3;B3GNT2;WT1;CDKN1A;HMGN5;RAB20;ESPN;VAMP1;SFXN1;RND3;CHGA;GJB1;AKT1;PKP3;PKP1;RAB12;RAB17;CYTIP;PTGES;CDH1;MYO7A;RAB44;TLE1;CLDN5;RAB11FIP1;GAS6;SIN3B;ZCCHC12;MYH11;PM20D2;GPSM1;VDR;AMOT;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;DUSP5;HEY1;RNF144A;PDE4B
6748,GO:0019884,0.892482806157436,0.349974690879579,1,172,antigen processing and presentation of exogenous antigen,BP,ITGB5
5021,GO:0010822,0.89285585634357,0.349237517837456,1,162,positive regulation of mitochondrion organization,BP,PMAIP1
19550,GO:1903320,0.893296172375127,0.270027130147484,2,274,regulation of protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1
8208,GO:0031967,0.893628890372196,0.173850628047038,10,1063,organelle envelope,CC,PMAIP1;HMGCS2;RAB40B;SLC25A53;TYRO3;REEP1;VAMP1;SFXN1;PTGES;ACSL4
8212,GO:0031975,0.893628890372196,0.173850628047038,10,1063,envelope,CC,PMAIP1;HMGCS2;RAB40B;SLC25A53;TYRO3;REEP1;VAMP1;SFXN1;PTGES;ACSL4
21653,GO:2001252,0.894428108308958,0.345866502013353,1,148,positive regulation of chromosome organization,BP,LIF
3585,GO:0007005,0.894800857277824,0.215012828357391,4,495,mitochondrion organization,BP,PMAIP1;SESN2;AKT1;RAB38
7441,GO:0030427,0.895542352294632,0.343376756117295,1,146,site of polarized growth,CC,ITGA3
2788,GO:0005775,0.896594502527805,0.340789994552995,1,164,vacuolar lumen,CC,SDC4
2761,GO:0005743,0.896921542651345,0.230225428904308,3,454,mitochondrial inner membrane,CC,HMGCS2;SLC25A53;SFXN1
9352,GO:0034248,0.897157872979601,0.229983067831176,3,366,regulation of cellular amide metabolic process,BP,SESN2;BMP4;AKT1
3574,GO:0006986,0.899298028419636,0.334641222240831,1,161,response to unfolded protein,BP,PIK3R1
11799,GO:0044429,0.899696076824419,0.173315640648507,8,919,mitochondrial part,CC,GLDC;PMAIP1;HMGCS2;SLC25A53;REEP1;VAMP1;SFXN1;ACSL4
13058,GO:0048002,0.899918838033064,0.333053952856998,1,178,antigen processing and presentation of peptide antigen,BP,ITGB5
7867,GO:0031301,0.9008466943204,0.331078917223275,1,160,integral component of organelle membrane,CC,TMEM163
11872,GO:0044712,0.903021471456106,0.164080354243334,9,922,single-organism catabolic process,BP,ACTN3;GLDC;ADORA1;KHK;SESN2;PFKFB3;AKT1;PIK3CG;PDE4B
3480,GO:0006839,0.90389238165702,0.24935780614844,2,296,mitochondrial transport,BP,PMAIP1;SLC25A53
19109,GO:1902275,0.90469130296962,0.32216733230726,1,154,regulation of chromatin organization,BP,LIF
3218,GO:0006479,0.905698309294861,0.31973642343147,1,159,protein methylation,BP,RAB3D
4011,GO:0008213,0.905698309294861,0.31973642343147,1,159,protein alkylation,BP,RAB3D
5532,GO:0015630,0.906164470313411,0.152914829322805,11,1035,microtubule cytoskeleton,CC,TUBG2;RAB6C;MARK4;PRKACB;PSRC1;CAMSAP3;AKT1;UNC119;RAB3D;FAM110B;PDE4B
6003,GO:0016579,0.906711063129733,0.243831792372227,2,276,protein deubiquitination,BP,FOXO4;AXIN1
5745,GO:0016053,0.907918265820531,0.241383399603607,2,285,organic acid biosynthetic process,BP,EDN1;PTGES
12624,GO:0046394,0.907918265820531,0.241383399603607,2,285,carboxylic acid biosynthetic process,BP,EDN1;PTGES
7544,GO:0030674,0.910623085020079,0.307932675865944,1,161,protein binding, bridging,MF,PIK3R1
19836,GO:1903900,0.911204140354882,0.306394513392109,1,175,regulation of viral life cycle,BP,NOTCH1
18113,GO:0098656,0.911292024482714,0.234671761747109,2,262,anion transmembrane transport,BP,TTYH1;AKT1
5752,GO:0016070,0.911316574940304,0.115816527766304,54,4437,RNA metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;PKP3;PKP1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
946,GO:0002221,0.91219392858632,0.304077694301521,1,165,pattern recognition receptor signaling pathway,BP,TYRO3
11276,GO:0043229,0.912290881112154,0.111314777791726,152,11553,intracellular organelle,CC,ITGA5;FHOD3;BEX4;TMEM163;ADRA2C;SYT5;WNT3;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;TF;ITGB5;ITGB4;PMAIP1;GADD45A;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;NMT2;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;SESN2;AXIN1;RHOQ;RHOB;NUAK2;PFKFB3;SCIN;PSRC1;SDC4;SPTB;HBEGF;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;SLC2A14;ESPN;VAMP1;SFXN1;RND3;CHGA;MSN;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;WNT2B;CYTIP;PTGES;KITLG;NPPC;NAB2;CDH1;EPN1;MYO7A;BCAR1;RAB44;TLE1;CLDN5;PIK3CG;RAB11FIP1;GAS6;SIN3B;ZCCHC12;MYH11;PM20D2;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PARVB;PDE4B
16061,GO:0070647,0.912429588727448,0.143909507137042,11,1072,protein modification by small protein conjugation or removal,BP,TSPAN17;FBXO41;RAB40B;RAB40A;FOXO4;MAGEC2;AXIN1;AKT1;SPSB1;DTX4;RNF144A
7866,GO:0031300,0.91462925178589,0.29805949267437,1,170,intrinsic component of organelle membrane,CC,TMEM163
2969,GO:0006066,0.916405070290165,0.224103305269097,2,289,alcohol metabolic process,BP,HMGCS2;VDR
12032,GO:0045111,0.91715520525733,0.291435471790192,1,222,intermediate filament cytoskeleton,CC,PKP1
3237,GO:0006508,0.918685298351302,0.124098115787983,17,1634,proteolysis,BP,PMAIP1;CRB2;RHBDL3;DHH;SERPINA5;PLAU;PRKACB;MAPK12;FOXO4;AXIN1;CTGF;AKT1;CST9L;GAS6;PM20D2;ARAF;RNF144A
3212,GO:0006473,0.919053116316414,0.287003715299965,1,173,protein acetylation,BP,LIF
1616,GO:0003682,0.919155644117914,0.173408353432225,4,470,chromatin binding,MF,NOTCH1;FOXO4;HMGN5;SIN3B
13931,GO:0051188,0.920292079027332,0.283782821459122,1,184,cofactor biosynthetic process,BP,ACSL4
18163,GO:0098791,0.920639196551486,0.215312244316153,2,282,Golgi subcompartment,CC,CDH1;RAB38
10149,GO:0035966,0.921254202740951,0.281383979243545,1,178,response to topologically incorrect protein,BP,PIK3R1
18832,GO:1901564,0.921321528004402,0.115475084545911,22,2159,organonitrogen compound metabolic process,BP,ACTN3;GLDC;PNMT;ITGB8;SLC52A3;GUCY1B3;EDN1;MBOAT2;PDGFB;WNT5A;SESN2;RHOQ;NPR1;PFKFB3;SDC4;BMP4;B3GNT2;CHGA;AKT1;NPPC;GAS6;PDE4B
16060,GO:0070646,0.921896229287064,0.212637183254948,2,291,protein modification by small protein removal,BP,FOXO4;AXIN1
6168,GO:0016874,0.922101875274666,0.279286702643676,1,170,ligase activity,MF,ACSL4
3326,GO:0006611,0.922457118560349,0.278325542617931,1,176,protein export from nucleus,BP,GAS6
3976,GO:0008168,0.922523054192793,0.278156460205193,1,176,methyltransferase activity,MF,PNMT
4353,GO:0009059,0.924713563488545,0.0985181337075875,60,4943,macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;NMT2;DKK3;EDN1;PHLDA1;CCL20;PRND;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;NAB2;CDH1;INHBB;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
74,GO:0000151,0.92591163004633,0.204120472513283,2,286,ubiquitin ligase complex,CC,TSPAN17;RNF144A
7154,GO:0022892,0.929038415458815,0.119565200018778,11,1110,substrate-specific transporter activity,MF,TF;SLC45A4;KCNK6;TTYH1;KCNH2;SLC2A14;SFXN1;KCNG2;GAS6;KCND1;CLDN16
471,GO:0001227,0.930000813345601,0.258574954389959,1,179,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,ZFPM1
3350,GO:0006643,0.932105724872167,0.2528821928684,1,185,membrane lipid metabolic process,BP,ITGB8
3878,GO:0007623,0.933006185249621,0.250417888507354,1,189,circadian rhythm,BP,ADORA1
6086,GO:0016741,0.934470567850147,0.246443732846901,1,187,transferase activity, transferring one-carbon groups,MF,PNMT
6685,GO:0019752,0.936374874020649,0.116930687444991,8,909,carboxylic acid metabolic process,BP,ACTN3;GLDC;EDN1;SESN2;PFKFB3;AKT1;PTGES;ACSL4
13913,GO:0051168,0.938935587276886,0.234041701726581,1,192,nuclear export,BP,GAS6
1217,GO:0002697,0.939010256200976,0.175183846269617,2,324,regulation of immune effector process,BP,WNT5A;CLCF1
2702,GO:0005635,0.939135050759967,0.150765251451823,3,412,nuclear envelope,CC,RAB40B;TYRO3;PTGES
6740,GO:0019866,0.940157636878112,0.148574446840075,3,506,organelle inner membrane,CC,HMGCS2;SLC25A53;SFXN1
17528,GO:0090304,0.940890590710667,0.0786428334095223,59,4910,nucleic acid metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;GADD45A;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
6022,GO:0016604,0.941676891128629,0.117041750150013,6,686,nuclear body,CC,GADD45A;SPTBN4;FOXO4;WT1;CDKN1A;ZCCHC12
6097,GO:0016758,0.942384963277415,0.224254463740342,1,193,transferase activity, transferring hexosyl groups,MF,B3GNT2
14170,GO:0051603,0.945074143246333,0.117234991879018,5,617,proteolysis involved in cellular protein catabolic process,BP,PMAIP1;AXIN1;AKT1;ARAF;RNF144A
18847,GO:1901605,0.946036883608139,0.213594376925396,1,206,alpha-amino acid metabolic process,BP,GLDC
15581,GO:0061630,0.946079509421355,0.213532701098895,1,195,ubiquitin protein ligase activity,MF,RNF144A
3202,GO:0006457,0.947368619746643,0.209597878709066,1,221,protein folding,BP,NPPC
11406,GO:0043436,0.947567171514492,0.0958508360614203,9,1016,oxoacid metabolic process,BP,ACTN3;GLDC;EDN1;SESN2;PFKFB3;B3GNT2;AKT1;PTGES;ACSL4
15593,GO:0061659,0.949944481430936,0.202024212320949,1,200,ubiquitin-like protein ligase activity,MF,RNF144A
4041,GO:0008270,0.950223709075751,0.0892439656124763,10,1061,zinc ion binding,MF,TMEM163;DHH;RABIF;LIMS2;WT1;DRP2;DTX4;ZCCHC12;VDR;RNF144A
4352,GO:0009058,0.950292159786665,0.065708880083635,73,6057,biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;PNMT;CRB2;DHH;WNT6;WNT7A;ZFPM1;HMGCS2;ACVR1;NMT2;GUCY1B3;DKK3;EDN1;PHLDA1;CCL20;MBOAT2;PRND;MAPK12;FZD7;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;PTGES;KITLG;NPPC;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;ACSL4;FZD8;HEY1;PIM2
312,GO:0000819,0.950923644728446,0.199036120920446,1,206,sister chromatid segregation,BP,PSRC1
18841,GO:1901576,0.951051143025735,0.0648247250331132,72,5982,organic substance biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;PNMT;CRB2;DHH;WNT6;WNT7A;ZFPM1;HMGCS2;ACVR1;NMT2;GUCY1B3;DKK3;EDN1;PHLDA1;CCL20;MBOAT2;PRND;MAPK12;FZD7;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;PTGES;KITLG;NPPC;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;ACSL4;FZD8;HEY1;PIM2
2977,GO:0006082,0.953233624707609,0.0866406260133256,9,1031,organic acid metabolic process,BP,ACTN3;GLDC;EDN1;SESN2;PFKFB3;B3GNT2;AKT1;PTGES;ACSL4
5935,GO:0016458,0.956331558872468,0.182167692104091,1,248,gene silencing,BP,BMP4
9533,GO:0034645,0.957102275197047,0.0584656377092783,56,4781,cellular macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;NMT2;DKK3;EDN1;PHLDA1;PRND;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
14173,GO:0051607,0.957271175002301,0.179264886132554,1,231,defense response to virus,BP,PMAIP1
3239,GO:0006511,0.95887060334588,0.0984969711017423,4,548,ubiquitin-dependent protein catabolic process,BP,AXIN1;AKT1;ARAF;RNF144A
11234,GO:0043169,0.959318383715631,0.0565203824551233,48,4015,cation binding,MF,ITGA3;ITGA5;TMEM163;SYT5;ACTN3;ACTN2;NOTCH1;GLDC;CDH23;TF;CRB2;RHBDL3;DHH;DSC2;SERPINA5;ZFPM1;ACVR1;RABIF;GUCY1B3;CASQ2;PRKACB;TTYH1;PRND;MAPK12;LIMS2;CDH2;SESN2;NUAK2;SCIN;WT1;CDKN1A;DLL1;DRP2;DDR1;DSG3;TPD52;JAG2;CDH1;HPCAL1;GAS6;DTX4;ZCCHC12;DSC3;VDR;ARAF;KCND1;RNF144A;PDE4B
3452,GO:0006790,0.96028474699483,0.12433607330819,2,358,sulfur compound metabolic process,BP,B3GNT2;ACSL4
3012,GO:0006139,0.961344231395109,0.0522911510374396,65,5512,nucleobase-containing compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;GADD45A;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
6775,GO:0019941,0.961534402616362,0.0930516892919933,4,555,modification-dependent protein catabolic process,BP,AXIN1;AKT1;ARAF;RNF144A
11688,GO:0044249,0.961739022729371,0.0514783257184957,70,5897,cellular biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;PNMT;CRB2;WNT6;WNT7A;ZFPM1;HMGCS2;ACVR1;NMT2;GUCY1B3;DKK3;EDN1;PHLDA1;CCL20;MBOAT2;PRND;MAPK12;FZD7;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;PTGES;KITLG;NPPC;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;ACSL4;FZD8;HEY1;PIM2
3865,GO:0007608,0.961986259393939,0.163675064996024,1,402,sensory perception of smell,BP,B3GNT2
18834,GO:1901566,0.962221874021772,0.0681711937147392,11,1317,organonitrogen compound biosynthetic process,BP,PNMT;GUCY1B3;EDN1;PDGFB;SESN2;NPR1;SDC4;BMP4;B3GNT2;AKT1;NPPC
11705,GO:0044271,0.963544144795074,0.0503436375863575,54,4709,cellular nitrogen compound biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
11524,GO:0043632,0.963723380837686,0.0885249289218081,4,561,modification-dependent macromolecule catabolic process,BP,AXIN1;AKT1;ARAF;RNF144A
10594,GO:0040029,0.964417341425375,0.155875294680264,1,262,regulation of gene expression, epigenetic,BP,BMP4
19182,GO:1902494,0.966406276259356,0.0613596381086966,11,1259,catalytic complex,CC,TSPAN17;GLDC;ACVR1;PIK3R2;PIK3R1;SESN2;CDKN1A;PIK3CA;PIK3CG;SIN3B;RNF144A
2773,GO:0005759,0.966508973829875,0.108213903699757,2,410,mitochondrial matrix,CC,GLDC;HMGCS2
12872,GO:0046914,0.967215666012202,0.0587847510007188,12,1303,transition metal ion binding,MF,TMEM163;TF;DHH;RABIF;PRND;LIMS2;WT1;DRP2;DTX4;ZCCHC12;VDR;RNF144A
7335,GO:0030246,0.970533188428201,0.134811302066296,1,256,carbohydrate binding,MF,LGALS4
5464,GO:0015291,0.970647914820677,0.134495900147969,1,227,secondary active transmembrane transporter activity,MF,SLC45A4
14626,GO:0055114,0.971654464471557,0.0596113382606939,7,940,oxidation-reduction process,BP,ACTN3;GLDC;SESN2;PFKFB3;BMP2;AKT1;PIK3CA
366,GO:0000981,0.972244007998641,0.0651367470058994,5,676,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,ZFPM1;FOXO4;WT1;VDR;HEY1
13086,GO:0048037,0.972381651212832,0.128206768190447,1,252,cofactor binding,MF,GLDC
12664,GO:0046483,0.972622797623214,0.0376867319680238,66,5674,heterocycle metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;GADD45A;CRB2;WNT6;WNT7A;ZFPM1;SLC52A3;ACVR1;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
13663,GO:0050792,0.972914452924747,0.126260333355818,1,258,regulation of viral process,BP,NOTCH1
367,GO:0000982,0.973109164116143,0.0904680844666179,2,366,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,ZFPM1;WT1
6116,GO:0016788,0.973212271569944,0.0631481447396626,5,697,hydrolase activity, acting on ester bonds,MF,ADORA1;PTPN7;PFKFB3;DUSP5;PDE4B
4020,GO:0008233,0.973225049789447,0.0682444835068484,4,614,peptidase activity,MF,RHBDL3;DHH;PLAU;PM20D2
18780,GO:1901360,0.973746839513903,0.0360824045028809,69,5915,organic cyclic compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;PNMT;GADD45A;CRB2;DHH;WNT6;WNT7A;ZFPM1;SLC52A3;HMGCS2;ACVR1;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
11663,GO:0044212,0.97411651319355,0.0577243285503166,6,771,transcription regulatory region DNA binding,MF,NOTCH1;GADD45A;ZFPM1;WNT5A;WT1;VDR
3110,GO:0006310,0.974540460579947,0.120324836185716,1,250,DNA recombination,BP,CLCF1
360,GO:0000975,0.974610733185842,0.0567535935929726,6,773,regulatory region DNA binding,MF,NOTCH1;GADD45A;ZFPM1;WNT5A;WT1;VDR
406,GO:0001067,0.974881077663148,0.0562214770055515,6,774,regulatory region nucleic acid binding,MF,NOTCH1;GADD45A;ZFPM1;WNT5A;WT1;VDR
1878,GO:0004175,0.975132992264753,0.0847783418246914,2,405,endopeptidase activity,MF,RHBDL3;PLAU
4111,GO:0008380,0.976478757133828,0.0809741223772548,2,401,RNA splicing,BP,PIK3R1;WT1
3411,GO:0006725,0.976598136065076,0.0324803723630299,66,5710,cellular aromatic compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;PNMT;GADD45A;CRB2;WNT6;WNT7A;ZFPM1;ACVR1;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
3169,GO:0006412,0.976965040238479,0.0669542674287805,3,581,translation,BP,SESN2;BMP4;AKT1
412,GO:0001077,0.977762252157823,0.108187140617038,1,255,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,WT1
6096,GO:0016757,0.977945805267637,0.107468095109347,1,261,transferase activity, transferring glycosyl groups,MF,B3GNT2
4590,GO:0009593,0.978474120384148,0.105172620512423,1,454,detection of chemical stimulus,BP,CASQ2
3222,GO:0006486,0.978505478553499,0.105310463477842,1,261,protein glycosylation,BP,B3GNT2
11393,GO:0043413,0.978505478553499,0.105310463477842,1,261,macromolecule glycosylation,BP,B3GNT2
18181,GO:0098813,0.979324247965724,0.102117960719752,1,265,nuclear chromosome segregation,BP,PSRC1
12842,GO:0046872,0.979838261157213,0.0294189489436966,45,3929,metal ion binding,MF,ITGA3;ITGA5;TMEM163;SYT5;ACTN3;ACTN2;NOTCH1;CDH23;TF;CRB2;RHBDL3;DHH;DSC2;ZFPM1;ACVR1;RABIF;GUCY1B3;CASQ2;PRKACB;TTYH1;PRND;MAPK12;LIMS2;CDH2;NUAK2;SCIN;WT1;CDKN1A;DLL1;DRP2;DDR1;DSG3;TPD52;JAG2;CDH1;HPCAL1;GAS6;DTX4;ZCCHC12;DSC3;VDR;ARAF;KCND1;RNF144A;PDE4B
11563,GO:0043903,0.979881083640993,0.099902979606226,1,280,regulation of symbiosis, encompassing mutualism through parasitism,BP,NOTCH1
290,GO:0000790,0.980035138030637,0.099259585645366,1,300,nuclear chromatin,CC,SIN3B
7477,GO:0030522,0.980392904498674,0.0979196005608242,1,262,intracellular receptor signaling pathway,BP,VDR
15724,GO:0070085,0.980977689163296,0.0955785458989164,1,269,glycosylation,BP,B3GNT2
11163,GO:0043043,0.982170683968351,0.0538090267083073,3,605,peptide biosynthetic process,BP,SESN2;BMP4;AKT1
286,GO:0000785,0.983081881841557,0.061513809491957,2,459,chromatin,CC,HMGN5;SIN3B
3864,GO:0007606,0.983150677493884,0.0865436702348587,1,473,sensory perception of chemical stimulus,BP,B3GNT2
13745,GO:0050906,0.98322800982317,0.0862287933278841,1,468,detection of stimulus involved in sensory perception,BP,ADORA1
3244,GO:0006518,0.983819131164138,0.0441003206955741,4,735,peptide metabolic process,BP,SESN2;BMP4;AKT1;GAS6
5993,GO:0016569,0.984335770167352,0.0481913280105114,3,516,covalent chromatin modification,BP,LIF;HMGN5;SIN3B
5994,GO:0016570,0.985745366176285,0.0533044658588054,2,410,histone modification,BP,LIF;SIN3B
8908,GO:0033044,0.985760452095859,0.075785422913249,1,281,regulation of chromosome organization,BP,LIF
11486,GO:0043565,0.987482195218024,0.0287721036068859,7,957,sequence-specific DNA binding,MF,POU3F1;NOTCH1;ZFPM1;FOXO4;WT1;VDR;HEY1
3115,GO:0006325,0.988572701455199,0.0325382565339314,4,709,chromatin organization,BP,LIF;ZFPM1;HMGN5;SIN3B
3623,GO:0007059,0.989254452481743,0.0602841737988295,1,308,chromosome segregation,BP,PSRC1
11504,GO:0043603,0.989591763408537,0.0274649286762399,5,882,cellular amide metabolic process,BP,ITGB8;SESN2;BMP4;AKT1;GAS6
15686,GO:0070011,0.990321560717324,0.0317664631046539,3,596,peptidase activity, acting on L-amino acid peptides,MF,RHBDL3;PLAU;PM20D2
4195,GO:0008509,0.990430816394398,0.0548367509843481,1,304,anion transmembrane transporter activity,MF,TTYH1
10948,GO:0042623,0.990513294237581,0.0544479970191594,1,305,ATPase activity, coupled,MF,MYO7A
3245,GO:0006520,0.991866012130649,0.0479410787407946,1,349,cellular amino acid metabolic process,BP,GLDC
11505,GO:0043604,0.992168740092564,0.02639844645022,3,676,amide biosynthetic process,BP,SESN2;BMP4;AKT1
1625,GO:0003700,0.992587903256046,0.0164967720833196,9,1183,transcription factor activity, sequence-specific DNA binding,MF,POU3F1;NOTCH1;ZFPM1;FOXO4;WNT5A;WT1;LZTS1;VDR;HEY1
409,GO:0001071,0.992658579239799,0.01635305987924,9,1184,nucleic acid binding transcription factor activity,MF,POU3F1;NOTCH1;ZFPM1;FOXO4;WNT5A;WT1;LZTS1;VDR;HEY1
3085,GO:0006281,0.992689359218862,0.0301826883634026,2,493,DNA repair,BP,GADD45A;FGF10
11816,GO:0044451,0.992778374936149,0.01751808059236,7,1010,nucleoplasm part,CC,GADD45A;SPTBN4;FOXO4;WT1;CDKN1A;SIN3B;ZCCHC12
2752,GO:0005730,0.993513649290944,0.0180154957900901,5,861,nucleolus,CC,PHLDA1;MRO;MAGEC2;WT1;CDKN1A
6381,GO:0018205,0.994079137510265,0.0368485593614975,1,342,peptidyl-lysine modification,BP,LIF
17776,GO:0097159,0.994268306214741,0.00853497969225091,64,5716,organic cyclic compound binding,MF,ADRA2B;ADRA2C;POU3F1;TUBG2;RAB6C;NOTCH1;GLDC;MARK4;RAB27A;RASL11B;GADD45A;ZFPM1;ACVR1;GUCY1B3;ADORA1;RAB40B;RAB40A;PRKACB;FLVCR2;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;WT1;HMGN5;PKN3;RAB20;WNK4;RND3;MSN;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;ZCCHC12;MYH11;LZTS1;VDR;ARAF;RAB38;RAB3D;ACSL4;HEY1;ACTA2;PIM2;PDE4B
5753,GO:0016071,0.99432414708981,0.0199107794422373,3,674,mRNA metabolic process,BP,PRR5L;PKP3;PKP1
472,GO:0001228,0.994774403342013,0.0331926407339374,1,352,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,WT1
7126,GO:0022804,0.995032515604884,0.0318153379328858,1,350,active transmembrane transporter activity,MF,SLC45A4
9530,GO:0034641,0.995091488824521,0.00732301614874991,67,6132,cellular nitrogen compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;ITGB8;GADD45A;CRB2;WNT6;WNT7A;ZFPM1;SLC52A3;ACVR1;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
5951,GO:0016491,0.995312813264617,0.0168196275639498,3,701,oxidoreductase activity,MF,GLDC;SESN2;BMP2
18783,GO:1901363,0.996290064967503,0.00565031039612541,62,5633,heterocyclic compound binding,MF,POU3F1;TUBG2;RAB6C;NOTCH1;GLDC;MARK4;RAB27A;RASL11B;GADD45A;ZFPM1;ACVR1;GUCY1B3;ADORA1;RAB40B;RAB40A;PRKACB;FLVCR2;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;WT1;HMGN5;PKN3;RAB20;WNK4;RND3;MSN;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;ZCCHC12;MYH11;LZTS1;VDR;ARAF;RAB38;RAB3D;ACSL4;HEY1;ACTA2;PIM2;PDE4B
3458,GO:0006807,0.996407055164567,0.00539240509293247,72,6563,nitrogen compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;GLDC;PNMT;ITGB8;GADD45A;CRB2;WNT6;WNT7A;ZFPM1;SLC52A3;ACVR1;GUCY1B3;DKK3;EDN1;MBOAT2;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
6180,GO:0016887,0.998155115047599,0.0137043627430138,1,406,ATPase activity,MF,MYO7A
8211,GO:0031974,0.998533217627418,0.0024234877384057,46,4694,membrane-enclosed lumen,CC,WNT3;WNT4;POU3F1;ACTN2;NOTCH1;GLDC;RAB27A;TF;GADD45A;CRISPLD2;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;CASQ2;EDN1;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;FSTL3;PDGFB;FOXO4;WNT5B;WNT5A;MAGEC2;PFKFB3;PSRC1;SDC4;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;PTGES;TLE1;GAS6;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
11280,GO:0043233,0.998533217627418,0.0024234877384057,46,4694,organelle lumen,CC,WNT3;WNT4;POU3F1;ACTN2;NOTCH1;GLDC;RAB27A;TF;GADD45A;CRISPLD2;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;CASQ2;EDN1;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;FSTL3;PDGFB;FOXO4;WNT5B;WNT5A;MAGEC2;PFKFB3;PSRC1;SDC4;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;PTGES;TLE1;GAS6;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
15688,GO:0070013,0.998533217627418,0.0024234877384057,46,4694,intracellular organelle lumen,CC,WNT3;WNT4;POU3F1;ACTN2;NOTCH1;GLDC;RAB27A;TF;GADD45A;CRISPLD2;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;CASQ2;EDN1;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;FSTL3;PDGFB;FOXO4;WNT5B;WNT5A;MAGEC2;PFKFB3;PSRC1;SDC4;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;PTGES;TLE1;GAS6;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
11819,GO:0044454,0.998534183102577,0.0112288706549471,1,476,nuclear chromosome part,CC,SIN3B
1620,GO:0003690,0.998702836607455,0.00535276855091726,3,723,double-stranded DNA binding,MF,ZFPM1;WT1;HEY1
9544,GO:0034660,0.99897606684518,0.00822174374651305,1,529,ncRNA metabolic process,BP,HRAS
113,GO:0000228,0.999113332892757,0.0072543709253705,1,508,nuclear chromosome,CC,SIN3B
20893,GO:1990837,0.999434635458289,0.00316938775921033,2,653,sequence-specific double-stranded DNA binding,MF,ZFPM1;HEY1
7480,GO:0030529,0.999435027119153,0.00316480692349397,2,756,intracellular ribonucleoprotein complex,CC,PKP3;PKP1
20910,GO:1990904,0.999443869452768,0.00312029791329527,2,757,ribonucleoprotein complex,CC,PKP3;PKP1
3155,GO:0006396,0.999450390765685,0.00246101460226618,3,872,RNA processing,BP,PIK3R1;BMP4;WT1
13987,GO:0051276,0.999557827432325,0.0015614028045731,5,1106,chromosome organization,BP,LIF;ZFPM1;PSRC1;HMGN5;SIN3B
362,GO:0000977,0.99969721974675,0.0028167059082262,1,542,RNA polymerase II regulatory region sequence-specific DNA binding,MF,ZFPM1
388,GO:0001012,0.999702407641396,0.00277380938147717,1,543,RNA polymerase II regulatory region DNA binding,MF,ZFPM1
11797,GO:0044427,0.999808158000576,0.0011933319185466,2,793,chromosomal part,CC,HMGN5;SIN3B
361,GO:0000976,0.999912036836861,0.00093197868382944,1,618,transcription regulatory region sequence-specific DNA binding,MF,ZFPM1
2711,GO:0005654,0.999936798127206,0.000137755309211001,24,3159,nucleoplasm,CC,POU3F1;NOTCH1;GADD45A;ZFPM1;PRKACB;SPTBN4;MAPK12;FSTL3;FOXO4;PFKFB3;PSRC1;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;TLE1;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
2742,GO:0005694,0.999958090194936,0.000297016075434028,2,897,chromosome,CC,HMGN5;SIN3B
11278,GO:0043231,0.999964582612584,6.06358847606936e-05,109,9934,intracellular membrane-bounded organelle,CC,ITGA5;BEX4;WNT3;WNT4;POU3F1;RAB6C;NOTCH1;GLDC;RAB27A;ITGB4;PMAIP1;GADD45A;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;NMT2;ADORA1;CASQ2;EDN1;RAB40B;PHLDA1;MRO;PRKACB;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;LIMS2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;FOXO4;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;RHOB;NUAK2;PFKFB3;PSRC1;SDC4;SPTB;BMP2;B3GNT2;WT1;CDKN1A;HMGN5;PKN3;RAB20;SLC2A14;VAMP1;SFXN1;RND3;CHGA;MSN;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;WNT2B;CYTIP;PTGES;NAB2;CDH1;EPN1;MYO7A;RAB44;TLE1;PIK3CG;RAB11FIP1;GAS6;SIN3B;ZCCHC12;PM20D2;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;RAB38;RAB3D;ACSL4;FAM110B;FZD8;DUSP5;HEY1;RNF144A
11798,GO:0044428,0.999992806792818,1.58264453189239e-05,31,4050,nuclear part,CC,POU3F1;NOTCH1;GADD45A;ZFPM1;RAB40B;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;TYRO3;FSTL3;FOXO4;MAGEC2;PFKFB3;PSRC1;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;PTGES;TLE1;SIN3B;ZCCHC12;PM20D2;VDR;AMOT;DUSP5;HEY1
8213,GO:0031981,0.999993960716283,1.39046537660663e-05,27,3713,nuclear lumen,CC,POU3F1;NOTCH1;GADD45A;ZFPM1;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;FSTL3;FOXO4;MAGEC2;PFKFB3;PSRC1;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;TLE1;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
1613,GO:0003677,0.999999739394633,9.47739850508092e-07,11,2382,DNA binding,MF,POU3F1;NOTCH1;GADD45A;ZFPM1;FOXO4;WNT5A;WT1;HMGN5;LZTS1;VDR;HEY1
1634,GO:0003723,0.999999932884743,5.4677436079164e-07,3,1541,RNA binding,MF,WT1;HMGN5;MSN
2701,GO:0005634,0.999999987662858,2.82463114915659e-08,54,6684,nucleus,CC,BEX4;POU3F1;RAB6C;NOTCH1;GLDC;ITGB4;PMAIP1;GADD45A;ZFPM1;RAB40B;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;TYRO3;LIMS2;FSTL3;FGF10;PIK3R2;PIK3R1;FOXO4;TJP3;HRAS;MAGEC2;SESN2;AXIN1;RHOB;NUAK2;PFKFB3;PSRC1;WT1;CDKN1A;HMGN5;PKN3;SLC2A14;MSN;AKT1;PKP3;PKP1;CYTIP;PTGES;NAB2;EPN1;TLE1;SIN3B;ZCCHC12;PM20D2;VDR;AMOT;LAMA5;SH3BP4;DUSP5;HEY1
11272,GO:0043225,0.999999999999962,0.805128327156172,0,13,ATPase-coupled anion transmembrane transporter activity,MF,
18310,GO:0099133,0.999999999999962,0.805128327156172,0,13,ATP hydrolysis coupled anion transmembrane transport,BP,
3601,GO:0007028,0.999999999999996,0.853056702585674,0,10,cytoplasm organization,BP,
3,GO:0000009,1,0.985269857777638,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.972211127061147,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000012,1,0.892753174765684,0,8,single strand break repair,BP,
6,GO:0000014,1,0.894801093148262,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
7,GO:0000015,1,0.947627833320792,0,4,phosphopyruvate hydratase complex,CC,
8,GO:0000016,1,0.983426667501085,0,1,lactase activity,MF,
10,GO:0000019,1,0.924175601145431,0,5,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.862373722777515,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.951123166016917,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.95335717907292,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.790197158840421,0,22,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.894765438407046,0,15,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.742050726736341,0,23,mannosyltransferase activity,MF,
17,GO:0000032,1,0.987762819794679,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.961705210542351,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.97876088619549,0,2,acyl binding,MF,
20,GO:0000036,1,0.994857040334026,0,1,ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process,MF,
21,GO:0000038,1,0.685821552327923,0,26,very long-chain fatty acid metabolic process,BP,
23,GO:0000042,1,0.728431829618373,0,19,protein targeting to Golgi,BP,
25,GO:0000049,1,0.486139076554303,0,49,tRNA binding,MF,
26,GO:0000050,1,0.865633604711293,0,11,urea cycle,BP,
27,GO:0000052,1,0.889100422944711,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.987502426474146,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.863580670974165,0,12,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.91513127726729,0,7,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.929898244715237,0,6,ribosomal small subunit export from nucleus,BP,
33,GO:0000062,1,0.805894598658054,0,16,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.957233022012173,0,3,L-ornithine transmembrane transporter activity,MF,
35,GO:0000066,1,0.97336674282035,0,2,mitochondrial ornithine transport,BP,
38,GO:0000076,1,0.793014218873795,0,17,DNA replication checkpoint,BP,
42,GO:0000083,1,0.69046674928686,0,25,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
44,GO:0000095,1,0.985781226225567,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
45,GO:0000096,1,0.574689020484011,0,38,sulfur amino acid metabolic process,BP,
46,GO:0000097,1,0.794907217375229,0,16,sulfur amino acid biosynthetic process,BP,
47,GO:0000098,1,0.862868734635982,0,10,sulfur amino acid catabolic process,BP,
48,GO:0000099,1,0.896242699681625,0,7,sulfur amino acid transmembrane transporter activity,MF,
49,GO:0000101,1,0.911352608682775,0,6,sulfur amino acid transport,BP,
50,GO:0000103,1,0.95965331272301,0,3,sulfate assimilation,BP,
51,GO:0000104,1,0.951946374400048,0,4,succinate dehydrogenase activity,MF,
52,GO:0000105,1,0.969055343795179,0,2,histidine biosynthetic process,BP,
53,GO:0000109,1,0.811044895263765,0,15,nucleotide-excision repair complex,CC,
54,GO:0000110,1,0.956400272224486,0,3,nucleotide-excision repair factor 1 complex,CC,
55,GO:0000111,1,0.983451945808524,0,1,nucleotide-excision repair factor 2 complex,CC,
56,GO:0000117,1,0.983426667501871,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
58,GO:0000120,1,0.932668580693824,0,5,RNA polymerase I transcription factor complex,CC,
59,GO:0000121,1,0.983714147414541,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000123,1,0.318916462503684,0,78,histone acetyltransferase complex,CC,
62,GO:0000124,1,0.862893071206322,0,11,SAGA complex,CC,
63,GO:0000125,1,0.941887401574231,0,5,PCAF complex,CC,
64,GO:0000126,1,0.967150340603835,0,2,transcription factor TFIIIB complex,CC,
65,GO:0000127,1,0.91522085512092,0,6,transcription factor TFIIIC complex,CC,
67,GO:0000137,1,0.9129715655902,0,6,Golgi cis cisterna,CC,
68,GO:0000138,1,0.929090434159735,0,5,Golgi trans cisterna,CC,
73,GO:0000150,1,0.892755265894062,0,8,recombinase activity,MF,
75,GO:0000152,1,0.585199686092733,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.848995967348876,0,12,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.713215830851448,0,27,rRNA modification,BP,
79,GO:0000159,1,0.734821416062607,0,20,protein phosphatase type 2A complex,CC,
81,GO:0000164,1,0.860336823112067,0,10,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.989825625357721,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.968616178360468,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.968616178360468,0,2,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.988406936607954,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.669835197836348,0,28,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.887788723137677,0,11,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.877734937575929,0,10,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.751857246029971,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.948721281633788,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.854949758736267,0,10,rDNA binding,MF,
94,GO:0000183,1,0.76373459728125,0,39,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.3273707606353,0,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
100,GO:0000189,1,0.954805558115746,0,3,MAPK import into nucleus,BP,
102,GO:0000210,1,0.983486425653298,0,1,NAD+ diphosphatase activity,MF,
103,GO:0000212,1,0.852968317413685,0,11,meiotic spindle organization,BP,
104,GO:0000213,1,0.946717929963379,0,4,tRNA-intron endonuclease activity,MF,
105,GO:0000214,1,0.947677989025794,0,4,tRNA-intron endonuclease complex,CC,
106,GO:0000215,1,0.992401501838757,0,1,tRNA 2'-phosphotransferase activity,MF,
107,GO:0000217,1,0.704350219450987,0,23,DNA secondary structure binding,MF,
108,GO:0000220,1,0.922144857245519,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
109,GO:0000221,1,0.954073649775603,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
110,GO:0000224,1,0.984788016681898,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
111,GO:0000225,1,0.991411378127125,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
114,GO:0000229,1,0.980548132905404,0,2,cytoplasmic chromosome,CC,
115,GO:0000235,1,0.921988190124518,0,5,astral microtubule,CC,
117,GO:0000243,1,0.905380129234618,0,8,commitment complex,CC,
118,GO:0000244,1,0.826831331735397,0,12,spliceosomal tri-snRNP complex assembly,BP,
119,GO:0000245,1,0.460798926686247,0,55,spliceosomal complex assembly,BP,
120,GO:0000246,1,0.983426667503251,0,1,delta24(24-1) sterol reductase activity,MF,
121,GO:0000247,1,0.991398151683651,0,1,C-8 sterol isomerase activity,MF,
122,GO:0000248,1,0.983426667503154,0,1,C-5 sterol desaturase activity,MF,
123,GO:0000250,1,0.983426667503251,0,1,lanosterol synthase activity,MF,
124,GO:0000252,1,0.98868294898152,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
125,GO:0000253,1,0.971697314836579,0,3,3-keto sterol reductase activity,MF,
126,GO:0000254,1,0.984728932554734,0,1,C-4 methylsterol oxidase activity,MF,
127,GO:0000255,1,0.941154974288303,0,4,allantoin metabolic process,BP,
128,GO:0000256,1,0.989549801672682,0,1,allantoin catabolic process,BP,
129,GO:0000257,1,0.99006355571529,0,1,nitrilase activity,MF,
130,GO:0000262,1,0.988710667160623,0,1,mitochondrial chromosome,CC,
131,GO:0000266,1,0.600352785778555,0,33,mitochondrial fission,BP,
132,GO:0000268,1,0.929302705826543,0,5,peroxisome targeting sequence binding,MF,
133,GO:0000270,1,0.939941596671859,0,7,peptidoglycan metabolic process,BP,
135,GO:0000272,1,0.648553585111562,0,29,polysaccharide catabolic process,BP,
136,GO:0000274,1,0.995434821968634,0,1,mitochondrial proton-transporting ATP synthase, stator stalk,CC,
137,GO:0000275,1,0.969521136138059,0,4,mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),CC,
138,GO:0000276,1,0.925563244738284,0,10,mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),CC,
142,GO:0000285,1,0.942534801684234,0,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
144,GO:0000288,1,0.371285685491053,0,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
145,GO:0000289,1,0.594238203968194,0,34,nuclear-transcribed mRNA poly(A) tail shortening,BP,
146,GO:0000290,1,0.881495519776194,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
147,GO:0000291,1,0.653016780018332,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
148,GO:0000293,1,0.952491015264694,0,3,ferric-chelate reductase activity,MF,
149,GO:0000294,1,0.968041085566565,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
150,GO:0000295,1,0.855231101091978,0,11,adenine nucleotide transmembrane transporter activity,MF,
151,GO:0000296,1,0.985558803838324,0,1,spermine transport,BP,
152,GO:0000298,1,0.946650719048175,0,4,endopolyphosphatase activity,MF,
153,GO:0000301,1,0.67421047294927,0,24,retrograde transport, vesicle recycling within Golgi,BP,
157,GO:0000306,1,0.953355870751752,0,3,extrinsic component of vacuolar membrane,CC,
159,GO:0000308,1,0.96712697239887,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
160,GO:0000309,1,0.954909888168039,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
161,GO:0000313,1,0.494138521727322,0,78,organellar ribosome,CC,
162,GO:0000314,1,0.786920668260106,0,26,organellar small ribosomal subunit,CC,
163,GO:0000315,1,0.637327464936695,0,49,organellar large ribosomal subunit,CC,
164,GO:0000320,1,0.951096177116515,0,3,re-entry into mitotic cell cycle,BP,
165,GO:0000322,1,0.959868893555437,0,3,storage vacuole,CC,
167,GO:0000333,1,0.967126892153617,0,2,telomerase catalytic core complex,CC,
168,GO:0000334,1,0.990537578449754,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
169,GO:0000338,1,0.877982330340032,0,10,protein deneddylation,BP,
170,GO:0000339,1,0.81108691717506,0,15,RNA cap binding,MF,
171,GO:0000340,1,0.898781394267742,0,7,RNA 7-methylguanosine cap binding,MF,
172,GO:0000346,1,0.834446288971682,0,13,transcription export complex,CC,
173,GO:0000347,1,0.926556281059271,0,6,THO complex,CC,
174,GO:0000349,1,0.985354804230221,0,1,generation of catalytic spliceosome for first transesterification step,BP,
175,GO:0000350,1,0.962533211753404,0,3,generation of catalytic spliceosome for second transesterification step,BP,
176,GO:0000354,1,0.967290884114936,0,2,cis assembly of pre-catalytic spliceosome,BP,
177,GO:0000375,1,0.0129098267150219,0,309,RNA splicing, via transesterification reactions,BP,
178,GO:0000377,1,0.0134288191781311,0,306,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
179,GO:0000379,1,0.959287488981977,0,3,tRNA-type intron splice site recognition and cleavage,BP,
180,GO:0000380,1,0.486542696026231,0,48,alternative mRNA splicing, via spliceosome,BP,
181,GO:0000381,1,0.573744238372862,0,37,regulation of alternative mRNA splicing, via spliceosome,BP,
182,GO:0000384,1,0.977034465171795,0,2,first spliceosomal transesterification activity,MF,
183,GO:0000386,1,0.971754903637761,0,2,second spliceosomal transesterification activity,MF,
184,GO:0000387,1,0.607941605450553,0,38,spliceosomal snRNP assembly,BP,
185,GO:0000389,1,0.914290931358736,0,6,mRNA 3'-splice site recognition,BP,
186,GO:0000390,1,0.975265124031394,0,2,spliceosomal complex disassembly,BP,
187,GO:0000393,1,0.948434506789227,0,4,spliceosomal conformational changes to generate catalytic conformation,BP,
188,GO:0000394,1,0.80971751381952,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
189,GO:0000395,1,0.915974466529592,0,6,mRNA 5'-splice site recognition,BP,
190,GO:0000398,1,0.0134288191781311,0,306,mRNA splicing, via spliceosome,BP,
191,GO:0000400,1,0.786155019425842,0,16,four-way junction DNA binding,MF,
192,GO:0000403,1,0.936100483053025,0,4,Y-form DNA binding,MF,
193,GO:0000404,1,0.983451945808524,0,1,heteroduplex DNA loop binding,MF,
194,GO:0000405,1,0.891257561069265,0,7,bubble DNA binding,MF,
195,GO:0000407,1,0.650483468401954,0,27,pre-autophagosomal structure,CC,
196,GO:0000408,1,0.958522696216091,0,3,EKC/KEOPS complex,CC,
197,GO:0000409,1,0.983426667500347,0,1,regulation of transcription by galactose,BP,
198,GO:0000411,1,0.983426667500347,0,1,positive regulation of transcription by galactose,BP,
199,GO:0000413,1,0.650787769609669,0,38,protein peptidyl-prolyl isomerization,BP,
200,GO:0000414,1,0.93574635941743,0,4,regulation of histone H3-K36 methylation,BP,
201,GO:0000415,1,0.983426667500985,0,1,negative regulation of histone H3-K36 methylation,BP,
202,GO:0000416,1,0.98343607742502,0,1,positive regulation of histone H3-K36 methylation,BP,
203,GO:0000421,1,0.676028166829024,0,28,autophagosome membrane,CC,
204,GO:0000422,1,0.330441553740286,0,77,mitophagy,BP,
205,GO:0000423,1,0.771651215343324,0,17,macromitophagy,BP,
206,GO:0000428,1,0.174820773352291,0,125,DNA-directed RNA polymerase complex,CC,
207,GO:0000429,1,0.946006327025263,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
208,GO:0000430,1,0.96195161408455,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
209,GO:0000431,1,0.983426667500347,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
210,GO:0000432,1,0.96195161408455,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
211,GO:0000433,1,0.985152587803752,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
212,GO:0000435,1,0.983426667500347,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
213,GO:0000436,1,0.946006327025263,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
214,GO:0000437,1,0.985152587803752,0,1,carbon catabolite repression of transcription from RNA polymerase II promoter,BP,
215,GO:0000438,1,0.964495583333361,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
216,GO:0000439,1,0.892867005116442,0,8,core TFIIH complex,CC,
217,GO:0000444,1,0.946977492835453,0,4,MIS12/MIND type complex,CC,
218,GO:0000445,1,0.926556281059271,0,6,THO complex part of transcription export complex,CC,
219,GO:0000447,1,0.890387488711475,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
220,GO:0000448,1,0.968914365908221,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
221,GO:0000451,1,0.971109003510465,0,2,rRNA 2'-O-methylation,BP,
222,GO:0000453,1,0.971109003510465,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
223,GO:0000454,1,0.975320721245498,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
224,GO:0000459,1,0.935320043639537,0,5,exonucleolytic trimming involved in rRNA processing,BP,
225,GO:0000460,1,0.683622622753408,0,29,maturation of 5.8S rRNA,BP,
226,GO:0000461,1,0.988537720092998,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000462,1,0.638255796141403,0,36,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000463,1,0.902452270146471,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000466,1,0.783760193687608,0,18,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
230,GO:0000467,1,0.935320043639537,0,5,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000469,1,0.734641780144121,0,23,cleavage involved in rRNA processing,BP,
232,GO:0000470,1,0.783800067877818,0,21,maturation of LSU-rRNA,BP,
233,GO:0000472,1,0.953816323749976,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000478,1,0.820493509601135,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
235,GO:0000479,1,0.820493509601135,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
236,GO:0000480,1,0.911155965977046,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
237,GO:0000481,1,0.983452536100796,0,1,maturation of 5S rRNA,BP,
238,GO:0000491,1,0.923182023214195,0,6,small nucleolar ribonucleoprotein complex assembly,BP,
239,GO:0000492,1,0.949725596897317,0,4,box C/D snoRNP assembly,BP,
240,GO:0000493,1,0.972057222203387,0,2,box H/ACA snoRNP assembly,BP,
241,GO:0000494,1,0.991312379435752,0,1,box C/D snoRNA 3'-end processing,BP,
242,GO:0000495,1,0.984680431882196,0,1,box H/ACA snoRNA 3'-end processing,BP,
243,GO:0000502,1,0.473770001548282,0,65,proteasome complex,CC,
244,GO:0000506,1,0.907443257045916,0,8,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
246,GO:0000700,1,0.947291269448029,0,4,mismatch base pair DNA N-glycosylase activity,MF,
247,GO:0000701,1,0.977769580937468,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
248,GO:0000702,1,0.968255214257764,0,3,oxidized base lesion DNA N-glycosylase activity,MF,
249,GO:0000703,1,0.980925778427361,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
250,GO:0000706,1,0.941506419680079,0,4,meiotic DNA double-strand break processing,BP,
251,GO:0000707,1,0.918358065979191,0,6,meiotic DNA recombinase assembly,BP,
252,GO:0000710,1,0.967267749260206,0,2,meiotic mismatch repair,BP,
253,GO:0000711,1,0.973378909979523,0,2,meiotic DNA repair synthesis,BP,
254,GO:0000712,1,0.830769979968685,0,12,resolution of meiotic recombination intermediates,BP,
255,GO:0000715,1,0.742945588148457,0,23,nucleotide-excision repair, DNA damage recognition,BP,
256,GO:0000717,1,0.743348411711981,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
257,GO:0000718,1,0.98800274491119,0,1,nucleotide-excision repair, DNA damage removal,BP,
258,GO:0000720,1,0.958048438768064,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
259,GO:0000722,1,0.607388265876417,0,36,telomere maintenance via recombination,BP,
260,GO:0000723,1,0.137615815725958,0,147,telomere maintenance,BP,
261,GO:0000724,1,0.230629643964196,0,97,double-strand break repair via homologous recombination,BP,
262,GO:0000725,1,0.227086373411556,0,98,recombinational repair,BP,
263,GO:0000726,1,0.391136946925203,0,74,non-recombinational repair,BP,
264,GO:0000727,1,0.932388632652932,0,5,double-strand break repair via break-induced replication,BP,
265,GO:0000729,1,0.697857076659538,0,23,DNA double-strand break processing,BP,
266,GO:0000730,1,0.864898322946329,0,10,DNA recombinase assembly,BP,
267,GO:0000731,1,0.370066986338334,0,68,DNA synthesis involved in DNA repair,BP,
268,GO:0000732,1,0.67420428493691,0,25,strand displacement,BP,
269,GO:0000733,1,0.867785587070164,0,9,DNA strand renaturation,BP,
270,GO:0000737,1,0.729868182785612,0,23,DNA catabolic process, endonucleolytic,BP,
271,GO:0000738,1,0.976375024465837,0,2,DNA catabolic process, exonucleolytic,BP,
272,GO:0000741,1,0.987899864828234,0,1,karyogamy,BP,
273,GO:0000768,1,0.51995356130016,0,47,syncytium formation by plasma membrane fusion,BP,
274,GO:0000773,1,0.99249475714563,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
275,GO:0000774,1,0.869222930165244,0,10,adenyl-nucleotide exchange factor activity,MF,
276,GO:0000775,1,0.0732290534692884,0,176,chromosome, centromeric region,CC,
277,GO:0000776,1,0.171578363602094,0,121,kinetochore,CC,
278,GO:0000777,1,0.257500732687093,0,94,condensed chromosome kinetochore,CC,
279,GO:0000778,1,0.890908353561001,0,8,condensed nuclear chromosome kinetochore,CC,
280,GO:0000779,1,0.223682242864041,0,104,condensed chromosome, centromeric region,CC,
281,GO:0000780,1,0.82126704502395,0,14,condensed nuclear chromosome, centromeric region,CC,
282,GO:0000781,1,0.124689353908489,0,161,chromosome, telomeric region,CC,
283,GO:0000782,1,0.845225916683167,0,11,telomere cap complex,CC,
284,GO:0000783,1,0.845225916683167,0,11,nuclear telomere cap complex,CC,
285,GO:0000784,1,0.205626735520051,0,126,nuclear chromosome, telomeric region,CC,
287,GO:0000786,1,0.535933675784634,0,101,nucleosome,CC,
288,GO:0000788,1,0.827249391480163,0,37,nuclear nucleosome,CC,
289,GO:0000789,1,0.991744653621753,0,1,cytoplasmic chromatin,CC,
291,GO:0000791,1,0.644259915648929,0,32,euchromatin,CC,
292,GO:0000792,1,0.347239149676024,0,71,heterochromatin,CC,
293,GO:0000793,1,0.0619435482463284,0,192,condensed chromosome,CC,
294,GO:0000794,1,0.32310422900875,0,78,condensed nuclear chromosome,CC,
295,GO:0000795,1,0.639471729490197,0,32,synaptonemal complex,CC,
296,GO:0000796,1,0.889576587901871,0,7,condensin complex,CC,
297,GO:0000797,1,0.983426667502809,0,1,condensin core heterodimer,CC,
298,GO:0000798,1,0.925677292232378,0,5,nuclear cohesin complex,CC,
299,GO:0000799,1,0.951096177117655,0,3,nuclear condensin complex,CC,
300,GO:0000800,1,0.833834645570289,0,12,lateral element,CC,
301,GO:0000801,1,0.898658601959183,0,8,central element,CC,
302,GO:0000802,1,0.983477861783854,0,1,transverse filament,CC,
306,GO:0000808,1,0.869717619048475,0,9,origin recognition complex,CC,
307,GO:0000811,1,0.958809640320268,0,3,GINS complex,CC,
308,GO:0000812,1,0.882680845827181,0,9,Swr1 complex,CC,
309,GO:0000813,1,0.868954801020037,0,10,ESCRT I complex,CC,
310,GO:0000814,1,0.966553407251366,0,3,ESCRT II complex,CC,
311,GO:0000815,1,0.863634586308272,0,11,ESCRT III complex,CC,
313,GO:0000820,1,0.931785772380806,0,5,regulation of glutamine family amino acid metabolic process,BP,
314,GO:0000821,1,0.969296629384465,0,2,regulation of arginine metabolic process,BP,
315,GO:0000822,1,0.951814658719583,0,3,inositol hexakisphosphate binding,MF,
316,GO:0000823,1,0.987662673417147,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
317,GO:0000824,1,0.987662673417147,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
318,GO:0000825,1,0.987662673417147,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
319,GO:0000827,1,0.926997430574415,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
320,GO:0000828,1,0.926997430574415,0,5,inositol hexakisphosphate kinase activity,MF,
321,GO:0000829,1,0.926997430574415,0,5,inositol heptakisphosphate kinase activity,MF,
322,GO:0000831,1,0.984262387431147,0,1,inositol hexakisphosphate 6-kinase activity,MF,
323,GO:0000832,1,0.926997430574415,0,5,inositol hexakisphosphate 5-kinase activity,MF,
324,GO:0000835,1,0.910475746820477,0,6,ER ubiquitin ligase complex,CC,
325,GO:0000836,1,0.925824603394447,0,5,Hrd1p ubiquitin ligase complex,CC,
326,GO:0000839,1,0.956489623378545,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
327,GO:0000900,1,0.811869161840283,0,13,translation repressor activity, nucleic acid binding,MF,
331,GO:0000912,1,0.951288705940793,0,3,assembly of actomyosin apparatus involved in cytokinesis,BP,
332,GO:0000915,1,0.951288705940793,0,3,actomyosin contractile ring assembly,BP,
333,GO:0000917,1,0.987393297642661,0,1,barrier septum assembly,BP,
334,GO:0000920,1,0.794563103835831,0,17,cell separation after cytokinesis,BP,
335,GO:0000921,1,0.983426667502857,0,1,septin ring assembly,BP,
337,GO:0000923,1,0.906305690961453,0,6,equatorial microtubule organizing center,CC,
339,GO:0000931,1,0.893444395254169,0,7,gamma-tubulin large complex,CC,
340,GO:0000932,1,0.233321354516688,0,101,P-body,CC,
341,GO:0000938,1,0.937033178613916,0,4,GARP complex,CC,
342,GO:0000939,1,0.974804981992181,0,2,condensed chromosome inner kinetochore,CC,
343,GO:0000940,1,0.827463200177558,0,12,condensed chromosome outer kinetochore,CC,
344,GO:0000942,1,0.942978681486695,0,4,condensed nuclear chromosome outer kinetochore,CC,
345,GO:0000956,1,0.10835305246404,0,198,nuclear-transcribed mRNA catabolic process,BP,
346,GO:0000957,1,0.938009973712398,0,4,mitochondrial RNA catabolic process,BP,
347,GO:0000958,1,0.968614756759016,0,2,mitochondrial mRNA catabolic process,BP,
348,GO:0000959,1,0.65756390732204,0,29,mitochondrial RNA metabolic process,BP,
349,GO:0000960,1,0.938009973712398,0,4,regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000961,1,0.968407661015318,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000962,1,0.968614756759016,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000963,1,0.806164493345517,0,15,mitochondrial RNA processing,BP,
353,GO:0000964,1,0.96840766101764,0,2,mitochondrial RNA 5'-end processing,BP,
354,GO:0000965,1,0.95467262248023,0,3,mitochondrial RNA 3'-end processing,BP,
355,GO:0000966,1,0.908365850653287,0,6,RNA 5'-end processing,BP,
356,GO:0000967,1,0.953816323749976,0,3,rRNA 5'-end processing,BP,
357,GO:0000972,1,0.91136423233414,0,6,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
358,GO:0000973,1,0.955859834639615,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000974,1,0.859256246121874,0,11,Prp19 complex,CC,
363,GO:0000978,1,0.00732387442275618,0,330,RNA polymerase II core promoter proximal region sequence-specific DNA binding,MF,
365,GO:0000980,1,0.382754928422842,0,65,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
369,GO:0000987,1,0.00602354629158254,0,342,core promoter proximal region sequence-specific DNA binding,MF,
372,GO:0000990,1,0.88183664813039,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.973119783160626,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.968757731746273,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.718170971810807,0,23,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.987742697245773,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.93584227687543,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0000997,1,0.983429645376708,0,1,mitochondrial RNA polymerase core promoter sequence-specific DNA binding,MF,
379,GO:0000999,1,0.985084878788461,0,1,RNA polymerase III type 1 promoter transcriptional preinitiation complex assembly,BP,
380,GO:0001002,1,0.968757731746273,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
381,GO:0001003,1,0.968757731746273,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
382,GO:0001004,1,0.985084878788461,0,1,transcription factor activity, RNA polymerase III promoter sequence-specific binding, TFIIIB recruiting,MF,
383,GO:0001005,1,0.985084878788461,0,1,transcription factor activity, RNA polymerase III type 1 promoter sequence-specific binding, TFIIIB recruiting,MF,
384,GO:0001007,1,0.924568584783896,0,5,transcription factor activity, RNA polymerase III transcription factor binding,MF,
385,GO:0001009,1,0.985084878788461,0,1,transcription from RNA polymerase III type 2 promoter,BP,
386,GO:0001010,1,0.956099353251437,0,3,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
387,GO:0001011,1,0.983426667498676,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
389,GO:0001013,1,0.887511649462869,0,8,RNA polymerase I regulatory region DNA binding,MF,
390,GO:0001016,1,0.907927085764232,0,7,RNA polymerase III regulatory region DNA binding,MF,
391,GO:0001018,1,0.983429645376708,0,1,mitochondrial RNA polymerase regulatory region DNA binding,MF,
392,GO:0001022,1,0.985084878788461,0,1,transcription initiation from RNA polymerase III type 1 promoter,BP,
393,GO:0001025,1,0.919824307501176,0,5,RNA polymerase III transcription factor binding,MF,
394,GO:0001026,1,0.967150340603835,0,2,TFIIIB-type transcription factor activity,MF,
395,GO:0001030,1,0.925420492530248,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
396,GO:0001031,1,0.925420492530248,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
397,GO:0001032,1,0.942668242308468,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
398,GO:0001034,1,0.97287947603199,0,2,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
399,GO:0001042,1,0.919830667085101,0,5,RNA polymerase I core binding,MF,
400,GO:0001044,1,0.983429645376708,0,1,mitochondrial RNA polymerase regulatory region sequence-specific DNA binding,MF,
403,GO:0001054,1,0.893362448179545,0,9,RNA polymerase I activity,MF,
404,GO:0001055,1,0.885908811838004,0,10,RNA polymerase II activity,MF,
405,GO:0001056,1,0.831982842478375,0,14,RNA polymerase III activity,MF,
407,GO:0001069,1,0.983426667502365,0,1,regulatory region RNA binding,MF,
408,GO:0001070,1,0.984758283648755,0,1,RNA binding transcription factor activity,MF,
410,GO:0001075,1,0.869389214600993,0,9,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
414,GO:0001079,1,0.986081633239475,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
415,GO:0001080,1,0.986081633239475,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
416,GO:0001082,1,0.985499877640152,0,1,transcription factor activity, RNA polymerase I transcription factor binding,MF,
417,GO:0001083,1,0.923738692861821,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
419,GO:0001087,1,0.983426667498676,0,1,transcription factor activity, TFIIB-class binding,MF,
420,GO:0001091,1,0.850329853948578,0,11,RNA polymerase II basal transcription factor binding,MF,
421,GO:0001093,1,0.955143084274017,0,3,TFIIB-class transcription factor binding,MF,
422,GO:0001094,1,0.905279600196561,0,7,TFIID-class transcription factor binding,MF,
423,GO:0001096,1,0.983442228172494,0,1,TFIIF-class transcription factor binding,MF,
424,GO:0001098,1,0.605047185776984,0,35,basal transcription machinery binding,MF,
425,GO:0001099,1,0.605047185776984,0,35,basal RNA polymerase II transcription machinery binding,MF,
426,GO:0001100,1,0.984728932554734,0,1,negative regulation of exit from mitosis,BP,
429,GO:0001103,1,0.661126944913874,0,28,RNA polymerase II repressing transcription factor binding,MF,
433,GO:0001128,1,0.990174602943603,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
434,GO:0001129,1,0.939310196197971,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
435,GO:0001132,1,0.939310196197971,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
436,GO:0001133,1,0.986396783778228,0,1,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
439,GO:0001147,1,0.967196110879348,0,2,transcription termination site sequence-specific DNA binding,MF,
440,GO:0001153,1,0.985084878788461,0,1,transcription factor activity, RNA polymerase III transcription factor recruiting,MF,
441,GO:0001156,1,0.951096177104806,0,3,TFIIIC-class transcription factor binding,MF,
442,GO:0001158,1,0.290711593584228,0,83,enhancer sequence-specific DNA binding,MF,
443,GO:0001159,1,0.00574495024169239,0,345,core promoter proximal region DNA binding,MF,
444,GO:0001160,1,0.967196110879348,0,2,transcription termination site DNA binding,MF,
445,GO:0001161,1,0.855024139234576,0,11,intronic transcription regulatory region sequence-specific DNA binding,MF,
446,GO:0001162,1,0.896904589257885,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
447,GO:0001163,1,0.887511649462869,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
448,GO:0001164,1,0.887511649462869,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
449,GO:0001165,1,0.983426667503005,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
450,GO:0001167,1,0.985499877640152,0,1,RNA polymerase I transcription factor activity, sequence-specific DNA binding,MF,
451,GO:0001169,1,0.985499877640152,0,1,transcription factor activity, RNA polymerase I CORE element sequence-specific binding,MF,
452,GO:0001172,1,0.967126892153087,0,2,transcription, RNA-templated,BP,
453,GO:0001179,1,0.987335703005302,0,1,RNA polymerase I transcription factor binding,MF,
454,GO:0001180,1,0.956897003926964,0,3,transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript,BP,
455,GO:0001181,1,0.983433360113906,0,1,transcription factor activity, core RNA polymerase I binding,MF,
456,GO:0001186,1,0.985499877640152,0,1,transcription factor activity, RNA polymerase I transcription factor recruiting,MF,
457,GO:0001187,1,0.985499877640152,0,1,transcription factor activity, RNA polymerase I CORE element binding transcription factor recruiting,MF,
458,GO:0001188,1,0.973018462733702,0,2,RNA polymerase I transcriptional preinitiation complex assembly,BP,
459,GO:0001189,1,0.973018462733702,0,2,RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript,BP,
462,GO:0001205,1,0.686348510595413,0,26,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
463,GO:0001206,1,0.858974391186402,0,10,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
464,GO:0001207,1,0.98360861865074,0,1,histone displacement,BP,
465,GO:0001221,1,0.595951033573747,0,34,transcription cofactor binding,MF,
466,GO:0001222,1,0.868996844747974,0,10,transcription corepressor binding,MF,
467,GO:0001223,1,0.744502551441223,0,19,transcription coactivator binding,MF,
468,GO:0001224,1,0.951249620635778,0,3,RNA polymerase II transcription cofactor binding,MF,
469,GO:0001225,1,0.967126892149359,0,2,RNA polymerase II transcription coactivator binding,MF,
470,GO:0001226,1,0.983585305180971,0,1,RNA polymerase II transcription corepressor binding,MF,
473,GO:0001300,1,0.967661806612834,0,2,chronological cell aging,BP,
474,GO:0001302,1,0.920274884110599,0,6,replicative cell aging,BP,
475,GO:0001306,1,0.975841922385491,0,2,age-dependent response to oxidative stress,BP,
476,GO:0001315,1,0.992287966875777,0,1,age-dependent response to reactive oxygen species,BP,
477,GO:0001325,1,0.783648462394812,0,15,formation of extrachromosomal circular DNA,BP,
478,GO:0001401,1,0.987808265871384,0,1,mitochondrial sorting and assembly machinery complex,CC,
479,GO:0001405,1,0.957979301254578,0,3,presequence translocase-associated import motor,CC,
485,GO:0001507,1,0.968770222802784,0,2,acetylcholine catabolic process in synaptic cleft,BP,
487,GO:0001510,1,0.482983516001316,0,51,RNA methylation,BP,
488,GO:0001512,1,0.991490907508798,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
489,GO:0001514,1,0.884906826688125,0,9,selenocysteine incorporation,BP,
490,GO:0001515,1,0.954151442951227,0,4,opioid peptide activity,MF,
492,GO:0001517,1,0.895245261776572,0,7,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
493,GO:0001518,1,0.797074302296216,0,14,voltage-gated sodium channel complex,CC,
494,GO:0001519,1,0.97089626042744,0,2,peptide amidation,BP,
495,GO:0001520,1,0.909417824845522,0,8,outer dense fiber,CC,
496,GO:0001522,1,0.80430897600596,0,18,pseudouridine synthesis,BP,
499,GO:0001527,1,0.860567029181411,0,10,microfibril,CC,
500,GO:0001530,1,0.75119617322448,0,21,lipopolysaccharide binding,MF,
501,GO:0001532,1,0.983601081534302,0,1,interleukin-21 receptor activity,MF,
503,GO:0001534,1,0.953146701934828,0,3,radial spoke,CC,
504,GO:0001536,1,0.968413345513214,0,2,radial spoke stalk,CC,
505,GO:0001537,1,0.930795784872682,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
506,GO:0001539,1,0.706779597361015,0,24,cilium or flagellum-dependent cell motility,BP,
507,GO:0001540,1,0.619642611127165,0,33,beta-amyloid binding,MF,
509,GO:0001542,1,0.879218089669959,0,8,ovulation from ovarian follicle,BP,
510,GO:0001543,1,0.98342666749961,0,1,ovarian follicle rupture,BP,
511,GO:0001544,1,0.983426667499854,0,1,initiation of primordial ovarian follicle growth,BP,
512,GO:0001545,1,0.968315867882454,0,2,primary ovarian follicle growth,BP,
513,GO:0001546,1,0.960991730609913,0,3,preantral ovarian follicle growth,BP,
514,GO:0001547,1,0.912405253365927,0,6,antral ovarian follicle growth,BP,
515,GO:0001550,1,0.967126892153958,0,2,ovarian cumulus expansion,BP,
516,GO:0001553,1,0.862449327119316,0,10,luteinization,BP,
517,GO:0001554,1,0.919994197650876,0,5,luteolysis,BP,
518,GO:0001555,1,0.970831228395493,0,2,oocyte growth,BP,
521,GO:0001560,1,0.951096177114323,0,3,regulation of cell growth by extracellular stimulus,BP,
522,GO:0001561,1,0.90482724692091,0,7,fatty acid alpha-oxidation,BP,
524,GO:0001567,1,0.977461902158392,0,2,cholesterol 25-hydroxylase activity,MF,
529,GO:0001574,1,0.899258384335788,0,7,ganglioside biosynthetic process,BP,
530,GO:0001575,1,0.973628206018255,0,2,globoside metabolic process,BP,
531,GO:0001576,1,0.986322428969776,0,1,globoside biosynthetic process,BP,
533,GO:0001579,1,0.967659475789484,0,2,medium-chain fatty acid transport,BP,
534,GO:0001580,1,0.749054669392902,0,33,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
535,GO:0001581,1,0.9674843492633,0,2,detection of chemical stimulus involved in sensory perception of sour taste,BP,
536,GO:0001582,1,0.969794177778552,0,2,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
537,GO:0001587,1,0.983426667502908,0,1,Gq/11-coupled serotonin receptor activity,MF,
538,GO:0001588,1,0.951288261061897,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
539,GO:0001591,1,0.927733569683022,0,8,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
540,GO:0001594,1,0.943274694497318,0,7,trace-amine receptor activity,MF,
541,GO:0001595,1,0.953074549697369,0,4,angiotensin receptor activity,MF,
542,GO:0001596,1,0.985435071969403,0,1,angiotensin type I receptor activity,MF,
543,GO:0001601,1,0.95581650475226,0,3,peptide YY receptor activity,MF,
544,GO:0001602,1,0.955137199085542,0,4,pancreatic polypeptide receptor activity,MF,
545,GO:0001604,1,0.991332142217516,0,1,urotensin II receptor activity,MF,
546,GO:0001605,1,0.983426667502615,0,1,adrenomedullin receptor activity,MF,
547,GO:0001607,1,0.970250069318637,0,2,neuromedin U receptor activity,MF,
548,GO:0001608,1,0.824908381453882,0,14,G-protein coupled nucleotide receptor activity,MF,
550,GO:0001614,1,0.748185709731323,0,21,purinergic nucleotide receptor activity,MF,
551,GO:0001616,1,0.992574451227034,0,1,growth hormone secretagogue receptor activity,MF,
553,GO:0001621,1,0.989334749678119,0,1,ADP receptor activity,MF,
554,GO:0001626,1,0.98359341188355,0,1,nociceptin receptor activity,MF,
555,GO:0001631,1,0.984771751341943,0,1,cysteinyl leukotriene receptor activity,MF,
556,GO:0001632,1,0.972902139991077,0,2,leukotriene B4 receptor activity,MF,
557,GO:0001635,1,0.96807326417748,0,2,calcitonin gene-related peptide receptor activity,MF,
558,GO:0001637,1,0.727207559574566,0,23,G-protein coupled chemoattractant receptor activity,MF,
559,GO:0001640,1,0.920851519121961,0,5,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
560,GO:0001641,1,0.968206705782462,0,2,group II metabotropic glutamate receptor activity,MF,
561,GO:0001642,1,0.983426667503302,0,1,group III metabotropic glutamate receptor activity,MF,
563,GO:0001650,1,0.16996256045376,0,121,fibrillar center,CC,
564,GO:0001651,1,0.991312379435752,0,1,dense fibrillar component,CC,
565,GO:0001652,1,0.956279354408151,0,4,granular component,CC,
573,GO:0001660,1,0.860782879401071,0,10,fever generation,BP,
574,GO:0001661,1,0.907317955098563,0,6,conditioned taste aversion,BP,
575,GO:0001662,1,0.649362456111393,0,30,behavioral fear response,BP,
577,GO:0001665,1,0.919876047139017,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
581,GO:0001671,1,0.722104187255574,0,23,ATPase activator activity,MF,
582,GO:0001672,1,0.864927482757435,0,9,regulation of chromatin assembly or disassembly,BP,
583,GO:0001673,1,0.837218366828631,0,14,male germ cell nucleus,CC,
584,GO:0001674,1,0.955132281973611,0,3,female germ cell nucleus,CC,
585,GO:0001675,1,0.854233089227341,0,12,acrosome assembly,BP,
588,GO:0001680,1,0.985607998290606,0,1,tRNA 3'-terminal CCA addition,BP,
589,GO:0001681,1,0.984106248625974,0,1,sialate O-acetylesterase activity,MF,
590,GO:0001682,1,0.882226426504541,0,11,tRNA 5'-leader removal,BP,
591,GO:0001692,1,0.958937425337947,0,4,histamine metabolic process,BP,
592,GO:0001694,1,0.978622739432191,0,2,histamine biosynthetic process,BP,
593,GO:0001695,1,0.993117423875273,0,1,histamine catabolic process,BP,
594,GO:0001696,1,0.805648982782054,0,17,gastric acid secretion,BP,
595,GO:0001697,1,0.984146459763919,0,1,histamine-induced gastric acid secretion,BP,
596,GO:0001698,1,0.980198568737719,0,2,gastrin-induced gastric acid secretion,BP,
606,GO:0001711,1,0.791488524795923,0,16,endodermal cell fate commitment,BP,
608,GO:0001714,1,0.884847351578557,0,9,endodermal cell fate specification,BP,
610,GO:0001716,1,0.986461591601428,0,1,L-amino-acid oxidase activity,MF,
611,GO:0001725,1,0.474429958859916,0,49,stress fiber,CC,
613,GO:0001727,1,0.924420115272003,0,5,lipid kinase activity,MF,
614,GO:0001729,1,0.967647404161056,0,2,ceramide kinase activity,MF,
615,GO:0001730,1,0.956410922336943,0,3,2'-5'-oligoadenylate synthetase activity,MF,
616,GO:0001731,1,0.886027055055334,0,8,formation of translation preinitiation complex,BP,
617,GO:0001732,1,0.970528857195746,0,2,formation of cytoplasmic translation initiation complex,BP,
618,GO:0001733,1,0.946679172696543,0,4,galactosylceramide sulfotransferase activity,MF,
619,GO:0001735,1,0.968428617639534,0,2,prenylcysteine oxidase activity,MF,
622,GO:0001739,1,0.915473153971547,0,6,sex chromatin,CC,
623,GO:0001740,1,0.934684081710735,0,5,Barr body,CC,
631,GO:0001758,1,0.912516834953529,0,7,retinal dehydrogenase activity,MF,
633,GO:0001760,1,0.990760322235858,0,1,aminocarboxymuconate-semialdehyde decarboxylase activity,MF,
636,GO:0001765,1,0.87213888005761,0,10,membrane raft assembly,BP,
637,GO:0001766,1,0.888008131395967,0,9,membrane raft polarization,BP,
638,GO:0001767,1,0.883068640938078,0,9,establishment of lymphocyte polarity,BP,
639,GO:0001768,1,0.897957372990888,0,8,establishment of T cell polarity,BP,
640,GO:0001770,1,0.98342666750015,0,1,establishment of natural killer cell polarity,BP,
642,GO:0001772,1,0.625431972771751,0,33,immunological synapse,CC,
643,GO:0001773,1,0.695625661923367,0,29,myeloid dendritic cell activation,BP,
644,GO:0001774,1,0.782615259308755,0,18,microglial cell activation,BP,
647,GO:0001777,1,0.962473435979577,0,4,T cell homeostatic proliferation,BP,
648,GO:0001778,1,0.883064153495462,0,8,plasma membrane repair,BP,
651,GO:0001781,1,0.910829639248753,0,7,neutrophil apoptotic process,BP,
652,GO:0001782,1,0.673684178373299,0,28,B cell homeostasis,BP,
653,GO:0001783,1,0.728236953108678,0,23,B cell apoptotic process,BP,
655,GO:0001785,1,0.968925942677442,0,2,prostaglandin J receptor activity,MF,
657,GO:0001787,1,0.843670774787213,0,12,natural killer cell proliferation,BP,
658,GO:0001791,1,0.99015913373109,0,1,IgM binding,MF,
659,GO:0001792,1,0.983426667503251,0,1,polymeric immunoglobulin receptor activity,MF,
660,GO:0001794,1,0.978903658495075,0,2,type IIa hypersensitivity,BP,
661,GO:0001796,1,0.978903658495075,0,2,regulation of type IIa hypersensitivity,BP,
662,GO:0001798,1,0.978903658495075,0,2,positive regulation of type IIa hypersensitivity,BP,
663,GO:0001802,1,0.980035099233108,0,2,type III hypersensitivity,BP,
664,GO:0001803,1,0.980035099233108,0,2,regulation of type III hypersensitivity,BP,
665,GO:0001805,1,0.980035099233108,0,2,positive regulation of type III hypersensitivity,BP,
666,GO:0001806,1,0.94479030238093,0,4,type IV hypersensitivity,BP,
667,GO:0001807,1,0.960366376072986,0,3,regulation of type IV hypersensitivity,BP,
668,GO:0001808,1,0.970167810938268,0,2,negative regulation of type IV hypersensitivity,BP,
669,GO:0001809,1,0.989898441190231,0,1,positive regulation of type IV hypersensitivity,BP,
670,GO:0001810,1,0.971539581992344,0,3,regulation of type I hypersensitivity,BP,
671,GO:0001812,1,0.971539581992344,0,3,positive regulation of type I hypersensitivity,BP,
676,GO:0001820,1,0.871446131105795,0,11,serotonin secretion,BP,
680,GO:0001824,1,0.438271022706987,0,58,blastocyst development,BP,
681,GO:0001825,1,0.66845658833623,0,28,blastocyst formation,BP,
682,GO:0001826,1,0.880362553148981,0,8,inner cell mass cell differentiation,BP,
683,GO:0001827,1,0.953445468164215,0,3,inner cell mass cell fate commitment,BP,
684,GO:0001828,1,0.952974002928215,0,3,inner cell mass cellular morphogenesis,BP,
685,GO:0001829,1,0.816968716183655,0,14,trophectodermal cell differentiation,BP,
686,GO:0001831,1,0.969995071161119,0,2,trophectodermal cellular morphogenesis,BP,
687,GO:0001832,1,0.782538658471075,0,16,blastocyst growth,BP,
688,GO:0001833,1,0.853982866301806,0,10,inner cell mass cell proliferation,BP,
689,GO:0001834,1,0.983426667499956,0,1,trophectodermal cell proliferation,BP,
690,GO:0001835,1,0.983612651923942,0,1,blastocyst hatching,BP,
701,GO:0001846,1,0.849766093220519,0,12,opsonin binding,MF,
702,GO:0001847,1,0.943518695107657,0,4,opsonin receptor activity,MF,
703,GO:0001848,1,0.767385376530942,0,19,complement binding,MF,
704,GO:0001849,1,0.899909198440688,0,8,complement component C1q binding,MF,
705,GO:0001850,1,0.987495105056426,0,1,complement component C3a binding,MF,
706,GO:0001851,1,0.971128173326993,0,2,complement component C3b binding,MF,
707,GO:0001855,1,0.972381140267681,0,2,complement component C4b binding,MF,
708,GO:0001856,1,0.985394715715374,0,1,complement component C5a binding,MF,
709,GO:0001861,1,0.983426667497591,0,1,complement component C4b receptor activity,MF,
710,GO:0001865,1,0.882196353649704,0,8,NK T cell differentiation,BP,
711,GO:0001866,1,0.926400591657495,0,6,NK T cell proliferation,BP,
712,GO:0001867,1,0.878044133297849,0,10,complement activation, lectin pathway,BP,
713,GO:0001868,1,0.970824693863449,0,2,regulation of complement activation, lectin pathway,BP,
714,GO:0001869,1,0.970824693863449,0,2,negative regulation of complement activation, lectin pathway,BP,
715,GO:0001871,1,0.74428413564374,0,21,pattern binding,MF,
716,GO:0001872,1,0.986989908634441,0,1,(1->3)-beta-D-glucan binding,MF,
717,GO:0001875,1,0.932071501903382,0,5,lipopolysaccharide receptor activity,MF,
718,GO:0001878,1,0.926967577451411,0,6,response to yeast,BP,
719,GO:0001880,1,0.942104901434237,0,4,Mullerian duct regression,BP,
720,GO:0001881,1,0.619928054233064,0,32,receptor recycling,BP,
723,GO:0001884,1,0.968447117721831,0,2,pyrimidine nucleoside binding,MF,
725,GO:0001886,1,0.860618866047051,0,10,endothelial cell morphogenesis,BP,
726,GO:0001887,1,0.939037274150564,0,4,selenium compound metabolic process,BP,
727,GO:0001888,1,0.967751425123124,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
730,GO:0001891,1,0.77342996374312,0,18,phagocytic cup,CC,
735,GO:0001897,1,0.970300969153238,0,2,cytolysis by symbiont of host cells,BP,
736,GO:0001905,1,0.951115630577391,0,3,activation of membrane attack complex,BP,
738,GO:0001907,1,0.946393469229176,0,4,killing by symbiont of host cells,BP,
740,GO:0001910,1,0.505445703569194,0,50,regulation of leukocyte mediated cytotoxicity,BP,
741,GO:0001911,1,0.832788622379791,0,13,negative regulation of leukocyte mediated cytotoxicity,BP,
742,GO:0001912,1,0.65052103679309,0,32,positive regulation of leukocyte mediated cytotoxicity,BP,
744,GO:0001914,1,0.758196340280286,0,21,regulation of T cell mediated cytotoxicity,BP,
745,GO:0001915,1,0.924652844208716,0,5,negative regulation of T cell mediated cytotoxicity,BP,
746,GO:0001916,1,0.839035348574026,0,14,positive regulation of T cell mediated cytotoxicity,BP,
748,GO:0001918,1,0.984203459471406,0,1,farnesylated protein binding,MF,
749,GO:0001919,1,0.71412980351254,0,22,regulation of receptor recycling,BP,
750,GO:0001920,1,0.940512205680046,0,4,negative regulation of receptor recycling,BP,
751,GO:0001921,1,0.818551483492883,0,13,positive regulation of receptor recycling,BP,
752,GO:0001922,1,0.951096177119416,0,3,B-1 B cell homeostasis,BP,
753,GO:0001923,1,0.957894919273398,0,3,B-1 B cell differentiation,BP,
762,GO:0001937,1,0.639522516196534,0,31,negative regulation of endothelial cell proliferation,BP,
764,GO:0001939,1,0.888953511157945,0,8,female pronucleus,CC,
765,GO:0001940,1,0.926339109411522,0,5,male pronucleus,CC,
770,GO:0001946,1,0.77972441010031,0,16,lymphangiogenesis,BP,
773,GO:0001949,1,0.985109325723906,0,1,sebaceous gland cell differentiation,BP,
774,GO:0001951,1,0.936418786655492,0,4,intestinal D-glucose absorption,BP,
778,GO:0001955,1,0.889131038827403,0,8,blood vessel maturation,BP,
779,GO:0001956,1,0.842436268829247,0,11,positive regulation of neurotransmitter secretion,BP,
780,GO:0001957,1,0.914265535792089,0,6,intramembranous ossification,BP,
786,GO:0001964,1,0.689702111585025,0,25,startle response,BP,
787,GO:0001965,1,0.765024906638191,0,19,G-protein alpha-subunit binding,MF,
788,GO:0001966,1,0.990088166239541,0,1,thigmotaxis,BP,
789,GO:0001967,1,0.823455850844242,0,13,suckling behavior,BP,
791,GO:0001969,1,0.951115630577391,0,3,regulation of activation of membrane attack complex,BP,
792,GO:0001970,1,0.967146672143928,0,2,positive regulation of activation of membrane attack complex,BP,
793,GO:0001971,1,0.983426667499461,0,1,negative regulation of activation of membrane attack complex,BP,
797,GO:0001975,1,0.684530002049429,0,27,response to amphetamine,BP,
798,GO:0001976,1,0.838906631984775,0,13,neurological system process involved in regulation of systemic arterial blood pressure,BP,
800,GO:0001978,1,0.979920389573342,0,2,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
801,GO:0001979,1,0.988146097238329,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
802,GO:0001980,1,0.993558837117699,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
803,GO:0001983,1,0.979920389573342,0,2,baroreceptor response to increased systemic arterial blood pressure,BP,
804,GO:0001984,1,0.993882883687647,0,1,artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure,BP,
805,GO:0001985,1,0.985951928115823,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
807,GO:0001991,1,0.761262199292241,0,19,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
808,GO:0001992,1,0.930481931777813,0,5,regulation of systemic arterial blood pressure by vasopressin,BP,
809,GO:0001993,1,0.875152572240441,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
810,GO:0001994,1,0.942677154179619,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
811,GO:0001996,1,0.942420682744022,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
812,GO:0001997,1,0.97025832192201,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
813,GO:0001999,1,0.921496083685369,0,5,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
814,GO:0002001,1,0.921496083685369,0,5,renin secretion into blood stream,BP,
815,GO:0002002,1,0.839596140122431,0,13,regulation of angiotensin levels in blood,BP,
816,GO:0002003,1,0.853754904768975,0,12,angiotensin maturation,BP,
817,GO:0002005,1,0.951254801453922,0,3,angiotensin catabolic process in blood,BP,
818,GO:0002007,1,0.988146097238329,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
821,GO:0002016,1,0.883963172543712,0,9,regulation of blood volume by renin-angiotensin,BP,
822,GO:0002017,1,0.971399255143763,0,2,regulation of blood volume by renal aldosterone,BP,
823,GO:0002018,1,0.944729079101786,0,4,renin-angiotensin regulation of aldosterone production,BP,
824,GO:0002019,1,0.963318191195908,0,3,regulation of renal output by angiotensin,BP,
826,GO:0002021,1,0.74140153016015,0,22,response to dietary excess,BP,
827,GO:0002023,1,0.968132710006644,0,3,reduction of food intake in response to dietary excess,BP,
828,GO:0002024,1,0.881554750363272,0,9,diet induced thermogenesis,BP,
829,GO:0002025,1,0.955811045054581,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
833,GO:0002029,1,0.825113079649509,0,14,desensitization of G-protein coupled receptor protein signaling pathway,BP,
834,GO:0002031,1,0.847783691273844,0,12,G-protein coupled receptor internalization,BP,
835,GO:0002032,1,0.973840580570573,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
836,GO:0002033,1,0.9840191099322,0,1,angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
837,GO:0002034,1,0.941113694688724,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
838,GO:0002035,1,0.937308045115284,0,4,brain renin-angiotensin system,BP,
839,GO:0002036,1,0.940068068030576,0,4,regulation of L-glutamate transport,BP,
840,GO:0002037,1,0.986180643581696,0,1,negative regulation of L-glutamate transport,BP,
841,GO:0002038,1,0.985647073098095,0,1,positive regulation of L-glutamate transport,BP,
842,GO:0002039,1,0.356376560541151,0,68,p53 binding,MF,
844,GO:0002041,1,0.985555312988971,0,1,intussusceptive angiogenesis,BP,
847,GO:0002046,1,0.971060114859621,0,3,opsin binding,MF,
848,GO:0002051,1,0.935793735210593,0,4,osteoblast fate commitment,BP,
851,GO:0002054,1,0.950700832416248,0,4,nucleobase binding,MF,
852,GO:0002055,1,0.994312128798443,0,1,adenine binding,MF,
853,GO:0002058,1,0.986168662552243,0,1,uracil binding,MF,
854,GO:0002059,1,0.986168662552243,0,1,thymine binding,MF,
855,GO:0002060,1,0.964036764368536,0,3,purine nucleobase binding,MF,
856,GO:0002061,1,0.986168662552243,0,1,pyrimidine nucleobase binding,MF,
858,GO:0002063,1,0.692810229566202,0,23,chondrocyte development,BP,
866,GO:0002071,1,0.975526059485101,0,2,glandular epithelial cell maturation,BP,
868,GO:0002074,1,0.922533620778253,0,5,extraocular skeletal muscle development,BP,
869,GO:0002076,1,0.769640501709247,0,18,osteoblast development,BP,
870,GO:0002077,1,0.99003284639713,0,1,acrosome matrix dispersal,BP,
871,GO:0002079,1,0.948145894478775,0,4,inner acrosomal membrane,CC,
873,GO:0002081,1,0.94885143033184,0,4,outer acrosomal membrane,CC,
875,GO:0002083,1,0.988458307022838,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
876,GO:0002084,1,0.946844981558287,0,4,protein depalmitoylation,BP,
878,GO:0002086,1,0.978163755384587,0,2,diaphragm contraction,BP,
882,GO:0002090,1,0.593155122608112,0,34,regulation of receptor internalization,BP,
883,GO:0002091,1,0.89419847568708,0,7,negative regulation of receptor internalization,BP,
884,GO:0002092,1,0.711948386789566,0,22,positive regulation of receptor internalization,BP,
886,GO:0002094,1,0.972226133787329,0,2,polyprenyltransferase activity,MF,
887,GO:0002097,1,0.827248801636714,0,13,tRNA wobble base modification,BP,
888,GO:0002098,1,0.877829217220244,0,9,tRNA wobble uridine modification,BP,
889,GO:0002100,1,0.983426667501135,0,1,tRNA wobble adenosine to inosine editing,BP,
890,GO:0002101,1,0.958295254413753,0,3,tRNA wobble cytosine modification,BP,
892,GO:0002113,1,0.985572797966427,0,1,interleukin-33 binding,MF,
893,GO:0002114,1,0.96924084306236,0,2,interleukin-33 receptor activity,MF,
894,GO:0002115,1,0.864794076443201,0,10,store-operated calcium entry,BP,
895,GO:0002116,1,0.891027159620049,0,7,semaphorin receptor complex,CC,
896,GO:0002118,1,0.892544106952903,0,9,aggressive behavior,BP,
897,GO:0002121,1,0.967460077024093,0,2,inter-male aggressive behavior,BP,
898,GO:0002125,1,0.96257236631466,0,4,maternal aggressive behavior,BP,
899,GO:0002127,1,0.989627215244459,0,1,wobble base cytosine methylation,BP,
900,GO:0002133,1,0.96712689214423,0,2,polycystin complex,CC,
901,GO:0002134,1,0.968447117721831,0,2,UTP binding,MF,
902,GO:0002135,1,0.984769051492201,0,1,CTP binding,MF,
903,GO:0002138,1,0.896661151115817,0,8,retinoic acid biosynthetic process,BP,
906,GO:0002141,1,0.970234984668612,0,2,stereocilia ankle link,CC,
907,GO:0002142,1,0.983426667494048,0,1,stereocilia ankle link complex,CC,
908,GO:0002143,1,0.960528648531584,0,3,tRNA wobble position uridine thiolation,BP,
909,GO:0002148,1,0.983634907080281,0,1,hypochlorous acid metabolic process,BP,
910,GO:0002149,1,0.983634907080281,0,1,hypochlorous acid biosynthetic process,BP,
911,GO:0002151,1,0.895100105279867,0,7,G-quadruplex RNA binding,MF,
912,GO:0002152,1,0.983511239669819,0,1,bile acid conjugation,BP,
913,GO:0002153,1,0.985129335762414,0,1,steroid receptor RNA activator RNA binding,MF,
914,GO:0002154,1,0.936499611402627,0,5,thyroid hormone mediated signaling pathway,BP,
915,GO:0002155,1,0.952285327182281,0,4,regulation of thyroid hormone mediated signaling pathway,BP,
916,GO:0002158,1,0.897584167395156,0,8,osteoclast proliferation,BP,
918,GO:0002161,1,0.843633740270506,0,11,aminoacyl-tRNA editing activity,MF,
919,GO:0002162,1,0.877837202055255,0,9,dystroglycan binding,MF,
920,GO:0002169,1,0.968456187465255,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
921,GO:0002174,1,0.983955915701001,0,1,mammary stem cell proliferation,BP,
922,GO:0002175,1,0.935882347164907,0,4,protein localization to paranode region of axon,BP,
923,GO:0002176,1,0.931368073572284,0,6,male germ cell proliferation,BP,
924,GO:0002177,1,0.927980625959218,0,6,manchette,CC,
925,GO:0002178,1,0.852253484108802,0,11,palmitoyltransferase complex,CC,
926,GO:0002181,1,0.551660600474711,0,47,cytoplasmic translation,BP,
927,GO:0002182,1,0.967126892152599,0,2,cytoplasmic translational elongation,BP,
928,GO:0002183,1,0.735205353162792,0,22,cytoplasmic translational initiation,BP,
929,GO:0002184,1,0.967800441136647,0,2,cytoplasmic translational termination,BP,
930,GO:0002188,1,0.951446617559837,0,3,translation reinitiation,BP,
931,GO:0002189,1,0.958586540328118,0,3,ribose phosphate diphosphokinase complex,CC,
932,GO:0002190,1,0.811355183718092,0,15,cap-independent translational initiation,BP,
933,GO:0002191,1,0.958003272534857,0,3,cap-dependent translational initiation,BP,
934,GO:0002192,1,0.846344696591729,0,12,IRES-dependent translational initiation,BP,
936,GO:0002194,1,0.983782100485865,0,1,hepatocyte cell migration,BP,
937,GO:0002196,1,0.987158450059716,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
938,GO:0002199,1,0.879329108826001,0,9,zona pellucida receptor complex,CC,
942,GO:0002209,1,0.649362456111393,0,30,behavioral defense response,BP,
943,GO:0002215,1,0.961740267964345,0,3,defense response to nematode,BP,
949,GO:0002225,1,0.96199330627545,0,5,positive regulation of antimicrobial peptide production,BP,
950,GO:0002227,1,0.869916219503417,0,21,innate immune response in mucosa,BP,
952,GO:0002230,1,0.767939832676871,0,19,positive regulation of defense response to virus by host,BP,
953,GO:0002232,1,0.961170299939715,0,3,leukocyte chemotaxis involved in inflammatory response,BP,
954,GO:0002236,1,0.985469041537599,0,1,detection of misfolded protein,BP,
956,GO:0002238,1,0.953833972972881,0,3,response to molecule of fungal origin,BP,
958,GO:0002246,1,0.918736029524016,0,6,wound healing involved in inflammatory response,BP,
959,GO:0002248,1,0.928992221875787,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
960,GO:0002249,1,0.923397589458336,0,6,lymphocyte anergy,BP,
965,GO:0002254,1,0.958679543725016,0,3,kinin cascade,BP,
969,GO:0002264,1,0.987490227772392,0,1,endothelial cell activation involved in immune response,BP,
970,GO:0002266,1,0.97129755700455,0,2,follicular dendritic cell activation,BP,
971,GO:0002268,1,0.97129755700455,0,2,follicular dendritic cell differentiation,BP,
974,GO:0002276,1,0.986234894551021,0,1,basophil activation involved in immune response,BP,
975,GO:0002277,1,0.963726594709152,0,3,myeloid dendritic cell activation involved in immune response,BP,
976,GO:0002278,1,0.925807642957419,0,6,eosinophil activation involved in immune response,BP,
978,GO:0002281,1,0.878605139162181,0,9,macrophage activation involved in immune response,BP,
979,GO:0002282,1,0.968579615998542,0,2,microglial cell activation involved in immune response,BP,
984,GO:0002290,1,0.984070096703214,0,1,gamma-delta T cell activation involved in immune response,BP,
985,GO:0002291,1,0.894447425568247,0,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
990,GO:0002296,1,0.97671685399144,0,2,T-helper 1 cell lineage commitment,BP,
991,GO:0002298,1,0.979440228564863,0,2,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
992,GO:0002299,1,0.988898160643439,0,1,alpha-beta intraepithelial T cell differentiation,BP,
993,GO:0002300,1,0.988898160643439,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
994,GO:0002302,1,0.975497778422267,0,2,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
995,GO:0002304,1,0.973957440934563,0,2,gamma-delta intraepithelial T cell differentiation,BP,
996,GO:0002305,1,0.973957440934563,0,2,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
997,GO:0002309,1,0.941122776140186,0,5,T cell proliferation involved in immune response,BP,
1000,GO:0002314,1,0.958346461961834,0,3,germinal center B cell differentiation,BP,
1002,GO:0002316,1,0.983426667503251,0,1,follicular B cell differentiation,BP,
1003,GO:0002317,1,0.958033948713629,0,4,plasma cell differentiation,BP,
1006,GO:0002322,1,0.922951537040925,0,5,B cell proliferation involved in immune response,BP,
1008,GO:0002325,1,0.960299287630083,0,4,natural killer cell differentiation involved in immune response,BP,
1009,GO:0002326,1,0.936985494781795,0,4,B cell lineage commitment,BP,
1010,GO:0002327,1,0.876373370608789,0,8,immature B cell differentiation,BP,
1012,GO:0002329,1,0.92145071919897,0,5,pre-B cell differentiation,BP,
1013,GO:0002331,1,0.952777651374624,0,3,pre-B cell allelic exclusion,BP,
1014,GO:0002332,1,0.983426667501923,0,1,transitional stage B cell differentiation,BP,
1015,GO:0002333,1,0.983426667501923,0,1,transitional one stage B cell differentiation,BP,
1017,GO:0002337,1,0.974039749733574,0,2,B-1a B cell differentiation,BP,
1018,GO:0002339,1,0.964662124845633,0,3,B cell selection,BP,
1019,GO:0002343,1,0.984563314143549,0,1,peripheral B cell selection,BP,
1020,GO:0002344,1,0.984563314143549,0,1,B cell affinity maturation,BP,
1021,GO:0002347,1,0.802495399950603,0,16,response to tumor cell,BP,
1022,GO:0002349,1,0.920583571974144,0,6,histamine production involved in inflammatory response,BP,
1023,GO:0002351,1,0.96330349668279,0,3,serotonin production involved in inflammatory response,BP,
1024,GO:0002352,1,0.979788079271547,0,2,B cell negative selection,BP,
1025,GO:0002353,1,0.958679543725016,0,3,plasma kallikrein-kinin cascade,BP,
1026,GO:0002355,1,0.985115468635746,0,1,detection of tumor cell,BP,
1027,GO:0002357,1,0.969802504616247,0,2,defense response to tumor cell,BP,
1028,GO:0002358,1,0.979045784138308,0,2,B cell homeostatic proliferation,BP,
1030,GO:0002361,1,0.936149009765934,0,5,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1031,GO:0002362,1,0.985404763103359,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1035,GO:0002368,1,0.970255749770814,0,2,B cell cytokine production,BP,
1036,GO:0002369,1,0.675137718179699,0,29,T cell cytokine production,BP,
1037,GO:0002370,1,0.968216148281525,0,2,natural killer cell cytokine production,BP,
1038,GO:0002371,1,0.913633928815464,0,6,dendritic cell cytokine production,BP,
1039,GO:0002373,1,0.992877973487527,0,1,plasmacytoid dendritic cell cytokine production,BP,
1043,GO:0002378,1,0.952355803174203,0,3,immunoglobulin biosynthetic process,BP,
1044,GO:0002380,1,0.983426667503104,0,1,immunoglobulin secretion involved in immune response,BP,
1046,GO:0002384,1,0.97479197642282,0,2,hepatic immune response,BP,
1049,GO:0002396,1,0.952001489151493,0,5,MHC protein complex assembly,BP,
1050,GO:0002397,1,0.987081772333771,0,1,MHC class I protein complex assembly,BP,
1051,GO:0002399,1,0.964462501403572,0,4,MHC class II protein complex assembly,BP,
1053,GO:0002408,1,0.958110761267565,0,4,myeloid dendritic cell chemotaxis,BP,
1056,GO:0002416,1,0.987820931616327,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1057,GO:0002418,1,0.833984094151024,0,13,immune response to tumor cell,BP,
1058,GO:0002420,1,0.894256245787576,0,8,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1059,GO:0002423,1,0.894256245787576,0,8,natural killer cell mediated immune response to tumor cell,BP,
1060,GO:0002424,1,0.969219548799448,0,2,T cell mediated immune response to tumor cell,BP,
1061,GO:0002426,1,0.97691483332611,0,2,immunoglobulin production in mucosal tissue,BP,
1062,GO:0002428,1,0.964633757444995,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1064,GO:0002430,1,0.858267300433117,0,11,complement receptor mediated signaling pathway,BP,
1066,GO:0002432,1,0.983426667503154,0,1,granuloma formation,BP,
1068,GO:0002434,1,0.979255347194462,0,2,immune complex clearance,BP,
1069,GO:0002436,1,0.979255347194462,0,2,immune complex clearance by monocytes and macrophages,BP,
1071,GO:0002438,1,0.776237716878188,0,20,acute inflammatory response to antigenic stimulus,BP,
1072,GO:0002439,1,0.952958242010501,0,4,chronic inflammatory response to antigenic stimulus,BP,
1074,GO:0002441,1,0.920583571974144,0,6,histamine secretion involved in inflammatory response,BP,
1075,GO:0002442,1,0.96330349668279,0,3,serotonin secretion involved in inflammatory response,BP,
1078,GO:0002445,1,0.978903658495075,0,2,type II hypersensitivity,BP,
1080,GO:0002447,1,0.925807642957419,0,6,eosinophil mediated immunity,BP,
1083,GO:0002455,1,0.567955415564899,0,42,humoral immune response mediated by circulating immunoglobulin,BP,
1085,GO:0002457,1,0.927483946369258,0,5,T cell antigen processing and presentation,BP,
1086,GO:0002458,1,0.971823843959398,0,2,peripheral T cell tolerance induction,BP,
1088,GO:0002461,1,0.957680804786068,0,3,tolerance induction dependent upon immune response,BP,
1089,GO:0002465,1,0.971823843959398,0,2,peripheral tolerance induction,BP,
1090,GO:0002467,1,0.807470780450314,0,15,germinal center formation,BP,
1091,GO:0002468,1,0.902479159039938,0,8,dendritic cell antigen processing and presentation,BP,
1093,GO:0002475,1,0.87058259203572,0,10,antigen processing and presentation via MHC class Ib,BP,
1094,GO:0002476,1,0.97187491714458,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1095,GO:0002477,1,0.992550171902003,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1098,GO:0002480,1,0.913915246844168,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1099,GO:0002481,1,0.992550171902003,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1100,GO:0002483,1,0.890954916119229,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1101,GO:0002488,1,0.983426667503346,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1102,GO:0002489,1,0.983426667503346,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1103,GO:0002495,1,0.277155172788119,0,93,antigen processing and presentation of peptide antigen via MHC class II,BP,
1104,GO:0002501,1,0.960160206568578,0,4,peptide antigen assembly with MHC protein complex,BP,
1105,GO:0002502,1,0.987081772333771,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1106,GO:0002503,1,0.972727560589997,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1107,GO:0002504,1,0.272537499566338,0,94,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1108,GO:0002505,1,0.982361742722248,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1109,GO:0002506,1,0.982361742722248,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1110,GO:0002507,1,0.707446105697404,0,24,tolerance induction,BP,
1111,GO:0002508,1,0.970967610529425,0,2,central tolerance induction,BP,
1112,GO:0002509,1,0.986218762837224,0,1,central tolerance induction to self antigen,BP,
1113,GO:0002510,1,0.984536613720224,0,1,central B cell tolerance induction,BP,
1114,GO:0002513,1,0.926940335872573,0,5,tolerance induction to self antigen,BP,
1115,GO:0002514,1,0.968218516738476,0,2,B cell tolerance induction,BP,
1116,GO:0002517,1,0.834354799214421,0,13,T cell tolerance induction,BP,
1117,GO:0002518,1,0.991096224378579,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1118,GO:0002519,1,0.973909932198477,0,2,natural killer cell tolerance induction,BP,
1121,GO:0002522,1,0.97140767511083,0,2,leukocyte migration involved in immune response,BP,
1123,GO:0002524,1,0.890037580446195,0,9,hypersensitivity,BP,
1124,GO:0002525,1,0.959058350778902,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1126,GO:0002528,1,0.967587818706605,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1127,GO:0002532,1,0.530989097474711,0,46,production of molecular mediator involved in inflammatory response,BP,
1128,GO:0002534,1,0.680925205492972,0,27,cytokine production involved in inflammatory response,BP,
1129,GO:0002536,1,0.963554254556055,0,4,respiratory burst involved in inflammatory response,BP,
1130,GO:0002537,1,0.967126892150519,0,2,nitric oxide production involved in inflammatory response,BP,
1131,GO:0002538,1,0.968666099710301,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1132,GO:0002540,1,0.968666099710301,0,2,leukotriene production involved in inflammatory response,BP,
1133,GO:0002541,1,0.958075703210011,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1134,GO:0002542,1,0.972323645151028,0,2,Factor XII activation,BP,
1135,GO:0002543,1,0.969016702067371,0,2,activation of blood coagulation via clotting cascade,BP,
1137,GO:0002545,1,0.971113698661792,0,2,chronic inflammatory response to non-antigenic stimulus,BP,
1140,GO:0002553,1,0.920583571974144,0,6,histamine secretion by mast cell,BP,
1141,GO:0002554,1,0.96330349668279,0,3,serotonin secretion by platelet,BP,
1143,GO:0002566,1,0.831734486859224,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1144,GO:0002568,1,0.92051492559504,0,5,somatic diversification of T cell receptor genes,BP,
1145,GO:0002572,1,0.967478152303141,0,2,pro-T cell differentiation,BP,
1148,GO:0002577,1,0.819887731689581,0,16,regulation of antigen processing and presentation,BP,
1149,GO:0002578,1,0.918276186991163,0,6,negative regulation of antigen processing and presentation,BP,
1150,GO:0002579,1,0.904233998126982,0,9,positive regulation of antigen processing and presentation,BP,
1151,GO:0002580,1,0.943487282611137,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1152,GO:0002581,1,0.957528844255443,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1153,GO:0002582,1,0.98533826119787,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1154,GO:0002583,1,0.935061707410463,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1155,GO:0002584,1,0.948978401229938,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1156,GO:0002585,1,0.98533826119787,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1157,GO:0002586,1,0.959390292490647,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1158,GO:0002587,1,0.97366753031199,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1159,GO:0002588,1,0.98533826119787,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1160,GO:0002589,1,0.974645936554366,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1161,GO:0002590,1,0.974645936554366,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1162,GO:0002604,1,0.902479159039938,0,8,regulation of dendritic cell antigen processing and presentation,BP,
1163,GO:0002605,1,0.983426667501675,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1164,GO:0002606,1,0.917693777670542,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1165,GO:0002625,1,0.974564002989224,0,2,regulation of T cell antigen processing and presentation,BP,
1166,GO:0002626,1,0.986939888461523,0,1,negative regulation of T cell antigen processing and presentation,BP,
1167,GO:0002634,1,0.881945484862448,0,9,regulation of germinal center formation,BP,
1168,GO:0002635,1,0.968218516731356,0,2,negative regulation of germinal center formation,BP,
1169,GO:0002636,1,0.973451582145926,0,3,positive regulation of germinal center formation,BP,
1171,GO:0002638,1,0.886231080564253,0,8,negative regulation of immunoglobulin production,BP,
1173,GO:0002640,1,0.984728932554734,0,1,regulation of immunoglobulin biosynthetic process,BP,
1174,GO:0002642,1,0.984728932554734,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1175,GO:0002643,1,0.782104947455188,0,17,regulation of tolerance induction,BP,
1176,GO:0002644,1,0.970802506957044,0,2,negative regulation of tolerance induction,BP,
1177,GO:0002645,1,0.878076207355786,0,9,positive regulation of tolerance induction,BP,
1178,GO:0002646,1,0.984536613720224,0,1,regulation of central tolerance induction,BP,
1179,GO:0002648,1,0.984536613720224,0,1,positive regulation of central tolerance induction,BP,
1180,GO:0002649,1,0.983426667502958,0,1,regulation of tolerance induction to self antigen,BP,
1181,GO:0002651,1,0.983426667502958,0,1,positive regulation of tolerance induction to self antigen,BP,
1182,GO:0002652,1,0.971064898988489,0,2,regulation of tolerance induction dependent upon immune response,BP,
1183,GO:0002654,1,0.985404763103359,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1184,GO:0002658,1,0.985404763103359,0,1,regulation of peripheral tolerance induction,BP,
1185,GO:0002660,1,0.985404763103359,0,1,positive regulation of peripheral tolerance induction,BP,
1186,GO:0002661,1,0.968218516738476,0,2,regulation of B cell tolerance induction,BP,
1187,GO:0002663,1,0.968218516738476,0,2,positive regulation of B cell tolerance induction,BP,
1188,GO:0002664,1,0.859328815157015,0,11,regulation of T cell tolerance induction,BP,
1189,GO:0002665,1,0.984355126393904,0,1,negative regulation of T cell tolerance induction,BP,
1190,GO:0002666,1,0.906910662138965,0,7,positive regulation of T cell tolerance induction,BP,
1191,GO:0002667,1,0.923397589458336,0,6,regulation of T cell anergy,BP,
1192,GO:0002668,1,0.984355126393904,0,1,negative regulation of T cell anergy,BP,
1193,GO:0002669,1,0.958563996660926,0,3,positive regulation of T cell anergy,BP,
1197,GO:0002676,1,0.870862420313021,0,11,regulation of chronic inflammatory response,BP,
1198,GO:0002677,1,0.920358355817749,0,6,negative regulation of chronic inflammatory response,BP,
1199,GO:0002678,1,0.954891589216393,0,4,positive regulation of chronic inflammatory response,BP,
1201,GO:0002681,1,0.92051492559504,0,5,somatic recombination of T cell receptor gene segments,BP,
1209,GO:0002689,1,0.823104583377417,0,14,negative regulation of leukocyte chemotaxis,BP,
1211,GO:0002691,1,0.733745436372246,0,23,regulation of cellular extravasation,BP,
1212,GO:0002692,1,0.90519521566687,0,8,negative regulation of cellular extravasation,BP,
1213,GO:0002693,1,0.830169127123019,0,13,positive regulation of cellular extravasation,BP,
1218,GO:0002698,1,0.247100185441239,0,102,negative regulation of immune effector process,BP,
1221,GO:0002701,1,0.672998325765199,0,30,negative regulation of production of molecular mediator of immune response,BP,
1224,GO:0002704,1,0.546746129550281,0,44,negative regulation of leukocyte mediated immunity,BP,
1227,GO:0002707,1,0.638738688979817,0,33,negative regulation of lymphocyte mediated immunity,BP,
1229,GO:0002709,1,0.502357176080656,0,51,regulation of T cell mediated immunity,BP,
1230,GO:0002710,1,0.809772712453533,0,16,negative regulation of T cell mediated immunity,BP,
1231,GO:0002711,1,0.652484901093943,0,31,positive regulation of T cell mediated immunity,BP,
1233,GO:0002713,1,0.877763552303365,0,9,negative regulation of B cell mediated immunity,BP,
1235,GO:0002715,1,0.627766855259403,0,33,regulation of natural killer cell mediated immunity,BP,
1236,GO:0002716,1,0.857233183417372,0,11,negative regulation of natural killer cell mediated immunity,BP,
1237,GO:0002717,1,0.754370340971462,0,20,positive regulation of natural killer cell mediated immunity,BP,
1239,GO:0002719,1,0.74842269598441,0,23,negative regulation of cytokine production involved in immune response,BP,
1241,GO:0002721,1,0.984563314143549,0,1,regulation of B cell cytokine production,BP,
1242,GO:0002724,1,0.744519782458834,0,22,regulation of T cell cytokine production,BP,
1243,GO:0002725,1,0.921609865799071,0,7,negative regulation of T cell cytokine production,BP,
1244,GO:0002726,1,0.818101798550656,0,14,positive regulation of T cell cytokine production,BP,
1245,GO:0002727,1,0.968216148281525,0,2,regulation of natural killer cell cytokine production,BP,
1246,GO:0002728,1,0.983426667503104,0,1,negative regulation of natural killer cell cytokine production,BP,
1247,GO:0002729,1,0.98453420551145,0,1,positive regulation of natural killer cell cytokine production,BP,
1248,GO:0002730,1,0.929035804864742,0,5,regulation of dendritic cell cytokine production,BP,
1249,GO:0002731,1,0.976422190238282,0,2,negative regulation of dendritic cell cytokine production,BP,
1250,GO:0002732,1,0.983426667503104,0,1,positive regulation of dendritic cell cytokine production,BP,
1251,GO:0002736,1,0.992877973487527,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1252,GO:0002737,1,0.992877973487527,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1254,GO:0002740,1,0.935548994519255,0,6,negative regulation of cytokine secretion involved in immune response,BP,
1256,GO:0002752,1,0.977199735784329,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1257,GO:0002753,1,0.445094784215728,0,53,cytoplasmic pattern recognition receptor signaling pathway,BP,
1258,GO:0002755,1,0.591879766761737,0,36,MyD88-dependent toll-like receptor signaling pathway,BP,
1259,GO:0002756,1,0.623254782681907,0,33,MyD88-independent toll-like receptor signaling pathway,BP,
1262,GO:0002759,1,0.934170624054869,0,7,regulation of antimicrobial humoral response,BP,
1263,GO:0002760,1,0.96199330627545,0,5,positive regulation of antimicrobial humoral response,BP,
1268,GO:0002765,1,0.918679069293046,0,6,immune response-inhibiting signal transduction,BP,
1269,GO:0002767,1,0.931237112862871,0,5,immune response-inhibiting cell surface receptor signaling pathway,BP,
1271,GO:0002769,1,0.988677413700218,0,1,natural killer cell inhibitory signaling pathway,BP,
1272,GO:0002774,1,0.952586469544884,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1273,GO:0002775,1,0.936789406314123,0,7,antimicrobial peptide production,BP,
1274,GO:0002777,1,0.994072387421552,0,2,antimicrobial peptide biosynthetic process,BP,
1275,GO:0002778,1,0.936789406314123,0,7,antibacterial peptide production,BP,
1276,GO:0002780,1,0.994072387421552,0,2,antibacterial peptide biosynthetic process,BP,
1277,GO:0002784,1,0.94606354733936,0,6,regulation of antimicrobial peptide production,BP,
1278,GO:0002785,1,0.983443534740647,0,1,negative regulation of antimicrobial peptide production,BP,
1279,GO:0002786,1,0.94606354733936,0,6,regulation of antibacterial peptide production,BP,
1280,GO:0002787,1,0.983443534740647,0,1,negative regulation of antibacterial peptide production,BP,
1285,GO:0002803,1,0.96199330627545,0,5,positive regulation of antibacterial peptide production,BP,
1286,GO:0002805,1,0.994072387421552,0,2,regulation of antimicrobial peptide biosynthetic process,BP,
1287,GO:0002807,1,0.994072387421552,0,2,positive regulation of antimicrobial peptide biosynthetic process,BP,
1288,GO:0002808,1,0.994072387421552,0,2,regulation of antibacterial peptide biosynthetic process,BP,
1289,GO:0002815,1,0.994072387421552,0,2,biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
1290,GO:0002816,1,0.994072387421552,0,2,regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
1292,GO:0002820,1,0.596423436722837,0,38,negative regulation of adaptive immune response,BP,
1295,GO:0002823,1,0.623817830209432,0,35,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1297,GO:0002825,1,0.739274110561398,0,22,regulation of T-helper 1 type immune response,BP,
1298,GO:0002826,1,0.902910604240004,0,7,negative regulation of T-helper 1 type immune response,BP,
1299,GO:0002827,1,0.817864011724671,0,15,positive regulation of T-helper 1 type immune response,BP,
1300,GO:0002828,1,0.687795003784628,0,27,regulation of type 2 immune response,BP,
1301,GO:0002829,1,0.857578713061079,0,11,negative regulation of type 2 immune response,BP,
1302,GO:0002830,1,0.812808306155052,0,15,positive regulation of type 2 immune response,BP,
1304,GO:0002832,1,0.612919427335638,0,34,negative regulation of response to biotic stimulus,BP,
1306,GO:0002834,1,0.855364522076377,0,11,regulation of response to tumor cell,BP,
1307,GO:0002835,1,0.969179998022492,0,2,negative regulation of response to tumor cell,BP,
1308,GO:0002836,1,0.897382212341454,0,8,positive regulation of response to tumor cell,BP,
1309,GO:0002837,1,0.855364522076377,0,11,regulation of immune response to tumor cell,BP,
1310,GO:0002838,1,0.969179998022492,0,2,negative regulation of immune response to tumor cell,BP,
1311,GO:0002839,1,0.897382212341454,0,8,positive regulation of immune response to tumor cell,BP,
1312,GO:0002840,1,0.969219548799448,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1313,GO:0002842,1,0.985469041537599,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1314,GO:0002849,1,0.985404763103359,0,1,regulation of peripheral T cell tolerance induction,BP,
1315,GO:0002851,1,0.985404763103359,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1316,GO:0002855,1,0.894256245787576,0,8,regulation of natural killer cell mediated immune response to tumor cell,BP,
1317,GO:0002856,1,0.969179998022492,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1318,GO:0002857,1,0.922703304560604,0,6,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1319,GO:0002858,1,0.894256245787576,0,8,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1320,GO:0002859,1,0.969179998022492,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1321,GO:0002860,1,0.922703304560604,0,6,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1322,GO:0002861,1,0.768016608514234,0,21,regulation of inflammatory response to antigenic stimulus,BP,
1323,GO:0002862,1,0.876876524660775,0,10,negative regulation of inflammatory response to antigenic stimulus,BP,
1324,GO:0002863,1,0.87591828946376,0,11,positive regulation of inflammatory response to antigenic stimulus,BP,
1325,GO:0002864,1,0.858056689482132,0,12,regulation of acute inflammatory response to antigenic stimulus,BP,
1326,GO:0002865,1,0.942339627071472,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1327,GO:0002866,1,0.910580954615092,0,8,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1328,GO:0002870,1,0.923397589458336,0,6,T cell anergy,BP,
1329,GO:0002874,1,0.966930561518573,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1330,GO:0002875,1,0.988523564156021,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1331,GO:0002876,1,0.978157347488185,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1332,GO:0002877,1,0.959058350778902,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1333,GO:0002878,1,0.983678680603845,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1334,GO:0002879,1,0.974972853196786,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1335,GO:0002880,1,0.971113698661792,0,2,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1336,GO:0002881,1,0.983670184455431,0,1,negative regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1337,GO:0002882,1,0.987235931111992,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1338,GO:0002883,1,0.904714650517117,0,8,regulation of hypersensitivity,BP,
1339,GO:0002884,1,0.970167810938268,0,2,negative regulation of hypersensitivity,BP,
1340,GO:0002885,1,0.932542378280011,0,6,positive regulation of hypersensitivity,BP,
1341,GO:0002886,1,0.588806844665533,0,38,regulation of myeloid leukocyte mediated immunity,BP,
1342,GO:0002887,1,0.866639284895787,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1343,GO:0002888,1,0.79114399395165,0,18,positive regulation of myeloid leukocyte mediated immunity,BP,
1345,GO:0002890,1,0.877763552303365,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1347,GO:0002892,1,0.978903658495075,0,2,regulation of type II hypersensitivity,BP,
1348,GO:0002894,1,0.978903658495075,0,2,positive regulation of type II hypersensitivity,BP,
1349,GO:0002895,1,0.984536613720224,0,1,regulation of central B cell tolerance induction,BP,
1350,GO:0002897,1,0.984536613720224,0,1,positive regulation of central B cell tolerance induction,BP,
1351,GO:0002901,1,0.959394701348339,0,4,mature B cell apoptotic process,BP,
1352,GO:0002902,1,0.788604323617363,0,18,regulation of B cell apoptotic process,BP,
1353,GO:0002903,1,0.856993249839626,0,12,negative regulation of B cell apoptotic process,BP,
1354,GO:0002904,1,0.966100950819585,0,3,positive regulation of B cell apoptotic process,BP,
1355,GO:0002905,1,0.959394701348339,0,4,regulation of mature B cell apoptotic process,BP,
1356,GO:0002906,1,0.959394701348339,0,4,negative regulation of mature B cell apoptotic process,BP,
1357,GO:0002911,1,0.923397589458336,0,6,regulation of lymphocyte anergy,BP,
1358,GO:0002912,1,0.984355126393904,0,1,negative regulation of lymphocyte anergy,BP,
1359,GO:0002913,1,0.958563996660926,0,3,positive regulation of lymphocyte anergy,BP,
1360,GO:0002920,1,0.519977179911713,0,49,regulation of humoral immune response,BP,
1361,GO:0002921,1,0.848766167373891,0,11,negative regulation of humoral immune response,BP,
1362,GO:0002922,1,0.847247037186113,0,15,positive regulation of humoral immune response,BP,
1363,GO:0002923,1,0.892719064994693,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1364,GO:0002924,1,0.933936078220103,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1365,GO:0002925,1,0.955879669334447,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1366,GO:0002930,1,0.970449749412768,0,2,trabecular meshwork development,BP,
1368,GO:0002933,1,0.932178322691786,0,5,lipid hydroxylation,BP,
1370,GO:0002940,1,0.985930958901179,0,1,tRNA N2-guanine methylation,BP,
1371,GO:0002943,1,0.961352748628139,0,3,tRNA dihydrouridine synthesis,BP,
1372,GO:0002944,1,0.969280918273441,0,2,cyclin K-CDK12 complex,CC,
1373,GO:0002945,1,0.969280918275091,0,2,cyclin K-CDK13 complex,CC,
1374,GO:0002946,1,0.989627215244459,0,1,tRNA C5-cytosine methylation,BP,
1375,GO:0002947,1,0.983426667503304,0,1,tumor necrosis factor receptor superfamily complex,CC,
1376,GO:0002949,1,0.962341228886832,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1377,GO:0002950,1,0.956718701365542,0,3,ceramide phosphoethanolamine synthase activity,MF,
1383,GO:0003010,1,0.935805745781241,0,5,voluntary skeletal muscle contraction,BP,
1384,GO:0003011,1,0.961950848625673,0,3,involuntary skeletal muscle contraction,BP,
1390,GO:0003017,1,0.983426667497739,0,1,lymph circulation,BP,
1392,GO:0003025,1,0.948959844383577,0,4,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1393,GO:0003026,1,0.984728932554734,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1394,GO:0003027,1,0.988146097238329,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1395,GO:0003029,1,0.988146097238329,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1396,GO:0003032,1,0.969578072424996,0,2,detection of oxygen,BP,
1398,GO:0003050,1,0.967356105885134,0,2,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1399,GO:0003051,1,0.952533418170102,0,3,angiotensin-mediated drinking behavior,BP,
1400,GO:0003056,1,0.907830122768365,0,6,regulation of vascular smooth muscle contraction,BP,
1401,GO:0003057,1,0.93222012518456,0,5,regulation of the force of heart contraction by chemical signal,BP,
1402,GO:0003058,1,0.990843747764937,0,1,hormonal regulation of the force of heart contraction,BP,
1405,GO:0003065,1,0.987682609379996,0,1,positive regulation of heart rate by epinephrine,BP,
1406,GO:0003068,1,0.992287966875777,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1407,GO:0003069,1,0.992287966875777,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1408,GO:0003070,1,0.992287966875777,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1410,GO:0003072,1,0.941113694688724,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1412,GO:0003081,1,0.70446006055221,0,25,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1413,GO:0003083,1,0.994679552360307,0,1,negative regulation of renal output by angiotensin,BP,
1414,GO:0003084,1,0.891400942798227,0,9,positive regulation of systemic arterial blood pressure,BP,
1419,GO:0003095,1,0.958584258311823,0,3,pressure natriuresis,BP,
1421,GO:0003097,1,0.911730814572271,0,6,renal water transport,BP,
1422,GO:0003099,1,0.961373280921148,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1425,GO:0003105,1,0.933700584140103,0,6,negative regulation of glomerular filtration,BP,
1426,GO:0003106,1,0.994679552360307,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1427,GO:0003127,1,0.967126892149507,0,2,detection of nodal flow,BP,
1431,GO:0003131,1,0.984131985637324,0,1,mesodermal-endodermal cell signaling,BP,
1434,GO:0003136,1,0.983963369018216,0,1,negative regulation of heart induction by canonical Wnt signaling pathway,BP,
1435,GO:0003137,1,0.991384933405719,0,1,Notch signaling pathway involved in heart induction,BP,
1436,GO:0003138,1,0.983426667501086,0,1,primary heart field specification,BP,
1438,GO:0003140,1,0.899457900992009,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1439,GO:0003142,1,0.985368058605826,0,1,cardiogenic plate morphogenesis,BP,
1441,GO:0003144,1,0.987966604900825,0,1,embryonic heart tube formation,BP,
1442,GO:0003147,1,0.992130533984497,0,1,neural crest cell migration involved in heart formation,BP,
1445,GO:0003150,1,0.923937482899898,0,5,muscular septum morphogenesis,BP,
1454,GO:0003163,1,0.958793875608593,0,3,sinoatrial node development,BP,
1455,GO:0003164,1,0.929491819925218,0,5,His-Purkinje system development,BP,
1456,GO:0003165,1,0.97069443689696,0,2,Purkinje myocyte development,BP,
1457,GO:0003166,1,0.945159900215221,0,4,bundle of His development,BP,
1458,GO:0003167,1,0.983426667502857,0,1,atrioventricular bundle cell differentiation,BP,
1459,GO:0003168,1,0.987054088967679,0,1,Purkinje myocyte differentiation,BP,
1463,GO:0003172,1,0.983426667501086,0,1,sinoatrial valve development,BP,
1473,GO:0003185,1,0.983426667501086,0,1,sinoatrial valve morphogenesis,BP,
1478,GO:0003193,1,0.97255461964142,0,2,pulmonary valve formation,BP,
1482,GO:0003199,1,0.946401460890646,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1489,GO:0003210,1,0.991384933405719,0,1,cardiac atrium formation,BP,
1494,GO:0003218,1,0.971611187173607,0,2,cardiac left ventricle formation,BP,
1496,GO:0003220,1,0.967126892137792,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1497,GO:0003221,1,0.95460482945993,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1499,GO:0003223,1,0.893023220780763,0,7,ventricular compact myocardium morphogenesis,BP,
1500,GO:0003226,1,0.983426667496313,0,1,right ventricular compact myocardium morphogenesis,BP,
1505,GO:0003235,1,0.991384933405719,0,1,sinus venosus development,BP,
1506,GO:0003236,1,0.991384933405719,0,1,sinus venosus morphogenesis,BP,
1508,GO:0003245,1,0.972468164284174,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1509,GO:0003247,1,0.988474582868779,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1510,GO:0003249,1,0.967126892142003,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1511,GO:0003250,1,0.967126892142003,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1512,GO:0003251,1,0.983426667498183,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1513,GO:0003252,1,0.98342666749464,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1514,GO:0003253,1,0.952397717800436,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1515,GO:0003254,1,0.552023668734284,0,41,regulation of membrane depolarization,BP,
1517,GO:0003257,1,0.936666925292529,0,4,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1518,GO:0003259,1,0.991384933405719,0,1,cardioblast anterior-lateral migration,BP,
1519,GO:0003260,1,0.991384933405719,0,1,cardioblast migration,BP,
1520,GO:0003263,1,0.879164561084077,0,9,cardioblast proliferation,BP,
1527,GO:0003275,1,0.955861393095319,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1528,GO:0003278,1,0.916185213459023,0,6,apoptotic process involved in heart morphogenesis,BP,
1533,GO:0003285,1,0.970784781384648,0,2,septum secundum development,BP,
1535,GO:0003290,1,0.983518192086538,0,1,atrial septum secundum morphogenesis,BP,
1536,GO:0003292,1,0.970694436896913,0,2,cardiac septum cell differentiation,BP,
1537,GO:0003294,1,0.983685065836084,0,1,atrial ventricular junction remodeling,BP,
1539,GO:0003299,1,0.749513612659618,0,19,muscle hypertrophy in response to stress,BP,
1546,GO:0003310,1,0.899592663306438,0,7,pancreatic A cell differentiation,BP,
1547,GO:0003311,1,0.98348170472041,0,1,pancreatic D cell differentiation,BP,
1548,GO:0003312,1,0.971158636338914,0,2,pancreatic PP cell differentiation,BP,
1549,GO:0003318,1,0.991384933405719,0,1,cell migration to the midline involved in heart development,BP,
1550,GO:0003321,1,0.90104898390928,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1551,GO:0003322,1,0.983426667500396,0,1,pancreatic A cell development,BP,
1553,GO:0003326,1,0.971158636338914,0,2,pancreatic A cell fate commitment,BP,
1554,GO:0003327,1,0.986388474029908,0,1,type B pancreatic cell fate commitment,BP,
1555,GO:0003329,1,0.971158636338914,0,2,pancreatic PP cell fate commitment,BP,
1556,GO:0003330,1,0.958196664321271,0,3,regulation of extracellular matrix constituent secretion,BP,
1557,GO:0003331,1,0.958196664321271,0,3,positive regulation of extracellular matrix constituent secretion,BP,
1558,GO:0003333,1,0.356855641739316,0,67,amino acid transmembrane transport,BP,
1559,GO:0003334,1,0.850907609767348,0,11,keratinocyte development,BP,
1560,GO:0003335,1,0.975214296644528,0,2,corneocyte development,BP,
1561,GO:0003336,1,0.984774454346527,0,1,corneocyte desquamation,BP,
1565,GO:0003340,1,0.960508027644775,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1566,GO:0003341,1,0.512564589719989,0,48,cilium movement,BP,
1567,GO:0003342,1,0.971104489270081,0,2,proepicardium development,BP,
1568,GO:0003343,1,0.971104489270081,0,2,septum transversum development,BP,
1570,GO:0003345,1,0.983427703233707,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1572,GO:0003350,1,0.956865710923003,0,3,pulmonary myocardium development,BP,
1573,GO:0003351,1,0.774655979952998,0,19,epithelial cilium movement,BP,
1574,GO:0003352,1,0.838459885590273,0,11,regulation of cilium movement,BP,
1575,GO:0003353,1,0.98386065106111,0,1,positive regulation of cilium movement,BP,
1576,GO:0003356,1,0.852223251347202,0,10,regulation of cilium beat frequency,BP,
1577,GO:0003357,1,0.898001565441177,0,7,noradrenergic neuron differentiation,BP,
1578,GO:0003358,1,0.95367527043546,0,3,noradrenergic neuron development,BP,
1579,GO:0003359,1,0.984968562250546,0,1,noradrenergic neuron fate commitment,BP,
1580,GO:0003360,1,0.895624003735401,0,7,brainstem development,BP,
1581,GO:0003363,1,0.983426667501479,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1583,GO:0003366,1,0.967907951989754,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1584,GO:0003373,1,0.89041097365359,0,7,dynamin family protein polymerization involved in membrane fission,BP,
1585,GO:0003374,1,0.89041097365359,0,7,dynamin family protein polymerization involved in mitochondrial fission,BP,
1586,GO:0003376,1,0.838594493634724,0,12,sphingosine-1-phosphate signaling pathway,BP,
1588,GO:0003383,1,0.951096177114133,0,3,apical constriction,BP,
1589,GO:0003400,1,0.986007651161438,0,1,regulation of COPII vesicle coating,BP,
1592,GO:0003404,1,0.968666317438793,0,2,optic vesicle morphogenesis,BP,
1593,GO:0003406,1,0.936527978349522,0,4,retinal pigment epithelium development,BP,
1594,GO:0003407,1,0.416675363294903,0,57,neural retina development,BP,
1596,GO:0003409,1,0.983578108826551,0,1,optic cup structural organization,BP,
1598,GO:0003414,1,0.983428995562572,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1599,GO:0003415,1,0.93599193223041,0,4,chondrocyte hypertrophy,BP,
1604,GO:0003420,1,0.969006934033871,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1605,GO:0003421,1,0.983427624119544,0,1,growth plate cartilage axis specification,BP,
1606,GO:0003422,1,0.967130122613755,0,2,growth plate cartilage morphogenesis,BP,
1607,GO:0003429,1,0.983428995562572,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1608,GO:0003430,1,0.96781089265274,0,2,growth plate cartilage chondrocyte growth,BP,
1609,GO:0003431,1,0.938328852301766,0,4,growth plate cartilage chondrocyte development,BP,
1610,GO:0003433,1,0.909739984534052,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1614,GO:0003678,1,0.473846421430311,0,47,DNA helicase activity,MF,
1615,GO:0003680,1,0.901129690856667,0,8,AT DNA binding,MF,
1617,GO:0003684,1,0.397991079943587,0,62,damaged DNA binding,MF,
1618,GO:0003688,1,0.81822316688844,0,13,DNA replication origin binding,MF,
1619,GO:0003689,1,0.893138037529611,0,8,DNA clamp loader activity,MF,
1621,GO:0003691,1,0.871844772920145,0,9,double-stranded telomeric DNA binding,MF,
1622,GO:0003692,1,0.985944292306334,0,1,left-handed Z-DNA binding,MF,
1624,GO:0003697,1,0.259531339757109,0,91,single-stranded DNA binding,MF,
1626,GO:0003705,1,0.250769350554313,0,94,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1628,GO:0003708,1,0.898169808028226,0,7,retinoic acid receptor activity,MF,
1632,GO:0003720,1,0.895231538087872,0,7,telomerase activity,MF,
1633,GO:0003721,1,0.983426667503399,0,1,telomerase RNA reverse transcriptase activity,MF,
1635,GO:0003724,1,0.338938021980055,0,68,RNA helicase activity,MF,
1637,GO:0003726,1,0.953531369602483,0,3,double-stranded RNA adenosine deaminase activity,MF,
1638,GO:0003727,1,0.340092703024989,0,72,single-stranded RNA binding,MF,
1639,GO:0003729,1,0.0789619239489882,0,176,mRNA binding,MF,
1640,GO:0003730,1,0.4173707150187,0,57,mRNA 3'-UTR binding,MF,
1641,GO:0003735,1,0.303776382016924,0,154,structural constituent of ribosome,MF,
1642,GO:0003743,1,0.505426846479568,0,50,translation initiation factor activity,MF,
1643,GO:0003746,1,0.814539368705158,0,15,translation elongation factor activity,MF,
1644,GO:0003747,1,0.912317000517137,0,6,translation release factor activity,MF,
1645,GO:0003755,1,0.650787769609669,0,38,peptidyl-prolyl cis-trans isomerase activity,MF,
1646,GO:0003756,1,0.761910420757886,0,18,protein disulfide isomerase activity,MF,
1648,GO:0003777,1,0.301070224313534,0,76,microtubule motor activity,MF,
1650,GO:0003785,1,0.730029474518034,0,26,actin monomer binding,MF,
1651,GO:0003796,1,0.924954086471611,0,11,lysozyme activity,MF,
1652,GO:0003810,1,0.86863167040232,0,9,protein-glutamine gamma-glutamyltransferase activity,MF,
1653,GO:0003823,1,0.460245441271632,0,64,antigen binding,MF,
1655,GO:0003826,1,0.972479262480724,0,2,alpha-ketoacid dehydrogenase activity,MF,
1656,GO:0003827,1,0.983978485041012,0,1,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1657,GO:0003828,1,0.911531824956881,0,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1658,GO:0003829,1,0.953485511688079,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1659,GO:0003830,1,0.983426667502609,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1660,GO:0003831,1,0.886458040642715,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1661,GO:0003835,1,0.967126892152746,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1662,GO:0003836,1,0.915444476275257,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1663,GO:0003837,1,0.986396783778228,0,1,beta-ureidopropionase activity,MF,
1664,GO:0003839,1,0.956720498998977,0,4,gamma-glutamylcyclotransferase activity,MF,
1665,GO:0003840,1,0.927514081249578,0,6,gamma-glutamyltransferase activity,MF,
1667,GO:0003842,1,0.983612651923942,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1668,GO:0003844,1,0.983737465785256,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1669,GO:0003845,1,0.97715548456301,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1670,GO:0003846,1,0.930676212596466,0,6,2-acylglycerol O-acyltransferase activity,MF,
1671,GO:0003847,1,0.942863893733167,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1672,GO:0003854,1,0.936671994737406,0,5,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1673,GO:0003857,1,0.889666682173479,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1674,GO:0003858,1,0.96776214400278,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1675,GO:0003860,1,0.987015053147216,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1676,GO:0003863,1,0.972479262480724,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1677,GO:0003865,1,0.9558549769923,0,3,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1678,GO:0003867,1,0.98342666750271,0,1,4-aminobutyrate transaminase activity,MF,
1679,GO:0003868,1,0.988307643515236,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1680,GO:0003870,1,0.972164988682604,0,2,5-aminolevulinate synthase activity,MF,
1681,GO:0003872,1,0.952628404478249,0,3,6-phosphofructokinase activity,MF,
1683,GO:0003874,1,0.992913066894507,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1684,GO:0003875,1,0.971393293968767,0,2,ADP-ribosylarginine hydrolase activity,MF,
1685,GO:0003876,1,0.952786629532296,0,3,AMP deaminase activity,MF,
1686,GO:0003878,1,0.983426667503199,0,1,ATP citrate synthase activity,MF,
1687,GO:0003880,1,0.974092457042282,0,2,protein C-terminal carboxyl O-methyltransferase activity,MF,
1688,GO:0003881,1,0.987273786436746,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1689,GO:0003882,1,0.985036584069117,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1690,GO:0003883,1,0.968407745640743,0,2,CTP synthase activity,MF,
1691,GO:0003884,1,0.977384462490783,0,2,D-amino-acid oxidase activity,MF,
1692,GO:0003886,1,0.951096221559428,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1693,GO:0003887,1,0.685187478709962,0,26,DNA-directed DNA polymerase activity,MF,
1694,GO:0003896,1,0.959004477512194,0,3,DNA primase activity,MF,
1695,GO:0003899,1,0.593354297367447,0,40,DNA-directed 5'-3' RNA polymerase activity,MF,
1696,GO:0003905,1,0.991859090558725,0,1,alkylbase DNA N-glycosylase activity,MF,
1697,GO:0003906,1,0.83909736547131,0,14,DNA-(apurinic or apyrimidinic site) lyase activity,MF,
1698,GO:0003908,1,0.990683644876206,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1699,GO:0003909,1,0.897681363008477,0,7,DNA ligase activity,MF,
1700,GO:0003910,1,0.910228462296707,0,6,DNA ligase (ATP) activity,MF,
1701,GO:0003912,1,0.986516502255753,0,1,DNA nucleotidylexotransferase activity,MF,
1702,GO:0003916,1,0.897139039887158,0,7,DNA topoisomerase activity,MF,
1703,GO:0003917,1,0.939102257904756,0,4,DNA topoisomerase type I activity,MF,
1704,GO:0003918,1,0.955326971127142,0,3,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1705,GO:0003919,1,0.98682085955111,0,1,FMN adenylyltransferase activity,MF,
1706,GO:0003920,1,0.976525761289239,0,2,GMP reductase activity,MF,
1707,GO:0003921,1,0.984994982367092,0,1,GMP synthase activity,MF,
1708,GO:0003922,1,0.984994982367092,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1709,GO:0003923,1,0.929144232311288,0,5,GPI-anchor transamidase activity,MF,
1711,GO:0003933,1,0.986905989498196,0,1,GTP cyclohydrolase activity,MF,
1712,GO:0003934,1,0.986905989498196,0,1,GTP cyclohydrolase I activity,MF,
1713,GO:0003937,1,0.986285617164255,0,1,IMP cyclohydrolase activity,MF,
1714,GO:0003938,1,0.973205184529939,0,2,IMP dehydrogenase activity,MF,
1715,GO:0003939,1,0.984812627494499,0,1,L-iditol 2-dehydrogenase activity,MF,
1716,GO:0003940,1,0.985908188314079,0,1,L-iduronidase activity,MF,
1717,GO:0003941,1,0.96388007287353,0,3,L-serine ammonia-lyase activity,MF,
1718,GO:0003943,1,0.968955563617701,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1719,GO:0003944,1,0.985859227942471,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1720,GO:0003945,1,0.943367567509539,0,4,N-acetyllactosamine synthase activity,MF,
1721,GO:0003947,1,0.983845874760961,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1722,GO:0003948,1,0.986322428969776,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1723,GO:0003950,1,0.723010812593705,0,22,NAD+ ADP-ribosyltransferase activity,MF,
1724,GO:0003951,1,0.770145265343729,0,16,NAD+ kinase activity,MF,
1725,GO:0003952,1,0.985057614653143,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1726,GO:0003953,1,0.968958981885783,0,3,NAD+ nucleosidase activity,MF,
1727,GO:0003954,1,0.758217837635614,0,38,NADH dehydrogenase activity,MF,
1728,GO:0003955,1,0.968675434413405,0,2,NAD(P)H dehydrogenase (quinone) activity,MF,
1729,GO:0003956,1,0.948959641233241,0,5,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1730,GO:0003957,1,0.983426667502958,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1731,GO:0003958,1,0.907490708622134,0,6,NADPH-hemoprotein reductase activity,MF,
1732,GO:0003960,1,0.951198697441253,0,4,NADPH:quinone reductase activity,MF,
1733,GO:0003962,1,0.987912661362616,0,1,cystathionine gamma-synthase activity,MF,
1734,GO:0003963,1,0.984728932554734,0,1,RNA-3'-phosphate cyclase activity,MF,
1735,GO:0003964,1,0.895231538087872,0,7,RNA-directed DNA polymerase activity,MF,
1736,GO:0003968,1,0.967126892153087,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1737,GO:0003973,1,0.976766665223147,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1738,GO:0003974,1,0.988611208323898,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1739,GO:0003975,1,0.986097347811661,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1740,GO:0003976,1,0.9608107789986,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1741,GO:0003977,1,0.96919617903352,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1742,GO:0003978,1,0.988611208323898,0,1,UDP-glucose 4-epimerase activity,MF,
1743,GO:0003979,1,0.983656310666685,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1744,GO:0003980,1,0.967126892147616,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1745,GO:0003983,1,0.986101284024369,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1746,GO:0003985,1,0.959422724794432,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1747,GO:0003986,1,0.959109369144725,0,4,acetyl-CoA hydrolase activity,MF,
1748,GO:0003987,1,0.951904080433216,0,3,acetate-CoA ligase activity,MF,
1749,GO:0003988,1,0.921900326521641,0,6,acetyl-CoA C-acyltransferase activity,MF,
1750,GO:0003989,1,0.96712689214384,0,2,acetyl-CoA carboxylase activity,MF,
1751,GO:0003990,1,0.969963470902708,0,2,acetylcholinesterase activity,MF,
1752,GO:0003993,1,0.886737472879353,0,9,acid phosphatase activity,MF,
1753,GO:0003994,1,0.968000020534805,0,2,aconitate hydratase activity,MF,
1754,GO:0003995,1,0.788324549087837,0,16,acyl-CoA dehydrogenase activity,MF,
1755,GO:0003996,1,0.905532554396237,0,7,acyl-CoA ligase activity,MF,
1756,GO:0003997,1,0.91388314466777,0,6,acyl-CoA oxidase activity,MF,
1757,GO:0003998,1,0.986037004333336,0,2,acylphosphatase activity,MF,
1758,GO:0003999,1,0.994312128798443,0,1,adenine phosphoribosyltransferase activity,MF,
1759,GO:0004000,1,0.859961763373867,0,10,adenosine deaminase activity,MF,
1760,GO:0004001,1,0.986463694180628,0,1,adenosine kinase activity,MF,
1761,GO:0004003,1,0.589952447741771,0,33,ATP-dependent DNA helicase activity,MF,
1762,GO:0004004,1,0.34454265658457,0,67,ATP-dependent RNA helicase activity,MF,
1763,GO:0004008,1,0.967126892148585,0,2,copper-exporting ATPase activity,MF,
1764,GO:0004012,1,0.727808569565821,0,19,phospholipid-translocating ATPase activity,MF,
1765,GO:0004013,1,0.985551825213358,0,1,adenosylhomocysteinase activity,MF,
1766,GO:0004014,1,0.983602856825306,0,1,adenosylmethionine decarboxylase activity,MF,
1767,GO:0004016,1,0.846178402134832,0,10,adenylate cyclase activity,MF,
1768,GO:0004017,1,0.896885721257342,0,7,adenylate kinase activity,MF,
1769,GO:0004018,1,0.989366935492526,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1770,GO:0004019,1,0.972132581090181,0,2,adenylosuccinate synthase activity,MF,
1771,GO:0004020,1,0.968440615952273,0,2,adenylylsulfate kinase activity,MF,
1772,GO:0004021,1,0.970831870878065,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1773,GO:0004022,1,0.887398086597456,0,9,alcohol dehydrogenase (NAD) activity,MF,
1774,GO:0004024,1,0.924693826747659,0,6,alcohol dehydrogenase activity, zinc-dependent,MF,
1775,GO:0004027,1,0.984023185149677,0,2,alcohol sulfotransferase activity,MF,
1776,GO:0004028,1,0.927233680544819,0,5,3-chloroallyl aldehyde dehydrogenase activity,MF,
1777,GO:0004029,1,0.801791685113107,0,14,aldehyde dehydrogenase (NAD) activity,MF,
1778,GO:0004030,1,0.899978996843666,0,7,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1779,GO:0004031,1,0.969550725833312,0,2,aldehyde oxidase activity,MF,
1780,GO:0004032,1,0.928520948860944,0,7,alditol:NADP+ 1-oxidoreductase activity,MF,
1781,GO:0004033,1,0.743535546479805,0,25,aldo-keto reductase (NADP) activity,MF,
1782,GO:0004034,1,0.984939504141857,0,1,aldose 1-epimerase activity,MF,
1783,GO:0004035,1,0.939775259468347,0,4,alkaline phosphatase activity,MF,
1784,GO:0004037,1,0.989549801672682,0,1,allantoicase activity,MF,
1785,GO:0004040,1,0.960242186786727,0,3,amidase activity,MF,
1786,GO:0004042,1,0.986388474029908,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1787,GO:0004043,1,0.983464023325546,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1788,GO:0004044,1,0.983434025032292,0,1,amidophosphoribosyltransferase activity,MF,
1789,GO:0004045,1,0.972618535736237,0,3,aminoacyl-tRNA hydrolase activity,MF,
1790,GO:0004046,1,0.942353225011299,0,5,aminoacylase activity,MF,
1791,GO:0004047,1,0.975757108816498,0,2,aminomethyltransferase activity,MF,
1792,GO:0004051,1,0.984731585042037,0,1,arachidonate 5-lipoxygenase activity,MF,
1793,GO:0004052,1,0.955263371232963,0,3,arachidonate 12-lipoxygenase activity,MF,
1794,GO:0004053,1,0.976464616454752,0,2,arginase activity,MF,
1795,GO:0004055,1,0.987502426474146,0,1,argininosuccinate synthase activity,MF,
1796,GO:0004056,1,0.98673021283246,0,1,argininosuccinate lyase activity,MF,
1797,GO:0004057,1,0.985829354394863,0,1,arginyltransferase activity,MF,
1798,GO:0004058,1,0.986610580862572,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1799,GO:0004059,1,0.989431541561524,0,1,aralkylamine N-acetyltransferase activity,MF,
1800,GO:0004060,1,0.966800073714515,0,3,arylamine N-acetyltransferase activity,MF,
1801,GO:0004061,1,0.988159237720704,0,1,arylformamidase activity,MF,
1802,GO:0004062,1,0.882583742487234,0,11,aryl sulfotransferase activity,MF,
1803,GO:0004063,1,0.979119525692975,0,2,aryldialkylphosphatase activity,MF,
1804,GO:0004064,1,0.933116890316217,0,6,arylesterase activity,MF,
1805,GO:0004065,1,0.830970531555611,0,12,arylsulfatase activity,MF,
1806,GO:0004066,1,0.970623667307003,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1807,GO:0004067,1,0.972805359609794,0,2,asparaginase activity,MF,
1808,GO:0004068,1,0.983443834687134,0,1,aspartate 1-decarboxylase activity,MF,
1809,GO:0004069,1,0.961642051845973,0,3,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1810,GO:0004070,1,0.983426667500101,0,1,aspartate carbamoyltransferase activity,MF,
1811,GO:0004074,1,0.985417736741096,0,2,biliverdin reductase activity,MF,
1812,GO:0004075,1,0.922529298946098,0,5,biotin carboxylase activity,MF,
1813,GO:0004077,1,0.983426667501431,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1814,GO:0004078,1,0.983426667501431,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1815,GO:0004079,1,0.983426667501431,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1816,GO:0004080,1,0.983426667501431,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1817,GO:0004081,1,0.976910849820066,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1818,GO:0004082,1,0.957446622180706,0,4,bisphosphoglycerate mutase activity,MF,
1819,GO:0004084,1,0.972185360111517,0,2,branched-chain-amino-acid transaminase activity,MF,
1820,GO:0004085,1,0.987054088967679,0,1,butyryl-CoA dehydrogenase activity,MF,
1821,GO:0004087,1,0.983426667501773,0,1,carbamoyl-phosphate synthase (ammonia) activity,MF,
1822,GO:0004088,1,0.967126892150859,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1823,GO:0004089,1,0.852587571464395,0,13,carbonate dehydratase activity,MF,
1824,GO:0004090,1,0.961911434780292,0,4,carbonyl reductase (NADPH) activity,MF,
1825,GO:0004092,1,0.984141915519058,0,1,carnitine O-acetyltransferase activity,MF,
1826,GO:0004095,1,0.937333444110542,0,4,carnitine O-palmitoyltransferase activity,MF,
1827,GO:0004096,1,0.96379182675953,0,3,catalase activity,MF,
1828,GO:0004098,1,0.987132801490618,0,1,cerebroside-sulfatase activity,MF,
1829,GO:0004102,1,0.984986147485597,0,1,choline O-acetyltransferase activity,MF,
1830,GO:0004103,1,0.973070779615647,0,2,choline kinase activity,MF,
1831,GO:0004104,1,0.954831211651939,0,3,cholinesterase activity,MF,
1832,GO:0004105,1,0.972389374686161,0,2,choline-phosphate cytidylyltransferase activity,MF,
1833,GO:0004108,1,0.983890557950773,0,1,citrate (Si)-synthase activity,MF,
1834,GO:0004109,1,0.969489656423622,0,2,coproporphyrinogen oxidase activity,MF,
1835,GO:0004111,1,0.928923890195872,0,6,creatine kinase activity,MF,
1837,GO:0004113,1,0.983426667502413,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1840,GO:0004117,1,0.954463259165826,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1841,GO:0004118,1,0.951096177111184,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1842,GO:0004119,1,0.967126892153617,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1843,GO:0004122,1,0.984620385657398,0,1,cystathionine beta-synthase activity,MF,
1844,GO:0004123,1,0.987912661362616,0,1,cystathionine gamma-lyase activity,MF,
1845,GO:0004126,1,0.915448148992083,0,8,cytidine deaminase activity,MF,
1846,GO:0004127,1,0.938632486276514,0,4,cytidylate kinase activity,MF,
1847,GO:0004128,1,0.905438257447852,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1848,GO:0004129,1,0.835316849266878,0,26,cytochrome-c oxidase activity,MF,
1849,GO:0004131,1,0.993209476376177,0,1,cytosine deaminase activity,MF,
1850,GO:0004132,1,0.986567638345282,0,1,dCMP deaminase activity,MF,
1851,GO:0004133,1,0.983426667500003,0,1,glycogen debranching enzyme activity,MF,
1852,GO:0004134,1,0.983426667500003,0,1,4-alpha-glucanotransferase activity,MF,
1853,GO:0004135,1,0.983426667500003,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1854,GO:0004137,1,0.968293490917488,0,2,deoxycytidine kinase activity,MF,
1855,GO:0004138,1,0.99237048907605,0,1,deoxyguanosine kinase activity,MF,
1856,GO:0004139,1,0.98800274491119,0,1,deoxyribose-phosphate aldolase activity,MF,
1857,GO:0004140,1,0.972239669849782,0,2,dephospho-CoA kinase activity,MF,
1858,GO:0004142,1,0.958603645979505,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1859,GO:0004143,1,0.833213824977836,0,11,diacylglycerol kinase activity,MF,
1860,GO:0004144,1,0.939622759299455,0,5,diacylglycerol O-acyltransferase activity,MF,
1861,GO:0004145,1,0.970687955136487,0,3,diamine N-acetyltransferase activity,MF,
1862,GO:0004146,1,0.983426965534487,0,1,dihydrofolate reductase activity,MF,
1863,GO:0004148,1,0.98345849459887,0,1,dihydrolipoyl dehydrogenase activity,MF,
1864,GO:0004149,1,0.984090593450433,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1865,GO:0004151,1,0.983426667500101,0,1,dihydroorotase activity,MF,
1866,GO:0004152,1,0.98640510554394,0,1,dihydroorotate dehydrogenase activity,MF,
1867,GO:0004155,1,0.988404240067971,0,1,6,7-dihydropteridine reductase activity,MF,
1868,GO:0004157,1,0.969823625859079,0,2,dihydropyrimidinase activity,MF,
1869,GO:0004161,1,0.973658230798779,0,2,dimethylallyltranstransferase activity,MF,
1870,GO:0004163,1,0.987632857033407,0,1,diphosphomevalonate decarboxylase activity,MF,
1871,GO:0004164,1,0.987672635562838,0,1,diphthine synthase activity,MF,
1872,GO:0004165,1,0.953617448229291,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1873,GO:0004167,1,0.976168427367497,0,3,dopachrome isomerase activity,MF,
1874,GO:0004168,1,0.985889296504208,0,1,dolichol kinase activity,MF,
1875,GO:0004169,1,0.945746689656506,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1876,GO:0004170,1,0.987278531599617,0,1,dUTP diphosphatase activity,MF,
1877,GO:0004174,1,0.969198626545951,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1879,GO:0004176,1,0.9374197004224,0,4,ATP-dependent peptidase activity,MF,
1880,GO:0004177,1,0.539830990529749,0,40,aminopeptidase activity,MF,
1881,GO:0004180,1,0.589054048726713,0,37,carboxypeptidase activity,MF,
1882,GO:0004181,1,0.70177513939846,0,25,metallocarboxypeptidase activity,MF,
1883,GO:0004185,1,0.931874197508686,0,5,serine-type carboxypeptidase activity,MF,
1884,GO:0004190,1,0.724929164683997,0,24,aspartic-type endopeptidase activity,MF,
1885,GO:0004197,1,0.316525331538477,0,80,cysteine-type endopeptidase activity,MF,
1886,GO:0004198,1,0.754762156555184,0,19,calcium-dependent cysteine-type endopeptidase activity,MF,
1887,GO:0004222,1,0.177079566216833,0,112,metalloendopeptidase activity,MF,
1889,GO:0004298,1,0.832722054452825,0,21,threonine-type endopeptidase activity,MF,
1890,GO:0004300,1,0.89901920082077,0,8,enoyl-CoA hydratase activity,MF,
1891,GO:0004301,1,0.936969951544216,0,5,epoxide hydrolase activity,MF,
1892,GO:0004303,1,0.891370752509209,0,10,estradiol 17-beta-dehydrogenase activity,MF,
1893,GO:0004304,1,0.974636808935292,0,2,estrone sulfotransferase activity,MF,
1894,GO:0004305,1,0.942197935033455,0,4,ethanolamine kinase activity,MF,
1895,GO:0004306,1,0.98735006200746,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1896,GO:0004307,1,0.977759755730213,0,2,ethanolaminephosphotransferase activity,MF,
1897,GO:0004308,1,0.920840726365491,0,6,exo-alpha-sialidase activity,MF,
1898,GO:0004310,1,0.986245001384253,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1899,GO:0004311,1,0.93981412287946,0,4,farnesyltranstransferase activity,MF,
1900,GO:0004312,1,0.856879685320027,0,11,fatty acid synthase activity,MF,
1901,GO:0004313,1,0.983426667498527,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1902,GO:0004314,1,0.9705709900761,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1903,GO:0004315,1,0.974195231250167,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1904,GO:0004316,1,0.983426667498527,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1905,GO:0004317,1,0.983426667498527,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1906,GO:0004319,1,0.983426667498527,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1907,GO:0004320,1,0.971471088697689,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1908,GO:0004321,1,0.918673294606333,0,6,fatty-acyl-CoA synthase activity,MF,
1909,GO:0004322,1,0.920703884472998,0,6,ferroxidase activity,MF,
1910,GO:0004324,1,0.987160786174616,0,1,ferredoxin-NADP+ reductase activity,MF,
1911,GO:0004325,1,0.983426667499955,0,1,ferrochelatase activity,MF,
1912,GO:0004326,1,0.984919350008787,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1913,GO:0004329,1,0.967216149455231,0,2,formate-tetrahydrofolate ligase activity,MF,
1915,GO:0004332,1,0.962985314518169,0,3,fructose-bisphosphate aldolase activity,MF,
1916,GO:0004333,1,0.987672635562838,0,1,fumarate hydratase activity,MF,
1917,GO:0004334,1,0.989508294626228,0,1,fumarylacetoacetase activity,MF,
1918,GO:0004335,1,0.973910692898566,0,2,galactokinase activity,MF,
1919,GO:0004336,1,0.983995437729547,0,1,galactosylceramidase activity,MF,
1920,GO:0004337,1,0.973658230798779,0,2,geranyltranstransferase activity,MF,
1921,GO:0004339,1,0.983426667500841,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1922,GO:0004340,1,0.921366869312607,0,5,glucokinase activity,MF,
1923,GO:0004341,1,0.987024218811306,0,1,gluconolactonase activity,MF,
1924,GO:0004342,1,0.972790966469848,0,2,glucosamine-6-phosphate deaminase activity,MF,
1925,GO:0004343,1,0.983426875402649,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1926,GO:0004345,1,0.969054240556855,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1927,GO:0004346,1,0.956701545241875,0,3,glucose-6-phosphatase activity,MF,
1928,GO:0004347,1,0.986326534224499,0,1,glucose-6-phosphate isomerase activity,MF,
1929,GO:0004348,1,0.957466335322475,0,3,glucosylceramidase activity,MF,
1930,GO:0004349,1,0.983492511859743,0,1,glutamate 5-kinase activity,MF,
1931,GO:0004350,1,0.983492511859743,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1932,GO:0004351,1,0.953980448088529,0,3,glutamate decarboxylase activity,MF,
1933,GO:0004352,1,0.9691527954801,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1934,GO:0004353,1,0.9691527954801,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1935,GO:0004356,1,0.967126892154296,0,2,glutamate-ammonia ligase activity,MF,
1936,GO:0004357,1,0.967477941780756,0,2,glutamate-cysteine ligase activity,MF,
1937,GO:0004359,1,0.953751437425279,0,3,glutaminase activity,MF,
1938,GO:0004360,1,0.967528039503109,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1939,GO:0004361,1,0.98808066581473,0,1,glutaryl-CoA dehydrogenase activity,MF,
1940,GO:0004362,1,0.985629265814754,0,1,glutathione-disulfide reductase activity,MF,
1941,GO:0004363,1,0.987118849001766,0,1,glutathione synthase activity,MF,
1942,GO:0004364,1,0.818782512461144,0,23,glutathione transferase activity,MF,
1943,GO:0004365,1,0.979738735634717,0,2,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1944,GO:0004366,1,0.967800441137523,0,2,glycerol-3-phosphate O-acyltransferase activity,MF,
1945,GO:0004367,1,0.967738681292253,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1946,GO:0004368,1,0.967738335358906,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1947,GO:0004370,1,0.954895871649461,0,3,glycerol kinase activity,MF,
1948,GO:0004372,1,0.97095929135171,0,2,glycine hydroxymethyltransferase activity,MF,
1949,GO:0004373,1,0.967477026151171,0,2,glycogen (starch) synthase activity,MF,
1951,GO:0004376,1,0.9413151698935,0,4,glycolipid mannosyltransferase activity,MF,
1952,GO:0004377,1,0.984796191921123,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1953,GO:0004378,1,0.984001687426431,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1955,GO:0004380,1,0.988788646963824,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1956,GO:0004381,1,0.988788646963824,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1957,GO:0004382,1,0.97016795721826,0,2,guanosine-diphosphatase activity,MF,
1959,GO:0004385,1,0.815280760642961,0,13,guanylate kinase activity,MF,
1960,GO:0004386,1,0.0955464928952818,0,147,helicase activity,MF,
1961,GO:0004392,1,0.977021423529051,0,2,heme oxygenase (decyclizing) activity,MF,
1962,GO:0004394,1,0.983426667503302,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1963,GO:0004395,1,0.990677269526394,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1964,GO:0004396,1,0.921366869312607,0,5,hexokinase activity,MF,
1965,GO:0004397,1,0.983692963243612,0,1,histidine ammonia-lyase activity,MF,
1966,GO:0004398,1,0.985158817924019,0,1,histidine decarboxylase activity,MF,
1967,GO:0004402,1,0.444137641989486,0,54,histone acetyltransferase activity,MF,
1969,GO:0004408,1,0.985565794756864,0,1,holocytochrome-c synthase activity,MF,
1970,GO:0004411,1,0.987021926285317,0,1,homogentisate 1,2-dioxygenase activity,MF,
1971,GO:0004415,1,0.917022062692076,0,6,hyalurononglucosaminidase activity,MF,
1972,GO:0004416,1,0.972939519486341,0,2,hydroxyacylglutathione hydrolase activity,MF,
1973,GO:0004418,1,0.989431541561524,0,1,hydroxymethylbilane synthase activity,MF,
1974,GO:0004419,1,0.97423421369778,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1975,GO:0004420,1,0.983426667503102,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1977,GO:0004422,1,0.989741121028373,0,1,hypoxanthine phosphoribosyltransferase activity,MF,
1978,GO:0004423,1,0.983426667501678,0,1,iduronate-2-sulfatase activity,MF,
1979,GO:0004427,1,0.967956777220474,0,3,inorganic diphosphatase activity,MF,
1980,GO:0004430,1,0.935416997099509,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1981,GO:0004435,1,0.65016548087968,0,27,phosphatidylinositol phospholipase C activity,MF,
1982,GO:0004438,1,0.794694616805476,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1983,GO:0004439,1,0.87825971221696,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1984,GO:0004441,1,0.986312179002375,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1985,GO:0004445,1,0.922756876337637,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1986,GO:0004446,1,0.984099260716134,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1987,GO:0004447,1,0.967614558533038,0,2,iodide peroxidase activity,MF,
1988,GO:0004448,1,0.937226686648181,0,5,isocitrate dehydrogenase activity,MF,
1989,GO:0004449,1,0.962696047903393,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1990,GO:0004450,1,0.973547835630449,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1991,GO:0004452,1,0.976371857725438,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
1993,GO:0004457,1,0.915033297631832,0,7,lactate dehydrogenase activity,MF,
1994,GO:0004458,1,0.971391855013652,0,2,D-lactate dehydrogenase (cytochrome) activity,MF,
1995,GO:0004459,1,0.941988431080719,0,5,L-lactate dehydrogenase activity,MF,
1996,GO:0004461,1,0.964486416262552,0,3,lactose synthase activity,MF,
1997,GO:0004462,1,0.986505903178236,0,1,lactoylglutathione lyase activity,MF,
1998,GO:0004463,1,0.986384323663026,0,1,leukotriene-A4 hydrolase activity,MF,
1999,GO:0004464,1,0.988749328285526,0,2,leukotriene-C4 synthase activity,MF,
2000,GO:0004465,1,0.898863580538186,0,8,lipoprotein lipase activity,MF,
2001,GO:0004466,1,0.946397294725809,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
2003,GO:0004468,1,0.923259548121004,0,6,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
2004,GO:0004470,1,0.944490239136982,0,4,malic enzyme activity,MF,
2005,GO:0004471,1,0.953416875684478,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
2006,GO:0004473,1,0.953416875684478,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
2007,GO:0004474,1,0.983426667501724,0,1,malate synthase activity,MF,
2008,GO:0004475,1,0.988655300479096,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
2009,GO:0004476,1,0.987762819794679,0,1,mannose-6-phosphate isomerase activity,MF,
2010,GO:0004477,1,0.939430658851199,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
2011,GO:0004478,1,0.967925353197841,0,2,methionine adenosyltransferase activity,MF,
2012,GO:0004479,1,0.984284718486085,0,1,methionyl-tRNA formyltransferase activity,MF,
2013,GO:0004482,1,0.983426667501184,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2014,GO:0004484,1,0.983426667503104,0,1,mRNA guanylyltransferase activity,MF,
2015,GO:0004485,1,0.968456187465255,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2016,GO:0004486,1,0.983492142903563,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2017,GO:0004487,1,0.955241012247956,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2018,GO:0004488,1,0.939430658851199,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2019,GO:0004489,1,0.983426667500052,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2020,GO:0004490,1,0.988732891730711,0,1,methylglutaconyl-CoA hydratase activity,MF,
2021,GO:0004491,1,0.985942385253858,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2022,GO:0004492,1,0.986212725892648,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2023,GO:0004493,1,0.993372996941813,0,1,methylmalonyl-CoA epimerase activity,MF,
2024,GO:0004494,1,0.98391685812541,0,1,methylmalonyl-CoA mutase activity,MF,
2025,GO:0004496,1,0.986386398470818,0,1,mevalonate kinase activity,MF,
2026,GO:0004497,1,0.267577662353645,0,91,monooxygenase activity,MF,
2027,GO:0004498,1,0.984919350008787,0,1,calcidiol 1-monooxygenase activity,MF,
2028,GO:0004499,1,0.929037390739833,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2029,GO:0004500,1,0.968310512499474,0,2,dopamine beta-monooxygenase activity,MF,
2030,GO:0004502,1,0.983426667502609,0,1,kynurenine 3-monooxygenase activity,MF,
2031,GO:0004503,1,0.986425962517831,0,1,monophenol monooxygenase activity,MF,
2032,GO:0004504,1,0.983435827084472,0,1,peptidylglycine monooxygenase activity,MF,
2033,GO:0004505,1,0.962551116101684,0,3,phenylalanine 4-monooxygenase activity,MF,
2034,GO:0004506,1,0.983875770723926,0,1,squalene monooxygenase activity,MF,
2035,GO:0004507,1,0.967719346008499,0,2,steroid 11-beta-monooxygenase activity,MF,
2036,GO:0004508,1,0.987288030753513,0,1,steroid 17-alpha-monooxygenase activity,MF,
2037,GO:0004509,1,0.986578345939663,0,1,steroid 21-monooxygenase activity,MF,
2038,GO:0004510,1,0.973018978780498,0,2,tryptophan 5-monooxygenase activity,MF,
2039,GO:0004511,1,0.987123496878505,0,1,tyrosine 3-monooxygenase activity,MF,
2040,GO:0004512,1,0.985654217471866,0,1,inositol-3-phosphate synthase activity,MF,
2041,GO:0004513,1,0.985489571218687,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2042,GO:0004514,1,0.972583232298322,0,2,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2043,GO:0004515,1,0.939080849878684,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2044,GO:0004517,1,0.952613141961679,0,3,nitric-oxide synthase activity,MF,
2045,GO:0004518,1,0.0614683425115619,0,199,nuclease activity,MF,
2046,GO:0004519,1,0.184636720938127,0,125,endonuclease activity,MF,
2047,GO:0004520,1,0.495990398657676,0,50,endodeoxyribonuclease activity,MF,
2048,GO:0004521,1,0.526798433728143,0,50,endoribonuclease activity,MF,
2049,GO:0004522,1,0.973137105562928,0,4,ribonuclease A activity,MF,
2050,GO:0004523,1,0.929584091760403,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2051,GO:0004525,1,0.940839599287677,0,4,ribonuclease III activity,MF,
2052,GO:0004526,1,0.892547289327677,0,10,ribonuclease P activity,MF,
2053,GO:0004527,1,0.337772158409579,0,73,exonuclease activity,MF,
2054,GO:0004528,1,0.926975171063735,0,5,phosphodiesterase I activity,MF,
2055,GO:0004529,1,0.761086620514641,0,19,exodeoxyribonuclease activity,MF,
2056,GO:0004530,1,0.9837469230169,0,1,deoxyribonuclease I activity,MF,
2057,GO:0004531,1,0.978310190656158,0,2,deoxyribonuclease II activity,MF,
2058,GO:0004532,1,0.63083898945042,0,32,exoribonuclease activity,MF,
2059,GO:0004534,1,0.967196110880362,0,2,5'-3' exoribonuclease activity,MF,
2060,GO:0004535,1,0.826169993168951,0,12,poly(A)-specific ribonuclease activity,MF,
2061,GO:0004536,1,0.382482411337649,0,69,deoxyribonuclease activity,MF,
2062,GO:0004540,1,0.302967189321295,0,90,ribonuclease activity,MF,
2063,GO:0004549,1,0.830957404645594,0,15,tRNA-specific ribonuclease activity,MF,
2064,GO:0004550,1,0.820405963939357,0,16,nucleoside diphosphate kinase activity,MF,
2065,GO:0004551,1,0.82594794257162,0,14,nucleotide diphosphatase activity,MF,
2066,GO:0004553,1,0.288804991653623,0,88,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
2067,GO:0004555,1,0.987326145032158,0,1,alpha,alpha-trehalase activity,MF,
2068,GO:0004556,1,0.938268518426777,0,5,alpha-amylase activity,MF,
2069,GO:0004557,1,0.973328483457088,0,2,alpha-galactosidase activity,MF,
2070,GO:0004558,1,0.935356642509549,0,4,alpha-1,4-glucosidase activity,MF,
2071,GO:0004559,1,0.808828953062159,0,13,alpha-mannosidase activity,MF,
2072,GO:0004560,1,0.972686771564485,0,2,alpha-L-fucosidase activity,MF,
2073,GO:0004561,1,0.984220836518161,0,1,alpha-N-acetylglucosaminidase activity,MF,
2074,GO:0004563,1,0.927049360867317,0,5,beta-N-acetylhexosaminidase activity,MF,
2075,GO:0004564,1,0.98342666750138,0,1,beta-fructofuranosidase activity,MF,
2076,GO:0004565,1,0.913001109642596,0,6,beta-galactosidase activity,MF,
2077,GO:0004566,1,0.957361934123178,0,3,beta-glucuronidase activity,MF,
2078,GO:0004567,1,0.983564981186366,0,1,beta-mannosidase activity,MF,
2079,GO:0004568,1,0.959036414779142,0,3,chitinase activity,MF,
2080,GO:0004569,1,0.983426667503056,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2081,GO:0004571,1,0.893865202475935,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2082,GO:0004572,1,0.967126892152599,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2083,GO:0004573,1,0.98432315421633,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2084,GO:0004574,1,0.967154334063134,0,2,oligo-1,6-glucosidase activity,MF,
2085,GO:0004575,1,0.98342666750138,0,1,sucrose alpha-glucosidase activity,MF,
2086,GO:0004576,1,0.882325089835991,0,10,oligosaccharyl transferase activity,MF,
2087,GO:0004577,1,0.975996930647109,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2088,GO:0004578,1,0.983426793805024,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2089,GO:0004579,1,0.890076123815875,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2090,GO:0004581,1,0.991295924633653,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2091,GO:0004582,1,0.97774236698752,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2092,GO:0004583,1,0.940133173747736,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2093,GO:0004584,1,0.985312069336748,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2094,GO:0004585,1,0.988404240067971,0,1,ornithine carbamoyltransferase activity,MF,
2095,GO:0004586,1,0.98640510554394,0,1,ornithine decarboxylase activity,MF,
2096,GO:0004587,1,0.986776485357772,0,1,ornithine-oxo-acid transaminase activity,MF,
2097,GO:0004588,1,0.984486710654955,0,1,orotate phosphoribosyltransferase activity,MF,
2098,GO:0004590,1,0.984486710654955,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2099,GO:0004591,1,0.951122764598316,0,3,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2100,GO:0004594,1,0.941541296874546,0,4,pantothenate kinase activity,MF,
2101,GO:0004595,1,0.985530963125257,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2102,GO:0004596,1,0.858318177114423,0,11,peptide alpha-N-acetyltransferase activity,MF,
2103,GO:0004597,1,0.983449219037142,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2104,GO:0004598,1,0.983435827084472,0,1,peptidylamidoglycolate lyase activity,MF,
2105,GO:0004601,1,0.61900774563461,0,43,peroxidase activity,MF,
2106,GO:0004602,1,0.830404837390788,0,20,glutathione peroxidase activity,MF,
2108,GO:0004605,1,0.953266576407432,0,3,phosphatidate cytidylyltransferase activity,MF,
2109,GO:0004607,1,0.990118983056019,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2110,GO:0004608,1,0.99249475714563,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2111,GO:0004609,1,0.970798287768989,0,2,phosphatidylserine decarboxylase activity,MF,
2112,GO:0004610,1,0.986699546985679,0,1,phosphoacetylglucosamine mutase activity,MF,
2113,GO:0004611,1,0.971471861582187,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2114,GO:0004613,1,0.971471861582187,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2115,GO:0004614,1,0.955936244268271,0,3,phosphoglucomutase activity,MF,
2116,GO:0004615,1,0.976125725242195,0,2,phosphomannomutase activity,MF,
2117,GO:0004616,1,0.957777646302774,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2118,GO:0004617,1,0.986608426636293,0,1,phosphoglycerate dehydrogenase activity,MF,
2119,GO:0004618,1,0.973754826573876,0,2,phosphoglycerate kinase activity,MF,
2120,GO:0004619,1,0.957446622180706,0,4,phosphoglycerate mutase activity,MF,
2122,GO:0004621,1,0.985560550415529,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2123,GO:0004622,1,0.753480885720948,0,19,lysophospholipase activity,MF,
2124,GO:0004623,1,0.665754156858738,0,32,phospholipase A2 activity,MF,
2126,GO:0004630,1,0.916933391687104,0,6,phospholipase D activity,MF,
2127,GO:0004631,1,0.990474443795611,0,1,phosphomevalonate kinase activity,MF,
2128,GO:0004632,1,0.990693212074519,0,1,phosphopantothenate--cysteine ligase activity,MF,
2129,GO:0004633,1,0.985814490801918,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2130,GO:0004634,1,0.947627833320792,0,4,phosphopyruvate hydratase activity,MF,
2131,GO:0004637,1,0.983502394857654,0,1,phosphoribosylamine-glycine ligase activity,MF,
2132,GO:0004638,1,0.983552066272807,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2133,GO:0004639,1,0.983552066272807,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2134,GO:0004641,1,0.983502394857654,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2135,GO:0004642,1,0.983426667502171,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2136,GO:0004643,1,0.986285617164255,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2137,GO:0004644,1,0.983502394857654,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2138,GO:0004645,1,0.911049098968753,0,6,phosphorylase activity,MF,
2139,GO:0004647,1,0.961831652568336,0,3,phosphoserine phosphatase activity,MF,
2140,GO:0004648,1,0.986194655812155,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2141,GO:0004649,1,0.971812432510703,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2142,GO:0004651,1,0.972070146087604,0,2,polynucleotide 5'-phosphatase activity,MF,
2143,GO:0004652,1,0.875592123273658,0,8,polynucleotide adenylyltransferase activity,MF,
2144,GO:0004653,1,0.737534662916354,0,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2145,GO:0004654,1,0.983426667503004,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2146,GO:0004655,1,0.983662313704872,0,1,porphobilinogen synthase activity,MF,
2147,GO:0004656,1,0.941410674380747,0,4,procollagen-proline 4-dioxygenase activity,MF,
2148,GO:0004657,1,0.974213883144109,0,2,proline dehydrogenase activity,MF,
2149,GO:0004658,1,0.972680227483991,0,2,propionyl-CoA carboxylase activity,MF,
2150,GO:0004659,1,0.802804443238116,0,15,prenyltransferase activity,MF,
2151,GO:0004660,1,0.972983680269154,0,2,protein farnesyltransferase activity,MF,
2152,GO:0004661,1,0.933814651745137,0,5,protein geranylgeranyltransferase activity,MF,
2153,GO:0004662,1,0.973167496059491,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2154,GO:0004663,1,0.948689331480355,0,4,Rab geranylgeranyltransferase activity,MF,
2155,GO:0004666,1,0.967126892154634,0,2,prostaglandin-endoperoxide synthase activity,MF,
2156,GO:0004667,1,0.982432836066447,0,2,prostaglandin-D synthase activity,MF,
2157,GO:0004668,1,0.923864593654315,0,5,protein-arginine deiminase activity,MF,
2158,GO:0004671,1,0.983426667502809,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2163,GO:0004676,1,0.983426667500197,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2164,GO:0004677,1,0.951778401555192,0,3,DNA-dependent protein kinase activity,MF,
2165,GO:0004679,1,0.897474212234649,0,7,AMP-activated protein kinase activity,MF,
2166,GO:0004683,1,0.649700444258787,0,28,calmodulin-dependent protein kinase activity,MF,
2167,GO:0004686,1,0.983426667499757,0,1,elongation factor-2 kinase activity,MF,
2168,GO:0004687,1,0.936049178921938,0,4,myosin light chain kinase activity,MF,
2169,GO:0004689,1,0.925625595029588,0,5,phosphorylase kinase activity,MF,
2172,GO:0004692,1,0.967254608706972,0,2,cGMP-dependent protein kinase activity,MF,
2173,GO:0004693,1,0.694272527396792,0,27,cyclin-dependent protein serine/threonine kinase activity,MF,
2174,GO:0004694,1,0.936228797357857,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2176,GO:0004698,1,0.94558027700047,0,4,calcium-dependent protein kinase C activity,MF,
2177,GO:0004699,1,0.951897078867132,0,3,calcium-independent protein kinase C activity,MF,
2179,GO:0004703,1,0.930610508191612,0,5,G-protein coupled receptor kinase activity,MF,
2180,GO:0004704,1,0.914439340324706,0,6,NF-kappaB-inducing kinase activity,MF,
2181,GO:0004705,1,0.957189368071865,0,3,JUN kinase activity,MF,
2182,GO:0004706,1,0.951205048535775,0,3,JUN kinase kinase kinase activity,MF,
2184,GO:0004708,1,0.81995401631611,0,13,MAP kinase kinase activity,MF,
2186,GO:0004711,1,0.955539596820515,0,3,ribosomal protein S6 kinase activity,MF,
2190,GO:0004715,1,0.458035767645094,0,50,non-membrane spanning protein tyrosine kinase activity,MF,
2192,GO:0004719,1,0.955478534797931,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2193,GO:0004720,1,0.951380289540389,0,3,protein-lysine 6-oxidase activity,MF,
2195,GO:0004722,1,0.36677470563789,0,67,protein serine/threonine phosphatase activity,MF,
2196,GO:0004723,1,0.90522011036093,0,6,calcium-dependent protein serine/threonine phosphatase activity,MF,
2198,GO:0004726,1,0.887134935283288,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2199,GO:0004727,1,0.977091434809013,0,2,prenylated protein tyrosine phosphatase activity,MF,
2200,GO:0004728,1,0.984648274463338,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2201,GO:0004729,1,0.987907540571087,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2202,GO:0004730,1,0.98831833041481,0,1,pseudouridylate synthase activity,MF,
2203,GO:0004731,1,0.968821264062895,0,2,purine-nucleoside phosphorylase activity,MF,
2204,GO:0004733,1,0.983494754742227,0,1,pyridoxamine-phosphate oxidase activity,MF,
2205,GO:0004735,1,0.960625239353126,0,3,pyrroline-5-carboxylate reductase activity,MF,
2206,GO:0004736,1,0.983426667503346,0,1,pyruvate carboxylase activity,MF,
2207,GO:0004738,1,0.916906041018077,0,6,pyruvate dehydrogenase activity,MF,
2208,GO:0004739,1,0.963005863870025,0,3,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2209,GO:0004740,1,0.937353633927141,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2210,GO:0004741,1,0.951098586548398,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2211,GO:0004742,1,0.983426667503199,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2212,GO:0004743,1,0.968793582539711,0,2,pyruvate kinase activity,MF,
2213,GO:0004744,1,0.984582974432554,0,1,retinal isomerase activity,MF,
2215,GO:0004747,1,0.99110925961328,0,1,ribokinase activity,MF,
2216,GO:0004748,1,0.951426103240089,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2217,GO:0004749,1,0.936842280866501,0,5,ribose phosphate diphosphokinase activity,MF,
2218,GO:0004750,1,0.9855274968745,0,1,ribulose-phosphate 3-epimerase activity,MF,
2219,GO:0004751,1,0.987451314978707,0,1,ribose-5-phosphate isomerase activity,MF,
2220,GO:0004753,1,0.983426667501579,0,1,saccharopine dehydrogenase activity,MF,
2221,GO:0004756,1,0.970500340277343,0,2,selenide, water dikinase activity,MF,
2222,GO:0004757,1,0.989502375219843,0,1,sepiapterin reductase activity,MF,
2223,GO:0004758,1,0.925848536873688,0,5,serine C-palmitoyltransferase activity,MF,
2224,GO:0004760,1,0.988666351505513,0,1,serine-pyruvate transaminase activity,MF,
2225,GO:0004766,1,0.990613638837093,0,1,spermidine synthase activity,MF,
2226,GO:0004767,1,0.918774099259547,0,6,sphingomyelin phosphodiesterase activity,MF,
2227,GO:0004768,1,0.952536008850477,0,3,stearoyl-CoA 9-desaturase activity,MF,
2228,GO:0004769,1,0.967904522452353,0,3,steroid delta-isomerase activity,MF,
2229,GO:0004771,1,0.941136569923366,0,4,sterol esterase activity,MF,
2230,GO:0004772,1,0.970096675609431,0,2,sterol O-acyltransferase activity,MF,
2231,GO:0004773,1,0.983426667500985,0,1,steryl-sulfatase activity,MF,
2232,GO:0004774,1,0.961320122914664,0,3,succinate-CoA ligase activity,MF,
2233,GO:0004775,1,0.975629164101722,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2234,GO:0004776,1,0.974967399704725,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2235,GO:0004777,1,0.983426667502463,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2236,GO:0004778,1,0.988529020721145,0,1,succinyl-CoA hydrolase activity,MF,
2237,GO:0004779,1,0.968440615952273,0,2,sulfate adenylyltransferase activity,MF,
2238,GO:0004781,1,0.968440615952273,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2239,GO:0004782,1,0.968077207582068,0,2,sulfinoalanine decarboxylase activity,MF,
2240,GO:0004784,1,0.952154459439602,0,5,superoxide dismutase activity,MF,
2241,GO:0004788,1,0.985321884811008,0,1,thiamine diphosphokinase activity,MF,
2242,GO:0004790,1,0.984736899495618,0,1,thioether S-methyltransferase activity,MF,
2243,GO:0004791,1,0.897034716883201,0,10,thioredoxin-disulfide reductase activity,MF,
2244,GO:0004792,1,0.966394961463562,0,3,thiosulfate sulfurtransferase activity,MF,
2245,GO:0004793,1,0.97095929135171,0,2,threonine aldolase activity,MF,
2246,GO:0004794,1,0.978608375577645,0,2,L-threonine ammonia-lyase activity,MF,
2247,GO:0004796,1,0.986226822659447,0,1,thromboxane-A synthase activity,MF,
2248,GO:0004797,1,0.972312758296811,0,2,thymidine kinase activity,MF,
2249,GO:0004798,1,0.975537422808287,0,2,thymidylate kinase activity,MF,
2250,GO:0004799,1,0.988766311713202,0,1,thymidylate synthase activity,MF,
2251,GO:0004800,1,0.958490736562784,0,3,thyroxine 5'-deiodinase activity,MF,
2252,GO:0004801,1,0.990811617137353,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2253,GO:0004802,1,0.955622644330578,0,3,transketolase activity,MF,
2254,GO:0004803,1,0.952355803174917,0,3,transposase activity,MF,
2255,GO:0004806,1,0.754578368296377,0,21,triglyceride lipase activity,MF,
2256,GO:0004807,1,0.989484632295048,0,1,triose-phosphate isomerase activity,MF,
2257,GO:0004809,1,0.958144376538405,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2258,GO:0004810,1,0.985607998290606,0,1,tRNA adenylyltransferase activity,MF,
2259,GO:0004812,1,0.517672216765984,0,44,aminoacyl-tRNA ligase activity,MF,
2260,GO:0004813,1,0.954818913282896,0,3,alanine-tRNA ligase activity,MF,
2261,GO:0004814,1,0.953336870212978,0,4,arginine-tRNA ligase activity,MF,
2262,GO:0004815,1,0.969193774659445,0,2,aspartate-tRNA ligase activity,MF,
2263,GO:0004816,1,0.969884692599997,0,2,asparagine-tRNA ligase activity,MF,
2264,GO:0004817,1,0.971980397456852,0,2,cysteine-tRNA ligase activity,MF,
2265,GO:0004818,1,0.967127175431375,0,2,glutamate-tRNA ligase activity,MF,
2266,GO:0004819,1,0.985045578433779,0,1,glutamine-tRNA ligase activity,MF,
2267,GO:0004820,1,0.973151985391688,0,2,glycine-tRNA ligase activity,MF,
2268,GO:0004821,1,0.971927800655985,0,2,histidine-tRNA ligase activity,MF,
2269,GO:0004822,1,0.967164636951474,0,2,isoleucine-tRNA ligase activity,MF,
2270,GO:0004823,1,0.967126892154975,0,2,leucine-tRNA ligase activity,MF,
2271,GO:0004824,1,0.986234894551021,0,1,lysine-tRNA ligase activity,MF,
2272,GO:0004825,1,0.968257688105884,0,2,methionine-tRNA ligase activity,MF,
2273,GO:0004826,1,0.930787242439323,0,5,phenylalanine-tRNA ligase activity,MF,
2274,GO:0004827,1,0.969049321437464,0,2,proline-tRNA ligase activity,MF,
2275,GO:0004828,1,0.973707440817741,0,2,serine-tRNA ligase activity,MF,
2276,GO:0004829,1,0.953624065411033,0,3,threonine-tRNA ligase activity,MF,
2277,GO:0004830,1,0.968802222658267,0,2,tryptophan-tRNA ligase activity,MF,
2278,GO:0004831,1,0.969990949835853,0,2,tyrosine-tRNA ligase activity,MF,
2279,GO:0004832,1,0.95111843074827,0,3,valine-tRNA ligase activity,MF,
2280,GO:0004833,1,0.96296829516256,0,3,tryptophan 2,3-dioxygenase activity,MF,
2281,GO:0004835,1,0.983426667502463,0,1,tubulin-tyrosine ligase activity,MF,
2282,GO:0004838,1,0.984254363789522,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2283,GO:0004839,1,0.936856028812558,0,4,ubiquitin activating enzyme activity,MF,
2285,GO:0004843,1,0.3226014574616,0,73,thiol-dependent ubiquitin-specific protease activity,MF,
2286,GO:0004844,1,0.939430602805882,0,5,uracil DNA N-glycosylase activity,MF,
2287,GO:0004849,1,0.935000070960513,0,5,uridine kinase activity,MF,
2288,GO:0004850,1,0.972916264325596,0,2,uridine phosphorylase activity,MF,
2289,GO:0004852,1,0.990100485821345,0,1,uroporphyrinogen-III synthase activity,MF,
2290,GO:0004853,1,0.98991670010378,0,1,uroporphyrinogen decarboxylase activity,MF,
2291,GO:0004854,1,0.967126892153423,0,2,xanthine dehydrogenase activity,MF,
2292,GO:0004855,1,0.983426667501771,0,1,xanthine oxidase activity,MF,
2293,GO:0004856,1,0.9834394456677,0,1,xylulokinase activity,MF,
2295,GO:0004859,1,0.89230975486842,0,11,phospholipase inhibitor activity,MF,
2299,GO:0004864,1,0.631117291453878,0,33,protein phosphatase inhibitor activity,MF,
2300,GO:0004865,1,0.899842941708459,0,8,protein serine/threonine phosphatase inhibitor activity,MF,
2306,GO:0004873,1,0.979037040709369,0,2,asialoglycoprotein receptor activity,MF,
2307,GO:0004874,1,0.967126892152988,0,2,aryl hydrocarbon receptor activity,MF,
2308,GO:0004875,1,0.87084904374353,0,10,complement receptor activity,MF,
2309,GO:0004876,1,0.986912755940205,0,1,complement component C3a receptor activity,MF,
2310,GO:0004877,1,0.983426667497591,0,1,complement component C3b receptor activity,MF,
2311,GO:0004878,1,0.970345775918914,0,2,complement component C5a receptor activity,MF,
2313,GO:0004882,1,0.958797792872709,0,3,androgen receptor activity,MF,
2314,GO:0004883,1,0.983426667500692,0,1,glucocorticoid receptor activity,MF,
2315,GO:0004886,1,0.958916688077192,0,3,9-cis retinoic acid receptor activity,MF,
2316,GO:0004887,1,0.904276198718303,0,7,thyroid hormone receptor activity,MF,
2318,GO:0004890,1,0.749315514917083,0,19,GABA-A receptor activity,MF,
2319,GO:0004896,1,0.276737189246636,0,88,cytokine receptor activity,MF,
2320,GO:0004897,1,0.938716225841863,0,4,ciliary neurotrophic factor receptor activity,MF,
2321,GO:0004900,1,0.98738366916793,0,1,erythropoietin receptor activity,MF,
2322,GO:0004904,1,0.931310919354886,0,5,interferon receptor activity,MF,
2323,GO:0004905,1,0.973354884596609,0,2,type I interferon receptor activity,MF,
2324,GO:0004906,1,0.972187293818802,0,2,interferon-gamma receptor activity,MF,
2325,GO:0004908,1,0.900732594528661,0,7,interleukin-1 receptor activity,MF,
2326,GO:0004909,1,0.970476013439702,0,2,interleukin-1, Type I, activating receptor activity,MF,
2327,GO:0004910,1,0.973695712170117,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2328,GO:0004911,1,0.95672792955013,0,3,interleukin-2 receptor activity,MF,
2329,GO:0004912,1,0.971683569957018,0,2,interleukin-3 receptor activity,MF,
2330,GO:0004913,1,0.974426667240579,0,2,interleukin-4 receptor activity,MF,
2331,GO:0004914,1,0.970251895797798,0,2,interleukin-5 receptor activity,MF,
2332,GO:0004915,1,0.967351909500442,0,2,interleukin-6 receptor activity,MF,
2333,GO:0004917,1,0.976780602445324,0,2,interleukin-7 receptor activity,MF,
2334,GO:0004918,1,0.96943957111989,0,2,interleukin-8 receptor activity,MF,
2335,GO:0004919,1,0.986042558870148,0,1,interleukin-9 receptor activity,MF,
2336,GO:0004920,1,0.928300705480017,0,5,interleukin-10 receptor activity,MF,
2337,GO:0004921,1,0.98365546150649,0,1,interleukin-11 receptor activity,MF,
2338,GO:0004923,1,0.967351909493862,0,2,leukemia inhibitory factor receptor activity,MF,
2339,GO:0004924,1,0.951337019066658,0,3,oncostatin-M receptor activity,MF,
2340,GO:0004925,1,0.983426667494932,0,1,prolactin receptor activity,MF,
2342,GO:0004931,1,0.907063194500431,0,7,extracellular ATP-gated cation channel activity,MF,
2345,GO:0004937,1,0.956757414133591,0,3,alpha1-adrenergic receptor activity,MF,
2347,GO:0004939,1,0.955811045054581,0,3,beta-adrenergic receptor activity,MF,
2348,GO:0004940,1,0.984083713531824,0,1,beta1-adrenergic receptor activity,MF,
2349,GO:0004941,1,0.9865398861192,0,1,beta2-adrenergic receptor activity,MF,
2350,GO:0004945,1,0.953074549697369,0,4,angiotensin type II receptor activity,MF,
2351,GO:0004946,1,0.980021299662763,0,2,bombesin receptor activity,MF,
2352,GO:0004947,1,0.974139097614161,0,2,bradykinin receptor activity,MF,
2353,GO:0004948,1,0.960487494692166,0,3,calcitonin receptor activity,MF,
2354,GO:0004949,1,0.955307526074503,0,3,cannabinoid receptor activity,MF,
2355,GO:0004950,1,0.727207559574566,0,23,chemokine receptor activity,MF,
2356,GO:0004951,1,0.974600767753314,0,2,cholecystokinin receptor activity,MF,
2357,GO:0004952,1,0.882528279662702,0,12,dopamine neurotransmitter receptor activity,MF,
2358,GO:0004953,1,0.807085014535244,0,15,icosanoid receptor activity,MF,
2359,GO:0004954,1,0.851634958642001,0,11,prostanoid receptor activity,MF,
2360,GO:0004955,1,0.864058041560615,0,10,prostaglandin receptor activity,MF,
2361,GO:0004956,1,0.968925942677442,0,2,prostaglandin D receptor activity,MF,
2362,GO:0004957,1,0.916207397782058,0,6,prostaglandin E receptor activity,MF,
2363,GO:0004958,1,0.968407661016819,0,2,prostaglandin F receptor activity,MF,
2364,GO:0004960,1,0.985631043093334,0,1,thromboxane receptor activity,MF,
2365,GO:0004961,1,0.985631043093334,0,1,thromboxane A2 receptor activity,MF,
2366,GO:0004962,1,0.967129467001007,0,2,endothelin receptor activity,MF,
2367,GO:0004963,1,0.968315867882454,0,2,follicle-stimulating hormone receptor activity,MF,
2368,GO:0004964,1,0.983757653963509,0,1,luteinizing hormone receptor activity,MF,
2369,GO:0004965,1,0.951096177118034,0,3,G-protein coupled GABA receptor activity,MF,
2370,GO:0004966,1,0.930452416397038,0,7,galanin receptor activity,MF,
2371,GO:0004967,1,0.959027058069516,0,3,glucagon receptor activity,MF,
2372,GO:0004968,1,0.967126892153958,0,2,gonadotropin-releasing hormone receptor activity,MF,
2373,GO:0004969,1,0.909789827052169,0,6,histamine receptor activity,MF,
2374,GO:0004970,1,0.72861741833328,0,19,ionotropic glutamate receptor activity,MF,
2375,GO:0004971,1,0.935330099172056,0,4,AMPA glutamate receptor activity,MF,
2376,GO:0004972,1,0.889576534873491,0,7,NMDA glutamate receptor activity,MF,
2377,GO:0004974,1,0.947722837371227,0,4,leukotriene receptor activity,MF,
2378,GO:0004977,1,0.930736127343616,0,6,melanocortin receptor activity,MF,
2379,GO:0004978,1,0.983446363261683,0,1,corticotropin receptor activity,MF,
2380,GO:0004979,1,0.987316598817985,0,1,beta-endorphin receptor activity,MF,
2381,GO:0004980,1,0.965674100934596,0,3,melanocyte-stimulating hormone receptor activity,MF,
2382,GO:0004982,1,0.954883857000303,0,4,N-formyl peptide receptor activity,MF,
2383,GO:0004983,1,0.898210390890531,0,8,neuropeptide Y receptor activity,MF,
2384,GO:0004984,1,0.0554526583086345,0,376,olfactory receptor activity,MF,
2385,GO:0004985,1,0.905052289584275,0,8,opioid receptor activity,MF,
2386,GO:0004990,1,0.983426667503199,0,1,oxytocin receptor activity,MF,
2387,GO:0004991,1,0.970707264527435,0,2,parathyroid hormone receptor activity,MF,
2388,GO:0004992,1,0.956712267831784,0,3,platelet activating factor receptor activity,MF,
2389,GO:0004993,1,0.743640514041992,0,26,G-protein coupled serotonin receptor activity,MF,
2390,GO:0004994,1,0.933367277343852,0,5,somatostatin receptor activity,MF,
2391,GO:0004995,1,0.957240013100319,0,3,tachykinin receptor activity,MF,
2392,GO:0004996,1,0.974384689194038,0,2,thyroid-stimulating hormone receptor activity,MF,
2393,GO:0004997,1,0.990236627159128,0,1,thyrotropin-releasing hormone receptor activity,MF,
2394,GO:0004998,1,0.967700166653241,0,2,transferrin receptor activity,MF,
2395,GO:0004999,1,0.956635537463761,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2396,GO:0005000,1,0.904663471672811,0,7,vasopressin receptor activity,MF,
2397,GO:0005001,1,0.767369534800914,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2398,GO:0005003,1,0.739586315809856,0,19,ephrin receptor activity,MF,
2399,GO:0005004,1,0.891199203478301,0,7,GPI-linked ephrin receptor activity,MF,
2400,GO:0005005,1,0.886380616175677,0,8,transmembrane-ephrin receptor activity,MF,
2401,GO:0005006,1,0.969288416171861,0,2,epidermal growth factor-activated receptor activity,MF,
2402,GO:0005007,1,0.920494958926492,0,5,fibroblast growth factor-activated receptor activity,MF,
2403,GO:0005008,1,0.983426667500641,0,1,hepatocyte growth factor-activated receptor activity,MF,
2404,GO:0005009,1,0.983426667497887,0,1,insulin-activated receptor activity,MF,
2405,GO:0005010,1,0.951096177105519,0,3,insulin-like growth factor-activated receptor activity,MF,
2406,GO:0005011,1,0.967126892156327,0,2,macrophage colony-stimulating factor receptor activity,MF,
2407,GO:0005017,1,0.956712267829291,0,3,platelet-derived growth factor-activated receptor activity,MF,
2408,GO:0005018,1,0.983426667500744,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2409,GO:0005019,1,0.972837247983559,0,2,platelet-derived growth factor beta-receptor activity,MF,
2410,GO:0005020,1,0.983426667502414,0,1,stem cell factor receptor activity,MF,
2411,GO:0005021,1,0.890944177280598,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2414,GO:0005026,1,0.970952613614523,0,2,transforming growth factor beta receptor activity, type II,MF,
2415,GO:0005030,1,0.936955490052572,0,4,neurotrophin receptor activity,MF,
2416,GO:0005031,1,0.719463574243581,0,24,tumor necrosis factor-activated receptor activity,MF,
2417,GO:0005034,1,0.983690624007748,0,1,osmosensor activity,MF,
2418,GO:0005035,1,0.719463574243581,0,24,death receptor activity,MF,
2419,GO:0005041,1,0.811822709160274,0,13,low-density lipoprotein receptor activity,MF,
2420,GO:0005042,1,0.967144990909558,0,2,netrin receptor activity,MF,
2421,GO:0005044,1,0.524556828583261,0,41,scavenger receptor activity,MF,
2422,GO:0005046,1,0.973416544012686,0,2,KDEL sequence binding,MF,
2423,GO:0005047,1,0.942587290771692,0,4,signal recognition particle binding,MF,
2424,GO:0005048,1,0.533660103843999,0,43,signal sequence binding,MF,
2425,GO:0005049,1,0.893422489937344,0,7,nuclear export signal receptor activity,MF,
2426,GO:0005052,1,0.96739683036525,0,2,peroxisome matrix targeting signal-1 binding,MF,
2427,GO:0005053,1,0.989331827584257,0,1,peroxisome matrix targeting signal-2 binding,MF,
2428,GO:0005055,1,0.976821921720172,0,2,laminin receptor activity,MF,
2431,GO:0005070,1,0.425754001951018,0,57,SH3/SH2 adaptor activity,MF,
2432,GO:0005072,1,0.849039648040348,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2433,GO:0005078,1,0.890068367809489,0,7,MAP-kinase scaffold activity,MF,
2436,GO:0005086,1,0.745815222224136,0,19,ARF guanyl-nucleotide exchange factor activity,MF,
2437,GO:0005087,1,0.952346626011057,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2439,GO:0005089,1,0.275169910649964,0,78,Rho guanyl-nucleotide exchange factor activity,MF,
2440,GO:0005090,1,0.986007651161438,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2442,GO:0005093,1,0.970514384487523,0,2,Rab GDP-dissociation inhibitor activity,MF,
2443,GO:0005094,1,0.971433435888167,0,3,Rho GDP-dissociation inhibitor activity,MF,
2444,GO:0005095,1,0.819196670048292,0,14,GTPase inhibitor activity,MF,
2454,GO:0005114,1,0.896450020063277,0,7,type II transforming growth factor beta receptor binding,MF,
2456,GO:0005119,1,0.951197768931484,0,3,smoothened binding,MF,
2457,GO:0005123,1,0.806533139554109,0,15,death receptor binding,MF,
2458,GO:0005124,1,0.986228839500914,0,1,scavenger receptor binding,MF,
2462,GO:0005128,1,0.974044041746343,0,2,erythropoietin receptor binding,MF,
2463,GO:0005129,1,0.994013325679686,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
2464,GO:0005130,1,0.98915193379364,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2465,GO:0005131,1,0.932567615820881,0,5,growth hormone receptor binding,MF,
2466,GO:0005132,1,0.884006372039393,0,17,type I interferon receptor binding,MF,
2467,GO:0005133,1,0.991044168321855,0,1,interferon-gamma receptor binding,MF,
2468,GO:0005134,1,0.94562878291664,0,5,interleukin-2 receptor binding,MF,
2469,GO:0005135,1,0.976690027234101,0,2,interleukin-3 receptor binding,MF,
2470,GO:0005136,1,0.965123460913291,0,3,interleukin-4 receptor binding,MF,
2471,GO:0005137,1,0.979851450430105,0,2,interleukin-5 receptor binding,MF,
2472,GO:0005138,1,0.909261379905931,0,7,interleukin-6 receptor binding,MF,
2473,GO:0005139,1,0.986367752251628,0,1,interleukin-7 receptor binding,MF,
2474,GO:0005140,1,0.995401088492396,0,1,interleukin-9 receptor binding,MF,
2475,GO:0005141,1,0.988523564156021,0,1,interleukin-10 receptor binding,MF,
2476,GO:0005142,1,0.985341599334663,0,1,interleukin-11 receptor binding,MF,
2477,GO:0005143,1,0.931258271399788,0,5,interleukin-12 receptor binding,MF,
2478,GO:0005144,1,0.990581907561477,0,1,interleukin-13 receptor binding,MF,
2480,GO:0005147,1,0.987340486400627,0,1,oncostatin-M receptor binding,MF,
2481,GO:0005148,1,0.985796918957935,0,2,prolactin receptor binding,MF,
2482,GO:0005149,1,0.784730633815001,0,17,interleukin-1 receptor binding,MF,
2483,GO:0005150,1,0.971379701893873,0,2,interleukin-1, Type I receptor binding,MF,
2484,GO:0005151,1,0.971351934085601,0,2,interleukin-1, Type II receptor binding,MF,
2485,GO:0005152,1,0.956516579618933,0,3,interleukin-1 receptor antagonist activity,MF,
2486,GO:0005153,1,0.983722120793552,0,1,interleukin-8 receptor binding,MF,
2488,GO:0005157,1,0.962476685653975,0,3,macrophage colony-stimulating factor receptor binding,MF,
2493,GO:0005163,1,0.992123711221884,0,1,nerve growth factor receptor binding,MF,
2494,GO:0005164,1,0.680982514244878,0,30,tumor necrosis factor receptor binding,MF,
2496,GO:0005166,1,0.968126451119075,0,3,neurotrophin p75 receptor binding,MF,
2499,GO:0005169,1,0.967126892154587,0,2,neurotrophin TRKB receptor binding,MF,
2500,GO:0005170,1,0.983426667502267,0,1,neurotrophin TRKC receptor binding,MF,
2501,GO:0005171,1,0.973343263613582,0,2,hepatocyte growth factor receptor binding,MF,
2504,GO:0005174,1,0.973242231537653,0,2,CD40 receptor binding,MF,
2505,GO:0005175,1,0.994805199910606,0,1,CD27 receptor binding,MF,
2506,GO:0005176,1,0.960623466851369,0,3,ErbB-2 class receptor binding,MF,
2509,GO:0005183,1,0.98808066581473,0,1,gonadotropin hormone-releasing hormone activity,MF,
2510,GO:0005184,1,0.812548899481037,0,27,neuropeptide hormone activity,MF,
2511,GO:0005185,1,0.991244599615033,0,2,neurohypophyseal hormone activity,MF,
2513,GO:0005199,1,0.983538396391024,0,1,structural constituent of cell wall,MF,
2516,GO:0005212,1,0.849241285957288,0,20,structural constituent of eye lens,MF,
2519,GO:0005217,1,0.641136608458036,0,28,intracellular ligand-gated ion channel activity,MF,
2520,GO:0005219,1,0.944105017288255,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2521,GO:0005220,1,0.951096177099093,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2522,GO:0005221,1,0.864826953325801,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2523,GO:0005222,1,0.935435187262034,0,4,intracellular cAMP activated cation channel activity,MF,
2524,GO:0005223,1,0.936158995670325,0,4,intracellular cGMP activated cation channel activity,MF,
2526,GO:0005227,1,0.643432044771691,0,30,calcium activated cation channel activity,MF,
2527,GO:0005229,1,0.770950887696924,0,16,intracellular calcium activated chloride channel activity,MF,
2528,GO:0005230,1,0.321388106860864,0,75,extracellular ligand-gated ion channel activity,MF,
2529,GO:0005231,1,0.477836542621547,0,48,excitatory extracellular ligand-gated ion channel activity,MF,
2530,GO:0005234,1,0.728961537783559,0,19,extracellular-glutamate-gated ion channel activity,MF,
2531,GO:0005237,1,0.912978319969575,0,6,inhibitory extracellular ligand-gated ion channel activity,MF,
2537,GO:0005247,1,0.833707170322686,0,12,voltage-gated chloride channel activity,MF,
2538,GO:0005248,1,0.688201122670019,0,23,voltage-gated sodium channel activity,MF,
2542,GO:0005252,1,0.983426680859918,0,1,open rectifier potassium channel activity,MF,
2545,GO:0005260,1,0.983426667501282,0,1,intracellular ATPase-gated chloride channel activity,MF,
2549,GO:0005272,1,0.482485641191598,0,45,sodium channel activity,MF,
2550,GO:0005275,1,0.956010419933338,0,3,amine transmembrane transporter activity,MF,
2551,GO:0005276,1,0.984697349286787,0,1,vesicular hydrogen:amino acid antiporter activity,MF,
2552,GO:0005277,1,0.957970383493087,0,3,acetylcholine transmembrane transporter activity,MF,
2553,GO:0005280,1,0.909752836898824,0,6,hydrogen:amino acid symporter activity,MF,
2554,GO:0005283,1,0.837782581278024,0,11,sodium:amino acid symporter activity,MF,
2555,GO:0005287,1,0.983426667499561,0,1,high-affinity basic amino acid transmembrane transporter activity,MF,
2556,GO:0005289,1,0.983426667499561,0,1,high-affinity arginine transmembrane transporter activity,MF,
2557,GO:0005290,1,0.969459349948648,0,2,L-histidine transmembrane transporter activity,MF,
2558,GO:0005292,1,0.983426667499561,0,1,high-affinity lysine transmembrane transporter activity,MF,
2559,GO:0005294,1,0.951908647039479,0,3,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2560,GO:0005298,1,0.967134298222902,0,2,proline:sodium symporter activity,MF,
2561,GO:0005302,1,0.983692963243612,0,1,L-tyrosine transmembrane transporter activity,MF,
2562,GO:0005307,1,0.983426667502464,0,1,choline:sodium symporter activity,MF,
2563,GO:0005308,1,0.967169115595505,0,2,creatine transmembrane transporter activity,MF,
2564,GO:0005309,1,0.983469599615877,0,1,creatine:sodium symporter activity,MF,
2565,GO:0005310,1,0.601792844233115,0,32,dicarboxylic acid transmembrane transporter activity,MF,
2566,GO:0005313,1,0.800059626900075,0,14,L-glutamate transmembrane transporter activity,MF,
2567,GO:0005314,1,0.89806021167928,0,7,high-affinity glutamate transmembrane transporter activity,MF,
2568,GO:0005315,1,0.935940712353866,0,4,inorganic phosphate transmembrane transporter activity,MF,
2569,GO:0005316,1,0.983586637625317,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2570,GO:0005319,1,0.186232827242751,0,116,lipid transporter activity,MF,
2571,GO:0005324,1,0.941697293158279,0,5,long-chain fatty acid transporter activity,MF,
2572,GO:0005325,1,0.98344323830847,0,1,peroxisomal fatty-acyl-CoA transporter activity,MF,
2573,GO:0005326,1,0.676233703573448,0,25,neurotransmitter transporter activity,MF,
2574,GO:0005328,1,0.735394386793837,0,19,neurotransmitter:sodium symporter activity,MF,
2575,GO:0005329,1,0.924855818127841,0,5,dopamine transmembrane transporter activity,MF,
2576,GO:0005330,1,0.967126995248583,0,2,dopamine:sodium symporter activity,MF,
2577,GO:0005332,1,0.940984320485153,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2578,GO:0005333,1,0.956411255122596,0,3,norepinephrine transmembrane transporter activity,MF,
2579,GO:0005334,1,0.98354319660451,0,1,norepinephrine:sodium symporter activity,MF,
2580,GO:0005335,1,0.983426667503053,0,1,serotonin:sodium symporter activity,MF,
2581,GO:0005337,1,0.874305969587992,0,9,nucleoside transmembrane transporter activity,MF,
2582,GO:0005338,1,0.883061796383999,0,9,nucleotide-sugar transmembrane transporter activity,MF,
2583,GO:0005342,1,0.117493681799705,0,141,organic acid transmembrane transporter activity,MF,
2584,GO:0005343,1,0.682116260467917,0,25,organic acid:sodium symporter activity,MF,
2585,GO:0005344,1,0.904621775430867,0,14,oxygen transporter activity,MF,
2586,GO:0005345,1,0.92174293256177,0,6,purine nucleobase transmembrane transporter activity,MF,
2587,GO:0005346,1,0.855231101091978,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2588,GO:0005347,1,0.87886480942716,0,9,ATP transmembrane transporter activity,MF,
2589,GO:0005350,1,0.956787699608624,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2591,GO:0005353,1,0.985452018212821,0,1,fructose transmembrane transporter activity,MF,
2593,GO:0005362,1,0.969434929570641,0,2,low-affinity glucose:sodium symporter activity,MF,
2594,GO:0005365,1,0.96712689214452,0,2,myo-inositol transmembrane transporter activity,MF,
2595,GO:0005366,1,0.983426667500248,0,1,myo-inositol:proton symporter activity,MF,
2596,GO:0005367,1,0.983426667495132,0,1,myo-inositol:sodium symporter activity,MF,
2597,GO:0005368,1,0.983426667500841,0,1,taurine transmembrane transporter activity,MF,
2598,GO:0005369,1,0.983426667500841,0,1,taurine:sodium symporter activity,MF,
2599,GO:0005372,1,0.84552483766297,0,12,water transmembrane transporter activity,MF,
2600,GO:0005375,1,0.920365685786861,0,6,copper ion transmembrane transporter activity,MF,
2602,GO:0005384,1,0.941488677818932,0,4,manganese ion transmembrane transporter activity,MF,
2603,GO:0005385,1,0.717657686036056,0,22,zinc ion transmembrane transporter activity,MF,
2604,GO:0005388,1,0.791471594580192,0,14,calcium-transporting ATPase activity,MF,
2605,GO:0005391,1,0.865049233236348,0,10,sodium:potassium-exchanging ATPase activity,MF,
2606,GO:0005395,1,0.983426667499805,0,1,eye pigment precursor transporter activity,MF,
2608,GO:0005412,1,0.913943678519632,0,6,glucose:sodium symporter activity,MF,
2609,GO:0005415,1,0.95788133446947,0,3,nucleoside:sodium symporter activity,MF,
2610,GO:0005416,1,0.762122206266009,0,17,cation:amino acid symporter activity,MF,
2611,GO:0005427,1,0.967410909509369,0,2,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2612,GO:0005432,1,0.924401923143901,0,5,calcium:sodium antiporter activity,MF,
2613,GO:0005436,1,0.860400256780029,0,10,sodium:phosphate symporter activity,MF,
2614,GO:0005451,1,0.798247728463652,0,14,monovalent cation:proton antiporter activity,MF,
2615,GO:0005452,1,0.690110295471679,0,24,inorganic anion exchanger activity,MF,
2616,GO:0005456,1,0.987563694431352,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2617,GO:0005457,1,0.952566095724595,0,3,GDP-fucose transmembrane transporter activity,MF,
2618,GO:0005459,1,0.979291685349768,0,2,UDP-galactose transmembrane transporter activity,MF,
2619,GO:0005461,1,0.983426667500887,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2620,GO:0005462,1,0.969726472997792,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2621,GO:0005464,1,0.983426667500447,0,1,UDP-xylose transmembrane transporter activity,MF,
2622,GO:0005471,1,0.963379064232665,0,3,ATP:ADP antiporter activity,MF,
2623,GO:0005476,1,0.987288030753513,0,1,carnitine:acyl carnitine antiporter activity,MF,
2624,GO:0005477,1,0.983470438857301,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2625,GO:0005483,1,0.954948572035176,0,3,soluble NSF attachment protein activity,MF,
2627,GO:0005487,1,0.651571186138338,0,28,nucleocytoplasmic transporter activity,MF,
2630,GO:0005497,1,0.95604508611094,0,4,androgen binding,MF,
2633,GO:0005502,1,0.957196825038842,0,3,11-cis retinal binding,MF,
2634,GO:0005503,1,0.986783122517661,0,1,all-trans retinal binding,MF,
2635,GO:0005504,1,0.78185256883547,0,25,fatty acid binding,MF,
2643,GO:0005519,1,0.983426677385721,0,1,cytoskeletal regulatory protein binding,MF,
2647,GO:0005523,1,0.839431871406664,0,14,tropomyosin binding,MF,
2650,GO:0005527,1,0.840032754094315,0,14,macrolide binding,MF,
2651,GO:0005528,1,0.840032754094315,0,14,FK506 binding,MF,
2652,GO:0005534,1,0.946854072425847,0,4,galactose binding,MF,
2653,GO:0005536,1,0.840420856950865,0,11,glucose binding,MF,
2654,GO:0005537,1,0.785958476700076,0,17,mannose binding,MF,
2657,GO:0005542,1,0.894686579722295,0,10,folic acid binding,MF,
2663,GO:0005548,1,0.484262893056719,0,47,phospholipid transporter activity,MF,
2664,GO:0005549,1,0.538549188046981,0,84,odorant binding,MF,
2665,GO:0005550,1,0.995897970018643,0,1,pheromone binding,MF,
2668,GO:0005577,1,0.876884503303473,0,9,fibrinogen complex,CC,
2670,GO:0005579,1,0.90386649495139,0,7,membrane attack complex,CC,
2671,GO:0005581,1,0.267221273835276,0,88,collagen trimer,CC,
2672,GO:0005582,1,0.983426667502316,0,1,collagen type XV trimer,CC,
2673,GO:0005583,1,0.820790877228786,0,12,fibrillar collagen trimer,CC,
2674,GO:0005584,1,0.967126892152602,0,2,collagen type I trimer,CC,
2675,GO:0005585,1,0.983426667502609,0,1,collagen type II trimer,CC,
2676,GO:0005586,1,0.983426667502018,0,1,collagen type III trimer,CC,
2677,GO:0005587,1,0.904574522570939,0,6,collagen type IV trimer,CC,
2678,GO:0005588,1,0.951096177110087,0,3,collagen type V trimer,CC,
2679,GO:0005589,1,0.956760038296601,0,3,collagen type VI trimer,CC,
2680,GO:0005590,1,0.98342666749764,0,1,collagen type VII trimer,CC,
2681,GO:0005591,1,0.984559650500708,0,1,collagen type VIII trimer,CC,
2682,GO:0005592,1,0.967126892150181,0,2,collagen type XI trimer,CC,
2683,GO:0005593,1,0.906568475808879,0,6,FACIT collagen trimer,CC,
2684,GO:0005594,1,0.953192244815837,0,3,collagen type IX trimer,CC,
2685,GO:0005595,1,0.98342666749695,0,1,collagen type XII trimer,CC,
2686,GO:0005596,1,0.983426667500842,0,1,collagen type XIV trimer,CC,
2687,GO:0005597,1,0.983426667501871,0,1,collagen type XVI trimer,CC,
2688,GO:0005598,1,0.984559650500708,0,1,short-chain collagen trimer,CC,
2689,GO:0005600,1,0.983792438567467,0,1,collagen type XIII trimer,CC,
2690,GO:0005602,1,0.984027106919912,0,2,complement component C1 complex,CC,
2694,GO:0005607,1,0.967126892153136,0,2,laminin-2 complex,CC,
2697,GO:0005614,1,0.816831285109981,0,13,interstitial matrix,CC,
2703,GO:0005637,1,0.476206622908865,0,51,nuclear inner membrane,CC,
2704,GO:0005638,1,0.940689197636906,0,4,lamin filament,CC,
2705,GO:0005639,1,0.808027971352611,0,14,integral component of nuclear inner membrane,CC,
2706,GO:0005640,1,0.722801409683606,0,23,nuclear outer membrane,CC,
2708,GO:0005642,1,0.926473953086507,0,5,annulate lamellae,CC,
2709,GO:0005643,1,0.341879516896397,0,72,nuclear pore,CC,
2710,GO:0005652,1,0.885179314801596,0,8,nuclear lamina,CC,
2712,GO:0005655,1,0.923697175060487,0,7,nucleolar ribonuclease P complex,CC,
2713,GO:0005656,1,0.971970846745196,0,2,nuclear pre-replicative complex,CC,
2714,GO:0005657,1,0.393613081263007,0,65,replication fork,CC,
2715,GO:0005658,1,0.913865550802345,0,6,alpha DNA polymerase:primase complex,CC,
2716,GO:0005662,1,0.808698418577339,0,15,DNA replication factor A complex,CC,
2717,GO:0005663,1,0.926970302411021,0,6,DNA replication factor C complex,CC,
2718,GO:0005664,1,0.869717619048475,0,9,nuclear origin of replication recognition complex,CC,
2719,GO:0005665,1,0.803543750015752,0,18,DNA-directed RNA polymerase II, core complex,CC,
2720,GO:0005666,1,0.806253905328104,0,17,DNA-directed RNA polymerase III complex,CC,
2722,GO:0005668,1,0.976280388645739,0,2,RNA polymerase transcription factor SL1 complex,CC,
2723,GO:0005669,1,0.622301306205148,0,35,transcription factor TFIID complex,CC,
2724,GO:0005671,1,0.822305677250619,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2725,GO:0005672,1,0.945281368353038,0,5,transcription factor TFIIA complex,CC,
2726,GO:0005673,1,0.989031513196479,0,1,transcription factor TFIIE complex,CC,
2727,GO:0005674,1,0.974411080626157,0,2,transcription factor TFIIF complex,CC,
2728,GO:0005675,1,0.851189973089668,0,12,holo TFIIH complex,CC,
2729,GO:0005677,1,0.868453357767265,0,9,chromatin silencing complex,CC,
2730,GO:0005680,1,0.760158593088362,0,21,anaphase-promoting complex,CC,
2731,GO:0005681,1,0.090242651573753,0,174,spliceosomal complex,CC,
2732,GO:0005682,1,0.766480318450018,0,20,U5 snRNP,CC,
2733,GO:0005683,1,0.94008389773389,0,7,U7 snRNP,CC,
2734,GO:0005684,1,0.650909833517515,0,33,U2-type spliceosomal complex,CC,
2735,GO:0005685,1,0.801623926536395,0,19,U1 snRNP,CC,
2736,GO:0005686,1,0.830238996465859,0,17,U2 snRNP,CC,
2737,GO:0005687,1,0.906118404602382,0,10,U4 snRNP,CC,
2738,GO:0005688,1,0.946790941436668,0,6,U6 snRNP,CC,
2739,GO:0005689,1,0.762910852913749,0,25,U12-type spliceosomal complex,CC,
2740,GO:0005690,1,0.98591576634118,0,1,U4atac snRNP,CC,
2741,GO:0005691,1,0.9834266675032,0,1,U6atac snRNP,CC,
2743,GO:0005697,1,0.750005218221919,0,21,telomerase holoenzyme complex,CC,
2744,GO:0005712,1,0.968657739979012,0,2,chiasma,CC,
2745,GO:0005713,1,0.968866019474706,0,2,recombination nodule,CC,
2746,GO:0005715,1,0.984983208785348,0,1,late recombination nodule,CC,
2747,GO:0005719,1,0.726777207825268,0,24,nuclear euchromatin,CC,
2748,GO:0005720,1,0.619647438811644,0,33,nuclear heterochromatin,CC,
2749,GO:0005721,1,0.755441371725398,0,18,pericentric heterochromatin,CC,
2750,GO:0005724,1,0.988474582868779,0,1,nuclear telomeric heterochromatin,CC,
2751,GO:0005726,1,0.951153008615487,0,3,perichromatin fibrils,CC,
2753,GO:0005731,1,0.988049419275219,0,1,nucleolus organizer region,CC,
2754,GO:0005732,1,0.840293837408787,0,16,small nucleolar ribonucleoprotein complex,CC,
2755,GO:0005736,1,0.867560970703356,0,11,DNA-directed RNA polymerase I complex,CC,
2760,GO:0005742,1,0.910902862297641,0,9,mitochondrial outer membrane translocase complex,CC,
2762,GO:0005744,1,0.888789468985004,0,10,mitochondrial inner membrane presequence translocase complex,CC,
2763,GO:0005745,1,0.968540455438268,0,2,m-AAA complex,CC,
2764,GO:0005746,1,0.540742969468634,0,77,mitochondrial respiratory chain,CC,
2765,GO:0005747,1,0.729169620071208,0,42,mitochondrial respiratory chain complex I,CC,
2766,GO:0005749,1,0.951946374400048,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2767,GO:0005750,1,0.893348173252333,0,11,mitochondrial respiratory chain complex III,CC,
2768,GO:0005751,1,0.940100443548383,0,12,mitochondrial respiratory chain complex IV,CC,
2769,GO:0005753,1,0.854840745264181,0,20,mitochondrial proton-transporting ATP synthase complex,CC,
2770,GO:0005754,1,0.987407762369456,0,1,mitochondrial proton-transporting ATP synthase, catalytic core,CC,
2771,GO:0005757,1,0.993788964544904,0,1,mitochondrial permeability transition pore complex,CC,
2772,GO:0005758,1,0.443972617635923,0,68,mitochondrial intermembrane space,CC,
2774,GO:0005760,1,0.967126892155216,0,2,gamma DNA polymerase complex,CC,
2775,GO:0005761,1,0.494138521727322,0,78,mitochondrial ribosome,CC,
2776,GO:0005762,1,0.637327464936695,0,49,mitochondrial large ribosomal subunit,CC,
2777,GO:0005763,1,0.786920668260106,0,26,mitochondrial small ribosomal subunit,CC,
2781,GO:0005767,1,0.830332040999734,0,14,secondary lysosome,CC,
2792,GO:0005779,1,0.829915861495609,0,14,integral component of peroxisomal membrane,CC,
2793,GO:0005782,1,0.561461459705053,0,43,peroxisomal matrix,CC,
2795,GO:0005784,1,0.965820129287081,0,4,Sec61 translocon complex,CC,
2796,GO:0005785,1,0.926099697327244,0,6,signal recognition particle receptor complex,CC,
2797,GO:0005786,1,0.929853545163764,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2798,GO:0005787,1,0.944847799753139,0,5,signal peptidase complex,CC,
2805,GO:0005795,1,0.158750187554817,0,120,Golgi stack,CC,
2807,GO:0005797,1,0.941827750637544,0,4,Golgi medial cisterna,CC,
2813,GO:0005814,1,0.200444454410277,0,105,centriole,CC,
2815,GO:0005818,1,0.921988190124518,0,5,aster,CC,
2817,GO:0005826,1,0.937927158629908,0,4,actomyosin contractile ring,CC,
2818,GO:0005827,1,0.924271501300284,0,5,polar microtubule,CC,
2819,GO:0005828,1,0.906832152955861,0,6,kinetochore microtubule,CC,
2821,GO:0005832,1,0.854546623555519,0,11,chaperonin-containing T-complex,CC,
2822,GO:0005833,1,0.933217365221106,0,12,hemoglobin complex,CC,
2823,GO:0005834,1,0.634564239560719,0,35,heterotrimeric G-protein complex,CC,
2824,GO:0005838,1,0.775397447990928,0,21,proteasome regulatory particle,CC,
2825,GO:0005839,1,0.825470106888731,0,21,proteasome core complex,CC,
2826,GO:0005840,1,0.130751467506055,0,219,ribosome,CC,
2827,GO:0005844,1,0.545862178158566,0,44,polysome,CC,
2828,GO:0005845,1,0.828788174372669,0,13,mRNA cap binding complex,CC,
2829,GO:0005846,1,0.969972836476415,0,2,nuclear cap binding complex,CC,
2830,GO:0005847,1,0.816859264052684,0,14,mRNA cleavage and polyadenylation specificity factor complex,CC,
2831,GO:0005849,1,0.754755288547412,0,19,mRNA cleavage factor complex,CC,
2832,GO:0005850,1,0.936549049421223,0,4,eukaryotic translation initiation factor 2 complex,CC,
2833,GO:0005851,1,0.921865641010072,0,6,eukaryotic translation initiation factor 2B complex,CC,
2834,GO:0005852,1,0.805354405983376,0,17,eukaryotic translation initiation factor 3 complex,CC,
2835,GO:0005853,1,0.954603635088939,0,4,eukaryotic translation elongation factor 1 complex,CC,
2837,GO:0005858,1,0.822463123438074,0,12,axonemal dynein complex,CC,
2839,GO:0005861,1,0.937446638471446,0,8,troponin complex,CC,
2840,GO:0005862,1,0.947856966403899,0,4,muscle thin filament tropomyosin,CC,
2841,GO:0005863,1,0.951106556024455,0,3,striated muscle myosin thick filament,CC,
2843,GO:0005868,1,0.751044148560521,0,22,cytoplasmic dynein complex,CC,
2844,GO:0005869,1,0.899757950501237,0,8,dynactin complex,CC,
2845,GO:0005871,1,0.432843533317356,0,52,kinesin complex,CC,
2846,GO:0005873,1,0.967126892153087,0,2,plus-end kinesin complex,CC,
2848,GO:0005875,1,0.119358936422733,0,141,microtubule associated complex,CC,
2850,GO:0005879,1,0.957456411863364,0,3,axonemal microtubule,CC,
2853,GO:0005883,1,0.87739707075641,0,8,neurofilament,CC,
2855,GO:0005885,1,0.88057758592109,0,11,Arp2/3 protein complex,CC,
2858,GO:0005889,1,0.967192223312067,0,2,hydrogen:potassium-exchanging ATPase complex,CC,
2859,GO:0005890,1,0.866568991484853,0,11,sodium:potassium-exchanging ATPase complex,CC,
2861,GO:0005892,1,0.779017489437891,0,17,acetylcholine-gated channel complex,CC,
2862,GO:0005895,1,0.986011517660774,0,1,interleukin-5 receptor complex,CC,
2863,GO:0005896,1,0.958857778273807,0,3,interleukin-6 receptor complex,CC,
2864,GO:0005898,1,0.983426667503346,0,1,interleukin-13 receptor complex,CC,
2865,GO:0005899,1,0.951096177107802,0,3,insulin receptor complex,CC,
2866,GO:0005900,1,0.967371776646983,0,2,oncostatin-M receptor complex,CC,
2874,GO:0005914,1,0.983552635096111,0,1,spot adherens junction,CC,
2882,GO:0005927,1,0.966019532715333,0,3,muscle tendon junction,CC,
2884,GO:0005930,1,0.279607057330228,0,84,axoneme,CC,
2886,GO:0005940,1,0.983865870928059,0,1,septin ring,CC,
2890,GO:0005945,1,0.967583190789908,0,2,6-phosphofructokinase complex,CC,
2891,GO:0005947,1,0.933959532081944,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2893,GO:0005953,1,0.973167496059491,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2894,GO:0005954,1,0.984959811914398,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2895,GO:0005955,1,0.935987172082137,0,4,calcineurin complex,CC,
2896,GO:0005956,1,0.976026257209738,0,2,protein kinase CK2 complex,CC,
2897,GO:0005958,1,0.95587433180641,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2899,GO:0005964,1,0.925625595029588,0,5,phosphorylase kinase complex,CC,
2900,GO:0005965,1,0.972983680269154,0,2,protein farnesyltransferase complex,CC,
2901,GO:0005967,1,0.953141649756614,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2902,GO:0005968,1,0.943660662625455,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2903,GO:0005969,1,0.983426667499068,0,1,serine-pyruvate aminotransferase complex,CC,
2904,GO:0005971,1,0.967462356093352,0,2,ribonucleoside-diphosphate reductase complex,CC,
2910,GO:0005980,1,0.676520469108983,0,26,glycogen catabolic process,BP,
2911,GO:0005981,1,0.922132166786356,0,6,regulation of glycogen catabolic process,BP,
2912,GO:0005982,1,0.983426667500841,0,1,starch metabolic process,BP,
2913,GO:0005983,1,0.983426667500841,0,1,starch catabolic process,BP,
2914,GO:0005984,1,0.872176095706615,0,10,disaccharide metabolic process,BP,
2915,GO:0005985,1,0.963352706992889,0,3,sucrose metabolic process,BP,
2916,GO:0005986,1,0.97956134953107,0,2,sucrose biosynthetic process,BP,
2917,GO:0005988,1,0.961725596203361,0,3,lactose metabolic process,BP,
2918,GO:0005989,1,0.961725596203361,0,3,lactose biosynthetic process,BP,
2919,GO:0005991,1,0.987326145032158,0,1,trehalose metabolic process,BP,
2920,GO:0005993,1,0.987326145032158,0,1,trehalose catabolic process,BP,
2922,GO:0005997,1,0.954875327813633,0,4,xylulose metabolic process,BP,
2923,GO:0005998,1,0.9834394456677,0,1,xylulose catabolic process,BP,
2924,GO:0005999,1,0.977174471598405,0,2,xylulose biosynthetic process,BP,
2927,GO:0006002,1,0.883593254171027,0,9,fructose 6-phosphate metabolic process,BP,
2929,GO:0006004,1,0.788890158880653,0,15,fucose metabolic process,BP,
2932,GO:0006011,1,0.915858076151201,0,6,UDP-glucose metabolic process,BP,
2933,GO:0006012,1,0.842721632496454,0,12,galactose metabolic process,BP,
2934,GO:0006013,1,0.887192319485263,0,8,mannose metabolic process,BP,
2935,GO:0006014,1,0.9699124394683,0,3,D-ribose metabolic process,BP,
2936,GO:0006015,1,0.947926768643694,0,4,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2937,GO:0006020,1,0.847906722021967,0,11,inositol metabolic process,BP,
2938,GO:0006021,1,0.94307724727461,0,4,inositol biosynthetic process,BP,
2945,GO:0006030,1,0.959036414779142,0,3,chitin metabolic process,BP,
2946,GO:0006032,1,0.959036414779142,0,3,chitin catabolic process,BP,
2947,GO:0006037,1,0.989250273261631,0,1,cell wall chitin metabolic process,BP,
2948,GO:0006040,1,0.606217755354839,0,34,amino sugar metabolic process,BP,
2949,GO:0006041,1,0.956314351061265,0,3,glucosamine metabolic process,BP,
2950,GO:0006043,1,0.985541380331911,0,1,glucosamine catabolic process,BP,
2951,GO:0006044,1,0.799888038313677,0,15,N-acetylglucosamine metabolic process,BP,
2952,GO:0006045,1,0.967130957903385,0,2,N-acetylglucosamine biosynthetic process,BP,
2953,GO:0006047,1,0.816705182124951,0,14,UDP-N-acetylglucosamine metabolic process,BP,
2954,GO:0006048,1,0.879001866308886,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2955,GO:0006049,1,0.983978485041012,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2956,GO:0006050,1,0.978319640496979,0,2,mannosamine metabolic process,BP,
2957,GO:0006051,1,0.978319640496979,0,2,N-acetylmannosamine metabolic process,BP,
2958,GO:0006054,1,0.882748385999241,0,9,N-acetylneuraminate metabolic process,BP,
2959,GO:0006055,1,0.990843747764937,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2960,GO:0006056,1,0.987762819794679,0,1,mannoprotein metabolic process,BP,
2961,GO:0006057,1,0.987762819794679,0,1,mannoprotein biosynthetic process,BP,
2962,GO:0006059,1,0.965111143350298,0,3,hexitol metabolic process,BP,
2963,GO:0006060,1,0.974792140742003,0,2,sorbitol metabolic process,BP,
2964,GO:0006061,1,0.989825625357721,0,1,sorbitol biosynthetic process,BP,
2965,GO:0006062,1,0.984812627494499,0,1,sorbitol catabolic process,BP,
2966,GO:0006063,1,0.732969049810643,0,22,uronic acid metabolic process,BP,
2967,GO:0006064,1,0.941893893425375,0,5,glucuronate catabolic process,BP,
2968,GO:0006065,1,0.953905946956227,0,3,UDP-glucuronate biosynthetic process,BP,
2970,GO:0006067,1,0.756113279728231,0,21,ethanol metabolic process,BP,
2971,GO:0006068,1,0.858147715232703,0,12,ethanol catabolic process,BP,
2972,GO:0006069,1,0.842006892703729,0,12,ethanol oxidation,BP,
2973,GO:0006071,1,0.808708008867305,0,16,glycerol metabolic process,BP,
2974,GO:0006072,1,0.894319211924867,0,7,glycerol-3-phosphate metabolic process,BP,
2978,GO:0006083,1,0.951531863222055,0,3,acetate metabolic process,BP,
2979,GO:0006084,1,0.60515892983409,0,34,acetyl-CoA metabolic process,BP,
2980,GO:0006085,1,0.733175761430269,0,20,acetyl-CoA biosynthetic process,BP,
2981,GO:0006086,1,0.792595981485239,0,15,acetyl-CoA biosynthetic process from pyruvate,BP,
2987,GO:0006097,1,0.973547835630449,0,2,glyoxylate cycle,BP,
2988,GO:0006098,1,0.817010447791575,0,16,pentose-phosphate shunt,BP,
2989,GO:0006099,1,0.662537704118448,0,30,tricarboxylic acid cycle,BP,
2990,GO:0006101,1,0.619620702406903,0,34,citrate metabolic process,BP,
2991,GO:0006102,1,0.937055315604878,0,5,isocitrate metabolic process,BP,
2992,GO:0006103,1,0.784095046290948,0,16,2-oxoglutarate metabolic process,BP,
2993,GO:0006104,1,0.944477709007135,0,4,succinyl-CoA metabolic process,BP,
2994,GO:0006105,1,0.861015540235572,0,10,succinate metabolic process,BP,
2995,GO:0006106,1,0.959420444376964,0,3,fumarate metabolic process,BP,
2996,GO:0006107,1,0.845330301113851,0,12,oxaloacetate metabolic process,BP,
2997,GO:0006108,1,0.900610038152961,0,8,malate metabolic process,BP,
3003,GO:0006114,1,0.939234622489026,0,4,glycerol biosynthetic process,BP,
3004,GO:0006116,1,0.956629533473505,0,3,NADH oxidation,BP,
3005,GO:0006117,1,0.984680431882196,0,1,acetaldehyde metabolic process,BP,
3007,GO:0006120,1,0.68533979268478,0,46,mitochondrial electron transport, NADH to ubiquinone,BP,
3008,GO:0006121,1,0.966701258004617,0,3,mitochondrial electron transport, succinate to ubiquinone,BP,
3009,GO:0006122,1,0.865151370556505,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
3010,GO:0006123,1,0.890572976551867,0,17,mitochondrial electron transport, cytochrome c to oxygen,BP,
3011,GO:0006127,1,0.984048373073413,0,1,glycerophosphate shuttle,BP,
3014,GO:0006144,1,0.75828804161033,0,19,purine nucleobase metabolic process,BP,
3015,GO:0006145,1,0.935610205005119,0,4,purine nucleobase catabolic process,BP,
3016,GO:0006147,1,0.983426667502119,0,1,guanine catabolic process,BP,
3017,GO:0006148,1,0.985149477412485,0,1,inosine catabolic process,BP,
3018,GO:0006152,1,0.924503737509419,0,6,purine nucleoside catabolic process,BP,
3019,GO:0006154,1,0.989031513196479,0,1,adenosine catabolic process,BP,
3020,GO:0006157,1,0.989031513196479,0,1,deoxyadenosine catabolic process,BP,
3024,GO:0006166,1,0.942296800030251,0,5,purine ribonucleoside salvage,BP,
3025,GO:0006167,1,0.916059442136468,0,7,AMP biosynthetic process,BP,
3026,GO:0006168,1,0.984111357942807,0,2,adenine salvage,BP,
3027,GO:0006169,1,0.986463694180628,0,1,adenosine salvage,BP,
3029,GO:0006172,1,0.969270117567992,0,2,ADP biosynthetic process,BP,
3030,GO:0006173,1,0.983456163464194,0,1,dADP biosynthetic process,BP,
3031,GO:0006175,1,0.986463694180628,0,1,dATP biosynthetic process,BP,
3032,GO:0006177,1,0.958600590946447,0,3,GMP biosynthetic process,BP,
3033,GO:0006178,1,0.989741121028373,0,1,guanine salvage,BP,
3035,GO:0006183,1,0.891180802979455,0,11,GTP biosynthetic process,BP,
3036,GO:0006185,1,0.99251552446236,0,1,dGDP biosynthetic process,BP,
3037,GO:0006188,1,0.860836384044389,0,10,IMP biosynthetic process,BP,
3038,GO:0006189,1,0.912880388767931,0,6,'de novo' IMP biosynthetic process,BP,
3039,GO:0006193,1,0.991761447367686,0,1,ITP catabolic process,BP,
3041,GO:0006196,1,0.967126892155507,0,2,AMP catabolic process,BP,
3043,GO:0006203,1,0.965140853522625,0,3,dGTP catabolic process,BP,
3044,GO:0006206,1,0.76224186990179,0,19,pyrimidine nucleobase metabolic process,BP,
3045,GO:0006207,1,0.908900463713301,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3046,GO:0006208,1,0.956474825567017,0,3,pyrimidine nucleobase catabolic process,BP,
3047,GO:0006210,1,0.956474825567017,0,3,thymine catabolic process,BP,
3048,GO:0006211,1,0.983426667497444,0,1,5-methylcytosine catabolic process,BP,
3049,GO:0006212,1,0.970114018283943,0,2,uracil catabolic process,BP,
3050,GO:0006213,1,0.561851992062715,0,47,pyrimidine nucleoside metabolic process,BP,
3051,GO:0006214,1,0.983721116157046,0,1,thymidine catabolic process,BP,
3052,GO:0006216,1,0.907869590508278,0,9,cytidine catabolic process,BP,
3053,GO:0006218,1,0.987578466761352,0,1,uridine catabolic process,BP,
3054,GO:0006220,1,0.568900178840394,0,45,pyrimidine nucleotide metabolic process,BP,
3055,GO:0006221,1,0.689593240986168,0,30,pyrimidine nucleotide biosynthetic process,BP,
3056,GO:0006222,1,0.868723983772313,0,10,UMP biosynthetic process,BP,
3057,GO:0006226,1,0.987278531599617,0,1,dUMP biosynthetic process,BP,
3058,GO:0006227,1,0.975537422808287,0,2,dUDP biosynthetic process,BP,
3059,GO:0006228,1,0.900544246668351,0,10,UTP biosynthetic process,BP,
3060,GO:0006231,1,0.973946720490135,0,2,dTMP biosynthetic process,BP,
3061,GO:0006233,1,0.975537422808287,0,2,dTDP biosynthetic process,BP,
3062,GO:0006235,1,0.955260719788444,0,4,dTTP biosynthetic process,BP,
3063,GO:0006238,1,0.990805197582932,0,1,CMP salvage,BP,
3064,GO:0006241,1,0.855568144182374,0,14,CTP biosynthetic process,BP,
3065,GO:0006244,1,0.862913424783769,0,12,pyrimidine nucleotide catabolic process,BP,
3066,GO:0006253,1,0.991657523588261,0,1,dCTP catabolic process,BP,
3067,GO:0006256,1,0.983961872790192,0,1,UDP catabolic process,BP,
3068,GO:0006258,1,0.976303448243704,0,2,UDP-glucose catabolic process,BP,
3072,GO:0006264,1,0.860436550737882,0,10,mitochondrial DNA replication,BP,
3073,GO:0006265,1,0.869892183440682,0,9,DNA topological change,BP,
3074,GO:0006266,1,0.722055623322858,0,24,DNA ligation,BP,
3075,GO:0006267,1,0.971970846745196,0,2,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3076,GO:0006268,1,0.896508715704134,0,7,DNA unwinding involved in DNA replication,BP,
3077,GO:0006269,1,0.943212507325752,0,4,DNA replication, synthesis of RNA primer,BP,
3078,GO:0006270,1,0.563413894303498,0,39,DNA replication initiation,BP,
3079,GO:0006271,1,0.79550680386517,0,16,DNA strand elongation involved in DNA replication,BP,
3080,GO:0006272,1,0.967126892150375,0,2,leading strand elongation,BP,
3081,GO:0006273,1,0.88680590298461,0,8,lagging strand elongation,BP,
3082,GO:0006274,1,0.984728932554734,0,1,DNA replication termination,BP,
3084,GO:0006278,1,0.403420881891271,0,62,RNA-dependent DNA biosynthetic process,BP,
3087,GO:0006283,1,0.384118368755358,0,73,transcription-coupled nucleotide-excision repair,BP,
3088,GO:0006284,1,0.566125387429034,0,41,base-excision repair,BP,
3089,GO:0006285,1,0.882273681752107,0,10,base-excision repair, AP site formation,BP,
3090,GO:0006286,1,0.98006662046503,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3091,GO:0006287,1,0.927796381991674,0,5,base-excision repair, gap-filling,BP,
3092,GO:0006288,1,0.960916312659453,0,3,base-excision repair, DNA ligation,BP,
3093,GO:0006289,1,0.214825779196496,0,114,nucleotide-excision repair,BP,
3094,GO:0006290,1,0.90630299470254,0,7,pyrimidine dimer repair,BP,
3095,GO:0006293,1,0.740137837194531,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3096,GO:0006294,1,0.680709244322646,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3097,GO:0006295,1,0.740137837194531,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3098,GO:0006296,1,0.60744283091824,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3099,GO:0006297,1,0.733580923547496,0,23,nucleotide-excision repair, DNA gap filling,BP,
3100,GO:0006298,1,0.628883289444731,0,31,mismatch repair,BP,
3101,GO:0006301,1,0.49681386275983,0,50,postreplication repair,BP,
3102,GO:0006302,1,0.059213428140441,0,199,double-strand break repair,BP,
3103,GO:0006303,1,0.435869241418995,0,67,double-strand break repair via nonhomologous end joining,BP,
3107,GO:0006307,1,0.877076186796946,0,10,DNA dealkylation involved in DNA repair,BP,
3108,GO:0006308,1,0.657809552450073,0,31,DNA catabolic process,BP,
3109,GO:0006309,1,0.773464167207503,0,19,apoptotic DNA fragmentation,BP,
3111,GO:0006311,1,0.952586912968632,0,3,meiotic gene conversion,BP,
3112,GO:0006312,1,0.510118827447312,0,47,mitotic recombination,BP,
3113,GO:0006313,1,0.96840766101798,0,2,transposition, DNA-mediated,BP,
3114,GO:0006323,1,0.129530470295597,0,185,DNA packaging,BP,
3116,GO:0006333,1,0.147903154958396,0,174,chromatin assembly or disassembly,BP,
3117,GO:0006334,1,0.275951358623596,0,132,nucleosome assembly,BP,
3118,GO:0006335,1,0.818378302214495,0,32,DNA replication-dependent nucleosome assembly,BP,
3119,GO:0006336,1,0.602030505165056,0,48,DNA replication-independent nucleosome assembly,BP,
3120,GO:0006337,1,0.788139270607214,0,18,nucleosome disassembly,BP,
3121,GO:0006338,1,0.136500927040513,0,149,chromatin remodeling,BP,
3122,GO:0006342,1,0.331746093085553,0,114,chromatin silencing,BP,
3123,GO:0006343,1,0.983428532458556,0,1,establishment of chromatin silencing,BP,
3124,GO:0006344,1,0.936399255222942,0,4,maintenance of chromatin silencing,BP,
3125,GO:0006346,1,0.770180813595887,0,20,methylation-dependent chromatin silencing,BP,
3126,GO:0006348,1,0.898152772910375,0,9,chromatin silencing at telomere,BP,
3127,GO:0006349,1,0.779551251275851,0,16,regulation of gene expression by genetic imprinting,BP,
3130,GO:0006353,1,0.243292583654837,0,104,DNA-templated transcription, termination,BP,
3133,GO:0006356,1,0.63100634357055,0,31,regulation of transcription from RNA polymerase I promoter,BP,
3136,GO:0006360,1,0.437255754890751,0,59,transcription from RNA polymerase I promoter,BP,
3137,GO:0006361,1,0.661245237153278,0,32,transcription initiation from RNA polymerase I promoter,BP,
3138,GO:0006362,1,0.669604902580099,0,31,transcription elongation from RNA polymerase I promoter,BP,
3139,GO:0006363,1,0.681100625892247,0,30,termination of RNA polymerase I transcription,BP,
3140,GO:0006364,1,0.0646857943407134,0,242,rRNA processing,BP,
3144,GO:0006369,1,0.384144612839263,0,69,termination of RNA polymerase II transcription,BP,
3145,GO:0006370,1,0.685773063882343,0,30,7-methylguanosine mRNA capping,BP,
3146,GO:0006376,1,0.676837521931837,0,26,mRNA splice site selection,BP,
3147,GO:0006378,1,0.557356284257504,0,39,mRNA polyadenylation,BP,
3148,GO:0006379,1,0.716233286349263,0,25,mRNA cleavage,BP,
3149,GO:0006382,1,0.938612122211301,0,4,adenosine to inosine editing,BP,
3151,GO:0006384,1,0.886597287396885,0,8,transcription initiation from RNA polymerase III promoter,BP,
3152,GO:0006388,1,0.849612298587239,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3153,GO:0006390,1,0.911686733368683,0,7,transcription from mitochondrial promoter,BP,
3154,GO:0006391,1,0.958697357365709,0,3,transcription initiation from mitochondrial promoter,BP,
3156,GO:0006397,1,0.0013499465902162,0,461,mRNA processing,BP,
3157,GO:0006398,1,0.927696063203197,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3158,GO:0006399,1,0.10164945205854,0,166,tRNA metabolic process,BP,
3159,GO:0006400,1,0.418481689818864,0,62,tRNA modification,BP,
3162,GO:0006403,1,0.0423309807866437,0,218,RNA localization,BP,
3163,GO:0006404,1,0.955670842362847,0,3,RNA import into nucleus,BP,
3164,GO:0006405,1,0.138190627615357,0,137,RNA export from nucleus,BP,
3165,GO:0006406,1,0.203671008432162,0,108,mRNA export from nucleus,BP,
3166,GO:0006407,1,0.975195584515633,0,2,rRNA export from nucleus,BP,
3167,GO:0006408,1,0.974364930709566,0,2,snRNA export from nucleus,BP,
3168,GO:0006409,1,0.624303059363633,0,31,tRNA export from nucleus,BP,
3170,GO:0006413,1,0.128830190962568,0,188,translational initiation,BP,
3171,GO:0006414,1,0.246378075154327,0,130,translational elongation,BP,
3172,GO:0006415,1,0.358833915816606,0,100,translational termination,BP,
3174,GO:0006418,1,0.499148916850776,0,48,tRNA aminoacylation for protein translation,BP,
3175,GO:0006419,1,0.954818913282896,0,3,alanyl-tRNA aminoacylation,BP,
3176,GO:0006420,1,0.953336870212978,0,4,arginyl-tRNA aminoacylation,BP,
3177,GO:0006421,1,0.953921485993364,0,3,asparaginyl-tRNA aminoacylation,BP,
3178,GO:0006422,1,0.985411476801085,0,1,aspartyl-tRNA aminoacylation,BP,
3179,GO:0006423,1,0.971980397456852,0,2,cysteinyl-tRNA aminoacylation,BP,
3180,GO:0006424,1,0.967127175431375,0,2,glutamyl-tRNA aminoacylation,BP,
3181,GO:0006425,1,0.985045578433779,0,1,glutaminyl-tRNA aminoacylation,BP,
3182,GO:0006426,1,0.973151985391688,0,2,glycyl-tRNA aminoacylation,BP,
3183,GO:0006427,1,0.971927800655985,0,2,histidyl-tRNA aminoacylation,BP,
3184,GO:0006428,1,0.967164636951474,0,2,isoleucyl-tRNA aminoacylation,BP,
3185,GO:0006429,1,0.967126892154975,0,2,leucyl-tRNA aminoacylation,BP,
3186,GO:0006430,1,0.986234894551021,0,1,lysyl-tRNA aminoacylation,BP,
3187,GO:0006431,1,0.968257688105884,0,2,methionyl-tRNA aminoacylation,BP,
3188,GO:0006432,1,0.945441959511213,0,4,phenylalanyl-tRNA aminoacylation,BP,
3189,GO:0006433,1,0.969049321437464,0,2,prolyl-tRNA aminoacylation,BP,
3190,GO:0006434,1,0.973707440817741,0,2,seryl-tRNA aminoacylation,BP,
3191,GO:0006435,1,0.953624065411033,0,3,threonyl-tRNA aminoacylation,BP,
3192,GO:0006436,1,0.968802222658267,0,2,tryptophanyl-tRNA aminoacylation,BP,
3193,GO:0006437,1,0.969990949835853,0,2,tyrosyl-tRNA aminoacylation,BP,
3194,GO:0006438,1,0.95111843074827,0,3,valyl-tRNA aminoacylation,BP,
3195,GO:0006446,1,0.374014692241939,0,70,regulation of translational initiation,BP,
3196,GO:0006447,1,0.955832850180357,0,3,regulation of translational initiation by iron,BP,
3197,GO:0006448,1,0.707366542709254,0,26,regulation of translational elongation,BP,
3198,GO:0006449,1,0.884351091493846,0,8,regulation of translational termination,BP,
3199,GO:0006450,1,0.810060829427354,0,16,regulation of translational fidelity,BP,
3200,GO:0006451,1,0.884906826688125,0,9,translational readthrough,BP,
3201,GO:0006452,1,0.957836445666497,0,3,translational frameshifting,BP,
3203,GO:0006458,1,0.642624488401851,0,32,'de novo' protein folding,BP,
3205,GO:0006463,1,0.983434462177059,0,1,steroid hormone receptor complex assembly,BP,
3211,GO:0006471,1,0.739839522539645,0,22,protein ADP-ribosylation,BP,
3213,GO:0006474,1,0.794285006226776,0,16,N-terminal protein amino acid acetylation,BP,
3216,GO:0006477,1,0.898928044501356,0,7,protein sulfation,BP,
3217,GO:0006478,1,0.973587338574775,0,2,peptidyl-tyrosine sulfation,BP,
3219,GO:0006480,1,0.977722126876881,0,2,N-terminal protein amino acid methylation,BP,
3220,GO:0006481,1,0.974092457042282,0,2,C-terminal protein methylation,BP,
3221,GO:0006482,1,0.631879890670002,0,28,protein demethylation,BP,
3223,GO:0006487,1,0.400254329976266,0,67,protein N-linked glycosylation,BP,
3224,GO:0006488,1,0.749181067468553,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3225,GO:0006489,1,0.901714754997918,0,7,dolichyl diphosphate biosynthetic process,BP,
3226,GO:0006490,1,0.737777123372871,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3227,GO:0006491,1,0.751777140608648,0,18,N-glycan processing,BP,
3232,GO:0006500,1,0.973868326201127,0,2,N-terminal protein palmitoylation,BP,
3234,GO:0006505,1,0.642576587051327,0,33,GPI anchor metabolic process,BP,
3235,GO:0006506,1,0.652007820431211,0,32,GPI anchor biosynthetic process,BP,
3236,GO:0006507,1,0.985560550415529,0,1,GPI anchor release,BP,
3238,GO:0006509,1,0.56381887295516,0,39,membrane protein ectodomain proteolysis,BP,
3240,GO:0006513,1,0.428059134046573,0,57,protein monoubiquitination,BP,
3241,GO:0006515,1,0.715044108376171,0,23,misfolded or incompletely synthesized protein catabolic process,BP,
3242,GO:0006516,1,0.788237794313427,0,17,glycoprotein catabolic process,BP,
3243,GO:0006517,1,0.601223956407356,0,34,protein deglycosylation,BP,
3246,GO:0006521,1,0.515874430205285,0,60,regulation of cellular amino acid metabolic process,BP,
3247,GO:0006522,1,0.935382337002692,0,5,alanine metabolic process,BP,
3248,GO:0006524,1,0.935382337002692,0,5,alanine catabolic process,BP,
3249,GO:0006525,1,0.793964281793769,0,17,arginine metabolic process,BP,
3250,GO:0006526,1,0.949986443253775,0,4,arginine biosynthetic process,BP,
3251,GO:0006527,1,0.880435671554063,0,9,arginine catabolic process,BP,
3252,GO:0006528,1,0.935365745356592,0,5,asparagine metabolic process,BP,
3253,GO:0006529,1,0.970623667307003,0,2,asparagine biosynthetic process,BP,
3254,GO:0006530,1,0.972805359609794,0,2,asparagine catabolic process,BP,
3255,GO:0006531,1,0.862664515395026,0,11,aspartate metabolic process,BP,
3256,GO:0006532,1,0.961642051845973,0,3,aspartate biosynthetic process,BP,
3257,GO:0006533,1,0.961618338819054,0,3,aspartate catabolic process,BP,
3258,GO:0006534,1,0.826730301772784,0,13,cysteine metabolic process,BP,
3259,GO:0006535,1,0.984620385657398,0,1,cysteine biosynthetic process from serine,BP,
3260,GO:0006536,1,0.645841192908429,0,29,glutamate metabolic process,BP,
3261,GO:0006537,1,0.907684536400565,0,6,glutamate biosynthetic process,BP,
3262,GO:0006538,1,0.898093530796759,0,7,glutamate catabolic process,BP,
3263,GO:0006540,1,0.970059575403929,0,2,glutamate decarboxylation to succinate,BP,
3264,GO:0006541,1,0.696459816049242,0,24,glutamine metabolic process,BP,
3265,GO:0006542,1,0.967126892154296,0,2,glutamine biosynthetic process,BP,
3266,GO:0006543,1,0.952179238347923,0,3,glutamine catabolic process,BP,
3268,GO:0006545,1,0.930535922096695,0,5,glycine biosynthetic process,BP,
3270,GO:0006547,1,0.878114227730913,0,9,histidine metabolic process,BP,
3271,GO:0006548,1,0.90616651606796,0,7,histidine catabolic process,BP,
3272,GO:0006549,1,0.927170275679632,0,5,isoleucine metabolic process,BP,
3273,GO:0006550,1,0.97484903127414,0,2,isoleucine catabolic process,BP,
3274,GO:0006551,1,0.905608607506666,0,7,leucine metabolic process,BP,
3275,GO:0006552,1,0.931526190642823,0,5,leucine catabolic process,BP,
3276,GO:0006553,1,0.846801148434755,0,11,lysine metabolic process,BP,
3277,GO:0006554,1,0.860514613287551,0,10,lysine catabolic process,BP,
3278,GO:0006555,1,0.751834979910653,0,20,methionine metabolic process,BP,
3279,GO:0006556,1,0.954698630726836,0,3,S-adenosylmethionine biosynthetic process,BP,
3280,GO:0006557,1,0.983602856825306,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3281,GO:0006558,1,0.882876127037077,0,10,L-phenylalanine metabolic process,BP,
3282,GO:0006559,1,0.882876127037077,0,10,L-phenylalanine catabolic process,BP,
3283,GO:0006560,1,0.88321375401822,0,9,proline metabolic process,BP,
3284,GO:0006561,1,0.916987246746964,0,6,proline biosynthetic process,BP,
3285,GO:0006562,1,0.947395635555229,0,4,proline catabolic process,BP,
3286,GO:0006563,1,0.869299001486574,0,10,L-serine metabolic process,BP,
3287,GO:0006564,1,0.920475239385379,0,6,L-serine biosynthetic process,BP,
3288,GO:0006565,1,0.958853133416497,0,3,L-serine catabolic process,BP,
3289,GO:0006566,1,0.975530062796885,0,2,threonine metabolic process,BP,
3290,GO:0006567,1,0.988771891387024,0,1,threonine catabolic process,BP,
3291,GO:0006568,1,0.843574832054979,0,13,tryptophan metabolic process,BP,
3292,GO:0006569,1,0.868154279691376,0,11,tryptophan catabolic process,BP,
3293,GO:0006570,1,0.887644913291217,0,9,tyrosine metabolic process,BP,
3294,GO:0006572,1,0.94075515583281,0,5,tyrosine catabolic process,BP,
3295,GO:0006573,1,0.875347202229178,0,9,valine metabolic process,BP,
3296,GO:0006574,1,0.946710315468321,0,4,valine catabolic process,BP,
3297,GO:0006575,1,0.112833566202358,0,161,cellular modified amino acid metabolic process,BP,
3298,GO:0006576,1,0.528221141659933,0,49,cellular biogenic amine metabolic process,BP,
3299,GO:0006577,1,0.76626757165129,0,17,amino-acid betaine metabolic process,BP,
3300,GO:0006578,1,0.897459067549955,0,7,amino-acid betaine biosynthetic process,BP,
3301,GO:0006579,1,0.954266281534623,0,3,amino-acid betaine catabolic process,BP,
3302,GO:0006580,1,0.98440110090942,0,1,ethanolamine metabolic process,BP,
3303,GO:0006581,1,0.968770222802784,0,2,acetylcholine catabolic process,BP,
3305,GO:0006583,1,0.97198037997193,0,2,melanin biosynthetic process from tyrosine,BP,
3307,GO:0006585,1,0.987123496878505,0,1,dopamine biosynthetic process from tyrosine,BP,
3308,GO:0006586,1,0.793393799274318,0,18,indolalkylamine metabolic process,BP,
3309,GO:0006589,1,0.968310512499474,0,2,octopamine biosynthetic process,BP,
3310,GO:0006590,1,0.783210449046885,0,16,thyroid hormone generation,BP,
3311,GO:0006591,1,0.910891364159953,0,7,ornithine metabolic process,BP,
3312,GO:0006592,1,0.983492511859743,0,1,ornithine biosynthetic process,BP,
3313,GO:0006593,1,0.988404240067971,0,1,ornithine catabolic process,BP,
3314,GO:0006595,1,0.839480773568952,0,15,polyamine metabolic process,BP,
3315,GO:0006596,1,0.865241912798517,0,12,polyamine biosynthetic process,BP,
3316,GO:0006597,1,0.971976173356513,0,2,spermine biosynthetic process,BP,
3317,GO:0006598,1,0.937792966868259,0,6,polyamine catabolic process,BP,
3318,GO:0006599,1,0.988912275994095,0,1,phosphagen metabolic process,BP,
3319,GO:0006600,1,0.86334609815722,0,11,creatine metabolic process,BP,
3320,GO:0006601,1,0.977176955580452,0,2,creatine biosynthetic process,BP,
3321,GO:0006603,1,0.988912275994095,0,1,phosphocreatine metabolic process,BP,
3324,GO:0006607,1,0.705090643732514,0,22,NLS-bearing protein import into nucleus,BP,
3325,GO:0006610,1,0.885632589178185,0,8,ribosomal protein import into nucleus,BP,
3328,GO:0006613,1,0.482622342740613,0,96,cotranslational protein targeting to membrane,BP,
3329,GO:0006614,1,0.519124562973816,0,91,SRP-dependent cotranslational protein targeting to membrane,BP,
3330,GO:0006616,1,0.939048851245065,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3331,GO:0006617,1,0.979072502538304,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3332,GO:0006620,1,0.925913839393123,0,6,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3333,GO:0006621,1,0.879820630504738,0,9,protein retention in ER lumen,BP,
3334,GO:0006622,1,0.764928911565285,0,17,protein targeting to lysosome,BP,
3335,GO:0006623,1,0.659541486087623,0,28,protein targeting to vacuole,BP,
3336,GO:0006624,1,0.98031720106715,0,2,vacuolar protein processing,BP,
3337,GO:0006625,1,0.771700240284131,0,17,protein targeting to peroxisome,BP,
3338,GO:0006626,1,0.158901607877213,0,141,protein targeting to mitochondrion,BP,
3339,GO:0006627,1,0.920287933321158,0,7,protein processing involved in protein targeting to mitochondrion,BP,
3349,GO:0006642,1,0.937103755323148,0,4,triglyceride mobilization,BP,
3352,GO:0006646,1,0.832736194577388,0,12,phosphatidylethanolamine biosynthetic process,BP,
3353,GO:0006649,1,0.967400024592669,0,2,phospholipid transfer to membrane,BP,
3355,GO:0006651,1,0.960787133974625,0,4,diacylglycerol biosynthetic process,BP,
3356,GO:0006654,1,0.600370336787911,0,35,phosphatidic acid biosynthetic process,BP,
3357,GO:0006655,1,0.869249995836636,0,9,phosphatidylglycerol biosynthetic process,BP,
3358,GO:0006656,1,0.623654383059805,0,35,phosphatidylcholine biosynthetic process,BP,
3359,GO:0006657,1,0.907022627890843,0,7,CDP-choline pathway,BP,
3360,GO:0006658,1,0.662833569638147,0,30,phosphatidylserine metabolic process,BP,
3361,GO:0006659,1,0.940565173851596,0,4,phosphatidylserine biosynthetic process,BP,
3362,GO:0006660,1,0.987722621313945,0,1,phosphatidylserine catabolic process,BP,
3364,GO:0006662,1,0.880441421644495,0,11,glycerol ether metabolic process,BP,
3365,GO:0006663,1,0.944596113975561,0,4,platelet activating factor biosynthetic process,BP,
3368,GO:0006666,1,0.983426667502414,0,1,3-keto-sphinganine metabolic process,BP,
3369,GO:0006667,1,0.961005538131731,0,3,sphinganine metabolic process,BP,
3370,GO:0006668,1,0.967754728073444,0,2,sphinganine-1-phosphate metabolic process,BP,
3371,GO:0006669,1,0.983915449723607,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3372,GO:0006670,1,0.869419586241486,0,10,sphingosine metabolic process,BP,
3373,GO:0006671,1,0.983426667503153,0,1,phytosphingosine metabolic process,BP,
3375,GO:0006677,1,0.817482122043254,0,14,glycosylceramide metabolic process,BP,
3376,GO:0006678,1,0.899871670779991,0,7,glucosylceramide metabolic process,BP,
3377,GO:0006679,1,0.972118218088008,0,2,glucosylceramide biosynthetic process,BP,
3378,GO:0006680,1,0.953568327941575,0,3,glucosylceramide catabolic process,BP,
3379,GO:0006681,1,0.928370522336689,0,5,galactosylceramide metabolic process,BP,
3380,GO:0006682,1,0.971885986716058,0,2,galactosylceramide biosynthetic process,BP,
3381,GO:0006683,1,0.983995437729547,0,1,galactosylceramide catabolic process,BP,
3382,GO:0006684,1,0.822854785796459,0,14,sphingomyelin metabolic process,BP,
3383,GO:0006685,1,0.915030526952257,0,6,sphingomyelin catabolic process,BP,
3384,GO:0006686,1,0.921885249933175,0,6,sphingomyelin biosynthetic process,BP,
3386,GO:0006688,1,0.80042206370933,0,15,glycosphingolipid biosynthetic process,BP,
3387,GO:0006689,1,0.920841025964226,0,6,ganglioside catabolic process,BP,
3389,GO:0006691,1,0.717435004214271,0,27,leukotriene metabolic process,BP,
3394,GO:0006696,1,0.97547187603342,0,2,ergosterol biosynthetic process,BP,
3395,GO:0006699,1,0.603559177989256,0,34,bile acid biosynthetic process,BP,
3397,GO:0006701,1,0.910764519697359,0,7,progesterone biosynthetic process,BP,
3399,GO:0006703,1,0.862148467138154,0,12,estrogen biosynthetic process,BP,
3402,GO:0006706,1,0.686587589850212,0,27,steroid catabolic process,BP,
3403,GO:0006707,1,0.859883574242085,0,11,cholesterol catabolic process,BP,
3404,GO:0006710,1,0.949620200928951,0,4,androgen catabolic process,BP,
3405,GO:0006711,1,0.97415582822672,0,2,estrogen catabolic process,BP,
3406,GO:0006713,1,0.987687600664566,0,1,glucocorticoid catabolic process,BP,
3407,GO:0006714,1,0.979719129199316,0,2,sesquiterpenoid metabolic process,BP,
3410,GO:0006722,1,0.985172881203875,0,1,triterpenoid metabolic process,BP,
3412,GO:0006726,1,0.942944296169099,0,4,eye pigment biosynthetic process,BP,
3413,GO:0006729,1,0.921557849656812,0,7,tetrahydrobiopterin biosynthetic process,BP,
3414,GO:0006730,1,0.634600730390417,0,33,one-carbon metabolic process,BP,
3419,GO:0006738,1,0.985149477412485,0,1,nicotinamide riboside catabolic process,BP,
3420,GO:0006739,1,0.661007558724605,0,31,NADP metabolic process,BP,
3421,GO:0006740,1,0.954915342007056,0,3,NADPH regeneration,BP,
3422,GO:0006741,1,0.95578558225815,0,3,NADP biosynthetic process,BP,
3423,GO:0006742,1,0.976426384321809,0,2,NADP catabolic process,BP,
3424,GO:0006743,1,0.838160592384984,0,14,ubiquinone metabolic process,BP,
3425,GO:0006744,1,0.852295254227354,0,13,ubiquinone biosynthetic process,BP,
3426,GO:0006747,1,0.98682085955111,0,1,FAD biosynthetic process,BP,
3427,GO:0006749,1,0.594971847181027,0,46,glutathione metabolic process,BP,
3428,GO:0006750,1,0.816599946508982,0,15,glutathione biosynthetic process,BP,
3429,GO:0006751,1,0.908990648167726,0,8,glutathione catabolic process,BP,
3431,GO:0006754,1,0.625252414637649,0,42,ATP biosynthetic process,BP,
3433,GO:0006760,1,0.69703861059422,0,25,folic acid-containing compound metabolic process,BP,
3436,GO:0006768,1,0.846940927803776,0,11,biotin metabolic process,BP,
3438,GO:0006772,1,0.943548675994167,0,4,thiamine metabolic process,BP,
3440,GO:0006776,1,0.899005110245146,0,8,vitamin A metabolic process,BP,
3441,GO:0006777,1,0.9143512836505,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3442,GO:0006778,1,0.618633093359037,0,36,porphyrin-containing compound metabolic process,BP,
3443,GO:0006779,1,0.72203753480095,0,24,porphyrin-containing compound biosynthetic process,BP,
3444,GO:0006780,1,0.976242259748051,0,2,uroporphyrinogen III biosynthetic process,BP,
3445,GO:0006781,1,0.986003787696943,0,1,succinyl-CoA pathway,BP,
3446,GO:0006782,1,0.901811929912407,0,8,protoporphyrinogen IX biosynthetic process,BP,
3447,GO:0006783,1,0.76849561301828,0,20,heme biosynthetic process,BP,
3448,GO:0006784,1,0.967559490328279,0,2,heme a biosynthetic process,BP,
3449,GO:0006787,1,0.924979877104455,0,7,porphyrin-containing compound catabolic process,BP,
3450,GO:0006788,1,0.977021423529051,0,2,heme oxidation,BP,
3451,GO:0006789,1,0.970823134720428,0,2,bilirubin conjugation,BP,
3455,GO:0006797,1,0.984099260716134,0,1,polyphosphate metabolic process,BP,
3457,GO:0006805,1,0.256594642507957,0,103,xenobiotic metabolic process,BP,
3459,GO:0006808,1,0.963715912953863,0,3,regulation of nitrogen utilization,BP,
3467,GO:0006817,1,0.694321809588884,0,24,phosphate ion transport,BP,
3468,GO:0006818,1,0.162696583850962,0,154,hydrogen transport,BP,
3471,GO:0006824,1,0.936042864326485,0,5,cobalt ion transport,BP,
3472,GO:0006825,1,0.785797920481885,0,18,copper ion transport,BP,
3474,GO:0006828,1,0.839120160903639,0,11,manganese ion transport,BP,
3475,GO:0006829,1,0.679549857319569,0,26,zinc II ion transport,BP,
3476,GO:0006833,1,0.772715663549817,0,19,water transport,BP,
3479,GO:0006837,1,0.809083823380916,0,16,serotonin transport,BP,
3481,GO:0006842,1,0.940517151614511,0,4,tricarboxylic acid transport,BP,
3482,GO:0006843,1,0.988666351505513,0,1,mitochondrial citrate transport,BP,
3483,GO:0006844,1,0.97277316961814,0,2,acyl carnitine transport,BP,
3484,GO:0006848,1,0.939093300330577,0,4,pyruvate transport,BP,
3485,GO:0006850,1,0.954880041681638,0,3,mitochondrial pyruvate transport,BP,
3486,GO:0006851,1,0.897842590751623,0,8,mitochondrial calcium ion transport,BP,
3487,GO:0006853,1,0.846128197661538,0,11,carnitine shuttle,BP,
3488,GO:0006855,1,0.711933453872291,0,22,drug transmembrane transport,BP,
3489,GO:0006857,1,0.869376624278991,0,9,oligopeptide transport,BP,
3490,GO:0006858,1,0.970667315205805,0,2,extracellular transport,BP,
3491,GO:0006860,1,0.987026512077187,0,1,extracellular amino acid transport,BP,
3493,GO:0006863,1,0.912186928836806,0,7,purine nucleobase transport,BP,
3494,GO:0006864,1,0.97307323968579,0,2,pyrimidine nucleotide transport,BP,
3496,GO:0006867,1,0.969459349948648,0,2,asparagine transport,BP,
3497,GO:0006868,1,0.925498998440597,0,5,glutamine transport,BP,
3502,GO:0006876,1,0.983427993670479,0,1,cellular cadmium ion homeostasis,BP,
3505,GO:0006880,1,0.9588256222995,0,5,intracellular sequestering of iron ion,BP,
3506,GO:0006882,1,0.702863798230491,0,25,cellular zinc ion homeostasis,BP,
3507,GO:0006883,1,0.814911131821314,0,13,cellular sodium ion homeostasis,BP,
3508,GO:0006884,1,0.770954161999874,0,17,cell volume homeostasis,BP,
3516,GO:0006893,1,0.510515942726011,0,45,Golgi to plasma membrane transport,BP,
3517,GO:0006895,1,0.746848896251608,0,18,Golgi to endosome transport,BP,
3518,GO:0006896,1,0.855618365062873,0,10,Golgi to vacuole transport,BP,
3521,GO:0006900,1,0.209656147615004,0,109,membrane budding,BP,
3522,GO:0006901,1,0.400640092342394,0,64,vesicle coating,BP,
3523,GO:0006903,1,0.310570161524041,0,80,vesicle targeting,BP,
3526,GO:0006907,1,0.76434475086275,0,18,pinocytosis,BP,
3534,GO:0006921,1,0.65689878457321,0,30,cellular component disassembly involved in execution phase of apoptosis,BP,
3536,GO:0006925,1,0.795116209999538,0,17,inflammatory cell apoptotic process,BP,
3538,GO:0006929,1,0.662307605333674,0,27,substrate-dependent cell migration,BP,
3539,GO:0006930,1,0.885880561063636,0,8,substrate-dependent cell migration, cell extension,BP,
3540,GO:0006931,1,0.945804055931427,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3541,GO:0006933,1,0.945666898806783,0,4,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3549,GO:0006948,1,0.983739551070219,0,1,induction by virus of host cell-cell fusion,BP,
3550,GO:0006949,1,0.503556658224643,0,49,syncytium formation,BP,
3553,GO:0006953,1,0.57063095194518,0,46,acute-phase response,BP,
3556,GO:0006956,1,0.475307214348757,0,55,complement activation,BP,
3557,GO:0006957,1,0.820321244058412,0,14,complement activation, alternative pathway,BP,
3558,GO:0006958,1,0.642865223720339,0,32,complement activation, classical pathway,BP,
3560,GO:0006963,1,0.994072387421552,0,2,positive regulation of antibacterial peptide biosynthetic process,BP,
3561,GO:0006965,1,0.994072387421552,0,2,positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
3562,GO:0006968,1,0.477222727134115,0,59,cellular defense response,BP,
3564,GO:0006971,1,0.884768989334456,0,8,hypotonic response,BP,
3571,GO:0006982,1,0.970653340988865,0,3,response to lipid hydroperoxide,BP,
3572,GO:0006983,1,0.857186717800646,0,10,ER overload response,BP,
3573,GO:0006984,1,0.538683275188614,0,42,ER-nucleus signaling pathway,BP,
3575,GO:0006987,1,0.887661884159508,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3576,GO:0006990,1,0.944479669272262,0,4,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3577,GO:0006991,1,0.866818633066674,0,9,response to sterol depletion,BP,
3578,GO:0006995,1,0.939276068323028,0,4,cellular response to nitrogen starvation,BP,
3580,GO:0006997,1,0.138949731164236,0,136,nucleus organization,BP,
3581,GO:0006998,1,0.30244046623175,0,81,nuclear envelope organization,BP,
3582,GO:0006999,1,0.80699139222062,0,14,nuclear pore organization,BP,
3583,GO:0007000,1,0.917153167775184,0,6,nucleolus organization,BP,
3584,GO:0007004,1,0.416255872732014,0,60,telomere maintenance via telomerase,BP,
3587,GO:0007007,1,0.808977945087623,0,18,inner mitochondrial membrane organization,BP,
3588,GO:0007008,1,0.916710363122091,0,8,outer mitochondrial membrane organization,BP,
3591,GO:0007014,1,0.983437397741892,0,1,actin ubiquitination,BP,
3595,GO:0007018,1,0.0288457568920619,0,237,microtubule-based movement,BP,
3596,GO:0007019,1,0.655222359642097,0,29,microtubule depolymerization,BP,
3598,GO:0007021,1,0.934693442940547,0,6,tubulin complex assembly,BP,
3599,GO:0007023,1,0.95431811024875,0,4,post-chaperonin tubulin folding pathway,BP,
3600,GO:0007026,1,0.785149469597062,0,17,negative regulation of microtubule depolymerization,BP,
3604,GO:0007031,1,0.648569980553679,0,31,peroxisome organization,BP,
3608,GO:0007035,1,0.778770947140208,0,18,vacuolar acidification,BP,
3609,GO:0007037,1,0.983426667501871,0,1,vacuolar phosphate transport,BP,
3610,GO:0007039,1,0.889725521594932,0,8,protein catabolic process in the vacuole,BP,
3613,GO:0007042,1,0.928625533032536,0,6,lysosomal lumen acidification,BP,
3621,GO:0007056,1,0.96120170349115,0,3,spindle assembly involved in female meiosis,BP,
3622,GO:0007057,1,0.971946649207168,0,2,spindle assembly involved in female meiosis I,BP,
3624,GO:0007060,1,0.954171466168598,0,3,male meiosis chromosome segregation,BP,
3625,GO:0007062,1,0.187262479769786,0,115,sister chromatid cohesion,BP,
3626,GO:0007063,1,0.767276890102262,0,17,regulation of sister chromatid cohesion,BP,
3627,GO:0007064,1,0.744401193985736,0,19,mitotic sister chromatid cohesion,BP,
3628,GO:0007066,1,0.985426149723562,0,2,female meiosis sister chromatid cohesion,BP,
3630,GO:0007068,1,0.967126892154055,0,2,negative regulation of transcription during mitotic cell cycle,BP,
3631,GO:0007070,1,0.967126892154055,0,2,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
3632,GO:0007072,1,0.988049419275219,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3633,GO:0007076,1,0.797542266666794,0,14,mitotic chromosome condensation,BP,
3634,GO:0007077,1,0.533097598360261,0,42,mitotic nuclear envelope disassembly,BP,
3635,GO:0007079,1,0.951460163718525,0,3,mitotic chromosome movement towards spindle pole,BP,
3637,GO:0007084,1,0.873615067711863,0,10,mitotic nuclear envelope reassembly,BP,
3639,GO:0007089,1,0.940301310145705,0,4,traversing start control point of mitotic cell cycle,BP,
3640,GO:0007091,1,0.51477584045443,0,46,metaphase/anaphase transition of mitotic cell cycle,BP,
3642,GO:0007094,1,0.674105510735848,0,27,mitotic spindle assembly checkpoint,BP,
3644,GO:0007096,1,0.781182276446039,0,18,regulation of exit from mitosis,BP,
3645,GO:0007097,1,0.86258889261083,0,9,nuclear migration,BP,
3647,GO:0007099,1,0.659072845300719,0,27,centriole replication,BP,
3648,GO:0007100,1,0.821512852901266,0,13,mitotic centrosome separation,BP,
3649,GO:0007113,1,0.964546492683738,0,3,endomitotic cell cycle,BP,
3651,GO:0007127,1,0.266821508705293,0,93,meiosis I,BP,
3652,GO:0007129,1,0.595085520798485,0,37,synapsis,BP,
3653,GO:0007130,1,0.771435851361478,0,19,synaptonemal complex assembly,BP,
3654,GO:0007131,1,0.531519594595893,0,43,reciprocal meiotic recombination,BP,
3655,GO:0007135,1,0.899973007442633,0,8,meiosis II,BP,
3657,GO:0007141,1,0.795610290059878,0,17,male meiosis I,BP,
3658,GO:0007143,1,0.701339867098524,0,24,female meiotic division,BP,
3659,GO:0007144,1,0.91357733530678,0,6,female meiosis I,BP,
3660,GO:0007146,1,0.984728932554734,0,1,meiotic recombination nodule assembly,BP,
3661,GO:0007147,1,0.98344967443138,0,1,female meiosis II,BP,
3666,GO:0007158,1,0.785284412379062,0,15,neuron cell-cell adhesion,BP,
3669,GO:0007161,1,0.935815728435103,0,4,calcium-independent cell-matrix adhesion,BP,
3678,GO:0007171,1,0.813288176315895,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3679,GO:0007172,1,0.885252750687555,0,8,signal complex assembly,BP,
3681,GO:0007174,1,0.985762852771326,0,1,epidermal growth factor catabolic process,BP,
3682,GO:0007175,1,0.841600195117495,0,11,negative regulation of epidermal growth factor-activated receptor activity,BP,
3686,GO:0007181,1,0.957835834865669,0,3,transforming growth factor beta receptor complex assembly,BP,
3688,GO:0007183,1,0.810730675775162,0,14,SMAD protein complex assembly,BP,
3690,GO:0007185,1,0.894612512368134,0,7,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3695,GO:0007190,1,0.568412385605595,0,38,activation of adenylate cyclase activity,BP,
3696,GO:0007191,1,0.862064472495485,0,10,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3698,GO:0007194,1,0.690783722126877,0,28,negative regulation of adenylate cyclase activity,BP,
3699,GO:0007195,1,0.883827500388327,0,11,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3700,GO:0007196,1,0.861300403040173,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3701,GO:0007197,1,0.928721574613832,0,5,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3702,GO:0007198,1,0.95168714609848,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3703,GO:0007199,1,0.968942088703487,0,2,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3708,GO:0007206,1,0.967126892151486,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3709,GO:0007207,1,0.915846327924145,0,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3710,GO:0007208,1,0.96735568391821,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3711,GO:0007210,1,0.743640514041992,0,26,serotonin receptor signaling pathway,BP,
3712,GO:0007212,1,0.544914929250137,0,45,dopamine receptor signaling pathway,BP,
3713,GO:0007213,1,0.81275482767058,0,15,G-protein coupled acetylcholine receptor signaling pathway,BP,
3714,GO:0007214,1,0.704653305764551,0,23,gamma-aminobutyric acid signaling pathway,BP,
3715,GO:0007215,1,0.305844344965837,0,76,glutamate receptor signaling pathway,BP,
3716,GO:0007216,1,0.799599338254593,0,14,G-protein coupled glutamate receptor signaling pathway,BP,
3717,GO:0007217,1,0.924256652995307,0,7,tachykinin receptor signaling pathway,BP,
3718,GO:0007218,1,0.324847565081035,0,98,neuropeptide signaling pathway,BP,
3724,GO:0007225,1,0.983426667502908,0,1,patched ligand maturation,BP,
3725,GO:0007227,1,0.940475880176266,0,4,signal transduction downstream of smoothened,BP,
3726,GO:0007228,1,0.956328259990506,0,3,positive regulation of hh target transcription factor activity,BP,
3728,GO:0007231,1,0.959832907560302,0,3,osmosensory signaling pathway,BP,
3730,GO:0007250,1,0.764764205597421,0,18,activation of NF-kappaB-inducing kinase activity,BP,
3732,GO:0007253,1,0.868564024227164,0,11,cytoplasmic sequestering of NF-kappaB,BP,
3734,GO:0007256,1,0.904678090069417,0,6,activation of JNKK activity,BP,
3736,GO:0007258,1,0.941677332415059,0,4,JUN phosphorylation,BP,
3739,GO:0007262,1,0.887318931259212,0,8,STAT protein import into nucleus,BP,
3748,GO:0007271,1,0.607781732589032,0,35,synaptic transmission, cholinergic,BP,
3750,GO:0007274,1,0.64980584352056,0,29,neuromuscular synaptic transmission,BP,
3755,GO:0007284,1,0.983426667503056,0,1,spermatogonial cell division,BP,
3757,GO:0007288,1,0.889013166844036,0,8,sperm axoneme assembly,BP,
3758,GO:0007289,1,0.810085826872477,0,17,spermatid nucleus differentiation,BP,
3759,GO:0007290,1,0.958922669973046,0,4,spermatid nucleus elongation,BP,
3760,GO:0007291,1,0.992591806724069,0,1,sperm individualization,BP,
3762,GO:0007296,1,0.939983487629356,0,4,vitellogenesis,BP,
3763,GO:0007308,1,0.968423116816807,0,2,oocyte construction,BP,
3764,GO:0007309,1,0.968423116816807,0,2,oocyte axis specification,BP,
3765,GO:0007314,1,0.968423116816807,0,2,oocyte anterior/posterior axis specification,BP,
3766,GO:0007315,1,0.968423116816807,0,2,pole plasm assembly,BP,
3767,GO:0007320,1,0.848010927443824,0,13,insemination,BP,
3768,GO:0007321,1,0.993323141663568,0,1,sperm displacement,BP,
3770,GO:0007339,1,0.631533839033142,0,34,binding of sperm to zona pellucida,BP,
3771,GO:0007340,1,0.65899562325538,0,35,acrosome reaction,BP,
3772,GO:0007341,1,0.93264997795411,0,6,penetration of zona pellucida,BP,
3774,GO:0007343,1,0.933141924165497,0,5,egg activation,BP,
3775,GO:0007344,1,0.987899864828234,0,1,pronuclear fusion,BP,
3777,GO:0007349,1,0.992591806724069,0,1,cellularization,BP,
3780,GO:0007352,1,0.962201060328537,0,3,zygotic specification of dorsal/ventral axis,BP,
3785,GO:0007371,1,0.983434641771548,0,1,ventral midline determination,BP,
3788,GO:0007387,1,0.984363774367443,0,1,anterior compartment pattern formation,BP,
3789,GO:0007388,1,0.984363774367443,0,1,posterior compartment specification,BP,
3793,GO:0007400,1,0.984968562250546,0,1,neuroblast fate determination,BP,
3794,GO:0007402,1,0.978203505515282,0,2,ganglion mother cell fate determination,BP,
3795,GO:0007403,1,0.983511021466145,0,1,glial cell fate determination,BP,
3797,GO:0007406,1,0.922671764919614,0,5,negative regulation of neuroblast proliferation,BP,
3800,GO:0007412,1,0.964917872431112,0,3,axon target recognition,BP,
3801,GO:0007413,1,0.71369149917855,0,21,axonal fasciculation,BP,
3804,GO:0007418,1,0.940534976611088,0,4,ventral midline development,BP,
3808,GO:0007424,1,0.984734240689121,0,1,open tracheal system development,BP,
3811,GO:0007439,1,0.968892847783573,0,2,ectodermal digestive tract development,BP,
3814,GO:0007468,1,0.958475528744139,0,3,regulation of rhodopsin gene expression,BP,
3816,GO:0007493,1,0.96909276652368,0,2,endodermal cell fate determination,BP,
3818,GO:0007495,1,0.983665790532393,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3819,GO:0007497,1,0.967126892154924,0,2,posterior midgut development,BP,
3821,GO:0007499,1,0.983426667503004,0,1,ectoderm and mesoderm interaction,BP,
3823,GO:0007501,1,0.817210056352365,0,14,mesodermal cell fate specification,BP,
3824,GO:0007506,1,0.924150500085819,0,7,gonadal mesoderm development,BP,
3826,GO:0007509,1,0.968508973704233,0,2,mesoderm migration involved in gastrulation,BP,
3827,GO:0007512,1,0.842888657125069,0,12,adult heart development,BP,
3829,GO:0007518,1,0.973090268941606,0,2,myoblast fate determination,BP,
3831,GO:0007520,1,0.598855973470972,0,38,myoblast fusion,BP,
3832,GO:0007521,1,0.967231185031325,0,2,muscle cell fate determination,BP,
3833,GO:0007522,1,0.983426667501479,0,1,visceral muscle development,BP,
3834,GO:0007525,1,0.968328334307354,0,2,somatic muscle development,BP,
3835,GO:0007528,1,0.526843193419937,0,41,neuromuscular junction development,BP,
3836,GO:0007529,1,0.983430139654734,0,1,establishment of synaptic specificity at neuromuscular junction,BP,
3838,GO:0007538,1,0.951410304763702,0,3,primary sex determination,BP,
3839,GO:0007542,1,0.967127129541986,0,2,primary sex determination, germ-line,BP,
3841,GO:0007549,1,0.874624354880863,0,9,dosage compensation,BP,
3847,GO:0007571,1,0.975841922385491,0,2,age-dependent general metabolic decline,BP,
3848,GO:0007576,1,0.984766354797669,0,1,nucleolar fragmentation,BP,
3856,GO:0007597,1,0.777952239714223,0,19,blood coagulation, intrinsic pathway,BP,
3857,GO:0007598,1,0.929192024212173,0,5,blood coagulation, extrinsic pathway,BP,
3870,GO:0007614,1,0.879413806549304,0,9,short-term memory,BP,
3871,GO:0007616,1,0.624689477527032,0,30,long-term memory,BP,
3872,GO:0007617,1,0.745099188663534,0,21,mating behavior,BP,
3873,GO:0007618,1,0.598033757387088,0,38,mating,BP,
3874,GO:0007619,1,0.956316046460756,0,3,courtship behavior,BP,
3875,GO:0007620,1,0.77756153339824,0,20,copulation,BP,
3876,GO:0007621,1,0.951234305517313,0,4,negative regulation of female receptivity,BP,
3879,GO:0007624,1,0.983426667503304,0,1,ultradian rhythm,BP,
3880,GO:0007625,1,0.799732100949949,0,18,grooming behavior,BP,
3884,GO:0007632,1,0.469568983210693,0,50,visual behavior,BP,
3885,GO:0007634,1,0.985066674606299,0,1,optokinetic behavior,BP,
3886,GO:0007635,1,0.77982754098389,0,17,chemosensory behavior,BP,
3893,GO:0008020,1,0.944779128227181,0,4,G-protein coupled photoreceptor activity,MF,
3896,GO:0008023,1,0.508727395976924,0,45,transcription elongation factor complex,CC,
3897,GO:0008024,1,0.881668977933568,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3898,GO:0008026,1,0.206330866110759,0,99,ATP-dependent helicase activity,MF,
3899,GO:0008028,1,0.576099281358159,0,37,monocarboxylic acid transmembrane transporter activity,MF,
3900,GO:0008033,1,0.233003953955432,0,108,tRNA processing,BP,
3901,GO:0008035,1,0.894234042829628,0,9,high-density lipoprotein particle binding,MF,
3903,GO:0008038,1,0.580646700256584,0,34,neuron recognition,BP,
3904,GO:0008039,1,0.989134658985333,0,1,synaptic target recognition,BP,
3905,GO:0008043,1,0.984359768140538,0,2,intracellular ferritin complex,CC,
3907,GO:0008046,1,0.892813464384453,0,7,axon guidance receptor activity,MF,
3909,GO:0008048,1,0.953263159650589,0,5,calcium sensitive guanylate cyclase activator activity,MF,
3910,GO:0008049,1,0.987114204078389,0,1,male courtship behavior,BP,
3911,GO:0008050,1,0.968801454881952,0,2,female courtship behavior,BP,
3912,GO:0008052,1,0.99248783824138,0,1,sensory organ boundary specification,BP,
3913,GO:0008053,1,0.768690776314909,0,19,mitochondrial fusion,BP,
3914,GO:0008057,1,0.983426667499705,0,1,eye pigment granule organization,BP,
3915,GO:0008061,1,0.893475954434299,0,8,chitin binding,MF,
3916,GO:0008063,1,0.909044146502308,0,6,Toll signaling pathway,BP,
3919,GO:0008066,1,0.638029357065222,0,27,glutamate receptor activity,MF,
3920,GO:0008068,1,0.983890557950773,0,1,extracellular-glutamate-gated chloride channel activity,MF,
3921,GO:0008073,1,0.972161768576851,0,3,ornithine decarboxylase inhibitor activity,MF,
3925,GO:0008079,1,0.912317000517137,0,6,translation termination factor activity,MF,
3926,GO:0008080,1,0.305389651805777,0,83,N-acetyltransferase activity,MF,
3929,GO:0008088,1,0.514094837602038,0,45,axo-dendritic transport,BP,
3930,GO:0008089,1,0.6514390312083,0,30,anterograde axonal transport,BP,
3931,GO:0008090,1,0.879015578633862,0,9,retrograde axonal transport,BP,
3934,GO:0008093,1,0.843896629468287,0,11,cytoskeletal adaptor activity,MF,
3935,GO:0008094,1,0.321132224157517,0,74,DNA-dependent ATPase activity,MF,
3936,GO:0008097,1,0.947209957477766,0,6,5S rRNA binding,MF,
3939,GO:0008106,1,0.826523893271846,0,16,alcohol dehydrogenase (NADP+) activity,MF,
3940,GO:0008107,1,0.967453483254851,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3941,GO:0008108,1,0.990224203500204,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3942,GO:0008109,1,0.953485511689173,0,3,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3943,GO:0008111,1,0.986811960913406,0,1,alpha-methylacyl-CoA racemase activity,MF,
3944,GO:0008112,1,0.988816628009084,0,1,nicotinamide N-methyltransferase activity,MF,
3945,GO:0008113,1,0.979695703429684,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3946,GO:0008115,1,0.985146370134175,0,1,sarcosine oxidase activity,MF,
3947,GO:0008116,1,0.983426667501921,0,1,prostaglandin-I synthase activity,MF,
3948,GO:0008117,1,0.983426667501724,0,1,sphinganine-1-phosphate aldolase activity,MF,
3949,GO:0008118,1,0.985794133070218,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3950,GO:0008119,1,0.983613391591721,0,1,thiopurine S-methyltransferase activity,MF,
3951,GO:0008120,1,0.988501766267468,0,1,ceramide glucosyltransferase activity,MF,
3952,GO:0008121,1,0.928811795588781,0,8,ubiquinol-cytochrome-c reductase activity,MF,
3953,GO:0008123,1,0.984051682817874,0,1,cholesterol 7-alpha-monooxygenase activity,MF,
3954,GO:0008124,1,0.977793018900549,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3955,GO:0008126,1,0.984106248625974,0,1,acetylesterase activity,MF,
3956,GO:0008127,1,0.99046814285105,0,1,quercetin 2,3-dioxygenase activity,MF,
3957,GO:0008131,1,0.922465568391303,0,5,primary amine oxidase activity,MF,
3959,GO:0008135,1,0.325793978359605,0,80,translation factor activity, RNA binding,MF,
3960,GO:0008137,1,0.758217837635614,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3962,GO:0008139,1,0.669293743268953,0,26,nuclear localization sequence binding,MF,
3963,GO:0008140,1,0.892589602855797,0,8,cAMP response element binding protein binding,MF,
3964,GO:0008142,1,0.924208631175364,0,5,oxysterol binding,MF,
3965,GO:0008143,1,0.827853786324284,0,12,poly(A) binding,MF,
3966,GO:0008144,1,0.265106365088072,0,96,drug binding,MF,
3967,GO:0008146,1,0.481133427449113,0,52,sulfotransferase activity,MF,
3968,GO:0008147,1,0.990745390158995,0,2,structural constituent of bone,MF,
3972,GO:0008156,1,0.605500356018399,0,34,negative regulation of DNA replication,BP,
3973,GO:0008157,1,0.758260622362185,0,18,protein phosphatase 1 binding,MF,
3974,GO:0008158,1,0.960299160895172,0,3,hedgehog receptor activity,MF,
3975,GO:0008160,1,0.984585446275923,0,1,protein tyrosine phosphatase activator activity,MF,
3977,GO:0008169,1,0.959034129565544,0,3,C-methyltransferase activity,MF,
3979,GO:0008171,1,0.815226469106438,0,15,O-methyltransferase activity,MF,
3980,GO:0008172,1,0.908095167261078,0,7,S-methyltransferase activity,MF,
3981,GO:0008173,1,0.518850200526888,0,45,RNA methyltransferase activity,MF,
3982,GO:0008174,1,0.957157103998546,0,3,mRNA methyltransferase activity,MF,
3983,GO:0008175,1,0.690723082358704,0,25,tRNA methyltransferase activity,MF,
3984,GO:0008176,1,0.978623578488773,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3985,GO:0008177,1,0.967085672006092,0,3,succinate dehydrogenase (ubiquinone) activity,MF,
3986,GO:0008179,1,0.833765871572186,0,12,adenylate cyclase binding,MF,
3988,GO:0008184,1,0.951868962443789,0,3,glycogen phosphorylase activity,MF,
3989,GO:0008186,1,0.338807434209806,0,68,RNA-dependent ATPase activity,MF,
3990,GO:0008187,1,0.729482054002513,0,21,poly-pyrimidine tract binding,MF,
3991,GO:0008188,1,0.571338258287407,0,44,neuropeptide receptor activity,MF,
3992,GO:0008190,1,0.885457066932956,0,9,eukaryotic initiation factor 4E binding,MF,
3993,GO:0008191,1,0.819882974764235,0,15,metalloendopeptidase inhibitor activity,MF,
3994,GO:0008192,1,0.957870580508279,0,3,RNA guanylyltransferase activity,MF,
3995,GO:0008193,1,0.974015002453054,0,2,tRNA guanylyltransferase activity,MF,
3997,GO:0008195,1,0.951096177116468,0,3,phosphatidate phosphatase activity,MF,
4004,GO:0008204,1,0.97547187603342,0,2,ergosterol metabolic process,BP,
4005,GO:0008206,1,0.520705670022973,0,45,bile acid metabolic process,BP,
4008,GO:0008210,1,0.735125576874642,0,23,estrogen metabolic process,BP,
4012,GO:0008214,1,0.631879890670002,0,28,protein dealkylation,BP,
4013,GO:0008215,1,0.919612267714987,0,7,spermine metabolic process,BP,
4014,GO:0008216,1,0.913293635685007,0,8,spermidine metabolic process,BP,
4016,GO:0008218,1,0.955564508780571,0,3,bioluminescence,BP,
4019,GO:0008228,1,0.850605920227062,0,12,opsonization,BP,
4021,GO:0008234,1,0.0699183583864132,0,179,cysteine-type peptidase activity,MF,
4022,GO:0008235,1,0.439510911465404,0,55,metalloexopeptidase activity,MF,
4024,GO:0008237,1,0.0615892705552634,0,183,metallopeptidase activity,MF,
4026,GO:0008239,1,0.878821367214629,0,9,dipeptidyl-peptidase activity,MF,
4027,GO:0008240,1,0.951249140997973,0,3,tripeptidyl-peptidase activity,MF,
4028,GO:0008241,1,0.97252473042374,0,2,peptidyl-dipeptidase activity,MF,
4029,GO:0008242,1,0.853279949414945,0,12,omega peptidase activity,MF,
4030,GO:0008250,1,0.869450077975192,0,12,oligosaccharyltransferase complex,CC,
4031,GO:0008251,1,0.968003409173087,0,2,tRNA-specific adenosine deaminase activity,MF,
4032,GO:0008252,1,0.831081677890801,0,13,nucleotidase activity,MF,
4033,GO:0008253,1,0.857974419051204,0,11,5'-nucleotidase activity,MF,
4034,GO:0008254,1,0.983426667500005,0,1,3'-nucleotidase activity,MF,
4035,GO:0008260,1,0.971202306455268,0,2,3-oxoacid CoA-transferase activity,MF,
4036,GO:0008263,1,0.968831602174214,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
4037,GO:0008265,1,0.984311612317777,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
4038,GO:0008266,1,0.766204061416169,0,18,poly(U) RNA binding,MF,
4039,GO:0008267,1,0.983426667499068,0,1,poly-glutamine tract binding,MF,
4040,GO:0008269,1,0.973210964660173,0,2,JAK pathway signal transduction adaptor activity,MF,
4042,GO:0008271,1,0.809746884293262,0,13,secondary active sulfate transmembrane transporter activity,MF,
4043,GO:0008272,1,0.786218563887164,0,15,sulfate transport,BP,
4044,GO:0008273,1,0.926860714147925,0,5,calcium, potassium:sodium antiporter activity,MF,
4045,GO:0008274,1,0.893444395254169,0,7,gamma-tubulin ring complex,CC,
4046,GO:0008275,1,0.951306602589582,0,3,gamma-tubulin small complex,CC,
4047,GO:0008276,1,0.368536750611792,0,67,protein methyltransferase activity,MF,
4049,GO:0008278,1,0.870333928119306,0,9,cohesin complex,CC,
4050,GO:0008281,1,0.96712689215454,0,2,sulfonylurea receptor activity,MF,
4051,GO:0008282,1,0.937406456287468,0,4,ATP-sensitive potassium channel complex,CC,
4056,GO:0008287,1,0.501464703833358,0,45,protein serine/threonine phosphatase complex,CC,
4058,GO:0008290,1,0.894624409499308,0,8,F-actin capping protein complex,CC,
4059,GO:0008291,1,0.937952211371346,0,4,acetylcholine metabolic process,BP,
4060,GO:0008292,1,0.968192636055349,0,2,acetylcholine biosynthetic process,BP,
4061,GO:0008294,1,0.9671268921466,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
4062,GO:0008295,1,0.949246540118161,0,4,spermidine biosynthetic process,BP,
4063,GO:0008296,1,0.875977381307038,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4064,GO:0008297,1,0.902441653840605,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4065,GO:0008298,1,0.842503721818785,0,12,intracellular mRNA localization,BP,
4067,GO:0008300,1,0.904642629412358,0,8,isoprenoid catabolic process,BP,
4068,GO:0008301,1,0.759442449730353,0,19,DNA binding, bending,MF,
4070,GO:0008306,1,0.339547514984049,0,72,associative learning,BP,
4072,GO:0008308,1,0.775056208121405,0,18,voltage-gated anion channel activity,MF,
4073,GO:0008309,1,0.946573932736679,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4074,GO:0008310,1,0.931677129523763,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4075,GO:0008311,1,0.976244112560121,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4076,GO:0008312,1,0.916732231150472,0,7,7S RNA binding,MF,
4077,GO:0008318,1,0.903762429178799,0,7,protein prenyltransferase activity,MF,
4078,GO:0008320,1,0.838012757118508,0,17,protein transmembrane transporter activity,MF,
4079,GO:0008321,1,0.952340473536163,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4081,GO:0008327,1,0.766079018645393,0,21,methyl-CpG binding,MF,
4082,GO:0008328,1,0.504550375556291,0,45,ionotropic glutamate receptor complex,CC,
4083,GO:0008329,1,0.799469453249564,0,17,signaling pattern recognition receptor activity,MF,
4084,GO:0008330,1,0.959378723572159,0,3,protein tyrosine/threonine phosphatase activity,MF,
4085,GO:0008331,1,0.823300557627012,0,12,high voltage-gated calcium channel activity,MF,
4086,GO:0008332,1,0.951096177105661,0,3,low voltage-gated calcium channel activity,MF,
4088,GO:0008334,1,0.733234255275922,0,24,histone mRNA metabolic process,BP,
4089,GO:0008336,1,0.987198264305229,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4090,GO:0008340,1,0.831405862385112,0,12,determination of adult lifespan,BP,
4091,GO:0008343,1,0.909877787318817,0,10,adult feeding behavior,BP,
4093,GO:0008347,1,0.529494312047004,0,44,glial cell migration,BP,
4094,GO:0008348,1,0.983443534740647,0,1,negative regulation of antimicrobial humoral response,BP,
4095,GO:0008349,1,0.936574795287058,0,4,MAP kinase kinase kinase kinase activity,MF,
4096,GO:0008352,1,0.984477364801439,0,1,katanin complex,CC,
4097,GO:0008353,1,0.804016857569605,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4098,GO:0008354,1,0.89544440190309,0,7,germ cell migration,BP,
4099,GO:0008355,1,0.967126892155359,0,2,olfactory learning,BP,
4100,GO:0008356,1,0.781522687268341,0,17,asymmetric cell division,BP,
4101,GO:0008358,1,0.968423116816807,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4105,GO:0008373,1,0.733886942090282,0,21,sialyltransferase activity,MF,
4108,GO:0008376,1,0.582453737010107,0,34,acetylgalactosaminyltransferase activity,MF,
4110,GO:0008379,1,0.96118610677214,0,5,thioredoxin peroxidase activity,MF,
4112,GO:0008381,1,0.881491712399122,0,8,mechanically-gated ion channel activity,MF,
4113,GO:0008384,1,0.951298920198526,0,3,IkappaB kinase activity,MF,
4114,GO:0008385,1,0.861995391322109,0,11,IkappaB kinase complex,CC,
4115,GO:0008386,1,0.986825313330565,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4116,GO:0008387,1,0.985597405954989,0,1,steroid 7-alpha-hydroxylase activity,MF,
4117,GO:0008389,1,0.975829903456722,0,2,coumarin 7-hydroxylase activity,MF,
4118,GO:0008391,1,0.805503875203035,0,16,arachidonic acid monooxygenase activity,MF,
4119,GO:0008392,1,0.805503875203035,0,16,arachidonic acid epoxygenase activity,MF,
4120,GO:0008395,1,0.753170732367258,0,20,steroid hydroxylase activity,MF,
4121,GO:0008396,1,0.971015548723558,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4122,GO:0008397,1,0.983426767367589,0,1,sterol 12-alpha-hydroxylase activity,MF,
4123,GO:0008398,1,0.983775317839248,0,1,sterol 14-demethylase activity,MF,
4124,GO:0008401,1,0.943997220158753,0,4,retinoic acid 4-hydroxylase activity,MF,
4125,GO:0008403,1,0.983675976604856,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4126,GO:0008404,1,0.987340486400627,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4127,GO:0008405,1,0.987340486400627,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4129,GO:0008408,1,0.499034167725574,0,48,3'-5' exonuclease activity,MF,
4130,GO:0008409,1,0.827657129463291,0,12,5'-3' exonuclease activity,MF,
4131,GO:0008410,1,0.959070289122648,0,3,CoA-transferase activity,MF,
4132,GO:0008413,1,0.981181556975986,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4133,GO:0008417,1,0.814428243818166,0,13,fucosyltransferase activity,MF,
4134,GO:0008418,1,0.991670906568163,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4135,GO:0008419,1,0.984498464782598,0,1,RNA lariat debranching enzyme activity,MF,
4136,GO:0008420,1,0.919013143184011,0,6,CTD phosphatase activity,MF,
4137,GO:0008422,1,0.926892232977366,0,5,beta-glucosidase activity,MF,
4138,GO:0008424,1,0.983585305180971,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4139,GO:0008425,1,0.990677269526394,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4140,GO:0008426,1,0.967350354461675,0,3,protein kinase C inhibitor activity,MF,
4141,GO:0008427,1,0.968394071808184,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4142,GO:0008428,1,0.955052158066999,0,3,ribonuclease inhibitor activity,MF,
4144,GO:0008430,1,0.932831718159841,0,5,selenium binding,MF,
4145,GO:0008431,1,0.955688121238817,0,3,vitamin E binding,MF,
4146,GO:0008432,1,0.905719250702046,0,7,JUN kinase binding,MF,
4148,GO:0008437,1,0.986677732268827,0,1,thyrotropin-releasing hormone activity,MF,
4149,GO:0008440,1,0.868316662841213,0,10,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4150,GO:0008441,1,0.968675127305296,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4151,GO:0008442,1,0.986791982480919,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4153,GO:0008444,1,0.985908188314079,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4154,GO:0008445,1,0.988578257129805,0,1,D-aspartate oxidase activity,MF,
4155,GO:0008446,1,0.988265011149744,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4156,GO:0008448,1,0.98745859684024,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4157,GO:0008449,1,0.951096177117512,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4158,GO:0008453,1,0.974525129116917,0,2,alanine-glyoxylate transaminase activity,MF,
4159,GO:0008454,1,0.955501756830079,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4160,GO:0008455,1,0.984375749176824,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4161,GO:0008456,1,0.983435876792907,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4162,GO:0008457,1,0.983426667503348,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4163,GO:0008458,1,0.98361191421251,0,1,carnitine O-octanoyltransferase activity,MF,
4164,GO:0008459,1,0.969165880342266,0,2,chondroitin 6-sulfotransferase activity,MF,
4165,GO:0008460,1,0.987114204078389,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4166,GO:0008465,1,0.990850180449793,0,1,glycerate dehydrogenase activity,MF,
4167,GO:0008466,1,0.971347351938045,0,2,glycogenin glucosyltransferase activity,MF,
4168,GO:0008467,1,0.908948404571263,0,7,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4169,GO:0008469,1,0.903849887650745,0,7,histone-arginine N-methyltransferase activity,MF,
4170,GO:0008470,1,0.983426667503004,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4171,GO:0008474,1,0.935332326204686,0,5,palmitoyl-(protein) hydrolase activity,MF,
4172,GO:0008475,1,0.951938885644591,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4173,GO:0008476,1,0.973587338574775,0,2,protein-tyrosine sulfotransferase activity,MF,
4174,GO:0008478,1,0.983426667499806,0,1,pyridoxal kinase activity,MF,
4175,GO:0008479,1,0.941598356816015,0,6,queuine tRNA-ribosyltransferase activity,MF,
4176,GO:0008480,1,0.983571445812305,0,1,sarcosine dehydrogenase activity,MF,
4177,GO:0008481,1,0.971435221395133,0,2,sphinganine kinase activity,MF,
4178,GO:0008482,1,0.985408118408524,0,1,sulfite oxidase activity,MF,
4179,GO:0008483,1,0.78375829121703,0,17,transaminase activity,MF,
4180,GO:0008484,1,0.766381832697421,0,17,sulfuric ester hydrolase activity,MF,
4181,GO:0008486,1,0.946650719048175,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4182,GO:0008488,1,0.983678228586038,0,1,gamma-glutamyl carboxylase activity,MF,
4183,GO:0008489,1,0.984007193345642,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4184,GO:0008493,1,0.987323757376136,0,1,tetracycline transporter activity,MF,
4185,GO:0008494,1,0.900009346187855,0,7,translation activator activity,MF,
4186,GO:0008495,1,0.983866526340532,0,1,protoheme IX farnesyltransferase activity,MF,
4187,GO:0008496,1,0.983426667503251,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4189,GO:0008502,1,0.96709747084252,0,3,melatonin receptor activity,MF,
4190,GO:0008503,1,0.917605408472758,0,6,benzodiazepine receptor activity,MF,
4191,GO:0008504,1,0.869499717183398,0,9,monoamine transmembrane transporter activity,MF,
4193,GO:0008507,1,0.983458952104332,0,1,sodium:iodide symporter activity,MF,
4194,GO:0008508,1,0.927263539678238,0,6,bile acid:sodium symporter activity,MF,
4196,GO:0008510,1,0.935482277019585,0,4,sodium:bicarbonate symporter activity,MF,
4197,GO:0008511,1,0.967126892152311,0,2,sodium:potassium:chloride symporter activity,MF,
4198,GO:0008513,1,0.958707591309986,0,3,secondary active organic cation transmembrane transporter activity,MF,
4199,GO:0008514,1,0.058647159650031,0,186,organic anion transmembrane transporter activity,MF,
4201,GO:0008517,1,0.921237913171756,0,6,folic acid transporter activity,MF,
4202,GO:0008518,1,0.984113284802993,0,1,reduced folate carrier activity,MF,
4203,GO:0008519,1,0.673844512654006,0,27,ammonium transmembrane transporter activity,MF,
4204,GO:0008520,1,0.968994049490878,0,2,L-ascorbate:sodium symporter activity,MF,
4205,GO:0008521,1,0.984479696476155,0,1,acetyl-CoA transporter activity,MF,
4206,GO:0008523,1,0.967273627458349,0,2,sodium-dependent multivitamin transmembrane transporter activity,MF,
4207,GO:0008525,1,0.907005507489644,0,6,phosphatidylcholine transporter activity,MF,
4208,GO:0008526,1,0.894519859834889,0,7,phosphatidylinositol transporter activity,MF,
4209,GO:0008527,1,0.783187923803426,0,25,taste receptor activity,MF,
4211,GO:0008531,1,0.984375749176824,0,1,riboflavin kinase activity,MF,
4213,GO:0008534,1,0.97916809638684,0,2,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4214,GO:0008535,1,0.767819519111149,0,20,respiratory chain complex IV assembly,BP,
4215,GO:0008536,1,0.611446559710686,0,32,Ran GTPase binding,MF,
4216,GO:0008537,1,0.969411936191227,0,3,proteasome activator complex,CC,
4217,GO:0008540,1,0.889637525449081,0,10,proteasome regulatory particle, base subcomplex,CC,
4218,GO:0008541,1,0.920099019993584,0,7,proteasome regulatory particle, lid subcomplex,CC,
4219,GO:0008542,1,0.503443694434535,0,45,visual learning,BP,
4222,GO:0008545,1,0.983434111118256,0,1,JUN kinase kinase activity,MF,
4223,GO:0008553,1,0.918908407387696,0,7,hydrogen-exporting ATPase activity, phosphorylative mechanism,MF,
4224,GO:0008554,1,0.983426667502856,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4225,GO:0008555,1,0.983426667502217,0,1,chloride-transporting ATPase activity,MF,
4226,GO:0008556,1,0.855815206758057,0,11,potassium-transporting ATPase activity,MF,
4227,GO:0008559,1,0.889743676730002,0,7,xenobiotic-transporting ATPase activity,MF,
4228,GO:0008565,1,0.262884850881428,0,95,protein transporter activity,MF,
4229,GO:0008568,1,0.881469935950681,0,8,microtubule-severing ATPase activity,MF,
4230,GO:0008569,1,0.941531392863179,0,4,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4231,GO:0008574,1,0.765332851412252,0,16,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4232,GO:0008579,1,0.983426667502314,0,1,JUN kinase phosphatase activity,MF,
4233,GO:0008582,1,0.922516538312357,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4236,GO:0008588,1,0.947022090810788,0,4,release of cytoplasmic sequestered NF-kappaB,BP,
4238,GO:0008592,1,0.983621657795192,0,1,regulation of Toll signaling pathway,BP,
4240,GO:0008594,1,0.983426667503346,0,1,photoreceptor cell morphogenesis,BP,
4242,GO:0008597,1,0.957519240406974,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4244,GO:0008607,1,0.940946959315799,0,4,phosphorylase kinase regulator activity,MF,
4245,GO:0008608,1,0.677973464329133,0,26,attachment of spindle microtubules to kinetochore,BP,
4246,GO:0008609,1,0.983426667499461,0,1,alkylglycerone-phosphate synthase activity,MF,
4248,GO:0008611,1,0.941889734003709,0,4,ether lipid biosynthetic process,BP,
4249,GO:0008612,1,0.95304934687683,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4250,GO:0008613,1,0.994627919807112,0,1,diuretic hormone activity,MF,
4251,GO:0008614,1,0.969916341111825,0,2,pyridoxine metabolic process,BP,
4252,GO:0008615,1,0.969916341111825,0,2,pyridoxine biosynthetic process,BP,
4253,GO:0008616,1,0.941598356816015,0,6,queuosine biosynthetic process,BP,
4254,GO:0008617,1,0.99237048907605,0,1,guanosine metabolic process,BP,
4255,GO:0008622,1,0.938248844366814,0,5,epsilon DNA polymerase complex,CC,
4256,GO:0008623,1,0.968781775144843,0,2,CHRAC,CC,
4258,GO:0008626,1,0.949009207021083,0,4,granzyme-mediated apoptotic signaling pathway,BP,
4259,GO:0008627,1,0.904540866569158,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4260,GO:0008628,1,0.96614108782147,0,4,hormone-mediated apoptotic signaling pathway,BP,
4263,GO:0008635,1,0.880971632983311,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4265,GO:0008641,1,0.856215143565002,0,10,small protein activating enzyme activity,MF,
4268,GO:0008649,1,0.838746327835257,0,13,rRNA methyltransferase activity,MF,
4269,GO:0008652,1,0.336834035041942,0,75,cellular amino acid biosynthetic process,BP,
4270,GO:0008653,1,0.983426793805024,0,1,lipopolysaccharide metabolic process,BP,
4272,GO:0008655,1,0.868292221489976,0,11,pyrimidine-containing compound salvage,BP,
4273,GO:0008656,1,0.814110747282947,0,15,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4274,GO:0008665,1,0.992401501838757,0,1,2'-phosphotransferase activity,MF,
4275,GO:0008670,1,0.979605491351716,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4276,GO:0008689,1,0.990677269526394,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4277,GO:0008700,1,0.984728932554734,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4278,GO:0008705,1,0.983426667496216,0,1,methionine synthase activity,MF,
4279,GO:0008709,1,0.992790423696907,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4280,GO:0008721,1,0.984951089777405,0,1,D-serine ammonia-lyase activity,MF,
4281,GO:0008725,1,0.991859090558725,0,1,DNA-3-methyladenine glycosylase activity,MF,
4282,GO:0008732,1,0.97095929135171,0,2,L-allo-threonine aldolase activity,MF,
4283,GO:0008745,1,0.959385913601157,0,4,N-acetylmuramoyl-L-alanine amidase activity,MF,
4284,GO:0008746,1,0.975440043649722,0,2,NAD(P)+ transhydrogenase activity,MF,
4285,GO:0008747,1,0.988912275994095,0,1,N-acetylneuraminate lyase activity,MF,
4286,GO:0008750,1,0.983426667502958,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4287,GO:0008753,1,0.983499787855243,0,1,NADPH dehydrogenase (quinone) activity,MF,
4289,GO:0008761,1,0.983426667502316,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4290,GO:0008768,1,0.993401519967317,0,1,UDP-sugar diphosphatase activity,MF,
4291,GO:0008775,1,0.987509754480947,0,1,acetate CoA-transferase activity,MF,
4292,GO:0008781,1,0.978874244063293,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4293,GO:0008783,1,0.985893068778292,0,1,agmatinase activity,MF,
4294,GO:0008785,1,0.988878427746911,0,1,alkyl hydroperoxide reductase activity,MF,
4295,GO:0008794,1,0.993075030111578,0,1,arsenate reductase (glutaredoxin) activity,MF,
4296,GO:0008796,1,0.976910849820066,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4297,GO:0008798,1,0.968925406886569,0,2,beta-aspartyl-peptidase activity,MF,
4298,GO:0008802,1,0.983464023325546,0,1,betaine-aldehyde dehydrogenase activity,MF,
4299,GO:0008803,1,0.992529378159864,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4300,GO:0008808,1,0.983430378849187,0,1,cardiolipin synthase activity,MF,
4301,GO:0008811,1,0.993609047018882,0,1,chloramphenicol O-acetyltransferase activity,MF,
4302,GO:0008812,1,0.983447031998769,0,1,choline dehydrogenase activity,MF,
4303,GO:0008817,1,0.983426667503304,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4304,GO:0008821,1,0.882471708929023,0,9,crossover junction endodeoxyribonuclease activity,MF,
4305,GO:0008823,1,0.951096322718214,0,3,cupric reductase activity,MF,
4306,GO:0008829,1,0.987529328037738,0,1,dCTP deaminase activity,MF,
4307,GO:0008832,1,0.983652926593764,0,1,dGTPase activity,MF,
4308,GO:0008843,1,0.985479292514988,0,1,endochitinase activity,MF,
4309,GO:0008852,1,0.984123929934353,0,1,exodeoxyribonuclease I activity,MF,
4310,GO:0008853,1,0.949727563452125,0,4,exodeoxyribonuclease III activity,MF,
4311,GO:0008859,1,0.992758970498065,0,1,exoribonuclease II activity,MF,
4312,GO:0008865,1,0.935669344813975,0,4,fructokinase activity,MF,
4313,GO:0008887,1,0.983622421140954,0,1,glycerate kinase activity,MF,
4314,GO:0008889,1,0.908658549424313,0,6,glycerophosphodiester phosphodiesterase activity,MF,
4315,GO:0008890,1,0.988771891387024,0,1,glycine C-acetyltransferase activity,MF,
4316,GO:0008891,1,0.987889640668758,0,1,glycolate oxidase activity,MF,
4317,GO:0008892,1,0.983426667502119,0,1,guanine deaminase activity,MF,
4318,GO:0008893,1,0.9921578435965,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4319,GO:0008894,1,0.984309524246425,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4320,GO:0008897,1,0.984073483086431,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4321,GO:0008898,1,0.983426667496216,0,1,S-adenosylmethionine-homocysteine S-methyltransferase activity,MF,
4322,GO:0008900,1,0.956873552766413,0,3,hydrogen:potassium-exchanging ATPase activity,MF,
4323,GO:0008903,1,0.991704398505106,0,1,hydroxypyruvate isomerase activity,MF,
4324,GO:0008905,1,0.988655300479096,0,1,mannose-phosphate guanylyltransferase activity,MF,
4325,GO:0008934,1,0.941208540093398,0,4,inositol monophosphate 1-phosphatase activity,MF,
4326,GO:0008940,1,0.953617090634923,0,3,nitrate reductase activity,MF,
4327,GO:0008941,1,0.971987106761174,0,2,nitric oxide dioxygenase activity,MF,
4328,GO:0008948,1,0.942211136949013,0,4,oxaloacetate decarboxylase activity,MF,
4329,GO:0008955,1,0.983426726089436,0,1,peptidoglycan glycosyltransferase activity,MF,
4330,GO:0008962,1,0.98465979410434,0,1,phosphatidylglycerophosphatase activity,MF,
4331,GO:0008963,1,0.986097347811661,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4332,GO:0008967,1,0.970539776531144,0,2,phosphoglycolate phosphatase activity,MF,
4333,GO:0008969,1,0.963966157974547,0,3,phosphohistidine phosphatase activity,MF,
4334,GO:0008970,1,0.862558821830796,0,10,phosphatidylcholine 1-acylhydrolase activity,MF,
4335,GO:0008973,1,0.983615622358766,0,1,phosphopentomutase activity,MF,
4336,GO:0008988,1,0.969690119055175,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4337,GO:0008995,1,0.984648274463338,0,1,ribonuclease E activity,MF,
4338,GO:0009000,1,0.984992034276784,0,1,selenocysteine lyase activity,MF,
4339,GO:0009007,1,0.983442087309245,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4340,GO:0009008,1,0.92662839642788,0,5,DNA-methyltransferase activity,MF,
4341,GO:0009013,1,0.983426667502463,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4342,GO:0009019,1,0.939051496122708,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4343,GO:0009020,1,0.986881236347469,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4344,GO:0009032,1,0.988350460214267,0,1,thymidine phosphorylase activity,MF,
4345,GO:0009041,1,0.960008907027646,0,3,uridylate kinase activity,MF,
4346,GO:0009048,1,0.898734924203621,0,7,dosage compensation by inactivation of X chromosome,BP,
4347,GO:0009051,1,0.964964217009756,0,3,pentose-phosphate shunt, oxidative branch,BP,
4348,GO:0009052,1,0.935182626418898,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4355,GO:0009061,1,0.985202777168143,0,1,anaerobic respiration,BP,
4358,GO:0009064,1,0.362996385684083,0,70,glutamine family amino acid metabolic process,BP,
4359,GO:0009065,1,0.693753851128697,0,25,glutamine family amino acid catabolic process,BP,
4360,GO:0009066,1,0.476658876817458,0,52,aspartate family amino acid metabolic process,BP,
4361,GO:0009067,1,0.735253500723878,0,21,aspartate family amino acid biosynthetic process,BP,
4362,GO:0009068,1,0.7827711377187,0,17,aspartate family amino acid catabolic process,BP,
4364,GO:0009070,1,0.795095902257249,0,16,serine family amino acid biosynthetic process,BP,
4366,GO:0009072,1,0.683639588985089,0,29,aromatic amino acid family metabolic process,BP,
4367,GO:0009074,1,0.766416576699119,0,21,aromatic amino acid family catabolic process,BP,
4368,GO:0009078,1,0.935382337002692,0,5,pyruvate family amino acid metabolic process,BP,
4369,GO:0009080,1,0.935382337002692,0,5,pyruvate family amino acid catabolic process,BP,
4370,GO:0009081,1,0.715969259974768,0,23,branched-chain amino acid metabolic process,BP,
4371,GO:0009082,1,0.972185360111517,0,2,branched-chain amino acid biosynthetic process,BP,
4372,GO:0009083,1,0.752827674270341,0,20,branched-chain amino acid catabolic process,BP,
4373,GO:0009084,1,0.77738518659648,0,17,glutamine family amino acid biosynthetic process,BP,
4374,GO:0009085,1,0.984073483086431,0,1,lysine biosynthetic process,BP,
4375,GO:0009086,1,0.840987816465501,0,12,methionine biosynthetic process,BP,
4376,GO:0009087,1,0.983519580266634,0,1,methionine catabolic process,BP,
4377,GO:0009092,1,0.946515658867227,0,4,homoserine metabolic process,BP,
4378,GO:0009093,1,0.962377917271699,0,3,cysteine catabolic process,BP,
4379,GO:0009098,1,0.972185360111517,0,2,leucine biosynthetic process,BP,
4380,GO:0009099,1,0.972185360111517,0,2,valine biosynthetic process,BP,
4383,GO:0009103,1,0.983426793805024,0,1,lipopolysaccharide biosynthetic process,BP,
4384,GO:0009106,1,0.96487931577738,0,3,lipoate metabolic process,BP,
4385,GO:0009107,1,0.981109621901688,0,2,lipoate biosynthetic process,BP,
4387,GO:0009109,1,0.858357735759325,0,12,coenzyme catabolic process,BP,
4389,GO:0009111,1,0.862917973343203,0,11,vitamin catabolic process,BP,
4390,GO:0009112,1,0.587401844747536,0,37,nucleobase metabolic process,BP,
4391,GO:0009113,1,0.856745879121623,0,11,purine nucleobase biosynthetic process,BP,
4392,GO:0009115,1,0.967126892153423,0,2,xanthine catabolic process,BP,
4396,GO:0009120,1,0.927504953507444,0,6,deoxyribonucleoside metabolic process,BP,
4398,GO:0009124,1,0.345248188153383,0,85,nucleoside monophosphate biosynthetic process,BP,
4399,GO:0009125,1,0.865350982804757,0,11,nucleoside monophosphate catabolic process,BP,
4401,GO:0009127,1,0.452333038800902,0,65,purine nucleoside monophosphate biosynthetic process,BP,
4402,GO:0009128,1,0.88877201607257,0,9,purine nucleoside monophosphate catabolic process,BP,
4403,GO:0009129,1,0.825911829278366,0,14,pyrimidine nucleoside monophosphate metabolic process,BP,
4404,GO:0009130,1,0.835307050358405,0,13,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4405,GO:0009131,1,0.988760734801355,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4407,GO:0009133,1,0.925335405721968,0,6,nucleoside diphosphate biosynthetic process,BP,
4408,GO:0009134,1,0.910791206107329,0,7,nucleoside diphosphate catabolic process,BP,
4410,GO:0009136,1,0.96201469843098,0,3,purine nucleoside diphosphate biosynthetic process,BP,
4411,GO:0009137,1,0.949011329353332,0,4,purine nucleoside diphosphate catabolic process,BP,
4412,GO:0009138,1,0.959890034878975,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4413,GO:0009139,1,0.975537422808287,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4414,GO:0009140,1,0.983961872790192,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4416,GO:0009142,1,0.438954355892159,0,70,nucleoside triphosphate biosynthetic process,BP,
4417,GO:0009143,1,0.866560093535022,0,11,nucleoside triphosphate catabolic process,BP,
4419,GO:0009145,1,0.549528113340872,0,54,purine nucleoside triphosphate biosynthetic process,BP,
4420,GO:0009146,1,0.930994201099465,0,6,purine nucleoside triphosphate catabolic process,BP,
4421,GO:0009147,1,0.774659986680027,0,22,pyrimidine nucleoside triphosphate metabolic process,BP,
4422,GO:0009148,1,0.803710263144412,0,19,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4423,GO:0009149,1,0.991657523588261,0,1,pyrimidine nucleoside triphosphate catabolic process,BP,
4425,GO:0009151,1,0.887232052665273,0,10,purine deoxyribonucleotide metabolic process,BP,
4427,GO:0009153,1,0.962880960606891,0,3,purine deoxyribonucleotide biosynthetic process,BP,
4429,GO:0009155,1,0.928533123605276,0,6,purine deoxyribonucleotide catabolic process,BP,
4430,GO:0009156,1,0.383462978991509,0,77,ribonucleoside monophosphate biosynthetic process,BP,
4431,GO:0009157,1,0.913512708274571,0,7,deoxyribonucleoside monophosphate biosynthetic process,BP,
4432,GO:0009158,1,0.896203938244441,0,8,ribonucleoside monophosphate catabolic process,BP,
4433,GO:0009159,1,0.973660599621589,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4435,GO:0009162,1,0.88278215735814,0,10,deoxyribonucleoside monophosphate metabolic process,BP,
4436,GO:0009163,1,0.562505840517416,0,47,nucleoside biosynthetic process,BP,
4437,GO:0009164,1,0.718713427487705,0,27,nucleoside catabolic process,BP,
4441,GO:0009168,1,0.452333038800902,0,65,purine ribonucleoside monophosphate biosynthetic process,BP,
4442,GO:0009169,1,0.896203938244441,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4443,GO:0009170,1,0.99251552446236,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4444,GO:0009173,1,0.868723983772313,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4445,GO:0009174,1,0.868723983772313,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4446,GO:0009176,1,0.950746411387737,0,4,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4447,GO:0009177,1,0.961555338345198,0,3,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4448,GO:0009178,1,0.988760734801355,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4450,GO:0009180,1,0.96201469843098,0,3,purine ribonucleoside diphosphate biosynthetic process,BP,
4451,GO:0009181,1,0.949011329353332,0,4,purine ribonucleoside diphosphate catabolic process,BP,
4452,GO:0009182,1,0.965493951593057,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4453,GO:0009183,1,0.976094999959217,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4454,GO:0009184,1,0.989140414603695,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4456,GO:0009186,1,0.941872075211045,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4458,GO:0009188,1,0.96201469843098,0,3,ribonucleoside diphosphate biosynthetic process,BP,
4459,GO:0009189,1,0.952214828721398,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4461,GO:0009191,1,0.925428538043414,0,6,ribonucleoside diphosphate catabolic process,BP,
4462,GO:0009192,1,0.989140414603695,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
4463,GO:0009193,1,0.983961872790192,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4464,GO:0009195,1,0.983961872790192,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4465,GO:0009196,1,0.975537422808287,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4466,GO:0009197,1,0.975537422808287,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4468,GO:0009200,1,0.838835125449485,0,15,deoxyribonucleoside triphosphate metabolic process,BP,
4469,GO:0009201,1,0.511768256740473,0,59,ribonucleoside triphosphate biosynthetic process,BP,
4470,GO:0009202,1,0.942327575567067,0,5,deoxyribonucleoside triphosphate biosynthetic process,BP,
4471,GO:0009203,1,0.991761447367686,0,1,ribonucleoside triphosphate catabolic process,BP,
4472,GO:0009204,1,0.930896619503965,0,6,deoxyribonucleoside triphosphate catabolic process,BP,
4474,GO:0009206,1,0.557087252774193,0,53,purine ribonucleoside triphosphate biosynthetic process,BP,
4475,GO:0009207,1,0.991761447367686,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4476,GO:0009208,1,0.828347459663385,0,16,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4477,GO:0009209,1,0.841379420456844,0,15,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4478,GO:0009211,1,0.935236347171406,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4479,GO:0009212,1,0.955260719788444,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4480,GO:0009213,1,0.991657523588261,0,1,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4482,GO:0009215,1,0.912072126001491,0,8,purine deoxyribonucleoside triphosphate metabolic process,BP,
4483,GO:0009216,1,0.986463694180628,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4484,GO:0009217,1,0.938730008997467,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4485,GO:0009218,1,0.733845697519185,0,24,pyrimidine ribonucleotide metabolic process,BP,
4486,GO:0009219,1,0.814659484342194,0,17,pyrimidine deoxyribonucleotide metabolic process,BP,
4487,GO:0009220,1,0.757560491869653,0,22,pyrimidine ribonucleotide biosynthetic process,BP,
4488,GO:0009221,1,0.928968111096314,0,6,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4489,GO:0009222,1,0.983961872790192,0,1,pyrimidine ribonucleotide catabolic process,BP,
4490,GO:0009223,1,0.876986243384544,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4491,GO:0009224,1,0.990805197582932,0,1,CMP biosynthetic process,BP,
4492,GO:0009225,1,0.622719286447048,0,34,nucleotide-sugar metabolic process,BP,
4493,GO:0009226,1,0.751517494708333,0,21,nucleotide-sugar biosynthetic process,BP,
4494,GO:0009227,1,0.960660043821895,0,3,nucleotide-sugar catabolic process,BP,
4495,GO:0009229,1,0.985321884811008,0,1,thiamine diphosphate biosynthetic process,BP,
4496,GO:0009231,1,0.984375749176824,0,1,riboflavin biosynthetic process,BP,
4497,GO:0009233,1,0.953149287863217,0,3,menaquinone metabolic process,BP,
4498,GO:0009234,1,0.983446198396837,0,1,menaquinone biosynthetic process,BP,
4499,GO:0009235,1,0.768837229605391,0,21,cobalamin metabolic process,BP,
4500,GO:0009236,1,0.951746748134615,0,3,cobalamin biosynthetic process,BP,
4501,GO:0009237,1,0.983973920810479,0,1,siderophore metabolic process,BP,
4502,GO:0009240,1,0.942103959949955,0,5,isopentenyl diphosphate biosynthetic process,BP,
4503,GO:0009245,1,0.994857040334026,0,1,lipid A biosynthetic process,BP,
4504,GO:0009247,1,0.472056257152115,0,55,glycolipid biosynthetic process,BP,
4505,GO:0009249,1,0.967074718038484,0,4,protein lipoylation,BP,
4507,GO:0009251,1,0.665290257784409,0,27,glucan catabolic process,BP,
4508,GO:0009253,1,0.939941596671859,0,7,peptidoglycan catabolic process,BP,
4509,GO:0009256,1,0.921942863496701,0,5,10-formyltetrahydrofolate metabolic process,BP,
4510,GO:0009257,1,0.967216149455231,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4511,GO:0009258,1,0.967400024592476,0,2,10-formyltetrahydrofolate catabolic process,BP,
4515,GO:0009262,1,0.679305161142997,0,31,deoxyribonucleotide metabolic process,BP,
4516,GO:0009263,1,0.851007585584229,0,12,deoxyribonucleotide biosynthetic process,BP,
4517,GO:0009264,1,0.804500418687822,0,18,deoxyribonucleotide catabolic process,BP,
4518,GO:0009265,1,0.894475345556861,0,9,2'-deoxyribonucleotide biosynthetic process,BP,
4521,GO:0009268,1,0.565319354501603,0,40,response to pH,BP,
4522,GO:0009295,1,0.578352565001651,0,38,nucleoid,CC,
4523,GO:0009298,1,0.953239529373115,0,4,GDP-mannose biosynthetic process,BP,
4524,GO:0009299,1,0.712249196825154,0,23,mRNA transcription,BP,
4525,GO:0009301,1,0.406448986885004,0,65,snRNA transcription,BP,
4526,GO:0009303,1,0.679019905185411,0,28,rRNA transcription,BP,
4527,GO:0009304,1,0.900068902824146,0,7,tRNA transcription,BP,
4528,GO:0009305,1,0.983426667501431,0,1,protein biotinylation,BP,
4530,GO:0009308,1,0.21061601232215,0,125,amine metabolic process,BP,
4531,GO:0009309,1,0.76429605863232,0,22,amine biosynthetic process,BP,
4532,GO:0009310,1,0.720617103642843,0,25,amine catabolic process,BP,
4533,GO:0009311,1,0.460116718410562,0,54,oligosaccharide metabolic process,BP,
4534,GO:0009312,1,0.807303481835096,0,16,oligosaccharide biosynthetic process,BP,
4535,GO:0009313,1,0.827081463329778,0,13,oligosaccharide catabolic process,BP,
4537,GO:0009328,1,0.957487148139448,0,3,phenylalanine-tRNA ligase complex,CC,
4538,GO:0009330,1,0.967134298221498,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4539,GO:0009331,1,0.951697866885296,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4540,GO:0009346,1,0.983426667503199,0,1,citrate lyase complex,CC,
4541,GO:0009353,1,0.990298885902045,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4542,GO:0009360,1,0.984388923271241,0,1,DNA polymerase III complex,CC,
4543,GO:0009368,1,0.976868578391684,0,2,endopeptidase Clp complex,CC,
4544,GO:0009372,1,0.983591359917946,0,1,quorum sensing,BP,
4545,GO:0009374,1,0.922529298950207,0,5,biotin binding,MF,
4546,GO:0009378,1,0.919851036629632,0,5,four-way junction helicase activity,MF,
4547,GO:0009383,1,0.968060307545044,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4548,GO:0009384,1,0.972422373332446,0,2,N-acylmannosamine kinase activity,MF,
4549,GO:0009386,1,0.974414021184703,0,2,translational attenuation,BP,
4550,GO:0009394,1,0.722718255242487,0,27,2'-deoxyribonucleotide metabolic process,BP,
4551,GO:0009395,1,0.59514007930007,0,36,phospholipid catabolic process,BP,
4552,GO:0009396,1,0.86519882704625,0,10,folic acid-containing compound biosynthetic process,BP,
4553,GO:0009397,1,0.960891778773311,0,3,folic acid-containing compound catabolic process,BP,
4554,GO:0009398,1,0.984375749176824,0,1,FMN biosynthetic process,BP,
4555,GO:0009399,1,0.991607407909571,0,1,nitrogen fixation,BP,
4556,GO:0009400,1,0.984101003177701,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4557,GO:0009403,1,0.983718115921101,0,1,toxin biosynthetic process,BP,
4558,GO:0009404,1,0.831618843574634,0,12,toxin metabolic process,BP,
4559,GO:0009405,1,0.96712689215265,0,2,pathogenesis,BP,
4561,GO:0009409,1,0.534269624829598,0,44,response to cold,BP,
4562,GO:0009410,1,0.225441084951082,0,113,response to xenobiotic stimulus,BP,
4564,GO:0009414,1,0.893106788714991,0,8,response to water deprivation,BP,
4565,GO:0009415,1,0.814019023280707,0,14,response to water,BP,
4567,GO:0009435,1,0.718812620770992,0,23,NAD biosynthetic process,BP,
4568,GO:0009436,1,0.959641509156848,0,3,glyoxylate catabolic process,BP,
4569,GO:0009437,1,0.817755285918367,0,13,carnitine metabolic process,BP,
4570,GO:0009438,1,0.939972350424142,0,5,methylglyoxal metabolic process,BP,
4571,GO:0009439,1,0.981085303611342,0,2,cyanate metabolic process,BP,
4572,GO:0009440,1,0.981085303611342,0,2,cyanate catabolic process,BP,
4573,GO:0009441,1,0.964630298548179,0,3,glycolate metabolic process,BP,
4574,GO:0009443,1,0.983426667499806,0,1,pyridoxal 5'-phosphate salvage,BP,
4575,GO:0009444,1,0.983426667502269,0,1,pyruvate oxidation,BP,
4576,GO:0009445,1,0.930295469304558,0,6,putrescine metabolic process,BP,
4577,GO:0009446,1,0.945043703440078,0,4,putrescine biosynthetic process,BP,
4578,GO:0009447,1,0.972740993159169,0,3,putrescine catabolic process,BP,
4579,GO:0009448,1,0.924566954504461,0,5,gamma-aminobutyric acid metabolic process,BP,
4580,GO:0009449,1,0.952915940389083,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4581,GO:0009450,1,0.967126892154148,0,2,gamma-aminobutyric acid catabolic process,BP,
4582,GO:0009451,1,0.198300116241423,0,116,RNA modification,BP,
4583,GO:0009452,1,0.656987982940995,0,34,7-methylguanosine RNA capping,BP,
4589,GO:0009590,1,0.986476325400994,0,1,detection of gravity,BP,
4591,GO:0009595,1,0.742961731736122,0,21,detection of biotic stimulus,BP,
4592,GO:0009597,1,0.926009462002858,0,5,detection of virus,BP,
4595,GO:0009608,1,0.975740834914397,0,2,response to symbiont,BP,
4596,GO:0009609,1,0.975740834914397,0,2,response to symbiotic bacterium,BP,
4602,GO:0009624,1,0.967067885068544,0,3,response to nematode,BP,
4604,GO:0009629,1,0.888079873258465,0,9,response to gravity,BP,
4605,GO:0009631,1,0.983426667502512,0,1,cold acclimation,BP,
4606,GO:0009635,1,0.911728850917674,0,7,response to herbicide,BP,
4608,GO:0009637,1,0.96729982301339,0,2,response to blue light,BP,
4609,GO:0009642,1,0.82996274226477,0,12,response to light intensity,BP,
4610,GO:0009644,1,0.969986975464069,0,2,response to high light intensity,BP,
4611,GO:0009645,1,0.983487822403037,0,1,response to low light intensity stimulus,BP,
4612,GO:0009646,1,0.983583320421907,0,1,response to absence of light,BP,
4613,GO:0009648,1,0.725179171830914,0,23,photoperiodism,BP,
4614,GO:0009649,1,0.701841893655507,0,25,entrainment of circadian clock,BP,
4615,GO:0009650,1,0.829933836274529,0,13,UV protection,BP,
4618,GO:0009673,1,0.983443834687134,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4619,GO:0009692,1,0.984602838154034,0,1,ethylene metabolic process,BP,
4620,GO:0009698,1,0.914126426965229,0,7,phenylpropanoid metabolic process,BP,
4624,GO:0009720,1,0.983885818244508,0,1,detection of hormone stimulus,BP,
4626,GO:0009726,1,0.951540294232919,0,3,detection of endogenous stimulus,BP,
4627,GO:0009730,1,0.947297158115839,0,4,detection of carbohydrate stimulus,BP,
4628,GO:0009732,1,0.947297158115839,0,4,detection of hexose stimulus,BP,
4629,GO:0009737,1,0.983426667503199,0,1,response to abscisic acid,BP,
4630,GO:0009738,1,0.983426667503199,0,1,abscisic acid-activated signaling pathway,BP,
4636,GO:0009751,1,0.984851418050556,0,1,response to salicylic acid,BP,
4637,GO:0009753,1,0.961855892143638,0,4,response to jasmonic acid,BP,
4639,GO:0009756,1,0.908765120938926,0,7,carbohydrate mediated signaling,BP,
4640,GO:0009757,1,0.937778961809247,0,5,hexose mediated signaling,BP,
4641,GO:0009758,1,0.983426667498183,0,1,carbohydrate utilization,BP,
4642,GO:0009785,1,0.96729982301339,0,2,blue light signaling pathway,BP,
4643,GO:0009786,1,0.963183645258485,0,3,regulation of asymmetric cell division,BP,
4644,GO:0009787,1,0.983426667503199,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4645,GO:0009789,1,0.983426667503199,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4649,GO:0009794,1,0.942413092046605,0,4,regulation of mitotic cell cycle, embryonic,BP,
4652,GO:0009804,1,0.914126426965229,0,7,coumarin metabolic process,BP,
4653,GO:0009810,1,0.985855483080867,0,1,stilbene metabolic process,BP,
4654,GO:0009812,1,0.846932571960623,0,12,flavonoid metabolic process,BP,
4655,GO:0009814,1,0.985881761090033,0,1,defense response, incompatible interaction,BP,
4656,GO:0009817,1,0.985881761090033,0,1,defense response to fungus, incompatible interaction,BP,
4657,GO:0009820,1,0.907445686698785,0,7,alkaloid metabolic process,BP,
4658,GO:0009822,1,0.961562306950064,0,3,alkaloid catabolic process,BP,
4659,GO:0009826,1,0.962048750285459,0,3,unidimensional cell growth,BP,
4660,GO:0009838,1,0.920708828296086,0,6,abscission,BP,
4661,GO:0009841,1,0.985325162827555,0,1,mitochondrial endopeptidase Clp complex,CC,
4664,GO:0009881,1,0.831434927693509,0,14,photoreceptor activity,MF,
4665,GO:0009882,1,0.96729982301339,0,2,blue light photoreceptor activity,MF,
4682,GO:0009917,1,0.985054600913577,0,1,sterol 5-alpha reductase activity,MF,
4683,GO:0009918,1,0.984490228516902,0,1,sterol delta7 reductase activity,MF,
4684,GO:0009922,1,0.902216791765655,0,7,fatty acid elongase activity,MF,
4686,GO:0009931,1,0.849091590332522,0,11,calcium-dependent protein serine/threonine kinase activity,MF,
4689,GO:0009949,1,0.988827839667624,0,1,polarity specification of anterior/posterior axis,BP,
4694,GO:0009955,1,0.985870480808563,0,1,adaxial/abaxial pattern specification,BP,
4695,GO:0009956,1,0.983427036229152,0,1,radial pattern formation,BP,
4696,GO:0009957,1,0.952934098108281,0,3,epidermal cell fate specification,BP,
4700,GO:0009972,1,0.907869590508278,0,9,cytidine deamination,BP,
4702,GO:0009982,1,0.838101047555317,0,13,pseudouridine synthase activity,MF,
4707,GO:0009992,1,0.985963404624498,0,1,cellular water homeostasis,BP,
4710,GO:0009997,1,0.983963369018216,0,1,negative regulation of cardioblast cell fate specification,BP,
4714,GO:0010009,1,0.969607637473545,0,2,cytoplasmic side of endosome membrane,CC,
4715,GO:0010015,1,0.994020585908706,0,1,root morphogenesis,BP,
4716,GO:0010021,1,0.983693902795086,0,1,amylopectin biosynthetic process,BP,
4717,GO:0010025,1,0.946793272976661,0,4,wax biosynthetic process,BP,
4718,GO:0010032,1,0.912905675614837,0,6,meiotic chromosome condensation,BP,
4720,GO:0010034,1,0.983470721015824,0,1,response to acetate,BP,
4722,GO:0010037,1,0.983753871288844,0,1,response to carbon dioxide,BP,
4725,GO:0010040,1,0.932599865993869,0,5,response to iron(II) ion,BP,
4726,GO:0010041,1,0.934058486936894,0,5,response to iron(III) ion,BP,
4727,GO:0010042,1,0.800330481597105,0,15,response to manganese ion,BP,
4729,GO:0010044,1,0.928598057046473,0,5,response to aluminum ion,BP,
4730,GO:0010045,1,0.983426667499561,0,1,response to nickel cation,BP,
4731,GO:0010046,1,0.948735376203789,0,4,response to mycotoxin,BP,
4732,GO:0010053,1,0.994020585908706,0,1,root epidermal cell differentiation,BP,
4733,GO:0010054,1,0.994020585908706,0,1,trichoblast differentiation,BP,
4734,GO:0010070,1,0.985146370134175,0,1,zygote asymmetric cell division,BP,
4735,GO:0010085,1,0.986342985336837,0,1,polarity specification of proximal/distal axis,BP,
4737,GO:0010106,1,0.986939888461523,0,1,cellular response to iron ion starvation,BP,
4738,GO:0010107,1,0.653840715427166,0,28,potassium ion import,BP,
4739,GO:0010124,1,0.991148416031784,0,1,phenylacetate catabolic process,BP,
4740,GO:0010133,1,0.958247385979115,0,3,proline catabolic process to glutamate,BP,
4741,GO:0010138,1,0.93867919671549,0,5,pyrimidine ribonucleotide salvage,BP,
4742,GO:0010155,1,0.824948259711454,0,17,regulation of proton transport,BP,
4743,GO:0010157,1,0.968381744968281,0,2,response to chlorate,BP,
4745,GO:0010160,1,0.99248783824138,0,1,formation of animal organ boundary,BP,
4746,GO:0010164,1,0.988594720064736,0,1,response to cesium ion,BP,
4748,GO:0010166,1,0.946793272976661,0,4,wax metabolic process,BP,
4750,GO:0010172,1,0.836930695270133,0,11,embryonic body morphogenesis,BP,
4751,GO:0010181,1,0.785979415998975,0,16,FMN binding,MF,
4752,GO:0010182,1,0.937778961809247,0,5,sugar mediated signaling pathway,BP,
4753,GO:0010189,1,0.988262352750944,0,1,vitamin E biosynthetic process,BP,
4756,GO:0010216,1,0.904880775821178,0,6,maintenance of DNA methylation,BP,
4758,GO:0010225,1,0.831015493076005,0,12,response to UV-C,BP,
4760,GO:0010232,1,0.983721116157046,0,1,vascular transport,BP,
4762,GO:0010248,1,0.836846008447918,0,13,establishment or maintenance of transmembrane electrochemical gradient,BP,
4763,GO:0010255,1,0.937778961809247,0,5,glucose mediated signaling pathway,BP,
4765,GO:0010257,1,0.610301721906455,0,55,NADH dehydrogenase complex assembly,BP,
4767,GO:0010260,1,0.984702581540073,0,1,animal organ senescence,BP,
4768,GO:0010265,1,0.918066594956838,0,6,SCF complex assembly,BP,
4769,GO:0010266,1,0.961714377557171,0,3,response to vitamin B1,BP,
4770,GO:0010269,1,0.930003432993832,0,6,response to selenium ion,BP,
4771,GO:0010273,1,0.976456704383982,0,2,detoxification of copper ion,BP,
4772,GO:0010286,1,0.957185467967223,0,3,heat acclimation,BP,
4774,GO:0010309,1,0.988280976675277,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4775,GO:0010310,1,0.846863650493816,0,13,regulation of hydrogen peroxide metabolic process,BP,
4776,GO:0010314,1,0.848901730184664,0,11,phosphatidylinositol-5-phosphate binding,MF,
4779,GO:0010335,1,0.983426667503104,0,1,response to non-ionic osmotic stress,BP,
4780,GO:0010340,1,0.930719817523679,0,5,carboxyl-O-methyltransferase activity,MF,
4781,GO:0010348,1,0.984728932554734,0,1,lithium:proton antiporter activity,MF,
4782,GO:0010359,1,0.920381585376859,0,5,regulation of anion channel activity,BP,
4783,GO:0010360,1,0.967712707436332,0,2,negative regulation of anion channel activity,BP,
4784,GO:0010369,1,0.809561443542093,0,14,chromocenter,CC,
4785,GO:0010370,1,0.970288021419311,0,2,perinucleolar chromocenter,CC,
4786,GO:0010383,1,0.989250273261631,0,1,cell wall polysaccharide metabolic process,BP,
4788,GO:0010387,1,0.954935022209416,0,3,COP9 signalosome assembly,BP,
4790,GO:0010390,1,0.704429792339924,0,23,histone monoubiquitination,BP,
4791,GO:0010420,1,0.990677269526394,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4792,GO:0010421,1,0.849654988411483,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4793,GO:0010428,1,0.983426667501579,0,1,methyl-CpNpG binding,MF,
4794,GO:0010430,1,0.969550725833556,0,2,fatty acid omega-oxidation,BP,
4795,GO:0010446,1,0.963283011251432,0,3,response to alkaline pH,BP,
4796,GO:0010447,1,0.728882532526378,0,22,response to acidic pH,BP,
4797,GO:0010452,1,0.869476024372497,0,9,histone H3-K36 methylation,BP,
4800,GO:0010455,1,0.886730619897956,0,9,positive regulation of cell fate commitment,BP,
4801,GO:0010457,1,0.862772662083875,0,9,centriole-centriole cohesion,BP,
4802,GO:0010458,1,0.667763587428276,0,30,exit from mitosis,BP,
4807,GO:0010465,1,0.968190302072153,0,2,nerve growth factor receptor activity,MF,
4813,GO:0010477,1,0.983614876806543,0,1,response to sulfur dioxide,BP,
4814,GO:0010481,1,0.973977949228157,0,2,epidermal cell division,BP,
4815,GO:0010482,1,0.973977949228157,0,2,regulation of epidermal cell division,BP,
4816,GO:0010484,1,0.951579609414911,0,3,H3 histone acetyltransferase activity,MF,
4817,GO:0010485,1,0.765276173706378,0,17,H4 histone acetyltransferase activity,MF,
4818,GO:0010494,1,0.549715992910015,0,39,cytoplasmic stress granule,CC,
4819,GO:0010496,1,0.986690812150216,0,1,intercellular transport,BP,
4821,GO:0010499,1,0.937359741984968,0,4,proteasomal ubiquitin-independent protein catabolic process,BP,
4822,GO:0010501,1,0.49859522019195,0,45,RNA secondary structure unwinding,BP,
4826,GO:0010509,1,0.983426667502018,0,1,polyamine homeostasis,BP,
4827,GO:0010510,1,0.825693488982817,0,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4830,GO:0010513,1,0.943960937903635,0,4,positive regulation of phosphatidylinositol biosynthetic process,BP,
4833,GO:0010519,1,0.906884807832483,0,7,negative regulation of phospholipase activity,BP,
4834,GO:0010520,1,0.968243233087732,0,2,regulation of reciprocal meiotic recombination,BP,
4835,GO:0010521,1,0.96051369794464,0,3,telomerase inhibitor activity,MF,
4838,GO:0010524,1,0.545145241327179,0,45,positive regulation of calcium ion transport into cytosol,BP,
4839,GO:0010528,1,0.834793561849373,0,13,regulation of transposition,BP,
4840,GO:0010529,1,0.834793561849373,0,13,negative regulation of transposition,BP,
4841,GO:0010531,1,0.983723127713326,0,1,activation of JAK1 kinase activity,BP,
4842,GO:0010533,1,0.913502415210877,0,8,regulation of activation of Janus kinase activity,BP,
4843,GO:0010534,1,0.913502415210877,0,8,regulation of activation of JAK2 kinase activity,BP,
4844,GO:0010535,1,0.933736957938832,0,6,positive regulation of activation of JAK2 kinase activity,BP,
4845,GO:0010536,1,0.933736957938832,0,6,positive regulation of activation of Janus kinase activity,BP,
4852,GO:0010560,1,0.78747963155521,0,17,positive regulation of glycoprotein biosynthetic process,BP,
4859,GO:0010569,1,0.739920548950059,0,20,regulation of double-strand break repair via homologous recombination,BP,
4860,GO:0010571,1,0.905441588142367,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4861,GO:0010572,1,0.951968215433824,0,3,positive regulation of platelet activation,BP,
4862,GO:0010573,1,0.621817891885447,0,33,vascular endothelial growth factor production,BP,
4863,GO:0010574,1,0.63231725155801,0,32,regulation of vascular endothelial growth factor production,BP,
4864,GO:0010575,1,0.664947271246664,0,27,positive regulation of vascular endothelial growth factor production,BP,
4865,GO:0010578,1,0.913959674428213,0,6,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4866,GO:0010579,1,0.913959674428213,0,6,positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4868,GO:0010587,1,0.906675849752741,0,6,miRNA catabolic process,BP,
4869,GO:0010591,1,0.662799640242973,0,28,regulation of lamellipodium assembly,BP,
4870,GO:0010592,1,0.781642394953133,0,17,positive regulation of lamellipodium assembly,BP,
4871,GO:0010593,1,0.945637008750206,0,4,negative regulation of lamellipodium assembly,BP,
4875,GO:0010603,1,0.878037649624649,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4878,GO:0010606,1,0.919972726262144,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4879,GO:0010607,1,0.986872257469862,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4881,GO:0010609,1,0.969896686273268,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4882,GO:0010610,1,0.983426667498428,0,1,regulation of mRNA stability involved in response to stress,BP,
4884,GO:0010612,1,0.909850206622419,0,6,regulation of cardiac muscle adaptation,BP,
4886,GO:0010614,1,0.795677974266763,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4887,GO:0010615,1,0.967201769277983,0,2,positive regulation of cardiac muscle adaptation,BP,
4888,GO:0010616,1,0.95138001531965,0,3,negative regulation of cardiac muscle adaptation,BP,
4889,GO:0010621,1,0.964493135585691,0,3,negative regulation of transcription by transcription factor localization,BP,
4891,GO:0010624,1,0.924778094618282,0,5,regulation of Schwann cell proliferation,BP,
4892,GO:0010626,1,0.924778094618282,0,5,negative regulation of Schwann cell proliferation,BP,
4899,GO:0010635,1,0.88728776085608,0,8,regulation of mitochondrial fusion,BP,
4900,GO:0010636,1,0.968376599084072,0,2,positive regulation of mitochondrial fusion,BP,
4901,GO:0010637,1,0.930837907825704,0,5,negative regulation of mitochondrial fusion,BP,
4905,GO:0010641,1,0.921928779662356,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4907,GO:0010643,1,0.952044748022888,0,3,cell communication by chemical coupling,BP,
4909,GO:0010645,1,0.967670689188829,0,2,regulation of cell communication by chemical coupling,BP,
4914,GO:0010650,1,0.967126892149019,0,2,positive regulation of cell communication by electrical coupling,BP,
4915,GO:0010652,1,0.967670689188829,0,2,positive regulation of cell communication by chemical coupling,BP,
4919,GO:0010659,1,0.666230749733846,0,28,cardiac muscle cell apoptotic process,BP,
4921,GO:0010661,1,0.792813757770426,0,16,positive regulation of muscle cell apoptotic process,BP,
4923,GO:0010663,1,0.881398583319839,0,8,positive regulation of striated muscle cell apoptotic process,BP,
4925,GO:0010665,1,0.692079963325477,0,25,regulation of cardiac muscle cell apoptotic process,BP,
4926,GO:0010666,1,0.881398583319839,0,8,positive regulation of cardiac muscle cell apoptotic process,BP,
4927,GO:0010667,1,0.785305959520454,0,17,negative regulation of cardiac muscle cell apoptotic process,BP,
4929,GO:0010669,1,0.712538229887156,0,24,epithelial structure maintenance,BP,
4933,GO:0010692,1,0.866482871151328,0,9,regulation of alkaline phosphatase activity,BP,
4934,GO:0010693,1,0.955832850180692,0,3,negative regulation of alkaline phosphatase activity,BP,
4935,GO:0010694,1,0.906537984669309,0,6,positive regulation of alkaline phosphatase activity,BP,
4936,GO:0010698,1,0.979167824100082,0,2,acetyltransferase activator activity,MF,
4938,GO:0010701,1,0.950027845097777,0,4,positive regulation of norepinephrine secretion,BP,
4939,GO:0010705,1,0.967919486014353,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4940,GO:0010710,1,0.962125168880867,0,3,regulation of collagen catabolic process,BP,
4941,GO:0010711,1,0.994056908089788,0,1,negative regulation of collagen catabolic process,BP,
4943,GO:0010713,1,0.901923882997413,0,8,negative regulation of collagen metabolic process,BP,
4946,GO:0010716,1,0.948533917598475,0,4,negative regulation of extracellular matrix disassembly,BP,
4949,GO:0010719,1,0.690134127463025,0,26,negative regulation of epithelial to mesenchymal transition,BP,
4952,GO:0010722,1,0.983426667500053,0,1,regulation of ferrochelatase activity,BP,
4954,GO:0010725,1,0.95728639226238,0,3,regulation of primitive erythrocyte differentiation,BP,
4955,GO:0010726,1,0.97048542037752,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4956,GO:0010727,1,0.927822840740837,0,6,negative regulation of hydrogen peroxide metabolic process,BP,
4957,GO:0010728,1,0.956283370588993,0,3,regulation of hydrogen peroxide biosynthetic process,BP,
4958,GO:0010729,1,0.986586925474517,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4959,GO:0010730,1,0.969286148526542,0,2,negative regulation of hydrogen peroxide biosynthetic process,BP,
4960,GO:0010731,1,0.985386364126359,0,1,protein glutathionylation,BP,
4961,GO:0010732,1,0.985386364126359,0,1,regulation of protein glutathionylation,BP,
4962,GO:0010734,1,0.985386364126359,0,1,negative regulation of protein glutathionylation,BP,
4963,GO:0010735,1,0.938781041419106,0,4,positive regulation of transcription via serum response element binding,BP,
4964,GO:0010736,1,0.970694436898322,0,2,serum response element binding,MF,
4965,GO:0010737,1,0.653364045974521,0,29,protein kinase A signaling,BP,
4966,GO:0010738,1,0.748782140263428,0,19,regulation of protein kinase A signaling,BP,
4967,GO:0010739,1,0.919905641523312,0,6,positive regulation of protein kinase A signaling,BP,
4968,GO:0010742,1,0.620743457567878,0,34,macrophage derived foam cell differentiation,BP,
4969,GO:0010743,1,0.671170283944783,0,29,regulation of macrophage derived foam cell differentiation,BP,
4970,GO:0010744,1,0.812458179886765,0,16,positive regulation of macrophage derived foam cell differentiation,BP,
4971,GO:0010745,1,0.826234266878707,0,13,negative regulation of macrophage derived foam cell differentiation,BP,
4974,GO:0010749,1,0.947808563171355,0,4,regulation of nitric oxide mediated signal transduction,BP,
4975,GO:0010750,1,0.983426667503104,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
4976,GO:0010751,1,0.96378410138749,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4977,GO:0010752,1,0.967126892153859,0,2,regulation of cGMP-mediated signaling,BP,
4978,GO:0010754,1,0.983426667501675,0,1,negative regulation of cGMP-mediated signaling,BP,
4979,GO:0010755,1,0.863624698319824,0,11,regulation of plasminogen activation,BP,
4980,GO:0010756,1,0.94004365990289,0,5,positive regulation of plasminogen activation,BP,
4981,GO:0010757,1,0.918727005628057,0,6,negative regulation of plasminogen activation,BP,
4982,GO:0010758,1,0.774341832658928,0,20,regulation of macrophage chemotaxis,BP,
4983,GO:0010759,1,0.833193959055861,0,15,positive regulation of macrophage chemotaxis,BP,
4984,GO:0010760,1,0.945084028370382,0,4,negative regulation of macrophage chemotaxis,BP,
4988,GO:0010764,1,0.887235100742562,0,8,negative regulation of fibroblast migration,BP,
4991,GO:0010767,1,0.952059271605129,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4992,GO:0010768,1,0.983426667500986,0,1,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4996,GO:0010792,1,0.909457689794933,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4997,GO:0010793,1,0.922958994430686,0,5,regulation of mRNA export from nucleus,BP,
4998,GO:0010795,1,0.990677269526394,0,1,regulation of ubiquinone biosynthetic process,BP,
4999,GO:0010796,1,0.964325472481383,0,3,regulation of multivesicular body size,BP,
5000,GO:0010797,1,0.991011702526276,0,1,regulation of multivesicular body size involved in endosome transport,BP,
5003,GO:0010801,1,0.808099639299183,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
5006,GO:0010805,1,0.984679136082936,0,1,regulation of lysine import,BP,
5007,GO:0010807,1,0.926191403318109,0,5,regulation of synaptic vesicle priming,BP,
5008,GO:0010808,1,0.983426667500986,0,1,positive regulation of synaptic vesicle priming,BP,
5012,GO:0010813,1,0.973000837941415,0,2,neuropeptide catabolic process,BP,
5013,GO:0010814,1,0.983426667502513,0,1,substance P catabolic process,BP,
5014,GO:0010815,1,0.9309959011076,0,5,bradykinin catabolic process,BP,
5015,GO:0010816,1,0.983426667502513,0,1,calcitonin catabolic process,BP,
5024,GO:0010825,1,0.907062445838821,0,6,positive regulation of centrosome duplication,BP,
5025,GO:0010826,1,0.867646946644383,0,10,negative regulation of centrosome duplication,BP,
5028,GO:0010829,1,0.80862263508515,0,15,negative regulation of glucose transport,BP,
5030,GO:0010831,1,0.670465238367105,0,30,positive regulation of myotube differentiation,BP,
5032,GO:0010833,1,0.349826917621656,0,71,telomere maintenance via telomere lengthening,BP,
5033,GO:0010835,1,0.930907398978678,0,5,regulation of protein ADP-ribosylation,BP,
5034,GO:0010836,1,0.986638653780727,0,1,negative regulation of protein ADP-ribosylation,BP,
5038,GO:0010840,1,0.946867849401075,0,6,regulation of circadian sleep/wake cycle, wakefulness,BP,
5039,GO:0010841,1,0.958803329818097,0,5,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
5040,GO:0010842,1,0.708405956394294,0,22,retina layer formation,BP,
5041,GO:0010845,1,0.968243233087732,0,2,positive regulation of reciprocal meiotic recombination,BP,
5042,GO:0010847,1,0.940178726580756,0,4,regulation of chromatin assembly,BP,
5043,GO:0010848,1,0.967290884118128,0,2,regulation of chromatin disassembly,BP,
5044,GO:0010849,1,0.985900622458962,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
5045,GO:0010851,1,0.908123005616419,0,9,cyclase regulator activity,MF,
5046,GO:0010852,1,0.985548340511754,0,1,cyclase inhibitor activity,MF,
5047,GO:0010853,1,0.936976895220202,0,7,cyclase activator activity,MF,
5048,GO:0010854,1,0.983426667503302,0,1,adenylate cyclase regulator activity,MF,
5049,GO:0010855,1,0.983426667503302,0,1,adenylate cyclase inhibitor activity,MF,
5050,GO:0010857,1,0.835900604655724,0,12,calcium-dependent protein kinase activity,MF,
5051,GO:0010858,1,0.968394071808184,0,3,calcium-dependent protein kinase regulator activity,MF,
5052,GO:0010859,1,0.9834266675032,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5056,GO:0010866,1,0.795542427016001,0,16,regulation of triglyceride biosynthetic process,BP,
5057,GO:0010867,1,0.849977974483375,0,11,positive regulation of triglyceride biosynthetic process,BP,
5058,GO:0010868,1,0.967134914116173,0,2,negative regulation of triglyceride biosynthetic process,BP,
5061,GO:0010871,1,0.908942207254871,0,6,negative regulation of receptor biosynthetic process,BP,
5062,GO:0010872,1,0.884467613361729,0,11,regulation of cholesterol esterification,BP,
5063,GO:0010873,1,0.912906270312407,0,9,positive regulation of cholesterol esterification,BP,
5064,GO:0010874,1,0.754345097356313,0,20,regulation of cholesterol efflux,BP,
5065,GO:0010875,1,0.816961153585389,0,14,positive regulation of cholesterol efflux,BP,
5067,GO:0010877,1,0.977018830193503,0,2,lipid transport involved in lipid storage,BP,
5068,GO:0010878,1,0.793524745859474,0,15,cholesterol storage,BP,
5069,GO:0010879,1,0.985647073098095,0,1,cholesterol transport involved in cholesterol storage,BP,
5073,GO:0010883,1,0.555158787918043,0,42,regulation of lipid storage,BP,
5074,GO:0010884,1,0.739609565573141,0,22,positive regulation of lipid storage,BP,
5075,GO:0010885,1,0.818590745511333,0,13,regulation of cholesterol storage,BP,
5076,GO:0010886,1,0.893269368503193,0,7,positive regulation of cholesterol storage,BP,
5077,GO:0010887,1,0.916435957070056,0,6,negative regulation of cholesterol storage,BP,
5078,GO:0010888,1,0.78529038390499,0,17,negative regulation of lipid storage,BP,
5079,GO:0010889,1,0.857805266882688,0,12,regulation of sequestering of triglyceride,BP,
5080,GO:0010890,1,0.926110615225706,0,7,positive regulation of sequestering of triglyceride,BP,
5081,GO:0010891,1,0.926267563030159,0,5,negative regulation of sequestering of triglyceride,BP,
5086,GO:0010898,1,0.918871626931442,0,8,positive regulation of triglyceride catabolic process,BP,
5087,GO:0010899,1,0.964614446169667,0,3,regulation of phosphatidylcholine catabolic process,BP,
5088,GO:0010900,1,0.996391471935698,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5089,GO:0010901,1,0.967246397376722,0,5,regulation of very-low-density lipoprotein particle remodeling,BP,
5090,GO:0010902,1,0.981590742219829,0,2,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5091,GO:0010903,1,0.985387769809232,0,3,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5092,GO:0010904,1,0.985942385253858,0,1,regulation of UDP-glucose catabolic process,BP,
5093,GO:0010905,1,0.985942385253858,0,1,negative regulation of UDP-glucose catabolic process,BP,
5096,GO:0010908,1,0.967209858472895,0,2,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5097,GO:0010909,1,0.967209858472895,0,2,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5098,GO:0010911,1,0.924549008779114,0,5,regulation of isomerase activity,BP,
5099,GO:0010912,1,0.924549008779114,0,5,positive regulation of isomerase activity,BP,
5100,GO:0010915,1,0.97572647987991,0,4,regulation of very-low-density lipoprotein particle clearance,BP,
5101,GO:0010916,1,0.97572647987991,0,4,negative regulation of very-low-density lipoprotein particle clearance,BP,
5103,GO:0010918,1,0.952560738575306,0,4,positive regulation of mitochondrial membrane potential,BP,
5104,GO:0010919,1,0.820879444284845,0,14,regulation of inositol phosphate biosynthetic process,BP,
5105,GO:0010920,1,0.984085429030766,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5109,GO:0010924,1,0.984085429030766,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5110,GO:0010925,1,0.984085429030766,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5112,GO:0010931,1,0.983426667498775,0,1,macrophage tolerance induction,BP,
5113,GO:0010932,1,0.983426667498775,0,1,regulation of macrophage tolerance induction,BP,
5114,GO:0010933,1,0.983426667498775,0,1,positive regulation of macrophage tolerance induction,BP,
5117,GO:0010936,1,0.929546745290233,0,5,negative regulation of macrophage cytokine production,BP,
5118,GO:0010939,1,0.719236056663679,0,26,regulation of necrotic cell death,BP,
5119,GO:0010940,1,0.941189424764707,0,6,positive regulation of necrotic cell death,BP,
5122,GO:0010944,1,0.88344582671475,0,9,negative regulation of transcription by competitive promoter binding,BP,
5124,GO:0010949,1,0.968984030234865,0,2,negative regulation of intestinal phytosterol absorption,BP,
5128,GO:0010954,1,0.770887260852722,0,18,positive regulation of protein processing,BP,
5129,GO:0010955,1,0.596836890405672,0,37,negative regulation of protein processing,BP,
5130,GO:0010956,1,0.9534678760631,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5131,GO:0010957,1,0.929303666426537,0,5,negative regulation of vitamin D biosynthetic process,BP,
5132,GO:0010958,1,0.942348168582726,0,4,regulation of amino acid import,BP,
5134,GO:0010960,1,0.835250127602455,0,11,magnesium ion homeostasis,BP,
5135,GO:0010961,1,0.922176484239678,0,5,cellular magnesium ion homeostasis,BP,
5137,GO:0010963,1,0.97438254050957,0,2,regulation of L-arginine import,BP,
5138,GO:0010965,1,0.51477584045443,0,46,regulation of mitotic sister chromatid separation,BP,
5139,GO:0010966,1,0.922773391161854,0,5,regulation of phosphate transport,BP,
5140,GO:0010967,1,0.988159237720704,0,1,regulation of polyamine biosynthetic process,BP,
5141,GO:0010968,1,0.924840831221571,0,5,regulation of microtubule nucleation,BP,
5142,GO:0010970,1,0.166068930417021,0,121,transport along microtubule,BP,
5143,GO:0010971,1,0.742271976345911,0,20,positive regulation of G2/M transition of mitotic cell cycle,BP,
5150,GO:0010982,1,0.965197949284718,0,3,regulation of high-density lipoprotein particle clearance,BP,
5151,GO:0010983,1,0.969225551615124,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5152,GO:0010984,1,0.838453808229733,0,15,regulation of lipoprotein particle clearance,BP,
5153,GO:0010985,1,0.929772689447263,0,7,negative regulation of lipoprotein particle clearance,BP,
5154,GO:0010986,1,0.944255087212538,0,4,positive regulation of lipoprotein particle clearance,BP,
5155,GO:0010987,1,0.995845060763382,0,1,negative regulation of high-density lipoprotein particle clearance,BP,
5156,GO:0010988,1,0.895847170833343,0,9,regulation of low-density lipoprotein particle clearance,BP,
5157,GO:0010989,1,0.948947645938458,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5158,GO:0010990,1,0.911197135422437,0,6,regulation of SMAD protein complex assembly,BP,
5159,GO:0010991,1,0.926558102681117,0,5,negative regulation of SMAD protein complex assembly,BP,
5160,GO:0010992,1,0.937544949352604,0,4,ubiquitin homeostasis,BP,
5161,GO:0010993,1,0.938164000781531,0,5,regulation of ubiquitin homeostasis,BP,
5162,GO:0010994,1,0.938164000781531,0,5,free ubiquitin chain polymerization,BP,
5164,GO:0010997,1,0.911887941424564,0,6,anaphase-promoting complex binding,MF,
5165,GO:0010998,1,0.84493364482279,0,11,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5166,GO:0010999,1,0.983426667503104,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5168,GO:0012502,1,0.97536378228332,0,2,induction of programmed cell death,BP,
5171,GO:0012507,1,0.476742334439364,0,56,ER to Golgi transport vesicle membrane,CC,
5172,GO:0012510,1,0.822145680376471,0,14,trans-Golgi network transport vesicle membrane,CC,
5174,GO:0014003,1,0.591112682906226,0,37,oligodendrocyte development,BP,
5178,GO:0014010,1,0.909446516892153,0,6,Schwann cell proliferation,BP,
5179,GO:0014011,1,0.984728932554734,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5180,GO:0014012,1,0.932430196730891,0,6,peripheral nervous system axon regeneration,BP,
5184,GO:0014016,1,0.955539314457553,0,3,neuroblast differentiation,BP,
5185,GO:0014017,1,0.984968562250546,0,1,neuroblast fate commitment,BP,
5187,GO:0014022,1,0.952005946870246,0,3,neural plate elongation,BP,
5189,GO:0014029,1,0.84551837298529,0,12,neural crest formation,BP,
5193,GO:0014034,1,0.964292287940231,0,3,neural crest cell fate commitment,BP,
5194,GO:0014036,1,0.991194194283556,0,1,neural crest cell fate specification,BP,
5196,GO:0014038,1,0.956641120801995,0,3,regulation of Schwann cell differentiation,BP,
5197,GO:0014040,1,0.9683599609261,0,2,positive regulation of Schwann cell differentiation,BP,
5198,GO:0014041,1,0.844483167956065,0,11,regulation of neuron maturation,BP,
5199,GO:0014042,1,0.935331777056882,0,4,positive regulation of neuron maturation,BP,
5200,GO:0014043,1,0.93931259948562,0,4,negative regulation of neuron maturation,BP,
5206,GO:0014049,1,0.894151880967016,0,8,positive regulation of glutamate secretion,BP,
5208,GO:0014051,1,0.878251782694847,0,8,gamma-aminobutyric acid secretion,BP,
5209,GO:0014052,1,0.923126633225223,0,5,regulation of gamma-aminobutyric acid secretion,BP,
5210,GO:0014053,1,0.98342666750271,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5211,GO:0014054,1,0.938687861849459,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5212,GO:0014055,1,0.95500207510631,0,3,acetylcholine secretion, neurotransmission,BP,
5213,GO:0014056,1,0.95500207510631,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5214,GO:0014057,1,0.970090329585344,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5218,GO:0014062,1,0.912570500246738,0,7,regulation of serotonin secretion,BP,
5219,GO:0014063,1,0.945554716009386,0,4,negative regulation of serotonin secretion,BP,
5220,GO:0014064,1,0.983426667503053,0,1,positive regulation of serotonin secretion,BP,
5223,GO:0014067,1,0.854256998245992,0,11,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5227,GO:0014072,1,0.653383905884394,0,31,response to isoquinoline alkaloid,BP,
5229,GO:0014075,1,0.585251754767556,0,38,response to amine,BP,
5232,GO:0014705,1,0.983426667503248,0,1,C zone,CC,
5234,GO:0014707,1,0.958073313311672,0,3,branchiomeric skeletal muscle development,BP,
5235,GO:0014717,1,0.962784689432567,0,3,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5236,GO:0014718,1,0.97368037468707,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5238,GO:0014721,1,0.935805745781241,0,5,twitch skeletal muscle contraction,BP,
5239,GO:0014722,1,0.939998222976467,0,5,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5240,GO:0014724,1,0.967172051360896,0,2,regulation of twitch skeletal muscle contraction,BP,
5245,GO:0014734,1,0.954091004231692,0,3,skeletal muscle hypertrophy,BP,
5246,GO:0014735,1,0.961805300047999,0,3,regulation of muscle atrophy,BP,
5247,GO:0014736,1,0.97355178097376,0,2,negative regulation of muscle atrophy,BP,
5248,GO:0014737,1,0.987935740848099,0,1,positive regulation of muscle atrophy,BP,
5249,GO:0014738,1,0.964399943581337,0,3,regulation of muscle hyperplasia,BP,
5250,GO:0014739,1,0.995050105351797,0,1,positive regulation of muscle hyperplasia,BP,
5251,GO:0014740,1,0.969197999897121,0,2,negative regulation of muscle hyperplasia,BP,
5252,GO:0014741,1,0.770067421557934,0,18,negative regulation of muscle hypertrophy,BP,
5255,GO:0014744,1,0.935039700899154,0,5,positive regulation of muscle adaptation,BP,
5256,GO:0014745,1,0.882790402516823,0,8,negative regulation of muscle adaptation,BP,
5257,GO:0014801,1,0.992543238897423,0,1,longitudinal sarcoplasmic reticulum,CC,
5258,GO:0014802,1,0.948407483360812,0,4,terminal cisterna,CC,
5259,GO:0014804,1,0.986867772486034,0,1,terminal cisterna lumen,CC,
5260,GO:0014805,1,0.958522602329615,0,4,smooth muscle adaptation,BP,
5261,GO:0014806,1,0.974123142076212,0,2,smooth muscle hyperplasia,BP,
5264,GO:0014809,1,0.955223343926119,0,4,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5265,GO:0014810,1,0.993991553437523,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5267,GO:0014813,1,0.985657794256111,0,1,skeletal muscle satellite cell commitment,BP,
5268,GO:0014816,1,0.907996470601351,0,6,skeletal muscle satellite cell differentiation,BP,
5272,GO:0014822,1,0.984734240689121,0,1,detection of wounding,BP,
5276,GO:0014827,1,0.943011373723631,0,4,intestine smooth muscle contraction,BP,
5278,GO:0014831,1,0.896883578788001,0,7,gastro-intestinal system smooth muscle contraction,BP,
5279,GO:0014832,1,0.90055887250788,0,7,urinary bladder smooth muscle contraction,BP,
5281,GO:0014835,1,0.969293132752171,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5282,GO:0014839,1,0.977322770899568,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
5283,GO:0014841,1,0.855711489312544,0,10,skeletal muscle satellite cell proliferation,BP,
5284,GO:0014842,1,0.870140863967394,0,9,regulation of skeletal muscle satellite cell proliferation,BP,
5285,GO:0014843,1,0.983426667500544,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5286,GO:0014846,1,0.967126892154102,0,2,esophagus smooth muscle contraction,BP,
5287,GO:0014848,1,0.90055887250788,0,7,urinary tract smooth muscle contraction,BP,
5288,GO:0014850,1,0.795304101337836,0,16,response to muscle activity,BP,
5289,GO:0014852,1,0.984064199029079,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5290,GO:0014853,1,0.984064199029079,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5293,GO:0014856,1,0.846145190042815,0,11,skeletal muscle cell proliferation,BP,
5294,GO:0014857,1,0.860413925036764,0,10,regulation of skeletal muscle cell proliferation,BP,
5295,GO:0014858,1,0.988827839667624,0,1,positive regulation of skeletal muscle cell proliferation,BP,
5296,GO:0014859,1,0.967975476861054,0,2,negative regulation of skeletal muscle cell proliferation,BP,
5297,GO:0014861,1,0.983426667502217,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5301,GO:0014873,1,0.972798955187979,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5303,GO:0014876,1,0.989959389291832,0,1,response to injury involved in regulation of muscle adaptation,BP,
5305,GO:0014878,1,0.943792238095926,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5307,GO:0014886,1,0.967300523767272,0,2,transition between slow and fast fiber,BP,
5308,GO:0014887,1,0.749513612659618,0,19,cardiac muscle adaptation,BP,
5313,GO:0014895,1,0.994679552360307,0,1,smooth muscle hypertrophy,BP,
5316,GO:0014898,1,0.749513612659618,0,19,cardiac muscle hypertrophy in response to stress,BP,
5317,GO:0014900,1,0.953754488519723,0,4,muscle hyperplasia,BP,
5318,GO:0014901,1,0.962784689432567,0,3,satellite cell activation involved in skeletal muscle regeneration,BP,
5320,GO:0014904,1,0.625030642296515,0,32,myotube cell development,BP,
5321,GO:0014905,1,0.993731290461825,0,1,myoblast fusion involved in skeletal muscle regeneration,BP,
5322,GO:0014908,1,0.965159809691304,0,3,myotube differentiation involved in skeletal muscle regeneration,BP,
5326,GO:0014912,1,0.746420427054403,0,20,negative regulation of smooth muscle cell migration,BP,
5327,GO:0014916,1,0.954461579028918,0,3,regulation of lung blood pressure,BP,
5328,GO:0015002,1,0.835316849266878,0,26,heme-copper terminal oxidase activity,MF,
5329,GO:0015012,1,0.677573017309199,0,24,heparan sulfate proteoglycan biosynthetic process,BP,
5330,GO:0015014,1,0.951214160182762,0,3,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5331,GO:0015015,1,0.92359179591619,0,5,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5332,GO:0015016,1,0.935447241496691,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5333,GO:0015018,1,0.960617019497498,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5334,GO:0015019,1,0.983426667502364,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5335,GO:0015020,1,0.630755958252614,0,31,glucuronosyltransferase activity,MF,
5336,GO:0015026,1,0.594317817393061,0,36,coreceptor activity,MF,
5337,GO:0015030,1,0.512850807135407,0,49,Cajal body,CC,
5339,GO:0015035,1,0.786464771397891,0,21,protein disulfide oxidoreductase activity,MF,
5340,GO:0015036,1,0.628384414411709,0,39,disulfide oxidoreductase activity,MF,
5341,GO:0015037,1,0.860018313384797,0,13,peptide disulfide oxidoreductase activity,MF,
5342,GO:0015038,1,0.952948678442025,0,5,glutathione disulfide oxidoreductase activity,MF,
5343,GO:0015039,1,0.987160786174616,0,1,NADPH-adrenodoxin reductase activity,MF,
5344,GO:0015052,1,0.984524604531394,0,1,beta3-adrenergic receptor activity,MF,
5345,GO:0015054,1,0.986200672379079,0,1,gastrin receptor activity,MF,
5346,GO:0015055,1,0.987490227772392,0,1,secretin receptor activity,MF,
5347,GO:0015056,1,0.973044879572255,0,2,corticotrophin-releasing factor receptor activity,MF,
5348,GO:0015057,1,0.922724552683078,0,5,thrombin-activated receptor activity,MF,
5349,GO:0015065,1,0.961504572667343,0,3,uridine nucleotide receptor activity,MF,
5350,GO:0015067,1,0.984655947092956,0,1,amidinotransferase activity,MF,
5351,GO:0015068,1,0.984655947092956,0,1,glycine amidinotransferase activity,MF,
5352,GO:0015074,1,0.863262550318624,0,10,DNA integration,BP,
5355,GO:0015078,1,0.325741151064245,0,101,hydrogen ion transmembrane transporter activity,MF,
5357,GO:0015081,1,0.0923093588894337,0,151,sodium ion transmembrane transporter activity,MF,
5359,GO:0015086,1,0.983426667503302,0,1,cadmium ion transmembrane transporter activity,MF,
5360,GO:0015087,1,0.983426667503302,0,1,cobalt ion transmembrane transporter activity,MF,
5361,GO:0015088,1,0.983426667502857,0,1,copper uptake transmembrane transporter activity,MF,
5363,GO:0015093,1,0.951210996352976,0,3,ferrous iron transmembrane transporter activity,MF,
5364,GO:0015094,1,0.983426667503302,0,1,lead ion transmembrane transporter activity,MF,
5366,GO:0015098,1,0.987158450059716,0,1,molybdate ion transmembrane transporter activity,MF,
5367,GO:0015101,1,0.81929436825208,0,14,organic cation transmembrane transporter activity,MF,
5369,GO:0015105,1,0.990569230810668,0,1,arsenite transmembrane transporter activity,MF,
5370,GO:0015106,1,0.732938425885481,0,19,bicarbonate transmembrane transporter activity,MF,
5372,GO:0015111,1,0.951127404649192,0,3,iodide transmembrane transporter activity,MF,
5373,GO:0015112,1,0.984496107575637,0,1,nitrate transmembrane transporter activity,MF,
5374,GO:0015114,1,0.771548280053102,0,17,phosphate ion transmembrane transporter activity,MF,
5375,GO:0015116,1,0.79937170078192,0,14,sulfate transmembrane transporter activity,MF,
5376,GO:0015117,1,0.987198264305229,0,1,thiosulfate transmembrane transporter activity,MF,
5377,GO:0015119,1,0.95412864002471,0,3,hexose phosphate transmembrane transporter activity,MF,
5378,GO:0015125,1,0.832825758470639,0,13,bile acid transmembrane transporter activity,MF,
5379,GO:0015126,1,0.983426667502856,0,1,canalicular bile acid transmembrane transporter activity,MF,
5380,GO:0015127,1,0.983426667502562,0,1,bilirubin transmembrane transporter activity,MF,
5381,GO:0015129,1,0.926308003048275,0,5,lactate transmembrane transporter activity,MF,
5382,GO:0015130,1,0.983426667503304,0,1,mevalonate transmembrane transporter activity,MF,
5383,GO:0015131,1,0.987198264305229,0,1,oxaloacetate transmembrane transporter activity,MF,
5384,GO:0015132,1,0.983426667503248,0,1,prostaglandin transmembrane transporter activity,MF,
5385,GO:0015136,1,0.983566808153595,0,1,sialic acid transmembrane transporter activity,MF,
5386,GO:0015137,1,0.940517151614511,0,4,citrate transmembrane transporter activity,MF,
5387,GO:0015139,1,0.984070096703214,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5388,GO:0015140,1,0.975087316784521,0,2,malate transmembrane transporter activity,MF,
5389,GO:0015141,1,0.954949975216385,0,3,succinate transmembrane transporter activity,MF,
5390,GO:0015142,1,0.940517151614511,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5391,GO:0015143,1,0.870498481215197,0,10,urate transmembrane transporter activity,MF,
5395,GO:0015152,1,0.986249049395682,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5398,GO:0015165,1,0.922282898327793,0,6,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5399,GO:0015166,1,0.876901832112467,0,9,polyol transmembrane transporter activity,MF,
5400,GO:0015168,1,0.920232348086943,0,6,glycerol transmembrane transporter activity,MF,
5401,GO:0015171,1,0.303790638119797,0,78,amino acid transmembrane transporter activity,MF,
5402,GO:0015172,1,0.800059626900075,0,14,acidic amino acid transmembrane transporter activity,MF,
5403,GO:0015173,1,0.953441624965758,0,3,aromatic amino acid transmembrane transporter activity,MF,
5404,GO:0015174,1,0.873304240173983,0,9,basic amino acid transmembrane transporter activity,MF,
5405,GO:0015175,1,0.622565531809558,0,31,neutral amino acid transmembrane transporter activity,MF,
5406,GO:0015179,1,0.454031154999131,0,52,L-amino acid transmembrane transporter activity,MF,
5407,GO:0015180,1,0.893704824539707,0,7,L-alanine transmembrane transporter activity,MF,
5408,GO:0015181,1,0.941129899624839,0,4,arginine transmembrane transporter activity,MF,
5409,GO:0015182,1,0.969459349948648,0,2,L-asparagine transmembrane transporter activity,MF,
5410,GO:0015183,1,0.940678650839748,0,4,L-aspartate transmembrane transporter activity,MF,
5411,GO:0015184,1,0.941566481360376,0,4,L-cystine transmembrane transporter activity,MF,
5412,GO:0015185,1,0.926581163974342,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5413,GO:0015186,1,0.941018902949814,0,4,L-glutamine transmembrane transporter activity,MF,
5414,GO:0015187,1,0.882645141389071,0,8,glycine transmembrane transporter activity,MF,
5415,GO:0015189,1,0.956993332956872,0,3,L-lysine transmembrane transporter activity,MF,
5416,GO:0015190,1,0.984222783158252,0,1,L-leucine transmembrane transporter activity,MF,
5417,GO:0015191,1,0.984222783158252,0,1,L-methionine transmembrane transporter activity,MF,
5418,GO:0015193,1,0.891560737509254,0,7,L-proline transmembrane transporter activity,MF,
5419,GO:0015194,1,0.881015201279711,0,9,L-serine transmembrane transporter activity,MF,
5420,GO:0015195,1,0.983426667503252,0,1,L-threonine transmembrane transporter activity,MF,
5421,GO:0015196,1,0.984983208785348,0,1,L-tryptophan transmembrane transporter activity,MF,
5422,GO:0015197,1,0.219573774631207,0,106,peptide transporter activity,MF,
5423,GO:0015198,1,0.920136516001538,0,5,oligopeptide transporter activity,MF,
5424,GO:0015199,1,0.944775348047785,0,4,amino-acid betaine transmembrane transporter activity,MF,
5425,GO:0015203,1,0.993369433313218,0,1,polyamine transmembrane transporter activity,MF,
5426,GO:0015204,1,0.93976725509925,0,4,urea transmembrane transporter activity,MF,
5427,GO:0015205,1,0.893153909708382,0,8,nucleobase transmembrane transporter activity,MF,
5428,GO:0015207,1,0.963379064232665,0,3,adenine transmembrane transporter activity,MF,
5429,GO:0015211,1,0.94144617611474,0,4,purine nucleoside transmembrane transporter activity,MF,
5430,GO:0015215,1,0.795830595848421,0,16,nucleotide transmembrane transporter activity,MF,
5431,GO:0015216,1,0.841047960553583,0,12,purine nucleotide transmembrane transporter activity,MF,
5432,GO:0015217,1,0.87886480942716,0,9,ADP transmembrane transporter activity,MF,
5433,GO:0015218,1,0.97307323968579,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5434,GO:0015220,1,0.907555203847788,0,6,choline transmembrane transporter activity,MF,
5435,GO:0015222,1,0.955321058450054,0,3,serotonin transmembrane transporter activity,MF,
5436,GO:0015226,1,0.944775348047785,0,4,carnitine transmembrane transporter activity,MF,
5437,GO:0015227,1,0.97277316961814,0,2,acyl carnitine transmembrane transporter activity,MF,
5438,GO:0015228,1,0.969592073929455,0,2,coenzyme A transmembrane transporter activity,MF,
5439,GO:0015229,1,0.968994049490878,0,2,L-ascorbic acid transporter activity,MF,
5440,GO:0015230,1,0.969712695520183,0,2,FAD transmembrane transporter activity,MF,
5442,GO:0015234,1,0.943104681083021,0,4,thiamine transmembrane transporter activity,MF,
5443,GO:0015235,1,0.960584261605827,0,3,cobalamin transporter activity,MF,
5444,GO:0015238,1,0.739380418551646,0,20,drug transmembrane transporter activity,MF,
5445,GO:0015245,1,0.832128595218983,0,13,fatty acid transporter activity,MF,
5446,GO:0015247,1,0.967126892145874,0,2,aminophospholipid transporter activity,MF,
5447,GO:0015248,1,0.673791838622932,0,28,sterol transporter activity,MF,
5448,GO:0015250,1,0.859783160529436,0,11,water channel activity,MF,
5449,GO:0015252,1,0.913117283828486,0,6,hydrogen ion channel activity,MF,
5450,GO:0015254,1,0.950696329975183,0,4,glycerol channel activity,MF,
5451,GO:0015265,1,0.955607815316615,0,3,urea channel activity,MF,
5452,GO:0015266,1,0.885722255771317,0,11,protein channel activity,MF,
5454,GO:0015269,1,0.763942569459497,0,19,calcium-activated potassium channel activity,MF,
5456,GO:0015272,1,0.923045627749963,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5457,GO:0015275,1,0.951352911155166,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5459,GO:0015277,1,0.920540473541307,0,5,kainate selective glutamate receptor activity,MF,
5460,GO:0015278,1,0.753990848807253,0,18,calcium-release channel activity,MF,
5461,GO:0015279,1,0.845688239475006,0,11,store-operated calcium channel activity,MF,
5462,GO:0015280,1,0.867145959942124,0,9,ligand-gated sodium channel activity,MF,
5463,GO:0015288,1,0.925242778464144,0,6,porin activity,MF,
5465,GO:0015292,1,0.984728932554734,0,1,uniporter activity,MF,
5469,GO:0015296,1,0.464523733348239,0,49,anion:cation symporter activity,MF,
5470,GO:0015297,1,0.294849205635895,0,79,antiporter activity,MF,
5471,GO:0015298,1,0.605354071511457,0,32,solute:cation antiporter activity,MF,
5472,GO:0015299,1,0.741100312341872,0,19,solute:proton antiporter activity,MF,
5473,GO:0015301,1,0.616826462827491,0,31,anion:anion antiporter activity,MF,
5474,GO:0015307,1,0.95863010162973,0,3,drug:proton antiporter activity,MF,
5475,GO:0015315,1,0.95412864002471,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5476,GO:0015319,1,0.983890557950773,0,1,sodium:inorganic phosphate symporter activity,MF,
5477,GO:0015320,1,0.988233157938526,0,1,phosphate ion carrier activity,MF,
5478,GO:0015321,1,0.898275091640498,0,7,sodium-dependent phosphate transmembrane transporter activity,MF,
5479,GO:0015322,1,0.967410909509369,0,2,secondary active oligopeptide transmembrane transporter activity,MF,
5480,GO:0015327,1,0.983426667497199,0,1,cystine:glutamate antiporter activity,MF,
5481,GO:0015328,1,0.983426667497199,0,1,cystine secondary active transmembrane transporter activity,MF,
5482,GO:0015333,1,0.939306715809032,0,4,peptide:proton symporter activity,MF,
5483,GO:0015347,1,0.787891275090665,0,16,sodium-independent organic anion transmembrane transporter activity,MF,
5484,GO:0015349,1,0.921991650075677,0,5,thyroid hormone transmembrane transporter activity,MF,
5485,GO:0015350,1,0.967802175604873,0,2,methotrexate transporter activity,MF,
5486,GO:0015361,1,0.985090971810382,0,1,low-affinity sodium:dicarboxylate symporter activity,MF,
5487,GO:0015362,1,0.983426667503345,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5488,GO:0015367,1,0.98773265345152,0,1,oxoglutarate:malate antiporter activity,MF,
5489,GO:0015368,1,0.856770625706637,0,10,calcium:cation antiporter activity,MF,
5490,GO:0015370,1,0.433278158758923,0,54,solute:sodium symporter activity,MF,
5491,GO:0015373,1,0.983458952104332,0,1,monovalent anion:sodium symporter activity,MF,
5492,GO:0015375,1,0.967952999391693,0,2,glycine:sodium symporter activity,MF,
5493,GO:0015377,1,0.860495722496616,0,9,cation:chloride symporter activity,MF,
5494,GO:0015378,1,0.983426667501971,0,1,sodium:chloride symporter activity,MF,
5495,GO:0015379,1,0.904759817232542,0,6,potassium:chloride symporter activity,MF,
5496,GO:0015382,1,0.967706701752831,0,2,sodium:sulfate symporter activity,MF,
5497,GO:0015385,1,0.811581557003388,0,13,sodium:proton antiporter activity,MF,
5498,GO:0015386,1,0.836968391874257,0,11,potassium:proton antiporter activity,MF,
5499,GO:0015389,1,0.972506864919263,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5500,GO:0015390,1,0.985799676023169,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5501,GO:0015399,1,0.189360225070646,0,117,primary active transmembrane transporter activity,MF,
5502,GO:0015403,1,0.954134652253184,0,3,thiamine uptake transmembrane transporter activity,MF,
5503,GO:0015405,1,0.189360225070646,0,117,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
5504,GO:0015410,1,0.983427478185134,0,1,manganese-transporting ATPase activity,MF,
5505,GO:0015420,1,0.983426667500937,0,1,cobalamin-transporting ATPase activity,MF,
5506,GO:0015421,1,0.983471574761973,0,1,oligopeptide-transporting ATPase activity,MF,
5507,GO:0015431,1,0.983426667500937,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5508,GO:0015432,1,0.967169802678498,0,2,bile acid-exporting ATPase activity,MF,
5509,GO:0015433,1,0.967180698936364,0,2,peptide antigen-transporting ATPase activity,MF,
5510,GO:0015439,1,0.983885143791916,0,1,heme-transporting ATPase activity,MF,
5511,GO:0015440,1,0.93589932007104,0,4,peptide-transporting ATPase activity,MF,
5512,GO:0015450,1,0.928412140057227,0,8,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5513,GO:0015459,1,0.529765079515347,0,44,potassium channel regulator activity,MF,
5514,GO:0015464,1,0.726413634670981,0,22,acetylcholine receptor activity,MF,
5515,GO:0015467,1,0.85220527155292,0,10,G-protein activated inward rectifier potassium channel activity,MF,
5516,GO:0015485,1,0.571788550880999,0,43,cholesterol binding,MF,
5517,GO:0015489,1,0.993369433313218,0,1,putrescine transmembrane transporter activity,MF,
5518,GO:0015491,1,0.641249329173153,0,28,cation:cation antiporter activity,MF,
5519,GO:0015495,1,0.984697349286787,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5520,GO:0015499,1,0.984490228516902,0,1,formate transmembrane transporter activity,MF,
5521,GO:0015501,1,0.967135949420653,0,2,glutamate:sodium symporter activity,MF,
5522,GO:0015526,1,0.95412864002471,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5523,GO:0015538,1,0.983566808153595,0,1,sialic acid:proton symporter activity,MF,
5524,GO:0015556,1,0.887266041640797,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5525,GO:0015562,1,0.92581858285783,0,5,efflux transmembrane transporter activity,MF,
5526,GO:0015563,1,0.939333385649526,0,4,uptake transmembrane transporter activity,MF,
5527,GO:0015578,1,0.98502463533255,0,1,mannose transmembrane transporter activity,MF,
5528,GO:0015605,1,0.759290994600257,0,19,organophosphate ester transmembrane transporter activity,MF,
5529,GO:0015607,1,0.98344323830847,0,1,fatty-acyl-CoA transporter activity,MF,
5530,GO:0015616,1,0.951482436667497,0,3,DNA translocase activity,MF,
5534,GO:0015633,1,0.986297860662191,0,1,zinc-transporting ATPase activity,MF,
5535,GO:0015635,1,0.985486141903953,0,1,short-chain fatty acid transporter activity,MF,
5536,GO:0015636,1,0.985486141903953,0,1,short-chain fatty acid uptake transporter activity,MF,
5537,GO:0015639,1,0.983426667503302,0,1,ferrous iron uptake transmembrane transporter activity,MF,
5538,GO:0015643,1,0.856162847294052,0,11,toxic substance binding,MF,
5540,GO:0015651,1,0.890189650695836,0,8,quaternary ammonium group transmembrane transporter activity,MF,
5541,GO:0015658,1,0.984222783158252,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5542,GO:0015659,1,0.984490228516902,0,1,formate uptake transmembrane transporter activity,MF,
5543,GO:0015660,1,0.984490228516902,0,1,formate efflux transmembrane transporter activity,MF,
5544,GO:0015662,1,0.572263424573404,0,37,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5545,GO:0015665,1,0.876901832112467,0,9,alcohol transmembrane transporter activity,MF,
5546,GO:0015669,1,0.845109829272475,0,19,gas transport,BP,
5547,GO:0015670,1,0.948166617456784,0,4,carbon dioxide transport,BP,
5548,GO:0015671,1,0.891332192706029,0,15,oxygen transport,BP,
5550,GO:0015677,1,0.904574661088441,0,6,copper ion import,BP,
5551,GO:0015679,1,0.983426667498525,0,1,plasma membrane copper ion transport,BP,
5552,GO:0015680,1,0.972045797629189,0,3,intracellular copper ion transport,BP,
5555,GO:0015688,1,0.964784299693868,0,3,iron chelate transport,BP,
5556,GO:0015689,1,0.987158450059716,0,1,molybdate ion transport,BP,
5557,GO:0015691,1,0.938572165772164,0,4,cadmium ion transport,BP,
5558,GO:0015692,1,0.983426667503302,0,1,lead ion transport,BP,
5560,GO:0015694,1,0.983426667502562,0,1,mercury ion transport,BP,
5561,GO:0015695,1,0.746521516327916,0,21,organic cation transport,BP,
5563,GO:0015697,1,0.863366905587891,0,10,quaternary ammonium group transport,BP,
5565,GO:0015701,1,0.538682670317743,0,44,bicarbonate transport,BP,
5566,GO:0015705,1,0.919854512442558,0,5,iodide transport,BP,
5567,GO:0015706,1,0.984496107575637,0,1,nitrate transport,BP,
5568,GO:0015707,1,0.983427993670479,0,1,nitrite transport,BP,
5569,GO:0015709,1,0.987198264305229,0,1,thiosulfate transport,BP,
5571,GO:0015712,1,0.916820556779534,0,6,hexose phosphate transport,BP,
5573,GO:0015721,1,0.653456110467914,0,30,bile acid and bile salt transport,BP,
5574,GO:0015722,1,0.951494332207298,0,3,canalicular bile acid transport,BP,
5575,GO:0015723,1,0.983426667502562,0,1,bilirubin transport,BP,
5576,GO:0015724,1,0.984490228516902,0,1,formate transport,BP,
5577,GO:0015727,1,0.910951165116167,0,6,lactate transport,BP,
5578,GO:0015728,1,0.983426667503304,0,1,mevalonate transport,BP,
5579,GO:0015729,1,0.987198264305229,0,1,oxaloacetate transport,BP,
5581,GO:0015734,1,0.983426667500841,0,1,taurine transport,BP,
5582,GO:0015739,1,0.983566808153595,0,1,sialic acid transport,BP,
5583,GO:0015740,1,0.826262287008262,0,12,C4-dicarboxylate transport,BP,
5584,GO:0015742,1,0.95860047476437,0,3,alpha-ketoglutarate transport,BP,
5585,GO:0015743,1,0.987198264305229,0,1,malate transport,BP,
5586,GO:0015744,1,0.954949975216385,0,3,succinate transport,BP,
5587,GO:0015746,1,0.940517151614511,0,4,citrate transport,BP,
5588,GO:0015747,1,0.868216723704915,0,10,urate transport,BP,
5591,GO:0015755,1,0.970522917623509,0,2,fructose transport,BP,
5593,GO:0015760,1,0.916820556779534,0,6,glucose-6-phosphate transport,BP,
5594,GO:0015761,1,0.98502463533255,0,1,mannose transport,BP,
5598,GO:0015780,1,0.893333473285836,0,8,nucleotide-sugar transport,BP,
5599,GO:0015781,1,0.922282898327793,0,6,pyrimidine nucleotide-sugar transport,BP,
5600,GO:0015782,1,0.987563694431352,0,1,CMP-N-acetylneuraminate transport,BP,
5601,GO:0015783,1,0.952566095724595,0,3,GDP-fucose transport,BP,
5602,GO:0015785,1,0.979291685349768,0,2,UDP-galactose transport,BP,
5603,GO:0015787,1,0.983426667500887,0,1,UDP-glucuronic acid transport,BP,
5604,GO:0015788,1,0.969726472997792,0,2,UDP-N-acetylglucosamine transport,BP,
5605,GO:0015790,1,0.983426667500447,0,1,UDP-xylose transport,BP,
5606,GO:0015791,1,0.84897763571426,0,11,polyol transport,BP,
5607,GO:0015793,1,0.920232348086943,0,6,glycerol transport,BP,
5608,GO:0015797,1,0.984490228516902,0,1,mannitol transport,BP,
5609,GO:0015798,1,0.951096177101426,0,3,myo-inositol transport,BP,
5610,GO:0015800,1,0.673899372474851,0,25,acidic amino acid transport,BP,
5611,GO:0015801,1,0.924225157292302,0,5,aromatic amino acid transport,BP,
5612,GO:0015802,1,0.826031932134192,0,13,basic amino acid transport,BP,
5613,GO:0015803,1,0.938204786548313,0,4,branched-chain amino acid transport,BP,
5614,GO:0015804,1,0.583016673258983,0,35,neutral amino acid transport,BP,
5615,GO:0015805,1,0.985781226225567,0,1,S-adenosyl-L-methionine transport,BP,
5616,GO:0015807,1,0.385053252656007,0,63,L-amino acid transport,BP,
5617,GO:0015808,1,0.893704824539707,0,7,L-alanine transport,BP,
5618,GO:0015809,1,0.890201526841255,0,8,arginine transport,BP,
5619,GO:0015810,1,0.865265354863511,0,9,aspartate transport,BP,
5620,GO:0015811,1,0.941566481360376,0,4,L-cystine transport,BP,
5621,GO:0015812,1,0.827462658789966,0,12,gamma-aminobutyric acid transport,BP,
5622,GO:0015813,1,0.696840401773985,0,23,L-glutamate transport,BP,
5623,GO:0015816,1,0.853615097921414,0,10,glycine transport,BP,
5624,GO:0015817,1,0.969459349948648,0,2,histidine transport,BP,
5625,GO:0015819,1,0.942328717277342,0,4,lysine transport,BP,
5626,GO:0015820,1,0.953247335674908,0,3,leucine transport,BP,
5627,GO:0015821,1,0.984222783158252,0,1,methionine transport,BP,
5628,GO:0015822,1,0.957233022012173,0,3,ornithine transport,BP,
5629,GO:0015824,1,0.862238665834886,0,9,proline transport,BP,
5630,GO:0015825,1,0.881015201279711,0,9,L-serine transport,BP,
5631,GO:0015826,1,0.983426667503252,0,1,threonine transport,BP,
5632,GO:0015827,1,0.954804212873761,0,3,tryptophan transport,BP,
5633,GO:0015828,1,0.983692963243612,0,1,tyrosine transport,BP,
5636,GO:0015838,1,0.91631476847184,0,6,amino-acid betaine transport,BP,
5637,GO:0015840,1,0.921922446181821,0,6,urea transport,BP,
5638,GO:0015842,1,0.946071160889234,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5640,GO:0015846,1,0.926619035679606,0,6,polyamine transport,BP,
5641,GO:0015847,1,0.993369433313218,0,1,putrescine transport,BP,
5644,GO:0015851,1,0.883893091534377,0,9,nucleobase transport,BP,
5645,GO:0015853,1,0.953393229924682,0,4,adenine transport,BP,
5646,GO:0015855,1,0.956787699608624,0,3,pyrimidine nucleobase transport,BP,
5648,GO:0015860,1,0.970975063397529,0,2,purine nucleoside transmembrane transport,BP,
5649,GO:0015862,1,0.985418202847162,0,1,uridine transport,BP,
5650,GO:0015864,1,0.971424098822207,0,2,pyrimidine nucleoside transport,BP,
5652,GO:0015866,1,0.87886480942716,0,9,ADP transport,BP,
5653,GO:0015867,1,0.850536715346277,0,11,ATP transport,BP,
5655,GO:0015870,1,0.926237555272041,0,5,acetylcholine transport,BP,
5656,GO:0015871,1,0.877709258289847,0,8,choline transport,BP,
5659,GO:0015876,1,0.984479696476155,0,1,acetyl-CoA transport,BP,
5660,GO:0015878,1,0.983575865593412,0,1,biotin transport,BP,
5661,GO:0015879,1,0.931761649788238,0,5,carnitine transport,BP,
5662,GO:0015880,1,0.969592073929455,0,2,coenzyme A transport,BP,
5663,GO:0015881,1,0.967169115595505,0,2,creatine transport,BP,
5664,GO:0015882,1,0.968994049490878,0,2,L-ascorbic acid transport,BP,
5665,GO:0015883,1,0.969712695520183,0,2,FAD transport,BP,
5666,GO:0015884,1,0.915282230859569,0,7,folic acid transport,BP,
5668,GO:0015887,1,0.983575865593412,0,1,pantothenate transmembrane transport,BP,
5669,GO:0015888,1,0.928030909816614,0,5,thiamine transport,BP,
5670,GO:0015889,1,0.901629081886321,0,8,cobalamin transport,BP,
5671,GO:0015891,1,0.964784299693868,0,3,siderophore transport,BP,
5673,GO:0015904,1,0.987323757376136,0,1,tetracycline transport,BP,
5676,GO:0015910,1,0.969200866134536,0,2,peroxisomal long-chain fatty acid import,BP,
5678,GO:0015912,1,0.985486141903953,0,1,short-chain fatty acid transport,BP,
5679,GO:0015913,1,0.985486141903953,0,1,short-chain fatty acid import,BP,
5680,GO:0015914,1,0.443911905839304,0,57,phospholipid transport,BP,
5681,GO:0015916,1,0.984479696476155,0,1,fatty-acyl-CoA transport,BP,
5682,GO:0015917,1,0.951096177106849,0,3,aminophospholipid transport,BP,
5683,GO:0015918,1,0.314327233635809,0,83,sterol transport,BP,
5684,GO:0015919,1,0.895221911220565,0,7,peroxisomal membrane transport,BP,
5685,GO:0015920,1,0.972089715802786,0,2,lipopolysaccharide transport,BP,
5686,GO:0015922,1,0.988578257129805,0,1,aspartate oxidase activity,MF,
5687,GO:0015923,1,0.795524248255386,0,14,mannosidase activity,MF,
5688,GO:0015924,1,0.864467647653042,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5689,GO:0015925,1,0.888640914886154,0,8,galactosidase activity,MF,
5690,GO:0015926,1,0.825287197474626,0,12,glucosidase activity,MF,
5691,GO:0015927,1,0.987326145032158,0,1,trehalase activity,MF,
5692,GO:0015928,1,0.972686771564485,0,2,fucosidase activity,MF,
5693,GO:0015929,1,0.824846492687807,0,13,hexosaminidase activity,MF,
5695,GO:0015932,1,0.592495712769965,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5696,GO:0015934,1,0.395827587725231,0,110,large ribosomal subunit,CC,
5697,GO:0015935,1,0.581470088837598,0,68,small ribosomal subunit,CC,
5698,GO:0015936,1,0.823124433577754,0,14,coenzyme A metabolic process,BP,
5699,GO:0015937,1,0.871954606386199,0,10,coenzyme A biosynthetic process,BP,
5700,GO:0015938,1,0.99237048907605,0,1,coenzyme A catabolic process,BP,
5701,GO:0015939,1,0.904066503246566,0,7,pantothenate metabolic process,BP,
5702,GO:0015942,1,0.919990549597223,0,6,formate metabolic process,BP,
5703,GO:0015949,1,0.75164352322776,0,22,nucleobase-containing small molecule interconversion,BP,
5704,GO:0015959,1,0.90369750117827,0,7,diadenosine polyphosphate metabolic process,BP,
5705,GO:0015960,1,0.954636195103178,0,3,diadenosine polyphosphate biosynthetic process,BP,
5706,GO:0015961,1,0.946650719048175,0,4,diadenosine polyphosphate catabolic process,BP,
5707,GO:0015965,1,0.954636195103178,0,3,diadenosine tetraphosphate metabolic process,BP,
5708,GO:0015966,1,0.954636195103178,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5710,GO:0015985,1,0.785930032430568,0,25,energy coupled proton transport, down electrochemical gradient,BP,
5711,GO:0015986,1,0.785930032430568,0,25,ATP synthesis coupled proton transport,BP,
5712,GO:0015988,1,0.706115246695276,0,27,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5713,GO:0015991,1,0.706115246695276,0,27,ATP hydrolysis coupled proton transport,BP,
5714,GO:0015992,1,0.167630496947792,0,152,proton transport,BP,
5715,GO:0015993,1,0.970781012784781,0,2,molecular hydrogen transport,BP,
5716,GO:0016004,1,0.873082401710501,0,11,phospholipase activator activity,MF,
5717,GO:0016005,1,0.968330846536205,0,2,phospholipase A2 activator activity,MF,
5718,GO:0016010,1,0.737423499701178,0,21,dystrophin-associated glycoprotein complex,CC,
5719,GO:0016011,1,0.907322190186238,0,7,dystroglycan complex,CC,
5720,GO:0016012,1,0.922618110195158,0,6,sarcoglycan complex,CC,
5721,GO:0016013,1,0.94430052418654,0,4,syntrophin complex,CC,
5722,GO:0016015,1,0.913202419942724,0,7,morphogen activity,MF,
5723,GO:0016018,1,0.876580918060891,0,10,cyclosporin A binding,MF,
5724,GO:0016019,1,0.94858523114621,0,5,peptidoglycan receptor activity,MF,
5727,GO:0016024,1,0.841834225786843,0,11,CDP-diacylglycerol biosynthetic process,BP,
5728,GO:0016028,1,0.983447888989373,0,1,rhabdomere,CC,
5729,GO:0016031,1,0.978867852970679,0,2,tRNA import into mitochondrion,BP,
5731,GO:0016034,1,0.990224203500204,0,1,maleylacetoacetate isomerase activity,MF,
5732,GO:0016035,1,0.958912441593456,0,3,zeta DNA polymerase complex,CC,
5733,GO:0016036,1,0.985631043093334,0,1,cellular response to phosphate starvation,BP,
5734,GO:0016037,1,0.98424837989983,0,1,light absorption,BP,
5735,GO:0016038,1,0.98424837989983,0,1,absorption of visible light,BP,
5738,GO:0016045,1,0.840033026219153,0,12,detection of bacterium,BP,
5739,GO:0016046,1,0.983426667501871,0,1,detection of fungus,BP,
5749,GO:0016062,1,0.968793744053204,0,2,adaptation of rhodopsin mediated signaling,BP,
5751,GO:0016068,1,0.971539581992344,0,3,type I hypersensitivity,BP,
5754,GO:0016072,1,0.0410334387629431,0,273,rRNA metabolic process,BP,
5755,GO:0016073,1,0.356007962797385,0,77,snRNA metabolic process,BP,
5756,GO:0016074,1,0.874156070640239,0,13,snoRNA metabolic process,BP,
5757,GO:0016075,1,0.815586523349053,0,15,rRNA catabolic process,BP,
5758,GO:0016077,1,0.983426667501431,0,1,snoRNA catabolic process,BP,
5759,GO:0016078,1,0.961285421445256,0,3,tRNA catabolic process,BP,
5761,GO:0016080,1,0.935373918072387,0,4,synaptic vesicle targeting,BP,
5762,GO:0016081,1,0.881673527751935,0,8,synaptic vesicle docking,BP,
5763,GO:0016082,1,0.81621630398598,0,13,synaptic vesicle priming,BP,
5764,GO:0016093,1,0.902646901118725,0,8,polyprenol metabolic process,BP,
5765,GO:0016094,1,0.967276785912142,0,2,polyprenol biosynthetic process,BP,
5766,GO:0016095,1,0.964512306220588,0,3,polyprenol catabolic process,BP,
5767,GO:0016098,1,0.924209105637511,0,6,monoterpenoid metabolic process,BP,
5769,GO:0016102,1,0.896661151115817,0,8,diterpenoid biosynthetic process,BP,
5770,GO:0016103,1,0.95311281722109,0,4,diterpenoid catabolic process,BP,
5771,GO:0016107,1,0.979719129199316,0,2,sesquiterpenoid catabolic process,BP,
5772,GO:0016108,1,0.984080291479883,0,1,tetraterpenoid metabolic process,BP,
5773,GO:0016114,1,0.873030955816688,0,10,terpenoid biosynthetic process,BP,
5774,GO:0016115,1,0.933779033591159,0,6,terpenoid catabolic process,BP,
5775,GO:0016116,1,0.984080291479883,0,1,carotenoid metabolic process,BP,
5776,GO:0016119,1,0.984080291479883,0,1,carotene metabolic process,BP,
5777,GO:0016121,1,0.984080291479883,0,1,carotene catabolic process,BP,
5778,GO:0016122,1,0.984080291479883,0,1,xanthophyll metabolic process,BP,
5781,GO:0016127,1,0.859883574242085,0,11,sterol catabolic process,BP,
5782,GO:0016128,1,0.960340983265286,0,3,phytosteroid metabolic process,BP,
5783,GO:0016129,1,0.960340983265286,0,3,phytosteroid biosynthetic process,BP,
5784,GO:0016131,1,0.984490228516902,0,1,brassinosteroid metabolic process,BP,
5785,GO:0016132,1,0.984490228516902,0,1,brassinosteroid biosynthetic process,BP,
5786,GO:0016137,1,0.795812914353452,0,18,glycoside metabolic process,BP,
5787,GO:0016139,1,0.892427778096376,0,8,glycoside catabolic process,BP,
5788,GO:0016149,1,0.953571712562051,0,3,translation release factor activity, codon specific,MF,
5789,GO:0016151,1,0.973839569655041,0,2,nickel cation binding,MF,
5790,GO:0016153,1,0.983537609403458,0,1,urocanate hydratase activity,MF,
5791,GO:0016154,1,0.988350460214267,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5792,GO:0016155,1,0.967400024592476,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5793,GO:0016160,1,0.92271420713489,0,6,amylase activity,MF,
5794,GO:0016165,1,0.970086742038924,0,2,linoleate 13S-lipoxygenase activity,MF,
5795,GO:0016167,1,0.957295686087428,0,3,glial cell-derived neurotrophic factor receptor activity,MF,
5796,GO:0016174,1,0.908876864386809,0,6,NAD(P)H oxidase activity,MF,
5797,GO:0016175,1,0.882820669086469,0,9,superoxide-generating NADPH oxidase activity,MF,
5799,GO:0016180,1,0.773855234755118,0,18,snRNA processing,BP,
5800,GO:0016182,1,0.983426667502809,0,1,synaptic vesicle budding from endosome,BP,
5801,GO:0016185,1,0.967310534021583,0,2,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5802,GO:0016188,1,0.875043343171411,0,9,synaptic vesicle maturation,BP,
5803,GO:0016189,1,0.983426667499068,0,1,synaptic vesicle to endosome fusion,BP,
5804,GO:0016191,1,0.922182848413479,0,5,synaptic vesicle uncoating,BP,
5807,GO:0016198,1,0.894315178340166,0,7,axon choice point recognition,BP,
5808,GO:0016199,1,0.921053979977931,0,5,axon midline choice point recognition,BP,
5810,GO:0016203,1,0.983426667499806,0,1,muscle attachment,BP,
5811,GO:0016206,1,0.969661162808918,0,2,catechol O-methyltransferase activity,MF,
5812,GO:0016208,1,0.864309908832172,0,11,AMP binding,MF,
5814,GO:0016211,1,0.967126892154296,0,2,ammonia ligase activity,MF,
5815,GO:0016212,1,0.971039467430014,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5816,GO:0016213,1,0.983692025897521,0,1,linoleoyl-CoA desaturase activity,MF,
5817,GO:0016215,1,0.952536008850477,0,3,acyl-CoA desaturase activity,MF,
5818,GO:0016222,1,0.96899637831225,0,2,procollagen-proline 4-dioxygenase complex,CC,
5819,GO:0016226,1,0.815568912428965,0,18,iron-sulfur cluster assembly,BP,
5820,GO:0016229,1,0.725382384711491,0,27,steroid dehydrogenase activity,MF,
5821,GO:0016230,1,0.973529070244983,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5822,GO:0016231,1,0.983426667502513,0,1,beta-N-acetylglucosaminidase activity,MF,
5823,GO:0016232,1,0.98415468786887,0,1,HNK-1 sulfotransferase activity,MF,
5824,GO:0016233,1,0.532502497953111,0,53,telomere capping,BP,
5825,GO:0016234,1,0.322855951306991,0,75,inclusion body,CC,
5826,GO:0016235,1,0.560240066127774,0,38,aggresome,CC,
5828,GO:0016237,1,0.967133434783566,0,2,lysosomal microautophagy,BP,
5830,GO:0016240,1,0.946930854413617,0,4,autophagosome docking,BP,
5833,GO:0016243,1,0.983426667504532,0,1,regulation of autophagosome size,BP,
5834,GO:0016246,1,0.861015047394018,0,10,RNA interference,BP,
5837,GO:0016250,1,0.984244406719021,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5838,GO:0016254,1,0.820054977740911,0,15,preassembly of GPI anchor in ER membrane,BP,
5839,GO:0016255,1,0.904242631882919,0,7,attachment of GPI anchor to protein,BP,
5840,GO:0016256,1,0.974358395302088,0,2,N-glycan processing to lysosome,BP,
5841,GO:0016259,1,0.956860692291138,0,3,selenocysteine metabolic process,BP,
5842,GO:0016260,1,0.985657794256111,0,1,selenocysteine biosynthetic process,BP,
5843,GO:0016262,1,0.95609566386732,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5844,GO:0016263,1,0.974741488529019,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5847,GO:0016267,1,0.974741488529019,0,2,O-glycan processing, core 1,BP,
5848,GO:0016269,1,0.984913619920026,0,1,O-glycan processing, core 3,BP,
5849,GO:0016272,1,0.945934570909935,0,7,prefoldin complex,CC,
5850,GO:0016273,1,0.850091287237538,0,11,arginine N-methyltransferase activity,MF,
5851,GO:0016274,1,0.850091287237538,0,11,protein-arginine N-methyltransferase activity,MF,
5852,GO:0016277,1,0.98518072135659,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5853,GO:0016278,1,0.515975019194924,0,43,lysine N-methyltransferase activity,MF,
5854,GO:0016279,1,0.523998324818601,0,42,protein-lysine N-methyltransferase activity,MF,
5855,GO:0016281,1,0.878270734405034,0,9,eukaryotic translation initiation factor 4F complex,CC,
5856,GO:0016282,1,0.983426667503104,0,1,eukaryotic 43S preinitiation complex,CC,
5857,GO:0016286,1,0.943081334437466,0,4,small conductance calcium-activated potassium channel activity,MF,
5858,GO:0016287,1,0.984411136523716,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5859,GO:0016289,1,0.784614640588049,0,19,CoA hydrolase activity,MF,
5860,GO:0016290,1,0.882696949612438,0,10,palmitoyl-CoA hydrolase activity,MF,
5861,GO:0016295,1,0.971471088697689,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5862,GO:0016296,1,0.971471088697689,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5863,GO:0016297,1,0.971471088697689,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5865,GO:0016300,1,0.938056733754292,0,4,tRNA (uracil) methyltransferase activity,MF,
5869,GO:0016308,1,0.896747804567272,0,7,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5870,GO:0016309,1,0.95138544752835,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5873,GO:0016312,1,0.938275254700288,0,4,inositol bisphosphate phosphatase activity,MF,
5874,GO:0016314,1,0.955003142861369,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5875,GO:0016316,1,0.967126892152941,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5876,GO:0016320,1,0.974229623246511,0,2,endoplasmic reticulum membrane fusion,BP,
5877,GO:0016321,1,0.955468102960457,0,3,female meiosis chromosome segregation,BP,
5878,GO:0016322,1,0.857911873750402,0,10,neuron remodeling,BP,
5885,GO:0016333,1,0.983949267029538,0,1,morphogenesis of follicular epithelium,BP,
5886,GO:0016334,1,0.983949267029538,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5890,GO:0016340,1,0.967126892150764,0,2,calcium-dependent cell-matrix adhesion,BP,
5892,GO:0016344,1,0.951987151437172,0,3,meiotic chromosome movement towards spindle pole,BP,
5895,GO:0016362,1,0.967126892139199,0,2,activin receptor activity, type II,MF,
5897,GO:0016401,1,0.972608211100136,0,2,palmitoyl-CoA oxidase activity,MF,
5898,GO:0016402,1,0.955466003829635,0,3,pristanoyl-CoA oxidase activity,MF,
5899,GO:0016403,1,0.973848907528863,0,2,dimethylargininase activity,MF,
5900,GO:0016404,1,0.967950797764222,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5901,GO:0016405,1,0.828601895574316,0,13,CoA-ligase activity,MF,
5902,GO:0016406,1,0.907342729022112,0,6,carnitine O-acyltransferase activity,MF,
5903,GO:0016407,1,0.247163828437901,0,99,acetyltransferase activity,MF,
5904,GO:0016408,1,0.767267785355501,0,19,C-acyltransferase activity,MF,
5905,GO:0016409,1,0.574170951599596,0,37,palmitoyltransferase activity,MF,
5908,GO:0016412,1,0.988355825254821,0,1,serine O-acyltransferase activity,MF,
5909,GO:0016413,1,0.905122578674967,0,7,O-acetyltransferase activity,MF,
5910,GO:0016414,1,0.98361191421251,0,1,O-octanoyltransferase activity,MF,
5911,GO:0016415,1,0.976482191402967,0,2,octanoyltransferase activity,MF,
5912,GO:0016416,1,0.921794576949664,0,5,O-palmitoyltransferase activity,MF,
5913,GO:0016417,1,0.64269044432051,0,30,S-acyltransferase activity,MF,
5914,GO:0016418,1,0.967126892150763,0,2,S-acetyltransferase activity,MF,
5915,GO:0016419,1,0.9705709900761,0,2,S-malonyltransferase activity,MF,
5916,GO:0016420,1,0.9705709900761,0,2,malonyltransferase activity,MF,
5917,GO:0016421,1,0.911020884752567,0,6,CoA carboxylase activity,MF,
5918,GO:0016422,1,0.973289550552576,0,2,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5919,GO:0016423,1,0.854528779534046,0,11,tRNA (guanine) methyltransferase activity,MF,
5920,GO:0016426,1,0.956416024381223,0,3,tRNA (adenine) methyltransferase activity,MF,
5921,GO:0016427,1,0.903775737848703,0,7,tRNA (cytosine) methyltransferase activity,MF,
5922,GO:0016428,1,0.943167720500704,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5923,GO:0016429,1,0.956416024381223,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5924,GO:0016433,1,0.922476346532975,0,6,rRNA (adenine) methyltransferase activity,MF,
5925,GO:0016434,1,0.968060307545044,0,2,rRNA (cytosine) methyltransferase activity,MF,
5926,GO:0016435,1,0.971109003510465,0,2,rRNA (guanine) methyltransferase activity,MF,
5928,GO:0016442,1,0.855885957182916,0,10,RISC complex,CC,
5931,GO:0016446,1,0.845761216470266,0,11,somatic hypermutation of immunoglobulin genes,BP,
5933,GO:0016453,1,0.948648378142228,0,4,C-acetyltransferase activity,MF,
5934,GO:0016454,1,0.925848536873688,0,5,C-palmitoyltransferase activity,MF,
5940,GO:0016469,1,0.620081360641176,0,46,proton-transporting two-sector ATPase complex,CC,
5941,GO:0016471,1,0.818241397666118,0,16,vacuolar proton-transporting V-type ATPase complex,CC,
5942,GO:0016476,1,0.953710162889107,0,3,regulation of embryonic cell shape,BP,
5944,GO:0016479,1,0.941192517919808,0,4,negative regulation of transcription from RNA polymerase I promoter,BP,
5948,GO:0016486,1,0.661998415431382,0,32,peptide hormone processing,BP,
5949,GO:0016487,1,0.979719129199316,0,2,farnesol metabolic process,BP,
5950,GO:0016488,1,0.979719129199316,0,2,farnesol catabolic process,BP,
5952,GO:0016492,1,0.972263787810345,0,2,G-protein coupled neurotensin receptor activity,MF,
5953,GO:0016493,1,0.859595159153164,0,11,C-C chemokine receptor activity,MF,
5954,GO:0016494,1,0.90707771515705,0,7,C-X-C chemokine receptor activity,MF,
5955,GO:0016495,1,0.983670184455431,0,1,C-X3-C chemokine receptor activity,MF,
5956,GO:0016496,1,0.983610444648156,0,1,substance P receptor activity,MF,
5957,GO:0016497,1,0.985143265969194,0,1,substance K receptor activity,MF,
5958,GO:0016499,1,0.974396724140547,0,2,orexin receptor activity,MF,
5959,GO:0016500,1,0.847109831302889,0,11,protein-hormone receptor activity,MF,
5960,GO:0016501,1,0.986347105636772,0,1,prostacyclin receptor activity,MF,
5961,GO:0016502,1,0.748185709731323,0,21,nucleotide receptor activity,MF,
5962,GO:0016503,1,0.966364118762983,0,4,pheromone receptor activity,MF,
5963,GO:0016504,1,0.614385995543339,0,36,peptidase activator activity,MF,
5964,GO:0016505,1,0.786243808425187,0,18,peptidase activator activity involved in apoptotic process,MF,
5965,GO:0016507,1,0.983802975266754,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5966,GO:0016508,1,0.95241095577193,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5967,GO:0016509,1,0.95515675622539,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5968,GO:0016514,1,0.802238609393344,0,15,SWI/SNF complex,CC,
5969,GO:0016517,1,0.986758819011907,0,1,interleukin-12 receptor activity,MF,
5970,GO:0016519,1,0.986556949449043,0,1,gastric inhibitory peptide receptor activity,MF,
5971,GO:0016520,1,0.957569200147684,0,4,growth hormone-releasing hormone receptor activity,MF,
5972,GO:0016521,1,0.983678680603845,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5976,GO:0016530,1,0.953441292002796,0,5,metallochaperone activity,MF,
5977,GO:0016531,1,0.969511382317938,0,4,copper chaperone activity,MF,
5978,GO:0016532,1,0.976456704383982,0,2,superoxide dismutase copper chaperone activity,MF,
5979,GO:0016533,1,0.960344132407685,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5980,GO:0016534,1,0.968642089285902,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5982,GO:0016539,1,0.975384206121925,0,2,intein-mediated protein splicing,BP,
5983,GO:0016540,1,0.847230988671434,0,11,protein autoprocessing,BP,
5984,GO:0016553,1,0.868629660975904,0,10,base conversion or substitution editing,BP,
5985,GO:0016554,1,0.952109167983332,0,4,cytidine to uridine editing,BP,
5986,GO:0016556,1,0.85310719041419,0,12,mRNA modification,BP,
5987,GO:0016557,1,0.963469558585082,0,3,peroxisome membrane biogenesis,BP,
5988,GO:0016558,1,0.834216419346595,0,12,protein import into peroxisome matrix,BP,
5989,GO:0016559,1,0.899397043766819,0,9,peroxisome fission,BP,
5990,GO:0016560,1,0.95136165920618,0,3,protein import into peroxisome matrix, docking,BP,
5991,GO:0016561,1,0.97071552814311,0,2,protein import into peroxisome matrix, translocation,BP,
5995,GO:0016571,1,0.16027483348148,0,121,histone methylation,BP,
5996,GO:0016572,1,0.603919018032598,0,34,histone phosphorylation,BP,
5998,GO:0016574,1,0.552234131464984,0,39,histone ubiquitination,BP,
6000,GO:0016576,1,0.911240103164657,0,6,histone dephosphorylation,BP,
6001,GO:0016577,1,0.650337343267367,0,26,histone demethylation,BP,
6002,GO:0016578,1,0.729545104621435,0,21,histone deubiquitination,BP,
6005,GO:0016581,1,0.764593789868387,0,17,NuRD complex,CC,
6006,GO:0016584,1,0.914161479367693,0,8,nucleosome positioning,BP,
6007,GO:0016586,1,0.983426667503104,0,1,RSC complex,CC,
6008,GO:0016589,1,0.902419891129045,0,7,NURF complex,CC,
6009,GO:0016590,1,0.983426667501479,0,1,ACF complex,CC,
6010,GO:0016591,1,0.250537917215817,0,100,DNA-directed RNA polymerase II, holoenzyme,CC,
6011,GO:0016592,1,0.617943043535656,0,35,mediator complex,CC,
6012,GO:0016593,1,0.901432880658638,0,7,Cdc73/Paf1 complex,CC,
6014,GO:0016595,1,0.864105661997524,0,9,glutamate binding,MF,
6015,GO:0016596,1,0.984728932554734,0,1,thienylcyclohexylpiperidine binding,MF,
6017,GO:0016598,1,0.973472128720716,0,2,protein arginylation,BP,
6019,GO:0016601,1,0.625933570530082,0,30,Rac protein signal transduction,BP,
6020,GO:0016602,1,0.9460038959469,0,4,CCAAT-binding factor complex,CC,
6021,GO:0016603,1,0.97431287103078,0,2,glutaminyl-peptide cyclotransferase activity,MF,
6025,GO:0016608,1,0.990982527610916,0,2,growth hormone-releasing hormone activity,MF,
6027,GO:0016615,1,0.899639269424944,0,8,malate dehydrogenase activity,MF,
6029,GO:0016618,1,0.990850180449793,0,1,hydroxypyruvate reductase activity,MF,
6030,GO:0016620,1,0.598979207051974,0,35,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
6031,GO:0016623,1,0.95780762040993,0,3,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
6032,GO:0016624,1,0.890713509025492,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
6033,GO:0016627,1,0.461576174997355,0,56,oxidoreductase activity, acting on the CH-CH group of donors,MF,
6034,GO:0016628,1,0.721040154853245,0,25,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
6035,GO:0016634,1,0.875270858858304,0,9,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
6036,GO:0016635,1,0.953936427864446,0,4,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
6038,GO:0016639,1,0.95946510931853,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
6039,GO:0016641,1,0.806330248310765,0,14,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
6041,GO:0016645,1,0.696343705769949,0,25,oxidoreductase activity, acting on the CH-NH group of donors,MF,
6042,GO:0016646,1,0.793882329816097,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
6043,GO:0016647,1,0.960226718175784,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
6044,GO:0016649,1,0.969198626545951,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
6045,GO:0016651,1,0.348598929139642,0,98,oxidoreductase activity, acting on NAD(P)H,MF,
6046,GO:0016652,1,0.975440043649722,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
6047,GO:0016653,1,0.834277460982804,0,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
6048,GO:0016655,1,0.655218969164939,0,51,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
6049,GO:0016657,1,0.976525761289239,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
6050,GO:0016661,1,0.930956282239103,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
6051,GO:0016662,1,0.984620385657398,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
6053,GO:0016668,1,0.835481110936471,0,15,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
6054,GO:0016670,1,0.894615788781741,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
6055,GO:0016671,1,0.8832519161539,0,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
6056,GO:0016672,1,0.983335041160537,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
6057,GO:0016675,1,0.822667601082889,0,27,oxidoreductase activity, acting on a heme group of donors,MF,
6058,GO:0016676,1,0.835316849266878,0,26,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
6059,GO:0016679,1,0.914506369634858,0,9,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
6060,GO:0016681,1,0.928811795588781,0,8,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
6062,GO:0016701,1,0.710236932101708,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
6063,GO:0016702,1,0.717717600567738,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
6064,GO:0016705,1,0.115445256501153,0,146,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
6065,GO:0016706,1,0.531705313946962,0,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
6066,GO:0016708,1,0.971987106761174,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6067,GO:0016709,1,0.598742823299258,0,35,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6068,GO:0016711,1,0.984602838154034,0,1,flavonoid 3'-monooxygenase activity,MF,
6069,GO:0016712,1,0.703152069944154,0,25,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6070,GO:0016713,1,0.903597277565004,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
6071,GO:0016714,1,0.91039048594775,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
6072,GO:0016715,1,0.936483686597596,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
6073,GO:0016716,1,0.97068835099894,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen,MF,
6074,GO:0016717,1,0.936746160683543,0,4,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
6075,GO:0016721,1,0.952154459439602,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6076,GO:0016722,1,0.7954380122663,0,15,oxidoreductase activity, oxidizing metal ions,MF,
6077,GO:0016723,1,0.876848964594639,0,8,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
6078,GO:0016724,1,0.920703884472998,0,6,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6079,GO:0016725,1,0.855530881552322,0,10,oxidoreductase activity, acting on CH or CH2 groups,MF,
6080,GO:0016726,1,0.967126892153423,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
6081,GO:0016727,1,0.983426667501771,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6082,GO:0016728,1,0.951426103240089,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6083,GO:0016730,1,0.987160786174616,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6084,GO:0016731,1,0.987160786174616,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6087,GO:0016742,1,0.885280765006693,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6088,GO:0016743,1,0.972022301699433,0,2,carboxyl- or carbamoyltransferase activity,MF,
6089,GO:0016744,1,0.946840366692566,0,4,transferase activity, transferring aldehyde or ketonic groups,MF,
6092,GO:0016748,1,0.956696625310287,0,3,succinyltransferase activity,MF,
6093,GO:0016749,1,0.972164988682604,0,2,N-succinyltransferase activity,MF,
6094,GO:0016751,1,0.984090593450433,0,1,S-succinyltransferase activity,MF,
6095,GO:0016755,1,0.740262028697379,0,22,transferase activity, transferring amino-acyl groups,MF,
6098,GO:0016763,1,0.522307123515588,0,47,transferase activity, transferring pentosyl groups,MF,
6099,GO:0016765,1,0.538586467610314,0,53,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6100,GO:0016768,1,0.988180300044407,0,1,spermine synthase activity,MF,
6101,GO:0016769,1,0.764283576421677,0,19,transferase activity, transferring nitrogenous groups,MF,
6104,GO:0016774,1,0.957678822648641,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6106,GO:0016776,1,0.580803211735756,0,39,phosphotransferase activity, phosphate group as acceptor,MF,
6107,GO:0016778,1,0.923087506619946,0,6,diphosphotransferase activity,MF,
6108,GO:0016779,1,0.175779761695294,0,122,nucleotidyltransferase activity,MF,
6109,GO:0016780,1,0.771541088466826,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6110,GO:0016781,1,0.970500340277343,0,2,phosphotransferase activity, paired acceptors,MF,
6111,GO:0016782,1,0.387694181332472,0,69,transferase activity, transferring sulfur-containing groups,MF,
6112,GO:0016783,1,0.873753879825009,0,11,sulfurtransferase activity,MF,
6113,GO:0016784,1,0.989399199546474,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6114,GO:0016785,1,0.983426667501871,0,1,transferase activity, transferring selenium-containing groups,MF,
6117,GO:0016790,1,0.687336005088175,0,29,thiolester hydrolase activity,MF,
6119,GO:0016793,1,0.983652926593764,0,1,triphosphoric monoester hydrolase activity,MF,
6120,GO:0016794,1,0.9921578435965,0,1,diphosphoric monoester hydrolase activity,MF,
6121,GO:0016796,1,0.496378548726438,0,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6122,GO:0016798,1,0.210309740947229,0,113,hydrolase activity, acting on glycosyl bonds,MF,
6123,GO:0016799,1,0.755299043274858,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6124,GO:0016801,1,0.884823906094175,0,9,hydrolase activity, acting on ether bonds,MF,
6125,GO:0016802,1,0.985551825213358,0,1,trialkylsulfonium hydrolase activity,MF,
6126,GO:0016803,1,0.897801256233384,0,8,ether hydrolase activity,MF,
6130,GO:0016812,1,0.909621278115618,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6131,GO:0016813,1,0.85705663751067,0,11,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6132,GO:0016814,1,0.632489060782074,0,33,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6133,GO:0016815,1,0.99006355571529,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6136,GO:0016820,1,0.199183451447959,0,111,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,MF,
6137,GO:0016822,1,0.967444128344265,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6138,GO:0016823,1,0.967444128344265,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6139,GO:0016826,1,0.984244406719021,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6141,GO:0016830,1,0.522511096464733,0,46,carbon-carbon lyase activity,MF,
6142,GO:0016831,1,0.631447081743005,0,32,carboxy-lyase activity,MF,
6143,GO:0016832,1,0.883222869005461,0,9,aldehyde-lyase activity,MF,
6144,GO:0016833,1,0.948716130662819,0,4,oxo-acid-lyase activity,MF,
6145,GO:0016835,1,0.446773092256451,0,62,carbon-oxygen lyase activity,MF,
6146,GO:0016836,1,0.571371024321321,0,43,hydro-lyase activity,MF,
6147,GO:0016838,1,0.992913066894507,0,1,carbon-oxygen lyase activity, acting on phosphates,MF,
6148,GO:0016840,1,0.884862539935511,0,9,carbon-nitrogen lyase activity,MF,
6149,GO:0016841,1,0.935978937044319,0,5,ammonia-lyase activity,MF,
6150,GO:0016842,1,0.96006549753261,0,3,amidine-lyase activity,MF,
6151,GO:0016843,1,0.984728932554734,0,1,amine-lyase activity,MF,
6152,GO:0016844,1,0.984728932554734,0,1,strictosidine synthase activity,MF,
6153,GO:0016846,1,0.927349588320924,0,7,carbon-sulfur lyase activity,MF,
6156,GO:0016854,1,0.833710881849294,0,13,racemase and epimerase activity,MF,
6157,GO:0016855,1,0.984951089777405,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6158,GO:0016857,1,0.874463699998013,0,9,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6159,GO:0016859,1,0.634461499832117,0,40,cis-trans isomerase activity,MF,
6161,GO:0016861,1,0.903385183037973,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6162,GO:0016862,1,0.995641439960648,0,1,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6163,GO:0016863,1,0.873200543733826,0,12,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6164,GO:0016864,1,0.761910420757886,0,18,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6165,GO:0016866,1,0.70263472199153,0,26,intramolecular transferase activity,MF,
6166,GO:0016868,1,0.878578244772377,0,10,intramolecular transferase activity, phosphotransferases,MF,
6167,GO:0016872,1,0.985654217471866,0,1,intramolecular lyase activity,MF,
6169,GO:0016875,1,0.517672216765984,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6170,GO:0016876,1,0.517672216765984,0,44,ligase activity, forming aminoacyl-tRNA and related compounds,MF,
6173,GO:0016879,1,0.495004135259543,0,47,ligase activity, forming carbon-nitrogen bonds,MF,
6174,GO:0016880,1,0.967126892154296,0,2,acid-ammonia (or amide) ligase activity,MF,
6175,GO:0016881,1,0.773888769897802,0,17,acid-amino acid ligase activity,MF,
6176,GO:0016882,1,0.976886273689813,0,2,cyclo-ligase activity,MF,
6177,GO:0016884,1,0.878013717486492,0,9,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6178,GO:0016885,1,0.883476410793285,0,8,ligase activity, forming carbon-carbon bonds,MF,
6179,GO:0016886,1,0.883966724922542,0,8,ligase activity, forming phosphoric ester bonds,MF,
6181,GO:0016888,1,0.861523320670194,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6182,GO:0016889,1,0.852782896575388,0,12,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6183,GO:0016890,1,0.972905874589245,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6184,GO:0016891,1,0.71033176708017,0,26,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6185,GO:0016892,1,0.912783082278966,0,9,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6186,GO:0016893,1,0.630359700295663,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6187,GO:0016894,1,0.778358711348155,0,21,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6188,GO:0016895,1,0.761086620514641,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6189,GO:0016896,1,0.647779649533116,0,30,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6190,GO:0016898,1,0.971391855013652,0,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6191,GO:0016899,1,0.960582566833051,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6192,GO:0016900,1,0.984405619285115,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6193,GO:0016901,1,0.92224322909353,0,5,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6194,GO:0016903,1,0.525089621386704,0,44,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6195,GO:0016907,1,0.928721574613832,0,5,G-protein coupled acetylcholine receptor activity,MF,
6196,GO:0016909,1,0.957189368071865,0,3,SAP kinase activity,MF,
6197,GO:0016913,1,0.987067917345448,0,1,follicle-stimulating hormone activity,MF,
6198,GO:0016917,1,0.712628381169242,0,22,GABA receptor activity,MF,
6199,GO:0016918,1,0.87365161599168,0,13,retinal binding,MF,
6200,GO:0016920,1,0.98342666750015,0,1,pyroglutamyl-peptidase activity,MF,
6201,GO:0016922,1,0.722007990567163,0,21,ligand-dependent nuclear receptor binding,MF,
6202,GO:0016925,1,0.267018368504585,0,88,protein sumoylation,BP,
6203,GO:0016926,1,0.895525804922186,0,7,protein desumoylation,BP,
6204,GO:0016929,1,0.895525804922186,0,7,SUMO-specific protease activity,MF,
6205,GO:0016933,1,0.928369189740207,0,5,extracellular-glycine-gated ion channel activity,MF,
6206,GO:0016934,1,0.928369189740207,0,5,extracellular-glycine-gated chloride channel activity,MF,
6207,GO:0016935,1,0.967527509524849,0,2,glycine-gated chloride channel complex,CC,
6209,GO:0016938,1,0.983931810110493,0,1,kinesin I complex,CC,
6210,GO:0016939,1,0.951509074339794,0,3,kinesin II complex,CC,
6212,GO:0016942,1,0.932353479649355,0,5,insulin-like growth factor binding protein complex,CC,
6213,GO:0016964,1,0.983426667491784,0,1,alpha-2 macroglobulin receptor activity,MF,
6214,GO:0016971,1,0.953275757529369,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6215,GO:0016972,1,0.937473696887165,0,4,thiol oxidase activity,MF,
6216,GO:0016973,1,0.816335088641129,0,14,poly(A)+ mRNA export from nucleus,BP,
6217,GO:0016979,1,0.978157735511321,0,2,lipoate-protein ligase activity,MF,
6218,GO:0016990,1,0.985607998290606,0,1,arginine deiminase activity,MF,
6219,GO:0016992,1,0.988272990670061,0,1,lipoate synthase activity,MF,
6220,GO:0016997,1,0.920840726365491,0,6,alpha-sialidase activity,MF,
6221,GO:0016998,1,0.979736021502245,0,3,cell wall macromolecule catabolic process,BP,
6222,GO:0016999,1,0.971781343481545,0,2,antibiotic metabolic process,BP,
6224,GO:0017003,1,0.985565794756864,0,1,protein-heme linkage,BP,
6225,GO:0017004,1,0.715656252719465,0,26,cytochrome complex assembly,BP,
6226,GO:0017005,1,0.983447031998769,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6227,GO:0017006,1,0.985565794756864,0,1,protein-tetrapyrrole linkage,BP,
6228,GO:0017014,1,0.848230277270657,0,12,protein nitrosylation,BP,
6232,GO:0017018,1,0.935330099170045,0,4,myosin phosphatase activity,MF,
6233,GO:0017020,1,0.984064199029079,0,1,myosin phosphatase regulator activity,MF,
6235,GO:0017024,1,0.993188209414577,0,1,myosin I binding,MF,
6236,GO:0017025,1,0.728908259478731,0,23,TBP-class protein binding,MF,
6237,GO:0017034,1,0.923479300886909,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6239,GO:0017040,1,0.931285544887769,0,5,ceramidase activity,MF,
6240,GO:0017042,1,0.971846227632907,0,2,glycosylceramidase activity,MF,
6241,GO:0017045,1,0.990613638837093,0,1,corticotropin-releasing hormone activity,MF,
6244,GO:0017049,1,0.788073629148073,0,16,GTP-Rho binding,MF,
6245,GO:0017050,1,0.971435221395133,0,2,D-erythro-sphingosine kinase activity,MF,
6247,GO:0017055,1,0.968885421602751,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6248,GO:0017056,1,0.741506899822201,0,19,structural constituent of nuclear pore,MF,
6249,GO:0017057,1,0.975781221236497,0,2,6-phosphogluconolactonase activity,MF,
6250,GO:0017059,1,0.891701927306572,0,8,serine C-palmitoyltransferase complex,CC,
6251,GO:0017060,1,0.957013163183837,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6252,GO:0017061,1,0.983426667502708,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6253,GO:0017062,1,0.940294263452486,0,5,respiratory chain complex III assembly,BP,
6254,GO:0017064,1,0.973070146587998,0,2,fatty acid amide hydrolase activity,MF,
6255,GO:0017065,1,0.988855916797976,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6256,GO:0017069,1,0.658699392281577,0,33,snRNA binding,MF,
6257,GO:0017070,1,0.897392837802865,0,9,U6 snRNA binding,MF,
6258,GO:0017071,1,0.98344514914827,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6259,GO:0017075,1,0.741286655130861,0,19,syntaxin-1 binding,MF,
6261,GO:0017077,1,0.966648488924733,0,3,oxidative phosphorylation uncoupler activity,MF,
6262,GO:0017080,1,0.614410024294442,0,36,sodium channel regulator activity,MF,
6264,GO:0017084,1,0.983492511859743,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6265,GO:0017085,1,0.864147160043258,0,10,response to insecticide,BP,
6266,GO:0017089,1,0.964817371804941,0,3,glycolipid transporter activity,MF,
6267,GO:0017090,1,0.983952953813746,0,1,meprin A complex,CC,
6268,GO:0017091,1,0.7161172606867,0,23,AU-rich element binding,MF,
6269,GO:0017095,1,0.951096260231915,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6270,GO:0017096,1,0.990224203500204,0,1,acetylserotonin O-methyltransferase activity,MF,
6271,GO:0017098,1,0.970255997593542,0,2,sulfonylurea receptor binding,MF,
6272,GO:0017099,1,0.974905281279154,0,2,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6273,GO:0017101,1,0.848156799460763,0,11,aminoacyl-tRNA synthetase multienzyme complex,CC,
6274,GO:0017102,1,0.968636926329002,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6275,GO:0017108,1,0.911504252426997,0,6,5'-flap endonuclease activity,MF,
6276,GO:0017109,1,0.967477941780756,0,2,glutamate-cysteine ligase complex,CC,
6277,GO:0017110,1,0.832277672880525,0,13,nucleoside-diphosphatase activity,MF,
6280,GO:0017113,1,0.983721116157046,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6281,GO:0017116,1,0.968260817315296,0,2,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6282,GO:0017119,1,0.81797208121377,0,13,Golgi transport complex,CC,
6283,GO:0017121,1,0.837162258284717,0,12,phospholipid scrambling,BP,
6285,GO:0017125,1,0.983426667502908,0,1,deoxycytidyl transferase activity,MF,
6286,GO:0017126,1,0.983426667502267,0,1,nucleologenesis,BP,
6287,GO:0017127,1,0.798130767120114,0,17,cholesterol transporter activity,MF,
6288,GO:0017128,1,0.86308331409285,0,10,phospholipid scramblase activity,MF,
6289,GO:0017129,1,0.971629449065549,0,2,triglyceride binding,MF,
6290,GO:0017133,1,0.985341599334663,0,1,mitochondrial electron transfer flavoprotein complex,CC,
6291,GO:0017134,1,0.719931639318396,0,23,fibroblast growth factor binding,MF,
6292,GO:0017136,1,0.798136770740941,0,15,NAD-dependent histone deacetylase activity,MF,
6294,GO:0017143,1,0.969296578232798,0,2,insecticide metabolic process,BP,
6295,GO:0017144,1,0.641402477144036,0,32,drug metabolic process,BP,
6297,GO:0017146,1,0.846207980838221,0,10,NMDA selective glutamate receptor complex,CC,
6300,GO:0017150,1,0.961352748628139,0,3,tRNA dihydrouridine synthase activity,MF,
6301,GO:0017151,1,0.883494236336638,0,8,DEAD/H-box RNA helicase binding,MF,
6302,GO:0017153,1,0.952911242147882,0,3,sodium:dicarboxylate symporter activity,MF,
6303,GO:0017154,1,0.833377898615123,0,11,semaphorin receptor activity,MF,
6307,GO:0017159,1,0.970449355566324,0,2,pantetheine hydrolase activity,MF,
6308,GO:0017160,1,0.82524353196339,0,13,Ral GTPase binding,MF,
6309,GO:0017161,1,0.967126892152941,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6310,GO:0017162,1,0.872320426643044,0,9,aryl hydrocarbon receptor binding,MF,
6311,GO:0017166,1,0.861405014896688,0,9,vinculin binding,MF,
6312,GO:0017168,1,0.983426667503345,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6313,GO:0017169,1,0.911642930091364,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6315,GO:0017172,1,0.988616710030069,0,1,cysteine dioxygenase activity,MF,
6316,GO:0017174,1,0.991980865352406,0,1,glycine N-methyltransferase activity,MF,
6317,GO:0017176,1,0.941052820716324,0,5,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6318,GO:0017177,1,0.983427104125773,0,1,glucosidase II complex,CC,
6319,GO:0017182,1,0.913825929780331,0,6,peptidyl-diphthamide metabolic process,BP,
6320,GO:0017183,1,0.913825929780331,0,6,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6321,GO:0017185,1,0.936182045973487,0,4,peptidyl-lysine hydroxylation,BP,
6322,GO:0017186,1,0.97431287103078,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6323,GO:0017187,1,0.875485243749149,0,11,peptidyl-glutamic acid carboxylation,BP,
6324,GO:0017188,1,0.983426667501626,0,1,aspartate N-acetyltransferase activity,MF,
6325,GO:0017196,1,0.917440378524334,0,6,N-terminal peptidyl-methionine acetylation,BP,
6326,GO:0017198,1,0.982505536016954,0,2,N-terminal peptidyl-serine acetylation,BP,
6327,GO:0018002,1,0.982505536016954,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6328,GO:0018003,1,0.985677354965363,0,2,peptidyl-lysine N6-acetylation,BP,
6330,GO:0018009,1,0.986132882680505,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6331,GO:0018011,1,0.984728932554734,0,1,N-terminal peptidyl-alanine methylation,BP,
6332,GO:0018012,1,0.984728932554734,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6333,GO:0018013,1,0.984728932554734,0,1,N-terminal peptidyl-glycine methylation,BP,
6334,GO:0018016,1,0.984728932554734,0,1,N-terminal peptidyl-proline dimethylation,BP,
6335,GO:0018022,1,0.212424957145337,0,102,peptidyl-lysine methylation,BP,
6336,GO:0018023,1,0.627719247891576,0,32,peptidyl-lysine trimethylation,BP,
6337,GO:0018024,1,0.583955414271119,0,35,histone-lysine N-methyltransferase activity,MF,
6338,GO:0018025,1,0.984728932554734,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6339,GO:0018026,1,0.914656657153738,0,6,peptidyl-lysine monomethylation,BP,
6340,GO:0018027,1,0.801377143277392,0,15,peptidyl-lysine dimethylation,BP,
6341,GO:0018032,1,0.983435827084472,0,1,protein amidation,BP,
6342,GO:0018057,1,0.98371712039167,0,1,peptidyl-lysine oxidation,BP,
6343,GO:0018063,1,0.985565794756864,0,1,cytochrome c-heme linkage,BP,
6344,GO:0018065,1,0.923050293435343,0,8,protein-cofactor linkage,BP,
6345,GO:0018076,1,0.935330099163821,0,4,N-terminal peptidyl-lysine acetylation,BP,
6346,GO:0018094,1,0.98351865326559,0,1,protein polyglycylation,BP,
6347,GO:0018095,1,0.882175836836369,0,8,protein polyglutamylation,BP,
6348,GO:0018101,1,0.923864593654315,0,5,protein citrullination,BP,
6349,GO:0018103,1,0.93205746117396,0,5,protein C-linked glycosylation,BP,
6351,GO:0018106,1,0.994370697511255,0,1,peptidyl-histidine phosphorylation,BP,
6354,GO:0018114,1,0.984951089777405,0,1,threonine racemase activity,MF,
6355,GO:0018117,1,0.988415030534275,0,1,protein adenylylation,BP,
6356,GO:0018119,1,0.848230277270657,0,12,peptidyl-cysteine S-nitrosylation,BP,
6358,GO:0018126,1,0.766983871778528,0,17,protein hydroxylation,BP,
6361,GO:0018149,1,0.554977291735417,0,59,peptide cross-linking,BP,
6362,GO:0018153,1,0.970377368876202,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6363,GO:0018158,1,0.904273981966786,0,9,protein oxidation,BP,
6364,GO:0018160,1,0.989431541561524,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6365,GO:0018169,1,0.98911166306213,0,1,ribosomal S6-glutamic acid ligase activity,MF,
6366,GO:0018171,1,0.965595900112714,0,3,peptidyl-cysteine oxidation,BP,
6367,GO:0018175,1,0.988415030534275,0,1,protein nucleotidylation,BP,
6368,GO:0018190,1,0.988355825254821,0,1,protein octanoylation,BP,
6369,GO:0018191,1,0.988355825254821,0,1,peptidyl-serine octanoylation,BP,
6370,GO:0018192,1,0.98502761782828,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6372,GO:0018194,1,0.984728932554734,0,1,peptidyl-alanine modification,BP,
6373,GO:0018195,1,0.719723054289745,0,23,peptidyl-arginine modification,BP,
6374,GO:0018196,1,0.555177658923276,0,44,peptidyl-asparagine modification,BP,
6375,GO:0018197,1,0.951117990263639,0,3,peptidyl-aspartic acid modification,BP,
6377,GO:0018199,1,0.945448090613443,0,4,peptidyl-glutamine modification,BP,
6378,GO:0018200,1,0.656623182779317,0,30,peptidyl-glutamic acid modification,BP,
6380,GO:0018202,1,0.893614009876246,0,8,peptidyl-histidine modification,BP,
6382,GO:0018206,1,0.857842917836934,0,12,peptidyl-methionine modification,BP,
6383,GO:0018208,1,0.542721454621236,0,50,peptidyl-proline modification,BP,
6386,GO:0018211,1,0.93205746117396,0,5,peptidyl-tryptophan modification,BP,
6388,GO:0018214,1,0.875485243749149,0,11,protein carboxylation,BP,
6389,GO:0018216,1,0.800258427920167,0,15,peptidyl-arginine methylation,BP,
6390,GO:0018217,1,0.983426667504532,0,1,peptidyl-aspartic acid phosphorylation,BP,
6391,GO:0018230,1,0.90954172909831,0,6,peptidyl-L-cysteine S-palmitoylation,BP,
6392,GO:0018231,1,0.90954172909831,0,6,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6393,GO:0018242,1,0.936732848166846,0,4,protein O-linked glycosylation via serine,BP,
6394,GO:0018243,1,0.936349779291987,0,4,protein O-linked glycosylation via threonine,BP,
6395,GO:0018262,1,0.970377368876202,0,2,isopeptide cross-linking,BP,
6396,GO:0018271,1,0.983426667501431,0,1,biotin-protein ligase activity,MF,
6397,GO:0018272,1,0.987912661362616,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6398,GO:0018277,1,0.9689839699157,0,2,protein deamination,BP,
6399,GO:0018279,1,0.564556254264801,0,43,protein N-linked glycosylation via asparagine,BP,
6400,GO:0018282,1,0.968930150174413,0,2,metal incorporation into metallo-sulfur cluster,BP,
6401,GO:0018283,1,0.968930150174413,0,2,iron incorporation into metallo-sulfur cluster,BP,
6402,GO:0018293,1,0.991063673398296,0,1,protein-FAD linkage,BP,
6403,GO:0018298,1,0.844779110664664,0,13,protein-chromophore linkage,BP,
6404,GO:0018307,1,0.978046355030211,0,2,enzyme active site formation,BP,
6405,GO:0018312,1,0.970894196823074,0,2,peptidyl-serine ADP-ribosylation,BP,
6406,GO:0018315,1,0.983426667503251,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6407,GO:0018317,1,0.93205746117396,0,5,protein C-linked glycosylation via tryptophan,BP,
6408,GO:0018323,1,0.992913066894507,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6409,GO:0018342,1,0.861500239529117,0,10,protein prenylation,BP,
6410,GO:0018343,1,0.957612172707025,0,3,protein farnesylation,BP,
6411,GO:0018344,1,0.904445937820605,0,7,protein geranylgeranylation,BP,
6412,GO:0018345,1,0.695625838143083,0,24,protein palmitoylation,BP,
6413,GO:0018350,1,0.985224985248713,0,1,protein esterification,BP,
6414,GO:0018352,1,0.973379021573782,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6415,GO:0018364,1,0.98685736547417,0,2,peptidyl-glutamine methylation,BP,
6419,GO:0018395,1,0.983450982062668,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6420,GO:0018400,1,0.983426667500693,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6421,GO:0018401,1,0.925074252201394,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6422,GO:0018406,1,0.93205746117396,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6424,GO:0018423,1,0.990509139728495,0,1,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6425,GO:0018444,1,0.967800441136647,0,2,translation release factor complex,CC,
6426,GO:0018455,1,0.990594593324392,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6427,GO:0018467,1,0.984515054534747,0,1,formaldehyde dehydrogenase activity,MF,
6428,GO:0018478,1,0.985942385253858,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6429,GO:0018479,1,0.97415582822672,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6430,GO:0018585,1,0.986028954454859,0,1,fluorene oxygenase activity,MF,
6431,GO:0018636,1,0.970466136816908,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6432,GO:0018675,1,0.976845725182526,0,2,(S)-limonene 6-monooxygenase activity,MF,
6433,GO:0018676,1,0.976845725182526,0,2,(S)-limonene 7-monooxygenase activity,MF,
6434,GO:0018685,1,0.946216639526074,0,4,alkane 1-monooxygenase activity,MF,
6435,GO:0018733,1,0.991148416031784,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6436,GO:0018738,1,0.991128828326226,0,1,S-formylglutathione hydrolase activity,MF,
6437,GO:0018773,1,0.988249071568082,0,1,acetylpyruvate hydrolase activity,MF,
6438,GO:0018872,1,0.984980273215803,0,1,arsonoacetate metabolic process,BP,
6439,GO:0018874,1,0.986446894545736,0,1,benzoate metabolic process,BP,
6440,GO:0018879,1,0.942163072308,0,4,biphenyl metabolic process,BP,
6441,GO:0018885,1,0.988296968136483,0,1,carbon tetrachloride metabolic process,BP,
6442,GO:0018894,1,0.939259165983019,0,4,dibenzo-p-dioxin metabolic process,BP,
6443,GO:0018904,1,0.854905018756856,0,13,ether metabolic process,BP,
6444,GO:0018910,1,0.988296968136483,0,1,benzene metabolic process,BP,
6445,GO:0018916,1,0.965565611171536,0,3,nitrobenzene metabolic process,BP,
6446,GO:0018917,1,0.986028954454859,0,1,fluorene metabolic process,BP,
6447,GO:0018931,1,0.977432961485571,0,2,naphthalene metabolic process,BP,
6449,GO:0018963,1,0.95725288788106,0,3,phthalate metabolic process,BP,
6450,GO:0018964,1,0.983426667503251,0,1,propylene metabolic process,BP,
6451,GO:0018969,1,0.984015916374423,0,1,thiocyanate metabolic process,BP,
6452,GO:0018979,1,0.987480481992368,0,1,trichloroethylene metabolic process,BP,
6453,GO:0018992,1,0.967127129541986,0,2,germ-line sex determination,BP,
6454,GO:0018993,1,0.968063499283766,0,2,somatic sex determination,BP,
6455,GO:0018995,1,0.809666695338216,0,14,host,CC,
6457,GO:0019002,1,0.972150391950258,0,2,GMP binding,MF,
6459,GO:0019005,1,0.486121107020061,0,50,SCF ubiquitin ligase complex,CC,
6460,GO:0019008,1,0.973295739858901,0,2,molybdopterin synthase complex,CC,
6461,GO:0019012,1,0.940295235677535,0,4,virion,CC,
6462,GO:0019028,1,0.984728932554734,0,1,viral capsid,CC,
6463,GO:0019031,1,0.954880041681638,0,3,viral envelope,CC,
6464,GO:0019034,1,0.967126892154876,0,2,viral replication complex,CC,
6465,GO:0019035,1,0.983426667501779,0,1,viral integration complex,CC,
6466,GO:0019042,1,0.853352639557318,0,11,viral latency,BP,
6467,GO:0019043,1,0.882373806120433,0,9,establishment of viral latency,BP,
6468,GO:0019045,1,0.967126892148536,0,2,latent virus replication,BP,
6469,GO:0019046,1,0.967126892148536,0,2,release from viral latency,BP,
6470,GO:0019048,1,0.589576243660055,0,35,modulation by virus of host morphology or physiology,BP,
6471,GO:0019049,1,0.954386941858277,0,3,evasion or tolerance of host defenses by virus,BP,
6472,GO:0019050,1,0.961554461230338,0,3,suppression by virus of host apoptotic process,BP,
6473,GO:0019054,1,0.719789412579683,0,22,modulation by virus of host process,BP,
6474,GO:0019056,1,0.984053342088746,0,1,modulation by virus of host transcription,BP,
6476,GO:0019060,1,0.934775998830161,0,5,intracellular transport of viral protein in host cell,BP,
6477,GO:0019061,1,0.985611535207427,0,1,uncoating of virus,BP,
6480,GO:0019065,1,0.952305215663209,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6481,GO:0019068,1,0.602541630662363,0,37,virion assembly,BP,
6482,GO:0019072,1,0.967126892153522,0,2,viral genome packaging,BP,
6483,GO:0019074,1,0.967126892153522,0,2,viral RNA genome packaging,BP,
6484,GO:0019075,1,0.969690119055175,0,2,virus maturation,BP,
6485,GO:0019076,1,0.587675217905531,0,35,viral release from host cell,BP,
6487,GO:0019080,1,0.133882130066301,0,185,viral gene expression,BP,
6488,GO:0019081,1,0.870599466052126,0,10,viral translation,BP,
6489,GO:0019082,1,0.983426667503302,0,1,viral protein processing,BP,
6490,GO:0019083,1,0.156562767953585,0,174,viral transcription,BP,
6491,GO:0019085,1,0.967269588237709,0,2,early viral transcription,BP,
6492,GO:0019086,1,0.944488060504215,0,4,late viral transcription,BP,
6493,GO:0019087,1,0.958621167549551,0,3,transformation of host cell by virus,BP,
6494,GO:0019088,1,0.988766311713202,0,1,immortalization of host cell by virus,BP,
6495,GO:0019089,1,0.983426667500986,0,1,transmission of virus,BP,
6496,GO:0019098,1,0.659190248557061,0,29,reproductive behavior,BP,
6497,GO:0019100,1,0.967127129541986,0,2,male germ-line sex determination,BP,
6498,GO:0019101,1,0.983992329944554,0,1,female somatic sex determination,BP,
6499,GO:0019102,1,0.983813110673525,0,1,male somatic sex determination,BP,
6500,GO:0019103,1,0.94025721499042,0,5,pyrimidine nucleotide binding,MF,
6501,GO:0019104,1,0.842674752638692,0,14,DNA N-glycosylase activity,MF,
6503,GO:0019113,1,0.976845725182526,0,2,limonene monooxygenase activity,MF,
6504,GO:0019115,1,0.986783122517661,0,1,benzaldehyde dehydrogenase activity,MF,
6505,GO:0019118,1,0.99006355571529,0,1,phenanthrene-epoxide hydrolase activity,MF,
6506,GO:0019119,1,0.99006355571529,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6507,GO:0019135,1,0.987214720326502,0,1,deoxyhypusine monooxygenase activity,MF,
6508,GO:0019136,1,0.950044469874371,0,4,deoxynucleoside kinase activity,MF,
6509,GO:0019144,1,0.980199746483718,0,2,ADP-sugar diphosphatase activity,MF,
6510,GO:0019145,1,0.984876680452831,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6511,GO:0019153,1,0.988694027903648,0,1,protein-disulfide reductase (glutathione) activity,MF,
6512,GO:0019158,1,0.935669344813975,0,4,mannokinase activity,MF,
6513,GO:0019166,1,0.961784035732174,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6514,GO:0019171,1,0.983426667498527,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6515,GO:0019184,1,0.790202489231119,0,17,nonribosomal peptide biosynthetic process,BP,
6516,GO:0019185,1,0.968162539012522,0,2,snRNA-activating protein complex,CC,
6517,GO:0019187,1,0.983426793805024,0,1,beta-1,4-mannosyltransferase activity,MF,
6518,GO:0019198,1,0.767369534800914,0,16,transmembrane receptor protein phosphatase activity,MF,
6521,GO:0019201,1,0.693436931321162,0,24,nucleotide kinase activity,MF,
6522,GO:0019202,1,0.983492511859743,0,1,amino acid kinase activity,MF,
6524,GO:0019205,1,0.522754786353579,0,47,nucleobase-containing compound kinase activity,MF,
6525,GO:0019206,1,0.835395783279268,0,13,nucleoside kinase activity,MF,
6531,GO:0019212,1,0.615938486387969,0,35,phosphatase inhibitor activity,MF,
6542,GO:0019227,1,0.904941952569421,0,7,neuronal action potential propagation,BP,
6543,GO:0019228,1,0.602669631039841,0,33,neuronal action potential,BP,
6545,GO:0019230,1,0.941906392088311,0,4,proprioception,BP,
6547,GO:0019236,1,0.937072064364177,0,7,response to pheromone,BP,
6548,GO:0019237,1,0.921837901637434,0,5,centromeric DNA binding,MF,
6549,GO:0019238,1,0.914407645319897,0,6,cyclohydrolase activity,MF,
6550,GO:0019239,1,0.691032342933179,0,27,deaminase activity,MF,
6551,GO:0019240,1,0.924543157543291,0,5,citrulline biosynthetic process,BP,
6552,GO:0019242,1,0.986326534224499,0,1,methylglyoxal biosynthetic process,BP,
6553,GO:0019243,1,0.972939519486341,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6554,GO:0019244,1,0.990721943666155,0,1,lactate biosynthetic process from pyruvate,BP,
6555,GO:0019249,1,0.967396188706169,0,3,lactate biosynthetic process,BP,
6556,GO:0019254,1,0.954352683397504,0,3,carnitine metabolic process, CoA-linked,BP,
6557,GO:0019255,1,0.972984933513994,0,2,glucose 1-phosphate metabolic process,BP,
6558,GO:0019262,1,0.95533621161186,0,4,N-acetylneuraminate catabolic process,BP,
6559,GO:0019264,1,0.97095929135171,0,2,glycine biosynthetic process from serine,BP,
6560,GO:0019265,1,0.974525129116917,0,2,glycine biosynthetic process, by transamination of glyoxylate,BP,
6561,GO:0019276,1,0.955662395939586,0,3,UDP-N-acetylgalactosamine metabolic process,BP,
6562,GO:0019285,1,0.96718366045249,0,2,glycine betaine biosynthetic process from choline,BP,
6563,GO:0019287,1,0.964906248851612,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6564,GO:0019290,1,0.983973920810479,0,1,siderophore biosynthetic process,BP,
6565,GO:0019303,1,0.982239164071078,0,2,D-ribose catabolic process,BP,
6566,GO:0019310,1,0.989591432912315,0,1,inositol catabolic process,BP,
6567,GO:0019317,1,0.86554750002383,0,9,fucose catabolic process,BP,
6571,GO:0019321,1,0.866981688226444,0,12,pentose metabolic process,BP,
6572,GO:0019322,1,0.950324320286054,0,4,pentose biosynthetic process,BP,
6573,GO:0019323,1,0.944257153892753,0,5,pentose catabolic process,BP,
6574,GO:0019336,1,0.87229539748225,0,9,phenol-containing compound catabolic process,BP,
6575,GO:0019341,1,0.984602838154034,0,1,dibenzo-p-dioxin catabolic process,BP,
6576,GO:0019343,1,0.972718184717224,0,2,cysteine biosynthetic process via cystathionine,BP,
6577,GO:0019344,1,0.958421403828822,0,3,cysteine biosynthetic process,BP,
6578,GO:0019346,1,0.946515658867227,0,4,transsulfuration,BP,
6579,GO:0019348,1,0.936724777552837,0,5,dolichol metabolic process,BP,
6580,GO:0019355,1,0.954909888168039,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6581,GO:0019359,1,0.68698818209977,0,26,nicotinamide nucleotide biosynthetic process,BP,
6583,GO:0019363,1,0.68698818209977,0,26,pyridine nucleotide biosynthetic process,BP,
6584,GO:0019364,1,0.976426384321809,0,2,pyridine nucleotide catabolic process,BP,
6585,GO:0019367,1,0.902216791765655,0,7,fatty acid elongation, saturated fatty acid,BP,
6586,GO:0019368,1,0.932387922568027,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6588,GO:0019370,1,0.842181013442257,0,16,leukotriene biosynthetic process,BP,
6590,GO:0019372,1,0.817968360729582,0,16,lipoxygenase pathway,BP,
6591,GO:0019373,1,0.756358073673952,0,20,epoxygenase P450 pathway,BP,
6592,GO:0019374,1,0.91843635970211,0,6,galactolipid metabolic process,BP,
6593,GO:0019375,1,0.971885986716058,0,2,galactolipid biosynthetic process,BP,
6594,GO:0019376,1,0.973468585053942,0,2,galactolipid catabolic process,BP,
6595,GO:0019377,1,0.822145791365719,0,14,glycolipid catabolic process,BP,
6596,GO:0019388,1,0.91085357525904,0,7,galactose catabolic process,BP,
6597,GO:0019389,1,0.984522212251702,0,1,glucuronoside metabolic process,BP,
6598,GO:0019391,1,0.984522212251702,0,1,glucuronoside catabolic process,BP,
6600,GO:0019400,1,0.780468647045711,0,19,alditol metabolic process,BP,
6601,GO:0019401,1,0.929676020291078,0,5,alditol biosynthetic process,BP,
6602,GO:0019402,1,0.9900697047622,0,1,galactitol metabolic process,BP,
6603,GO:0019405,1,0.915073647125009,0,6,alditol catabolic process,BP,
6604,GO:0019406,1,0.989825625357721,0,1,hexitol biosynthetic process,BP,
6605,GO:0019407,1,0.984812627494499,0,1,hexitol catabolic process,BP,
6606,GO:0019408,1,0.983426667502856,0,1,dolichol biosynthetic process,BP,
6607,GO:0019413,1,0.967569891257446,0,2,acetate biosynthetic process,BP,
6608,GO:0019417,1,0.967172271891287,0,2,sulfur oxidation,BP,
6609,GO:0019418,1,0.96568649178548,0,3,sulfide oxidation,BP,
6610,GO:0019427,1,0.967569891257446,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6612,GO:0019432,1,0.554604727926474,0,40,triglyceride biosynthetic process,BP,
6616,GO:0019441,1,0.912645782426146,0,7,tryptophan catabolic process to kynurenine,BP,
6617,GO:0019442,1,0.977598378931967,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6618,GO:0019448,1,0.962377917271699,0,3,L-cysteine catabolic process,BP,
6620,GO:0019470,1,0.940555682008987,0,4,4-hydroxyproline catabolic process,BP,
6621,GO:0019471,1,0.863964299226572,0,10,4-hydroxyproline metabolic process,BP,
6622,GO:0019474,1,0.939856304865844,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6623,GO:0019477,1,0.939856304865844,0,4,L-lysine catabolic process,BP,
6624,GO:0019478,1,0.977384462490783,0,2,D-amino acid catabolic process,BP,
6625,GO:0019481,1,0.985697341070322,0,1,L-alanine catabolic process, by transamination,BP,
6626,GO:0019482,1,0.941088100726023,0,4,beta-alanine metabolic process,BP,
6627,GO:0019483,1,0.970338440903241,0,2,beta-alanine biosynthetic process,BP,
6628,GO:0019509,1,0.934559770507568,0,5,L-methionine salvage from methylthioadenosine,BP,
6629,GO:0019510,1,0.985551825213358,0,1,S-adenosylhomocysteine catabolic process,BP,
6630,GO:0019511,1,0.847161337980495,0,11,peptidyl-proline hydroxylation,BP,
6631,GO:0019516,1,0.975512067084349,0,2,lactate oxidation,BP,
6632,GO:0019518,1,0.988771891387024,0,1,L-threonine catabolic process to glycine,BP,
6633,GO:0019519,1,0.984812627494499,0,1,pentitol metabolic process,BP,
6634,GO:0019520,1,0.971876377292361,0,2,aldonic acid metabolic process,BP,
6635,GO:0019521,1,0.971876377292361,0,2,D-gluconate metabolic process,BP,
6636,GO:0019527,1,0.984812627494499,0,1,pentitol catabolic process,BP,
6637,GO:0019530,1,0.898111094395478,0,7,taurine metabolic process,BP,
6638,GO:0019531,1,0.836789186807543,0,11,oxalate transmembrane transporter activity,MF,
6639,GO:0019532,1,0.827298334785943,0,12,oxalate transport,BP,
6640,GO:0019534,1,0.924701088402215,0,5,toxin transporter activity,MF,
6642,GO:0019541,1,0.967569891257446,0,2,propionate metabolic process,BP,
6643,GO:0019542,1,0.967569891257446,0,2,propionate biosynthetic process,BP,
6644,GO:0019546,1,0.985607998290606,0,1,arginine deiminase pathway,BP,
6645,GO:0019547,1,0.989543864477559,0,1,arginine catabolic process to ornithine,BP,
6646,GO:0019550,1,0.971396638492588,0,2,glutamate catabolic process to aspartate,BP,
6647,GO:0019551,1,0.971396638492588,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6648,GO:0019556,1,0.941811895017325,0,4,histidine catabolic process to glutamate and formamide,BP,
6649,GO:0019557,1,0.941811895017325,0,4,histidine catabolic process to glutamate and formate,BP,
6650,GO:0019563,1,0.929189863396665,0,5,glycerol catabolic process,BP,
6651,GO:0019566,1,0.984728932554734,0,1,arabinose metabolic process,BP,
6652,GO:0019585,1,0.732969049810643,0,22,glucuronate metabolic process,BP,
6653,GO:0019605,1,0.986446894545736,0,1,butyrate metabolic process,BP,
6654,GO:0019614,1,0.884430957965907,0,8,catechol-containing compound catabolic process,BP,
6655,GO:0019626,1,0.934931860610555,0,5,short-chain fatty acid catabolic process,BP,
6656,GO:0019627,1,0.842748956915338,0,13,urea metabolic process,BP,
6658,GO:0019640,1,0.941893893425375,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6662,GO:0019673,1,0.925705399174401,0,7,GDP-mannose metabolic process,BP,
6664,GO:0019676,1,0.969738033107044,0,2,ammonia assimilation cycle,BP,
6665,GO:0019677,1,0.983486425653298,0,1,NAD catabolic process,BP,
6667,GO:0019692,1,0.702320715830257,0,29,deoxyribose phosphate metabolic process,BP,
6669,GO:0019694,1,0.898111094395478,0,7,alkanesulfonate metabolic process,BP,
6670,GO:0019695,1,0.864351002776274,0,9,choline metabolic process,BP,
6671,GO:0019706,1,0.684293663368087,0,26,protein-cysteine S-palmitoyltransferase activity,MF,
6672,GO:0019707,1,0.684293663368087,0,26,protein-cysteine S-acyltransferase activity,MF,
6673,GO:0019720,1,0.9143512836505,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6678,GO:0019731,1,0.728794331466412,0,39,antibacterial humoral response,BP,
6679,GO:0019732,1,0.970235552712322,0,2,antifungal humoral response,BP,
6680,GO:0019740,1,0.947741500405307,0,4,nitrogen utilization,BP,
6681,GO:0019742,1,0.985172881203875,0,1,pentacyclic triterpenoid metabolic process,BP,
6682,GO:0019747,1,0.967961994694362,0,3,regulation of isoprenoid metabolic process,BP,
6684,GO:0019751,1,0.215346453493088,0,105,polyol metabolic process,BP,
6686,GO:0019755,1,0.874120383431715,0,10,one-carbon compound transport,BP,
6687,GO:0019763,1,0.951474959572993,0,5,immunoglobulin receptor activity,MF,
6688,GO:0019767,1,0.986772926226343,0,2,IgE receptor activity,MF,
6689,GO:0019770,1,0.987820931616327,0,1,IgG receptor activity,MF,
6690,GO:0019773,1,0.931834541887542,0,8,proteasome core complex, alpha-subunit complex,CC,
6691,GO:0019774,1,0.994195248899802,0,1,proteasome core complex, beta-subunit complex,CC,
6692,GO:0019776,1,0.958406298991683,0,3,Atg8 ligase activity,MF,
6693,GO:0019777,1,0.976258597963144,0,2,Atg12 transferase activity,MF,
6694,GO:0019778,1,0.983426667502658,0,1,Atg12 activating enzyme activity,MF,
6695,GO:0019780,1,0.983426667500887,0,1,FAT10 activating enzyme activity,MF,
6696,GO:0019781,1,0.973910228974332,0,2,NEDD8 activating enzyme activity,MF,
6697,GO:0019782,1,0.983559595704581,0,1,ISG15 activating enzyme activity,MF,
6698,GO:0019783,1,0.159677871242413,0,119,ubiquitin-like protein-specific protease activity,MF,
6699,GO:0019784,1,0.926195962188852,0,6,NEDD8-specific protease activity,MF,
6700,GO:0019785,1,0.970180348610764,0,2,ISG15-specific protease activity,MF,
6702,GO:0019788,1,0.948404319063241,0,5,NEDD8 transferase activity,MF,
6703,GO:0019789,1,0.79572953401141,0,16,SUMO transferase activity,MF,
6704,GO:0019798,1,0.941410674380747,0,4,procollagen-proline dioxygenase activity,MF,
6705,GO:0019799,1,0.984728932554734,0,1,tubulin N-acetyltransferase activity,MF,
6706,GO:0019800,1,0.913249047367147,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6707,GO:0019805,1,0.963724368297782,0,3,quinolinate biosynthetic process,BP,
6708,GO:0019807,1,0.989934980909134,0,1,aspartoacylase activity,MF,
6709,GO:0019808,1,0.961795425056836,0,3,polyamine binding,MF,
6710,GO:0019809,1,0.977830532260512,0,2,spermidine binding,MF,
6711,GO:0019810,1,0.983602856825306,0,1,putrescine binding,MF,
6712,GO:0019811,1,0.983426667503053,0,1,cocaine binding,MF,
6713,GO:0019814,1,0.944770169705376,0,5,immunoglobulin complex,CC,
6714,GO:0019815,1,0.965613521013138,0,3,B cell receptor complex,CC,
6715,GO:0019825,1,0.574396593198081,0,46,oxygen binding,MF,
6716,GO:0019826,1,0.953787124954196,0,3,oxygen sensor activity,MF,
6719,GO:0019829,1,0.435956877555124,0,63,cation-transporting ATPase activity,MF,
6720,GO:0019834,1,0.963988417721962,0,4,phospholipase A2 inhibitor activity,MF,
6721,GO:0019835,1,0.683171195221188,0,31,cytolysis,BP,
6722,GO:0019836,1,0.970300969153238,0,2,hemolysis by symbiont of host erythrocytes,BP,
6725,GO:0019841,1,0.882806724245489,0,13,retinol binding,MF,
6727,GO:0019843,1,0.611432685737625,0,49,rRNA binding,MF,
6728,GO:0019852,1,0.865268070575296,0,11,L-ascorbic acid metabolic process,BP,
6729,GO:0019853,1,0.976560406635299,0,2,L-ascorbic acid biosynthetic process,BP,
6730,GO:0019855,1,0.913926493758568,0,8,calcium channel inhibitor activity,MF,
6731,GO:0019856,1,0.908900463713301,0,6,pyrimidine nucleobase biosynthetic process,BP,
6732,GO:0019857,1,0.983426667497444,0,1,5-methylcytosine metabolic process,BP,
6733,GO:0019858,1,0.960127361511948,0,3,cytosine metabolic process,BP,
6734,GO:0019859,1,0.956474825567017,0,3,thymine metabolic process,BP,
6735,GO:0019860,1,0.95921469419384,0,3,uracil metabolic process,BP,
6736,GO:0019862,1,0.978603816476217,0,2,IgA binding,MF,
6737,GO:0019863,1,0.951203122666115,0,5,IgE binding,MF,
6738,GO:0019864,1,0.883872768411709,0,11,IgG binding,MF,
6739,GO:0019865,1,0.781336136861751,0,21,immunoglobulin binding,MF,
6743,GO:0019870,1,0.903745999276786,0,7,potassium channel inhibitor activity,MF,
6744,GO:0019871,1,0.926550016654323,0,5,sodium channel inhibitor activity,MF,
6745,GO:0019878,1,0.984073483086431,0,1,lysine biosynthetic process via aminoadipic acid,BP,
6747,GO:0019883,1,0.853528150950059,0,11,antigen processing and presentation of endogenous antigen,BP,
6749,GO:0019885,1,0.901548693855574,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6750,GO:0019886,1,0.286066795929422,0,90,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
6752,GO:0019888,1,0.370065170813539,0,69,protein phosphatase regulator activity,MF,
6754,GO:0019896,1,0.883283674778888,0,8,axonal transport of mitochondrion,BP,
6764,GO:0019907,1,0.911822175615958,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6765,GO:0019908,1,0.795492533538951,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6766,GO:0019911,1,0.87153587760466,0,10,structural constituent of myelin sheath,MF,
6768,GO:0019915,1,0.41562079868124,0,62,lipid storage,BP,
6769,GO:0019918,1,0.955650292649735,0,3,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6770,GO:0019919,1,0.944663182644393,0,4,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6772,GO:0019933,1,0.512385539074758,0,48,cAMP-mediated signaling,BP,
6776,GO:0019948,1,0.969673144865392,0,2,SUMO activating enzyme activity,MF,
6779,GO:0019956,1,0.755108473740908,0,19,chemokine binding,MF,
6780,GO:0019957,1,0.904961726475581,0,7,C-C chemokine binding,MF,
6781,GO:0019958,1,0.925382305599512,0,5,C-X-C chemokine binding,MF,
6782,GO:0019959,1,0.953370678688775,0,3,interleukin-8 binding,MF,
6783,GO:0019960,1,0.920057817360917,0,5,C-X3-C chemokine binding,MF,
6784,GO:0019961,1,0.967192746401921,0,2,interferon binding,MF,
6785,GO:0019962,1,0.983426667501332,0,1,type I interferon binding,MF,
6786,GO:0019964,1,0.983493627040072,0,1,interferon-gamma binding,MF,
6787,GO:0019966,1,0.893401988912695,0,8,interleukin-1 binding,MF,
6788,GO:0019969,1,0.983436644142705,0,1,interleukin-10 binding,MF,
6789,GO:0019970,1,0.98365546150649,0,1,interleukin-11 binding,MF,
6790,GO:0019972,1,0.975121543988591,0,2,interleukin-12 binding,MF,
6791,GO:0019975,1,0.989615277731363,0,1,interleukin-17 binding,MF,
6792,GO:0019976,1,0.95672792955013,0,3,interleukin-2 binding,MF,
6793,GO:0019981,1,0.967351909500442,0,2,interleukin-6 binding,MF,
6794,GO:0019983,1,0.986042558870148,0,1,interleukin-9 binding,MF,
6795,GO:0019985,1,0.588544775945069,0,38,translesion synthesis,BP,
6796,GO:0019988,1,0.984284718486085,0,1,charged-tRNA amino acid modification,BP,
6797,GO:0019992,1,0.842046204256596,0,11,diacylglycerol binding,MF,
6798,GO:0020003,1,0.984276552972496,0,1,symbiont-containing vacuole,CC,
6799,GO:0020005,1,0.984276552972496,0,1,symbiont-containing vacuole membrane,CC,
6800,GO:0020012,1,0.984371383470671,0,1,evasion or tolerance of host immune response,BP,
6801,GO:0020016,1,0.951165803069232,0,3,ciliary pocket,CC,
6802,GO:0020018,1,0.951165803069232,0,3,ciliary pocket membrane,CC,
6803,GO:0020021,1,0.988766311713202,0,1,immortalization of host cell,BP,
6804,GO:0020027,1,0.818152451147578,0,15,hemoglobin metabolic process,BP,
6806,GO:0021501,1,0.986334753762597,0,1,prechordal plate formation,BP,
6808,GO:0021503,1,0.983426667498575,0,1,neural fold bending,BP,
6809,GO:0021508,1,0.983426667500544,0,1,floor plate formation,BP,
6810,GO:0021509,1,0.986739001327766,0,1,roof plate formation,BP,
6812,GO:0021511,1,0.712649228680798,0,23,spinal cord patterning,BP,
6813,GO:0021512,1,0.983426667503251,0,1,spinal cord anterior/posterior patterning,BP,
6814,GO:0021513,1,0.736903694067962,0,21,spinal cord dorsal/ventral patterning,BP,
6815,GO:0021514,1,0.795568105802431,0,16,ventral spinal cord interneuron differentiation,BP,
6817,GO:0021516,1,0.751122150424184,0,21,dorsal spinal cord development,BP,
6818,GO:0021517,1,0.532240192708593,0,44,ventral spinal cord development,BP,
6819,GO:0021519,1,0.990581907561477,0,1,spinal cord association neuron specification,BP,
6820,GO:0021520,1,0.850407834497592,0,12,spinal cord motor neuron cell fate specification,BP,
6821,GO:0021521,1,0.875232789942509,0,10,ventral spinal cord interneuron specification,BP,
6822,GO:0021522,1,0.637784543031773,0,32,spinal cord motor neuron differentiation,BP,
6823,GO:0021523,1,0.932706409223012,0,5,somatic motor neuron differentiation,BP,
6824,GO:0021524,1,0.961192082126779,0,3,visceral motor neuron differentiation,BP,
6825,GO:0021526,1,0.972720562097311,0,2,medial motor column neuron differentiation,BP,
6826,GO:0021527,1,0.825384872826992,0,14,spinal cord association neuron differentiation,BP,
6827,GO:0021528,1,0.984728932554734,0,1,commissural neuron differentiation in spinal cord,BP,
6828,GO:0021529,1,0.956924069602962,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6829,GO:0021530,1,0.956924069602962,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6832,GO:0021534,1,0.859004287142374,0,11,cell proliferation in hindbrain,BP,
6833,GO:0021535,1,0.800031117511572,0,14,cell migration in hindbrain,BP,
6836,GO:0021538,1,0.967175458368759,0,2,epithalamus development,BP,
6837,GO:0021539,1,0.974692201892321,0,2,subthalamus development,BP,
6838,GO:0021540,1,0.937472972161156,0,4,corpus callosum morphogenesis,BP,
6839,GO:0021541,1,0.983426667503248,0,1,ammon gyrus development,BP,
6840,GO:0021542,1,0.768396869574998,0,17,dentate gyrus development,BP,
6843,GO:0021545,1,0.504285284478069,0,48,cranial nerve development,BP,
6844,GO:0021546,1,0.913507480791587,0,7,rhombomere development,BP,
6845,GO:0021547,1,0.986334753762597,0,1,midbrain-hindbrain boundary initiation,BP,
6846,GO:0021548,1,0.865246037275095,0,10,pons development,BP,
6848,GO:0021550,1,0.969042657152895,0,2,medulla oblongata development,BP,
6849,GO:0021551,1,0.969251408465604,0,2,central nervous system morphogenesis,BP,
6850,GO:0021553,1,0.952142032356827,0,3,olfactory nerve development,BP,
6851,GO:0021554,1,0.847356955772145,0,12,optic nerve development,BP,
6852,GO:0021555,1,0.958468806580203,0,4,midbrain-hindbrain boundary morphogenesis,BP,
6853,GO:0021557,1,0.95658615713414,0,4,oculomotor nerve development,BP,
6854,GO:0021558,1,0.97255925216779,0,3,trochlear nerve development,BP,
6855,GO:0021559,1,0.853646465636348,0,11,trigeminal nerve development,BP,
6856,GO:0021560,1,0.968857850615815,0,2,abducens nerve development,BP,
6857,GO:0021561,1,0.861217793511702,0,10,facial nerve development,BP,
6858,GO:0021562,1,0.894117595970845,0,8,vestibulocochlear nerve development,BP,
6859,GO:0021563,1,0.922079808168646,0,5,glossopharyngeal nerve development,BP,
6860,GO:0021564,1,0.956613411566894,0,3,vagus nerve development,BP,
6861,GO:0021566,1,0.98342666750271,0,1,hypoglossal nerve development,BP,
6862,GO:0021568,1,0.978143003321232,0,2,rhombomere 2 development,BP,
6863,GO:0021569,1,0.961048904597026,0,3,rhombomere 3 development,BP,
6864,GO:0021570,1,0.981155920545575,0,2,rhombomere 4 development,BP,
6865,GO:0021571,1,0.960499624094774,0,3,rhombomere 5 development,BP,
6866,GO:0021572,1,0.983546471948082,0,1,rhombomere 6 development,BP,
6868,GO:0021576,1,0.985586841248435,0,1,hindbrain formation,BP,
6869,GO:0021577,1,0.968325849291497,0,2,hindbrain structural organization,BP,
6870,GO:0021578,1,0.910619848868428,0,6,hindbrain maturation,BP,
6871,GO:0021586,1,0.952586361536427,0,3,pons maturation,BP,
6873,GO:0021588,1,0.985586841248435,0,1,cerebellum formation,BP,
6874,GO:0021589,1,0.968325849291497,0,2,cerebellum structural organization,BP,
6875,GO:0021590,1,0.955953330750118,0,3,cerebellum maturation,BP,
6876,GO:0021591,1,0.674658654170099,0,26,ventricular system development,BP,
6877,GO:0021592,1,0.967126892150862,0,2,fourth ventricle development,BP,
6878,GO:0021593,1,0.972034599205524,0,2,rhombomere morphogenesis,BP,
6879,GO:0021594,1,0.984077732758283,0,1,rhombomere formation,BP,
6880,GO:0021598,1,0.968857850615815,0,2,abducens nerve morphogenesis,BP,
6881,GO:0021599,1,0.968857850615815,0,2,abducens nerve formation,BP,
6882,GO:0021602,1,0.667747708755297,0,27,cranial nerve morphogenesis,BP,
6883,GO:0021603,1,0.891705934802158,0,8,cranial nerve formation,BP,
6884,GO:0021604,1,0.862763419483316,0,10,cranial nerve structural organization,BP,
6885,GO:0021610,1,0.861217793511702,0,10,facial nerve morphogenesis,BP,
6886,GO:0021612,1,0.889600150059446,0,8,facial nerve structural organization,BP,
6887,GO:0021615,1,0.937623463574016,0,4,glossopharyngeal nerve morphogenesis,BP,
6888,GO:0021618,1,0.98342666750271,0,1,hypoglossal nerve morphogenesis,BP,
6889,GO:0021622,1,0.971936174053636,0,2,oculomotor nerve morphogenesis,BP,
6890,GO:0021623,1,0.971936174053636,0,2,oculomotor nerve formation,BP,
6891,GO:0021626,1,0.910619848868428,0,6,central nervous system maturation,BP,
6892,GO:0021631,1,0.907119604079538,0,6,optic nerve morphogenesis,BP,
6893,GO:0021633,1,0.969847219125319,0,2,optic nerve structural organization,BP,
6894,GO:0021634,1,0.983426667503348,0,1,optic nerve formation,BP,
6895,GO:0021636,1,0.921368039990222,0,5,trigeminal nerve morphogenesis,BP,
6896,GO:0021637,1,0.921368039990222,0,5,trigeminal nerve structural organization,BP,
6897,GO:0021639,1,0.988164498969272,0,1,trochlear nerve morphogenesis,BP,
6898,GO:0021642,1,0.988164498969272,0,1,trochlear nerve formation,BP,
6899,GO:0021644,1,0.972736732460471,0,2,vagus nerve morphogenesis,BP,
6900,GO:0021648,1,0.932691811385893,0,5,vestibulocochlear nerve morphogenesis,BP,
6901,GO:0021649,1,0.984936615570901,0,1,vestibulocochlear nerve structural organization,BP,
6902,GO:0021650,1,0.946959425212204,0,4,vestibulocochlear nerve formation,BP,
6903,GO:0021658,1,0.972034599205524,0,2,rhombomere 3 morphogenesis,BP,
6904,GO:0021660,1,0.984077732758283,0,1,rhombomere 3 formation,BP,
6905,GO:0021664,1,0.984077732758283,0,1,rhombomere 5 morphogenesis,BP,
6906,GO:0021666,1,0.984077732758283,0,1,rhombomere 5 formation,BP,
6907,GO:0021670,1,0.832450436399885,0,12,lateral ventricle development,BP,
6909,GO:0021678,1,0.961196049015857,0,3,third ventricle development,BP,
6913,GO:0021682,1,0.983426667501826,0,1,nerve maturation,BP,
6916,GO:0021685,1,0.983426667499906,0,1,cerebellar granular layer structural organization,BP,
6917,GO:0021686,1,0.988447470733908,0,1,cerebellar granular layer maturation,BP,
6920,GO:0021691,1,0.967127641968247,0,2,cerebellar Purkinje cell layer maturation,BP,
6923,GO:0021694,1,0.85689288899063,0,10,cerebellar Purkinje cell layer formation,BP,
6928,GO:0021699,1,0.955953330750118,0,3,cerebellar cortex maturation,BP,
6930,GO:0021702,1,0.85689288899063,0,10,cerebellar Purkinje cell differentiation,BP,
6931,GO:0021703,1,0.988164498969272,0,1,locus ceruleus development,BP,
6933,GO:0021718,1,0.968642089285902,0,2,superior olivary nucleus development,BP,
6934,GO:0021722,1,0.968642089285902,0,2,superior olivary nucleus maturation,BP,
6935,GO:0021723,1,0.983832058556469,0,1,medullary reticular formation development,BP,
6936,GO:0021730,1,0.9673792202171,0,2,trigeminal sensory nucleus development,BP,
6937,GO:0021732,1,0.985586841248435,0,1,midbrain-hindbrain boundary maturation,BP,
6938,GO:0021740,1,0.9673792202171,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6939,GO:0021747,1,0.951097883172424,0,3,cochlear nucleus development,BP,
6940,GO:0021750,1,0.984968562250546,0,1,vestibular nucleus development,BP,
6941,GO:0021754,1,0.99237048907605,0,1,facial nucleus development,BP,
6942,GO:0021756,1,0.776330032513499,0,16,striatum development,BP,
6943,GO:0021757,1,0.983447031998769,0,1,caudate nucleus development,BP,
6944,GO:0021758,1,0.983447031998769,0,1,putamen development,BP,
6945,GO:0021759,1,0.938200197583789,0,4,globus pallidus development,BP,
6946,GO:0021761,1,0.216215329317259,0,102,limbic system development,BP,
6947,GO:0021762,1,0.559054324708107,0,42,substantia nigra development,BP,
6948,GO:0021763,1,0.985755524774588,0,1,subthalamic nucleus development,BP,
6949,GO:0021764,1,0.935725947968865,0,4,amygdala development,BP,
6950,GO:0021766,1,0.311975011478488,0,76,hippocampus development,BP,
6951,GO:0021767,1,0.97310813224919,0,2,mammillary body development,BP,
6952,GO:0021768,1,0.983482363334595,0,1,nucleus accumbens development,BP,
6953,GO:0021769,1,0.939539113014892,0,4,orbitofrontal cortex development,BP,
6954,GO:0021771,1,0.983426667501824,0,1,lateral geniculate nucleus development,BP,
6956,GO:0021773,1,0.953581451868593,0,3,striatal medium spiny neuron differentiation,BP,
6957,GO:0021775,1,0.951096177112132,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6958,GO:0021776,1,0.951096177112132,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6959,GO:0021778,1,0.941061779714722,0,4,oligodendrocyte cell fate specification,BP,
6960,GO:0021779,1,0.941061779714722,0,4,oligodendrocyte cell fate commitment,BP,
6961,GO:0021780,1,0.941061779714722,0,4,glial cell fate specification,BP,
6962,GO:0021781,1,0.833004503439621,0,12,glial cell fate commitment,BP,
6964,GO:0021783,1,0.801253078411705,0,16,preganglionic parasympathetic fiber development,BP,
6966,GO:0021785,1,0.891069708456069,0,7,branchiomotor neuron axon guidance,BP,
6967,GO:0021793,1,0.983519580266634,0,1,chemorepulsion of branchiomotor axon,BP,
6968,GO:0021794,1,0.814159734827889,0,15,thalamus development,BP,
6969,GO:0021795,1,0.517989453318981,0,42,cerebral cortex cell migration,BP,
6970,GO:0021796,1,0.924022720640917,0,5,cerebral cortex regionalization,BP,
6973,GO:0021799,1,0.625998571405612,0,30,cerebral cortex radially oriented cell migration,BP,
6974,GO:0021800,1,0.876861303438256,0,8,cerebral cortex tangential migration,BP,
6975,GO:0021801,1,0.708687432482854,0,22,cerebral cortex radial glia guided migration,BP,
6976,GO:0021812,1,0.968325825234711,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6977,GO:0021813,1,0.984645723260009,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6978,GO:0021814,1,0.893199692966407,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6979,GO:0021815,1,0.921051564205365,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6980,GO:0021816,1,0.968407661016142,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6981,GO:0021817,1,0.951105344778763,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6982,GO:0021819,1,0.832286583287063,0,12,layer formation in cerebral cortex,BP,
6983,GO:0021822,1,0.986115084606364,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6984,GO:0021823,1,0.96712689215139,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6985,GO:0021824,1,0.968611915867781,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6986,GO:0021825,1,0.936766496683393,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6987,GO:0021826,1,0.853548761850223,0,10,substrate-independent telencephalic tangential migration,BP,
6988,GO:0021827,1,0.96712689215139,0,2,postnatal olfactory bulb interneuron migration,BP,
6989,GO:0021828,1,0.968611915867781,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6990,GO:0021830,1,0.866300190885306,0,9,interneuron migration from the subpallium to the cortex,BP,
6991,GO:0021831,1,0.969579525440784,0,2,embryonic olfactory bulb interneuron precursor migration,BP,
6992,GO:0021836,1,0.96712689215139,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6993,GO:0021840,1,0.968936912471747,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6994,GO:0021842,1,0.968936912471747,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6995,GO:0021843,1,0.853548761850223,0,10,substrate-independent telencephalic tangential interneuron migration,BP,
6997,GO:0021847,1,0.95296278246091,0,3,ventricular zone neuroblast division,BP,
6998,GO:0021849,1,0.967201247487983,0,2,neuroblast division in subventricular zone,BP,
6999,GO:0021852,1,0.969352249575019,0,2,pyramidal neuron migration,BP,
7000,GO:0021853,1,0.909048349505911,0,6,cerebral cortex GABAergic interneuron migration,BP,
7001,GO:0021854,1,0.745782392054738,0,22,hypothalamus development,BP,
7002,GO:0021855,1,0.944793208034,0,4,hypothalamus cell migration,BP,
7003,GO:0021856,1,0.968611915867781,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
7004,GO:0021858,1,0.99257098143858,0,1,GABAergic neuron differentiation in basal ganglia,BP,
7005,GO:0021859,1,0.852638914841716,0,10,pyramidal neuron differentiation,BP,
7006,GO:0021860,1,0.867016693078791,0,9,pyramidal neuron development,BP,
7007,GO:0021861,1,0.947906896747859,0,4,forebrain radial glial cell differentiation,BP,
7008,GO:0021869,1,0.91172989155915,0,6,forebrain ventricular zone progenitor cell division,BP,
7009,GO:0021870,1,0.983426667501335,0,1,Cajal-Retzius cell differentiation,BP,
7012,GO:0021873,1,0.877138875882495,0,8,forebrain neuroblast division,BP,
7013,GO:0021874,1,0.983963369018216,0,1,Wnt signaling pathway involved in forebrain neuroblast division,BP,
7017,GO:0021882,1,0.971330885008517,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
7020,GO:0021886,1,0.968611915867781,0,2,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
7021,GO:0021888,1,0.968611915867781,0,2,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
7024,GO:0021892,1,0.837891205837909,0,12,cerebral cortex GABAergic interneuron differentiation,BP,
7025,GO:0021893,1,0.971330885008517,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
7026,GO:0021894,1,0.888533232197444,0,8,cerebral cortex GABAergic interneuron development,BP,
7027,GO:0021895,1,0.717573004581839,0,22,cerebral cortex neuron differentiation,BP,
7028,GO:0021896,1,0.967126892145631,0,2,forebrain astrocyte differentiation,BP,
7029,GO:0021897,1,0.967126892145631,0,2,forebrain astrocyte development,BP,
7031,GO:0021902,1,0.908993101743221,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
7034,GO:0021910,1,0.890861183453036,0,7,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7035,GO:0021912,1,0.984063727260813,0,2,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
7036,GO:0021913,1,0.971623988276532,0,3,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
7037,GO:0021914,1,0.936714376452315,0,4,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7039,GO:0021919,1,0.983470157906174,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
7040,GO:0021920,1,0.990581907561477,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
7041,GO:0021924,1,0.871743546992193,0,10,cell proliferation in external granule layer,BP,
7042,GO:0021930,1,0.871743546992193,0,10,cerebellar granule cell precursor proliferation,BP,
7043,GO:0021932,1,0.854994569609822,0,10,hindbrain radial glia guided cell migration,BP,
7044,GO:0021933,1,0.988447470733908,0,1,radial glia guided migration of cerebellar granule cell,BP,
7045,GO:0021934,1,0.967525591491665,0,2,hindbrain tangential cell migration,BP,
7046,GO:0021935,1,0.983426667495278,0,1,cerebellar granule cell precursor tangential migration,BP,
7047,GO:0021936,1,0.860924959568187,0,10,regulation of cerebellar granule cell precursor proliferation,BP,
7048,GO:0021937,1,0.914308542153226,0,6,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
7049,GO:0021938,1,0.940534976611088,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
7050,GO:0021940,1,0.885678839663017,0,8,positive regulation of cerebellar granule cell precursor proliferation,BP,
7051,GO:0021941,1,0.972064818782534,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
7052,GO:0021942,1,0.924649496719383,0,5,radial glia guided migration of Purkinje cell,BP,
7053,GO:0021943,1,0.935502729859635,0,4,formation of radial glial scaffolds,BP,
7058,GO:0021956,1,0.986708293749922,0,1,central nervous system interneuron axonogenesis,BP,
7059,GO:0021957,1,0.911187492507249,0,6,corticospinal tract morphogenesis,BP,
7060,GO:0021960,1,0.920966624149861,0,5,anterior commissure morphogenesis,BP,
7061,GO:0021965,1,0.951096177109945,0,3,spinal cord ventral commissure morphogenesis,BP,
7062,GO:0021966,1,0.974176500112981,0,2,corticospinal neuron axon guidance,BP,
7063,GO:0021972,1,0.983426667502658,0,1,corticospinal neuron axon guidance through spinal cord,BP,
7065,GO:0021979,1,0.912480573718393,0,6,hypothalamus cell differentiation,BP,
7068,GO:0021985,1,0.968128471096218,0,2,neurohypophysis development,BP,
7069,GO:0021986,1,0.967175458368759,0,2,habenula development,BP,
7072,GO:0021993,1,0.983426667502314,0,1,initiation of neural tube closure,BP,
7073,GO:0021997,1,0.967126892149407,0,2,neural plate axis specification,BP,
7074,GO:0021998,1,0.983450982062668,0,1,neural plate mediolateral regionalization,BP,
7076,GO:0022004,1,0.985586841248435,0,1,midbrain-hindbrain boundary maturation during brain development,BP,
7077,GO:0022007,1,0.952005946870246,0,3,convergent extension involved in neural plate elongation,BP,
7080,GO:0022010,1,0.805650720571753,0,15,central nervous system myelination,BP,
7082,GO:0022012,1,0.983426667498823,0,1,subpallium cell proliferation in forebrain,BP,
7083,GO:0022013,1,0.983426667498428,0,1,pallium cell proliferation in forebrain,BP,
7084,GO:0022018,1,0.983426667498823,0,1,lateral ganglionic eminence cell proliferation,BP,
7085,GO:0022027,1,0.923966399007149,0,5,interkinetic nuclear migration,BP,
7086,GO:0022028,1,0.891833277751376,0,7,tangential migration from the subventricular zone to the olfactory bulb,BP,
7087,GO:0022029,1,0.423269720702992,0,55,telencephalon cell migration,BP,
7088,GO:0022030,1,0.708687432482854,0,22,telencephalon glial cell migration,BP,
7090,GO:0022038,1,0.809393244714166,0,14,corpus callosum development,BP,
7092,GO:0022401,1,0.825113079649509,0,14,negative adaptation of signaling pathway,BP,
7104,GO:0022417,1,0.929119846680635,0,7,protein maturation by protein folding,BP,
7106,GO:0022601,1,0.967683217322792,0,2,menstrual cycle phase,BP,
7110,GO:0022605,1,0.923487667313434,0,6,oogenesis stage,BP,
7114,GO:0022613,1,0.00486319875981894,0,420,ribonucleoprotein complex biogenesis,BP,
7116,GO:0022615,1,0.902649928769636,0,7,protein to membrane docking,BP,
7117,GO:0022616,1,0.719541285707883,0,22,DNA strand elongation,BP,
7119,GO:0022618,1,0.0845008767816963,0,183,ribonucleoprotein complex assembly,BP,
7120,GO:0022622,1,0.994020585908706,0,1,root system development,BP,
7121,GO:0022624,1,0.751654800515064,0,24,proteasome accessory complex,CC,
7122,GO:0022625,1,0.63218491822942,0,59,cytosolic large ribosomal subunit,CC,
7123,GO:0022626,1,0.414222909215843,0,111,cytosolic ribosome,CC,
7124,GO:0022627,1,0.727098584942865,0,44,cytosolic small ribosomal subunit,CC,
7127,GO:0022820,1,0.904759817232542,0,6,potassium ion symporter activity,MF,
7128,GO:0022821,1,0.775709661547913,0,16,potassium ion antiporter activity,MF,
7129,GO:0022824,1,0.471736318380527,0,49,transmitter-gated ion channel activity,MF,
7132,GO:0022833,1,0.881491712399122,0,8,mechanically gated channel activity,MF,
7134,GO:0022835,1,0.471736318380527,0,49,transmitter-gated channel activity,MF,
7137,GO:0022839,1,0.505087755563501,0,45,ion gated channel activity,MF,
7138,GO:0022840,1,0.899978967529365,0,7,leak channel activity,MF,
7139,GO:0022841,1,0.942037467192627,0,4,potassium ion leak channel activity,MF,
7140,GO:0022842,1,0.899978967529365,0,7,narrow pore channel activity,MF,
7142,GO:0022848,1,0.792158773615143,0,16,acetylcholine-gated cation-selective channel activity,MF,
7143,GO:0022850,1,0.938675063416946,0,5,serotonin-gated cation-selective channel activity,MF,
7144,GO:0022851,1,0.923457079045826,0,5,GABA-gated chloride ion channel activity,MF,
7145,GO:0022852,1,0.967290296870064,0,2,glycine-gated chloride ion channel activity,MF,
7146,GO:0022853,1,0.165140003640145,0,124,active ion transmembrane transporter activity,MF,
7148,GO:0022858,1,0.893704824539707,0,7,alanine transmembrane transporter activity,MF,
7149,GO:0022865,1,0.98388379686975,0,1,transmembrane electron transfer carrier,MF,
7150,GO:0022884,1,0.797001484448981,0,20,macromolecule transmembrane transporter activity,MF,
7151,GO:0022889,1,0.881015201279711,0,9,serine transmembrane transporter activity,MF,
7155,GO:0022897,1,0.939306715809032,0,4,proton-dependent peptide secondary active transmembrane transporter activity,MF,
7157,GO:0022900,1,0.38677081713082,0,99,electron transport chain,BP,
7158,GO:0022904,1,0.399087671680591,0,97,respiratory electron transport chain,BP,
7160,GO:0023016,1,0.954896366513587,0,3,signal transduction by trans-phosphorylation,BP,
7162,GO:0023021,1,0.955492189638208,0,3,termination of signal transduction,BP,
7163,GO:0023023,1,0.776938538006212,0,20,MHC protein complex binding,MF,
7164,GO:0023024,1,0.964396647546758,0,3,MHC class I protein complex binding,MF,
7165,GO:0023025,1,0.969756777562883,0,2,MHC class Ib protein complex binding,MF,
7166,GO:0023026,1,0.817203912463366,0,16,MHC class II protein complex binding,MF,
7167,GO:0023029,1,0.923296959302821,0,5,MHC class Ib protein binding,MF,
7168,GO:0023030,1,0.969756777562883,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7169,GO:0023035,1,0.892906714915009,0,8,CD40 signaling pathway,BP,
7170,GO:0023041,1,0.91463846879908,0,6,neuronal signal transduction,BP,
7175,GO:0023058,1,0.799344183503793,0,16,adaptation of signaling pathway,BP,
7178,GO:0030002,1,0.821732729914168,0,13,cellular anion homeostasis,BP,
7181,GO:0030007,1,0.881901636821079,0,8,cellular potassium ion homeostasis,BP,
7182,GO:0030008,1,0.918716007254208,0,8,TRAPP complex,CC,
7185,GO:0030014,1,0.790553404200121,0,15,CCR4-NOT complex,CC,
7186,GO:0030015,1,0.951865564834269,0,3,CCR4-NOT core complex,CC,
7190,GO:0030020,1,0.906568475809922,0,6,extracellular matrix structural constituent conferring tensile strength,MF,
7191,GO:0030021,1,0.938719196533169,0,6,extracellular matrix structural constituent conferring compression resistance,MF,
7192,GO:0030023,1,0.919824467120292,0,5,extracellular matrix constituent conferring elasticity,MF,
7198,GO:0030033,1,0.789526875207933,0,15,microvillus assembly,BP,
7201,GO:0030037,1,0.983426667502658,0,1,actin filament reorganization involved in cell cycle,BP,
7205,GO:0030043,1,0.956565643760217,0,3,actin filament fragmentation,BP,
7207,GO:0030047,1,0.951475138426808,0,3,actin modification,BP,
7210,GO:0030050,1,0.935330478390146,0,4,vesicle transport along actin filament,BP,
7215,GO:0030060,1,0.953872664987688,0,4,L-malate dehydrogenase activity,MF,
7216,GO:0030061,1,0.927680763335282,0,5,mitochondrial crista,CC,
7217,GO:0030062,1,0.920259176617826,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7218,GO:0030070,1,0.95698176163142,0,3,insulin processing,BP,
7219,GO:0030071,1,0.53189762086063,0,44,regulation of mitotic metaphase/anaphase transition,BP,
7222,GO:0030091,1,0.924479738463319,0,7,protein repair,BP,
7228,GO:0030103,1,0.979173778762268,0,2,vasopressin secretion,BP,
7230,GO:0030107,1,0.984070096703214,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7231,GO:0030108,1,0.989399199546474,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7232,GO:0030109,1,0.971407033574102,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7233,GO:0030110,1,0.988660824595432,0,1,HLA-C specific inhibitory MHC class I receptor activity,MF,
7235,GO:0030117,1,0.25471438955897,0,91,membrane coat,CC,
7236,GO:0030118,1,0.477391086474176,0,48,clathrin coat,CC,
7237,GO:0030119,1,0.514184679933418,0,43,AP-type membrane coat adaptor complex,CC,
7238,GO:0030120,1,0.484449609145692,0,49,vesicle coat,CC,
7239,GO:0030121,1,0.913707913895637,0,6,AP-1 adaptor complex,CC,
7240,GO:0030122,1,0.818922972003974,0,13,AP-2 adaptor complex,CC,
7241,GO:0030123,1,0.854122565861501,0,10,AP-3 adaptor complex,CC,
7242,GO:0030125,1,0.700058306692658,0,24,clathrin vesicle coat,CC,
7243,GO:0030126,1,0.834797931929006,0,13,COPI vesicle coat,CC,
7244,GO:0030127,1,0.829526378851563,0,12,COPII vesicle coat,CC,
7245,GO:0030128,1,0.805339549329184,0,14,clathrin coat of endocytic vesicle,CC,
7246,GO:0030130,1,0.839982785449984,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7247,GO:0030131,1,0.62850153263418,0,30,clathrin adaptor complex,CC,
7248,GO:0030132,1,0.766061009648169,0,18,clathrin coat of coated pit,CC,
7250,GO:0030134,1,0.357703224638298,0,75,ER to Golgi transport vesicle,CC,
7253,GO:0030137,1,0.723189628178285,0,23,COPI-coated vesicle,CC,
7255,GO:0030140,1,0.655736084170063,0,29,trans-Golgi network transport vesicle,CC,
7257,GO:0030144,1,0.954211373619937,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7258,GO:0030145,1,0.492673514374086,0,47,manganese ion binding,MF,
7259,GO:0030148,1,0.322033687380521,0,76,sphingolipid biosynthetic process,BP,
7260,GO:0030149,1,0.745449109165188,0,21,sphingolipid catabolic process,BP,
7261,GO:0030150,1,0.830545640505771,0,16,protein import into mitochondrial matrix,BP,
7262,GO:0030151,1,0.940545058975427,0,4,molybdenum ion binding,MF,
7265,GO:0030156,1,0.994319445226728,0,1,benzodiazepine receptor binding,MF,
7267,GO:0030158,1,0.952390056011625,0,3,protein xylosyltransferase activity,MF,
7269,GO:0030160,1,0.938940353884156,0,4,GKAP/Homer scaffold activity,MF,
7273,GO:0030166,1,0.400067646128401,0,58,proteoglycan biosynthetic process,BP,
7274,GO:0030167,1,0.940292819636274,0,4,proteoglycan catabolic process,BP,
7276,GO:0030169,1,0.80168810534933,0,14,low-density lipoprotein particle binding,MF,
7278,GO:0030171,1,0.973188314500805,0,2,voltage-gated proton channel activity,MF,
7279,GO:0030172,1,0.976381277115722,0,3,troponin C binding,MF,
7280,GO:0030173,1,0.452847447049914,0,53,integral component of Golgi membrane,CC,
7281,GO:0030174,1,0.925236837639912,0,5,regulation of DNA-dependent DNA replication initiation,BP,
7283,GO:0030176,1,0.148000026037252,0,137,integral component of endoplasmic reticulum membrane,CC,
7288,GO:0030184,1,0.984276552972496,0,1,nitric oxide transmembrane transporter activity,MF,
7290,GO:0030186,1,0.979758633791272,0,2,melatonin metabolic process,BP,
7291,GO:0030187,1,0.979758633791272,0,2,melatonin biosynthetic process,BP,
7293,GO:0030194,1,0.708837694401031,0,24,positive regulation of blood coagulation,BP,
7295,GO:0030197,1,0.962718420818724,0,3,extracellular matrix constituent, lubricant activity,MF,
7297,GO:0030199,1,0.556324450218848,0,37,collagen fibril organization,BP,
7298,GO:0030200,1,0.956142201904449,0,3,heparan sulfate proteoglycan catabolic process,BP,
7299,GO:0030201,1,0.616215871539089,0,30,heparan sulfate proteoglycan metabolic process,BP,
7300,GO:0030202,1,0.874967330189256,0,8,heparin metabolic process,BP,
7302,GO:0030204,1,0.528838283051986,0,41,chondroitin sulfate metabolic process,BP,
7303,GO:0030205,1,0.81976982789629,0,13,dermatan sulfate metabolic process,BP,
7304,GO:0030206,1,0.674243713170904,0,25,chondroitin sulfate biosynthetic process,BP,
7305,GO:0030207,1,0.810207125661734,0,14,chondroitin sulfate catabolic process,BP,
7306,GO:0030208,1,0.831496016840292,0,12,dermatan sulfate biosynthetic process,BP,
7307,GO:0030209,1,0.985908188314079,0,1,dermatan sulfate catabolic process,BP,
7308,GO:0030210,1,0.874967330189256,0,8,heparin biosynthetic process,BP,
7311,GO:0030214,1,0.80936921303082,0,14,hyaluronan catabolic process,BP,
7312,GO:0030215,1,0.860453886882275,0,10,semaphorin receptor binding,MF,
7318,GO:0030221,1,0.972980636286314,0,2,basophil differentiation,BP,
7319,GO:0030222,1,0.942344913623599,0,5,eosinophil differentiation,BP,
7320,GO:0030223,1,0.934500227501227,0,5,neutrophil differentiation,BP,
7323,GO:0030226,1,0.967126892145874,0,2,apolipoprotein receptor activity,MF,
7324,GO:0030228,1,0.774726264099795,0,16,lipoprotein particle receptor activity,MF,
7325,GO:0030229,1,0.936595014843937,0,4,very-low-density lipoprotein particle receptor activity,MF,
7326,GO:0030233,1,0.988442056876956,0,1,deoxynucleotide transmembrane transporter activity,MF,
7332,GO:0030240,1,0.93442315759164,0,5,skeletal muscle thin filament assembly,BP,
7334,GO:0030242,1,0.936570043230917,0,4,pexophagy,BP,
7336,GO:0030247,1,0.74428413564374,0,21,polysaccharide binding,MF,
7337,GO:0030249,1,0.92343238201522,0,8,guanylate cyclase regulator activity,MF,
7338,GO:0030250,1,0.936976895220202,0,7,guanylate cyclase activator activity,MF,
7339,GO:0030251,1,0.985548340511754,0,1,guanylate cyclase inhibitor activity,MF,
7340,GO:0030252,1,0.822032438541838,0,15,growth hormone secretion,BP,
7342,GO:0030259,1,0.922422581066036,0,6,lipid glycosylation,BP,
7344,GO:0030261,1,0.650752976326242,0,31,chromosome condensation,BP,
7345,GO:0030262,1,0.67531289652807,0,28,apoptotic nuclear changes,BP,
7346,GO:0030263,1,0.935734419281848,0,4,apoptotic chromosome condensation,BP,
7347,GO:0030264,1,0.983426667503296,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7348,GO:0030267,1,0.990850180449793,0,1,glyoxylate reductase (NADP) activity,MF,
7349,GO:0030272,1,0.993273363267434,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7350,GO:0030273,1,0.985133972157179,0,1,melanin-concentrating hormone receptor activity,MF,
7352,GO:0030275,1,0.788076759999688,0,17,LRR domain binding,MF,
7354,GO:0030277,1,0.785393306882798,0,17,maintenance of gastrointestinal epithelium,BP,
7359,GO:0030283,1,0.977952329981893,0,2,testosterone dehydrogenase [NAD(P)] activity,MF,
7360,GO:0030284,1,0.937053717376557,0,4,estrogen receptor activity,MF,
7362,GO:0030286,1,0.510353763299199,0,47,dynein complex,CC,
7363,GO:0030289,1,0.96359721091548,0,3,protein phosphatase 4 complex,CC,
7364,GO:0030290,1,0.983460115004183,0,1,sphingolipid activator protein activity,MF,
7366,GO:0030292,1,0.957231679986638,0,3,protein tyrosine kinase inhibitor activity,MF,
7367,GO:0030294,1,0.985853611792804,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7370,GO:0030297,1,0.894522373059577,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7371,GO:0030298,1,0.990940466439103,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7372,GO:0030299,1,0.836094895181578,0,14,intestinal cholesterol absorption,BP,
7373,GO:0030300,1,0.921018139917466,0,7,regulation of intestinal cholesterol absorption,BP,
7374,GO:0030301,1,0.353266995028746,0,76,cholesterol transport,BP,
7375,GO:0030302,1,0.988442056876956,0,1,deoxynucleotide transport,BP,
7376,GO:0030305,1,0.971436164950651,0,2,heparanase activity,MF,
7377,GO:0030306,1,0.882673075205837,0,8,ADP-ribosylation factor binding,MF,
7382,GO:0030312,1,0.985711813582725,0,1,external encapsulating structure,CC,
7384,GO:0030315,1,0.498903142065653,0,44,T-tubule,CC,
7386,GO:0030317,1,0.39379769825497,0,72,flagellated sperm motility,BP,
7388,GO:0030320,1,0.821732729914168,0,13,cellular monovalent inorganic anion homeostasis,BP,
7389,GO:0030321,1,0.930503832003168,0,5,transepithelial chloride transport,BP,
7390,GO:0030322,1,0.985729973065121,0,1,stabilization of membrane potential,BP,
7395,GO:0030327,1,0.952631618547017,0,3,prenylated protein catabolic process,BP,
7396,GO:0030328,1,0.968428617639534,0,2,prenylcysteine catabolic process,BP,
7397,GO:0030329,1,0.968428617639534,0,2,prenylcysteine metabolic process,BP,
7399,GO:0030331,1,0.557717563324192,0,38,estrogen receptor binding,MF,
7404,GO:0030337,1,0.975104867761274,0,2,DNA polymerase processivity factor activity,MF,
7405,GO:0030342,1,0.983675976604856,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7406,GO:0030343,1,0.973004439514259,0,2,vitamin D3 25-hydroxylase activity,MF,
7407,GO:0030345,1,0.938719196533169,0,6,structural constituent of tooth enamel,MF,
7408,GO:0030346,1,0.922287593081728,0,6,protein phosphatase 2B binding,MF,
7409,GO:0030348,1,0.954705773591393,0,3,syntaxin-3 binding,MF,
7410,GO:0030350,1,0.967164131886728,0,2,iron-responsive element binding,MF,
7411,GO:0030351,1,0.984099260716134,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7412,GO:0030354,1,0.994202543736181,0,1,melanin-concentrating hormone activity,MF,
7413,GO:0030366,1,0.978224915272337,0,2,molybdopterin synthase activity,MF,
7414,GO:0030368,1,0.880306442484654,0,8,interleukin-17 receptor activity,MF,
7415,GO:0030369,1,0.955511588612741,0,3,ICAM-3 receptor activity,MF,
7416,GO:0030371,1,0.694657542006936,0,24,translation repressor activity,MF,
7417,GO:0030372,1,0.983426667502856,0,1,high molecular weight B cell growth factor receptor binding,MF,
7420,GO:0030377,1,0.989609312748199,0,1,urokinase plasminogen activator receptor activity,MF,
7421,GO:0030378,1,0.984951089777405,0,1,serine racemase activity,MF,
7422,GO:0030379,1,0.983426667500202,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7423,GO:0030380,1,0.99089849503833,0,1,interleukin-17E receptor binding,MF,
7424,GO:0030382,1,0.987920347993421,0,1,sperm mitochondrion organization,BP,
7425,GO:0030387,1,0.989639162808683,0,1,fructosamine-3-kinase activity,MF,
7426,GO:0030388,1,0.919584465598856,0,7,fructose 1,6-bisphosphate metabolic process,BP,
7427,GO:0030389,1,0.989639162808683,0,1,fructosamine metabolic process,BP,
7428,GO:0030393,1,0.989639162808683,0,1,fructoselysine metabolic process,BP,
7429,GO:0030395,1,0.968636750735859,0,3,lactose binding,MF,
7430,GO:0030397,1,0.500858920749532,0,46,membrane disassembly,BP,
7431,GO:0030407,1,0.98715611468249,0,1,formimidoyltransferase activity,MF,
7432,GO:0030409,1,0.98715611468249,0,1,glutamate formimidoyltransferase activity,MF,
7433,GO:0030412,1,0.98715611468249,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7435,GO:0030421,1,0.993174039443204,0,1,defecation,BP,
7436,GO:0030422,1,0.945049239970511,0,4,production of siRNA involved in RNA interference,BP,
7437,GO:0030423,1,0.96137239707854,0,3,targeting of mRNA for destruction involved in RNA interference,BP,
7442,GO:0030429,1,0.989328906139524,0,1,kynureninase activity,MF,
7443,GO:0030430,1,0.940443163744735,0,4,host cell cytoplasm,CC,
7446,GO:0030433,1,0.353180504682818,0,71,ubiquitin-dependent ERAD pathway,BP,
7447,GO:0030449,1,0.63841093335838,0,31,regulation of complement activation,BP,
7448,GO:0030450,1,0.962395754370179,0,3,regulation of complement activation, classical pathway,BP,
7449,GO:0030451,1,0.983426667497591,0,1,regulation of complement activation, alternative pathway,BP,
7450,GO:0030473,1,0.951105344778763,0,3,nuclear migration along microtubule,BP,
7451,GO:0030478,1,0.936173122495699,0,4,actin cap,CC,
7453,GO:0030488,1,0.687550829695424,0,26,tRNA methylation,BP,
7454,GO:0030490,1,0.536965265870545,0,48,maturation of SSU-rRNA,BP,
7455,GO:0030492,1,0.966438415601634,0,5,hemoglobin binding,MF,
7457,GO:0030497,1,0.894363447470218,0,8,fatty acid elongation,BP,
7460,GO:0030502,1,0.813173759764609,0,16,negative regulation of bone mineralization,BP,
7461,GO:0030504,1,0.983426667498823,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7462,GO:0030505,1,0.967126892147616,0,2,inorganic diphosphate transport,BP,
7467,GO:0030511,1,0.69148203035332,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7471,GO:0030515,1,0.704961690571458,0,28,snoRNA binding,MF,
7474,GO:0030518,1,0.160089004821486,0,124,intracellular steroid hormone receptor signaling pathway,BP,
7475,GO:0030520,1,0.488201093169619,0,48,intracellular estrogen receptor signaling pathway,BP,
7476,GO:0030521,1,0.381524025513872,0,65,androgen receptor signaling pathway,BP,
7478,GO:0030523,1,0.983426667503199,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7479,GO:0030526,1,0.983426667502809,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7481,GO:0030532,1,0.431774479217434,0,65,small nuclear ribonucleoprotein complex,CC,
7486,GO:0030544,1,0.619659229767073,0,33,Hsp70 protein binding,MF,
7489,GO:0030547,1,0.817960890145612,0,15,receptor inhibitor activity,MF,
7490,GO:0030548,1,0.931279237689313,0,6,acetylcholine receptor regulator activity,MF,
7491,GO:0030549,1,0.99143454401075,0,1,acetylcholine receptor activator activity,MF,
7492,GO:0030550,1,0.95009744287224,0,4,acetylcholine receptor inhibitor activity,MF,
7495,GO:0030553,1,0.810889556561086,0,14,cGMP binding,MF,
7497,GO:0030572,1,0.983430378849187,0,1,phosphatidyltransferase activity,MF,
7498,GO:0030573,1,0.957364109379928,0,3,bile acid catabolic process,BP,
7499,GO:0030574,1,0.368399547139499,0,66,collagen catabolic process,BP,
7500,GO:0030575,1,0.854685149196672,0,10,nuclear body organization,BP,
7501,GO:0030576,1,0.969955116507221,0,2,Cajal body organization,BP,
7502,GO:0030578,1,0.941658834267496,0,4,PML body organization,BP,
7503,GO:0030579,1,0.915252805998566,0,6,ubiquitin-dependent SMAD protein catabolic process,BP,
7504,GO:0030580,1,0.990677269526394,0,1,quinone cofactor methyltransferase activity,MF,
7505,GO:0030581,1,0.934775998830161,0,5,symbiont intracellular protein transport in host,BP,
7506,GO:0030586,1,0.983583320421907,0,1,[methionine synthase] reductase activity,MF,
7508,GO:0030594,1,0.273298451972413,0,95,neurotransmitter receptor activity,MF,
7510,GO:0030611,1,0.993075030111578,0,1,arsenate reductase activity,MF,
7511,GO:0030613,1,0.976524997153876,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7512,GO:0030614,1,0.976524997153876,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7513,GO:0030616,1,0.983426667498183,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7514,GO:0030617,1,0.968073767614943,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7515,GO:0030618,1,0.920280288830081,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7516,GO:0030619,1,0.928793590224536,0,6,U1 snRNA binding,MF,
7517,GO:0030620,1,0.952794013168838,0,5,U2 snRNA binding,MF,
7518,GO:0030621,1,0.924193917887541,0,5,U4 snRNA binding,MF,
7519,GO:0030622,1,0.969574904112614,0,2,U4atac snRNA binding,MF,
7520,GO:0030623,1,0.983426667499856,0,1,U5 snRNA binding,MF,
7521,GO:0030624,1,0.9834266675032,0,1,U6atac snRNA binding,MF,
7522,GO:0030626,1,0.970824726210551,0,2,U12 snRNA binding,MF,
7523,GO:0030627,1,0.975327833475608,0,2,pre-mRNA 5'-splice site binding,MF,
7524,GO:0030628,1,0.929412472042416,0,6,pre-mRNA 3'-splice site binding,MF,
7525,GO:0030638,1,0.916554192946922,0,8,polyketide metabolic process,BP,
7527,GO:0030643,1,0.869582413203199,0,9,cellular phosphate ion homeostasis,BP,
7528,GO:0030644,1,0.945004930195507,0,4,cellular chloride ion homeostasis,BP,
7529,GO:0030647,1,0.903425442708368,0,9,aminoglycoside antibiotic metabolic process,BP,
7530,GO:0030653,1,0.983426667502562,0,1,beta-lactam antibiotic metabolic process,BP,
7536,GO:0030663,1,0.805631577457862,0,16,COPI-coated vesicle membrane,CC,
7545,GO:0030676,1,0.780454733746765,0,15,Rac guanyl-nucleotide exchange factor activity,MF,
7546,GO:0030677,1,0.889112003602866,0,10,ribonuclease P complex,CC,
7547,GO:0030678,1,0.962570010815577,0,3,mitochondrial ribonuclease P complex,CC,
7548,GO:0030681,1,0.923697175060487,0,7,multimeric ribonuclease P complex,CC,
7549,GO:0030682,1,0.984371383470671,0,1,evasion or tolerance of host defense response,BP,
7550,GO:0030683,1,0.984371383470671,0,1,evasion or tolerance by virus of host immune response,BP,
7551,GO:0030684,1,0.393583266950504,0,67,preribosome,CC,
7552,GO:0030686,1,0.6541754423281,0,29,90S preribosome,CC,
7553,GO:0030687,1,0.74905639493726,0,22,preribosome, large subunit precursor,CC,
7554,GO:0030688,1,0.850339947237241,0,11,preribosome, small subunit precursor,CC,
7555,GO:0030689,1,0.957193122656743,0,3,Noc complex,CC,
7556,GO:0030690,1,0.984160207987224,0,1,Noc1p-Noc2p complex,CC,
7557,GO:0030691,1,0.984160207987224,0,1,Noc2p-Noc3p complex,CC,
7558,GO:0030692,1,0.972600675255823,0,2,Noc4p-Nop14p complex,CC,
7560,GO:0030696,1,0.983685986724605,0,1,tRNA (m5U54) methyltransferase activity,MF,
7561,GO:0030697,1,0.983685986724605,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7562,GO:0030705,1,0.126975184277524,0,138,cytoskeleton-dependent intracellular transport,BP,
7563,GO:0030718,1,0.958772135911762,0,3,germ-line stem cell population maintenance,BP,
7564,GO:0030719,1,0.968423116816807,0,2,P granule organization,BP,
7566,GO:0030729,1,0.983557247740639,0,1,acetoacetate-CoA ligase activity,MF,
7567,GO:0030730,1,0.824753737426307,0,15,sequestering of triglyceride,BP,
7568,GO:0030731,1,0.992404949943118,0,1,guanidinoacetate N-methyltransferase activity,MF,
7570,GO:0030748,1,0.984736899495618,0,1,amine N-methyltransferase activity,MF,
7571,GO:0030760,1,0.988816628009084,0,1,pyridine N-methyltransferase activity,MF,
7572,GO:0030791,1,0.984980273215803,0,1,arsenite methyltransferase activity,MF,
7573,GO:0030792,1,0.984980273215803,0,1,methylarsonite methyltransferase activity,MF,
7580,GO:0030805,1,0.951667675770036,0,3,regulation of cyclic nucleotide catabolic process,BP,
7581,GO:0030806,1,0.967707983419544,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7582,GO:0030807,1,0.983426667501433,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7586,GO:0030811,1,0.951667675770036,0,3,regulation of nucleotide catabolic process,BP,
7587,GO:0030812,1,0.967707983419544,0,2,negative regulation of nucleotide catabolic process,BP,
7588,GO:0030813,1,0.983426667501433,0,1,positive regulation of nucleotide catabolic process,BP,
7594,GO:0030819,1,0.365723557463951,0,78,positive regulation of cAMP biosynthetic process,BP,
7595,GO:0030820,1,0.951667675770036,0,3,regulation of cAMP catabolic process,BP,
7596,GO:0030821,1,0.967707983419544,0,2,negative regulation of cAMP catabolic process,BP,
7597,GO:0030822,1,0.983426667501433,0,1,positive regulation of cAMP catabolic process,BP,
7599,GO:0030824,1,0.975514433699385,0,2,negative regulation of cGMP metabolic process,BP,
7602,GO:0030827,1,0.975514433699385,0,2,negative regulation of cGMP biosynthetic process,BP,
7611,GO:0030842,1,0.983426667502019,0,1,regulation of intermediate filament depolymerization,BP,
7612,GO:0030844,1,0.983426667502019,0,1,positive regulation of intermediate filament depolymerization,BP,
7613,GO:0030845,1,0.984085429030766,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7614,GO:0030846,1,0.983426667495718,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7618,GO:0030852,1,0.822985747521499,0,14,regulation of granulocyte differentiation,BP,
7619,GO:0030853,1,0.882005010535943,0,8,negative regulation of granulocyte differentiation,BP,
7620,GO:0030854,1,0.917671321427444,0,7,positive regulation of granulocyte differentiation,BP,
7626,GO:0030860,1,0.967164006330006,0,2,regulation of polarized epithelial cell differentiation,BP,
7627,GO:0030862,1,0.967164006330006,0,2,positive regulation of polarized epithelial cell differentiation,BP,
7632,GO:0030867,1,0.750089088082738,0,21,rough endoplasmic reticulum membrane,CC,
7634,GO:0030870,1,0.922988296384664,0,5,Mre11 complex,CC,
7635,GO:0030874,1,0.988049419275219,0,1,nucleolar chromatin,CC,
7639,GO:0030880,1,0.169060002916658,0,127,RNA polymerase complex,CC,
7640,GO:0030881,1,0.889165508620948,0,9,beta-2-microglobulin binding,MF,
7641,GO:0030882,1,0.933200332135234,0,5,lipid antigen binding,MF,
7642,GO:0030883,1,0.933200332135234,0,5,endogenous lipid antigen binding,MF,
7643,GO:0030884,1,0.933200332135234,0,5,exogenous lipid antigen binding,MF,
7644,GO:0030885,1,0.946359556393111,0,5,regulation of myeloid dendritic cell activation,BP,
7645,GO:0030886,1,0.964356493752756,0,3,negative regulation of myeloid dendritic cell activation,BP,
7646,GO:0030887,1,0.989077249011558,0,1,positive regulation of myeloid dendritic cell activation,BP,
7648,GO:0030889,1,0.802811521165068,0,15,negative regulation of B cell proliferation,BP,
7650,GO:0030891,1,0.941168601728207,0,5,VCB complex,CC,
7651,GO:0030893,1,0.910324745046736,0,6,meiotic cohesin complex,CC,
7652,GO:0030894,1,0.6623291900504,0,30,replisome,CC,
7653,GO:0030895,1,0.958507791666493,0,3,apolipoprotein B mRNA editing enzyme complex,CC,
7654,GO:0030896,1,0.922599028560902,0,6,checkpoint clamp complex,CC,
7655,GO:0030897,1,0.79832396651417,0,14,HOPS complex,CC,
7657,GO:0030899,1,0.974692291672754,0,2,calcium-dependent ATPase activity,MF,
7662,GO:0030904,1,0.741215829563259,0,20,retromer complex,CC,
7663,GO:0030905,1,0.941188660974954,0,4,retromer, tubulation complex,CC,
7664,GO:0030906,1,0.944545383788847,0,4,retromer, cargo-selective complex,CC,
7665,GO:0030908,1,0.975384206121925,0,2,protein splicing,BP,
7667,GO:0030911,1,0.910659605495204,0,6,TPR domain binding,MF,
7668,GO:0030913,1,0.897750982427706,0,7,paranodal junction assembly,BP,
7669,GO:0030914,1,0.835823930826587,0,13,STAGA complex,CC,
7670,GO:0030915,1,0.931361677101709,0,6,Smc5-Smc6 complex,CC,
7673,GO:0030920,1,0.982505536016954,0,2,peptidyl-serine acetylation,BP,
7674,GO:0030934,1,0.951096177105706,0,3,anchoring collagen complex,CC,
7675,GO:0030935,1,0.984559650500708,0,1,sheet-forming collagen trimer,CC,
7676,GO:0030936,1,0.983792438567467,0,1,transmembrane collagen trimer,CC,
7677,GO:0030942,1,0.962596808721495,0,3,endoplasmic reticulum signal peptide binding,MF,
7678,GO:0030943,1,0.967416342699851,0,3,mitochondrion targeting sequence binding,MF,
7680,GO:0030948,1,0.901073191860666,0,7,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7682,GO:0030950,1,0.937623081426601,0,4,establishment or maintenance of actin cytoskeleton polarity,BP,
7683,GO:0030951,1,0.951941428002227,0,3,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7684,GO:0030952,1,0.892550528517802,0,7,establishment or maintenance of cytoskeleton polarity,BP,
7685,GO:0030953,1,0.906482493551376,0,6,astral microtubule organization,BP,
7686,GO:0030955,1,0.802149221830177,0,14,potassium ion binding,MF,
7687,GO:0030956,1,0.980261045838147,0,2,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7689,GO:0030961,1,0.984728932554734,0,1,peptidyl-arginine hydroxylation,BP,
7690,GO:0030964,1,0.729169620071208,0,42,NADH dehydrogenase complex,CC,
7692,GO:0030969,1,0.953074540220992,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7693,GO:0030970,1,0.683505231290948,0,26,retrograde protein transport, ER to cytosol,BP,
7695,GO:0030974,1,0.988442056876956,0,1,thiamine pyrophosphate transport,BP,
7696,GO:0030975,1,0.985321884811008,0,1,thiamine binding,MF,
7697,GO:0030976,1,0.924700631723774,0,5,thiamine pyrophosphate binding,MF,
7698,GO:0030977,1,0.987573539727232,0,1,taurine binding,MF,
7699,GO:0030981,1,0.96824718244421,0,2,cortical microtubule cytoskeleton,CC,
7700,GO:0030983,1,0.827380046713422,0,12,mismatched DNA binding,MF,
7701,GO:0030984,1,0.991338733930065,0,1,kininogen binding,MF,
7702,GO:0030990,1,0.658384889753195,0,28,intraciliary transport particle,CC,
7703,GO:0030991,1,0.89193510859577,0,7,intraciliary transport particle A,CC,
7704,GO:0030992,1,0.770892851550671,0,18,intraciliary transport particle B,CC,
7705,GO:0030997,1,0.953807111612352,0,3,regulation of centriole-centriole cohesion,BP,
7707,GO:0031001,1,0.984728932554734,0,1,response to brefeldin A,BP,
7708,GO:0031002,1,0.990753920282674,0,1,actin rod,CC,
7709,GO:0031005,1,0.83786924190577,0,11,filamin binding,MF,
7710,GO:0031010,1,0.845481545112141,0,11,ISWI-type complex,CC,
7711,GO:0031011,1,0.838644216567794,0,14,Ino80 complex,CC,
7713,GO:0031013,1,0.950096838919055,0,5,troponin I binding,MF,
7714,GO:0031014,1,0.975151726183742,0,4,troponin T binding,MF,
7716,GO:0031017,1,0.926230875533963,0,6,exocrine pancreas development,BP,
7718,GO:0031021,1,0.963366190707201,0,3,interphase microtubule organizing center,CC,
7719,GO:0031022,1,0.967127156418034,0,2,nuclear migration along microfilament,BP,
7724,GO:0031038,1,0.986245001384253,0,1,myosin II filament organization,BP,
7727,GO:0031048,1,0.984728932554734,0,1,chromatin silencing by small RNA,BP,
7728,GO:0031049,1,0.984131985637324,0,1,programmed DNA elimination,BP,
7730,GO:0031052,1,0.984131985637324,0,1,chromosome breakage,BP,
7731,GO:0031053,1,0.865287789681409,0,9,primary miRNA processing,BP,
7732,GO:0031054,1,0.819660477406038,0,13,pre-miRNA processing,BP,
7733,GO:0031055,1,0.674768781510733,0,41,chromatin remodeling at centromere,BP,
7735,GO:0031057,1,0.552347687642651,0,39,negative regulation of histone modification,BP,
7737,GO:0031060,1,0.410326749559801,0,58,regulation of histone methylation,BP,
7738,GO:0031061,1,0.741747275181879,0,19,negative regulation of histone methylation,BP,
7739,GO:0031062,1,0.604756341725429,0,33,positive regulation of histone methylation,BP,
7740,GO:0031063,1,0.694786473040625,0,25,regulation of histone deacetylation,BP,
7741,GO:0031064,1,0.93779767824453,0,5,negative regulation of histone deacetylation,BP,
7742,GO:0031065,1,0.77958403356147,0,16,positive regulation of histone deacetylation,BP,
7744,GO:0031071,1,0.985260191042468,0,1,cysteine desulfurase activity,MF,
7746,GO:0031074,1,0.943583034709967,0,4,nucleocytoplasmic shuttling complex,CC,
7748,GO:0031077,1,0.908222990598765,0,7,post-embryonic camera-type eye development,BP,
7749,GO:0031078,1,0.842015568819208,0,11,histone deacetylase activity (H3-K14 specific),MF,
7750,GO:0031080,1,0.860705617863897,0,10,nuclear pore outer ring,CC,
7751,GO:0031081,1,0.983426667503302,0,1,nuclear pore distribution,BP,
7752,GO:0031082,1,0.766886337429665,0,19,BLOC complex,CC,
7753,GO:0031083,1,0.831994224716948,0,14,BLOC-1 complex,CC,
7754,GO:0031084,1,0.952155851329499,0,3,BLOC-2 complex,CC,
7755,GO:0031085,1,0.968127347678957,0,2,BLOC-3 complex,CC,
7756,GO:0031086,1,0.885780690563421,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7757,GO:0031087,1,0.900334504421429,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7758,GO:0031088,1,0.919344967849348,0,6,platelet dense granule membrane,CC,
7759,GO:0031089,1,0.856664829727627,0,13,platelet dense granule lumen,CC,
7762,GO:0031092,1,0.778109020069239,0,17,platelet alpha granule membrane,CC,
7765,GO:0031095,1,0.874930748915608,0,8,platelet dense tubular network membrane,CC,
7771,GO:0031104,1,0.983426667503345,0,1,dendrite regeneration,BP,
7772,GO:0031105,1,0.91713586237667,0,6,septin complex,CC,
7773,GO:0031106,1,0.983426667502857,0,1,septin ring organization,BP,
7776,GO:0031111,1,0.684029311795513,0,26,negative regulation of microtubule polymerization or depolymerization,BP,
7779,GO:0031114,1,0.77233143513482,0,18,regulation of microtubule depolymerization,BP,
7780,GO:0031115,1,0.866575290111429,0,10,negative regulation of microtubule polymerization,BP,
7782,GO:0031117,1,0.963138529854865,0,3,positive regulation of microtubule depolymerization,BP,
7783,GO:0031118,1,0.94500443602493,0,6,rRNA pseudouridine synthesis,BP,
7784,GO:0031119,1,0.950913044218022,0,4,tRNA pseudouridine synthesis,BP,
7785,GO:0031120,1,0.964893453493569,0,4,snRNA pseudouridine synthesis,BP,
7787,GO:0031123,1,0.192961528840901,0,114,RNA 3'-end processing,BP,
7788,GO:0031124,1,0.269427046698936,0,89,mRNA 3'-end processing,BP,
7789,GO:0031125,1,0.900629567790707,0,10,rRNA 3'-end processing,BP,
7790,GO:0031126,1,0.929418420209068,0,7,snoRNA 3'-end processing,BP,
7791,GO:0031127,1,0.967453483254851,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7793,GO:0031129,1,0.983426667502414,0,1,inductive cell-cell signaling,BP,
7795,GO:0031134,1,0.968407661017497,0,2,sister chromatid biorientation,BP,
7797,GO:0031145,1,0.398042942911106,0,80,anaphase-promoting complex-dependent catabolic process,BP,
7798,GO:0031146,1,0.425928907056625,0,71,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7799,GO:0031151,1,0.98342666749971,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7800,GO:0031161,1,0.983701498911882,0,1,phosphatidylinositol catabolic process,BP,
7801,GO:0031163,1,0.815568912428965,0,18,metallo-sulfur cluster assembly,BP,
7802,GO:0031166,1,0.951613858592608,0,3,integral component of vacuolar membrane,CC,
7803,GO:0031167,1,0.814118983117233,0,16,rRNA methylation,BP,
7805,GO:0031177,1,0.978368590400941,0,2,phosphopantetheine binding,MF,
7806,GO:0031179,1,0.97089626042744,0,2,peptide modification,BP,
7808,GO:0031204,1,0.979132639697335,0,2,posttranslational protein targeting to membrane, translocation,BP,
7809,GO:0031205,1,0.962903739420755,0,3,endoplasmic reticulum Sec complex,CC,
7810,GO:0031208,1,0.96838948713097,0,2,POZ domain binding,MF,
7811,GO:0031209,1,0.876298196477646,0,8,SCAR complex,CC,
7813,GO:0031211,1,0.891701927306572,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7814,GO:0031213,1,0.967127992772641,0,2,RSF complex,CC,
7820,GO:0031227,1,0.136893088558222,0,142,intrinsic component of endoplasmic reticulum membrane,CC,
7821,GO:0031228,1,0.419618385207371,0,58,intrinsic component of Golgi membrane,CC,
7822,GO:0031229,1,0.808027971352611,0,14,intrinsic component of nuclear inner membrane,CC,
7823,GO:0031231,1,0.829915861495609,0,14,intrinsic component of peroxisomal membrane,CC,
7825,GO:0031233,1,0.718431301632253,0,25,intrinsic component of external side of plasma membrane,CC,
7828,GO:0031247,1,0.97109799223411,0,2,actin rod assembly,BP,
7829,GO:0031248,1,0.277761043841627,0,88,protein acetyltransferase complex,CC,
7830,GO:0031249,1,0.98512162401357,0,1,denatured protein binding,MF,
7831,GO:0031251,1,0.967126892153134,0,2,PAN complex,CC,
7836,GO:0031257,1,0.984728932554734,0,1,cell trailing edge membrane,CC,
7837,GO:0031258,1,0.748503493228403,0,19,lamellipodium membrane,CC,
7838,GO:0031259,1,0.984728932554734,0,1,uropod membrane,CC,
7839,GO:0031260,1,0.991879343305166,0,1,pseudopodium membrane,CC,
7840,GO:0031261,1,0.931930394665748,0,5,DNA replication preinitiation complex,CC,
7841,GO:0031262,1,0.95871321382532,0,4,Ndc80 complex,CC,
7842,GO:0031264,1,0.876055622182635,0,9,death-inducing signaling complex,CC,
7843,GO:0031265,1,0.914455710379551,0,6,CD95 death-inducing signaling complex,CC,
7845,GO:0031268,1,0.800576331649203,0,16,pseudopodium organization,BP,
7846,GO:0031269,1,0.807136643390262,0,15,pseudopodium assembly,BP,
7847,GO:0031271,1,0.984728932554734,0,1,lateral pseudopodium assembly,BP,
7848,GO:0031272,1,0.833488050241098,0,13,regulation of pseudopodium assembly,BP,
7849,GO:0031274,1,0.846422698879046,0,12,positive regulation of pseudopodium assembly,BP,
7850,GO:0031275,1,0.984728932554734,0,1,regulation of lateral pseudopodium assembly,BP,
7851,GO:0031279,1,0.292115528727073,0,89,regulation of cyclase activity,BP,
7852,GO:0031280,1,0.673843801479168,0,30,negative regulation of cyclase activity,BP,
7853,GO:0031281,1,0.435577052199494,0,59,positive regulation of cyclase activity,BP,
7854,GO:0031282,1,0.859579584360947,0,13,regulation of guanylate cyclase activity,BP,
7855,GO:0031283,1,0.975514433699385,0,2,negative regulation of guanylate cyclase activity,BP,
7856,GO:0031284,1,0.881166662197249,0,11,positive regulation of guanylate cyclase activity,BP,
7857,GO:0031289,1,0.983807722493411,0,1,actin phosphorylation,BP,
7858,GO:0031290,1,0.723367393299879,0,21,retinal ganglion cell axon guidance,BP,
7859,GO:0031291,1,0.983426667503296,0,1,Ran protein signal transduction,BP,
7860,GO:0031293,1,0.785447475149978,0,16,membrane protein intracellular domain proteolysis,BP,
7863,GO:0031296,1,0.968914230894871,0,4,B cell costimulation,BP,
7864,GO:0031297,1,0.691607209829136,0,24,replication fork processing,BP,
7865,GO:0031298,1,0.921776818512914,0,6,replication fork protection complex,CC,
7868,GO:0031302,1,0.983426667502513,0,1,intrinsic component of endosome membrane,CC,
7869,GO:0031304,1,0.719802482714735,0,25,intrinsic component of mitochondrial inner membrane,CC,
7870,GO:0031305,1,0.719802482714735,0,25,integral component of mitochondrial inner membrane,CC,
7871,GO:0031306,1,0.717498696702475,0,24,intrinsic component of mitochondrial outer membrane,CC,
7872,GO:0031307,1,0.729606383890424,0,23,integral component of mitochondrial outer membrane,CC,
7873,GO:0031308,1,0.984728932554734,0,1,intrinsic component of nuclear outer membrane,CC,
7874,GO:0031309,1,0.984728932554734,0,1,integral component of nuclear outer membrane,CC,
7875,GO:0031310,1,0.951613858592608,0,3,intrinsic component of vacuolar membrane,CC,
7876,GO:0031312,1,0.659621566628764,0,28,extrinsic component of organelle membrane,CC,
7877,GO:0031313,1,0.914428804364983,0,6,extrinsic component of endosome membrane,CC,
7878,GO:0031314,1,0.918498420163098,0,6,extrinsic component of mitochondrial inner membrane,CC,
7879,GO:0031315,1,0.96776470050392,0,2,extrinsic component of mitochondrial outer membrane,CC,
7880,GO:0031320,1,0.984812627494499,0,1,hexitol dehydrogenase activity,MF,
7890,GO:0031332,1,0.841692006357763,0,11,RNAi effector complex,CC,
7893,GO:0031335,1,0.970735289928478,0,2,regulation of sulfur amino acid metabolic process,BP,
7894,GO:0031337,1,0.985631043093334,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7895,GO:0031338,1,0.369134726976602,0,66,regulation of vesicle fusion,BP,
7896,GO:0031339,1,0.924613318051585,0,5,negative regulation of vesicle fusion,BP,
7897,GO:0031340,1,0.898757199891017,0,8,positive regulation of vesicle fusion,BP,
7898,GO:0031341,1,0.467834950724658,0,57,regulation of cell killing,BP,
7899,GO:0031342,1,0.806817741764913,0,16,negative regulation of cell killing,BP,
7900,GO:0031343,1,0.621571088018507,0,36,positive regulation of cell killing,BP,
7907,GO:0031362,1,0.768301763253916,0,20,anchored component of external side of plasma membrane,CC,
7909,GO:0031369,1,0.66928001210562,0,29,translation initiation factor binding,MF,
7910,GO:0031370,1,0.983426667502908,0,1,eukaryotic initiation factor 4G binding,MF,
7911,GO:0031371,1,0.884870337606399,0,9,ubiquitin conjugating enzyme complex,CC,
7912,GO:0031372,1,0.974052204498339,0,2,UBC13-MMS2 complex,CC,
7913,GO:0031379,1,0.967280959234479,0,2,RNA-directed RNA polymerase complex,CC,
7914,GO:0031380,1,0.983583320421907,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7915,GO:0031386,1,0.924786394504698,0,8,protein tag,MF,
7916,GO:0031389,1,0.984014323910838,0,1,Rad17 RFC-like complex,CC,
7917,GO:0031390,1,0.893154182489082,0,8,Ctf18 RFC-like complex,CC,
7918,GO:0031392,1,0.92163583093711,0,6,regulation of prostaglandin biosynthetic process,BP,
7919,GO:0031393,1,0.967420293476465,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7920,GO:0031394,1,0.952680005981092,0,4,positive regulation of prostaglandin biosynthetic process,BP,
7922,GO:0031397,1,0.183284631078593,0,134,negative regulation of protein ubiquitination,BP,
7927,GO:0031402,1,0.814280022758341,0,13,sodium ion binding,MF,
7928,GO:0031403,1,0.967221510382103,0,2,lithium ion binding,MF,
7929,GO:0031404,1,0.885002852245313,0,9,chloride ion binding,MF,
7931,GO:0031407,1,0.98530228173233,0,1,oxylipin metabolic process,BP,
7933,GO:0031414,1,0.871521776585433,0,10,N-terminal protein acetyltransferase complex,CC,
7934,GO:0031415,1,0.938339399384231,0,5,NatA complex,CC,
7935,GO:0031416,1,0.975559909706341,0,2,NatB complex,CC,
7936,GO:0031417,1,0.952083434137872,0,3,NatC complex,CC,
7937,GO:0031418,1,0.761917025036524,0,18,L-ascorbic acid binding,MF,
7938,GO:0031419,1,0.882822506834017,0,9,cobalamin binding,MF,
7939,GO:0031420,1,0.738136756413443,0,19,alkali metal ion binding,MF,
7941,GO:0031427,1,0.939896006161919,0,4,response to methotrexate,BP,
7942,GO:0031428,1,0.954423768769604,0,4,box C/D snoRNP complex,CC,
7943,GO:0031429,1,0.956704301844723,0,5,box H/ACA snoRNP complex,CC,
7944,GO:0031430,1,0.660826682907665,0,29,M band,CC,
7946,GO:0031433,1,0.907209080263114,0,7,telethonin binding,MF,
7948,GO:0031435,1,0.773365060870958,0,16,mitogen-activated protein kinase kinase kinase binding,MF,
7949,GO:0031436,1,0.968305864783357,0,2,BRCA1-BARD1 complex,CC,
7950,GO:0031437,1,0.969138462003752,0,2,regulation of mRNA cleavage,BP,
7951,GO:0031438,1,0.983776442232462,0,1,negative regulation of mRNA cleavage,BP,
7952,GO:0031439,1,0.98512162401357,0,1,positive regulation of mRNA cleavage,BP,
7953,GO:0031440,1,0.733922603715687,0,20,regulation of mRNA 3'-end processing,BP,
7954,GO:0031441,1,0.879573166413325,0,8,negative regulation of mRNA 3'-end processing,BP,
7955,GO:0031442,1,0.887118277370961,0,8,positive regulation of mRNA 3'-end processing,BP,
7956,GO:0031443,1,0.96717205135993,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7957,GO:0031444,1,0.967573473437719,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7958,GO:0031445,1,0.972091483385914,0,2,regulation of heterochromatin assembly,BP,
7959,GO:0031446,1,0.983472584656398,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7960,GO:0031448,1,0.983472584656398,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7961,GO:0031449,1,0.98342666750138,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7962,GO:0031453,1,0.972091483385914,0,2,positive regulation of heterochromatin assembly,BP,
7963,GO:0031455,1,0.96718366045249,0,2,glycine betaine metabolic process,BP,
7964,GO:0031456,1,0.96718366045249,0,2,glycine betaine biosynthetic process,BP,
7965,GO:0031460,1,0.983426667502758,0,1,glycine betaine transport,BP,
7966,GO:0031461,1,0.0773944096191465,0,171,cullin-RING ubiquitin ligase complex,CC,
7967,GO:0031462,1,0.890307901326014,0,9,Cul2-RING ubiquitin ligase complex,CC,
7968,GO:0031463,1,0.338774726032956,0,70,Cul3-RING ubiquitin ligase complex,CC,
7969,GO:0031464,1,0.865002878993117,0,10,Cul4A-RING E3 ubiquitin ligase complex,CC,
7970,GO:0031465,1,0.935274666730539,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7971,GO:0031466,1,0.927993615563502,0,6,Cul5-RING ubiquitin ligase complex,CC,
7972,GO:0031467,1,0.949080270047318,0,4,Cul7-RING ubiquitin ligase complex,CC,
7973,GO:0031468,1,0.791875159664166,0,17,nuclear envelope reassembly,BP,
7974,GO:0031475,1,0.989134658985333,0,1,myosin V complex,CC,
7980,GO:0031493,1,0.956873469257478,0,3,nucleosomal histone binding,MF,
7981,GO:0031494,1,0.984728932554734,0,1,regulation of mating type switching,BP,
7982,GO:0031497,1,0.214090050040035,0,149,chromatin assembly,BP,
7983,GO:0031498,1,0.762334894516433,0,20,chromatin disassembly,BP,
7984,GO:0031501,1,0.963380016424985,0,4,mannosyltransferase complex,CC,
7986,GO:0031506,1,0.987762819794679,0,1,cell wall glycoprotein biosynthetic process,BP,
7987,GO:0031507,1,0.847753674100603,0,12,heterochromatin assembly,BP,
7988,GO:0031508,1,0.952425341724001,0,4,pericentric heterochromatin assembly,BP,
7989,GO:0031509,1,0.965373538700304,0,3,telomeric heterochromatin assembly,BP,
7990,GO:0031510,1,0.959527064917073,0,3,SUMO activating enzyme complex,CC,
7991,GO:0031514,1,0.174259455556683,0,128,motile cilium,CC,
7992,GO:0031515,1,0.957131627030131,0,3,tRNA (m1A) methyltransferase complex,CC,
7993,GO:0031519,1,0.510568663877499,0,44,PcG protein complex,CC,
7994,GO:0031523,1,0.968026311956315,0,2,Myb complex,CC,
7995,GO:0031526,1,0.458697659400125,0,52,brush border membrane,CC,
7999,GO:0031531,1,0.981611692353509,0,3,thyrotropin-releasing hormone receptor binding,MF,
8001,GO:0031536,1,0.943856046942043,0,5,positive regulation of exit from mitosis,BP,
8002,GO:0031543,1,0.861447137340394,0,10,peptidyl-proline dioxygenase activity,MF,
8003,GO:0031544,1,0.983832058556469,0,1,peptidyl-proline 3-dioxygenase activity,MF,
8004,GO:0031545,1,0.875611706205701,0,9,peptidyl-proline 4-dioxygenase activity,MF,
8005,GO:0031547,1,0.919824307514617,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
8006,GO:0031548,1,0.96712689215454,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8007,GO:0031549,1,0.983426667502217,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8008,GO:0031550,1,0.983426667503346,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8009,GO:0031554,1,0.983426667495718,0,1,regulation of DNA-templated transcription, termination,BP,
8010,GO:0031559,1,0.983426667503251,0,1,oxidosqualene cyclase activity,MF,
8014,GO:0031573,1,0.814392802131596,0,15,intra-S DNA damage checkpoint,BP,
8015,GO:0031577,1,0.600559347785594,0,35,spindle checkpoint,BP,
8016,GO:0031579,1,0.72592889256542,0,23,membrane raft organization,BP,
8017,GO:0031580,1,0.888008131395967,0,9,membrane raft distribution,BP,
8020,GO:0031584,1,0.924436773817045,0,6,activation of phospholipase D activity,BP,
8021,GO:0031585,1,0.935330780354056,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
8022,GO:0031587,1,0.951096869740721,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
8025,GO:0031590,1,0.968964719910183,0,2,wybutosine metabolic process,BP,
8026,GO:0031591,1,0.968964719910183,0,2,wybutosine biosynthetic process,BP,
8027,GO:0031592,1,0.983426667499166,0,1,centrosomal corona,CC,
8028,GO:0031593,1,0.547851080614756,0,39,polyubiquitin binding,MF,
8029,GO:0031594,1,0.437577179002685,0,55,neuromuscular junction,CC,
8030,GO:0031595,1,0.91036737006532,0,8,nuclear proteasome complex,CC,
8031,GO:0031597,1,0.884843365026933,0,10,cytosolic proteasome complex,CC,
8032,GO:0031616,1,0.889222520361993,0,9,spindle pole centrosome,CC,
8033,GO:0031618,1,0.884973287193901,0,8,nuclear pericentric heterochromatin,CC,
8034,GO:0031620,1,0.889567268546533,0,8,regulation of fever generation,BP,
8035,GO:0031622,1,0.904565106570766,0,7,positive regulation of fever generation,BP,
8036,GO:0031623,1,0.311466475490072,0,79,receptor internalization,BP,
8039,GO:0031626,1,0.983426667502414,0,1,beta-endorphin binding,MF,
8040,GO:0031627,1,0.952196668093863,0,3,telomeric loop formation,BP,
8041,GO:0031628,1,0.891634896667098,0,9,opioid receptor binding,MF,
8042,GO:0031629,1,0.810241208953981,0,15,synaptic vesicle fusion to presynaptic active zone membrane,BP,
8043,GO:0031630,1,0.956765818687126,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
8044,GO:0031635,1,0.970952613614278,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
8049,GO:0031642,1,0.906270250451255,0,7,negative regulation of myelination,BP,
8050,GO:0031643,1,0.841125754475043,0,11,positive regulation of myelination,BP,
8052,GO:0031645,1,0.819034753359126,0,16,negative regulation of neurological system process,BP,
8053,GO:0031646,1,0.728514234469417,0,22,positive regulation of neurological system process,BP,
8056,GO:0031649,1,0.76967131875023,0,17,heat generation,BP,
8057,GO:0031650,1,0.832223542719052,0,12,regulation of heat generation,BP,
8058,GO:0031651,1,0.983426667503302,0,1,negative regulation of heat generation,BP,
8059,GO:0031652,1,0.860529123327022,0,10,positive regulation of heat generation,BP,
8061,GO:0031658,1,0.983426667502019,0,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
8063,GO:0031660,1,0.986314227490632,0,1,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,BP,
8064,GO:0031662,1,0.986314227490632,0,1,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,BP,
8067,GO:0031665,1,0.897467895930037,0,9,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
8073,GO:0031672,1,0.566403304332633,0,41,A band,CC,
8074,GO:0031673,1,0.983426667489226,0,1,H zone,CC,
8076,GO:0031681,1,0.875887015541369,0,9,G-protein beta-subunit binding,MF,
8077,GO:0031682,1,0.983817942617793,0,1,G-protein gamma-subunit binding,MF,
8079,GO:0031685,1,0.967440818622974,0,2,adenosine receptor binding,MF,
8080,GO:0031686,1,0.983745862865737,0,1,A1 adenosine receptor binding,MF,
8082,GO:0031691,1,0.973185321394531,0,2,alpha-1A adrenergic receptor binding,MF,
8083,GO:0031692,1,0.957055732869296,0,3,alpha-1B adrenergic receptor binding,MF,
8085,GO:0031695,1,0.985011252792697,0,1,alpha-2B adrenergic receptor binding,MF,
8086,GO:0031696,1,0.968686472303469,0,2,alpha-2C adrenergic receptor binding,MF,
8087,GO:0031697,1,0.951096716042168,0,3,beta-1 adrenergic receptor binding,MF,
8088,GO:0031698,1,0.942015461522331,0,4,beta-2 adrenergic receptor binding,MF,
8089,GO:0031699,1,0.968206705782512,0,2,beta-3 adrenergic receptor binding,MF,
8090,GO:0031700,1,0.989555741402394,0,1,adrenomedullin receptor binding,MF,
8091,GO:0031701,1,0.846840137117374,0,11,angiotensin receptor binding,MF,
8092,GO:0031702,1,0.858979861799746,0,10,type 1 angiotensin receptor binding,MF,
8093,GO:0031703,1,0.984679136082936,0,1,type 2 angiotensin receptor binding,MF,
8094,GO:0031704,1,0.983636504172295,0,1,apelin receptor binding,MF,
8098,GO:0031710,1,0.992284534115118,0,1,neuromedin B receptor binding,MF,
8099,GO:0031711,1,0.969215127645075,0,2,bradykinin receptor binding,MF,
8100,GO:0031714,1,0.983426667502513,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8101,GO:0031715,1,0.983426667502513,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8102,GO:0031716,1,0.987035206250961,0,2,calcitonin receptor binding,MF,
8103,GO:0031720,1,0.98606665892013,0,3,haptoglobin binding,MF,
8104,GO:0031721,1,0.993760115777693,0,1,hemoglobin alpha binding,MF,
8105,GO:0031724,1,0.991096224378579,0,1,CXCR5 chemokine receptor binding,MF,
8106,GO:0031726,1,0.969277974418096,0,5,CCR1 chemokine receptor binding,MF,
8107,GO:0031727,1,0.979255347194462,0,2,CCR2 chemokine receptor binding,MF,
8108,GO:0031728,1,0.98586058676967,0,3,CCR3 chemokine receptor binding,MF,
8109,GO:0031729,1,0.986212528179327,0,2,CCR4 chemokine receptor binding,MF,
8110,GO:0031730,1,0.943070758442292,0,6,CCR5 chemokine receptor binding,MF,
8112,GO:0031732,1,0.988089418897793,0,2,CCR7 chemokine receptor binding,MF,
8113,GO:0031735,1,0.979186177646888,0,3,CCR10 chemokine receptor binding,MF,
8114,GO:0031737,1,0.983599669920145,0,1,CX3C chemokine receptor binding,MF,
8115,GO:0031739,1,0.986200672379079,0,1,cholecystokinin receptor binding,MF,
8116,GO:0031741,1,0.986200672379079,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8117,GO:0031748,1,0.890795306159926,0,8,D1 dopamine receptor binding,MF,
8118,GO:0031749,1,0.956011309197679,0,3,D2 dopamine receptor binding,MF,
8119,GO:0031750,1,0.972647154817956,0,2,D3 dopamine receptor binding,MF,
8120,GO:0031751,1,0.988299635900946,0,1,D4 dopamine receptor binding,MF,
8121,GO:0031752,1,0.955809595079366,0,3,D5 dopamine receptor binding,MF,
8122,GO:0031753,1,0.984199632676386,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8123,GO:0031755,1,0.984199632676386,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8124,GO:0031762,1,0.973185321394531,0,2,follicle-stimulating hormone receptor binding,MF,
8125,GO:0031763,1,0.994020585908706,0,1,galanin receptor binding,MF,
8126,GO:0031764,1,0.994020585908706,0,1,type 1 galanin receptor binding,MF,
8127,GO:0031765,1,0.994020585908706,0,1,type 2 galanin receptor binding,MF,
8128,GO:0031766,1,0.994020585908706,0,1,type 3 galanin receptor binding,MF,
8129,GO:0031768,1,0.994495436116341,0,1,ghrelin receptor binding,MF,
8130,GO:0031770,1,0.996467730613345,0,1,growth hormone-releasing hormone receptor binding,MF,
8131,GO:0031771,1,0.995528640221343,0,1,type 1 hypocretin receptor binding,MF,
8132,GO:0031772,1,0.995528640221343,0,1,type 2 hypocretin receptor binding,MF,
8133,GO:0031773,1,0.994510135999198,0,1,kisspeptin receptor binding,MF,
8134,GO:0031775,1,0.983426667498821,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8135,GO:0031779,1,0.96617577445424,0,4,melanocortin receptor binding,MF,
8136,GO:0031780,1,0.979724501683413,0,2,corticotropin hormone receptor binding,MF,
8137,GO:0031781,1,0.96617577445424,0,4,type 3 melanocortin receptor binding,MF,
8138,GO:0031782,1,0.96617577445424,0,4,type 4 melanocortin receptor binding,MF,
8139,GO:0031783,1,0.979724501683413,0,2,type 5 melanocortin receptor binding,MF,
8140,GO:0031798,1,0.98342666749951,0,1,type 1 metabotropic glutamate receptor binding,MF,
8141,GO:0031800,1,0.960066626759856,0,3,type 3 metabotropic glutamate receptor binding,MF,
8142,GO:0031802,1,0.968399853552682,0,2,type 5 metabotropic glutamate receptor binding,MF,
8143,GO:0031811,1,0.983427224674367,0,1,G-protein coupled nucleotide receptor binding,MF,
8144,GO:0031812,1,0.983427224674367,0,1,P2Y1 nucleotide receptor binding,MF,
8145,GO:0031821,1,0.90041357808938,0,7,G-protein coupled serotonin receptor binding,MF,
8146,GO:0031826,1,0.962326959029442,0,3,type 2A serotonin receptor binding,MF,
8147,GO:0031834,1,0.99151415844103,0,1,neurokinin receptor binding,MF,
8148,GO:0031835,1,0.99151415844103,0,1,substance P receptor binding,MF,
8149,GO:0031838,1,0.976380644841301,0,4,haptoglobin-hemoglobin complex,CC,
8150,GO:0031848,1,0.854637495040942,0,10,protection from non-homologous end joining at telomere,BP,
8152,GO:0031851,1,0.993911830912465,0,1,kappa-type opioid receptor binding,MF,
8153,GO:0031852,1,0.940526825111654,0,4,mu-type opioid receptor binding,MF,
8154,GO:0031854,1,0.996804250379486,0,1,orexigenic neuropeptide QRFP receptor binding,MF,
8155,GO:0031855,1,0.996011506942388,0,1,oxytocin receptor binding,MF,
8156,GO:0031856,1,0.993781750160452,0,1,parathyroid hormone receptor binding,MF,
8157,GO:0031857,1,0.993781750160452,0,1,type 1 parathyroid hormone receptor binding,MF,
8158,GO:0031858,1,0.983678680603845,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8159,GO:0031859,1,0.987128147708203,0,1,platelet activating factor receptor binding,MF,
8160,GO:0031860,1,0.951115388354083,0,3,telomeric 3' overhang formation,BP,
8161,GO:0031861,1,0.997930758311506,0,1,prolactin-releasing peptide receptor binding,MF,
8162,GO:0031862,1,0.967128918449342,0,2,prostanoid receptor binding,MF,
8163,GO:0031867,1,0.983428727808074,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8164,GO:0031870,1,0.983426667501383,0,1,thromboxane A2 receptor binding,MF,
8165,GO:0031871,1,0.955107345654188,0,3,proteinase activated receptor binding,MF,
8166,GO:0031877,1,0.983426667500642,0,1,somatostatin receptor binding,MF,
8167,GO:0031883,1,0.98627340078158,0,1,taste receptor binding,MF,
8168,GO:0031893,1,0.964895192146732,0,3,vasopressin receptor binding,MF,
8169,GO:0031894,1,0.978719741948368,0,2,V1A vasopressin receptor binding,MF,
8170,GO:0031895,1,0.9952140852687,0,1,V1B vasopressin receptor binding,MF,
8171,GO:0031896,1,0.985876117522909,0,1,V2 vasopressin receptor binding,MF,
8175,GO:0031904,1,0.707358455842695,0,29,endosome lumen,CC,
8176,GO:0031905,1,0.976099799405977,0,2,early endosome lumen,CC,
8177,GO:0031906,1,0.927561268413608,0,7,late endosome lumen,CC,
8178,GO:0031907,1,0.561461459705053,0,43,microbody lumen,CC,
8179,GO:0031914,1,0.929870583736823,0,5,negative regulation of synaptic plasticity,BP,
8180,GO:0031915,1,0.876327747920503,0,9,positive regulation of synaptic plasticity,BP,
8182,GO:0031930,1,0.989472816440571,0,1,mitochondria-nucleus signaling pathway,BP,
8183,GO:0031931,1,0.898337061952689,0,7,TORC1 complex,CC,
8185,GO:0031933,1,0.95834740053439,0,3,telomeric heterochromatin,CC,
8186,GO:0031935,1,0.721604917550251,0,21,regulation of chromatin silencing,BP,
8187,GO:0031936,1,0.873838942880302,0,9,negative regulation of chromatin silencing,BP,
8188,GO:0031937,1,0.879749000929804,0,8,positive regulation of chromatin silencing,BP,
8189,GO:0031938,1,0.975668167795464,0,2,regulation of chromatin silencing at telomere,BP,
8190,GO:0031940,1,0.988474582868779,0,1,positive regulation of chromatin silencing at telomere,BP,
8199,GO:0031953,1,0.835734200280735,0,11,negative regulation of protein autophosphorylation,BP,
8202,GO:0031958,1,0.77774088470312,0,16,corticosteroid receptor signaling pathway,BP,
8203,GO:0031959,1,0.983426667502316,0,1,mineralocorticoid receptor signaling pathway,BP,
8205,GO:0031962,1,0.983426667501579,0,1,mineralocorticoid receptor binding,MF,
8206,GO:0031965,1,0.0155797401247372,0,280,nuclear membrane,CC,
8217,GO:0031985,1,0.252184238341888,0,90,Golgi cisterna,CC,
8218,GO:0031987,1,0.868730907480233,0,9,locomotion involved in locomotory behavior,BP,
8219,GO:0031989,1,0.980021299662763,0,2,bombesin receptor signaling pathway,BP,
8220,GO:0031990,1,0.969112135205581,0,2,mRNA export from nucleus in response to heat stress,BP,
8222,GO:0031995,1,0.896383244912737,0,8,insulin-like growth factor II binding,MF,
8223,GO:0031996,1,0.810094924354301,0,14,thioesterase binding,MF,
8224,GO:0031997,1,0.960066626759856,0,3,N-terminal myristoylation domain binding,MF,
8227,GO:0032000,1,0.877305233993854,0,9,positive regulation of fatty acid beta-oxidation,BP,
8228,GO:0032002,1,0.957063915895825,0,3,interleukin-28 receptor complex,CC,
8229,GO:0032003,1,0.984728932554734,0,1,interleukin-28 receptor binding,MF,
8233,GO:0032009,1,0.882280048678117,0,8,early phagosome,CC,
8234,GO:0032010,1,0.93457170840465,0,5,phagolysosome,CC,
8235,GO:0032011,1,0.779532819477416,0,15,ARF protein signal transduction,BP,
8236,GO:0032012,1,0.779532819477416,0,15,regulation of ARF protein signal transduction,BP,
8237,GO:0032020,1,0.932030060023164,0,6,ISG15-protein conjugation,BP,
8238,GO:0032021,1,0.940295235677535,0,4,NELF complex,CC,
8239,GO:0032023,1,0.985597405954989,0,1,trypsinogen activation,BP,
8240,GO:0032024,1,0.418228981897555,0,63,positive regulation of insulin secretion,BP,
8241,GO:0032025,1,0.878623143482504,0,9,response to cobalt ion,BP,
8243,GO:0032027,1,0.915547528410038,0,6,myosin light chain binding,MF,
8244,GO:0032028,1,0.986249049395682,0,1,myosin head/neck binding,MF,
8247,GO:0032038,1,0.986240802376521,0,2,myosin II heavy chain binding,MF,
8248,GO:0032039,1,0.838709918113474,0,11,integrator complex,CC,
8249,GO:0032040,1,0.654846984854725,0,30,small-subunit processome,CC,
8250,GO:0032041,1,0.842015568819208,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8252,GO:0032044,1,0.972926508935627,0,2,DSIF complex,CC,
8253,GO:0032045,1,0.831847197470739,0,12,guanyl-nucleotide exchange factor complex,CC,
8254,GO:0032048,1,0.813951391256956,0,14,cardiolipin metabolic process,BP,
8255,GO:0032049,1,0.897950547627815,0,7,cardiolipin biosynthetic process,BP,
8256,GO:0032050,1,0.934769845539255,0,5,clathrin heavy chain binding,MF,
8257,GO:0032051,1,0.916027615127245,0,6,clathrin light chain binding,MF,
8259,GO:0032053,1,0.954100619178623,0,3,ciliary basal body organization,BP,
8261,GO:0032056,1,0.911584144665888,0,6,positive regulation of translation in response to stress,BP,
8262,GO:0032057,1,0.902175211703487,0,7,negative regulation of translational initiation in response to stress,BP,
8263,GO:0032058,1,0.937077253681739,0,4,positive regulation of translational initiation in response to stress,BP,
8264,GO:0032059,1,0.897094866518944,0,7,bleb,CC,
8265,GO:0032060,1,0.863717398736453,0,10,bleb assembly,BP,
8266,GO:0032066,1,0.951805699859123,0,3,nucleolus to nucleoplasm transport,BP,
8270,GO:0032072,1,0.983511896538118,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8271,GO:0032074,1,0.904031818057935,0,7,negative regulation of nuclease activity,BP,
8273,GO:0032076,1,0.977645705124029,0,2,negative regulation of deoxyribonuclease activity,BP,
8275,GO:0032078,1,0.993181123627435,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8278,GO:0032089,1,0.967695510432122,0,2,NACHT domain binding,MF,
8279,GO:0032090,1,0.97677305551774,0,2,Pyrin domain binding,MF,
8282,GO:0032093,1,0.984728932554734,0,1,SAM domain binding,MF,
8284,GO:0032095,1,0.835618275369128,0,17,regulation of response to food,BP,
8285,GO:0032096,1,0.894241753080072,0,10,negative regulation of response to food,BP,
8286,GO:0032097,1,0.970341725484422,0,4,positive regulation of response to food,BP,
8287,GO:0032098,1,0.807016984020199,0,21,regulation of appetite,BP,
8288,GO:0032099,1,0.894241753080072,0,10,negative regulation of appetite,BP,
8289,GO:0032100,1,0.970341725484422,0,4,positive regulation of appetite,BP,
8293,GO:0032104,1,0.761283831618639,0,23,regulation of response to extracellular stimulus,BP,
8294,GO:0032105,1,0.867354524044566,0,12,negative regulation of response to extracellular stimulus,BP,
8295,GO:0032106,1,0.942466312489016,0,6,positive regulation of response to extracellular stimulus,BP,
8296,GO:0032107,1,0.761283831618639,0,23,regulation of response to nutrient levels,BP,
8297,GO:0032108,1,0.867354524044566,0,12,negative regulation of response to nutrient levels,BP,
8298,GO:0032109,1,0.942466312489016,0,6,positive regulation of response to nutrient levels,BP,
8299,GO:0032113,1,0.991044168321855,0,1,regulation of carbohydrate phosphatase activity,BP,
8300,GO:0032116,1,0.96840766101139,0,2,SMC loading complex,CC,
8301,GO:0032119,1,0.850589877341161,0,12,sequestering of zinc ion,BP,
8302,GO:0032127,1,0.967393434157272,0,2,dense core granule membrane,CC,
8303,GO:0032129,1,0.972093326939592,0,2,histone deacetylase activity (H3-K9 specific),MF,
8304,GO:0032133,1,0.939795628159755,0,5,chromosome passenger complex,CC,
8305,GO:0032135,1,0.911731927504851,0,6,DNA insertion or deletion binding,MF,
8306,GO:0032137,1,0.952858828479671,0,3,guanine/thymine mispair binding,MF,
8307,GO:0032138,1,0.936230018134698,0,4,single base insertion or deletion binding,MF,
8308,GO:0032139,1,0.957932590708862,0,3,dinucleotide insertion or deletion binding,MF,
8309,GO:0032142,1,0.951352847082839,0,3,single guanine insertion binding,MF,
8310,GO:0032143,1,0.967387870330413,0,2,single thymine insertion binding,MF,
8311,GO:0032144,1,0.98342666750271,0,1,4-aminobutyrate transaminase complex,CC,
8312,GO:0032145,1,0.98342666750271,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8318,GO:0032156,1,0.901930461671518,0,7,septin cytoskeleton,CC,
8319,GO:0032173,1,0.983865870928059,0,1,septin collar,CC,
8320,GO:0032181,1,0.967387870330172,0,2,dinucleotide repeat insertion binding,MF,
8322,GO:0032183,1,0.777833485386378,0,16,SUMO binding,MF,
8323,GO:0032184,1,0.921523361029224,0,5,SUMO polymer binding,MF,
8324,GO:0032185,1,0.968407661017497,0,2,septin cytoskeleton organization,BP,
8326,GO:0032194,1,0.983446198396837,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8327,GO:0032196,1,0.794991582773728,0,16,transposition,BP,
8328,GO:0032197,1,0.98342685243827,0,1,transposition, RNA-mediated,BP,
8329,GO:0032200,1,0.126974939283833,0,160,telomere organization,BP,
8330,GO:0032201,1,0.911867709215944,0,6,telomere maintenance via semi-conservative replication,BP,
8331,GO:0032202,1,0.945010209466311,0,4,telomere assembly,BP,
8332,GO:0032203,1,0.987352457745635,0,1,telomere formation via telomerase,BP,
8333,GO:0032204,1,0.340984121497685,0,71,regulation of telomere maintenance,BP,
8334,GO:0032205,1,0.616002475004909,0,31,negative regulation of telomere maintenance,BP,
8335,GO:0032206,1,0.487339262913004,0,48,positive regulation of telomere maintenance,BP,
8336,GO:0032207,1,0.98401273432067,0,1,regulation of telomere maintenance via recombination,BP,
8337,GO:0032208,1,0.98401273432067,0,1,negative regulation of telomere maintenance via recombination,BP,
8338,GO:0032210,1,0.495673807582222,0,47,regulation of telomere maintenance via telomerase,BP,
8339,GO:0032211,1,0.797234773118961,0,15,negative regulation of telomere maintenance via telomerase,BP,
8340,GO:0032212,1,0.616036918213007,0,33,positive regulation of telomere maintenance via telomerase,BP,
8341,GO:0032213,1,0.968226299050826,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8342,GO:0032214,1,0.968226299050826,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8345,GO:0032222,1,0.889637419568416,0,9,regulation of synaptic transmission, cholinergic,BP,
8346,GO:0032223,1,0.984677841075189,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8347,GO:0032224,1,0.917764234666949,0,7,positive regulation of synaptic transmission, cholinergic,BP,
8349,GO:0032226,1,0.909714727119498,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8350,GO:0032227,1,0.951341692853612,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8353,GO:0032230,1,0.834647553990578,0,13,positive regulation of synaptic transmission, GABAergic,BP,
8355,GO:0032232,1,0.707428229277007,0,23,negative regulation of actin filament bundle assembly,BP,
8357,GO:0032237,1,0.940436213552519,0,4,activation of store-operated calcium channel activity,BP,
8359,GO:0032240,1,0.967126892148005,0,2,negative regulation of nucleobase-containing compound transport,BP,
8365,GO:0032261,1,0.914800926729814,0,7,purine nucleotide salvage,BP,
8366,GO:0032262,1,0.93867919671549,0,5,pyrimidine nucleotide salvage,BP,
8367,GO:0032264,1,0.943010152576677,0,4,IMP salvage,BP,
8368,GO:0032266,1,0.637780356287873,0,29,phosphatidylinositol-3-phosphate binding,MF,
8376,GO:0032275,1,0.878493712802947,0,9,luteinizing hormone secretion,BP,
8381,GO:0032280,1,0.943621483594995,0,4,symmetric synapse,CC,
8382,GO:0032281,1,0.681389682573331,0,27,AMPA glutamate receptor complex,CC,
8383,GO:0032286,1,0.938815165506507,0,4,central nervous system myelin maintenance,BP,
8385,GO:0032288,1,0.754367225019854,0,18,myelin assembly,BP,
8386,GO:0032289,1,0.954968678251614,0,3,central nervous system myelin formation,BP,
8387,GO:0032290,1,0.968407661011294,0,2,peripheral nervous system myelin formation,BP,
8388,GO:0032291,1,0.805650720571753,0,15,axon ensheathment in central nervous system,BP,
8390,GO:0032296,1,0.940839599287677,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8391,GO:0032298,1,0.985728153675824,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8392,GO:0032299,1,0.964908841617573,0,3,ribonuclease H2 complex,CC,
8393,GO:0032300,1,0.877136451513798,0,8,mismatch repair complex,CC,
8394,GO:0032301,1,0.967387870330413,0,2,MutSalpha complex,CC,
8395,GO:0032302,1,0.967387870330172,0,2,MutSbeta complex,CC,
8397,GO:0032304,1,0.953478212638838,0,3,negative regulation of icosanoid secretion,BP,
8403,GO:0032311,1,0.979865669771954,0,2,angiogenin-PRI complex,CC,
8404,GO:0032324,1,0.903747232235112,0,7,molybdopterin cofactor biosynthetic process,BP,
8405,GO:0032328,1,0.852994257400718,0,10,alanine transport,BP,
8406,GO:0032329,1,0.867503412387425,0,10,serine transport,BP,
8424,GO:0032356,1,0.887386665807651,0,8,oxidized DNA binding,MF,
8425,GO:0032357,1,0.887386665807651,0,8,oxidized purine DNA binding,MF,
8426,GO:0032358,1,0.993573175263409,0,1,oxidized pyrimidine DNA binding,MF,
8427,GO:0032361,1,0.986690812150216,0,1,pyridoxal phosphate catabolic process,BP,
8429,GO:0032365,1,0.641611107780784,0,30,intracellular lipid transport,BP,
8430,GO:0032366,1,0.78157549426014,0,17,intracellular sterol transport,BP,
8431,GO:0032367,1,0.78157549426014,0,17,intracellular cholesterol transport,BP,
8435,GO:0032371,1,0.57965139700691,0,42,regulation of sterol transport,BP,
8436,GO:0032372,1,0.874421669001104,0,12,negative regulation of sterol transport,BP,
8437,GO:0032373,1,0.760516080265169,0,19,positive regulation of sterol transport,BP,
8438,GO:0032374,1,0.57965139700691,0,42,regulation of cholesterol transport,BP,
8439,GO:0032375,1,0.874421669001104,0,12,negative regulation of cholesterol transport,BP,
8440,GO:0032376,1,0.760516080265169,0,19,positive regulation of cholesterol transport,BP,
8441,GO:0032377,1,0.90603872049523,0,7,regulation of intracellular lipid transport,BP,
8442,GO:0032378,1,0.983447371970266,0,1,negative regulation of intracellular lipid transport,BP,
8443,GO:0032379,1,0.962613369192326,0,3,positive regulation of intracellular lipid transport,BP,
8444,GO:0032380,1,0.90603872049523,0,7,regulation of intracellular sterol transport,BP,
8445,GO:0032381,1,0.983447371970266,0,1,negative regulation of intracellular sterol transport,BP,
8446,GO:0032382,1,0.962613369192326,0,3,positive regulation of intracellular sterol transport,BP,
8447,GO:0032383,1,0.90603872049523,0,7,regulation of intracellular cholesterol transport,BP,
8448,GO:0032384,1,0.983447371970266,0,1,negative regulation of intracellular cholesterol transport,BP,
8449,GO:0032385,1,0.962613369192326,0,3,positive regulation of intracellular cholesterol transport,BP,
8453,GO:0032389,1,0.937546416999116,0,4,MutLalpha complex,CC,
8455,GO:0032392,1,0.296763410066255,0,80,DNA geometric change,BP,
8456,GO:0032393,1,0.896613485236432,0,9,MHC class I receptor activity,MF,
8457,GO:0032394,1,0.973704612413383,0,2,MHC class Ib receptor activity,MF,
8458,GO:0032395,1,0.900270241380839,0,10,MHC class II receptor activity,MF,
8459,GO:0032396,1,0.94498604776982,0,4,inhibitory MHC class I receptor activity,MF,
8460,GO:0032397,1,0.989399199546474,0,1,activating MHC class I receptor activity,MF,
8461,GO:0032398,1,0.988254381878812,0,1,MHC class Ib protein complex,CC,
8462,GO:0032399,1,0.973428896785853,0,3,HECT domain binding,MF,
8467,GO:0032404,1,0.891197723721213,0,8,mismatch repair complex binding,MF,
8468,GO:0032405,1,0.931124591041559,0,5,MutLalpha complex binding,MF,
8469,GO:0032407,1,0.930346459551813,0,5,MutSalpha complex binding,MF,
8476,GO:0032415,1,0.928173973916857,0,6,regulation of sodium:proton antiporter activity,BP,
8477,GO:0032416,1,0.975553448929896,0,2,negative regulation of sodium:proton antiporter activity,BP,
8478,GO:0032417,1,0.951438107253156,0,4,positive regulation of sodium:proton antiporter activity,BP,
8480,GO:0032419,1,0.985762852771326,0,1,extrinsic component of lysosome membrane,CC,
8483,GO:0032422,1,0.970890180386795,0,2,purine-rich negative regulatory element binding,MF,
8484,GO:0032423,1,0.951449133830661,0,3,regulation of mismatch repair,BP,
8485,GO:0032425,1,0.967485773252065,0,2,positive regulation of mismatch repair,BP,
8488,GO:0032428,1,0.983460115004183,0,1,beta-N-acetylgalactosaminidase activity,MF,
8489,GO:0032429,1,0.880200919123435,0,10,regulation of phospholipase A2 activity,BP,
8490,GO:0032430,1,0.945960851970953,0,5,positive regulation of phospholipase A2 activity,BP,
8491,GO:0032431,1,0.959944737110095,0,4,activation of phospholipase A2 activity,BP,
8492,GO:0032432,1,0.437634612316097,0,55,actin filament bundle,CC,
8495,GO:0032435,1,0.727432142793888,0,23,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8497,GO:0032437,1,0.942328110037102,0,4,cuticular plate,CC,
8499,GO:0032439,1,0.936685161110385,0,4,endosome localization,BP,
8500,GO:0032440,1,0.990766726395059,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8501,GO:0032444,1,0.953551708833925,0,3,activin responsive factor complex,CC,
8502,GO:0032445,1,0.985452018212821,0,1,fructose import,BP,
8504,GO:0032448,1,0.988788646963824,0,1,DNA hairpin binding,MF,
8505,GO:0032449,1,0.951406286865144,0,3,CBM complex,CC,
8506,GO:0032450,1,0.951123166016917,0,3,maltose alpha-glucosidase activity,MF,
8507,GO:0032451,1,0.580030468891291,0,34,demethylase activity,MF,
8508,GO:0032452,1,0.670838465255118,0,24,histone demethylase activity,MF,
8509,GO:0032453,1,0.904884752735188,0,6,histone demethylase activity (H3-K4 specific),MF,
8510,GO:0032454,1,0.861037010996673,0,9,histone demethylase activity (H3-K9 specific),MF,
8511,GO:0032455,1,0.943856371724308,0,4,nerve growth factor processing,BP,
8513,GO:0032458,1,0.983427646296815,0,1,slow endocytic recycling,BP,
8515,GO:0032460,1,0.822424705157574,0,15,negative regulation of protein oligomerization,BP,
8517,GO:0032462,1,0.804055560509669,0,16,regulation of protein homooligomerization,BP,
8518,GO:0032463,1,0.867315297834764,0,10,negative regulation of protein homooligomerization,BP,
8519,GO:0032464,1,0.912359450575326,0,7,positive regulation of protein homooligomerization,BP,
8520,GO:0032465,1,0.386709265510207,0,66,regulation of cytokinesis,BP,
8521,GO:0032466,1,0.904255829399172,0,7,negative regulation of cytokinesis,BP,
8522,GO:0032467,1,0.594738131336602,0,37,positive regulation of cytokinesis,BP,
8523,GO:0032468,1,0.98348269460299,0,1,Golgi calcium ion homeostasis,BP,
8524,GO:0032469,1,0.746842031875368,0,20,endoplasmic reticulum calcium ion homeostasis,BP,
8525,GO:0032470,1,0.967172051358379,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8526,GO:0032471,1,0.917037768510793,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8527,GO:0032472,1,0.970548874573565,0,2,Golgi calcium ion transport,BP,
8528,GO:0032473,1,0.983426667497643,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8529,GO:0032474,1,0.967128364650913,0,2,otolith morphogenesis,BP,
8531,GO:0032480,1,0.536433434480339,0,43,negative regulation of type I interferon production,BP,
8532,GO:0032481,1,0.349856912288037,0,71,positive regulation of type I interferon production,BP,
8533,GO:0032482,1,0.910063045430601,0,6,Rab protein signal transduction,BP,
8534,GO:0032483,1,0.935768045033087,0,4,regulation of Rab protein signal transduction,BP,
8535,GO:0032484,1,0.951265222943615,0,3,Ral protein signal transduction,BP,
8536,GO:0032485,1,0.951265222943615,0,3,regulation of Ral protein signal transduction,BP,
8537,GO:0032486,1,0.811173548091011,0,13,Rap protein signal transduction,BP,
8538,GO:0032487,1,0.951114909949673,0,3,regulation of Rap protein signal transduction,BP,
8539,GO:0032488,1,0.915607460370874,0,8,Cdc42 protein signal transduction,BP,
8540,GO:0032489,1,0.956250622356497,0,5,regulation of Cdc42 protein signal transduction,BP,
8541,GO:0032490,1,0.854623560772216,0,11,detection of molecule of bacterial origin,BP,
8542,GO:0032493,1,0.901702006374768,0,7,response to bacterial lipoprotein,BP,
8543,GO:0032494,1,0.896126019047909,0,8,response to peptidoglycan,BP,
8546,GO:0032497,1,0.956045236894186,0,4,detection of lipopolysaccharide,BP,
8547,GO:0032498,1,0.983426667503104,0,1,detection of muramyl dipeptide,BP,
8548,GO:0032499,1,0.975653555700331,0,2,detection of peptidoglycan,BP,
8549,GO:0032500,1,0.983426667503104,0,1,muramyl dipeptide binding,MF,
8555,GO:0032508,1,0.342275295397112,0,71,DNA duplex unwinding,BP,
8556,GO:0032509,1,0.848683787291768,0,12,endosome transport via multivesicular body sorting pathway,BP,
8557,GO:0032510,1,0.937744824200077,0,4,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8558,GO:0032511,1,0.931798202039792,0,6,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8559,GO:0032515,1,0.812045682548543,0,15,negative regulation of phosphoprotein phosphatase activity,BP,
8560,GO:0032516,1,0.794081114078777,0,15,positive regulation of phosphoprotein phosphatase activity,BP,
8561,GO:0032525,1,0.878858823661763,0,10,somite rostral/caudal axis specification,BP,
8563,GO:0032527,1,0.579133552696433,0,37,protein exit from endoplasmic reticulum,BP,
8564,GO:0032528,1,0.695443127792639,0,23,microvillus organization,BP,
8565,GO:0032530,1,0.811374683054091,0,13,regulation of microvillus organization,BP,
8566,GO:0032532,1,0.896053889267046,0,7,regulation of microvillus length,BP,
8567,GO:0032534,1,0.905538497304694,0,6,regulation of microvillus assembly,BP,
8570,GO:0032541,1,0.940573431301189,0,4,cortical endoplasmic reticulum,CC,
8572,GO:0032543,1,0.304832581109829,0,114,mitochondrial translation,BP,
8573,GO:0032545,1,0.974663444180303,0,2,CURI complex,CC,
8576,GO:0032551,1,0.968447117721831,0,2,pyrimidine ribonucleoside binding,MF,
8577,GO:0032552,1,0.924433411070579,0,6,deoxyribonucleotide binding,MF,
8579,GO:0032554,1,0.932212638679,0,5,purine deoxyribonucleotide binding,MF,
8581,GO:0032556,1,0.991657523588261,0,1,pyrimidine deoxyribonucleotide binding,MF,
8582,GO:0032557,1,0.954985169861779,0,3,pyrimidine ribonucleotide binding,MF,
8583,GO:0032558,1,0.947708317545571,0,4,adenyl deoxyribonucleotide binding,MF,
8585,GO:0032560,1,0.983652926593764,0,1,guanyl deoxyribonucleotide binding,MF,
8587,GO:0032564,1,0.947708317545571,0,4,dATP binding,MF,
8588,GO:0032567,1,0.983652926593764,0,1,dGTP binding,MF,
8591,GO:0032574,1,0.983426700388727,0,1,5'-3' RNA helicase activity,MF,
8592,GO:0032575,1,0.983426700388727,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8593,GO:0032580,1,0.326374486217324,0,73,Golgi cisterna membrane,CC,
8594,GO:0032581,1,0.987410175725191,0,1,ER-dependent peroxisome organization,BP,
8595,GO:0032584,1,0.91104159357941,0,6,growth cone membrane,CC,
8598,GO:0032588,1,0.319450410321563,0,80,trans-Golgi network membrane,CC,
8600,GO:0032590,1,0.731674693836783,0,21,dendrite membrane,CC,
8601,GO:0032591,1,0.86132877485711,0,9,dendritic spine membrane,CC,
8602,GO:0032592,1,0.481765277640314,0,54,integral component of mitochondrial membrane,CC,
8603,GO:0032593,1,0.908045630300759,0,7,insulin-responsive compartment,CC,
8604,GO:0032594,1,0.881422757494679,0,9,protein transport within lipid bilayer,BP,
8605,GO:0032595,1,0.985976828446026,0,1,B cell receptor transport within lipid bilayer,BP,
8606,GO:0032596,1,0.913766597644719,0,6,protein transport into membrane raft,BP,
8607,GO:0032597,1,0.985976828446026,0,1,B cell receptor transport into membrane raft,BP,
8608,GO:0032599,1,0.985976828446026,0,1,protein transport out of membrane raft,BP,
8609,GO:0032600,1,0.985976828446026,0,1,chemokine receptor transport out of membrane raft,BP,
8610,GO:0032601,1,0.983823475959947,0,2,connective tissue growth factor production,BP,
8612,GO:0032603,1,0.99306091186479,0,1,fractalkine production,BP,
8613,GO:0032604,1,0.823401235759017,0,15,granulocyte macrophage colony-stimulating factor production,BP,
8616,GO:0032607,1,0.718283194485458,0,22,interferon-alpha production,BP,
8617,GO:0032608,1,0.4899347463741,0,47,interferon-beta production,BP,
8623,GO:0032615,1,0.480603629904394,0,51,interleukin-12 production,BP,
8624,GO:0032616,1,0.759815505921054,0,21,interleukin-13 production,BP,
8625,GO:0032618,1,0.976105467680952,0,2,interleukin-15 production,BP,
8626,GO:0032620,1,0.719460594978057,0,25,interleukin-17 production,BP,
8627,GO:0032621,1,0.89461514864865,0,7,interleukin-18 production,BP,
8629,GO:0032625,1,0.983463896807736,0,1,interleukin-21 production,BP,
8630,GO:0032627,1,0.89953278721842,0,8,interleukin-23 production,BP,
8631,GO:0032632,1,0.944790638734673,0,4,interleukin-3 production,BP,
8633,GO:0032634,1,0.758985883204409,0,20,interleukin-5 production,BP,
8636,GO:0032639,1,0.972276179888932,0,2,TRAIL production,BP,
8638,GO:0032641,1,0.962367957661818,0,3,lymphotoxin A production,BP,
8640,GO:0032643,1,0.990581907561477,0,1,regulation of connective tissue growth factor production,BP,
8641,GO:0032644,1,0.99306091186479,0,1,regulation of fractalkine production,BP,
8642,GO:0032645,1,0.823401235759017,0,15,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8644,GO:0032647,1,0.725870097658903,0,21,regulation of interferon-alpha production,BP,
8645,GO:0032648,1,0.504158610515223,0,45,regulation of interferon-beta production,BP,
8651,GO:0032655,1,0.496551968792537,0,49,regulation of interleukin-12 production,BP,
8652,GO:0032656,1,0.773416019409863,0,19,regulation of interleukin-13 production,BP,
8653,GO:0032658,1,0.987712600835568,0,1,regulation of interleukin-15 production,BP,
8654,GO:0032660,1,0.748592130918563,0,22,regulation of interleukin-17 production,BP,
8655,GO:0032661,1,0.92503352738524,0,5,regulation of interleukin-18 production,BP,
8657,GO:0032667,1,0.89953278721842,0,8,regulation of interleukin-23 production,BP,
8658,GO:0032672,1,0.960714224241973,0,3,regulation of interleukin-3 production,BP,
8660,GO:0032674,1,0.765965024971466,0,19,regulation of interleukin-5 production,BP,
8663,GO:0032679,1,0.972276179888932,0,2,regulation of TRAIL production,BP,
8665,GO:0032681,1,0.984355126393904,0,1,regulation of lymphotoxin A production,BP,
8666,GO:0032682,1,0.810786085639914,0,16,negative regulation of chemokine production,BP,
8667,GO:0032685,1,0.983601790212309,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8669,GO:0032687,1,0.932081073204215,0,5,negative regulation of interferon-alpha production,BP,
8670,GO:0032688,1,0.839583062632471,0,12,negative regulation of interferon-beta production,BP,
8672,GO:0032690,1,0.989651120410726,0,1,negative regulation of interleukin-1 alpha production,BP,
8673,GO:0032691,1,0.868639782978665,0,12,negative regulation of interleukin-1 beta production,BP,
8676,GO:0032695,1,0.798375792401703,0,15,negative regulation of interleukin-12 production,BP,
8677,GO:0032696,1,0.941209339845341,0,5,negative regulation of interleukin-13 production,BP,
8678,GO:0032700,1,0.855350802977615,0,11,negative regulation of interleukin-17 production,BP,
8679,GO:0032701,1,0.97231277720427,0,2,negative regulation of interleukin-18 production,BP,
8680,GO:0032703,1,0.772771793244083,0,18,negative regulation of interleukin-2 production,BP,
8681,GO:0032707,1,0.968958754015815,0,2,negative regulation of interleukin-23 production,BP,
8682,GO:0032712,1,0.985448622796376,0,1,negative regulation of interleukin-3 production,BP,
8684,GO:0032714,1,0.912937216131786,0,7,negative regulation of interleukin-5 production,BP,
8686,GO:0032717,1,0.804931273310645,0,16,negative regulation of interleukin-8 production,BP,
8689,GO:0032723,1,0.990581907561477,0,1,positive regulation of connective tissue growth factor production,BP,
8690,GO:0032724,1,0.99306091186479,0,1,positive regulation of fractalkine production,BP,
8691,GO:0032725,1,0.842350129863783,0,13,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8692,GO:0032727,1,0.778819634053039,0,16,positive regulation of interferon-alpha production,BP,
8693,GO:0032728,1,0.638459910911596,0,29,positive regulation of interferon-beta production,BP,
8698,GO:0032733,1,0.673629096625955,0,29,positive regulation of interleukin-10 production,BP,
8699,GO:0032735,1,0.64339347224045,0,32,positive regulation of interleukin-12 production,BP,
8700,GO:0032736,1,0.821766432070289,0,14,positive regulation of interleukin-13 production,BP,
8701,GO:0032738,1,0.987712600835568,0,1,positive regulation of interleukin-15 production,BP,
8702,GO:0032740,1,0.850253997955387,0,13,positive regulation of interleukin-17 production,BP,
8703,GO:0032741,1,0.967223649404394,0,2,positive regulation of interleukin-18 production,BP,
8705,GO:0032747,1,0.941656787513082,0,5,positive regulation of interleukin-23 production,BP,
8706,GO:0032752,1,0.974901874802987,0,2,positive regulation of interleukin-3 production,BP,
8707,GO:0032753,1,0.731548548835594,0,22,positive regulation of interleukin-4 production,BP,
8708,GO:0032754,1,0.850467765341074,0,11,positive regulation of interleukin-5 production,BP,
8711,GO:0032759,1,0.972276179888932,0,2,positive regulation of TRAIL production,BP,
8713,GO:0032761,1,0.984355126393904,0,1,positive regulation of lymphotoxin A production,BP,
8715,GO:0032763,1,0.936618427831583,0,5,regulation of mast cell cytokine production,BP,
8716,GO:0032764,1,0.972617048971025,0,2,negative regulation of mast cell cytokine production,BP,
8717,GO:0032765,1,0.96299206447985,0,3,positive regulation of mast cell cytokine production,BP,
8718,GO:0032767,1,0.96344539695548,0,3,copper-dependent protein binding,MF,
8720,GO:0032769,1,0.857132821706843,0,11,negative regulation of monooxygenase activity,BP,
8722,GO:0032771,1,0.983426667503251,0,1,regulation of monophenol monooxygenase activity,BP,
8723,GO:0032773,1,0.983426667503251,0,1,positive regulation of monophenol monooxygenase activity,BP,
8725,GO:0032775,1,0.983442087309245,0,1,DNA methylation on adenine,BP,
8726,GO:0032776,1,0.939764890175558,0,4,DNA methylation on cytosine,BP,
8727,GO:0032777,1,0.942570101777387,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8728,GO:0032780,1,0.87670948921515,0,11,negative regulation of ATPase activity,BP,
8730,GO:0032782,1,0.911017213685194,0,6,bile acid secretion,BP,
8731,GO:0032783,1,0.975862188366453,0,2,ELL-EAF complex,CC,
8734,GO:0032786,1,0.727838533211076,0,22,positive regulation of DNA-templated transcription, elongation,BP,
8736,GO:0032788,1,0.988529020721145,0,1,saturated monocarboxylic acid metabolic process,BP,
8737,GO:0032789,1,0.988529020721145,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8738,GO:0032790,1,0.889343160716779,0,8,ribosome disassembly,BP,
8739,GO:0032792,1,0.933046563453884,0,5,negative regulation of CREB transcription factor activity,BP,
8740,GO:0032793,1,0.805141176808173,0,14,positive regulation of CREB transcription factor activity,BP,
8743,GO:0032796,1,0.97216113886948,0,2,uropod organization,BP,
8744,GO:0032797,1,0.860288875717632,0,11,SMN complex,CC,
8745,GO:0032798,1,0.969690119055175,0,2,Swi5-Sfr1 complex,CC,
8746,GO:0032799,1,0.819990230018121,0,14,low-density lipoprotein receptor particle metabolic process,BP,
8749,GO:0032802,1,0.932257631761786,0,5,low-density lipoprotein particle receptor catabolic process,BP,
8750,GO:0032803,1,0.932257631761786,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8751,GO:0032804,1,0.972094153711115,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8752,GO:0032805,1,0.974838305773154,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8753,GO:0032806,1,0.708641144741644,0,24,carboxy-terminal domain protein kinase complex,CC,
8754,GO:0032807,1,0.958641633569244,0,3,DNA ligase IV complex,CC,
8756,GO:0032809,1,0.749301374761478,0,19,neuronal cell body membrane,CC,
8757,GO:0032810,1,0.972516396805881,0,2,sterol response element binding,MF,
8759,GO:0032812,1,0.993053855187995,0,1,positive regulation of epinephrine secretion,BP,
8760,GO:0032813,1,0.568944084341023,0,43,tumor necrosis factor receptor superfamily binding,MF,
8762,GO:0032815,1,0.921200100266646,0,7,negative regulation of natural killer cell activation,BP,
8764,GO:0032817,1,0.883341946793452,0,9,regulation of natural killer cell proliferation,BP,
8765,GO:0032819,1,0.912900493373726,0,7,positive regulation of natural killer cell proliferation,BP,
8767,GO:0032824,1,0.971574636223626,0,3,negative regulation of natural killer cell differentiation,BP,
8769,GO:0032826,1,0.960299287630083,0,4,regulation of natural killer cell differentiation involved in immune response,BP,
8770,GO:0032827,1,0.971574636223626,0,3,negative regulation of natural killer cell differentiation involved in immune response,BP,
8771,GO:0032829,1,0.965143840921364,0,3,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8772,GO:0032831,1,0.965143840921364,0,3,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8773,GO:0032832,1,0.979440228564863,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8774,GO:0032834,1,0.979440228564863,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8777,GO:0032838,1,0.397959040112884,0,62,cell projection cytoplasm,CC,
8778,GO:0032839,1,0.715674293732083,0,22,dendrite cytoplasm,CC,
8779,GO:0032841,1,0.983451945808524,0,1,calcitonin binding,MF,
8783,GO:0032847,1,0.940345243409865,0,5,regulation of cellular pH reduction,BP,
8784,GO:0032848,1,0.983428431308179,0,1,negative regulation of cellular pH reduction,BP,
8785,GO:0032849,1,0.956193796730008,0,4,positive regulation of cellular pH reduction,BP,
8792,GO:0032875,1,0.88979471497608,0,7,regulation of DNA endoreduplication,BP,
8793,GO:0032876,1,0.935337858454127,0,4,negative regulation of DNA endoreduplication,BP,
8794,GO:0032877,1,0.967136755861912,0,2,positive regulation of DNA endoreduplication,BP,
8795,GO:0032878,1,0.726005631625132,0,20,regulation of establishment or maintenance of cell polarity,BP,
8801,GO:0032889,1,0.984820887811098,0,1,regulation of vacuole fusion, non-autophagic,BP,
8805,GO:0032897,1,0.713412321135758,0,24,negative regulation of viral transcription,BP,
8809,GO:0032901,1,0.983427383580849,0,1,positive regulation of neurotrophin production,BP,
8810,GO:0032902,1,0.967274570289782,0,2,nerve growth factor production,BP,
8811,GO:0032905,1,0.869935320365212,0,9,transforming growth factor beta1 production,BP,
8812,GO:0032906,1,0.880566992855752,0,8,transforming growth factor beta2 production,BP,
8813,GO:0032907,1,0.953562840441617,0,3,transforming growth factor beta3 production,BP,
8814,GO:0032908,1,0.869935320365212,0,9,regulation of transforming growth factor beta1 production,BP,
8815,GO:0032909,1,0.880566992855752,0,8,regulation of transforming growth factor beta2 production,BP,
8816,GO:0032910,1,0.953562840441617,0,3,regulation of transforming growth factor beta3 production,BP,
8817,GO:0032911,1,0.951151664158134,0,3,negative regulation of transforming growth factor beta1 production,BP,
8818,GO:0032912,1,0.967183310546702,0,2,negative regulation of transforming growth factor beta2 production,BP,
8819,GO:0032913,1,0.985976828446026,0,1,negative regulation of transforming growth factor beta3 production,BP,
8820,GO:0032914,1,0.91462956183406,0,6,positive regulation of transforming growth factor beta1 production,BP,
8821,GO:0032915,1,0.973413965354664,0,2,positive regulation of transforming growth factor beta2 production,BP,
8822,GO:0032916,1,0.967126892147759,0,2,positive regulation of transforming growth factor beta3 production,BP,
8823,GO:0032917,1,0.970687955136487,0,3,polyamine acetylation,BP,
8824,GO:0032918,1,0.970687955136487,0,3,spermidine acetylation,BP,
8825,GO:0032919,1,0.992696167789598,0,1,spermine acetylation,BP,
8826,GO:0032920,1,0.992696167789598,0,1,putrescine acetylation,BP,
8827,GO:0032922,1,0.454540568109224,0,51,circadian regulation of gene expression,BP,
8831,GO:0032927,1,0.88868520813385,0,8,positive regulation of activin receptor signaling pathway,BP,
8832,GO:0032928,1,0.84634496345793,0,13,regulation of superoxide anion generation,BP,
8833,GO:0032929,1,0.977360523647181,0,2,negative regulation of superoxide anion generation,BP,
8834,GO:0032930,1,0.88056297410463,0,10,positive regulation of superoxide anion generation,BP,
8835,GO:0032933,1,0.881111303866859,0,8,SREBP signaling pathway,BP,
8836,GO:0032934,1,0.529049920932564,0,48,sterol binding,MF,
8837,GO:0032937,1,0.953199961571951,0,3,SREBP-SCAP-Insig complex,CC,
8845,GO:0032954,1,0.967265020526894,0,2,regulation of cytokinetic process,BP,
8847,GO:0032957,1,0.867200407073731,0,9,inositol trisphosphate metabolic process,BP,
8848,GO:0032958,1,0.746321989892692,0,20,inositol phosphate biosynthetic process,BP,
8849,GO:0032959,1,0.896524236005223,0,7,inositol trisphosphate biosynthetic process,BP,
8850,GO:0032960,1,0.9270072549397,0,5,regulation of inositol trisphosphate biosynthetic process,BP,
8851,GO:0032962,1,0.942633627481215,0,4,positive regulation of inositol trisphosphate biosynthetic process,BP,
8855,GO:0032966,1,0.907318348807988,0,7,negative regulation of collagen biosynthetic process,BP,
8857,GO:0032968,1,0.8271493217831,0,13,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8859,GO:0032971,1,0.954495897057437,0,4,regulation of muscle filament sliding,BP,
8860,GO:0032972,1,0.98618347125822,0,2,regulation of muscle filament sliding speed,BP,
8861,GO:0032976,1,0.993788964544904,0,1,release of matrix enzymes from mitochondria,BP,
8862,GO:0032980,1,0.985140164917807,0,1,keratinocyte activation,BP,
8863,GO:0032981,1,0.610301721906455,0,55,mitochondrial respiratory chain complex I assembly,BP,
8865,GO:0032983,1,0.967767953481258,0,2,kainate selective glutamate receptor complex,CC,
8867,GO:0032986,1,0.773060900294657,0,20,protein-DNA complex disassembly,BP,
8868,GO:0032988,1,0.828102332711104,0,13,ribonucleoprotein complex disassembly,BP,
8872,GO:0032993,1,0.15329983623891,0,188,protein-DNA complex,CC,
8873,GO:0032994,1,0.6351939228124,0,39,protein-lipid complex,CC,
8874,GO:0032996,1,0.98730706436518,0,1,Bcl3-Bcl10 complex,CC,
8875,GO:0032997,1,0.980615484805456,0,2,Fc receptor complex,CC,
8876,GO:0032998,1,0.980615484805456,0,2,Fc-epsilon receptor I complex,CC,
8878,GO:0033003,1,0.599546029619779,0,37,regulation of mast cell activation,BP,
8879,GO:0033004,1,0.845897052331504,0,12,negative regulation of mast cell activation,BP,
8880,GO:0033005,1,0.825868638119071,0,15,positive regulation of mast cell activation,BP,
8881,GO:0033006,1,0.676078144358067,0,29,regulation of mast cell activation involved in immune response,BP,
8882,GO:0033007,1,0.895218733262478,0,8,negative regulation of mast cell activation involved in immune response,BP,
8883,GO:0033008,1,0.852997797299987,0,13,positive regulation of mast cell activation involved in immune response,BP,
8885,GO:0033011,1,0.946204624920016,0,4,perinuclear theca,CC,
8886,GO:0033013,1,0.475378453992732,0,57,tetrapyrrole metabolic process,BP,
8887,GO:0033014,1,0.687150960689624,0,27,tetrapyrrole biosynthetic process,BP,
8888,GO:0033015,1,0.924979877104455,0,7,tetrapyrrole catabolic process,BP,
8896,GO:0033029,1,0.927206550917514,0,5,regulation of neutrophil apoptotic process,BP,
8897,GO:0033030,1,0.983426667501235,0,1,negative regulation of neutrophil apoptotic process,BP,
8898,GO:0033031,1,0.942836269007768,0,4,positive regulation of neutrophil apoptotic process,BP,
8901,GO:0033034,1,0.888989923315036,0,8,positive regulation of myeloid cell apoptotic process,BP,
8903,GO:0033037,1,0.983426667501773,0,1,polysaccharide localization,BP,
8904,GO:0033038,1,0.866661656469837,0,18,bitter taste receptor activity,MF,
8905,GO:0033040,1,0.9674843492633,0,2,sour taste receptor activity,MF,
8906,GO:0033041,1,0.969794177778552,0,2,sweet taste receptor activity,MF,
8909,GO:0033045,1,0.410273544181707,0,61,regulation of sister chromatid segregation,BP,
8910,GO:0033046,1,0.613305622775135,0,33,negative regulation of sister chromatid segregation,BP,
8911,GO:0033047,1,0.476428205084178,0,51,regulation of mitotic sister chromatid segregation,BP,
8912,GO:0033048,1,0.623661845723701,0,32,negative regulation of mitotic sister chromatid segregation,BP,
8913,GO:0033058,1,0.967126892144615,0,2,directional locomotion,BP,
8915,GO:0033061,1,0.904328843458822,0,7,DNA recombinase mediator complex,CC,
8916,GO:0033063,1,0.932604013863654,0,5,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8917,GO:0033065,1,0.977611283602813,0,2,Rad51C-XRCC3 complex,CC,
8918,GO:0033076,1,0.962964030486829,0,3,isoquinoline alkaloid metabolic process,BP,
8920,GO:0033078,1,0.960442454147015,0,3,extrathymic T cell differentiation,BP,
8924,GO:0033082,1,0.97201434985126,0,2,regulation of extrathymic T cell differentiation,BP,
8930,GO:0033089,1,0.850572045869551,0,11,positive regulation of T cell differentiation in thymus,BP,
8931,GO:0033091,1,0.95943724198946,0,3,positive regulation of immature T cell proliferation,BP,
8932,GO:0033092,1,0.974394994449599,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8934,GO:0033106,1,0.984627953628669,0,1,cis-Golgi network membrane,CC,
8935,GO:0033108,1,0.466485069803245,0,77,mitochondrial respiratory chain complex assembly,BP,
8936,GO:0033116,1,0.399703127126077,0,66,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8937,GO:0033119,1,0.699701944928682,0,25,negative regulation of RNA splicing,BP,
8939,GO:0033121,1,0.951667675770036,0,3,regulation of purine nucleotide catabolic process,BP,
8940,GO:0033122,1,0.967707983419544,0,2,negative regulation of purine nucleotide catabolic process,BP,
8941,GO:0033123,1,0.983426667501433,0,1,positive regulation of purine nucleotide catabolic process,BP,
8942,GO:0033127,1,0.827151489221114,0,13,regulation of histone phosphorylation,BP,
8943,GO:0033128,1,0.960475141310865,0,3,negative regulation of histone phosphorylation,BP,
8944,GO:0033129,1,0.887966216891779,0,8,positive regulation of histone phosphorylation,BP,
8945,GO:0033130,1,0.885071597172802,0,8,acetylcholine receptor binding,MF,
8946,GO:0033131,1,0.904283043261605,0,8,regulation of glucokinase activity,BP,
8947,GO:0033132,1,0.947195102859384,0,4,negative regulation of glucokinase activity,BP,
8948,GO:0033133,1,0.954705626205663,0,4,positive regulation of glucokinase activity,BP,
8950,GO:0033136,1,0.890347591739917,0,8,serine phosphorylation of STAT3 protein,BP,
8951,GO:0033137,1,0.708693858350982,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8954,GO:0033140,1,0.971738489735398,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8956,GO:0033142,1,0.969578635068868,0,2,progesterone receptor binding,MF,
8957,GO:0033143,1,0.379414944097397,0,64,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8958,GO:0033144,1,0.618683300770289,0,31,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8959,GO:0033145,1,0.807764591448378,0,15,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8960,GO:0033146,1,0.62632071746979,0,30,regulation of intracellular estrogen receptor signaling pathway,BP,
8961,GO:0033147,1,0.815326737193629,0,13,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8962,GO:0033148,1,0.86713483252412,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8963,GO:0033149,1,0.967142475566986,0,2,FFAT motif binding,MF,
8964,GO:0033150,1,0.96015566485305,0,3,cytoskeletal calyx,CC,
8965,GO:0033151,1,0.817672663140552,0,13,V(D)J recombination,BP,
8966,GO:0033152,1,0.942215400502326,0,4,immunoglobulin V(D)J recombination,BP,
8967,GO:0033153,1,0.92051492559504,0,5,T cell receptor V(D)J recombination,BP,
8971,GO:0033160,1,0.840093605639136,0,12,positive regulation of protein import into nucleus, translocation,BP,
8973,GO:0033165,1,0.958606215405165,0,3,interphotoreceptor matrix,CC,
8974,GO:0033167,1,0.983426667496558,0,1,ARC complex,CC,
8975,GO:0033168,1,0.983426667496558,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8976,GO:0033169,1,0.847859523877846,0,10,histone H3-K9 demethylation,BP,
8977,GO:0033170,1,0.893138037529611,0,8,protein-DNA loading ATPase activity,MF,
8979,GO:0033176,1,0.750122289098548,0,23,proton-transporting V-type ATPase complex,CC,
8980,GO:0033177,1,0.804441828028501,0,21,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8981,GO:0033178,1,0.830773140781205,0,16,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8982,GO:0033179,1,0.878067623755003,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8983,GO:0033180,1,0.888487742336888,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8984,GO:0033182,1,0.864684619206107,0,9,regulation of histone ubiquitination,BP,
8985,GO:0033183,1,0.952806497054591,0,3,negative regulation of histone ubiquitination,BP,
8986,GO:0033184,1,0.921582196776319,0,5,positive regulation of histone ubiquitination,BP,
8987,GO:0033185,1,0.97774236698752,0,3,dolichol-phosphate-mannose synthase complex,CC,
8988,GO:0033186,1,0.953285854922025,0,3,CAF-1 complex,CC,
8989,GO:0033188,1,0.956718701365542,0,3,sphingomyelin synthase activity,MF,
8990,GO:0033189,1,0.796412600530448,0,17,response to vitamin A,BP,
8991,GO:0033192,1,0.935583423439086,0,4,calmodulin-dependent protein phosphatase activity,MF,
8992,GO:0033193,1,0.983426667502659,0,1,Lsd1/2 complex,CC,
8993,GO:0033194,1,0.810540322383799,0,16,response to hydroperoxide,BP,
8994,GO:0033197,1,0.843486655338684,0,12,response to vitamin E,BP,
8995,GO:0033198,1,0.647676150253041,0,31,response to ATP,BP,
8996,GO:0033202,1,0.838644216567794,0,14,DNA helicase complex,CC,
8997,GO:0033204,1,0.984940949603179,0,1,ribonuclease P RNA binding,MF,
8998,GO:0033206,1,0.920858204651878,0,5,meiotic cytokinesis,BP,
9000,GO:0033210,1,0.876366231017619,0,9,leptin-mediated signaling pathway,BP,
9001,GO:0033211,1,0.914625278954756,0,6,adiponectin-activated signaling pathway,BP,
9002,GO:0033212,1,0.985282790167759,0,1,iron assimilation,BP,
9003,GO:0033214,1,0.985282790167759,0,1,iron assimilation by chelation and transport,BP,
9004,GO:0033216,1,0.928475474587312,0,5,ferric iron import,BP,
9006,GO:0033227,1,0.924286483720619,0,5,dsRNA transport,BP,
9007,GO:0033229,1,0.983435876792907,0,1,cysteine transmembrane transporter activity,MF,
9008,GO:0033231,1,0.983426669406348,0,1,carbohydrate export,BP,
9009,GO:0033233,1,0.742133789288463,0,21,regulation of protein sumoylation,BP,
9010,GO:0033234,1,0.867411205400756,0,10,negative regulation of protein sumoylation,BP,
9011,GO:0033235,1,0.855895409637316,0,11,positive regulation of protein sumoylation,BP,
9012,GO:0033238,1,0.407661994105642,0,76,regulation of cellular amine metabolic process,BP,
9013,GO:0033239,1,0.9376690999757,0,4,negative regulation of cellular amine metabolic process,BP,
9014,GO:0033240,1,0.884420616003759,0,9,positive regulation of cellular amine metabolic process,BP,
9015,GO:0033241,1,0.983426667498132,0,1,regulation of cellular amine catabolic process,BP,
9016,GO:0033242,1,0.983426667498132,0,1,negative regulation of cellular amine catabolic process,BP,
9017,GO:0033256,1,0.902617142742963,0,7,I-kappaB/NF-kappaB complex,CC,
9018,GO:0033257,1,0.97129755700455,0,2,Bcl3/NF-kappaB2 complex,CC,
9019,GO:0033260,1,0.652612317053139,0,29,nuclear DNA replication,BP,
9020,GO:0033262,1,0.816276888567802,0,13,regulation of nuclear cell cycle DNA replication,BP,
9021,GO:0033263,1,0.93578700937378,0,4,CORVET complex,CC,
9022,GO:0033265,1,0.940886097264523,0,4,choline binding,MF,
9025,GO:0033269,1,0.938698689204459,0,4,internode region of axon,CC,
9028,GO:0033274,1,0.983426667500052,0,1,response to vitamin B2,BP,
9030,GO:0033276,1,0.821196535641297,0,14,transcription factor TFTC complex,CC,
9031,GO:0033277,1,0.969338824202069,0,2,abortive mitotic cell cycle,BP,
9034,GO:0033290,1,0.983426667503302,0,1,eukaryotic 48S preinitiation complex,CC,
9035,GO:0033291,1,0.997061471984394,0,1,eukaryotic 80S initiation complex,CC,
9036,GO:0033292,1,0.95748309046901,0,3,T-tubule organization,BP,
9038,GO:0033299,1,0.931552438229173,0,5,secretion of lysosomal enzymes,BP,
9039,GO:0033300,1,0.937223953679464,0,4,dehydroascorbic acid transporter activity,MF,
9040,GO:0033301,1,0.983436696762307,0,1,cell cycle comprising mitosis without cytokinesis,BP,
9041,GO:0033306,1,0.970902332533587,0,2,phytol metabolic process,BP,
9042,GO:0033313,1,0.898670289446382,0,8,meiotic cell cycle checkpoint,BP,
9043,GO:0033314,1,0.881416846924535,0,9,mitotic DNA replication checkpoint,BP,
9044,GO:0033315,1,0.992480921107235,0,1,meiotic DNA replication checkpoint,BP,
9045,GO:0033316,1,0.983826495175854,0,1,meiotic spindle assembly checkpoint,BP,
9046,GO:0033319,1,0.986306038053932,0,1,UDP-D-xylose metabolic process,BP,
9047,GO:0033320,1,0.986306038053932,0,1,UDP-D-xylose biosynthetic process,BP,
9048,GO:0033326,1,0.953662253079245,0,3,cerebrospinal fluid secretion,BP,
9050,GO:0033328,1,0.983452239819199,0,1,peroxisome membrane targeting sequence binding,MF,
9051,GO:0033341,1,0.968500812573682,0,2,regulation of collagen binding,BP,
9052,GO:0033342,1,0.984823647548524,0,1,negative regulation of collagen binding,BP,
9053,GO:0033343,1,0.983426667499217,0,1,positive regulation of collagen binding,BP,
9054,GO:0033344,1,0.594537446150249,0,40,cholesterol efflux,BP,
9055,GO:0033345,1,0.985255368142812,0,1,asparagine catabolic process via L-aspartate,BP,
9056,GO:0033353,1,0.93750108220905,0,4,S-adenosylmethionine cycle,BP,
9058,GO:0033364,1,0.974358395293408,0,2,mast cell secretory granule organization,BP,
9060,GO:0033366,1,0.990779541324844,0,1,protein localization to secretory granule,BP,
9061,GO:0033367,1,0.990779541324844,0,1,protein localization to mast cell secretory granule,BP,
9062,GO:0033368,1,0.990779541324844,0,1,protease localization to mast cell secretory granule,BP,
9063,GO:0033370,1,0.990779541324844,0,1,maintenance of protein location in mast cell secretory granule,BP,
9064,GO:0033371,1,0.990779541324844,0,1,T cell secretory granule organization,BP,
9065,GO:0033373,1,0.990779541324844,0,1,maintenance of protease location in mast cell secretory granule,BP,
9066,GO:0033374,1,0.990779541324844,0,1,protein localization to T cell secretory granule,BP,
9067,GO:0033375,1,0.990779541324844,0,1,protease localization to T cell secretory granule,BP,
9068,GO:0033377,1,0.990779541324844,0,1,maintenance of protein location in T cell secretory granule,BP,
9069,GO:0033379,1,0.990779541324844,0,1,maintenance of protease location in T cell secretory granule,BP,
9070,GO:0033380,1,0.990779541324844,0,1,granzyme B localization to T cell secretory granule,BP,
9071,GO:0033382,1,0.990779541324844,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
9072,GO:0033383,1,0.973658230798779,0,2,geranyl diphosphate metabolic process,BP,
9073,GO:0033384,1,0.973658230798779,0,2,geranyl diphosphate biosynthetic process,BP,
9074,GO:0033385,1,0.984163903536332,0,1,geranylgeranyl diphosphate metabolic process,BP,
9075,GO:0033386,1,0.984163903536332,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
9076,GO:0033387,1,0.970056165976688,0,2,putrescine biosynthetic process from ornithine,BP,
9077,GO:0033388,1,0.985893068778292,0,1,putrescine biosynthetic process from arginine,BP,
9078,GO:0033391,1,0.826434704843918,0,12,chromatoid body,CC,
9079,GO:0033477,1,0.986725823054687,0,1,S-methylmethionine metabolic process,BP,
9081,GO:0033484,1,0.961098066641118,0,3,nitric oxide homeostasis,BP,
9082,GO:0033488,1,0.983775317839248,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
9083,GO:0033489,1,0.95984370442726,0,3,cholesterol biosynthetic process via desmosterol,BP,
9084,GO:0033490,1,0.95984370442726,0,3,cholesterol biosynthetic process via lathosterol,BP,
9085,GO:0033499,1,0.984939504141857,0,1,galactose catabolic process via UDP-galactose,BP,
9087,GO:0033503,1,0.932429074733176,0,5,HULC complex,CC,
9088,GO:0033504,1,0.908403829475778,0,7,floor plate development,BP,
9089,GO:0033505,1,0.96999507116112,0,2,floor plate morphogenesis,BP,
9090,GO:0033512,1,0.954029854262284,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
9091,GO:0033514,1,0.985146370134175,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9092,GO:0033522,1,0.749761780228207,0,19,histone H2A ubiquitination,BP,
9093,GO:0033523,1,0.857437225882547,0,10,histone H2B ubiquitination,BP,
9094,GO:0033539,1,0.89899149561078,0,8,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
9095,GO:0033540,1,0.828360664338304,0,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9097,GO:0033552,1,0.994275566742343,0,1,response to vitamin B3,BP,
9098,GO:0033553,1,0.940811795307891,0,4,rDNA heterochromatin,CC,
9100,GO:0033555,1,0.385284333113248,0,66,multicellular organismal response to stress,BP,
9101,GO:0033557,1,0.954880041681638,0,3,Slx1-Slx4 complex,CC,
9104,GO:0033560,1,0.983426965534487,0,1,folate reductase activity,MF,
9107,GO:0033564,1,0.919849070313254,0,5,anterior/posterior axon guidance,BP,
9108,GO:0033565,1,0.952082264252519,0,3,ESCRT-0 complex,CC,
9109,GO:0033566,1,0.970088998163162,0,2,gamma-tubulin complex localization,BP,
9110,GO:0033567,1,0.942643195684741,0,4,DNA replication, Okazaki fragment processing,BP,
9111,GO:0033570,1,0.983426667502463,0,1,transferrin transmembrane transporter activity,MF,
9114,GO:0033577,1,0.969040122724797,0,2,protein glycosylation in endoplasmic reticulum,BP,
9115,GO:0033578,1,0.926125678893603,0,5,protein glycosylation in Golgi,BP,
9116,GO:0033588,1,0.913498085546669,0,6,Elongator holoenzyme complex,CC,
9117,GO:0033590,1,0.958724235868521,0,3,response to cobalamin,BP,
9118,GO:0033591,1,0.930837745899442,0,5,response to L-ascorbic acid,BP,
9119,GO:0033592,1,0.921918779176696,0,5,RNA strand annealing activity,MF,
9120,GO:0033593,1,0.983426667495326,0,1,BRCA2-MAGE-D1 complex,CC,
9121,GO:0033594,1,0.950785512494236,0,4,response to hydroxyisoflavone,BP,
9122,GO:0033595,1,0.969573915187853,0,2,response to genistein,BP,
9123,GO:0033596,1,0.951127182854503,0,3,TSC1-TSC2 complex,CC,
9125,GO:0033599,1,0.783648043379214,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9126,GO:0033600,1,0.927852166562477,0,5,negative regulation of mammary gland epithelial cell proliferation,BP,
9127,GO:0033601,1,0.893384187386771,0,7,positive regulation of mammary gland epithelial cell proliferation,BP,
9128,GO:0033602,1,0.952121512128795,0,3,negative regulation of dopamine secretion,BP,
9132,GO:0033606,1,0.985976828446026,0,1,chemokine receptor transport within lipid bilayer,BP,
9133,GO:0033609,1,0.984728932554734,0,1,oxalate metabolic process,BP,
9136,GO:0033615,1,0.958347435816863,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9137,GO:0033617,1,0.832717013789526,0,14,mitochondrial respiratory chain complex IV assembly,BP,
9138,GO:0033619,1,0.444121124424413,0,55,membrane protein proteolysis,BP,
9139,GO:0033622,1,0.753478326629776,0,18,integrin activation,BP,
9140,GO:0033623,1,0.8553498823277,0,10,regulation of integrin activation,BP,
9141,GO:0033624,1,0.967216003376947,0,2,negative regulation of integrin activation,BP,
9142,GO:0033625,1,0.928860053488856,0,5,positive regulation of integrin activation,BP,
9143,GO:0033626,1,0.983437731995426,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9146,GO:0033629,1,0.874718020811965,0,9,negative regulation of cell adhesion mediated by integrin,BP,
9147,GO:0033630,1,0.797535802811593,0,17,positive regulation of cell adhesion mediated by integrin,BP,
9149,GO:0033632,1,0.895835368431198,0,8,regulation of cell-cell adhesion mediated by integrin,BP,
9150,GO:0033633,1,0.983426667502809,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9151,GO:0033634,1,0.951087354620562,0,4,positive regulation of cell-cell adhesion mediated by integrin,BP,
9152,GO:0033643,1,0.86619600340614,0,9,host cell part,CC,
9153,GO:0033644,1,0.983426667503302,0,1,host cell membrane,CC,
9154,GO:0033646,1,0.895652087409667,0,7,host intracellular part,CC,
9155,GO:0033647,1,0.925305718574645,0,5,host intracellular organelle,CC,
9156,GO:0033648,1,0.925305718574645,0,5,host intracellular membrane-bounded organelle,CC,
9157,GO:0033650,1,0.987869227208269,0,1,host cell mitochondrion,CC,
9158,GO:0033655,1,0.940443163744735,0,4,host cell cytoplasm part,CC,
9159,GO:0033668,1,0.945615730503691,0,4,negative regulation by symbiont of host apoptotic process,BP,
9162,GO:0033676,1,0.989801431911876,0,1,double-stranded DNA-dependent ATPase activity,MF,
9163,GO:0033677,1,0.969045374236696,0,2,DNA/RNA helicase activity,MF,
9164,GO:0033678,1,0.984470388936783,0,1,5'-3' DNA/RNA helicase activity,MF,
9165,GO:0033680,1,0.984470388936783,0,1,ATP-dependent DNA/RNA helicase activity,MF,
9166,GO:0033682,1,0.984470388936783,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9167,GO:0033683,1,0.590405464139819,0,39,nucleotide-excision repair, DNA incision,BP,
9168,GO:0033684,1,0.908366233410938,0,7,regulation of luteinizing hormone secretion,BP,
9169,GO:0033685,1,0.959720313616301,0,3,negative regulation of luteinizing hormone secretion,BP,
9170,GO:0033686,1,0.946499457469376,0,4,positive regulation of luteinizing hormone secretion,BP,
9173,GO:0033689,1,0.862495609250769,0,9,negative regulation of osteoblast proliferation,BP,
9175,GO:0033691,1,0.86832454681059,0,9,sialic acid binding,MF,
9177,GO:0033693,1,0.951719024838618,0,3,neurofilament bundle assembly,BP,
9178,GO:0033695,1,0.943523271479885,0,4,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9179,GO:0033699,1,0.986608426636293,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9180,GO:0033700,1,0.884549828518466,0,12,phospholipid efflux,BP,
9181,GO:0033735,1,0.992821911253573,0,1,aspartate dehydrogenase activity,MF,
9182,GO:0033737,1,0.984876680452831,0,1,1-pyrroline dehydrogenase activity,MF,
9183,GO:0033743,1,0.947048446165447,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9184,GO:0033746,1,0.983450982062668,0,1,histone demethylase activity (H3-R2 specific),MF,
9185,GO:0033749,1,0.983450982062668,0,1,histone demethylase activity (H4-R3 specific),MF,
9186,GO:0033750,1,0.863580670974165,0,12,ribosome localization,BP,
9187,GO:0033753,1,0.863580670974165,0,12,establishment of ribosome localization,BP,
9188,GO:0033754,1,0.974523998756338,0,2,indoleamine 2,3-dioxygenase activity,MF,
9190,GO:0033764,1,0.747567277892504,0,25,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9191,GO:0033765,1,0.9558549769923,0,3,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9192,GO:0033768,1,0.983787819456433,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9193,GO:0033778,1,0.983426767367589,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9194,GO:0033780,1,0.984230601554668,0,1,taurochenodeoxycholate 6alpha-hydroxylase activity,MF,
9195,GO:0033781,1,0.986334753762597,0,1,cholesterol 24-hydroxylase activity,MF,
9196,GO:0033787,1,0.984099260716134,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9197,GO:0033791,1,0.985462222960467,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9198,GO:0033798,1,0.986285617164255,0,1,thyroxine 5-deiodinase activity,MF,
9199,GO:0033814,1,0.989717066048738,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9200,GO:0033819,1,0.992751985579685,0,1,lipoyl(octanoyl) transferase activity,MF,
9201,GO:0033823,1,0.983879771943761,0,1,procollagen glucosyltransferase activity,MF,
9202,GO:0033829,1,0.960384107029813,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9203,GO:0033842,1,0.967265032999988,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9204,GO:0033857,1,0.967126892153183,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9205,GO:0033858,1,0.983679586263671,0,1,N-acetylgalactosamine kinase activity,MF,
9206,GO:0033860,1,0.917371188705833,0,8,regulation of NAD(P)H oxidase activity,BP,
9207,GO:0033861,1,0.97246132568356,0,3,negative regulation of NAD(P)H oxidase activity,BP,
9208,GO:0033862,1,0.98388379686975,0,1,UMP kinase activity,MF,
9209,GO:0033864,1,0.943356195152077,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9210,GO:0033865,1,0.637556575751318,0,33,nucleoside bisphosphate metabolic process,BP,
9211,GO:0033866,1,0.794753714877327,0,16,nucleoside bisphosphate biosynthetic process,BP,
9212,GO:0033867,1,0.988436645880594,0,1,Fas-activated serine/threonine kinase activity,MF,
9213,GO:0033869,1,0.99237048907605,0,1,nucleoside bisphosphate catabolic process,BP,
9214,GO:0033871,1,0.986935358959301,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9215,GO:0033872,1,0.971603357986628,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9216,GO:0033875,1,0.637556575751318,0,33,ribonucleoside bisphosphate metabolic process,BP,
9217,GO:0033878,1,0.983429935863518,0,1,hormone-sensitive lipase activity,MF,
9218,GO:0033882,1,0.991378327332964,0,1,choloyl-CoA hydrolase activity,MF,
9219,GO:0033883,1,0.978419339578413,0,2,pyridoxal phosphatase activity,MF,
9220,GO:0033885,1,0.985855483080867,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9221,GO:0033897,1,0.990779541324844,0,1,ribonuclease T2 activity,MF,
9222,GO:0033906,1,0.972999869646743,0,2,hyaluronoglucuronidase activity,MF,
9223,GO:0033919,1,0.983427104125773,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9224,GO:0033925,1,0.983426667503104,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9225,GO:0033961,1,0.987892195619441,0,1,cis-stilbene-oxide hydrolase activity,MF,
9226,GO:0033962,1,0.759047739968916,0,18,cytoplasmic mRNA processing body assembly,BP,
9227,GO:0033967,1,0.991312379435752,0,1,box C/D snoRNA metabolic process,BP,
9228,GO:0033979,1,0.984680431882196,0,1,box H/ACA snoRNA metabolic process,BP,
9229,GO:0033981,1,0.995012915288871,0,1,D-dopachrome decarboxylase activity,MF,
9230,GO:0033989,1,0.984408900781729,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9232,GO:0034014,1,0.985560550415529,0,1,response to triglyceride,BP,
9233,GO:0034021,1,0.990714806067948,0,2,response to silicon dioxide,BP,
9234,GO:0034030,1,0.794753714877327,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
9235,GO:0034031,1,0.99237048907605,0,1,ribonucleoside bisphosphate catabolic process,BP,
9236,GO:0034032,1,0.637556575751318,0,33,purine nucleoside bisphosphate metabolic process,BP,
9237,GO:0034033,1,0.794753714877327,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
9238,GO:0034034,1,0.99237048907605,0,1,purine nucleoside bisphosphate catabolic process,BP,
9239,GO:0034035,1,0.774716606656193,0,19,purine ribonucleoside bisphosphate metabolic process,BP,
9240,GO:0034036,1,0.911510261667595,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9241,GO:0034038,1,0.991187648239397,0,1,deoxyhypusine synthase activity,MF,
9242,GO:0034039,1,0.987084084085022,0,1,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9243,GO:0034040,1,0.951549014759511,0,3,lipid-transporting ATPase activity,MF,
9244,GO:0034041,1,0.967587330687514,0,2,sterol-transporting ATPase activity,MF,
9245,GO:0034045,1,0.801504234079133,0,14,pre-autophagosomal structure membrane,CC,
9246,GO:0034046,1,0.923515169017812,0,5,poly(G) binding,MF,
9247,GO:0034056,1,0.937123757677957,0,4,estrogen response element binding,MF,
9248,GO:0034057,1,0.968521267639567,0,2,RNA strand-exchange activity,MF,
9249,GO:0034058,1,0.863132396920908,0,9,endosomal vesicle fusion,BP,
9251,GO:0034061,1,0.613294977654712,0,33,DNA polymerase activity,MF,
9252,GO:0034062,1,0.575082932401601,0,42,5'-3' RNA polymerase activity,MF,
9253,GO:0034063,1,0.84895582649125,0,10,stress granule assembly,BP,
9254,GO:0034066,1,0.990461844189707,0,1,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9255,GO:0034067,1,0.602864474972484,0,32,protein localization to Golgi apparatus,BP,
9256,GO:0034080,1,0.708523822678428,0,37,CENP-A containing nucleosome assembly,BP,
9257,GO:0034085,1,0.956004175235373,0,3,establishment of sister chromatid cohesion,BP,
9258,GO:0034086,1,0.873247367639945,0,9,maintenance of sister chromatid cohesion,BP,
9259,GO:0034088,1,0.873247367639945,0,9,maintenance of mitotic sister chromatid cohesion,BP,
9260,GO:0034091,1,0.93033014652415,0,5,regulation of maintenance of sister chromatid cohesion,BP,
9261,GO:0034092,1,0.967126892142003,0,2,negative regulation of maintenance of sister chromatid cohesion,BP,
9262,GO:0034093,1,0.961957686799267,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9264,GO:0034098,1,0.868750616415149,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9270,GO:0034110,1,0.719313529248898,0,22,regulation of homotypic cell-cell adhesion,BP,
9271,GO:0034111,1,0.816508314060589,0,13,negative regulation of homotypic cell-cell adhesion,BP,
9272,GO:0034112,1,0.956319809369353,0,4,positive regulation of homotypic cell-cell adhesion,BP,
9275,GO:0034115,1,0.882133886412339,0,9,negative regulation of heterotypic cell-cell adhesion,BP,
9277,GO:0034117,1,0.99567155934496,0,1,erythrocyte aggregation,BP,
9278,GO:0034118,1,0.99567155934496,0,1,regulation of erythrocyte aggregation,BP,
9279,GO:0034120,1,0.99567155934496,0,1,positive regulation of erythrocyte aggregation,BP,
9282,GO:0034123,1,0.766148705202403,0,18,positive regulation of toll-like receptor signaling pathway,BP,
9283,GO:0034124,1,0.946404443481527,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9284,GO:0034125,1,0.975191632722867,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9285,GO:0034127,1,0.894984890103112,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9286,GO:0034128,1,0.90696081861021,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9287,GO:0034130,1,0.98409752126087,0,1,toll-like receptor 1 signaling pathway,BP,
9288,GO:0034134,1,0.865084929008715,0,10,toll-like receptor 2 signaling pathway,BP,
9289,GO:0034135,1,0.935338488276836,0,5,regulation of toll-like receptor 2 signaling pathway,BP,
9290,GO:0034136,1,0.967481517491706,0,2,negative regulation of toll-like receptor 2 signaling pathway,BP,
9291,GO:0034137,1,0.966781078676991,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
9292,GO:0034138,1,0.781395994011873,0,16,toll-like receptor 3 signaling pathway,BP,
9293,GO:0034139,1,0.869451220656446,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9294,GO:0034140,1,0.951694336618613,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9295,GO:0034141,1,0.899017538281369,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9296,GO:0034142,1,0.663530599664055,0,28,toll-like receptor 4 signaling pathway,BP,
9297,GO:0034143,1,0.807263684252222,0,14,regulation of toll-like receptor 4 signaling pathway,BP,
9298,GO:0034144,1,0.92214683238531,0,5,negative regulation of toll-like receptor 4 signaling pathway,BP,
9299,GO:0034145,1,0.875456846756002,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9300,GO:0034146,1,0.967126892155359,0,2,toll-like receptor 5 signaling pathway,BP,
9301,GO:0034147,1,0.983426667503154,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9302,GO:0034148,1,0.983426667503154,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9303,GO:0034150,1,0.983426667501628,0,1,toll-like receptor 6 signaling pathway,BP,
9304,GO:0034154,1,0.923663463867744,0,5,toll-like receptor 7 signaling pathway,BP,
9305,GO:0034155,1,0.983478489430682,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
9306,GO:0034157,1,0.983478489430682,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
9307,GO:0034158,1,0.983426667503296,0,1,toll-like receptor 8 signaling pathway,BP,
9308,GO:0034162,1,0.750439395591304,0,18,toll-like receptor 9 signaling pathway,BP,
9309,GO:0034163,1,0.951228745047701,0,3,regulation of toll-like receptor 9 signaling pathway,BP,
9310,GO:0034164,1,0.983426667500693,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
9311,GO:0034165,1,0.967261685242565,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9312,GO:0034166,1,0.983572385455245,0,1,toll-like receptor 10 signaling pathway,BP,
9313,GO:0034182,1,0.93033014652415,0,5,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9314,GO:0034183,1,0.967126892142003,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9315,GO:0034184,1,0.961957686799267,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9316,GO:0034185,1,0.778476930708887,0,16,apolipoprotein binding,MF,
9317,GO:0034186,1,0.944610241941873,0,4,apolipoprotein A-I binding,MF,
9318,GO:0034188,1,0.967126892145874,0,2,apolipoprotein A-I receptor activity,MF,
9319,GO:0034189,1,0.967174187770451,0,2,very-low-density lipoprotein particle binding,MF,
9320,GO:0034190,1,0.930758082723507,0,6,apolipoprotein receptor binding,MF,
9321,GO:0034191,1,0.949942975861034,0,4,apolipoprotein A-I receptor binding,MF,
9322,GO:0034196,1,0.935257551677186,0,5,acylglycerol transport,BP,
9323,GO:0034197,1,0.935257551677186,0,5,triglyceride transport,BP,
9326,GO:0034201,1,0.929293670510833,0,5,response to oleic acid,BP,
9327,GO:0034203,1,0.983426667502517,0,1,glycolipid translocation,BP,
9328,GO:0034204,1,0.682470983236774,0,23,lipid translocation,BP,
9329,GO:0034205,1,0.813382928800544,0,14,beta-amyloid formation,BP,
9330,GO:0034211,1,0.983426667497643,0,1,GTP-dependent protein kinase activity,MF,
9331,GO:0034212,1,0.393950972944671,0,63,peptide N-acetyltransferase activity,MF,
9332,GO:0034213,1,0.988974585037157,0,1,quinolinate catabolic process,BP,
9333,GO:0034214,1,0.899192657657063,0,7,protein hexamerization,BP,
9336,GO:0034224,1,0.972662391124194,0,2,cellular response to zinc ion starvation,BP,
9337,GO:0034226,1,0.968358686519233,0,2,lysine import,BP,
9338,GO:0034227,1,0.936885606758163,0,5,tRNA thio-modification,BP,
9339,GO:0034230,1,0.983426667502908,0,1,enkephalin processing,BP,
9340,GO:0034231,1,0.983426667502908,0,1,islet amyloid polypeptide processing,BP,
9341,GO:0034235,1,0.902557906360582,0,7,GPI anchor binding,MF,
9343,GO:0034237,1,0.770477417032401,0,16,protein kinase A regulatory subunit binding,MF,
9344,GO:0034238,1,0.953617093241466,0,3,macrophage fusion,BP,
9345,GO:0034239,1,0.953617093241466,0,3,regulation of macrophage fusion,BP,
9346,GO:0034241,1,0.953617093241466,0,3,positive regulation of macrophage fusion,BP,
9347,GO:0034242,1,0.962061916396879,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9350,GO:0034245,1,0.983429645376708,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9351,GO:0034247,1,0.980615212632678,0,2,snoRNA splicing,BP,
9354,GO:0034250,1,0.195998162594186,0,116,positive regulation of cellular amide metabolic process,BP,
9355,GO:0034255,1,0.986081633239475,0,1,regulation of urea metabolic process,BP,
9357,GO:0034271,1,0.969734176758348,0,2,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9358,GO:0034272,1,0.969734176758348,0,2,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9359,GO:0034274,1,0.951280393158525,0,3,Atg12-Atg5-Atg16 complex,CC,
9360,GO:0034275,1,0.988839062300597,0,1,kynurenic acid metabolic process,BP,
9361,GO:0034276,1,0.988839062300597,0,1,kynurenic acid biosynthetic process,BP,
9364,GO:0034287,1,0.947297158115839,0,4,detection of monosaccharide stimulus,BP,
9365,GO:0034308,1,0.488689626107383,0,53,primary alcohol metabolic process,BP,
9366,GO:0034309,1,0.992913066894507,0,1,primary alcohol biosynthetic process,BP,
9367,GO:0034310,1,0.830543886736566,0,15,primary alcohol catabolic process,BP,
9368,GO:0034311,1,0.860568662677415,0,11,diol metabolic process,BP,
9369,GO:0034312,1,0.891877911320467,0,8,diol biosynthetic process,BP,
9370,GO:0034314,1,0.638694973453744,0,32,Arp2/3 complex-mediated actin nucleation,BP,
9371,GO:0034315,1,0.788349322689106,0,16,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9372,GO:0034316,1,0.936674841436326,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9378,GO:0034334,1,0.967126892154155,0,2,adherens junction maintenance,BP,
9379,GO:0034337,1,0.983427953048742,0,1,RNA folding,BP,
9380,GO:0034338,1,0.984106248625974,0,1,short-chain carboxylesterase activity,MF,
9383,GO:0034342,1,0.971111881326466,0,2,response to type III interferon,BP,
9384,GO:0034343,1,0.951553587496352,0,3,type III interferon production,BP,
9385,GO:0034344,1,0.951553587496352,0,3,regulation of type III interferon production,BP,
9386,GO:0034346,1,0.983817336433704,0,1,positive regulation of type III interferon production,BP,
9390,GO:0034354,1,0.990760322235858,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9391,GO:0034356,1,0.840712246074632,0,11,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
9392,GO:0034358,1,0.654935620695306,0,37,plasma lipoprotein particle,CC,
9393,GO:0034359,1,0.98342666749257,0,1,mature chylomicron,CC,
9394,GO:0034360,1,0.98342666749257,0,1,chylomicron remnant,CC,
9395,GO:0034361,1,0.821622715553673,0,19,very-low-density lipoprotein particle,CC,
9396,GO:0034362,1,0.861553132033212,0,12,low-density lipoprotein particle,CC,
9397,GO:0034363,1,0.96537993919537,0,4,intermediate-density lipoprotein particle,CC,
9398,GO:0034364,1,0.780969412275466,0,26,high-density lipoprotein particle,CC,
9399,GO:0034365,1,0.987358066615232,0,2,discoidal high-density lipoprotein particle,CC,
9400,GO:0034366,1,0.938374888964088,0,8,spherical high-density lipoprotein particle,CC,
9401,GO:0034367,1,0.758527336817637,0,25,macromolecular complex remodeling,BP,
9402,GO:0034368,1,0.758527336817637,0,25,protein-lipid complex remodeling,BP,
9403,GO:0034369,1,0.758527336817637,0,25,plasma lipoprotein particle remodeling,BP,
9404,GO:0034370,1,0.9023058093939,0,11,triglyceride-rich lipoprotein particle remodeling,BP,
9405,GO:0034371,1,0.967703593967746,0,3,chylomicron remodeling,BP,
9406,GO:0034372,1,0.9023058093939,0,11,very-low-density lipoprotein particle remodeling,BP,
9407,GO:0034373,1,0.988644260634344,0,1,intermediate-density lipoprotein particle remodeling,BP,
9408,GO:0034374,1,0.870179101077793,0,12,low-density lipoprotein particle remodeling,BP,
9409,GO:0034375,1,0.857096158302569,0,15,high-density lipoprotein particle remodeling,BP,
9410,GO:0034377,1,0.78588834648814,0,20,plasma lipoprotein particle assembly,BP,
9411,GO:0034378,1,0.973096491362583,0,2,chylomicron assembly,BP,
9412,GO:0034379,1,0.903415173211312,0,8,very-low-density lipoprotein particle assembly,BP,
9413,GO:0034380,1,0.899543049674881,0,10,high-density lipoprotein particle assembly,BP,
9414,GO:0034381,1,0.669971617645592,0,32,plasma lipoprotein particle clearance,BP,
9415,GO:0034382,1,0.93838816091477,0,7,chylomicron remnant clearance,BP,
9416,GO:0034383,1,0.779875253585572,0,18,low-density lipoprotein particle clearance,BP,
9417,GO:0034384,1,0.921349705901032,0,9,high-density lipoprotein particle clearance,BP,
9418,GO:0034385,1,0.821622715553673,0,19,triglyceride-rich plasma lipoprotein particle,CC,
9419,GO:0034388,1,0.911999164025903,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9420,GO:0034389,1,0.810634546565977,0,15,lipid particle organization,BP,
9424,GO:0034393,1,0.899545037000811,0,8,positive regulation of smooth muscle cell apoptotic process,BP,
9426,GO:0034395,1,0.97268946751002,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9427,GO:0034397,1,0.816925498123768,0,13,telomere localization,BP,
9428,GO:0034398,1,0.909559775070856,0,6,telomere tethering at nuclear periphery,BP,
9430,GO:0034402,1,0.969112135209947,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9432,GO:0034414,1,0.969434532768209,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9433,GO:0034416,1,0.984099260716134,0,1,bisphosphoglycerate phosphatase activity,MF,
9434,GO:0034417,1,0.984099260716134,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9435,GO:0034418,1,0.97140613984318,0,2,urate biosynthetic process,BP,
9436,GO:0034421,1,0.953331707700781,0,3,post-translational protein acetylation,BP,
9437,GO:0034423,1,0.984541439691888,0,1,autophagosome lumen,CC,
9438,GO:0034427,1,0.920896166464993,0,7,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9439,GO:0034431,1,0.946650719048175,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9440,GO:0034432,1,0.946650719048175,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9441,GO:0034433,1,0.849522451887559,0,14,steroid esterification,BP,
9442,GO:0034434,1,0.849522451887559,0,14,sterol esterification,BP,
9443,GO:0034435,1,0.849522451887559,0,14,cholesterol esterification,BP,
9444,GO:0034436,1,0.960362399201691,0,3,glycoprotein transport,BP,
9445,GO:0034437,1,0.967605408659863,0,2,glycoprotein transporter activity,MF,
9446,GO:0034439,1,0.975214047533003,0,2,lipoprotein lipid oxidation,BP,
9448,GO:0034441,1,0.971537961286536,0,3,plasma lipoprotein oxidation,BP,
9449,GO:0034442,1,0.959318292271948,0,4,regulation of lipoprotein oxidation,BP,
9450,GO:0034443,1,0.97540291784961,0,3,negative regulation of lipoprotein oxidation,BP,
9451,GO:0034444,1,0.983701932103294,0,2,regulation of plasma lipoprotein oxidation,BP,
9452,GO:0034445,1,0.983701932103294,0,2,negative regulation of plasma lipoprotein oxidation,BP,
9454,GO:0034447,1,0.951179516032711,0,6,very-low-density lipoprotein particle clearance,BP,
9455,GO:0034448,1,0.987544038937597,0,1,EGO complex,CC,
9456,GO:0034450,1,0.829721548671502,0,13,ubiquitin-ubiquitin ligase activity,MF,
9457,GO:0034451,1,0.67869351739159,0,25,centriolar satellite,CC,
9460,GO:0034454,1,0.905919137496454,0,6,microtubule anchoring at centrosome,BP,
9461,GO:0034455,1,0.968663523442819,0,2,t-UTP complex,CC,
9462,GO:0034456,1,0.974663444180303,0,2,UTP-C complex,CC,
9463,GO:0034457,1,0.968210539330948,0,3,Mpp10 complex,CC,
9464,GO:0034458,1,0.984939504141857,0,1,3'-5' RNA helicase activity,MF,
9465,GO:0034462,1,0.985700954607697,0,1,small-subunit processome assembly,BP,
9466,GO:0034463,1,0.997061471984394,0,1,90S preribosome assembly,BP,
9467,GO:0034464,1,0.871927159827766,0,9,BBSome,CC,
9468,GO:0034465,1,0.949068963418733,0,4,response to carbon monoxide,BP,
9469,GO:0034466,1,0.984246391703275,0,1,chromaffin granule lumen,CC,
9470,GO:0034470,1,0.00992705502505424,0,372,ncRNA processing,BP,
9471,GO:0034471,1,0.953816323749976,0,3,ncRNA 5'-end processing,BP,
9472,GO:0034472,1,0.90684072226427,0,8,snRNA 3'-end processing,BP,
9473,GO:0034474,1,0.983426667500249,0,1,U2 snRNA 3'-end processing,BP,
9474,GO:0034475,1,0.95215537882787,0,5,U4 snRNA 3'-end processing,BP,
9475,GO:0034477,1,0.984728932554734,0,1,U6 snRNA 3'-end processing,BP,
9476,GO:0034481,1,0.915566940793094,0,6,chondroitin sulfotransferase activity,MF,
9477,GO:0034483,1,0.795229507081041,0,15,heparan sulfate sulfotransferase activity,MF,
9478,GO:0034485,1,0.937721290467682,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9479,GO:0034486,1,0.986552679127082,0,1,vacuolar transmembrane transport,BP,
9480,GO:0034497,1,0.891066895176876,0,7,protein localization to pre-autophagosomal structure,BP,
9481,GO:0034498,1,0.901478873288362,0,7,early endosome to Golgi transport,BP,
9482,GO:0034499,1,0.967126892152118,0,2,late endosome to Golgi transport,BP,
9483,GO:0034501,1,0.800569525859134,0,15,protein localization to kinetochore,BP,
9484,GO:0034502,1,0.39802866074894,0,63,protein localization to chromosome,BP,
9487,GO:0034506,1,0.983426667503346,0,1,chromosome, centromeric core domain,CC,
9488,GO:0034508,1,0.592157348010105,0,49,centromere complex assembly,BP,
9489,GO:0034511,1,0.93500505828881,0,5,U3 snoRNA binding,MF,
9490,GO:0034513,1,0.956704301844723,0,5,box H/ACA snoRNA binding,MF,
9491,GO:0034516,1,0.989328906139524,0,1,response to vitamin B6,BP,
9492,GO:0034518,1,0.828788174372669,0,13,RNA cap binding complex,CC,
9493,GO:0034545,1,0.988249071568082,0,1,fumarylpyruvate hydrolase activity,MF,
9494,GO:0034551,1,0.940294263452486,0,5,mitochondrial respiratory chain complex III assembly,BP,
9495,GO:0034552,1,0.982716020648119,0,2,respiratory chain complex II assembly,BP,
9496,GO:0034553,1,0.982716020648119,0,2,mitochondrial respiratory chain complex II assembly,BP,
9497,GO:0034584,1,0.951390469892392,0,3,piRNA binding,MF,
9498,GO:0034587,1,0.783299334079141,0,16,piRNA metabolic process,BP,
9499,GO:0034589,1,0.983426667503252,0,1,hydroxyproline transport,BP,
9500,GO:0034590,1,0.983426667503252,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9501,GO:0034593,1,0.659659318954794,0,26,phosphatidylinositol bisphosphate phosphatase activity,MF,
9502,GO:0034594,1,0.910613499397096,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9503,GO:0034595,1,0.808278881372295,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9504,GO:0034596,1,0.852112314216582,0,10,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9505,GO:0034597,1,0.941469251693274,0,4,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9507,GO:0034602,1,0.983426667503252,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9508,GO:0034603,1,0.916906041018077,0,6,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9509,GO:0034604,1,0.916906041018077,0,6,pyruvate dehydrogenase (NAD+) activity,MF,
9514,GO:0034616,1,0.804785511041386,0,14,response to laminar fluid shear stress,BP,
9515,GO:0034617,1,0.940344362082223,0,4,tetrahydrobiopterin binding,MF,
9516,GO:0034618,1,0.913234009792522,0,6,arginine binding,MF,
9519,GO:0034625,1,0.964083743637546,0,3,fatty acid elongation, monounsaturated fatty acid,BP,
9520,GO:0034626,1,0.942438978275917,0,4,fatty acid elongation, polyunsaturated fatty acid,BP,
9521,GO:0034627,1,0.946085142657305,0,4,'de novo' NAD biosynthetic process,BP,
9522,GO:0034628,1,0.954909888168039,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9524,GO:0034632,1,0.992941171638291,0,1,retinol transporter activity,MF,
9525,GO:0034633,1,0.992941171638291,0,1,retinol transport,BP,
9526,GO:0034634,1,0.983426667500937,0,1,glutathione transmembrane transporter activity,MF,
9527,GO:0034635,1,0.970328577617085,0,2,glutathione transport,BP,
9529,GO:0034638,1,0.908094830889911,0,7,phosphatidylcholine catabolic process,BP,
9531,GO:0034643,1,0.777491573642225,0,17,establishment of mitochondrion localization, microtubule-mediated,BP,
9534,GO:0034647,1,0.967126892145924,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9535,GO:0034648,1,0.935650833014396,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9536,GO:0034649,1,0.983427383580849,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9539,GO:0034653,1,0.95311281722109,0,4,retinoic acid catabolic process,BP,
9542,GO:0034656,1,0.921246334406574,0,7,nucleobase-containing small molecule catabolic process,BP,
9543,GO:0034657,1,0.957754241220807,0,3,GID complex,CC,
9545,GO:0034661,1,0.715074682146749,0,23,ncRNA catabolic process,BP,
9546,GO:0034663,1,0.868611138544354,0,10,endoplasmic reticulum chaperone complex,CC,
9547,GO:0034665,1,0.967132860985304,0,2,integrin alpha1-beta1 complex,CC,
9548,GO:0034666,1,0.951450820761186,0,3,integrin alpha2-beta1 complex,CC,
9550,GO:0034668,1,0.983426838108843,0,1,integrin alpha4-beta1 complex,CC,
9551,GO:0034669,1,0.967907951989754,0,2,integrin alpha4-beta7 complex,CC,
9552,GO:0034670,1,0.983426667497102,0,1,chemotaxis to arachidonic acid,BP,
9553,GO:0034673,1,0.957186429653945,0,3,inhibin-betaglycan-ActRII complex,CC,
9554,GO:0034676,1,0.983426667501727,0,1,integrin alpha6-beta4 complex,CC,
9555,GO:0034677,1,0.983432736513537,0,1,integrin alpha7-beta1 complex,CC,
9556,GO:0034678,1,0.951258076729717,0,3,integrin alpha8-beta1 complex,CC,
9557,GO:0034679,1,0.983426673031185,0,1,integrin alpha9-beta1 complex,CC,
9558,GO:0034680,1,0.967132860984916,0,2,integrin alpha10-beta1 complex,CC,
9559,GO:0034681,1,0.96713286098506,0,2,integrin alpha11-beta1 complex,CC,
9560,GO:0034683,1,0.96712689215207,0,2,integrin alphav-beta3 complex,CC,
9562,GO:0034685,1,0.968842741679397,0,2,integrin alphav-beta6 complex,CC,
9564,GO:0034687,1,0.967632232223555,0,2,integrin alphaL-beta2 complex,CC,
9565,GO:0034693,1,0.985000887935494,0,1,U11/U12 snRNP,CC,
9570,GO:0034699,1,0.937345752449344,0,4,response to luteinizing hormone,BP,
9575,GO:0034706,1,0.722432285752553,0,20,sodium channel complex,CC,
9577,GO:0034708,1,0.313635339785568,0,83,methyltransferase complex,CC,
9578,GO:0034709,1,0.892190786296454,0,12,methylosome,CC,
9579,GO:0034711,1,0.932175550682261,0,5,inhibin binding,MF,
9580,GO:0034713,1,0.87034860820888,0,9,type I transforming growth factor beta receptor binding,MF,
9581,GO:0034714,1,0.95370275451401,0,3,type III transforming growth factor beta receptor binding,MF,
9582,GO:0034715,1,0.946570959769967,0,6,pICln-Sm protein complex,CC,
9583,GO:0034718,1,0.98342666750217,0,1,SMN-Gemin2 complex,CC,
9584,GO:0034719,1,0.825894775606501,0,17,SMN-Sm protein complex,CC,
9585,GO:0034720,1,0.904884752735188,0,6,histone H3-K4 demethylation,BP,
9586,GO:0034721,1,0.967126892145924,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9587,GO:0034722,1,0.989296813148842,0,1,gamma-glutamyl-peptidase activity,MF,
9588,GO:0034723,1,0.818378302214495,0,32,DNA replication-dependent nucleosome organization,BP,
9589,GO:0034724,1,0.592031978975306,0,49,DNA replication-independent nucleosome organization,BP,
9590,GO:0034727,1,0.967133434783566,0,2,piecemeal microautophagy of nucleus,BP,
9591,GO:0034728,1,0.188697479792892,0,159,nucleosome organization,BP,
9592,GO:0034729,1,0.958558784600296,0,3,histone H3-K79 methylation,BP,
9593,GO:0034736,1,0.970096675609431,0,2,cholesterol O-acyltransferase activity,MF,
9594,GO:0034739,1,0.975140267675641,0,2,histone deacetylase activity (H4-K16 specific),MF,
9595,GO:0034750,1,0.967209853702573,0,2,Scrib-APC-beta-catenin complex,CC,
9596,GO:0034751,1,0.959622252474029,0,3,aryl hydrocarbon receptor complex,CC,
9597,GO:0034752,1,0.983426667501135,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9598,GO:0034753,1,0.983426667501135,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9601,GO:0034756,1,0.960153362009,0,4,regulation of iron ion transport,BP,
9602,GO:0034757,1,0.980163131629424,0,2,negative regulation of iron ion transport,BP,
9603,GO:0034758,1,0.979586953935502,0,2,positive regulation of iron ion transport,BP,
9604,GO:0034759,1,0.980163131629424,0,2,regulation of iron ion transmembrane transport,BP,
9605,GO:0034760,1,0.980163131629424,0,2,negative regulation of iron ion transmembrane transport,BP,
9612,GO:0034769,1,0.970005207430189,0,2,basement membrane disassembly,BP,
9613,GO:0034770,1,0.908162572610321,0,6,histone H4-K20 methylation,BP,
9614,GO:0034773,1,0.939039631531309,0,4,histone H4-K20 trimethylation,BP,
9616,GO:0034775,1,0.983426667500937,0,1,glutathione transmembrane transport,BP,
9617,GO:0034776,1,0.859407065105348,0,10,response to histamine,BP,
9618,GO:0034875,1,0.943523271479885,0,4,caffeine oxidase activity,MF,
9619,GO:0034899,1,0.986357419546302,0,1,trimethylamine monooxygenase activity,MF,
9620,GO:0034959,1,0.983426667502513,0,1,endothelin maturation,BP,
9621,GO:0034963,1,0.991312379435752,0,1,box C/D snoRNA processing,BP,
9622,GO:0034964,1,0.984680431882196,0,1,box H/ACA snoRNA processing,BP,
9623,GO:0034968,1,0.233001683229548,0,96,histone lysine methylation,BP,
9624,GO:0034969,1,0.850878728382034,0,11,histone arginine methylation,BP,
9625,GO:0034970,1,0.968678265708933,0,2,histone H3-R2 methylation,BP,
9626,GO:0034971,1,0.970200873935002,0,2,histone H3-R17 methylation,BP,
9627,GO:0034972,1,0.985855483080867,0,1,histone H3-R26 methylation,BP,
9628,GO:0034975,1,0.831508410247654,0,12,protein folding in endoplasmic reticulum,BP,
9630,GO:0034979,1,0.798136770740941,0,15,NAD-dependent protein deacetylase activity,MF,
9631,GO:0034982,1,0.88537253650927,0,10,mitochondrial protein processing,BP,
9632,GO:0034983,1,0.900552105316343,0,7,peptidyl-lysine deacetylation,BP,
9633,GO:0034986,1,0.983426667500053,0,1,iron chaperone activity,MF,
9634,GO:0034987,1,0.921334962255016,0,6,immunoglobulin receptor binding,MF,
9635,GO:0034988,1,0.968719080109256,0,2,Fc-gamma receptor I complex binding,MF,
9636,GO:0034991,1,0.941275008696278,0,4,nuclear meiotic cohesin complex,CC,
9637,GO:0034992,1,0.89832969669721,0,7,microtubule organizing center attachment site,CC,
9638,GO:0034993,1,0.89832969669721,0,7,LINC complex,CC,
9639,GO:0034998,1,0.984728932554734,0,1,oligosaccharyltransferase I complex,CC,
9640,GO:0035003,1,0.985548340511754,0,1,subapical complex,CC,
9645,GO:0035020,1,0.822933567629674,0,12,regulation of Rac protein signal transduction,BP,
9646,GO:0035021,1,0.938718107948108,0,4,negative regulation of Rac protein signal transduction,BP,
9647,GO:0035022,1,0.967126892153911,0,2,positive regulation of Rac protein signal transduction,BP,
9650,GO:0035025,1,0.692093615407309,0,25,positive regulation of Rho protein signal transduction,BP,
9651,GO:0035026,1,0.967265321965041,0,2,leading edge cell differentiation,BP,
9652,GO:0035032,1,0.912285540964252,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9653,GO:0035033,1,0.968692638983057,0,3,histone deacetylase regulator activity,MF,
9654,GO:0035034,1,0.970225759461458,0,2,histone acetyltransferase regulator activity,MF,
9655,GO:0035035,1,0.670887590678214,0,26,histone acetyltransferase binding,MF,
9656,GO:0035036,1,0.546554469248635,0,45,sperm-egg recognition,BP,
9657,GO:0035037,1,0.983426667503102,0,1,sperm entry,BP,
9658,GO:0035038,1,0.969490323430642,0,2,female pronucleus assembly,BP,
9659,GO:0035039,1,0.982398522394635,0,2,male pronucleus assembly,BP,
9660,GO:0035041,1,0.996880945362845,0,1,sperm chromatin decondensation,BP,
9661,GO:0035042,1,0.996880945362845,0,1,fertilization, exchange of chromosomal proteins,BP,
9662,GO:0035048,1,0.983440725147892,0,1,splicing factor protein import into nucleus,BP,
9666,GO:0035061,1,0.951096177117036,0,3,interchromatin granule,CC,
9667,GO:0035063,1,0.967140015745,0,2,nuclear speck organization,BP,
9668,GO:0035064,1,0.444312092884608,0,53,methylated histone binding,MF,
9671,GO:0035067,1,0.786327586688744,0,16,negative regulation of histone acetylation,BP,
9672,GO:0035068,1,0.91504096610985,0,6,micro-ribonucleoprotein complex,CC,
9673,GO:0035082,1,0.543947710863461,0,42,axoneme assembly,BP,
9674,GO:0035087,1,0.946688833665738,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9679,GO:0035092,1,0.906070771134231,0,8,sperm chromatin condensation,BP,
9680,GO:0035093,1,0.95574320442371,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9682,GO:0035095,1,0.894979690690322,0,7,behavioral response to nicotine,BP,
9683,GO:0035097,1,0.391296673134327,0,63,histone methyltransferase complex,CC,
9684,GO:0035098,1,0.768614189075888,0,17,ESC/E(Z) complex,CC,
9685,GO:0035101,1,0.953617090634595,0,3,FACT complex,CC,
9686,GO:0035102,1,0.832091501303738,0,12,PRC1 complex,CC,
9687,GO:0035105,1,0.983706318834391,0,1,sterol regulatory element binding protein import into nucleus,BP,
9688,GO:0035106,1,0.953042918056758,0,3,operant conditioning,BP,
9695,GO:0035120,1,0.983426667495572,0,1,post-embryonic appendage morphogenesis,BP,
9696,GO:0035127,1,0.983426667495572,0,1,post-embryonic limb morphogenesis,BP,
9697,GO:0035128,1,0.983426667495572,0,1,post-embryonic forelimb morphogenesis,BP,
9700,GO:0035145,1,0.743140309261422,0,20,exon-exon junction complex,CC,
9704,GO:0035166,1,0.951753912977178,0,3,post-embryonic hemopoiesis,BP,
9705,GO:0035173,1,0.792528586585931,0,16,histone kinase activity,MF,
9706,GO:0035174,1,0.925585959272717,0,6,histone serine kinase activity,MF,
9707,GO:0035175,1,0.988091104477908,0,1,histone kinase activity (H3-S10 specific),MF,
9708,GO:0035176,1,0.501142176141997,0,47,social behavior,BP,
9709,GO:0035184,1,0.910878382071463,0,6,histone threonine kinase activity,MF,
9710,GO:0035188,1,0.983612651923942,0,1,hatching,BP,
9711,GO:0035189,1,0.954438409482508,0,3,Rb-E2F complex,CC,
9715,GO:0035197,1,0.88449465682789,0,8,siRNA binding,MF,
9716,GO:0035198,1,0.80807953429074,0,14,miRNA binding,MF,
9717,GO:0035226,1,0.983774195859156,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9718,GO:0035227,1,0.983774195859156,0,1,regulation of glutamate-cysteine ligase activity,BP,
9719,GO:0035229,1,0.983774195859156,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9721,GO:0035235,1,0.654408569637365,0,26,ionotropic glutamate receptor signaling pathway,BP,
9723,GO:0035240,1,0.862380685223685,0,13,dopamine binding,MF,
9724,GO:0035241,1,0.955752471344504,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
9725,GO:0035242,1,0.944663182644393,0,4,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9726,GO:0035243,1,0.955650292649735,0,3,protein-arginine omega-N symmetric methyltransferase activity,MF,
9727,GO:0035246,1,0.850091287237538,0,11,peptidyl-arginine N-methylation,BP,
9728,GO:0035247,1,0.902757979547971,0,7,peptidyl-arginine omega-N-methylation,BP,
9729,GO:0035248,1,0.984061682534133,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9732,GO:0035251,1,0.876968079025601,0,9,UDP-glucosyltransferase activity,MF,
9733,GO:0035252,1,0.91214473229563,0,6,UDP-xylosyltransferase activity,MF,
9734,GO:0035253,1,0.882418313286275,0,8,ciliary rootlet,CC,
9735,GO:0035254,1,0.601647740816175,0,33,glutamate receptor binding,MF,
9736,GO:0035255,1,0.711887402085704,0,22,ionotropic glutamate receptor binding,MF,
9737,GO:0035256,1,0.917839560527877,0,6,G-protein coupled glutamate receptor binding,MF,
9739,GO:0035258,1,0.279207770067982,0,84,steroid hormone receptor binding,MF,
9740,GO:0035259,1,0.816570024716852,0,13,glucocorticoid receptor binding,MF,
9741,GO:0035261,1,0.967126892142535,0,2,external genitalia morphogenesis,BP,
9742,GO:0035262,1,0.96919986476713,0,2,gonad morphogenesis,BP,
9745,GO:0035267,1,0.779470240107787,0,18,NuA4 histone acetyltransferase complex,CC,
9746,GO:0035268,1,0.806878689326514,0,16,protein mannosylation,BP,
9747,GO:0035269,1,0.877249426313895,0,11,protein O-linked mannosylation,BP,
9750,GO:0035276,1,0.956734660060342,0,3,ethanol binding,MF,
9751,GO:0035278,1,0.824026204446372,0,13,miRNA mediated inhibition of translation,BP,
9752,GO:0035279,1,0.968437569186387,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9753,GO:0035280,1,0.899870155544719,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9754,GO:0035281,1,0.975519886965025,0,2,pre-miRNA export from nucleus,BP,
9756,GO:0035283,1,0.956039336289601,0,3,central nervous system segmentation,BP,
9757,GO:0035284,1,0.956039336289601,0,3,brain segmentation,BP,
9758,GO:0035290,1,0.952602160741759,0,3,trunk segmentation,BP,
9761,GO:0035299,1,0.983426667503154,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9767,GO:0035308,1,0.731818933823682,0,22,negative regulation of protein dephosphorylation,BP,
9768,GO:0035312,1,0.908937740913414,0,6,5'-3' exodeoxyribonuclease activity,MF,
9771,GO:0035325,1,0.889167517397584,0,9,Toll-like receptor binding,MF,
9772,GO:0035326,1,0.237724422140848,0,96,enhancer binding,MF,
9773,GO:0035327,1,0.775226140615173,0,21,transcriptionally active chromatin,CC,
9775,GO:0035330,1,0.864157008914719,0,9,regulation of hippo signaling,BP,
9776,GO:0035331,1,0.908017475182883,0,6,negative regulation of hippo signaling,BP,
9777,GO:0035332,1,0.983426667498278,0,1,positive regulation of hippo signaling,BP,
9782,GO:0035339,1,0.950846157983384,0,4,SPOTS complex,CC,
9783,GO:0035349,1,0.969592073929455,0,2,coenzyme A transmembrane transport,BP,
9784,GO:0035350,1,0.969712695520183,0,2,FAD transmembrane transport,BP,
9785,GO:0035354,1,0.967882294756889,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9786,GO:0035355,1,0.983426667501628,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9787,GO:0035356,1,0.906212223633044,0,7,cellular triglyceride homeostasis,BP,
9788,GO:0035357,1,0.736835317484455,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9789,GO:0035358,1,0.831953940365488,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9790,GO:0035359,1,0.95745003712055,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9791,GO:0035360,1,0.897589270680016,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9792,GO:0035363,1,0.972252935697833,0,2,histone locus body,CC,
9793,GO:0035368,1,0.938254008760293,0,5,selenocysteine insertion sequence binding,MF,
9794,GO:0035370,1,0.970441182519674,0,2,UBC13-UEV1A complex,CC,
9795,GO:0035371,1,0.75884028172847,0,17,microtubule plus-end,CC,
9796,GO:0035372,1,0.866126864908047,0,9,protein localization to microtubule,BP,
9797,GO:0035373,1,0.956478937237294,0,3,chondroitin sulfate proteoglycan binding,MF,
9798,GO:0035374,1,0.913325337215785,0,6,chondroitin sulfate binding,MF,
9799,GO:0035375,1,0.98342666749941,0,1,zymogen binding,MF,
9800,GO:0035376,1,0.904527927455595,0,9,sterol import,BP,
9801,GO:0035377,1,0.967962748746071,0,2,transepithelial water transport,BP,
9802,GO:0035378,1,0.971492685928626,0,2,carbon dioxide transmembrane transport,BP,
9803,GO:0035379,1,0.971492685928626,0,2,carbon dioxide transmembrane transporter activity,MF,
9804,GO:0035381,1,0.892024107065091,0,8,ATP-gated ion channel activity,MF,
9807,GO:0035385,1,0.892867482437067,0,7,Roundabout signaling pathway,BP,
9808,GO:0035397,1,0.970581816650712,0,2,helper T cell enhancement of adaptive immune response,BP,
9809,GO:0035400,1,0.983426667502316,0,1,histone tyrosine kinase activity,MF,
9810,GO:0035401,1,0.983426667502316,0,1,histone kinase activity (H3-Y41 specific),MF,
9811,GO:0035402,1,0.968502204533023,0,2,histone kinase activity (H3-T11 specific),MF,
9812,GO:0035403,1,0.967126892149457,0,2,histone kinase activity (H3-T6 specific),MF,
9813,GO:0035404,1,0.869413900427076,0,10,histone-serine phosphorylation,BP,
9814,GO:0035405,1,0.910878382071463,0,6,histone-threonine phosphorylation,BP,
9815,GO:0035406,1,0.983426667502316,0,1,histone-tyrosine phosphorylation,BP,
9816,GO:0035407,1,0.968502204533023,0,2,histone H3-T11 phosphorylation,BP,
9817,GO:0035408,1,0.967126892149457,0,2,histone H3-T6 phosphorylation,BP,
9818,GO:0035409,1,0.983426667502316,0,1,histone H3-Y41 phosphorylation,BP,
9819,GO:0035410,1,0.990934003351696,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9822,GO:0035413,1,0.840314186154503,0,11,positive regulation of catenin import into nucleus,BP,
9823,GO:0035414,1,0.846884499743591,0,11,negative regulation of catenin import into nucleus,BP,
9825,GO:0035419,1,0.967393434157029,0,2,activation of MAPK activity involved in innate immune response,BP,
9826,GO:0035425,1,0.956536023845676,0,3,autocrine signaling,BP,
9827,GO:0035426,1,0.923367410226394,0,5,extracellular matrix-cell signaling,BP,
9829,GO:0035434,1,0.920365685786861,0,6,copper ion transmembrane transport,BP,
9830,GO:0035435,1,0.761660557893143,0,18,phosphate ion transmembrane transport,BP,
9831,GO:0035437,1,0.865231418524275,0,10,maintenance of protein localization in endoplasmic reticulum,BP,
9832,GO:0035438,1,0.988196127107389,0,1,cyclic-di-GMP binding,MF,
9833,GO:0035441,1,0.951115068521493,0,3,cell migration involved in vasculogenesis,BP,
9834,GO:0035442,1,0.972983734770215,0,2,dipeptide transmembrane transport,BP,
9835,GO:0035443,1,0.983426667500937,0,1,tripeptide transmembrane transport,BP,
9836,GO:0035445,1,0.983731265579935,0,1,borate transmembrane transport,BP,
9838,GO:0035456,1,0.763541611479524,0,22,response to interferon-beta,BP,
9840,GO:0035458,1,0.828215596965061,0,14,cellular response to interferon-beta,BP,
9841,GO:0035459,1,0.852326567631857,0,10,cargo loading into vesicle,BP,
9842,GO:0035461,1,0.87016302098455,0,9,vitamin transmembrane transport,BP,
9843,GO:0035469,1,0.92104390361551,0,5,determination of pancreatic left/right asymmetry,BP,
9844,GO:0035470,1,0.976021103485893,0,2,positive regulation of vascular wound healing,BP,
9845,GO:0035472,1,0.983757653963509,0,1,choriogonadotropin hormone receptor activity,MF,
9846,GO:0035473,1,0.916457444134025,0,6,lipase binding,MF,
9847,GO:0035478,1,0.985597405954989,0,1,chylomicron binding,MF,
9848,GO:0035480,1,0.991384933405719,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9849,GO:0035481,1,0.991384933405719,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9850,GO:0035482,1,0.972555012016147,0,3,gastric motility,BP,
9851,GO:0035483,1,0.984019148687865,0,2,gastric emptying,BP,
9852,GO:0035490,1,0.983686447988429,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9853,GO:0035491,1,0.983686447988429,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9855,GO:0035494,1,0.955691043060692,0,3,SNARE complex disassembly,BP,
9856,GO:0035497,1,0.819604966817956,0,13,cAMP response element binding,MF,
9857,GO:0035498,1,0.983426716418242,0,1,carnosine metabolic process,BP,
9858,GO:0035499,1,0.983426716418242,0,1,carnosine biosynthetic process,BP,
9859,GO:0035500,1,0.967826393610003,0,2,MH2 domain binding,MF,
9860,GO:0035501,1,0.984131985637324,0,1,MH1 domain binding,MF,
9862,GO:0035504,1,0.989250273261631,0,1,regulation of myosin light chain kinase activity,BP,
9863,GO:0035505,1,0.989250273261631,0,1,positive regulation of myosin light chain kinase activity,BP,
9864,GO:0035507,1,0.894008475049191,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9865,GO:0035508,1,0.983426667501921,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9866,GO:0035509,1,0.924406312240429,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9867,GO:0035510,1,0.727565260380096,0,24,DNA dealkylation,BP,
9868,GO:0035511,1,0.935086706028324,0,5,oxidative DNA demethylation,BP,
9869,GO:0035513,1,0.941728010637611,0,4,oxidative RNA demethylation,BP,
9870,GO:0035514,1,0.976387717287834,0,2,DNA demethylase activity,MF,
9871,GO:0035515,1,0.941728010637611,0,4,oxidative RNA demethylase activity,MF,
9872,GO:0035516,1,0.983426667503252,0,1,oxidative DNA demethylase activity,MF,
9873,GO:0035517,1,0.967156652551945,0,2,PR-DUB complex,CC,
9874,GO:0035518,1,0.836823875571464,0,12,histone H2A monoubiquitination,BP,
9875,GO:0035519,1,0.958164084221498,0,4,protein K29-linked ubiquitination,BP,
9876,GO:0035520,1,0.861836593945033,0,9,monoubiquitinated protein deubiquitination,BP,
9877,GO:0035521,1,0.936928962029019,0,4,monoubiquitinated histone deubiquitination,BP,
9878,GO:0035522,1,0.936928962029019,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9879,GO:0035523,1,0.939892385293931,0,4,protein K29-linked deubiquitination,BP,
9880,GO:0035524,1,0.891560737509254,0,7,proline transmembrane transport,BP,
9881,GO:0035525,1,0.984680431882196,0,1,NF-kappaB p50/p65 complex,CC,
9882,GO:0035526,1,0.967126892155071,0,2,retrograde transport, plasma membrane to Golgi,BP,
9883,GO:0035529,1,0.930911936874607,0,5,NADH pyrophosphatase activity,MF,
9884,GO:0035538,1,0.983607166593984,0,1,carbohydrate response element binding,MF,
9885,GO:0035539,1,0.981181556975986,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9886,GO:0035542,1,0.869484732766998,0,9,regulation of SNARE complex assembly,BP,
9887,GO:0035543,1,0.988799831127694,0,1,positive regulation of SNARE complex assembly,BP,
9888,GO:0035544,1,0.967126892155069,0,2,negative regulation of SNARE complex assembly,BP,
9889,GO:0035545,1,0.98342682453947,0,1,determination of left/right asymmetry in nervous system,BP,
9890,GO:0035546,1,0.984070096703214,0,1,interferon-beta secretion,BP,
9891,GO:0035547,1,0.984070096703214,0,1,regulation of interferon-beta secretion,BP,
9892,GO:0035548,1,0.984070096703214,0,1,negative regulation of interferon-beta secretion,BP,
9893,GO:0035552,1,0.957521029467574,0,3,oxidative single-stranded DNA demethylation,BP,
9894,GO:0035553,1,0.956400858406044,0,3,oxidative single-stranded RNA demethylation,BP,
9896,GO:0035561,1,0.729484537162519,0,20,regulation of chromatin binding,BP,
9897,GO:0035562,1,0.875982892386186,0,8,negative regulation of chromatin binding,BP,
9898,GO:0035563,1,0.846817457548269,0,11,positive regulation of chromatin binding,BP,
9899,GO:0035564,1,0.936614987444875,0,4,regulation of kidney size,BP,
9900,GO:0035565,1,0.984184451274848,0,1,regulation of pronephros size,BP,
9901,GO:0035566,1,0.967709555259464,0,2,regulation of metanephros size,BP,
9903,GO:0035568,1,0.984728932554734,0,1,N-terminal peptidyl-proline methylation,BP,
9904,GO:0035570,1,0.984728932554734,0,1,N-terminal peptidyl-serine methylation,BP,
9905,GO:0035572,1,0.984728932554734,0,1,N-terminal peptidyl-serine dimethylation,BP,
9906,GO:0035573,1,0.984728932554734,0,1,N-terminal peptidyl-serine trimethylation,BP,
9907,GO:0035574,1,0.983426667501383,0,1,histone H4-K20 demethylation,BP,
9908,GO:0035575,1,0.983426667501383,0,1,histone demethylase activity (H4-K20 specific),MF,
9910,GO:0035578,1,0.326687345606068,0,88,azurophil granule lumen,CC,
9913,GO:0035581,1,0.88873366546412,0,8,sequestering of extracellular ligand from receptor,BP,
9914,GO:0035582,1,0.950009830294631,0,4,sequestering of BMP in extracellular matrix,BP,
9915,GO:0035583,1,0.951096177103709,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9917,GO:0035585,1,0.983426667493113,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9921,GO:0035589,1,0.824908381453882,0,14,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9922,GO:0035590,1,0.735770985925328,0,22,purinergic nucleotide receptor signaling pathway,BP,
9924,GO:0035594,1,0.941245807798949,0,4,ganglioside binding,MF,
9925,GO:0035596,1,0.970402374024896,0,2,methylthiotransferase activity,MF,
9926,GO:0035597,1,0.98659121972751,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9927,GO:0035598,1,0.983592042024508,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9928,GO:0035600,1,0.970402374024896,0,2,tRNA methylthiolation,BP,
9930,GO:0035602,1,0.983426667503348,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9931,GO:0035603,1,0.983426667503348,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9932,GO:0035604,1,0.983426667503348,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9933,GO:0035605,1,0.99037390360901,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9934,GO:0035606,1,0.985945405206021,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9935,GO:0035607,1,0.967126892154198,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9936,GO:0035608,1,0.880052558677465,0,8,protein deglutamylation,BP,
9937,GO:0035609,1,0.924549549026579,0,5,C-terminal protein deglutamylation,BP,
9938,GO:0035610,1,0.92041820444952,0,5,protein side chain deglutamylation,BP,
9939,GO:0035611,1,0.984105372501053,0,1,protein branching point deglutamylation,BP,
9940,GO:0035612,1,0.892657110730537,0,7,AP-2 adaptor complex binding,MF,
9941,GO:0035613,1,0.8498626803583,0,11,RNA stem-loop binding,MF,
9942,GO:0035614,1,0.963846418279187,0,3,snRNA stem-loop binding,MF,
9943,GO:0035615,1,0.846288905483832,0,11,clathrin adaptor activity,MF,
9944,GO:0035616,1,0.951333435275081,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9945,GO:0035617,1,0.95479272046173,0,3,stress granule disassembly,BP,
9946,GO:0035620,1,0.967126892153908,0,2,ceramide transporter activity,MF,
9947,GO:0035621,1,0.970423590708169,0,2,ER to Golgi ceramide transport,BP,
9948,GO:0035622,1,0.983426908875151,0,1,intrahepatic bile duct development,BP,
9949,GO:0035623,1,0.983620137063362,0,1,renal glucose absorption,BP,
9952,GO:0035627,1,0.923609964183705,0,5,ceramide transport,BP,
9954,GO:0035631,1,0.844596239988167,0,11,CD40 receptor complex,CC,
9955,GO:0035633,1,0.937449145705629,0,4,maintenance of permeability of blood-brain barrier,BP,
9956,GO:0035634,1,0.945718254638647,0,5,response to stilbenoid,BP,
9959,GO:0035638,1,0.983426667502908,0,1,signal maturation,BP,
9962,GO:0035641,1,0.838262062397978,0,12,locomotory exploration behavior,BP,
9963,GO:0035642,1,0.983896014586774,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9964,GO:0035643,1,0.988148723890186,0,1,L-DOPA receptor activity,MF,
9965,GO:0035644,1,0.983856763431323,0,1,phosphoanandamide dephosphorylation,BP,
9966,GO:0035645,1,0.983426667503251,0,1,enteric smooth muscle cell differentiation,BP,
9972,GO:0035662,1,0.980160898662959,0,3,Toll-like receptor 4 binding,MF,
9973,GO:0035663,1,0.95589348577393,0,3,Toll-like receptor 2 binding,MF,
9974,GO:0035664,1,0.987712600835568,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9975,GO:0035665,1,0.987712600835568,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9976,GO:0035666,1,0.675495459609971,0,28,TRIF-dependent toll-like receptor signaling pathway,BP,
9977,GO:0035668,1,0.967577800467265,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9978,GO:0035669,1,0.967577800467265,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9979,GO:0035671,1,0.932406040612681,0,5,enone reductase activity,MF,
9980,GO:0035672,1,0.910362971373989,0,6,oligopeptide transmembrane transport,BP,
9981,GO:0035673,1,0.935647548814422,0,4,oligopeptide transmembrane transporter activity,MF,
9982,GO:0035674,1,0.972489539817488,0,2,tricarboxylic acid transmembrane transport,BP,
9983,GO:0035684,1,0.994275566742343,0,1,helper T cell extravasation,BP,
9984,GO:0035686,1,0.913119778414669,0,7,sperm fibrous sheath,CC,
9986,GO:0035691,1,0.973965616258634,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9987,GO:0035692,1,0.973965616258099,0,2,macrophage migration inhibitory factor receptor complex,CC,
9988,GO:0035693,1,0.990380170129055,0,1,NOS2-CD74 complex,CC,
9989,GO:0035694,1,0.940731571809052,0,4,mitochondrial protein catabolic process,BP,
9990,GO:0035695,1,0.983426667503252,0,1,mitophagy by induced vacuole formation,BP,
9991,GO:0035696,1,0.952515144566062,0,3,monocyte extravasation,BP,
9992,GO:0035697,1,0.959863003973993,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9993,GO:0035698,1,0.974587003659478,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9994,GO:0035700,1,0.972805931014343,0,2,astrocyte chemotaxis,BP,
9996,GO:0035704,1,0.984893663486023,0,1,helper T cell chemotaxis,BP,
9997,GO:0035705,1,0.984893663486023,0,1,T-helper 17 cell chemotaxis,BP,
9998,GO:0035708,1,0.983486079821096,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9999,GO:0035709,1,0.969588942320551,0,2,memory T cell activation,BP,
10001,GO:0035711,1,0.974632940756103,0,2,T-helper 1 cell activation,BP,
10002,GO:0035712,1,0.967352726427607,0,2,T-helper 2 cell activation,BP,
10003,GO:0035713,1,0.983486079821096,0,1,response to nitrogen dioxide,BP,
10004,GO:0035714,1,0.983486079821096,0,1,cellular response to nitrogen dioxide,BP,
10005,GO:0035717,1,0.984449633853529,0,1,chemokine (C-C motif) ligand 7 binding,MF,
10006,GO:0035718,1,0.990380170129055,0,1,macrophage migration inhibitory factor binding,MF,
10007,GO:0035720,1,0.955745368943603,0,3,intraciliary anterograde transport,BP,
10008,GO:0035721,1,0.87103211572417,0,9,intraciliary retrograde transport,BP,
10009,GO:0035722,1,0.954319227176982,0,3,interleukin-12-mediated signaling pathway,BP,
10010,GO:0035723,1,0.955917014348577,0,3,interleukin-15-mediated signaling pathway,BP,
10011,GO:0035724,1,0.983426667500495,0,1,CD24 biosynthetic process,BP,
10012,GO:0035725,1,0.111222286725779,0,144,sodium ion transmembrane transport,BP,
10013,GO:0035726,1,0.907648866458803,0,7,common myeloid progenitor cell proliferation,BP,
10014,GO:0035727,1,0.941067063294438,0,4,lysophosphatidic acid binding,MF,
10017,GO:0035730,1,0.992731041067136,0,1,S-nitrosoglutathione binding,MF,
10018,GO:0035731,1,0.992731041067136,0,1,dinitrosyl-iron complex binding,MF,
10019,GO:0035732,1,0.992731041067136,0,1,nitric oxide storage,BP,
10020,GO:0035733,1,0.893494865338699,0,7,hepatic stellate cell activation,BP,
10021,GO:0035735,1,0.581929025073935,0,38,intraciliary transport involved in cilium assembly,BP,
10022,GO:0035739,1,0.932095659779139,0,5,CD4-positive, alpha-beta T cell proliferation,BP,
10023,GO:0035740,1,0.948551374320952,0,4,CD8-positive, alpha-beta T cell proliferation,BP,
10024,GO:0035743,1,0.849569180083941,0,13,CD4-positive, alpha-beta T cell cytokine production,BP,
10025,GO:0035744,1,0.977783276075922,0,2,T-helper 1 cell cytokine production,BP,
10026,GO:0035745,1,0.874973677937725,0,11,T-helper 2 cell cytokine production,BP,
10027,GO:0035746,1,0.990972814227871,0,1,granzyme A production,BP,
10029,GO:0035748,1,0.907652821911957,0,6,myelin sheath abaxonal region,CC,
10030,GO:0035749,1,0.916825455521773,0,6,myelin sheath adaxonal region,CC,
10031,GO:0035750,1,0.983426667502217,0,1,protein localization to myelin sheath abaxonal region,BP,
10032,GO:0035751,1,0.876461927415625,0,10,regulation of lysosomal lumen pH,BP,
10033,GO:0035752,1,0.987130474230358,0,1,lysosomal lumen pH elevation,BP,
10035,GO:0035755,1,0.984697349286787,0,1,cardiolipin hydrolase activity,MF,
10036,GO:0035757,1,0.986003787696943,0,1,chemokine (C-C motif) ligand 19 binding,MF,
10037,GO:0035758,1,0.986003787696943,0,1,chemokine (C-C motif) ligand 21 binding,MF,
10038,GO:0035759,1,0.977780155688636,0,2,mesangial cell-matrix adhesion,BP,
10039,GO:0035766,1,0.921481971540573,0,7,cell chemotaxis to fibroblast growth factor,BP,
10041,GO:0035768,1,0.921481971540573,0,7,endothelial cell chemotaxis to fibroblast growth factor,BP,
10042,GO:0035769,1,0.991096224378579,0,1,B cell chemotaxis across high endothelial venule,BP,
10043,GO:0035770,1,0.0662582988478782,0,185,ribonucleoprotein granule,CC,
10044,GO:0035771,1,0.919862245580704,0,6,interleukin-4-mediated signaling pathway,BP,
10045,GO:0035772,1,0.987833615541307,0,1,interleukin-13-mediated signaling pathway,BP,
10046,GO:0035773,1,0.455695183986888,0,55,insulin secretion involved in cellular response to glucose stimulus,BP,
10047,GO:0035774,1,0.705360647282266,0,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
10048,GO:0035782,1,0.990972814227871,0,1,mature natural killer cell chemotaxis,BP,
10049,GO:0035783,1,0.983486079821096,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
10050,GO:0035786,1,0.984728932554734,0,1,protein complex oligomerization,BP,
10054,GO:0035790,1,0.951097931635508,0,3,platelet-derived growth factor receptor-alpha signaling pathway,BP,
10058,GO:0035795,1,0.950346487953439,0,4,negative regulation of mitochondrial membrane permeability,BP,
10059,GO:0035799,1,0.935830493171041,0,4,ureter maturation,BP,
10060,GO:0035800,1,0.973552841199284,0,2,deubiquitinase activator activity,MF,
10063,GO:0035803,1,0.979624095446571,0,2,egg coat formation,BP,
10064,GO:0035805,1,0.985711813582725,0,1,egg coat,CC,
10067,GO:0035811,1,0.955421512761045,0,5,negative regulation of urine volume,BP,
10073,GO:0035822,1,0.936796224424709,0,4,gene conversion,BP,
10074,GO:0035825,1,0.531519594595893,0,43,reciprocal DNA recombination,BP,
10075,GO:0035826,1,0.928314249887767,0,5,rubidium ion transport,BP,
10076,GO:0035838,1,0.951096177116609,0,3,growing cell tip,CC,
10077,GO:0035841,1,0.967126892152409,0,2,new growing cell tip,CC,
10079,GO:0035845,1,0.869673409558573,0,9,photoreceptor cell outer segment organization,BP,
10080,GO:0035846,1,0.985583325820876,0,1,oviduct epithelium development,BP,
10081,GO:0035847,1,0.985583325820876,0,1,uterine epithelium development,BP,
10082,GO:0035849,1,0.985583325820876,0,1,nephric duct elongation,BP,
10084,GO:0035851,1,0.983905666411096,0,1,Krueppel-associated box domain binding,MF,
10085,GO:0035852,1,0.985583325820876,0,1,horizontal cell localization,BP,
10086,GO:0035853,1,0.983426667503104,0,1,chromosome passenger complex localization to spindle midzone,BP,
10087,GO:0035854,1,0.973088090565188,0,2,eosinophil fate commitment,BP,
10090,GO:0035860,1,0.910802764668332,0,6,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
10091,GO:0035861,1,0.647727294951042,0,29,site of double-strand break,CC,
10092,GO:0035862,1,0.983426667501431,0,1,dITP metabolic process,BP,
10093,GO:0035863,1,0.983426667501431,0,1,dITP catabolic process,BP,
10094,GO:0035864,1,0.839109340371142,0,12,response to potassium ion,BP,
10095,GO:0035865,1,0.90459181684933,0,7,cellular response to potassium ion,BP,
10096,GO:0035867,1,0.935330099161948,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10098,GO:0035870,1,0.975324093729537,0,2,dITP diphosphatase activity,MF,
10099,GO:0035871,1,0.850517558112425,0,10,protein K11-linked deubiquitination,BP,
10100,GO:0035872,1,0.596388799639705,0,34,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10101,GO:0035873,1,0.910951165116167,0,6,lactate transmembrane transport,BP,
10102,GO:0035877,1,0.946139931769953,0,4,death effector domain binding,MF,
10104,GO:0035879,1,0.954119836693422,0,3,plasma membrane lactate transport,BP,
10105,GO:0035880,1,0.956934055846745,0,3,embryonic nail plate morphogenesis,BP,
10106,GO:0035881,1,0.886170360463655,0,8,amacrine cell differentiation,BP,
10109,GO:0035887,1,0.987912661362616,0,1,aortic smooth muscle cell differentiation,BP,
10110,GO:0035890,1,0.587675217905531,0,35,exit from host,BP,
10111,GO:0035891,1,0.587675217905531,0,35,exit from host cell,BP,
10112,GO:0035897,1,0.915900007097735,0,6,proteolysis in other organism,BP,
10113,GO:0035898,1,0.955079700326691,0,3,parathyroid hormone secretion,BP,
10117,GO:0035905,1,0.942121585656322,0,4,ascending aorta development,BP,
10120,GO:0035910,1,0.942121585656322,0,4,ascending aorta morphogenesis,BP,
10123,GO:0035915,1,0.986512260377887,0,1,pore formation in membrane of other organism,BP,
10124,GO:0035921,1,0.986293776483911,0,1,desmosome disassembly,BP,
10125,GO:0035922,1,0.97255461964142,0,2,foramen ovale closure,BP,
10127,GO:0035925,1,0.839608111997176,0,11,mRNA 3'-UTR AU-rich region binding,MF,
10128,GO:0035926,1,0.93826917306241,0,4,chemokine (C-C motif) ligand 2 secretion,BP,
10129,GO:0035927,1,0.947506984623639,0,5,RNA import into mitochondrion,BP,
10130,GO:0035928,1,0.967964906190766,0,3,rRNA import into mitochondrion,BP,
10135,GO:0035933,1,0.910252570372009,0,8,glucocorticoid secretion,BP,
10136,GO:0035934,1,0.967198857398788,0,3,corticosterone secretion,BP,
10137,GO:0035935,1,0.983594099641158,0,1,androgen secretion,BP,
10138,GO:0035936,1,0.967263819157912,0,2,testosterone secretion,BP,
10139,GO:0035938,1,0.956271787830959,0,3,estradiol secretion,BP,
10141,GO:0035945,1,0.984939504141857,0,1,mitochondrial ncRNA surveillance,BP,
10142,GO:0035946,1,0.984939504141857,0,1,mitochondrial mRNA surveillance,BP,
10143,GO:0035947,1,0.912428242045846,0,6,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10144,GO:0035948,1,0.942665740685071,0,4,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10145,GO:0035962,1,0.949614547731567,0,4,response to interleukin-13,BP,
10146,GO:0035963,1,0.956325971662845,0,3,cellular response to interleukin-13,BP,
10147,GO:0035964,1,0.944146655891342,0,4,COPI-coated vesicle budding,BP,
10148,GO:0035965,1,0.918723720116629,0,6,cardiolipin acyl-chain remodeling,BP,
10152,GO:0035971,1,0.990972814227871,0,1,peptidyl-histidine dephosphorylation,BP,
10153,GO:0035973,1,0.935511273969265,0,4,aggrephagy,BP,
10154,GO:0035976,1,0.939113429591302,0,5,transcription factor AP-1 complex,CC,
10155,GO:0035977,1,0.939628562019147,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10156,GO:0035978,1,0.984131985637324,0,1,histone H2A-S139 phosphorylation,BP,
10157,GO:0035981,1,0.972644834167095,0,2,tongue muscle cell differentiation,BP,
10158,GO:0035983,1,0.952175811849644,0,3,response to trichostatin A,BP,
10159,GO:0035984,1,0.952175811849644,0,3,cellular response to trichostatin A,BP,
10160,GO:0035985,1,0.950725440149158,0,4,senescence-associated heterochromatin focus,CC,
10161,GO:0035986,1,0.962776130319341,0,3,senescence-associated heterochromatin focus assembly,BP,
10169,GO:0035995,1,0.957246748268194,0,4,detection of muscle stretch,BP,
10170,GO:0035998,1,0.986905989498196,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10171,GO:0035999,1,0.882229051436552,0,9,tetrahydrofolate interconversion,BP,
10172,GO:0036002,1,0.687173285169601,0,27,pre-mRNA binding,MF,
10174,GO:0036004,1,0.990888822333225,0,1,GAF domain binding,MF,
10175,GO:0036005,1,0.867664808445362,0,10,response to macrophage colony-stimulating factor,BP,
10176,GO:0036006,1,0.867664808445362,0,10,cellular response to macrophage colony-stimulating factor stimulus,BP,
10177,GO:0036009,1,0.991312379435752,0,1,protein-glutamine N-methyltransferase activity,MF,
10179,GO:0036015,1,0.939058166460805,0,5,response to interleukin-3,BP,
10180,GO:0036016,1,0.939058166460805,0,5,cellular response to interleukin-3,BP,
10181,GO:0036017,1,0.950759788527673,0,6,response to erythropoietin,BP,
10182,GO:0036018,1,0.953925835063228,0,5,cellular response to erythropoietin,BP,
10183,GO:0036019,1,0.752762802017573,0,19,endolysosome,CC,
10184,GO:0036020,1,0.809272098741529,0,14,endolysosome membrane,CC,
10185,GO:0036021,1,0.942574704505826,0,4,endolysosome lumen,CC,
10186,GO:0036022,1,0.958776964894019,0,3,limb joint morphogenesis,BP,
10187,GO:0036023,1,0.958776964894019,0,3,embryonic skeletal limb joint morphogenesis,BP,
10195,GO:0036031,1,0.991464365286308,0,1,recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex,BP,
10196,GO:0036033,1,0.935330099159609,0,4,mediator complex binding,MF,
10197,GO:0036034,1,0.970030802455593,0,2,mediator complex assembly,BP,
10199,GO:0036037,1,0.796842138298075,0,16,CD8-positive, alpha-beta T cell activation,BP,
10200,GO:0036038,1,0.852092564588152,0,12,MKS complex,CC,
10201,GO:0036041,1,0.906347216568256,0,10,long-chain fatty acid binding,MF,
10202,GO:0036042,1,0.973342125486809,0,3,long-chain fatty acyl-CoA binding,MF,
10203,GO:0036046,1,0.983696734707719,0,1,protein demalonylation,BP,
10204,GO:0036047,1,0.983696734707719,0,1,peptidyl-lysine demalonylation,BP,
10205,GO:0036048,1,0.983696734707719,0,1,protein desuccinylation,BP,
10206,GO:0036049,1,0.983696734707719,0,1,peptidyl-lysine desuccinylation,BP,
10207,GO:0036053,1,0.984352972426897,0,1,glomerular endothelium fenestra,CC,
10208,GO:0036054,1,0.983696734707719,0,1,protein-malonyllysine demalonylase activity,MF,
10209,GO:0036055,1,0.983696734707719,0,1,protein-succinyllysine desuccinylase activity,MF,
10210,GO:0036056,1,0.879057232643573,0,8,filtration diaphragm,CC,
10211,GO:0036057,1,0.879057232643573,0,8,slit diaphragm,CC,
10212,GO:0036058,1,0.983426667503345,0,1,filtration diaphragm assembly,BP,
10213,GO:0036060,1,0.983426667503345,0,1,slit diaphragm assembly,BP,
10215,GO:0036065,1,0.694912071348984,0,23,fucosylation,BP,
10216,GO:0036066,1,0.838495211915521,0,11,protein O-linked fucosylation,BP,
10217,GO:0036071,1,0.983585305180971,0,1,N-glycan fucosylation,BP,
10218,GO:0036072,1,0.914265535792089,0,6,direct ossification,BP,
10220,GO:0036079,1,0.952566095724595,0,3,purine nucleotide-sugar transport,BP,
10221,GO:0036080,1,0.952566095724595,0,3,purine nucleotide-sugar transmembrane transporter activity,MF,
10222,GO:0036085,1,0.984728932554734,0,1,GDP-fucose import into Golgi lumen,BP,
10223,GO:0036088,1,0.988677413700218,0,1,D-serine catabolic process,BP,
10225,GO:0036090,1,0.973433957769311,0,2,cleavage furrow ingression,BP,
10228,GO:0036093,1,0.931368073572284,0,6,germ cell proliferation,BP,
10230,GO:0036100,1,0.943122593247399,0,4,leukotriene catabolic process,BP,
10231,GO:0036101,1,0.943122593247399,0,4,leukotriene B4 catabolic process,BP,
10232,GO:0036102,1,0.943122593247399,0,4,leukotriene B4 metabolic process,BP,
10233,GO:0036105,1,0.983452239819199,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10234,GO:0036109,1,0.832017638440437,0,13,alpha-linolenic acid metabolic process,BP,
10235,GO:0036111,1,0.984408900781729,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10236,GO:0036112,1,0.957979564197986,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10237,GO:0036114,1,0.989074385507877,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10238,GO:0036115,1,0.989074385507877,0,1,fatty-acyl-CoA catabolic process,BP,
10239,GO:0036116,1,0.989074385507877,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10240,GO:0036117,1,0.971383273622105,0,2,hyaluranon cable,CC,
10242,GO:0036119,1,0.739130250268184,0,20,response to platelet-derived growth factor,BP,
10243,GO:0036120,1,0.751228694760696,0,19,cellular response to platelet-derived growth factor stimulus,BP,
10244,GO:0036122,1,0.883828789181633,0,9,BMP binding,MF,
10245,GO:0036123,1,0.906843253600079,0,7,histone H3-K9 dimethylation,BP,
10246,GO:0036124,1,0.780019468279688,0,16,histone H3-K9 trimethylation,BP,
10247,GO:0036125,1,0.983802975266754,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10248,GO:0036126,1,0.388811529167471,0,71,sperm flagellum,CC,
10249,GO:0036128,1,0.892694125630677,0,8,CatSper complex,CC,
10250,GO:0036130,1,0.990934003351696,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10251,GO:0036131,1,0.990934003351696,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10252,GO:0036132,1,0.959477854059006,0,3,13-prostaglandin reductase activity,MF,
10253,GO:0036134,1,0.986226822659447,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10254,GO:0036135,1,0.968407661014684,0,2,Schwann cell migration,BP,
10255,GO:0036137,1,0.971039467430014,0,2,kynurenine aminotransferase activity,MF,
10256,GO:0036138,1,0.983426667500345,0,1,peptidyl-histidine hydroxylation,BP,
10257,GO:0036139,1,0.983426667500345,0,1,peptidyl-histidine dioxygenase activity,MF,
10258,GO:0036140,1,0.983426667500345,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10259,GO:0036143,1,0.993508701360886,0,1,kringle domain binding,MF,
10260,GO:0036145,1,0.9877276359255,0,1,dendritic cell homeostasis,BP,
10261,GO:0036146,1,0.968407662892049,0,2,cellular response to mycotoxin,BP,
10262,GO:0036148,1,0.796209238001028,0,17,phosphatidylglycerol acyl-chain remodeling,BP,
10263,GO:0036149,1,0.817550121041434,0,16,phosphatidylinositol acyl-chain remodeling,BP,
10264,GO:0036150,1,0.755476456167291,0,21,phosphatidylserine acyl-chain remodeling,BP,
10267,GO:0036153,1,0.984167611485957,0,1,triglyceride acyl-chain remodeling,BP,
10268,GO:0036155,1,0.901129264497203,0,7,acylglycerol acyl-chain remodeling,BP,
10269,GO:0036156,1,0.967126892137016,0,2,inner dynein arm,CC,
10270,GO:0036157,1,0.924590913901579,0,5,outer dynein arm,CC,
10271,GO:0036158,1,0.850524976198367,0,12,outer dynein arm assembly,BP,
10272,GO:0036159,1,0.881535750194707,0,9,inner dynein arm assembly,BP,
10273,GO:0036164,1,0.991771529465909,0,1,cell-abiotic substrate adhesion,BP,
10275,GO:0036179,1,0.984270462680204,0,1,osteoclast maturation,BP,
10276,GO:0036194,1,0.978403548418938,0,2,muscle cell projection,CC,
10277,GO:0036195,1,0.978403548418938,0,2,muscle cell projection membrane,CC,
10279,GO:0036215,1,0.95157080730965,0,3,response to stem cell factor,BP,
10280,GO:0036216,1,0.95157080730965,0,3,cellular response to stem cell factor stimulus,BP,
10281,GO:0036219,1,0.994495436116341,0,1,GTP diphosphatase activity,MF,
10282,GO:0036220,1,0.991761447367686,0,1,ITP diphosphatase activity,MF,
10283,GO:0036222,1,0.991761447367686,0,1,XTP diphosphatase activity,MF,
10284,GO:0036228,1,0.968990825586376,0,2,protein targeting to nuclear inner membrane,BP,
10286,GO:0036233,1,0.970448876387558,0,2,glycine import,BP,
10287,GO:0036245,1,0.972974870097892,0,2,cellular response to menadione,BP,
10288,GO:0036250,1,0.987021926285317,0,1,peroxisome transport along microtubule,BP,
10290,GO:0036258,1,0.660491033749078,0,30,multivesicular body assembly,BP,
10291,GO:0036260,1,0.656987982940995,0,34,RNA capping,BP,
10292,GO:0036261,1,0.983439322167495,0,1,7-methylguanosine cap hypermethylation,BP,
10293,GO:0036265,1,0.958077450226008,0,4,RNA (guanine-N7)-methylation,BP,
10294,GO:0036266,1,0.984754258727009,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10295,GO:0036269,1,0.972449946557795,0,2,swimming behavior,BP,
10296,GO:0036284,1,0.989232863986053,0,1,tubulobulbar complex,CC,
10297,GO:0036289,1,0.909858673132849,0,6,peptidyl-serine autophosphorylation,BP,
10298,GO:0036290,1,0.983426667503346,0,1,protein trans-autophosphorylation,BP,
10299,GO:0036292,1,0.973407663915882,0,2,DNA rewinding,BP,
10302,GO:0036295,1,0.89662995923081,0,7,cellular response to increased oxygen levels,BP,
10304,GO:0036297,1,0.528134421318598,0,43,interstrand cross-link repair,BP,
10305,GO:0036301,1,0.939065197277278,0,4,macrophage colony-stimulating factor production,BP,
10306,GO:0036302,1,0.891653559610987,0,7,atrioventricular canal development,BP,
10307,GO:0036303,1,0.754104451548543,0,18,lymph vessel morphogenesis,BP,
10309,GO:0036305,1,0.983426667501871,0,1,ameloblast differentiation,BP,
10310,GO:0036306,1,0.988685717667439,0,1,embryonic heart tube elongation,BP,
10311,GO:0036309,1,0.967126892133774,0,2,protein localization to M-band,BP,
10312,GO:0036310,1,0.881317857861824,0,8,annealing helicase activity,MF,
10314,GO:0036313,1,0.969017832747314,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10315,GO:0036314,1,0.688385018166897,0,24,response to sterol,BP,
10316,GO:0036315,1,0.770904994550764,0,16,cellular response to sterol,BP,
10317,GO:0036317,1,0.984728932554734,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10318,GO:0036323,1,0.983426667502908,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10319,GO:0036324,1,0.975090694248218,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10320,GO:0036326,1,0.983426667502908,0,1,VEGF-A-activated receptor activity,MF,
10321,GO:0036327,1,0.983426667502908,0,1,VEGF-B-activated receptor activity,MF,
10322,GO:0036332,1,0.983426667502908,0,1,placental growth factor-activated receptor activity,MF,
10323,GO:0036333,1,0.984542648174979,0,1,hepatocyte homeostasis,BP,
10324,GO:0036335,1,0.983426667502365,0,1,intestinal stem cell homeostasis,BP,
10326,GO:0036337,1,0.938331858811773,0,4,Fas signaling pathway,BP,
10327,GO:0036338,1,0.954880041681638,0,3,viral membrane,CC,
10329,GO:0036343,1,0.983426955534294,0,1,psychomotor behavior,BP,
10331,GO:0036345,1,0.972299062532586,0,2,platelet maturation,BP,
10332,GO:0036351,1,0.985469041537599,0,1,histone H2A-K13 ubiquitination,BP,
10333,GO:0036352,1,0.985469041537599,0,1,histone H2A-K15 ubiquitination,BP,
10334,GO:0036353,1,0.96716644060646,0,2,histone H2A-K119 monoubiquitination,BP,
10335,GO:0036361,1,0.984951089777405,0,1,racemase activity, acting on amino acids and derivatives,MF,
10336,GO:0036363,1,0.968447117722948,0,2,transforming growth factor beta activation,BP,
10337,GO:0036367,1,0.968793744053204,0,2,light adaption,BP,
10338,GO:0036369,1,0.967126892148342,0,2,transcription factor catabolic process,BP,
10339,GO:0036371,1,0.983426667498922,0,1,protein localization to T-tubule,BP,
10340,GO:0036372,1,0.992619598190901,0,1,opsin transport,BP,
10341,GO:0036374,1,0.927514081249578,0,6,glutathione hydrolase activity,MF,
10342,GO:0036376,1,0.904003036347937,0,8,sodium ion export from cell,BP,
10343,GO:0036378,1,0.958329247342645,0,3,calcitriol biosynthetic process from calciol,BP,
10345,GO:0036387,1,0.971970846745196,0,2,pre-replicative complex,CC,
10346,GO:0036388,1,0.971970846745196,0,2,pre-replicative complex assembly,BP,
10347,GO:0036392,1,0.983437397741892,0,1,chemokine (C-C motif) ligand 20 production,BP,
10348,GO:0036393,1,0.984015916374423,0,1,thiocyanate peroxidase activity,MF,
10349,GO:0036396,1,0.945676724424825,0,4,MIS complex,CC,
10350,GO:0036398,1,0.968911010478892,0,2,TCR signalosome,CC,
10351,GO:0036399,1,0.983591359917946,0,1,TCR signalosome assembly,BP,
10352,GO:0036402,1,0.937124359950386,0,6,proteasome-activating ATPase activity,MF,
10353,GO:0036403,1,0.984558430877212,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10354,GO:0036404,1,0.983426667496558,0,1,conversion of ds siRNA to ss siRNA,BP,
10355,GO:0036413,1,0.969272216283823,0,2,histone H3-R26 citrullination,BP,
10356,GO:0036414,1,0.923864593654315,0,5,histone citrullination,BP,
10357,GO:0036435,1,0.958118073012336,0,3,K48-linked polyubiquitin binding,MF,
10358,GO:0036438,1,0.940313764594602,0,4,maintenance of lens transparency,BP,
10359,GO:0036440,1,0.983890557950773,0,1,citrate synthase activity,MF,
10360,GO:0036442,1,0.761357771142174,0,22,hydrogen-exporting ATPase activity,MF,
10361,GO:0036444,1,0.938326322688648,0,4,mitochondrial calcium uptake,BP,
10362,GO:0036445,1,0.809080865195896,0,13,neuronal stem cell division,BP,
10363,GO:0036446,1,0.95112034559436,0,3,myofibroblast differentiation,BP,
10364,GO:0036449,1,0.935754801176004,0,4,microtubule minus-end,CC,
10365,GO:0036452,1,0.690469257897605,0,27,ESCRT complex,CC,
10366,GO:0036454,1,0.932353479649355,0,5,growth factor complex,CC,
10367,GO:0036455,1,0.991607407909571,0,1,iron-sulfur transferase activity,MF,
10368,GO:0036457,1,0.960346795643415,0,3,keratohyalin granule,CC,
10369,GO:0036458,1,0.985908188314079,0,1,hepatocyte growth factor binding,MF,
10370,GO:0036459,1,0.184764527115232,0,109,thiol-dependent ubiquitinyl hydrolase activity,MF,
10372,GO:0036462,1,0.909459274875667,0,7,TRAIL-activated apoptotic signaling pathway,BP,
10373,GO:0036464,1,0.0785976326310005,0,174,cytoplasmic ribonucleoprotein granule,CC,
10375,GO:0036466,1,0.967126892154827,0,2,synaptic vesicle recycling via endosome,BP,
10376,GO:0036468,1,0.986610580862572,0,1,L-dopa decarboxylase activity,MF,
10377,GO:0036470,1,0.992913066894507,0,1,tyrosine 3-monooxygenase activator activity,MF,
10378,GO:0036471,1,0.992913066894507,0,1,cellular response to glyoxal,BP,
10380,GO:0036474,1,0.721977788543031,0,23,cell death in response to hydrogen peroxide,BP,
10381,GO:0036475,1,0.775250751566576,0,17,neuron death in response to oxidative stress,BP,
10382,GO:0036476,1,0.961295762081988,0,3,neuron death in response to hydrogen peroxide,BP,
10384,GO:0036478,1,0.992913066894507,0,1,L-dopa decarboxylase activator activity,MF,
10385,GO:0036479,1,0.983426667497643,0,1,peroxidase inhibitor activity,MF,
10386,GO:0036480,1,0.899441244789967,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10387,GO:0036481,1,0.925336666753313,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10388,GO:0036482,1,0.9774976736942,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10389,GO:0036483,1,0.983426667503053,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10390,GO:0036484,1,0.952602160741759,0,3,trunk neural crest cell migration,BP,
10391,GO:0036486,1,0.952602160741759,0,3,ventral trunk neural crest cell migration,BP,
10392,GO:0036487,1,0.983426667498132,0,1,nitric-oxide synthase inhibitor activity,MF,
10393,GO:0036488,1,0.980646132101673,0,2,CHOP-C/EBP complex,CC,
10395,GO:0036491,1,0.896464669188404,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10396,GO:0036492,1,0.896464669188404,0,7,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10397,GO:0036493,1,0.956677906897094,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10398,GO:0036494,1,0.983426667501971,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10399,GO:0036496,1,0.9748262967009,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10400,GO:0036497,1,0.985256975000529,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10401,GO:0036498,1,0.392765851618017,0,64,IRE1-mediated unfolded protein response,BP,
10402,GO:0036499,1,0.761730417581451,0,20,PERK-mediated unfolded protein response,BP,
10403,GO:0036500,1,0.864178435936665,0,10,ATF6-mediated unfolded protein response,BP,
10404,GO:0036501,1,0.983426667503153,0,1,UFD1-NPL4 complex,CC,
10405,GO:0036502,1,0.983713160950567,0,1,Derlin-1-VIMP complex,CC,
10406,GO:0036503,1,0.280693999045473,0,87,ERAD pathway,BP,
10407,GO:0036505,1,0.969195382956093,0,2,prosaposin receptor activity,MF,
10408,GO:0036506,1,0.955148535008821,0,3,maintenance of unfolded protein,BP,
10409,GO:0036507,1,0.700690012119259,0,24,protein demannosylation,BP,
10410,GO:0036508,1,0.700690012119259,0,24,protein alpha-1,2-demannosylation,BP,
10411,GO:0036509,1,0.971570869444887,0,2,trimming of terminal mannose on B branch,BP,
10412,GO:0036510,1,0.955466794153693,0,3,trimming of terminal mannose on C branch,BP,
10413,GO:0036511,1,0.971570869444887,0,2,trimming of first mannose on A branch,BP,
10414,GO:0036512,1,0.971570869444887,0,2,trimming of second mannose on A branch,BP,
10415,GO:0036513,1,0.849140148442866,0,11,Derlin-1 retrotranslocation complex,CC,
10420,GO:0036520,1,0.985586841248435,0,1,astrocyte-dopaminergic neuron signaling,BP,
10421,GO:0036524,1,0.992913066894507,0,1,protein deglycase activity,MF,
10422,GO:0036525,1,0.992913066894507,0,1,protein deglycation,BP,
10423,GO:0036526,1,0.992913066894507,0,1,peptidyl-cysteine deglycation,BP,
10424,GO:0036527,1,0.992913066894507,0,1,peptidyl-arginine deglycation,BP,
10425,GO:0036528,1,0.992913066894507,0,1,peptidyl-lysine deglycation,BP,
10426,GO:0036529,1,0.992913066894507,0,1,protein deglycation, glyoxal removal,BP,
10427,GO:0036530,1,0.992913066894507,0,1,protein deglycation, methylglyoxal removal,BP,
10428,GO:0036531,1,0.992913066894507,0,1,glutathione deglycation,BP,
10430,GO:0038002,1,0.983426667502216,0,1,endocrine signaling,BP,
10431,GO:0038003,1,0.876764882176582,0,10,opioid receptor signaling pathway,BP,
10432,GO:0038007,1,0.935355277672097,0,4,netrin-activated signaling pathway,BP,
10433,GO:0038009,1,0.990029778762667,0,1,regulation of signal transduction by receptor internalization,BP,
10434,GO:0038016,1,0.9691933745801,0,2,insulin receptor internalization,BP,
10435,GO:0038018,1,0.967126892152845,0,2,Wnt receptor catabolic process,BP,
10436,GO:0038021,1,0.983426667503251,0,1,leptin receptor activity,MF,
10438,GO:0038024,1,0.389833752770829,0,61,cargo receptor activity,MF,
10439,GO:0038025,1,0.967153824503518,0,2,reelin receptor activity,MF,
10440,GO:0038026,1,0.935356149629877,0,4,reelin-mediated signaling pathway,BP,
10441,GO:0038027,1,0.923226686152206,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10445,GO:0038033,1,0.929181780034307,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10447,GO:0038036,1,0.890235300557976,0,8,sphingosine-1-phosphate receptor activity,MF,
10448,GO:0038037,1,0.951096177115227,0,3,G-protein coupled receptor dimeric complex,CC,
10449,GO:0038038,1,0.983426667500347,0,1,G-protein coupled receptor homodimeric complex,CC,
10450,GO:0038039,1,0.967126892153859,0,2,G-protein coupled receptor heterodimeric complex,CC,
10451,GO:0038042,1,0.983426667500347,0,1,dimeric G-protein coupled receptor signaling pathway,BP,
10452,GO:0038043,1,0.970251895797798,0,2,interleukin-5-mediated signaling pathway,BP,
10453,GO:0038044,1,0.922059616764609,0,5,transforming growth factor-beta secretion,BP,
10454,GO:0038046,1,0.987772898544362,0,1,enkephalin receptor activity,MF,
10455,GO:0038047,1,0.987316598817985,0,1,morphine receptor activity,MF,
10456,GO:0038048,1,0.98342666750266,0,1,dynorphin receptor activity,MF,
10457,GO:0038049,1,0.967126892145099,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10458,GO:0038051,1,0.983426667500692,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10459,GO:0038052,1,0.968689701367106,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10469,GO:0038085,1,0.942068489931546,0,4,vascular endothelial growth factor binding,MF,
10470,GO:0038086,1,0.951144050984324,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10471,GO:0038089,1,0.913777493837753,0,6,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10472,GO:0038091,1,0.951144050984324,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10473,GO:0038092,1,0.827093887480608,0,14,nodal signaling pathway,BP,
10478,GO:0038097,1,0.983426667502269,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10479,GO:0038098,1,0.970190816915389,0,2,sequestering of BMP from receptor via BMP binding,BP,
10480,GO:0038100,1,0.975929857333666,0,2,nodal binding,MF,
10481,GO:0038101,1,0.987992404699708,0,1,sequestering of nodal from receptor via nodal binding,BP,
10482,GO:0038106,1,0.983757653963509,0,1,choriogonadotropin hormone binding,MF,
10483,GO:0038107,1,0.914614377694717,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10484,GO:0038108,1,0.938622704788963,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10485,GO:0038109,1,0.95157080730965,0,3,Kit signaling pathway,BP,
10486,GO:0038110,1,0.929690887089253,0,5,interleukin-2-mediated signaling pathway,BP,
10487,GO:0038111,1,0.976780602445324,0,2,interleukin-7-mediated signaling pathway,BP,
10488,GO:0038112,1,0.96943957111989,0,2,interleukin-8-mediated signaling pathway,BP,
10489,GO:0038113,1,0.986042558870148,0,1,interleukin-9-mediated signaling pathway,BP,
10490,GO:0038114,1,0.983601081534302,0,1,interleukin-21-mediated signaling pathway,BP,
10491,GO:0038115,1,0.986003787696943,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10492,GO:0038116,1,0.986003787696943,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10493,GO:0038117,1,0.986003787696943,0,1,C-C motif chemokine 19 receptor activity,MF,
10494,GO:0038118,1,0.992096438783521,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10495,GO:0038121,1,0.986003787696943,0,1,C-C motif chemokine 21 receptor activity,MF,
10496,GO:0038123,1,0.956986363521007,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10497,GO:0038124,1,0.943318330758465,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10500,GO:0038129,1,0.957452172286029,0,3,ERBB3 signaling pathway,BP,
10501,GO:0038131,1,0.987086396575216,0,1,neuregulin receptor activity,MF,
10503,GO:0038133,1,0.986522870688917,0,1,ERBB2-ERBB3 signaling pathway,BP,
10504,GO:0038145,1,0.931190148405504,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10505,GO:0038154,1,0.98365546150649,0,1,interleukin-11-mediated signaling pathway,BP,
10506,GO:0038155,1,0.971118843870301,0,2,interleukin-23-mediated signaling pathway,BP,
10507,GO:0038156,1,0.971683569957018,0,2,interleukin-3-mediated signaling pathway,BP,
10508,GO:0038158,1,0.972076419171153,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10509,GO:0038161,1,0.925441815924041,0,5,prolactin signaling pathway,BP,
10510,GO:0038162,1,0.971018576864214,0,2,erythropoietin-mediated signaling pathway,BP,
10511,GO:0038163,1,0.964064198460765,0,3,thrombopoietin-mediated signaling pathway,BP,
10512,GO:0038164,1,0.983446034454651,0,1,thrombopoietin receptor activity,MF,
10513,GO:0038165,1,0.93929107920837,0,4,oncostatin-M-mediated signaling pathway,BP,
10515,GO:0038167,1,0.983426667502216,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10516,GO:0038168,1,0.983426667502216,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10517,GO:0038169,1,0.933367277343852,0,5,somatostatin receptor signaling pathway,BP,
10518,GO:0038170,1,0.933367277343852,0,5,somatostatin signaling pathway,BP,
10519,GO:0038171,1,0.910228027430349,0,6,cannabinoid signaling pathway,BP,
10520,GO:0038172,1,0.96924084306236,0,2,interleukin-33-mediated signaling pathway,BP,
10521,GO:0038178,1,0.970345775918914,0,2,complement component C5a signaling pathway,BP,
10523,GO:0038180,1,0.883847954916852,0,8,nerve growth factor signaling pathway,BP,
10525,GO:0038182,1,0.989296813148842,0,1,G-protein coupled bile acid receptor activity,MF,
10527,GO:0038184,1,0.989296813148842,0,1,cell surface bile acid receptor signaling pathway,BP,
10528,GO:0038185,1,0.986081633239475,0,1,intracellular bile acid receptor signaling pathway,BP,
10530,GO:0038187,1,0.799469453249564,0,17,pattern recognition receptor activity,MF,
10531,GO:0038188,1,0.974600767753314,0,2,cholecystokinin signaling pathway,BP,
10532,GO:0038189,1,0.968660667740191,0,2,neuropilin signaling pathway,BP,
10533,GO:0038190,1,0.968660667740191,0,2,VEGF-activated neuropilin signaling pathway,BP,
10534,GO:0038191,1,0.983426667501871,0,1,neuropilin binding,MF,
10535,GO:0038192,1,0.986556949449043,0,1,gastric inhibitory peptide signaling pathway,BP,
10536,GO:0038193,1,0.985631043093334,0,1,thromboxane A2 signaling pathway,BP,
10537,GO:0038194,1,0.974384689194038,0,2,thyroid-stimulating hormone signaling pathway,BP,
10538,GO:0038195,1,0.989609312748199,0,1,urokinase plasminogen activator signaling pathway,BP,
10542,GO:0039003,1,0.967127945407715,0,2,pronephric field specification,BP,
10543,GO:0039007,1,0.983426667502019,0,1,pronephric nephron morphogenesis,BP,
10544,GO:0039008,1,0.983426667502019,0,1,pronephric nephron tubule morphogenesis,BP,
10545,GO:0039017,1,0.967127945407715,0,2,pattern specification involved in pronephros development,BP,
10546,GO:0039019,1,0.951849357207094,0,3,pronephric nephron development,BP,
10547,GO:0039020,1,0.967872167349628,0,2,pronephric nephron tubule development,BP,
10548,GO:0039022,1,0.983426667502019,0,1,pronephric duct development,BP,
10549,GO:0039023,1,0.983426667502019,0,1,pronephric duct morphogenesis,BP,
10550,GO:0039506,1,0.967946839474691,0,2,modulation by virus of host molecular function,BP,
10551,GO:0039507,1,0.967946839474691,0,2,suppression by virus of host molecular function,BP,
10552,GO:0039513,1,0.984260376681913,0,1,suppression by virus of host catalytic activity,BP,
10553,GO:0039516,1,0.984260376681913,0,1,modulation by virus of host catalytic activity,BP,
10554,GO:0039519,1,0.967126892153665,0,2,modulation by virus of host autophagy,BP,
10555,GO:0039520,1,0.983426667502018,0,1,induction by virus of host autophagy,BP,
10556,GO:0039521,1,0.983426667502658,0,1,suppression by virus of host autophagy,BP,
10557,GO:0039526,1,0.961554461230338,0,3,modulation by virus of host apoptotic process,BP,
10558,GO:0039528,1,0.712457763699645,0,22,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10559,GO:0039529,1,0.765560462044817,0,17,RIG-I signaling pathway,BP,
10560,GO:0039530,1,0.880618220072146,0,9,MDA-5 signaling pathway,BP,
10561,GO:0039531,1,0.780819860367171,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10562,GO:0039532,1,0.885638001109785,0,8,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10563,GO:0039533,1,0.917844262584197,0,6,regulation of MDA-5 signaling pathway,BP,
10564,GO:0039534,1,0.95985504714779,0,3,negative regulation of MDA-5 signaling pathway,BP,
10565,GO:0039535,1,0.804954524730184,0,14,regulation of RIG-I signaling pathway,BP,
10566,GO:0039536,1,0.912998029889921,0,6,negative regulation of RIG-I signaling pathway,BP,
10567,GO:0039552,1,0.983426667502073,0,1,RIG-I binding,MF,
10568,GO:0039650,1,0.984260376681913,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10569,GO:0039656,1,0.956160680165568,0,3,modulation by virus of host gene expression,BP,
10571,GO:0039689,1,0.953921405537299,0,3,negative stranded viral RNA replication,BP,
10572,GO:0039692,1,0.864525606916903,0,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10573,GO:0039694,1,0.715705401853238,0,22,viral RNA genome replication,BP,
10574,GO:0039702,1,0.753691357317903,0,21,viral budding via host ESCRT complex,BP,
10575,GO:0039703,1,0.715705401853238,0,22,RNA replication,BP,
10577,GO:0039713,1,0.983504855665434,0,1,viral factory,CC,
10578,GO:0039714,1,0.983504855665434,0,1,cytoplasmic viral factory,CC,
10582,GO:0040009,1,0.969220400639482,0,2,regulation of growth rate,BP,
10587,GO:0040015,1,0.859001135418469,0,10,negative regulation of multicellular organism growth,BP,
10588,GO:0040016,1,0.891202228497233,0,8,embryonic cleavage,BP,
10593,GO:0040023,1,0.809445159748889,0,13,establishment of nucleus localization,BP,
10595,GO:0040030,1,0.978974207058743,0,2,regulation of molecular function, epigenetic,BP,
10596,GO:0040031,1,0.949735573661994,0,5,snRNA modification,BP,
10597,GO:0040032,1,0.987186532114042,0,1,post-embryonic body morphogenesis,BP,
10598,GO:0040033,1,0.824026204446372,0,13,negative regulation of translation, ncRNA-mediated,BP,
10602,GO:0040038,1,0.951273936983055,0,3,polar body extrusion after meiotic divisions,BP,
10603,GO:0040040,1,0.98342666750138,0,1,thermosensory behavior,BP,
10604,GO:0042000,1,0.985144817662511,0,1,translocation of peptides or proteins into host,BP,
10605,GO:0042007,1,0.989729088569874,0,1,interleukin-18 binding,MF,
10606,GO:0042008,1,0.983475100046871,0,1,interleukin-18 receptor activity,MF,
10607,GO:0042011,1,0.983739551070219,0,1,interleukin-16 binding,MF,
10608,GO:0042012,1,0.983739551070219,0,1,interleukin-16 receptor activity,MF,
10609,GO:0042015,1,0.95483633425268,0,3,interleukin-20 binding,MF,
10610,GO:0042017,1,0.984182567706684,0,1,interleukin-22 binding,MF,
10611,GO:0042018,1,0.984182567706684,0,1,interleukin-22 receptor activity,MF,
10612,GO:0042019,1,0.971118843870301,0,2,interleukin-23 binding,MF,
10613,GO:0042020,1,0.971118843870301,0,2,interleukin-23 receptor activity,MF,
10614,GO:0042022,1,0.986758819011907,0,1,interleukin-12 receptor complex,CC,
10615,GO:0042023,1,0.88979471497608,0,7,DNA endoreduplication,BP,
10616,GO:0042025,1,0.952384193252281,0,3,host cell nucleus,CC,
10617,GO:0042026,1,0.707174465362969,0,24,protein refolding,BP,
10618,GO:0042030,1,0.951155031223127,0,4,ATPase inhibitor activity,MF,
10622,GO:0042040,1,0.983426667503251,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10623,GO:0042043,1,0.824473478857863,0,12,neurexin family protein binding,MF,
10626,GO:0042048,1,0.87576936127336,0,8,olfactory behavior,BP,
10627,GO:0042053,1,0.783126148524723,0,17,regulation of dopamine metabolic process,BP,
10628,GO:0042054,1,0.49115854130808,0,47,histone methyltransferase activity,MF,
10634,GO:0042069,1,0.783126148524723,0,17,regulation of catecholamine metabolic process,BP,
10635,GO:0042073,1,0.522623107354916,0,45,intraciliary transport,BP,
10637,GO:0042078,1,0.953803634497934,0,4,germ-line stem cell division,BP,
10638,GO:0042083,1,0.988766311713202,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10639,GO:0042084,1,0.983426667496216,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10642,GO:0042090,1,0.892951864294161,0,8,interleukin-12 biosynthetic process,BP,
10643,GO:0042091,1,0.954873974055439,0,3,interleukin-10 biosynthetic process,BP,
10644,GO:0042092,1,0.63155804911745,0,34,type 2 immune response,BP,
10646,GO:0042094,1,0.747770525977889,0,21,interleukin-2 biosynthetic process,BP,
10651,GO:0042101,1,0.775670790056796,0,19,T cell receptor complex,CC,
10652,GO:0042102,1,0.285277368255118,0,95,positive regulation of T cell proliferation,BP,
10653,GO:0042104,1,0.709824364391231,0,27,positive regulation of activated T cell proliferation,BP,
10654,GO:0042105,1,0.949268931915618,0,5,alpha-beta T cell receptor complex,CC,
10657,GO:0042109,1,0.962367957661818,0,3,lymphotoxin A biosynthetic process,BP,
10661,GO:0042117,1,0.908701497745315,0,8,monocyte activation,BP,
10662,GO:0042118,1,0.863288833541629,0,10,endothelial cell activation,BP,
10664,GO:0042126,1,0.941077028103847,0,4,nitrate metabolic process,BP,
10666,GO:0042128,1,0.985408118408524,0,1,nitrate assimilation,BP,
10669,GO:0042131,1,0.984816754109529,0,1,thiamine phosphate phosphatase activity,MF,
10670,GO:0042132,1,0.97956134953107,0,2,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10671,GO:0042133,1,0.644707464454208,0,29,neurotransmitter metabolic process,BP,
10672,GO:0042134,1,0.978983334466459,0,2,rRNA primary transcript binding,MF,
10673,GO:0042135,1,0.845091702836782,0,11,neurotransmitter catabolic process,BP,
10674,GO:0042136,1,0.765337139732303,0,17,neurotransmitter biosynthetic process,BP,
10675,GO:0042137,1,0.971225216557625,0,2,sequestering of neurotransmitter,BP,
10676,GO:0042138,1,0.938527703958289,0,5,meiotic DNA double-strand break formation,BP,
10677,GO:0042140,1,0.984728932554734,0,1,late meiotic recombination nodule assembly,BP,
10678,GO:0042144,1,0.96849809839392,0,2,vacuole fusion, non-autophagic,BP,
10680,GO:0042148,1,0.891032948944728,0,8,strand invasion,BP,
10684,GO:0042159,1,0.87996586088774,0,9,lipoprotein catabolic process,BP,
10685,GO:0042160,1,0.947454607859306,0,5,lipoprotein modification,BP,
10686,GO:0042161,1,0.947454607859306,0,5,lipoprotein oxidation,BP,
10687,GO:0042162,1,0.607889186314734,0,32,telomeric DNA binding,MF,
10688,GO:0042163,1,0.989615277731363,0,1,interleukin-12 beta subunit binding,MF,
10689,GO:0042164,1,0.985354804230221,0,1,interleukin-12 alpha subunit binding,MF,
10690,GO:0042165,1,0.718724648449899,0,22,neurotransmitter binding,MF,
10691,GO:0042166,1,0.776300581040051,0,17,acetylcholine binding,MF,
10692,GO:0042167,1,0.924979877104455,0,7,heme catabolic process,BP,
10693,GO:0042168,1,0.691340804292179,0,29,heme metabolic process,BP,
10694,GO:0042169,1,0.625218162554684,0,30,SH2 domain binding,MF,
10698,GO:0042177,1,0.255451944750661,0,99,negative regulation of protein catabolic process,BP,
10699,GO:0042178,1,0.885760831170976,0,10,xenobiotic catabolic process,BP,
10702,GO:0042182,1,0.909860555946602,0,7,ketone catabolic process,BP,
10703,GO:0042196,1,0.975923364757125,0,2,chlorinated hydrocarbon metabolic process,BP,
10704,GO:0042197,1,0.975923364757125,0,2,halogenated hydrocarbon metabolic process,BP,
10705,GO:0042214,1,0.971407940618707,0,2,terpene metabolic process,BP,
10706,GO:0042219,1,0.750562560659997,0,21,cellular modified amino acid catabolic process,BP,
10707,GO:0042220,1,0.499789559566651,0,50,response to cocaine,BP,
10710,GO:0042223,1,0.974901874802987,0,2,interleukin-3 biosynthetic process,BP,
10711,GO:0042225,1,0.995401088492396,0,1,interleukin-5 biosynthetic process,BP,
10712,GO:0042226,1,0.791035313555242,0,18,interleukin-6 biosynthetic process,BP,
10713,GO:0042228,1,0.850125166490395,0,13,interleukin-8 biosynthetic process,BP,
10714,GO:0042231,1,0.975025394308091,0,2,interleukin-13 biosynthetic process,BP,
10715,GO:0042241,1,0.983621657795192,0,1,interleukin-18 biosynthetic process,BP,
10716,GO:0042245,1,0.968340926545206,0,2,RNA repair,BP,
10718,GO:0042247,1,0.983949267029538,0,1,establishment of planar polarity of follicular epithelium,BP,
10720,GO:0042253,1,0.94548257231013,0,5,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10721,GO:0042254,1,0.0325010179799994,0,292,ribosome biogenesis,BP,
10722,GO:0042255,1,0.608141707011625,0,48,ribosome assembly,BP,
10723,GO:0042256,1,0.940152330033082,0,5,mature ribosome assembly,BP,
10724,GO:0042262,1,0.9513939282101,0,5,DNA protection,BP,
10725,GO:0042264,1,0.967149071432541,0,2,peptidyl-aspartic acid hydroxylation,BP,
10726,GO:0042265,1,0.983426667500345,0,1,peptidyl-asparagine hydroxylation,BP,
10728,GO:0042268,1,0.899462721633132,0,9,regulation of cytolysis,BP,
10729,GO:0042269,1,0.648237747222841,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10730,GO:0042270,1,0.96024897849546,0,3,protection from natural killer cell mediated cytotoxicity,BP,
10731,GO:0042271,1,0.959468906551266,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10732,GO:0042272,1,0.939136771724858,0,4,nuclear RNA export factor complex,CC,
10733,GO:0042273,1,0.517884938031486,0,58,ribosomal large subunit biogenesis,BP,
10734,GO:0042274,1,0.483753535122319,0,61,ribosomal small subunit biogenesis,BP,
10735,GO:0042275,1,0.989128906020354,0,1,error-free postreplication DNA repair,BP,
10736,GO:0042276,1,0.767675484222541,0,20,error-prone translesion synthesis,BP,
10739,GO:0042281,1,0.971798596892292,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10740,GO:0042282,1,0.983426667503102,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10741,GO:0042284,1,0.977327610390849,0,2,sphingolipid delta-4 desaturase activity,MF,
10742,GO:0042285,1,0.91214473229563,0,6,xylosyltransferase activity,MF,
10743,GO:0042287,1,0.660415799433046,0,29,MHC protein binding,MF,
10744,GO:0042288,1,0.764775852190016,0,19,MHC class I protein binding,MF,
10745,GO:0042289,1,0.93482977370906,0,5,MHC class II protein binding,MF,
10746,GO:0042292,1,0.98502761782828,0,1,URM1 activating enzyme activity,MF,
10747,GO:0042296,1,0.952476886611519,0,4,ISG15 transferase activity,MF,
10749,GO:0042301,1,0.847524417353897,0,11,phosphate ion binding,MF,
10751,GO:0042304,1,0.604141658273251,0,37,regulation of fatty acid biosynthetic process,BP,
10755,GO:0042309,1,0.976273090149561,0,2,homoiothermy,BP,
10759,GO:0042316,1,0.983426667502562,0,1,penicillin metabolic process,BP,
10760,GO:0042320,1,0.952569975382547,0,6,regulation of circadian sleep/wake cycle, REM sleep,BP,
10762,GO:0042322,1,0.98516052713903,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10764,GO:0042324,1,0.995528640221343,0,1,hypocretin receptor binding,MF,
10768,GO:0042328,1,0.967246797941561,0,2,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10770,GO:0042335,1,0.953425598497837,0,3,cuticle development,BP,
10772,GO:0042340,1,0.830934000900044,0,12,keratan sulfate catabolic process,BP,
10774,GO:0042346,1,0.719170842194844,0,24,positive regulation of NF-kappaB import into nucleus,BP,
10777,GO:0042350,1,0.962227374027674,0,3,GDP-L-fucose biosynthetic process,BP,
10778,GO:0042351,1,0.978444690536225,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10779,GO:0042352,1,0.983426900193547,0,1,GDP-L-fucose salvage,BP,
10780,GO:0042354,1,0.86554750002383,0,9,L-fucose metabolic process,BP,
10781,GO:0042355,1,0.86554750002383,0,9,L-fucose catabolic process,BP,
10782,GO:0042356,1,0.99006355571529,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10783,GO:0042357,1,0.973160001495587,0,2,thiamine diphosphate metabolic process,BP,
10785,GO:0042360,1,0.947147359716463,0,4,vitamin E metabolic process,BP,
10786,GO:0042361,1,0.969195214864434,0,2,menaquinone catabolic process,BP,
10788,GO:0042363,1,0.880490022658102,0,9,fat-soluble vitamin catabolic process,BP,
10789,GO:0042364,1,0.872659868906682,0,9,water-soluble vitamin biosynthetic process,BP,
10790,GO:0042365,1,0.980053331041122,0,2,water-soluble vitamin catabolic process,BP,
10792,GO:0042369,1,0.953187693731055,0,3,vitamin D catabolic process,BP,
10793,GO:0042371,1,0.983446198396837,0,1,vitamin K biosynthetic process,BP,
10794,GO:0042373,1,0.929671045044503,0,6,vitamin K metabolic process,BP,
10795,GO:0042374,1,0.961160612805478,0,3,phylloquinone metabolic process,BP,
10796,GO:0042376,1,0.961160612805478,0,3,phylloquinone catabolic process,BP,
10797,GO:0042377,1,0.969195214864434,0,2,vitamin K catabolic process,BP,
10799,GO:0042382,1,0.910169325433527,0,6,paraspeckles,CC,
10802,GO:0042392,1,0.97483086441332,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10803,GO:0042393,1,0.0874049594800856,0,180,histone binding,MF,
10804,GO:0042396,1,0.988912275994095,0,1,phosphagen biosynthetic process,BP,
10805,GO:0042398,1,0.577042225230859,0,39,cellular modified amino acid biosynthetic process,BP,
10806,GO:0042401,1,0.771106228557141,0,21,cellular biogenic amine biosynthetic process,BP,
10807,GO:0042402,1,0.732777199417744,0,24,cellular biogenic amine catabolic process,BP,
10808,GO:0042403,1,0.742713295234148,0,20,thyroid hormone metabolic process,BP,
10809,GO:0042404,1,0.986285617164255,0,1,thyroid hormone catabolic process,BP,
10810,GO:0042405,1,0.836903179001443,0,11,nuclear inclusion body,CC,
10811,GO:0042406,1,0.933258742418622,0,5,extrinsic component of endoplasmic reticulum membrane,CC,
10812,GO:0042407,1,0.858384177646256,0,12,cristae formation,BP,
10813,GO:0042412,1,0.973169586148211,0,2,taurine biosynthetic process,BP,
10814,GO:0042413,1,0.984910759583086,0,1,carnitine catabolic process,BP,
10816,GO:0042415,1,0.858582519285738,0,10,norepinephrine metabolic process,BP,
10817,GO:0042416,1,0.840646259213305,0,12,dopamine biosynthetic process,BP,
10820,GO:0042420,1,0.899002732579084,0,7,dopamine catabolic process,BP,
10821,GO:0042421,1,0.911820492008545,0,6,norepinephrine biosynthetic process,BP,
10823,GO:0042424,1,0.884430957965907,0,8,catecholamine catabolic process,BP,
10824,GO:0042426,1,0.90640881833049,0,6,choline catabolic process,BP,
10825,GO:0042427,1,0.959989350778199,0,3,serotonin biosynthetic process,BP,
10826,GO:0042428,1,0.848248735411762,0,11,serotonin metabolic process,BP,
10827,GO:0042430,1,0.702585087173072,0,26,indole-containing compound metabolic process,BP,
10828,GO:0042431,1,0.985681118036814,0,1,indole metabolic process,BP,
10829,GO:0042435,1,0.940554587608557,0,5,indole-containing compound biosynthetic process,BP,
10830,GO:0042436,1,0.868154279691376,0,11,indole-containing compound catabolic process,BP,
10832,GO:0042439,1,0.953203935550111,0,3,ethanolamine-containing compound metabolic process,BP,
10834,GO:0042441,1,0.942944296169099,0,4,eye pigment metabolic process,BP,
10837,GO:0042447,1,0.867847676269204,0,10,hormone catabolic process,BP,
10838,GO:0042448,1,0.811633429940372,0,16,progesterone metabolic process,BP,
10839,GO:0042450,1,0.98673021283246,0,1,arginine biosynthetic process via ornithine,BP,
10840,GO:0042451,1,0.785344285038827,0,21,purine nucleoside biosynthetic process,BP,
10841,GO:0042454,1,0.815565577527659,0,17,ribonucleoside catabolic process,BP,
10842,GO:0042455,1,0.62192375607812,0,39,ribonucleoside biosynthetic process,BP,
10848,GO:0042473,1,0.878033211861999,0,9,outer ear morphogenesis,BP,
10854,GO:0042483,1,0.938917763469425,0,4,negative regulation of odontogenesis,BP,
10856,GO:0042488,1,0.961457000519269,0,3,positive regulation of odontogenesis of dentin-containing tooth,BP,
10857,GO:0042489,1,0.969307507432114,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10862,GO:0042494,1,0.936060766537381,0,4,detection of bacterial lipoprotein,BP,
10863,GO:0042495,1,0.967882294756889,0,2,detection of triacyl bacterial lipopeptide,BP,
10864,GO:0042496,1,0.967222449717395,0,2,detection of diacyl bacterial lipopeptide,BP,
10865,GO:0042497,1,0.983523828891453,0,1,triacyl lipopeptide binding,MF,
10866,GO:0042500,1,0.926988660253187,0,5,aspartic endopeptidase activity, intramembrane cleaving,MF,
10868,GO:0042502,1,0.984728932554734,0,1,tyrosine phosphorylation of Stat2 protein,BP,
10870,GO:0042504,1,0.936650076301722,0,5,tyrosine phosphorylation of Stat4 protein,BP,
10871,GO:0042505,1,0.962882334798915,0,3,tyrosine phosphorylation of Stat6 protein,BP,
10872,GO:0042506,1,0.758485202956506,0,22,tyrosine phosphorylation of Stat5 protein,BP,
10877,GO:0042512,1,0.963893061108576,0,3,negative regulation of tyrosine phosphorylation of Stat1 protein,BP,
10880,GO:0042518,1,0.900917413977752,0,7,negative regulation of tyrosine phosphorylation of Stat3 protein,BP,
10881,GO:0042519,1,0.936650076301722,0,5,regulation of tyrosine phosphorylation of Stat4 protein,BP,
10882,GO:0042520,1,0.95215124745157,0,4,positive regulation of tyrosine phosphorylation of Stat4 protein,BP,
10883,GO:0042521,1,0.983723127713326,0,1,negative regulation of tyrosine phosphorylation of Stat4 protein,BP,
10884,GO:0042522,1,0.789445222978082,0,19,regulation of tyrosine phosphorylation of Stat5 protein,BP,
10885,GO:0042523,1,0.825259901849318,0,16,positive regulation of tyrosine phosphorylation of Stat5 protein,BP,
10886,GO:0042524,1,0.956635771601649,0,3,negative regulation of tyrosine phosphorylation of Stat5 protein,BP,
10887,GO:0042525,1,0.962882334798915,0,3,regulation of tyrosine phosphorylation of Stat6 protein,BP,
10888,GO:0042526,1,0.974457703163885,0,2,positive regulation of tyrosine phosphorylation of Stat6 protein,BP,
10889,GO:0042527,1,0.988122489883223,0,1,negative regulation of tyrosine phosphorylation of Stat6 protein,BP,
10891,GO:0042532,1,0.862093240942617,0,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10892,GO:0042533,1,0.773160104233669,0,19,tumor necrosis factor biosynthetic process,BP,
10893,GO:0042534,1,0.773160104233669,0,19,regulation of tumor necrosis factor biosynthetic process,BP,
10894,GO:0042535,1,0.854339138789002,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10895,GO:0042536,1,0.932608066345041,0,6,negative regulation of tumor necrosis factor biosynthetic process,BP,
10896,GO:0042537,1,0.77999069532726,0,19,benzene-containing compound metabolic process,BP,
10898,GO:0042539,1,0.967386491577893,0,2,hypotonic salinity response,BP,
10899,GO:0042541,1,0.885218666306006,0,9,hemoglobin biosynthetic process,BP,
10901,GO:0042543,1,0.995739387765767,0,1,protein N-linked glycosylation via arginine,BP,
10902,GO:0042546,1,0.987762819794679,0,1,cell wall biogenesis,BP,
10906,GO:0042555,1,0.83870613737855,0,11,MCM complex,CC,
10907,GO:0042558,1,0.650819426519769,0,31,pteridine-containing compound metabolic process,BP,
10908,GO:0042559,1,0.821505119567529,0,15,pteridine-containing compound biosynthetic process,BP,
10909,GO:0042560,1,0.960891778773311,0,3,pteridine-containing compound catabolic process,BP,
10911,GO:0042564,1,0.983426667503199,0,1,NLS-dependent protein nuclear import complex,CC,
10912,GO:0042565,1,0.975519886965025,0,2,RNA nuclear export complex,CC,
10913,GO:0042567,1,0.939221732924243,0,4,insulin-like growth factor ternary complex,CC,
10914,GO:0042568,1,0.99268919828576,0,1,insulin-like growth factor binary complex,CC,
10915,GO:0042571,1,0.978417505083556,0,2,immunoglobulin complex, circulating,CC,
10916,GO:0042572,1,0.680740101957911,0,28,retinol metabolic process,BP,
10917,GO:0042573,1,0.741822175115408,0,22,retinoic acid metabolic process,BP,
10918,GO:0042574,1,0.848536843642482,0,11,retinal metabolic process,BP,
10919,GO:0042575,1,0.78601275405785,0,17,DNA polymerase complex,CC,
10920,GO:0042577,1,0.969722496498644,0,2,lipid phosphatase activity,MF,
10926,GO:0042584,1,0.910670483262147,0,6,chromaffin granule membrane,CC,
10927,GO:0042585,1,0.969413708588529,0,2,germinal vesicle,CC,
10928,GO:0042586,1,0.991398151683651,0,1,peptide deformylase activity,MF,
10929,GO:0042587,1,0.915104238159334,0,6,glycogen granule,CC,
10931,GO:0042589,1,0.857977687837344,0,11,zymogen granule membrane,CC,
10936,GO:0042595,1,0.976590082256478,0,2,behavioral response to starvation,BP,
10937,GO:0042596,1,0.628923409984971,0,32,fear response,BP,
10938,GO:0042599,1,0.794653277649766,0,17,lamellar body,CC,
10939,GO:0042602,1,0.993458640329364,0,1,riboflavin reductase (NADPH) activity,MF,
10940,GO:0042605,1,0.754387917054464,0,23,peptide antigen binding,MF,
10941,GO:0042608,1,0.912427651286446,0,7,T cell receptor binding,MF,
10942,GO:0042609,1,0.9076656622994,0,7,CD4 receptor binding,MF,
10943,GO:0042610,1,0.972773726258346,0,2,CD8 receptor binding,MF,
10944,GO:0042611,1,0.785461643781889,0,24,MHC protein complex,CC,
10945,GO:0042612,1,0.920667258363393,0,8,MHC class I protein complex,CC,
10946,GO:0042613,1,0.853190598993415,0,16,MHC class II protein complex,CC,
10947,GO:0042622,1,0.799483330032863,0,16,photoreceptor outer segment membrane,CC,
10949,GO:0042624,1,0.994679552360307,0,1,ATPase activity, uncoupled,MF,
10950,GO:0042625,1,0.356675298200326,0,75,ATPase coupled ion transmembrane transporter activity,MF,
10951,GO:0042626,1,0.204061962614436,0,109,ATPase activity, coupled to transmembrane movement of substances,MF,
10952,GO:0042627,1,0.879534658682348,0,13,chylomicron,CC,
10953,GO:0042628,1,0.985659583797435,0,1,mating plug formation,BP,
10955,GO:0042631,1,0.951129332713884,0,3,cellular response to water deprivation,BP,
10956,GO:0042632,1,0.398429068400297,0,68,cholesterol homeostasis,BP,
10960,GO:0042636,1,0.929563068569453,0,5,negative regulation of hair cycle,BP,
10961,GO:0042637,1,0.947757709752073,0,4,catagen,BP,
10963,GO:0042641,1,0.389965586740862,0,61,actomyosin,CC,
10964,GO:0042643,1,0.967653684545697,0,2,actomyosin, actin portion,CC,
10965,GO:0042645,1,0.578352565001651,0,38,mitochondrial nucleoid,CC,
10966,GO:0042658,1,0.990380170129055,0,1,MHC class II protein binding, via antigen binding groove,MF,
10968,GO:0042660,1,0.967654734445452,0,2,positive regulation of cell fate specification,BP,
10969,GO:0042661,1,0.905949597585476,0,7,regulation of mesodermal cell fate specification,BP,
10970,GO:0042662,1,0.951998518407601,0,4,negative regulation of mesodermal cell fate specification,BP,
10971,GO:0042663,1,0.948813644215362,0,4,regulation of endodermal cell fate specification,BP,
10972,GO:0042664,1,0.991384933405719,0,1,negative regulation of endodermal cell fate specification,BP,
10975,GO:0042667,1,0.99202838856208,0,1,auditory receptor cell fate specification,BP,
10976,GO:0042668,1,0.972261161117918,0,3,auditory receptor cell fate determination,BP,
10977,GO:0042670,1,0.870639639370902,0,9,retinal cone cell differentiation,BP,
10978,GO:0042684,1,0.983963369018216,0,1,cardioblast cell fate commitment,BP,
10979,GO:0042685,1,0.983963369018216,0,1,cardioblast cell fate specification,BP,
10980,GO:0042686,1,0.983963369018216,0,1,regulation of cardioblast cell fate specification,BP,
10983,GO:0042694,1,0.993652142649469,0,1,muscle cell fate specification,BP,
10986,GO:0042699,1,0.930157872377781,0,5,follicle-stimulating hormone signaling pathway,BP,
10987,GO:0042700,1,0.967452415087244,0,2,luteinizing hormone signaling pathway,BP,
10988,GO:0042701,1,0.95310705399659,0,4,progesterone secretion,BP,
10989,GO:0042703,1,0.983992329944554,0,1,menstruation,BP,
10990,GO:0042704,1,0.967362068026352,0,2,uterine wall breakdown,BP,
10991,GO:0042709,1,0.985335015448221,0,1,succinate-CoA ligase complex,CC,
10992,GO:0042710,1,0.970235552712322,0,2,biofilm formation,BP,
10993,GO:0042711,1,0.834261872927616,0,13,maternal behavior,BP,
10994,GO:0042713,1,0.916325560734085,0,6,sperm ejaculation,BP,
10995,GO:0042719,1,0.951917608355811,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10996,GO:0042720,1,0.983083730965914,0,2,mitochondrial inner membrane peptidase complex,CC,
10997,GO:0042721,1,0.988302304385589,0,1,mitochondrial inner membrane protein insertion complex,CC,
10998,GO:0042723,1,0.901998778295614,0,7,thiamine-containing compound metabolic process,BP,
11000,GO:0042727,1,0.971401681280607,0,2,flavin-containing compound biosynthetic process,BP,
11001,GO:0042728,1,0.983427738433103,0,1,flavin-containing compound catabolic process,BP,
11003,GO:0042731,1,0.943518234489235,0,4,PH domain binding,MF,
11004,GO:0042732,1,0.96924602181287,0,3,D-xylose metabolic process,BP,
11007,GO:0042737,1,0.822222608724402,0,14,drug catabolic process,BP,
11008,GO:0042738,1,0.853485534651371,0,11,exogenous drug catabolic process,BP,
11010,GO:0042743,1,0.595618775779378,0,42,hydrogen peroxide metabolic process,BP,
11011,GO:0042744,1,0.770870016416436,0,22,hydrogen peroxide catabolic process,BP,
11013,GO:0042746,1,0.946867849401075,0,6,circadian sleep/wake cycle, wakefulness,BP,
11014,GO:0042747,1,0.918811493591055,0,9,circadian sleep/wake cycle, REM sleep,BP,
11018,GO:0042753,1,0.802504219071538,0,18,positive regulation of circadian rhythm,BP,
11020,GO:0042755,1,0.66996350701824,0,32,eating behavior,BP,
11021,GO:0042756,1,0.882985662626138,0,10,drinking behavior,BP,
11022,GO:0042758,1,0.898361671999978,0,7,long-chain fatty acid catabolic process,BP,
11023,GO:0042759,1,0.856240901334587,0,10,long-chain fatty acid biosynthetic process,BP,
11024,GO:0042760,1,0.924186567833147,0,5,very long-chain fatty acid catabolic process,BP,
11025,GO:0042761,1,0.880190411084948,0,9,very long-chain fatty acid biosynthetic process,BP,
11026,GO:0042762,1,0.73810624851918,0,19,regulation of sulfur metabolic process,BP,
11027,GO:0042765,1,0.929144232311288,0,5,GPI-anchor transamidase complex,CC,
11028,GO:0042766,1,0.983426667498772,0,1,nucleosome mobilization,BP,
11029,GO:0042769,1,0.628477059315984,0,36,DNA damage response, detection of DNA damage,BP,
11033,GO:0042773,1,0.479954530873213,0,83,ATP synthesis coupled electron transport,BP,
11034,GO:0042774,1,0.984728932554734,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
11035,GO:0042775,1,0.487420085009886,0,82,mitochondrial ATP synthesis coupled electron transport,BP,
11036,GO:0042776,1,0.857234566425248,0,19,mitochondrial ATP synthesis coupled proton transport,BP,
11037,GO:0042779,1,0.969434532768209,0,2,tRNA 3'-trailer cleavage,BP,
11038,GO:0042780,1,0.929107358315393,0,5,tRNA 3'-end processing,BP,
11039,GO:0042781,1,0.969434532768209,0,2,3'-tRNA processing endoribonuclease activity,MF,
11041,GO:0042788,1,0.903551384656983,0,7,polysomal ribosome,CC,
11042,GO:0042789,1,0.772299272434609,0,18,mRNA transcription from RNA polymerase II promoter,BP,
11043,GO:0042790,1,0.827398949047534,0,13,transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
11044,GO:0042791,1,0.91522085512092,0,6,5S class rRNA transcription from RNA polymerase III type 1 promoter,BP,
11045,GO:0042795,1,0.406448986885004,0,65,snRNA transcription from RNA polymerase II promoter,BP,
11046,GO:0042796,1,0.941295318412248,0,4,snRNA transcription from RNA polymerase III promoter,BP,
11047,GO:0042797,1,0.91522085512092,0,6,tRNA transcription from RNA polymerase III promoter,BP,
11048,GO:0042799,1,0.983426667494097,0,1,histone methyltransferase activity (H4-K20 specific),MF,
11049,GO:0042800,1,0.831506432515991,0,13,histone methyltransferase activity (H3-K4 specific),MF,
11050,GO:0042801,1,0.983426667501429,0,1,polo kinase kinase activity,MF,
11053,GO:0042805,1,0.529888130747115,0,40,actinin binding,MF,
11054,GO:0042806,1,0.946220907897267,0,4,fucose binding,MF,
11055,GO:0042809,1,0.796943171815604,0,15,vitamin D receptor binding,MF,
11057,GO:0042816,1,0.925540525962009,0,5,vitamin B6 metabolic process,BP,
11058,GO:0042819,1,0.95383957826866,0,3,vitamin B6 biosynthetic process,BP,
11059,GO:0042820,1,0.986690812150216,0,1,vitamin B6 catabolic process,BP,
11060,GO:0042822,1,0.954319522619312,0,3,pyridoxal phosphate metabolic process,BP,
11061,GO:0042823,1,0.967193855487839,0,2,pyridoxal phosphate biosynthetic process,BP,
11062,GO:0042824,1,0.939335588539255,0,4,MHC class I peptide loading complex,CC,
11063,GO:0042825,1,0.951631491819674,0,3,TAP complex,CC,
11064,GO:0042826,1,0.212041248189184,0,102,histone deacetylase binding,MF,
11065,GO:0042827,1,0.774463133823544,0,20,platelet dense granule,CC,
11067,GO:0042834,1,0.88078578154462,0,10,peptidoglycan binding,MF,
11068,GO:0042835,1,0.967126892155216,0,2,BRE binding,MF,
11069,GO:0042839,1,0.989399199546474,0,1,D-glucuronate metabolic process,BP,
11070,GO:0042840,1,0.989399199546474,0,1,D-glucuronate catabolic process,BP,
11071,GO:0042843,1,0.991879343305166,0,1,D-xylose catabolic process,BP,
11072,GO:0042851,1,0.946097055243288,0,4,L-alanine metabolic process,BP,
11073,GO:0042853,1,0.946097055243288,0,4,L-alanine catabolic process,BP,
11074,GO:0042866,1,0.932685267981025,0,5,pyruvate biosynthetic process,BP,
11075,GO:0042883,1,0.983435876792907,0,1,cysteine transport,BP,
11077,GO:0042887,1,0.648930236394753,0,33,amide transmembrane transporter activity,MF,
11078,GO:0042891,1,0.987323757376136,0,1,antibiotic transport,BP,
11079,GO:0042895,1,0.987323757376136,0,1,antibiotic transporter activity,MF,
11080,GO:0042903,1,0.970577666715272,0,2,tubulin deacetylase activity,MF,
11081,GO:0042904,1,0.941974379987537,0,4,9-cis-retinoic acid biosynthetic process,BP,
11082,GO:0042905,1,0.941974379987537,0,4,9-cis-retinoic acid metabolic process,BP,
11083,GO:0042908,1,0.84622480427038,0,10,xenobiotic transport,BP,
11084,GO:0042910,1,0.860494870622953,0,9,xenobiotic transporter activity,MF,
11085,GO:0042918,1,0.983426667500841,0,1,alkanesulfonate transport,BP,
11086,GO:0042921,1,0.79086071791031,0,15,glucocorticoid receptor signaling pathway,BP,
11087,GO:0042922,1,0.993760115777693,0,1,neuromedin U receptor binding,MF,
11088,GO:0042923,1,0.763408434129554,0,21,neuropeptide binding,MF,
11089,GO:0042924,1,0.986430142920359,0,1,neuromedin U binding,MF,
11090,GO:0042927,1,0.984728932554734,0,1,siderophore transporter activity,MF,
11091,GO:0042930,1,0.984728932554734,0,1,enterobactin transport,BP,
11092,GO:0042931,1,0.984728932554734,0,1,enterobactin transporter activity,MF,
11093,GO:0042936,1,0.983704384158376,0,1,dipeptide transporter activity,MF,
11094,GO:0042937,1,0.983426667500937,0,1,tripeptide transporter activity,MF,
11095,GO:0042938,1,0.957126580264298,0,3,dipeptide transport,BP,
11096,GO:0042939,1,0.970328577617085,0,2,tripeptide transport,BP,
11097,GO:0042940,1,0.908957367757216,0,6,D-amino acid transport,BP,
11098,GO:0042941,1,0.986912755940205,0,1,D-alanine transport,BP,
11099,GO:0042942,1,0.971783923011872,0,2,D-serine transport,BP,
11100,GO:0042946,1,0.984728932554734,0,1,glucoside transport,BP,
11101,GO:0042947,1,0.984728932554734,0,1,glucoside transmembrane transporter activity,MF,
11103,GO:0042954,1,0.951096177092383,0,3,lipoprotein transporter activity,MF,
11104,GO:0042959,1,0.983426667500841,0,1,alkanesulfonate transporter activity,MF,
11106,GO:0042975,1,0.859907961019112,0,10,peroxisome proliferator activated receptor binding,MF,
11107,GO:0042976,1,0.84048880742318,0,13,activation of Janus kinase activity,BP,
11108,GO:0042977,1,0.868812292342798,0,11,activation of JAK2 kinase activity,BP,
11109,GO:0042978,1,0.967126892147231,0,2,ornithine decarboxylase activator activity,MF,
11110,GO:0042979,1,0.940200100571226,0,5,ornithine decarboxylase regulator activity,MF,
11112,GO:0042982,1,0.634862470519797,0,31,amyloid precursor protein metabolic process,BP,
11113,GO:0042983,1,0.902278639704955,0,7,amyloid precursor protein biosynthetic process,BP,
11114,GO:0042984,1,0.902278639704955,0,7,regulation of amyloid precursor protein biosynthetic process,BP,
11115,GO:0042985,1,0.942076802149823,0,4,negative regulation of amyloid precursor protein biosynthetic process,BP,
11116,GO:0042986,1,0.970653427294559,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
11117,GO:0042987,1,0.73431770373625,0,21,amyloid precursor protein catabolic process,BP,
11118,GO:0042988,1,0.983426667502414,0,1,X11-like protein binding,MF,
11124,GO:0042994,1,0.7376604638031,0,22,cytoplasmic sequestering of transcription factor,BP,
11126,GO:0042996,1,0.908463817444591,0,6,regulation of Golgi to plasma membrane protein transport,BP,
11127,GO:0042997,1,0.939350474600848,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
11128,GO:0042998,1,0.967127510905837,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
11129,GO:0042999,1,0.983426667503005,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
11130,GO:0043000,1,0.973169410965439,0,2,Golgi to plasma membrane CFTR protein transport,BP,
11131,GO:0043001,1,0.64031070069883,0,30,Golgi to plasma membrane protein transport,BP,
11132,GO:0043002,1,0.983426667503005,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
11133,GO:0043004,1,0.983426667503005,0,1,cytoplasmic sequestering of CFTR protein,BP,
11135,GO:0043006,1,0.971360230819072,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
11136,GO:0043008,1,0.883017270557152,0,8,ATP-dependent protein binding,MF,
11139,GO:0043011,1,0.78754556788606,0,19,myeloid dendritic cell differentiation,BP,
11140,GO:0043012,1,0.98464063036516,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11141,GO:0043014,1,0.717185302240483,0,22,alpha-tubulin binding,MF,
11143,GO:0043016,1,0.984355126393904,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11144,GO:0043017,1,0.984355126393904,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11145,GO:0043020,1,0.883728929416772,0,10,NADPH oxidase complex,CC,
11146,GO:0043021,1,0.250324940742784,0,99,ribonucleoprotein complex binding,MF,
11147,GO:0043022,1,0.521303277462636,0,45,ribosome binding,MF,
11148,GO:0043023,1,0.919640582761965,0,7,ribosomal large subunit binding,MF,
11149,GO:0043024,1,0.831294260623036,0,13,ribosomal small subunit binding,MF,
11155,GO:0043031,1,0.919358197197522,0,7,negative regulation of macrophage activation,BP,
11157,GO:0043033,1,0.983426667500003,0,1,isoamylase complex,CC,
11159,GO:0043035,1,0.983430860156209,0,1,chromatin insulator sequence binding,MF,
11160,GO:0043038,1,0.481153070315756,0,51,amino acid activation,BP,
11161,GO:0043039,1,0.489268008886711,0,50,tRNA aminoacylation,BP,
11162,GO:0043041,1,0.983462770978377,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11164,GO:0043044,1,0.446521186380419,0,69,ATP-dependent chromatin remodeling,BP,
11165,GO:0043045,1,0.904064041792685,0,7,DNA methylation involved in embryo development,BP,
11166,GO:0043046,1,0.737613583412029,0,20,DNA methylation involved in gamete generation,BP,
11167,GO:0043047,1,0.869537428292202,0,9,single-stranded telomeric DNA binding,MF,
11168,GO:0043048,1,0.985889296504208,0,1,dolichyl monophosphate biosynthetic process,BP,
11169,GO:0043049,1,0.983782100485865,0,1,otic placode formation,BP,
11170,GO:0043060,1,0.984983208785348,0,1,meiotic metaphase I plate congression,BP,
11172,GO:0043063,1,0.983426667502758,0,1,intercellular bridge organization,BP,
11178,GO:0043073,1,0.79962721748778,0,17,germ cell nucleus,CC,
11180,GO:0043084,1,0.887099900014573,0,9,penile erection,BP,
11184,GO:0043090,1,0.762931320604148,0,17,amino acid import,BP,
11185,GO:0043091,1,0.942349439578067,0,4,L-arginine import,BP,
11186,GO:0043092,1,0.787107983805526,0,15,L-amino acid import,BP,
11187,GO:0043094,1,0.647165205893731,0,33,cellular metabolic compound salvage,BP,
11188,GO:0043095,1,0.994510135999198,0,1,regulation of GTP cyclohydrolase I activity,BP,
11189,GO:0043096,1,0.984111357942807,0,2,purine nucleobase salvage,BP,
11190,GO:0043097,1,0.868292221489976,0,11,pyrimidine nucleoside salvage,BP,
11191,GO:0043101,1,0.821855851035681,0,15,purine-containing compound salvage,BP,
11192,GO:0043102,1,0.908210594954347,0,7,amino acid salvage,BP,
11193,GO:0043103,1,0.989741121028373,0,1,hypoxanthine salvage,BP,
11194,GO:0043105,1,0.994510135999198,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11195,GO:0043111,1,0.990569230810668,0,1,replication fork arrest,BP,
11199,GO:0043116,1,0.862811883554099,0,10,negative regulation of vascular permeability,BP,
11200,GO:0043117,1,0.882222198220287,0,9,positive regulation of vascular permeability,BP,
11201,GO:0043120,1,0.954652385720147,0,3,tumor necrosis factor binding,MF,
11202,GO:0043121,1,0.848084793106544,0,10,neurotrophin binding,MF,
11207,GO:0043126,1,0.989250273261631,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11208,GO:0043128,1,0.989250273261631,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11209,GO:0043129,1,0.907436358760586,0,7,surfactant homeostasis,BP,
11211,GO:0043132,1,0.969584392737824,0,2,NAD transport,BP,
11212,GO:0043133,1,0.98861544997923,0,2,hindgut contraction,BP,
11213,GO:0043134,1,0.98861544997923,0,2,regulation of hindgut contraction,BP,
11214,GO:0043136,1,0.983714147414541,0,1,glycerol-3-phosphatase activity,MF,
11215,GO:0043137,1,0.958225091478809,0,3,DNA replication, removal of RNA primer,BP,
11216,GO:0043138,1,0.828644523856177,0,12,3'-5' DNA helicase activity,MF,
11217,GO:0043139,1,0.902243266319103,0,7,5'-3' DNA helicase activity,MF,
11218,GO:0043140,1,0.904600810363378,0,6,ATP-dependent 3'-5' DNA helicase activity,MF,
11219,GO:0043141,1,0.930459070205055,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11220,GO:0043142,1,0.837796528519847,0,12,single-stranded DNA-dependent ATPase activity,MF,
11221,GO:0043143,1,0.985328443939497,0,1,regulation of translation by machinery localization,BP,
11222,GO:0043144,1,0.911396395320141,0,9,snoRNA processing,BP,
11224,GO:0043152,1,0.943088653523948,0,4,induction of bacterial agglutination,BP,
11225,GO:0043153,1,0.754421574134246,0,19,entrainment of circadian clock by photoperiod,BP,
11227,GO:0043159,1,0.960657414060943,0,3,acrosomal matrix,CC,
11228,GO:0043160,1,0.984728932554734,0,1,acrosomal lumen,CC,
11230,GO:0043162,1,0.778260749789464,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11231,GO:0043163,1,0.952822886838185,0,3,cell envelope organization,BP,
11236,GO:0043171,1,0.65241232342165,0,29,peptide catabolic process,BP,
11237,GO:0043173,1,0.844444508102627,0,13,nucleotide salvage,BP,
11238,GO:0043174,1,0.818160428469173,0,16,nucleoside salvage,BP,
11239,GO:0043175,1,0.642429340839189,0,30,RNA polymerase core enzyme binding,MF,
11240,GO:0043176,1,0.85431963587902,0,11,amine binding,MF,
11242,GO:0043178,1,0.382507718605514,0,73,alcohol binding,MF,
11244,GO:0043181,1,0.983454569993941,0,1,vacuolar sequestering,BP,
11245,GO:0043183,1,0.975251239012633,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11247,GO:0043185,1,0.986355355260577,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11248,GO:0043186,1,0.783458254818713,0,16,P granule,CC,
11249,GO:0043189,1,0.779470240107787,0,18,H4/H2A histone acetyltransferase complex,CC,
11250,GO:0043190,1,0.877705803895632,0,8,ATP-binding cassette (ABC) transporter complex,CC,
11253,GO:0043196,1,0.91066939432903,0,8,varicosity,CC,
11256,GO:0043199,1,0.943136466664963,0,4,sulfate binding,MF,
11263,GO:0043208,1,0.892113315199297,0,8,glycosphingolipid binding,MF,
11265,GO:0043210,1,0.987573539727232,0,1,alkanesulfonate binding,MF,
11266,GO:0043215,1,0.983426669406348,0,1,daunorubicin transport,BP,
11269,GO:0043219,1,0.944846292817514,0,4,lateral loop,CC,
11271,GO:0043221,1,0.983427861508851,0,1,SMC family protein binding,MF,
11284,GO:0043237,1,0.921225000774996,0,6,laminin-1 binding,MF,
11285,GO:0043240,1,0.881644584000635,0,8,Fanconi anaemia nuclear complex,CC,
11290,GO:0043247,1,0.826524927323712,0,12,telomere maintenance in response to DNA damage,BP,
11291,GO:0043248,1,0.86415924963429,0,13,proteasome assembly,BP,
11292,GO:0043249,1,0.86121199965618,0,11,erythrocyte maturation,BP,
11293,GO:0043250,1,0.989232863986053,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11294,GO:0043251,1,0.989232863986053,0,1,sodium-dependent organic anion transport,BP,
11295,GO:0043252,1,0.691489513011328,0,25,sodium-independent organic anion transport,BP,
11299,GO:0043257,1,0.983426667501628,0,1,laminin-8 complex,CC,
11302,GO:0043262,1,0.956876162615544,0,3,adenosine-diphosphatase activity,MF,
11303,GO:0043265,1,0.983706318834391,0,1,ectoplasm,CC,
11310,GO:0043273,1,0.983426667502171,0,1,CTPase activity,MF,
11311,GO:0043274,1,0.800562751505298,0,15,phospholipase binding,MF,
11314,GO:0043278,1,0.653383905884394,0,31,response to morphine,BP,
11318,GO:0043291,1,0.967126892140888,0,2,RAVE complex,CC,
11320,GO:0043293,1,0.971441145472771,0,2,apoptosome,CC,
11325,GO:0043300,1,0.579188583417271,0,39,regulation of leukocyte degranulation,BP,
11326,GO:0043301,1,0.85232451059953,0,11,negative regulation of leukocyte degranulation,BP,
11327,GO:0043302,1,0.791311634391093,0,18,positive regulation of leukocyte degranulation,BP,
11329,GO:0043304,1,0.676078144358067,0,29,regulation of mast cell degranulation,BP,
11330,GO:0043305,1,0.909860394174822,0,7,negative regulation of mast cell degranulation,BP,
11331,GO:0043306,1,0.852997797299987,0,13,positive regulation of mast cell degranulation,BP,
11332,GO:0043307,1,0.913956278010176,0,7,eosinophil activation,BP,
11333,GO:0043308,1,0.925807642957419,0,6,eosinophil degranulation,BP,
11334,GO:0043309,1,0.959387292134297,0,3,regulation of eosinophil degranulation,BP,
11335,GO:0043310,1,0.984893663486023,0,1,negative regulation of eosinophil degranulation,BP,
11336,GO:0043311,1,0.97410402482189,0,2,positive regulation of eosinophil degranulation,BP,
11338,GO:0043313,1,0.922242650798659,0,5,regulation of neutrophil degranulation,BP,
11339,GO:0043314,1,0.967126892151728,0,2,negative regulation of neutrophil degranulation,BP,
11340,GO:0043315,1,0.983426667503304,0,1,positive regulation of neutrophil degranulation,BP,
11342,GO:0043317,1,0.983492142903563,0,1,regulation of cytotoxic T cell degranulation,BP,
11343,GO:0043318,1,0.983492142903563,0,1,negative regulation of cytotoxic T cell degranulation,BP,
11345,GO:0043321,1,0.968449773004404,0,2,regulation of natural killer cell degranulation,BP,
11346,GO:0043323,1,0.968449773004404,0,2,positive regulation of natural killer cell degranulation,BP,
11347,GO:0043324,1,0.942944296169099,0,4,pigment metabolic process involved in developmental pigmentation,BP,
11349,GO:0043328,1,0.959201347741439,0,4,protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11352,GO:0043335,1,0.973461052170934,0,2,protein unfolding,BP,
11353,GO:0043337,1,0.983430378849187,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11354,GO:0043353,1,0.905406906900301,0,7,enucleate erythrocyte differentiation,BP,
11355,GO:0043366,1,0.970595503154683,0,2,beta selection,BP,
11359,GO:0043370,1,0.595782302269201,0,38,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11360,GO:0043371,1,0.813839808897253,0,15,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11361,GO:0043372,1,0.710542027822935,0,25,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11363,GO:0043374,1,0.850695215346849,0,11,CD8-positive, alpha-beta T cell differentiation,BP,
11364,GO:0043375,1,0.983428431308179,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11365,GO:0043376,1,0.967152822370116,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11366,GO:0043378,1,0.983426965534487,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11367,GO:0043379,1,0.874688826656064,0,9,memory T cell differentiation,BP,
11368,GO:0043380,1,0.889436856808405,0,8,regulation of memory T cell differentiation,BP,
11369,GO:0043381,1,0.984728932554734,0,1,negative regulation of memory T cell differentiation,BP,
11370,GO:0043382,1,0.918420841223027,0,6,positive regulation of memory T cell differentiation,BP,
11371,GO:0043383,1,0.828202648514209,0,13,negative T cell selection,BP,
11372,GO:0043385,1,0.985496439087101,0,1,mycotoxin metabolic process,BP,
11373,GO:0043388,1,0.502801049187193,0,49,positive regulation of DNA binding,BP,
11374,GO:0043390,1,0.985496439087101,0,1,aflatoxin B1 metabolic process,BP,
11377,GO:0043394,1,0.604164032893827,0,34,proteoglycan binding,MF,
11378,GO:0043395,1,0.76825529273772,0,18,heparan sulfate proteoglycan binding,MF,
11379,GO:0043396,1,0.953397548019384,0,3,corticotropin-releasing hormone secretion,BP,
11380,GO:0043397,1,0.953397548019384,0,3,regulation of corticotropin-releasing hormone secretion,BP,
11381,GO:0043398,1,0.958516437172289,0,3,HLH domain binding,MF,
11382,GO:0043400,1,0.947840009045166,0,5,cortisol secretion,BP,
11384,GO:0043402,1,0.952355803162957,0,3,glucocorticoid mediated signaling pathway,BP,
11395,GO:0043415,1,0.930054476568245,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11396,GO:0043416,1,0.919645003776536,0,6,regulation of skeletal muscle tissue regeneration,BP,
11397,GO:0043418,1,0.954041237345443,0,3,homocysteine catabolic process,BP,
11398,GO:0043420,1,0.989328906139524,0,1,anthranilate metabolic process,BP,
11399,GO:0043422,1,0.838368813834009,0,12,protein kinase B binding,MF,
11400,GO:0043423,1,0.983426667503199,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11401,GO:0043425,1,0.672882471253322,0,26,bHLH transcription factor binding,MF,
11402,GO:0043426,1,0.923823883129437,0,5,MRF binding,MF,
11405,GO:0043435,1,0.92663651905356,0,5,response to corticotropin-releasing hormone,BP,
11407,GO:0043438,1,0.984046722594671,0,1,acetoacetic acid metabolic process,BP,
11408,GO:0043449,1,0.968283648023348,0,2,cellular alkene metabolic process,BP,
11410,GO:0043456,1,0.957446622180706,0,4,regulation of pentose-phosphate shunt,BP,
11412,GO:0043461,1,0.947741357182051,0,4,proton-transporting ATP synthase complex assembly,BP,
11417,GO:0043471,1,0.870461832113121,0,11,regulation of cellular carbohydrate catabolic process,BP,
11419,GO:0043474,1,0.942944296169099,0,4,pigment metabolic process involved in pigmentation,BP,
11424,GO:0043486,1,0.619844110139948,0,48,histone exchange,BP,
11428,GO:0043490,1,0.967347764659694,0,2,malate-aspartate shuttle,BP,
11430,GO:0043492,1,0.159694935241602,0,124,ATPase activity, coupled to movement of substances,MF,
11431,GO:0043495,1,0.910228162844566,0,7,protein anchor,MF,
11432,GO:0043496,1,0.762846411311765,0,20,regulation of protein homodimerization activity,BP,
11433,GO:0043497,1,0.892633103179979,0,8,regulation of protein heterodimerization activity,BP,
11437,GO:0043503,1,0.977046783389381,0,2,skeletal muscle fiber adaptation,BP,
11438,GO:0043504,1,0.952355803210567,0,3,mitochondrial DNA repair,BP,
11441,GO:0043508,1,0.81519448130142,0,14,negative regulation of JUN kinase activity,BP,
11442,GO:0043509,1,0.985996069873542,0,1,activin A complex,CC,
11443,GO:0043511,1,0.975862472078324,0,2,inhibin complex,CC,
11444,GO:0043512,1,0.975862472078324,0,2,inhibin A complex,CC,
11445,GO:0043513,1,0.989723076066294,0,1,inhibin B complex,CC,
11446,GO:0043514,1,0.975121543988591,0,2,interleukin-12 complex,CC,
11447,GO:0043515,1,0.942727790460179,0,4,kinetochore binding,MF,
11450,GO:0043518,1,0.825216182191432,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11451,GO:0043519,1,0.986245001384253,0,1,regulation of myosin II filament organization,BP,
11452,GO:0043522,1,0.862576288763146,0,11,leucine zipper domain binding,MF,
11455,GO:0043525,1,0.509191866595513,0,48,positive regulation of neuron apoptotic process,BP,
11456,GO:0043527,1,0.936667892322653,0,5,tRNA methyltransferase complex,CC,
11459,GO:0043533,1,0.922496928880524,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11464,GO:0043538,1,0.983807722493411,0,1,regulation of actin phosphorylation,BP,
11465,GO:0043539,1,0.702754008039146,0,25,protein serine/threonine kinase activator activity,MF,
11466,GO:0043540,1,0.987925476042536,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11467,GO:0043541,1,0.951913848798075,0,3,UDP-N-acetylglucosamine transferase complex,CC,
11470,GO:0043544,1,0.98345849459887,0,1,lipoamide binding,MF,
11471,GO:0043545,1,0.903747232235112,0,7,molybdopterin cofactor metabolic process,BP,
11472,GO:0043546,1,0.90880064199538,0,6,molybdopterin cofactor binding,MF,
11479,GO:0043553,1,0.968763724195508,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11481,GO:0043558,1,0.779805949989722,0,17,regulation of translational initiation in response to stress,BP,
11484,GO:0043562,1,0.939276068323028,0,4,cellular response to nitrogen levels,BP,
11485,GO:0043564,1,0.963799178614873,0,3,Ku70:Ku80 complex,CC,
11488,GO:0043568,1,0.843010031155012,0,13,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11490,GO:0043570,1,0.935582536370749,0,4,maintenance of DNA repeat elements,BP,
11491,GO:0043574,1,0.75890977569833,0,18,peroxisomal transport,BP,
11493,GO:0043578,1,0.951105344772529,0,3,nuclear matrix organization,BP,
11497,GO:0043586,1,0.755925059901706,0,20,tongue development,BP,
11498,GO:0043587,1,0.874436469487934,0,9,tongue morphogenesis,BP,
11500,GO:0043589,1,0.863294256602038,0,9,skin morphogenesis,BP,
11501,GO:0043596,1,0.543715876004085,0,43,nuclear replication fork,CC,
11502,GO:0043601,1,0.668876809696984,0,29,nuclear replisome,CC,
11503,GO:0043602,1,0.984868231357013,0,1,nitrate catabolic process,BP,
11506,GO:0043605,1,0.964062686229541,0,3,cellular amide catabolic process,BP,
11507,GO:0043606,1,0.941811895017325,0,4,formamide metabolic process,BP,
11508,GO:0043610,1,0.983426667498183,0,1,regulation of carbohydrate utilization,BP,
11509,GO:0043614,1,0.967126892154536,0,2,multi-eIF complex,CC,
11510,GO:0043615,1,0.903779233416874,0,8,astrocyte cell migration,BP,
11516,GO:0043622,1,0.935848684871198,0,4,cortical microtubule organization,BP,
11519,GO:0043625,1,0.948945363541059,0,4,delta DNA polymerase complex,CC,
11520,GO:0043626,1,0.990227308534714,0,1,PCNA complex,CC,
11522,GO:0043628,1,0.777867683837597,0,20,ncRNA 3'-end processing,BP,
11523,GO:0043631,1,0.548184344925497,0,40,RNA polyadenylation,BP,
11525,GO:0043633,1,0.935263801216806,0,5,polyadenylation-dependent RNA catabolic process,BP,
11526,GO:0043634,1,0.951028772472847,0,4,polyadenylation-dependent ncRNA catabolic process,BP,
11527,GO:0043647,1,0.361554322462753,0,67,inositol phosphate metabolic process,BP,
11528,GO:0043648,1,0.254139511375937,0,96,dicarboxylic acid metabolic process,BP,
11529,GO:0043649,1,0.815973243681509,0,15,dicarboxylic acid catabolic process,BP,
11530,GO:0043650,1,0.813576695805967,0,14,dicarboxylic acid biosynthetic process,BP,
11531,GO:0043651,1,0.78817526827502,0,17,linoleic acid metabolic process,BP,
11532,GO:0043652,1,0.896959879949836,0,7,engulfment of apoptotic cell,BP,
11533,GO:0043653,1,0.908791110668896,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
11534,GO:0043654,1,0.913395335572815,0,7,recognition of apoptotic cell,BP,
11535,GO:0043656,1,0.895652087409667,0,7,intracellular region of host,CC,
11536,GO:0043657,1,0.809666695338216,0,14,host cell,CC,
11537,GO:0043666,1,0.574953136946538,0,37,regulation of phosphoprotein phosphatase activity,BP,
11539,GO:0043682,1,0.967126892148585,0,2,copper-transporting ATPase activity,MF,
11540,GO:0043686,1,0.960975868795068,0,3,co-translational protein modification,BP,
11542,GO:0043691,1,0.826854162221069,0,17,reverse cholesterol transport,BP,
11545,GO:0043733,1,0.991859090558725,0,1,DNA-3-methylbase glycosylase activity,MF,
11546,GO:0043734,1,0.950666739408772,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11547,GO:0043739,1,0.983614876806543,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11548,GO:0043754,1,0.983426667495967,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11549,GO:0043783,1,0.985341599334663,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11550,GO:0043795,1,0.989825625357721,0,1,glyceraldehyde oxidoreductase activity,MF,
11551,GO:0043812,1,0.95139350887053,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11552,GO:0043813,1,0.920102614916163,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11553,GO:0043843,1,0.984731585042037,0,1,ADP-specific glucokinase activity,MF,
11554,GO:0043849,1,0.983982307906505,0,1,Ras palmitoyltransferase activity,MF,
11555,GO:0043855,1,0.864826953325801,0,9,cyclic nucleotide-gated ion channel activity,MF,
11556,GO:0043865,1,0.984222783158252,0,1,methionine transmembrane transporter activity,MF,
11557,GO:0043874,1,0.986638653780727,0,1,acireductone synthase activity,MF,
11558,GO:0043890,1,0.985286031014875,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11559,GO:0043891,1,0.979738735634717,0,2,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11564,GO:0043914,1,0.983426891722675,0,1,NADPH:sulfur oxidoreductase activity,MF,
11565,GO:0043916,1,0.991859090558725,0,1,DNA-7-methylguanine glycosylase activity,MF,
11566,GO:0043921,1,0.699337682451764,0,25,modulation by host of viral transcription,BP,
11567,GO:0043922,1,0.849422696553806,0,12,negative regulation by host of viral transcription,BP,
11568,GO:0043923,1,0.794651946772785,0,15,positive regulation by host of viral transcription,BP,
11569,GO:0043924,1,0.983426667490358,0,1,suramin binding,MF,
11570,GO:0043928,1,0.668299165443388,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11572,GO:0043932,1,0.946869633902699,0,4,ossification involved in bone remodeling,BP,
11574,GO:0043946,1,0.987902422683201,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11575,GO:0043947,1,0.987902422683201,0,1,positive regulation by host of symbiont catalytic activity,BP,
11576,GO:0043949,1,0.748750553091255,0,21,regulation of cAMP-mediated signaling,BP,
11577,GO:0043950,1,0.898590565009689,0,9,positive regulation of cAMP-mediated signaling,BP,
11578,GO:0043951,1,0.917512470000258,0,6,negative regulation of cAMP-mediated signaling,BP,
11581,GO:0043967,1,0.424668409267995,0,58,histone H4 acetylation,BP,
11582,GO:0043968,1,0.813174045312308,0,15,histone H2A acetylation,BP,
11583,GO:0043969,1,0.983426667498184,0,1,histone H2B acetylation,BP,
11584,GO:0043970,1,0.845708564163416,0,11,histone H3-K9 acetylation,BP,
11585,GO:0043973,1,0.985868603426793,0,1,histone H3-K4 acetylation,BP,
11587,GO:0043981,1,0.834663571381223,0,12,histone H4-K5 acetylation,BP,
11588,GO:0043982,1,0.834663571381223,0,12,histone H4-K8 acetylation,BP,
11589,GO:0043983,1,0.94528033302001,0,4,histone H4-K12 acetylation,BP,
11590,GO:0043984,1,0.767250199241422,0,17,histone H4-K16 acetylation,BP,
11591,GO:0043985,1,0.915727874426843,0,6,histone H4-R3 methylation,BP,
11592,GO:0043987,1,0.943110368477411,0,4,histone H3-S10 phosphorylation,BP,
11593,GO:0043988,1,0.958869490392025,0,3,histone H3-S28 phosphorylation,BP,
11594,GO:0043990,1,0.983753333271827,0,1,histone H2A-S1 phosphorylation,BP,
11595,GO:0043995,1,0.868624772722792,0,9,histone acetyltransferase activity (H4-K5 specific),MF,
11596,GO:0043996,1,0.868624772722792,0,9,histone acetyltransferase activity (H4-K8 specific),MF,
11597,GO:0043997,1,0.983722120793552,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11598,GO:0043998,1,0.983556084200224,0,1,H2A histone acetyltransferase activity,MF,
11599,GO:0044003,1,0.526726897311123,0,43,modification by symbiont of host morphology or physiology,BP,
11600,GO:0044004,1,0.946393469229176,0,4,disruption by symbiont of host cell,BP,
11601,GO:0044007,1,0.983426667500986,0,1,dissemination or transmission of symbiont from host,BP,
11602,GO:0044010,1,0.970235552712322,0,2,single-species biofilm formation,BP,
11603,GO:0044020,1,0.945608680185757,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11604,GO:0044026,1,0.957269518342412,0,3,DNA hypermethylation,BP,
11605,GO:0044027,1,0.973399403043213,0,2,hypermethylation of CpG island,BP,
11609,GO:0044033,1,0.0934625163953723,0,209,multi-organism metabolic process,BP,
11610,GO:0044034,1,0.953921405537299,0,3,multi-organism biosynthetic process,BP,
11611,GO:0044035,1,0.98847729800523,0,1,multi-organism catabolic process,BP,
11612,GO:0044036,1,0.957341375391269,0,5,cell wall macromolecule metabolic process,BP,
11613,GO:0044038,1,0.987762819794679,0,1,cell wall macromolecule biosynthetic process,BP,
11615,GO:0044053,1,0.985144817662511,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11621,GO:0044068,1,0.684657937003655,0,25,modulation by symbiont of host cellular process,BP,
11631,GO:0044094,1,0.967126892154876,0,2,host cell nuclear part,CC,
11632,GO:0044106,1,0.232441796428154,0,118,cellular amine metabolic process,BP,
11633,GO:0044107,1,0.934819125813406,0,5,cellular alcohol metabolic process,BP,
11634,GO:0044108,1,0.934819125813406,0,5,cellular alcohol biosynthetic process,BP,
11635,GO:0044110,1,0.79752602202917,0,19,growth involved in symbiotic interaction,BP,
11636,GO:0044111,1,0.972094153708835,0,2,development involved in symbiotic interaction,BP,
11637,GO:0044115,1,0.98847729800523,0,1,development of symbiont involved in interaction with host,BP,
11638,GO:0044116,1,0.79752602202917,0,19,growth of symbiont involved in interaction with host,BP,
11639,GO:0044117,1,0.801944454686707,0,18,growth of symbiont in host,BP,
11640,GO:0044126,1,0.825425971076267,0,15,regulation of growth of symbiont in host,BP,
11641,GO:0044128,1,0.983426667502561,0,1,positive regulation of growth of symbiont in host,BP,
11642,GO:0044130,1,0.839346767487765,0,14,negative regulation of growth of symbiont in host,BP,
11643,GO:0044133,1,0.994495436116341,0,1,growth of symbiont on or near host,BP,
11644,GO:0044139,1,0.994495436116341,0,1,modulation of growth of symbiont on or near host,BP,
11645,GO:0044140,1,0.994495436116341,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11646,GO:0044144,1,0.820878713738609,0,16,modulation of growth of symbiont involved in interaction with host,BP,
11647,GO:0044145,1,0.98847729800523,0,1,modulation of development of symbiont involved in interaction with host,BP,
11648,GO:0044146,1,0.834723143596822,0,15,negative regulation of growth of symbiont involved in interaction with host,BP,
11649,GO:0044147,1,0.98847729800523,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11650,GO:0044148,1,0.983426667502561,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11651,GO:0044154,1,0.897031851481637,0,7,histone H3-K14 acetylation,BP,
11652,GO:0044179,1,0.970300969153238,0,2,hemolysis in other organism,BP,
11653,GO:0044183,1,0.697783193789584,0,27,protein binding involved in protein folding,MF,
11654,GO:0044190,1,0.987869227208269,0,1,host cell mitochondrial envelope,CC,
11655,GO:0044194,1,0.942711952770377,0,4,cytolytic granule,CC,
11656,GO:0044205,1,0.95500552300529,0,3,'de novo' UMP biosynthetic process,BP,
11657,GO:0044206,1,0.93867919671549,0,5,UMP salvage,BP,
11658,GO:0044207,1,0.983426667503302,0,1,translation initiation ternary complex,CC,
11659,GO:0044208,1,0.961794624618199,0,3,'de novo' AMP biosynthetic process,BP,
11660,GO:0044209,1,0.980852496256452,0,2,AMP salvage,BP,
11661,GO:0044210,1,0.968407745640743,0,2,'de novo' CTP biosynthetic process,BP,
11662,GO:0044211,1,0.964813793852926,0,3,CTP salvage,BP,
11664,GO:0044213,1,0.855024139234576,0,11,intronic transcription regulatory region DNA binding,MF,
11665,GO:0044214,1,0.951156701569045,0,3,spanning component of plasma membrane,CC,
11666,GO:0044215,1,0.755719007125938,0,19,other organism,CC,
11667,GO:0044216,1,0.755719007125938,0,19,other organism cell,CC,
11668,GO:0044217,1,0.755719007125938,0,19,other organism part,CC,
11669,GO:0044218,1,0.953827315971848,0,3,other organism cell membrane,CC,
11670,GO:0044220,1,0.983426667502809,0,1,host cell perinuclear region of cytoplasm,CC,
11671,GO:0044221,1,0.983426667503302,0,1,host cell synapse,CC,
11672,GO:0044224,1,0.851690612321816,0,10,juxtaparanode region of axon,CC,
11673,GO:0044228,1,0.983426667502905,0,1,host cell surface,CC,
11674,GO:0044231,1,0.983426667503302,0,1,host cell presynaptic membrane,CC,
11680,GO:0044240,1,0.965705586806395,0,4,multicellular organismal lipid catabolic process,BP,
11681,GO:0044241,1,0.727126209204709,0,27,lipid digestion,BP,
11683,GO:0044243,1,0.332764437414388,0,74,multicellular organismal catabolic process,BP,
11684,GO:0044245,1,0.940173536397613,0,4,polysaccharide digestion,BP,
11686,GO:0044247,1,0.665290257784409,0,27,cellular polysaccharide catabolic process,BP,
11689,GO:0044252,1,0.886969652611014,0,9,negative regulation of multicellular organismal metabolic process,BP,
11691,GO:0044254,1,0.935750337515344,0,4,multicellular organismal protein catabolic process,BP,
11693,GO:0044256,1,0.935750337515344,0,4,protein digestion,BP,
11695,GO:0044258,1,0.985224985248713,0,1,intestinal lipid catabolic process,BP,
11701,GO:0044266,1,0.935750337515344,0,4,multicellular organismal macromolecule catabolic process,BP,
11703,GO:0044268,1,0.920237607637171,0,5,multicellular organismal protein metabolic process,BP,
11707,GO:0044273,1,0.487921020854171,0,50,sulfur compound catabolic process,BP,
11708,GO:0044275,1,0.526373633123454,0,45,cellular carbohydrate catabolic process,BP,
11709,GO:0044279,1,0.953827315971848,0,3,other organism membrane,CC,
11713,GO:0044284,1,0.993152796524549,0,1,mitochondrial crista junction,CC,
11715,GO:0044292,1,0.87433387494839,0,9,dendrite terminus,CC,
11716,GO:0044294,1,0.920243396597784,0,5,dendritic growth cone,CC,
11717,GO:0044295,1,0.771829566784621,0,16,axonal growth cone,CC,
11719,GO:0044298,1,0.749301374761478,0,19,cell body membrane,CC,
11720,GO:0044299,1,0.994275566742343,0,1,C-fiber,CC,
11721,GO:0044300,1,0.920730989688632,0,5,cerebellar mossy fiber,CC,
11722,GO:0044301,1,0.97287723517541,0,2,climbing fiber,CC,
11723,GO:0044302,1,0.967536383108223,0,2,dentate gyrus mossy fiber,CC,
11725,GO:0044305,1,0.935422072707683,0,4,calyx of Held,CC,
11727,GO:0044307,1,0.983426667494194,0,1,dendritic branch,CC,
11728,GO:0044308,1,0.95109617711375,0,3,axonal spine,CC,
11730,GO:0044313,1,0.951103129136383,0,3,protein K6-linked deubiquitination,BP,
11731,GO:0044314,1,0.958255986238511,0,4,protein K27-linked ubiquitination,BP,
11732,GO:0044316,1,0.968386579668883,0,2,cone cell pedicle,CC,
11733,GO:0044317,1,0.990014449599855,0,1,rod spherule,CC,
11737,GO:0044322,1,0.693063815647405,0,25,endoplasmic reticulum quality control compartment,CC,
11738,GO:0044323,1,0.93568897211663,0,4,retinoic acid-responsive element binding,MF,
11739,GO:0044324,1,0.982419178015718,0,2,regulation of transcription involved in anterior/posterior axis specification,BP,
11741,GO:0044326,1,0.954280529008383,0,3,dendritic spine neck,CC,
11742,GO:0044327,1,0.917506481662211,0,6,dendritic spine head,CC,
11744,GO:0044332,1,0.891483940230212,0,7,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11745,GO:0044333,1,0.987250104775321,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11746,GO:0044334,1,0.967209858472895,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11747,GO:0044335,1,0.972860082348449,0,2,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11748,GO:0044336,1,0.95392962207239,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11749,GO:0044337,1,0.983426667500151,0,1,canonical Wnt signaling pathway involved in positive regulation of apoptotic process,BP,
11753,GO:0044341,1,0.86915399435501,0,9,sodium-dependent phosphate transport,BP,
11754,GO:0044342,1,0.775182768356454,0,17,type B pancreatic cell proliferation,BP,
11755,GO:0044343,1,0.967654734448018,0,2,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11757,GO:0044345,1,0.983426667503104,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11759,GO:0044349,1,0.98800274491119,0,1,DNA excision,BP,
11760,GO:0044351,1,0.900065298138845,0,7,macropinocytosis,BP,
11761,GO:0044352,1,0.94017602806273,0,4,pinosome,CC,
11762,GO:0044354,1,0.94017602806273,0,4,macropinosome,CC,
11763,GO:0044355,1,0.989579525633124,0,1,clearance of foreign intracellular DNA,BP,
11764,GO:0044356,1,0.989579525633124,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11765,GO:0044359,1,0.918853440724559,0,7,modulation of molecular function in other organism,BP,
11766,GO:0044362,1,0.918853440724559,0,7,negative regulation of molecular function in other organism,BP,
11768,GO:0044374,1,0.983435581223901,0,1,sequence-specific DNA binding, bending,MF,
11769,GO:0044375,1,0.972301752822539,0,3,regulation of peroxisome size,BP,
11770,GO:0044376,1,0.966691392098975,0,3,RNA polymerase II complex import to nucleus,BP,
11771,GO:0044377,1,0.983435581223901,0,1,RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending,MF,
11772,GO:0044378,1,0.973044231666843,0,2,non-sequence-specific DNA binding, bending,MF,
11773,GO:0044380,1,0.565779040362776,0,36,protein localization to cytoskeleton,BP,
11775,GO:0044387,1,0.890693330374381,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11776,GO:0044388,1,0.944241229925064,0,5,small protein activating enzyme binding,MF,
11779,GO:0044391,1,0.232814123134267,0,177,ribosomal subunit,CC,
11780,GO:0044393,1,0.952147838889419,0,3,microspike,CC,
11781,GO:0044395,1,0.984638088674279,0,1,protein targeting to vacuolar membrane,BP,
11784,GO:0044407,1,0.970235552712322,0,2,single-species biofilm formation in or on host organism,BP,
11786,GO:0044413,1,0.954386941858277,0,3,avoidance of host defenses,BP,
11787,GO:0044415,1,0.954386941858277,0,3,evasion or tolerance of host defenses,BP,
11788,GO:0044416,1,0.975380881805929,0,2,induction by symbiont of host defense response,BP,
11789,GO:0044417,1,0.985144817662511,0,1,translocation of molecules into host,BP,
11794,GO:0044423,1,0.940295235677535,0,4,virion part,CC,
11812,GO:0044447,1,0.706169964467748,0,22,axoneme part,CC,
11817,GO:0044452,1,0.102404410272503,0,161,nucleolar part,CC,
11818,GO:0044453,1,0.79567770128233,0,15,nuclear membrane part,CC,
11820,GO:0044455,1,0.152456368063033,0,179,mitochondrial membrane part,CC,
11822,GO:0044458,1,0.757035643882636,0,20,motile cilium assembly,BP,
11826,GO:0044467,1,0.969081430054182,0,2,glial cell-derived neurotrophic factor secretion,BP,
11827,GO:0044501,1,0.983592726012168,0,1,modulation of signal transduction in other organism,BP,
11828,GO:0044524,1,0.987912661362616,0,1,protein sulfhydration,BP,
11829,GO:0044530,1,0.953977094939923,0,3,supraspliceosomal complex,CC,
11830,GO:0044531,1,0.929940124688182,0,5,modulation of programmed cell death in other organism,BP,
11831,GO:0044532,1,0.929940124688182,0,5,modulation of apoptotic process in other organism,BP,
11832,GO:0044533,1,0.97536378228332,0,2,positive regulation of apoptotic process in other organism,BP,
11833,GO:0044537,1,0.9877176096172,0,1,regulation of circulating fibrinogen levels,BP,
11834,GO:0044539,1,0.917398114202825,0,6,long-chain fatty acid import,BP,
11835,GO:0044540,1,0.987912661362616,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11836,GO:0044546,1,0.851677652222902,0,11,NLRP3 inflammasome complex assembly,BP,
11837,GO:0044547,1,0.92436275347906,0,5,DNA topoisomerase binding,MF,
11838,GO:0044548,1,0.852302001479744,0,13,S100 protein binding,MF,
11839,GO:0044549,1,0.994510135999198,0,1,GTP cyclohydrolase binding,MF,
11842,GO:0044558,1,0.983426667502615,0,1,uterine smooth muscle relaxation,BP,
11843,GO:0044565,1,0.973598526886295,0,2,dendritic cell proliferation,BP,
11844,GO:0044571,1,0.961361407372266,0,4,[2Fe-2S] cluster assembly,BP,
11845,GO:0044594,1,0.984408900781729,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11846,GO:0044595,1,0.990677269526394,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11847,GO:0044596,1,0.990677269526394,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11848,GO:0044597,1,0.916554192946922,0,8,daunorubicin metabolic process,BP,
11849,GO:0044598,1,0.916554192946922,0,8,doxorubicin metabolic process,BP,
11850,GO:0044599,1,0.984728932554734,0,1,AP-5 adaptor complex,CC,
11851,GO:0044609,1,0.986132882680505,0,1,DBIRD complex,CC,
11852,GO:0044610,1,0.985647073098095,0,1,FMN transmembrane transporter activity,MF,
11853,GO:0044611,1,0.951096177116036,0,3,nuclear pore inner ring,CC,
11854,GO:0044613,1,0.924319099037486,0,6,nuclear pore central transport channel,CC,
11855,GO:0044614,1,0.936417943333284,0,4,nuclear pore cytoplasmic filaments,CC,
11856,GO:0044615,1,0.909229289768644,0,6,nuclear pore nuclear basket,CC,
11857,GO:0044620,1,0.994857040334026,0,1,ACP phosphopantetheine attachment site binding,MF,
11859,GO:0044665,1,0.676768890660802,0,27,MLL1/2 complex,CC,
11860,GO:0044666,1,0.901546269689636,0,7,MLL3/4 complex,CC,
11861,GO:0044691,1,0.951096178007913,0,3,tooth eruption,BP,
11866,GO:0044704,1,0.985659583797435,0,1,single-organism reproductive behavior,BP,
11873,GO:0044713,1,0.994495436116341,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11874,GO:0044714,1,0.994495436116341,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11875,GO:0044715,1,0.980287867081198,0,2,8-oxo-dGDP phosphatase activity,MF,
11876,GO:0044716,1,0.989140414603695,0,1,8-oxo-GDP phosphatase activity,MF,
11877,GO:0044717,1,0.989140414603695,0,1,8-hydroxy-dADP phosphatase activity,MF,
11878,GO:0044721,1,0.987021926285317,0,1,protein import into peroxisome matrix, substrate release,BP,
11879,GO:0044722,1,0.983427624119544,0,1,renal phosphate excretion,BP,
11882,GO:0044725,1,0.975767751891741,0,2,chromatin reprogramming in the zygote,BP,
11883,GO:0044726,1,0.992212551565198,0,1,protection of DNA demethylation of female pronucleus,BP,
11884,GO:0044727,1,0.983426667495772,0,1,DNA demethylation of male pronucleus,BP,
11887,GO:0044736,1,0.940295235677535,0,4,acid-sensing ion channel activity,MF,
11888,GO:0044743,1,0.585855412395312,0,42,protein transmembrane import into intracellular organelle,BP,
11890,GO:0044745,1,0.983426667499561,0,1,amino acid transmembrane import,BP,
11892,GO:0044753,1,0.967697059687105,0,2,amphisome,CC,
11893,GO:0044754,1,0.886088784184116,0,9,autolysosome,CC,
11899,GO:0044769,1,0.708560124653869,0,31,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11901,GO:0044771,1,0.938631912707655,0,5,meiotic cell cycle phase transition,BP,
11905,GO:0044778,1,0.956403435676995,0,4,meiotic DNA integrity checkpoint,BP,
11906,GO:0044779,1,0.983826495175854,0,1,meiotic spindle checkpoint,BP,
11909,GO:0044784,1,0.510748913191657,0,47,metaphase/anaphase transition of cell cycle,BP,
11910,GO:0044785,1,0.976151011005824,0,2,metaphase/anaphase transition of meiotic cell cycle,BP,
11911,GO:0044786,1,0.580570992864625,0,36,cell cycle DNA replication,BP,
11912,GO:0044788,1,0.750162337706757,0,20,modulation by host of viral process,BP,
11913,GO:0044789,1,0.920230737059625,0,5,modulation by host of viral release from host cell,BP,
11914,GO:0044791,1,0.920230737059625,0,5,positive regulation by host of viral release from host cell,BP,
11915,GO:0044793,1,0.906025002870414,0,7,negative regulation by host of viral process,BP,
11916,GO:0044794,1,0.828034887825509,0,13,positive regulation by host of viral process,BP,
11917,GO:0044795,1,0.991391541523167,0,1,trans-Golgi network to recycling endosome transport,BP,
11918,GO:0044796,1,0.990227308534714,0,1,DNA polymerase processivity factor complex,CC,
11924,GO:0044804,1,0.823340569804837,0,13,nucleophagy,BP,
11925,GO:0044805,1,0.967133434783566,0,2,late nucleophagy,BP,
11926,GO:0044806,1,0.905547631365771,0,6,G-quadruplex DNA unwinding,BP,
11927,GO:0044815,1,0.476608418782713,0,108,DNA packaging complex,CC,
11930,GO:0044821,1,0.924893254193517,0,5,meiotic telomere tethering at nuclear periphery,BP,
11931,GO:0044827,1,0.845458358515701,0,11,modulation by host of viral genome replication,BP,
11932,GO:0044828,1,0.938299813437048,0,4,negative regulation by host of viral genome replication,BP,
11933,GO:0044829,1,0.90107830507177,0,7,positive regulation by host of viral genome replication,BP,
11934,GO:0044830,1,0.9834266675032,0,1,modulation by host of viral RNA genome replication,BP,
11935,GO:0044837,1,0.951288705940793,0,3,actomyosin contractile ring organization,BP,
11939,GO:0044849,1,0.809606105562905,0,15,estrous cycle,BP,
11942,GO:0044854,1,0.933628808559167,0,5,plasma membrane raft assembly,BP,
11943,GO:0044855,1,0.984312657560027,0,1,plasma membrane raft distribution,BP,
11944,GO:0044856,1,0.984312657560027,0,1,plasma membrane raft localization,BP,
11945,GO:0044857,1,0.933628808559167,0,5,plasma membrane raft organization,BP,
11946,GO:0044858,1,0.984312657560027,0,1,plasma membrane raft polarization,BP,
11947,GO:0044860,1,0.941004002171449,0,4,protein localization to plasma membrane raft,BP,
11948,GO:0044861,1,0.970884892063459,0,2,protein transport into plasma membrane raft,BP,
11949,GO:0044866,1,0.980036416593176,0,2,modulation by host of viral exo-alpha-sialidase activity,BP,
11950,GO:0044867,1,0.980036416593176,0,2,modulation by host of viral catalytic activity,BP,
11951,GO:0044868,1,0.963792597593763,0,3,modulation by host of viral molecular function,BP,
11952,GO:0044869,1,0.980036416593176,0,2,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11953,GO:0044870,1,0.980036416593176,0,2,modulation by host of viral glycoprotein metabolic process,BP,
11954,GO:0044871,1,0.980036416593176,0,2,negative regulation by host of viral glycoprotein metabolic process,BP,
11957,GO:0045002,1,0.897706616110603,0,7,double-strand break repair via single-strand annealing,BP,
11958,GO:0045003,1,0.864898322946329,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11959,GO:0045004,1,0.967193114723873,0,2,DNA replication proofreading,BP,
11960,GO:0045005,1,0.654869021615099,0,28,DNA-dependent DNA replication maintenance of fidelity,BP,
11961,GO:0045006,1,0.90155190390676,0,10,DNA deamination,BP,
11962,GO:0045007,1,0.966730227262334,0,3,depurination,BP,
11963,GO:0045008,1,0.900856501906419,0,8,depyrimidination,BP,
11966,GO:0045013,1,0.970745191795629,0,2,carbon catabolite repression of transcription,BP,
11967,GO:0045014,1,0.970745191795629,0,2,negative regulation of transcription by glucose,BP,
11968,GO:0045016,1,0.983550370083736,0,1,mitochondrial magnesium ion transport,BP,
11970,GO:0045019,1,0.85081929829408,0,12,negative regulation of nitric oxide biosynthetic process,BP,
11973,GO:0045025,1,0.968614756759016,0,2,mitochondrial degradosome,CC,
11975,GO:0045027,1,0.98627340078158,0,1,DNA end binding,MF,
11976,GO:0045028,1,0.824908381453882,0,14,G-protein coupled purinergic nucleotide receptor activity,MF,
11977,GO:0045029,1,0.972700778423193,0,2,UDP-activated nucleotide receptor activity,MF,
11978,GO:0045030,1,0.9884908843697,0,1,UTP-activated nucleotide receptor activity,MF,
11979,GO:0045031,1,0.970786636498243,0,2,ATP-activated adenosine receptor activity,MF,
11980,GO:0045032,1,0.983745862865737,0,1,ADP-activated adenosine receptor activity,MF,
11981,GO:0045039,1,0.958364337865818,0,5,protein import into mitochondrial inner membrane,BP,
11982,GO:0045040,1,0.936506098175947,0,6,protein import into mitochondrial outer membrane,BP,
11983,GO:0045041,1,0.974780801183634,0,2,protein import into mitochondrial intermembrane space,BP,
11984,GO:0045046,1,0.910299338469336,0,6,protein import into peroxisome membrane,BP,
11985,GO:0045047,1,0.466027250170974,0,100,protein targeting to ER,BP,
11986,GO:0045048,1,0.931098644128862,0,5,protein insertion into ER membrane,BP,
11987,GO:0045053,1,0.968128471088758,0,2,protein retention in Golgi apparatus,BP,
11992,GO:0045059,1,0.874886628476321,0,10,positive thymic T cell selection,BP,
11993,GO:0045060,1,0.842169044707665,0,12,negative thymic T cell selection,BP,
11995,GO:0045062,1,0.988096328148759,0,1,extrathymic T cell selection,BP,
11996,GO:0045063,1,0.787572954514653,0,17,T-helper 1 cell differentiation,BP,
11997,GO:0045064,1,0.808021433221477,0,16,T-helper 2 cell differentiation,BP,
11998,GO:0045065,1,0.956512243084127,0,3,cytotoxic T cell differentiation,BP,
11999,GO:0045066,1,0.743711063504285,0,21,regulatory T cell differentiation,BP,
12002,GO:0045071,1,0.514958689896593,0,50,negative regulation of viral genome replication,BP,
12005,GO:0045074,1,0.954873974055439,0,3,regulation of interleukin-10 biosynthetic process,BP,
12006,GO:0045075,1,0.892951864294161,0,8,regulation of interleukin-12 biosynthetic process,BP,
12007,GO:0045076,1,0.777120394821639,0,18,regulation of interleukin-2 biosynthetic process,BP,
12008,GO:0045077,1,0.946297144122123,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
12010,GO:0045079,1,0.972731395472269,0,3,negative regulation of chemokine biosynthetic process,BP,
12012,GO:0045081,1,0.983451848308174,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
12013,GO:0045082,1,0.970943236541964,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
12014,GO:0045083,1,0.983426667503348,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
12015,GO:0045084,1,0.923313937198909,0,6,positive regulation of interleukin-12 biosynthetic process,BP,
12016,GO:0045085,1,0.951519441728891,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
12017,GO:0045086,1,0.832833323936172,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
12021,GO:0045091,1,0.889612391642632,0,8,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12022,GO:0045092,1,0.983454779055671,0,1,interleukin-18 receptor complex,CC,
12023,GO:0045095,1,0.381535155410182,0,92,keratin filament,CC,
12024,GO:0045098,1,0.972795774673021,0,2,type III intermediate filament,CC,
12027,GO:0045105,1,0.967158418327497,0,2,intermediate filament polymerization or depolymerization,BP,
12028,GO:0045106,1,0.983426667502019,0,1,intermediate filament depolymerization,BP,
12029,GO:0045108,1,0.983426667502019,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
12033,GO:0045112,1,0.92140967384381,0,6,integrin biosynthetic process,BP,
12034,GO:0045113,1,0.936942085659838,0,5,regulation of integrin biosynthetic process,BP,
12035,GO:0045116,1,0.839130337548455,0,15,protein neddylation,BP,
12037,GO:0045118,1,0.914294764954216,0,6,azole transporter activity,MF,
12038,GO:0045120,1,0.81374707337961,0,14,pronucleus,CC,
12043,GO:0045127,1,0.988811026299455,0,1,N-acetylglucosamine kinase activity,MF,
12044,GO:0045130,1,0.984351896647588,0,1,keratan sulfotransferase activity,MF,
12045,GO:0045131,1,0.983889200435356,0,1,pre-mRNA branch point binding,MF,
12046,GO:0045132,1,0.365918582583954,0,70,meiotic chromosome segregation,BP,
12047,GO:0045134,1,0.939625255626063,0,4,uridine-diphosphatase activity,MF,
12050,GO:0045141,1,0.843078709951055,0,11,meiotic telomere clustering,BP,
12051,GO:0045142,1,0.983426772326857,0,1,triplex DNA binding,MF,
12052,GO:0045143,1,0.508966430944529,0,48,homologous chromosome segregation,BP,
12053,GO:0045144,1,0.915124135374705,0,7,meiotic sister chromatid segregation,BP,
12054,GO:0045145,1,0.968629650773808,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
12055,GO:0045153,1,0.991031175595458,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
12056,GO:0045155,1,0.974605876021199,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
12057,GO:0045159,1,0.940095850688814,0,5,myosin II binding,MF,
12058,GO:0045160,1,0.983426667502857,0,1,myosin I complex,CC,
12061,GO:0045163,1,0.952753570931885,0,3,clustering of voltage-gated potassium channels,BP,
12065,GO:0045174,1,0.983335041160537,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12066,GO:0045176,1,0.847477374981881,0,11,apical protein localization,BP,
12069,GO:0045179,1,0.916131010731535,0,7,apical cortex,CC,
12070,GO:0045180,1,0.919824307510981,0,5,basal cortex,CC,
12071,GO:0045182,1,0.57955626011359,0,37,translation regulator activity,MF,
12074,GO:0045186,1,0.983426667499658,0,1,zonula adherens assembly,BP,
12077,GO:0045189,1,0.993177581334886,0,1,connective tissue growth factor biosynthetic process,BP,
12080,GO:0045196,1,0.953379963454961,0,3,establishment or maintenance of neuroblast polarity,BP,
12084,GO:0045200,1,0.953379963454961,0,3,establishment of neuroblast polarity,BP,
12086,GO:0045204,1,0.951131338552288,0,3,MAPK export from nucleus,BP,
12087,GO:0045208,1,0.983463019172781,0,1,MAPK phosphatase export from nucleus,BP,
12088,GO:0045209,1,0.983463019172781,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
12091,GO:0045212,1,0.984677841075189,0,1,neurotransmitter receptor biosynthetic process,BP,
12092,GO:0045213,1,0.959159835168122,0,3,neurotransmitter receptor metabolic process,BP,
12097,GO:0045219,1,0.983426667502119,0,1,regulation of FasL biosynthetic process,BP,
12098,GO:0045221,1,0.983426667502119,0,1,negative regulation of FasL biosynthetic process,BP,
12099,GO:0045222,1,0.991378327332964,0,1,CD4 biosynthetic process,BP,
12100,GO:0045223,1,0.991378327332964,0,1,regulation of CD4 biosynthetic process,BP,
12101,GO:0045225,1,0.991378327332964,0,1,negative regulation of CD4 biosynthetic process,BP,
12102,GO:0045226,1,0.955032325842818,0,3,extracellular polysaccharide biosynthetic process,BP,
12103,GO:0045229,1,0.952822886838185,0,3,external encapsulating structure organization,BP,
12104,GO:0045234,1,0.987702592018801,0,1,protein palmitoleylation,BP,
12105,GO:0045236,1,0.854388416340759,0,15,CXCR chemokine receptor binding,MF,
12106,GO:0045239,1,0.836625958343745,0,12,tricarboxylic acid cycle enzyme complex,CC,
12107,GO:0045240,1,0.859690507548201,0,10,dihydrolipoyl dehydrogenase complex,CC,
12108,GO:0045244,1,0.985335015448221,0,1,succinate-CoA ligase complex (GDP-forming),CC,
12109,GO:0045251,1,0.985341599334663,0,1,electron transfer flavoprotein complex,CC,
12110,GO:0045252,1,0.911568052076857,0,6,oxoglutarate dehydrogenase complex,CC,
12111,GO:0045254,1,0.888661480164276,0,8,pyruvate dehydrogenase complex,CC,
12112,GO:0045257,1,0.951946374400048,0,4,succinate dehydrogenase complex (ubiquinone),CC,
12113,GO:0045259,1,0.846184285738314,0,21,proton-transporting ATP synthase complex,CC,
12114,GO:0045261,1,0.956950352925226,0,5,proton-transporting ATP synthase complex, catalytic core F(1),CC,
12115,GO:0045263,1,0.916193718913292,0,11,proton-transporting ATP synthase complex, coupling factor F(o),CC,
12116,GO:0045265,1,0.995434821968634,0,1,proton-transporting ATP synthase, stator stalk,CC,
12117,GO:0045267,1,0.987407762369456,0,1,proton-transporting ATP synthase, catalytic core,CC,
12118,GO:0045271,1,0.729169620071208,0,42,respiratory chain complex I,CC,
12119,GO:0045273,1,0.951946374400048,0,4,respiratory chain complex II,CC,
12120,GO:0045275,1,0.893348173252333,0,11,respiratory chain complex III,CC,
12121,GO:0045277,1,0.932807432631745,0,14,respiratory chain complex IV,CC,
12122,GO:0045281,1,0.951946374400048,0,4,succinate dehydrogenase complex,CC,
12123,GO:0045283,1,0.951946374400048,0,4,fumarate reductase complex,CC,
12124,GO:0045292,1,0.783719157169777,0,17,mRNA cis splicing, via spliceosome,BP,
12125,GO:0045293,1,0.945676724424825,0,4,mRNA editing complex,CC,
12129,GO:0045297,1,0.985659583797435,0,1,post-mating behavior,BP,
12130,GO:0045298,1,0.961056313785095,0,3,tubulin complex,CC,
12131,GO:0045299,1,0.983426667498034,0,1,otolith mineralization,BP,
12134,GO:0045322,1,0.983909843106672,0,1,unmethylated CpG binding,MF,
12135,GO:0045323,1,0.955493125295358,0,3,interleukin-1 receptor complex,CC,
12136,GO:0045324,1,0.8139471339947,0,15,late endosome to vacuole transport,BP,
12137,GO:0045329,1,0.927919262729933,0,5,carnitine biosynthetic process,BP,
12138,GO:0045332,1,0.693989970899824,0,22,phospholipid translocation,BP,
12142,GO:0045337,1,0.973658230798779,0,2,farnesyl diphosphate biosynthetic process,BP,
12143,GO:0045338,1,0.960264089575,0,3,farnesyl diphosphate metabolic process,BP,
12144,GO:0045340,1,0.992913066894507,0,1,mercury ion binding,MF,
12145,GO:0045341,1,0.900666965808747,0,7,MHC class I biosynthetic process,BP,
12146,GO:0045342,1,0.851229346437449,0,13,MHC class II biosynthetic process,BP,
12147,GO:0045343,1,0.900666965808747,0,7,regulation of MHC class I biosynthetic process,BP,
12148,GO:0045345,1,0.906462494509605,0,6,positive regulation of MHC class I biosynthetic process,BP,
12149,GO:0045346,1,0.865582303228,0,12,regulation of MHC class II biosynthetic process,BP,
12150,GO:0045347,1,0.942798841970891,0,5,negative regulation of MHC class II biosynthetic process,BP,
12151,GO:0045348,1,0.907577378566252,0,8,positive regulation of MHC class II biosynthetic process,BP,
12152,GO:0045349,1,0.915112237148976,0,6,interferon-alpha biosynthetic process,BP,
12153,GO:0045350,1,0.881714079783546,0,8,interferon-beta biosynthetic process,BP,
12154,GO:0045351,1,0.836162482728482,0,12,type I interferon biosynthetic process,BP,
12155,GO:0045352,1,0.987722621313945,0,1,interleukin-1 Type I receptor antagonist activity,MF,
12156,GO:0045353,1,0.987722621313945,0,1,interleukin-1 Type II receptor antagonist activity,MF,
12157,GO:0045354,1,0.915112237148976,0,6,regulation of interferon-alpha biosynthetic process,BP,
12158,GO:0045355,1,0.978000447795922,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
12159,GO:0045356,1,0.935702899071211,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
12160,GO:0045357,1,0.881714079783546,0,8,regulation of interferon-beta biosynthetic process,BP,
12161,GO:0045358,1,0.989355222492892,0,1,negative regulation of interferon-beta biosynthetic process,BP,
12162,GO:0045359,1,0.891205276376619,0,7,positive regulation of interferon-beta biosynthetic process,BP,
12165,GO:0045366,1,0.983426667502269,0,1,regulation of interleukin-13 biosynthetic process,BP,
12166,GO:0045368,1,0.983426667502269,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
12167,GO:0045381,1,0.983621657795192,0,1,regulation of interleukin-18 biosynthetic process,BP,
12168,GO:0045399,1,0.974901874802987,0,2,regulation of interleukin-3 biosynthetic process,BP,
12169,GO:0045401,1,0.974901874802987,0,2,positive regulation of interleukin-3 biosynthetic process,BP,
12172,GO:0045404,1,0.968040025176393,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12173,GO:0045405,1,0.995401088492396,0,1,regulation of interleukin-5 biosynthetic process,BP,
12174,GO:0045407,1,0.995401088492396,0,1,positive regulation of interleukin-5 biosynthetic process,BP,
12175,GO:0045408,1,0.812529974941814,0,16,regulation of interleukin-6 biosynthetic process,BP,
12176,GO:0045409,1,0.940080772327591,0,5,negative regulation of interleukin-6 biosynthetic process,BP,
12177,GO:0045410,1,0.892557367066358,0,8,positive regulation of interleukin-6 biosynthetic process,BP,
12178,GO:0045414,1,0.864460748793105,0,12,regulation of interleukin-8 biosynthetic process,BP,
12179,GO:0045415,1,0.950486988363765,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12180,GO:0045416,1,0.908753169040497,0,8,positive regulation of interleukin-8 biosynthetic process,BP,
12181,GO:0045423,1,0.953630342141221,0,4,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12182,GO:0045425,1,0.959563542122317,0,3,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12188,GO:0045448,1,0.942413092046605,0,4,mitotic cell cycle, embryonic,BP,
12190,GO:0045454,1,0.421958369061474,0,68,cell redox homeostasis,BP,
12192,GO:0045472,1,0.852501873712671,0,12,response to ether,BP,
12193,GO:0045475,1,0.857350687669313,0,11,locomotor rhythm,BP,
12194,GO:0045485,1,0.983426667503154,0,1,omega-6 fatty acid desaturase activity,MF,
12196,GO:0045495,1,0.783458254818713,0,16,pole plasm,CC,
12197,GO:0045499,1,0.870520653268133,0,9,chemorepellent activity,MF,
12198,GO:0045503,1,0.939645076575434,0,4,dynein light chain binding,MF,
12199,GO:0045504,1,0.943895389866869,0,4,dynein heavy chain binding,MF,
12201,GO:0045509,1,0.967524181400956,0,2,interleukin-27 receptor activity,MF,
12202,GO:0045513,1,0.989615277731363,0,1,interleukin-27 binding,MF,
12203,GO:0045517,1,0.990888822333225,0,1,interleukin-20 receptor binding,MF,
12204,GO:0045518,1,0.98241749636018,0,2,interleukin-22 receptor binding,MF,
12205,GO:0045519,1,0.977640490926053,0,2,interleukin-23 receptor binding,MF,
12206,GO:0045523,1,0.98378101665096,0,2,interleukin-27 receptor binding,MF,
12207,GO:0045540,1,0.825331725424994,0,13,regulation of cholesterol biosynthetic process,BP,
12208,GO:0045541,1,0.940253703050914,0,5,negative regulation of cholesterol biosynthetic process,BP,
12209,GO:0045542,1,0.921605937729307,0,5,positive regulation of cholesterol biosynthetic process,BP,
12210,GO:0045545,1,0.911823032516052,0,6,syndecan binding,MF,
12211,GO:0045550,1,0.979719129199316,0,2,geranylgeranyl reductase activity,MF,
12212,GO:0045553,1,0.983832679877801,0,1,TRAIL biosynthetic process,BP,
12213,GO:0045554,1,0.983832679877801,0,1,regulation of TRAIL biosynthetic process,BP,
12214,GO:0045556,1,0.983832679877801,0,1,positive regulation of TRAIL biosynthetic process,BP,
12215,GO:0045569,1,0.945813726868101,0,4,TRAIL binding,MF,
12216,GO:0045575,1,0.979691706338047,0,2,basophil activation,BP,
12218,GO:0045577,1,0.703966918645594,0,24,regulation of B cell differentiation,BP,
12219,GO:0045578,1,0.950173669262209,0,4,negative regulation of B cell differentiation,BP,
12220,GO:0045579,1,0.828922331258234,0,13,positive regulation of B cell differentiation,BP,
12223,GO:0045582,1,0.359138634250248,0,73,positive regulation of T cell differentiation,BP,
12224,GO:0045583,1,0.971984433270106,0,2,regulation of cytotoxic T cell differentiation,BP,
12225,GO:0045585,1,0.971984433270106,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12226,GO:0045586,1,0.919824586353109,0,5,regulation of gamma-delta T cell differentiation,BP,
12227,GO:0045588,1,0.951096465391253,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12228,GO:0045589,1,0.766767939850967,0,19,regulation of regulatory T cell differentiation,BP,
12229,GO:0045590,1,0.95470224662664,0,3,negative regulation of regulatory T cell differentiation,BP,
12230,GO:0045591,1,0.857583391376421,0,12,positive regulation of regulatory T cell differentiation,BP,
12238,GO:0045602,1,0.897128162059536,0,7,negative regulation of endothelial cell differentiation,BP,
12245,GO:0045609,1,0.99202838856208,0,1,positive regulation of auditory receptor cell differentiation,BP,
12247,GO:0045617,1,0.900442161821497,0,8,negative regulation of keratinocyte differentiation,BP,
12252,GO:0045622,1,0.670555893719,0,30,regulation of T-helper cell differentiation,BP,
12253,GO:0045623,1,0.827494244009752,0,14,negative regulation of T-helper cell differentiation,BP,
12254,GO:0045624,1,0.772152628903284,0,19,positive regulation of T-helper cell differentiation,BP,
12255,GO:0045625,1,0.874395128047449,0,10,regulation of T-helper 1 cell differentiation,BP,
12256,GO:0045626,1,0.952896266683683,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12257,GO:0045627,1,0.924896025145779,0,6,positive regulation of T-helper 1 cell differentiation,BP,
12258,GO:0045628,1,0.843608828197417,0,12,regulation of T-helper 2 cell differentiation,BP,
12259,GO:0045629,1,0.94352985227084,0,4,negative regulation of T-helper 2 cell differentiation,BP,
12260,GO:0045630,1,0.894122846196738,0,8,positive regulation of T-helper 2 cell differentiation,BP,
12263,GO:0045633,1,0.99202838856208,0,1,positive regulation of mechanoreceptor differentiation,BP,
12269,GO:0045643,1,0.977305912410095,0,2,regulation of eosinophil differentiation,BP,
12270,GO:0045645,1,0.977305912410095,0,2,positive regulation of eosinophil differentiation,BP,
12272,GO:0045647,1,0.888224614123887,0,8,negative regulation of erythrocyte differentiation,BP,
12273,GO:0045648,1,0.714755538462601,0,23,positive regulation of erythrocyte differentiation,BP,
12275,GO:0045650,1,0.909185841080843,0,7,negative regulation of macrophage differentiation,BP,
12278,GO:0045653,1,0.923842497015805,0,18,negative regulation of megakaryocyte differentiation,BP,
12280,GO:0045655,1,0.766368180904166,0,18,regulation of monocyte differentiation,BP,
12281,GO:0045656,1,0.90355998826307,0,7,negative regulation of monocyte differentiation,BP,
12282,GO:0045657,1,0.874037912266169,0,9,positive regulation of monocyte differentiation,BP,
12283,GO:0045658,1,0.967149881924186,0,2,regulation of neutrophil differentiation,BP,
12284,GO:0045659,1,0.967149881924186,0,2,negative regulation of neutrophil differentiation,BP,
12287,GO:0045663,1,0.737671706000529,0,21,positive regulation of myoblast differentiation,BP,
12296,GO:0045672,1,0.711167922051202,0,24,positive regulation of osteoclast differentiation,BP,
12303,GO:0045703,1,0.990934003351696,0,1,ketoreductase activity,MF,
12304,GO:0045713,1,0.865021832434674,0,10,low-density lipoprotein particle receptor biosynthetic process,BP,
12305,GO:0045714,1,0.876108496897395,0,9,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12306,GO:0045715,1,0.951096177116036,0,3,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12307,GO:0045716,1,0.952489815467457,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12308,GO:0045717,1,0.822197881335147,0,14,negative regulation of fatty acid biosynthetic process,BP,
12309,GO:0045719,1,0.922374791589239,0,5,negative regulation of glycogen biosynthetic process,BP,
12310,GO:0045720,1,0.971586973723357,0,2,negative regulation of integrin biosynthetic process,BP,
12311,GO:0045721,1,0.832868226455855,0,13,negative regulation of gluconeogenesis,BP,
12312,GO:0045722,1,0.858157394987076,0,10,positive regulation of gluconeogenesis,BP,
12313,GO:0045723,1,0.844533812960574,0,14,positive regulation of fatty acid biosynthetic process,BP,
12314,GO:0045724,1,0.738231082580139,0,20,positive regulation of cilium assembly,BP,
12316,GO:0045726,1,0.952996102065327,0,3,positive regulation of integrin biosynthetic process,BP,
12317,GO:0045727,1,0.245121399094706,0,100,positive regulation of translation,BP,
12318,GO:0045728,1,0.986042558870148,0,1,respiratory burst after phagocytosis,BP,
12323,GO:0045738,1,0.773033332803889,0,17,negative regulation of DNA repair,BP,
12328,GO:0045743,1,0.915254743211186,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12333,GO:0045751,1,0.983621657795192,0,1,negative regulation of Toll signaling pathway,BP,
12334,GO:0045759,1,0.908994600055756,0,7,negative regulation of action potential,BP,
12335,GO:0045760,1,0.854719823264604,0,11,positive regulation of action potential,BP,
12336,GO:0045761,1,0.351704728508597,0,74,regulation of adenylate cyclase activity,BP,
12337,GO:0045762,1,0.508086899757122,0,46,positive regulation of adenylate cyclase activity,BP,
12338,GO:0045763,1,0.967126892149744,0,2,negative regulation of cellular amino acid metabolic process,BP,
12339,GO:0045764,1,0.965023160267809,0,3,positive regulation of cellular amino acid metabolic process,BP,
12342,GO:0045769,1,0.983426667495869,0,1,negative regulation of asymmetric cell division,BP,
12343,GO:0045773,1,0.538849003673906,0,39,positive regulation of axon extension,BP,
12348,GO:0045780,1,0.82782535477318,0,13,positive regulation of bone resorption,BP,
12354,GO:0045794,1,0.920084134566198,0,5,negative regulation of cell volume,BP,
12355,GO:0045795,1,0.983426667500399,0,1,positive regulation of cell volume,BP,
12356,GO:0045796,1,0.968984030234865,0,2,negative regulation of intestinal cholesterol absorption,BP,
12357,GO:0045799,1,0.955978813999118,0,3,positive regulation of chromatin assembly or disassembly,BP,
12360,GO:0045814,1,0.258100953926665,0,130,negative regulation of gene expression, epigenetic,BP,
12361,GO:0045815,1,0.437145623320062,0,79,positive regulation of gene expression, epigenetic,BP,
12362,GO:0045818,1,0.996368611078759,0,1,negative regulation of glycogen catabolic process,BP,
12363,GO:0045819,1,0.983426831230428,0,1,positive regulation of glycogen catabolic process,BP,
12365,GO:0045821,1,0.823714977609245,0,13,positive regulation of glycolytic process,BP,
12369,GO:0045827,1,0.990934003351696,0,1,negative regulation of isoprenoid metabolic process,BP,
12370,GO:0045829,1,0.939870514929551,0,4,negative regulation of isotype switching,BP,
12377,GO:0045838,1,0.89464587069092,0,9,positive regulation of membrane potential,BP,
12380,GO:0045841,1,0.644899621990503,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
12381,GO:0045842,1,0.912832890132424,0,6,positive regulation of mitotic metaphase/anaphase transition,BP,
12384,GO:0045848,1,0.986081633239475,0,1,positive regulation of nitrogen utilization,BP,
12386,GO:0045852,1,0.910951403050633,0,6,pH elevation,BP,
12391,GO:0045869,1,0.904610987272506,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12392,GO:0045870,1,0.983426667501779,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12393,GO:0045872,1,0.973485438286162,0,2,positive regulation of rhodopsin gene expression,BP,
12394,GO:0045875,1,0.951096177103852,0,3,negative regulation of sister chromatid cohesion,BP,
12395,GO:0045876,1,0.902168019789536,0,7,positive regulation of sister chromatid cohesion,BP,
12397,GO:0045880,1,0.65133603478684,0,27,positive regulation of smoothened signaling pathway,BP,
12398,GO:0045887,1,0.983426667499856,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12401,GO:0045896,1,0.951096177116799,0,3,regulation of transcription during mitotic cell cycle,BP,
12402,GO:0045897,1,0.983426667501826,0,1,positive regulation of transcription during mitotic cell cycle,BP,
12403,GO:0045898,1,0.837005955065862,0,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12404,GO:0045899,1,0.878468872036824,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12405,GO:0045900,1,0.944891503449616,0,4,negative regulation of translational elongation,BP,
12406,GO:0045901,1,0.93868407196288,0,5,positive regulation of translational elongation,BP,
12407,GO:0045903,1,0.981174662396927,0,2,positive regulation of translational fidelity,BP,
12408,GO:0045905,1,0.957836445666497,0,3,positive regulation of translational termination,BP,
12409,GO:0045906,1,0.896577435318097,0,7,negative regulation of vasoconstriction,BP,
12411,GO:0045910,1,0.713885580146199,0,21,negative regulation of DNA recombination,BP,
12415,GO:0045914,1,0.969545074728109,0,2,negative regulation of catecholamine metabolic process,BP,
12416,GO:0045915,1,0.920898274729189,0,6,positive regulation of catecholamine metabolic process,BP,
12417,GO:0045916,1,0.889372843155879,0,8,negative regulation of complement activation,BP,
12418,GO:0045917,1,0.955050939538718,0,3,positive regulation of complement activation,BP,
12419,GO:0045918,1,0.965921595214179,0,4,negative regulation of cytolysis,BP,
12420,GO:0045919,1,0.931205996938925,0,5,positive regulation of cytolysis,BP,
12424,GO:0045923,1,0.670673543185358,0,30,positive regulation of fatty acid metabolic process,BP,
12425,GO:0045924,1,0.904363912182279,0,8,regulation of female receptivity,BP,
12426,GO:0045925,1,0.96493688177693,0,3,positive regulation of female receptivity,BP,
12437,GO:0045938,1,0.93747458097378,0,7,positive regulation of circadian sleep/wake cycle, sleep,BP,
12440,GO:0045943,1,0.724449661925148,0,21,positive regulation of transcription from RNA polymerase I promoter,BP,
12442,GO:0045945,1,0.866331520904606,0,9,positive regulation of transcription from RNA polymerase III promoter,BP,
12443,GO:0045947,1,0.749204141657398,0,21,negative regulation of translational initiation,BP,
12444,GO:0045948,1,0.714319830313113,0,23,positive regulation of translational initiation,BP,
12445,GO:0045950,1,0.939754438885729,0,4,negative regulation of mitotic recombination,BP,
12446,GO:0045953,1,0.871688116627657,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12447,GO:0045954,1,0.775141659601362,0,18,positive regulation of natural killer cell mediated cytotoxicity,BP,
12449,GO:0045956,1,0.730309377869176,0,21,positive regulation of calcium ion-dependent exocytosis,BP,
12450,GO:0045957,1,0.983426667497591,0,1,negative regulation of complement activation, alternative pathway,BP,
12451,GO:0045959,1,0.962395754370179,0,3,negative regulation of complement activation, classical pathway,BP,
12452,GO:0045963,1,0.969545074728109,0,2,negative regulation of dopamine metabolic process,BP,
12453,GO:0045964,1,0.920898274729189,0,6,positive regulation of dopamine metabolic process,BP,
12454,GO:0045974,1,0.824026204446372,0,13,regulation of translation, ncRNA-mediated,BP,
12455,GO:0045976,1,0.967210199446946,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12456,GO:0045977,1,0.989531997697684,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12463,GO:0045990,1,0.916715507898406,0,6,carbon catabolite regulation of transcription,BP,
12464,GO:0045991,1,0.930324272671991,0,5,carbon catabolite activation of transcription,BP,
12466,GO:0045993,1,0.983426667503104,0,1,negative regulation of translational initiation by iron,BP,
12467,GO:0045994,1,0.971943069610393,0,2,positive regulation of translational initiation by iron,BP,
12469,GO:0046005,1,0.983216900536488,0,3,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12470,GO:0046006,1,0.599617958287161,0,39,regulation of activated T cell proliferation,BP,
12471,GO:0046007,1,0.860245955796058,0,10,negative regulation of activated T cell proliferation,BP,
12472,GO:0046010,1,0.968276370159939,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12473,GO:0046013,1,0.968489563894103,0,3,regulation of T cell homeostatic proliferation,BP,
12474,GO:0046015,1,0.921241836139055,0,6,regulation of transcription by glucose,BP,
12475,GO:0046016,1,0.946006327028011,0,4,positive regulation of transcription by glucose,BP,
12476,GO:0046021,1,0.951096177116799,0,3,regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
12477,GO:0046022,1,0.983426667501826,0,1,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
12478,GO:0046030,1,0.837125196169745,0,11,inositol trisphosphate phosphatase activity,MF,
12480,GO:0046032,1,0.989051501533994,0,1,ADP catabolic process,BP,
12481,GO:0046033,1,0.84465171481843,0,12,AMP metabolic process,BP,
12483,GO:0046035,1,0.990805197582932,0,1,CMP metabolic process,BP,
12484,GO:0046036,1,0.855568144182374,0,14,CTP metabolic process,BP,
12485,GO:0046037,1,0.738529500775327,0,20,GMP metabolic process,BP,
12486,GO:0046038,1,0.989741121028373,0,1,GMP catabolic process,BP,
12488,GO:0046040,1,0.822953140763788,0,13,IMP metabolic process,BP,
12489,GO:0046041,1,0.976410649386165,0,2,ITP metabolic process,BP,
12490,GO:0046048,1,0.983961872790192,0,1,UDP metabolic process,BP,
12491,GO:0046049,1,0.868723983772313,0,10,UMP metabolic process,BP,
12492,GO:0046051,1,0.886599792832022,0,11,UTP metabolic process,BP,
12493,GO:0046054,1,0.99251552446236,0,1,dGMP metabolic process,BP,
12494,GO:0046056,1,0.972775501551282,0,2,dADP metabolic process,BP,
12495,GO:0046057,1,0.989140414603695,0,1,dADP catabolic process,BP,
12497,GO:0046060,1,0.947264308037307,0,5,dATP metabolic process,BP,
12498,GO:0046061,1,0.967507205668433,0,3,dATP catabolic process,BP,
12499,GO:0046065,1,0.991657523588261,0,1,dCTP metabolic process,BP,
12500,GO:0046066,1,0.981736880699334,0,2,dGDP metabolic process,BP,
12501,GO:0046067,1,0.989140414603695,0,1,dGDP catabolic process,BP,
12503,GO:0046069,1,0.89560784329917,0,7,cGMP catabolic process,BP,
12504,GO:0046070,1,0.957776213688529,0,4,dGTP metabolic process,BP,
12505,GO:0046072,1,0.975537422808287,0,2,dTDP metabolic process,BP,
12506,GO:0046073,1,0.973946720490135,0,2,dTMP metabolic process,BP,
12507,GO:0046075,1,0.955260719788444,0,4,dTTP metabolic process,BP,
12508,GO:0046077,1,0.975537422808287,0,2,dUDP metabolic process,BP,
12509,GO:0046078,1,0.965214445019738,0,3,dUMP metabolic process,BP,
12510,GO:0046079,1,0.988760734801355,0,1,dUMP catabolic process,BP,
12511,GO:0046080,1,0.987278531599617,0,1,dUTP metabolic process,BP,
12512,GO:0046083,1,0.984111357942807,0,2,adenine metabolic process,BP,
12513,GO:0046084,1,0.984111357942807,0,2,adenine biosynthetic process,BP,
12514,GO:0046085,1,0.906740033345157,0,7,adenosine metabolic process,BP,
12515,GO:0046086,1,0.970113787513799,0,2,adenosine biosynthetic process,BP,
12516,GO:0046087,1,0.907869590508278,0,9,cytidine metabolic process,BP,
12517,GO:0046090,1,0.989031513196479,0,1,deoxyadenosine metabolic process,BP,
12518,GO:0046092,1,0.983426667502562,0,1,deoxycytidine metabolic process,BP,
12519,GO:0046098,1,0.957531389897776,0,3,guanine metabolic process,BP,
12520,GO:0046099,1,0.989741121028373,0,1,guanine biosynthetic process,BP,
12521,GO:0046100,1,0.965228392375618,0,3,hypoxanthine metabolic process,BP,
12522,GO:0046101,1,0.965228392375618,0,3,hypoxanthine biosynthetic process,BP,
12523,GO:0046102,1,0.974343210416923,0,2,inosine metabolic process,BP,
12524,GO:0046103,1,0.989031513196479,0,1,inosine biosynthetic process,BP,
12525,GO:0046104,1,0.956482764952324,0,3,thymidine metabolic process,BP,
12526,GO:0046108,1,0.972916264325596,0,2,uridine metabolic process,BP,
12527,GO:0046110,1,0.956517509568529,0,3,xanthine metabolic process,BP,
12528,GO:0046111,1,0.989031513196479,0,1,xanthine biosynthetic process,BP,
12529,GO:0046112,1,0.778649034809224,0,17,nucleobase biosynthetic process,BP,
12530,GO:0046113,1,0.909691140361391,0,6,nucleobase catabolic process,BP,
12531,GO:0046116,1,0.941598356816015,0,6,queuosine metabolic process,BP,
12532,GO:0046121,1,0.961256635432194,0,3,deoxyribonucleoside catabolic process,BP,
12533,GO:0046122,1,0.981485339984911,0,2,purine deoxyribonucleoside metabolic process,BP,
12534,GO:0046124,1,0.989031513196479,0,1,purine deoxyribonucleoside catabolic process,BP,
12535,GO:0046125,1,0.956482764952324,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12536,GO:0046127,1,0.983721116157046,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12538,GO:0046129,1,0.785344285038827,0,21,purine ribonucleoside biosynthetic process,BP,
12539,GO:0046130,1,0.924503737509419,0,6,purine ribonucleoside catabolic process,BP,
12540,GO:0046131,1,0.677377640024644,0,32,pyrimidine ribonucleoside metabolic process,BP,
12541,GO:0046132,1,0.770318196096809,0,21,pyrimidine ribonucleoside biosynthetic process,BP,
12542,GO:0046133,1,0.882201891948006,0,11,pyrimidine ribonucleoside catabolic process,BP,
12543,GO:0046134,1,0.696785056714622,0,29,pyrimidine nucleoside biosynthetic process,BP,
12544,GO:0046135,1,0.786918656643201,0,20,pyrimidine nucleoside catabolic process,BP,
12545,GO:0046136,1,0.968942024914633,0,3,positive regulation of vitamin metabolic process,BP,
12546,GO:0046137,1,0.920876042687657,0,6,negative regulation of vitamin metabolic process,BP,
12547,GO:0046144,1,0.988677413700218,0,1,D-alanine family amino acid metabolic process,BP,
12548,GO:0046146,1,0.921557849656812,0,7,tetrahydrobiopterin metabolic process,BP,
12550,GO:0046149,1,0.924979877104455,0,7,pigment catabolic process,BP,
12551,GO:0046160,1,0.967559490328279,0,2,heme a metabolic process,BP,
12552,GO:0046164,1,0.529576977609457,0,46,alcohol catabolic process,BP,
12554,GO:0046166,1,0.975865676163103,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12555,GO:0046167,1,0.954895871649461,0,3,glycerol-3-phosphate biosynthetic process,BP,
12556,GO:0046168,1,0.967738681292253,0,2,glycerol-3-phosphate catabolic process,BP,
12557,GO:0046173,1,0.559009675921733,0,40,polyol biosynthetic process,BP,
12558,GO:0046174,1,0.763738649494768,0,18,polyol catabolic process,BP,
12559,GO:0046176,1,0.984728932554734,0,1,aldonic acid catabolic process,BP,
12560,GO:0046177,1,0.984728932554734,0,1,D-gluconate catabolic process,BP,
12562,GO:0046185,1,0.86330873706579,0,11,aldehyde catabolic process,BP,
12564,GO:0046203,1,0.979450800329468,0,2,spermidine catabolic process,BP,
12565,GO:0046204,1,0.992696167789598,0,1,nor-spermidine metabolic process,BP,
12566,GO:0046208,1,0.953095177136641,0,4,spermine catabolic process,BP,
12568,GO:0046210,1,0.984868231357013,0,1,nitric oxide catabolic process,BP,
12569,GO:0046218,1,0.868154279691376,0,11,indolalkylamine catabolic process,BP,
12570,GO:0046219,1,0.940554587608557,0,5,indolalkylamine biosynthetic process,BP,
12571,GO:0046222,1,0.985496439087101,0,1,aflatoxin metabolic process,BP,
12572,GO:0046226,1,0.979054122647826,0,2,coumarin catabolic process,BP,
12573,GO:0046247,1,0.984080291479883,0,1,terpene catabolic process,BP,
12574,GO:0046271,1,0.979054122647826,0,2,phenylpropanoid catabolic process,BP,
12575,GO:0046272,1,0.985855483080867,0,1,stilbene catabolic process,BP,
12576,GO:0046292,1,0.959607118918832,0,3,formaldehyde metabolic process,BP,
12577,GO:0046293,1,0.983426667502857,0,1,formaldehyde biosynthetic process,BP,
12578,GO:0046294,1,0.975780687750417,0,2,formaldehyde catabolic process,BP,
12579,GO:0046295,1,0.992913066894507,0,1,glycolate biosynthetic process,BP,
12580,GO:0046296,1,0.987889640668758,0,1,glycolate catabolic process,BP,
12581,GO:0046305,1,0.973169586148211,0,2,alkanesulfonate biosynthetic process,BP,
12582,GO:0046314,1,0.988912275994095,0,1,phosphocreatine biosynthetic process,BP,
12583,GO:0046316,1,0.984728932554734,0,1,gluconokinase activity,MF,
12584,GO:0046317,1,0.983426667502512,0,1,regulation of glucosylceramide biosynthetic process,BP,
12585,GO:0046318,1,0.983426667502512,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12587,GO:0046321,1,0.813707865328318,0,14,positive regulation of fatty acid oxidation,BP,
12591,GO:0046325,1,0.845040638762962,0,12,negative regulation of glucose import,BP,
12593,GO:0046327,1,0.984424618216714,0,1,glycerol biosynthetic process from pyruvate,BP,
12599,GO:0046333,1,0.968310512499474,0,2,octopamine metabolic process,BP,
12600,GO:0046337,1,0.79302846074298,0,15,phosphatidylethanolamine metabolic process,BP,
12601,GO:0046338,1,0.968070237510699,0,2,phosphatidylethanolamine catabolic process,BP,
12602,GO:0046339,1,0.813948057008324,0,15,diacylglycerol metabolic process,BP,
12603,GO:0046340,1,0.963551294293728,0,3,diacylglycerol catabolic process,BP,
12604,GO:0046341,1,0.831113258283123,0,12,CDP-diacylglycerol metabolic process,BP,
12605,GO:0046348,1,0.888470649668933,0,9,amino sugar catabolic process,BP,
12606,GO:0046349,1,0.850094730008952,0,11,amino sugar biosynthetic process,BP,
12607,GO:0046351,1,0.942066063779215,0,5,disaccharide biosynthetic process,BP,
12608,GO:0046352,1,0.987326145032158,0,1,disaccharide catabolic process,BP,
12609,GO:0046356,1,0.978596952478404,0,2,acetyl-CoA catabolic process,BP,
12610,GO:0046360,1,0.986216749767847,0,1,2-oxobutyrate biosynthetic process,BP,
12611,GO:0046361,1,0.986216749767847,0,1,2-oxobutyrate metabolic process,BP,
12614,GO:0046368,1,0.946430203989886,0,4,GDP-L-fucose metabolic process,BP,
12615,GO:0046370,1,0.974792140742003,0,2,fructose biosynthetic process,BP,
12616,GO:0046373,1,0.984728932554734,0,1,L-arabinose metabolic process,BP,
12617,GO:0046379,1,0.955032325842818,0,3,extracellular polysaccharide metabolic process,BP,
12618,GO:0046380,1,0.98343080149108,0,1,N-acetylneuraminate biosynthetic process,BP,
12619,GO:0046381,1,0.990843747764937,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12620,GO:0046385,1,0.894475345556861,0,9,deoxyribose phosphate biosynthetic process,BP,
12621,GO:0046386,1,0.791307376708583,0,19,deoxyribose phosphate catabolic process,BP,
12623,GO:0046391,1,0.947926768643694,0,4,5-phosphoribose 1-diphosphate metabolic process,BP,
12626,GO:0046398,1,0.938093538474626,0,4,UDP-glucuronate metabolic process,BP,
12627,GO:0046403,1,0.98800274491119,0,1,polynucleotide 3'-phosphatase activity,MF,
12628,GO:0046404,1,0.959869213974752,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12629,GO:0046415,1,0.85036655231012,0,11,urate metabolic process,BP,
12630,GO:0046416,1,0.962674504742747,0,3,D-amino acid metabolic process,BP,
12632,GO:0046426,1,0.474703730986507,0,49,negative regulation of JAK-STAT cascade,BP,
12635,GO:0046436,1,0.988677413700218,0,1,D-alanine metabolic process,BP,
12636,GO:0046437,1,0.984951089777405,0,1,D-amino acid biosynthetic process,BP,
12637,GO:0046439,1,0.90222107615999,0,7,L-cysteine metabolic process,BP,
12638,GO:0046440,1,0.939856304865844,0,4,L-lysine metabolic process,BP,
12639,GO:0046443,1,0.98682085955111,0,1,FAD metabolic process,BP,
12640,GO:0046444,1,0.984375749176824,0,1,FMN metabolic process,BP,
12641,GO:0046448,1,0.985057614653143,0,1,tropane alkaloid metabolic process,BP,
12642,GO:0046449,1,0.935330099173697,0,4,creatinine metabolic process,BP,
12643,GO:0046452,1,0.969938943906027,0,2,dihydrofolate metabolic process,BP,
12646,GO:0046459,1,0.83394267935669,0,13,short-chain fatty acid metabolic process,BP,
12647,GO:0046460,1,0.541347834342289,0,42,neutral lipid biosynthetic process,BP,
12649,GO:0046462,1,0.972638275219276,0,2,monoacylglycerol metabolic process,BP,
12650,GO:0046463,1,0.541347834342289,0,42,acylglycerol biosynthetic process,BP,
12652,GO:0046465,1,0.901714754997918,0,7,dolichyl diphosphate metabolic process,BP,
12653,GO:0046466,1,0.713198891775973,0,24,membrane lipid catabolic process,BP,
12654,GO:0046467,1,0.189542768138646,0,116,membrane lipid biosynthetic process,BP,
12655,GO:0046469,1,0.917447852041304,0,6,platelet activating factor metabolic process,BP,
12657,GO:0046471,1,0.648215187722685,0,31,phosphatidylglycerol metabolic process,BP,
12658,GO:0046473,1,0.600370336787911,0,35,phosphatidic acid metabolic process,BP,
12660,GO:0046475,1,0.777828447492096,0,17,glycerophospholipid catabolic process,BP,
12661,GO:0046476,1,0.944784913228672,0,4,glycosylceramide biosynthetic process,BP,
12662,GO:0046477,1,0.917720387519001,0,6,glycosylceramide catabolic process,BP,
12663,GO:0046479,1,0.845049751465348,0,12,glycosphingolipid catabolic process,BP,
12665,GO:0046485,1,0.907864011714619,0,7,ether lipid metabolic process,BP,
12669,GO:0046490,1,0.942103959949955,0,5,isopentenyl diphosphate metabolic process,BP,
12670,GO:0046491,1,0.993372996941813,0,1,L-methylmalonyl-CoA metabolic process,BP,
12671,GO:0046493,1,0.994857040334026,0,1,lipid A metabolic process,BP,
12672,GO:0046495,1,0.985149477412485,0,1,nicotinamide riboside metabolic process,BP,
12674,GO:0046498,1,0.923393992859487,0,6,S-adenosylhomocysteine metabolic process,BP,
12675,GO:0046499,1,0.983602856825306,0,1,S-adenosylmethioninamine metabolic process,BP,
12676,GO:0046500,1,0.834629710118318,0,13,S-adenosylmethionine metabolic process,BP,
12677,GO:0046501,1,0.872154073299365,0,10,protoporphyrinogen IX metabolic process,BP,
12678,GO:0046502,1,0.976242259748051,0,2,uroporphyrinogen III metabolic process,BP,
12680,GO:0046504,1,0.941889734003709,0,4,glycerol ether biosynthetic process,BP,
12681,GO:0046511,1,0.97088489206181,0,2,sphinganine biosynthetic process,BP,
12682,GO:0046512,1,0.891877911320467,0,8,sphingosine biosynthetic process,BP,
12683,GO:0046513,1,0.498570765558911,0,47,ceramide biosynthetic process,BP,
12684,GO:0046514,1,0.838148356407849,0,13,ceramide catabolic process,BP,
12685,GO:0046519,1,0.832263120704229,0,13,sphingoid metabolic process,BP,
12686,GO:0046520,1,0.87709098767656,0,9,sphingoid biosynthetic process,BP,
12687,GO:0046521,1,0.987316598817985,0,1,sphingoid catabolic process,BP,
12688,GO:0046523,1,0.983741121142222,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12689,GO:0046525,1,0.988007919363986,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12690,GO:0046526,1,0.984812627494499,0,1,D-xylulose reductase activity,MF,
12691,GO:0046527,1,0.786691516951328,0,16,glucosyltransferase activity,MF,
12695,GO:0046534,1,0.983426667503104,0,1,positive regulation of photoreceptor cell differentiation,BP,
12696,GO:0046538,1,0.957446622180706,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12697,GO:0046539,1,0.993117423875273,0,1,histamine N-methyltransferase activity,MF,
12698,GO:0046540,1,0.790298667126521,0,19,U4/U6 x U5 tri-snRNP complex,CC,
12701,GO:0046544,1,0.983426667502512,0,1,development of secondary male sexual characteristics,BP,
12704,GO:0046548,1,0.865559964083617,0,9,retinal rod cell development,BP,
12705,GO:0046549,1,0.870639639370902,0,9,retinal cone cell development,BP,
12706,GO:0046554,1,0.99041781763152,0,1,malate dehydrogenase (NADP+) activity,MF,
12707,GO:0046556,1,0.984728932554734,0,1,alpha-L-arabinofuranosidase activity,MF,
12708,GO:0046570,1,0.990715554984435,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12709,GO:0046573,1,0.967828463753115,0,3,lactonohydrolase activity,MF,
12710,GO:0046577,1,0.983432549902312,0,1,long-chain-alcohol oxidase activity,MF,
12714,GO:0046581,1,0.907630685451969,0,6,intercellular canaliculus,CC,
12715,GO:0046586,1,0.97706772581458,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12716,GO:0046587,1,0.983853541538817,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12717,GO:0046588,1,0.993103286130315,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12718,GO:0046592,1,0.974706170511796,0,2,polyamine oxidase activity,MF,
12719,GO:0046596,1,0.690862363040339,0,29,regulation of viral entry into host cell,BP,
12720,GO:0046597,1,0.791863745313367,0,19,negative regulation of viral entry into host cell,BP,
12721,GO:0046598,1,0.887374292847155,0,9,positive regulation of viral entry into host cell,BP,
12722,GO:0046599,1,0.794433243616165,0,15,regulation of centriole replication,BP,
12723,GO:0046600,1,0.914536161330125,0,6,negative regulation of centriole replication,BP,
12724,GO:0046601,1,0.951336206404337,0,3,positive regulation of centriole replication,BP,
12725,GO:0046602,1,0.874538357672224,0,9,regulation of mitotic centrosome separation,BP,
12726,GO:0046604,1,0.930269194388727,0,5,positive regulation of mitotic centrosome separation,BP,
12728,GO:0046606,1,0.867646946644383,0,10,negative regulation of centrosome cycle,BP,
12729,GO:0046607,1,0.843787589895712,0,11,positive regulation of centrosome cycle,BP,
12730,GO:0046618,1,0.927111526428449,0,5,drug export,BP,
12731,GO:0046619,1,0.967476458073437,0,2,optic placode formation involved in camera-type eye formation,BP,
12733,GO:0046621,1,0.70069352959172,0,23,negative regulation of organ growth,BP,
12735,GO:0046623,1,0.983426667502758,0,1,sphingolipid-translocating ATPase activity,MF,
12736,GO:0046624,1,0.926138064092872,0,5,sphingolipid transporter activity,MF,
12737,GO:0046625,1,0.815656095673196,0,14,sphingolipid binding,MF,
12739,GO:0046627,1,0.639711326908451,0,30,negative regulation of insulin receptor signaling pathway,BP,
12740,GO:0046628,1,0.838515618195244,0,12,positive regulation of insulin receptor signaling pathway,BP,
12744,GO:0046633,1,0.694004935025904,0,26,alpha-beta T cell proliferation,BP,
12745,GO:0046634,1,0.356558561066191,0,74,regulation of alpha-beta T cell activation,BP,
12746,GO:0046635,1,0.498344972333925,0,50,positive regulation of alpha-beta T cell activation,BP,
12747,GO:0046636,1,0.689679074116405,0,27,negative regulation of alpha-beta T cell activation,BP,
12748,GO:0046637,1,0.478508410347447,0,53,regulation of alpha-beta T cell differentiation,BP,
12749,GO:0046638,1,0.587240357896427,0,38,positive regulation of alpha-beta T cell differentiation,BP,
12750,GO:0046639,1,0.780621332461224,0,18,negative regulation of alpha-beta T cell differentiation,BP,
12751,GO:0046640,1,0.726284379026275,0,23,regulation of alpha-beta T cell proliferation,BP,
12752,GO:0046641,1,0.772837510917354,0,19,positive regulation of alpha-beta T cell proliferation,BP,
12753,GO:0046642,1,0.935911117512018,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12754,GO:0046643,1,0.890159070793122,0,7,regulation of gamma-delta T cell activation,BP,
12755,GO:0046645,1,0.920426568145739,0,5,positive regulation of gamma-delta T cell activation,BP,
12758,GO:0046653,1,0.780207865241627,0,17,tetrahydrofolate metabolic process,BP,
12759,GO:0046654,1,0.91057032075118,0,6,tetrahydrofolate biosynthetic process,BP,
12760,GO:0046655,1,0.769142305049901,0,18,folic acid metabolic process,BP,
12761,GO:0046657,1,0.993273363267434,0,1,folic acid catabolic process,BP,
12762,GO:0046658,1,0.571756510847937,0,44,anchored component of plasma membrane,CC,
12765,GO:0046666,1,0.952619084307488,0,4,retinal cell programmed cell death,BP,
12766,GO:0046668,1,0.970847217603563,0,2,regulation of retinal cell programmed cell death,BP,
12767,GO:0046671,1,0.983428431308179,0,1,negative regulation of retinal cell programmed cell death,BP,
12770,GO:0046680,1,0.986314227490632,0,1,response to DDT,BP,
12772,GO:0046684,1,0.948753399056595,0,4,response to pyrethroid,BP,
12775,GO:0046687,1,0.991801802024,0,1,response to chromate,BP,
12776,GO:0046688,1,0.722507819855419,0,25,response to copper ion,BP,
12777,GO:0046689,1,0.865381361911657,0,11,response to mercury ion,BP,
12778,GO:0046690,1,0.983487822403037,0,1,response to tellurium ion,BP,
12779,GO:0046691,1,0.984076881338371,0,1,intracellular canaliculus,CC,
12780,GO:0046692,1,0.993323141663568,0,1,sperm competition,BP,
12781,GO:0046696,1,0.922764405859663,0,6,lipopolysaccharide receptor complex,CC,
12784,GO:0046703,1,0.913738926188677,0,9,natural killer cell lectin-like receptor binding,MF,
12785,GO:0046707,1,0.972658879176597,0,2,IDP metabolic process,BP,
12786,GO:0046709,1,0.972658879176597,0,2,IDP catabolic process,BP,
12787,GO:0046710,1,0.806419677615179,0,14,GDP metabolic process,BP,
12788,GO:0046711,1,0.99251552446236,0,1,GDP biosynthetic process,BP,
12789,GO:0046712,1,0.989140414603695,0,1,GDP catabolic process,BP,
12790,GO:0046713,1,0.983731265579935,0,1,borate transport,BP,
12791,GO:0046715,1,0.983731265579935,0,1,borate transmembrane transporter activity,MF,
12792,GO:0046716,1,0.780988441823378,0,17,muscle cell cellular homeostasis,BP,
12795,GO:0046719,1,0.874382051692568,0,9,regulation by virus of viral protein levels in host cell,BP,
12796,GO:0046724,1,0.973331642257006,0,2,oxalic acid secretion,BP,
12797,GO:0046725,1,0.98346203317877,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12798,GO:0046726,1,0.951142733132806,0,3,positive regulation by virus of viral protein levels in host cell,BP,
12799,GO:0046730,1,0.975380881805929,0,2,induction of host immune response by virus,BP,
12800,GO:0046732,1,0.975380881805929,0,2,active induction of host immune response by virus,BP,
12801,GO:0046745,1,0.984728932554734,0,1,viral capsid secondary envelopment,BP,
12802,GO:0046755,1,0.721303901554186,0,24,viral budding,BP,
12804,GO:0046778,1,0.971657196694023,0,2,modification by virus of host mRNA processing,BP,
12805,GO:0046782,1,0.418226298260471,0,64,regulation of viral transcription,BP,
12806,GO:0046784,1,0.898463716985652,0,8,viral mRNA export from host cell nucleus,BP,
12808,GO:0046786,1,0.98342666750271,0,1,viral replication complex formation and maintenance,BP,
12810,GO:0046790,1,0.897934007996952,0,8,virion binding,MF,
12812,GO:0046811,1,0.978749122630837,0,2,histone deacetylase inhibitor activity,MF,
12815,GO:0046817,1,0.990940466439103,0,1,chemokine receptor antagonist activity,MF,
12820,GO:0046826,1,0.918574967137426,0,7,negative regulation of protein export from nucleus,BP,
12822,GO:0046831,1,0.838433114763169,0,11,regulation of RNA export from nucleus,BP,
12823,GO:0046832,1,0.967126892148005,0,2,negative regulation of RNA export from nucleus,BP,
12824,GO:0046833,1,0.955167568737719,0,3,positive regulation of RNA export from nucleus,BP,
12827,GO:0046836,1,0.927377268186112,0,6,glycolipid transport,BP,
12828,GO:0046838,1,0.852134142198555,0,10,phosphorylated carbohydrate dephosphorylation,BP,
12829,GO:0046839,1,0.668154820889441,0,25,phospholipid dephosphorylation,BP,
12831,GO:0046848,1,0.985263300639141,0,3,hydroxyapatite binding,MF,
12835,GO:0046852,1,0.82782535477318,0,13,positive regulation of bone remodeling,BP,
12837,GO:0046855,1,0.866216508282281,0,9,inositol phosphate dephosphorylation,BP,
12838,GO:0046856,1,0.677756718152266,0,24,phosphatidylinositol dephosphorylation,BP,
12839,GO:0046864,1,0.992941171638291,0,1,isoprenoid transport,BP,
12840,GO:0046865,1,0.992941171638291,0,1,terpenoid transport,BP,
12841,GO:0046870,1,0.929917255497503,0,6,cadmium ion binding,MF,
12844,GO:0046874,1,0.944289216283249,0,5,quinolinate metabolic process,BP,
12847,GO:0046878,1,0.955281964255038,0,4,positive regulation of saliva secretion,BP,
12860,GO:0046898,1,0.942122224571073,0,4,response to cycloheximide,BP,
12861,GO:0046899,1,0.969486542891433,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12862,GO:0046900,1,0.984919350008787,0,1,tetrahydrofolylpolyglutamate metabolic process,BP,
12863,GO:0046901,1,0.984919350008787,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12866,GO:0046904,1,0.989627215244459,0,1,calcium oxalate binding,MF,
12869,GO:0046909,1,0.984546278400255,0,1,intermembrane transport,BP,
12870,GO:0046911,1,0.991246637861128,0,1,metal chelating activity,MF,
12875,GO:0046920,1,0.884599464352675,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12876,GO:0046921,1,0.983585305180971,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12877,GO:0046922,1,0.967578444353702,0,2,peptide-O-fucosyltransferase activity,MF,
12878,GO:0046923,1,0.949714577043387,0,4,ER retention sequence binding,MF,
12879,GO:0046928,1,0.464733223345983,0,51,regulation of neurotransmitter secretion,BP,
12880,GO:0046929,1,0.842385131917107,0,11,negative regulation of neurotransmitter secretion,BP,
12881,GO:0046930,1,0.792926693162835,0,17,pore complex,CC,
12882,GO:0046931,1,0.801996810501849,0,15,pore complex assembly,BP,
12883,GO:0046933,1,0.868815578025921,0,16,proton-transporting ATP synthase activity, rotational mechanism,MF,
12887,GO:0046940,1,0.960833618269982,0,3,nucleoside monophosphate phosphorylation,BP,
12889,GO:0046943,1,0.135129012129004,0,131,carboxylic acid transmembrane transporter activity,MF,
12890,GO:0046946,1,0.951938885644591,0,3,hydroxylysine metabolic process,BP,
12891,GO:0046947,1,0.951938885644591,0,3,hydroxylysine biosynthetic process,BP,
12895,GO:0046952,1,0.941940378669291,0,4,ketone body catabolic process,BP,
12896,GO:0046958,1,0.906547892383609,0,6,nonassociative learning,BP,
12897,GO:0046959,1,0.935436385656343,0,4,habituation,BP,
12898,GO:0046960,1,0.969065655139621,0,2,sensitization,BP,
12899,GO:0046961,1,0.78320769418436,0,19,proton-transporting ATPase activity, rotational mechanism,MF,
12900,GO:0046963,1,0.973123030636224,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12901,GO:0046964,1,0.973123030636224,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12903,GO:0046966,1,0.680188758658477,0,27,thyroid hormone receptor binding,MF,
12904,GO:0046967,1,0.967617358163542,0,2,cytosol to ER transport,BP,
12905,GO:0046968,1,0.955012552545094,0,3,peptide antigen transport,BP,
12906,GO:0046969,1,0.972093326939592,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12907,GO:0046970,1,0.986935358959301,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12908,GO:0046972,1,0.868624772722792,0,9,histone acetyltransferase activity (H4-K16 specific),MF,
12909,GO:0046974,1,0.92099541297424,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12910,GO:0046975,1,0.913793393845312,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12911,GO:0046976,1,0.952176589410757,0,3,histone methyltransferase activity (H3-K27 specific),MF,
12912,GO:0046977,1,0.942642976117625,0,4,TAP binding,MF,
12913,GO:0046978,1,0.942642976117625,0,4,TAP1 binding,MF,
12914,GO:0046979,1,0.958531807521008,0,3,TAP2 binding,MF,
12915,GO:0046980,1,0.983426667503346,0,1,tapasin binding,MF,
12918,GO:0046984,1,0.944141186149501,0,4,regulation of hemoglobin biosynthetic process,BP,
12919,GO:0046985,1,0.960055165917005,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12920,GO:0046986,1,0.983426667503104,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12921,GO:0046997,1,0.967592721646364,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12922,GO:0047006,1,0.97970202697073,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12923,GO:0047012,1,0.98868294898152,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12924,GO:0047015,1,0.992790423696907,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12925,GO:0047016,1,0.985934764644734,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12926,GO:0047017,1,0.975800814276652,0,2,prostaglandin-F synthase activity,MF,
12927,GO:0047020,1,0.990934003351696,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12928,GO:0047021,1,0.990824462822371,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12929,GO:0047023,1,0.972274874570821,0,3,androsterone dehydrogenase activity,MF,
12930,GO:0047025,1,0.976117873130505,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12931,GO:0047035,1,0.942632590584498,0,6,testosterone dehydrogenase (NAD+) activity,MF,
12932,GO:0047042,1,0.989953283560941,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12933,GO:0047045,1,0.97350524228864,0,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12934,GO:0047057,1,0.984405619285115,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12935,GO:0047066,1,0.99286394784187,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12936,GO:0047086,1,0.970466136816908,0,3,ketosteroid monooxygenase activity,MF,
12937,GO:0047105,1,0.984876680452831,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12938,GO:0047115,1,0.962584330963352,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12939,GO:0047117,1,0.983426667498527,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12940,GO:0047127,1,0.990005259317338,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12941,GO:0047130,1,0.983426667501579,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12942,GO:0047131,1,0.983426667501579,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12943,GO:0047134,1,0.926894182636789,0,7,protein-disulfide reductase activity,MF,
12945,GO:0047150,1,0.98488798990886,0,1,betaine-homocysteine S-methyltransferase activity,MF,
12946,GO:0047159,1,0.983426733197828,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12947,GO:0047166,1,0.987077151048127,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12948,GO:0047173,1,0.98342666750276,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12949,GO:0047179,1,0.983152729049971,0,2,platelet-activating factor acetyltransferase activity,MF,
12950,GO:0047184,1,0.92886125369118,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12951,GO:0047191,1,0.983426733197828,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12952,GO:0047192,1,0.954627200231224,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12953,GO:0047196,1,0.976152355448012,0,2,long-chain-alcohol O-fatty-acyltransferase activity,MF,
12954,GO:0047198,1,0.991967304321469,0,1,cysteine-S-conjugate N-acetyltransferase activity,MF,
12955,GO:0047220,1,0.984211150941242,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12956,GO:0047223,1,0.954071564054801,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12957,GO:0047224,1,0.984913619920026,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12958,GO:0047225,1,0.985814490801918,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
12959,GO:0047237,1,0.951719861262356,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12960,GO:0047238,1,0.9203145616493,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12961,GO:0047256,1,0.983426667503348,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12962,GO:0047263,1,0.984007193345642,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12963,GO:0047273,1,0.983568651140861,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12964,GO:0047275,1,0.969718750028618,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12965,GO:0047277,1,0.986926308852344,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12966,GO:0047280,1,0.983426667503056,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12967,GO:0047288,1,0.976763036360983,0,2,monosialoganglioside sialyltransferase activity,MF,
12968,GO:0047290,1,0.988425832476277,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12969,GO:0047291,1,0.985489571218687,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12970,GO:0047293,1,0.988458307022838,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12971,GO:0047298,1,0.98342666750271,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12972,GO:0047305,1,0.985697341070322,0,1,(R)-3-amino-2-methylpropionate-pyruvate transaminase activity,MF,
12973,GO:0047322,1,0.967126892149115,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12974,GO:0047323,1,0.986148754612068,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12975,GO:0047325,1,0.983608982877898,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12976,GO:0047326,1,0.987662673417147,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12977,GO:0047341,1,0.983511458249465,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12978,GO:0047372,1,0.862355593647151,0,10,acylglycerol lipase activity,MF,
12979,GO:0047374,1,0.961669059086234,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12980,GO:0047389,1,0.967362068026016,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12981,GO:0047390,1,0.983426805565048,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12982,GO:0047391,1,0.967619052397252,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12983,GO:0047394,1,0.985742730195421,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12984,GO:0047395,1,0.983955915701001,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12985,GO:0047408,1,0.987894751296291,0,1,alkenylglycerophosphocholine hydrolase activity,MF,
12986,GO:0047409,1,0.987894751296291,0,1,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12987,GO:0047429,1,0.893909563143756,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12988,GO:0047442,1,0.987288030753513,0,1,17-alpha-hydroxyprogesterone aldolase activity,MF,
12989,GO:0047444,1,0.990843747764937,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12990,GO:0047451,1,0.983426667498527,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12991,GO:0047464,1,0.983426667502611,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12992,GO:0047484,1,0.878372212717516,0,9,regulation of response to osmotic stress,BP,
12994,GO:0047493,1,0.956718701365542,0,3,ceramide cholinephosphotransferase activity,MF,
12995,GO:0047496,1,0.582867093017052,0,36,vesicle transport along microtubule,BP,
12996,GO:0047497,1,0.777491573642225,0,17,mitochondrion transport along microtubule,BP,
12997,GO:0047498,1,0.900040786696081,0,8,calcium-dependent phospholipase A2 activity,MF,
12998,GO:0047499,1,0.915365355746614,0,6,calcium-independent phospholipase A2 activity,MF,
12999,GO:0047522,1,0.959477854059006,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
13000,GO:0047536,1,0.985794133070218,0,1,2-aminoadipate transaminase activity,MF,
13001,GO:0047545,1,0.983426667501332,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
13002,GO:0047555,1,0.813771577614839,0,14,3',5'-cyclic-GMP phosphodiesterase activity,MF,
13003,GO:0047560,1,0.983426667502414,0,1,3-dehydrosphinganine reductase activity,MF,
13004,GO:0047598,1,0.984490228516902,0,1,7-dehydrocholesterol reductase activity,MF,
13005,GO:0047617,1,0.801064127256203,0,17,acyl-CoA hydrolase activity,MF,
13006,GO:0047620,1,0.983955915701001,0,1,acylglycerol kinase activity,MF,
13007,GO:0047621,1,0.988249071568082,0,1,acylpyruvate hydrolase activity,MF,
13008,GO:0047623,1,0.952786629532296,0,3,adenosine-phosphate deaminase activity,MF,
13009,GO:0047631,1,0.958859825209205,0,4,ADP-ribose diphosphatase activity,MF,
13010,GO:0047635,1,0.970831870878065,0,2,alanine-oxo-acid transaminase activity,MF,
13011,GO:0047638,1,0.984230601554668,0,1,albendazole monooxygenase activity,MF,
13012,GO:0047658,1,0.988159237720704,0,1,alpha-amino-acid esterase activity,MF,
13013,GO:0047661,1,0.984951089777405,0,1,amino-acid racemase activity,MF,
13015,GO:0047685,1,0.989212583026046,0,1,amine sulfotransferase activity,MF,
13016,GO:0047693,1,0.994495436116341,0,1,ATP diphosphatase activity,MF,
13017,GO:0047696,1,0.968875202432069,0,2,beta-adrenergic receptor kinase activity,MF,
13018,GO:0047704,1,0.986752206415306,0,1,bile-salt sulfotransferase activity,MF,
13019,GO:0047708,1,0.977853431952584,0,2,biotinidase activity,MF,
13020,GO:0047710,1,0.975410172362705,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
13021,GO:0047714,1,0.989302642381565,0,1,galactolipase activity,MF,
13022,GO:0047718,1,0.969875332227587,0,3,indanol dehydrogenase activity,MF,
13023,GO:0047726,1,0.984868231357013,0,1,iron-cytochrome-c reductase activity,MF,
13024,GO:0047730,1,0.983426716418242,0,1,carnosine synthase activity,MF,
13025,GO:0047734,1,0.984728932554734,0,1,CDP-glycerol diphosphatase activity,MF,
13026,GO:0047743,1,0.991128828326226,0,1,chlordecone reductase activity,MF,
13027,GO:0047747,1,0.985289274961252,0,1,cholate-CoA ligase activity,MF,
13028,GO:0047750,1,0.984074080117149,0,2,cholestenol delta-isomerase activity,MF,
13029,GO:0047751,1,0.9558549769923,0,3,cholestenone 5-alpha-reductase activity,MF,
13030,GO:0047756,1,0.944702782035286,0,4,chondroitin 4-sulfotransferase activity,MF,
13031,GO:0047757,1,0.967126892150038,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
13032,GO:0047760,1,0.903562510411714,0,7,butyrate-CoA ligase activity,MF,
13033,GO:0047783,1,0.967719346008499,0,2,corticosterone 18-monooxygenase activity,MF,
13034,GO:0047787,1,0.975472641993194,0,2,delta4-3-oxosteroid 5beta-reductase activity,MF,
13035,GO:0047800,1,0.983436909090753,0,1,cysteamine dioxygenase activity,MF,
13036,GO:0047801,1,0.986156708719938,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
13037,GO:0047837,1,0.991879343305166,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
13038,GO:0047840,1,0.991657523588261,0,1,dCTP diphosphatase activity,MF,
13039,GO:0047844,1,0.966512847186798,0,3,deoxycytidine deaminase activity,MF,
13040,GO:0047856,1,0.991148416031784,0,1,dihydrocoumarin hydrolase activity,MF,
13041,GO:0047860,1,0.990639064271142,0,1,diiodophenylpyruvate reductase activity,MF,
13042,GO:0047865,1,0.983755488884969,0,1,dimethylglycine dehydrogenase activity,MF,
13043,GO:0047874,1,0.986224806572263,0,1,dolichyldiphosphatase activity,MF,
13044,GO:0047888,1,0.986921788248224,0,1,fatty acid peroxidase activity,MF,
13045,GO:0047894,1,0.969943004626082,0,3,flavonol 3-sulfotransferase activity,MF,
13046,GO:0047915,1,0.988238459597637,0,1,ganglioside galactosyltransferase activity,MF,
13047,GO:0047933,1,0.983426667498479,0,1,glucose-1,6-bisphosphate synthase activity,MF,
13048,GO:0047936,1,0.98342666749784,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
13049,GO:0047939,1,0.989399199546474,0,1,L-glucuronate reductase activity,MF,
13050,GO:0047946,1,0.986400943159058,0,1,glutamine N-acyltransferase activity,MF,
13051,GO:0047961,1,0.952106153666758,0,4,glycine N-acyltransferase activity,MF,
13052,GO:0047962,1,0.988688487049875,0,1,glycine N-benzoyltransferase activity,MF,
13053,GO:0047963,1,0.983511239669819,0,1,glycine N-choloyltransferase activity,MF,
13054,GO:0047969,1,0.987889640668758,0,1,glyoxylate oxidase activity,MF,
13055,GO:0047977,1,0.969950447471883,0,2,hepoxilin-epoxide hydrolase activity,MF,
13056,GO:0047982,1,0.987912661362616,0,1,homocysteine desulfhydrase activity,MF,
13057,GO:0047988,1,0.987142117912342,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
13059,GO:0048003,1,0.902514491731667,0,7,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
13060,GO:0048006,1,0.983431477616573,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
13061,GO:0048007,1,0.902514491731667,0,7,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
13068,GO:0048014,1,0.951096177118276,0,3,Tie signaling pathway,BP,
13073,GO:0048019,1,0.875449480401311,0,10,receptor antagonist activity,MF,
13077,GO:0048023,1,0.947382498373692,0,4,positive regulation of melanin biosynthetic process,BP,
13078,GO:0048024,1,0.362838314453462,0,68,regulation of mRNA splicing, via spliceosome,BP,
13079,GO:0048025,1,0.74139766626575,0,20,negative regulation of mRNA splicing, via spliceosome,BP,
13080,GO:0048026,1,0.80649516806827,0,15,positive regulation of mRNA splicing, via spliceosome,BP,
13081,GO:0048027,1,0.772006873925465,0,21,mRNA 5'-UTR binding,MF,
13082,GO:0048029,1,0.40192848008239,0,62,monosaccharide binding,MF,
13083,GO:0048030,1,0.957294102261505,0,4,disaccharide binding,MF,
13084,GO:0048033,1,0.983866526340532,0,1,heme o metabolic process,BP,
13085,GO:0048034,1,0.983866526340532,0,1,heme O biosynthetic process,BP,
13087,GO:0048038,1,0.807117834520454,0,17,quinone binding,MF,
13088,GO:0048039,1,0.931202010709378,0,6,ubiquinone binding,MF,
13089,GO:0048040,1,0.986306038053932,0,1,UDP-glucuronate decarboxylase activity,MF,
13092,GO:0048050,1,0.931707380535317,0,6,post-embryonic eye morphogenesis,BP,
13093,GO:0048058,1,0.983567727640382,0,1,compound eye corneal lens development,BP,
13095,GO:0048069,1,0.884788772590801,0,8,eye pigmentation,BP,
13097,GO:0048073,1,0.967126892155359,0,2,regulation of eye pigmentation,BP,
13098,GO:0048075,1,0.983426667503252,0,1,positive regulation of eye pigmentation,BP,
13100,GO:0048096,1,0.871538765104277,0,9,chromatin-mediated maintenance of transcription,BP,
13101,GO:0048101,1,0.969614683751626,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
13102,GO:0048102,1,0.919312975822252,0,6,autophagic cell death,BP,
13104,GO:0048104,1,0.935335659967867,0,4,establishment of body hair or bristle planar orientation,BP,
13105,GO:0048105,1,0.935335659967867,0,4,establishment of body hair planar orientation,BP,
13106,GO:0048133,1,0.953803634497934,0,4,male germ-line stem cell asymmetric division,BP,
13107,GO:0048137,1,0.984728932554734,0,1,spermatocyte division,BP,
13108,GO:0048143,1,0.92580451033839,0,5,astrocyte activation,BP,
13112,GO:0048147,1,0.659712590529676,0,31,negative regulation of fibroblast proliferation,BP,
13113,GO:0048148,1,0.78477395049112,0,19,behavioral response to cocaine,BP,
13114,GO:0048149,1,0.843225515960038,0,14,behavioral response to ethanol,BP,
13115,GO:0048156,1,0.866779714403315,0,10,tau protein binding,MF,
13116,GO:0048160,1,0.983426667503004,0,1,primary follicle stage,BP,
13117,GO:0048162,1,0.960991730609913,0,3,multi-layer follicle stage,BP,
13118,GO:0048165,1,0.967126892153958,0,2,fused antrum stage,BP,
13122,GO:0048170,1,0.937403494838095,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
13123,GO:0048172,1,0.803925461980016,0,14,regulation of short-term neuronal synaptic plasticity,BP,
13124,GO:0048174,1,0.983426667503345,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
13129,GO:0048180,1,0.985996069873542,0,1,activin complex,CC,
13131,GO:0048188,1,0.830697225394042,0,13,Set1C/COMPASS complex,CC,
13133,GO:0048194,1,0.869554011594173,0,9,Golgi vesicle budding,BP,
13134,GO:0048199,1,0.38262074998474,0,67,vesicle targeting, to, from or within Golgi,BP,
13135,GO:0048200,1,0.944146655891342,0,4,Golgi transport vesicle coating,BP,
13136,GO:0048203,1,0.971289414093371,0,2,vesicle targeting, trans-Golgi to endosome,BP,
13137,GO:0048205,1,0.944146655891342,0,4,COPI coating of Golgi vesicle,BP,
13138,GO:0048207,1,0.411590316620478,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
13139,GO:0048208,1,0.411590316620478,0,62,COPII vesicle coating,BP,
13140,GO:0048209,1,0.969665272223389,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
13141,GO:0048210,1,0.973760159737771,0,2,Golgi vesicle fusion to target membrane,BP,
13142,GO:0048211,1,0.983428447906001,0,1,Golgi vesicle docking,BP,
13143,GO:0048213,1,0.97216389898511,0,2,Golgi vesicle prefusion complex stabilization,BP,
13144,GO:0048227,1,0.891589356736035,0,8,plasma membrane to endosome transport,BP,
13147,GO:0048239,1,0.970452903517209,0,2,negative regulation of DNA recombination at telomere,BP,
13148,GO:0048240,1,0.770615415612685,0,21,sperm capacitation,BP,
13152,GO:0048244,1,0.988329028832807,0,1,phytanoyl-CoA dioxygenase activity,MF,
13153,GO:0048245,1,0.90278316505261,0,11,eosinophil chemotaxis,BP,
13154,GO:0048246,1,0.712763571864475,0,29,macrophage chemotaxis,BP,
13156,GO:0048248,1,0.953645973799224,0,5,CXCR3 chemokine receptor binding,MF,
13157,GO:0048250,1,0.976411017368273,0,2,mitochondrial iron ion transport,BP,
13159,GO:0048254,1,0.953159018200003,0,4,snoRNA localization,BP,
13161,GO:0048256,1,0.88329044573447,0,8,flap endonuclease activity,MF,
13162,GO:0048257,1,0.970119613657234,0,2,3'-flap endonuclease activity,MF,
13168,GO:0048264,1,0.983854828357024,0,1,determination of ventral identity,BP,
13169,GO:0048265,1,0.656735221785577,0,30,response to pain,BP,
13170,GO:0048266,1,0.813758354865546,0,14,behavioral response to pain,BP,
13171,GO:0048268,1,0.789599581295193,0,16,clathrin coat assembly,BP,
13172,GO:0048269,1,0.970698097479282,0,2,methionine adenosyltransferase complex,CC,
13173,GO:0048270,1,0.986336810527875,0,1,methionine adenosyltransferase regulator activity,MF,
13174,GO:0048273,1,0.926779905806385,0,5,mitogen-activated protein kinase p38 binding,MF,
13176,GO:0048280,1,0.868137391924316,0,10,vesicle fusion with Golgi apparatus,BP,
13181,GO:0048290,1,0.913321346114212,0,6,isotype switching to IgA isotypes,BP,
13182,GO:0048291,1,0.824470346661681,0,14,isotype switching to IgG isotypes,BP,
13184,GO:0048294,1,0.95308207101992,0,3,negative regulation of isotype switching to IgE isotypes,BP,
13186,GO:0048296,1,0.928599270545918,0,5,regulation of isotype switching to IgA isotypes,BP,
13187,GO:0048297,1,0.986140812598069,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13188,GO:0048298,1,0.941653047802916,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13189,GO:0048302,1,0.836636407601641,0,13,regulation of isotype switching to IgG isotypes,BP,
13190,GO:0048304,1,0.877729042357926,0,10,positive regulation of isotype switching to IgG isotypes,BP,
13191,GO:0048305,1,0.773870216600302,0,21,immunoglobulin secretion,BP,
13193,GO:0048308,1,0.819953036483659,0,14,organelle inheritance,BP,
13194,GO:0048311,1,0.816509597402958,0,13,mitochondrion distribution,BP,
13195,GO:0048312,1,0.88618780425122,0,8,intracellular distribution of mitochondria,BP,
13196,GO:0048313,1,0.819953036483659,0,14,Golgi inheritance,BP,
13200,GO:0048321,1,0.986342985336837,0,1,axial mesodermal cell differentiation,BP,
13201,GO:0048322,1,0.986342985336837,0,1,axial mesodermal cell fate commitment,BP,
13202,GO:0048327,1,0.986342985336837,0,1,axial mesodermal cell fate specification,BP,
13205,GO:0048337,1,0.983963369018216,0,1,positive regulation of mesodermal cell fate specification,BP,
13206,GO:0048338,1,0.983450982062668,0,1,mesoderm structural organization,BP,
13210,GO:0048342,1,0.972426270546834,0,2,paraxial mesodermal cell differentiation,BP,
13211,GO:0048343,1,0.972426270546834,0,2,paraxial mesodermal cell fate commitment,BP,
13212,GO:0048352,1,0.983450982062668,0,1,paraxial mesoderm structural organization,BP,
13213,GO:0048364,1,0.994020585908706,0,1,root development,BP,
13214,GO:0048365,1,0.500325720767442,0,44,Rac GTPase binding,MF,
13215,GO:0048368,1,0.8141308004336,0,15,lateral mesoderm development,BP,
13216,GO:0048369,1,0.941606770064534,0,4,lateral mesoderm morphogenesis,BP,
13217,GO:0048370,1,0.941606770064534,0,4,lateral mesoderm formation,BP,
13218,GO:0048371,1,0.95238448710085,0,3,lateral mesodermal cell differentiation,BP,
13219,GO:0048372,1,0.967150805357641,0,2,lateral mesodermal cell fate commitment,BP,
13220,GO:0048377,1,0.967150805357641,0,2,lateral mesodermal cell fate specification,BP,
13221,GO:0048378,1,0.967150805357641,0,2,regulation of lateral mesodermal cell fate specification,BP,
13223,GO:0048384,1,0.650902789314281,0,30,retinoic acid receptor signaling pathway,BP,
13224,GO:0048385,1,0.798890660493247,0,16,regulation of retinoic acid receptor signaling pathway,BP,
13225,GO:0048386,1,0.938589183617578,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13226,GO:0048387,1,0.862905608074623,0,10,negative regulation of retinoic acid receptor signaling pathway,BP,
13227,GO:0048388,1,0.960892842632018,0,3,endosomal lumen acidification,BP,
13232,GO:0048403,1,0.951096869747099,0,3,brain-derived neurotrophic factor binding,MF,
13233,GO:0048406,1,0.906168721531157,0,6,nerve growth factor binding,MF,
13235,GO:0048408,1,0.964304669761732,0,3,epidermal growth factor binding,MF,
13239,GO:0048475,1,0.25471438955897,0,91,coated membrane,CC,
13240,GO:0048476,1,0.939876389892388,0,5,Holliday junction resolvase complex,CC,
13242,GO:0048478,1,0.915790750475879,0,6,replication fork protection,BP,
13247,GO:0048487,1,0.624793873565691,0,34,beta-tubulin binding,MF,
13250,GO:0048490,1,0.791519301468278,0,17,anterograde synaptic vesicle transport,BP,
13251,GO:0048495,1,0.923717890956374,0,5,Roundabout binding,MF,
13252,GO:0048496,1,0.937001700434446,0,4,maintenance of animal organ identity,BP,
13253,GO:0048499,1,0.968757731748938,0,2,synaptic vesicle membrane organization,BP,
13254,GO:0048500,1,0.892263131420204,0,9,signal recognition particle,CC,
13268,GO:0048525,1,0.226809807583017,0,106,negative regulation of viral process,BP,
13272,GO:0048535,1,0.809346492231405,0,16,lymph node development,BP,
13276,GO:0048539,1,0.900468120640252,0,7,bone marrow development,BP,
13280,GO:0048548,1,0.870336593023302,0,9,regulation of pinocytosis,BP,
13281,GO:0048549,1,0.937158408421053,0,4,positive regulation of pinocytosis,BP,
13282,GO:0048550,1,0.928715890352446,0,5,negative regulation of pinocytosis,BP,
13284,GO:0048560,1,0.971963227076483,0,2,establishment of anatomical structure orientation,BP,
13285,GO:0048561,1,0.985807077309511,0,1,establishment of animal organ orientation,BP,
13290,GO:0048567,1,0.984734240689121,0,1,ectodermal digestive tract morphogenesis,BP,
13294,GO:0048571,1,0.99412965695281,0,1,long-day photoperiodism,BP,
13303,GO:0048597,1,0.970448087493172,0,3,post-embryonic camera-type eye morphogenesis,BP,
13308,GO:0048611,1,0.968892847783573,0,2,embryonic ectodermal digestive tract development,BP,
13309,GO:0048613,1,0.984734240689121,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13310,GO:0048617,1,0.868064060694025,0,9,embryonic foregut morphogenesis,BP,
13311,GO:0048619,1,0.953710992680891,0,3,embryonic hindgut morphogenesis,BP,
13312,GO:0048621,1,0.986314227490632,0,1,post-embryonic digestive tract morphogenesis,BP,
13313,GO:0048625,1,0.92722011501276,0,5,myoblast fate commitment,BP,
13314,GO:0048627,1,0.973678523472013,0,2,myoblast development,BP,
13317,GO:0048632,1,0.967842895239739,0,2,negative regulation of skeletal muscle tissue growth,BP,
13326,GO:0048642,1,0.852652656493224,0,11,negative regulation of skeletal muscle tissue development,BP,
13336,GO:0048664,1,0.881747214068992,0,10,neuron fate determination,BP,
13343,GO:0048671,1,0.868721289283248,0,9,negative regulation of collateral sprouting,BP,
13345,GO:0048673,1,0.988777473821184,0,1,collateral sprouting of intact axon in response to injury,BP,
13347,GO:0048677,1,0.951702332982444,0,3,axon extension involved in regeneration,BP,
13349,GO:0048679,1,0.720368529394668,0,22,regulation of axon regeneration,BP,
13350,GO:0048680,1,0.919395203184649,0,6,positive regulation of axon regeneration,BP,
13351,GO:0048681,1,0.836313682210855,0,12,negative regulation of axon regeneration,BP,
13352,GO:0048682,1,0.951702332982444,0,3,sprouting of injured axon,BP,
13353,GO:0048683,1,0.988777473821184,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13354,GO:0048685,1,0.988777473821184,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13355,GO:0048686,1,0.967743222352684,0,2,regulation of sprouting of injured axon,BP,
13356,GO:0048687,1,0.984053342088746,0,1,positive regulation of sprouting of injured axon,BP,
13357,GO:0048688,1,0.983426667502414,0,1,negative regulation of sprouting of injured axon,BP,
13358,GO:0048690,1,0.967743222352684,0,2,regulation of axon extension involved in regeneration,BP,
13359,GO:0048691,1,0.984053342088746,0,1,positive regulation of axon extension involved in regeneration,BP,
13360,GO:0048692,1,0.983426667502414,0,1,negative regulation of axon extension involved in regeneration,BP,
13363,GO:0048698,1,0.983426667502658,0,1,negative regulation of collateral sprouting in absence of injury,BP,
13366,GO:0048702,1,0.892540509881857,0,7,embryonic neurocranium morphogenesis,BP,
13367,GO:0048703,1,0.846581269030551,0,11,embryonic viscerocranium morphogenesis,BP,
13375,GO:0048712,1,0.835930535222192,0,12,negative regulation of astrocyte differentiation,BP,
13377,GO:0048714,1,0.796230353944171,0,16,positive regulation of oligodendrocyte differentiation,BP,
13383,GO:0048733,1,0.895960634112663,0,7,sebaceous gland development,BP,
13387,GO:0048741,1,0.653394978881398,0,29,skeletal muscle fiber development,BP,
13388,GO:0048742,1,0.866739667153498,0,10,regulation of skeletal muscle fiber development,BP,
13389,GO:0048743,1,0.909448439486645,0,7,positive regulation of skeletal muscle fiber development,BP,
13392,GO:0048749,1,0.967265623839895,0,2,compound eye development,BP,
13396,GO:0048755,1,0.864755278961804,0,9,branching morphogenesis of a nerve,BP,
13399,GO:0048763,1,0.935330099139952,0,4,calcium-induced calcium release activity,MF,
13400,GO:0048764,1,0.994020585908706,0,1,trichoblast maturation,BP,
13401,GO:0048765,1,0.994020585908706,0,1,root hair cell differentiation,BP,
13402,GO:0048767,1,0.994020585908706,0,1,root hair elongation,BP,
13403,GO:0048769,1,0.9600959101777,0,3,sarcomerogenesis,BP,
13407,GO:0048787,1,0.938015280900067,0,4,presynaptic active zone membrane,CC,
13408,GO:0048788,1,0.967126892128643,0,2,cytoskeleton of presynaptic active zone,CC,
13409,GO:0048789,1,0.983426667502708,0,1,cytoskeletal matrix organization at active zone,BP,
13410,GO:0048790,1,0.989244467547671,0,1,maintenance of presynaptic active zone structure,BP,
13412,GO:0048792,1,0.983507581079746,0,1,spontaneous exocytosis of neurotransmitter,BP,
13413,GO:0048793,1,0.88080363380984,0,8,pronephros development,BP,
13421,GO:0048817,1,0.967126892154685,0,2,negative regulation of hair follicle maturation,BP,
13425,GO:0048821,1,0.720913453297636,0,23,erythrocyte development,BP,
13426,GO:0048822,1,0.969811869340084,0,2,enucleate erythrocyte development,BP,
13428,GO:0048840,1,0.922857656832713,0,5,otolith development,BP,
13430,GO:0048842,1,0.894238146211718,0,7,positive regulation of axon extension involved in axon guidance,BP,
13439,GO:0048855,1,0.983426667500985,0,1,adenohypophysis morphogenesis,BP,
13441,GO:0048857,1,0.411413714369214,0,62,neural nucleus development,BP,
13443,GO:0048859,1,0.943354990448008,0,5,formation of anatomical boundary,BP,
13447,GO:0048865,1,0.904631828467092,0,8,stem cell fate commitment,BP,
13448,GO:0048866,1,0.965109279909032,0,3,stem cell fate specification,BP,
13449,GO:0048867,1,0.963498364472287,0,3,stem cell fate determination,BP,
13454,GO:0048873,1,0.657005782299925,0,30,homeostasis of number of cells within a tissue,BP,
13455,GO:0048874,1,0.983591359917946,0,1,homeostasis of number of cells in a free-living population,BP,
13456,GO:0048875,1,0.880982587928287,0,9,chemical homeostasis within a tissue,BP,
13458,GO:0048880,1,0.936609698840787,0,4,sensory system development,BP,
13459,GO:0048892,1,0.983832058556469,0,1,lateral line nerve development,BP,
13460,GO:0048894,1,0.983832058556469,0,1,efferent axon development in a lateral line nerve,BP,
13461,GO:0048925,1,0.983832058556469,0,1,lateral line system development,BP,
13462,GO:0048934,1,0.8199745321175,0,13,peripheral nervous system neuron differentiation,BP,
13463,GO:0048935,1,0.8199745321175,0,13,peripheral nervous system neuron development,BP,
13464,GO:0048936,1,0.955413231065832,0,3,peripheral nervous system neuron axonogenesis,BP,
13466,GO:0050023,1,0.987330922549027,0,1,L-fuconate dehydratase activity,MF,
13467,GO:0050031,1,0.985146370134175,0,1,L-pipecolate oxidase activity,MF,
13468,GO:0050038,1,0.993637771456672,0,1,L-xylulose reductase (NADP+) activity,MF,
13469,GO:0050051,1,0.943122593247399,0,4,leukotriene-B4 20-monooxygenase activity,MF,
13470,GO:0050062,1,0.969926635213212,0,2,long-chain-fatty-acyl-CoA reductase activity,MF,
13471,GO:0050072,1,0.905791397971566,0,7,m7G(5')pppN diphosphatase activity,MF,
13472,GO:0050080,1,0.985911975806286,0,1,malonyl-CoA decarboxylase activity,MF,
13473,GO:0050104,1,0.989244467547671,0,1,L-gulonate 3-dehydrogenase activity,MF,
13474,GO:0050113,1,0.989591432912315,0,1,inositol oxygenase activity,MF,
13475,GO:0050115,1,0.98342666750276,0,1,myosin-light-chain-phosphatase activity,MF,
13476,GO:0050119,1,0.967126892151439,0,2,N-acetylglucosamine deacetylase activity,MF,
13477,GO:0050121,1,0.989390392515629,0,1,N-acylglucosamine 2-epimerase activity,MF,
13478,GO:0050124,1,0.98343080149108,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13479,GO:0050129,1,0.983652085803538,0,1,N-formylglutamate deformylase activity,MF,
13480,GO:0050135,1,0.978748181862732,0,2,NAD(P)+ nucleosidase activity,MF,
13481,GO:0050136,1,0.758217837635614,0,38,NADH dehydrogenase (quinone) activity,MF,
13482,GO:0050144,1,0.984728932554734,0,1,nucleoside deoxyribosyltransferase activity,MF,
13483,GO:0050145,1,0.960833618269982,0,3,nucleoside phosphate kinase activity,MF,
13484,GO:0050146,1,0.983426667502267,0,1,nucleoside phosphotransferase activity,MF,
13485,GO:0050152,1,0.990619991832821,0,1,omega-amidase activity,MF,
13486,GO:0050178,1,0.995641439960648,0,1,phenylpyruvate tautomerase activity,MF,
13487,GO:0050197,1,0.985472455448814,0,1,phytanate-CoA ligase activity,MF,
13488,GO:0050201,1,0.983426900193547,0,1,fucokinase activity,MF,
13489,GO:0050211,1,0.983879771943761,0,1,procollagen galactosyltransferase activity,MF,
13491,GO:0050221,1,0.990824462822371,0,1,prostaglandin-E2 9-reductase activity,MF,
13492,GO:0050252,1,0.95530849196122,0,3,retinol O-fatty-acyltransferase activity,MF,
13493,GO:0050253,1,0.967960748989622,0,2,retinyl-palmitate esterase activity,MF,
13494,GO:0050254,1,0.960511139502969,0,3,rhodopsin kinase activity,MF,
13495,GO:0050262,1,0.969690119055175,0,2,ribosylnicotinamide kinase activity,MF,
13496,GO:0050265,1,0.951775797619261,0,3,RNA uridylyltransferase activity,MF,
13497,GO:0050277,1,0.983428655268849,0,1,sedoheptulokinase activity,MF,
13498,GO:0050290,1,0.983426667502908,0,1,sphingomyelin phosphodiesterase D activity,MF,
13499,GO:0050291,1,0.899992035136072,0,7,sphingosine N-acyltransferase activity,MF,
13500,GO:0050294,1,0.956850060956376,0,4,steroid sulfotransferase activity,MF,
13502,GO:0050309,1,0.956701545241875,0,3,sugar-terminal-phosphatase activity,MF,
13503,GO:0050313,1,0.992696167789598,0,1,sulfur dioxygenase activity,MF,
13505,GO:0050333,1,0.987657696721872,0,1,thiamin-triphosphatase activity,MF,
13506,GO:0050346,1,0.984728932554734,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13507,GO:0050347,1,0.972211127061147,0,2,trans-octaprenyltranstransferase activity,MF,
13508,GO:0050353,1,0.984080291479883,0,1,trimethyllysine dioxygenase activity,MF,
13509,GO:0050355,1,0.983426667503104,0,1,triphosphatase activity,MF,
13510,GO:0050379,1,0.983426667502611,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13511,GO:0050405,1,0.967126892149115,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13512,GO:0050421,1,0.984620385657398,0,1,nitrite reductase (NO-forming) activity,MF,
13513,GO:0050427,1,0.774716606656193,0,19,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13514,GO:0050428,1,0.911510261667595,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13515,GO:0050429,1,0.983426667500887,0,1,calcium-dependent phospholipase C activity,MF,
13519,GO:0050434,1,0.572142007864806,0,41,positive regulation of viral transcription,BP,
13520,GO:0050435,1,0.686748561335568,0,26,beta-amyloid metabolic process,BP,
13521,GO:0050436,1,0.967127272263009,0,2,microfibril binding,MF,
13522,GO:0050444,1,0.983583320421907,0,1,aquacobalamin reductase (NADPH) activity,MF,
13523,GO:0050462,1,0.990843747764937,0,1,N-acetylneuraminate synthase activity,MF,
13524,GO:0050473,1,0.953152902026853,0,3,arachidonate 15-lipoxygenase activity,MF,
13525,GO:0050479,1,0.984728932554734,0,1,glyceryl-ether monooxygenase activity,MF,
13526,GO:0050480,1,0.986121010490359,0,1,imidazolonepropionase activity,MF,
13527,GO:0050482,1,0.70097461535676,0,29,arachidonic acid secretion,BP,
13528,GO:0050497,1,0.970402374024896,0,2,transferase activity, transferring alkylthio groups,MF,
13529,GO:0050501,1,0.942384172613288,0,4,hyaluronan synthase activity,MF,
13530,GO:0050508,1,0.951214103507955,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13531,GO:0050509,1,0.967246797941561,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13532,GO:0050510,1,0.93581930126788,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13533,GO:0050512,1,0.986322428969776,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13534,GO:0050528,1,0.985218624551564,0,1,acyloxyacyl hydrolase activity,MF,
13535,GO:0050542,1,0.946006369160352,0,6,icosanoid binding,MF,
13536,GO:0050543,1,0.949782885461028,0,6,icosatetraenoic acid binding,MF,
13537,GO:0050544,1,0.957644933912781,0,5,arachidonic acid binding,MF,
13538,GO:0050560,1,0.98354319660451,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13539,GO:0050561,1,0.983426955534294,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13540,GO:0050567,1,0.980261045838147,0,2,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13541,GO:0050571,1,0.988627721862152,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13542,GO:0050577,1,0.99006355571529,0,1,GDP-L-fucose synthase activity,MF,
13543,GO:0050591,1,0.984230601554668,0,1,quinine 3-monooxygenase activity,MF,
13544,GO:0050610,1,0.983335041160537,0,2,methylarsonate reductase activity,MF,
13545,GO:0050613,1,0.972355233402361,0,2,delta14-sterol reductase activity,MF,
13546,GO:0050614,1,0.983426667503251,0,1,delta24-sterol reductase activity,MF,
13547,GO:0050632,1,0.989717066048738,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13548,GO:0050646,1,0.987848860242178,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13549,GO:0050647,1,0.987848860242178,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13550,GO:0050648,1,0.987848860242178,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13551,GO:0050649,1,0.984230601554668,0,1,testosterone 6-beta-hydroxylase activity,MF,
13552,GO:0050650,1,0.642759935219373,0,29,chondroitin sulfate proteoglycan biosynthetic process,BP,
13553,GO:0050651,1,0.795776812532491,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13554,GO:0050652,1,0.983436383804034,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13555,GO:0050653,1,0.967136505690724,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13556,GO:0050654,1,0.524844037208254,0,42,chondroitin sulfate proteoglycan metabolic process,BP,
13557,GO:0050655,1,0.784552325216235,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13558,GO:0050656,1,0.909531650422677,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13559,GO:0050657,1,0.0655852876088378,0,186,nucleic acid transport,BP,
13560,GO:0050658,1,0.0655852876088378,0,186,RNA transport,BP,
13561,GO:0050659,1,0.967126892153664,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13562,GO:0050660,1,0.330338127956109,0,73,flavin adenine dinucleotide binding,MF,
13563,GO:0050661,1,0.529995337708198,0,45,NADP binding,MF,
13564,GO:0050662,1,0.0784196381263175,0,177,coenzyme binding,MF,
13566,GO:0050664,1,0.815868628008441,0,14,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13567,GO:0050665,1,0.884503769133124,0,9,hydrogen peroxide biosynthetic process,BP,
13568,GO:0050666,1,0.970735289928478,0,2,regulation of homocysteine metabolic process,BP,
13569,GO:0050667,1,0.811306479869717,0,14,homocysteine metabolic process,BP,
13570,GO:0050668,1,0.985631043093334,0,1,positive regulation of homocysteine metabolic process,BP,
13581,GO:0050681,1,0.52882285145774,0,42,androgen receptor binding,MF,
13582,GO:0050682,1,0.967126892147616,0,2,AF-2 domain binding,MF,
13583,GO:0050683,1,0.983426667503348,0,1,AF-1 domain binding,MF,
13584,GO:0050684,1,0.221039984026612,0,100,regulation of mRNA processing,BP,
13585,GO:0050685,1,0.716614738478975,0,23,positive regulation of mRNA processing,BP,
13586,GO:0050686,1,0.641413153052578,0,29,negative regulation of mRNA processing,BP,
13587,GO:0050687,1,0.738449410665272,0,20,negative regulation of defense response to virus,BP,
13588,GO:0050688,1,0.290281496397747,0,86,regulation of defense response to virus,BP,
13589,GO:0050689,1,0.947927185543331,0,4,negative regulation of defense response to virus by host,BP,
13590,GO:0050690,1,0.673414372342863,0,28,regulation of defense response to virus by virus,BP,
13591,GO:0050691,1,0.655414705361208,0,31,regulation of defense response to virus by host,BP,
13592,GO:0050692,1,0.955238591407443,0,3,DBD domain binding,MF,
13593,GO:0050693,1,0.921371575462253,0,6,LBD domain binding,MF,
13594,GO:0050694,1,0.946679172696543,0,4,galactose 3-O-sulfotransferase activity,MF,
13595,GO:0050698,1,0.968604995545671,0,2,proteoglycan sulfotransferase activity,MF,
13596,GO:0050699,1,0.722543000658044,0,21,WW domain binding,MF,
13597,GO:0050700,1,0.894459430662665,0,7,CARD domain binding,MF,
13600,GO:0050703,1,0.946005553787515,0,5,interleukin-1 alpha secretion,BP,
13602,GO:0050705,1,0.950484427162251,0,4,regulation of interleukin-1 alpha secretion,BP,
13609,GO:0050712,1,0.989651120410726,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13610,GO:0050713,1,0.943849801697018,0,5,negative regulation of interleukin-1 beta secretion,BP,
13614,GO:0050717,1,0.96042541489884,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13617,GO:0050720,1,0.971003277896295,0,3,interleukin-1 beta biosynthetic process,BP,
13619,GO:0050722,1,0.976887602179373,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13620,GO:0050725,1,0.976887602179373,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13627,GO:0050732,1,0.545221199109808,0,41,negative regulation of peptidyl-tyrosine phosphorylation,BP,
13628,GO:0050733,1,0.906781465097768,0,7,RS domain binding,MF,
13629,GO:0050746,1,0.830817251549898,0,14,regulation of lipoprotein metabolic process,BP,
13630,GO:0050747,1,0.936114565205832,0,5,positive regulation of lipoprotein metabolic process,BP,
13631,GO:0050748,1,0.931600691399837,0,6,negative regulation of lipoprotein metabolic process,BP,
13632,GO:0050750,1,0.797644200216088,0,16,low-density lipoprotein particle receptor binding,MF,
13633,GO:0050751,1,0.99306091186479,0,1,fractalkine biosynthetic process,BP,
13634,GO:0050752,1,0.99306091186479,0,1,regulation of fractalkine biosynthetic process,BP,
13635,GO:0050754,1,0.99306091186479,0,1,positive regulation of fractalkine biosynthetic process,BP,
13637,GO:0050756,1,0.99306091186479,0,1,fractalkine metabolic process,BP,
13638,GO:0050757,1,0.97628135670451,0,2,thymidylate synthase biosynthetic process,BP,
13639,GO:0050758,1,0.97628135670451,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13640,GO:0050760,1,0.984528198925408,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13642,GO:0050765,1,0.862124346851494,0,11,negative regulation of phagocytosis,BP,
13651,GO:0050774,1,0.796959556861037,0,15,negative regulation of dendrite morphogenesis,BP,
13652,GO:0050775,1,0.587126006356247,0,33,positive regulation of dendrite morphogenesis,BP,
13656,GO:0050779,1,0.728286427505018,0,20,RNA destabilization,BP,
13657,GO:0050780,1,0.7958824938012,0,15,dopamine receptor binding,MF,
13658,GO:0050783,1,0.985057614653143,0,1,cocaine metabolic process,BP,
13659,GO:0050786,1,0.929556336095153,0,11,RAGE receptor binding,MF,
13660,GO:0050787,1,0.976456704387992,0,2,detoxification of mercury ion,BP,
13668,GO:0050798,1,0.562463065419616,0,43,activated T cell proliferation,BP,
13678,GO:0050811,1,0.817363238405358,0,14,GABA receptor binding,MF,
13679,GO:0050812,1,0.812207975315237,0,13,regulation of acyl-CoA biosynthetic process,BP,
13680,GO:0050815,1,0.919417933480715,0,6,phosphoserine binding,MF,
13681,GO:0050816,1,0.959855252320994,0,3,phosphothreonine binding,MF,
13685,GO:0050820,1,0.697073268649895,0,25,positive regulation of coagulation,BP,
13687,GO:0050822,1,0.983481377369544,0,1,peptide stabilization,BP,
13688,GO:0050823,1,0.983481377369544,0,1,peptide antigen stabilization,BP,
13689,GO:0050828,1,0.984728932554734,0,1,regulation of liquid surface tension,BP,
13693,GO:0050833,1,0.939093300330577,0,4,pyruvate transmembrane transporter activity,MF,
13696,GO:0050847,1,0.939200361508637,0,4,progesterone receptor signaling pathway,BP,
13699,GO:0050850,1,0.612828278940638,0,38,positive regulation of calcium-mediated signaling,BP,
13703,GO:0050854,1,0.518482056368427,0,45,regulation of antigen receptor-mediated signaling pathway,BP,
13704,GO:0050855,1,0.809263109048015,0,14,regulation of B cell receptor signaling pathway,BP,
13705,GO:0050856,1,0.623910413093702,0,33,regulation of T cell receptor signaling pathway,BP,
13706,GO:0050857,1,0.770852825829525,0,18,positive regulation of antigen receptor-mediated signaling pathway,BP,
13707,GO:0050858,1,0.741762565551197,0,21,negative regulation of antigen receptor-mediated signaling pathway,BP,
13708,GO:0050859,1,0.944697947996256,0,4,negative regulation of B cell receptor signaling pathway,BP,
13709,GO:0050860,1,0.773970675020157,0,18,negative regulation of T cell receptor signaling pathway,BP,
13710,GO:0050861,1,0.897961659177123,0,7,positive regulation of B cell receptor signaling pathway,BP,
13711,GO:0050862,1,0.872982152755376,0,10,positive regulation of T cell receptor signaling pathway,BP,
13718,GO:0050869,1,0.645787210426859,0,30,negative regulation of B cell activation,BP,
13722,GO:0050873,1,0.603308236936146,0,39,brown fat cell differentiation,BP,
13728,GO:0050882,1,0.91996964005112,0,5,voluntary musculoskeletal movement,BP,
13729,GO:0050883,1,0.973859169305306,0,2,musculoskeletal movement, spinal reflex action,BP,
13730,GO:0050884,1,0.793905765213662,0,16,neuromuscular process controlling posture,BP,
13736,GO:0050893,1,0.941626338549917,0,4,sensory processing,BP,
13737,GO:0050894,1,0.983426667500642,0,1,determination of affect,BP,
13739,GO:0050897,1,0.983426667501431,0,1,cobalt ion binding,MF,
13741,GO:0050901,1,0.748788948260001,0,21,leukocyte tethering or rolling,BP,
13742,GO:0050902,1,0.968657657686291,0,2,leukocyte adhesive activation,BP,
13743,GO:0050904,1,0.958145813758004,0,3,diapedesis,BP,
13746,GO:0050907,1,0.0355522211755758,0,419,detection of chemical stimulus involved in sensory perception,BP,
13747,GO:0050908,1,0.771495701651914,0,17,detection of light stimulus involved in visual perception,BP,
13748,GO:0050909,1,0.497352735659843,0,62,sensory perception of taste,BP,
13749,GO:0050910,1,0.833059549244296,0,12,detection of mechanical stimulus involved in sensory perception of sound,BP,
13750,GO:0050911,1,0.0554526583086345,0,376,detection of chemical stimulus involved in sensory perception of smell,BP,
13751,GO:0050912,1,0.676866808532944,0,40,detection of chemical stimulus involved in sensory perception of taste,BP,
13752,GO:0050913,1,0.697773184626109,0,38,sensory perception of bitter taste,BP,
13753,GO:0050915,1,0.92382565531286,0,5,sensory perception of sour taste,BP,
13754,GO:0050916,1,0.917973557964248,0,6,sensory perception of sweet taste,BP,
13755,GO:0050917,1,0.916850773196359,0,6,sensory perception of umami taste,BP,
13761,GO:0050923,1,0.935418486079282,0,4,regulation of negative chemotaxis,BP,
13762,GO:0050924,1,0.983426667502658,0,1,positive regulation of negative chemotaxis,BP,
13763,GO:0050925,1,0.967126892150323,0,2,negative regulation of negative chemotaxis,BP,
13766,GO:0050928,1,0.983426667502365,0,1,negative regulation of positive chemotaxis,BP,
13767,GO:0050929,1,0.983426667502658,0,1,induction of negative chemotaxis,BP,
13775,GO:0050955,1,0.951096177117511,0,3,thermoception,BP,
13777,GO:0050960,1,0.983426667503304,0,1,detection of temperature stimulus involved in thermoception,BP,
13779,GO:0050962,1,0.771495701651914,0,17,detection of light stimulus involved in sensory perception,BP,
13781,GO:0050966,1,0.879784544176282,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13782,GO:0050968,1,0.9523558031742,0,3,detection of chemical stimulus involved in sensory perception of pain,BP,
13783,GO:0050974,1,0.691683869368656,0,24,detection of mechanical stimulus involved in sensory perception,BP,
13784,GO:0050975,1,0.960763015325988,0,3,sensory perception of touch,BP,
13785,GO:0050976,1,0.971210159020633,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13786,GO:0050982,1,0.526144906108855,0,42,detection of mechanical stimulus,BP,
13787,GO:0050992,1,0.976371857725438,0,2,dimethylallyl diphosphate biosynthetic process,BP,
13788,GO:0050993,1,0.976371857725438,0,2,dimethylallyl diphosphate metabolic process,BP,
13793,GO:0050998,1,0.789053792920607,0,16,nitric-oxide synthase binding,MF,
13796,GO:0051001,1,0.913902383217416,0,7,negative regulation of nitric-oxide synthase activity,BP,
13797,GO:0051004,1,0.845611206492261,0,15,regulation of lipoprotein lipase activity,BP,
13798,GO:0051005,1,0.950177599112713,0,5,negative regulation of lipoprotein lipase activity,BP,
13799,GO:0051006,1,0.889972772230228,0,10,positive regulation of lipoprotein lipase activity,BP,
13800,GO:0051010,1,0.833543561480851,0,11,microtubule plus-end binding,MF,
13802,GO:0051012,1,0.971683569956681,0,2,microtubule sliding,BP,
13803,GO:0051013,1,0.912204745492636,0,6,microtubule severing,BP,
13806,GO:0051016,1,0.794235286984826,0,16,barbed-end actin filament capping,BP,
13809,GO:0051019,1,0.69799493957504,0,23,mitogen-activated protein kinase binding,MF,
13811,GO:0051021,1,0.955398985241864,0,3,GDP-dissociation inhibitor binding,MF,
13812,GO:0051022,1,0.955398985241864,0,3,Rho GDP-dissociation inhibitor binding,MF,
13813,GO:0051023,1,0.819770627323173,0,17,regulation of immunoglobulin secretion,BP,
13814,GO:0051024,1,0.889734148081765,0,11,positive regulation of immunoglobulin secretion,BP,
13815,GO:0051025,1,0.96853935259367,0,2,negative regulation of immunoglobulin secretion,BP,
13816,GO:0051026,1,0.912125819930489,0,6,chiasma assembly,BP,
13817,GO:0051028,1,0.1170732597297,0,143,mRNA transport,BP,
13818,GO:0051029,1,0.943951890913022,0,5,rRNA transport,BP,
13819,GO:0051030,1,0.962811105577138,0,3,snRNA transport,BP,
13820,GO:0051031,1,0.611084619783641,0,33,tRNA transport,BP,
13821,GO:0051032,1,0.95109629928378,0,3,nucleic acid transmembrane transporter activity,MF,
13822,GO:0051033,1,0.95109629928378,0,3,RNA transmembrane transporter activity,MF,
13823,GO:0051036,1,0.933940264958752,0,5,regulation of endosome size,BP,
13824,GO:0051037,1,0.967305839870145,0,2,regulation of transcription involved in meiotic cell cycle,BP,
13825,GO:0051038,1,0.983426667503053,0,1,negative regulation of transcription involved in meiotic cell cycle,BP,
13826,GO:0051039,1,0.98360861865074,0,1,positive regulation of transcription involved in meiotic cell cycle,BP,
13828,GO:0051041,1,0.983599669920145,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13830,GO:0051043,1,0.74332759475954,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13831,GO:0051044,1,0.81807232292585,0,14,positive regulation of membrane protein ectodomain proteolysis,BP,
13832,GO:0051045,1,0.90870561525575,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
13846,GO:0051059,1,0.67909191097774,0,28,NF-kappaB binding,MF,
13847,GO:0051066,1,0.975461441342787,0,2,dihydrobiopterin metabolic process,BP,
13848,GO:0051068,1,0.98345849459887,0,1,dihydrolipoamide metabolic process,BP,
13849,GO:0051081,1,0.500858920749532,0,46,nuclear envelope disassembly,BP,
13850,GO:0051082,1,0.247153510924202,0,104,unfolded protein binding,MF,
13851,GO:0051083,1,0.973847808814151,0,2,'de novo' cotranslational protein folding,BP,
13852,GO:0051084,1,0.800461304369429,0,16,'de novo' posttranslational protein folding,BP,
13853,GO:0051085,1,0.845321923267658,0,12,chaperone mediated protein folding requiring cofactor,BP,
13854,GO:0051086,1,0.986854335357924,0,1,chaperone mediated protein folding independent of cofactor,BP,
13855,GO:0051087,1,0.300476103807283,0,86,chaperone binding,MF,
13856,GO:0051088,1,0.95113220149972,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13857,GO:0051089,1,0.983426805565048,0,1,constitutive protein ectodomain proteolysis,BP,
13863,GO:0051095,1,0.876521584687002,0,9,regulation of helicase activity,BP,
13864,GO:0051096,1,0.916784312770668,0,6,positive regulation of helicase activity,BP,
13865,GO:0051097,1,0.956098125312669,0,3,negative regulation of helicase activity,BP,
13870,GO:0051102,1,0.983426667503345,0,1,DNA ligation involved in DNA recombination,BP,
13871,GO:0051103,1,0.86403759841319,0,11,DNA ligation involved in DNA repair,BP,
13872,GO:0051105,1,0.924390761083903,0,5,regulation of DNA ligation,BP,
13873,GO:0051106,1,0.939411749968137,0,4,positive regulation of DNA ligation,BP,
13874,GO:0051107,1,0.984014323910838,0,1,negative regulation of DNA ligation,BP,
13877,GO:0051120,1,0.954005538794461,0,3,hepoxilin A3 synthase activity,MF,
13878,GO:0051121,1,0.925046934808003,0,5,hepoxilin metabolic process,BP,
13879,GO:0051122,1,0.925046934808003,0,5,hepoxilin biosynthetic process,BP,
13880,GO:0051123,1,0.661735527869445,0,30,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13881,GO:0051124,1,0.892239019559447,0,7,synaptic growth at neuromuscular junction,BP,
13883,GO:0051126,1,0.925942711687002,0,6,negative regulation of actin nucleation,BP,
13888,GO:0051131,1,0.785431146859579,0,18,chaperone-mediated protein complex assembly,BP,
13889,GO:0051132,1,0.875935899783461,0,10,NK T cell activation,BP,
13890,GO:0051133,1,0.901439920280892,0,8,regulation of NK T cell activation,BP,
13891,GO:0051134,1,0.987202962341087,0,1,negative regulation of NK T cell activation,BP,
13892,GO:0051135,1,0.913129657780781,0,7,positive regulation of NK T cell activation,BP,
13893,GO:0051136,1,0.910999748649131,0,6,regulation of NK T cell differentiation,BP,
13894,GO:0051138,1,0.937235851118656,0,4,positive regulation of NK T cell differentiation,BP,
13895,GO:0051139,1,0.983427993670479,0,1,metal ion:proton antiporter activity,MF,
13896,GO:0051140,1,0.953367601679614,0,4,regulation of NK T cell proliferation,BP,
13897,GO:0051142,1,0.953367601679614,0,4,positive regulation of NK T cell proliferation,BP,
13905,GO:0051152,1,0.866436560286781,0,10,positive regulation of smooth muscle cell differentiation,BP,
13909,GO:0051156,1,0.710226287935693,0,25,glucose 6-phosphate metabolic process,BP,
13910,GO:0051160,1,0.984812627494499,0,1,L-xylitol catabolic process,BP,
13911,GO:0051164,1,0.984812627494499,0,1,L-xylitol metabolic process,BP,
13912,GO:0051167,1,0.941893893425375,0,5,xylulose 5-phosphate metabolic process,BP,
13920,GO:0051176,1,0.922789779908928,0,5,positive regulation of sulfur metabolic process,BP,
13921,GO:0051177,1,0.915124135374705,0,7,meiotic sister chromatid cohesion,BP,
13925,GO:0051182,1,0.910542338736135,0,6,coenzyme transport,BP,
13928,GO:0051185,1,0.940966787355826,0,4,coenzyme transporter activity,MF,
13930,GO:0051187,1,0.783347736297709,0,20,cofactor catabolic process,BP,
13932,GO:0051189,1,0.903747232235112,0,7,prosthetic group metabolic process,BP,
13933,GO:0051192,1,0.994857040334026,0,1,prosthetic group binding,MF,
13944,GO:0051213,1,0.29599267906837,0,82,dioxygenase activity,MF,
13951,GO:0051225,1,0.282003442921555,0,84,spindle assembly,BP,
13952,GO:0051228,1,0.983426667502466,0,1,mitotic spindle disassembly,BP,
13953,GO:0051230,1,0.983426667502466,0,1,spindle disassembly,BP,
13954,GO:0051231,1,0.849665879217422,0,11,spindle elongation,BP,
13955,GO:0051232,1,0.985273086224779,0,1,meiotic spindle elongation,BP,
13959,GO:0051236,1,0.0623764992114238,0,189,establishment of RNA localization,BP,
13973,GO:0051255,1,0.863432143019736,0,10,spindle midzone assembly,BP,
13974,GO:0051256,1,0.876603042200632,0,9,mitotic spindle midzone assembly,BP,
13975,GO:0051257,1,0.984983208785348,0,1,meiotic spindle midzone assembly,BP,
13981,GO:0051264,1,0.984167611485957,0,1,mono-olein transacylation activity,MF,
13982,GO:0051265,1,0.984167611485957,0,1,diolein transacylation activity,MF,
13983,GO:0051267,1,0.983617119365912,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13990,GO:0051281,1,0.630214445815434,0,34,positive regulation of release of sequestered calcium ion into cytosol,BP,
13994,GO:0051286,1,0.890981142259362,0,7,cell tip,CC,
13995,GO:0051287,1,0.475435077335562,0,53,NAD binding,MF,
13997,GO:0051290,1,0.713938374247293,0,43,protein heterotetramerization,BP,
13999,GO:0051292,1,0.870339882458498,0,9,nuclear pore complex assembly,BP,
14002,GO:0051295,1,0.928204903463752,0,5,establishment of meiotic spindle localization,BP,
14003,GO:0051296,1,0.992198863513634,0,1,establishment of meiotic spindle orientation,BP,
14006,GO:0051299,1,0.807892556870269,0,14,centrosome separation,BP,
14010,GO:0051304,1,0.378345724822548,0,66,chromosome separation,BP,
14011,GO:0051305,1,0.905768668302575,0,6,chromosome movement towards spindle pole,BP,
14012,GO:0051306,1,0.498770711691134,0,48,mitotic sister chromatid separation,BP,
14013,GO:0051307,1,0.785300437034567,0,16,meiotic chromosome separation,BP,
14014,GO:0051308,1,0.984728932554734,0,1,male meiosis chromosome separation,BP,
14016,GO:0051311,1,0.984983208785348,0,1,meiotic metaphase plate congression,BP,
14017,GO:0051315,1,0.870396289492845,0,9,attachment of mitotic spindle microtubules to kinetochore,BP,
14021,GO:0051339,1,0.292258877672348,0,90,regulation of lyase activity,BP,
14022,GO:0051340,1,0.898900157769936,0,8,regulation of ligase activity,BP,
14024,GO:0051342,1,0.893935384776267,0,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
14025,GO:0051343,1,0.944531089429778,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
14026,GO:0051344,1,0.931129306462894,0,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
14031,GO:0051349,1,0.439703706311515,0,59,positive regulation of lyase activity,BP,
14032,GO:0051350,1,0.656770450385345,0,32,negative regulation of lyase activity,BP,
14033,GO:0051351,1,0.925521851367307,0,6,positive regulation of ligase activity,BP,
14034,GO:0051352,1,0.971245121620852,0,2,negative regulation of ligase activity,BP,
14036,GO:0051354,1,0.761110031848332,0,22,negative regulation of oxidoreductase activity,BP,
14037,GO:0051355,1,0.983429986042242,0,1,proprioception involved in equilibrioception,BP,
14038,GO:0051365,1,0.953722168345431,0,3,cellular response to potassium ion starvation,BP,
14039,GO:0051371,1,0.748527058683082,0,18,muscle alpha-actinin binding,MF,
14041,GO:0051377,1,0.951454316399228,0,3,mannose-ethanolamine phosphotransferase activity,MF,
14042,GO:0051378,1,0.85431963587902,0,11,serotonin binding,MF,
14044,GO:0051380,1,0.93996824700347,0,4,norepinephrine binding,MF,
14045,GO:0051382,1,0.848633114382378,0,11,kinetochore assembly,BP,
14046,GO:0051383,1,0.796571759509945,0,15,kinetochore organization,BP,
14049,GO:0051386,1,0.841959354533128,0,11,regulation of neurotrophin TRK receptor signaling pathway,BP,
14050,GO:0051387,1,0.941434626915525,0,4,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
14051,GO:0051388,1,0.920992018338608,0,5,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
14052,GO:0051389,1,0.983426667495474,0,1,inactivation of MAPKK activity,BP,
14053,GO:0051391,1,0.983426724396287,0,1,tRNA acetylation,BP,
14054,GO:0051392,1,0.983426724396287,0,1,tRNA N-acetyltransferase activity,MF,
14055,GO:0051393,1,0.600652790724525,0,32,alpha-actinin binding,MF,
14056,GO:0051394,1,0.990029778762667,0,1,regulation of nerve growth factor receptor activity,BP,
14057,GO:0051400,1,0.876306413678604,0,10,BH domain binding,MF,
14060,GO:0051409,1,0.870302463909314,0,10,response to nitrosative stress,BP,
14061,GO:0051410,1,0.936295239638588,0,5,detoxification of nitrogen compound,BP,
14063,GO:0051414,1,0.927575095009688,0,5,response to cortisol,BP,
14064,GO:0051415,1,0.906305690961453,0,6,interphase microtubule nucleation by interphase microtubule organizing center,BP,
14065,GO:0051418,1,0.891279117489205,0,7,microtubule nucleation by microtubule organizing center,BP,
14066,GO:0051424,1,0.987441616091237,0,1,corticotropin-releasing hormone binding,MF,
14067,GO:0051425,1,0.935524954274889,0,4,PTB domain binding,MF,
14070,GO:0051429,1,0.941774094986206,0,6,corticotropin-releasing hormone receptor binding,MF,
14071,GO:0051430,1,0.957136379000027,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
14072,GO:0051431,1,0.970080009331092,0,4,corticotropin-releasing hormone receptor 2 binding,MF,
14073,GO:0051433,1,0.983426667503053,0,1,BH2 domain binding,MF,
14074,GO:0051434,1,0.946710761740851,0,4,BH3 domain binding,MF,
14075,GO:0051436,1,0.439812792463108,0,71,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,
14076,GO:0051437,1,0.408611000756371,0,76,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,BP,
14078,GO:0051439,1,0.433627681752768,0,72,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,
14079,GO:0051440,1,0.98344967443138,0,1,regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle,BP,
14080,GO:0051441,1,0.98344967443138,0,1,positive regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle,BP,
14082,GO:0051444,1,0.382912815841794,0,83,negative regulation of ubiquitin-protein transferase activity,BP,
14086,GO:0051450,1,0.822122100659704,0,14,myoblast proliferation,BP,
14087,GO:0051451,1,0.864164467687713,0,10,myoblast migration,BP,
14090,GO:0051454,1,0.910951403050633,0,6,intracellular pH elevation,BP,
14091,GO:0051457,1,0.794880880867174,0,15,maintenance of protein location in nucleus,BP,
14092,GO:0051458,1,0.922216631445437,0,7,corticotropin secretion,BP,
14093,GO:0051459,1,0.936529743210426,0,6,regulation of corticotropin secretion,BP,
14094,GO:0051460,1,0.987441616091237,0,1,negative regulation of corticotropin secretion,BP,
14095,GO:0051461,1,0.948443264754205,0,5,positive regulation of corticotropin secretion,BP,
14096,GO:0051462,1,0.947840009045166,0,5,regulation of cortisol secretion,BP,
14097,GO:0051463,1,0.983426667501085,0,1,negative regulation of cortisol secretion,BP,
14098,GO:0051464,1,0.963816081377557,0,4,positive regulation of cortisol secretion,BP,
14099,GO:0051466,1,0.969466891448638,0,2,positive regulation of corticotropin-releasing hormone secretion,BP,
14101,GO:0051481,1,0.831141169565368,0,14,negative regulation of cytosolic calcium ion concentration,BP,
14104,GO:0051490,1,0.957608214281177,0,3,negative regulation of filopodium assembly,BP,
14111,GO:0051497,1,0.738341084884212,0,20,negative regulation of stress fiber assembly,BP,
14112,GO:0051499,1,0.974931501525109,0,2,D-aminoacyl-tRNA deacylase activity,MF,
14113,GO:0051500,1,0.974931501525109,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
14114,GO:0051503,1,0.82766171828923,0,13,adenine nucleotide transport,BP,
14115,GO:0051510,1,0.990753920282674,0,1,regulation of unidimensional cell growth,BP,
14116,GO:0051511,1,0.990753920282674,0,1,negative regulation of unidimensional cell growth,BP,
14117,GO:0051525,1,0.927740247097368,0,5,NFAT protein binding,MF,
14119,GO:0051532,1,0.801313963442315,0,15,regulation of NFAT protein import into nucleus,BP,
14120,GO:0051533,1,0.866561167873669,0,10,positive regulation of NFAT protein import into nucleus,BP,
14121,GO:0051534,1,0.924748565187716,0,5,negative regulation of NFAT protein import into nucleus,BP,
14122,GO:0051536,1,0.43149763626265,0,62,iron-sulfur cluster binding,MF,
14123,GO:0051537,1,0.768625788971935,0,21,2 iron, 2 sulfur cluster binding,MF,
14124,GO:0051538,1,0.959729992991154,0,3,3 iron, 4 sulfur cluster binding,MF,
14125,GO:0051539,1,0.574350845223532,0,40,4 iron, 4 sulfur cluster binding,MF,
14126,GO:0051540,1,0.43149763626265,0,62,metal cluster binding,MF,
14133,GO:0051548,1,0.967126892150668,0,2,negative regulation of keratinocyte migration,BP,
14135,GO:0051552,1,0.913200675652816,0,6,flavone metabolic process,BP,
14136,GO:0051560,1,0.794457283313546,0,16,mitochondrial calcium ion homeostasis,BP,
14137,GO:0051561,1,0.897640704399913,0,8,positive regulation of mitochondrial calcium ion concentration,BP,
14138,GO:0051562,1,0.976035642693643,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
14139,GO:0051563,1,0.967190206304785,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
14140,GO:0051567,1,0.605308988772942,0,32,histone H3-K9 methylation,BP,
14141,GO:0051568,1,0.504629937979994,0,47,histone H3-K4 methylation,BP,
14142,GO:0051569,1,0.694738064443891,0,24,regulation of histone H3-K4 methylation,BP,
14143,GO:0051570,1,0.701775959178512,0,23,regulation of histone H3-K9 methylation,BP,
14144,GO:0051571,1,0.806770823278682,0,14,positive regulation of histone H3-K4 methylation,BP,
14145,GO:0051572,1,0.939097674886244,0,4,negative regulation of histone H3-K4 methylation,BP,
14146,GO:0051573,1,0.829041428901167,0,12,negative regulation of histone H3-K9 methylation,BP,
14147,GO:0051574,1,0.860118553484215,0,10,positive regulation of histone H3-K9 methylation,BP,
14148,GO:0051575,1,0.924204035112855,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
14150,GO:0051581,1,0.955796647866541,0,3,negative regulation of neurotransmitter uptake,BP,
14151,GO:0051582,1,0.963991627110721,0,3,positive regulation of neurotransmitter uptake,BP,
14154,GO:0051585,1,0.983680494091283,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
14155,GO:0051586,1,0.963991627110721,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
14157,GO:0051589,1,0.805123003703732,0,14,negative regulation of neurotransmitter transport,BP,
14158,GO:0051590,1,0.812080311049339,0,14,positive regulation of neurotransmitter transport,BP,
14161,GO:0051593,1,0.865423309341695,0,11,response to folic acid,BP,
14162,GO:0051594,1,0.947297158115839,0,4,detection of glucose,BP,
14163,GO:0051595,1,0.973420224999351,0,2,response to methylglyoxal,BP,
14164,GO:0051596,1,0.972939519486341,0,2,methylglyoxal catabolic process,BP,
14165,GO:0051597,1,0.903585402633802,0,7,response to methylmercury,BP,
14166,GO:0051598,1,0.97084085288413,0,2,meiotic recombination checkpoint,BP,
14167,GO:0051599,1,0.911486068590059,0,6,response to hydrostatic pressure,BP,
14175,GO:0051610,1,0.93995297025886,0,4,serotonin uptake,BP,
14176,GO:0051611,1,0.955796647866541,0,3,regulation of serotonin uptake,BP,
14177,GO:0051612,1,0.955796647866541,0,3,negative regulation of serotonin uptake,BP,
14178,GO:0051615,1,0.983426667501923,0,1,histamine uptake,BP,
14179,GO:0051620,1,0.983680494091283,0,1,norepinephrine uptake,BP,
14180,GO:0051621,1,0.983680494091283,0,1,regulation of norepinephrine uptake,BP,
14181,GO:0051622,1,0.983680494091283,0,1,negative regulation of norepinephrine uptake,BP,
14185,GO:0051642,1,0.719759215056352,0,21,centrosome localization,BP,
14186,GO:0051643,1,0.968407661009259,0,2,endoplasmic reticulum localization,BP,
14187,GO:0051645,1,0.834428018671219,0,12,Golgi localization,BP,
14188,GO:0051646,1,0.561696601884295,0,38,mitochondrion localization,BP,
14189,GO:0051647,1,0.719459490679427,0,21,nucleus localization,BP,
14195,GO:0051654,1,0.768255472774515,0,18,establishment of mitochondrion localization,BP,
14197,GO:0051657,1,0.850011957699141,0,10,maintenance of organelle location,BP,
14198,GO:0051659,1,0.969391161258344,0,2,maintenance of mitochondrion location,BP,
14199,GO:0051660,1,0.935598579278206,0,4,establishment of centrosome localization,BP,
14200,GO:0051661,1,0.920749192311264,0,5,maintenance of centrosome location,BP,
14201,GO:0051664,1,0.983426667503302,0,1,nuclear pore localization,BP,
14202,GO:0051665,1,0.873970419085655,0,10,membrane raft localization,BP,
14204,GO:0051673,1,0.975947093991677,0,2,membrane disruption in other organism,BP,
14206,GO:0051683,1,0.905361784735551,0,7,establishment of Golgi localization,BP,
14207,GO:0051684,1,0.951677773932974,0,3,maintenance of Golgi location,BP,
14208,GO:0051685,1,0.984728932554734,0,1,maintenance of ER location,BP,
14209,GO:0051691,1,0.979829024880684,0,2,cellular oligosaccharide metabolic process,BP,
14210,GO:0051692,1,0.979829024880684,0,2,cellular oligosaccharide catabolic process,BP,
14212,GO:0051694,1,0.900890825539548,0,7,pointed-end actin filament capping,BP,
14214,GO:0051697,1,0.945930766620738,0,4,protein delipidation,BP,
14216,GO:0051702,1,0.430900707735028,0,62,interaction with symbiont,BP,
14217,GO:0051703,1,0.501142176141997,0,47,intraspecies interaction between organisms,BP,
14219,GO:0051705,1,0.396925898393414,0,63,multi-organism behavior,BP,
14221,GO:0051708,1,0.934775998830161,0,5,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14222,GO:0051709,1,0.909663683726637,0,7,regulation of killing of cells of other organism,BP,
14223,GO:0051712,1,0.924737703953244,0,6,positive regulation of killing of cells of other organism,BP,
14224,GO:0051715,1,0.970300969153238,0,2,cytolysis in other organism,BP,
14226,GO:0051717,1,0.967788383011464,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14228,GO:0051722,1,0.985006806018802,0,1,protein C-terminal methylesterase activity,MF,
14229,GO:0051723,1,0.985006806018802,0,1,protein methylesterase activity,MF,
14230,GO:0051724,1,0.985647073098095,0,1,NAD transporter activity,MF,
14231,GO:0051725,1,0.946408910593244,0,4,protein de-ADP-ribosylation,BP,
14233,GO:0051728,1,0.983879771943761,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14234,GO:0051729,1,0.983879771943761,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14235,GO:0051731,1,0.943958303984011,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14236,GO:0051732,1,0.987899864828234,0,1,polyribonucleotide kinase activity,MF,
14237,GO:0051733,1,0.959869213974752,0,3,polydeoxyribonucleotide kinase activity,MF,
14238,GO:0051734,1,0.959869213974752,0,3,ATP-dependent polynucleotide kinase activity,MF,
14239,GO:0051736,1,0.987899864828234,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14240,GO:0051747,1,0.99284292196966,0,1,cytosine C-5 DNA demethylase activity,MF,
14241,GO:0051748,1,0.986101284024369,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14242,GO:0051754,1,0.952936659960482,0,3,meiotic sister chromatid cohesion, centromeric,BP,
14243,GO:0051758,1,0.98342666750094,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14244,GO:0051764,1,0.827467948707365,0,12,actin crosslink formation,BP,
14245,GO:0051765,1,0.971473050877134,0,2,inositol tetrakisphosphate kinase activity,MF,
14246,GO:0051766,1,0.854075807704681,0,11,inositol trisphosphate kinase activity,MF,
14251,GO:0051775,1,0.864545518901731,0,11,response to redox state,BP,
14252,GO:0051780,1,0.983426667503304,0,1,behavioral response to nutrient,BP,
14254,GO:0051782,1,0.789345298406845,0,16,negative regulation of cell division,BP,
14258,GO:0051786,1,0.983568651140861,0,1,all-trans-retinol 13,14-reductase activity,MF,
14259,GO:0051787,1,0.826924556735396,0,13,misfolded protein binding,MF,
14260,GO:0051788,1,0.727420733189518,0,22,response to misfolded protein,BP,
14261,GO:0051790,1,0.945273321867928,0,4,short-chain fatty acid biosynthetic process,BP,
14262,GO:0051791,1,0.93618967949581,0,5,medium-chain fatty acid metabolic process,BP,
14263,GO:0051792,1,0.979790152836933,0,2,medium-chain fatty acid biosynthetic process,BP,
14264,GO:0051793,1,0.984590399497301,0,1,medium-chain fatty acid catabolic process,BP,
14265,GO:0051794,1,0.947757709752073,0,4,regulation of timing of catagen,BP,
14266,GO:0051795,1,0.963732394379072,0,3,positive regulation of timing of catagen,BP,
14267,GO:0051796,1,0.983426667503251,0,1,negative regulation of timing of catagen,BP,
14270,GO:0051799,1,0.945154159167714,0,4,negative regulation of hair follicle development,BP,
14271,GO:0051800,1,0.971099435888973,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14272,GO:0051801,1,0.970300969153238,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14273,GO:0051805,1,0.984371383470671,0,1,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14275,GO:0051807,1,0.984371383470671,0,1,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14276,GO:0051808,1,0.985144817662511,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14277,GO:0051817,1,0.268089296020535,0,93,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
14278,GO:0051818,1,0.875223161396018,0,12,disruption of cells of other organism involved in symbiotic interaction,BP,
14279,GO:0051821,1,0.983426667500986,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14280,GO:0051823,1,0.869250089135167,0,9,regulation of synapse structural plasticity,BP,
14282,GO:0051832,1,0.954386941858277,0,3,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14283,GO:0051834,1,0.954386941858277,0,3,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14284,GO:0051835,1,0.943406423749782,0,4,positive regulation of synapse structural plasticity,BP,
14285,GO:0051836,1,0.985144817662511,0,1,translocation of molecules into other organism involved in symbiotic interaction,BP,
14286,GO:0051851,1,0.455762828238323,0,58,modification by host of symbiont morphology or physiology,BP,
14287,GO:0051852,1,0.924814971351799,0,8,disruption by host of symbiont cells,BP,
14288,GO:0051861,1,0.764853177847938,0,19,glycolipid binding,MF,
14289,GO:0051864,1,0.921042685055349,0,5,histone demethylase activity (H3-K36 specific),MF,
14290,GO:0051865,1,0.449747113429285,0,53,protein autoubiquitination,BP,
14291,GO:0051866,1,0.974294045087385,0,2,general adaptation syndrome,BP,
14292,GO:0051867,1,0.990667710679396,0,1,general adaptation syndrome, behavioral process,BP,
14293,GO:0051870,1,0.967514289113563,0,3,methotrexate binding,MF,
14294,GO:0051873,1,0.924814971351799,0,8,killing by host of symbiont cells,BP,
14296,GO:0051877,1,0.968560983974766,0,2,pigment granule aggregation in cell center,BP,
14297,GO:0051878,1,0.983477861783854,0,1,lateral element assembly,BP,
14298,GO:0051879,1,0.627038848001153,0,31,Hsp90 protein binding,MF,
14299,GO:0051880,1,0.889870332421579,0,7,G-quadruplex DNA binding,MF,
14301,GO:0051882,1,0.745088852224245,0,22,mitochondrial depolarization,BP,
14302,GO:0051883,1,0.875223161396018,0,12,killing of cells in other organism involved in symbiotic interaction,BP,
14305,GO:0051886,1,0.983426667502463,0,1,negative regulation of timing of anagen,BP,
14306,GO:0051890,1,0.893499672844723,0,7,regulation of cardioblast differentiation,BP,
14307,GO:0051891,1,0.923376222266196,0,5,positive regulation of cardioblast differentiation,BP,
14308,GO:0051892,1,0.967654734448164,0,2,negative regulation of cardioblast differentiation,BP,
14311,GO:0051895,1,0.801146188818663,0,14,negative regulation of focal adhesion assembly,BP,
14314,GO:0051898,1,0.60798114430787,0,34,negative regulation of protein kinase B signaling,BP,
14316,GO:0051900,1,0.767386722261234,0,19,regulation of mitochondrial depolarization,BP,
14317,GO:0051901,1,0.889316778363886,0,9,positive regulation of mitochondrial depolarization,BP,
14318,GO:0051902,1,0.918566121062606,0,6,negative regulation of mitochondrial depolarization,BP,
14319,GO:0051903,1,0.984515054534747,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14322,GO:0051908,1,0.983652085803538,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14323,GO:0051916,1,0.983910541575551,0,1,granulocyte colony-stimulating factor binding,MF,
14324,GO:0051917,1,0.819015786778865,0,14,regulation of fibrinolysis,BP,
14325,GO:0051918,1,0.87018099595989,0,10,negative regulation of fibrinolysis,BP,
14326,GO:0051919,1,0.942282031859629,0,4,positive regulation of fibrinolysis,BP,
14327,GO:0051920,1,0.928355783311312,0,8,peroxiredoxin activity,MF,
14328,GO:0051923,1,0.8062234919276,0,16,sulfation,BP,
14335,GO:0051933,1,0.935330099169436,0,4,amino acid neurotransmitter reuptake,BP,
14337,GO:0051935,1,0.935330099169436,0,4,glutamate reuptake,BP,
14339,GO:0051938,1,0.860749958468807,0,9,L-glutamate import,BP,
14340,GO:0051939,1,0.983426667503104,0,1,gamma-aminobutyric acid import,BP,
14342,GO:0051941,1,0.967126892152118,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14343,GO:0051944,1,0.963991627110721,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14344,GO:0051945,1,0.983680494091283,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14345,GO:0051946,1,0.967126892152118,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14351,GO:0051957,1,0.806497054871538,0,15,positive regulation of amino acid transport,BP,
14352,GO:0051958,1,0.967802175604873,0,2,methotrexate transport,BP,
14353,GO:0051959,1,0.828871616695883,0,12,dynein light intermediate chain binding,MF,
14362,GO:0051968,1,0.728940618621642,0,20,positive regulation of synaptic transmission, glutamatergic,BP,
14363,GO:0051969,1,0.818733909988073,0,16,regulation of transmission of nerve impulse,BP,
14364,GO:0051970,1,0.95000035776594,0,5,negative regulation of transmission of nerve impulse,BP,
14365,GO:0051971,1,0.919700400757525,0,7,positive regulation of transmission of nerve impulse,BP,
14366,GO:0051972,1,0.518206273236639,0,44,regulation of telomerase activity,BP,
14367,GO:0051973,1,0.59189853043934,0,35,positive regulation of telomerase activity,BP,
14368,GO:0051974,1,0.875751380807971,0,9,negative regulation of telomerase activity,BP,
14369,GO:0051977,1,0.978518389620585,0,2,lysophospholipid transport,BP,
14370,GO:0051978,1,0.985925255988041,0,1,lysophospholipid transporter activity,MF,
14371,GO:0051983,1,0.30667766466977,0,80,regulation of chromosome segregation,BP,
14372,GO:0051984,1,0.746257561178738,0,19,positive regulation of chromosome segregation,BP,
14373,GO:0051985,1,0.608511418591856,0,34,negative regulation of chromosome segregation,BP,
14374,GO:0051987,1,0.943962824004807,0,4,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14375,GO:0051988,1,0.845473772292069,0,11,regulation of attachment of spindle microtubules to kinetochore,BP,
14376,GO:0051990,1,0.970282795929254,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14377,GO:0051996,1,0.986245001384253,0,1,squalene synthase activity,MF,
14378,GO:0051998,1,0.930719817523679,0,5,protein carboxyl O-methyltransferase activity,MF,
14379,GO:0052026,1,0.984053342088746,0,1,modulation by symbiont of host transcription,BP,
14380,GO:0052027,1,0.983592726012168,0,1,modulation by symbiont of host signal transduction pathway,BP,
14381,GO:0052031,1,0.975380881805929,0,2,modulation by symbiont of host defense response,BP,
14382,GO:0052040,1,0.929940124688182,0,5,modulation by symbiont of host programmed cell death,BP,
14383,GO:0052041,1,0.945615730503691,0,4,negative regulation by symbiont of host programmed cell death,BP,
14384,GO:0052042,1,0.97536378228332,0,2,positive regulation by symbiont of host programmed cell death,BP,
14385,GO:0052047,1,0.968949191958442,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14386,GO:0052053,1,0.984260376681913,0,1,negative regulation by symbiont of host catalytic activity,BP,
14387,GO:0052055,1,0.937142051725545,0,5,modulation by symbiont of host molecular function,BP,
14388,GO:0052056,1,0.967946839474691,0,2,negative regulation by symbiont of host molecular function,BP,
14389,GO:0052066,1,0.9834266675003,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14390,GO:0052097,1,0.983591359917946,0,1,interspecies quorum sensing,BP,
14391,GO:0052106,1,0.983591359917946,0,1,quorum sensing involved in interaction with host,BP,
14392,GO:0052126,1,0.587675217905531,0,35,movement in host environment,BP,
14393,GO:0052148,1,0.984260376681913,0,1,modulation by symbiont of host catalytic activity,BP,
14394,GO:0052150,1,0.929940124688182,0,5,modulation by symbiont of host apoptotic process,BP,
14395,GO:0052151,1,0.97536378228332,0,2,positive regulation by symbiont of host apoptotic process,BP,
14396,GO:0052173,1,0.917652723076731,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
14397,GO:0052182,1,0.985279552420128,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14398,GO:0052190,1,0.9834266675003,0,1,modulation by symbiont of host phagocytosis,BP,
14399,GO:0052191,1,0.9834266675003,0,1,positive regulation by symbiont of host phagocytosis,BP,
14400,GO:0052192,1,0.587675217905531,0,35,movement in environment of other organism involved in symbiotic interaction,BP,
14401,GO:0052199,1,0.964609729915619,0,3,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14402,GO:0052200,1,0.917652723076731,0,6,response to host defenses,BP,
14403,GO:0052203,1,0.952938551569235,0,4,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14404,GO:0052204,1,0.918853440724559,0,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14405,GO:0052205,1,0.918853440724559,0,7,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14406,GO:0052212,1,0.985279552420128,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14407,GO:0052213,1,0.985279552420128,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14408,GO:0052214,1,0.98847729800523,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14409,GO:0052227,1,0.98847729800523,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14410,GO:0052229,1,0.98847729800523,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14411,GO:0052231,1,0.9834266675003,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14412,GO:0052248,1,0.929940124688182,0,5,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14413,GO:0052250,1,0.983592726012168,0,1,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14414,GO:0052251,1,0.975380881805929,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14415,GO:0052255,1,0.975380881805929,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14416,GO:0052312,1,0.68816917530598,0,26,modulation of transcription in other organism involved in symbiotic interaction,BP,
14417,GO:0052314,1,0.973905780209212,0,2,phytoalexin metabolic process,BP,
14418,GO:0052330,1,0.97536378228332,0,2,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14419,GO:0052331,1,0.970300969153238,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14420,GO:0052360,1,0.98847729800523,0,1,catabolism by host of symbiont macromolecule,BP,
14421,GO:0052361,1,0.98847729800523,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14422,GO:0052362,1,0.98847729800523,0,1,catabolism by host of symbiont protein,BP,
14423,GO:0052363,1,0.98847729800523,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14424,GO:0052364,1,0.98847729800523,0,1,catabolism by host of substance in symbiont,BP,
14425,GO:0052370,1,0.9834266675003,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14426,GO:0052381,1,0.986148754612068,0,1,tRNA dimethylallyltransferase activity,MF,
14427,GO:0052403,1,0.980036416593176,0,2,negative regulation by host of symbiont catalytic activity,BP,
14428,GO:0052405,1,0.949287580849349,0,5,negative regulation by host of symbiont molecular function,BP,
14429,GO:0052416,1,0.98847729800523,0,1,metabolism by host of symbiont macromolecule,BP,
14430,GO:0052417,1,0.98847729800523,0,1,metabolism by host of symbiont protein,BP,
14431,GO:0052418,1,0.98847729800523,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14432,GO:0052419,1,0.98847729800523,0,1,metabolism by host of substance in symbiont,BP,
14433,GO:0052422,1,0.952938551569235,0,4,modulation by host of symbiont catalytic activity,BP,
14434,GO:0052428,1,0.934342946230107,0,6,modification by host of symbiont molecular function,BP,
14435,GO:0052433,1,0.929940124688182,0,5,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14436,GO:0052472,1,0.699337682451764,0,25,modulation by host of symbiont transcription,BP,
14437,GO:0052490,1,0.945615730503691,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14438,GO:0052501,1,0.97536378228332,0,2,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14439,GO:0052509,1,0.975380881805929,0,2,positive regulation by symbiont of host defense response,BP,
14440,GO:0052510,1,0.975380881805929,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14441,GO:0052522,1,0.9834266675003,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14444,GO:0052550,1,0.988249071568082,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14445,GO:0052551,1,0.983426667503056,0,1,response to defense-related nitric oxide production by other organism involved in symbiotic interaction,BP,
14446,GO:0052552,1,0.975380881805929,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14447,GO:0052553,1,0.975380881805929,0,2,modulation by symbiont of host immune response,BP,
14448,GO:0052564,1,0.933122065437912,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
14449,GO:0052565,1,0.983426667503056,0,1,response to defense-related host nitric oxide production,BP,
14450,GO:0052567,1,0.988249071568082,0,1,response to defense-related host reactive oxygen species production,BP,
14451,GO:0052572,1,0.933122065437912,0,5,response to host immune response,BP,
14452,GO:0052590,1,0.983426667501527,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14453,GO:0052591,1,0.983426667501527,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14454,GO:0052593,1,0.968253211192052,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14455,GO:0052594,1,0.968253211192052,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14456,GO:0052595,1,0.968253211192052,0,2,aliphatic-amine oxidase activity,MF,
14457,GO:0052596,1,0.968253211192052,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14458,GO:0052629,1,0.835326414985342,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14459,GO:0052642,1,0.972573346079539,0,2,lysophosphatidic acid phosphatase activity,MF,
14460,GO:0052646,1,0.883196465635394,0,8,alditol phosphate metabolic process,BP,
14461,GO:0052650,1,0.893078497793187,0,9,NADP-retinol dehydrogenase activity,MF,
14462,GO:0052651,1,0.972638275219276,0,2,monoacylglycerol catabolic process,BP,
14464,GO:0052654,1,0.972185360111517,0,2,L-leucine transaminase activity,MF,
14465,GO:0052655,1,0.972185360111517,0,2,L-valine transaminase activity,MF,
14466,GO:0052656,1,0.972185360111517,0,2,L-isoleucine transaminase activity,MF,
14467,GO:0052657,1,0.989741121028373,0,1,guanine phosphoribosyltransferase activity,MF,
14468,GO:0052658,1,0.90735938462882,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14469,GO:0052659,1,0.863128690981108,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14470,GO:0052666,1,0.986881236347469,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14471,GO:0052689,1,0.166778049162,0,132,carboxylic ester hydrolase activity,MF,
14472,GO:0052692,1,0.989723076066294,0,1,raffinose alpha-galactosidase activity,MF,
14473,GO:0052695,1,0.778234958926565,0,17,cellular glucuronidation,BP,
14474,GO:0052696,1,0.928712209243739,0,5,flavonoid glucuronidation,BP,
14475,GO:0052697,1,0.876187197932113,0,9,xenobiotic glucuronidation,BP,
14476,GO:0052723,1,0.926997430574415,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14477,GO:0052724,1,0.926997430574415,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14478,GO:0052725,1,0.983608982877898,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14479,GO:0052726,1,0.983608982877898,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14480,GO:0052731,1,0.986247025013002,0,1,phosphocholine phosphatase activity,MF,
14481,GO:0052732,1,0.986247025013002,0,1,phosphoethanolamine phosphatase activity,MF,
14482,GO:0052739,1,0.965483916616286,0,3,phosphatidylserine 1-acylhydrolase activity,MF,
14483,GO:0052740,1,0.977361091985854,0,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14484,GO:0052741,1,0.976845725182526,0,2,(R)-limonene 6-monooxygenase activity,MF,
14486,GO:0052743,1,0.835309246071504,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14487,GO:0052744,1,0.794694616805476,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
14488,GO:0052745,1,0.737515226422987,0,19,inositol phosphate phosphatase activity,MF,
14489,GO:0052746,1,0.983426667503154,0,1,inositol phosphorylation,BP,
14490,GO:0052794,1,0.948557622935741,0,4,exo-alpha-(2->3)-sialidase activity,MF,
14491,GO:0052795,1,0.948557622935741,0,4,exo-alpha-(2->6)-sialidase activity,MF,
14492,GO:0052796,1,0.948557622935741,0,4,exo-alpha-(2->8)-sialidase activity,MF,
14493,GO:0052798,1,0.986285617164255,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14494,GO:0052803,1,0.860658179931476,0,11,imidazole-containing compound metabolic process,BP,
14495,GO:0052805,1,0.90616651606796,0,7,imidazole-containing compound catabolic process,BP,
14496,GO:0052810,1,0.968161782742902,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14497,GO:0052811,1,0.920810748684595,0,5,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14498,GO:0052812,1,0.952113983824961,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14500,GO:0052815,1,0.975031143541901,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14501,GO:0052816,1,0.983511239669819,0,1,long-chain acyl-CoA hydrolase activity,MF,
14502,GO:0052817,1,0.983511239669819,0,1,very long chain acyl-CoA hydrolase activity,MF,
14503,GO:0052821,1,0.991859090558725,0,1,DNA-7-methyladenine glycosylase activity,MF,
14504,GO:0052822,1,0.991859090558725,0,1,DNA-3-methylguanine glycosylase activity,MF,
14505,GO:0052825,1,0.983608982877898,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14506,GO:0052826,1,0.984099260716134,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14507,GO:0052827,1,0.967967811081195,0,2,inositol pentakisphosphate phosphatase activity,MF,
14508,GO:0052828,1,0.967126892152941,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14509,GO:0052829,1,0.986312179002375,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14510,GO:0052830,1,0.983608982877898,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14511,GO:0052831,1,0.983608982877898,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14512,GO:0052832,1,0.941208540093398,0,4,inositol monophosphate 3-phosphatase activity,MF,
14513,GO:0052833,1,0.941208540093398,0,4,inositol monophosphate 4-phosphatase activity,MF,
14514,GO:0052834,1,0.941208540093398,0,4,inositol monophosphate phosphatase activity,MF,
14515,GO:0052835,1,0.983608982877898,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14516,GO:0052836,1,0.958512145001828,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14517,GO:0052839,1,0.958512145001828,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14518,GO:0052840,1,0.946650719048175,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14519,GO:0052841,1,0.946650719048175,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14520,GO:0052842,1,0.946650719048175,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14521,GO:0052843,1,0.946650719048175,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14522,GO:0052844,1,0.946650719048175,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14523,GO:0052845,1,0.946650719048175,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14524,GO:0052846,1,0.946650719048175,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14525,GO:0052847,1,0.946650719048175,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14526,GO:0052848,1,0.946650719048175,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14527,GO:0052851,1,0.951096322718214,0,3,ferric-chelate reductase (NADPH) activity,MF,
14528,GO:0052852,1,0.976766665223147,0,2,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14529,GO:0052853,1,0.976766665223147,0,2,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14530,GO:0052854,1,0.976766665223147,0,2,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14531,GO:0052858,1,0.983461065177811,0,1,peptidyl-lysine acetyltransferase activity,MF,
14532,GO:0052866,1,0.627520862986008,0,29,phosphatidylinositol phosphate phosphatase activity,MF,
14533,GO:0052869,1,0.985295772150267,0,1,arachidonic acid omega-hydroxylase activity,MF,
14534,GO:0052870,1,0.969405054547521,0,2,tocopherol omega-hydroxylase activity,MF,
14535,GO:0052871,1,0.969405054547521,0,2,alpha-tocopherol omega-hydroxylase activity,MF,
14536,GO:0052872,1,0.985295772150267,0,1,tocotrienol omega-hydroxylase activity,MF,
14537,GO:0052884,1,0.984582974432554,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14538,GO:0052885,1,0.984582974432554,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14539,GO:0052890,1,0.987054088967679,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14540,GO:0052894,1,0.986386398470818,0,1,norspermine:oxygen oxidoreductase activity,MF,
14541,GO:0052895,1,0.986386398470818,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14542,GO:0052899,1,0.988159237720704,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14543,GO:0052901,1,0.974706170511796,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14544,GO:0052902,1,0.988159237720704,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14545,GO:0052903,1,0.988159237720704,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14546,GO:0052904,1,0.988159237720704,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14547,GO:0052906,1,0.983426667502314,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14548,GO:0052907,1,0.984728932554734,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14549,GO:0052909,1,0.984728932554734,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14550,GO:0052917,1,0.985269857777638,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14551,GO:0052918,1,0.983426667501086,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14552,GO:0052925,1,0.989143293407293,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14553,GO:0052926,1,0.983426667501086,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14554,GO:0052927,1,0.985607998290606,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14555,GO:0052928,1,0.985607998290606,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14556,GO:0052929,1,0.985607998290606,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14560,GO:0055005,1,0.954949887855974,0,3,ventricular cardiac myofibril assembly,BP,
14566,GO:0055011,1,0.969986141053112,0,3,atrial cardiac muscle cell differentiation,BP,
14567,GO:0055012,1,0.768419594107439,0,18,ventricular cardiac muscle cell differentiation,BP,
14569,GO:0055014,1,0.969986141053112,0,3,atrial cardiac muscle cell development,BP,
14570,GO:0055015,1,0.834852862795166,0,13,ventricular cardiac muscle cell development,BP,
14575,GO:0055022,1,0.800479257236411,0,15,negative regulation of cardiac muscle tissue growth,BP,
14580,GO:0055029,1,0.177787764950639,0,124,nuclear DNA-directed RNA polymerase complex,CC,
14583,GO:0055048,1,0.983426667500003,0,1,anastral spindle assembly,BP,
14585,GO:0055057,1,0.809080865195896,0,13,neuroblast division,BP,
14586,GO:0055059,1,0.922449517322365,0,5,asymmetric neuroblast division,BP,
14587,GO:0055062,1,0.827765285398703,0,12,phosphate ion homeostasis,BP,
14588,GO:0055064,1,0.929339441722079,0,5,chloride ion homeostasis,BP,
14591,GO:0055069,1,0.691198112418939,0,26,zinc ion homeostasis,BP,
14594,GO:0055073,1,0.978993497506928,0,2,cadmium ion homeostasis,BP,
14598,GO:0055077,1,0.941786680991684,0,4,gap junction hemi-channel activity,MF,
14601,GO:0055081,1,0.554126352835384,0,41,anion homeostasis,BP,
14603,GO:0055083,1,0.769230745685061,0,17,monovalent inorganic anion homeostasis,BP,
14606,GO:0055087,1,0.958558784603032,0,3,Ski complex,CC,
14608,GO:0055089,1,0.831322592818991,0,13,fatty acid homeostasis,BP,
14610,GO:0055091,1,0.888479780793313,0,9,phospholipid homeostasis,BP,
14611,GO:0055092,1,0.398429068400297,0,68,sterol homeostasis,BP,
14613,GO:0055094,1,0.741211715168736,0,22,response to lipoprotein particle,BP,
14614,GO:0055095,1,0.953974180495986,0,3,lipoprotein particle mediated signaling,BP,
14615,GO:0055096,1,0.953974180495986,0,3,low-density lipoprotein particle mediated signaling,BP,
14616,GO:0055098,1,0.79896048845292,0,16,response to low-density lipoprotein particle,BP,
14617,GO:0055099,1,0.96207516315348,0,3,response to high density lipoprotein particle,BP,
14618,GO:0055100,1,0.95372942309899,0,3,adiponectin binding,MF,
14619,GO:0055102,1,0.859884081824145,0,16,lipase inhibitor activity,MF,
14620,GO:0055103,1,0.983617119365912,0,1,ligase regulator activity,MF,
14621,GO:0055105,1,0.964376011302365,0,5,ubiquitin-protein transferase inhibitor activity,MF,
14622,GO:0055106,1,0.821352300433019,0,16,ubiquitin-protein transferase regulator activity,MF,
14623,GO:0055108,1,0.986796416926194,0,1,Golgi to transport vesicle transport,BP,
14625,GO:0055113,1,0.983426667495771,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14630,GO:0055120,1,0.992130533984497,0,1,striated muscle dense body,CC,
14632,GO:0055129,1,0.946729902178504,0,4,L-proline biosynthetic process,BP,
14633,GO:0055130,1,0.988677413700218,0,1,D-alanine catabolic process,BP,
14635,GO:0060001,1,0.98342666749828,0,1,minus-end directed microfilament motor activity,MF,
14636,GO:0060002,1,0.951098967663416,0,3,plus-end directed microfilament motor activity,MF,
14637,GO:0060003,1,0.967126892148585,0,2,copper ion export,BP,
14638,GO:0060004,1,0.753601948342104,0,18,reflex,BP,
14639,GO:0060005,1,0.935758070142003,0,4,vestibular reflex,BP,
14640,GO:0060007,1,0.983426667503302,0,1,linear vestibuloocular reflex,BP,
14641,GO:0060008,1,0.764316433086095,0,18,Sertoli cell differentiation,BP,
14642,GO:0060009,1,0.810627176631551,0,14,Sertoli cell development,BP,
14643,GO:0060010,1,0.983566502548431,0,1,Sertoli cell fate commitment,BP,
14644,GO:0060011,1,0.948724669625168,0,4,Sertoli cell proliferation,BP,
14645,GO:0060012,1,0.898608726939705,0,7,synaptic transmission, glycinergic,BP,
14646,GO:0060013,1,0.879349901852096,0,8,righting reflex,BP,
14647,GO:0060014,1,0.97486847281473,0,2,granulosa cell differentiation,BP,
14648,GO:0060016,1,0.990728334563944,0,1,granulosa cell development,BP,
14649,GO:0060017,1,0.897493933588515,0,7,parathyroid gland development,BP,
14650,GO:0060018,1,0.936483545279749,0,4,astrocyte fate commitment,BP,
14652,GO:0060020,1,0.901526443767153,0,7,Bergmann glial cell differentiation,BP,
14654,GO:0060022,1,0.907778059105067,0,6,hard palate development,BP,
14655,GO:0060023,1,0.925144894042009,0,5,soft palate development,BP,
14657,GO:0060025,1,0.967126892153136,0,2,regulation of synaptic activity,BP,
14663,GO:0060032,1,0.967187732382433,0,2,notochord regression,BP,
14664,GO:0060033,1,0.850881387474126,0,11,anatomical structure regression,BP,
14665,GO:0060034,1,0.983426716418242,0,1,notochord cell differentiation,BP,
14666,GO:0060035,1,0.983426716418242,0,1,notochord cell development,BP,
14670,GO:0060040,1,0.949501673828424,0,4,retinal bipolar neuron differentiation,BP,
14674,GO:0060044,1,0.860489926408421,0,10,negative regulation of cardiac muscle cell proliferation,BP,
14676,GO:0060046,1,0.815817870981839,0,19,regulation of acrosome reaction,BP,
14679,GO:0060049,1,0.788943950997562,0,17,regulation of protein glycosylation,BP,
14680,GO:0060050,1,0.890291574240529,0,8,positive regulation of protein glycosylation,BP,
14681,GO:0060051,1,0.959441188035232,0,3,negative regulation of protein glycosylation,BP,
14682,GO:0060052,1,0.870787396215546,0,9,neurofilament cytoskeleton organization,BP,
14683,GO:0060053,1,0.968904931971164,0,2,neurofilament cytoskeleton,CC,
14685,GO:0060055,1,0.761486639084944,0,18,angiogenesis involved in wound healing,BP,
14689,GO:0060059,1,0.885552118980898,0,8,embryonic retina morphogenesis in camera-type eye,BP,
14690,GO:0060060,1,0.967414511020073,0,2,post-embryonic retina morphogenesis in camera-type eye,BP,
14699,GO:0060072,1,0.967133086294328,0,2,large conductance calcium-activated potassium channel activity,MF,
14700,GO:0060073,1,0.894423546418099,0,7,micturition,BP,
14701,GO:0060074,1,0.758725142728538,0,17,synapse maturation,BP,
14704,GO:0060077,1,0.831796258159047,0,12,inhibitory synapse,CC,
14707,GO:0060080,1,0.801209114557168,0,14,inhibitory postsynaptic potential,BP,
14708,GO:0060081,1,0.84167587286348,0,12,membrane hyperpolarization,BP,
14709,GO:0060083,1,0.951273936984343,0,3,smooth muscle contraction involved in micturition,BP,
14710,GO:0060084,1,0.95364916024064,0,3,synaptic transmission involved in micturition,BP,
14711,GO:0060086,1,0.968218008046062,0,2,circadian temperature homeostasis,BP,
14716,GO:0060091,1,0.883217710065991,0,9,kinocilium,CC,
14717,GO:0060099,1,0.847471518456595,0,11,regulation of phagocytosis, engulfment,BP,
14718,GO:0060100,1,0.872058452290279,0,9,positive regulation of phagocytosis, engulfment,BP,
14719,GO:0060101,1,0.987202962341087,0,1,negative regulation of phagocytosis, engulfment,BP,
14720,GO:0060112,1,0.982015590775086,0,2,generation of ovulation cycle rhythm,BP,
14722,GO:0060114,1,0.992529378159864,0,1,vestibular receptor cell differentiation,BP,
14724,GO:0060118,1,0.992529378159864,0,1,vestibular receptor cell development,BP,
14728,GO:0060123,1,0.869337785296793,0,11,regulation of growth hormone secretion,BP,
14729,GO:0060124,1,0.914054824472565,0,8,positive regulation of growth hormone secretion,BP,
14730,GO:0060125,1,0.967126892151392,0,2,negative regulation of growth hormone secretion,BP,
14732,GO:0060127,1,0.985755524774588,0,1,prolactin secreting cell differentiation,BP,
14735,GO:0060133,1,0.980564750306283,0,2,somatotropin secreting cell development,BP,
14736,GO:0060134,1,0.819059939615833,0,13,prepulse inhibition,BP,
14740,GO:0060139,1,0.97536378228332,0,2,positive regulation of apoptotic process by virus,BP,
14741,GO:0060142,1,0.718135114765359,0,26,regulation of syncytium formation by plasma membrane fusion,BP,
14742,GO:0060143,1,0.734102542316012,0,24,positive regulation of syncytium formation by plasma membrane fusion,BP,
14745,GO:0060149,1,0.83097914288054,0,12,negative regulation of posttranscriptional gene silencing,BP,
14746,GO:0060151,1,0.967126892155214,0,2,peroxisome localization,BP,
14747,GO:0060152,1,0.967126892155214,0,2,microtubule-based peroxisome localization,BP,
14748,GO:0060154,1,0.960739906493108,0,3,cellular process regulating host cell cycle in response to virus,BP,
14751,GO:0060158,1,0.857979333641891,0,13,phospholipase C-activating dopamine receptor signaling pathway,BP,
14752,GO:0060159,1,0.868090934124843,0,10,regulation of dopamine receptor signaling pathway,BP,
14753,GO:0060160,1,0.957965536256221,0,3,negative regulation of dopamine receptor signaling pathway,BP,
14754,GO:0060161,1,0.926681986708152,0,5,positive regulation of dopamine receptor signaling pathway,BP,
14755,GO:0060163,1,0.976146796036672,0,2,subpallium neuron fate commitment,BP,
14756,GO:0060164,1,0.953518360680783,0,4,regulation of timing of neuron differentiation,BP,
14757,GO:0060165,1,0.984968562250546,0,1,regulation of timing of subpallium neuron differentiation,BP,
14758,GO:0060166,1,0.958741650730293,0,3,olfactory pit development,BP,
14759,GO:0060167,1,0.957869714418135,0,3,regulation of adenosine receptor signaling pathway,BP,
14760,GO:0060168,1,0.968494032923008,0,2,positive regulation of adenosine receptor signaling pathway,BP,
14761,GO:0060169,1,0.989031513196479,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14763,GO:0060171,1,0.967126892146019,0,2,stereocilium membrane,CC,
14766,GO:0060175,1,0.983426667500102,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14767,GO:0060177,1,0.839596140122431,0,13,regulation of angiotensin metabolic process,BP,
14769,GO:0060179,1,0.921555601362856,0,6,male mating behavior,BP,
14770,GO:0060180,1,0.890547592544704,0,9,female mating behavior,BP,
14771,GO:0060184,1,0.983879771943761,0,1,cell cycle switching,BP,
14772,GO:0060187,1,0.967126892154148,0,2,cell pole,CC,
14774,GO:0060192,1,0.838781362725499,0,15,negative regulation of lipase activity,BP,
14777,GO:0060198,1,0.837197470192736,0,12,clathrin-sculpted vesicle,CC,
14778,GO:0060199,1,0.943827645491944,0,4,clathrin-sculpted glutamate transport vesicle,CC,
14779,GO:0060200,1,0.958396688661015,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14780,GO:0060201,1,0.958396688661015,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14781,GO:0060203,1,0.943827645491944,0,4,clathrin-sculpted glutamate transport vesicle membrane,CC,
14783,GO:0060211,1,0.852316141178767,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14784,GO:0060212,1,0.987529328037738,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14785,GO:0060213,1,0.852316141178767,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14786,GO:0060214,1,0.947295828461908,0,4,endocardium formation,BP,
14789,GO:0060217,1,0.983426667502659,0,1,hemangioblast cell differentiation,BP,
14790,GO:0060218,1,0.769663603367907,0,17,hematopoietic stem cell differentiation,BP,
14791,GO:0060219,1,0.782189564026719,0,16,camera-type eye photoreceptor cell differentiation,BP,
14792,GO:0060221,1,0.956850988395877,0,3,retinal rod cell differentiation,BP,
14793,GO:0060228,1,0.954524216723926,0,6,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14794,GO:0060229,1,0.854096187659465,0,13,lipase activator activity,MF,
14795,GO:0060230,1,0.972837415033165,0,3,lipoprotein lipase activator activity,MF,
14797,GO:0060232,1,0.968712385168292,0,2,delamination,BP,
14800,GO:0060242,1,0.874117510441701,0,9,contact inhibition,BP,
14801,GO:0060243,1,0.983426667503248,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14802,GO:0060244,1,0.940050636975836,0,4,negative regulation of cell proliferation involved in contact inhibition,BP,
14803,GO:0060245,1,0.983434641771548,0,1,detection of cell density,BP,
14804,GO:0060246,1,0.983434641771548,0,1,detection of cell density by contact stimulus,BP,
14805,GO:0060248,1,0.983434641771548,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14808,GO:0060252,1,0.862393182529393,0,10,positive regulation of glial cell proliferation,BP,
14810,GO:0060254,1,0.987563694431352,0,1,regulation of N-terminal protein palmitoylation,BP,
14812,GO:0060259,1,0.794579362381374,0,20,regulation of feeding behavior,BP,
14813,GO:0060260,1,0.68401885735826,0,26,regulation of transcription initiation from RNA polymerase II promoter,BP,
14814,GO:0060261,1,0.764799717043982,0,19,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14815,GO:0060262,1,0.987563694431352,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14816,GO:0060263,1,0.878486971652553,0,11,regulation of respiratory burst,BP,
14817,GO:0060264,1,0.963554254556055,0,4,regulation of respiratory burst involved in inflammatory response,BP,
14818,GO:0060265,1,0.981067511756104,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14819,GO:0060266,1,0.975781307073292,0,3,negative regulation of respiratory burst involved in inflammatory response,BP,
14820,GO:0060267,1,0.948580182807054,0,5,positive regulation of respiratory burst,BP,
14821,GO:0060268,1,0.959607721757401,0,4,negative regulation of respiratory burst,BP,
14826,GO:0060280,1,0.985452018212821,0,1,negative regulation of ovulation,BP,
14828,GO:0060282,1,0.940887677844008,0,4,positive regulation of oocyte development,BP,
14831,GO:0060285,1,0.718707146428698,0,23,cilium-dependent cell motility,BP,
14832,GO:0060287,1,0.887580672558574,0,8,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14833,GO:0060290,1,0.884577672539087,0,8,transdifferentiation,BP,
14834,GO:0060291,1,0.429119724285441,0,56,long-term synaptic potentiation,BP,
14836,GO:0060293,1,0.783458254818713,0,16,germ plasm,CC,
14837,GO:0060294,1,0.834133718681126,0,14,cilium movement involved in cell motility,BP,
14838,GO:0060295,1,0.925273968125216,0,5,regulation of cilium movement involved in cell motility,BP,
14839,GO:0060296,1,0.925273968125216,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14842,GO:0060299,1,0.990029778762667,0,1,negative regulation of sarcomere organization,BP,
14843,GO:0060300,1,0.945243457496545,0,4,regulation of cytokine activity,BP,
14844,GO:0060301,1,0.984936615570901,0,1,positive regulation of cytokine activity,BP,
14845,GO:0060302,1,0.975877435029332,0,2,negative regulation of cytokine activity,BP,
14846,GO:0060304,1,0.983819764933214,0,1,regulation of phosphatidylinositol dephosphorylation,BP,
14847,GO:0060305,1,0.984085429030766,0,1,regulation of cell diameter,BP,
14850,GO:0060309,1,0.986858732628789,0,2,elastin catabolic process,BP,
14851,GO:0060310,1,0.994056908089788,0,1,regulation of elastin catabolic process,BP,
14852,GO:0060311,1,0.994056908089788,0,1,negative regulation of elastin catabolic process,BP,
14853,GO:0060312,1,0.876641062392651,0,9,regulation of blood vessel remodeling,BP,
14854,GO:0060313,1,0.961378367112724,0,3,negative regulation of blood vessel remodeling,BP,
14857,GO:0060316,1,0.898748185452486,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14866,GO:0060327,1,0.984280629284145,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14867,GO:0060330,1,0.747034794190506,0,21,regulation of response to interferon-gamma,BP,
14868,GO:0060331,1,0.951674151229837,0,4,negative regulation of response to interferon-gamma,BP,
14869,GO:0060332,1,0.940710108819259,0,4,positive regulation of response to interferon-gamma,BP,
14870,GO:0060333,1,0.321189377255418,0,84,interferon-gamma-mediated signaling pathway,BP,
14871,GO:0060334,1,0.759489492743209,0,20,regulation of interferon-gamma-mediated signaling pathway,BP,
14872,GO:0060335,1,0.940710108819259,0,4,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14873,GO:0060336,1,0.951674151229837,0,4,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14876,GO:0060339,1,0.915119397398892,0,6,negative regulation of type I interferon-mediated signaling pathway,BP,
14879,GO:0060342,1,0.971689191260759,0,2,photoreceptor inner segment membrane,CC,
14881,GO:0060345,1,0.983545373437418,0,1,spleen trabecula formation,BP,
14882,GO:0060346,1,0.854454899901045,0,10,bone trabecula formation,BP,
14888,GO:0060352,1,0.909573357877471,0,7,cell adhesion molecule production,BP,
14889,GO:0060353,1,0.939525083757877,0,5,regulation of cell adhesion molecule production,BP,
14890,GO:0060354,1,0.993174039443204,0,1,negative regulation of cell adhesion molecule production,BP,
14891,GO:0060355,1,0.945983825132966,0,4,positive regulation of cell adhesion molecule production,BP,
14892,GO:0060356,1,0.985650643752424,0,1,leucine import,BP,
14893,GO:0060359,1,0.195622488430597,0,116,response to ammonium ion,BP,
14895,GO:0060364,1,0.940224763982733,0,4,frontal suture morphogenesis,BP,
14896,GO:0060366,1,0.983426667498823,0,1,lambdoid suture morphogenesis,BP,
14897,GO:0060367,1,0.983426667498823,0,1,sagittal suture morphogenesis,BP,
14898,GO:0060368,1,0.898008673544045,0,7,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14899,GO:0060369,1,0.940448964847287,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14900,GO:0060370,1,0.975640155568421,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14901,GO:0060371,1,0.896298633473526,0,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14902,GO:0060372,1,0.914710651790579,0,6,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14903,GO:0060373,1,0.91120270487015,0,6,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14907,GO:0060378,1,0.983426667499313,0,1,regulation of brood size,BP,
14909,GO:0060380,1,0.986430142920359,0,1,regulation of single-stranded telomeric DNA binding,BP,
14910,GO:0060381,1,0.986430142920359,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14911,GO:0060382,1,0.967126892153231,0,2,regulation of DNA strand elongation,BP,
14912,GO:0060383,1,0.983426667503348,0,1,positive regulation of DNA strand elongation,BP,
14913,GO:0060384,1,0.669613518509618,0,25,innervation,BP,
14914,GO:0060385,1,0.923223764812246,0,5,axonogenesis involved in innervation,BP,
14915,GO:0060386,1,0.983426667501779,0,1,synapse assembly involved in innervation,BP,
14919,GO:0060392,1,0.96179040709695,0,3,negative regulation of SMAD protein import into nucleus,BP,
14921,GO:0060394,1,0.861520116485666,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14924,GO:0060397,1,0.813140805316465,0,15,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
14925,GO:0060398,1,0.945859711325363,0,4,regulation of growth hormone receptor signaling pathway,BP,
14926,GO:0060399,1,0.961802537376172,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14927,GO:0060400,1,0.983426667503004,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14930,GO:0060404,1,0.98344507003102,0,1,axonemal microtubule depolymerization,BP,
14931,GO:0060405,1,0.921676410283658,0,6,regulation of penile erection,BP,
14932,GO:0060406,1,0.947609454329996,0,4,positive regulation of penile erection,BP,
14933,GO:0060407,1,0.989031513196479,0,1,negative regulation of penile erection,BP,
14937,GO:0060414,1,0.951439972424229,0,3,aorta smooth muscle tissue morphogenesis,BP,
14943,GO:0060422,1,0.985541380331911,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14954,GO:0060434,1,0.968407661017598,0,2,bronchus morphogenesis,BP,
14966,GO:0060446,1,0.984734240689121,0,1,branching involved in open tracheal system development,BP,
14968,GO:0060448,1,0.956873157313107,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14970,GO:0060450,1,0.996011506942388,0,1,positive regulation of hindgut contraction,BP,
14972,GO:0060453,1,0.882803118499015,0,10,regulation of gastric acid secretion,BP,
14973,GO:0060454,1,0.967290884118274,0,2,positive regulation of gastric acid secretion,BP,
14974,GO:0060455,1,0.958027345820552,0,5,negative regulation of gastric acid secretion,BP,
14975,GO:0060456,1,0.880982006528073,0,11,positive regulation of digestive system process,BP,
14977,GO:0060458,1,0.973731932936039,0,2,right lung development,BP,
14978,GO:0060459,1,0.961428385152541,0,3,left lung development,BP,
14979,GO:0060460,1,0.972292251348534,0,2,left lung morphogenesis,BP,
14980,GO:0060461,1,0.984734240689121,0,1,right lung morphogenesis,BP,
14983,GO:0060465,1,0.967305870105169,0,2,pharynx development,BP,
14984,GO:0060466,1,0.983426667500495,0,1,activation of meiosis involved in egg activation,BP,
14985,GO:0060467,1,0.927149764118402,0,6,negative regulation of fertilization,BP,
14986,GO:0060468,1,0.976198776764759,0,2,prevention of polyspermy,BP,
14987,GO:0060473,1,0.99046814285105,0,1,cortical granule,CC,
14988,GO:0060474,1,0.966245947307101,0,4,positive regulation of flagellated sperm motility involved in capacitation,BP,
14989,GO:0060478,1,0.947557861366905,0,4,acrosomal vesicle exocytosis,BP,
14991,GO:0060480,1,0.961162900693709,0,4,lung goblet cell differentiation,BP,
14992,GO:0060481,1,0.945230999359875,0,5,lobar bronchus epithelium development,BP,
14994,GO:0060484,1,0.866175421566402,0,10,lung-associated mesenchyme development,BP,
14996,GO:0060486,1,0.93934638925954,0,4,Clara cell differentiation,BP,
14998,GO:0060488,1,0.967126892146648,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14999,GO:0060489,1,0.967126892146648,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
15000,GO:0060490,1,0.967126892146648,0,2,lateral sprouting involved in lung morphogenesis,BP,
15008,GO:0060509,1,0.926112634887296,0,5,Type I pneumocyte differentiation,BP,
15012,GO:0060514,1,0.983813110673525,0,1,prostate induction,BP,
15013,GO:0060515,1,0.983813110673525,0,1,prostate field specification,BP,
15014,GO:0060516,1,0.972439147858739,0,2,primary prostatic bud elongation,BP,
15015,GO:0060517,1,0.983426908875151,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
15016,GO:0060520,1,0.983813110673525,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
15017,GO:0060523,1,0.956320504622069,0,3,prostate epithelial cord elongation,BP,
15019,GO:0060526,1,0.9067979703534,0,6,prostate glandular acinus morphogenesis,BP,
15020,GO:0060527,1,0.9067979703534,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
15022,GO:0060529,1,0.967126892155263,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
15023,GO:0060532,1,0.967127129543002,0,2,bronchus cartilage development,BP,
15031,GO:0060542,1,0.983426667501724,0,1,regulation of strand invasion,BP,
15032,GO:0060544,1,0.763693301431209,0,19,regulation of necroptotic process,BP,
15033,GO:0060545,1,0.970677497715764,0,2,positive regulation of necroptotic process,BP,
15034,GO:0060546,1,0.868350703864968,0,9,negative regulation of necroptotic process,BP,
15035,GO:0060547,1,0.85167577021333,0,12,negative regulation of necrotic cell death,BP,
15037,GO:0060549,1,0.991044168321855,0,1,regulation of fructose 1,6-bisphosphate 1-phosphatase activity,BP,
15038,GO:0060550,1,0.991044168321855,0,1,positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity,BP,
15039,GO:0060551,1,0.991044168321855,0,1,regulation of fructose 1,6-bisphosphate metabolic process,BP,
15040,GO:0060552,1,0.991044168321855,0,1,positive regulation of fructose 1,6-bisphosphate metabolic process,BP,
15042,GO:0060557,1,0.968942024914633,0,3,positive regulation of vitamin D biosynthetic process,BP,
15044,GO:0060559,1,0.968942024914633,0,3,positive regulation of calcidiol 1-monooxygenase activity,BP,
15049,GO:0060566,1,0.983426667495718,0,1,positive regulation of DNA-templated transcription, termination,BP,
15052,GO:0060573,1,0.875232789942509,0,10,cell fate specification involved in pattern specification,BP,
15056,GO:0060577,1,0.974601747471246,0,2,pulmonary vein morphogenesis,BP,
15057,GO:0060578,1,0.985755524774588,0,1,superior vena cava morphogenesis,BP,
15058,GO:0060579,1,0.822541203437288,0,14,ventral spinal cord interneuron fate commitment,BP,
15059,GO:0060580,1,0.986388474029908,0,1,ventral spinal cord interneuron fate determination,BP,
15060,GO:0060581,1,0.822541203437288,0,14,cell fate commitment involved in pattern specification,BP,
15061,GO:0060582,1,0.986388474029908,0,1,cell fate determination involved in pattern specification,BP,
15065,GO:0060587,1,0.975214047533003,0,2,regulation of lipoprotein lipid oxidation,BP,
15066,GO:0060588,1,0.991564064766655,0,1,negative regulation of lipoprotein lipid oxidation,BP,
15068,GO:0060590,1,0.586958020773277,0,38,ATPase regulator activity,MF,
15069,GO:0060591,1,0.930764853564034,0,5,chondroblast differentiation,BP,
15073,GO:0060596,1,0.951211595092561,0,3,mammary placode formation,BP,
15074,GO:0060598,1,0.990869491592818,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
15076,GO:0060600,1,0.860906994409022,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
15080,GO:0060605,1,0.932747315946075,0,5,tube lumen cavitation,BP,
15082,GO:0060611,1,0.985103195280682,0,1,mammary gland fat development,BP,
15084,GO:0060613,1,0.938242619435199,0,4,fat pad development,BP,
15086,GO:0060620,1,0.97700859545829,0,3,regulation of cholesterol import,BP,
15087,GO:0060621,1,0.992160443567291,0,2,negative regulation of cholesterol import,BP,
15088,GO:0060623,1,0.963263466053238,0,3,regulation of chromosome condensation,BP,
15090,GO:0060628,1,0.829644942273884,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
15091,GO:0060629,1,0.971501441974017,0,2,regulation of homologous chromosome segregation,BP,
15092,GO:0060631,1,0.897130489032422,0,7,regulation of meiosis I,BP,
15093,GO:0060632,1,0.768566620371761,0,17,regulation of microtubule-based movement,BP,
15094,GO:0060633,1,0.922900002207902,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
15099,GO:0060662,1,0.932747315946075,0,5,salivary gland cavitation,BP,
15102,GO:0060666,1,0.921236989870459,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
15104,GO:0060668,1,0.98345175105883,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
15106,GO:0060670,1,0.8496125661518,0,11,branching involved in labyrinthine layer morphogenesis,BP,
15107,GO:0060671,1,0.95571238633726,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
15108,GO:0060672,1,0.95571238633726,0,3,epithelial cell morphogenesis involved in placental branching,BP,
15113,GO:0060678,1,0.985657794256111,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15115,GO:0060683,1,0.984238471013986,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
15121,GO:0060689,1,0.955363675704316,0,3,cell differentiation involved in salivary gland development,BP,
15122,GO:0060690,1,0.987600674591234,0,1,epithelial cell differentiation involved in salivary gland development,BP,
15123,GO:0060691,1,0.987600674591234,0,1,epithelial cell maturation involved in salivary gland development,BP,
15125,GO:0060694,1,0.983699131992627,0,2,regulation of cholesterol transporter activity,BP,
15126,GO:0060695,1,0.996300075560339,0,1,negative regulation of cholesterol transporter activity,BP,
15127,GO:0060696,1,0.930328459002997,0,6,regulation of phospholipid catabolic process,BP,
15128,GO:0060697,1,0.978741160558493,0,2,positive regulation of phospholipid catabolic process,BP,
15129,GO:0060698,1,0.967470893222433,0,2,endoribonuclease inhibitor activity,MF,
15130,GO:0060699,1,0.943590769206554,0,4,regulation of endoribonuclease activity,BP,
15131,GO:0060700,1,0.92794859458397,0,5,regulation of ribonuclease activity,BP,
15132,GO:0060701,1,0.967470893222433,0,2,negative regulation of ribonuclease activity,BP,
15133,GO:0060702,1,0.967470893222433,0,2,negative regulation of endoribonuclease activity,BP,
15134,GO:0060703,1,0.984358363364733,0,1,deoxyribonuclease inhibitor activity,MF,
15143,GO:0060715,1,0.967946839473095,0,2,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
15145,GO:0060717,1,0.907126491552566,0,6,chorion development,BP,
15146,GO:0060718,1,0.922410291670283,0,5,chorionic trophoblast cell differentiation,BP,
15147,GO:0060720,1,0.976567424090852,0,2,spongiotrophoblast cell proliferation,BP,
15148,GO:0060721,1,0.976567424090852,0,2,regulation of spongiotrophoblast cell proliferation,BP,
15149,GO:0060722,1,0.976567424090852,0,2,cell proliferation involved in embryonic placenta development,BP,
15150,GO:0060723,1,0.976567424090852,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
15151,GO:0060729,1,0.925703001803136,0,5,intestinal epithelial structure maintenance,BP,
15152,GO:0060730,1,0.968404533454555,0,2,regulation of intestinal epithelial structure maintenance,BP,
15153,GO:0060731,1,0.983591359917946,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
15154,GO:0060732,1,0.848232269063713,0,12,positive regulation of inositol phosphate biosynthetic process,BP,
15155,GO:0060733,1,0.967133086295198,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
15156,GO:0060734,1,0.968926987221557,0,2,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
15157,GO:0060735,1,0.990051264799687,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
15158,GO:0060736,1,0.837511939147909,0,11,prostate gland growth,BP,
15159,GO:0060737,1,0.940468409676072,0,4,prostate gland morphogenetic growth,BP,
15160,GO:0060738,1,0.972751421654103,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
15161,GO:0060739,1,0.983426667499507,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
15163,GO:0060741,1,0.965740101035577,0,3,prostate gland stromal morphogenesis,BP,
15165,GO:0060743,1,0.953062722812337,0,3,epithelial cell maturation involved in prostate gland development,BP,
15168,GO:0060746,1,0.834261872927616,0,13,parental behavior,BP,
15173,GO:0060752,1,0.968984030234865,0,2,intestinal phytosterol absorption,BP,
15174,GO:0060753,1,0.924756246706227,0,6,regulation of mast cell chemotaxis,BP,
15175,GO:0060754,1,0.934631113956033,0,5,positive regulation of mast cell chemotaxis,BP,
15180,GO:0060763,1,0.961977316515227,0,3,mammary duct terminal end bud growth,BP,
15181,GO:0060764,1,0.973867280291816,0,2,cell-cell signaling involved in mammary gland development,BP,
15182,GO:0060765,1,0.681408874166845,0,26,regulation of androgen receptor signaling pathway,BP,
15183,GO:0060766,1,0.832845953553486,0,12,negative regulation of androgen receptor signaling pathway,BP,
15186,GO:0060769,1,0.956778410037638,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
15187,GO:0060770,1,0.921464557734066,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
15189,GO:0060781,1,0.988827839667624,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
15190,GO:0060782,1,0.988827839667624,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
15191,GO:0060783,1,0.988827839667624,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
15192,GO:0060784,1,0.983426908875151,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
15194,GO:0060789,1,0.914607880426477,0,7,hair follicle placode formation,BP,
15196,GO:0060796,1,0.974838078153162,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15197,GO:0060800,1,0.956400865284134,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15198,GO:0060802,1,0.986342985336837,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15199,GO:0060803,1,0.989314308659834,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15201,GO:0060806,1,0.988206692916358,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15202,GO:0060807,1,0.985368058605826,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15204,GO:0060816,1,0.983426667496166,0,1,random inactivation of X chromosome,BP,
15205,GO:0060817,1,0.985855483080867,0,1,inactivation of paternal X chromosome,BP,
15206,GO:0060821,1,0.983426667498278,0,1,inactivation of X chromosome by DNA methylation,BP,
15208,GO:0060825,1,0.975695951675391,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15209,GO:0060827,1,0.983426667503345,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15211,GO:0060829,1,0.983426667503345,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15212,GO:0060830,1,0.960231323473382,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15214,GO:0060836,1,0.898094327879212,0,7,lymphatic endothelial cell differentiation,BP,
15216,GO:0060838,1,0.967476820846146,0,2,lymphatic endothelial cell fate commitment,BP,
15225,GO:0060849,1,0.967476820846146,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15226,GO:0060850,1,0.81786730499528,0,15,regulation of transcription involved in cell fate commitment,BP,
15229,GO:0060857,1,0.985604464442691,0,1,establishment of glial blood-brain barrier,BP,
15231,GO:0060873,1,0.983426667498823,0,1,anterior semicircular canal development,BP,
15232,GO:0060875,1,0.983426667498823,0,1,lateral semicircular canal development,BP,
15238,GO:0060901,1,0.983426667503251,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15239,GO:0060903,1,0.938682569282297,0,4,positive regulation of meiosis I,BP,
15240,GO:0060904,1,0.983426691931981,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15243,GO:0060912,1,0.95475694129384,0,3,cardiac cell fate specification,BP,
15244,GO:0060913,1,0.961601304746949,0,3,cardiac cell fate determination,BP,
15247,GO:0060916,1,0.924958615744402,0,5,mesenchymal cell proliferation involved in lung development,BP,
15248,GO:0060920,1,0.930691050135724,0,5,cardiac pacemaker cell differentiation,BP,
15249,GO:0060921,1,0.958793875608593,0,3,sinoatrial node cell differentiation,BP,
15250,GO:0060922,1,0.970694436896913,0,2,atrioventricular node cell differentiation,BP,
15252,GO:0060926,1,0.938780827335258,0,4,cardiac pacemaker cell development,BP,
15253,GO:0060927,1,0.987054088967679,0,1,cardiac pacemaker cell fate commitment,BP,
15254,GO:0060928,1,0.970694436896913,0,2,atrioventricular node cell development,BP,
15255,GO:0060929,1,0.987054088967679,0,1,atrioventricular node cell fate commitment,BP,
15256,GO:0060931,1,0.967126892153955,0,2,sinoatrial node cell development,BP,
15257,GO:0060932,1,0.970694436897981,0,2,His-Purkinje system cell differentiation,BP,
15258,GO:0060935,1,0.952791303205629,0,3,cardiac fibroblast cell differentiation,BP,
15259,GO:0060936,1,0.952791303205629,0,3,cardiac fibroblast cell development,BP,
15260,GO:0060938,1,0.952791303205629,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15261,GO:0060939,1,0.952791303205629,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15262,GO:0060940,1,0.968850470886172,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15268,GO:0060965,1,0.859242575968461,0,10,negative regulation of gene silencing by miRNA,BP,
15270,GO:0060967,1,0.83097914288054,0,12,negative regulation of gene silencing by RNA,BP,
15272,GO:0060969,1,0.726066753030587,0,21,negative regulation of gene silencing,BP,
15273,GO:0060971,1,0.942849175799422,0,4,embryonic heart tube left/right pattern formation,BP,
15276,GO:0060974,1,0.983582981820893,0,2,cell migration involved in heart formation,BP,
15277,GO:0060975,1,0.991384933405719,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15280,GO:0060978,1,0.952556686214128,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15282,GO:0060980,1,0.983446198396837,0,1,cell migration involved in coronary vasculogenesis,BP,
15283,GO:0060981,1,0.983426667501771,0,1,cell migration involved in coronary angiogenesis,BP,
15286,GO:0060987,1,0.985452018212821,0,1,lipid tube,CC,
15287,GO:0060988,1,0.953096556319878,0,3,lipid tube assembly,BP,
15288,GO:0060989,1,0.983469322271536,0,1,lipid tube assembly involved in organelle fusion,BP,
15289,GO:0060992,1,0.907886984019149,0,6,response to fungicide,BP,
15292,GO:0060995,1,0.967478139161337,0,2,cell-cell signaling involved in kidney development,BP,
15295,GO:0060998,1,0.393681347309106,0,60,regulation of dendritic spine development,BP,
15296,GO:0060999,1,0.568106879220888,0,37,positive regulation of dendritic spine development,BP,
15297,GO:0061000,1,0.825023838488765,0,12,negative regulation of dendritic spine development,BP,
15298,GO:0061001,1,0.583109511015616,0,34,regulation of dendritic spine morphogenesis,BP,
15299,GO:0061002,1,0.910170017630132,0,6,negative regulation of dendritic spine morphogenesis,BP,
15300,GO:0061003,1,0.757401616799215,0,17,positive regulation of dendritic spine morphogenesis,BP,
15304,GO:0061009,1,0.933197476027967,0,5,common bile duct development,BP,
15305,GO:0061010,1,0.957264745392702,0,3,gall bladder development,BP,
15306,GO:0061011,1,0.987853947623787,0,1,hepatic duct development,BP,
15309,GO:0061015,1,0.988143471308835,0,1,snRNA import into nucleus,BP,
15310,GO:0061017,1,0.97222970946269,0,2,hepatoblast differentiation,BP,
15313,GO:0061026,1,0.983426667494786,0,1,cardiac muscle tissue regeneration,BP,
15317,GO:0061030,1,0.948751527802293,0,4,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15318,GO:0061031,1,0.961702324055953,0,3,endodermal digestive tract morphogenesis,BP,
15321,GO:0061034,1,0.967126892154634,0,2,olfactory bulb mitral cell layer development,BP,
15326,GO:0061040,1,0.983426667498183,0,1,female gonad morphogenesis,BP,
15328,GO:0061042,1,0.874427549775043,0,9,vascular wound healing,BP,
15329,GO:0061043,1,0.944182469499429,0,4,regulation of vascular wound healing,BP,
15330,GO:0061044,1,0.983686447988429,0,1,negative regulation of vascular wound healing,BP,
15334,GO:0061048,1,0.988323678184138,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15338,GO:0061052,1,0.930301766124057,0,5,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15341,GO:0061055,1,0.938467991504734,0,4,myotome development,BP,
15342,GO:0061056,1,0.946825690230952,0,4,sclerotome development,BP,
15345,GO:0061073,1,0.955285329227236,0,3,ciliary body morphogenesis,BP,
15346,GO:0061074,1,0.916521224923283,0,6,regulation of neural retina development,BP,
15347,GO:0061075,1,0.971330885008517,0,2,positive regulation of neural retina development,BP,
15348,GO:0061076,1,0.983710215107683,0,1,negative regulation of neural retina development,BP,
15349,GO:0061077,1,0.424697724454275,0,62,chaperone-mediated protein folding,BP,
15350,GO:0061078,1,0.995641439960648,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15353,GO:0061083,1,0.939804605271615,0,4,regulation of protein refolding,BP,
15354,GO:0061084,1,0.939804605271615,0,4,negative regulation of protein refolding,BP,
15355,GO:0061085,1,0.868788432746732,0,9,regulation of histone H3-K27 methylation,BP,
15356,GO:0061086,1,0.940802179356557,0,4,negative regulation of histone H3-K27 methylation,BP,
15357,GO:0061087,1,0.909792940559167,0,6,positive regulation of histone H3-K27 methylation,BP,
15358,GO:0061088,1,0.857147229224419,0,10,regulation of sequestering of zinc ion,BP,
15359,GO:0061090,1,0.985187007472927,0,1,positive regulation of sequestering of zinc ion,BP,
15360,GO:0061091,1,0.951096178955381,0,3,regulation of phospholipid translocation,BP,
15361,GO:0061092,1,0.951096178955381,0,3,positive regulation of phospholipid translocation,BP,
15364,GO:0061099,1,0.701138363800295,0,23,negative regulation of protein tyrosine kinase activity,BP,
15365,GO:0061100,1,0.984968562250546,0,1,lung neuroendocrine cell differentiation,BP,
15367,GO:0061102,1,0.974657263513654,0,2,stomach neuroendocrine cell differentiation,BP,
15368,GO:0061103,1,0.984968562250546,0,1,carotid body glomus cell differentiation,BP,
15369,GO:0061104,1,0.969349663465675,0,2,adrenal chromaffin cell differentiation,BP,
15370,GO:0061105,1,0.989531997697684,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15371,GO:0061106,1,0.989531997697684,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15373,GO:0061108,1,0.985659583797435,0,1,seminal vesicle epithelium development,BP,
15375,GO:0061113,1,0.944556802783296,0,4,pancreas morphogenesis,BP,
15376,GO:0061114,1,0.983782100485865,0,1,branching involved in pancreas morphogenesis,BP,
15378,GO:0061117,1,0.800479257236411,0,15,negative regulation of heart growth,BP,
15379,GO:0061133,1,0.935478852253175,0,6,endopeptidase activator activity,MF,
15385,GO:0061141,1,0.95909852630445,0,3,lung ciliated cell differentiation,BP,
15387,GO:0061144,1,0.98374269645965,0,1,alveolar secondary septum development,BP,
15388,GO:0061145,1,0.967127129543002,0,2,lung smooth muscle development,BP,
15393,GO:0061152,1,0.97483686329469,0,2,trachea submucosa development,BP,
15394,GO:0061153,1,0.97483686329469,0,2,trachea gland development,BP,
15398,GO:0061157,1,0.740563960650752,0,19,mRNA destabilization,BP,
15399,GO:0061158,1,0.825685886875189,0,12,3'-UTR-mediated mRNA destabilization,BP,
15401,GO:0061168,1,0.993745700181558,0,1,regulation of hair follicle placode formation,BP,
15402,GO:0061170,1,0.993745700181558,0,1,negative regulation of hair follicle placode formation,BP,
15403,GO:0061178,1,0.501204505023275,0,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15404,GO:0061179,1,0.914867996932121,0,8,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15406,GO:0061181,1,0.983426667503248,0,1,regulation of chondrocyte development,BP,
15409,GO:0061185,1,0.986752206415306,0,1,negative regulation of dermatome development,BP,
15410,GO:0061187,1,0.967126892152599,0,2,regulation of chromatin silencing at rDNA,BP,
15411,GO:0061188,1,0.967126892152599,0,2,negative regulation of chromatin silencing at rDNA,BP,
15412,GO:0061189,1,0.988827839667624,0,1,positive regulation of sclerotome development,BP,
15413,GO:0061190,1,0.988827839667624,0,1,regulation of sclerotome development,BP,
15414,GO:0061193,1,0.99248783824138,0,1,taste bud development,BP,
15415,GO:0061196,1,0.910233329967799,0,6,fungiform papilla development,BP,
15416,GO:0061197,1,0.923509180730236,0,5,fungiform papilla morphogenesis,BP,
15417,GO:0061198,1,0.953935465932196,0,3,fungiform papilla formation,BP,
15418,GO:0061200,1,0.889174321930747,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15419,GO:0061202,1,0.889174321930747,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15421,GO:0061206,1,0.984184451274848,0,1,mesonephros morphogenesis,BP,
15424,GO:0061215,1,0.984184451274848,0,1,mesonephric nephron development,BP,
15429,GO:0061228,1,0.984184451274848,0,1,mesonephric nephron morphogenesis,BP,
15430,GO:0061235,1,0.984184451274848,0,1,mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis,BP,
15432,GO:0061289,1,0.967478139161337,0,2,Wnt signaling pathway involved in kidney development,BP,
15433,GO:0061290,1,0.967478139161337,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15434,GO:0061295,1,0.984184451274848,0,1,regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
15435,GO:0061296,1,0.984184451274848,0,1,negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
15438,GO:0061300,1,0.972740663993927,0,2,cerebellum vasculature development,BP,
15439,GO:0061301,1,0.983426667499806,0,1,cerebellum vasculature morphogenesis,BP,
15442,GO:0061304,1,0.935330099168642,0,4,retinal blood vessel morphogenesis,BP,
15443,GO:0061307,1,0.899823340409028,0,8,cardiac neural crest cell differentiation involved in heart development,BP,
15444,GO:0061308,1,0.899823340409028,0,8,cardiac neural crest cell development involved in heart development,BP,
15445,GO:0061309,1,0.926803052242922,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15449,GO:0061316,1,0.931606660084222,0,5,canonical Wnt signaling pathway involved in heart development,BP,
15450,GO:0061317,1,0.947228979627277,0,4,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15453,GO:0061324,1,0.983511021466145,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15468,GO:0061355,1,0.956657263610779,0,3,Wnt protein secretion,BP,
15469,GO:0061356,1,0.956657263610779,0,3,regulation of Wnt protein secretion,BP,
15470,GO:0061357,1,0.968948423115462,0,2,positive regulation of Wnt protein secretion,BP,
15471,GO:0061358,1,0.987316598817985,0,1,negative regulation of Wnt protein secretion,BP,
15472,GO:0061360,1,0.983426667503348,0,1,optic chiasma development,BP,
15473,GO:0061364,1,0.95109617711632,0,3,apoptotic process involved in luteolysis,BP,
15474,GO:0061365,1,0.880375366712727,0,11,positive regulation of triglyceride lipase activity,BP,
15475,GO:0061366,1,0.958622318226334,0,3,behavioral response to chemical pain,BP,
15476,GO:0061368,1,0.958622318226334,0,3,behavioral response to formalin induced pain,BP,
15480,GO:0061373,1,0.97310813224919,0,2,mammillary axonal complex development,BP,
15481,GO:0061374,1,0.989508294626228,0,1,mammillothalamic axonal tract development,BP,
15483,GO:0061378,1,0.976167780412278,0,2,corpora quadrigemina development,BP,
15484,GO:0061379,1,0.976167780412278,0,2,inferior colliculus development,BP,
15485,GO:0061381,1,0.989508294626228,0,1,cell migration in diencephalon,BP,
15488,GO:0061386,1,0.967126892148538,0,2,closure of optic fissure,BP,
15490,GO:0061394,1,0.974718488334767,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15491,GO:0061395,1,0.988052019173529,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15492,GO:0061402,1,0.969658169839152,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15493,GO:0061408,1,0.986042558870148,0,1,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15496,GO:0061428,1,0.943317611298094,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15497,GO:0061430,1,0.826348314185304,0,12,bone trabecula morphogenesis,BP,
15498,GO:0061433,1,0.986935358959301,0,1,cellular response to caloric restriction,BP,
15504,GO:0061441,1,0.96861191586846,0,2,renal artery morphogenesis,BP,
15506,GO:0061444,1,0.983426667501433,0,1,endocardial cushion cell development,BP,
15509,GO:0061450,1,0.907282049579802,0,8,trophoblast cell migration,BP,
15510,GO:0061451,1,0.983832058556469,0,1,retrotrapezoid nucleus development,BP,
15511,GO:0061452,1,0.983832058556469,0,1,retrotrapezoid nucleus neuron differentiation,BP,
15513,GO:0061459,1,0.983426667499561,0,1,L-arginine transmembrane transporter activity,MF,
15514,GO:0061461,1,0.968358686519233,0,2,L-lysine import,BP,
15516,GO:0061467,1,0.983431349581021,0,1,basolateral protein localization,BP,
15517,GO:0061469,1,0.865954005220424,0,9,regulation of type B pancreatic cell proliferation,BP,
15518,GO:0061470,1,0.939461198459757,0,4,T follicular helper cell differentiation,BP,
15519,GO:0061474,1,0.984771751341943,0,1,phagolysosome membrane,CC,
15520,GO:0061476,1,0.983753871288844,0,1,response to anticoagulant,BP,
15521,GO:0061481,1,0.993573175263409,0,1,response to TNF agonist,BP,
15522,GO:0061484,1,0.907704486111005,0,6,hematopoietic stem cell homeostasis,BP,
15523,GO:0061485,1,0.983426667499658,0,1,memory T cell proliferation,BP,
15524,GO:0061501,1,0.984728932554734,0,1,cyclic-GMP-AMP synthase activity,MF,
15525,GO:0061502,1,0.940199503748267,0,4,early endosome to recycling endosome transport,BP,
15526,GO:0061505,1,0.955326971127142,0,3,DNA topoisomerase II activity,MF,
15527,GO:0061507,1,0.988196127107389,0,1,cyclic-GMP-AMP binding,MF,
15528,GO:0061511,1,0.94464971568498,0,4,centriole elongation,BP,
15529,GO:0061512,1,0.631479014521256,0,31,protein localization to cilium,BP,
15530,GO:0061513,1,0.95412864002471,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15532,GO:0061517,1,0.968858907162548,0,2,macrophage proliferation,BP,
15533,GO:0061518,1,0.968858907162548,0,2,microglial cell proliferation,BP,
15534,GO:0061519,1,0.983456927394023,0,1,macrophage homeostasis,BP,
15535,GO:0061523,1,0.98344507003102,0,1,cilium disassembly,BP,
15537,GO:0061526,1,0.940206577986143,0,4,acetylcholine secretion,BP,
15538,GO:0061528,1,0.98342666750271,0,1,aspartate secretion,BP,
15539,GO:0061534,1,0.983426667494294,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15540,GO:0061535,1,0.967126892146069,0,2,glutamate secretion, neurotransmission,BP,
15541,GO:0061536,1,0.983636504172295,0,1,glycine secretion,BP,
15542,GO:0061537,1,0.983636504172295,0,1,glycine secretion, neurotransmission,BP,
15543,GO:0061542,1,0.990677269526394,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15544,GO:0061547,1,0.967477026151171,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15545,GO:0061548,1,0.810309265228662,0,13,ganglion development,BP,
15546,GO:0061549,1,0.864094306297148,0,9,sympathetic ganglion development,BP,
15547,GO:0061550,1,0.922253320871436,0,5,cranial ganglion development,BP,
15548,GO:0061551,1,0.937719439898298,0,4,trigeminal ganglion development,BP,
15549,GO:0061552,1,0.984936615570901,0,1,ganglion morphogenesis,BP,
15552,GO:0061574,1,0.956392423527824,0,3,ASAP complex,CC,
15553,GO:0061575,1,0.965394629566998,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15554,GO:0061577,1,0.857257693524954,0,10,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15555,GO:0061578,1,0.869296831381175,0,9,Lys63-specific deubiquitinase activity,MF,
15556,GO:0061580,1,0.983426667503348,0,1,colon epithelial cell migration,BP,
15557,GO:0061582,1,0.967126892153423,0,2,intestinal epithelial cell migration,BP,
15558,GO:0061588,1,0.92170362736629,0,5,calcium activated phospholipid scrambling,BP,
15559,GO:0061589,1,0.937240967736778,0,4,calcium activated phosphatidylserine scrambling,BP,
15560,GO:0061590,1,0.92170362736629,0,5,calcium activated phosphatidylcholine scrambling,BP,
15561,GO:0061591,1,0.92170362736629,0,5,calcium activated galactosylceramide scrambling,BP,
15562,GO:0061598,1,0.983426667503251,0,1,molybdopterin adenylyltransferase activity,MF,
15563,GO:0061599,1,0.983426667503251,0,1,molybdopterin molybdotransferase activity,MF,
15564,GO:0061604,1,0.98502761782828,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15565,GO:0061605,1,0.98502761782828,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15566,GO:0061609,1,0.985100134735632,0,1,fructose-1-phosphate aldolase activity,MF,
15567,GO:0061611,1,0.987762819794679,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15570,GO:0061617,1,0.936072535174613,0,6,MICOS complex,CC,
15571,GO:0061618,1,0.983426667495278,0,1,sublamina densa,CC,
15574,GO:0061622,1,0.973873635089887,0,2,glycolytic process through glucose-1-phosphate,BP,
15575,GO:0061623,1,0.9900697047622,0,1,glycolytic process from galactose,BP,
15578,GO:0061627,1,0.986725823054687,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15579,GO:0061628,1,0.95315850277358,0,3,H3K27me3 modified histone binding,MF,
15580,GO:0061629,1,0.989825625357721,0,1,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15582,GO:0061631,1,0.669202907287693,0,29,ubiquitin conjugating enzyme activity,MF,
15583,GO:0061635,1,0.919579554960643,0,6,regulation of protein complex stability,BP,
15585,GO:0061641,1,0.708523822678428,0,37,CENP-A containing chromatin organization,BP,
15588,GO:0061646,1,0.98342666750271,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15589,GO:0061647,1,0.525395310781257,0,41,histone H3-K9 modification,BP,
15590,GO:0061649,1,0.983426667503004,0,1,ubiquitinated histone binding,MF,
15591,GO:0061650,1,0.663234543793259,0,30,ubiquitin-like protein conjugating enzyme activity,MF,
15592,GO:0061656,1,0.991096224378579,0,1,SUMO conjugating enzyme activity,MF,
15594,GO:0061663,1,0.983426667499806,0,1,NEDD8 ligase activity,MF,
15595,GO:0061665,1,0.929152218710487,0,5,SUMO ligase activity,MF,
15596,GO:0061668,1,0.942867883499686,0,4,mitochondrial ribosome assembly,BP,
15597,GO:0061669,1,0.951096177111992,0,3,spontaneous neurotransmitter secretion,BP,
15598,GO:0061670,1,0.989244467547671,0,1,evoked neurotransmitter secretion,BP,
15599,GO:0061673,1,0.968407661014684,0,2,mitotic spindle astral microtubule,CC,
15600,GO:0061676,1,0.943463341050059,0,4,importin-alpha family protein binding,MF,
15601,GO:0061682,1,0.985384696125502,0,1,seminal vesicle morphogenesis,BP,
15602,GO:0061684,1,0.846339872044202,0,11,chaperone-mediated autophagy,BP,
15603,GO:0061687,1,0.947435149469691,0,4,detoxification of inorganic compound,BP,
15604,GO:0061689,1,0.941085057699245,0,4,tricellular tight junction,CC,
15605,GO:0061690,1,0.991305795966007,0,1,lipoamidase activity,MF,
15607,GO:0061697,1,0.983696734707719,0,1,protein-glutaryllysine deglutarylase activity,MF,
15608,GO:0061698,1,0.983696734707719,0,1,protein deglutarylation,BP,
15609,GO:0061699,1,0.983696734707719,0,1,peptidyl-lysine deglutarylation,BP,
15611,GO:0061702,1,0.868881304827824,0,11,inflammasome complex,CC,
15612,GO:0061709,1,0.983426667500641,0,1,reticulophagy,BP,
15613,GO:0061711,1,0.974567337099068,0,2,N(6)-L-threonylcarbamoyladenine synthase,MF,
15614,GO:0061712,1,0.983592042024508,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15615,GO:0061713,1,0.992130533984497,0,1,anterior neural tube closure,BP,
15616,GO:0061714,1,0.98382027473808,0,2,folic acid receptor activity,MF,
15618,GO:0061723,1,0.968716128406188,0,2,glycophagy,BP,
15620,GO:0061726,1,0.330441553740286,0,77,mitochondrion disassembly,BP,
15621,GO:0061727,1,0.972939519486341,0,2,methylglyoxal catabolic process to lactate,BP,
15622,GO:0061731,1,0.951426103240089,0,3,ribonucleoside-diphosphate reductase activity,MF,
15623,GO:0061732,1,0.913273806740933,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15624,GO:0061733,1,0.437332510784374,0,55,peptide-lysine-N-acetyltransferase activity,MF,
15625,GO:0061734,1,0.919858902690465,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15626,GO:0061736,1,0.983426667501824,0,1,engulfment of target by autophagosome,BP,
15627,GO:0061737,1,0.938078207128656,0,5,leukotriene signaling pathway,BP,
15628,GO:0061738,1,0.956677887723427,0,3,late endosomal microautophagy,BP,
15629,GO:0061739,1,0.983617119365912,0,1,protein lipidation involved in autophagosome assembly,BP,
15630,GO:0061740,1,0.970201303621073,0,2,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15631,GO:0061741,1,0.986552679127082,0,1,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15632,GO:0061743,1,0.945448094999596,0,4,motor learning,BP,
15633,GO:0061744,1,0.967127175431477,0,2,motor behavior,BP,
15634,GO:0061749,1,0.967126892153761,0,2,forked DNA-dependent helicase activity,MF,
15635,GO:0061750,1,0.985435071969403,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15636,GO:0061752,1,0.971353157134848,0,2,telomeric repeat-containing RNA binding,MF,
15637,GO:0061753,1,0.983426667501824,0,1,substrate localization to autophagosome,BP,
15638,GO:0061756,1,0.712653166067415,0,24,leukocyte adhesion to vascular endothelial cell,BP,
15639,GO:0061757,1,0.972473529708821,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15640,GO:0061762,1,0.951096177112326,0,3,CAMKK-AMPK signaling cascade,BP,
15641,GO:0061763,1,0.969519810848115,0,2,multivesicular body-lysosome fusion,BP,
15642,GO:0061767,1,0.983426667501579,0,1,negative regulation of lung blood pressure,BP,
15643,GO:0061768,1,0.983426667502759,0,1,magnesium:sodium antiporter activity,MF,
15644,GO:0061769,1,0.969690119055175,0,2,ribosylnicotinate kinase activity,MF,
15645,GO:0061770,1,0.986042558870148,0,1,translation elongation factor binding,MF,
15646,GO:0061771,1,0.986935358959301,0,1,response to caloric restriction,BP,
15648,GO:0061778,1,0.770950887696924,0,16,intracellular chloride channel activity,MF,
15649,GO:0061782,1,0.983426667503345,0,1,vesicle fusion with vesicle,BP,
15650,GO:0061783,1,0.887375905195614,0,15,peptidoglycan muralytic activity,MF,
15651,GO:0061792,1,0.951115388354129,0,3,secretory granule maturation,BP,
15652,GO:0061798,1,0.983426667503302,0,1,GTP 3',8'-cyclase activity,MF,
15653,GO:0061799,1,0.983426667503302,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15654,GO:0061809,1,0.978748181862732,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15655,GO:0061811,1,0.989349369876905,0,1,ADP-ribosyl cyclase activity,MF,
15656,GO:0061812,1,0.989349369876905,0,1,cyclic ADP-ribose hydrolase,MF,
15657,GO:0061819,1,0.953937725212734,0,3,telomeric DNA-containing double minutes formation,BP,
15658,GO:0061820,1,0.864727908699348,0,9,telomeric D-loop disassembly,BP,
15659,GO:0061821,1,0.935332238934421,0,4,telomeric D-loop binding,MF,
15660,GO:0061825,1,0.983426867548376,0,1,podosome core,CC,
15661,GO:0061827,1,0.984769051492201,0,1,sperm head,CC,
15662,GO:0061833,1,0.96946073005764,0,2,protein localization to tricellular tight junction,BP,
15663,GO:0061842,1,0.710236541805245,0,22,microtubule organizing center localization,BP,
15664,GO:0061844,1,0.936789406314123,0,7,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15665,GO:0061845,1,0.983608982877898,0,1,neuron projection branch point,CC,
15666,GO:0061846,1,0.983608982877898,0,1,dendritic spine cytoplasm,CC,
15667,GO:0061847,1,0.985496439087101,0,1,response to cholecystokinin,BP,
15668,GO:0061849,1,0.967126892153761,0,2,telomeric G-quadruplex DNA binding,MF,
15669,GO:0061850,1,0.993252053348278,0,1,growth cone leading edge,CC,
15670,GO:0065001,1,0.943257618613861,0,4,specification of axis polarity,BP,
15671,GO:0065002,1,0.508072632054542,0,53,intracellular protein transmembrane transport,BP,
15673,GO:0065004,1,0.0718059117213713,0,227,protein-DNA complex assembly,BP,
15674,GO:0065005,1,0.74899148130012,0,23,protein-lipid complex assembly,BP,
15675,GO:0065006,1,0.982361742722248,0,2,protein-carbohydrate complex assembly,BP,
15679,GO:0065010,1,0.955854526587483,0,3,extracellular membrane-bounded organelle,CC,
15680,GO:0070001,1,0.718010028809015,0,25,aspartic-type peptidase activity,MF,
15681,GO:0070002,1,0.99046814285105,0,1,glutamic-type peptidase activity,MF,
15682,GO:0070003,1,0.832722054452825,0,21,threonine-type peptidase activity,MF,
15683,GO:0070006,1,0.748389993090027,0,18,metalloaminopeptidase activity,MF,
15684,GO:0070008,1,0.874911714474633,0,9,serine-type exopeptidase activity,MF,
15685,GO:0070009,1,0.983586637625317,0,1,serine-type aminopeptidase activity,MF,
15687,GO:0070012,1,0.985234549583279,0,1,oligopeptidase activity,MF,
15690,GO:0070022,1,0.935600300671648,0,4,transforming growth factor beta receptor complex,CC,
15691,GO:0070025,1,0.984620385657398,0,1,carbon monoxide binding,MF,
15692,GO:0070026,1,0.977462759445128,0,2,nitric oxide binding,MF,
15693,GO:0070032,1,0.946015502686045,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15694,GO:0070033,1,0.956378748771787,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15695,GO:0070034,1,0.803292417796918,0,17,telomerase RNA binding,MF,
15696,GO:0070035,1,0.206330866110759,0,99,purine NTP-dependent helicase activity,MF,
15697,GO:0070037,1,0.992103254097921,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15698,GO:0070039,1,0.971109003510465,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15699,GO:0070044,1,0.960241412600574,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15701,GO:0070051,1,0.95240977119512,0,3,fibrinogen binding,MF,
15702,GO:0070052,1,0.959208680381897,0,3,collagen V binding,MF,
15704,GO:0070054,1,0.953074540220992,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15705,GO:0070055,1,0.953074540220992,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15707,GO:0070060,1,0.98342666749779,0,1,'de novo' actin filament nucleation,BP,
15708,GO:0070061,1,0.928995075901048,0,5,fructose binding,MF,
15710,GO:0070063,1,0.527375934686829,0,44,RNA polymerase binding,MF,
15711,GO:0070064,1,0.759515322780767,0,18,proline-rich region binding,MF,
15712,GO:0070069,1,0.794404855165682,0,28,cytochrome complex,CC,
15713,GO:0070070,1,0.863150971390096,0,9,proton-transporting V-type ATPase complex assembly,BP,
15714,GO:0070071,1,0.818017074502633,0,13,proton-transporting two-sector ATPase complex assembly,BP,
15715,GO:0070072,1,0.863150971390096,0,9,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15717,GO:0070076,1,0.683813691594357,0,23,histone lysine demethylation,BP,
15718,GO:0070077,1,0.983450982062668,0,1,histone arginine demethylation,BP,
15719,GO:0070078,1,0.983450982062668,0,1,histone H3-R2 demethylation,BP,
15720,GO:0070079,1,0.983450982062668,0,1,histone H4-R3 demethylation,BP,
15722,GO:0070081,1,0.931865401547845,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15723,GO:0070083,1,0.931865401547845,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15725,GO:0070086,1,0.949519742271706,0,4,ubiquitin-dependent endocytosis,BP,
15726,GO:0070087,1,0.905130515929906,0,6,chromo shadow domain binding,MF,
15727,GO:0070091,1,0.92238408995868,0,7,glucagon secretion,BP,
15728,GO:0070092,1,0.930556445220579,0,6,regulation of glucagon secretion,BP,
15729,GO:0070093,1,0.967511010373163,0,3,negative regulation of glucagon secretion,BP,
15730,GO:0070094,1,0.994502785411503,0,1,positive regulation of glucagon secretion,BP,
15731,GO:0070095,1,0.95807884868506,0,3,fructose-6-phosphate binding,MF,
15732,GO:0070096,1,0.978867852970679,0,2,mitochondrial outer membrane translocase complex assembly,BP,
15733,GO:0070097,1,0.905704348063395,0,6,delta-catenin binding,MF,
15736,GO:0070100,1,0.92685409899612,0,5,negative regulation of chemokine-mediated signaling pathway,BP,
15738,GO:0070102,1,0.858295852566358,0,10,interleukin-6-mediated signaling pathway,BP,
15739,GO:0070103,1,0.97269172280425,0,2,regulation of interleukin-6-mediated signaling pathway,BP,
15740,GO:0070104,1,0.988122489883223,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15741,GO:0070105,1,0.984384519079771,0,1,positive regulation of interleukin-6-mediated signaling pathway,BP,
15742,GO:0070106,1,0.967524181400956,0,2,interleukin-27-mediated signaling pathway,BP,
15743,GO:0070110,1,0.954539143579463,0,3,ciliary neurotrophic factor receptor complex,CC,
15744,GO:0070119,1,0.983426667503304,0,1,ciliary neurotrophic factor binding,MF,
15745,GO:0070120,1,0.926704721676802,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15746,GO:0070121,1,0.983426667502019,0,1,Kupffer's vesicle development,BP,
15747,GO:0070122,1,0.98342707854912,0,1,isopeptidase activity,MF,
15748,GO:0070123,1,0.98342666750094,0,1,transforming growth factor beta receptor activity, type III,MF,
15749,GO:0070124,1,0.976493474045961,0,2,mitochondrial translational initiation,BP,
15750,GO:0070125,1,0.454963799561175,0,84,mitochondrial translational elongation,BP,
15751,GO:0070126,1,0.447914749352851,0,85,mitochondrial translational termination,BP,
15752,GO:0070127,1,0.924086380615471,0,5,tRNA aminoacylation for mitochondrial protein translation,BP,
15753,GO:0070129,1,0.839001222322692,0,13,regulation of mitochondrial translation,BP,
15754,GO:0070130,1,0.984728932554734,0,1,negative regulation of mitochondrial translation,BP,
15755,GO:0070131,1,0.911506626364016,0,7,positive regulation of mitochondrial translation,BP,
15756,GO:0070137,1,0.951311787028084,0,3,ubiquitin-like protein-specific endopeptidase activity,MF,
15757,GO:0070138,1,0.98342707854912,0,1,ubiquitin-like protein-specific isopeptidase activity,MF,
15758,GO:0070139,1,0.951311787028084,0,3,SUMO-specific endopeptidase activity,MF,
15759,GO:0070140,1,0.98342707854912,0,1,SUMO-specific isopeptidase activity,MF,
15761,GO:0070142,1,0.938713941418399,0,4,synaptic vesicle budding,BP,
15762,GO:0070143,1,0.983426667502856,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15763,GO:0070145,1,0.98354319660451,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15764,GO:0070159,1,0.985244141856821,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15770,GO:0070165,1,0.968424941222481,0,2,positive regulation of adiponectin secretion,BP,
15771,GO:0070166,1,0.818147028266319,0,14,enamel mineralization,BP,
15776,GO:0070171,1,0.968651968834094,0,2,negative regulation of tooth mineralization,BP,
15778,GO:0070173,1,0.948235748144509,0,4,regulation of enamel mineralization,BP,
15779,GO:0070175,1,0.975997703056046,0,2,positive regulation of enamel mineralization,BP,
15780,GO:0070176,1,0.98763781913169,0,1,DRM complex,CC,
15781,GO:0070178,1,0.973798197774616,0,2,D-serine metabolic process,BP,
15782,GO:0070179,1,0.984951089777405,0,1,D-serine biosynthetic process,BP,
15783,GO:0070180,1,0.989880121794364,0,2,large ribosomal subunit rRNA binding,MF,
15784,GO:0070181,1,0.92123068475112,0,8,small ribosomal subunit rRNA binding,MF,
15785,GO:0070182,1,0.796326986754713,0,15,DNA polymerase binding,MF,
15786,GO:0070184,1,0.986042558870148,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15787,GO:0070187,1,0.913927756530721,0,6,shelterin complex,CC,
15788,GO:0070189,1,0.898981611774627,0,8,kynurenine metabolic process,BP,
15789,GO:0070191,1,0.984728932554734,0,1,methionine-R-sulfoxide reductase activity,MF,
15790,GO:0070192,1,0.441355041878845,0,56,chromosome organization involved in meiotic cell cycle,BP,
15791,GO:0070193,1,0.748846554975554,0,21,synaptonemal complex organization,BP,
15792,GO:0070194,1,0.985984515907278,0,1,synaptonemal complex disassembly,BP,
15793,GO:0070195,1,0.978107017357933,0,2,growth hormone receptor complex,CC,
15794,GO:0070197,1,0.924893254193517,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15795,GO:0070198,1,0.668521578037939,0,27,protein localization to chromosome, telomeric region,BP,
15796,GO:0070199,1,0.746876001661982,0,21,establishment of protein localization to chromosome,BP,
15797,GO:0070200,1,0.799108347726274,0,15,establishment of protein localization to telomere,BP,
15799,GO:0070202,1,0.865011494953535,0,10,regulation of establishment of protein localization to chromosome,BP,
15800,GO:0070203,1,0.865011494953535,0,10,regulation of establishment of protein localization to telomere,BP,
15801,GO:0070206,1,0.513861445050783,0,46,protein trimerization,BP,
15802,GO:0070207,1,0.707903044678812,0,26,protein homotrimerization,BP,
15803,GO:0070208,1,0.824289329228432,0,12,protein heterotrimerization,BP,
15804,GO:0070212,1,0.951143315849009,0,3,protein poly-ADP-ribosylation,BP,
15805,GO:0070213,1,0.936681936398576,0,4,protein auto-ADP-ribosylation,BP,
15806,GO:0070217,1,0.987742697245773,0,1,transcription factor TFIIIB complex assembly,BP,
15807,GO:0070221,1,0.96568649178548,0,3,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15816,GO:0070235,1,0.916528514082585,0,6,regulation of activation-induced cell death of T cells,BP,
15817,GO:0070236,1,0.944223078908128,0,4,negative regulation of activation-induced cell death of T cells,BP,
15818,GO:0070237,1,0.983426667502414,0,1,positive regulation of activation-induced cell death of T cells,BP,
15819,GO:0070238,1,0.988291634768173,0,1,activated T cell autonomous cell death,BP,
15820,GO:0070239,1,0.988291634768173,0,1,regulation of activated T cell autonomous cell death,BP,
15821,GO:0070241,1,0.988291634768173,0,1,positive regulation of activated T cell autonomous cell death,BP,
15826,GO:0070246,1,0.990487052527725,0,1,natural killer cell apoptotic process,BP,
15827,GO:0070247,1,0.990487052527725,0,1,regulation of natural killer cell apoptotic process,BP,
15828,GO:0070251,1,0.985472455448814,0,1,pristanate-CoA ligase activity,MF,
15830,GO:0070253,1,0.968459083313882,0,4,somatostatin secretion,BP,
15834,GO:0070257,1,0.917590598554675,0,6,positive regulation of mucus secretion,BP,
15835,GO:0070259,1,0.968427715775414,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15836,GO:0070260,1,0.984728932554734,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15837,GO:0070262,1,0.839348897475884,0,12,peptidyl-serine dephosphorylation,BP,
15838,GO:0070265,1,0.533677832374115,0,48,necrotic cell death,BP,
15839,GO:0070266,1,0.597801187338177,0,36,necroptotic process,BP,
15840,GO:0070267,1,0.983458267475984,0,1,oncosis,BP,
15842,GO:0070269,1,0.934825674065691,0,6,pyroptosis,BP,
15844,GO:0070272,1,0.947741357182051,0,4,proton-transporting ATP synthase complex biogenesis,BP,
15845,GO:0070273,1,0.732981586498506,0,20,phosphatidylinositol-4-phosphate binding,MF,
15846,GO:0070274,1,0.975898296891649,0,2,RES complex,CC,
15849,GO:0070283,1,0.988272990670061,0,1,radical SAM enzyme activity,MF,
15850,GO:0070286,1,0.738865273391489,0,21,axonemal dynein complex assembly,BP,
15851,GO:0070287,1,0.98344967443138,0,1,ferritin receptor activity,MF,
15852,GO:0070288,1,0.984359768140538,0,2,ferritin complex,CC,
15853,GO:0070290,1,0.925161581698924,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15854,GO:0070292,1,0.983765306578343,0,1,N-acylphosphatidylethanolamine metabolic process,BP,
15857,GO:0070295,1,0.957586786451725,0,3,renal water absorption,BP,
15859,GO:0070300,1,0.800884073114881,0,15,phosphatidic acid binding,MF,
15864,GO:0070305,1,0.89508902399484,0,7,response to cGMP,BP,
15867,GO:0070309,1,0.935227579686026,0,5,lens fiber cell morphogenesis,BP,
15868,GO:0070314,1,0.892925614806515,0,8,G1 to G0 transition,BP,
15869,GO:0070315,1,0.954752440651444,0,3,G1 to G0 transition involved in cell differentiation,BP,
15873,GO:0070320,1,0.984453075057737,0,1,inward rectifier potassium channel inhibitor activity,MF,
15874,GO:0070324,1,0.926706915785501,0,6,thyroid hormone binding,MF,
15875,GO:0070325,1,0.760114924811241,0,21,lipoprotein particle receptor binding,MF,
15876,GO:0070326,1,0.94797327466721,0,4,very-low-density lipoprotein particle receptor binding,MF,
15877,GO:0070327,1,0.881448848966862,0,9,thyroid hormone transport,BP,
15879,GO:0070330,1,0.732169656285948,0,22,aromatase activity,MF,
15880,GO:0070335,1,0.983426667500101,0,1,aspartate binding,MF,
15881,GO:0070336,1,0.96840766101638,0,2,flap-structured DNA binding,MF,
15882,GO:0070337,1,0.983426667501724,0,1,3'-flap-structured DNA binding,MF,
15883,GO:0070339,1,0.916903571597854,0,6,response to bacterial lipopeptide,BP,
15884,GO:0070340,1,0.951839109593374,0,3,detection of bacterial lipopeptide,BP,
15886,GO:0070342,1,0.997265515654528,0,1,brown fat cell proliferation,BP,
15889,GO:0070345,1,0.915811254061853,0,6,negative regulation of fat cell proliferation,BP,
15891,GO:0070347,1,0.997265515654528,0,1,regulation of brown fat cell proliferation,BP,
15892,GO:0070349,1,0.997265515654528,0,1,positive regulation of brown fat cell proliferation,BP,
15894,GO:0070351,1,0.993177581334886,0,1,negative regulation of white fat cell proliferation,BP,
15896,GO:0070358,1,0.951096465387394,0,3,actin polymerization-dependent cell motility,BP,
15897,GO:0070361,1,0.98372413691889,0,1,mitochondrial light strand promoter anti-sense binding,MF,
15898,GO:0070362,1,0.98372413691889,0,1,mitochondrial heavy strand promoter anti-sense binding,MF,
15899,GO:0070363,1,0.98698078738749,0,1,mitochondrial light strand promoter sense binding,MF,
15900,GO:0070365,1,0.835454643556704,0,13,hepatocyte differentiation,BP,
15901,GO:0070366,1,0.978044526241886,0,2,regulation of hepatocyte differentiation,BP,
15902,GO:0070367,1,0.986544147461856,0,1,negative regulation of hepatocyte differentiation,BP,
15903,GO:0070368,1,0.991384933405719,0,1,positive regulation of hepatocyte differentiation,BP,
15904,GO:0070369,1,0.967209858472895,0,2,beta-catenin-TCF7L2 complex,CC,
15905,GO:0070370,1,0.957185467967223,0,3,cellular heat acclimation,BP,
15910,GO:0070375,1,0.953487697065674,0,3,ERK5 cascade,BP,
15911,GO:0070376,1,0.984017511714002,0,1,regulation of ERK5 cascade,BP,
15912,GO:0070377,1,0.984017511714002,0,1,negative regulation of ERK5 cascade,BP,
15913,GO:0070381,1,0.983520982414149,0,1,endosome to plasma membrane transport vesicle,CC,
15915,GO:0070383,1,0.933503970802845,0,6,DNA cytosine deamination,BP,
15917,GO:0070389,1,0.898959756192269,0,7,chaperone cofactor-dependent protein refolding,BP,
15918,GO:0070390,1,0.988075450823006,0,1,transcription export complex 2,CC,
15920,GO:0070392,1,0.992096438783521,0,1,detection of lipoteichoic acid,BP,
15921,GO:0070401,1,0.974226991830356,0,2,NADP+ binding,MF,
15922,GO:0070402,1,0.83716342534219,0,13,NADPH binding,MF,
15923,GO:0070403,1,0.834041002950321,0,13,NAD+ binding,MF,
15924,GO:0070404,1,0.980985666066451,0,2,NADH binding,MF,
15926,GO:0070407,1,0.98372413691889,0,1,oxidation-dependent protein catabolic process,BP,
15927,GO:0070408,1,0.983426667501773,0,1,carbamoyl phosphate metabolic process,BP,
15928,GO:0070409,1,0.983426667501773,0,1,carbamoyl phosphate biosynthetic process,BP,
15929,GO:0070410,1,0.848494090514012,0,11,co-SMAD binding,MF,
15931,GO:0070412,1,0.690639291171275,0,23,R-SMAD binding,MF,
15932,GO:0070417,1,0.912435336337222,0,6,cellular response to cold,BP,
15933,GO:0070418,1,0.983426667502466,0,1,DNA-dependent protein kinase complex,CC,
15934,GO:0070419,1,0.893556337096307,0,8,nonhomologous end joining complex,CC,
15935,GO:0070423,1,0.604559866195273,0,33,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15936,GO:0070424,1,0.877991280125064,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15937,GO:0070425,1,0.967549888576213,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15938,GO:0070426,1,0.954110698137592,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15939,GO:0070427,1,0.941676539212446,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15940,GO:0070428,1,0.967126892154004,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15941,GO:0070429,1,0.983426667503154,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15942,GO:0070430,1,0.983426667501871,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15943,GO:0070431,1,0.870394331740201,0,9,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15944,GO:0070432,1,0.92314377437116,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15945,GO:0070433,1,0.967549888576213,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15946,GO:0070434,1,0.954110698137592,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15947,GO:0070435,1,0.968533940996348,0,2,Shc-EGFR complex,CC,
15948,GO:0070436,1,0.967316795462638,0,2,Grb2-EGFR complex,CC,
15949,GO:0070442,1,0.989959389291832,0,1,integrin alphaIIb-beta3 complex,CC,
15952,GO:0070446,1,0.986935358959301,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15953,GO:0070447,1,0.983787244817848,0,1,positive regulation of oligodendrocyte progenitor proliferation,BP,
15954,GO:0070449,1,0.987283279705319,0,1,elongin complex,CC,
15955,GO:0070458,1,0.965565611171536,0,3,cellular detoxification of nitrogen compound,BP,
15956,GO:0070459,1,0.918393926463824,0,6,prolactin secretion,BP,
15957,GO:0070460,1,0.983427738433103,0,1,thyroid-stimulating hormone secretion,BP,
15958,GO:0070461,1,0.667455759492339,0,28,SAGA-type complex,CC,
15959,GO:0070462,1,0.98344507003102,0,1,plus-end specific microtubule depolymerization,BP,
15960,GO:0070463,1,0.983491409131409,0,1,tubulin-dependent ATPase activity,MF,
15961,GO:0070469,1,0.507874775550336,0,82,respiratory chain,CC,
15965,GO:0070474,1,0.922073342107569,0,6,positive regulation of uterine smooth muscle contraction,BP,
15966,GO:0070475,1,0.943251882507078,0,5,rRNA base methylation,BP,
15967,GO:0070476,1,0.995506108644345,0,1,rRNA (guanine-N7)-methylation,BP,
15968,GO:0070478,1,0.983426667503302,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15969,GO:0070481,1,0.983986148397243,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15971,GO:0070483,1,0.983665790532393,0,1,detection of hypoxia,BP,
15974,GO:0070488,1,0.992354750639023,0,2,neutrophil aggregation,BP,
15975,GO:0070489,1,0.986953494759361,0,1,T cell aggregation,BP,
15976,GO:0070491,1,0.419676699567963,0,58,repressing transcription factor binding,MF,
15977,GO:0070492,1,0.861881937765527,0,11,oligosaccharide binding,MF,
15978,GO:0070493,1,0.826580003492155,0,12,thrombin-activated receptor signaling pathway,BP,
15979,GO:0070494,1,0.956331197159676,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15980,GO:0070495,1,0.956331197159676,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15981,GO:0070498,1,0.744173520097992,0,20,interleukin-1-mediated signaling pathway,BP,
15982,GO:0070506,1,0.969145063481942,0,2,high-density lipoprotein particle receptor activity,MF,
15984,GO:0070508,1,0.904527927455595,0,9,cholesterol import,BP,
15986,GO:0070510,1,0.983426667500102,0,1,regulation of histone H4-K20 methylation,BP,
15987,GO:0070512,1,0.983426667500102,0,1,positive regulation of histone H4-K20 methylation,BP,
15988,GO:0070513,1,0.895863181110106,0,9,death domain binding,MF,
15989,GO:0070522,1,0.939367253330074,0,4,ERCC4-ERCC1 complex,CC,
15990,GO:0070524,1,0.989780294986208,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15991,GO:0070525,1,0.83882209110408,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
15994,GO:0070530,1,0.760255295164624,0,17,K63-linked polyubiquitin binding,MF,
15995,GO:0070531,1,0.89764441852005,0,7,BRCA1-A complex,CC,
15996,GO:0070534,1,0.552817569368068,0,41,protein K63-linked ubiquitination,BP,
15997,GO:0070535,1,0.923392854206277,0,5,histone H2A K63-linked ubiquitination,BP,
15998,GO:0070536,1,0.653518389046235,0,27,protein K63-linked deubiquitination,BP,
15999,GO:0070537,1,0.953262782356304,0,3,histone H2A K63-linked deubiquitination,BP,
16000,GO:0070538,1,0.981592828806107,0,2,oleic acid binding,MF,
16001,GO:0070539,1,0.983477549870039,0,1,linoleic acid binding,MF,
16002,GO:0070541,1,0.967358648587627,0,2,response to platinum ion,BP,
16004,GO:0070543,1,0.970043893806149,0,2,response to linoleic acid,BP,
16005,GO:0070544,1,0.921042685055349,0,5,histone H3-K36 demethylation,BP,
16006,GO:0070545,1,0.941191309575694,0,4,PeBoW complex,CC,
16007,GO:0070546,1,0.956099555295784,0,3,L-phenylalanine aminotransferase activity,MF,
16008,GO:0070547,1,0.984254363789522,0,1,L-tyrosine aminotransferase activity,MF,
16009,GO:0070548,1,0.967528039503109,0,2,L-glutamine aminotransferase activity,MF,
16010,GO:0070551,1,0.984728932554734,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
16011,GO:0070552,1,0.927864985796876,0,5,BRISC complex,CC,
16012,GO:0070553,1,0.984728932554734,0,1,nicotinic acid receptor activity,MF,
16013,GO:0070554,1,0.96978064947005,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
16016,GO:0070560,1,0.984085429030766,0,1,protein secretion by platelet,BP,
16018,GO:0070562,1,0.911105903891369,0,6,regulation of vitamin D receptor signaling pathway,BP,
16019,GO:0070563,1,0.969946674581839,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
16020,GO:0070564,1,0.971276136780632,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
16021,GO:0070566,1,0.6988318340098,0,23,adenylyltransferase activity,MF,
16022,GO:0070567,1,0.881015874795436,0,9,cytidylyltransferase activity,MF,
16023,GO:0070568,1,0.931383718557262,0,5,guanylyltransferase activity,MF,
16024,GO:0070569,1,0.90073059736199,0,7,uridylyltransferase activity,MF,
16025,GO:0070570,1,0.688596752071475,0,25,regulation of neuron projection regeneration,BP,
16026,GO:0070571,1,0.823934755036627,0,13,negative regulation of neuron projection regeneration,BP,
16027,GO:0070572,1,0.907126529248514,0,7,positive regulation of neuron projection regeneration,BP,
16028,GO:0070573,1,0.957051028563183,0,3,metallodipeptidase activity,MF,
16029,GO:0070574,1,0.938572165772164,0,4,cadmium ion transmembrane transport,BP,
16030,GO:0070576,1,0.953254005189251,0,3,vitamin D 24-hydroxylase activity,MF,
16031,GO:0070577,1,0.755619581274275,0,17,lysine-acetylated histone binding,MF,
16032,GO:0070578,1,0.89267924819337,0,8,RISC-loading complex,CC,
16033,GO:0070579,1,0.936504380704923,0,4,methylcytosine dioxygenase activity,MF,
16034,GO:0070584,1,0.764333716254775,0,20,mitochondrion morphogenesis,BP,
16036,GO:0070586,1,0.868351834176027,0,10,cell-cell adhesion involved in gastrulation,BP,
16037,GO:0070587,1,0.882133886412339,0,9,regulation of cell-cell adhesion involved in gastrulation,BP,
16039,GO:0070589,1,0.987762819794679,0,1,cellular component macromolecule biosynthetic process,BP,
16040,GO:0070593,1,0.983426667500102,0,1,dendrite self-avoidance,BP,
16041,GO:0070601,1,0.891409919343316,0,7,centromeric sister chromatid cohesion,BP,
16042,GO:0070602,1,0.951181824865436,0,3,regulation of centromeric sister chromatid cohesion,BP,
16043,GO:0070603,1,0.340406139316088,0,73,SWI/SNF superfamily-type complex,CC,
16044,GO:0070611,1,0.98453420551145,0,1,histone methyltransferase activity (H3-R2 specific),MF,
16045,GO:0070612,1,0.98453420551145,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
16047,GO:0070615,1,0.983426667503345,0,1,nucleosome-dependent ATPase activity,MF,
16048,GO:0070618,1,0.98441561761483,0,1,Grb2-Sos complex,CC,
16049,GO:0070625,1,0.986355355260577,0,1,zymogen granule exocytosis,BP,
16050,GO:0070626,1,0.989366935492526,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
16052,GO:0070628,1,0.854530338300764,0,12,proteasome binding,MF,
16054,GO:0070634,1,0.958329983336278,0,3,transepithelial ammonium transport,BP,
16055,GO:0070637,1,0.985149477412485,0,1,pyridine nucleoside metabolic process,BP,
16056,GO:0070638,1,0.985149477412485,0,1,pyridine nucleoside catabolic process,BP,
16057,GO:0070640,1,0.942443759915068,0,4,vitamin D3 metabolic process,BP,
16058,GO:0070643,1,0.973004439514259,0,2,vitamin D 25-hydroxylase activity,MF,
16062,GO:0070649,1,0.951273936983055,0,3,formin-nucleated actin cable assembly,BP,
16063,GO:0070651,1,0.983986148397243,0,1,nonfunctional rRNA decay,BP,
16064,GO:0070652,1,0.895438969013415,0,8,HAUS complex,CC,
16065,GO:0070653,1,0.985387769809232,0,3,high-density lipoprotein particle receptor binding,MF,
16072,GO:0070667,1,0.983787244817848,0,1,negative regulation of mast cell proliferation,BP,
16074,GO:0070669,1,0.878432756914406,0,9,response to interleukin-2,BP,
16075,GO:0070670,1,0.627770022137747,0,34,response to interleukin-4,BP,
16076,GO:0070671,1,0.924521909017574,0,5,response to interleukin-12,BP,
16079,GO:0070676,1,0.963641546971502,0,3,intralumenal vesicle formation,BP,
16080,GO:0070679,1,0.860664583934765,0,9,inositol 1,4,5 trisphosphate binding,MF,
16081,GO:0070681,1,0.980261045838147,0,2,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
16082,GO:0070682,1,0.958690167923249,0,3,proteasome regulatory particle assembly,BP,
16083,GO:0070684,1,0.991530781343413,0,1,seminal clot liquefaction,BP,
16084,GO:0070685,1,0.986230857096709,0,1,macropinocytic cup,CC,
16085,GO:0070694,1,0.984728932554734,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
16086,GO:0070695,1,0.923211709449782,0,5,FHF complex,CC,
16088,GO:0070697,1,0.941153705724198,0,4,activin receptor binding,MF,
16089,GO:0070698,1,0.970611584998039,0,2,type I activin receptor binding,MF,
16090,GO:0070699,1,0.969653882101623,0,2,type II activin receptor binding,MF,
16092,GO:0070701,1,0.96712689213663,0,2,mucus layer,CC,
16093,GO:0070702,1,0.98342666749833,0,1,inner mucus layer,CC,
16094,GO:0070703,1,0.98342666749833,0,1,outer mucus layer,CC,
16095,GO:0070704,1,0.983426667503154,0,1,sterol desaturase activity,MF,
16096,GO:0070715,1,0.983591359917946,0,1,sodium-dependent organic cation transport,BP,
16097,GO:0070717,1,0.751803810422413,0,18,poly-purine tract binding,MF,
16098,GO:0070722,1,0.98348336107552,0,1,Tle3-Aes complex,CC,
16099,GO:0070723,1,0.722597865993792,0,21,response to cholesterol,BP,
16103,GO:0070733,1,0.988415030534275,0,1,protein adenylyltransferase activity,MF,
16104,GO:0070734,1,0.773000847070745,0,18,histone H3-K27 methylation,BP,
16105,GO:0070735,1,0.98351865326559,0,1,protein-glycine ligase activity,MF,
16106,GO:0070736,1,0.98351865326559,0,1,protein-glycine ligase activity, initiating,MF,
16107,GO:0070739,1,0.915194132304261,0,6,protein-glutamic acid ligase activity,MF,
16108,GO:0070740,1,0.956306277107822,0,3,tubulin-glutamic acid ligase activity,MF,
16109,GO:0070741,1,0.646415791119567,0,31,response to interleukin-6,BP,
16111,GO:0070743,1,0.977640490926053,0,2,interleukin-23 complex,CC,
16112,GO:0070761,1,0.924601998002547,0,6,pre-snoRNP complex,CC,
16113,GO:0070765,1,0.918532061075263,0,6,gamma-secretase complex,CC,
16114,GO:0070772,1,0.983739551070219,0,1,PAS complex,CC,
16115,GO:0070773,1,0.99015604166239,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
16116,GO:0070774,1,0.983426667503153,0,1,phytoceramidase activity,MF,
16117,GO:0070775,1,0.894340415108844,0,7,H3 histone acetyltransferase complex,CC,
16118,GO:0070776,1,0.894340415108844,0,7,MOZ/MORF histone acetyltransferase complex,CC,
16119,GO:0070777,1,0.935356668504836,0,4,D-aspartate transport,BP,
16120,GO:0070778,1,0.940678650839748,0,4,L-aspartate transport,BP,
16121,GO:0070779,1,0.935356668504836,0,4,D-aspartate import,BP,
16122,GO:0070780,1,0.97483086441332,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
16123,GO:0070781,1,0.972022301700794,0,2,response to biotin,BP,
16124,GO:0070782,1,0.986054249359654,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
16125,GO:0070813,1,0.939538321498076,0,5,hydrogen sulfide metabolic process,BP,
16126,GO:0070814,1,0.946452635193228,0,4,hydrogen sulfide biosynthetic process,BP,
16127,GO:0070815,1,0.936182045973487,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
16128,GO:0070816,1,0.806692499511289,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
16129,GO:0070818,1,0.987907540571087,0,1,protoporphyrinogen oxidase activity,MF,
16133,GO:0070826,1,0.983426667503302,0,1,paraferritin complex,CC,
16134,GO:0070827,1,0.952559480206169,0,3,chromatin maintenance,BP,
16135,GO:0070828,1,0.806267757518809,0,15,heterochromatin organization,BP,
16136,GO:0070829,1,0.983426667500052,0,1,heterochromatin maintenance,BP,
16138,GO:0070831,1,0.86996777429449,0,9,basement membrane assembly,BP,
16139,GO:0070836,1,0.945491638799268,0,4,caveola assembly,BP,
16140,GO:0070837,1,0.937223953679464,0,4,dehydroascorbic acid transport,BP,
16142,GO:0070839,1,0.967244943066525,0,2,divalent metal ion export,BP,
16143,GO:0070840,1,0.732183363553447,0,19,dynein complex binding,MF,
16144,GO:0070841,1,0.731685312934288,0,21,inclusion body assembly,BP,
16145,GO:0070842,1,0.944003631475191,0,4,aggresome assembly,BP,
16146,GO:0070843,1,0.983426667503348,0,1,misfolded protein transport,BP,
16147,GO:0070844,1,0.983426667503348,0,1,polyubiquitinated protein transport,BP,
16148,GO:0070845,1,0.983426667503348,0,1,polyubiquitinated misfolded protein transport,BP,
16149,GO:0070846,1,0.983426667503348,0,1,Hsp90 deacetylation,BP,
16150,GO:0070847,1,0.93037663524913,0,6,core mediator complex,CC,
16155,GO:0070853,1,0.967126892148439,0,2,myosin VI binding,MF,
16156,GO:0070856,1,0.983426667501335,0,1,myosin VI light chain binding,MF,
16157,GO:0070857,1,0.869826020297907,0,9,regulation of bile acid biosynthetic process,BP,
16158,GO:0070858,1,0.956642218820597,0,3,negative regulation of bile acid biosynthetic process,BP,
16159,GO:0070859,1,0.955034712583655,0,3,positive regulation of bile acid biosynthetic process,BP,
16160,GO:0070860,1,0.985499877640152,0,1,RNA polymerase I core factor complex,CC,
16161,GO:0070861,1,0.725783313243113,0,21,regulation of protein exit from endoplasmic reticulum,BP,
16162,GO:0070862,1,0.875880294746643,0,9,negative regulation of protein exit from endoplasmic reticulum,BP,
16163,GO:0070863,1,0.856860793734799,0,10,positive regulation of protein exit from endoplasmic reticulum,BP,
16165,GO:0070874,1,0.919024148603703,0,6,negative regulation of glycogen metabolic process,BP,
16167,GO:0070876,1,0.93905149612346,0,4,SOSS complex,CC,
16168,GO:0070877,1,0.968407661017789,0,2,microprocessor complex,CC,
16169,GO:0070878,1,0.877419859910223,0,8,primary miRNA binding,MF,
16170,GO:0070883,1,0.949323497941479,0,4,pre-miRNA binding,MF,
16173,GO:0070886,1,0.875865671337462,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16175,GO:0070888,1,0.599205037160066,0,35,E-box binding,MF,
16176,GO:0070889,1,0.970103786196514,0,2,platelet alpha granule organization,BP,
16177,GO:0070890,1,0.968994049490878,0,2,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16178,GO:0070891,1,0.95273322668591,0,4,lipoteichoic acid binding,MF,
16179,GO:0070892,1,0.986392627401713,0,1,lipoteichoic acid receptor activity,MF,
16180,GO:0070893,1,0.967885220989861,0,2,transposon integration,BP,
16181,GO:0070894,1,0.967885220989861,0,2,regulation of transposon integration,BP,
16182,GO:0070895,1,0.967885220989861,0,2,negative regulation of transposon integration,BP,
16183,GO:0070897,1,0.605250546147481,0,36,DNA-templated transcriptional preinitiation complex assembly,BP,
16184,GO:0070898,1,0.968757731741908,0,2,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16185,GO:0070899,1,0.983860001501999,0,1,mitochondrial tRNA wobble uridine modification,BP,
16186,GO:0070900,1,0.886262894051487,0,9,mitochondrial tRNA modification,BP,
16187,GO:0070901,1,0.949330398148318,0,4,mitochondrial tRNA methylation,BP,
16188,GO:0070902,1,0.98831833041481,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
16189,GO:0070903,1,0.986836460786804,0,1,mitochondrial tRNA thio-modification,BP,
16190,GO:0070904,1,0.968994049490878,0,2,transepithelial L-ascorbic acid transport,BP,
16191,GO:0070905,1,0.955333379321678,0,3,serine binding,MF,
16192,GO:0070911,1,0.650842398997297,0,32,global genome nucleotide-excision repair,BP,
16193,GO:0070914,1,0.852523795449789,0,11,UV-damage excision repair,BP,
16197,GO:0070922,1,0.888976864594214,0,8,small RNA loading onto RISC,BP,
16199,GO:0070926,1,0.983427836177216,0,1,regulation of ATP:ADP antiporter activity,BP,
16200,GO:0070931,1,0.983426667501771,0,1,Golgi-associated vesicle lumen,CC,
16201,GO:0070932,1,0.734672451953383,0,20,histone H3 deacetylation,BP,
16202,GO:0070933,1,0.869982944502538,0,9,histone H4 deacetylation,BP,
16203,GO:0070934,1,0.925025482081957,0,5,CRD-mediated mRNA stabilization,BP,
16204,GO:0070935,1,0.855175853082293,0,10,3'-UTR-mediated mRNA stabilization,BP,
16205,GO:0070936,1,0.493970783247474,0,48,protein K48-linked ubiquitination,BP,
16206,GO:0070937,1,0.909689819749421,0,6,CRD-mediated mRNA stability complex,CC,
16207,GO:0070938,1,0.841673170856758,0,11,contractile ring,CC,
16208,GO:0070939,1,0.952116054088782,0,3,Dsl1/NZR complex,CC,
16209,GO:0070940,1,0.926693334068948,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16210,GO:0070942,1,0.945575759466287,0,6,neutrophil mediated cytotoxicity,BP,
16211,GO:0070943,1,0.945575759466287,0,6,neutrophil mediated killing of symbiont cell,BP,
16212,GO:0070944,1,0.952252010319109,0,5,neutrophil mediated killing of bacterium,BP,
16213,GO:0070945,1,0.965683940779826,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16214,GO:0070946,1,0.992983378530701,0,1,neutrophil mediated killing of gram-positive bacterium,BP,
16215,GO:0070947,1,0.992990418798386,0,1,neutrophil mediated killing of fungus,BP,
16216,GO:0070948,1,0.984045075041391,0,1,regulation of neutrophil mediated cytotoxicity,BP,
16217,GO:0070949,1,0.984045075041391,0,1,regulation of neutrophil mediated killing of symbiont cell,BP,
16218,GO:0070950,1,0.984045075041391,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16219,GO:0070951,1,0.984045075041391,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16220,GO:0070960,1,0.984045075041391,0,1,positive regulation of neutrophil mediated cytotoxicity,BP,
16221,GO:0070961,1,0.984045075041391,0,1,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16222,GO:0070962,1,0.984045075041391,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16223,GO:0070963,1,0.984045075041391,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16224,GO:0070966,1,0.951637339359831,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16225,GO:0070970,1,0.850335377730187,0,10,interleukin-2 secretion,BP,
16227,GO:0070972,1,0.315616853831357,0,126,protein localization to endoplasmic reticulum,BP,
16228,GO:0070973,1,0.94277342727979,0,4,protein localization to endoplasmic reticulum exit site,BP,
16229,GO:0070974,1,0.983813110673525,0,1,POU domain binding,MF,
16230,GO:0070975,1,0.983426667499806,0,1,FHA domain binding,MF,
16231,GO:0070976,1,0.984364858975373,0,1,TIR domain binding,MF,
16233,GO:0070979,1,0.714840126706917,0,26,protein K11-linked ubiquitination,BP,
16234,GO:0070980,1,0.985331728146524,0,1,biphenyl catabolic process,BP,
16235,GO:0070981,1,0.985428315063711,0,1,L-asparagine biosynthetic process,BP,
16236,GO:0070982,1,0.985428315063711,0,1,L-asparagine metabolic process,BP,
16237,GO:0070984,1,0.983426667503302,0,1,SET domain binding,MF,
16238,GO:0070985,1,0.97918561464287,0,2,TFIIK complex,CC,
16240,GO:0070987,1,0.784613577730408,0,18,error-free translesion synthesis,BP,
16241,GO:0070988,1,0.423733738204808,0,57,demethylation,BP,
16242,GO:0070989,1,0.847710283659907,0,12,oxidative demethylation,BP,
16243,GO:0070990,1,0.919041504651494,0,8,snRNP binding,MF,
16244,GO:0070991,1,0.968306964058414,0,2,medium-chain-acyl-CoA dehydrogenase activity,MF,
16245,GO:0070992,1,0.98089787863519,0,2,translation initiation complex,CC,
16246,GO:0070993,1,0.967126892155359,0,2,translation preinitiation complex,CC,
16247,GO:0070994,1,0.983426667503056,0,1,detection of oxidative stress,BP,
16248,GO:0070995,1,0.953997853349781,0,3,NADPH oxidation,BP,
16249,GO:0070996,1,0.97057441020429,0,3,type 1 melanocortin receptor binding,MF,
16251,GO:0071000,1,0.973084903739906,0,2,response to magnetism,BP,
16252,GO:0071001,1,0.962013886912245,0,3,U4/U6 snRNP,CC,
16253,GO:0071004,1,0.810086828497354,0,16,U2-type prespliceosome,CC,
16254,GO:0071006,1,0.954978102959475,0,3,U2-type catalytic step 1 spliceosome,CC,
16255,GO:0071007,1,0.985351498366802,0,1,U2-type catalytic step 2 spliceosome,CC,
16256,GO:0071008,1,0.944845248059034,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16257,GO:0071010,1,0.785816666301082,0,19,prespliceosome,CC,
16258,GO:0071011,1,0.764992139035224,0,23,precatalytic spliceosome,CC,
16259,GO:0071012,1,0.943337888400565,0,4,catalytic step 1 spliceosome,CC,
16260,GO:0071013,1,0.271145937582795,0,95,catalytic step 2 spliceosome,CC,
16261,GO:0071014,1,0.909405537196064,0,7,post-mRNA release spliceosomal complex,CC,
16262,GO:0071020,1,0.97605412844131,0,2,post-spliceosomal complex,CC,
16263,GO:0071021,1,0.988096328148759,0,1,U2-type post-spliceosomal complex,CC,
16264,GO:0071025,1,0.861996247754732,0,12,RNA surveillance,BP,
16265,GO:0071026,1,0.984939504141857,0,1,cytoplasmic RNA surveillance,BP,
16266,GO:0071027,1,0.889434338263973,0,10,nuclear RNA surveillance,BP,
16267,GO:0071028,1,0.889434338263973,0,10,nuclear mRNA surveillance,BP,
16268,GO:0071029,1,0.951028772472847,0,4,nuclear ncRNA surveillance,BP,
16269,GO:0071030,1,0.972492750443268,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16270,GO:0071031,1,0.977487159496569,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16271,GO:0071033,1,0.939258857860307,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16272,GO:0071034,1,0.946103512080234,0,4,CUT catabolic process,BP,
16273,GO:0071035,1,0.951028772472847,0,4,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16274,GO:0071038,1,0.977487159496569,0,2,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16275,GO:0071042,1,0.983426667503004,0,1,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16276,GO:0071043,1,0.946103512080234,0,4,CUT metabolic process,BP,
16277,GO:0071044,1,0.853655490703372,0,11,histone mRNA catabolic process,BP,
16278,GO:0071045,1,0.988442056876956,0,1,nuclear histone mRNA catabolic process,BP,
16279,GO:0071046,1,0.951028772472847,0,4,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16280,GO:0071047,1,0.983426667503004,0,1,polyadenylation-dependent mRNA catabolic process,BP,
16281,GO:0071048,1,0.972492750443268,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16282,GO:0071049,1,0.977487159496569,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16283,GO:0071051,1,0.95215537882787,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16285,GO:0071065,1,0.967872206773481,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16288,GO:0071073,1,0.907871566807187,0,7,positive regulation of phospholipid biosynthetic process,BP,
16289,GO:0071074,1,0.97073531575885,0,2,eukaryotic initiation factor eIF2 binding,MF,
16290,GO:0071077,1,0.969592073929455,0,2,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16291,GO:0071103,1,0.0377837460251426,0,265,DNA conformation change,BP,
16292,GO:0071104,1,0.962945965364395,0,3,response to interleukin-9,BP,
16293,GO:0071105,1,0.976577825343299,0,2,response to interleukin-11,BP,
16294,GO:0071106,1,0.969592073929455,0,2,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16295,GO:0071107,1,0.856695059677252,0,11,response to parathyroid hormone,BP,
16296,GO:0071108,1,0.675913419695567,0,25,protein K48-linked deubiquitination,BP,
16297,GO:0071109,1,0.967126892146167,0,2,superior temporal gyrus development,BP,
16298,GO:0071110,1,0.983426667501431,0,1,histone biotinylation,BP,
16299,GO:0071133,1,0.983697683106668,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16300,GO:0071139,1,0.96829102550803,0,2,resolution of recombination intermediates,BP,
16301,GO:0071140,1,0.96829102550803,0,2,resolution of mitotic recombination intermediates,BP,
16302,GO:0071141,1,0.863754453393548,0,9,SMAD protein complex,CC,
16303,GO:0071144,1,0.96712689214699,0,2,SMAD2-SMAD3 protein complex,CC,
16304,GO:0071146,1,0.986148754612068,0,1,SMAD3-SMAD4 protein complex,CC,
16305,GO:0071148,1,0.967126892148824,0,2,TEAD-1-YAP complex,CC,
16306,GO:0071149,1,0.969672880560555,0,2,TEAD-2-YAP complex,CC,
16310,GO:0071159,1,0.978351656389326,0,2,NF-kappaB complex,CC,
16311,GO:0071163,1,0.962940528349971,0,3,DNA replication preinitiation complex assembly,BP,
16312,GO:0071164,1,0.983439322167495,0,1,RNA trimethylguanosine synthase activity,MF,
16313,GO:0071166,1,0.159116956128614,0,127,ribonucleoprotein complex localization,BP,
16314,GO:0071167,1,0.983439322167495,0,1,ribonucleoprotein complex import into nucleus,BP,
16315,GO:0071168,1,0.811767753342015,0,15,protein localization to chromatin,BP,
16316,GO:0071169,1,0.934695547001121,0,6,establishment of protein localization to chromatin,BP,
16317,GO:0071170,1,0.984728932554734,0,1,site-specific DNA replication termination,BP,
16318,GO:0071171,1,0.984728932554734,0,1,site-specific DNA replication termination at RTS1 barrier,BP,
16319,GO:0071173,1,0.664695914579339,0,28,spindle assembly checkpoint,BP,
16320,GO:0071174,1,0.655782638616024,0,29,mitotic spindle checkpoint,BP,
16321,GO:0071203,1,0.940575427919105,0,4,WASH complex,CC,
16322,GO:0071204,1,0.923004237251581,0,6,histone pre-mRNA 3'end processing complex,CC,
16323,GO:0071205,1,0.935330099159888,0,4,protein localization to juxtaparanode region of axon,BP,
16324,GO:0071206,1,0.983426667499464,0,1,establishment of protein localization to juxtaparanode region of axon,BP,
16325,GO:0071207,1,0.971622347629792,0,2,histone pre-mRNA stem-loop binding,MF,
16326,GO:0071208,1,0.963838020260714,0,4,histone pre-mRNA DCP binding,MF,
16327,GO:0071209,1,0.968508409837142,0,3,U7 snRNA binding,MF,
16328,GO:0071211,1,0.954119836692086,0,3,protein targeting to vacuole involved in autophagy,BP,
16330,GO:0071215,1,0.983426667503199,0,1,cellular response to abscisic acid stimulus,BP,
16332,GO:0071217,1,0.983426669406348,0,1,cellular response to external biotic stimulus,BP,
16333,GO:0071218,1,0.760414694766276,0,19,cellular response to misfolded protein,BP,
16335,GO:0071220,1,0.916903571597854,0,6,cellular response to bacterial lipoprotein,BP,
16336,GO:0071221,1,0.916903571597854,0,6,cellular response to bacterial lipopeptide,BP,
16339,GO:0071224,1,0.976868081072195,0,2,cellular response to peptidoglycan,BP,
16340,GO:0071225,1,0.921372502039651,0,5,cellular response to muramyl dipeptide,BP,
16341,GO:0071226,1,0.953833972972881,0,3,cellular response to molecule of fungal origin,BP,
16342,GO:0071228,1,0.983967874437797,0,1,cellular response to tumor cell,BP,
16345,GO:0071231,1,0.98382027473808,0,2,cellular response to folic acid,BP,
16347,GO:0071236,1,0.802676062216937,0,15,cellular response to antibiotic,BP,
16349,GO:0071242,1,0.453308799902427,0,55,cellular response to ammonium ion,BP,
16350,GO:0071243,1,0.825390723669713,0,15,cellular response to arsenic-containing substance,BP,
16351,GO:0071245,1,0.983447457550241,0,1,cellular response to carbon monoxide,BP,
16352,GO:0071247,1,0.991801802024,0,1,cellular response to chromate,BP,
16354,GO:0071250,1,0.983426667501085,0,1,cellular response to nitrite,BP,
16355,GO:0071253,1,0.912597502447363,0,6,connexin binding,MF,
16356,GO:0071256,1,0.965820129287081,0,4,translocon complex,CC,
16357,GO:0071257,1,0.831193357105371,0,12,cellular response to electrical stimulus,BP,
16358,GO:0071258,1,0.983426667503304,0,1,cellular response to gravity,BP,
16359,GO:0071259,1,0.973084903739906,0,2,cellular response to magnetism,BP,
16361,GO:0071262,1,0.967133086295198,0,2,regulation of translational initiation in response to starvation,BP,
16362,GO:0071264,1,0.967133086295198,0,2,positive regulation of translational initiation in response to starvation,BP,
16363,GO:0071265,1,0.897228381964483,0,8,L-methionine biosynthetic process,BP,
16364,GO:0071266,1,0.987912661362616,0,1,'de novo' L-methionine biosynthetic process,BP,
16365,GO:0071267,1,0.908210594954347,0,7,L-methionine salvage,BP,
16366,GO:0071268,1,0.985551825213358,0,1,homocysteine biosynthetic process,BP,
16367,GO:0071275,1,0.986077712167715,0,1,cellular response to aluminum ion,BP,
16370,GO:0071279,1,0.961953022827899,0,3,cellular response to cobalt ion,BP,
16371,GO:0071280,1,0.845901306968166,0,12,cellular response to copper ion,BP,
16373,GO:0071283,1,0.978965935043448,0,2,cellular response to iron(III) ion,BP,
16376,GO:0071286,1,0.910290450789999,0,6,cellular response to magnesium ion,BP,
16377,GO:0071287,1,0.868748430498737,0,9,cellular response to manganese ion,BP,
16378,GO:0071288,1,0.961358007144493,0,3,cellular response to mercury ion,BP,
16379,GO:0071294,1,0.852015546302822,0,18,cellular response to zinc ion,BP,
16381,GO:0071298,1,0.983511458249465,0,1,cellular response to L-ascorbic acid,BP,
16383,GO:0071301,1,0.983426667499806,0,1,cellular response to vitamin B1,BP,
16385,GO:0071306,1,0.97098788063368,0,2,cellular response to vitamin E,BP,
16390,GO:0071314,1,0.962700903124323,0,3,cellular response to cocaine,BP,
16391,GO:0071315,1,0.950131380032892,0,4,cellular response to morphine,BP,
16392,GO:0071316,1,0.89568593311118,0,8,cellular response to nicotine,BP,
16393,GO:0071317,1,0.950131380032892,0,4,cellular response to isoquinoline alkaloid,BP,
16394,GO:0071318,1,0.841169609999046,0,13,cellular response to ATP,BP,
16396,GO:0071321,1,0.904659161948397,0,6,cellular response to cGMP,BP,
16398,GO:0071324,1,0.983426667502615,0,1,cellular response to disaccharide stimulus,BP,
16400,GO:0071329,1,0.983426667502615,0,1,cellular response to sucrose stimulus,BP,
16402,GO:0071332,1,0.927574193796224,0,5,cellular response to fructose stimulus,BP,
16407,GO:0071339,1,0.676768890660802,0,27,MLL1 complex,CC,
16408,GO:0071340,1,0.85076892627693,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16409,GO:0071344,1,0.979252017706112,0,2,diphosphate metabolic process,BP,
16413,GO:0071348,1,0.983426667502857,0,1,cellular response to interleukin-11,BP,
16414,GO:0071349,1,0.954319227176982,0,3,cellular response to interleukin-12,BP,
16415,GO:0071350,1,0.955917014348577,0,3,cellular response to interleukin-15,BP,
16417,GO:0071352,1,0.914675173342327,0,6,cellular response to interleukin-2,BP,
16418,GO:0071353,1,0.647405228743639,0,31,cellular response to interleukin-4,BP,
16419,GO:0071354,1,0.679817845538569,0,27,cellular response to interleukin-6,BP,
16420,GO:0071355,1,0.986042558870148,0,1,cellular response to interleukin-9,BP,
16425,GO:0071361,1,0.833561669947957,0,12,cellular response to ethanol,BP,
16426,GO:0071362,1,0.917887107555168,0,6,cellular response to ether,BP,
16431,GO:0071373,1,0.953145665411752,0,3,cellular response to luteinizing hormone stimulus,BP,
16432,GO:0071374,1,0.882745268869564,0,8,cellular response to parathyroid hormone stimulus,BP,
16434,GO:0071376,1,0.92663651905356,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16442,GO:0071386,1,0.951240181912815,0,3,cellular response to corticosterone stimulus,BP,
16443,GO:0071387,1,0.983426667502414,0,1,cellular response to cortisol stimulus,BP,
16445,GO:0071391,1,0.826840994804016,0,12,cellular response to estrogen stimulus,BP,
16446,GO:0071392,1,0.608266384947844,0,35,cellular response to estradiol stimulus,BP,
16447,GO:0071393,1,0.983426667503345,0,1,cellular response to progesterone stimulus,BP,
16449,GO:0071395,1,0.961855892143638,0,4,cellular response to jasmonic acid stimulus,BP,
16451,GO:0071397,1,0.809200687612077,0,13,cellular response to cholesterol,BP,
16453,GO:0071400,1,0.968698482712844,0,2,cellular response to oleic acid,BP,
16454,GO:0071401,1,0.985560550415529,0,1,cellular response to triglyceride,BP,
16455,GO:0071402,1,0.815748059690554,0,16,cellular response to lipoprotein particle stimulus,BP,
16456,GO:0071403,1,0.994275566742343,0,1,cellular response to high density lipoprotein particle stimulus,BP,
16457,GO:0071404,1,0.836729769035576,0,13,cellular response to low-density lipoprotein particle stimulus,BP,
16459,GO:0071409,1,0.956463882001919,0,3,cellular response to cycloheximide,BP,
16460,GO:0071412,1,0.985586841248435,0,1,cellular response to genistein,BP,
16461,GO:0071413,1,0.985586841248435,0,1,cellular response to hydroxyisoflavone,BP,
16464,GO:0071418,1,0.990100485821345,0,1,cellular response to amine stimulus,BP,
16465,GO:0071420,1,0.891757606202044,0,7,cellular response to histamine,BP,
16466,GO:0071421,1,0.926506439542242,0,5,manganese ion transmembrane transport,BP,
16467,GO:0071422,1,0.954949975216385,0,3,succinate transmembrane transport,BP,
16468,GO:0071423,1,0.987198264305229,0,1,malate transmembrane transport,BP,
16470,GO:0071426,1,0.164146019754771,0,125,ribonucleoprotein complex export from nucleus,BP,
16471,GO:0071427,1,0.203671008432162,0,108,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16472,GO:0071428,1,0.842147159878268,0,14,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16473,GO:0071431,1,0.624303059363633,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16475,GO:0071436,1,0.87427341293697,0,10,sodium ion export,BP,
16478,GO:0071439,1,0.886604296348798,0,8,clathrin complex,CC,
16479,GO:0071440,1,0.924759885513805,0,5,regulation of histone H3-K14 acetylation,BP,
16480,GO:0071441,1,0.983428532458556,0,1,negative regulation of histone H3-K14 acetylation,BP,
16481,GO:0071442,1,0.940346748060466,0,4,positive regulation of histone H3-K14 acetylation,BP,
16482,GO:0071444,1,0.998327147316378,0,1,cellular response to pheromone,BP,
16483,GO:0071447,1,0.897244514001114,0,8,cellular response to hydroperoxide,BP,
16484,GO:0071449,1,0.993039746735989,0,1,cellular response to lipid hydroperoxide,BP,
16488,GO:0071454,1,0.983426667499757,0,1,cellular response to anoxia,BP,
16489,GO:0071455,1,0.89662995923081,0,7,cellular response to hyperoxia,BP,
16491,GO:0071458,1,0.912828139952524,0,6,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16492,GO:0071459,1,0.766421406474037,0,18,protein localization to chromosome, centromeric region,BP,
16493,GO:0071460,1,0.981930079117533,0,2,cellular response to cell-matrix adhesion,BP,
16494,GO:0071461,1,0.975312986456922,0,2,cellular response to redox state,BP,
16495,GO:0071462,1,0.921917163564364,0,5,cellular response to water stimulus,BP,
16496,GO:0071464,1,0.969293132751541,0,2,cellular response to hydrostatic pressure,BP,
16497,GO:0071466,1,0.241813332701762,0,107,cellular response to xenobiotic stimulus,BP,
16498,GO:0071467,1,0.745723798020915,0,20,cellular response to pH,BP,
16499,GO:0071468,1,0.841315110935223,0,11,cellular response to acidic pH,BP,
16500,GO:0071469,1,0.971210159024812,0,2,cellular response to alkaline pH,BP,
16501,GO:0071470,1,0.646894022272906,0,29,cellular response to osmotic stress,BP,
16502,GO:0071471,1,0.983426667503104,0,1,cellular response to non-ionic osmotic stress,BP,
16503,GO:0071472,1,0.878821327724524,0,8,cellular response to salt stress,BP,
16504,GO:0071474,1,0.884840892459951,0,8,cellular hyperosmotic response,BP,
16505,GO:0071475,1,0.953769097978296,0,3,cellular hyperosmotic salinity response,BP,
16506,GO:0071476,1,0.899686264665871,0,7,cellular hypotonic response,BP,
16507,GO:0071477,1,0.967386491577893,0,2,cellular hypotonic salinity response,BP,
16511,GO:0071481,1,0.821469204474154,0,13,cellular response to X-ray,BP,
16513,GO:0071483,1,0.96729982301339,0,2,cellular response to blue light,BP,
16514,GO:0071484,1,0.967280959233462,0,2,cellular response to light intensity,BP,
16515,GO:0071485,1,0.983583320421907,0,1,cellular response to absence of light,BP,
16516,GO:0071486,1,0.983426667502315,0,1,cellular response to high light intensity,BP,
16517,GO:0071492,1,0.956249111924136,0,3,cellular response to UV-A,BP,
16519,GO:0071494,1,0.95110226900017,0,3,cellular response to UV-C,BP,
16522,GO:0071498,1,0.762487309886181,0,18,cellular response to fluid shear stress,BP,
16523,GO:0071499,1,0.901371753220478,0,7,cellular response to laminar fluid shear stress,BP,
16524,GO:0071500,1,0.92798883736401,0,6,cellular response to nitrosative stress,BP,
16525,GO:0071501,1,0.881111303866859,0,8,cellular response to sterol depletion,BP,
16526,GO:0071502,1,0.933337573579917,0,5,cellular response to temperature stimulus,BP,
16527,GO:0071503,1,0.922124993775631,0,5,response to heparin,BP,
16528,GO:0071504,1,0.935603805398893,0,4,cellular response to heparin,BP,
16532,GO:0071515,1,0.984728932554734,0,1,genetic imprinting at mating-type locus,BP,
16533,GO:0071516,1,0.984728932554734,0,1,establishment of imprinting at mating-type locus,BP,
16534,GO:0071526,1,0.687301322765775,0,23,semaphorin-plexin signaling pathway,BP,
16535,GO:0071527,1,0.985305541169944,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16536,GO:0071528,1,0.983427439403278,0,1,tRNA re-export from nucleus,BP,
16537,GO:0071529,1,0.984668798188448,0,1,cementum mineralization,BP,
16538,GO:0071532,1,0.921495181026681,0,5,ankyrin repeat binding,MF,
16539,GO:0071535,1,0.942817362855079,0,4,RING-like zinc finger domain binding,MF,
16540,GO:0071538,1,0.985496439087101,0,1,SH2 domain-mediated complex assembly,BP,
16541,GO:0071539,1,0.696994321939437,0,23,protein localization to centrosome,BP,
16542,GO:0071540,1,0.983426667502267,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16543,GO:0071541,1,0.918695684084693,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16545,GO:0071543,1,0.946650719048175,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16546,GO:0071544,1,0.99015604166239,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16547,GO:0071545,1,0.843460787309813,0,11,inositol phosphate catabolic process,BP,
16548,GO:0071546,1,0.892992588066804,0,7,pi-body,CC,
16549,GO:0071547,1,0.926088102929166,0,5,piP-body,CC,
16552,GO:0071550,1,0.886774908675836,0,9,death-inducing signaling complex assembly,BP,
16553,GO:0071553,1,0.961504572667343,0,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
16554,GO:0071554,1,0.957341375391269,0,5,cell wall organization or biogenesis,BP,
16555,GO:0071556,1,0.720195169400346,0,28,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16556,GO:0071557,1,0.935330099169434,0,4,histone H3-K27 demethylation,BP,
16557,GO:0071558,1,0.935330099169434,0,4,histone demethylase activity (H3-K27 specific),MF,
16560,GO:0071561,1,0.983426667502562,0,1,nucleus-vacuole junction,CC,
16561,GO:0071564,1,0.835151121459928,0,12,npBAF complex,CC,
16562,GO:0071565,1,0.808501288077409,0,14,nBAF complex,CC,
16563,GO:0071566,1,0.983938310118583,0,1,UFM1 activating enzyme activity,MF,
16564,GO:0071567,1,0.977903191613802,0,2,UFM1 hydrolase activity,MF,
16565,GO:0071568,1,0.976473838784912,0,2,UFM1 transferase activity,MF,
16566,GO:0071569,1,0.925264361191355,0,6,protein ufmylation,BP,
16567,GO:0071573,1,0.983958144398298,0,1,shelterin complex assembly,BP,
16568,GO:0071575,1,0.983454779055671,0,1,integral component of external side of plasma membrane,CC,
16569,GO:0071577,1,0.705747487228006,0,23,zinc II ion transmembrane transport,BP,
16570,GO:0071578,1,0.88461054877324,0,8,zinc II ion transmembrane import,BP,
16571,GO:0071579,1,0.970936691290842,0,2,regulation of zinc ion transport,BP,
16572,GO:0071580,1,0.98663432665508,0,1,regulation of zinc ion transmembrane transport,BP,
16573,GO:0071581,1,0.98663432665508,0,1,regulation of zinc ion transmembrane import,BP,
16574,GO:0071582,1,0.98663432665508,0,1,negative regulation of zinc ion transport,BP,
16575,GO:0071583,1,0.98663432665508,0,1,negative regulation of zinc ion transmembrane transport,BP,
16576,GO:0071584,1,0.98663432665508,0,1,negative regulation of zinc ion transmembrane import,BP,
16577,GO:0071585,1,0.98663432665508,0,1,detoxification of cadmium ion,BP,
16578,GO:0071586,1,0.962319597988804,0,3,CAAX-box protein processing,BP,
16579,GO:0071593,1,0.960342255604092,0,3,lymphocyte aggregation,BP,
16580,GO:0071595,1,0.969690119055175,0,2,Nem1-Spo7 phosphatase complex,CC,
16581,GO:0071596,1,0.951096177110851,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16582,GO:0071598,1,0.960533916840738,0,3,neuronal ribonucleoprotein granule,CC,
16585,GO:0071602,1,0.983426667503153,0,1,phytosphingosine biosynthetic process,BP,
16586,GO:0071603,1,0.936763140346156,0,4,endothelial cell-cell adhesion,BP,
16587,GO:0071604,1,0.654814903587995,0,28,transforming growth factor beta production,BP,
16588,GO:0071605,1,0.854958816722402,0,12,monocyte chemotactic protein-1 production,BP,
16589,GO:0071608,1,0.967440312746083,0,2,macrophage inflammatory protein-1 alpha production,BP,
16590,GO:0071609,1,0.885990739097859,0,8,chemokine (C-C motif) ligand 5 production,BP,
16591,GO:0071611,1,0.954857820650126,0,3,granulocyte colony-stimulating factor production,BP,
16592,GO:0071612,1,0.983426667494936,0,1,IP-10 production,BP,
16593,GO:0071613,1,0.975965960730912,0,2,granzyme B production,BP,
16594,GO:0071614,1,0.987340486400627,0,1,linoleic acid epoxygenase activity,MF,
16595,GO:0071615,1,0.983718115921101,0,1,oxidative deethylation,BP,
16598,GO:0071619,1,0.985616846336288,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16601,GO:0071623,1,0.968407661017306,0,2,negative regulation of granulocyte chemotaxis,BP,
16603,GO:0071625,1,0.763873768762314,0,17,vocalization behavior,BP,
16604,GO:0071626,1,0.979149895503292,0,2,mastication,BP,
16605,GO:0071629,1,0.988442056876956,0,1,ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome,BP,
16606,GO:0071630,1,0.952380300110704,0,3,ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome,BP,
16607,GO:0071633,1,0.976057042872542,0,2,dihydroceramidase activity,MF,
16608,GO:0071634,1,0.665869021650748,0,27,regulation of transforming growth factor beta production,BP,
16609,GO:0071635,1,0.899655338639076,0,7,negative regulation of transforming growth factor beta production,BP,
16610,GO:0071636,1,0.778337813182901,0,17,positive regulation of transforming growth factor beta production,BP,
16611,GO:0071637,1,0.854958816722402,0,12,regulation of monocyte chemotactic protein-1 production,BP,
16612,GO:0071638,1,0.938759080541974,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16613,GO:0071639,1,0.910755290252641,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16614,GO:0071640,1,0.967440312746083,0,2,regulation of macrophage inflammatory protein 1 alpha production,BP,
16615,GO:0071641,1,0.983481377369544,0,1,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16616,GO:0071642,1,0.983690624007748,0,1,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16617,GO:0071649,1,0.896530554617167,0,7,regulation of chemokine (C-C motif) ligand 5 production,BP,
16618,GO:0071650,1,0.973719359068662,0,2,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16619,GO:0071651,1,0.920736270039104,0,5,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16620,GO:0071655,1,0.954857820650126,0,3,regulation of granulocyte colony-stimulating factor production,BP,
16621,GO:0071656,1,0.985448622796376,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16622,GO:0071657,1,0.968959342704137,0,2,positive regulation of granulocyte colony-stimulating factor production,BP,
16623,GO:0071658,1,0.983426667494936,0,1,regulation of IP-10 production,BP,
16624,GO:0071660,1,0.983426667494936,0,1,positive regulation of IP-10 production,BP,
16625,GO:0071661,1,0.975965960730912,0,2,regulation of granzyme B production,BP,
16626,GO:0071663,1,0.975965960730912,0,2,positive regulation of granzyme B production,BP,
16627,GO:0071664,1,0.951285853698889,0,3,catenin-TCF7L2 complex,CC,
16628,GO:0071665,1,0.983538396391024,0,1,gamma-catenin-TCF7L2 complex,CC,
16629,GO:0071670,1,0.89742830066434,0,8,smooth muscle cell chemotaxis,BP,
16630,GO:0071671,1,0.927652608805307,0,6,regulation of smooth muscle cell chemotaxis,BP,
16631,GO:0071672,1,0.958902865203635,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16632,GO:0071673,1,0.9626267202967,0,3,positive regulation of smooth muscle cell chemotaxis,BP,
16634,GO:0071675,1,0.606252159494093,0,40,regulation of mononuclear cell migration,BP,
16635,GO:0071676,1,0.910923341287392,0,6,negative regulation of mononuclear cell migration,BP,
16636,GO:0071677,1,0.790458349668364,0,22,positive regulation of mononuclear cell migration,BP,
16637,GO:0071678,1,0.98342666749941,0,1,olfactory bulb axon guidance,BP,
16638,GO:0071679,1,0.891455160335191,0,7,commissural neuron axon guidance,BP,
16641,GO:0071682,1,0.817878037569969,0,19,endocytic vesicle lumen,CC,
16642,GO:0071684,1,0.983612651923942,0,1,organism emergence from protective structure,BP,
16644,GO:0071691,1,0.983426667500347,0,1,cardiac muscle thin filament assembly,BP,
16645,GO:0071692,1,0.918773523082233,0,6,protein localization to extracellular region,BP,
16646,GO:0071694,1,0.918773523082233,0,6,maintenance of protein location in extracellular region,BP,
16652,GO:0071701,1,0.983426667502809,0,1,regulation of MAPK export from nucleus,BP,
16657,GO:0071707,1,0.990664525512003,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16659,GO:0071711,1,0.73170277270969,0,20,basement membrane organization,BP,
16660,GO:0071712,1,0.873608307815508,0,10,ER-associated misfolded protein catabolic process,BP,
16661,GO:0071714,1,0.983426667503248,0,1,icosanoid transmembrane transporter activity,MF,
16663,GO:0071723,1,0.867231458175106,0,10,lipopeptide binding,MF,
16664,GO:0071724,1,0.943318330758465,0,4,response to diacyl bacterial lipopeptide,BP,
16665,GO:0071725,1,0.956986363521007,0,3,response to triacyl bacterial lipopeptide,BP,
16666,GO:0071726,1,0.943318330758465,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16667,GO:0071727,1,0.956986363521007,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16671,GO:0071763,1,0.923357760564452,0,5,nuclear membrane organization,BP,
16672,GO:0071765,1,0.983426667503296,0,1,nuclear inner membrane organization,BP,
16678,GO:0071787,1,0.940747826303663,0,4,endoplasmic reticulum tubular network formation,BP,
16679,GO:0071791,1,0.968177608669723,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16680,GO:0071796,1,0.990518614197078,0,1,K6-linked polyubiquitin binding,MF,
16681,GO:0071797,1,0.956060660679398,0,3,LUBAC complex,CC,
16682,GO:0071798,1,0.932869920583843,0,5,response to prostaglandin D,BP,
16683,GO:0071799,1,0.932869920583843,0,5,cellular response to prostaglandin D stimulus,BP,
16686,GO:0071802,1,0.983426667503302,0,1,negative regulation of podosome assembly,BP,
16690,GO:0071806,1,0.472406405930598,0,60,protein transmembrane transport,BP,
16691,GO:0071812,1,0.969547332361449,0,2,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16692,GO:0071813,1,0.70770121064543,0,24,lipoprotein particle binding,MF,
16693,GO:0071814,1,0.70770121064543,0,24,protein-lipid complex binding,MF,
16694,GO:0071816,1,0.946793697514668,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16695,GO:0071817,1,0.938649905383842,0,5,MMXD complex,CC,
16696,GO:0071818,1,0.957179118168017,0,3,BAT3 complex,CC,
16697,GO:0071819,1,0.995573731884414,0,1,DUBm complex,CC,
16698,GO:0071820,1,0.989531997697684,0,1,N-box binding,MF,
16699,GO:0071821,1,0.983426667500101,0,1,FANCM-MHF complex,CC,
16701,GO:0071823,1,0.982361742722248,0,2,protein-carbohydrate complex subunit organization,BP,
16702,GO:0071824,1,0.048048699494092,0,256,protein-DNA complex subunit organization,BP,
16703,GO:0071825,1,0.617337850340205,0,38,protein-lipid complex subunit organization,BP,
16704,GO:0071826,1,0.0710042167978434,0,195,ribonucleoprotein complex subunit organization,BP,
16705,GO:0071827,1,0.647774167077416,0,35,plasma lipoprotein particle organization,BP,
16706,GO:0071830,1,0.93838816091477,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16707,GO:0071837,1,0.778831808667052,0,17,HMG box domain binding,MF,
16708,GO:0071838,1,0.929711027033552,0,6,cell proliferation in bone marrow,BP,
16709,GO:0071839,1,0.941298469437788,0,5,apoptotic process in bone marrow,BP,
16711,GO:0071846,1,0.994901522231914,0,1,actin filament debranching,BP,
16713,GO:0071848,1,0.969547332361449,0,2,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16716,GO:0071863,1,0.9296026302295,0,6,regulation of cell proliferation in bone marrow,BP,
16717,GO:0071864,1,0.9296026302295,0,6,positive regulation of cell proliferation in bone marrow,BP,
16718,GO:0071865,1,0.939786751019656,0,5,regulation of apoptotic process in bone marrow,BP,
16719,GO:0071866,1,0.939786751019656,0,5,negative regulation of apoptotic process in bone marrow,BP,
16726,GO:0071873,1,0.952691248561875,0,3,response to norepinephrine,BP,
16727,GO:0071874,1,0.968748736833835,0,2,cellular response to norepinephrine stimulus,BP,
16729,GO:0071877,1,0.913098133290852,0,6,regulation of adrenergic receptor signaling pathway,BP,
16730,GO:0071878,1,0.951097307520432,0,3,negative regulation of adrenergic receptor signaling pathway,BP,
16731,GO:0071879,1,0.953529524990476,0,3,positive regulation of adrenergic receptor signaling pathway,BP,
16733,GO:0071881,1,0.983427836177216,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16734,GO:0071882,1,0.983427836177216,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16736,GO:0071884,1,0.983426667501282,0,1,vitamin D receptor activator activity,MF,
16737,GO:0071885,1,0.977722126876881,0,2,N-terminal protein N-methyltransferase activity,MF,
16738,GO:0071886,1,0.96735568391821,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16740,GO:0071888,1,0.897956835070973,0,8,macrophage apoptotic process,BP,
16742,GO:0071890,1,0.983426667502413,0,1,bicarbonate binding,MF,
16744,GO:0071894,1,0.983511896538118,0,1,histone H2B conserved C-terminal lysine ubiquitination,BP,
16745,GO:0071895,1,0.953143373106141,0,3,odontoblast differentiation,BP,
16746,GO:0071896,1,0.93533009916583,0,4,protein localization to adherens junction,BP,
16748,GO:0071898,1,0.956956811992557,0,3,regulation of estrogen receptor binding,BP,
16749,GO:0071899,1,0.956956811992557,0,3,negative regulation of estrogen receptor binding,BP,
16753,GO:0071907,1,0.897401492847077,0,7,determination of digestive tract left/right asymmetry,BP,
16754,GO:0071908,1,0.983426667502217,0,1,determination of intestine left/right asymmetry,BP,
16755,GO:0071909,1,0.983426667502217,0,1,determination of stomach left/right asymmetry,BP,
16756,GO:0071910,1,0.905773981565247,0,6,determination of liver left/right asymmetry,BP,
16757,GO:0071914,1,0.983428655268849,0,1,prominosome,CC,
16758,GO:0071918,1,0.93976725509925,0,4,urea transmembrane transport,BP,
16759,GO:0071920,1,0.971141574347113,0,2,cleavage body,CC,
16760,GO:0071921,1,0.956004175235373,0,3,cohesin loading,BP,
16761,GO:0071922,1,0.956004175235373,0,3,regulation of cohesin loading,BP,
16762,GO:0071926,1,0.952820255526149,0,3,endocannabinoid signaling pathway,BP,
16763,GO:0071929,1,0.968698620553467,0,2,alpha-tubulin acetylation,BP,
16764,GO:0071930,1,0.952024794967652,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16765,GO:0071931,1,0.990088166239541,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16766,GO:0071933,1,0.89085574315585,0,8,Arp2/3 complex binding,MF,
16767,GO:0071934,1,0.943104681083021,0,4,thiamine transmembrane transport,BP,
16768,GO:0071936,1,0.875912529040378,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16769,GO:0071941,1,0.823468049197344,0,15,nitrogen cycle metabolic process,BP,
16770,GO:0071942,1,0.959329445286525,0,3,XPC complex,CC,
16772,GO:0071947,1,0.935692592683365,0,4,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16773,GO:0071949,1,0.780255139716712,0,17,FAD binding,MF,
16774,GO:0071951,1,0.984284718486085,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16775,GO:0071953,1,0.941592445488968,0,4,elastic fiber,CC,
16776,GO:0071954,1,0.983486079821096,0,1,chemokine (C-C motif) ligand 11 production,BP,
16777,GO:0071955,1,0.96712689215207,0,2,recycling endosome to Golgi transport,BP,
16778,GO:0071962,1,0.983461065177811,0,1,mitotic sister chromatid cohesion, centromeric,BP,
16780,GO:0071964,1,0.990753920282674,0,1,establishment of cell polarity regulating cell shape,BP,
16782,GO:0071976,1,0.983581352289469,0,1,cell gliding,BP,
16784,GO:0071986,1,0.911827498966911,0,6,Ragulator complex,CC,
16785,GO:0071987,1,0.952656911051957,0,3,WD40-repeat domain binding,MF,
16786,GO:0071997,1,0.983426667500937,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16788,GO:0072003,1,0.95693969530866,0,3,kidney rudiment formation,BP,
16789,GO:0072004,1,0.967127945407715,0,2,kidney field specification,BP,
16795,GO:0072011,1,0.96330023355317,0,3,glomerular endothelium development,BP,
16799,GO:0072016,1,0.984536613720224,0,1,glomerular parietal epithelial cell development,BP,
16801,GO:0072019,1,0.986121010490359,0,1,proximal convoluted tubule development,BP,
16802,GO:0072021,1,0.942926371928718,0,4,ascending thin limb development,BP,
16803,GO:0072023,1,0.974980317140696,0,2,thick ascending limb development,BP,
16804,GO:0072024,1,0.989261892547562,0,1,macula densa development,BP,
16805,GO:0072025,1,0.928582702748705,0,5,distal convoluted tubule development,BP,
16806,GO:0072027,1,0.984790738609099,0,1,connecting tubule development,BP,
16810,GO:0072036,1,0.983434641771548,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16815,GO:0072046,1,0.989466912346962,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16816,GO:0072047,1,0.936590239361615,0,5,proximal/distal pattern formation involved in nephron development,BP,
16820,GO:0072051,1,0.989261892547562,0,1,juxtaglomerular apparatus development,BP,
16823,GO:0072055,1,0.983426667502562,0,1,renal cortex development,BP,
16824,GO:0072059,1,0.983426667502562,0,1,cortical collecting duct development,BP,
16827,GO:0072069,1,0.956741387943663,0,3,DCT cell differentiation,BP,
16829,GO:0072071,1,0.976859073443175,0,2,kidney interstitial fibroblast differentiation,BP,
16838,GO:0072081,1,0.936590239361615,0,5,specification of nephron tubule identity,BP,
16839,GO:0072086,1,0.948742887565197,0,4,specification of loop of Henle identity,BP,
16844,GO:0072092,1,0.9510961771069,0,3,ureteric bud invasion,BP,
16845,GO:0072093,1,0.935337684998652,0,4,metanephric renal vesicle formation,BP,
16863,GO:0072114,1,0.967872167349628,0,2,pronephros morphogenesis,BP,
16867,GO:0072127,1,0.985657794256111,0,1,renal capsule development,BP,
16868,GO:0072128,1,0.985657794256111,0,1,renal capsule morphogenesis,BP,
16869,GO:0072129,1,0.985657794256111,0,1,renal capsule formation,BP,
16870,GO:0072130,1,0.985657794256111,0,1,renal capsule specification,BP,
16877,GO:0072137,1,0.937852010007047,0,4,condensed mesenchymal cell proliferation,BP,
16879,GO:0072139,1,0.954639411776894,0,3,glomerular parietal epithelial cell differentiation,BP,
16880,GO:0072141,1,0.976859073443175,0,2,renal interstitial fibroblast development,BP,
16890,GO:0072165,1,0.987193569217417,0,1,anterior mesonephric tubule development,BP,
16892,GO:0072167,1,0.987193569217417,0,1,specification of mesonephric tubule identity,BP,
16893,GO:0072168,1,0.987193569217417,0,1,specification of anterior mesonephric tubule identity,BP,
16894,GO:0072169,1,0.987193569217417,0,1,specification of posterior mesonephric tubule identity,BP,
16902,GO:0072177,1,0.891359116946709,0,8,mesonephric duct development,BP,
16905,GO:0072180,1,0.947442802781707,0,4,mesonephric duct morphogenesis,BP,
16906,GO:0072181,1,0.973817267268126,0,2,mesonephric duct formation,BP,
16908,GO:0072183,1,0.970866529400647,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16909,GO:0072184,1,0.987193569217417,0,1,renal vesicle progenitor cell differentiation,BP,
16910,GO:0072185,1,0.972696195762803,0,2,metanephric cap development,BP,
16911,GO:0072186,1,0.972696195762803,0,2,metanephric cap morphogenesis,BP,
16917,GO:0072194,1,0.959984002037476,0,3,kidney smooth muscle tissue development,BP,
16918,GO:0072195,1,0.988827839667624,0,1,kidney smooth muscle cell differentiation,BP,
16926,GO:0072204,1,0.967478139161337,0,2,cell-cell signaling involved in metanephros development,BP,
16928,GO:0072206,1,0.989261892547562,0,1,metanephric juxtaglomerular apparatus development,BP,
16930,GO:0072208,1,0.97083161480816,0,2,metanephric smooth muscle tissue development,BP,
16933,GO:0072213,1,0.985657794256111,0,1,metanephric capsule development,BP,
16934,GO:0072214,1,0.983426667502562,0,1,metanephric cortex development,BP,
16938,GO:0072218,1,0.942926371928718,0,4,metanephric ascending thin limb development,BP,
16939,GO:0072219,1,0.983426667502562,0,1,metanephric cortical collecting duct development,BP,
16940,GO:0072221,1,0.928582702748705,0,5,metanephric distal convoluted tubule development,BP,
16943,GO:0072227,1,0.989261892547562,0,1,metanephric macula densa development,BP,
16944,GO:0072229,1,0.986121010490359,0,1,metanephric proximal convoluted tubule development,BP,
16945,GO:0072233,1,0.974980317140696,0,2,metanephric thick ascending limb development,BP,
16947,GO:0072235,1,0.898048087829558,0,7,metanephric distal tubule development,BP,
16949,GO:0072237,1,0.969776760361638,0,2,metanephric proximal tubule development,BP,
16951,GO:0072240,1,0.956741387943663,0,3,metanephric DCT cell differentiation,BP,
16953,GO:0072244,1,0.95483111158425,0,3,metanephric glomerular epithelium development,BP,
16954,GO:0072248,1,0.95483111158425,0,3,metanephric glomerular visceral epithelial cell differentiation,BP,
16955,GO:0072249,1,0.95483111158425,0,3,metanephric glomerular visceral epithelial cell development,BP,
16959,GO:0072258,1,0.987193569217417,0,1,metanephric interstitial fibroblast differentiation,BP,
16960,GO:0072259,1,0.987193569217417,0,1,metanephric interstitial fibroblast development,BP,
16962,GO:0072265,1,0.985657794256111,0,1,metanephric capsule morphogenesis,BP,
16963,GO:0072266,1,0.985657794256111,0,1,metanephric capsule formation,BP,
16964,GO:0072267,1,0.985657794256111,0,1,metanephric capsule specification,BP,
16965,GO:0072268,1,0.945781305118348,0,4,pattern specification involved in metanephros development,BP,
16966,GO:0072272,1,0.97199489034148,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16968,GO:0072274,1,0.983426667501674,0,1,metanephric glomerular basement membrane development,BP,
16969,GO:0072275,1,0.953348782685225,0,3,metanephric glomerulus morphogenesis,BP,
16970,GO:0072276,1,0.953348782685225,0,3,metanephric glomerulus vasculature morphogenesis,BP,
16971,GO:0072277,1,0.953348782685225,0,3,metanephric glomerular capillary formation,BP,
16973,GO:0072282,1,0.886888988668512,0,8,metanephric nephron tubule morphogenesis,BP,
16976,GO:0072285,1,0.983434641771548,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16977,GO:0072286,1,0.984790738609099,0,1,metanephric connecting tubule development,BP,
16978,GO:0072287,1,0.983426667492525,0,1,metanephric distal tubule morphogenesis,BP,
16979,GO:0072289,1,0.935694976450469,0,4,metanephric nephron tubule formation,BP,
16982,GO:0072300,1,0.920647709556518,0,5,positive regulation of metanephric glomerulus development,BP,
16985,GO:0072303,1,0.983714147414541,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16986,GO:0072304,1,0.967127945407715,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16987,GO:0072305,1,0.967127945407715,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16989,GO:0072308,1,0.98346203317877,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16990,GO:0072309,1,0.967127945407715,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16993,GO:0072312,1,0.95483111158425,0,3,metanephric glomerular epithelial cell differentiation,BP,
16994,GO:0072313,1,0.95483111158425,0,3,metanephric glomerular epithelial cell development,BP,
16995,GO:0072318,1,0.909777822311678,0,6,clathrin coat disassembly,BP,
16996,GO:0072319,1,0.896997442560659,0,7,vesicle uncoating,BP,
16998,GO:0072321,1,0.902943266744916,0,9,chaperone-mediated protein transport,BP,
17003,GO:0072334,1,0.979291685349768,0,2,UDP-galactose transmembrane transport,BP,
17004,GO:0072337,1,0.68940860842467,0,26,modified amino acid transport,BP,
17005,GO:0072338,1,0.908929131910042,0,6,cellular lactam metabolic process,BP,
17006,GO:0072340,1,0.988159237720704,0,1,cellular lactam catabolic process,BP,
17008,GO:0072343,1,0.978052990415933,0,2,pancreatic stellate cell proliferation,BP,
17009,GO:0072344,1,0.983649575938418,0,1,rescue of stalled ribosome,BP,
17010,GO:0072345,1,0.94400851824246,0,4,NAADP-sensitive calcium-release channel activity,MF,
17011,GO:0072348,1,0.589157541957632,0,34,sulfur compound transport,BP,
17012,GO:0072349,1,0.756165732435427,0,18,modified amino acid transmembrane transporter activity,MF,
17013,GO:0072350,1,0.587936261833007,0,38,tricarboxylic acid metabolic process,BP,
17014,GO:0072354,1,0.972481913428753,0,2,histone kinase activity (H3-T3 specific),MF,
17015,GO:0072355,1,0.972481913428753,0,2,histone H3-T3 phosphorylation,BP,
17016,GO:0072356,1,0.967890861783774,0,2,chromosome passenger complex localization to kinetochore,BP,
17017,GO:0072357,1,0.896369333682325,0,7,PTW/PP1 phosphatase complex,CC,
17020,GO:0072361,1,0.9671268921451,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
17021,GO:0072362,1,0.983426667499118,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
17022,GO:0072363,1,0.983426667496803,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
17023,GO:0072364,1,0.967126892144278,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17024,GO:0072365,1,0.98342666749833,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
17025,GO:0072366,1,0.983426667496803,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
17026,GO:0072367,1,0.935808586471799,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
17027,GO:0072368,1,0.967126892151389,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
17028,GO:0072369,1,0.967621577665996,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
17029,GO:0072376,1,0.340388248535023,0,79,protein activation cascade,BP,
17030,GO:0072377,1,0.983960379347034,0,1,blood coagulation, common pathway,BP,
17031,GO:0072378,1,0.689900945274979,0,27,blood coagulation, fibrin clot formation,BP,
17032,GO:0072379,1,0.957179118168017,0,3,ER membrane insertion complex,CC,
17033,GO:0072383,1,0.8752639285882,0,8,plus-end-directed vesicle transport along microtubule,BP,
17034,GO:0072384,1,0.367543886581537,0,66,organelle transport along microtubule,BP,
17035,GO:0072385,1,0.951263039275148,0,3,minus-end-directed organelle transport along microtubule,BP,
17036,GO:0072386,1,0.860749952572285,0,9,plus-end-directed organelle transport along microtubule,BP,
17037,GO:0072387,1,0.970466114173151,0,2,flavin adenine dinucleotide metabolic process,BP,
17038,GO:0072388,1,0.98682085955111,0,1,flavin adenine dinucleotide biosynthetic process,BP,
17039,GO:0072389,1,0.983427738433103,0,1,flavin adenine dinucleotide catabolic process,BP,
17040,GO:0072393,1,0.876196468505331,0,8,microtubule anchoring at microtubule organizing center,BP,
17042,GO:0072396,1,0.909209555230748,0,6,response to cell cycle checkpoint signaling,BP,
17044,GO:0072402,1,0.909209555230748,0,6,response to DNA integrity checkpoint signaling,BP,
17046,GO:0072414,1,0.983426667500149,0,1,response to mitotic cell cycle checkpoint signaling,BP,
17048,GO:0072423,1,0.909209555230748,0,6,response to DNA damage checkpoint signaling,BP,
17049,GO:0072425,1,0.967577800460969,0,2,signal transduction involved in G2 DNA damage checkpoint,BP,
17050,GO:0072428,1,0.987302301550024,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
17051,GO:0072429,1,0.940122061960482,0,4,response to intra-S DNA damage checkpoint signaling,BP,
17053,GO:0072432,1,0.983426667500149,0,1,response to G1 DNA damage checkpoint signaling,BP,
17054,GO:0072434,1,0.967577800460969,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
17055,GO:0072487,1,0.93849598272775,0,4,MSL complex,CC,
17056,GO:0072488,1,0.769549954442163,0,18,ammonium transmembrane transport,BP,
17057,GO:0072492,1,0.987869227208269,0,1,host cell mitochondrial intermembrane space,CC,
17060,GO:0072501,1,0.869582413203199,0,9,cellular divalent inorganic anion homeostasis,BP,
17061,GO:0072502,1,0.869582413203199,0,9,cellular trivalent inorganic anion homeostasis,BP,
17063,GO:0072505,1,0.827765285398703,0,12,divalent inorganic anion homeostasis,BP,
17064,GO:0072506,1,0.827765285398703,0,12,trivalent inorganic anion homeostasis,BP,
17070,GO:0072513,1,0.946209353839663,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
17071,GO:0072517,1,0.983504855665434,0,1,host cell viral assembly compartment,CC,
17072,GO:0072518,1,0.98342666750094,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
17073,GO:0072520,1,0.858984416838763,0,10,seminiferous tubule development,BP,
17078,GO:0072525,1,0.655228290506939,0,29,pyridine-containing compound biosynthetic process,BP,
17079,GO:0072526,1,0.938653330796535,0,5,pyridine-containing compound catabolic process,BP,
17080,GO:0072527,1,0.378536245586739,0,75,pyrimidine-containing compound metabolic process,BP,
17081,GO:0072528,1,0.60884925621485,0,39,pyrimidine-containing compound biosynthetic process,BP,
17082,GO:0072529,1,0.681506846616775,0,31,pyrimidine-containing compound catabolic process,BP,
17083,GO:0072530,1,0.875581746104279,0,9,purine-containing compound transmembrane transport,BP,
17084,GO:0072531,1,0.819966012102488,0,14,pyrimidine-containing compound transmembrane transport,BP,
17085,GO:0072534,1,0.967126892150327,0,2,perineuronal net,CC,
17086,GO:0072535,1,0.960538129092905,0,3,tumor necrosis factor (ligand) superfamily member 11 production,BP,
17087,GO:0072536,1,0.971118843870301,0,2,interleukin-23 receptor complex,CC,
17088,GO:0072537,1,0.854382525475246,0,10,fibroblast activation,BP,
17089,GO:0072538,1,0.758607323711921,0,21,T-helper 17 type immune response,BP,
17090,GO:0072539,1,0.781737954920139,0,19,T-helper 17 cell differentiation,BP,
17091,GO:0072540,1,0.858664413009064,0,12,T-helper 17 cell lineage commitment,BP,
17092,GO:0072542,1,0.906355094992619,0,7,protein phosphatase activator activity,MF,
17093,GO:0072544,1,0.988148723890186,0,1,L-DOPA binding,MF,
17094,GO:0072545,1,0.974356018092189,0,2,tyrosine binding,MF,
17095,GO:0072546,1,0.776915689312587,0,18,ER membrane protein complex,CC,
17096,GO:0072553,1,0.912809460604158,0,6,terminal button organization,BP,
17097,GO:0072554,1,0.969095716307136,0,2,blood vessel lumenization,BP,
17098,GO:0072556,1,0.983426667503302,0,1,other organism presynaptic membrane,CC,
17099,GO:0072557,1,0.966126573137998,0,3,IPAF inflammasome complex,CC,
17100,GO:0072558,1,0.960104860519086,0,4,NLRP1 inflammasome complex,CC,
17101,GO:0072559,1,0.930801640848342,0,6,NLRP3 inflammasome complex,CC,
17102,GO:0072560,1,0.975526059485101,0,2,type B pancreatic cell maturation,BP,
17104,GO:0072563,1,0.972544614104062,0,2,endothelial microparticle,CC,
17105,GO:0072564,1,0.9748745378966,0,2,blood microparticle formation,BP,
17106,GO:0072566,1,0.971602805250493,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
17107,GO:0072567,1,0.875590935574699,0,10,chemokine (C-X-C motif) ligand 2 production,BP,
17108,GO:0072572,1,0.986117059144536,0,1,poly-ADP-D-ribose binding,MF,
17109,GO:0072573,1,0.983426667503154,0,1,tolerance induction to lipopolysaccharide,BP,
17114,GO:0072578,1,0.883587571287648,0,8,neurotransmitter-gated ion channel clustering,BP,
17115,GO:0072579,1,0.983426667503251,0,1,glycine receptor clustering,BP,
17118,GO:0072586,1,0.983426667503102,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
17119,GO:0072587,1,0.983426667503102,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
17120,GO:0072588,1,0.956704301844723,0,5,box H/ACA RNP complex,CC,
17121,GO:0072589,1,0.966301326662496,0,4,box H/ACA scaRNP complex,CC,
17122,GO:0072590,1,0.967126892146989,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
17123,GO:0072591,1,0.983426667501674,0,1,citrate-L-glutamate ligase activity,MF,
17124,GO:0072592,1,0.937706294590984,0,5,oxygen metabolic process,BP,
17128,GO:0072599,1,0.435798520991946,0,104,establishment of protein localization to endoplasmic reticulum,BP,
17129,GO:0072600,1,0.692763132365734,0,22,establishment of protein localization to Golgi,BP,
17131,GO:0072603,1,0.917875485610121,0,6,interleukin-5 secretion,BP,
17134,GO:0072608,1,0.900074844401646,0,8,interleukin-10 secretion,BP,
17135,GO:0072610,1,0.882404915257936,0,9,interleukin-12 secretion,BP,
17136,GO:0072611,1,0.901374006336661,0,8,interleukin-13 secretion,BP,
17137,GO:0072615,1,0.986081633239475,0,1,interleukin-17 secretion,BP,
17138,GO:0072616,1,0.98342666755414,0,1,interleukin-18 secretion,BP,
17139,GO:0072619,1,0.983463896807736,0,1,interleukin-21 secretion,BP,
17140,GO:0072641,1,0.955457427428037,0,3,type I interferon secretion,BP,
17141,GO:0072642,1,0.970926061584766,0,2,interferon-alpha secretion,BP,
17142,GO:0072643,1,0.771026625776077,0,17,interferon-gamma secretion,BP,
17146,GO:0072658,1,0.983426667496907,0,1,maintenance of protein location in membrane,BP,
17148,GO:0072660,1,0.983426667496907,0,1,maintenance of protein location in plasma membrane,BP,
17150,GO:0072662,1,0.771700240284131,0,17,protein localization to peroxisome,BP,
17151,GO:0072663,1,0.771700240284131,0,17,establishment of protein localization to peroxisome,BP,
17153,GO:0072666,1,0.630781800619276,0,31,establishment of protein localization to vacuole,BP,
17154,GO:0072669,1,0.931397342844657,0,7,tRNA-splicing ligase complex,CC,
17155,GO:0072671,1,0.984754258727009,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
17157,GO:0072673,1,0.802025787263716,0,14,lamellipodium morphogenesis,BP,
17158,GO:0072674,1,0.937809394941512,0,4,multinuclear osteoclast differentiation,BP,
17159,GO:0072675,1,0.952355803161857,0,3,osteoclast fusion,BP,
17161,GO:0072677,1,0.848717865841631,0,15,eosinophil migration,BP,
17164,GO:0072680,1,0.983697683106668,0,1,extracellular matrix-dependent thymocyte migration,BP,
17165,GO:0072681,1,0.983697683106668,0,1,fibronectin-dependent thymocyte migration,BP,
17166,GO:0072682,1,0.983517274358262,0,1,eosinophil extravasation,BP,
17167,GO:0072683,1,0.954367391934754,0,4,T cell extravasation,BP,
17168,GO:0072684,1,0.983429506821926,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17169,GO:0072686,1,0.36957629087151,0,65,mitotic spindle,CC,
17170,GO:0072687,1,0.894583573566421,0,8,meiotic spindle,CC,
17171,GO:0072695,1,0.970452903517209,0,2,regulation of DNA recombination at telomere,BP,
17172,GO:0072697,1,0.974712745433947,0,2,protein localization to cell cortex,BP,
17173,GO:0072698,1,0.594793707498044,0,33,protein localization to microtubule cytoskeleton,BP,
17174,GO:0072702,1,0.983426667501923,0,1,response to methyl methanesulfonate,BP,
17175,GO:0072703,1,0.983426667501923,0,1,cellular response to methyl methanesulfonate,BP,
17176,GO:0072706,1,0.984703891580552,0,1,response to sodium dodecyl sulfate,BP,
17177,GO:0072707,1,0.984703891580552,0,1,cellular response to sodium dodecyl sulfate,BP,
17178,GO:0072708,1,0.941232920391562,0,4,response to sorbitol,BP,
17179,GO:0072709,1,0.970945901824462,0,2,cellular response to sorbitol,BP,
17180,GO:0072710,1,0.892847162766627,0,7,response to hydroxyurea,BP,
17181,GO:0072711,1,0.906698999741807,0,6,cellular response to hydroxyurea,BP,
17182,GO:0072714,1,0.987935740848099,0,1,response to selenite ion,BP,
17183,GO:0072715,1,0.987935740848099,0,1,cellular response to selenite ion,BP,
17184,GO:0072716,1,0.949257943723387,0,4,response to actinomycin D,BP,
17185,GO:0072717,1,0.963981189590775,0,3,cellular response to actinomycin D,BP,
17186,GO:0072718,1,0.870365018341506,0,9,response to cisplatin,BP,
17187,GO:0072719,1,0.913013108863451,0,6,cellular response to cisplatin,BP,
17188,GO:0072720,1,0.969690119055175,0,2,response to dithiothreitol,BP,
17189,GO:0072721,1,0.984728932554734,0,1,cellular response to dithiothreitol,BP,
17190,GO:0072733,1,0.945134959043525,0,4,response to staurosporine,BP,
17191,GO:0072734,1,0.945134959043525,0,4,cellular response to staurosporine,BP,
17192,GO:0072737,1,0.970928284202221,0,2,response to diamide,BP,
17193,GO:0072738,1,0.970928284202221,0,2,cellular response to diamide,BP,
17194,GO:0072739,1,0.984728932554734,0,1,response to anisomycin,BP,
17195,GO:0072750,1,0.990556563085405,0,1,cellular response to leptomycin B,BP,
17196,GO:0072752,1,0.983426667500741,0,1,cellular response to rapamycin,BP,
17197,GO:0072755,1,0.983432965605857,0,1,cellular response to benomyl,BP,
17198,GO:0072757,1,0.953341620430516,0,3,cellular response to camptothecin,BP,
17199,GO:0075136,1,0.917652723076731,0,6,response to host,BP,
17200,GO:0075509,1,0.952305215663209,0,3,endocytosis involved in viral entry into host cell,BP,
17201,GO:0075519,1,0.994627919807112,0,1,microtubule-dependent intracellular transport of viral material,BP,
17202,GO:0075521,1,0.994627919807112,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17203,GO:0075522,1,0.904687170051167,0,7,IRES-dependent viral translational initiation,BP,
17204,GO:0075525,1,0.934323195732468,0,5,viral translational termination-reinitiation,BP,
17205,GO:0075528,1,0.975380881805929,0,2,modulation by virus of host immune response,BP,
17206,GO:0075606,1,0.994627919807112,0,1,transport of viral material towards nucleus,BP,
17207,GO:0075713,1,0.894181683723169,0,8,establishment of integrated proviral latency,BP,
17208,GO:0075732,1,0.967126892153908,0,2,viral penetration into host nucleus,BP,
17210,GO:0080008,1,0.670508475178514,0,26,Cul4-RING E3 ubiquitin ligase complex,CC,
17211,GO:0080009,1,0.945676724424825,0,4,mRNA methylation,BP,
17212,GO:0080019,1,0.969926635213212,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17213,GO:0080025,1,0.73975724564205,0,20,phosphatidylinositol-3,5-bisphosphate binding,MF,
17214,GO:0080033,1,0.983426667501085,0,1,response to nitrite,BP,
17215,GO:0080048,1,0.984728932554734,0,1,GDP-D-glucose phosphorylase activity,MF,
17216,GO:0080058,1,0.990088166239541,0,1,protein deglutathionylation,BP,
17217,GO:0080084,1,0.925420492530248,0,5,5S rDNA binding,MF,
17219,GO:0080101,1,0.99249475714563,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17220,GO:0080111,1,0.788660492783576,0,18,DNA demethylation,BP,
17221,GO:0080120,1,0.962319597988804,0,3,CAAX-box protein maturation,BP,
17222,GO:0080121,1,0.969592073929455,0,2,AMP transport,BP,
17223,GO:0080122,1,0.969592073929455,0,2,AMP transmembrane transporter activity,MF,
17224,GO:0080129,1,0.991818637092733,0,1,proteasome core complex assembly,BP,
17225,GO:0080130,1,0.956099555295784,0,3,L-phenylalanine:2-oxoglutarate aminotransferase activity,MF,
17226,GO:0080132,1,0.985109325723906,0,1,fatty acid alpha-hydroxylase activity,MF,
17229,GO:0080144,1,0.987207663324692,0,1,amino acid homeostasis,BP,
17230,GO:0080146,1,0.987912661362616,0,1,L-cysteine desulfhydrase activity,MF,
17231,GO:0080147,1,0.994020585908706,0,1,root hair cell development,BP,
17232,GO:0080154,1,0.759581856383086,0,25,regulation of fertilization,BP,
17233,GO:0080163,1,0.985213862181662,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17235,GO:0080182,1,0.837817156476086,0,13,histone H3-K4 trimethylation,BP,
17236,GO:0080184,1,0.936996139224896,0,5,response to phenylpropanoid,BP,
17237,GO:0085018,1,0.984276552972496,0,1,maintenance of symbiont-containing vacuole by host,BP,
17238,GO:0085020,1,0.912973040178641,0,7,protein K6-linked ubiquitination,BP,
17240,GO:0085032,1,0.983592726012168,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17246,GO:0086006,1,0.926530505255469,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17247,GO:0086007,1,0.919825680696051,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17252,GO:0086012,1,0.709469554698392,0,22,membrane depolarization during cardiac muscle cell action potential,BP,
17254,GO:0086014,1,0.744617577198992,0,18,atrial cardiac muscle cell action potential,BP,
17255,GO:0086015,1,0.861114913909,0,9,SA node cell action potential,BP,
17256,GO:0086016,1,0.84760744280587,0,10,AV node cell action potential,BP,
17257,GO:0086017,1,0.942396470884422,0,4,Purkinje myocyte action potential,BP,
17258,GO:0086018,1,0.861114913909,0,9,SA node cell to atrial cardiac muscle cell signalling,BP,
17260,GO:0086020,1,0.967381025153628,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17261,GO:0086021,1,0.967381025153628,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17263,GO:0086024,1,0.983426667498922,0,1,adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17264,GO:0086026,1,0.744617577198992,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
17265,GO:0086027,1,0.84760744280587,0,10,AV node cell to bundle of His cell signaling,BP,
17266,GO:0086028,1,0.899668782505456,0,7,bundle of His cell to Purkinje myocyte signaling,BP,
17269,GO:0086036,1,0.905122737435818,0,7,regulation of cardiac muscle cell membrane potential,BP,
17270,GO:0086037,1,0.98346326850211,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17271,GO:0086039,1,0.983426667498821,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17272,GO:0086040,1,0.983426667503056,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17273,GO:0086041,1,0.983426667500005,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17275,GO:0086043,1,0.899668782505456,0,7,bundle of His cell action potential,BP,
17276,GO:0086044,1,0.983685065836084,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
17277,GO:0086045,1,0.919824307504074,0,5,membrane depolarization during AV node cell action potential,BP,
17278,GO:0086046,1,0.91982430750274,0,5,membrane depolarization during SA node cell action potential,BP,
17279,GO:0086047,1,0.958029412247798,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17280,GO:0086048,1,0.951097596796239,0,3,membrane depolarization during bundle of His cell action potential,BP,
17281,GO:0086050,1,0.984076881338371,0,1,membrane repolarization during bundle of His cell action potential,BP,
17282,GO:0086052,1,0.984076881338371,0,1,membrane repolarization during SA node cell action potential,BP,
17283,GO:0086053,1,0.967381025153628,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
17284,GO:0086054,1,0.983685065836084,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
17285,GO:0086055,1,0.983685065836084,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
17286,GO:0086056,1,0.951096177106233,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17287,GO:0086057,1,0.983428135241463,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17288,GO:0086059,1,0.967126892148005,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17289,GO:0086060,1,0.983426667498525,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17290,GO:0086061,1,0.983426667498525,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17291,GO:0086062,1,0.974176500108839,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17292,GO:0086063,1,0.983426667498525,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17293,GO:0086064,1,0.702007065235901,0,23,cell communication by electrical coupling involved in cardiac conduction,BP,
17295,GO:0086066,1,0.744617577198992,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
17296,GO:0086067,1,0.83355022457332,0,11,AV node cell to bundle of His cell communication,BP,
17299,GO:0086070,1,0.846834607016638,0,10,SA node cell to atrial cardiac muscle cell communication,BP,
17300,GO:0086072,1,0.98497441146994,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17302,GO:0086075,1,0.95163099718713,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
17303,GO:0086076,1,0.983685065836084,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
17304,GO:0086077,1,0.967381025153628,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17305,GO:0086078,1,0.983685065836084,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
17306,GO:0086079,1,0.983685065836084,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
17308,GO:0086082,1,0.98497441146994,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17310,GO:0086087,1,0.984076881338371,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17311,GO:0086089,1,0.937355538226937,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17312,GO:0086090,1,0.984076881338371,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17314,GO:0086092,1,0.971714334880099,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17316,GO:0086098,1,0.968136357027455,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17317,GO:0086100,1,0.967129467001007,0,2,endothelin receptor signaling pathway,BP,
17319,GO:0089700,1,0.935556359869917,0,4,protein kinase D signaling,BP,
17320,GO:0089701,1,0.945044763860228,0,5,U2AF,CC,
17321,GO:0089709,1,0.969459349948648,0,2,L-histidine transmembrane transport,BP,
17322,GO:0089711,1,0.800059626900075,0,14,L-glutamate transmembrane transport,BP,
17323,GO:0089712,1,0.940678650839748,0,4,L-aspartate transmembrane transport,BP,
17324,GO:0089717,1,0.951156701569045,0,3,spanning component of membrane,CC,
17325,GO:0089718,1,0.983426667499561,0,1,amino acid import across plasma membrane,BP,
17326,GO:0089720,1,0.928100874796625,0,6,caspase binding,MF,
17332,GO:0090010,1,0.986342985336837,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17335,GO:0090024,1,0.968407661017306,0,2,negative regulation of neutrophil chemotaxis,BP,
17336,GO:0090025,1,0.775529062424881,0,22,regulation of monocyte chemotaxis,BP,
17337,GO:0090026,1,0.839183286288512,0,17,positive regulation of monocyte chemotaxis,BP,
17338,GO:0090027,1,0.939435256862798,0,4,negative regulation of monocyte chemotaxis,BP,
17342,GO:0090034,1,0.972280086606912,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17343,GO:0090035,1,0.972280086606912,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17346,GO:0090038,1,0.967433930263043,0,2,negative regulation of protein kinase C signaling,BP,
17347,GO:0090042,1,0.90080722954227,0,7,tubulin deacetylation,BP,
17348,GO:0090043,1,0.928123095856163,0,5,regulation of tubulin deacetylation,BP,
17349,GO:0090044,1,0.988666351505513,0,1,positive regulation of tubulin deacetylation,BP,
17350,GO:0090045,1,0.90122684732291,0,7,positive regulation of deacetylase activity,BP,
17352,GO:0090050,1,0.90462875540989,0,7,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17354,GO:0090063,1,0.938294853547883,0,4,positive regulation of microtubule nucleation,BP,
17355,GO:0090065,1,0.983426667503399,0,1,regulation of production of siRNA involved in RNA interference,BP,
17358,GO:0090069,1,0.851261698407449,0,10,regulation of ribosome biogenesis,BP,
17359,GO:0090070,1,0.908325293061227,0,6,positive regulation of ribosome biogenesis,BP,
17360,GO:0090071,1,0.937201348742123,0,4,negative regulation of ribosome biogenesis,BP,
17361,GO:0090073,1,0.900501501738184,0,8,positive regulation of protein homodimerization activity,BP,
17362,GO:0090074,1,0.928514782437011,0,5,negative regulation of protein homodimerization activity,BP,
17364,GO:0090076,1,0.967172051361717,0,2,relaxation of skeletal muscle,BP,
17365,GO:0090077,1,0.620743457567878,0,34,foam cell differentiation,BP,
17366,GO:0090079,1,0.730623325270653,0,20,translation regulator activity, nucleic acid binding,MF,
17367,GO:0090080,1,0.929426188516263,0,5,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17368,GO:0090081,1,0.979109153449679,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17369,GO:0090082,1,0.979109153449679,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17370,GO:0090083,1,0.788210645717005,0,16,regulation of inclusion body assembly,BP,
17371,GO:0090084,1,0.84510552491048,0,11,negative regulation of inclusion body assembly,BP,
17372,GO:0090085,1,0.899667381232653,0,8,regulation of protein deubiquitination,BP,
17373,GO:0090086,1,0.97072028503455,0,3,negative regulation of protein deubiquitination,BP,
17375,GO:0090088,1,0.972983734770215,0,2,regulation of oligopeptide transport,BP,
17376,GO:0090089,1,0.972983734770215,0,2,regulation of dipeptide transport,BP,
17378,GO:0090091,1,0.920782454376463,0,5,positive regulation of extracellular matrix disassembly,BP,
17380,GO:0090094,1,0.972696195762803,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17381,GO:0090095,1,0.985315338065266,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17382,GO:0090096,1,0.985315338065266,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17387,GO:0090104,1,0.98348170472041,0,1,pancreatic epsilon cell differentiation,BP,
17388,GO:0090107,1,0.960461715058532,0,3,regulation of high-density lipoprotein particle assembly,BP,
17389,GO:0090108,1,0.986396783778228,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17391,GO:0090110,1,0.921996467115082,0,5,cargo loading into COPII-coated vesicle,BP,
17392,GO:0090113,1,0.986007651161438,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17393,GO:0090114,1,0.385250244668899,0,66,COPII-coated vesicle budding,BP,
17394,GO:0090116,1,0.951096221559428,0,3,C-5 methylation of cytosine,BP,
17395,GO:0090118,1,0.925065371284567,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
17396,GO:0090119,1,0.970277350663947,0,2,vesicle-mediated cholesterol transport,BP,
17397,GO:0090122,1,0.986630002516302,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17398,GO:0090128,1,0.838122203175367,0,11,regulation of synapse maturation,BP,
17399,GO:0090129,1,0.880334306036941,0,8,positive regulation of synapse maturation,BP,
17405,GO:0090135,1,0.95714629704276,0,3,actin filament branching,BP,
17408,GO:0090140,1,0.751328846353654,0,19,regulation of mitochondrial fission,BP,
17409,GO:0090141,1,0.84210868148392,0,12,positive regulation of mitochondrial fission,BP,
17410,GO:0090148,1,0.838745499549733,0,11,membrane fission,BP,
17411,GO:0090149,1,0.969098820197448,0,2,mitochondrial membrane fission,BP,
17413,GO:0090151,1,0.848317351314458,0,15,establishment of protein localization to mitochondrial membrane,BP,
17414,GO:0090152,1,0.984539025113797,0,1,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission,BP,
17415,GO:0090153,1,0.832519165368012,0,13,regulation of sphingolipid biosynthetic process,BP,
17416,GO:0090154,1,0.888556004227452,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17417,GO:0090155,1,0.947165405491516,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17418,GO:0090156,1,0.963130148110704,0,3,cellular sphingolipid homeostasis,BP,
17419,GO:0090158,1,0.955772272997969,0,3,endoplasmic reticulum membrane organization,BP,
17420,GO:0090160,1,0.921083154664227,0,5,Golgi to lysosome transport,BP,
17421,GO:0090161,1,0.836629123943071,0,11,Golgi ribbon formation,BP,
17423,GO:0090164,1,0.968128471092487,0,2,asymmetric Golgi ribbon formation,BP,
17424,GO:0090166,1,0.918658847941808,0,6,Golgi disassembly,BP,
17425,GO:0090168,1,0.945046985682195,0,4,Golgi reassembly,BP,
17426,GO:0090169,1,0.79329404887192,0,16,regulation of spindle assembly,BP,
17427,GO:0090170,1,0.944505523177893,0,4,regulation of Golgi inheritance,BP,
17428,GO:0090171,1,0.983428995562572,0,1,chondrocyte morphogenesis,BP,
17431,GO:0090176,1,0.983426667501923,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17435,GO:0090181,1,0.71344311093041,0,23,regulation of cholesterol metabolic process,BP,
17436,GO:0090182,1,0.975453697663218,0,2,regulation of secretion of lysosomal enzymes,BP,
17441,GO:0090187,1,0.982439903394861,0,2,positive regulation of pancreatic juice secretion,BP,
17449,GO:0090195,1,0.825191583408174,0,13,chemokine secretion,BP,
17450,GO:0090196,1,0.83907664684948,0,12,regulation of chemokine secretion,BP,
17451,GO:0090197,1,0.852690169736582,0,11,positive regulation of chemokine secretion,BP,
17452,GO:0090198,1,0.984045075041391,0,1,negative regulation of chemokine secretion,BP,
17457,GO:0090204,1,0.96656985505668,0,3,protein localization to nuclear pore,BP,
17458,GO:0090205,1,0.906813288755622,0,6,positive regulation of cholesterol metabolic process,BP,
17459,GO:0090206,1,0.940253703050914,0,5,negative regulation of cholesterol metabolic process,BP,
17461,GO:0090208,1,0.78097598198823,0,19,positive regulation of triglyceride metabolic process,BP,
17463,GO:0090210,1,0.9682280218865,0,2,regulation of establishment of blood-brain barrier,BP,
17464,GO:0090212,1,0.9682280218865,0,2,negative regulation of establishment of blood-brain barrier,BP,
17465,GO:0090214,1,0.96836742545186,0,3,spongiotrophoblast layer developmental growth,BP,
17467,GO:0090219,1,0.952982615056805,0,3,negative regulation of lipid kinase activity,BP,
17468,GO:0090220,1,0.830703515280875,0,12,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17469,GO:0090222,1,0.983426667500641,0,1,centrosome-templated microtubule nucleation,BP,
17471,GO:0090230,1,0.915153469027721,0,6,regulation of centromere complex assembly,BP,
17472,GO:0090231,1,0.790983519086409,0,16,regulation of spindle checkpoint,BP,
17473,GO:0090232,1,0.889340384154179,0,8,positive regulation of spindle checkpoint,BP,
17474,GO:0090233,1,0.984435940978795,0,1,negative regulation of spindle checkpoint,BP,
17475,GO:0090234,1,0.952852752504219,0,3,regulation of kinetochore assembly,BP,
17476,GO:0090235,1,0.97065082464681,0,2,regulation of metaphase plate congression,BP,
17477,GO:0090237,1,0.924506136675086,0,6,regulation of arachidonic acid secretion,BP,
17478,GO:0090238,1,0.940090529258529,0,5,positive regulation of arachidonic acid secretion,BP,
17479,GO:0090239,1,0.846719765293755,0,12,regulation of histone H4 acetylation,BP,
17480,GO:0090240,1,0.912370631582487,0,7,positive regulation of histone H4 acetylation,BP,
17481,GO:0090241,1,0.934603667021165,0,5,negative regulation of histone H4 acetylation,BP,
17482,GO:0090244,1,0.942494239715953,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17483,GO:0090245,1,0.921469972991504,0,5,axis elongation involved in somitogenesis,BP,
17484,GO:0090246,1,0.983426667503104,0,1,convergent extension involved in somitogenesis,BP,
17485,GO:0090247,1,0.984648274463338,0,1,cell motility involved in somitogenic axis elongation,BP,
17486,GO:0090249,1,0.984648274463338,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17487,GO:0090251,1,0.983426667495327,0,1,protein localization involved in establishment of planar polarity,BP,
17489,GO:0090258,1,0.952110220034645,0,3,negative regulation of mitochondrial fission,BP,
17490,GO:0090259,1,0.921549068328605,0,5,regulation of retinal ganglion cell axon guidance,BP,
17491,GO:0090260,1,0.967126892154975,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17492,GO:0090261,1,0.950934572785934,0,4,positive regulation of inclusion body assembly,BP,
17494,GO:0090264,1,0.979255347194462,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17495,GO:0090265,1,0.979255347194462,0,2,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17496,GO:0090266,1,0.830895751936641,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17497,GO:0090267,1,0.904188811930166,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17498,GO:0090269,1,0.910297949903809,0,6,fibroblast growth factor production,BP,
17499,GO:0090270,1,0.910297949903809,0,6,regulation of fibroblast growth factor production,BP,
17500,GO:0090271,1,0.952355803169529,0,3,positive regulation of fibroblast growth factor production,BP,
17501,GO:0090272,1,0.955846818499377,0,3,negative regulation of fibroblast growth factor production,BP,
17502,GO:0090273,1,0.979732658223347,0,2,regulation of somatostatin secretion,BP,
17503,GO:0090274,1,0.979732658223347,0,2,positive regulation of somatostatin secretion,BP,
17505,GO:0090277,1,0.326644087466671,0,83,positive regulation of peptide hormone secretion,BP,
17510,GO:0090283,1,0.956317383460726,0,3,regulation of protein glycosylation in Golgi,BP,
17511,GO:0090284,1,0.983426667499956,0,1,positive regulation of protein glycosylation in Golgi,BP,
17512,GO:0090285,1,0.972435735624843,0,2,negative regulation of protein glycosylation in Golgi,BP,
17513,GO:0090286,1,0.893749230226489,0,8,cytoskeletal anchoring at nuclear membrane,BP,
17516,GO:0090289,1,0.939028249781369,0,5,regulation of osteoclast proliferation,BP,
17517,GO:0090290,1,0.970950247863394,0,3,positive regulation of osteoclast proliferation,BP,
17518,GO:0090291,1,0.967126892155409,0,2,negative regulation of osteoclast proliferation,BP,
17519,GO:0090292,1,0.951105344772529,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17520,GO:0090293,1,0.986081633239475,0,1,nitrogen catabolite regulation of transcription,BP,
17521,GO:0090294,1,0.986081633239475,0,1,nitrogen catabolite activation of transcription,BP,
17522,GO:0090296,1,0.943142702997315,0,4,regulation of mitochondrial DNA replication,BP,
17523,GO:0090297,1,0.990600939581185,0,1,positive regulation of mitochondrial DNA replication,BP,
17524,GO:0090298,1,0.952093303712126,0,3,negative regulation of mitochondrial DNA replication,BP,
17525,GO:0090299,1,0.988339738766748,0,1,regulation of neural crest formation,BP,
17526,GO:0090301,1,0.988339738766748,0,1,negative regulation of neural crest formation,BP,
17529,GO:0090305,1,0.0225799884240134,0,271,nucleic acid phosphodiester bond hydrolysis,BP,
17530,GO:0090306,1,0.929598918099768,0,5,spindle assembly involved in meiosis,BP,
17531,GO:0090307,1,0.454606686239971,0,52,mitotic spindle assembly,BP,
17532,GO:0090308,1,0.87000639979467,0,9,regulation of methylation-dependent chromatin silencing,BP,
17533,GO:0090309,1,0.935785765684246,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17534,GO:0090310,1,0.961310019655784,0,3,negative regulation of methylation-dependent chromatin silencing,BP,
17535,GO:0090311,1,0.602617201167037,0,35,regulation of protein deacetylation,BP,
17536,GO:0090312,1,0.733862728839968,0,21,positive regulation of protein deacetylation,BP,
17537,GO:0090313,1,0.685280191101661,0,27,regulation of protein targeting to membrane,BP,
17538,GO:0090314,1,0.738728421046336,0,22,positive regulation of protein targeting to membrane,BP,
17539,GO:0090315,1,0.930343773686139,0,5,negative regulation of protein targeting to membrane,BP,
17542,GO:0090320,1,0.985597405954989,0,1,regulation of chylomicron remnant clearance,BP,
17543,GO:0090321,1,0.985597405954989,0,1,positive regulation of chylomicron remnant clearance,BP,
17545,GO:0090323,1,0.995641439960648,0,1,prostaglandin secretion involved in immune response,BP,
17547,GO:0090325,1,0.941529819992356,0,4,regulation of locomotion involved in locomotory behavior,BP,
17548,GO:0090326,1,0.983582006490514,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17549,GO:0090327,1,0.983426667503302,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17551,GO:0090330,1,0.787816874185138,0,15,regulation of platelet aggregation,BP,
17552,GO:0090331,1,0.855147521095405,0,10,negative regulation of platelet aggregation,BP,
17553,GO:0090335,1,0.829876797316661,0,13,regulation of brown fat cell differentiation,BP,
17554,GO:0090336,1,0.914984410056134,0,7,positive regulation of brown fat cell differentiation,BP,
17555,GO:0090340,1,0.986396783778228,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17556,GO:0090341,1,0.988906627813444,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17557,GO:0090342,1,0.598505952949792,0,35,regulation of cell aging,BP,
17558,GO:0090343,1,0.889756026087849,0,9,positive regulation of cell aging,BP,
17559,GO:0090344,1,0.773281708088946,0,17,negative regulation of cell aging,BP,
17560,GO:0090345,1,0.973803831998751,0,2,cellular organohalogen metabolic process,BP,
17561,GO:0090346,1,0.973803831998751,0,2,cellular organofluorine metabolic process,BP,
17562,GO:0090347,1,0.988766311713202,0,1,regulation of cellular organohalogen metabolic process,BP,
17563,GO:0090348,1,0.988766311713202,0,1,regulation of cellular organofluorine metabolic process,BP,
17564,GO:0090349,1,0.988766311713202,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17565,GO:0090350,1,0.988766311713202,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17566,GO:0090357,1,0.990760322235858,0,1,regulation of tryptophan metabolic process,BP,
17567,GO:0090360,1,0.956729396538726,0,3,platelet-derived growth factor production,BP,
17568,GO:0090361,1,0.956729396538726,0,3,regulation of platelet-derived growth factor production,BP,
17569,GO:0090362,1,0.96990467749563,0,2,positive regulation of platelet-derived growth factor production,BP,
17570,GO:0090365,1,0.979258301814373,0,2,regulation of mRNA modification,BP,
17571,GO:0090366,1,0.993209476376177,0,1,positive regulation of mRNA modification,BP,
17572,GO:0090367,1,0.985953838967865,0,1,negative regulation of mRNA modification,BP,
17573,GO:0090370,1,0.949135137016884,0,4,negative regulation of cholesterol efflux,BP,
17574,GO:0090381,1,0.963406175293161,0,3,regulation of heart induction,BP,
17578,GO:0090386,1,0.98342666749951,0,1,phagosome maturation involved in apoptotic cell clearance,BP,
17579,GO:0090387,1,0.98342666749951,0,1,phagolysosome assembly involved in apoptotic cell clearance,BP,
17580,GO:0090389,1,0.98342666749951,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17581,GO:0090394,1,0.864317378095368,0,9,negative regulation of excitatory postsynaptic potential,BP,
17585,GO:0090402,1,0.9711436130917,0,2,oncogene-induced cell senescence,BP,
17586,GO:0090403,1,0.937632641647271,0,4,oxidative stress-induced premature senescence,BP,
17588,GO:0090409,1,0.985562297761056,0,1,malonyl-CoA synthetase activity,MF,
17589,GO:0090410,1,0.985562297761056,0,1,malonate catabolic process,BP,
17590,GO:0090416,1,0.984715717525981,0,1,nicotinate transporter activity,MF,
17591,GO:0090420,1,0.977432961485571,0,2,naphthalene-containing compound metabolic process,BP,
17592,GO:0090422,1,0.988442056876956,0,1,thiamine pyrophosphate transporter activity,MF,
17593,GO:0090425,1,0.983782100485865,0,1,acinar cell differentiation,BP,
17594,GO:0090427,1,0.95692836716915,0,3,activation of meiosis,BP,
17595,GO:0090435,1,0.908846872650492,0,7,protein localization to nuclear envelope,BP,
17596,GO:0090467,1,0.942349439578067,0,4,arginine import,BP,
17597,GO:0090472,1,0.983426667503302,0,1,dibasic protein processing,BP,
17598,GO:0090480,1,0.984728932554734,0,1,purine nucleotide-sugar transmembrane transport,BP,
17599,GO:0090481,1,0.933900447668634,0,5,pyrimidine nucleotide-sugar transmembrane transport,BP,
17600,GO:0090482,1,0.883937671259201,0,8,vitamin transmembrane transporter activity,MF,
17601,GO:0090484,1,0.706461723467234,0,23,drug transporter activity,MF,
17604,GO:0090498,1,0.954558526795025,0,3,extrinsic component of Golgi membrane,CC,
17605,GO:0090500,1,0.930873340357998,0,5,endocardial cushion to mesenchymal transition,BP,
17606,GO:0090501,1,0.183179547449523,0,127,RNA phosphodiester bond hydrolysis,BP,
17607,GO:0090502,1,0.432006847446981,0,64,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17608,GO:0090503,1,0.613769939940509,0,34,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17611,GO:0090520,1,0.838594493634724,0,12,sphingolipid mediated signaling pathway,BP,
17612,GO:0090521,1,0.937378483398747,0,4,glomerular visceral epithelial cell migration,BP,
17614,GO:0090527,1,0.907522758616624,0,6,actin filament reorganization,BP,
17615,GO:0090529,1,0.987393297642661,0,1,cell septum assembly,BP,
17616,GO:0090533,1,0.814398211935927,0,15,cation-transporting ATPase complex,CC,
17617,GO:0090534,1,0.988091104477908,0,1,calcium ion-transporting ATPase complex,CC,
17618,GO:0090537,1,0.967126892154198,0,2,CERF complex,CC,
17619,GO:0090541,1,0.968407661017789,0,2,MIT domain binding,MF,
17620,GO:0090543,1,0.911240663454495,0,7,Flemming body,CC,
17621,GO:0090544,1,0.710039077420969,0,23,BAF-type complex,CC,
17622,GO:0090545,1,0.764593789868387,0,17,CHD-type complex,CC,
17623,GO:0090554,1,0.935330100976441,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17624,GO:0090555,1,0.967126892151585,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17625,GO:0090556,1,0.967126892145874,0,2,phosphatidylserine-translocating ATPase activity,MF,
17627,GO:0090558,1,0.994020585908706,0,1,plant epidermis development,BP,
17629,GO:0090560,1,0.986052299050138,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17630,GO:0090568,1,0.616323234175889,0,31,nuclear transcriptional repressor complex,CC,
17631,GO:0090571,1,0.943918322429547,0,4,RNA polymerase II transcription repressor complex,CC,
17633,GO:0090576,1,0.88514530904836,0,8,RNA polymerase III transcription factor complex,CC,
17635,GO:0090594,1,0.918736029524016,0,6,inflammatory response to wounding,BP,
17638,GO:0090599,1,0.904600598417394,0,6,alpha-glucosidase activity,MF,
17639,GO:0090600,1,0.983427104125773,0,1,alpha-1,3-glucosidase activity,MF,
17640,GO:0090611,1,0.930747578510458,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17641,GO:0090615,1,0.983426667503004,0,1,mitochondrial mRNA processing,BP,
17642,GO:0090616,1,0.983426667503004,0,1,mitochondrial mRNA 3'-end processing,BP,
17643,GO:0090619,1,0.985331728146524,0,1,meiotic spindle pole,CC,
17644,GO:0090624,1,0.984728932554734,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17645,GO:0090625,1,0.984728932554734,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17646,GO:0090627,1,0.994020585908706,0,1,plant epidermal cell differentiation,BP,
17648,GO:0090631,1,0.975519886965025,0,2,pre-miRNA transporter activity,MF,
17649,GO:0090634,1,0.989157697361939,0,1,microglial cell mediated cytotoxicity,BP,
17650,GO:0090646,1,0.845780041222335,0,12,mitochondrial tRNA processing,BP,
17651,GO:0090648,1,0.983426667501186,0,1,response to environmental enrichment,BP,
17652,GO:0090649,1,0.92593395597706,0,5,response to oxygen-glucose deprivation,BP,
17653,GO:0090650,1,0.92593395597706,0,5,cellular response to oxygen-glucose deprivation,BP,
17654,GO:0090651,1,0.983426667500543,0,1,apical cytoplasm,CC,
17655,GO:0090656,1,0.783648462394812,0,15,t-circle formation,BP,
17656,GO:0090657,1,0.837292029117173,0,11,telomeric loop disassembly,BP,
17658,GO:0090661,1,0.966301326662496,0,4,box H/ACA telomerase RNP complex,CC,
17659,GO:0090662,1,0.356398662744536,0,74,ATP hydrolysis coupled transmembrane transport,BP,
17660,GO:0090665,1,0.737423499701178,0,21,glycoprotein complex,CC,
17661,GO:0090666,1,0.945861603261853,0,4,scaRNA localization to Cajal body,BP,
17662,GO:0090669,1,0.956544494417463,0,3,telomerase RNA stabilization,BP,
17663,GO:0090670,1,0.815079657625325,0,16,RNA localization to Cajal body,BP,
17664,GO:0090671,1,0.815079657625325,0,16,telomerase RNA localization to Cajal body,BP,
17665,GO:0090672,1,0.815079657625325,0,16,telomerase RNA localization,BP,
17666,GO:0090675,1,0.96718843251821,0,2,intermicrovillar adhesion,BP,
17667,GO:0090676,1,0.983963369018216,0,1,calcium ion transmembrane transport via low voltage-gated calcium channel,BP,
17670,GO:0090713,1,0.874688826656064,0,9,immunological memory process,BP,
17671,GO:0090715,1,0.874688826656064,0,9,immunological memory formation process,BP,
17672,GO:0090722,1,0.950790623850697,0,4,receptor-receptor interaction,MF,
17673,GO:0090723,1,0.784788203588218,0,16,growth cone part,CC,
17674,GO:0090724,1,0.926213244238435,0,5,central region of growth cone,CC,
17675,GO:0090725,1,0.976790626350595,0,2,peripheral region of growth cone,CC,
17676,GO:0090731,1,0.991246637861128,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17677,GO:0090732,1,0.990753920282674,0,1,cofilin-actin rod,CC,
17678,GO:0090734,1,0.647727294951042,0,29,site of DNA damage,CC,
17679,GO:0090735,1,0.864898322946329,0,10,DNA repair complex assembly,BP,
17680,GO:0090737,1,0.783648462394812,0,15,telomere maintenance via telomere trimming,BP,
17681,GO:0093001,1,0.983642158286954,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17682,GO:0095500,1,0.74946966417015,0,21,acetylcholine receptor signaling pathway,BP,
17683,GO:0097001,1,0.90228332156778,0,7,ceramide binding,MF,
17684,GO:0097003,1,0.969802118710541,0,2,adipokinetic hormone receptor activity,MF,
17685,GO:0097006,1,0.472051098319915,0,57,regulation of plasma lipoprotein particle levels,BP,
17687,GO:0097010,1,0.952467534394334,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17690,GO:0097013,1,0.971716749116853,0,3,phagocytic vesicle lumen,CC,
17691,GO:0097014,1,0.279607057330228,0,84,ciliary plasm,CC,
17692,GO:0097016,1,0.958326483551948,0,3,L27 domain binding,MF,
17695,GO:0097020,1,0.983539981515231,0,1,COPII adaptor activity,MF,
17697,GO:0097022,1,0.986003787696943,0,1,lymphocyte migration into lymph node,BP,
17698,GO:0097025,1,0.951096177117655,0,3,MPP7-DLG1-LIN7 complex,CC,
17699,GO:0097026,1,0.958110761264496,0,4,dendritic cell dendrite assembly,BP,
17700,GO:0097027,1,0.894014180470344,0,8,ubiquitin-protein transferase activator activity,MF,
17702,GO:0097029,1,0.957860293422456,0,4,mature conventional dendritic cell differentiation,BP,
17703,GO:0097031,1,0.610301721906455,0,55,mitochondrial respiratory chain complex I biogenesis,BP,
17704,GO:0097032,1,0.982716020648119,0,2,mitochondrial respiratory chain complex II biogenesis,BP,
17705,GO:0097033,1,0.940294263452486,0,5,mitochondrial respiratory chain complex III biogenesis,BP,
17706,GO:0097034,1,0.832717013789526,0,14,mitochondrial respiratory chain complex IV biogenesis,BP,
17707,GO:0097035,1,0.561439369396038,0,37,regulation of membrane lipid distribution,BP,
17708,GO:0097037,1,0.983506735854785,0,1,heme export,BP,
17710,GO:0097039,1,0.94021262454907,0,4,protein linear polyubiquitination,BP,
17711,GO:0097045,1,0.983426667502857,0,1,phosphatidylserine exposure on blood platelet,BP,
17713,GO:0097049,1,0.8982049918719,0,7,motor neuron apoptotic process,BP,
17714,GO:0097050,1,0.846076316961335,0,11,type B pancreatic cell apoptotic process,BP,
17715,GO:0097051,1,0.951100705891656,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17716,GO:0097052,1,0.960676155320882,0,3,L-kynurenine metabolic process,BP,
17717,GO:0097053,1,0.989328906139524,0,1,L-kynurenine catabolic process,BP,
17718,GO:0097055,1,0.985893068778292,0,1,agmatine biosynthetic process,BP,
17719,GO:0097056,1,0.946187518726344,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17720,GO:0097057,1,0.978422218495454,0,2,TRAF2-GSTP1 complex,CC,
17726,GO:0097065,1,0.972114281251258,0,2,anterior head development,BP,
17727,GO:0097066,1,0.696146678826178,0,24,response to thyroid hormone,BP,
17728,GO:0097067,1,0.792894840387025,0,15,cellular response to thyroid hormone stimulus,BP,
17729,GO:0097068,1,0.920467969626564,0,5,response to thyroxine,BP,
17730,GO:0097069,1,0.967477941780756,0,2,cellular response to thyroxine stimulus,BP,
17733,GO:0097086,1,0.983444445206073,0,1,amniotic stem cell differentiation,BP,
17734,GO:0097089,1,0.973970339953266,0,2,methyl-branched fatty acid metabolic process,BP,
17735,GO:0097090,1,0.853648206852641,0,10,presynaptic membrane organization,BP,
17738,GO:0097100,1,0.935191784158056,0,5,supercoiled DNA binding,MF,
17742,GO:0097105,1,0.875712578502955,0,8,presynaptic membrane assembly,BP,
17744,GO:0097107,1,0.919824307509413,0,5,postsynaptic density assembly,BP,
17745,GO:0097108,1,0.95113906230707,0,3,hedgehog family protein binding,MF,
17746,GO:0097109,1,0.92332278465577,0,5,neuroligin family protein binding,MF,
17748,GO:0097111,1,0.967126892150375,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17749,GO:0097112,1,0.967502830468618,0,2,gamma-aminobutyric acid receptor clustering,BP,
17750,GO:0097113,1,0.928673367833553,0,5,AMPA glutamate receptor clustering,BP,
17751,GO:0097114,1,0.942769158558414,0,4,NMDA glutamate receptor clustering,BP,
17752,GO:0097115,1,0.983426667502708,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17753,GO:0097116,1,0.951096177111564,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17754,GO:0097117,1,0.983426667500053,0,1,guanylate kinase-associated protein clustering,BP,
17757,GO:0097120,1,0.805923337319214,0,14,receptor localization to synapse,BP,
17758,GO:0097123,1,0.973034669704636,0,2,cyclin A1-CDK2 complex,CC,
17759,GO:0097124,1,0.970137400617501,0,2,cyclin A2-CDK2 complex,CC,
17760,GO:0097125,1,0.974379013107903,0,2,cyclin B1-CDK1 complex,CC,
17761,GO:0097129,1,0.973178187491919,0,2,cyclin D2-CDK4 complex,CC,
17762,GO:0097134,1,0.973199207704107,0,2,cyclin E1-CDK2 complex,CC,
17763,GO:0097135,1,0.970275171085214,0,2,cyclin E2-CDK2 complex,CC,
17764,GO:0097136,1,0.931051504857881,0,5,Bcl-2 family protein complex,CC,
17765,GO:0097144,1,0.993788964544904,0,1,BAX complex,CC,
17766,GO:0097149,1,0.951288899476265,0,3,centralspindlin complex,CC,
17768,GO:0097151,1,0.889576534881634,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17770,GO:0097153,1,0.846539696341427,0,15,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17771,GO:0097154,1,0.80649433750785,0,15,GABAergic neuron differentiation,BP,
17772,GO:0097155,1,0.951096177110134,0,3,fasciculation of sensory neuron axon,BP,
17773,GO:0097156,1,0.967126892153278,0,2,fasciculation of motor neuron axon,BP,
17774,GO:0097157,1,0.900520924390881,0,7,pre-mRNA intronic binding,MF,
17775,GO:0097158,1,0.988447470733908,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17777,GO:0097160,1,0.996681699336003,0,1,polychlorinated biphenyl binding,MF,
17778,GO:0097161,1,0.983426667501037,0,1,DH domain binding,MF,
17779,GO:0097162,1,0.983594099641158,0,1,MADS box domain binding,MF,
17781,GO:0097165,1,0.928004442070604,0,5,nuclear stress granule,CC,
17782,GO:0097166,1,0.97044974940859,0,2,lens epithelial cell proliferation,BP,
17783,GO:0097167,1,0.942611185498661,0,4,circadian regulation of translation,BP,
17784,GO:0097168,1,0.969734176758833,0,2,mesenchymal stem cell proliferation,BP,
17785,GO:0097169,1,0.965201920645756,0,4,AIM2 inflammasome complex,CC,
17786,GO:0097176,1,0.98530228173233,0,1,epoxide metabolic process,BP,
17787,GO:0097177,1,0.979460359493128,0,2,mitochondrial ribosome binding,MF,
17795,GO:0097187,1,0.956767012515361,0,3,dentinogenesis,BP,
17801,GO:0097195,1,0.956376796036852,0,3,pilomotor reflex,BP,
17802,GO:0097196,1,0.971892032861867,0,2,Shu complex,CC,
17804,GO:0097198,1,0.967547985439309,0,2,histone H3-K36 trimethylation,BP,
17805,GO:0097199,1,0.967946839474017,0,2,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17806,GO:0097200,1,0.856528247382863,0,13,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17807,GO:0097201,1,0.822666125242068,0,13,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17808,GO:0097202,1,0.865512945828726,0,10,activation of cysteine-type endopeptidase activity,BP,
17810,GO:0097208,1,0.91757813849423,0,6,alveolar lamellar body,CC,
17811,GO:0097209,1,0.944736510525897,0,4,epidermal lamellar body,CC,
17812,GO:0097210,1,0.924803960766141,0,5,response to gonadotropin-releasing hormone,BP,
17813,GO:0097211,1,0.924803960766141,0,5,cellular response to gonadotropin-releasing hormone,BP,
17814,GO:0097212,1,0.982346795231427,0,2,lysosomal membrane organization,BP,
17815,GO:0097213,1,0.995491092903734,0,1,regulation of lysosomal membrane permeability,BP,
17816,GO:0097214,1,0.995491092903734,0,1,positive regulation of lysosomal membrane permeability,BP,
17817,GO:0097222,1,0.983426667503004,0,1,mitochondrial mRNA polyadenylation,BP,
17819,GO:0097224,1,0.987899864828234,0,1,sperm connecting piece,CC,
17820,GO:0097225,1,0.820343550712112,0,15,sperm midpiece,CC,
17821,GO:0097226,1,0.985576304179513,0,1,sperm mitochondrial sheath,CC,
17822,GO:0097227,1,0.917135759811985,0,6,sperm annulus,CC,
17823,GO:0097228,1,0.742767661374381,0,20,sperm principal piece,CC,
17824,GO:0097229,1,0.990273954368882,0,1,sperm end piece,CC,
17825,GO:0097231,1,0.988059823210934,0,1,cell motility in response to calcium ion,BP,
17826,GO:0097232,1,0.967251904361233,0,2,lamellar body membrane,CC,
17827,GO:0097233,1,0.967251904361233,0,2,alveolar lamellar body membrane,CC,
17828,GO:0097237,1,0.890670924777952,0,8,cellular response to toxic substance,BP,
17829,GO:0097238,1,0.989825625357721,0,1,cellular response to methylglyoxal,BP,
17830,GO:0097240,1,0.924893254193517,0,5,chromosome attachment to the nuclear envelope,BP,
17832,GO:0097242,1,0.902203192969155,0,7,beta-amyloid clearance,BP,
17834,GO:0097254,1,0.986218762837224,0,1,renal tubular secretion,BP,
17835,GO:0097255,1,0.938762098831033,0,5,R2TP complex,CC,
17836,GO:0097258,1,0.969405054547521,0,2,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17837,GO:0097259,1,0.969405054547521,0,2,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17838,GO:0097260,1,0.984420111513356,0,1,eoxin A4 synthase activity,MF,
17839,GO:0097264,1,0.885289311206623,0,8,self proteolysis,BP,
17840,GO:0097267,1,0.87628154461528,0,9,omega-hydroxylase P450 pathway,BP,
17841,GO:0097272,1,0.972022301701086,0,2,ammonia homeostasis,BP,
17842,GO:0097273,1,0.983426667501724,0,1,creatinine homeostasis,BP,
17843,GO:0097274,1,0.967194227934114,0,2,urea homeostasis,BP,
17844,GO:0097275,1,0.983426667501724,0,1,cellular ammonia homeostasis,BP,
17845,GO:0097276,1,0.983426667501724,0,1,cellular creatinine homeostasis,BP,
17846,GO:0097277,1,0.983426667501724,0,1,cellular urea homeostasis,BP,
17848,GO:0097283,1,0.91475358490343,0,6,keratinocyte apoptotic process,BP,
17851,GO:0097291,1,0.986682089245975,0,1,renal phosphate ion absorption,BP,
17852,GO:0097296,1,0.835667077147569,0,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17853,GO:0097298,1,0.983426867548376,0,1,regulation of nucleus size,BP,
17854,GO:0097300,1,0.568118267760682,0,41,programmed necrotic cell death,BP,
17857,GO:0097319,1,0.985452018212821,0,1,carbohydrate import into cell,BP,
17858,GO:0097320,1,0.764322312379961,0,17,plasma membrane tubulation,BP,
17859,GO:0097322,1,0.898343276242928,0,7,7SK snRNA binding,MF,
17860,GO:0097324,1,0.967126892149213,0,2,melanocyte migration,BP,
17862,GO:0097326,1,0.983426667502414,0,1,melanocyte adhesion,BP,
17863,GO:0097327,1,0.941513678325285,0,5,response to antineoplastic agent,BP,
17864,GO:0097332,1,0.976267134718621,0,2,response to antipsychotic drug,BP,
17866,GO:0097340,1,0.850790068900422,0,11,inhibition of cysteine-type endopeptidase activity,BP,
17867,GO:0097341,1,0.850790068900422,0,11,zymogen inhibition,BP,
17868,GO:0097342,1,0.901234225511139,0,7,ripoptosome,CC,
17869,GO:0097343,1,0.938676783244092,0,4,ripoptosome assembly,BP,
17870,GO:0097344,1,0.983778133352475,0,1,Rix1 complex,CC,
17872,GO:0097346,1,0.757508476241712,0,21,INO80-type complex,CC,
17873,GO:0097350,1,0.941496268575448,0,4,neutrophil clearance,BP,
17874,GO:0097352,1,0.622359643882971,0,34,autophagosome maturation,BP,
17875,GO:0097354,1,0.861500239529117,0,10,prenylation,BP,
17876,GO:0097356,1,0.983426667499657,0,1,perinucleolar compartment,CC,
17877,GO:0097359,1,0.967126892147616,0,2,UDP-glucosylation,BP,
17878,GO:0097360,1,0.939250507970784,0,4,chorionic trophoblast cell proliferation,BP,
17879,GO:0097361,1,0.948238398750339,0,4,CIA complex,CC,
17880,GO:0097362,1,0.968677598446601,0,2,MCM8-MCM9 complex,CC,
17881,GO:0097363,1,0.983426667502067,0,1,protein O-GlcNAc transferase activity,MF,
17883,GO:0097368,1,0.943087489978033,0,4,establishment of Sertoli cell barrier,BP,
17884,GO:0097369,1,0.796082535598108,0,14,sodium ion import,BP,
17885,GO:0097371,1,0.90898078352652,0,6,MDM2/MDM4 family protein binding,MF,
17886,GO:0097372,1,0.988049419275219,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17887,GO:0097374,1,0.975417937931507,0,2,sensory neuron axon guidance,BP,
17888,GO:0097376,1,0.989723076066294,0,1,interneuron axon guidance,BP,
17890,GO:0097382,1,0.983426667501431,0,1,deoxynucleoside-diphosphatase activity,MF,
17891,GO:0097383,1,0.983426667501431,0,1,dIDP diphosphatase activity,MF,
17892,GO:0097384,1,0.918781275704928,0,6,cellular lipid biosynthetic process,BP,
17894,GO:0097393,1,0.983426667495572,0,1,telomeric repeat-containing RNA transcription,BP,
17895,GO:0097394,1,0.983426667495572,0,1,telomeric repeat-containing RNA transcription from RNA pol II promoter,BP,
17896,GO:0097396,1,0.983437397741892,0,1,response to interleukin-17,BP,
17897,GO:0097398,1,0.983437397741892,0,1,cellular response to interleukin-17,BP,
17898,GO:0097400,1,0.983437397741892,0,1,interleukin-17-mediated signaling pathway,BP,
17899,GO:0097401,1,0.983890557950773,0,1,synaptic vesicle lumen acidification,BP,
17900,GO:0097402,1,0.984840272085474,0,1,neuroblast migration,BP,
17901,GO:0097403,1,0.983842076053753,0,1,cellular response to raffinose,BP,
17902,GO:0097409,1,0.986883482922899,0,1,glial cytoplasmic inclusion,CC,
17903,GO:0097411,1,0.927152834302191,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17904,GO:0097413,1,0.923521719612166,0,6,Lewy body,CC,
17905,GO:0097414,1,0.986883482922899,0,1,classical Lewy body,CC,
17906,GO:0097418,1,0.921031591986627,0,5,neurofibrillary tangle,CC,
17908,GO:0097422,1,0.924016953065961,0,5,tubular endosome,CC,
17910,GO:0097427,1,0.968407661017688,0,2,microtubule bundle,CC,
17911,GO:0097428,1,0.939399409557929,0,7,protein maturation by iron-sulfur cluster transfer,BP,
17912,GO:0097431,1,0.819343833792014,0,13,mitotic spindle pole,CC,
17913,GO:0097433,1,0.913094441797794,0,6,dense body,CC,
17915,GO:0097440,1,0.820553375451078,0,12,apical dendrite,CC,
17916,GO:0097441,1,0.951891319687625,0,3,basilar dendrite,CC,
17917,GO:0097442,1,0.983426667501971,0,1,CA3 pyramidal cell dendrite,CC,
17918,GO:0097443,1,0.906205489618593,0,6,sorting endosome,CC,
17919,GO:0097444,1,0.983426667502513,0,1,spine apparatus,CC,
17920,GO:0097447,1,0.97585957806803,0,2,dendritic tree,CC,
17922,GO:0097450,1,0.962765934312684,0,3,astrocyte end-foot,CC,
17923,GO:0097451,1,0.967127232347024,0,2,glial limiting end-foot,CC,
17924,GO:0097452,1,0.949753584106291,0,4,GAIT complex,CC,
17925,GO:0097453,1,0.985165060492297,0,1,mesaxon,CC,
17926,GO:0097454,1,0.957559287642327,0,3,Schwann cell microvillus,CC,
17927,GO:0097457,1,0.983472584656398,0,1,hippocampal mossy fiber,CC,
17931,GO:0097461,1,0.935446320370453,0,4,ferric iron import into cell,BP,
17932,GO:0097462,1,0.986883482922899,0,1,Lewy neurite,CC,
17933,GO:0097466,1,0.939628562019147,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17934,GO:0097468,1,0.849654988411483,0,12,programmed cell death in response to reactive oxygen species,BP,
17935,GO:0097470,1,0.920378151208998,0,5,ribbon synapse,CC,
17936,GO:0097472,1,0.683275733920838,0,28,cyclin-dependent protein kinase activity,MF,
17937,GO:0097473,1,0.983426667502315,0,1,retinal rod cell apoptotic process,BP,
17938,GO:0097475,1,0.896313645879317,0,7,motor neuron migration,BP,
17939,GO:0097476,1,0.940919869430733,0,4,spinal cord motor neuron migration,BP,
17940,GO:0097477,1,0.95436393868156,0,3,lateral motor column neuron migration,BP,
17943,GO:0097484,1,0.66211797974011,0,27,dendrite extension,BP,
17945,GO:0097486,1,0.927561268413608,0,7,multivesicular body lumen,CC,
17946,GO:0097487,1,0.96097969798337,0,3,multivesicular body, internal vesicle,CC,
17947,GO:0097489,1,0.984723637060691,0,1,multivesicular body, internal vesicle lumen,CC,
17948,GO:0097490,1,0.936811220473987,0,4,sympathetic neuron projection extension,BP,
17949,GO:0097491,1,0.936811220473987,0,4,sympathetic neuron projection guidance,BP,
17950,GO:0097493,1,0.760813204081209,0,17,structural molecule activity conferring elasticity,MF,
17951,GO:0097494,1,0.972588819218499,0,2,regulation of vesicle size,BP,
17952,GO:0097497,1,0.983690624007748,0,1,blood vessel endothelial cell delamination,BP,
17953,GO:0097498,1,0.970703500734251,0,2,endothelial tube lumen extension,BP,
17954,GO:0097499,1,0.879185133622054,0,9,protein localization to non-motile cilium,BP,
17955,GO:0097500,1,0.929036977779061,0,5,receptor localization to non-motile cilium,BP,
17956,GO:0097501,1,0.947435173008702,0,4,stress response to metal ion,BP,
17957,GO:0097502,1,0.686781926989272,0,28,mannosylation,BP,
17958,GO:0097503,1,0.733886942090282,0,21,sialylation,BP,
17959,GO:0097504,1,0.871505005927229,0,10,Gemini of coiled bodies,CC,
17960,GO:0097505,1,0.983426667501771,0,1,Rad6-Rad18 complex,CC,
17961,GO:0097506,1,0.939430602805882,0,5,deaminated base DNA N-glycosylase activity,MF,
17962,GO:0097510,1,0.986478433228199,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17963,GO:0097512,1,0.928182292655049,0,7,cardiac myofibril,CC,
17964,GO:0097513,1,0.951096177109659,0,3,myosin II filament,CC,
17965,GO:0097517,1,0.474429958859916,0,49,contractile actin filament bundle,CC,
17966,GO:0097524,1,0.922306686539542,0,6,sperm plasma membrane,CC,
17967,GO:0097525,1,0.482847904794431,0,57,spliceosomal snRNP complex,CC,
17968,GO:0097526,1,0.760341762332233,0,24,spliceosomal tri-snRNP complex,CC,
17969,GO:0097527,1,0.917921263258551,0,6,necroptotic signaling pathway,BP,
17973,GO:0097534,1,0.984393340285881,0,1,lymphoid lineage cell migration,BP,
17974,GO:0097535,1,0.984393340285881,0,1,lymphoid lineage cell migration into thymus,BP,
17975,GO:0097536,1,0.970826303626599,0,2,thymus epithelium morphogenesis,BP,
17976,GO:0097539,1,0.862397511754244,0,9,ciliary transition fiber,CC,
17977,GO:0097541,1,0.984728932554734,0,1,axonemal basal plate,CC,
17978,GO:0097542,1,0.526898375695991,0,44,ciliary tip,CC,
17979,GO:0097543,1,0.96775638156975,0,2,ciliary inversin compartment,CC,
17981,GO:0097550,1,0.924454586327228,0,6,transcriptional preinitiation complex,CC,
17983,GO:0097573,1,0.990088166239541,0,1,glutathione oxidoreductase activity,MF,
17984,GO:0097576,1,0.601861168923194,0,36,vacuole fusion,BP,
17985,GO:0097577,1,0.9588256222995,0,5,sequestering of iron ion,BP,
17987,GO:0097598,1,0.968407661016815,0,2,sperm cytoplasmic droplet,CC,
17988,GO:0097602,1,0.822671933161811,0,14,cullin family protein binding,MF,
17989,GO:0097603,1,0.955112038216232,0,3,temperature-gated ion channel activity,MF,
17990,GO:0097604,1,0.971210159023889,0,2,temperature-gated cation channel activity,MF,
17992,GO:0097617,1,0.81246890847645,0,13,annealing activity,MF,
17994,GO:0097625,1,0.983426667499561,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17995,GO:0097626,1,0.983426667499561,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17996,GO:0097627,1,0.983426667499561,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17997,GO:0097629,1,0.952403740186932,0,3,extrinsic component of omegasome membrane,CC,
17998,GO:0097630,1,0.984728932554734,0,1,intrinsic component of omegasome membrane,CC,
17999,GO:0097631,1,0.984728932554734,0,1,integral component of omegasome membrane,CC,
18000,GO:0097632,1,0.968407661017013,0,2,extrinsic component of pre-autophagosomal structure membrane,CC,
18001,GO:0097635,1,0.967126892154296,0,2,extrinsic component of autophagosome membrane,CC,
18002,GO:0097636,1,0.967653262918094,0,2,intrinsic component of autophagosome membrane,CC,
18003,GO:0097637,1,0.967653262918094,0,2,integral component of autophagosome membrane,CC,
18004,GO:0097638,1,0.983426667499561,0,1,L-arginine import across plasma membrane,BP,
18005,GO:0097639,1,0.983426667499561,0,1,L-lysine import across plasma membrane,BP,
18006,GO:0097640,1,0.983426667499561,0,1,L-ornithine import across plasma membrane,BP,
18007,GO:0097642,1,0.945490763578759,0,4,calcitonin family receptor activity,MF,
18008,GO:0097644,1,0.983451945808524,0,1,calcitonin family binding,MF,
18009,GO:0097648,1,0.951096177115227,0,3,G-protein coupled receptor complex,CC,
18012,GO:0097676,1,0.953643390196494,0,3,histone H3-K36 dimethylation,BP,
18013,GO:0097677,1,0.959449494510739,0,3,STAT family protein binding,MF,
18014,GO:0097680,1,0.953694660681231,0,3,double-strand break repair via classical nonhomologous end joining,BP,
18015,GO:0097681,1,0.967126892140503,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
18016,GO:0097688,1,0.928673367833553,0,5,glutamate receptor clustering,BP,
18017,GO:0097689,1,0.983545373437418,0,1,iron channel activity,MF,
18018,GO:0097692,1,0.983426667501135,0,1,histone H3-K4 monomethylation,BP,
18019,GO:0097694,1,0.951610252263399,0,3,establishment of RNA localization to telomere,BP,
18020,GO:0097695,1,0.951610252263399,0,3,establishment of macromolecular complex localization to telomere,BP,
18022,GO:0097699,1,0.983426667503104,0,1,vascular endothelial cell response to fluid shear stress,BP,
18024,GO:0097709,1,0.913591065411604,0,6,connective tissue replacement,BP,
18026,GO:0097718,1,0.619160579132486,0,31,disordered domain specific binding,MF,
18028,GO:0097722,1,0.383598184017242,0,74,sperm motility,BP,
18029,GO:0097724,1,0.987487790228821,0,1,sperm flagellum movement,BP,
18030,GO:0097726,1,0.991627440799317,0,1,LEM domain binding,MF,
18031,GO:0097729,1,0.388811529167471,0,71,9+2 motile cilium,CC,
18034,GO:0097732,1,0.883217710065991,0,9,9+2 non-motile cilium,CC,
18037,GO:0097742,1,0.940233298304255,0,4,de novo centriole assembly,BP,
18039,GO:0097747,1,0.575082932401601,0,42,RNA polymerase activity,MF,
18042,GO:0098501,1,0.941259273660656,0,5,polynucleotide dephosphorylation,BP,
18043,GO:0098502,1,0.968307531322745,0,3,DNA dephosphorylation,BP,
18044,GO:0098503,1,0.98800274491119,0,1,DNA 3' dephosphorylation,BP,
18045,GO:0098504,1,0.98800274491119,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
18046,GO:0098505,1,0.884198960726511,0,8,G-rich strand telomeric DNA binding,MF,
18047,GO:0098506,1,0.98800274491119,0,1,polynucleotide 3' dephosphorylation,BP,
18048,GO:0098507,1,0.972070146087604,0,2,polynucleotide 5' dephosphorylation,BP,
18049,GO:0098518,1,0.960406608887946,0,3,polynucleotide phosphatase activity,MF,
18050,GO:0098519,1,0.929096398428286,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
18051,GO:0098528,1,0.926875199030982,0,5,skeletal muscle fiber differentiation,BP,
18052,GO:0098530,1,0.983426667501724,0,1,positive regulation of strand invasion,BP,
18054,GO:0098532,1,0.92006106642869,0,7,histone H3-K27 trimethylation,BP,
18055,GO:0098533,1,0.714722635445062,0,23,ATPase dependent transmembrane transport complex,CC,
18056,GO:0098534,1,0.642565049171569,0,29,centriole assembly,BP,
18057,GO:0098535,1,0.940233298304255,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
18058,GO:0098536,1,0.940233703475929,0,4,deuterosome,CC,
18060,GO:0098543,1,0.826100905288494,0,13,detection of other organism,BP,
18061,GO:0098547,1,0.985700954607697,0,1,lumenal side of Golgi membrane,CC,
18063,GO:0098553,1,0.720195169400346,0,28,lumenal side of endoplasmic reticulum membrane,CC,
18064,GO:0098554,1,0.877360268406058,0,9,cytoplasmic side of endoplasmic reticulum membrane,CC,
18065,GO:0098556,1,0.98808066581473,0,1,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
18066,GO:0098559,1,0.969607637473545,0,2,cytoplasmic side of early endosome membrane,CC,
18069,GO:0098573,1,0.473756817013628,0,55,intrinsic component of mitochondrial membrane,CC,
18070,GO:0098574,1,0.971093444373661,0,2,cytoplasmic side of lysosomal membrane,CC,
18071,GO:0098575,1,0.972452270247621,0,2,lumenal side of lysosomal membrane,CC,
18072,GO:0098576,1,0.942751007873825,0,4,lumenal side of membrane,CC,
18073,GO:0098581,1,0.77985688653459,0,18,detection of external biotic stimulus,BP,
18074,GO:0098582,1,0.96714692049633,0,2,innate vocalization behavior,BP,
18075,GO:0098583,1,0.979149895503292,0,2,learned vocalization behavior,BP,
18076,GO:0098586,1,0.558595855099518,0,40,cellular response to virus,BP,
18080,GO:0098592,1,0.951560925010501,0,3,cytoplasmic side of apical plasma membrane,CC,
18081,GO:0098594,1,0.994304813706895,0,1,mucin granule,CC,
18082,GO:0098595,1,0.985711813582725,0,1,perivitelline space,CC,
18086,GO:0098599,1,0.935332326204686,0,5,palmitoyl hydrolase activity,MF,
18087,GO:0098601,1,0.983519580266634,0,1,selenomethionine adenosyltransferase activity,MF,
18090,GO:0098619,1,0.987146780551002,0,1,selenocysteine-tRNA ligase activity,MF,
18091,GO:0098621,1,0.983426667501871,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
18092,GO:0098625,1,0.983430351745982,0,1,methylselenol reductase activity,MF,
18093,GO:0098626,1,0.983430351745982,0,1,methylseleninic acid reductase activity,MF,
18096,GO:0098633,1,0.984801657841097,0,1,collagen fibril binding,MF,
18097,GO:0098634,1,0.895361958485264,0,7,protein binding involved in cell-matrix adhesion,MF,
18099,GO:0098637,1,0.983426838108843,0,1,protein complex involved in cell-matrix adhesion,CC,
18100,GO:0098639,1,0.919829985579902,0,5,collagen binding involved in cell-matrix adhesion,MF,
18101,GO:0098640,1,0.973408491986342,0,2,integrin binding involved in cell-matrix adhesion,MF,
18103,GO:0098642,1,0.890601818736884,0,7,network-forming collagen trimer,CC,
18104,GO:0098643,1,0.820790877228786,0,12,banded collagen fibril,CC,
18105,GO:0098644,1,0.718799042553484,0,20,complex of collagen trimers,CC,
18106,GO:0098645,1,0.890601818736884,0,7,collagen network,CC,
18107,GO:0098646,1,0.984559650500708,0,1,collagen sheet,CC,
18108,GO:0098647,1,0.956760038296601,0,3,collagen beaded filament,CC,
18109,GO:0098648,1,0.98342666749764,0,1,collagen anchoring fibril,CC,
18110,GO:0098651,1,0.875834556607017,0,8,basement membrane collagen trimer,CC,
18111,GO:0098652,1,0.98342666749764,0,1,collagen type VII anchoring fibril,CC,
18119,GO:0098664,1,0.743640514041992,0,26,G-protein coupled serotonin receptor signaling pathway,BP,
18120,GO:0098665,1,0.973452156800296,0,2,serotonin receptor complex,CC,
18122,GO:0098679,1,0.9671268921451,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18123,GO:0098680,1,0.983426667503399,0,1,template-free RNA nucleotidyltransferase,MF,
18124,GO:0098687,1,0.00964912156634147,0,331,chromosomal region,CC,
18125,GO:0098700,1,0.901382684053476,0,7,neurotransmitter loading into synaptic vesicle,BP,
18126,GO:0098703,1,0.89305719173886,0,7,calcium ion import across plasma membrane,BP,
18127,GO:0098704,1,0.985452018212821,0,1,carbohydrate import across plasma membrane,BP,
18128,GO:0098706,1,0.983548689261493,0,1,ferric iron import across plasma membrane,BP,
18129,GO:0098711,1,0.983548689261493,0,1,iron ion import across plasma membrane,BP,
18130,GO:0098719,1,0.809510467281425,0,13,sodium ion import across plasma membrane,BP,
18131,GO:0098722,1,0.879821758407823,0,9,asymmetric stem cell division,BP,
18133,GO:0098728,1,0.953803634497934,0,4,germline stem cell asymmetric division,BP,
18135,GO:0098734,1,0.935332326204686,0,5,macromolecule depalmitoylation,BP,
18136,GO:0098735,1,0.929391103964327,0,5,positive regulation of the force of heart contraction,BP,
18137,GO:0098736,1,0.983426667498132,0,1,negative regulation of the force of heart contraction,BP,
18138,GO:0098739,1,0.624661208673509,0,30,import across plasma membrane,BP,
18141,GO:0098745,1,0.987925476042536,0,1,Dcp1-Dcp2 complex,CC,
18142,GO:0098746,1,0.983426667502809,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18143,GO:0098748,1,0.846288905483832,0,11,endocytic adaptor activity,MF,
18144,GO:0098749,1,0.983426667503004,0,1,cerebellar neuron development,BP,
18147,GO:0098756,1,0.983601081534302,0,1,response to interleukin-21,BP,
18148,GO:0098757,1,0.983601081534302,0,1,cellular response to interleukin-21,BP,
18149,GO:0098758,1,0.95364940812111,0,3,response to interleukin-8,BP,
18150,GO:0098759,1,0.95364940812111,0,3,cellular response to interleukin-8,BP,
18151,GO:0098760,1,0.96170088798457,0,3,response to interleukin-7,BP,
18152,GO:0098761,1,0.96170088798457,0,3,cellular response to interleukin-7,BP,
18153,GO:0098770,1,0.967134914108431,0,2,FBXO family protein binding,MF,
18157,GO:0098779,1,0.876753704367539,0,9,positive regulation of macromitophagy in response to mitochondrial depolarization,BP,
18158,GO:0098780,1,0.770539986104162,0,18,response to mitochondrial depolarisation,BP,
18159,GO:0098781,1,0.266834754037385,0,95,ncRNA transcription,BP,
18160,GO:0098782,1,0.987578466761352,0,1,mechanically-gated potassium channel activity,MF,
18161,GO:0098787,1,0.840277143576928,0,12,mRNA cleavage involved in mRNA processing,BP,
18162,GO:0098789,1,0.881671052231424,0,9,pre-mRNA cleavage required for polyadenylation,BP,
18164,GO:0098792,1,0.880700928757633,0,8,xenophagy,BP,
18167,GO:0098795,1,0.968437569186387,0,2,mRNA cleavage involved in gene silencing,BP,
18170,GO:0098798,1,0.303005254582225,0,130,mitochondrial protein complex,CC,
18171,GO:0098799,1,0.871419604914324,0,12,outer mitochondrial membrane protein complex,CC,
18172,GO:0098800,1,0.39203426315678,0,109,inner mitochondrial membrane protein complex,CC,
18175,GO:0098803,1,0.581888288025227,0,70,respiratory chain complex,CC,
18177,GO:0098808,1,0.971814112807856,0,2,mRNA cap binding,MF,
18178,GO:0098809,1,0.984620385657398,0,1,nitrite reductase activity,MF,
18182,GO:0098814,1,0.951096177111992,0,3,spontaneous synaptic transmission,BP,
18184,GO:0098821,1,0.923944141151696,0,5,BMP receptor activity,MF,
18185,GO:0098822,1,0.98502761782828,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18187,GO:0098828,1,0.889576534881634,0,7,modulation of inhibitory postsynaptic potential,BP,
18188,GO:0098829,1,0.98342666750089,0,1,intestinal folate absorption,BP,
18189,GO:0098830,1,0.983426667502809,0,1,presynaptic endosome,CC,
18190,GO:0098831,1,0.967126892128643,0,2,presynaptic active zone cytoplasmic component,CC,
18191,GO:0098833,1,0.98342666750271,0,1,presynaptic endocytic zone,CC,
18192,GO:0098835,1,0.98342666750271,0,1,presynaptic endocytic zone membrane,CC,
18193,GO:0098837,1,0.971310441019082,0,2,postsynaptic recycling endosome,CC,
18194,GO:0098838,1,0.984113284802993,0,1,reduced folate transmembrane transport,BP,
18195,GO:0098839,1,0.89137013849909,0,7,postsynaptic density membrane,CC,
18196,GO:0098840,1,0.519053479092897,0,46,protein transport along microtubule,BP,
18197,GO:0098843,1,0.98342666749951,0,1,postsynaptic endocytic zone,CC,
18198,GO:0098844,1,0.98342666749951,0,1,postsynaptic endocytic zone membrane,CC,
18199,GO:0098845,1,0.940620829500472,0,4,postsynaptic endosome,CC,
18200,GO:0098847,1,0.847025931720264,0,11,sequence-specific single stranded DNA binding,MF,
18201,GO:0098850,1,0.986935358959301,0,1,extrinsic component of synaptic vesicle membrane,CC,
18203,GO:0098855,1,0.951185151055913,0,3,HCN channel complex,CC,
18204,GO:0098856,1,0.836094895181578,0,14,intestinal lipid absorption,BP,
18210,GO:0098870,1,0.904941952569421,0,7,action potential propagation,BP,
18211,GO:0098871,1,0.988175030131424,0,1,postsynaptic actin cytoskeleton,CC,
18212,GO:0098875,1,0.983426667502908,0,1,epididymosome,CC,
18213,GO:0098876,1,0.359397833993481,0,68,vesicle-mediated transport to the plasma membrane,BP,
18214,GO:0098877,1,0.842901599845047,0,11,neurotransmitter receptor transport to plasma membrane,BP,
18215,GO:0098878,1,0.491118102956916,0,47,neurotransmitter receptor complex,CC,
18216,GO:0098881,1,0.940495130321004,0,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
18217,GO:0098883,1,0.987617988261782,0,1,synapse disassembly,BP,
18218,GO:0098884,1,0.98342666749951,0,1,postsynaptic neurotransmitter receptor internalization,BP,
18219,GO:0098885,1,0.967126892148536,0,2,modification of postsynaptic actin cytoskeleton,BP,
18220,GO:0098886,1,0.968407661017106,0,2,modification of dendritic spine,BP,
18221,GO:0098887,1,0.924194315460534,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18222,GO:0098888,1,0.983426667499955,0,1,extrinsic component of presynaptic membrane,CC,
18223,GO:0098890,1,0.983426667499955,0,1,extrinsic component of postsynaptic membrane,CC,
18224,GO:0098895,1,0.983426667503302,0,1,postsynaptic endosome membrane,CC,
18227,GO:0098902,1,0.920370552135055,0,6,regulation of membrane depolarization during action potential,BP,
18228,GO:0098903,1,0.876906605762695,0,8,regulation of membrane repolarization during action potential,BP,
18229,GO:0098904,1,0.952843574180193,0,3,regulation of AV node cell action potential,BP,
18230,GO:0098905,1,0.977447416631097,0,2,regulation of bundle of His cell action potential,BP,
18231,GO:0098906,1,0.983685065836084,0,1,regulation of Purkinje myocyte action potential,BP,
18232,GO:0098907,1,0.967126892138568,0,2,regulation of SA node cell action potential,BP,
18233,GO:0098908,1,0.932402550540507,0,5,regulation of neuronal action potential,BP,
18234,GO:0098909,1,0.892935438794113,0,8,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18235,GO:0098910,1,0.904812295208319,0,6,regulation of atrial cardiac muscle cell action potential,BP,
18237,GO:0098912,1,0.951096177105187,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18238,GO:0098914,1,0.909604243375979,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18241,GO:0098917,1,0.935330099170887,0,4,retrograde trans-synaptic signaling,BP,
18242,GO:0098918,1,0.987588329600388,0,1,structural constituent of synapse,MF,
18243,GO:0098920,1,0.983426667501727,0,1,retrograde trans-synaptic signaling by lipid,BP,
18244,GO:0098921,1,0.983426667501727,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
18245,GO:0098923,1,0.983426667500052,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18246,GO:0098924,1,0.983426667500052,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18248,GO:0098928,1,0.967126892128643,0,2,presynaptic signal transduction,BP,
18249,GO:0098930,1,0.575558298204191,0,38,axonal transport,BP,
18250,GO:0098935,1,0.951100996555273,0,3,dendritic transport,BP,
18251,GO:0098936,1,0.904574736682782,0,6,intrinsic component of postsynaptic membrane,CC,
18252,GO:0098937,1,0.951100996555273,0,3,anterograde dendritic transport,BP,
18253,GO:0098939,1,0.98342666750079,0,1,dendritic transport of mitochondrion,BP,
18254,GO:0098942,1,0.983426667502708,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18255,GO:0098943,1,0.972588819222932,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
18256,GO:0098948,1,0.95109617710609,0,3,intrinsic component of postsynaptic specialization membrane,CC,
18257,GO:0098953,1,0.988980265729991,0,1,receptor diffusion trapping,BP,
18258,GO:0098957,1,0.98342666750276,0,1,anterograde axonal transport of mitochondrion,BP,
18259,GO:0098960,1,0.740882101521168,0,20,postsynaptic neurotransmitter receptor activity,MF,
18260,GO:0098967,1,0.940495130321004,0,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18261,GO:0098968,1,0.983426667502414,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18262,GO:0098969,1,0.856980421347896,0,10,neurotransmitter receptor transport to postsynaptic membrane,BP,
18263,GO:0098970,1,0.988980265729991,0,1,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18264,GO:0098971,1,0.967131792487951,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18265,GO:0098972,1,0.98342666750079,0,1,anterograde dendritic transport of mitochondrion,BP,
18266,GO:0098973,1,0.987588329600388,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18267,GO:0098974,1,0.987588329600388,0,1,postsynaptic actin cytoskeleton organization,BP,
18268,GO:0098976,1,0.985051590296968,0,1,excitatory chemical synaptic transmission,BP,
18269,GO:0098982,1,0.983808915508208,0,1,GABA-ergic synapse,CC,
18271,GO:0098988,1,0.920851519121961,0,5,G-protein coupled glutamate receptor activity,MF,
18272,GO:0098989,1,0.97281730178777,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18273,GO:0098992,1,0.984977340777227,0,1,neuronal dense core vesicle,CC,
18274,GO:0098993,1,0.961921421562939,0,3,anchored component of synaptic vesicle membrane,CC,
18275,GO:0098999,1,0.983426667503302,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18277,GO:0099004,1,0.951096177112326,0,3,calmodulin dependent kinase signaling pathway,BP,
18278,GO:0099010,1,0.936568930013263,0,4,modification of postsynaptic structure,BP,
18279,GO:0099011,1,0.935330377896945,0,4,neuronal dense core vesicle exocytosis,BP,
18282,GO:0099038,1,0.983426667502758,0,1,ceramide-translocating ATPase activity,MF,
18283,GO:0099039,1,0.983426667502758,0,1,sphingolipid translocation,BP,
18284,GO:0099040,1,0.983426667502758,0,1,ceramide translocation,BP,
18285,GO:0099046,1,0.989579525633124,0,1,clearance of foreign intracellular nucleic acids,BP,
18286,GO:0099053,1,0.954868008401711,0,3,activating signal cointegrator 1 complex,CC,
18288,GO:0099055,1,0.904574736682782,0,6,integral component of postsynaptic membrane,CC,
18289,GO:0099060,1,0.95109617710609,0,3,integral component of postsynaptic specialization membrane,CC,
18290,GO:0099061,1,0.95109617710609,0,3,integral component of postsynaptic density membrane,CC,
18292,GO:0099072,1,0.914708580225069,0,6,regulation of postsynaptic specialization membrane neurotransmitter receptor levels,BP,
18293,GO:0099073,1,0.967279666991554,0,2,mitochondrion-derived vesicle,CC,
18294,GO:0099074,1,0.968310892824541,0,2,mitochondrion to lysosome transport,BP,
18295,GO:0099075,1,0.968310892824541,0,2,mitochondrion-derived vesicle mediated transport,BP,
18296,GO:0099078,1,0.959820875019125,0,4,BORC complex,CC,
18299,GO:0099082,1,0.983426667503345,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
18301,GO:0099086,1,0.639471729490197,0,32,synaptonemal structure,CC,
18303,GO:0099095,1,0.829480029839281,0,12,ligand-gated anion channel activity,MF,
18305,GO:0099111,1,0.166068930417021,0,121,microtubule-based transport,BP,
18306,GO:0099118,1,0.519053479092897,0,46,microtubule-based protein transport,BP,
18307,GO:0099122,1,0.969726472999874,0,2,RNA polymerase II C-terminal domain binding,MF,
18308,GO:0099131,1,0.386219604733535,0,68,ATP hydrolysis coupled ion transmembrane transport,BP,
18309,GO:0099132,1,0.472036997499517,0,56,ATP hydrolysis coupled cation transmembrane transport,BP,
18311,GO:0099142,1,0.983426667501282,0,1,intracellular ATP-gated ion channel activity,MF,
18312,GO:0099400,1,0.983426667497643,0,1,caveola neck,CC,
18313,GO:0099402,1,0.994020585908706,0,1,plant organ development,BP,
18314,GO:0099403,1,0.967126892142003,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18315,GO:0099404,1,0.967126892142003,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18316,GO:0099500,1,0.810241208953981,0,15,vesicle fusion to plasma membrane,BP,
18320,GO:0099509,1,0.984790738609099,0,1,regulation of presynaptic cytosolic calcium ion concentration,BP,
18323,GO:0099514,1,0.791519301468278,0,17,synaptic vesicle cytoskeletal transport,BP,
18324,GO:0099515,1,0.904575136623783,0,6,actin filament-based transport,BP,
18325,GO:0099516,1,0.395187273872879,0,59,ion antiporter activity,MF,
18326,GO:0099517,1,0.791519301468278,0,17,synaptic vesicle transport along microtubule,BP,
18327,GO:0099518,1,0.545091767361367,0,40,vesicle cytoskeletal trafficking,BP,
18328,GO:0099525,1,0.935330377896945,0,4,presynaptic dense core vesicle exocytosis,BP,
18329,GO:0099526,1,0.967126892128643,0,2,presynapse to nucleus signaling pathway,BP,
18330,GO:0099528,1,0.928721574613832,0,5,G-protein coupled neurotransmitter receptor activity,MF,
18331,GO:0099529,1,0.753382696577672,0,19,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18332,GO:0099530,1,0.983426667499217,0,1,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18334,GO:0099532,1,0.967126892150908,0,2,synaptic vesicle endosomal processing,BP,
18337,GO:0099538,1,0.983426667503345,0,1,synaptic signaling via neuropeptide,BP,
18338,GO:0099540,1,0.983426667503345,0,1,trans-synaptic signaling by neuropeptide,BP,
18339,GO:0099541,1,0.951099535581966,0,3,trans-synaptic signaling by lipid,BP,
18340,GO:0099542,1,0.951099535581966,0,3,trans-synaptic signaling by endocannabinoid,BP,
18341,GO:0099543,1,0.983426667500052,0,1,trans-synaptic signaling by soluble gas,BP,
18342,GO:0099545,1,0.967126892154439,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18343,GO:0099548,1,0.983426667500052,0,1,trans-synaptic signaling by nitric oxide,BP,
18344,GO:0099550,1,0.951099535582965,0,3,trans-synaptic signalling, modulating synaptic transmission,BP,
18345,GO:0099552,1,0.967130306991225,0,2,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18346,GO:0099553,1,0.967130306991225,0,2,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18347,GO:0099557,1,0.98342666750276,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18348,GO:0099558,1,0.978632883461856,0,2,maintenance of synapse structure,BP,
18349,GO:0099563,1,0.908397198428085,0,6,modification of synaptic structure,BP,
18351,GO:0099566,1,0.967126892150034,0,2,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18353,GO:0099569,1,0.967126892128643,0,2,presynaptic cytoskeleton,CC,
18354,GO:0099571,1,0.988175030131424,0,1,postsynaptic cytoskeleton,CC,
18356,GO:0099580,1,0.967126892152746,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18357,GO:0099583,1,0.967126892150034,0,2,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18359,GO:0099589,1,0.717044323674757,0,29,serotonin receptor activity,MF,
18360,GO:0099590,1,0.943514501264778,0,4,neurotransmitter receptor internalization,BP,
18362,GO:0099601,1,0.606401755218667,0,34,regulation of neurotransmitter receptor activity,BP,
18363,GO:0099602,1,0.931279237689313,0,6,neurotransmitter receptor regulator activity,MF,
18364,GO:0099604,1,0.753990848807253,0,18,ligand-gated calcium channel activity,MF,
18365,GO:0099607,1,0.98342666749833,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18366,GO:0099609,1,0.967126892152311,0,2,microtubule lateral binding,MF,
18367,GO:0099612,1,0.890349862917547,0,7,protein localization to axon,BP,
18368,GO:0099617,1,0.983525273361142,0,1,matrix side of mitochondrial inner membrane,CC,
18371,GO:0099624,1,0.873971500909346,0,9,atrial cardiac muscle cell membrane repolarization,BP,
18373,GO:0099628,1,0.988980265729991,0,1,neurotransmitter receptor diffusion trapping,BP,
18374,GO:0099634,1,0.871671646684352,0,9,postsynaptic specialization membrane,CC,
18375,GO:0099637,1,0.806182931822807,0,14,neurotransmitter receptor transport,BP,
18376,GO:0099638,1,0.893972176572198,0,7,endosome to plasma membrane protein transport,BP,
18377,GO:0099639,1,0.90901598575592,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18378,GO:0099640,1,0.993188209414577,0,1,axo-dendritic protein transport,BP,
18379,GO:0099641,1,0.993188209414577,0,1,anterograde axonal protein transport,BP,
18381,GO:0099738,1,0.796107122817138,0,16,cell cortex region,CC,
18382,GO:0100001,1,0.983426667502217,0,1,regulation of skeletal muscle contraction by action potential,BP,
18384,GO:0100012,1,0.963406175293161,0,3,regulation of heart induction by canonical Wnt signaling pathway,BP,
18385,GO:0100057,1,0.983426667499511,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18388,GO:0101005,1,0.180091482393618,0,111,ubiquitinyl hydrolase activity,MF,
18389,GO:0101020,1,0.932178322691786,0,5,estrogen 16-alpha-hydroxylase activity,MF,
18390,GO:0101023,1,0.988474582868779,0,1,vascular endothelial cell proliferation,BP,
18391,GO:0101030,1,0.990224203500204,0,1,tRNA-guanine transglycosylation,BP,
18392,GO:0101031,1,0.844525670447146,0,12,chaperone complex,CC,
18393,GO:0102005,1,0.989192334292824,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18394,GO:0102007,1,0.967828463753115,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18395,GO:0102008,1,0.983426667502609,0,1,cytosolic dipeptidase activity,MF,
18396,GO:0102009,1,0.987174818353056,0,1,proline dipeptidase activity,MF,
18397,GO:0102076,1,0.984080291479883,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18398,GO:0102077,1,0.973070146587998,0,2,oleamide hydrolase activity,MF,
18399,GO:0102084,1,0.969661162808918,0,2,L-dopa O-methyltransferase activity,MF,
18400,GO:0102132,1,0.983426667498527,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18401,GO:0102279,1,0.98342666750276,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18402,GO:0102320,1,0.984230601554668,0,1,1,8-cineole 2-exo-monooxygenase activity,MF,
18403,GO:0102336,1,0.902216791765655,0,7,3-oxo-arachidoyl-CoA synthase activity,MF,
18404,GO:0102337,1,0.902216791765655,0,7,3-oxo-cerotoyl-CoA synthase activity,MF,
18405,GO:0102338,1,0.902216791765655,0,7,3-oxo-lignoceronyl-CoA synthase activity,MF,
18406,GO:0102339,1,0.984777160505737,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18407,GO:0102340,1,0.984777160505737,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18408,GO:0102341,1,0.984777160505737,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18409,GO:0102342,1,0.984777160505737,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18410,GO:0102390,1,0.984522212251702,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18412,GO:0102483,1,0.988225210858363,0,1,scopolin beta-glucosidase activity,MF,
18413,GO:0102490,1,0.954323727922259,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18414,GO:0102522,1,0.985836804490334,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18415,GO:0102549,1,0.989302642381565,0,1,1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity,MF,
18416,GO:0102571,1,0.983426667502513,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18417,GO:0102704,1,0.984001687426431,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18418,GO:0102867,1,0.984311612317777,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18419,GO:0102991,1,0.917937058680658,0,7,myristoyl-CoA hydrolase activity,MF,
18420,GO:0103046,1,0.983426667502609,0,1,alanylglutamate dipeptidase activity,MF,
18421,GO:0103053,1,0.977613328957016,0,2,1-ethyladenine demethylase activity,MF,
18422,GO:0103073,1,0.973070146587998,0,2,anandamide amidohydrolase activity,MF,
18423,GO:0103095,1,0.976152355448012,0,2,wax ester synthase activity,MF,
18424,GO:0106001,1,0.936418786655492,0,4,intestinal hexose absorption,BP,
18427,GO:1900003,1,0.880316271511504,0,13,regulation of serine-type endopeptidase activity,BP,
18428,GO:1900004,1,0.902624395348824,0,11,negative regulation of serine-type endopeptidase activity,BP,
18429,GO:1900005,1,0.959130115955308,0,3,positive regulation of serine-type endopeptidase activity,BP,
18431,GO:1900010,1,0.987441616091237,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18432,GO:1900011,1,0.987441616091237,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18433,GO:1900015,1,0.711359486975278,0,24,regulation of cytokine production involved in inflammatory response,BP,
18434,GO:1900016,1,0.88112367223833,0,9,negative regulation of cytokine production involved in inflammatory response,BP,
18435,GO:1900017,1,0.8777381240536,0,10,positive regulation of cytokine production involved in inflammatory response,BP,
18438,GO:1900024,1,0.542109745143361,0,42,regulation of substrate adhesion-dependent cell spreading,BP,
18439,GO:1900025,1,0.840037077241859,0,11,negative regulation of substrate adhesion-dependent cell spreading,BP,
18440,GO:1900026,1,0.656442898609125,0,30,positive regulation of substrate adhesion-dependent cell spreading,BP,
18442,GO:1900028,1,0.935082321569419,0,5,negative regulation of ruffle assembly,BP,
18444,GO:1900034,1,0.325174822262678,0,74,regulation of cellular response to heat,BP,
18445,GO:1900035,1,0.984352972426897,0,1,negative regulation of cellular response to heat,BP,
18446,GO:1900036,1,0.985401410885867,0,1,positive regulation of cellular response to heat,BP,
18447,GO:1900037,1,0.868662392762773,0,10,regulation of cellular response to hypoxia,BP,
18448,GO:1900038,1,0.925857219167237,0,5,negative regulation of cellular response to hypoxia,BP,
18449,GO:1900039,1,0.974926538221092,0,2,positive regulation of cellular response to hypoxia,BP,
18450,GO:1900040,1,0.892514860286159,0,7,regulation of interleukin-2 secretion,BP,
18451,GO:1900041,1,0.937288160901234,0,4,negative regulation of interleukin-2 secretion,BP,
18452,GO:1900042,1,0.952243517772284,0,3,positive regulation of interleukin-2 secretion,BP,
18453,GO:1900044,1,0.89161817426172,0,7,regulation of protein K63-linked ubiquitination,BP,
18454,GO:1900045,1,0.937058626922204,0,4,negative regulation of protein K63-linked ubiquitination,BP,
18457,GO:1900048,1,0.708837694401031,0,24,positive regulation of hemostasis,BP,
18458,GO:1900052,1,0.990934003351696,0,1,regulation of retinoic acid biosynthetic process,BP,
18459,GO:1900053,1,0.990934003351696,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18460,GO:1900060,1,0.947165405491516,0,4,negative regulation of ceramide biosynthetic process,BP,
18461,GO:1900062,1,0.983437233169706,0,1,regulation of replicative cell aging,BP,
18462,GO:1900063,1,0.954198810922775,0,3,regulation of peroxisome organization,BP,
18463,GO:1900073,1,0.988808226475268,0,1,regulation of neuromuscular synaptic transmission,BP,
18464,GO:1900075,1,0.988808226475268,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18466,GO:1900077,1,0.619464504029074,0,32,negative regulation of cellular response to insulin stimulus,BP,
18468,GO:1900081,1,0.983426667498132,0,1,regulation of arginine catabolic process,BP,
18469,GO:1900082,1,0.983426667498132,0,1,negative regulation of arginine catabolic process,BP,
18470,GO:1900084,1,0.905670150843552,0,6,regulation of peptidyl-tyrosine autophosphorylation,BP,
18471,GO:1900085,1,0.984453075057737,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18472,GO:1900086,1,0.919977880249973,0,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18473,GO:1900087,1,0.681878070169208,0,27,positive regulation of G1/S transition of mitotic cell cycle,BP,
18474,GO:1900094,1,0.914614377694717,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18475,GO:1900095,1,0.983426667496166,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18476,GO:1900098,1,0.987600674591234,0,1,regulation of plasma cell differentiation,BP,
18477,GO:1900100,1,0.987600674591234,0,1,positive regulation of plasma cell differentiation,BP,
18479,GO:1900102,1,0.882403138790587,0,8,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18483,GO:1900107,1,0.911010715224699,0,7,regulation of nodal signaling pathway,BP,
18484,GO:1900108,1,0.963485440156166,0,3,negative regulation of nodal signaling pathway,BP,
18485,GO:1900109,1,0.95226984371819,0,4,regulation of histone H3-K9 dimethylation,BP,
18486,GO:1900110,1,0.979070986816878,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18487,GO:1900111,1,0.972628319016833,0,2,positive regulation of histone H3-K9 dimethylation,BP,
18488,GO:1900112,1,0.846979735859927,0,11,regulation of histone H3-K9 trimethylation,BP,
18489,GO:1900113,1,0.916200978987989,0,6,negative regulation of histone H3-K9 trimethylation,BP,
18490,GO:1900114,1,0.955059770959151,0,3,positive regulation of histone H3-K9 trimethylation,BP,
18491,GO:1900115,1,0.820831792383942,0,14,extracellular regulation of signal transduction,BP,
18492,GO:1900116,1,0.820831792383942,0,14,extracellular negative regulation of signal transduction,BP,
18493,GO:1900117,1,0.724788421138526,0,23,regulation of execution phase of apoptosis,BP,
18494,GO:1900118,1,0.893336114721991,0,8,negative regulation of execution phase of apoptosis,BP,
18495,GO:1900119,1,0.85104624104727,0,12,positive regulation of execution phase of apoptosis,BP,
18496,GO:1900120,1,0.743098796477821,0,21,regulation of receptor binding,BP,
18497,GO:1900121,1,0.842435325625304,0,12,negative regulation of receptor binding,BP,
18498,GO:1900122,1,0.893793312444592,0,8,positive regulation of receptor binding,BP,
18500,GO:1900126,1,0.953531042524899,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18502,GO:1900130,1,0.983452239819199,0,1,regulation of lipid binding,BP,
18503,GO:1900131,1,0.983452239819199,0,1,negative regulation of lipid binding,BP,
18504,GO:1900133,1,0.936921962864828,0,4,regulation of renin secretion into blood stream,BP,
18505,GO:1900134,1,0.983430139654734,0,1,negative regulation of renin secretion into blood stream,BP,
18506,GO:1900135,1,0.968514728201493,0,2,positive regulation of renin secretion into blood stream,BP,
18507,GO:1900138,1,0.960255742916803,0,3,negative regulation of phospholipase A2 activity,BP,
18508,GO:1900139,1,0.983426667502611,0,1,negative regulation of arachidonic acid secretion,BP,
18511,GO:1900145,1,0.939204360009416,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18512,GO:1900146,1,0.979201539605131,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18513,GO:1900147,1,0.968407661014684,0,2,regulation of Schwann cell migration,BP,
18514,GO:1900148,1,0.984728932554734,0,1,negative regulation of Schwann cell migration,BP,
18515,GO:1900149,1,0.983426667500003,0,1,positive regulation of Schwann cell migration,BP,
18516,GO:1900151,1,0.796227464847593,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18517,GO:1900152,1,0.987529328037738,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18518,GO:1900153,1,0.796227464847593,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18519,GO:1900154,1,0.971802058140951,0,2,regulation of bone trabecula formation,BP,
18520,GO:1900155,1,0.971802058140951,0,2,negative regulation of bone trabecula formation,BP,
18521,GO:1900157,1,0.96292639638027,0,3,regulation of bone mineralization involved in bone maturation,BP,
18522,GO:1900158,1,0.977311049049033,0,2,negative regulation of bone mineralization involved in bone maturation,BP,
18523,GO:1900159,1,0.985282790167759,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18524,GO:1900161,1,0.984202501590394,0,1,regulation of phospholipid scramblase activity,BP,
18525,GO:1900163,1,0.984202501590394,0,1,positive regulation of phospholipid scramblase activity,BP,
18526,GO:1900164,1,0.914614377694717,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18528,GO:1900166,1,0.969081430054182,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18529,GO:1900168,1,0.969081430054182,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18530,GO:1900169,1,0.968407661008144,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18531,GO:1900170,1,0.984728932554734,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18532,GO:1900175,1,0.939204360009416,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18533,GO:1900176,1,0.979201539605131,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18538,GO:1900190,1,0.970235552712322,0,2,regulation of single-species biofilm formation,BP,
18539,GO:1900191,1,0.970235552712322,0,2,negative regulation of single-species biofilm formation,BP,
18542,GO:1900195,1,0.972872609171626,0,2,positive regulation of oocyte maturation,BP,
18543,GO:1900200,1,0.951830186031392,0,3,mesenchymal cell apoptotic process involved in metanephros development,BP,
18544,GO:1900204,1,0.967127945407715,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18545,GO:1900205,1,0.967127945407715,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18546,GO:1900208,1,0.990600939581185,0,1,regulation of cardiolipin metabolic process,BP,
18547,GO:1900210,1,0.990600939581185,0,1,positive regulation of cardiolipin metabolic process,BP,
18548,GO:1900211,1,0.951830186031392,0,3,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18549,GO:1900212,1,0.951830186031392,0,3,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18550,GO:1900214,1,0.967127945407715,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18551,GO:1900215,1,0.967127945407715,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18552,GO:1900217,1,0.967127945407715,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18553,GO:1900218,1,0.967127945407715,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18554,GO:1900220,1,0.967126892152019,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18555,GO:1900221,1,0.917413172501838,0,6,regulation of beta-amyloid clearance,BP,
18556,GO:1900222,1,0.956325930888658,0,3,negative regulation of beta-amyloid clearance,BP,
18557,GO:1900223,1,0.983426667500444,0,1,positive regulation of beta-amyloid clearance,BP,
18558,GO:1900224,1,0.969995071156995,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18559,GO:1900225,1,0.866039293884487,0,10,regulation of NLRP3 inflammasome complex assembly,BP,
18560,GO:1900226,1,0.952360279821993,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18561,GO:1900227,1,0.923821249034081,0,5,positive regulation of NLRP3 inflammasome complex assembly,BP,
18562,GO:1900228,1,0.970235552712322,0,2,regulation of single-species biofilm formation in or on host organism,BP,
18563,GO:1900229,1,0.970235552712322,0,2,negative regulation of single-species biofilm formation in or on host organism,BP,
18564,GO:1900234,1,0.983429986042242,0,1,regulation of Kit signaling pathway,BP,
18565,GO:1900235,1,0.983429986042242,0,1,negative regulation of Kit signaling pathway,BP,
18569,GO:1900242,1,0.885622950181713,0,8,regulation of synaptic vesicle endocytosis,BP,
18570,GO:1900243,1,0.983426667502366,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18571,GO:1900244,1,0.953833988059761,0,3,positive regulation of synaptic vesicle endocytosis,BP,
18572,GO:1900245,1,0.941473209298614,0,4,positive regulation of MDA-5 signaling pathway,BP,
18573,GO:1900246,1,0.897595331301556,0,7,positive regulation of RIG-I signaling pathway,BP,
18574,GO:1900247,1,0.967126892152599,0,2,regulation of cytoplasmic translational elongation,BP,
18575,GO:1900248,1,0.967126892152599,0,2,negative regulation of cytoplasmic translational elongation,BP,
18576,GO:1900259,1,0.987179501645525,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18577,GO:1900260,1,0.987179501645525,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18578,GO:1900262,1,0.922954748987905,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18579,GO:1900264,1,0.922954748987905,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18580,GO:1900271,1,0.73604357056865,0,20,regulation of long-term synaptic potentiation,BP,
18581,GO:1900272,1,0.943861423473356,0,4,negative regulation of long-term synaptic potentiation,BP,
18582,GO:1900273,1,0.841241198080075,0,11,positive regulation of long-term synaptic potentiation,BP,
18584,GO:1900275,1,0.967203789679081,0,2,negative regulation of phospholipase C activity,BP,
18585,GO:1900276,1,0.983504855665434,0,1,regulation of proteinase activated receptor activity,BP,
18586,GO:1900279,1,0.983486079821096,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18587,GO:1900281,1,0.983486079821096,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18588,GO:1900363,1,0.856400644622229,0,10,regulation of mRNA polyadenylation,BP,
18589,GO:1900364,1,0.893313854923654,0,7,negative regulation of mRNA polyadenylation,BP,
18590,GO:1900365,1,0.96969960372248,0,2,positive regulation of mRNA polyadenylation,BP,
18591,GO:1900368,1,0.95109617711632,0,3,regulation of RNA interference,BP,
18592,GO:1900369,1,0.967126892153183,0,2,negative regulation of RNA interference,BP,
18593,GO:1900370,1,0.983426667502217,0,1,positive regulation of RNA interference,BP,
18599,GO:1900378,1,0.947382498373692,0,4,positive regulation of secondary metabolite biosynthetic process,BP,
18600,GO:1900383,1,0.983603213323204,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18601,GO:1900387,1,0.986293776483911,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18602,GO:1900390,1,0.979586953935502,0,2,regulation of iron ion import,BP,
18603,GO:1900402,1,0.86779049276052,0,9,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18606,GO:1900409,1,0.828069274335756,0,14,positive regulation of cellular response to oxidative stress,BP,
18607,GO:1900424,1,0.842370985912355,0,14,regulation of defense response to bacterium,BP,
18608,GO:1900425,1,0.940614316763414,0,4,negative regulation of defense response to bacterium,BP,
18609,GO:1900426,1,0.912516410212591,0,9,positive regulation of defense response to bacterium,BP,
18610,GO:1900449,1,0.603944019569769,0,34,regulation of glutamate receptor signaling pathway,BP,
18611,GO:1900451,1,0.911800562288485,0,6,positive regulation of glutamate receptor signaling pathway,BP,
18614,GO:1900454,1,0.967133796096359,0,2,positive regulation of long term synaptic depression,BP,
18615,GO:1900477,1,0.986367752251628,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18616,GO:1900483,1,0.984638088674279,0,1,regulation of protein targeting to vacuolar membrane,BP,
18617,GO:1900533,1,0.989074385507877,0,1,palmitic acid metabolic process,BP,
18618,GO:1900535,1,0.989074385507877,0,1,palmitic acid biosynthetic process,BP,
18622,GO:1900619,1,0.937952211371346,0,4,acetate ester metabolic process,BP,
18623,GO:1900620,1,0.968192636055349,0,2,acetate ester biosynthetic process,BP,
18624,GO:1900623,1,0.951260133839087,0,3,regulation of monocyte aggregation,BP,
18625,GO:1900625,1,0.951260133839087,0,3,positive regulation of monocyte aggregation,BP,
18626,GO:1900673,1,0.95458592701463,0,3,olefin metabolic process,BP,
18627,GO:1900719,1,0.983426667502615,0,1,regulation of uterine smooth muscle relaxation,BP,
18628,GO:1900721,1,0.983426667502615,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18630,GO:1900737,1,0.983504855665434,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18637,GO:1900747,1,0.944232087327251,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18638,GO:1900748,1,0.951096177115609,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18640,GO:1900756,1,0.967998257362417,0,2,protein processing in phagocytic vesicle,BP,
18641,GO:1900757,1,0.992661337499139,0,1,regulation of D-amino-acid oxidase activity,BP,
18642,GO:1900758,1,0.992661337499139,0,1,negative regulation of D-amino-acid oxidase activity,BP,
18643,GO:1900825,1,0.935885519899525,0,5,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18644,GO:1900826,1,0.990029778762667,0,1,negative regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18645,GO:1900827,1,0.983426667496907,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18646,GO:1900864,1,0.886262894051487,0,9,mitochondrial RNA modification,BP,
18647,GO:1900920,1,0.967126892152118,0,2,regulation of L-glutamate import,BP,
18648,GO:1901004,1,0.990632704551564,0,1,ubiquinone-6 metabolic process,BP,
18649,GO:1901006,1,0.990632704551564,0,1,ubiquinone-6 biosynthetic process,BP,
18655,GO:1901021,1,0.67146767516331,0,28,positive regulation of calcium ion transmembrane transporter activity,BP,
18656,GO:1901026,1,0.938676783244092,0,4,ripoptosome assembly involved in necroptotic process,BP,
18658,GO:1901029,1,0.906580805421393,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18661,GO:1901032,1,0.794315173396686,0,16,negative regulation of response to reactive oxygen species,BP,
18662,GO:1901033,1,0.901411009232182,0,8,positive regulation of response to reactive oxygen species,BP,
18663,GO:1901042,1,0.984679136082936,0,1,positive regulation of L-arginine import,BP,
18664,GO:1901052,1,0.983571445812305,0,1,sarcosine metabolic process,BP,
18665,GO:1901053,1,0.983571445812305,0,1,sarcosine catabolic process,BP,
18667,GO:1901069,1,0.978992483535441,0,2,guanosine-containing compound catabolic process,BP,
18668,GO:1901070,1,0.871228806637464,0,13,guanosine-containing compound biosynthetic process,BP,
18669,GO:1901071,1,0.756878206054308,0,19,glucosamine-containing compound metabolic process,BP,
18670,GO:1901072,1,0.945167683757477,0,4,glucosamine-containing compound catabolic process,BP,
18671,GO:1901073,1,0.967130957903385,0,2,glucosamine-containing compound biosynthetic process,BP,
18672,GO:1901074,1,0.968103937600999,0,2,regulation of engulfment of apoptotic cell,BP,
18673,GO:1901076,1,0.983426667500444,0,1,positive regulation of engulfment of apoptotic cell,BP,
18677,GO:1901080,1,0.983426667502615,0,1,regulation of relaxation of smooth muscle,BP,
18678,GO:1901082,1,0.983426667502615,0,1,positive regulation of relaxation of smooth muscle,BP,
18679,GO:1901086,1,0.983426667502562,0,1,benzylpenicillin metabolic process,BP,
18680,GO:1901090,1,0.970902302770969,0,2,regulation of protein tetramerization,BP,
18681,GO:1901091,1,0.970902302770969,0,2,negative regulation of protein tetramerization,BP,
18682,GO:1901093,1,0.970902302770969,0,2,regulation of protein homotetramerization,BP,
18683,GO:1901094,1,0.970902302770969,0,2,negative regulation of protein homotetramerization,BP,
18684,GO:1901096,1,0.865970799502079,0,9,regulation of autophagosome maturation,BP,
18685,GO:1901097,1,0.970244351717387,0,2,negative regulation of autophagosome maturation,BP,
18686,GO:1901098,1,0.907586149618162,0,6,positive regulation of autophagosome maturation,BP,
18688,GO:1901128,1,0.985681118036814,0,1,gentamycin metabolic process,BP,
18692,GO:1901142,1,0.910233998020239,0,6,insulin metabolic process,BP,
18693,GO:1901143,1,0.967191286764807,0,2,insulin catabolic process,BP,
18695,GO:1901146,1,0.984184451274848,0,1,mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
18696,GO:1901147,1,0.967127945407715,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18697,GO:1901159,1,0.941893893425375,0,5,xylulose 5-phosphate biosynthetic process,BP,
18698,GO:1901160,1,0.823219884535617,0,13,primary amino compound metabolic process,BP,
18699,GO:1901162,1,0.946444568796121,0,4,primary amino compound biosynthetic process,BP,
18700,GO:1901163,1,0.907282049579802,0,8,regulation of trophoblast cell migration,BP,
18701,GO:1901164,1,0.942224458590075,0,5,negative regulation of trophoblast cell migration,BP,
18702,GO:1901165,1,0.962923984857206,0,3,positive regulation of trophoblast cell migration,BP,
18703,GO:1901166,1,0.937197472797644,0,4,neural crest cell migration involved in autonomic nervous system development,BP,
18707,GO:1901187,1,0.96899566258691,0,2,regulation of ephrin receptor signaling pathway,BP,
18708,GO:1901189,1,0.985326802996629,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18709,GO:1901193,1,0.991584058825728,0,1,regulation of formation of translation preinitiation complex,BP,
18710,GO:1901194,1,0.991584058825728,0,1,negative regulation of formation of translation preinitiation complex,BP,
18712,GO:1901202,1,0.985348195596168,0,1,negative regulation of extracellular matrix assembly,BP,
18713,GO:1901203,1,0.863611321552244,0,9,positive regulation of extracellular matrix assembly,BP,
18714,GO:1901204,1,0.967126892147279,0,2,regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18715,GO:1901205,1,0.967126892147279,0,2,negative regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18716,GO:1901206,1,0.983426667500052,0,1,positive regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18717,GO:1901207,1,0.967231196955433,0,2,regulation of heart looping,BP,
18718,GO:1901208,1,0.983532710818145,0,1,negative regulation of heart looping,BP,
18719,GO:1901210,1,0.983532710818145,0,1,regulation of cardiac chamber formation,BP,
18720,GO:1901211,1,0.983532710818145,0,1,negative regulation of cardiac chamber formation,BP,
18724,GO:1901216,1,0.380785576894018,0,67,positive regulation of neuron death,BP,
18725,GO:1901219,1,0.983532710818145,0,1,regulation of cardiac chamber morphogenesis,BP,
18726,GO:1901220,1,0.983532710818145,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18727,GO:1901222,1,0.46832348786925,0,52,regulation of NIK/NF-kappaB signaling,BP,
18728,GO:1901223,1,0.868142530199909,0,10,negative regulation of NIK/NF-kappaB signaling,BP,
18729,GO:1901224,1,0.567183519552874,0,39,positive regulation of NIK/NF-kappaB signaling,BP,
18730,GO:1901228,1,0.936666925292529,0,4,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18731,GO:1901229,1,0.984648274463338,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18732,GO:1901231,1,0.984648274463338,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18733,GO:1901232,1,0.984648274463338,0,1,regulation of convergent extension involved in axis elongation,BP,
18734,GO:1901233,1,0.984648274463338,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18735,GO:1901246,1,0.975263558702348,0,2,regulation of lung ciliated cell differentiation,BP,
18736,GO:1901247,1,0.990581907561477,0,1,negative regulation of lung ciliated cell differentiation,BP,
18737,GO:1901248,1,0.984536613720224,0,1,positive regulation of lung ciliated cell differentiation,BP,
18738,GO:1901249,1,0.990581907561477,0,1,regulation of lung goblet cell differentiation,BP,
18739,GO:1901251,1,0.990581907561477,0,1,positive regulation of lung goblet cell differentiation,BP,
18740,GO:1901252,1,0.962569781520362,0,3,regulation of intracellular transport of viral material,BP,
18741,GO:1901253,1,0.978793076584699,0,2,negative regulation of intracellular transport of viral material,BP,
18742,GO:1901254,1,0.9834266675032,0,1,positive regulation of intracellular transport of viral material,BP,
18743,GO:1901255,1,0.972378396823459,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18744,GO:1901256,1,0.939065197277278,0,4,regulation of macrophage colony-stimulating factor production,BP,
18745,GO:1901257,1,0.985448622796376,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18746,GO:1901258,1,0.968959342704137,0,2,positive regulation of macrophage colony-stimulating factor production,BP,
18749,GO:1901269,1,0.994857040334026,0,1,lipooligosaccharide metabolic process,BP,
18750,GO:1901271,1,0.994857040334026,0,1,lipooligosaccharide biosynthetic process,BP,
18751,GO:1901291,1,0.987084084085022,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18754,GO:1901295,1,0.973125731061933,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18755,GO:1901296,1,0.987617988261782,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18756,GO:1901297,1,0.985326802996629,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18757,GO:1901298,1,0.869889839469035,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18758,GO:1901299,1,0.919229823594172,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18759,GO:1901300,1,0.946342889428064,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18760,GO:1901301,1,0.968043208716044,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18761,GO:1901303,1,0.984358363364733,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18762,GO:1901304,1,0.988159237720704,0,1,regulation of spermidine biosynthetic process,BP,
18763,GO:1901307,1,0.988159237720704,0,1,positive regulation of spermidine biosynthetic process,BP,
18764,GO:1901314,1,0.952806497054591,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18765,GO:1901315,1,0.952806497054591,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18766,GO:1901317,1,0.887913631924844,0,11,regulation of flagellated sperm motility,BP,
18767,GO:1901318,1,0.947936316689369,0,4,negative regulation of flagellated sperm motility,BP,
18768,GO:1901320,1,0.983963369018216,0,1,negative regulation of heart induction,BP,
18769,GO:1901321,1,0.979109153449679,0,2,positive regulation of heart induction,BP,
18770,GO:1901337,1,0.984479696476155,0,1,thioester transport,BP,
18772,GO:1901339,1,0.909761084014378,0,6,regulation of store-operated calcium channel activity,BP,
18773,GO:1901340,1,0.983426667503304,0,1,negative regulation of store-operated calcium channel activity,BP,
18774,GO:1901341,1,0.940436213552519,0,4,positive regulation of store-operated calcium channel activity,BP,
18777,GO:1901344,1,0.990556563085405,0,1,response to leptomycin B,BP,
18778,GO:1901350,1,0.983426667500198,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18779,GO:1901355,1,0.969703433246406,0,2,response to rapamycin,BP,
18784,GO:1901373,1,0.989717066048738,0,1,lipid hydroperoxide transport,BP,
18785,GO:1901374,1,0.900680169602081,0,7,acetate ester transport,BP,
18786,GO:1901375,1,0.957970383493087,0,3,acetate ester transmembrane transporter activity,MF,
18787,GO:1901376,1,0.985496439087101,0,1,organic heteropentacyclic compound metabolic process,BP,
18791,GO:1901382,1,0.939250507970784,0,4,regulation of chorionic trophoblast cell proliferation,BP,
18792,GO:1901383,1,0.969995071158887,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18794,GO:1901386,1,0.868093668266212,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18795,GO:1901387,1,0.91104228111403,0,7,positive regulation of voltage-gated calcium channel activity,BP,
18796,GO:1901388,1,0.984769051492201,0,1,regulation of transforming growth factor beta activation,BP,
18797,GO:1901389,1,0.984769051492201,0,1,negative regulation of transforming growth factor beta activation,BP,
18798,GO:1901407,1,0.881068102646845,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18799,GO:1901409,1,0.895923245014196,0,8,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18800,GO:1901419,1,0.983426667503199,0,1,regulation of response to alcohol,BP,
18801,GO:1901421,1,0.983426667503199,0,1,positive regulation of response to alcohol,BP,
18802,GO:1901474,1,0.914294764954216,0,6,azole transmembrane transporter activity,MF,
18803,GO:1901475,1,0.939093300330577,0,4,pyruvate transmembrane transport,BP,
18805,GO:1901490,1,0.922636786064696,0,5,regulation of lymphangiogenesis,BP,
18806,GO:1901491,1,0.951170854605964,0,3,negative regulation of lymphangiogenesis,BP,
18807,GO:1901492,1,0.970007236899918,0,2,positive regulation of lymphangiogenesis,BP,
18808,GO:1901503,1,0.941889734003709,0,4,ether biosynthetic process,BP,
18809,GO:1901505,1,0.578963499544222,0,38,carbohydrate derivative transporter activity,MF,
18810,GO:1901509,1,0.942845144826702,0,4,regulation of endothelial tube morphogenesis,BP,
18812,GO:1901523,1,0.928716635177842,0,5,icosanoid catabolic process,BP,
18813,GO:1901524,1,0.834000499066465,0,12,regulation of macromitophagy,BP,
18814,GO:1901525,1,0.951262835117576,0,3,negative regulation of macromitophagy,BP,
18815,GO:1901526,1,0.876753704367539,0,9,positive regulation of macromitophagy,BP,
18816,GO:1901529,1,0.951096177117224,0,3,positive regulation of anion channel activity,BP,
18819,GO:1901534,1,0.967202788133413,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18820,GO:1901535,1,0.960410526481444,0,3,regulation of DNA demethylation,BP,
18821,GO:1901536,1,0.960410526481444,0,3,negative regulation of DNA demethylation,BP,
18822,GO:1901538,1,0.904064041792685,0,7,changes to DNA methylation involved in embryo development,BP,
18823,GO:1901545,1,0.983842076053753,0,1,response to raffinose,BP,
18825,GO:1901551,1,0.983426667503296,0,1,negative regulation of endothelial cell development,BP,
18827,GO:1901555,1,0.9834266675003,0,1,response to paclitaxel,BP,
18828,GO:1901557,1,0.983426669406348,0,1,response to fenofibrate,BP,
18829,GO:1901558,1,0.97098788063329,0,2,response to metformin,BP,
18830,GO:1901561,1,0.983432965605857,0,1,response to benomyl,BP,
18831,GO:1901563,1,0.937538472462378,0,4,response to camptothecin,BP,
18835,GO:1901567,1,0.946006369160352,0,6,fatty acid derivative binding,MF,
18837,GO:1901569,1,0.928716635177842,0,5,fatty acid derivative catabolic process,BP,
18842,GO:1901580,1,0.983426667495572,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18843,GO:1901581,1,0.983426667495572,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18844,GO:1901582,1,0.983426667495572,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18845,GO:1901585,1,0.98414010319385,0,1,regulation of acid-sensing ion channel activity,BP,
18846,GO:1901594,1,0.983426667503304,0,1,response to capsazepine,BP,
18849,GO:1901607,1,0.413076691588498,0,61,alpha-amino acid biosynthetic process,BP,
18850,GO:1901608,1,0.990267727319466,0,1,regulation of vesicle transport along microtubule,BP,
18851,GO:1901609,1,0.990267727319466,0,1,negative regulation of vesicle transport along microtubule,BP,
18852,GO:1901611,1,0.911041952762859,0,7,phosphatidylglycerol binding,MF,
18853,GO:1901612,1,0.939080442157778,0,5,cardiolipin binding,MF,
18855,GO:1901616,1,0.413920135836762,0,62,organic hydroxy compound catabolic process,BP,
18857,GO:1901618,1,0.578115663078107,0,37,organic hydroxy compound transmembrane transporter activity,MF,
18860,GO:1901622,1,0.984668798188448,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18862,GO:1901624,1,0.952082802896156,0,4,negative regulation of lymphocyte chemotaxis,BP,
18863,GO:1901625,1,0.984728932554734,0,1,cellular response to ergosterol,BP,
18865,GO:1901627,1,0.985398061756451,0,1,negative regulation of postsynaptic membrane organization,BP,
18866,GO:1901628,1,0.949671783418178,0,4,positive regulation of postsynaptic membrane organization,BP,
18867,GO:1901629,1,0.974817781801707,0,2,regulation of presynaptic membrane organization,BP,
18868,GO:1901630,1,0.991246637861128,0,1,negative regulation of presynaptic membrane organization,BP,
18869,GO:1901631,1,0.983426667499068,0,1,positive regulation of presynaptic membrane organization,BP,
18870,GO:1901639,1,0.983426667501431,0,1,XDP catabolic process,BP,
18871,GO:1901640,1,0.983426667501431,0,1,XTP binding,MF,
18872,GO:1901641,1,0.983426667501431,0,1,ITP binding,MF,
18873,GO:1901642,1,0.901737513753591,0,7,nucleoside transmembrane transport,BP,
18878,GO:1901656,1,0.968407662892049,0,2,glycoside transport,BP,
18880,GO:1901658,1,0.641299633958756,0,35,glycosyl compound catabolic process,BP,
18881,GO:1901659,1,0.545007240097864,0,49,glycosyl compound biosynthetic process,BP,
18882,GO:1901660,1,0.909454116228467,0,6,calcium ion export,BP,
18883,GO:1901661,1,0.702071192818612,0,30,quinone metabolic process,BP,
18884,GO:1901662,1,0.961160612805478,0,3,quinone catabolic process,BP,
18885,GO:1901663,1,0.852295254227354,0,13,quinone biosynthetic process,BP,
18886,GO:1901664,1,0.976483923635831,0,2,regulation of NAD+ ADP-ribosyltransferase activity,BP,
18887,GO:1901666,1,0.976483923635831,0,2,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
18888,GO:1901668,1,0.953791505533203,0,4,regulation of superoxide dismutase activity,BP,
18889,GO:1901671,1,0.968584775675666,0,3,positive regulation of superoxide dismutase activity,BP,
18890,GO:1901673,1,0.819852940562725,0,14,regulation of mitotic spindle assembly,BP,
18892,GO:1901675,1,0.983426667500592,0,1,negative regulation of histone H3-K27 acetylation,BP,
18894,GO:1901677,1,0.761660557893143,0,18,phosphate transmembrane transporter activity,MF,
18896,GO:1901679,1,0.903269872875541,0,7,nucleotide transmembrane transport,BP,
18897,GO:1901680,1,0.983426667497199,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
18899,GO:1901682,1,0.626657887216667,0,30,sulfur compound transmembrane transporter activity,MF,
18900,GO:1901684,1,0.985681118036814,0,1,arsenate ion transmembrane transport,BP,
18901,GO:1901685,1,0.819174491239534,0,22,glutathione derivative metabolic process,BP,
18902,GO:1901687,1,0.819174491239534,0,22,glutathione derivative biosynthetic process,BP,
18907,GO:1901702,1,0.870498481215197,0,10,salt transmembrane transporter activity,MF,
18908,GO:1901706,1,0.984653386380109,0,1,mesenchymal cell differentiation involved in bone development,BP,
18909,GO:1901707,1,0.990556563085405,0,1,leptomycin B binding,MF,
18913,GO:1901725,1,0.890740713540927,0,7,regulation of histone deacetylase activity,BP,
18914,GO:1901726,1,0.983426667495869,0,1,negative regulation of histone deacetylase activity,BP,
18915,GO:1901727,1,0.921027905324851,0,5,positive regulation of histone deacetylase activity,BP,
18916,GO:1901738,1,0.983532710818145,0,1,regulation of vitamin A metabolic process,BP,
18917,GO:1901739,1,0.786482810350652,0,20,regulation of myoblast fusion,BP,
18918,GO:1901740,1,0.978276687344899,0,2,negative regulation of myoblast fusion,BP,
18919,GO:1901741,1,0.803963244308686,0,18,positive regulation of myoblast fusion,BP,
18920,GO:1901748,1,0.984893663486023,0,1,leukotriene D4 metabolic process,BP,
18921,GO:1901750,1,0.984893663486023,0,1,leukotriene D4 biosynthetic process,BP,
18922,GO:1901751,1,0.98530228173233,0,1,leukotriene A4 metabolic process,BP,
18924,GO:1901797,1,0.695331994551072,0,27,negative regulation of signal transduction by p53 class mediator,BP,
18926,GO:1901799,1,0.645447383710864,0,31,negative regulation of proteasomal protein catabolic process,BP,
18928,GO:1901804,1,0.98518072135659,0,1,beta-glucoside metabolic process,BP,
18929,GO:1901805,1,0.98518072135659,0,1,beta-glucoside catabolic process,BP,
18930,GO:1901834,1,0.987925476042536,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18931,GO:1901835,1,0.987925476042536,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18932,GO:1901836,1,0.864691736474375,0,10,regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18933,GO:1901837,1,0.973184484616874,0,2,negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18934,GO:1901838,1,0.888529642357448,0,8,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18936,GO:1901843,1,0.951876158199735,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
18937,GO:1901844,1,0.873838790246725,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
18938,GO:1901846,1,0.983426667503102,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
18939,GO:1901856,1,0.95412555508975,0,3,negative regulation of cellular respiration,BP,
18940,GO:1901857,1,0.928387603592464,0,6,positive regulation of cellular respiration,BP,
18941,GO:1901858,1,0.912419631882979,0,6,regulation of mitochondrial DNA metabolic process,BP,
18942,GO:1901859,1,0.952093303712126,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
18943,GO:1901860,1,0.974182741614804,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
18947,GO:1901873,1,0.983426667500693,0,1,regulation of post-translational protein modification,BP,
18948,GO:1901874,1,0.983426667500693,0,1,negative regulation of post-translational protein modification,BP,
18949,GO:1901876,1,0.982608275335644,0,2,regulation of calcium ion binding,BP,
18950,GO:1901877,1,0.982608275335644,0,2,negative regulation of calcium ion binding,BP,
18955,GO:1901889,1,0.740617308044214,0,19,negative regulation of cell junction assembly,BP,
18957,GO:1901894,1,0.928156462356171,0,6,regulation of calcium-transporting ATPase activity,BP,
18958,GO:1901895,1,0.971715540114336,0,2,negative regulation of calcium-transporting ATPase activity,BP,
18959,GO:1901896,1,0.960508643690256,0,3,positive regulation of calcium-transporting ATPase activity,BP,
18963,GO:1901906,1,0.946650719048175,0,4,diadenosine pentaphosphate metabolic process,BP,
18964,GO:1901907,1,0.946650719048175,0,4,diadenosine pentaphosphate catabolic process,BP,
18965,GO:1901908,1,0.946650719048175,0,4,diadenosine hexaphosphate metabolic process,BP,
18966,GO:1901909,1,0.946650719048175,0,4,diadenosine hexaphosphate catabolic process,BP,
18967,GO:1901910,1,0.946650719048175,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
18968,GO:1901911,1,0.946650719048175,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
18969,GO:1901962,1,0.985781226225567,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
18972,GO:1901970,1,0.912832890132424,0,6,positive regulation of mitotic sister chromatid separation,BP,
18974,GO:1901977,1,0.929387388156015,0,5,negative regulation of cell cycle checkpoint,BP,
18975,GO:1901978,1,0.874910198239075,0,9,positive regulation of cell cycle checkpoint,BP,
18976,GO:1901979,1,0.978409308339096,0,2,regulation of inward rectifier potassium channel activity,BP,
18979,GO:1901984,1,0.733919109338807,0,22,negative regulation of protein acetylation,BP,
18981,GO:1901986,1,0.989819573305761,0,1,response to ketamine,BP,
18984,GO:1901989,1,0.389718857074098,0,66,positive regulation of cell cycle phase transition,BP,
18987,GO:1901992,1,0.429646192411133,0,59,positive regulation of mitotic cell cycle phase transition,BP,
18988,GO:1901993,1,0.938631912707655,0,5,regulation of meiotic cell cycle phase transition,BP,
18989,GO:1901994,1,0.953191031801622,0,4,negative regulation of meiotic cell cycle phase transition,BP,
18990,GO:1901995,1,0.984728932554734,0,1,positive regulation of meiotic cell cycle phase transition,BP,
18993,GO:1902003,1,0.856437129391276,0,10,regulation of beta-amyloid formation,BP,
18994,GO:1902004,1,0.923762638258406,0,5,positive regulation of beta-amyloid formation,BP,
18996,GO:1902017,1,0.542361286275223,0,42,regulation of cilium assembly,BP,
18997,GO:1902018,1,0.869655527654548,0,9,negative regulation of cilium assembly,BP,
18998,GO:1902019,1,0.925273968125216,0,5,regulation of cilium-dependent cell motility,BP,
18999,GO:1902022,1,0.942328717277342,0,4,L-lysine transport,BP,
19000,GO:1902023,1,0.942349439578067,0,4,L-arginine transport,BP,
19001,GO:1902024,1,0.969459349948648,0,2,L-histidine transport,BP,
19002,GO:1902031,1,0.926074007559864,0,6,regulation of NADP metabolic process,BP,
19005,GO:1902036,1,0.907887062104871,0,6,regulation of hematopoietic stem cell differentiation,BP,
19006,GO:1902037,1,0.953587294217915,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19007,GO:1902038,1,0.983503823950954,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19009,GO:1902042,1,0.598940225732295,0,36,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19011,GO:1902044,1,0.969003739480154,0,2,regulation of Fas signaling pathway,BP,
19012,GO:1902045,1,0.985335015448221,0,1,negative regulation of Fas signaling pathway,BP,
19013,GO:1902047,1,0.956047932715511,0,4,polyamine transmembrane transport,BP,
19014,GO:1902065,1,0.875682715032902,0,9,response to L-glutamate,BP,
19015,GO:1902071,1,0.991259769589517,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19016,GO:1902073,1,0.991259769589517,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19018,GO:1902075,1,0.934070222647552,0,5,cellular response to salt,BP,
19019,GO:1902076,1,0.983426667495081,0,1,regulation of lateral motor column neuron migration,BP,
19020,GO:1902078,1,0.983426667495081,0,1,positive regulation of lateral motor column neuron migration,BP,
19021,GO:1902080,1,0.973513418108277,0,2,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19022,GO:1902081,1,0.973513418108277,0,2,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19023,GO:1902083,1,0.937186411366904,0,4,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19024,GO:1902093,1,0.936694318909075,0,7,positive regulation of flagellated sperm motility,BP,
19026,GO:1902099,1,0.527737320343697,0,45,regulation of metaphase/anaphase transition of cell cycle,BP,
19027,GO:1902100,1,0.639859498497271,0,31,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19028,GO:1902101,1,0.912832890132424,0,6,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19029,GO:1902102,1,0.976151011005824,0,2,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19030,GO:1902103,1,0.976151011005824,0,2,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19035,GO:1902109,1,0.966364625716623,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19038,GO:1902116,1,0.652304693572174,0,29,negative regulation of organelle assembly,BP,
19040,GO:1902118,1,0.987702592018801,0,1,calcidiol binding,MF,
19042,GO:1902122,1,0.986081633239475,0,1,chenodeoxycholic acid binding,MF,
19043,GO:1902159,1,0.977389176021797,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19044,GO:1902161,1,0.983426667501282,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19045,GO:1902162,1,0.980933267165455,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19046,GO:1902164,1,0.980933267165455,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19047,GO:1902165,1,0.839235992387839,0,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19048,GO:1902166,1,0.856830959409179,0,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19049,GO:1902167,1,0.995476081427612,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19051,GO:1902172,1,0.91475358490343,0,6,regulation of keratinocyte apoptotic process,BP,
19052,GO:1902173,1,0.983668420482896,0,1,negative regulation of keratinocyte apoptotic process,BP,
19053,GO:1902174,1,0.956776690443035,0,3,positive regulation of keratinocyte apoptotic process,BP,
19056,GO:1902177,1,0.923734972011004,0,6,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19057,GO:1902178,1,0.983426667503252,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19058,GO:1902186,1,0.622127951762783,0,31,regulation of viral release from host cell,BP,
19059,GO:1902187,1,0.78675325954246,0,15,negative regulation of viral release from host cell,BP,
19060,GO:1902188,1,0.802772538054114,0,15,positive regulation of viral release from host cell,BP,
19061,GO:1902202,1,0.943016132870733,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19062,GO:1902203,1,0.983426667502658,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19063,GO:1902204,1,0.986653822237532,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19064,GO:1902205,1,0.988122489883223,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19065,GO:1902206,1,0.988122489883223,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19066,GO:1902211,1,0.973032062018822,0,2,regulation of prolactin signaling pathway,BP,
19067,GO:1902212,1,0.988122489883223,0,1,negative regulation of prolactin signaling pathway,BP,
19068,GO:1902213,1,0.984728932554734,0,1,positive regulation of prolactin signaling pathway,BP,
19069,GO:1902214,1,0.976100018230521,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
19070,GO:1902215,1,0.988122489883223,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19071,GO:1902216,1,0.987833615541307,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
19072,GO:1902217,1,0.990286415471725,0,1,erythrocyte apoptotic process,BP,
19073,GO:1902218,1,0.934132269043618,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19074,GO:1902219,1,0.941855707986811,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19075,GO:1902220,1,0.991801802024,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19076,GO:1902221,1,0.882876127037077,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19077,GO:1902222,1,0.882876127037077,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19079,GO:1902225,1,0.984728932554734,0,1,negative regulation of acrosome reaction,BP,
19080,GO:1902226,1,0.962846802913537,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19081,GO:1902227,1,0.977408437000323,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19082,GO:1902228,1,0.985103195280682,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19083,GO:1902229,1,0.642595099755693,0,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19084,GO:1902230,1,0.721654625853084,0,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19085,GO:1902231,1,0.905138683823921,0,8,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19086,GO:1902232,1,0.972700439659321,0,2,regulation of positive thymic T cell selection,BP,
19087,GO:1902233,1,0.988122489883223,0,1,negative regulation of positive thymic T cell selection,BP,
19089,GO:1902236,1,0.78260790139364,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19091,GO:1902238,1,0.983426667503302,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19092,GO:1902239,1,0.983426667503302,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19093,GO:1902250,1,0.990286415471725,0,1,regulation of erythrocyte apoptotic process,BP,
19094,GO:1902251,1,0.990286415471725,0,1,negative regulation of erythrocyte apoptotic process,BP,
19095,GO:1902253,1,0.745030340356302,0,24,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19096,GO:1902254,1,0.788805216559291,0,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19097,GO:1902255,1,0.96985696425511,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19098,GO:1902256,1,0.955861393095319,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19099,GO:1902257,1,0.971972091609948,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19100,GO:1902259,1,0.80862937507854,0,15,regulation of delayed rectifier potassium channel activity,BP,
19101,GO:1902260,1,0.910093319704306,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19102,GO:1902261,1,0.944914243195292,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19103,GO:1902262,1,0.937965998145359,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19105,GO:1902267,1,0.956047932715511,0,4,regulation of polyamine transmembrane transport,BP,
19106,GO:1902268,1,0.972161768576851,0,3,negative regulation of polyamine transmembrane transport,BP,
19107,GO:1902269,1,0.983426667503251,0,1,positive regulation of polyamine transmembrane transport,BP,
19111,GO:1902283,1,0.983426667503346,0,1,negative regulation of primary amine oxidase activity,BP,
19113,GO:1902285,1,0.906092766044743,0,6,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19114,GO:1902287,1,0.921368039990222,0,5,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19115,GO:1902292,1,0.991240075116135,0,1,cell cycle DNA replication initiation,BP,
19116,GO:1902294,1,0.984728932554734,0,1,cell cycle DNA replication termination,BP,
19117,GO:1902296,1,0.983584641742892,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19118,GO:1902298,1,0.969397550237668,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19119,GO:1902299,1,0.971970846745196,0,2,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19122,GO:1902304,1,0.977035469180655,0,2,positive regulation of potassium ion export,BP,
19123,GO:1902305,1,0.459570740263981,0,56,regulation of sodium ion transmembrane transport,BP,
19124,GO:1902306,1,0.852156758189735,0,11,negative regulation of sodium ion transmembrane transport,BP,
19125,GO:1902307,1,0.776371649622468,0,18,positive regulation of sodium ion transmembrane transport,BP,
19126,GO:1902308,1,0.930006987416165,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19127,GO:1902309,1,0.95496093965042,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19128,GO:1902310,1,0.973874066972765,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19129,GO:1902311,1,0.987772898544362,0,1,regulation of copper ion transmembrane transport,BP,
19130,GO:1902315,1,0.991240075116135,0,1,nuclear cell cycle DNA replication initiation,BP,
19131,GO:1902317,1,0.984728932554734,0,1,nuclear DNA replication termination,BP,
19132,GO:1902319,1,0.983584641742892,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19133,GO:1902336,1,0.968660667740191,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19137,GO:1902340,1,0.976630715855063,0,2,negative regulation of chromosome condensation,BP,
19138,GO:1902356,1,0.987198264305229,0,1,oxaloacetate(2-) transmembrane transport,BP,
19139,GO:1902358,1,0.812370373693621,0,13,sulfate transmembrane transport,BP,
19140,GO:1902359,1,0.970813082080473,0,2,Notch signaling pathway involved in somitogenesis,BP,
19141,GO:1902361,1,0.954880041681638,0,3,mitochondrial pyruvate transmembrane transport,BP,
19142,GO:1902362,1,0.984184451274848,0,1,melanocyte apoptotic process,BP,
19143,GO:1902366,1,0.970813082080473,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19144,GO:1902367,1,0.970813082080473,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19147,GO:1902378,1,0.984936615570901,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19149,GO:1902380,1,0.98512162401357,0,1,positive regulation of endoribonuclease activity,BP,
19150,GO:1902396,1,0.983427066144146,0,1,protein localization to bicellular tight junction,BP,
19154,GO:1902410,1,0.914845924800261,0,6,mitotic cytokinetic process,BP,
19155,GO:1902412,1,0.954161899548618,0,3,regulation of mitotic cytokinesis,BP,
19156,GO:1902414,1,0.879815667885242,0,8,protein localization to cell junction,BP,
19157,GO:1902415,1,0.877346921943413,0,9,regulation of mRNA binding,BP,
19158,GO:1902416,1,0.902607734278064,0,7,positive regulation of mRNA binding,BP,
19159,GO:1902423,1,0.986077712167715,0,1,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19160,GO:1902425,1,0.986077712167715,0,1,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19161,GO:1902426,1,0.984435940978795,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19162,GO:1902430,1,0.914820115814556,0,6,negative regulation of beta-amyloid formation,BP,
19163,GO:1902442,1,0.983434824103805,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19164,GO:1902443,1,0.983434824103805,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19165,GO:1902444,1,0.991190920999648,0,1,riboflavin binding,MF,
19166,GO:1902445,1,0.971648267402439,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19168,GO:1902459,1,0.922593041363221,0,5,positive regulation of stem cell population maintenance,BP,
19169,GO:1902460,1,0.983426667503056,0,1,regulation of mesenchymal stem cell proliferation,BP,
19170,GO:1902462,1,0.983426667503056,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19171,GO:1902463,1,0.969544269558236,0,3,protein localization to cell leading edge,BP,
19172,GO:1902464,1,0.983426667503154,0,1,regulation of histone H3-K27 trimethylation,BP,
19173,GO:1902466,1,0.983426667503154,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19176,GO:1902475,1,0.641025421233235,0,29,L-alpha-amino acid transmembrane transport,BP,
19178,GO:1902480,1,0.985112395621401,0,1,protein localization to mitotic spindle,BP,
19179,GO:1902488,1,0.983426667498183,0,1,cholangiocyte apoptotic process,BP,
19180,GO:1902490,1,0.986783122517661,0,1,regulation of sperm capacitation,BP,
19181,GO:1902493,1,0.277761043841627,0,88,acetyltransferase complex,CC,
19184,GO:1902498,1,0.935969929866205,0,4,regulation of protein autoubiquitination,BP,
19185,GO:1902499,1,0.967788383007204,0,2,positive regulation of protein autoubiquitination,BP,
19186,GO:1902504,1,0.983885143791916,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19187,GO:1902510,1,0.919191449591802,0,7,regulation of apoptotic DNA fragmentation,BP,
19188,GO:1902511,1,0.984358363364733,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19189,GO:1902512,1,0.971572433568588,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19190,GO:1902513,1,0.943137181676678,0,4,regulation of organelle transport along microtubule,BP,
19191,GO:1902514,1,0.900485244274991,0,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19192,GO:1902523,1,0.967557914031616,0,2,positive regulation of protein K63-linked ubiquitination,BP,
19193,GO:1902524,1,0.972965656917705,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19194,GO:1902525,1,0.941095214961119,0,5,regulation of protein monoubiquitination,BP,
19195,GO:1902527,1,0.956946346353552,0,4,positive regulation of protein monoubiquitination,BP,
19196,GO:1902528,1,0.983426667498625,0,1,regulation of protein linear polyubiquitination,BP,
19197,GO:1902530,1,0.983426667498625,0,1,positive regulation of protein linear polyubiquitination,BP,
19201,GO:1902534,1,0.983426667501824,0,1,single-organism membrane invagination,BP,
19202,GO:1902544,1,0.977292921552569,0,2,regulation of DNA N-glycosylase activity,BP,
19203,GO:1902546,1,0.993573175263409,0,1,positive regulation of DNA N-glycosylase activity,BP,
19205,GO:1902548,1,0.928579324802849,0,5,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19207,GO:1902555,1,0.716210004280474,0,25,endoribonuclease complex,CC,
19208,GO:1902559,1,0.973123030636224,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19209,GO:1902560,1,0.976525761289239,0,2,GMP reductase complex,CC,
19210,GO:1902562,1,0.610247906236591,0,34,H4 histone acetyltransferase complex,CC,
19211,GO:1902563,1,0.910436739691893,0,6,regulation of neutrophil activation,BP,
19212,GO:1902564,1,0.954748828458923,0,3,negative regulation of neutrophil activation,BP,
19213,GO:1902565,1,0.983426667503304,0,1,positive regulation of neutrophil activation,BP,
19214,GO:1902566,1,0.947107877093372,0,4,regulation of eosinophil activation,BP,
19215,GO:1902567,1,0.972289151340855,0,2,negative regulation of eosinophil activation,BP,
19216,GO:1902568,1,0.97410402482189,0,2,positive regulation of eosinophil activation,BP,
19217,GO:1902569,1,0.987202962341087,0,1,negative regulation of activation of JAK2 kinase activity,BP,
19218,GO:1902570,1,0.909669968181309,0,7,protein localization to nucleolus,BP,
19219,GO:1902571,1,0.880316271511504,0,13,regulation of serine-type peptidase activity,BP,
19220,GO:1902572,1,0.902624395348824,0,11,negative regulation of serine-type peptidase activity,BP,
19221,GO:1902573,1,0.959130115955308,0,3,positive regulation of serine-type peptidase activity,BP,
19222,GO:1902576,1,0.940128017476804,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19229,GO:1902585,1,0.986690812150216,0,1,single-organism intercellular transport,BP,
19231,GO:1902590,1,0.721303901554186,0,24,multi-organism organelle organization,BP,
19232,GO:1902592,1,0.721303901554186,0,24,multi-organism membrane budding,BP,
19234,GO:1902594,1,0.967126892153908,0,2,multi-organism nuclear import,BP,
19235,GO:1902595,1,0.974321270953367,0,2,regulation of DNA replication origin binding,BP,
19236,GO:1902598,1,0.967169115595505,0,2,creatine transmembrane transport,BP,
19237,GO:1902600,1,0.316826515801859,0,104,hydrogen ion transmembrane transport,BP,
19238,GO:1902603,1,0.944775348047785,0,4,carnitine transmembrane transport,BP,
19239,GO:1902605,1,0.984299132165945,0,1,heterotrimeric G-protein complex assembly,BP,
19240,GO:1902606,1,0.98457055353119,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19241,GO:1902608,1,0.98457055353119,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19244,GO:1902616,1,0.97277316961814,0,2,acyl carnitine transmembrane transport,BP,
19245,GO:1902617,1,0.939551412319887,0,4,response to fluoride,BP,
19246,GO:1902618,1,0.983426667501479,0,1,cellular response to fluoride,BP,
19248,GO:1902623,1,0.968407661017306,0,2,negative regulation of neutrophil migration,BP,
19250,GO:1902626,1,0.977092318922225,0,3,assembly of large subunit precursor of preribosome,BP,
19251,GO:1902630,1,0.967126892150955,0,2,regulation of membrane hyperpolarization,BP,
19252,GO:1902631,1,0.983426667500298,0,1,negative regulation of membrane hyperpolarization,BP,
19253,GO:1902636,1,0.977360535909449,0,2,kinociliary basal body,CC,
19257,GO:1902659,1,0.962843104251515,0,3,regulation of glucose mediated signaling pathway,BP,
19258,GO:1902661,1,0.962843104251515,0,3,positive regulation of glucose mediated signaling pathway,BP,
19261,GO:1902669,1,0.894238146211718,0,7,positive regulation of axon guidance,BP,
19264,GO:1902683,1,0.959836055321234,0,3,regulation of receptor localization to synapse,BP,
19265,GO:1902684,1,0.990267727319466,0,1,negative regulation of receptor localization to synapse,BP,
19266,GO:1902685,1,0.983426667503251,0,1,positive regulation of receptor localization to synapse,BP,
19270,GO:1902691,1,0.98374269645965,0,1,respiratory basal cell differentiation,BP,
19272,GO:1902710,1,0.759454571724213,0,18,GABA receptor complex,CC,
19273,GO:1902711,1,0.77226720553335,0,17,GABA-A receptor complex,CC,
19274,GO:1902713,1,0.863873138612052,0,10,regulation of interferon-gamma secretion,BP,
19275,GO:1902714,1,0.943106247490146,0,4,negative regulation of interferon-gamma secretion,BP,
19276,GO:1902715,1,0.903810891229263,0,7,positive regulation of interferon-gamma secretion,BP,
19277,GO:1902722,1,0.968402452934571,0,2,positive regulation of prolactin secretion,BP,
19278,GO:1902723,1,0.967975476861054,0,2,negative regulation of skeletal muscle satellite cell proliferation,BP,
19279,GO:1902725,1,0.967842895240366,0,2,negative regulation of satellite cell differentiation,BP,
19280,GO:1902728,1,0.967126892153955,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19281,GO:1902730,1,0.967209858472895,0,2,positive regulation of proteoglycan biosynthetic process,BP,
19282,GO:1902731,1,0.95225324731193,0,3,negative regulation of chondrocyte proliferation,BP,
19283,GO:1902732,1,0.960365541157526,0,3,positive regulation of chondrocyte proliferation,BP,
19284,GO:1902737,1,0.9834266675032,0,1,dendritic filopodium,CC,
19285,GO:1902739,1,0.970926061584766,0,2,regulation of interferon-alpha secretion,BP,
19286,GO:1902741,1,0.970926061584766,0,2,positive regulation of interferon-alpha secretion,BP,
19288,GO:1902743,1,0.58250201662748,0,36,regulation of lamellipodium organization,BP,
19289,GO:1902744,1,0.929961051641781,0,5,negative regulation of lamellipodium organization,BP,
19290,GO:1902745,1,0.698602934239016,0,24,positive regulation of lamellipodium organization,BP,
19291,GO:1902746,1,0.944411578128311,0,4,regulation of lens fiber cell differentiation,BP,
19292,GO:1902747,1,0.986805294742457,0,1,negative regulation of lens fiber cell differentiation,BP,
19293,GO:1902748,1,0.98342666749774,0,1,positive regulation of lens fiber cell differentiation,BP,
19296,GO:1902751,1,0.734878197603338,0,21,positive regulation of cell cycle G2/M phase transition,BP,
19297,GO:1902765,1,0.968358686519233,0,2,L-arginine import into cell,BP,
19298,GO:1902766,1,0.977474864902012,0,2,skeletal muscle satellite cell migration,BP,
19299,GO:1902769,1,0.983426667495772,0,1,regulation of choline O-acetyltransferase activity,BP,
19300,GO:1902771,1,0.983426667495772,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19301,GO:1902773,1,0.983817942617793,0,1,GTPase activator complex,CC,
19302,GO:1902774,1,0.915937982427827,0,6,late endosome to lysosome transport,BP,
19303,GO:1902775,1,0.95228520740754,0,3,mitochondrial large ribosomal subunit assembly,BP,
19304,GO:1902803,1,0.568977169059235,0,37,regulation of synaptic vesicle transport,BP,
19305,GO:1902804,1,0.887400073605169,0,8,negative regulation of synaptic vesicle transport,BP,
19306,GO:1902805,1,0.922647661455005,0,5,positive regulation of synaptic vesicle transport,BP,
19309,GO:1902808,1,0.63775533395004,0,32,positive regulation of cell cycle G1/S phase transition,BP,
19310,GO:1902809,1,0.95711820656763,0,3,regulation of skeletal muscle fiber differentiation,BP,
19311,GO:1902811,1,0.972644834167095,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19312,GO:1902822,1,0.947078290219968,0,4,regulation of late endosome to lysosome transport,BP,
19313,GO:1902823,1,0.96727966698623,0,2,negative regulation of late endosome to lysosome transport,BP,
19314,GO:1902824,1,0.979118122979507,0,2,positive regulation of late endosome to lysosome transport,BP,
19315,GO:1902826,1,0.984679136082936,0,1,regulation of L-arginine import into cell,BP,
19316,GO:1902828,1,0.984679136082936,0,1,positive regulation of L-arginine import into cell,BP,
19317,GO:1902837,1,0.890709946292586,0,7,amino acid import into cell,BP,
19318,GO:1902847,1,0.984101003177701,0,1,regulation of neuronal signal transduction,BP,
19320,GO:1902855,1,0.817063567022025,0,13,regulation of non-motile cilium assembly,BP,
19321,GO:1902856,1,0.951118315054316,0,3,negative regulation of non-motile cilium assembly,BP,
19322,GO:1902857,1,0.872271943952927,0,9,positive regulation of non-motile cilium assembly,BP,
19323,GO:1902858,1,0.986121010490359,0,1,propionyl-CoA metabolic process,BP,
19324,GO:1902860,1,0.986121010490359,0,1,propionyl-CoA biosynthetic process,BP,
19325,GO:1902861,1,0.983426667502857,0,1,copper ion import into cell,BP,
19326,GO:1902866,1,0.901325972848614,0,7,regulation of retina development in camera-type eye,BP,
19327,GO:1902867,1,0.983710215107683,0,1,negative regulation of retina development in camera-type eye,BP,
19328,GO:1902868,1,0.971330885008517,0,2,positive regulation of retina development in camera-type eye,BP,
19329,GO:1902869,1,0.955506222300554,0,3,regulation of amacrine cell differentiation,BP,
19330,GO:1902870,1,0.983710215107683,0,1,negative regulation of amacrine cell differentiation,BP,
19331,GO:1902871,1,0.971330885008517,0,2,positive regulation of amacrine cell differentiation,BP,
19334,GO:1902884,1,0.816021631416223,0,15,positive regulation of response to oxidative stress,BP,
19335,GO:1902890,1,0.994020585908706,0,1,regulation of root hair elongation,BP,
19336,GO:1902891,1,0.994020585908706,0,1,negative regulation of root hair elongation,BP,
19340,GO:1902896,1,0.952203139486076,0,3,terminal web assembly,BP,
19342,GO:1902902,1,0.868220365366519,0,10,negative regulation of autophagosome assembly,BP,
19346,GO:1902908,1,0.971771003198171,0,2,regulation of melanosome transport,BP,
19347,GO:1902910,1,0.983426667503251,0,1,positive regulation of melanosome transport,BP,
19349,GO:1902913,1,0.99202838856208,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19350,GO:1902914,1,0.821255208038619,0,13,regulation of protein polyubiquitination,BP,
19351,GO:1902915,1,0.937058626922204,0,4,negative regulation of protein polyubiquitination,BP,
19352,GO:1902916,1,0.891226906642925,0,8,positive regulation of protein polyubiquitination,BP,
19354,GO:1902931,1,0.882217101303326,0,9,negative regulation of alcohol biosynthetic process,BP,
19355,GO:1902932,1,0.757390072266284,0,20,positive regulation of alcohol biosynthetic process,BP,
19357,GO:1902937,1,0.96969960372394,0,2,inward rectifier potassium channel complex,CC,
19358,GO:1902938,1,0.984022315014937,0,1,regulation of intracellular calcium activated chloride channel activity,BP,
19359,GO:1902939,1,0.984022315014937,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19360,GO:1902941,1,0.96712689215357,0,2,regulation of voltage-gated chloride channel activity,BP,
19361,GO:1902943,1,0.96712689215357,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19363,GO:1902947,1,0.954878359585497,0,3,regulation of tau-protein kinase activity,BP,
19364,GO:1902948,1,0.983426667495772,0,1,negative regulation of tau-protein kinase activity,BP,
19365,GO:1902949,1,0.984101003177701,0,1,positive regulation of tau-protein kinase activity,BP,
19366,GO:1902950,1,0.922302001329721,0,6,regulation of dendritic spine maintenance,BP,
19367,GO:1902951,1,0.961928599445841,0,3,negative regulation of dendritic spine maintenance,BP,
19368,GO:1902952,1,0.974817781805658,0,2,positive regulation of dendritic spine maintenance,BP,
19369,GO:1902953,1,0.941025245129014,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19370,GO:1902954,1,0.967126892144471,0,2,regulation of early endosome to recycling endosome transport,BP,
19371,GO:1902955,1,0.983426667495772,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19372,GO:1902956,1,0.946380371746067,0,4,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19373,GO:1902957,1,0.968169326484596,0,2,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19374,GO:1902958,1,0.9774976736942,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19375,GO:1902959,1,0.967130622982889,0,2,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19376,GO:1902960,1,0.983426667495772,0,1,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19377,GO:1902961,1,0.98343046095583,0,1,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19378,GO:1902962,1,0.967130622982889,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19379,GO:1902963,1,0.967130622982889,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19382,GO:1902969,1,0.862907485813126,0,10,mitotic DNA replication,BP,
19383,GO:1902975,1,0.991240075116135,0,1,mitotic DNA replication initiation,BP,
19384,GO:1902977,1,0.987044884836887,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19385,GO:1902979,1,0.984728932554734,0,1,mitotic DNA replication termination,BP,
19386,GO:1902983,1,0.983584641742892,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19387,GO:1902988,1,0.951748433537113,0,3,neurofibrillary tangle assembly,BP,
19388,GO:1902990,1,0.95767415285454,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19389,GO:1902991,1,0.821478540550066,0,13,regulation of amyloid precursor protein catabolic process,BP,
19390,GO:1902992,1,0.885736471575931,0,8,negative regulation of amyloid precursor protein catabolic process,BP,
19391,GO:1902993,1,0.923762638258406,0,5,positive regulation of amyloid precursor protein catabolic process,BP,
19392,GO:1902994,1,0.974817781803072,0,2,regulation of phospholipid efflux,BP,
19393,GO:1902995,1,0.974817781803072,0,2,positive regulation of phospholipid efflux,BP,
19394,GO:1902996,1,0.967790096704513,0,2,regulation of neurofibrillary tangle assembly,BP,
19395,GO:1902997,1,0.983426667495772,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19396,GO:1902998,1,0.984101003177701,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19397,GO:1903000,1,0.991246637861128,0,1,regulation of lipid transport across blood brain barrier,BP,
19398,GO:1903002,1,0.991246637861128,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19399,GO:1903003,1,0.942435747265841,0,4,positive regulation of protein deubiquitination,BP,
19400,GO:1903004,1,0.983427738433103,0,1,regulation of protein K63-linked deubiquitination,BP,
19401,GO:1903006,1,0.983427738433103,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19402,GO:1903007,1,0.983427738433103,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19403,GO:1903008,1,0.244824303792582,0,97,organelle disassembly,BP,
19406,GO:1903012,1,0.898546081813852,0,7,positive regulation of bone development,BP,
19407,GO:1903015,1,0.968495731035276,0,3,regulation of exo-alpha-sialidase activity,BP,
19408,GO:1903016,1,0.980036416593176,0,2,negative regulation of exo-alpha-sialidase activity,BP,
19409,GO:1903017,1,0.988225210858363,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19412,GO:1903020,1,0.765343351806492,0,19,positive regulation of glycoprotein metabolic process,BP,
19414,GO:1903026,1,0.947519603218978,0,6,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19415,GO:1903027,1,0.962395754372107,0,3,regulation of opsonization,BP,
19416,GO:1903028,1,0.983426667499558,0,1,positive regulation of opsonization,BP,
19417,GO:1903031,1,0.972049188406568,0,2,regulation of microtubule plus-end binding,BP,
19418,GO:1903033,1,0.972049188406568,0,2,positive regulation of microtubule plus-end binding,BP,
19425,GO:1903044,1,0.874521837222775,0,9,protein localization to membrane raft,BP,
19426,GO:1903045,1,0.983426667501871,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19430,GO:1903051,1,0.567604838658236,0,42,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19433,GO:1903054,1,0.920424332605113,0,6,negative regulation of extracellular matrix organization,BP,
19434,GO:1903055,1,0.789529918286468,0,15,positive regulation of extracellular matrix organization,BP,
19435,GO:1903056,1,0.971771003192725,0,2,regulation of melanosome organization,BP,
19436,GO:1903059,1,0.931462501239051,0,5,regulation of protein lipidation,BP,
19437,GO:1903060,1,0.987563694431352,0,1,negative regulation of protein lipidation,BP,
19438,GO:1903061,1,0.943195194769226,0,4,positive regulation of protein lipidation,BP,
19439,GO:1903069,1,0.876817536258963,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19440,GO:1903070,1,0.959354131828843,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19441,GO:1903071,1,0.900676047259158,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19442,GO:1903072,1,0.992913066894507,0,1,regulation of death-inducing signaling complex assembly,BP,
19443,GO:1903073,1,0.992913066894507,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19447,GO:1903080,1,0.992096438783521,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19448,GO:1903082,1,0.992096438783521,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19449,GO:1903093,1,0.983498595918452,0,2,regulation of protein K48-linked deubiquitination,BP,
19450,GO:1903094,1,0.983498595918452,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19451,GO:1903095,1,0.968407661017789,0,2,ribonuclease III complex,CC,
19452,GO:1903096,1,0.983826495175854,0,1,protein localization to meiotic spindle midzone,BP,
19454,GO:1903116,1,0.951096188843413,0,3,positive regulation of actin filament-based movement,BP,
19455,GO:1903118,1,0.985305541169944,0,1,urate homeostasis,BP,
19456,GO:1903121,1,0.947311807679366,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19457,GO:1903122,1,0.992913066894507,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19458,GO:1903123,1,0.983426667497643,0,1,regulation of thioredoxin peroxidase activity,BP,
19459,GO:1903124,1,0.983426667497643,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19460,GO:1903125,1,0.983426667497643,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19461,GO:1903126,1,0.986144782093158,0,1,negative regulation of centriole-centriole cohesion,BP,
19463,GO:1903135,1,0.96114641285226,0,3,cupric ion binding,MF,
19464,GO:1903136,1,0.932915623788608,0,6,cuprous ion binding,MF,
19466,GO:1903141,1,0.983426667503296,0,1,negative regulation of establishment of endothelial barrier,BP,
19468,GO:1903146,1,0.4975867214492,0,49,regulation of mitophagy,BP,
19469,GO:1903147,1,0.93102657308408,0,5,negative regulation of mitophagy,BP,
19470,GO:1903165,1,0.98440110090942,0,1,response to polycyclic arene,BP,
19471,GO:1903167,1,0.992913066894507,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19472,GO:1903168,1,0.992913066894507,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19475,GO:1903173,1,0.970902332533587,0,2,fatty alcohol metabolic process,BP,
19476,GO:1903176,1,0.992913066894507,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19477,GO:1903178,1,0.992913066894507,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19478,GO:1903179,1,0.976610946972954,0,2,regulation of dopamine biosynthetic process,BP,
19479,GO:1903181,1,0.976610946972954,0,2,positive regulation of dopamine biosynthetic process,BP,
19480,GO:1903182,1,0.991096224378579,0,1,regulation of SUMO transferase activity,BP,
19481,GO:1903184,1,0.992913066894507,0,1,L-dopa metabolic process,BP,
19482,GO:1903185,1,0.992913066894507,0,1,L-dopa biosynthetic process,BP,
19483,GO:1903189,1,0.992913066894507,0,1,glyoxal metabolic process,BP,
19484,GO:1903195,1,0.992913066894507,0,1,regulation of L-dopa biosynthetic process,BP,
19485,GO:1903197,1,0.992913066894507,0,1,positive regulation of L-dopa biosynthetic process,BP,
19486,GO:1903198,1,0.992913066894507,0,1,regulation of L-dopa decarboxylase activity,BP,
19487,GO:1903200,1,0.992913066894507,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19490,GO:1903203,1,0.781916133988178,0,16,regulation of oxidative stress-induced neuron death,BP,
19491,GO:1903204,1,0.822146716163116,0,13,negative regulation of oxidative stress-induced neuron death,BP,
19492,GO:1903205,1,0.739183725882466,0,21,regulation of hydrogen peroxide-induced cell death,BP,
19493,GO:1903206,1,0.794315173396686,0,16,negative regulation of hydrogen peroxide-induced cell death,BP,
19494,GO:1903207,1,0.961295762081988,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
19495,GO:1903208,1,0.961295762081988,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
19496,GO:1903209,1,0.848881893878141,0,12,positive regulation of oxidative stress-induced cell death,BP,
19497,GO:1903210,1,0.983426667501085,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19498,GO:1903214,1,0.289338991210226,0,91,regulation of protein targeting to mitochondrion,BP,
19499,GO:1903215,1,0.945248694798199,0,4,negative regulation of protein targeting to mitochondrion,BP,
19500,GO:1903216,1,0.974875963425055,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19501,GO:1903217,1,0.974875963425055,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19502,GO:1903223,1,0.967135979088877,0,2,positive regulation of oxidative stress-induced neuron death,BP,
19503,GO:1903224,1,0.917616508474269,0,6,regulation of endodermal cell differentiation,BP,
19504,GO:1903225,1,0.958793875602547,0,3,negative regulation of endodermal cell differentiation,BP,
19506,GO:1903233,1,0.967126892150518,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19507,GO:1903236,1,0.929323609114229,0,7,regulation of leukocyte tethering or rolling,BP,
19508,GO:1903237,1,0.967701210709017,0,4,negative regulation of leukocyte tethering or rolling,BP,
19509,GO:1903238,1,0.960346795656584,0,3,positive regulation of leukocyte tethering or rolling,BP,
19510,GO:1903242,1,0.909850206622419,0,6,regulation of cardiac muscle hypertrophy in response to stress,BP,
19511,GO:1903243,1,0.95138001531965,0,3,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19512,GO:1903244,1,0.967201769277983,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19513,GO:1903248,1,0.983426667498132,0,1,regulation of citrulline biosynthetic process,BP,
19514,GO:1903249,1,0.983426667498132,0,1,negative regulation of citrulline biosynthetic process,BP,
19515,GO:1903251,1,0.917734926338637,0,6,multi-ciliated epithelial cell differentiation,BP,
19516,GO:1903261,1,0.940188952140667,0,4,regulation of serine phosphorylation of STAT3 protein,BP,
19517,GO:1903262,1,0.971738489735398,0,2,negative regulation of serine phosphorylation of STAT3 protein,BP,
19518,GO:1903263,1,0.967536686454085,0,2,positive regulation of serine phosphorylation of STAT3 protein,BP,
19519,GO:1903265,1,0.927532336205368,0,5,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19520,GO:1903273,1,0.954759371847983,0,4,regulation of sodium ion export,BP,
19521,GO:1903275,1,0.954759371847983,0,4,positive regulation of sodium ion export,BP,
19522,GO:1903276,1,0.954759371847983,0,4,regulation of sodium ion export from cell,BP,
19523,GO:1903278,1,0.954759371847983,0,4,positive regulation of sodium ion export from cell,BP,
19524,GO:1903279,1,0.954792140656942,0,3,regulation of calcium:sodium antiporter activity,BP,
19525,GO:1903280,1,0.983426667502117,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19526,GO:1903281,1,0.970884892064821,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19527,GO:1903282,1,0.983680494091283,0,1,regulation of glutathione peroxidase activity,BP,
19528,GO:1903284,1,0.983680494091283,0,1,positive regulation of glutathione peroxidase activity,BP,
19529,GO:1903285,1,0.983680494091283,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19530,GO:1903286,1,0.942851271346429,0,4,regulation of potassium ion import,BP,
19531,GO:1903288,1,0.958743599122192,0,3,positive regulation of potassium ion import,BP,
19532,GO:1903293,1,0.501464703833358,0,45,phosphatase complex,CC,
19533,GO:1903294,1,0.98342666750271,0,1,regulation of glutamate secretion, neurotransmission,BP,
19534,GO:1903296,1,0.98342666750271,0,1,positive regulation of glutamate secretion, neurotransmission,BP,
19535,GO:1903297,1,0.940578178279621,0,4,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19536,GO:1903298,1,0.940578178279621,0,4,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19537,GO:1903299,1,0.904283043261605,0,8,regulation of hexokinase activity,BP,
19538,GO:1903300,1,0.947195102859384,0,4,negative regulation of hexokinase activity,BP,
19539,GO:1903301,1,0.954705626205663,0,4,positive regulation of hexokinase activity,BP,
19546,GO:1903314,1,0.986081633239475,0,1,regulation of nitrogen cycle metabolic process,BP,
19548,GO:1903318,1,0.596836890405672,0,37,negative regulation of protein maturation,BP,
19549,GO:1903319,1,0.758547244607751,0,19,positive regulation of protein maturation,BP,
19551,GO:1903321,1,0.160552649065603,0,143,negative regulation of protein modification by small protein conjugation or removal,BP,
19553,GO:1903332,1,0.906152858328463,0,7,regulation of protein folding,BP,
19554,GO:1903333,1,0.935707342754033,0,5,negative regulation of protein folding,BP,
19555,GO:1903335,1,0.932526102068548,0,5,regulation of vacuolar transport,BP,
19556,GO:1903336,1,0.96727966698623,0,2,negative regulation of vacuolar transport,BP,
19557,GO:1903337,1,0.979118122979507,0,2,positive regulation of vacuolar transport,BP,
19558,GO:1903347,1,0.939988738014896,0,4,negative regulation of bicellular tight junction assembly,BP,
19560,GO:1903349,1,0.937856602762393,0,4,omegasome membrane,CC,
19561,GO:1903350,1,0.823422801658814,0,13,response to dopamine,BP,
19562,GO:1903351,1,0.823422801658814,0,13,cellular response to dopamine,BP,
19563,GO:1903352,1,0.957233022012173,0,3,L-ornithine transmembrane transport,BP,
19564,GO:1903358,1,0.860312517920939,0,10,regulation of Golgi organization,BP,
19565,GO:1903361,1,0.944966674714878,0,5,protein localization to basolateral plasma membrane,BP,
19567,GO:1903363,1,0.496936020677452,0,51,negative regulation of cellular protein catabolic process,BP,
19569,GO:1903365,1,0.944873361433472,0,5,regulation of fear response,BP,
19570,GO:1903367,1,0.944873361433472,0,5,positive regulation of fear response,BP,
19571,GO:1903371,1,0.95109617711199,0,3,regulation of endoplasmic reticulum tubular network organization,BP,
19572,GO:1903373,1,0.967126892151537,0,2,positive regulation of endoplasmic reticulum tubular network organization,BP,
19573,GO:1903375,1,0.968611915867781,0,2,facioacoustic ganglion development,BP,
19574,GO:1903376,1,0.899441244789967,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19575,GO:1903377,1,0.945691141297025,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19576,GO:1903378,1,0.967135979088877,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19577,GO:1903381,1,0.983426667503053,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19578,GO:1903382,1,0.983426667503053,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19579,GO:1903383,1,0.9774976736942,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19580,GO:1903384,1,0.9774976736942,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19581,GO:1903385,1,0.967191286764711,0,2,regulation of homophilic cell adhesion,BP,
19582,GO:1903387,1,0.983426667502314,0,1,positive regulation of homophilic cell adhesion,BP,
19584,GO:1903392,1,0.787856432874015,0,15,negative regulation of adherens junction organization,BP,
19586,GO:1903394,1,0.985348195596168,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19587,GO:1903400,1,0.983426667499561,0,1,L-arginine transmembrane transport,BP,
19588,GO:1903401,1,0.956993332956872,0,3,L-lysine transmembrane transport,BP,
19589,GO:1903402,1,0.983427624119544,0,1,regulation of renal phosphate excretion,BP,
19590,GO:1903403,1,0.983427624119544,0,1,negative regulation of renal phosphate excretion,BP,
19591,GO:1903405,1,0.880540943618798,0,9,protein localization to nuclear body,BP,
19592,GO:1903406,1,0.983447457550241,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19593,GO:1903408,1,0.983447457550241,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19595,GO:1903410,1,0.968358686519233,0,2,L-lysine import into cell,BP,
19596,GO:1903411,1,0.983426667499561,0,1,L-ornithine import into cell,BP,
19597,GO:1903412,1,0.969535025598803,0,3,response to bile acid,BP,
19598,GO:1903413,1,0.969535025598803,0,3,cellular response to bile acid,BP,
19599,GO:1903414,1,0.983545373437418,0,1,iron cation export,BP,
19600,GO:1903416,1,0.910313442336936,0,6,response to glycoside,BP,
19601,GO:1903420,1,0.983426667500937,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19602,GO:1903421,1,0.808624437404273,0,14,regulation of synaptic vesicle recycling,BP,
19603,GO:1903422,1,0.951096694082165,0,3,negative regulation of synaptic vesicle recycling,BP,
19604,GO:1903423,1,0.938200849512888,0,4,positive regulation of synaptic vesicle recycling,BP,
19606,GO:1903427,1,0.767752662412126,0,19,negative regulation of reactive oxygen species biosynthetic process,BP,
19610,GO:1903431,1,0.909951731104627,0,6,positive regulation of cell maturation,BP,
19613,GO:1903434,1,0.983428049151643,0,1,negative regulation of constitutive secretory pathway,BP,
19615,GO:1903436,1,0.967265020526894,0,2,regulation of mitotic cytokinetic process,BP,
19616,GO:1903438,1,0.967265020526894,0,2,positive regulation of mitotic cytokinetic process,BP,
19617,GO:1903441,1,0.899222932684418,0,7,protein localization to ciliary membrane,BP,
19618,GO:1903444,1,0.983690624007748,0,1,negative regulation of brown fat cell differentiation,BP,
19619,GO:1903445,1,0.964616839432249,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19620,GO:1903450,1,0.983426667498378,0,1,regulation of G1 to G0 transition,BP,
19621,GO:1903452,1,0.983426667498378,0,1,positive regulation of G1 to G0 transition,BP,
19622,GO:1903461,1,0.983741645664804,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19623,GO:1903463,1,0.954889081125763,0,3,regulation of mitotic cell cycle DNA replication,BP,
19624,GO:1903464,1,0.970983459656292,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19625,GO:1903465,1,0.983426667501871,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19626,GO:1903487,1,0.97968056115246,0,2,regulation of lactation,BP,
19627,GO:1903488,1,0.991980865352406,0,1,negative regulation of lactation,BP,
19628,GO:1903489,1,0.987600674591234,0,1,positive regulation of lactation,BP,
19629,GO:1903490,1,0.967265020526894,0,2,positive regulation of mitotic cytokinesis,BP,
19630,GO:1903504,1,0.830895751936641,0,13,regulation of mitotic spindle checkpoint,BP,
19636,GO:1903513,1,0.683505231290948,0,26,endoplasmic reticulum to cytosol transport,BP,
19638,GO:1903515,1,0.983426667498821,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19639,GO:1903516,1,0.98401273432067,0,1,regulation of single strand break repair,BP,
19640,GO:1903517,1,0.98401273432067,0,1,negative regulation of single strand break repair,BP,
19646,GO:1903525,1,0.919843758336448,0,5,regulation of membrane tubulation,BP,
19647,GO:1903526,1,0.967147339024952,0,2,negative regulation of membrane tubulation,BP,
19648,GO:1903527,1,0.951096177115654,0,3,positive regulation of membrane tubulation,BP,
19653,GO:1903537,1,0.985273086224779,0,1,meiotic cell cycle process involved in oocyte maturation,BP,
19654,GO:1903538,1,0.985273086224779,0,1,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19655,GO:1903539,1,0.856980421347896,0,10,protein localization to postsynaptic membrane,BP,
19656,GO:1903540,1,0.856980421347896,0,10,establishment of protein localization to postsynaptic membrane,BP,
19658,GO:1903542,1,0.969528056070931,0,2,negative regulation of exosomal secretion,BP,
19662,GO:1903546,1,0.901846233829223,0,7,protein localization to photoreceptor outer segment,BP,
19663,GO:1903547,1,0.983139908335747,0,2,regulation of growth hormone activity,BP,
19670,GO:1903564,1,0.951187859031812,0,3,regulation of protein localization to cilium,BP,
19671,GO:1903565,1,0.983521452912664,0,1,negative regulation of protein localization to cilium,BP,
19672,GO:1903566,1,0.967126892146796,0,2,positive regulation of protein localization to cilium,BP,
19673,GO:1903567,1,0.983521452912664,0,1,regulation of protein localization to ciliary membrane,BP,
19674,GO:1903568,1,0.983521452912664,0,1,negative regulation of protein localization to ciliary membrane,BP,
19675,GO:1903570,1,0.983476161931517,0,1,regulation of protein kinase D signaling,BP,
19676,GO:1903572,1,0.983476161931517,0,1,positive regulation of protein kinase D signaling,BP,
19677,GO:1903573,1,0.580476986182802,0,37,negative regulation of response to endoplasmic reticulum stress,BP,
19678,GO:1903575,1,0.973153158396585,0,2,cornified envelope assembly,BP,
19679,GO:1903576,1,0.98640510554394,0,1,response to L-arginine,BP,
19683,GO:1903584,1,0.9834266675032,0,1,regulation of histone deubiquitination,BP,
19684,GO:1903586,1,0.9834266675032,0,1,positive regulation of histone deubiquitination,BP,
19685,GO:1903587,1,0.942276283709943,0,4,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19686,GO:1903588,1,0.958158959935705,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19687,GO:1903589,1,0.983426667501234,0,1,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19688,GO:1903593,1,0.964151775726182,0,3,regulation of histamine secretion by mast cell,BP,
19689,GO:1903595,1,0.964151775726182,0,3,positive regulation of histamine secretion by mast cell,BP,
19690,GO:1903596,1,0.93765557428154,0,4,regulation of gap junction assembly,BP,
19691,GO:1903597,1,0.983541313849098,0,1,negative regulation of gap junction assembly,BP,
19692,GO:1903598,1,0.95334953370643,0,3,positive regulation of gap junction assembly,BP,
19693,GO:1903599,1,0.767590461038241,0,19,positive regulation of mitophagy,BP,
19694,GO:1903608,1,0.900000255091064,0,7,protein localization to cytoplasmic stress granule,BP,
19695,GO:1903610,1,0.987024218811306,0,1,regulation of calcium-dependent ATPase activity,BP,
19696,GO:1903611,1,0.987024218811306,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19697,GO:1903613,1,0.983426667502269,0,1,regulation of protein tyrosine phosphatase activity,BP,
19698,GO:1903615,1,0.983426667502269,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19699,GO:1903618,1,0.983426667503399,0,1,regulation of transdifferentiation,BP,
19700,GO:1903620,1,0.983426667503399,0,1,positive regulation of transdifferentiation,BP,
19701,GO:1903621,1,0.986942154324683,0,1,protein localization to photoreceptor connecting cilium,BP,
19702,GO:1903624,1,0.90726007307288,0,8,regulation of DNA catabolic process,BP,
19703,GO:1903625,1,0.971584714886599,0,2,negative regulation of DNA catabolic process,BP,
19704,GO:1903626,1,0.971572433568588,0,3,positive regulation of DNA catabolic process,BP,
19705,GO:1903627,1,0.987024218811306,0,1,regulation of dUTP diphosphatase activity,BP,
19706,GO:1903629,1,0.987024218811306,0,1,positive regulation of dUTP diphosphatase activity,BP,
19707,GO:1903630,1,0.978132868579873,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19708,GO:1903631,1,0.987024218811306,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19709,GO:1903632,1,0.990992248721984,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19710,GO:1903633,1,0.987024218811306,0,1,regulation of leucine-tRNA ligase activity,BP,
19711,GO:1903634,1,0.987024218811306,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19712,GO:1903636,1,0.995641439960648,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19713,GO:1903638,1,0.995641439960648,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19714,GO:1903639,1,0.995988782303528,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19715,GO:1903640,1,0.995988782303528,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19716,GO:1903644,1,0.980452548107956,0,2,regulation of chaperone-mediated protein folding,BP,
19717,GO:1903645,1,0.995641439960648,0,1,negative regulation of chaperone-mediated protein folding,BP,
19719,GO:1903650,1,0.984840681380507,0,2,negative regulation of cytoplasmic transport,BP,
19721,GO:1903659,1,0.968837900899316,0,3,regulation of complement-dependent cytotoxicity,BP,
19722,GO:1903660,1,0.968837900899316,0,3,negative regulation of complement-dependent cytotoxicity,BP,
19726,GO:1903673,1,0.987063304929025,0,1,mitotic cleavage furrow formation,BP,
19727,GO:1903674,1,0.98709565392429,0,1,regulation of cap-dependent translational initiation,BP,
19728,GO:1903676,1,0.98709565392429,0,1,positive regulation of cap-dependent translational initiation,BP,
19729,GO:1903677,1,0.958686088098769,0,3,regulation of cap-independent translational initiation,BP,
19730,GO:1903679,1,0.958686088098769,0,3,positive regulation of cap-independent translational initiation,BP,
19731,GO:1903689,1,0.890378304417229,0,7,regulation of wound healing, spreading of epidermal cells,BP,
19732,GO:1903690,1,0.93533009916583,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19733,GO:1903691,1,0.967126892145732,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19734,GO:1903697,1,0.983547023736018,0,1,negative regulation of microvillus assembly,BP,
19735,GO:1903699,1,0.983426667494932,0,1,tarsal gland development,BP,
19736,GO:1903701,1,0.983426667502414,0,1,substantia propria of cornea development,BP,
19737,GO:1903704,1,0.983426667503399,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19741,GO:1903709,1,0.983426667494932,0,1,uterine gland development,BP,
19742,GO:1903712,1,0.983435876792907,0,1,cysteine transmembrane transport,BP,
19744,GO:1903717,1,0.983426667501773,0,1,response to ammonia,BP,
19745,GO:1903718,1,0.983426667501773,0,1,cellular response to ammonia,BP,
19748,GO:1903722,1,0.976761999037509,0,2,regulation of centriole elongation,BP,
19749,GO:1903723,1,0.993117423875273,0,1,negative regulation of centriole elongation,BP,
19750,GO:1903724,1,0.983531698263396,0,1,positive regulation of centriole elongation,BP,
19755,GO:1903742,1,0.990267727319466,0,1,regulation of anterograde synaptic vesicle transport,BP,
19756,GO:1903743,1,0.990267727319466,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19758,GO:1903748,1,0.904130738817554,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19760,GO:1903750,1,0.947366004963906,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19761,GO:1903751,1,0.947366004963906,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19762,GO:1903753,1,0.936021322501353,0,4,negative regulation of p38MAPK cascade,BP,
19763,GO:1903755,1,0.991096224378579,0,1,positive regulation of SUMO transferase activity,BP,
19764,GO:1903756,1,0.968895525514727,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19765,GO:1903758,1,0.968895525514727,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19766,GO:1903759,1,0.983690624007748,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19767,GO:1903760,1,0.951096188842698,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19768,GO:1903762,1,0.967126904075999,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19769,GO:1903763,1,0.95163099718713,0,3,gap junction channel activity involved in cell communication by electrical coupling,MF,
19770,GO:1903764,1,0.961191836422297,0,3,regulation of potassium ion export across plasma membrane,BP,
19771,GO:1903765,1,0.983785524561353,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19772,GO:1903766,1,0.993501545196378,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19773,GO:1903767,1,0.969794177778552,0,2,sweet taste receptor complex,CC,
19774,GO:1903768,1,0.969794177778552,0,2,taste receptor complex,CC,
19775,GO:1903770,1,0.98401273432067,0,1,negative regulation of beta-galactosidase activity,BP,
19776,GO:1903772,1,0.93667430260173,0,5,regulation of viral budding via host ESCRT complex,BP,
19777,GO:1903774,1,0.959831904217432,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19778,GO:1903775,1,0.983535787490925,0,1,regulation of DNA double-strand break processing,BP,
19779,GO:1903778,1,0.968318316670439,0,2,protein localization to vacuolar membrane,BP,
19781,GO:1903781,1,0.951096188843415,0,3,positive regulation of cardiac conduction,BP,
19782,GO:1903786,1,0.984305357758025,0,1,regulation of glutathione biosynthetic process,BP,
19783,GO:1903788,1,0.984305357758025,0,1,positive regulation of glutathione biosynthetic process,BP,
19784,GO:1903789,1,0.970990867332942,0,2,regulation of amino acid transmembrane transport,BP,
19787,GO:1903795,1,0.922492084747584,0,5,regulation of inorganic anion transmembrane transport,BP,
19788,GO:1903796,1,0.967712707431577,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19789,GO:1903797,1,0.953276812171806,0,3,positive regulation of inorganic anion transmembrane transport,BP,
19791,GO:1903799,1,0.892814461257091,0,7,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19793,GO:1903802,1,0.919824307515122,0,5,L-glutamate(1-) import into cell,BP,
19794,GO:1903814,1,0.993501545196378,0,1,regulation of collecting lymphatic vessel constriction,BP,
19795,GO:1903815,1,0.993501545196378,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19796,GO:1903817,1,0.910093319704306,0,7,negative regulation of voltage-gated potassium channel activity,BP,
19797,GO:1903818,1,0.929250218584691,0,5,positive regulation of voltage-gated potassium channel activity,BP,
19798,GO:1903823,1,0.98401273432067,0,1,telomere single strand break repair,BP,
19799,GO:1903824,1,0.98401273432067,0,1,negative regulation of telomere single strand break repair,BP,
19801,GO:1903826,1,0.941129899624839,0,4,arginine transmembrane transport,BP,
19806,GO:1903831,1,0.74946966417015,0,21,signal transduction involved in cellular response to ammonium ion,BP,
19807,GO:1903837,1,0.984968562250546,0,1,regulation of mRNA 3'-UTR binding,BP,
19808,GO:1903839,1,0.984968562250546,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19811,GO:1903846,1,0.69148203035332,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
19814,GO:1903850,1,0.984475036319805,0,1,regulation of cristae formation,BP,
19815,GO:1903852,1,0.984475036319805,0,1,positive regulation of cristae formation,BP,
19816,GO:1903859,1,0.75980851515273,0,18,regulation of dendrite extension,BP,
19817,GO:1903860,1,0.980344048980329,0,2,negative regulation of dendrite extension,BP,
19818,GO:1903861,1,0.775059022330307,0,16,positive regulation of dendrite extension,BP,
19819,GO:1903862,1,0.92008843859718,0,7,positive regulation of oxidative phosphorylation,BP,
19821,GO:1903874,1,0.951210996352976,0,3,ferrous iron transmembrane transport,BP,
19822,GO:1903881,1,0.983437397741892,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19823,GO:1903883,1,0.983437397741892,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19824,GO:1903884,1,0.983437397741892,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19825,GO:1903886,1,0.983437397741892,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19826,GO:1903888,1,0.994020585908706,0,1,regulation of plant epidermal cell differentiation,BP,
19827,GO:1903889,1,0.994020585908706,0,1,negative regulation of plant epidermal cell differentiation,BP,
19828,GO:1903891,1,0.967147787368467,0,2,regulation of ATF6-mediated unfolded protein response,BP,
19829,GO:1903892,1,0.983447888989373,0,1,negative regulation of ATF6-mediated unfolded protein response,BP,
19830,GO:1903894,1,0.843854958615946,0,12,regulation of IRE1-mediated unfolded protein response,BP,
19831,GO:1903895,1,0.967848140892882,0,2,negative regulation of IRE1-mediated unfolded protein response,BP,
19832,GO:1903896,1,0.896185927919218,0,8,positive regulation of IRE1-mediated unfolded protein response,BP,
19833,GO:1903897,1,0.865816717164114,0,10,regulation of PERK-mediated unfolded protein response,BP,
19834,GO:1903898,1,0.927077795412339,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19835,GO:1903899,1,0.949683018843706,0,4,positive regulation of PERK-mediated unfolded protein response,BP,
19837,GO:1903901,1,0.309113348202134,0,86,negative regulation of viral life cycle,BP,
19839,GO:1903903,1,0.969088490873148,0,2,regulation of establishment of T cell polarity,BP,
19840,GO:1903905,1,0.98453420551145,0,1,positive regulation of establishment of T cell polarity,BP,
19841,GO:1903906,1,0.984312657560027,0,1,regulation of plasma membrane raft polarization,BP,
19842,GO:1903909,1,0.916130710260188,0,6,regulation of receptor clustering,BP,
19843,GO:1903910,1,0.985398061756451,0,1,negative regulation of receptor clustering,BP,
19844,GO:1903911,1,0.944531015267798,0,4,positive regulation of receptor clustering,BP,
19845,GO:1903912,1,0.926945671248949,0,5,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19846,GO:1903916,1,0.985256975000529,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19847,GO:1903917,1,0.985256975000529,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19848,GO:1903918,1,0.98342666749961,0,1,regulation of actin filament severing,BP,
19849,GO:1903919,1,0.98342666749961,0,1,negative regulation of actin filament severing,BP,
19850,GO:1903921,1,0.967998257362417,0,2,regulation of protein processing in phagocytic vesicle,BP,
19851,GO:1903923,1,0.967998257362417,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19852,GO:1903924,1,0.985795979958113,0,1,estradiol binding,MF,
19853,GO:1903925,1,0.987302301550024,0,1,response to bisphenol A,BP,
19854,GO:1903926,1,0.987302301550024,0,1,cellular response to bisphenol A,BP,
19855,GO:1903935,1,0.928066203567655,0,5,response to sodium arsenite,BP,
19856,GO:1903936,1,0.943679587503651,0,4,cellular response to sodium arsenite,BP,
19857,GO:1903937,1,0.967158418328175,0,2,response to acrylamide,BP,
19858,GO:1903939,1,0.983552635096111,0,1,regulation of TORC2 signaling,BP,
19859,GO:1903943,1,0.986876745423811,0,1,regulation of hepatocyte apoptotic process,BP,
19860,GO:1903944,1,0.986876745423811,0,1,negative regulation of hepatocyte apoptotic process,BP,
19861,GO:1903946,1,0.983785524561353,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19862,GO:1903947,1,0.967126904075999,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19863,GO:1903949,1,0.96712690407624,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19864,GO:1903952,1,0.983426679624011,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19865,GO:1903954,1,0.983426679624011,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19866,GO:1903955,1,0.323959623444257,0,82,positive regulation of protein targeting to mitochondrion,BP,
19869,GO:1903961,1,0.937474734118427,0,4,positive regulation of anion transmembrane transport,BP,
19870,GO:1903963,1,0.70097461535676,0,29,arachidonate transport,BP,
19871,GO:1903969,1,0.962846802913537,0,3,regulation of response to macrophage colony-stimulating factor,BP,
19872,GO:1903970,1,0.977408437000323,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
19873,GO:1903971,1,0.985103195280682,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
19874,GO:1903972,1,0.962846802913537,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19875,GO:1903973,1,0.977408437000323,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19876,GO:1903974,1,0.985103195280682,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19877,GO:1903975,1,0.884772029942722,0,9,regulation of glial cell migration,BP,
19878,GO:1903976,1,0.948960182979085,0,4,negative regulation of glial cell migration,BP,
19879,GO:1903977,1,0.954139184554333,0,3,positive regulation of glial cell migration,BP,
19880,GO:1903978,1,0.981031377777223,0,2,regulation of microglial cell activation,BP,
19881,GO:1903979,1,0.991784979077437,0,1,negative regulation of microglial cell activation,BP,
19882,GO:1903980,1,0.981031377777223,0,2,positive regulation of microglial cell activation,BP,
19883,GO:1903984,1,0.954074592273279,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
19884,GO:1903988,1,0.983545373437418,0,1,ferrous iron export across plasma membrane,BP,
19885,GO:1903989,1,0.979586953935502,0,2,regulation of ferrous iron import into cell,BP,
19886,GO:1903991,1,0.979586953935502,0,2,positive regulation of ferrous iron import into cell,BP,
19887,GO:1903995,1,0.989157697361939,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19888,GO:1903997,1,0.989157697361939,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19889,GO:1903998,1,0.967126892149647,0,2,regulation of eating behavior,BP,
19890,GO:1903999,1,0.983426667502414,0,1,negative regulation of eating behavior,BP,
19891,GO:1904000,1,0.983426667498183,0,1,positive regulation of eating behavior,BP,
19892,GO:1904008,1,0.989819573305761,0,1,response to monosodium glutamate,BP,
19893,GO:1904009,1,0.989819573305761,0,1,cellular response to monosodium glutamate,BP,
19894,GO:1904010,1,0.989819573305761,0,1,response to Aroclor 1254,BP,
19895,GO:1904016,1,0.96712689215062,0,2,response to Thyroglobulin triiodothyronine,BP,
19896,GO:1904017,1,0.96712689215062,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
19899,GO:1904020,1,0.983516817803915,0,1,regulation of G-protein coupled receptor internalization,BP,
19900,GO:1904021,1,0.983516817803915,0,1,negative regulation of G-protein coupled receptor internalization,BP,
19903,GO:1904026,1,0.984801657841097,0,1,regulation of collagen fibril organization,BP,
19904,GO:1904027,1,0.984801657841097,0,1,negative regulation of collagen fibril organization,BP,
19910,GO:1904037,1,0.70636699914786,0,24,positive regulation of epithelial cell apoptotic process,BP,
19911,GO:1904041,1,0.983583320421907,0,1,regulation of cystathionine beta-synthase activity,BP,
19912,GO:1904042,1,0.983583320421907,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19913,GO:1904044,1,0.94836090915589,0,4,response to aldosterone,BP,
19914,GO:1904045,1,0.985844266781774,0,1,cellular response to aldosterone,BP,
19915,GO:1904046,1,0.993252053348278,0,1,negative regulation of vascular endothelial growth factor production,BP,
19916,GO:1904047,1,0.955930782619061,0,3,S-adenosyl-L-methionine binding,MF,
19917,GO:1904048,1,0.967126892148826,0,2,regulation of spontaneous neurotransmitter secretion,BP,
19918,GO:1904049,1,0.983426667496707,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
19919,GO:1904050,1,0.983426667503053,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19920,GO:1904054,1,0.983426667498183,0,1,regulation of cholangiocyte proliferation,BP,
19921,GO:1904056,1,0.983426667498183,0,1,positive regulation of cholangiocyte proliferation,BP,
19922,GO:1904057,1,0.973322220682034,0,2,negative regulation of sensory perception of pain,BP,
19923,GO:1904058,1,0.9418561284681,0,4,positive regulation of sensory perception of pain,BP,
19924,GO:1904059,1,0.967290884107384,0,2,regulation of locomotor rhythm,BP,
19928,GO:1904071,1,0.96712689215081,0,2,presynaptic active zone assembly,BP,
19929,GO:1904073,1,0.983426667499956,0,1,regulation of trophectodermal cell proliferation,BP,
19930,GO:1904075,1,0.983426667499956,0,1,positive regulation of trophectodermal cell proliferation,BP,
19931,GO:1904098,1,0.955931454640206,0,3,regulation of protein O-linked glycosylation,BP,
19932,GO:1904100,1,0.955931454640206,0,3,positive regulation of protein O-linked glycosylation,BP,
19933,GO:1904106,1,0.968520457700344,0,2,protein localization to microvillus,BP,
19934,GO:1904115,1,0.571806566653455,0,38,axon cytoplasm,CC,
19935,GO:1904116,1,0.951837447394138,0,3,response to vasopressin,BP,
19936,GO:1904117,1,0.951837447394138,0,3,cellular response to vasopressin,BP,
19937,GO:1904118,1,0.983737465785256,0,1,regulation of otic vesicle morphogenesis,BP,
19938,GO:1904120,1,0.983737465785256,0,1,positive regulation of otic vesicle morphogenesis,BP,
19939,GO:1904121,1,0.967126892151585,0,2,phosphatidylethanolamine transporter activity,MF,
19940,GO:1904124,1,0.964028179979132,0,3,microglial cell migration,BP,
19941,GO:1904139,1,0.964028179979132,0,3,regulation of microglial cell migration,BP,
19942,GO:1904140,1,0.989157697361939,0,1,negative regulation of microglial cell migration,BP,
19943,GO:1904141,1,0.985103195280682,0,1,positive regulation of microglial cell migration,BP,
19944,GO:1904149,1,0.989157697361939,0,1,regulation of microglial cell mediated cytotoxicity,BP,
19945,GO:1904151,1,0.989157697361939,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
19946,GO:1904152,1,0.827004982598838,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
19947,GO:1904153,1,0.875880294746643,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
19948,GO:1904154,1,0.96009388616841,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
19949,GO:1904155,1,0.983552350469914,0,1,DN2 thymocyte differentiation,BP,
19950,GO:1904156,1,0.983552350469914,0,1,DN3 thymocyte differentiation,BP,
19951,GO:1904158,1,0.954803581331981,0,3,axonemal central apparatus assembly,BP,
19952,GO:1904167,1,0.983426667496313,0,1,regulation of thyroid hormone receptor activity,BP,
19953,GO:1904168,1,0.983426667496313,0,1,negative regulation of thyroid hormone receptor activity,BP,
19954,GO:1904170,1,0.983704384158376,0,1,regulation of bleb assembly,BP,
19955,GO:1904172,1,0.983704384158376,0,1,positive regulation of bleb assembly,BP,
19956,GO:1904177,1,0.929252900228758,0,5,regulation of adipose tissue development,BP,
19957,GO:1904179,1,0.937857518981064,0,4,positive regulation of adipose tissue development,BP,
19958,GO:1904180,1,0.909404593630316,0,7,negative regulation of membrane depolarization,BP,
19959,GO:1904181,1,0.860068186256664,0,11,positive regulation of membrane depolarization,BP,
19960,GO:1904182,1,0.991305795966007,0,1,regulation of pyruvate dehydrogenase activity,BP,
19961,GO:1904192,1,0.983426667498183,0,1,regulation of cholangiocyte apoptotic process,BP,
19962,GO:1904193,1,0.983426667498183,0,1,negative regulation of cholangiocyte apoptotic process,BP,
19963,GO:1904195,1,0.983426667498183,0,1,regulation of granulosa cell proliferation,BP,
19964,GO:1904197,1,0.983426667498183,0,1,positive regulation of granulosa cell proliferation,BP,
19965,GO:1904199,1,0.983426667503345,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19966,GO:1904200,1,0.983426667498183,0,1,iodide transmembrane transport,BP,
19967,GO:1904201,1,0.983426667498183,0,1,regulation of iodide transport,BP,
19968,GO:1904202,1,0.983426667498183,0,1,negative regulation of iodide transport,BP,
19969,GO:1904204,1,0.967126892148439,0,2,regulation of skeletal muscle hypertrophy,BP,
19970,GO:1904205,1,0.983426667501186,0,1,negative regulation of skeletal muscle hypertrophy,BP,
19971,GO:1904206,1,0.983426667498183,0,1,positive regulation of skeletal muscle hypertrophy,BP,
19972,GO:1904207,1,0.969519036090979,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
19973,GO:1904209,1,0.969519036090979,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
19974,GO:1904210,1,0.989928884877706,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19975,GO:1904211,1,0.971376621935495,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
19976,GO:1904212,1,0.983426667498183,0,1,regulation of iodide transmembrane transport,BP,
19977,GO:1904213,1,0.983426667498183,0,1,negative regulation of iodide transmembrane transport,BP,
19978,GO:1904217,1,0.957964707410318,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
19979,GO:1904219,1,0.957964707410318,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
19980,GO:1904220,1,0.943332979173879,0,4,regulation of serine C-palmitoyltransferase activity,BP,
19981,GO:1904222,1,0.957964707410318,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
19982,GO:1904226,1,0.985942385253858,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
19983,GO:1904227,1,0.985942385253858,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
19984,GO:1904229,1,0.9769090427577,0,2,regulation of succinate dehydrogenase activity,BP,
19985,GO:1904231,1,0.9769090427577,0,2,positive regulation of succinate dehydrogenase activity,BP,
19986,GO:1904232,1,0.9769090427577,0,2,regulation of aconitate hydratase activity,BP,
19987,GO:1904234,1,0.9769090427577,0,2,positive regulation of aconitate hydratase activity,BP,
19988,GO:1904235,1,0.983426667498626,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
19989,GO:1904237,1,0.983426667498626,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
19991,GO:1904239,1,0.989928884877706,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19992,GO:1904240,1,0.989928884877706,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19993,GO:1904245,1,0.971893683320865,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
19994,GO:1904246,1,0.987925476042536,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
19995,GO:1904247,1,0.983773076289579,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
19996,GO:1904251,1,0.859219638567452,0,10,regulation of bile acid metabolic process,BP,
19997,GO:1904252,1,0.956642218820597,0,3,negative regulation of bile acid metabolic process,BP,
19998,GO:1904253,1,0.955034712583655,0,3,positive regulation of bile acid metabolic process,BP,
19999,GO:1904259,1,0.919824307510286,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20000,GO:1904261,1,0.919824307510286,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20002,GO:1904263,1,0.904170600806173,0,7,positive regulation of TORC1 signaling,BP,
20003,GO:1904264,1,0.830868021745912,0,12,ubiquitin protein ligase activity involved in ERAD pathway,MF,
20004,GO:1904265,1,0.983426667501135,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20005,GO:1904266,1,0.983426667500003,0,1,regulation of Schwann cell chemotaxis,BP,
20006,GO:1904268,1,0.983426667500003,0,1,positive regulation of Schwann cell chemotaxis,BP,
20007,GO:1904274,1,0.985799676023169,0,1,tricellular tight junction assembly,BP,
20008,GO:1904282,1,0.986939888461523,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20009,GO:1904283,1,0.986939888461523,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20010,GO:1904288,1,0.937281783224713,0,4,BAT3 complex binding,MF,
20011,GO:1904289,1,0.983885143791916,0,1,regulation of mitotic DNA damage checkpoint,BP,
20012,GO:1904292,1,0.665195762641737,0,27,regulation of ERAD pathway,BP,
20013,GO:1904293,1,0.8268169669173,0,13,negative regulation of ERAD pathway,BP,
20014,GO:1904294,1,0.819876914581505,0,13,positive regulation of ERAD pathway,BP,
20015,GO:1904298,1,0.983426667503304,0,1,regulation of transcytosis,BP,
20016,GO:1904300,1,0.983426667503304,0,1,positive regulation of transcytosis,BP,
20017,GO:1904301,1,0.983426667503304,0,1,regulation of maternal process involved in parturition,BP,
20018,GO:1904303,1,0.983426667503304,0,1,positive regulation of maternal process involved in parturition,BP,
20019,GO:1904304,1,0.983426667503304,0,1,regulation of gastro-intestinal system smooth muscle contraction,BP,
20020,GO:1904306,1,0.983426667503304,0,1,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20021,GO:1904313,1,0.973515811246229,0,2,response to methamphetamine hydrochloride,BP,
20022,GO:1904315,1,0.753382696577672,0,19,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20023,GO:1904316,1,0.983426667503304,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20024,GO:1904317,1,0.983426667503304,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20025,GO:1904321,1,0.860628095187996,0,9,response to forskolin,BP,
20026,GO:1904322,1,0.860628095187996,0,9,cellular response to forskolin,BP,
20027,GO:1904327,1,0.968407661015267,0,2,protein localization to cytosolic proteasome complex,BP,
20028,GO:1904338,1,0.869105504163202,0,10,regulation of dopaminergic neuron differentiation,BP,
20029,GO:1904339,1,0.956842473175518,0,3,negative regulation of dopaminergic neuron differentiation,BP,
20030,GO:1904340,1,0.951816213123036,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20031,GO:1904350,1,0.927860842859914,0,5,regulation of protein catabolic process in the vacuole,BP,
20032,GO:1904351,1,0.967279666993054,0,2,negative regulation of protein catabolic process in the vacuole,BP,
20033,GO:1904352,1,0.973684132169344,0,2,positive regulation of protein catabolic process in the vacuole,BP,
20034,GO:1904353,1,0.672085978872679,0,26,regulation of telomere capping,BP,
20035,GO:1904354,1,0.877963935079223,0,8,negative regulation of telomere capping,BP,
20036,GO:1904355,1,0.778531704995259,0,17,positive regulation of telomere capping,BP,
20037,GO:1904356,1,0.442554987796597,0,54,regulation of telomere maintenance via telomere lengthening,BP,
20038,GO:1904357,1,0.711948022997165,0,22,negative regulation of telomere maintenance via telomere lengthening,BP,
20039,GO:1904358,1,0.595754196840826,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
20040,GO:1904373,1,0.988991635209428,0,1,response to kainic acid,BP,
20044,GO:1904378,1,0.955148535008821,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20045,GO:1904379,1,0.968407661015267,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20046,GO:1904380,1,0.749029126098183,0,20,endoplasmic reticulum mannose trimming,BP,
20047,GO:1904381,1,0.951308578245026,0,3,Golgi apparatus mannose trimming,BP,
20048,GO:1904382,1,0.939628562019147,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20049,GO:1904383,1,0.954641547760498,0,3,response to sodium phosphate,BP,
20051,GO:1904386,1,0.920467969626564,0,5,response to L-phenylalanine derivative,BP,
20052,GO:1904387,1,0.967477941780756,0,2,cellular response to L-phenylalanine derivative,BP,
20053,GO:1904389,1,0.988991635209428,0,1,rod bipolar cell differentiation,BP,
20054,GO:1904391,1,0.988991635209428,0,1,response to ciliary neurotrophic factor,BP,
20055,GO:1904393,1,0.958396531367198,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20056,GO:1904394,1,0.985398061756451,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20057,GO:1904395,1,0.9726000010291,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20058,GO:1904396,1,0.88412408948004,0,8,regulation of neuromuscular junction development,BP,
20059,GO:1904397,1,0.974549781148461,0,2,negative regulation of neuromuscular junction development,BP,
20060,GO:1904398,1,0.956478937241841,0,3,positive regulation of neuromuscular junction development,BP,
20061,GO:1904399,1,0.988991635209428,0,1,heparan sulfate binding,MF,
20062,GO:1904400,1,0.983753871288844,0,1,response to Thyroid stimulating hormone,BP,
20063,GO:1904404,1,0.983426667499806,0,1,response to formaldehyde,BP,
20064,GO:1904406,1,0.85081929829408,0,12,negative regulation of nitric oxide metabolic process,BP,
20066,GO:1904408,1,0.991490907508798,0,1,melatonin binding,MF,
20067,GO:1904412,1,0.983450982062668,0,1,regulation of cardiac ventricle development,BP,
20068,GO:1904414,1,0.983450982062668,0,1,positive regulation of cardiac ventricle development,BP,
20069,GO:1904415,1,0.909928268346391,0,6,regulation of xenophagy,BP,
20070,GO:1904417,1,0.909928268346391,0,6,positive regulation of xenophagy,BP,
20071,GO:1904424,1,0.920830588189217,0,5,regulation of GTP binding,BP,
20072,GO:1904425,1,0.983432223714955,0,1,negative regulation of GTP binding,BP,
20073,GO:1904426,1,0.967875881537137,0,2,positive regulation of GTP binding,BP,
20074,GO:1904427,1,0.487658121416093,0,52,positive regulation of calcium ion transmembrane transport,BP,
20075,GO:1904428,1,0.983426667496017,0,1,negative regulation of tubulin deacetylation,BP,
20076,GO:1904429,1,0.89384905816765,0,7,regulation of t-circle formation,BP,
20077,GO:1904430,1,0.951737332336337,0,3,negative regulation of t-circle formation,BP,
20078,GO:1904431,1,0.939188280788956,0,4,positive regulation of t-circle formation,BP,
20079,GO:1904432,1,0.979586953935502,0,2,regulation of ferrous iron binding,BP,
20080,GO:1904434,1,0.979586953935502,0,2,positive regulation of ferrous iron binding,BP,
20081,GO:1904435,1,0.979586953935502,0,2,regulation of transferrin receptor binding,BP,
20082,GO:1904437,1,0.979586953935502,0,2,positive regulation of transferrin receptor binding,BP,
20083,GO:1904447,1,0.98342666750089,0,1,folic acid import into cell,BP,
20084,GO:1904448,1,0.98342666750271,0,1,regulation of aspartate secretion,BP,
20085,GO:1904450,1,0.98342666750271,0,1,positive regulation of aspartate secretion,BP,
20086,GO:1904454,1,0.983426667499166,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20087,GO:1904455,1,0.967126892152794,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20088,GO:1904456,1,0.987288030753513,0,1,negative regulation of neuronal action potential,BP,
20089,GO:1904457,1,0.98518072135659,0,1,positive regulation of neuronal action potential,BP,
20090,GO:1904464,1,0.987961453640098,0,1,regulation of matrix metallopeptidase secretion,BP,
20091,GO:1904465,1,0.987961453640098,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20092,GO:1904467,1,0.900954440442014,0,7,regulation of tumor necrosis factor secretion,BP,
20093,GO:1904468,1,0.954565733411416,0,3,negative regulation of tumor necrosis factor secretion,BP,
20094,GO:1904469,1,0.943847496407427,0,4,positive regulation of tumor necrosis factor secretion,BP,
20095,GO:1904478,1,0.902839202410966,0,9,regulation of intestinal absorption,BP,
20096,GO:1904479,1,0.949862356976673,0,4,negative regulation of intestinal absorption,BP,
20097,GO:1904481,1,0.985012736614487,0,1,response to tetrahydrofolate,BP,
20098,GO:1904482,1,0.985012736614487,0,1,cellular response to tetrahydrofolate,BP,
20099,GO:1904491,1,0.934960565357822,0,5,protein localization to ciliary transition zone,BP,
20100,GO:1904492,1,0.984622905141167,0,1,Ac-Asp-Glu binding,MF,
20101,GO:1904493,1,0.984622905141167,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20102,GO:1904499,1,0.983511021466145,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20103,GO:1904501,1,0.983511021466145,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20106,GO:1904505,1,0.938124736211175,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20107,GO:1904506,1,0.938124736211175,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20108,GO:1904515,1,0.983552635096111,0,1,positive regulation of TORC2 signaling,BP,
20109,GO:1904526,1,0.91206601767167,0,6,regulation of microtubule binding,BP,
20110,GO:1904527,1,0.968545081407705,0,2,negative regulation of microtubule binding,BP,
20111,GO:1904528,1,0.942592303896669,0,4,positive regulation of microtubule binding,BP,
20112,GO:1904529,1,0.967443429576405,0,2,regulation of actin filament binding,BP,
20113,GO:1904530,1,0.983748517642431,0,1,negative regulation of actin filament binding,BP,
20114,GO:1904531,1,0.983426667501923,0,1,positive regulation of actin filament binding,BP,
20115,GO:1904533,1,0.952177435106399,0,3,regulation of telomeric loop disassembly,BP,
20116,GO:1904534,1,0.968226299050826,0,2,negative regulation of telomeric loop disassembly,BP,
20117,GO:1904535,1,0.983426667503056,0,1,positive regulation of telomeric loop disassembly,BP,
20118,GO:1904542,1,0.984475036319805,0,1,regulation of free ubiquitin chain polymerization,BP,
20119,GO:1904544,1,0.984475036319805,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20120,GO:1904562,1,0.967126892148585,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20121,GO:1904565,1,0.983720614694209,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20122,GO:1904566,1,0.983720614694209,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20123,GO:1904567,1,0.983853541538817,0,1,response to wortmannin,BP,
20124,GO:1904568,1,0.983853541538817,0,1,cellular response to wortmannin,BP,
20125,GO:1904569,1,0.984040092908854,0,2,regulation of selenocysteine incorporation,BP,
20126,GO:1904570,1,0.987935740848099,0,1,negative regulation of selenocysteine incorporation,BP,
20127,GO:1904571,1,0.996056981778241,0,1,positive regulation of selenocysteine incorporation,BP,
20128,GO:1904572,1,0.987935740848099,0,1,negative regulation of mRNA binding,BP,
20129,GO:1904573,1,0.987935740848099,0,1,regulation of selenocysteine insertion sequence binding,BP,
20130,GO:1904574,1,0.987935740848099,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20131,GO:1904576,1,0.972678241199683,0,2,response to tunicamycin,BP,
20132,GO:1904577,1,0.972678241199683,0,2,cellular response to tunicamycin,BP,
20133,GO:1904578,1,0.962291760871731,0,3,response to thapsigargin,BP,
20134,GO:1904579,1,0.962291760871731,0,3,cellular response to thapsigargin,BP,
20135,GO:1904580,1,0.971961853305674,0,2,regulation of intracellular mRNA localization,BP,
20136,GO:1904582,1,0.971961853305674,0,2,positive regulation of intracellular mRNA localization,BP,
20137,GO:1904585,1,0.986046452668428,0,1,response to putrescine,BP,
20138,GO:1904586,1,0.986046452668428,0,1,cellular response to putrescine,BP,
20139,GO:1904587,1,0.930986634950201,0,5,response to glycoprotein,BP,
20140,GO:1904588,1,0.990805197582932,0,1,cellular response to glycoprotein,BP,
20144,GO:1904594,1,0.983426667495718,0,1,regulation of termination of RNA polymerase II transcription,BP,
20145,GO:1904595,1,0.983426667495718,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20146,GO:1904596,1,0.990205585630676,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20147,GO:1904597,1,0.990205585630676,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20148,GO:1904599,1,0.990205585630676,0,1,advanced glycation end-product binding,MF,
20149,GO:1904602,1,0.973452156800296,0,2,serotonin-activated cation-selective channel complex,CC,
20150,GO:1904603,1,0.990205585630676,0,1,regulation of advanced glycation end-product receptor activity,BP,
20151,GO:1904604,1,0.990205585630676,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20152,GO:1904606,1,0.983511458249465,0,1,fat cell apoptotic process,BP,
20153,GO:1904612,1,0.983753871288844,0,1,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20154,GO:1904616,1,0.967443429576405,0,2,regulation of actin binding,BP,
20155,GO:1904617,1,0.983748517642431,0,1,negative regulation of actin binding,BP,
20156,GO:1904618,1,0.983426667501923,0,1,positive regulation of actin binding,BP,
20157,GO:1904627,1,0.926860347327404,0,5,response to phorbol 13-acetate 12-myristate,BP,
20158,GO:1904628,1,0.926860347327404,0,5,cellular response to phorbol 13-acetate 12-myristate,BP,
20159,GO:1904631,1,0.985735435820236,0,1,response to glucoside,BP,
20160,GO:1904633,1,0.983426667501085,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20161,GO:1904635,1,0.983426667501085,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20162,GO:1904636,1,0.942073019897914,0,4,response to ionomycin,BP,
20163,GO:1904637,1,0.942073019897914,0,4,cellular response to ionomycin,BP,
20164,GO:1904638,1,0.983426667501085,0,1,response to resveratrol,BP,
20165,GO:1904639,1,0.983426667501085,0,1,cellular response to resveratrol,BP,
20166,GO:1904640,1,0.961588499161325,0,3,response to methionine,BP,
20167,GO:1904645,1,0.916850950004796,0,6,response to beta-amyloid,BP,
20168,GO:1904646,1,0.957704217794111,0,3,cellular response to beta-amyloid,BP,
20169,GO:1904647,1,0.983426667497788,0,1,response to rotenone,BP,
20170,GO:1904649,1,0.983511458249465,0,1,regulation of fat cell apoptotic process,BP,
20171,GO:1904651,1,0.983511458249465,0,1,positive regulation of fat cell apoptotic process,BP,
20173,GO:1904666,1,0.333498960115392,0,92,regulation of ubiquitin protein ligase activity,BP,
20174,GO:1904667,1,0.41920061003246,0,77,negative regulation of ubiquitin protein ligase activity,BP,
20175,GO:1904668,1,0.360935806768456,0,84,positive regulation of ubiquitin protein ligase activity,BP,
20178,GO:1904674,1,0.96764740416091,0,2,positive regulation of somatic stem cell population maintenance,BP,
20179,GO:1904675,1,0.983955915701001,0,1,regulation of somatic stem cell division,BP,
20180,GO:1904677,1,0.983955915701001,0,1,positive regulation of somatic stem cell division,BP,
20181,GO:1904680,1,0.712374786351351,0,27,peptide transmembrane transporter activity,MF,
20182,GO:1904681,1,0.98440110090942,0,1,response to 3-methylcholanthrene,BP,
20183,GO:1904683,1,0.90662766948816,0,6,regulation of metalloendopeptidase activity,BP,
20184,GO:1904684,1,0.935333707837966,0,4,negative regulation of metalloendopeptidase activity,BP,
20185,GO:1904685,1,0.969317672540104,0,2,positive regulation of metalloendopeptidase activity,BP,
20186,GO:1904688,1,0.950616429844193,0,4,regulation of cytoplasmic translational initiation,BP,
20187,GO:1904689,1,0.991584058825728,0,1,negative regulation of cytoplasmic translational initiation,BP,
20188,GO:1904690,1,0.958686088098769,0,3,positive regulation of cytoplasmic translational initiation,BP,
20189,GO:1904691,1,0.986160690308278,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20190,GO:1904692,1,0.983446529051692,0,1,positive regulation of type B pancreatic cell proliferation,BP,
20191,GO:1904693,1,0.951102171269775,0,3,midbrain morphogenesis,BP,
20192,GO:1904694,1,0.95235580316691,0,3,negative regulation of vascular smooth muscle contraction,BP,
20193,GO:1904700,1,0.984627953628669,0,1,granulosa cell apoptotic process,BP,
20194,GO:1904701,1,0.987617988261782,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20196,GO:1904706,1,0.903212998152068,0,8,negative regulation of vascular smooth muscle cell proliferation,BP,
20198,GO:1904708,1,0.984627953628669,0,1,regulation of granulosa cell apoptotic process,BP,
20199,GO:1904711,1,0.987617988261782,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20200,GO:1904713,1,0.968407661012362,0,2,beta-catenin destruction complex binding,MF,
20201,GO:1904714,1,0.887037057058788,0,8,regulation of chaperone-mediated autophagy,BP,
20202,GO:1904715,1,0.957040003280551,0,3,negative regulation of chaperone-mediated autophagy,BP,
20203,GO:1904716,1,0.985299025392367,0,1,positive regulation of chaperone-mediated autophagy,BP,
20204,GO:1904717,1,0.985051590296968,0,1,regulation of AMPA glutamate receptor clustering,BP,
20205,GO:1904719,1,0.985051590296968,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20206,GO:1904720,1,0.969138462003752,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20207,GO:1904721,1,0.983776442232462,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20208,GO:1904722,1,0.98512162401357,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20209,GO:1904723,1,0.987617988261782,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20210,GO:1904724,1,0.517879424596783,0,55,tertiary granule lumen,CC,
20211,GO:1904729,1,0.921018139917466,0,7,regulation of intestinal lipid absorption,BP,
20212,GO:1904730,1,0.968984030234865,0,2,negative regulation of intestinal lipid absorption,BP,
20213,GO:1904732,1,0.980170658831266,0,2,regulation of electron carrier activity,BP,
20214,GO:1904734,1,0.996689352866297,0,1,positive regulation of electron carrier activity,BP,
20216,GO:1904742,1,0.946472838932046,0,4,regulation of telomeric DNA binding,BP,
20217,GO:1904743,1,0.967126892146891,0,2,negative regulation of telomeric DNA binding,BP,
20218,GO:1904744,1,0.978646837661721,0,2,positive regulation of telomeric DNA binding,BP,
20222,GO:1904749,1,0.932504322559403,0,5,regulation of protein localization to nucleolus,BP,
20223,GO:1904750,1,0.983426667500641,0,1,negative regulation of protein localization to nucleolus,BP,
20224,GO:1904751,1,0.948222972329534,0,4,positive regulation of protein localization to nucleolus,BP,
20226,GO:1904753,1,0.956066354603963,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
20228,GO:1904760,1,0.95112034559436,0,3,regulation of myofibroblast differentiation,BP,
20229,GO:1904761,1,0.967151466262646,0,2,negative regulation of myofibroblast differentiation,BP,
20230,GO:1904762,1,0.983426667540112,0,1,positive regulation of myofibroblast differentiation,BP,
20231,GO:1904764,1,0.986552679127082,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20232,GO:1904772,1,0.984542648174979,0,1,response to tetrachloromethane,BP,
20233,GO:1904779,1,0.913003090982247,0,6,regulation of protein localization to centrosome,BP,
20234,GO:1904780,1,0.983426667500151,0,1,negative regulation of protein localization to centrosome,BP,
20235,GO:1904781,1,0.942407654501102,0,4,positive regulation of protein localization to centrosome,BP,
20236,GO:1904783,1,0.990753920282674,0,1,positive regulation of NMDA glutamate receptor activity,BP,
20237,GO:1904790,1,0.983958144398298,0,1,regulation of shelterin complex assembly,BP,
20238,GO:1904792,1,0.983958144398298,0,1,positive regulation of shelterin complex assembly,BP,
20239,GO:1904793,1,0.983511021466145,0,1,regulation of euchromatin binding,BP,
20240,GO:1904796,1,0.902166032731427,0,7,regulation of core promoter binding,BP,
20241,GO:1904797,1,0.983426667501335,0,1,negative regulation of core promoter binding,BP,
20242,GO:1904798,1,0.917375388381667,0,6,positive regulation of core promoter binding,BP,
20243,GO:1904799,1,0.983426719513247,0,1,regulation of neuron remodeling,BP,
20244,GO:1904800,1,0.983426719513247,0,1,negative regulation of neuron remodeling,BP,
20245,GO:1904803,1,0.995476081427612,0,1,regulation of translation involved in cellular response to UV,BP,
20246,GO:1904806,1,0.969690119055175,0,2,regulation of protein oxidation,BP,
20247,GO:1904808,1,0.969690119055175,0,2,positive regulation of protein oxidation,BP,
20248,GO:1904812,1,0.983426724396287,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20250,GO:1904814,1,0.828286758159262,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20251,GO:1904815,1,0.971214531066146,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20252,GO:1904816,1,0.852852489929797,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20253,GO:1904823,1,0.956787699608624,0,3,purine nucleobase transmembrane transport,BP,
20254,GO:1904826,1,0.983426667499511,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20255,GO:1904828,1,0.983426667499511,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20256,GO:1904829,1,0.987912661362616,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20257,GO:1904831,1,0.987912661362616,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20258,GO:1904833,1,0.968584775675666,0,3,positive regulation of removal of superoxide radicals,BP,
20259,GO:1904835,1,0.984936615570901,0,1,dorsal root ganglion morphogenesis,BP,
20261,GO:1904842,1,0.986042558870148,0,1,response to nitroglycerin,BP,
20262,GO:1904843,1,0.986042558870148,0,1,cellular response to nitroglycerin,BP,
20263,GO:1904844,1,0.964539704148482,0,3,response to L-glutamine,BP,
20264,GO:1904845,1,0.964539704148482,0,3,cellular response to L-glutamine,BP,
20265,GO:1904847,1,0.921481971540573,0,7,regulation of cell chemotaxis to fibroblast growth factor,BP,
20266,GO:1904848,1,0.991096224378579,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20267,GO:1904849,1,0.954034279830057,0,4,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20268,GO:1904850,1,0.983958144398298,0,1,negative regulation of establishment of protein localization to telomere,BP,
20269,GO:1904851,1,0.879121709322841,0,9,positive regulation of establishment of protein localization to telomere,BP,
20270,GO:1904854,1,0.985279552420128,0,1,proteasome core complex binding,MF,
20273,GO:1904863,1,0.983430324775012,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20274,GO:1904864,1,0.983430324775012,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20275,GO:1904867,1,0.880540943618798,0,9,protein localization to Cajal body,BP,
20276,GO:1904868,1,0.967126892143552,0,2,telomerase catalytic core complex assembly,BP,
20277,GO:1904869,1,0.891825673659027,0,8,regulation of protein localization to Cajal body,BP,
20278,GO:1904871,1,0.891825673659027,0,8,positive regulation of protein localization to Cajal body,BP,
20279,GO:1904872,1,0.825528834596471,0,15,regulation of telomerase RNA localization to Cajal body,BP,
20280,GO:1904874,1,0.825528834596471,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20281,GO:1904875,1,0.984014323910838,0,1,regulation of DNA ligase activity,BP,
20282,GO:1904876,1,0.984014323910838,0,1,negative regulation of DNA ligase activity,BP,
20283,GO:1904878,1,0.98342666749631,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20284,GO:1904879,1,0.969054240562237,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20285,GO:1904882,1,0.967126892143552,0,2,regulation of telomerase catalytic core complex assembly,BP,
20286,GO:1904884,1,0.967126892143552,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20289,GO:1904887,1,0.983426667497643,0,1,Wnt signalosome assembly,BP,
20294,GO:1904893,1,0.474703730986507,0,49,negative regulation of STAT cascade,BP,
20296,GO:1904895,1,0.988323678184138,0,1,ESCRT complex assembly,BP,
20297,GO:1904896,1,0.866081098273888,0,10,ESCRT complex disassembly,BP,
20298,GO:1904897,1,0.983565892671829,0,1,regulation of hepatic stellate cell proliferation,BP,
20299,GO:1904899,1,0.983565892671829,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20300,GO:1904902,1,0.988323678184138,0,1,ESCRT III complex assembly,BP,
20301,GO:1904903,1,0.866081098273888,0,10,ESCRT III complex disassembly,BP,
20302,GO:1904907,1,0.967126892142003,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20303,GO:1904908,1,0.967126892142003,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20304,GO:1904910,1,0.983958144398298,0,1,regulation of establishment of RNA localization to telomere,BP,
20305,GO:1904911,1,0.983958144398298,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20306,GO:1904913,1,0.983958144398298,0,1,regulation of establishment of macromolecular complex localization to telomere,BP,
20307,GO:1904914,1,0.983958144398298,0,1,negative regulation of establishment of macromolecular complex localization to telomere,BP,
20308,GO:1904923,1,0.832799891915983,0,13,regulation of mitophagy in response to mitochondrial depolarization,BP,
20309,GO:1904924,1,0.968844281526865,0,2,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20310,GO:1904925,1,0.832799891915983,0,13,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
20311,GO:1904928,1,0.967126892148293,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20312,GO:1904929,1,0.905697633392898,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20315,GO:1904935,1,0.989922791275372,0,1,positive regulation of cell proliferation in midbrain,BP,
20316,GO:1904936,1,0.909048349505911,0,6,interneuron migration,BP,
20318,GO:1904947,1,0.983834547651845,0,1,folic acid import into mitochondrion,BP,
20320,GO:1904949,1,0.702861709982067,0,24,ATPase complex,CC,
20326,GO:1904956,1,0.930756988354444,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20327,GO:1904958,1,0.959155181095349,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20328,GO:1904959,1,0.980170658831266,0,2,regulation of cytochrome-c oxidase activity,BP,
20329,GO:1904960,1,0.996689352866297,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20330,GO:1904970,1,0.921208613491984,0,5,brush border assembly,BP,
20331,GO:1904975,1,0.967126995247953,0,2,response to bleomycin,BP,
20332,GO:1904976,1,0.967126995247953,0,2,cellular response to bleomycin,BP,
20333,GO:1904978,1,0.953355870749511,0,3,regulation of endosome organization,BP,
20334,GO:1904979,1,0.985762852771326,0,1,negative regulation of endosome organization,BP,
20335,GO:1904980,1,0.98342666750015,0,1,positive regulation of endosome organization,BP,
20336,GO:1904990,1,0.985071215118948,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20337,GO:1904992,1,0.985071215118948,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20338,GO:1904994,1,0.874181418923331,0,11,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20339,GO:1904995,1,0.952180438596821,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20340,GO:1904996,1,0.91809977850376,0,6,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20341,GO:1904997,1,0.972473529708821,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20342,GO:1904998,1,0.983963369018216,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20343,GO:1904999,1,0.988323678184138,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20344,GO:1905000,1,0.983426667498474,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20345,GO:1905003,1,0.990760322235858,0,1,picolinic acid metabolic process,BP,
20346,GO:1905004,1,0.990760322235858,0,1,picolinic acid biosynthetic process,BP,
20348,GO:1905006,1,0.970845476270135,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20350,GO:1905008,1,0.984679136082936,0,1,regulation of L-lysine import into cell,BP,
20351,GO:1905010,1,0.984679136082936,0,1,positive regulation of L-lysine import into cell,BP,
20352,GO:1905012,1,0.990760322235858,0,1,regulation of 'de novo' NAD biosynthetic process from tryptophan,BP,
20353,GO:1905024,1,0.935671487565383,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20354,GO:1905025,1,0.983785524561353,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20355,GO:1905026,1,0.967126904075999,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20356,GO:1905030,1,0.688201122670019,0,23,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20357,GO:1905031,1,0.920160059515829,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20358,GO:1905032,1,0.983785524561353,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20359,GO:1905033,1,0.967126904075999,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20361,GO:1905038,1,0.832519165368012,0,13,regulation of membrane lipid metabolic process,BP,
20363,GO:1905040,1,0.984936615570901,0,1,otic placode development,BP,
20364,GO:1905041,1,0.983426667499657,0,1,regulation of epithelium regeneration,BP,
20365,GO:1905044,1,0.984728932554734,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20366,GO:1905045,1,0.984728932554734,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20367,GO:1905048,1,0.827620578146701,0,13,regulation of metallopeptidase activity,BP,
20368,GO:1905049,1,0.913434902108156,0,6,negative regulation of metallopeptidase activity,BP,
20369,GO:1905050,1,0.906086717730485,0,7,positive regulation of metallopeptidase activity,BP,
20370,GO:1905051,1,0.981434355258153,0,2,regulation of base-excision repair,BP,
20371,GO:1905053,1,0.981434355258153,0,2,positive regulation of base-excision repair,BP,
20372,GO:1905062,1,0.984371383470671,0,1,positive regulation of cardioblast proliferation,BP,
20375,GO:1905065,1,0.939869007916347,0,4,positive regulation of vascular smooth muscle cell differentiation,BP,
20376,GO:1905066,1,0.973125731061933,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20377,GO:1905067,1,0.987617988261782,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20378,GO:1905068,1,0.985326802996629,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20380,GO:1905071,1,0.967362068024947,0,2,occluding junction disassembly,BP,
20381,GO:1905073,1,0.967362068024947,0,2,regulation of occluding junction disassembly,BP,
20382,GO:1905075,1,0.967362068024947,0,2,positive regulation of occluding junction disassembly,BP,
20383,GO:1905089,1,0.983426667494394,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20384,GO:1905090,1,0.983426667494394,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20385,GO:1905097,1,0.924649183255275,0,5,regulation of guanyl-nucleotide exchange factor activity,BP,
20386,GO:1905098,1,0.956084399051413,0,3,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20387,GO:1905099,1,0.983426667501037,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20388,GO:1905103,1,0.983426667504532,0,1,integral component of lysosomal membrane,CC,
20390,GO:1905122,1,0.983426667504532,0,1,polyamine import,BP,
20391,GO:1905123,1,0.967126892156377,0,2,regulation of glucosylceramidase activity,BP,
20392,GO:1905132,1,0.976151011005824,0,2,regulation of meiotic chromosome separation,BP,
20393,GO:1905133,1,0.976151011005824,0,2,negative regulation of meiotic chromosome separation,BP,
20394,GO:1905143,1,0.988940557641968,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20395,GO:1905144,1,0.74946966417015,0,21,response to acetylcholine,BP,
20396,GO:1905145,1,0.74946966417015,0,21,cellular response to acetylcholine,BP,
20397,GO:1905146,1,0.937146746812491,0,4,lysosomal protein catabolic process,BP,
20398,GO:1905150,1,0.951249942170602,0,3,regulation of voltage-gated sodium channel activity,BP,
20399,GO:1905152,1,0.983426667501579,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20400,GO:1905153,1,0.833416539832111,0,12,regulation of membrane invagination,BP,
20401,GO:1905154,1,0.970840852883497,0,2,negative regulation of membrane invagination,BP,
20402,GO:1905155,1,0.872058452290279,0,9,positive regulation of membrane invagination,BP,
20403,GO:1905161,1,0.983426667502366,0,1,protein localization to phagocytic vesicle,BP,
20404,GO:1905162,1,0.983426667502366,0,1,regulation of phagosome maturation,BP,
20405,GO:1905165,1,0.952943319251682,0,3,regulation of lysosomal protein catabolic process,BP,
20406,GO:1905166,1,0.967279666993054,0,2,negative regulation of lysosomal protein catabolic process,BP,
20407,GO:1905169,1,0.983426667502366,0,1,regulation of protein localization to phagocytic vesicle,BP,
20408,GO:1905171,1,0.983426667502366,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20411,GO:1905202,1,0.968456187465255,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20412,GO:1905203,1,0.973793913512039,0,2,regulation of connective tissue replacement,BP,
20413,GO:1905204,1,0.990205585630676,0,1,negative regulation of connective tissue replacement,BP,
20414,GO:1905205,1,0.983426667502956,0,1,positive regulation of connective tissue replacement,BP,
20415,GO:1905206,1,0.930656384833024,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20419,GO:1905214,1,0.848490421638985,0,11,regulation of RNA binding,BP,
20420,GO:1905215,1,0.987935740848099,0,1,negative regulation of RNA binding,BP,
20421,GO:1905216,1,0.887642217478076,0,8,positive regulation of RNA binding,BP,
20422,GO:1905217,1,0.983753871288844,0,1,response to astaxanthin,BP,
20423,GO:1905222,1,0.983710704672046,0,1,atrioventricular canal morphogenesis,BP,
20424,GO:1905223,1,0.983426667501037,0,1,epicardium morphogenesis,BP,
20425,GO:1905224,1,0.967126892154393,0,2,clathrin-coated pit assembly,BP,
20426,GO:1905225,1,0.97470783546075,0,2,response to thyrotropin-releasing hormone,BP,
20427,GO:1905229,1,0.990805197582932,0,1,cellular response to thyrotropin-releasing hormone,BP,
20428,GO:1905230,1,0.983426669406348,0,1,response to borneol,BP,
20429,GO:1905231,1,0.983426669406348,0,1,cellular response to borneol,BP,
20430,GO:1905232,1,0.951272575235255,0,3,cellular response to L-glutamate,BP,
20431,GO:1905233,1,0.983426669406348,0,1,response to codeine,BP,
20432,GO:1905235,1,0.983426669406348,0,1,response to quercetin,BP,
20433,GO:1905237,1,0.977796716541405,0,2,response to cyclosporin A,BP,
20434,GO:1905239,1,0.983426667502609,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20435,GO:1905240,1,0.983426667502609,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20436,GO:1905242,1,0.984426876369333,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
20437,GO:1905243,1,0.984426876369333,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20438,GO:1905244,1,0.967389253950711,0,2,regulation of modification of synaptic structure,BP,
20439,GO:1905245,1,0.967130622982889,0,2,regulation of aspartic-type peptidase activity,BP,
20440,GO:1905246,1,0.983426667495772,0,1,negative regulation of aspartic-type peptidase activity,BP,
20441,GO:1905247,1,0.98343046095583,0,1,positive regulation of aspartic-type peptidase activity,BP,
20442,GO:1905255,1,0.98342666750089,0,1,regulation of RNA binding transcription factor activity,BP,
20443,GO:1905258,1,0.981999348184675,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20444,GO:1905259,1,0.981999348184675,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20445,GO:1905267,1,0.969434532768209,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20446,GO:1905268,1,0.482502576784106,0,48,negative regulation of chromatin organization,BP,
20448,GO:1905271,1,0.99513948009975,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20449,GO:1905273,1,0.99513948009975,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20450,GO:1905274,1,0.983426667500003,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20452,GO:1905277,1,0.98378380978692,0,1,negative regulation of epithelial tube formation,BP,
20454,GO:1905279,1,0.983426667497643,0,1,regulation of retrograde transport, endosome to Golgi,BP,
20455,GO:1905285,1,0.983450982062668,0,1,fibrous ring of heart morphogenesis,BP,
20456,GO:1905286,1,0.954964783514819,0,3,serine-type peptidase complex,CC,
20457,GO:1905289,1,0.983426667497643,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20458,GO:1905301,1,0.983426667503053,0,1,regulation of macropinocytosis,BP,
20459,GO:1905302,1,0.983426667503053,0,1,negative regulation of macropinocytosis,BP,
20460,GO:1905304,1,0.983426667498183,0,1,regulation of cardiac myofibril assembly,BP,
20461,GO:1905305,1,0.983426667498183,0,1,negative regulation of cardiac myofibril assembly,BP,
20462,GO:1905313,1,0.985881761090033,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20464,GO:1905323,1,0.913209845857734,0,6,telomerase holoenzyme complex assembly,BP,
20465,GO:1905327,1,0.988827839667624,0,1,tracheoesophageal septum formation,BP,
20469,GO:1905333,1,0.988350460214267,0,1,regulation of gastric motility,BP,
20470,GO:1905335,1,0.983426667493161,0,1,regulation of aggrephagy,BP,
20471,GO:1905337,1,0.983426667493161,0,1,positive regulation of aggrephagy,BP,
20472,GO:1905340,1,0.944286201761868,0,4,regulation of protein localization to kinetochore,BP,
20473,GO:1905341,1,0.984435940978795,0,1,negative regulation of protein localization to kinetochore,BP,
20474,GO:1905342,1,0.944286201761868,0,4,positive regulation of protein localization to kinetochore,BP,
20475,GO:1905344,1,0.984728932554734,0,1,prostaglandin catabolic process,BP,
20476,GO:1905348,1,0.716210004280474,0,25,endonuclease complex,CC,
20477,GO:1905354,1,0.751857246029971,0,22,exoribonuclease complex,CC,
20478,GO:1905355,1,0.983426667502513,0,1,spine apparatus assembly,BP,
20479,GO:1905359,1,0.983826495175854,0,1,protein localization to meiotic spindle,BP,
20480,GO:1905360,1,0.634564239560719,0,35,GTPase complex,CC,
20481,GO:1905361,1,0.881015201279711,0,9,L-serine transporter activity,MF,
20482,GO:1905365,1,0.985762852771326,0,1,regulation of intralumenal vesicle formation,BP,
20483,GO:1905366,1,0.985762852771326,0,1,negative regulation of intralumenal vesicle formation,BP,
20484,GO:1905368,1,0.356913953009068,0,86,peptidase complex,CC,
20485,GO:1905369,1,0.466723693334735,0,66,endopeptidase complex,CC,
20486,GO:1905370,1,0.985172881203875,0,1,serine-type endopeptidase complex,CC,
20487,GO:1905371,1,0.972837247983071,0,2,ceramide phosphoethanolamine metabolic process,BP,
20488,GO:1905373,1,0.972837247983071,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20492,GO:1905392,1,0.994020585908706,0,1,plant organ morphogenesis,BP,
20493,GO:1905394,1,0.954905174879317,0,3,retromer complex binding,MF,
20494,GO:1905395,1,0.961632310431883,0,3,response to flavonoid,BP,
20495,GO:1905397,1,0.989020106043659,0,1,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20496,GO:1905402,1,0.989020106043659,0,1,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20497,GO:1905404,1,0.989020106043659,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20498,GO:1905407,1,0.970990867332942,0,2,regulation of creatine transmembrane transporter activity,BP,
20499,GO:1905408,1,0.970990867332942,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20500,GO:1905419,1,0.987487790228821,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20501,GO:1905421,1,0.994020585908706,0,1,regulation of plant organ morphogenesis,BP,
20502,GO:1905422,1,0.994020585908706,0,1,negative regulation of plant organ morphogenesis,BP,
20503,GO:1905424,1,0.97118181633594,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20504,GO:1905426,1,0.97118181633594,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20505,GO:1905432,1,0.983426667503345,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20506,GO:1905433,1,0.983426667503345,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20508,GO:1905443,1,0.983426667503104,0,1,regulation of clathrin coat assembly,BP,
20509,GO:1905445,1,0.983426667503104,0,1,positive regulation of clathrin coat assembly,BP,
20510,GO:1905446,1,0.922127696377326,0,6,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20511,GO:1905447,1,0.968169326484596,0,2,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20512,GO:1905448,1,0.952450879479378,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20513,GO:1905449,1,0.970969051320966,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20514,GO:1905451,1,0.970969051320966,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20515,GO:1905453,1,0.983635704609235,0,1,regulation of myeloid progenitor cell differentiation,BP,
20518,GO:1905458,1,0.983426680859918,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20519,GO:1905462,1,0.983426667503348,0,1,regulation of DNA duplex unwinding,BP,
20520,GO:1905464,1,0.983426667503348,0,1,positive regulation of DNA duplex unwinding,BP,
20521,GO:1905468,1,0.983426667502366,0,1,regulation of clathrin-coated pit assembly,BP,
20522,GO:1905469,1,0.983426667502366,0,1,negative regulation of clathrin-coated pit assembly,BP,
20527,GO:1905483,1,0.983426667495081,0,1,regulation of motor neuron migration,BP,
20528,GO:1905485,1,0.983426667495081,0,1,positive regulation of motor neuron migration,BP,
20529,GO:1905508,1,0.696994321939437,0,23,protein localization to microtubule organizing center,BP,
20530,GO:1905515,1,0.481614534504861,0,47,non-motile cilium assembly,BP,
20531,GO:1905516,1,0.895177401055094,0,9,positive regulation of fertilization,BP,
20532,GO:1905517,1,0.681967535429915,0,32,macrophage migration,BP,
20533,GO:1905518,1,0.983426667502708,0,1,regulation of presynaptic active zone assembly,BP,
20534,GO:1905520,1,0.983426667502708,0,1,positive regulation of presynaptic active zone assembly,BP,
20535,GO:1905521,1,0.753397349262716,0,22,regulation of macrophage migration,BP,
20536,GO:1905522,1,0.945084028370382,0,4,negative regulation of macrophage migration,BP,
20537,GO:1905523,1,0.819410817808198,0,16,positive regulation of macrophage migration,BP,
20538,GO:1905524,1,0.983426667499462,0,1,negative regulation of protein autoubiquitination,BP,
20539,GO:1905535,1,0.983426667502364,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20540,GO:1905537,1,0.983426667502364,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20541,GO:1905546,1,0.985586841248435,0,1,cellular response to phenylpropanoid,BP,
20542,GO:1905547,1,0.988474582868779,0,1,regulation of telomeric heterochromatin assembly,BP,
20543,GO:1905549,1,0.988474582868779,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20544,GO:1905550,1,0.975964730181204,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20545,GO:1905552,1,0.975964730181204,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20546,GO:1905553,1,0.988474582868779,0,1,regulation of blood vessel branching,BP,
20547,GO:1905555,1,0.988474582868779,0,1,positive regulation blood vessel branching,BP,
20548,GO:1905562,1,0.988474582868779,0,1,regulation of vascular endothelial cell proliferation,BP,
20549,GO:1905564,1,0.988474582868779,0,1,positive regulation of vascular endothelial cell proliferation,BP,
20550,GO:1905572,1,0.984118593711386,0,1,ganglioside GM1 transport to membrane,BP,
20551,GO:1905573,1,0.971409238165778,0,2,ganglioside GM1 binding,MF,
20552,GO:1905574,1,0.984118593711386,0,1,ganglioside GM2 binding,MF,
20553,GO:1905575,1,0.984118593711386,0,1,ganglioside GM3 binding,MF,
20554,GO:1905576,1,0.956996720646518,0,3,ganglioside GT1b binding,MF,
20555,GO:1905577,1,0.984118593711386,0,1,ganglioside GP1c binding,MF,
20556,GO:1905578,1,0.985060631515345,0,1,regulation of ERBB3 signaling pathway,BP,
20557,GO:1905580,1,0.985060631515345,0,1,positive regulation of ERBB3 signaling pathway,BP,
20558,GO:1905581,1,0.98847729800523,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
20559,GO:1905590,1,0.98371712039167,0,1,fibronectin fibril organization,BP,
20560,GO:1905594,1,0.991490907508798,0,1,resveratrol binding,MF,
20561,GO:1905595,1,0.972114620569094,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20562,GO:1905596,1,0.983447371970266,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20563,GO:1905597,1,0.98847729800523,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20564,GO:1905598,1,0.983447371970266,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20565,GO:1905599,1,0.98847729800523,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20566,GO:1905600,1,0.956514676963818,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20567,GO:1905601,1,0.983447371970266,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20568,GO:1905602,1,0.972615862828695,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20569,GO:1905603,1,0.983426667502615,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20570,GO:1905605,1,0.983426667502615,0,1,positive regulation of maintenance of permeability of blood-brain barrier,BP,
20571,GO:1905606,1,0.951341692852565,0,3,regulation of presynapse assembly,BP,
20572,GO:1905608,1,0.983426667502708,0,1,positive regulation of presynapse assembly,BP,
20573,GO:1905610,1,0.983426667502364,0,1,regulation of mRNA cap binding,BP,
20574,GO:1905612,1,0.983426667502364,0,1,positive regulation of mRNA cap binding,BP,
20575,GO:1905616,1,0.968407661017013,0,2,regulation of miRNA mediated inhibition of translation,BP,
20576,GO:1905618,1,0.968407661017013,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20577,GO:1905634,1,0.956004175235373,0,3,regulation of protein localization to chromatin,BP,
20578,GO:1905636,1,0.990766726395059,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20579,GO:1905642,1,0.988088493727263,0,1,negative regulation of DNA methylation,BP,
20580,GO:1905643,1,0.988088493727263,0,1,positive regulation of DNA methylation,BP,
20583,GO:1905661,1,0.969716972560108,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20584,GO:1905663,1,0.969716972560108,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20585,GO:1905664,1,0.970906778793154,0,2,regulation of calcium ion import across plasma membrane,BP,
20588,GO:1905671,1,0.96973417675864,0,2,regulation of lysosome organization,BP,
20589,GO:1905672,1,0.986077712167715,0,1,negative regulation of lysosome organization,BP,
20590,GO:1905687,1,0.983426667501727,0,1,regulation of diacylglycerol kinase activity,BP,
20591,GO:1905689,1,0.983426667501727,0,1,positive regulation of diacylglycerol kinase activity,BP,
20592,GO:1905693,1,0.986081633239475,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20593,GO:1905695,1,0.986081633239475,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20594,GO:1905696,1,0.983426667502364,0,1,regulation of polysome binding,BP,
20595,GO:1905705,1,0.9834266675003,0,1,cellular response to paclitaxel,BP,
20596,GO:1905709,1,0.950346487953439,0,4,negative regulation of membrane permeability,BP,
20598,GO:1905711,1,0.983430378849187,0,1,response to phosphatidylethanolamine,BP,
20599,GO:1905715,1,0.984774454346527,0,1,regulation of cornification,BP,
20600,GO:1905716,1,0.984774454346527,0,1,negative regulation of cornification,BP,
20601,GO:1905747,1,0.979149895503292,0,2,negative regulation of saliva secretion,BP,
20602,GO:1905748,1,0.979149895503292,0,2,hard palate morphogenesis,BP,
20603,GO:1905764,1,0.953937725212734,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20604,GO:1905765,1,0.953937725212734,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20605,GO:1905767,1,0.983426667500544,0,1,regulation of double-stranded telomeric DNA binding,BP,
20606,GO:1905768,1,0.983426667500544,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20607,GO:1905770,1,0.905949597585476,0,7,regulation of mesodermal cell differentiation,BP,
20608,GO:1905771,1,0.951998518407601,0,4,negative regulation of mesodermal cell differentiation,BP,
20609,GO:1905772,1,0.983963369018216,0,1,positive regulation of mesodermal cell differentiation,BP,
20610,GO:1905774,1,0.983426667503348,0,1,regulation of DNA helicase activity,BP,
20611,GO:1905776,1,0.983426667503348,0,1,positive regulation of DNA helicase activity,BP,
20612,GO:1905777,1,0.968226299050826,0,2,regulation of exonuclease activity,BP,
20613,GO:1905778,1,0.968226299050826,0,2,negative regulation of exonuclease activity,BP,
20614,GO:1905793,1,0.967126892147325,0,2,protein localization to pericentriolar material,BP,
20615,GO:1905794,1,0.983426667496706,0,1,response to puromycin,BP,
20616,GO:1905795,1,0.983426667496706,0,1,cellular response to puromycin,BP,
20617,GO:1905802,1,0.984090593450433,0,1,regulation of cellular response to manganese ion,BP,
20619,GO:1905818,1,0.510748913191657,0,47,regulation of chromosome separation,BP,
20620,GO:1905819,1,0.639859498497271,0,31,negative regulation of chromosome separation,BP,
20621,GO:1905820,1,0.912832890132424,0,6,positive regulation of chromosome separation,BP,
20622,GO:1905838,1,0.968226299050826,0,2,regulation of telomeric D-loop disassembly,BP,
20623,GO:1905839,1,0.968226299050826,0,2,negative regulation of telomeric D-loop disassembly,BP,
20624,GO:1905853,1,0.991246637861128,0,1,regulation of heparan sulfate binding,BP,
20625,GO:1905855,1,0.991246637861128,0,1,positive regulation of heparan sulfate binding,BP,
20626,GO:1905858,1,0.991246637861128,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20627,GO:1905860,1,0.991246637861128,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20629,GO:1905871,1,0.990753920282674,0,1,regulation of protein localization to cell leading edge,BP,
20630,GO:1905873,1,0.990753920282674,0,1,positive regulation of protein localization to cell leading edge,BP,
20632,GO:1905875,1,0.990753920282674,0,1,negative regulation of postsynaptic density organization,BP,
20635,GO:1905881,1,0.940887677844008,0,4,positive regulation of oogenesis,BP,
20636,GO:1905890,1,0.991246637861128,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20637,GO:1905891,1,0.984101003177701,0,1,regulation of cellular response to thapsigargin,BP,
20638,GO:1905892,1,0.984101003177701,0,1,negative regulation of cellular response to thapsigargin,BP,
20639,GO:1905894,1,0.984101003177701,0,1,regulation of cellular response to tunicamycin,BP,
20640,GO:1905895,1,0.984101003177701,0,1,negative regulation of cellular response to tunicamycin,BP,
20643,GO:1905899,1,0.988827839667624,0,1,regulation of smooth muscle tissue development,BP,
20644,GO:1905900,1,0.988827839667624,0,1,negative regulation of smooth muscle tissue development,BP,
20645,GO:1905901,1,0.988827839667624,0,1,positive regulation of smooth muscle tissue development,BP,
20646,GO:1905902,1,0.905949597585476,0,7,regulation of mesoderm formation,BP,
20647,GO:1905903,1,0.951998518407601,0,4,negative regulation of mesoderm formation,BP,
20648,GO:1905904,1,0.983963369018216,0,1,positive regulation of mesoderm formation,BP,
20649,GO:1905906,1,0.965190171197232,0,3,regulation of amyloid fibril formation,BP,
20650,GO:1905907,1,0.978857531632188,0,2,negative regulation of amyloid fibril formation,BP,
20651,GO:1905912,1,0.987422253506645,0,1,regulation of calcium ion export from cell,BP,
20652,GO:1905913,1,0.987422253506645,0,1,negative regulation of calcium ion export from cell,BP,
20653,GO:1905918,1,0.986038668103771,0,1,regulation of CoA-transferase activity,BP,
20654,GO:1905920,1,0.986038668103771,0,1,positive regulation of CoA-transferase activity,BP,
20655,GO:1905936,1,0.959516946635205,0,4,regulation of germ cell proliferation,BP,
20656,GO:1905937,1,0.966672539813438,0,3,negative regulation of germ cell proliferation,BP,
20657,GO:1905938,1,0.992598751977773,0,1,positive regulation of germ cell proliferation,BP,
20665,GO:1905957,1,0.983426667503199,0,1,regulation of cellular response to alcohol,BP,
20666,GO:1905959,1,0.983426667503199,0,1,positive regulation of cellular response to alcohol,BP,
20667,GO:1990000,1,0.857131483601782,0,11,amyloid fibril formation,BP,
20668,GO:1990001,1,0.865136805539062,0,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
20669,GO:1990005,1,0.98808066581473,0,1,granular vesicle,CC,
20670,GO:1990008,1,0.98808066581473,0,1,neurosecretory vesicle,CC,
20671,GO:1990009,1,0.967139581641556,0,2,retinal cell apoptotic process,BP,
20672,GO:1990015,1,0.985165060492297,0,1,ensheathing process,CC,
20673,GO:1990022,1,0.966691392098975,0,3,RNA polymerase III complex localization to nucleus,BP,
20674,GO:1990023,1,0.862081465278901,0,10,mitotic spindle midzone,CC,
20675,GO:1990026,1,0.983472584656398,0,1,hippocampal mossy fiber expansion,CC,
20676,GO:1990029,1,0.983685065836084,0,1,vasomotion,BP,
20677,GO:1990030,1,0.983427013404485,0,1,pericellular basket,CC,
20678,GO:1990031,1,0.983687835061965,0,1,pinceau fiber,CC,
20679,GO:1990032,1,0.983426667503104,0,1,parallel fiber,CC,
20680,GO:1990034,1,0.924785821536696,0,5,calcium ion export from cell,BP,
20681,GO:1990035,1,0.837025755113993,0,11,calcium ion import into cell,BP,
20682,GO:1990036,1,0.957377276055809,0,3,calcium ion import into sarcoplasmic reticulum,BP,
20683,GO:1990037,1,0.961416276736524,0,3,Lewy body core,CC,
20684,GO:1990038,1,0.986883482922899,0,1,Lewy body corona,CC,
20685,GO:1990046,1,0.990600939581185,0,1,stress-induced mitochondrial fusion,BP,
20686,GO:1990047,1,0.985593881315823,0,1,spindle matrix,CC,
20687,GO:1990050,1,0.982491649637255,0,2,phosphatidic acid transporter activity,MF,
20688,GO:1990051,1,0.967210283275495,0,2,activation of protein kinase C activity,BP,
20689,GO:1990071,1,0.983426667500251,0,1,TRAPPII protein complex,CC,
20690,GO:1990072,1,0.984728932554734,0,1,TRAPPIII protein complex,CC,
20691,GO:1990074,1,0.983477239225756,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20692,GO:1990075,1,0.935743036728755,0,4,periciliary membrane compartment,CC,
20693,GO:1990079,1,0.992467092156107,0,1,cartilage homeostasis,BP,
20694,GO:1990081,1,0.991477632355198,0,1,trimethylamine receptor activity,MF,
20695,GO:1990086,1,0.937589441072171,0,4,lens fiber cell apoptotic process,BP,
20698,GO:1990108,1,0.983426667498378,0,1,protein linear deubiquitination,BP,
20699,GO:1990111,1,0.947100075616116,0,5,spermatoproteasome complex,CC,
20700,GO:1990117,1,0.993788964544904,0,1,B cell receptor apoptotic signaling pathway,BP,
20701,GO:1990118,1,0.809510467281425,0,13,sodium ion import into cell,BP,
20702,GO:1990123,1,0.919824307515122,0,5,L-glutamate import into cell,BP,
20704,GO:1990126,1,0.759993033990545,0,18,retrograde transport, endosome to plasma membrane,BP,
20705,GO:1990127,1,0.983426667503302,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20706,GO:1990130,1,0.942593078032562,0,4,GATOR1 complex,CC,
20708,GO:1990136,1,0.984859810553344,0,1,linoleate 9S-lipoxygenase activity,MF,
20710,GO:1990144,1,0.930274964841717,0,5,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20711,GO:1990145,1,0.983592042024508,0,1,maintenance of translational fidelity,BP,
20712,GO:1990164,1,0.968142070803497,0,2,histone H2A phosphorylation,BP,
20713,GO:1990166,1,0.985316973590687,0,1,protein localization to site of double-strand break,BP,
20714,GO:1990167,1,0.955735045932718,0,3,protein K27-linked deubiquitination,BP,
20715,GO:1990168,1,0.955735045934486,0,3,protein K33-linked deubiquitination,BP,
20716,GO:1990169,1,0.976456704383982,0,2,stress response to copper ion,BP,
20717,GO:1990170,1,0.98663432665508,0,1,stress response to cadmium ion,BP,
20719,GO:1990173,1,0.880540943618798,0,9,protein localization to nucleoplasm,BP,
20720,GO:1990174,1,0.983428135241463,0,1,phosphodiesterase decapping endonuclease activity,MF,
20721,GO:1990175,1,0.98342685243827,0,1,EH domain binding,MF,
20722,GO:1990180,1,0.985607998290606,0,1,mitochondrial tRNA 3'-end processing,BP,
20724,GO:1990183,1,0.993501545196378,0,1,lymphatic vascular process in circulatory system,BP,
20725,GO:1990186,1,0.993501545196378,0,1,regulation of lymphatic vessel size,BP,
20726,GO:1990188,1,0.984562092133899,0,1,euchromatin binding,MF,
20727,GO:1990189,1,0.966348121094307,0,3,peptide-serine-N-acetyltransferase activity,MF,
20728,GO:1990190,1,0.982505536016954,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20729,GO:1990192,1,0.993501545196378,0,1,collecting lymphatic vessel constriction,BP,
20731,GO:1990226,1,0.915694923579877,0,6,histone methyltransferase binding,MF,
20733,GO:1990239,1,0.926882820247204,0,5,steroid hormone binding,MF,
20734,GO:1990246,1,0.969690119055175,0,2,uniplex complex,CC,
20735,GO:1990247,1,0.890590478263807,0,7,N6-methyladenosine-containing RNA binding,MF,
20736,GO:1990253,1,0.906949857172589,0,6,cellular response to leucine starvation,BP,
20737,GO:1990254,1,0.927809007629717,0,5,keratin filament binding,MF,
20738,GO:1990256,1,0.983426667494886,0,1,signal clustering,BP,
20739,GO:1990258,1,0.991312379435752,0,1,histone glutamine methylation,BP,
20740,GO:1990259,1,0.991312379435752,0,1,histone-glutamine methyltransferase activity,MF,
20742,GO:1990264,1,0.983566808153595,0,1,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20744,GO:1990267,1,0.983634907080281,0,1,response to transition metal nanoparticle,BP,
20745,GO:1990268,1,0.983634907080281,0,1,response to gold nanoparticle,BP,
20746,GO:1990269,1,0.969726472999874,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20747,GO:1990272,1,0.987316598817985,0,1,anti-Mullerian hormone receptor activity,MF,
20748,GO:1990275,1,0.984034437074485,0,1,preribosome binding,MF,
20749,GO:1990314,1,0.906572704566644,0,7,cellular response to insulin-like growth factor stimulus,BP,
20751,GO:1990332,1,0.983426667503346,0,1,Ire1 complex,CC,
20752,GO:1990349,1,0.986690812150216,0,1,gap junction-mediated intercellular transport,BP,
20754,GO:1990356,1,0.991096224378579,0,1,sumoylated E2 ligase complex,CC,
20755,GO:1990357,1,0.960320770415394,0,3,terminal web,CC,
20756,GO:1990379,1,0.977294587933864,0,2,lipid transport across blood brain barrier,BP,
20757,GO:1990380,1,0.891148644977081,0,7,Lys48-specific deubiquitinase activity,MF,
20758,GO:1990381,1,0.832447278518329,0,12,ubiquitin-specific protease binding,MF,
20759,GO:1990384,1,0.990594593324392,0,1,hyaloid vascular plexus regression,BP,
20760,GO:1990386,1,0.986796416926194,0,1,mitotic cleavage furrow ingression,BP,
20761,GO:1990390,1,0.983493627040072,0,1,protein K33-linked ubiquitination,BP,
20762,GO:1990391,1,0.577784530494645,0,37,DNA repair complex,CC,
20763,GO:1990393,1,0.922807323968286,0,5,3M complex,CC,
20764,GO:1990399,1,0.983426667499657,0,1,epithelium regeneration,BP,
20765,GO:1990401,1,0.984238471013986,0,1,embryonic lung development,BP,
20766,GO:1990402,1,0.985881761090033,0,1,embryonic liver development,BP,
20767,GO:1990403,1,0.868652896225433,0,9,embryonic brain development,BP,
20768,GO:1990404,1,0.970894196823074,0,2,protein ADP-ribosylase activity,MF,
20769,GO:1990405,1,0.92888450144219,0,5,protein antigen binding,MF,
20770,GO:1990414,1,0.96941002512249,0,2,replication-born double-strand break repair via sister chromatid exchange,BP,
20771,GO:1990415,1,0.971656791341976,0,2,Pex17p-Pex14p docking complex,CC,
20772,GO:1990416,1,0.894998224451526,0,7,cellular response to brain-derived neurotrophic factor stimulus,BP,
20774,GO:1990421,1,0.983426667495572,0,1,subtelomeric heterochromatin,CC,
20775,GO:1990423,1,0.951862150374734,0,3,RZZ complex,CC,
20776,GO:1990425,1,0.983426667500052,0,1,ryanodine receptor complex,CC,
20777,GO:1990426,1,0.969397550237668,0,2,mitotic recombination-dependent replication fork processing,BP,
20779,GO:1990428,1,0.983440397627643,0,1,miRNA transport,BP,
20780,GO:1990429,1,0.971656791341976,0,2,peroxisomal importomer complex,CC,
20783,GO:1990439,1,0.983939035766445,0,1,MAP kinase threonine phosphatase activity,MF,
20784,GO:1990440,1,0.855564317078503,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20785,GO:1990441,1,0.927408186453009,0,5,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20786,GO:1990442,1,0.975212387781491,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
20787,GO:1990446,1,0.940747769136961,0,6,U1 snRNP binding,MF,
20788,GO:1990450,1,0.986318326725051,0,1,linear polyubiquitin binding,MF,
20789,GO:1990451,1,0.985003845412957,0,1,cellular stress response to acidic pH,BP,
20790,GO:1990452,1,0.967337376880342,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
20791,GO:1990454,1,0.905449158252776,0,6,L-type voltage-gated calcium channel complex,CC,
20793,GO:1990460,1,0.955285572247982,0,3,leptin receptor binding,MF,
20794,GO:1990462,1,0.983521924973459,0,1,omegasome,CC,
20795,GO:1990478,1,0.987012763581248,0,1,response to ultrasound,BP,
20796,GO:1990481,1,0.945092937686034,0,4,mRNA pseudouridine synthesis,BP,
20797,GO:1990498,1,0.983426667498378,0,1,mitotic spindle microtubule,CC,
20798,GO:1990502,1,0.967146425851135,0,2,dense core granule maturation,BP,
20799,GO:1990504,1,0.91982458163899,0,5,dense core granule exocytosis,BP,
20800,GO:1990505,1,0.969397550237668,0,2,mitotic DNA replication maintenance of fidelity,BP,
20801,GO:1990511,1,0.984111521224571,0,1,piRNA biosynthetic process,BP,
20802,GO:1990512,1,0.983606804791136,0,1,Cry-Per complex,CC,
20803,GO:1990519,1,0.97307323968579,0,2,mitochondrial pyrimidine nucleotide import,BP,
20804,GO:1990523,1,0.938653449418571,0,4,bone regeneration,BP,
20805,GO:1990539,1,0.985452018212821,0,1,fructose import across plasma membrane,BP,
20806,GO:1990542,1,0.443255418891149,0,70,mitochondrial transmembrane transport,BP,
20807,GO:1990564,1,0.937275118074396,0,5,protein polyufmylation,BP,
20808,GO:1990565,1,0.988280976675277,0,1,HSP90-CDC37 chaperone complex,CC,
20809,GO:1990569,1,0.969726472997792,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
20810,GO:1990572,1,0.983426667503399,0,1,TERT-RMRP complex,CC,
20811,GO:1990573,1,0.87705284242534,0,9,potassium ion import across plasma membrane,BP,
20813,GO:1990579,1,0.983426667503346,0,1,peptidyl-serine trans-autophosphorylation,BP,
20814,GO:1990583,1,0.986796416926194,0,1,phospholipase D activator activity,MF,
20815,GO:1990584,1,0.979830932078303,0,3,cardiac Troponin complex,CC,
20816,GO:1990589,1,0.971675894731333,0,2,ATF4-CREB1 transcription factor complex,CC,
20817,GO:1990590,1,0.973299376354686,0,2,ATF1-ATF4 transcription factor complex,CC,
20818,GO:1990592,1,0.937275118074396,0,5,protein K69-linked ufmylation,BP,
20819,GO:1990595,1,0.986569778368488,0,1,mast cell secretagogue receptor activity,MF,
20820,GO:1990597,1,0.953185622192968,0,3,AIP1-IRE1 complex,CC,
20821,GO:1990599,1,0.953937725212734,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
20822,GO:1990603,1,0.983583320421907,0,1,dark adaptation,BP,
20823,GO:1990604,1,0.937406121166705,0,4,IRE1-TRAF2-ASK1 complex,CC,
20824,GO:1990613,1,0.983475100046871,0,1,mitochondrial membrane fusion,BP,
20825,GO:1990614,1,0.983550370083736,0,1,mitochondrial magnesium ion transmembrane transport,BP,
20826,GO:1990617,1,0.981223402671978,0,2,CHOP-ATF4 complex,CC,
20827,GO:1990619,1,0.972093326939592,0,2,histone H3-K9 deacetylation,BP,
20828,GO:1990622,1,0.979687928033489,0,2,CHOP-ATF3 complex,CC,
20829,GO:1990630,1,0.983426667503346,0,1,IRE1-RACK1-PP2A complex,CC,
20830,GO:1990635,1,0.953982916677571,0,3,proximal dendrite,CC,
20831,GO:1990637,1,0.947617663688088,0,4,response to prolactin,BP,
20832,GO:1990641,1,0.983664742935683,0,2,response to iron ion starvation,BP,
20833,GO:1990646,1,0.975215117856179,0,2,cellular response to prolactin,BP,
20834,GO:1990654,1,0.983426667502708,0,1,sebum secreting cell proliferation,BP,
20835,GO:1990666,1,0.967147254856756,0,2,PCSK9-LDLR complex,CC,
20836,GO:1990667,1,0.972114620569094,0,2,PCSK9-AnxA2 complex,CC,
20837,GO:1990668,1,0.918245115197642,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
20838,GO:1990682,1,0.968775745898076,0,2,CSF1-CSF1R complex,CC,
20839,GO:1990696,1,0.970234984668612,0,2,USH2 complex,CC,
20840,GO:1990697,1,0.985803375140421,0,1,protein depalmitoleylation,BP,
20841,GO:1990698,1,0.971332288354102,0,2,palmitoleoyltransferase activity,MF,
20842,GO:1990699,1,0.985803375140421,0,1,palmitoleyl hydrolase activity,MF,
20843,GO:1990700,1,0.983426772326857,0,1,nucleolar chromatin organization,BP,
20844,GO:1990705,1,0.983426667498183,0,1,cholangiocyte proliferation,BP,
20845,GO:1990707,1,0.983426667495572,0,1,nuclear subtelomeric heterochromatin,CC,
20846,GO:1990708,1,0.98342666750266,0,1,conditioned place preference,BP,
20847,GO:1990709,1,0.956723491472292,0,3,presynaptic active zone organization,BP,
20849,GO:1990715,1,0.970324292561153,0,2,mRNA CDS binding,MF,
20850,GO:1990716,1,0.955577634240417,0,3,axonemal central apparatus,CC,
20851,GO:1990718,1,0.98342666749715,0,1,axonemal central pair projection,CC,
20852,GO:1990723,1,0.983827110798828,0,1,cytoplasmic periphery of the nuclear pore complex,CC,
20853,GO:1990726,1,0.969767595282292,0,4,Lsm1-7-Pat1 complex,CC,
20854,GO:1990729,1,0.986876745423811,0,1,primary miRNA modification,BP,
20855,GO:1990730,1,0.967167756163859,0,2,VCP-NSFL1C complex,CC,
20856,GO:1990736,1,0.983426667503345,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
20857,GO:1990737,1,0.95557008572885,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
20858,GO:1990739,1,0.983426667498183,0,1,granulosa cell proliferation,BP,
20859,GO:1990742,1,0.967126892155166,0,2,microvesicle,CC,
20860,GO:1990743,1,0.983426667496658,0,1,protein sialylation,BP,
20861,GO:1990744,1,0.986876745423811,0,1,primary miRNA methylation,BP,
20862,GO:1990745,1,0.952827843683074,0,3,EARP complex,CC,
20864,GO:1990751,1,0.983426667500003,0,1,Schwann cell chemotaxis,BP,
20865,GO:1990752,1,0.699176269686232,0,22,microtubule end,CC,
20866,GO:1990755,1,0.984728932554734,0,1,mitotic spindle microtubule depolymerization,BP,
20867,GO:1990761,1,0.95222398041681,0,3,growth cone lamellipodium,CC,
20868,GO:1990763,1,0.968566881268777,0,2,arrestin family protein binding,MF,
20870,GO:1990771,1,0.983426667501332,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
20871,GO:1990773,1,0.987961453640098,0,1,matrix metallopeptidase secretion,BP,
20872,GO:1990774,1,0.886093043899216,0,8,tumor necrosis factor secretion,BP,
20874,GO:1990777,1,0.654935620695306,0,37,lipoprotein particle,CC,
20877,GO:1990784,1,0.983426667503345,0,1,response to dsDNA,BP,
20879,GO:1990786,1,0.983426667503345,0,1,cellular response to dsDNA,BP,
20880,GO:1990790,1,0.989922791275372,0,1,response to glial cell derived neurotrophic factor,BP,
20881,GO:1990791,1,0.952913109542853,0,3,dorsal root ganglion development,BP,
20882,GO:1990792,1,0.989922791275372,0,1,cellular response to glial cell derived neurotrophic factor,BP,
20883,GO:1990796,1,0.983942674304424,0,1,photoreceptor cell terminal bouton,CC,
20884,GO:1990809,1,0.985647073098095,0,1,endoplasmic reticulum tubular network membrane organization,BP,
20885,GO:1990812,1,0.952223980423049,0,3,growth cone filopodium,CC,
20886,GO:1990822,1,0.916014723591779,0,6,basic amino acid transmembrane transport,BP,
20887,GO:1990823,1,0.983426667502857,0,1,response to leukemia inhibitory factor,BP,
20888,GO:1990825,1,0.887597065388322,0,8,sequence-specific mRNA binding,MF,
20889,GO:1990828,1,0.986046452668428,0,1,hepatocyte dedifferentiation,BP,
20890,GO:1990829,1,0.970784732747783,0,2,C-rich single-stranded DNA binding,MF,
20891,GO:1990830,1,0.983426667502857,0,1,cellular response to leukemia inhibitory factor,BP,
20892,GO:1990834,1,0.95516407231079,0,3,response to odorant,BP,
20894,GO:1990839,1,0.985496439087101,0,1,response to endothelin,BP,
20896,GO:1990843,1,0.983426667501085,0,1,subsarcolemmal mitochondrion,CC,
20897,GO:1990844,1,0.983426667501085,0,1,interfibrillar mitochondrion,CC,
20898,GO:1990845,1,0.832485595613631,0,13,adaptive thermogenesis,BP,
20900,GO:1990859,1,0.985496439087101,0,1,cellular response to endothelin,BP,
20901,GO:1990868,1,0.96811703984417,0,2,response to chemokine,BP,
20902,GO:1990869,1,0.96811703984417,0,2,cellular response to chemokine,BP,
20904,GO:1990876,1,0.983426667500691,0,1,cytoplasmic side of nuclear pore,CC,
20905,GO:1990879,1,0.969690119055175,0,2,CST complex,CC,
20906,GO:1990882,1,0.983426724396287,0,1,rRNA acetylation,BP,
20907,GO:1990883,1,0.983426724396287,0,1,rRNA cytidine N-acetyltransferase activity,MF,
20908,GO:1990884,1,0.983426724396287,0,1,RNA acetylation,BP,
20909,GO:1990889,1,0.987326145032158,0,1,H4K20me3 modified histone binding,MF,
20911,GO:1990907,1,0.951231013556255,0,3,beta-catenin-TCF complex,CC,
20913,GO:1990910,1,0.96419046440176,0,3,response to hypobaric hypoxia,BP,
20914,GO:1990911,1,0.986042558870148,0,1,response to psychosocial stress,BP,
20915,GO:1990913,1,0.984769051492201,0,1,sperm head plasma membrane,CC,
20916,GO:1990917,1,0.984769051492201,0,1,ooplasm,CC,
20917,GO:1990918,1,0.956592177424336,0,3,double-strand break repair involved in meiotic recombination,BP,
20918,GO:1990922,1,0.983565892671829,0,1,hepatic stellate cell proliferation,BP,
20919,GO:1990923,1,0.956567875350483,0,3,PET complex,CC,
20920,GO:1990926,1,0.970109652505552,0,2,short-term synaptic potentiation,BP,
20921,GO:1990927,1,0.967126892154393,0,2,calcium ion regulated lysosome exocytosis,BP,
20922,GO:1990928,1,0.960800404714995,0,3,response to amino acid starvation,BP,
20923,GO:1990930,1,0.988827839667624,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
20924,GO:1990931,1,0.983426667503252,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
20925,GO:1990932,1,0.983469571610852,0,3,5.8S rRNA binding,MF,
20927,GO:1990938,1,0.983426667504532,0,1,peptidyl-aspartic acid autophosphorylation,BP,
20928,GO:1990939,1,0.708579007939596,0,21,ATP-dependent microtubule motor activity,MF,
20929,GO:1990948,1,0.97756446395957,0,4,ubiquitin ligase inhibitor activity,MF,
20930,GO:1990955,1,0.983426667503348,0,1,G-rich single-stranded DNA binding,MF,
20931,GO:1990962,1,0.983426669406348,0,1,drug transport across blood-brain barrier,BP,
20932,GO:1990963,1,0.983426669406348,0,1,establishment of blood-retinal barrier,BP,
20933,GO:1990966,1,0.942587533600548,0,4,ATP generation from poly-ADP-D-ribose,BP,
20935,GO:1990968,1,0.98342666750089,0,1,modulation by host of RNA binding by virus,BP,
20936,GO:1990969,1,0.98342666750089,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
20937,GO:1990971,1,0.983426838108843,0,1,EMILIN complex,CC,
20938,GO:1990983,1,0.984661078025882,0,1,tRNA demethylation,BP,
20939,GO:1990984,1,0.984661078025882,0,1,tRNA demethylase activity,MF,
20940,GO:2000001,1,0.826561271432088,0,13,regulation of DNA damage checkpoint,BP,
20941,GO:2000002,1,0.944084654795922,0,4,negative regulation of DNA damage checkpoint,BP,
20948,GO:2000010,1,0.839646437526774,0,12,positive regulation of protein localization to cell surface,BP,
20949,GO:2000011,1,0.985870480808563,0,1,regulation of adaxial/abaxial pattern formation,BP,
20951,GO:2000016,1,0.993089154871235,0,1,negative regulation of determination of dorsal identity,BP,
20959,GO:2000035,1,0.932753300178862,0,5,regulation of stem cell division,BP,
20961,GO:2000040,1,0.970397537393228,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
20962,GO:2000041,1,0.970397537393228,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
20963,GO:2000042,1,0.905905101989894,0,6,negative regulation of double-strand break repair via homologous recombination,BP,
20964,GO:2000043,1,0.969565117317223,0,2,regulation of cardiac cell fate specification,BP,
20965,GO:2000044,1,0.983963369018216,0,1,negative regulation of cardiac cell fate specification,BP,
20968,GO:2000048,1,0.950483447724186,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
20971,GO:2000051,1,0.908074141083449,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
20973,GO:2000053,1,0.953134929357855,0,3,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20974,GO:2000054,1,0.969199864771979,0,2,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20975,GO:2000055,1,0.983426667496707,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20976,GO:2000056,1,0.987250104775321,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
20977,GO:2000057,1,0.987250104775321,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
20979,GO:2000059,1,0.855469613115107,0,13,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
20981,GO:2000061,1,0.988827839667624,0,1,regulation of ureter smooth muscle cell differentiation,BP,
20982,GO:2000062,1,0.988827839667624,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
20983,GO:2000063,1,0.988827839667624,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
20987,GO:2000067,1,0.994020585908706,0,1,regulation of root morphogenesis,BP,
20988,GO:2000074,1,0.895568394746183,0,8,regulation of type B pancreatic cell development,BP,
20989,GO:2000077,1,0.9696010836344,0,2,negative regulation of type B pancreatic cell development,BP,
20990,GO:2000078,1,0.967527680386932,0,3,positive regulation of type B pancreatic cell development,BP,
20991,GO:2000079,1,0.967654734448018,0,2,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20992,GO:2000080,1,0.983426667503104,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20993,GO:2000081,1,0.983963369018216,0,1,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20994,GO:2000095,1,0.827575867198411,0,12,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
20995,GO:2000096,1,0.895114056064649,0,7,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
20997,GO:2000098,1,0.97538756705303,0,2,negative regulation of smooth muscle cell-matrix adhesion,BP,
20998,GO:2000101,1,0.983955915701001,0,1,regulation of mammary stem cell proliferation,BP,
20999,GO:2000103,1,0.983955915701001,0,1,positive regulation of mammary stem cell proliferation,BP,
21000,GO:2000104,1,0.759724163701193,0,18,negative regulation of DNA-dependent DNA replication,BP,
21005,GO:2000109,1,0.908320602218904,0,7,regulation of macrophage apoptotic process,BP,
21006,GO:2000110,1,0.961652507060244,0,3,negative regulation of macrophage apoptotic process,BP,
21007,GO:2000111,1,0.958795694040213,0,3,positive regulation of macrophage apoptotic process,BP,
21010,GO:2000114,1,0.750675711374448,0,18,regulation of establishment of cell polarity,BP,
21013,GO:2000118,1,0.953738499071814,0,3,regulation of sodium-dependent phosphate transport,BP,
21014,GO:2000119,1,0.983902895368882,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21015,GO:2000120,1,0.985681118036814,0,1,positive regulation of sodium-dependent phosphate transport,BP,
21017,GO:2000124,1,0.968879909167905,0,2,regulation of endocannabinoid signaling pathway,BP,
21022,GO:2000142,1,0.594377607301737,0,35,regulation of DNA-templated transcription, initiation,BP,
21023,GO:2000143,1,0.907603582916831,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21024,GO:2000144,1,0.687233724772013,0,26,positive regulation of DNA-templated transcription, initiation,BP,
21028,GO:2000152,1,0.95748607207976,0,4,regulation of ubiquitin-specific protease activity,BP,
21029,GO:2000156,1,0.967728392731147,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21030,GO:2000157,1,0.983498595918452,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21031,GO:2000158,1,0.973552841199284,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21032,GO:2000167,1,0.983426667502217,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21033,GO:2000169,1,0.906475741450625,0,6,regulation of peptidyl-cysteine S-nitrosylation,BP,
21034,GO:2000170,1,0.967239646055695,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21035,GO:2000171,1,0.65365723076186,0,27,negative regulation of dendrite development,BP,
21036,GO:2000172,1,0.937142762237461,0,4,regulation of branching morphogenesis of a nerve,BP,
21037,GO:2000173,1,0.983426719513247,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21038,GO:2000174,1,0.983426680859918,0,1,regulation of pro-T cell differentiation,BP,
21039,GO:2000176,1,0.983426680859918,0,1,positive regulation of pro-T cell differentiation,BP,
21044,GO:2000182,1,0.951374244289977,0,3,regulation of progesterone biosynthetic process,BP,
21045,GO:2000184,1,0.983426667501085,0,1,positive regulation of progesterone biosynthetic process,BP,
21046,GO:2000185,1,0.985681118036814,0,1,regulation of phosphate transmembrane transport,BP,
21047,GO:2000187,1,0.985681118036814,0,1,positive regulation of phosphate transmembrane transport,BP,
21048,GO:2000188,1,0.838168579984328,0,12,regulation of cholesterol homeostasis,BP,
21049,GO:2000189,1,0.946180653283385,0,4,positive regulation of cholesterol homeostasis,BP,
21055,GO:2000196,1,0.986198072792096,0,2,positive regulation of female gonad development,BP,
21056,GO:2000197,1,0.907955094713522,0,6,regulation of ribonucleoprotein complex localization,BP,
21057,GO:2000199,1,0.983749050358529,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21058,GO:2000200,1,0.983749050358529,0,1,regulation of ribosomal subunit export from nucleus,BP,
21059,GO:2000202,1,0.983749050358529,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21060,GO:2000206,1,0.983749050358529,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21061,GO:2000208,1,0.983749050358529,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21063,GO:2000210,1,0.922719101798484,0,7,positive regulation of anoikis,BP,
21064,GO:2000211,1,0.969738033106462,0,2,regulation of glutamate metabolic process,BP,
21065,GO:2000212,1,0.983426667502611,0,1,negative regulation of glutamate metabolic process,BP,
21066,GO:2000213,1,0.986081633239475,0,1,positive regulation of glutamate metabolic process,BP,
21069,GO:2000226,1,0.989531997697684,0,1,regulation of pancreatic A cell differentiation,BP,
21070,GO:2000227,1,0.989531997697684,0,1,negative regulation of pancreatic A cell differentiation,BP,
21071,GO:2000229,1,0.978052990415933,0,2,regulation of pancreatic stellate cell proliferation,BP,
21072,GO:2000230,1,0.987352457745635,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21073,GO:2000231,1,0.990581907561477,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21074,GO:2000232,1,0.879047458020058,0,8,regulation of rRNA processing,BP,
21075,GO:2000233,1,0.967779858813763,0,2,negative regulation of rRNA processing,BP,
21076,GO:2000234,1,0.908325293061227,0,6,positive regulation of rRNA processing,BP,
21082,GO:2000252,1,0.932967859457826,0,7,negative regulation of feeding behavior,BP,
21083,GO:2000253,1,0.932316489162619,0,6,positive regulation of feeding behavior,BP,
21084,GO:2000254,1,0.959516946635205,0,4,regulation of male germ cell proliferation,BP,
21085,GO:2000255,1,0.966672539813438,0,3,negative regulation of male germ cell proliferation,BP,
21086,GO:2000256,1,0.992598751977773,0,1,positive regulation of male germ cell proliferation,BP,
21087,GO:2000257,1,0.631172599436506,0,32,regulation of protein activation cascade,BP,
21088,GO:2000258,1,0.889372843155879,0,8,negative regulation of protein activation cascade,BP,
21089,GO:2000259,1,0.955050939538718,0,3,positive regulation of protein activation cascade,BP,
21090,GO:2000266,1,0.98868294898152,0,1,regulation of blood coagulation, intrinsic pathway,BP,
21093,GO:2000271,1,0.891805220379781,0,7,positive regulation of fibroblast apoptotic process,BP,
21096,GO:2000275,1,0.953883504198031,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21097,GO:2000276,1,0.974414660473897,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21098,GO:2000277,1,0.992913066894507,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21100,GO:2000279,1,0.62505342769239,0,31,negative regulation of DNA biosynthetic process,BP,
21101,GO:2000280,1,0.994020585908706,0,1,regulation of root development,BP,
21102,GO:2000282,1,0.976456704383591,0,2,regulation of cellular amino acid biosynthetic process,BP,
21103,GO:2000283,1,0.983426667498132,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21104,GO:2000284,1,0.992913066894507,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21105,GO:2000286,1,0.953439214334873,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21106,GO:2000287,1,0.98572270009546,0,1,positive regulation of myotome development,BP,
21107,GO:2000288,1,0.916622547182586,0,6,positive regulation of myoblast proliferation,BP,
21108,GO:2000290,1,0.98572270009546,0,1,regulation of myotome development,BP,
21109,GO:2000291,1,0.86837607164223,0,10,regulation of myoblast proliferation,BP,
21110,GO:2000295,1,0.969625588830889,0,3,regulation of hydrogen peroxide catabolic process,BP,
21111,GO:2000296,1,0.98571289380997,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21112,GO:2000297,1,0.951487094645712,0,3,negative regulation of synapse maturation,BP,
21113,GO:2000298,1,0.968993659151022,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21114,GO:2000299,1,0.983542118240828,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21115,GO:2000300,1,0.659187661553228,0,27,regulation of synaptic vesicle exocytosis,BP,
21116,GO:2000301,1,0.94221381991138,0,4,negative regulation of synaptic vesicle exocytosis,BP,
21117,GO:2000302,1,0.951096177116657,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21118,GO:2000303,1,0.832519165368012,0,13,regulation of ceramide biosynthetic process,BP,
21119,GO:2000304,1,0.888556004227452,0,8,positive regulation of ceramide biosynthetic process,BP,
21120,GO:2000307,1,0.960538129092905,0,3,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21121,GO:2000308,1,0.985282790167759,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21122,GO:2000309,1,0.974887252548456,0,2,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21123,GO:2000310,1,0.788515152920656,0,16,regulation of NMDA receptor activity,BP,
21124,GO:2000311,1,0.756252185315112,0,19,regulation of AMPA receptor activity,BP,
21125,GO:2000312,1,0.953030586800473,0,3,regulation of kainate selective glutamate receptor activity,BP,
21126,GO:2000313,1,0.975695951675391,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21127,GO:2000314,1,0.988339738766748,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21128,GO:2000316,1,0.847986855149762,0,13,regulation of T-helper 17 type immune response,BP,
21129,GO:2000317,1,0.935932840283503,0,6,negative regulation of T-helper 17 type immune response,BP,
21130,GO:2000318,1,0.90605847492185,0,7,positive regulation of T-helper 17 type immune response,BP,
21131,GO:2000319,1,0.873830631326525,0,11,regulation of T-helper 17 cell differentiation,BP,
21132,GO:2000320,1,0.935932840283503,0,6,negative regulation of T-helper 17 cell differentiation,BP,
21133,GO:2000321,1,0.933664366743343,0,5,positive regulation of T-helper 17 cell differentiation,BP,
21135,GO:2000323,1,0.909166914523364,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21136,GO:2000324,1,0.970091546733954,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21137,GO:2000325,1,0.983426667501234,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21138,GO:2000327,1,0.983426667501234,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21139,GO:2000328,1,0.928571898018947,0,6,regulation of T-helper 17 cell lineage commitment,BP,
21140,GO:2000329,1,0.978063946028642,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21141,GO:2000330,1,0.949402489451535,0,4,positive regulation of T-helper 17 cell lineage commitment,BP,
21142,GO:2000331,1,0.967279895877065,0,2,regulation of terminal button organization,BP,
21143,GO:2000332,1,0.9748745378966,0,2,regulation of blood microparticle formation,BP,
21144,GO:2000334,1,0.9748745378966,0,2,positive regulation of blood microparticle formation,BP,
21145,GO:2000338,1,0.971602805250493,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21146,GO:2000340,1,0.971602805250493,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21147,GO:2000341,1,0.904761752568496,0,8,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21148,GO:2000342,1,0.969505203248413,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21149,GO:2000343,1,0.933228404017027,0,6,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21150,GO:2000344,1,0.895177401055094,0,9,positive regulation of acrosome reaction,BP,
21153,GO:2000347,1,0.904741673201575,0,7,positive regulation of hepatocyte proliferation,BP,
21154,GO:2000348,1,0.919447465463215,0,6,regulation of CD40 signaling pathway,BP,
21155,GO:2000349,1,0.970337156538041,0,2,negative regulation of CD40 signaling pathway,BP,
21156,GO:2000350,1,0.992096438783521,0,1,positive regulation of CD40 signaling pathway,BP,
21159,GO:2000353,1,0.833175528653742,0,13,positive regulation of endothelial cell apoptotic process,BP,
21160,GO:2000354,1,0.949016375373779,0,4,regulation of ovarian follicle development,BP,
21161,GO:2000355,1,0.986621363200597,0,1,negative regulation of ovarian follicle development,BP,
21162,GO:2000356,1,0.988827839667624,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21163,GO:2000357,1,0.988827839667624,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21164,GO:2000358,1,0.988827839667624,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21165,GO:2000359,1,0.955296230416169,0,4,regulation of binding of sperm to zona pellucida,BP,
21166,GO:2000360,1,0.955296230416169,0,4,negative regulation of binding of sperm to zona pellucida,BP,
21167,GO:2000361,1,0.983426667503104,0,1,regulation of prostaglandin-E synthase activity,BP,
21168,GO:2000363,1,0.983426667503104,0,1,positive regulation of prostaglandin-E synthase activity,BP,
21169,GO:2000364,1,0.958717390512828,0,3,regulation of STAT protein import into nucleus,BP,
21170,GO:2000366,1,0.958717390512828,0,3,positive regulation of STAT protein import into nucleus,BP,
21171,GO:2000367,1,0.989898441190231,0,1,regulation of acrosomal vesicle exocytosis,BP,
21172,GO:2000368,1,0.989898441190231,0,1,positive regulation of acrosomal vesicle exocytosis,BP,
21174,GO:2000370,1,0.907181746761467,0,6,positive regulation of clathrin-dependent endocytosis,BP,
21175,GO:2000371,1,0.940134114924159,0,4,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21176,GO:2000373,1,0.940134114924159,0,4,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21177,GO:2000374,1,0.982063914648295,0,2,regulation of oxygen metabolic process,BP,
21178,GO:2000376,1,0.995491092903734,0,1,positive regulation of oxygen metabolic process,BP,
21180,GO:2000378,1,0.541050326462984,0,44,negative regulation of reactive oxygen species metabolic process,BP,
21182,GO:2000380,1,0.809684515502713,0,16,regulation of mesoderm development,BP,
21183,GO:2000381,1,0.901541494736563,0,8,negative regulation of mesoderm development,BP,
21184,GO:2000382,1,0.939163145722829,0,5,positive regulation of mesoderm development,BP,
21187,GO:2000386,1,0.989898441190231,0,1,positive regulation of ovarian follicle development,BP,
21188,GO:2000387,1,0.989898441190231,0,1,regulation of antral ovarian follicle growth,BP,
21189,GO:2000388,1,0.989898441190231,0,1,positive regulation of antral ovarian follicle growth,BP,
21190,GO:2000389,1,0.951880493633406,0,3,regulation of neutrophil extravasation,BP,
21191,GO:2000391,1,0.951880493633406,0,3,positive regulation of neutrophil extravasation,BP,
21192,GO:2000392,1,0.879044154893772,0,8,regulation of lamellipodium morphogenesis,BP,
21193,GO:2000393,1,0.983426667502463,0,1,negative regulation of lamellipodium morphogenesis,BP,
21194,GO:2000394,1,0.893865308369644,0,7,positive regulation of lamellipodium morphogenesis,BP,
21195,GO:2000395,1,0.981514858794429,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21196,GO:2000397,1,0.981514858794429,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21198,GO:2000402,1,0.914217710099549,0,7,negative regulation of lymphocyte migration,BP,
21201,GO:2000405,1,0.991564064766655,0,1,negative regulation of T cell migration,BP,
21203,GO:2000407,1,0.959863003973993,0,3,regulation of T cell extravasation,BP,
21204,GO:2000409,1,0.972471879723361,0,2,positive regulation of T cell extravasation,BP,
21205,GO:2000410,1,0.961381459198645,0,3,regulation of thymocyte migration,BP,
21206,GO:2000412,1,0.974817056985373,0,2,positive regulation of thymocyte migration,BP,
21207,GO:2000413,1,0.983697683106668,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21208,GO:2000415,1,0.983697683106668,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21209,GO:2000416,1,0.931289223392696,0,6,regulation of eosinophil migration,BP,
21210,GO:2000417,1,0.970930304910783,0,2,negative regulation of eosinophil migration,BP,
21211,GO:2000418,1,0.959176965742521,0,4,positive regulation of eosinophil migration,BP,
21212,GO:2000419,1,0.983517274358262,0,1,regulation of eosinophil extravasation,BP,
21213,GO:2000420,1,0.983517274358262,0,1,negative regulation of eosinophil extravasation,BP,
21214,GO:2000422,1,0.97782405040208,0,2,regulation of eosinophil chemotaxis,BP,
21215,GO:2000424,1,0.97782405040208,0,2,positive regulation of eosinophil chemotaxis,BP,
21217,GO:2000426,1,0.987833615541307,0,1,negative regulation of apoptotic cell clearance,BP,
21219,GO:2000434,1,0.987529867025843,0,2,regulation of protein neddylation,BP,
21220,GO:2000435,1,0.987529867025843,0,2,negative regulation of protein neddylation,BP,
21221,GO:2000437,1,0.952515144566062,0,3,regulation of monocyte extravasation,BP,
21222,GO:2000438,1,0.983426667500495,0,1,negative regulation of monocyte extravasation,BP,
21223,GO:2000439,1,0.968569676946566,0,2,positive regulation of monocyte extravasation,BP,
21224,GO:2000446,1,0.983426667503199,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21225,GO:2000449,1,0.959863003973993,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21226,GO:2000451,1,0.972471879723361,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21227,GO:2000452,1,0.974587003659478,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21228,GO:2000454,1,0.987388481937439,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21229,GO:2000458,1,0.972805931014343,0,2,regulation of astrocyte chemotaxis,BP,
21231,GO:2000464,1,0.984893663486023,0,1,positive regulation of astrocyte chemotaxis,BP,
21232,GO:2000465,1,0.8817825275487,0,8,regulation of glycogen (starch) synthase activity,BP,
21233,GO:2000466,1,0.953733008288109,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21234,GO:2000467,1,0.926445959050097,0,5,positive regulation of glycogen (starch) synthase activity,BP,
21235,GO:2000468,1,0.967376528871872,0,2,regulation of peroxidase activity,BP,
21236,GO:2000469,1,0.983426667497643,0,1,negative regulation of peroxidase activity,BP,
21237,GO:2000470,1,0.983680494091283,0,1,positive regulation of peroxidase activity,BP,
21238,GO:2000471,1,0.968569672781297,0,2,regulation of hematopoietic stem cell migration,BP,
21239,GO:2000473,1,0.968569672781297,0,2,positive regulation of hematopoietic stem cell migration,BP,
21240,GO:2000474,1,0.968757731749471,0,2,regulation of opioid receptor signaling pathway,BP,
21241,GO:2000477,1,0.983426667503056,0,1,regulation of metanephric glomerular visceral epithelial cell development,BP,
21242,GO:2000478,1,0.983426667503056,0,1,positive regulation of metanephric glomerular visceral epithelial cell development,BP,
21245,GO:2000481,1,0.935331873279862,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21247,GO:2000483,1,0.924182837014593,0,6,negative regulation of interleukin-8 secretion,BP,
21249,GO:2000485,1,0.968758651380629,0,2,regulation of glutamine transport,BP,
21250,GO:2000486,1,0.983511458249465,0,1,negative regulation of glutamine transport,BP,
21251,GO:2000487,1,0.985000887935494,0,1,positive regulation of glutamine transport,BP,
21252,GO:2000489,1,0.908237577313585,0,6,regulation of hepatic stellate cell activation,BP,
21253,GO:2000490,1,0.970573607362443,0,2,negative regulation of hepatic stellate cell activation,BP,
21254,GO:2000491,1,0.93578171747117,0,4,positive regulation of hepatic stellate cell activation,BP,
21255,GO:2000492,1,0.983885143791916,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21256,GO:2000494,1,0.983885143791916,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21257,GO:2000501,1,0.921954490642032,0,9,regulation of natural killer cell chemotaxis,BP,
21258,GO:2000502,1,0.968130084756657,0,3,negative regulation of natural killer cell chemotaxis,BP,
21259,GO:2000503,1,0.952310645720346,0,6,positive regulation of natural killer cell chemotaxis,BP,
21260,GO:2000504,1,0.956316133406554,0,3,positive regulation of blood vessel remodeling,BP,
21262,GO:2000506,1,0.978930974439493,0,2,negative regulation of energy homeostasis,BP,
21263,GO:2000507,1,0.921383493101278,0,6,positive regulation of energy homeostasis,BP,
21266,GO:2000511,1,0.990972814227871,0,1,regulation of granzyme A production,BP,
21267,GO:2000513,1,0.990972814227871,0,1,positive regulation of granzyme A production,BP,
21268,GO:2000514,1,0.547172535651061,0,44,regulation of CD4-positive, alpha-beta T cell activation,BP,
21269,GO:2000515,1,0.783819419301277,0,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21270,GO:2000516,1,0.670197121561404,0,29,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21271,GO:2000517,1,0.990972814227871,0,1,regulation of T-helper 1 cell activation,BP,
21272,GO:2000518,1,0.990972814227871,0,1,negative regulation of T-helper 1 cell activation,BP,
21273,GO:2000520,1,0.961750445169955,0,3,regulation of immunological synapse formation,BP,
21274,GO:2000521,1,0.975403805628822,0,2,negative regulation of immunological synapse formation,BP,
21275,GO:2000522,1,0.986003787696943,0,1,positive regulation of immunological synapse formation,BP,
21276,GO:2000523,1,0.96972005664844,0,2,regulation of T cell costimulation,BP,
21277,GO:2000525,1,0.96972005664844,0,2,positive regulation of T cell costimulation,BP,
21278,GO:2000526,1,0.986003787696943,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21279,GO:2000527,1,0.993323141663568,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21280,GO:2000529,1,0.993323141663568,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21283,GO:2000534,1,0.983426667503056,0,1,positive regulation of renal albumin absorption,BP,
21284,GO:2000535,1,0.923469806372086,0,5,regulation of entry of bacterium into host cell,BP,
21285,GO:2000536,1,0.9834266675003,0,1,negative regulation of entry of bacterium into host cell,BP,
21286,GO:2000537,1,0.974548477984813,0,2,regulation of B cell chemotaxis,BP,
21287,GO:2000538,1,0.974548477984813,0,2,positive regulation of B cell chemotaxis,BP,
21288,GO:2000539,1,0.984882328896951,0,1,regulation of protein geranylgeranylation,BP,
21289,GO:2000541,1,0.984882328896951,0,1,positive regulation of protein geranylgeranylation,BP,
21291,GO:2000543,1,0.91587418779643,0,6,positive regulation of gastrulation,BP,
21292,GO:2000544,1,0.921481971540573,0,7,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21293,GO:2000545,1,0.991096224378579,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21294,GO:2000546,1,0.954034279830057,0,4,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21295,GO:2000547,1,0.974259220888183,0,3,regulation of dendritic cell dendrite assembly,BP,
21296,GO:2000548,1,0.993323141663568,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21297,GO:2000549,1,0.994731246250791,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21298,GO:2000551,1,0.908038479548571,0,8,regulation of T-helper 2 cell cytokine production,BP,
21299,GO:2000552,1,0.985173910098733,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21300,GO:2000553,1,0.921708427670119,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21301,GO:2000554,1,0.990972814227871,0,1,regulation of T-helper 1 cell cytokine production,BP,
21302,GO:2000556,1,0.990972814227871,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21303,GO:2000557,1,0.990972814227871,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21304,GO:2000558,1,0.990972814227871,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21305,GO:2000559,1,0.983426667500495,0,1,regulation of CD24 biosynthetic process,BP,
21306,GO:2000560,1,0.983426667500495,0,1,positive regulation of CD24 biosynthetic process,BP,
21307,GO:2000561,1,0.932095659779139,0,5,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21308,GO:2000562,1,0.963143607016371,0,3,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21309,GO:2000563,1,0.94780084196199,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21310,GO:2000564,1,0.948551374320952,0,4,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21311,GO:2000566,1,0.964501484497085,0,3,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21312,GO:2000567,1,0.969588942320551,0,2,regulation of memory T cell activation,BP,
21313,GO:2000568,1,0.969588942320551,0,2,positive regulation of memory T cell activation,BP,
21314,GO:2000569,1,0.967352726427607,0,2,regulation of T-helper 2 cell activation,BP,
21315,GO:2000570,1,0.967352726427607,0,2,positive regulation of T-helper 2 cell activation,BP,
21316,GO:2000571,1,0.983486079821096,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21317,GO:2000572,1,0.983486079821096,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21319,GO:2000574,1,0.952877391007713,0,3,regulation of microtubule motor activity,BP,
21320,GO:2000583,1,0.967128676123446,0,2,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21321,GO:2000584,1,0.967128676123446,0,2,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21324,GO:2000588,1,0.967126892152019,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21326,GO:2000590,1,0.983426667503056,0,1,negative regulation of metanephric mesenchymal cell migration,BP,
21328,GO:2000592,1,0.967127945407715,0,2,regulation of metanephric DCT cell differentiation,BP,
21329,GO:2000594,1,0.967127945407715,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21330,GO:2000595,1,0.983426667503348,0,1,regulation of optic nerve formation,BP,
21331,GO:2000597,1,0.983426667503348,0,1,positive regulation of optic nerve formation,BP,
21332,GO:2000601,1,0.894700148121145,0,7,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21333,GO:2000606,1,0.98378380978692,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21334,GO:2000607,1,0.98378380978692,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21335,GO:2000609,1,0.932307106259816,0,5,regulation of thyroid hormone generation,BP,
21336,GO:2000611,1,0.954274489525982,0,3,positive regulation of thyroid hormone generation,BP,
21337,GO:2000612,1,0.983427738433103,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21338,GO:2000615,1,0.873387669900546,0,9,regulation of histone H3-K9 acetylation,BP,
21339,GO:2000616,1,0.983426667502466,0,1,negative regulation of histone H3-K9 acetylation,BP,
21340,GO:2000617,1,0.902173534189398,0,7,positive regulation of histone H3-K9 acetylation,BP,
21341,GO:2000618,1,0.926884808710388,0,5,regulation of histone H4-K16 acetylation,BP,
21342,GO:2000619,1,0.958395710407682,0,3,negative regulation of histone H4-K16 acetylation,BP,
21343,GO:2000620,1,0.967126892150666,0,2,positive regulation of histone H4-K16 acetylation,BP,
21344,GO:2000622,1,0.935992835978184,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21345,GO:2000623,1,0.935992835978184,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21346,GO:2000625,1,0.968041085567337,0,2,regulation of miRNA catabolic process,BP,
21347,GO:2000627,1,0.968041085567337,0,2,positive regulation of miRNA catabolic process,BP,
21350,GO:2000631,1,0.983617119365912,0,1,regulation of pre-miRNA processing,BP,
21351,GO:2000632,1,0.983617119365912,0,1,negative regulation of pre-miRNA processing,BP,
21353,GO:2000638,1,0.983434824103805,0,1,regulation of SREBP signaling pathway,BP,
21354,GO:2000639,1,0.983434824103805,0,1,negative regulation of SREBP signaling pathway,BP,
21356,GO:2000642,1,0.984840681380507,0,2,negative regulation of early endosome to late endosome transport,BP,
21358,GO:2000644,1,0.901731190692987,0,7,regulation of receptor catabolic process,BP,
21359,GO:2000645,1,0.955981440243951,0,3,negative regulation of receptor catabolic process,BP,
21360,GO:2000646,1,0.958816921789173,0,3,positive regulation of receptor catabolic process,BP,
21361,GO:2000647,1,0.857398758644994,0,10,negative regulation of stem cell proliferation,BP,
21363,GO:2000649,1,0.531532606845359,0,46,regulation of sodium ion transmembrane transporter activity,BP,
21364,GO:2000650,1,0.856857522622588,0,10,negative regulation of sodium ion transmembrane transporter activity,BP,
21365,GO:2000651,1,0.827285627120539,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21367,GO:2000654,1,0.983428532458556,0,1,regulation of cellular response to testosterone stimulus,BP,
21368,GO:2000655,1,0.983428532458556,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21369,GO:2000656,1,0.987250104775321,0,1,regulation of apolipoprotein binding,BP,
21370,GO:2000657,1,0.987250104775321,0,1,negative regulation of apolipoprotein binding,BP,
21371,GO:2000659,1,0.927015739839211,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
21372,GO:2000660,1,0.955214376826137,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
21373,GO:2000661,1,0.98342666750271,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21374,GO:2000662,1,0.917875485610121,0,6,regulation of interleukin-5 secretion,BP,
21375,GO:2000663,1,0.975099711218978,0,2,negative regulation of interleukin-5 secretion,BP,
21376,GO:2000664,1,0.941320445188531,0,4,positive regulation of interleukin-5 secretion,BP,
21377,GO:2000665,1,0.901374006336661,0,8,regulation of interleukin-13 secretion,BP,
21378,GO:2000666,1,0.975099711218978,0,2,negative regulation of interleukin-13 secretion,BP,
21379,GO:2000667,1,0.924399236993864,0,6,positive regulation of interleukin-13 secretion,BP,
21382,GO:2000670,1,0.956152345632915,0,3,positive regulation of dendritic cell apoptotic process,BP,
21383,GO:2000671,1,0.939421202066759,0,4,regulation of motor neuron apoptotic process,BP,
21384,GO:2000672,1,0.955249133972811,0,3,negative regulation of motor neuron apoptotic process,BP,
21385,GO:2000674,1,0.860343895361293,0,10,regulation of type B pancreatic cell apoptotic process,BP,
21386,GO:2000675,1,0.908014299100729,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21387,GO:2000676,1,0.947520822420961,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
21390,GO:2000679,1,0.723959814977561,0,22,positive regulation of transcription regulatory region DNA binding,BP,
21391,GO:2000680,1,0.928314249887767,0,5,regulation of rubidium ion transport,BP,
21392,GO:2000681,1,0.95125441937285,0,3,negative regulation of rubidium ion transport,BP,
21393,GO:2000682,1,0.983426667499461,0,1,positive regulation of rubidium ion transport,BP,
21394,GO:2000683,1,0.968172065659674,0,2,regulation of cellular response to X-ray,BP,
21395,GO:2000685,1,0.984131985637324,0,1,positive regulation of cellular response to X-ray,BP,
21396,GO:2000686,1,0.93548572899244,0,4,regulation of rubidium ion transmembrane transporter activity,BP,
21397,GO:2000687,1,0.95125441937285,0,3,negative regulation of rubidium ion transmembrane transporter activity,BP,
21398,GO:2000688,1,0.983426667499461,0,1,positive regulation of rubidium ion transmembrane transporter activity,BP,
21399,GO:2000690,1,0.983426667503251,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21400,GO:2000691,1,0.983426667503251,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21402,GO:2000697,1,0.94820530320496,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21404,GO:2000699,1,0.98378380978692,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21405,GO:2000701,1,0.98378380978692,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21406,GO:2000702,1,0.98378380978692,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21407,GO:2000703,1,0.98378380978692,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21409,GO:2000706,1,0.983444445206073,0,1,negative regulation of dense core granule biogenesis,BP,
21411,GO:2000721,1,0.951252205470833,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21412,GO:2000722,1,0.968137486730232,0,2,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21413,GO:2000723,1,0.984454223724117,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21414,GO:2000724,1,0.983426667500497,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21418,GO:2000729,1,0.973427988665006,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21419,GO:2000733,1,0.98378380978692,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21420,GO:2000734,1,0.98378380978692,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21423,GO:2000738,1,0.789630807693082,0,15,positive regulation of stem cell differentiation,BP,
21424,GO:2000739,1,0.904591102576231,0,6,regulation of mesenchymal stem cell differentiation,BP,
21425,GO:2000740,1,0.983444445206073,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21426,GO:2000741,1,0.935330328784999,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21427,GO:2000742,1,0.972114281251258,0,2,regulation of anterior head development,BP,
21428,GO:2000744,1,0.972114281251258,0,2,positive regulation of anterior head development,BP,
21429,GO:2000751,1,0.984203459471406,0,1,histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore,BP,
21430,GO:2000752,1,0.984202501590394,0,1,regulation of glucosylceramide catabolic process,BP,
21431,GO:2000753,1,0.984202501590394,0,1,positive regulation of glucosylceramide catabolic process,BP,
21432,GO:2000754,1,0.984202501590394,0,1,regulation of sphingomyelin catabolic process,BP,
21433,GO:2000755,1,0.984202501590394,0,1,positive regulation of sphingomyelin catabolic process,BP,
21435,GO:2000757,1,0.757697048891172,0,19,negative regulation of peptidyl-lysine acetylation,BP,
21437,GO:2000759,1,0.98342666750276,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21438,GO:2000761,1,0.98342666750276,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21439,GO:2000763,1,0.985305541169944,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21440,GO:2000764,1,0.985305541169944,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21441,GO:2000765,1,0.819890898776832,0,13,regulation of cytoplasmic translation,BP,
21442,GO:2000766,1,0.882339175627451,0,8,negative regulation of cytoplasmic translation,BP,
21443,GO:2000767,1,0.943039400979154,0,4,positive regulation of cytoplasmic translation,BP,
21444,GO:2000768,1,0.955654467567761,0,3,positive regulation of nephron tubule epithelial cell differentiation,BP,
21445,GO:2000769,1,0.990753920282674,0,1,regulation of establishment or maintenance of cell polarity regulating cell shape,BP,
21446,GO:2000771,1,0.990753920282674,0,1,positive regulation of establishment or maintenance of cell polarity regulating cell shape,BP,
21447,GO:2000772,1,0.66292738510083,0,28,regulation of cellular senescence,BP,
21448,GO:2000773,1,0.84245937219035,0,11,negative regulation of cellular senescence,BP,
21449,GO:2000774,1,0.904499743064588,0,8,positive regulation of cellular senescence,BP,
21450,GO:2000775,1,0.986314227490632,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21451,GO:2000777,1,0.972425661520228,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21452,GO:2000778,1,0.778664879577604,0,19,positive regulation of interleukin-6 secretion,BP,
21453,GO:2000779,1,0.552687770828943,0,39,regulation of double-strand break repair,BP,
21454,GO:2000780,1,0.790692089518193,0,15,negative regulation of double-strand break repair,BP,
21455,GO:2000781,1,0.884126377399154,0,8,positive regulation of double-strand break repair,BP,
21456,GO:2000782,1,0.990753920282674,0,1,regulation of establishment of cell polarity regulating cell shape,BP,
21457,GO:2000784,1,0.990753920282674,0,1,positive regulation of establishment of cell polarity regulating cell shape,BP,
21460,GO:2000790,1,0.967128676119382,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21461,GO:2000791,1,0.967128676119382,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21462,GO:2000793,1,0.95585875531178,0,3,cell proliferation involved in heart valve development,BP,
21464,GO:2000795,1,0.98342666749892,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21465,GO:2000797,1,0.983444445206073,0,1,regulation of amniotic stem cell differentiation,BP,
21466,GO:2000798,1,0.983444445206073,0,1,negative regulation of amniotic stem cell differentiation,BP,
21467,GO:2000800,1,0.988350460214267,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21468,GO:2000802,1,0.988350460214267,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21469,GO:2000804,1,0.983426667495718,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21470,GO:2000806,1,0.983426667495718,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21472,GO:2000808,1,0.983426667502019,0,1,negative regulation of synaptic vesicle clustering,BP,
21476,GO:2000812,1,0.974334040077499,0,2,regulation of barbed-end actin filament capping,BP,
21477,GO:2000814,1,0.990753920282674,0,1,positive regulation of barbed-end actin filament capping,BP,
21478,GO:2000816,1,0.644899621990503,0,30,negative regulation of mitotic sister chromatid separation,BP,
21479,GO:2000818,1,0.971968070511829,0,2,negative regulation of myoblast proliferation,BP,
21480,GO:2000819,1,0.968122883597422,0,2,regulation of nucleotide-excision repair,BP,
21482,GO:2000821,1,0.941240516042145,0,4,regulation of grooming behavior,BP,
21483,GO:2000822,1,0.944873361433472,0,5,regulation of behavioral fear response,BP,
21484,GO:2000823,1,0.93112254439914,0,6,regulation of androgen receptor activity,BP,
21485,GO:2000824,1,0.969623639842294,0,2,negative regulation of androgen receptor activity,BP,
21486,GO:2000825,1,0.960297731461169,0,4,positive regulation of androgen receptor activity,BP,
21488,GO:2000827,1,0.984939504141857,0,1,mitochondrial RNA surveillance,BP,
21489,GO:2000828,1,0.97082469386243,0,2,regulation of parathyroid hormone secretion,BP,
21490,GO:2000830,1,0.983426667501871,0,1,positive regulation of parathyroid hormone secretion,BP,
21492,GO:2000832,1,0.967299823011212,0,2,negative regulation of steroid hormone secretion,BP,
21494,GO:2000834,1,0.983594099641158,0,1,regulation of androgen secretion,BP,
21495,GO:2000836,1,0.983594099641158,0,1,positive regulation of androgen secretion,BP,
21496,GO:2000843,1,0.967263819157912,0,2,regulation of testosterone secretion,BP,
21497,GO:2000845,1,0.967263819157912,0,2,positive regulation of testosterone secretion,BP,
21499,GO:2000847,1,0.967299823011212,0,2,negative regulation of corticosteroid hormone secretion,BP,
21501,GO:2000849,1,0.910252570372009,0,8,regulation of glucocorticoid secretion,BP,
21502,GO:2000850,1,0.967299823011212,0,2,negative regulation of glucocorticoid secretion,BP,
21503,GO:2000851,1,0.955636035838402,0,5,positive regulation of glucocorticoid secretion,BP,
21504,GO:2000852,1,0.967198857398788,0,3,regulation of corticosterone secretion,BP,
21505,GO:2000854,1,0.982207118485199,0,2,positive regulation of corticosterone secretion,BP,
21510,GO:2000864,1,0.956271787830959,0,3,regulation of estradiol secretion,BP,
21511,GO:2000866,1,0.972389374687233,0,2,positive regulation of estradiol secretion,BP,
21512,GO:2000870,1,0.982937495801486,0,2,regulation of progesterone secretion,BP,
21513,GO:2000872,1,0.996262031108636,0,1,positive regulation of progesterone secretion,BP,
21514,GO:2000878,1,0.972983734770215,0,2,positive regulation of oligopeptide transport,BP,
21515,GO:2000880,1,0.972983734770215,0,2,positive regulation of dipeptide transport,BP,
21516,GO:2000896,1,0.983693902795086,0,1,amylopectin metabolic process,BP,
21517,GO:2000909,1,0.97700859545829,0,3,regulation of sterol import,BP,
21518,GO:2000910,1,0.992160443567291,0,2,negative regulation of sterol import,BP,
21519,GO:2000969,1,0.935826764481821,0,4,positive regulation of AMPA receptor activity,BP,
21520,GO:2000970,1,0.985152587803752,0,1,regulation of detection of glucose,BP,
21521,GO:2000971,1,0.985152587803752,0,1,negative regulation of detection of glucose,BP,
21524,GO:2000977,1,0.948301198813905,0,4,regulation of forebrain neuron differentiation,BP,
21525,GO:2000978,1,0.980074589657872,0,2,negative regulation of forebrain neuron differentiation,BP,
21526,GO:2000979,1,0.983782100485865,0,1,positive regulation of forebrain neuron differentiation,BP,
21529,GO:2000982,1,0.99202838856208,0,1,positive regulation of inner ear receptor cell differentiation,BP,
21530,GO:2000983,1,0.985758747085669,0,2,regulation of ATP citrate synthase activity,BP,
21531,GO:2000984,1,0.985758747085669,0,2,negative regulation of ATP citrate synthase activity,BP,
21532,GO:2000987,1,0.944873361433472,0,5,positive regulation of behavioral fear response,BP,
21534,GO:2001013,1,0.935901326292602,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21535,GO:2001014,1,0.779630163603342,0,16,regulation of skeletal muscle cell differentiation,BP,
21536,GO:2001015,1,0.928285344533382,0,5,negative regulation of skeletal muscle cell differentiation,BP,
21537,GO:2001016,1,0.925785344098731,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21539,GO:2001021,1,0.450759068359799,0,57,negative regulation of response to DNA damage stimulus,BP,
21541,GO:2001023,1,0.921703441190691,0,5,regulation of response to drug,BP,
21542,GO:2001025,1,0.983426669406348,0,1,positive regulation of response to drug,BP,
21545,GO:2001028,1,0.841657709941619,0,13,positive regulation of endothelial cell chemotaxis,BP,
21546,GO:2001029,1,0.983426667502018,0,1,regulation of cellular glucuronidation,BP,
21547,GO:2001031,1,0.983426667502018,0,1,positive regulation of cellular glucuronidation,BP,
21548,GO:2001032,1,0.896597771705616,0,7,regulation of double-strand break repair via nonhomologous end joining,BP,
21549,GO:2001033,1,0.95488077903169,0,3,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21550,GO:2001034,1,0.954111992093138,0,3,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21551,GO:2001035,1,0.972644834167095,0,2,regulation of tongue muscle cell differentiation,BP,
21552,GO:2001037,1,0.972644834167095,0,2,positive regulation of tongue muscle cell differentiation,BP,
21553,GO:2001038,1,0.967820567748396,0,2,regulation of cellular response to drug,BP,
21555,GO:2001045,1,0.967132287009476,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21557,GO:2001049,1,0.986739001327766,0,1,regulation of tendon cell differentiation,BP,
21558,GO:2001051,1,0.986739001327766,0,1,positive regulation of tendon cell differentiation,BP,
21561,GO:2001055,1,0.973056974467892,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21564,GO:2001065,1,0.982696223166917,0,2,mannan binding,MF,
21565,GO:2001069,1,0.957577011655144,0,3,glycogen binding,MF,
21566,GO:2001070,1,0.968716128407639,0,2,starch binding,MF,
21569,GO:2001106,1,0.967126892150668,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21570,GO:2001108,1,0.983426667501037,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21571,GO:2001109,1,0.97044974940859,0,2,regulation of lens epithelial cell proliferation,BP,
21572,GO:2001111,1,0.97044974940859,0,2,positive regulation of lens epithelial cell proliferation,BP,
21573,GO:2001112,1,0.983426667502658,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21574,GO:2001113,1,0.983426667502658,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21576,GO:2001136,1,0.983548689261493,0,1,negative regulation of endocytic recycling,BP,
21578,GO:2001138,1,0.896507270479244,0,8,regulation of phospholipid transport,BP,
21579,GO:2001140,1,0.896507270479244,0,8,positive regulation of phospholipid transport,BP,
21581,GO:2001142,1,0.984715717525981,0,1,nicotinate transport,BP,
21582,GO:2001144,1,0.985953838967865,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21583,GO:2001145,1,0.985953838967865,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21584,GO:2001148,1,0.972983734770215,0,2,regulation of dipeptide transmembrane transport,BP,
21585,GO:2001150,1,0.972983734770215,0,2,positive regulation of dipeptide transmembrane transport,BP,
21586,GO:2001151,1,0.983636504172295,0,1,regulation of renal water transport,BP,
21587,GO:2001153,1,0.983636504172295,0,1,positive regulation of renal water transport,BP,
21588,GO:2001160,1,0.974714757719413,0,2,regulation of histone H3-K79 methylation,BP,
21589,GO:2001162,1,0.974714757719413,0,2,positive regulation of histone H3-K79 methylation,BP,
21590,GO:2001163,1,0.985616846336288,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21591,GO:2001165,1,0.985616846336288,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21592,GO:2001166,1,0.936796946370739,0,4,regulation of histone H2B ubiquitination,BP,
21593,GO:2001168,1,0.936796946370739,0,4,positive regulation of histone H2B ubiquitination,BP,
21594,GO:2001169,1,0.876799552882256,0,9,regulation of ATP biosynthetic process,BP,
21595,GO:2001170,1,0.952891066100749,0,3,negative regulation of ATP biosynthetic process,BP,
21596,GO:2001171,1,0.905764234043398,0,7,positive regulation of ATP biosynthetic process,BP,
21597,GO:2001176,1,0.970030802455593,0,2,regulation of mediator complex assembly,BP,
21598,GO:2001178,1,0.970030802455593,0,2,positive regulation of mediator complex assembly,BP,
21599,GO:2001179,1,0.914673751714459,0,7,regulation of interleukin-10 secretion,BP,
21600,GO:2001180,1,0.955408877859809,0,3,negative regulation of interleukin-10 secretion,BP,
21601,GO:2001181,1,0.957371576901378,0,4,positive regulation of interleukin-10 secretion,BP,
21602,GO:2001182,1,0.899678644651375,0,7,regulation of interleukin-12 secretion,BP,
21603,GO:2001183,1,0.95538722935761,0,3,negative regulation of interleukin-12 secretion,BP,
21604,GO:2001184,1,0.957537510219925,0,3,positive regulation of interleukin-12 secretion,BP,
21605,GO:2001185,1,0.890973126524596,0,8,regulation of CD8-positive, alpha-beta T cell activation,BP,
21606,GO:2001186,1,0.971217181244142,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21607,GO:2001187,1,0.948514391098595,0,4,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21608,GO:2001188,1,0.939230817701864,0,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21609,GO:2001189,1,0.959864124819331,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21610,GO:2001190,1,0.978507550155953,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21611,GO:2001191,1,0.984070096703214,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21612,GO:2001193,1,0.984070096703214,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21613,GO:2001197,1,0.919824307510286,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21614,GO:2001198,1,0.890558197322426,0,9,regulation of dendritic cell differentiation,BP,
21615,GO:2001199,1,0.940376145184472,0,5,negative regulation of dendritic cell differentiation,BP,
21616,GO:2001200,1,0.946520621643839,0,4,positive regulation of dendritic cell differentiation,BP,
21617,GO:2001201,1,0.951718539011384,0,3,regulation of transforming growth factor-beta secretion,BP,
21618,GO:2001202,1,0.967759700398855,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21619,GO:2001203,1,0.983426667502463,0,1,positive regulation of transforming growth factor-beta secretion,BP,
21622,GO:2001206,1,0.94204852247235,0,4,positive regulation of osteoclast development,BP,
21623,GO:2001207,1,0.983429986042242,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21624,GO:2001208,1,0.983429986042242,0,1,negative regulation of transcription elongation from RNA polymerase I promoter,BP,
21626,GO:2001213,1,0.983426667501771,0,1,negative regulation of vasculogenesis,BP,
21627,GO:2001214,1,0.873444710003828,0,10,positive regulation of vasculogenesis,BP,
21628,GO:2001222,1,0.654809612359741,0,27,regulation of neuron migration,BP,
21629,GO:2001223,1,0.880613932929095,0,8,negative regulation of neuron migration,BP,
21630,GO:2001224,1,0.862652093623733,0,9,positive regulation of neuron migration,BP,
21631,GO:2001225,1,0.884637801306594,0,8,regulation of chloride transport,BP,
21632,GO:2001226,1,0.952053109685209,0,3,negative regulation of chloride transport,BP,
21633,GO:2001228,1,0.983426667493163,0,1,regulation of response to gamma radiation,BP,
21634,GO:2001229,1,0.983426667493163,0,1,negative regulation of response to gamma radiation,BP,
21643,GO:2001241,1,0.825404174935771,0,14,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21647,GO:2001245,1,0.959187394848435,0,3,regulation of phosphatidylcholine biosynthetic process,BP,
21648,GO:2001246,1,0.983426733197828,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21649,GO:2001247,1,0.9834266675032,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21650,GO:2001248,1,0.986081633239475,0,1,regulation of ammonia assimilation cycle,BP,
21651,GO:2001250,1,0.986081633239475,0,1,positive regulation of ammonia assimilation cycle,BP,
21652,GO:2001251,1,0.180794815973369,0,113,negative regulation of chromosome organization,BP,
21654,GO:2001253,1,0.983854828357024,0,1,regulation of histone H3-K36 trimethylation,BP,
21655,GO:2001256,1,0.916807618780863,0,6,regulation of store-operated calcium entry,BP,
21659,GO:2001260,1,0.985305541169944,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21660,GO:2001262,1,0.985305541169944,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21661,GO:2001263,1,0.995344915005438,0,1,regulation of C-C chemokine binding,BP,
21662,GO:2001264,1,0.995344915005438,0,1,negative regulation of C-C chemokine binding,BP,
21663,GO:2001267,1,0.745790102324576,0,22,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21664,GO:2001268,1,0.944432146807071,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21665,GO:2001269,1,0.789714703935191,0,17,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21666,GO:2001270,1,0.947947831087195,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21667,GO:2001271,1,0.954080741326948,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21668,GO:2001272,1,0.993573175263409,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21670,GO:2001274,1,0.953258181899764,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21672,GO:2001279,1,0.92163583093711,0,6,regulation of unsaturated fatty acid biosynthetic process,BP,
21673,GO:2001280,1,0.952680005981092,0,4,positive regulation of unsaturated fatty acid biosynthetic process,BP,
21676,GO:2001288,1,0.973621008570659,0,2,positive regulation of caveolin-mediated endocytosis,BP,
21677,GO:2001293,1,0.953500111198539,0,3,malonyl-CoA metabolic process,BP,
21678,GO:2001294,1,0.985911975806286,0,1,malonyl-CoA catabolic process,BP,
21679,GO:2001295,1,0.96712689214384,0,2,malonyl-CoA biosynthetic process,BP,
21680,GO:2001300,1,0.92902335432083,0,6,lipoxin metabolic process,BP,
21681,GO:2001301,1,0.969950447471883,0,2,lipoxin biosynthetic process,BP,
21682,GO:2001302,1,0.969950447471883,0,2,lipoxin A4 metabolic process,BP,
21683,GO:2001303,1,0.969950447471883,0,2,lipoxin A4 biosynthetic process,BP,
21684,GO:2001304,1,0.98530228173233,0,1,lipoxin B4 metabolic process,BP,
21685,GO:2001306,1,0.98530228173233,0,1,lipoxin B4 biosynthetic process,BP,
21686,GO:2001311,1,0.987568615617131,0,1,lysobisphosphatidic acid metabolic process,BP,
21134,GO:2000322,1,0.881964569904768,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
16226,GO:0070971,1.00000000000004,0.846710471684792,0,11,endoplasmic reticulum exit site,CC,
1612,GO:0003676,1.00000000000028,0,13,3818,nucleic acid binding,MF,POU3F1;NOTCH1;GADD45A;ZFPM1;FOXO4;WNT5A;WT1;HMGN5;MSN;ZCCHC12;LZTS1;VDR;HEY1
